Mitch Report

date generated: 2024-05-09

Background

Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch

Input profiles

Here is the first few lines of the input profile.

The profiling data being passed to mitch

	iageonset	cloz	cognit	igaf	prs
A1BG	-0.0122052	-0.0165798	0.3759379	0.0341813	0.0766533
A1BG-AS1	0.0109188	0.0839094	0.4540171	0.0748189	0.0925632
A1CF	0.0083888	-0.0195474	0.2607092	0.3115766	0.0130198
A2M	-0.0224915	-0.0367321	0.0555301	0.0929506	0.0132791
A2M-AS1	0.0192998	-0.0528997	0.1349163	0.0605632	0.0416329
A2ML1	-0.0845744	0.0317153	0.0306328	0.1000253	-0.0310311

Here are some metrics about the input data profile:

Profiling data metrics

	Profile metrics
num_genes_in_profile	21942
duplicated_genes_present	0
num_profile_genes_in_sets	17453
num_profile_genes_not_in_sets	4489

Here is a plot of the input profiles. Note the dynamic ranges.

Here is the contour plot of the profile including all detected genes.

Input genesets

Here are some metrics about the gene sets used:

GMT file of genesets:

Gene set metrics

	Gene sets metrics
num_genesets	10461
num_genesets_excluded	3186
num_genesets_included	7275

Genes by sector

iageonset	cloz	cognit	igaf	prs	Count
-1	-1	-1	-1	-1	620
1	-1	-1	-1	-1	109
-1	0	-1	-1	-1	1
-1	1	-1	-1	-1	818
1	1	-1	-1	-1	148
-1	-1	1	-1	-1	704
1	-1	1	-1	-1	102
-1	1	1	-1	-1	1646
1	1	1	-1	-1	254
-1	-1	-1	1	-1	491
1	-1	-1	1	-1	133
-1	1	-1	1	-1	495
1	1	-1	1	-1	172
-1	1	0	1	-1	1
-1	-1	1	1	-1	1995
1	-1	1	1	-1	412
-1	1	1	1	-1	3480
0	1	1	1	-1	1
1	1	1	1	-1	773
-1	1	1	-1	0	1
-1	-1	-1	-1	1	508
1	-1	-1	-1	1	99
-1	1	-1	-1	1	569
1	1	-1	-1	1	113
-1	-1	1	-1	1	777
1	-1	1	-1	1	136
-1	1	1	-1	1	1628
1	1	1	-1	1	305
1	-1	1	0	1	1
-1	-1	-1	1	1	292
1	-1	-1	1	1	83
-1	1	-1	1	1	255
1	1	-1	1	1	101
-1	-1	1	1	1	1395
1	-1	1	1	1	397
-1	1	1	1	1	2224
1	1	1	1	1	703

Number of significant gene sets (FDR<0.05)= 920

Gene sets by sector

Gene sets by sector

s.iageonset	s.cloz	s.cognit	s.igaf	s.prs	Count
-1	-1	-1	-1	-1	13
1	-1	-1	-1	-1	30
-1	1	-1	-1	-1	31
1	1	-1	-1	-1	23
-1	-1	1	-1	-1	8
-1	1	1	-1	-1	34
1	1	1	-1	-1	4
-1	-1	-1	1	-1	7
1	-1	-1	1	-1	1
-1	1	-1	1	-1	5
1	1	-1	1	-1	1
-1	-1	1	1	-1	39
1	-1	1	1	-1	6
-1	1	1	1	-1	125
1	1	1	1	-1	7
-1	-1	-1	-1	1	23
1	-1	-1	-1	1	151
-1	1	-1	-1	1	38
1	1	-1	-1	1	155
-1	-1	1	-1	1	5
1	-1	1	-1	1	3
-1	1	1	-1	1	80
1	1	1	-1	1	45
-1	-1	-1	1	1	1
1	-1	-1	1	1	1
-1	1	-1	1	1	2
-1	-1	1	1	1	20
1	-1	1	1	1	6
-1	1	1	1	1	50
1	1	1	1	1	6

Interactive enrichment scatterplot

All sets with FDR<0.05. Try hovering over the points.

Top N sets irrespective of FDR. Try hovering over the points.

A heatmap of S values for top results

A plot of effect size versus significance

Significance is the -log2(p.adjustMANOVA) and effect size is the s.dist which is the hypotenuse of the s scores.

Results table

Top N= 50 gene sets

set	setSize	pMANOVA	p.adjustMANOVA	s.dist	s.iageonset	s.cloz	s.cognit	s.igaf	s.prs	p.iageonset	p.cloz	p.cognit	p.igaf	p.prs
GOBP DISRUPTION OF PLASMA MEMBRANE INTEGRITY IN ANOTHER ORGANISM	6	8.06e-07	3.68e-05	1.390	-0.979000	-0.6330	-0.0482	-0.7320	0.1620	3.24e-05	0.007200	0.838000	1.89e-03	0.491000
GOMF ALKANE 1 MONOOXYGENASE ACTIVITY	5	3.93e-03	4.50e-02	1.260	-0.333000	0.3560	0.8770	0.7100	-0.2640	1.97e-01	0.168000	0.000685	5.97e-03	0.306000
GOMF CCR6 CHEMOKINE RECEPTOR BINDING	5	3.29e-03	3.93e-02	1.240	-0.370000	0.4950	0.7830	0.7360	0.0446	1.52e-01	0.055300	0.002440	4.38e-03	0.863000
GOBP CHORIONIC TROPHOBLAST CELL PROLIFERATION	5	7.44e-04	1.21e-02	1.190	0.552000	-0.4500	0.3080	-0.1440	0.8930	3.24e-02	0.081500	0.234000	5.78e-01	0.000541
GOBP ANTIGEN PROCESSING AND PRESENTATION ENDOGENOUS LIPID ANTIGEN VIA MHC CLASS IB	5	5.26e-03	5.53e-02	1.170	-0.007390	-0.4670	0.6650	0.8430	-0.0927	9.77e-01	0.070600	0.010000	1.09e-03	0.720000
GOMF LIPID ANTIGEN BINDING	5	5.26e-03	5.53e-02	1.170	-0.007390	-0.4670	0.6650	0.8430	-0.0927	9.77e-01	0.070600	0.010000	1.09e-03	0.720000
GOBP LOBAR BRONCHUS EPITHELIUM DEVELOPMENT	5	2.89e-03	3.57e-02	1.170	0.019100	0.7280	0.3650	0.6330	-0.5600	9.41e-01	0.004810	0.158000	1.43e-02	0.030000
GOMF PIRNA BINDING	5	3.70e-03	4.30e-02	1.170	-0.724000	0.2480	0.8270	0.2980	-0.0732	5.06e-03	0.337000	0.001350	2.49e-01	0.777000
GOMF IMMUNOGLOBULIN RECEPTOR ACTIVITY	6	1.42e-03	2.05e-02	1.140	0.194000	0.8070	0.7200	0.2930	-0.0493	4.12e-01	0.000617	0.002260	2.14e-01	0.834000
GOBP PROTECTION FROM NATURAL KILLER CELL MEDIATED CYTOTOXICITY	6	2.70e-06	1.04e-04	1.120	0.197000	-0.8760	0.5540	-0.3850	0.0499	4.03e-01	0.000204	0.018700	1.02e-01	0.832000
GOBP MICROGLIAL CELL MEDIATED CYTOTOXICITY	5	5.16e-03	5.48e-02	1.120	-0.314000	0.6030	0.7220	0.1270	0.5010	2.24e-01	0.019600	0.005150	6.24e-01	0.052200
GOBP PROXIMAL DISTAL PATTERN FORMATION INVOLVED IN NEPHRON DEVELOPMENT	5	3.38e-03	4.01e-02	1.110	-0.021900	0.2040	0.0876	-0.8420	0.6820	9.32e-01	0.429000	0.734000	1.12e-03	0.008260
GOMF PEPTIDOGLYCAN IMMUNE RECEPTOR ACTIVITY	5	2.39e-03	3.09e-02	1.090	-0.516000	0.3080	-0.0816	-0.4400	-0.7890	4.59e-02	0.233000	0.752000	8.86e-02	0.002240
GOMF KETOSTEROID MONOOXYGENASE ACTIVITY	5	1.45e-02	1.14e-01	1.080	-0.293000	-0.3940	0.3420	0.8270	-0.3530	2.57e-01	0.127000	0.185000	1.36e-03	0.172000
GOBP POSITIVE REGULATION OF PYROPTOSIS	5	9.65e-03	8.54e-02	1.080	0.077000	-0.8070	-0.4110	-0.3990	0.4210	7.65e-01	0.001780	0.112000	1.22e-01	0.103000
GOMF HEMOGLOBIN ALPHA BINDING	5	2.08e-02	1.45e-01	1.070	-0.221000	-0.0391	0.5730	0.8780	-0.0503	3.92e-01	0.880000	0.026500	6.75e-04	0.846000
GOBP LOBAR BRONCHUS DEVELOPMENT	6	4.07e-03	4.63e-02	1.060	-0.012000	0.7070	0.4120	0.4250	-0.5130	9.59e-01	0.002690	0.080800	7.12e-02	0.029500
GOBP REGULATION OF CORTICOTROPIN SECRETION	5	1.66e-03	2.34e-02	1.060	0.915000	0.2600	0.3750	-0.2450	-0.0952	3.97e-04	0.313000	0.147000	3.43e-01	0.712000
GOMF PHOSPHOLIPASE A2 INHIBITOR ACTIVITY	6	6.78e-04	1.13e-02	1.050	0.530000	0.5850	-0.3660	0.1670	-0.5570	2.46e-02	0.013100	0.120000	4.78e-01	0.018100
GOMF FATTY ACYL COA SYNTHASE ACTIVITY	6	1.51e-03	2.16e-02	1.050	0.345000	0.8490	0.1330	0.3790	-0.3060	1.44e-01	0.000318	0.573000	1.08e-01	0.195000
GOBP FOREBRAIN NEURON FATE COMMITMENT	7	9.36e-04	1.47e-02	1.030	0.414000	0.1980	0.0219	-0.7340	0.5600	5.78e-02	0.363000	0.920000	7.71e-04	0.010300
GOBP STEM CELL FATE SPECIFICATION	6	4.21e-04	7.83e-03	1.030	-0.010600	0.4980	0.2460	-0.8610	0.0459	9.64e-01	0.034500	0.296000	2.58e-04	0.846000
GOBP REGULATION OF APOPTOTIC PROCESS IN BONE MARROW CELL	5	1.32e-02	1.07e-01	1.020	0.065000	-0.2390	0.7330	0.3600	0.5650	8.01e-01	0.355000	0.004510	1.64e-01	0.028500
GOBP REGULATION OF ACTIVATION OF JANUS KINASE ACTIVITY	7	2.70e-03	3.39e-02	1.020	-0.609000	0.2000	0.7200	0.3110	-0.1300	5.28e-03	0.360000	0.000967	1.54e-01	0.552000
GOBP FLAVONE METABOLIC PROCESS	6	8.75e-03	8.00e-02	1.020	0.237000	0.3190	0.4060	0.7030	-0.4710	3.16e-01	0.177000	0.085300	2.88e-03	0.045500
GOBP XENOBIOTIC GLUCURONIDATION	6	1.40e-02	1.12e-01	1.020	-0.082000	0.2910	0.5310	0.7910	-0.1870	7.28e-01	0.216000	0.024300	7.88e-04	0.428000
GOCC B CELL RECEPTOR COMPLEX	5	1.25e-02	1.03e-01	1.020	-0.222000	0.4460	0.6280	-0.0647	0.6200	3.90e-01	0.083800	0.015000	8.02e-01	0.016300
GOBP SPERMIDINE TRANSPORT	5	7.17e-03	6.91e-02	1.010	0.597000	-0.3930	-0.0300	0.3850	0.6000	2.08e-02	0.128000	0.908000	1.35e-01	0.020100
GOBP COMPARTMENT PATTERN SPECIFICATION	5	9.20e-03	8.25e-02	1.000	0.628000	0.5610	0.4650	-0.2110	0.1980	1.50e-02	0.029800	0.071900	4.14e-01	0.444000
GOCC ALPHA BETA T CELL RECEPTOR COMPLEX	5	4.52e-03	5.02e-02	1.000	0.371000	-0.4270	0.6310	-0.0210	0.5360	1.51e-01	0.098300	0.014600	9.35e-01	0.038000
GOBP DETOXIFICATION OF NITROGEN COMPOUND	5	3.89e-03	4.48e-02	0.995	-0.229000	-0.0877	0.7550	-0.2460	0.5480	3.76e-01	0.734000	0.003470	3.41e-01	0.033700
GOBP FLAVONOID GLUCURONIDATION	5	4.37e-02	2.32e-01	0.988	0.093100	0.1540	0.4400	0.7630	-0.4090	7.18e-01	0.550000	0.088400	3.15e-03	0.113000
GOMF ALCOHOL DEHYDROGENASE ACTIVITY ZINC DEPENDENT	7	2.92e-03	3.59e-02	0.985	0.000202	-0.3680	0.0602	0.7000	-0.5840	9.99e-01	0.091700	0.783000	1.35e-03	0.007460
GOBP PLATELET DEGRANULATION	7	3.78e-03	4.37e-02	0.984	-0.157000	0.5400	0.5400	0.5310	0.2820	4.73e-01	0.013300	0.013300	1.50e-02	0.196000
GOBP APOPTOTIC PROCESS IN BONE MARROW CELL	6	6.16e-03	6.21e-02	0.980	0.090900	-0.2080	0.7320	0.2720	0.5460	7.00e-01	0.378000	0.001910	2.48e-01	0.020500
GOCC FC RECEPTOR COMPLEX	5	1.77e-02	1.31e-01	0.975	-0.182000	0.4720	0.4260	-0.2310	0.6790	4.81e-01	0.067400	0.099100	3.70e-01	0.008580
GOCC CLATHRIN COMPLEX	6	4.18e-03	4.71e-02	0.975	-0.209000	0.7060	-0.1030	-0.0267	-0.6300	3.75e-01	0.002750	0.663000	9.10e-01	0.007520
GOBP ADENYLATE CYCLASE INHIBITING SEROTONIN RECEPTOR SIGNALING PATHWAY	7	6.66e-04	1.11e-02	0.974	0.318000	0.1660	0.6440	-0.2600	0.5800	1.45e-01	0.446000	0.003160	2.33e-01	0.007890
GOBP CELLULAR RESPONSE TO TEMPERATURE STIMULUS	5	1.78e-02	1.31e-01	0.965	0.560000	0.4760	0.4260	-0.2420	0.3880	3.00e-02	0.065200	0.099300	3.48e-01	0.133000
GOBP POSITIVE REGULATION OF GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION	5	1.70e-03	2.37e-02	0.950	0.431000	0.2560	0.2620	-0.6180	-0.4470	9.51e-02	0.321000	0.310000	1.66e-02	0.083600
GOBP NEGATIVE REGULATION OF NEUTROPHIL ACTIVATION	5	1.38e-02	1.10e-01	0.944	-0.682000	-0.2980	0.5800	-0.0101	0.0357	8.29e-03	0.248000	0.024600	9.69e-01	0.890000
GOMF METAL ION SENSOR ACTIVITY	5	5.82e-02	2.82e-01	0.943	0.070300	0.1930	0.4710	0.5520	-0.5660	7.85e-01	0.455000	0.068000	3.25e-02	0.028300
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL MATRIX ADHESION VIA FIBRONECTIN	5	1.09e-02	9.31e-02	0.943	-0.458000	-0.3490	-0.6260	0.2690	-0.3060	7.62e-02	0.177000	0.015300	2.98e-01	0.236000
GOBP RRNA PSEUDOURIDINE SYNTHESIS	7	1.17e-02	9.79e-02	0.942	-0.050600	-0.4840	-0.5070	-0.5160	0.3560	8.17e-01	0.026500	0.020300	1.80e-02	0.103000
GOMF IGE BINDING	5	3.30e-02	1.94e-01	0.941	-0.144000	0.8430	0.3720	0.0854	-0.0978	5.78e-01	0.001100	0.149000	7.41e-01	0.705000
GOMF ANKYRIN REPEAT BINDING	6	3.26e-02	1.93e-01	0.941	-0.018800	-0.2960	-0.4840	-0.6950	0.2810	9.36e-01	0.210000	0.040100	3.18e-03	0.233000
GOBP REGULATION OF NATURAL KILLER CELL CHEMOTAXIS	7	4.72e-04	8.48e-03	0.939	-0.166000	-0.3810	-0.0395	0.7950	0.2760	4.47e-01	0.080600	0.856000	2.72e-04	0.207000
GOBP NITRIC OXIDE TRANSPORT	5	1.88e-02	1.35e-01	0.936	0.048100	0.3950	0.2880	0.7610	0.2370	8.52e-01	0.126000	0.264000	3.21e-03	0.359000
GOBP MITOCHONDRIAL RESPIRASOME ASSEMBLY	10	5.64e-04	9.73e-03	0.935	0.245000	-0.3020	-0.4280	-0.7330	0.0489	1.79e-01	0.098400	0.019000	5.91e-05	0.789000
GOMF CXCR3 CHEMOKINE RECEPTOR BINDING	5	3.14e-02	1.89e-01	0.933	-0.601000	-0.6580	-0.0173	0.1530	-0.2310	1.98e-02	0.010900	0.947000	5.55e-01	0.371000

---

Results (complete table)

Click HERE to show results for all gene sets

Complete results

set	setSize	pMANOVA	p.adjustMANOVA	s.dist	s.iageonset	s.cloz	s.cognit	s.igaf	s.prs	p.iageonset	p.cloz	p.cognit	p.igaf	p.prs
GOBP DISRUPTION OF PLASMA MEMBRANE INTEGRITY IN ANOTHER ORGANISM	6	8.06e-07	3.68e-05	1.3900	-9.79e-01	-6.33e-01	-4.82e-02	-7.32e-01	1.62e-01	3.24e-05	7.20e-03	8.38e-01	1.89e-03	4.91e-01
GOMF ALKANE 1 MONOOXYGENASE ACTIVITY	5	3.93e-03	4.50e-02	1.2600	-3.33e-01	3.56e-01	8.77e-01	7.10e-01	-2.64e-01	1.97e-01	1.68e-01	6.85e-04	5.97e-03	3.06e-01
GOMF CCR6 CHEMOKINE RECEPTOR BINDING	5	3.29e-03	3.93e-02	1.2400	-3.70e-01	4.95e-01	7.83e-01	7.36e-01	4.46e-02	1.52e-01	5.53e-02	2.44e-03	4.38e-03	8.63e-01
GOBP CHORIONIC TROPHOBLAST CELL PROLIFERATION	5	7.44e-04	1.21e-02	1.1900	5.52e-01	-4.50e-01	3.08e-01	-1.44e-01	8.93e-01	3.24e-02	8.15e-02	2.34e-01	5.78e-01	5.41e-04
GOBP ANTIGEN PROCESSING AND PRESENTATION ENDOGENOUS LIPID ANTIGEN VIA MHC CLASS IB	5	5.26e-03	5.53e-02	1.1700	-7.39e-03	-4.67e-01	6.65e-01	8.43e-01	-9.27e-02	9.77e-01	7.06e-02	1.00e-02	1.09e-03	7.20e-01
GOMF LIPID ANTIGEN BINDING	5	5.26e-03	5.53e-02	1.1700	-7.39e-03	-4.67e-01	6.65e-01	8.43e-01	-9.27e-02	9.77e-01	7.06e-02	1.00e-02	1.09e-03	7.20e-01
GOBP LOBAR BRONCHUS EPITHELIUM DEVELOPMENT	5	2.89e-03	3.57e-02	1.1700	1.91e-02	7.28e-01	3.65e-01	6.33e-01	-5.60e-01	9.41e-01	4.81e-03	1.58e-01	1.43e-02	3.00e-02
GOMF PIRNA BINDING	5	3.70e-03	4.30e-02	1.1700	-7.24e-01	2.48e-01	8.27e-01	2.98e-01	-7.32e-02	5.06e-03	3.37e-01	1.35e-03	2.49e-01	7.77e-01
GOMF IMMUNOGLOBULIN RECEPTOR ACTIVITY	6	1.42e-03	2.05e-02	1.1400	1.94e-01	8.07e-01	7.20e-01	2.93e-01	-4.93e-02	4.12e-01	6.17e-04	2.26e-03	2.14e-01	8.34e-01
GOBP PROTECTION FROM NATURAL KILLER CELL MEDIATED CYTOTOXICITY	6	2.70e-06	1.04e-04	1.1200	1.97e-01	-8.76e-01	5.54e-01	-3.85e-01	4.99e-02	4.03e-01	2.04e-04	1.87e-02	1.02e-01	8.32e-01
GOBP MICROGLIAL CELL MEDIATED CYTOTOXICITY	5	5.16e-03	5.48e-02	1.1200	-3.14e-01	6.03e-01	7.22e-01	1.27e-01	5.01e-01	2.24e-01	1.96e-02	5.15e-03	6.24e-01	5.22e-02
GOBP PROXIMAL DISTAL PATTERN FORMATION INVOLVED IN NEPHRON DEVELOPMENT	5	3.38e-03	4.01e-02	1.1100	-2.19e-02	2.04e-01	8.76e-02	-8.42e-01	6.82e-01	9.32e-01	4.29e-01	7.34e-01	1.12e-03	8.26e-03
GOMF PEPTIDOGLYCAN IMMUNE RECEPTOR ACTIVITY	5	2.39e-03	3.09e-02	1.0900	-5.16e-01	3.08e-01	-8.16e-02	-4.40e-01	-7.89e-01	4.59e-02	2.33e-01	7.52e-01	8.86e-02	2.24e-03
GOMF KETOSTEROID MONOOXYGENASE ACTIVITY	5	1.45e-02	1.14e-01	1.0800	-2.93e-01	-3.94e-01	3.42e-01	8.27e-01	-3.53e-01	2.57e-01	1.27e-01	1.85e-01	1.36e-03	1.72e-01
GOBP POSITIVE REGULATION OF PYROPTOSIS	5	9.65e-03	8.54e-02	1.0800	7.70e-02	-8.07e-01	-4.11e-01	-3.99e-01	4.21e-01	7.65e-01	1.78e-03	1.12e-01	1.22e-01	1.03e-01
GOMF HEMOGLOBIN ALPHA BINDING	5	2.08e-02	1.45e-01	1.0700	-2.21e-01	-3.91e-02	5.73e-01	8.78e-01	-5.03e-02	3.92e-01	8.80e-01	2.65e-02	6.75e-04	8.46e-01
GOBP LOBAR BRONCHUS DEVELOPMENT	6	4.07e-03	4.63e-02	1.0600	-1.20e-02	7.07e-01	4.12e-01	4.25e-01	-5.13e-01	9.59e-01	2.69e-03	8.08e-02	7.12e-02	2.95e-02
GOBP REGULATION OF CORTICOTROPIN SECRETION	5	1.66e-03	2.34e-02	1.0600	9.15e-01	2.60e-01	3.75e-01	-2.45e-01	-9.52e-02	3.97e-04	3.13e-01	1.47e-01	3.43e-01	7.12e-01
GOMF PHOSPHOLIPASE A2 INHIBITOR ACTIVITY	6	6.78e-04	1.13e-02	1.0500	5.30e-01	5.85e-01	-3.66e-01	1.67e-01	-5.57e-01	2.46e-02	1.31e-02	1.20e-01	4.78e-01	1.81e-02
GOMF FATTY ACYL COA SYNTHASE ACTIVITY	6	1.51e-03	2.16e-02	1.0500	3.45e-01	8.49e-01	1.33e-01	3.79e-01	-3.06e-01	1.44e-01	3.18e-04	5.73e-01	1.08e-01	1.95e-01
GOBP FOREBRAIN NEURON FATE COMMITMENT	7	9.36e-04	1.47e-02	1.0300	4.14e-01	1.98e-01	2.19e-02	-7.34e-01	5.60e-01	5.78e-02	3.63e-01	9.20e-01	7.71e-04	1.03e-02
GOBP STEM CELL FATE SPECIFICATION	6	4.21e-04	7.83e-03	1.0300	-1.06e-02	4.98e-01	2.46e-01	-8.61e-01	4.59e-02	9.64e-01	3.45e-02	2.96e-01	2.58e-04	8.46e-01
GOBP REGULATION OF APOPTOTIC PROCESS IN BONE MARROW CELL	5	1.32e-02	1.07e-01	1.0200	6.50e-02	-2.39e-01	7.33e-01	3.60e-01	5.65e-01	8.01e-01	3.55e-01	4.51e-03	1.64e-01	2.85e-02
GOBP REGULATION OF ACTIVATION OF JANUS KINASE ACTIVITY	7	2.70e-03	3.39e-02	1.0200	-6.09e-01	2.00e-01	7.20e-01	3.11e-01	-1.30e-01	5.28e-03	3.60e-01	9.67e-04	1.54e-01	5.52e-01
GOBP FLAVONE METABOLIC PROCESS	6	8.75e-03	8.00e-02	1.0200	2.37e-01	3.19e-01	4.06e-01	7.03e-01	-4.71e-01	3.16e-01	1.77e-01	8.53e-02	2.88e-03	4.55e-02
GOBP XENOBIOTIC GLUCURONIDATION	6	1.40e-02	1.12e-01	1.0200	-8.20e-02	2.91e-01	5.31e-01	7.91e-01	-1.87e-01	7.28e-01	2.16e-01	2.43e-02	7.88e-04	4.28e-01
GOCC B CELL RECEPTOR COMPLEX	5	1.25e-02	1.03e-01	1.0200	-2.22e-01	4.46e-01	6.28e-01	-6.47e-02	6.20e-01	3.90e-01	8.38e-02	1.50e-02	8.02e-01	1.63e-02
GOBP SPERMIDINE TRANSPORT	5	7.17e-03	6.91e-02	1.0100	5.97e-01	-3.93e-01	-3.00e-02	3.85e-01	6.00e-01	2.08e-02	1.28e-01	9.08e-01	1.35e-01	2.01e-02
GOBP COMPARTMENT PATTERN SPECIFICATION	5	9.20e-03	8.25e-02	1.0000	6.28e-01	5.61e-01	4.65e-01	-2.11e-01	1.98e-01	1.50e-02	2.98e-02	7.19e-02	4.14e-01	4.44e-01
GOCC ALPHA BETA T CELL RECEPTOR COMPLEX	5	4.52e-03	5.02e-02	1.0000	3.71e-01	-4.27e-01	6.31e-01	-2.10e-02	5.36e-01	1.51e-01	9.83e-02	1.46e-02	9.35e-01	3.80e-02
GOBP DETOXIFICATION OF NITROGEN COMPOUND	5	3.89e-03	4.48e-02	0.9950	-2.29e-01	-8.77e-02	7.55e-01	-2.46e-01	5.48e-01	3.76e-01	7.34e-01	3.47e-03	3.41e-01	3.37e-02
GOBP FLAVONOID GLUCURONIDATION	5	4.37e-02	2.32e-01	0.9880	9.31e-02	1.54e-01	4.40e-01	7.63e-01	-4.09e-01	7.18e-01	5.50e-01	8.84e-02	3.15e-03	1.13e-01
GOMF ALCOHOL DEHYDROGENASE ACTIVITY ZINC DEPENDENT	7	2.92e-03	3.59e-02	0.9850	2.02e-04	-3.68e-01	6.02e-02	7.00e-01	-5.84e-01	9.99e-01	9.17e-02	7.83e-01	1.35e-03	7.46e-03
GOBP PLATELET DEGRANULATION	7	3.78e-03	4.37e-02	0.9840	-1.57e-01	5.40e-01	5.40e-01	5.31e-01	2.82e-01	4.73e-01	1.33e-02	1.33e-02	1.50e-02	1.96e-01
GOBP APOPTOTIC PROCESS IN BONE MARROW CELL	6	6.16e-03	6.21e-02	0.9800	9.09e-02	-2.08e-01	7.32e-01	2.72e-01	5.46e-01	7.00e-01	3.78e-01	1.91e-03	2.48e-01	2.05e-02
GOCC FC RECEPTOR COMPLEX	5	1.77e-02	1.31e-01	0.9750	-1.82e-01	4.72e-01	4.26e-01	-2.31e-01	6.79e-01	4.81e-01	6.74e-02	9.91e-02	3.70e-01	8.58e-03
GOCC CLATHRIN COMPLEX	6	4.18e-03	4.71e-02	0.9750	-2.09e-01	7.06e-01	-1.03e-01	-2.67e-02	-6.30e-01	3.75e-01	2.75e-03	6.63e-01	9.10e-01	7.52e-03
GOBP ADENYLATE CYCLASE INHIBITING SEROTONIN RECEPTOR SIGNALING PATHWAY	7	6.66e-04	1.11e-02	0.9740	3.18e-01	1.66e-01	6.44e-01	-2.60e-01	5.80e-01	1.45e-01	4.46e-01	3.16e-03	2.33e-01	7.89e-03
GOBP CELLULAR RESPONSE TO TEMPERATURE STIMULUS	5	1.78e-02	1.31e-01	0.9650	5.60e-01	4.76e-01	4.26e-01	-2.42e-01	3.88e-01	3.00e-02	6.52e-02	9.93e-02	3.48e-01	1.33e-01
GOBP POSITIVE REGULATION OF GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION	5	1.70e-03	2.37e-02	0.9500	4.31e-01	2.56e-01	2.62e-01	-6.18e-01	-4.47e-01	9.51e-02	3.21e-01	3.10e-01	1.66e-02	8.36e-02
GOBP NEGATIVE REGULATION OF NEUTROPHIL ACTIVATION	5	1.38e-02	1.10e-01	0.9440	-6.82e-01	-2.98e-01	5.80e-01	-1.01e-02	3.57e-02	8.29e-03	2.48e-01	2.46e-02	9.69e-01	8.90e-01
GOMF METAL ION SENSOR ACTIVITY	5	5.82e-02	2.82e-01	0.9430	7.03e-02	1.93e-01	4.71e-01	5.52e-01	-5.66e-01	7.85e-01	4.55e-01	6.80e-02	3.25e-02	2.83e-02
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL MATRIX ADHESION VIA FIBRONECTIN	5	1.09e-02	9.31e-02	0.9430	-4.58e-01	-3.49e-01	-6.26e-01	2.69e-01	-3.06e-01	7.62e-02	1.77e-01	1.53e-02	2.98e-01	2.36e-01
GOBP RRNA PSEUDOURIDINE SYNTHESIS	7	1.17e-02	9.79e-02	0.9420	-5.06e-02	-4.84e-01	-5.07e-01	-5.16e-01	3.56e-01	8.17e-01	2.65e-02	2.03e-02	1.80e-02	1.03e-01
GOMF IGE BINDING	5	3.30e-02	1.94e-01	0.9410	-1.44e-01	8.43e-01	3.72e-01	8.54e-02	-9.78e-02	5.78e-01	1.10e-03	1.49e-01	7.41e-01	7.05e-01
GOMF ANKYRIN REPEAT BINDING	6	3.26e-02	1.93e-01	0.9410	-1.88e-02	-2.96e-01	-4.84e-01	-6.95e-01	2.81e-01	9.36e-01	2.10e-01	4.01e-02	3.18e-03	2.33e-01
GOBP REGULATION OF NATURAL KILLER CELL CHEMOTAXIS	7	4.72e-04	8.48e-03	0.9390	-1.66e-01	-3.81e-01	-3.95e-02	7.95e-01	2.76e-01	4.47e-01	8.06e-02	8.56e-01	2.72e-04	2.07e-01
GOBP NITRIC OXIDE TRANSPORT	5	1.88e-02	1.35e-01	0.9360	4.81e-02	3.95e-01	2.88e-01	7.61e-01	2.37e-01	8.52e-01	1.26e-01	2.64e-01	3.21e-03	3.59e-01
GOBP MITOCHONDRIAL RESPIRASOME ASSEMBLY	10	5.64e-04	9.73e-03	0.9350	2.45e-01	-3.02e-01	-4.28e-01	-7.33e-01	4.89e-02	1.79e-01	9.84e-02	1.90e-02	5.91e-05	7.89e-01
GOMF CXCR3 CHEMOKINE RECEPTOR BINDING	5	3.14e-02	1.89e-01	0.9330	-6.01e-01	-6.58e-01	-1.73e-02	1.53e-01	-2.31e-01	1.98e-02	1.09e-02	9.47e-01	5.55e-01	3.71e-01
GOMF HEMOGLOBIN BINDING	9	4.30e-03	4.83e-02	0.9290	-3.30e-01	1.35e-01	5.38e-01	6.35e-01	-2.07e-01	8.61e-02	4.83e-01	5.20e-03	9.77e-04	2.83e-01
GOBP CELLULAR GLUCURONIDATION	18	1.53e-06	6.51e-05	0.9230	1.43e-01	7.79e-02	5.49e-01	7.20e-01	-7.66e-02	2.93e-01	5.67e-01	5.55e-05	1.21e-07	5.73e-01
GOBP POSITIVE REGULATION OF MEMORY T CELL DIFFERENTIATION	9	2.87e-04	5.67e-03	0.9210	-3.37e-01	6.41e-01	2.92e-01	3.80e-01	3.07e-01	8.03e-02	8.62e-04	1.29e-01	4.84e-02	1.11e-01
GOCC EGG COAT	5	7.70e-02	3.33e-01	0.9200	-4.77e-01	-7.90e-02	4.28e-01	6.33e-01	-1.69e-01	6.46e-02	7.60e-01	9.77e-02	1.42e-02	5.12e-01
GOBP PROTEIN LIPOYLATION	5	2.59e-02	1.65e-01	0.9080	5.26e-01	-4.32e-01	-1.20e-01	-5.59e-01	1.86e-01	4.17e-02	9.44e-02	6.43e-01	3.05e-02	4.72e-01
GOBP PREVENTION OF POLYSPERMY	7	7.81e-03	7.35e-02	0.9060	-7.06e-01	7.17e-02	1.48e-01	4.55e-01	-2.99e-01	1.22e-03	7.43e-01	4.99e-01	3.69e-02	1.71e-01
GOMF ESTROGEN 2 HYDROXYLASE ACTIVITY	5	1.69e-02	1.27e-01	0.9020	4.23e-01	-2.96e-01	-4.69e-01	4.64e-01	-3.34e-01	1.01e-01	2.52e-01	6.92e-02	7.23e-02	1.96e-01
GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS	5	5.24e-02	2.63e-01	0.9020	5.58e-02	2.55e-01	5.06e-01	2.93e-01	6.35e-01	8.29e-01	3.24e-01	5.03e-02	2.56e-01	1.39e-02
GOBP GLOMERULAR MESANGIAL CELL DEVELOPMENT	5	1.77e-02	1.31e-01	0.9010	6.02e-01	3.30e-01	-3.92e-01	8.62e-02	4.25e-01	1.98e-02	2.01e-01	1.29e-01	7.38e-01	9.98e-02
GOCC TRANSLOCON COMPLEX	5	7.52e-02	3.29e-01	0.9000	5.27e-01	-2.46e-01	-3.88e-01	-5.43e-01	1.65e-01	4.12e-02	3.42e-01	1.33e-01	3.54e-02	5.23e-01
GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 2B COMPLEX	5	9.83e-02	3.79e-01	0.9000	1.91e-01	-2.15e-01	-7.26e-01	-4.19e-01	1.58e-01	4.59e-01	4.06e-01	4.93e-03	1.04e-01	5.41e-01
GOMF ANDROSTAN 3 ALPHA 17 BETA DIOL DEHYDROGENASE ACTIVITY	8	5.33e-03	5.56e-02	0.8970	-5.02e-01	-3.78e-01	2.29e-01	5.71e-01	-1.78e-01	1.39e-02	6.41e-02	2.62e-01	5.13e-03	3.84e-01
GOBP LONG CHAIN FATTY ACID CATABOLIC PROCESS	8	6.69e-03	6.58e-02	0.8940	-2.09e-01	5.78e-01	5.26e-01	3.39e-01	1.75e-01	3.05e-01	4.66e-03	1.00e-02	9.67e-02	3.92e-01
GOBP NEGATIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE	5	5.69e-02	2.77e-01	0.8940	-1.06e-02	5.43e-01	3.88e-01	2.27e-01	-5.49e-01	9.67e-01	3.54e-02	1.33e-01	3.80e-01	3.35e-02
GOBP SYMPATHETIC NEURON PROJECTION EXTENSION	5	1.03e-01	3.89e-01	0.8930	-1.73e-01	2.22e-01	4.01e-01	5.84e-01	-4.65e-01	5.03e-01	3.90e-01	1.21e-01	2.37e-02	7.19e-02
GOMF N N DIMETHYLANILINE MONOOXYGENASE ACTIVITY	5	1.31e-02	1.06e-01	0.8870	-6.32e-01	-1.99e-01	-6.44e-02	3.99e-01	4.29e-01	1.44e-02	4.42e-01	8.03e-01	1.22e-01	9.67e-02
GOBP MULTI PASS TRANSMEMBRANE PROTEIN INSERTION INTO ER MEMBRANE	7	2.09e-02	1.45e-01	0.8850	-3.06e-02	-1.02e-01	-4.57e-01	-4.97e-01	5.62e-01	8.89e-01	6.41e-01	3.61e-02	2.29e-02	1.00e-02
GOCC MULTI PASS TRANSLOCON COMPLEX	7	2.09e-02	1.45e-01	0.8850	-3.06e-02	-1.02e-01	-4.57e-01	-4.97e-01	5.62e-01	8.89e-01	6.41e-01	3.61e-02	2.29e-02	1.00e-02
GOCC MHC CLASS I PROTEIN COMPLEX	10	7.86e-06	2.67e-04	0.8830	-4.50e-01	-4.66e-01	2.07e-01	-4.80e-01	-2.96e-01	1.38e-02	1.07e-02	2.57e-01	8.61e-03	1.06e-01
GOMF ACROSIN BINDING	5	9.64e-02	3.76e-01	0.8830	-4.44e-01	2.13e-01	4.62e-01	5.67e-01	-4.00e-02	8.52e-02	4.11e-01	7.35e-02	2.81e-02	8.77e-01
GOBP SPERMIDINE METABOLIC PROCESS	6	2.97e-02	1.82e-01	0.8820	3.08e-01	1.95e-01	-3.93e-01	-6.61e-01	-2.31e-01	1.92e-01	4.09e-01	9.52e-02	5.05e-03	3.27e-01
GOMF PROSTAGLANDIN E RECEPTOR ACTIVITY	5	9.26e-02	3.67e-01	0.8800	-2.52e-01	-7.54e-02	-6.73e-01	-4.55e-01	-2.14e-01	3.30e-01	7.70e-01	9.18e-03	7.79e-02	4.06e-01
GOCC CORTICAL ENDOPLASMIC RETICULUM	5	6.53e-02	3.01e-01	0.8800	5.99e-02	5.62e-01	4.38e-01	2.39e-01	4.53e-01	8.17e-01	2.94e-02	9.01e-02	3.55e-01	7.96e-02
GOMF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY INVOLVED IN CARDIAC MUSCLE CELL ACTION POTENTIAL	5	1.02e-01	3.87e-01	0.8770	-5.07e-01	-1.05e-02	3.33e-01	5.57e-01	-3.03e-01	4.97e-02	9.68e-01	1.97e-01	3.11e-02	2.41e-01
GOBP MEDIUM CHAIN FATTY ACID CATABOLIC PROCESS	5	3.76e-02	2.12e-01	0.8740	5.75e-03	7.42e-01	2.72e-01	-3.59e-01	-1.03e-01	9.82e-01	4.08e-03	2.92e-01	1.64e-01	6.90e-01
GOBP REGULATION OF CELL CHEMOTAXIS TO FIBROBLAST GROWTH FACTOR	9	1.98e-03	2.67e-02	0.8730	-3.92e-01	-4.24e-01	-4.75e-01	3.46e-02	-4.51e-01	4.16e-02	2.78e-02	1.37e-02	8.58e-01	1.92e-02
GOBP MRNA PSEUDOURIDINE SYNTHESIS	8	1.10e-02	9.39e-02	0.8730	2.64e-01	-5.13e-01	-4.60e-01	-4.61e-01	6.32e-02	1.95e-01	1.20e-02	2.41e-02	2.39e-02	7.57e-01
GOBP NEGATIVE REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS	6	4.34e-02	2.31e-01	0.8720	-5.86e-01	2.88e-01	4.99e-01	2.80e-01	-8.20e-02	1.30e-02	2.22e-01	3.42e-02	2.35e-01	7.28e-01
GOBP REGULATION OF T HELPER 17 CELL LINEAGE COMMITMENT	7	1.22e-02	1.01e-01	0.8710	-3.43e-01	6.48e-01	4.15e-01	7.59e-02	2.10e-01	1.16e-01	3.00e-03	5.71e-02	7.28e-01	3.37e-01
GOCC MUSCLE MYOSIN COMPLEX	15	4.57e-06	1.67e-04	0.8710	-1.71e-01	-6.04e-01	-1.86e-01	4.68e-01	-3.33e-01	2.52e-01	5.13e-05	2.12e-01	1.69e-03	2.57e-02
GOCC MULTIVESICULAR BODY LUMEN	6	2.00e-02	1.41e-01	0.8690	3.71e-01	4.88e-01	6.01e-01	-3.69e-02	1.29e-01	1.16e-01	3.85e-02	1.08e-02	8.76e-01	5.85e-01
GOBP CATECHOL CONTAINING COMPOUND CATABOLIC PROCESS	5	8.99e-02	3.62e-01	0.8650	-2.90e-01	7.50e-02	6.53e-01	3.09e-01	-3.70e-01	2.62e-01	7.72e-01	1.15e-02	2.32e-01	1.52e-01
GOMF NITRITE REDUCTASE ACTIVITY	5	1.00e-01	3.84e-01	0.8610	-2.20e-01	3.14e-01	6.77e-01	2.51e-01	2.72e-01	3.93e-01	2.24e-01	8.77e-03	3.32e-01	2.92e-01
GOBP REGULATION OF NEUTROPHIL DEGRANULATION	8	6.07e-03	6.14e-02	0.8590	-3.88e-01	2.28e-01	7.20e-01	1.21e-01	-4.46e-02	5.77e-02	2.64e-01	4.19e-04	5.55e-01	8.27e-01
GOBP CYTOLYSIS BY HOST OF SYMBIONT CELLS	6	2.17e-02	1.49e-01	0.8580	-1.74e-01	-7.36e-01	-6.92e-02	3.81e-01	1.17e-01	4.60e-01	1.79e-03	7.69e-01	1.06e-01	6.20e-01
GOBP LEUKOTRIENE B4 METABOLIC PROCESS	5	1.40e-01	4.60e-01	0.8570	-1.25e-01	4.08e-01	5.47e-01	4.97e-01	-7.97e-02	6.28e-01	1.14e-01	3.40e-02	5.42e-02	7.58e-01
GOCC GATOR2 COMPLEX	5	1.15e-01	4.15e-01	0.8550	3.41e-01	-4.94e-01	-5.04e-01	-3.14e-01	1.33e-01	1.87e-01	5.57e-02	5.08e-02	2.24e-01	6.06e-01
GOBP NEGATIVE REGULATION OF FEEDING BEHAVIOR	6	1.03e-02	8.97e-02	0.8530	1.24e-02	3.15e-01	5.32e-01	-3.37e-02	-5.87e-01	9.58e-01	1.82e-01	2.41e-02	8.86e-01	1.28e-02
GOBP APOPTOTIC PROCESS INVOLVED IN HEART MORPHOGENESIS	7	3.47e-02	2.01e-01	0.8510	4.74e-02	2.75e-01	-4.36e-01	-5.80e-01	3.45e-01	8.28e-01	2.08e-01	4.57e-02	7.89e-03	1.14e-01
GOBP INDOLE CONTAINING COMPOUND BIOSYNTHETIC PROCESS	5	1.51e-01	4.76e-01	0.8510	-3.93e-01	8.05e-02	5.56e-01	4.77e-01	-1.59e-01	1.28e-01	7.55e-01	3.12e-02	6.46e-02	5.37e-01
GOBP ASPARAGINE METABOLIC PROCESS	5	6.49e-02	3.00e-01	0.8470	1.23e-01	2.01e-01	-7.04e-01	-2.06e-01	-3.52e-01	6.33e-01	4.35e-01	6.37e-03	4.25e-01	1.73e-01
GOCC LIPOPOLYSACCHARIDE RECEPTOR COMPLEX	5	4.14e-02	2.25e-01	0.8450	-1.56e-01	2.08e-01	-1.65e-01	-6.07e-01	-5.01e-01	5.45e-01	4.21e-01	5.22e-01	1.88e-02	5.23e-02
GOBP NEGATIVE REGULATION OF CERAMIDE BIOSYNTHETIC PROCESS	5	1.37e-01	4.55e-01	0.8450	-1.65e-02	-1.65e-02	-7.12e-01	-4.52e-01	-4.74e-02	9.49e-01	9.49e-01	5.84e-03	8.02e-02	8.54e-01
GOMF PHOSPHOTRANSFERASE ACTIVITY NITROGENOUS GROUP AS ACCEPTOR	6	3.68e-02	2.09e-01	0.8430	-4.74e-01	3.63e-02	-3.07e-01	-5.87e-01	-2.16e-01	4.42e-02	8.78e-01	1.93e-01	1.28e-02	3.60e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON DIPHENOLS AND RELATED SUBSTANCES AS DONORS	8	1.86e-02	1.35e-01	0.8430	1.60e-01	-9.50e-02	-5.87e-01	-5.01e-01	-2.85e-01	4.34e-01	6.42e-01	4.04e-03	1.42e-02	1.63e-01
GOMF N ACETYLLACTOSAMINE SYNTHASE ACTIVITY	5	5.85e-02	2.82e-01	0.8410	-5.10e-01	6.49e-01	8.81e-02	-1.30e-01	-2.95e-02	4.82e-02	1.19e-02	7.33e-01	6.15e-01	9.09e-01
GOMF PROTEIN ARGININE DEIMINASE ACTIVITY	5	5.17e-02	2.61e-01	0.8410	-4.22e-01	7.18e-02	-2.41e-01	3.93e-01	-5.58e-01	1.03e-01	7.81e-01	3.51e-01	1.28e-01	3.08e-02
GOCC SPERM HEAD PLASMA MEMBRANE	6	5.40e-02	2.68e-01	0.8400	1.14e-01	-3.97e-01	3.15e-01	6.54e-01	-9.04e-02	6.28e-01	9.18e-02	1.82e-01	5.51e-03	7.01e-01
GOBP DISRUPTION OF CELLULAR ANATOMICAL STRUCTURE IN ANOTHER ORGANISM	10	8.55e-04	1.37e-02	0.8400	-5.77e-01	-6.03e-01	-1.93e-02	-6.74e-02	-6.76e-02	1.58e-03	9.64e-04	9.16e-01	7.12e-01	7.11e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION OF LIPID ANTIGEN VIA MHC CLASS IB	7	2.74e-02	1.73e-01	0.8400	1.73e-02	-4.00e-01	5.24e-01	5.16e-01	5.80e-02	9.37e-01	6.68e-02	1.64e-02	1.80e-02	7.90e-01
GOCC VOLTAGE GATED SODIUM CHANNEL COMPLEX	14	5.00e-05	1.36e-03	0.8390	-4.51e-01	-3.68e-02	-4.88e-02	4.59e-01	-5.35e-01	3.47e-03	8.12e-01	7.52e-01	2.93e-03	5.25e-04
GOBP POSITIVE REGULATION OF ANTIMICROBIAL HUMORAL RESPONSE	8	1.14e-02	9.62e-02	0.8380	-6.09e-01	-3.47e-01	2.20e-01	3.25e-01	-2.40e-01	2.87e-03	8.93e-02	2.81e-01	1.11e-01	2.39e-01
GOMF COMPLEMENT COMPONENT C3B BINDING	9	4.84e-03	5.24e-02	0.8370	-4.34e-01	-3.47e-01	1.02e-01	5.68e-01	-2.40e-01	2.40e-02	7.14e-02	5.97e-01	3.15e-03	2.12e-01
GOMF MEDIUM CHAIN FATTY ACID COA LIGASE ACTIVITY	8	7.92e-03	7.43e-02	0.8360	2.81e-01	7.13e-01	2.40e-01	1.98e-01	-1.20e-01	1.69e-01	4.79e-04	2.40e-01	3.32e-01	5.58e-01
GOBP REGULATION OF BINDING OF SPERM TO ZONA PELLUCIDA	5	1.45e-01	4.67e-01	0.8340	-3.82e-01	-5.41e-02	6.13e-01	4.01e-01	-1.00e-01	1.39e-01	8.34e-01	1.76e-02	1.21e-01	6.99e-01
GOBP EXOCYST LOCALIZATION	5	7.43e-02	3.26e-01	0.8330	1.85e-01	6.55e-01	4.70e-01	-5.10e-02	-8.39e-02	4.74e-01	1.11e-02	6.87e-02	8.43e-01	7.45e-01
GOBP CLEAVAGE FURROW FORMATION	7	2.09e-02	1.45e-01	0.8330	-4.19e-01	2.70e-01	-4.55e-01	-4.49e-01	-1.92e-01	5.47e-02	2.17e-01	3.73e-02	3.98e-02	3.80e-01
GOCC RADIAL SPOKE	5	1.60e-01	4.92e-01	0.8320	-1.33e-02	1.69e-01	-5.05e-01	-6.36e-01	5.60e-02	9.59e-01	5.13e-01	5.04e-02	1.38e-02	8.28e-01
GOBP RIBOFLAVIN METABOLIC PROCESS	5	1.16e-01	4.16e-01	0.8290	1.72e-02	4.89e-01	-3.80e-01	-5.30e-01	1.52e-01	9.47e-01	5.84e-02	1.41e-01	4.02e-02	5.56e-01
GOMF ALCOHOL DEHYDROGENASE NAD P PLUS ACTIVITY	10	5.32e-03	5.56e-02	0.8280	-2.07e-01	-1.49e-01	2.14e-01	6.17e-01	-4.42e-01	2.58e-01	4.14e-01	2.42e-01	7.35e-04	1.55e-02
GOBP CARDIAC MUSCLE CELL CARDIAC MUSCLE CELL ADHESION	7	4.06e-02	2.22e-01	0.8280	1.05e-01	-1.81e-01	5.28e-01	5.35e-01	-2.78e-01	6.29e-01	4.08e-01	1.55e-02	1.43e-02	2.03e-01
GOBP PEPTIDOGLYCAN METABOLIC PROCESS	6	3.98e-02	2.19e-01	0.8280	-5.06e-01	1.04e-01	4.92e-02	1.07e-02	-6.44e-01	3.17e-02	6.58e-01	8.35e-01	9.64e-01	6.27e-03
GOCC OTHER ORGANISM PART	5	8.53e-02	3.53e-01	0.8270	-5.11e-01	-5.47e-01	-2.05e-01	1.81e-01	-2.22e-01	4.80e-02	3.43e-02	4.27e-01	4.82e-01	3.90e-01
GOBP SUCCINATE METABOLIC PROCESS	5	1.07e-01	3.98e-01	0.8270	3.46e-01	-2.48e-01	-5.05e-01	-3.01e-01	-3.97e-01	1.80e-01	3.38e-01	5.07e-02	2.43e-01	1.25e-01
GOBP NEGATIVE REGULATION OF PHOTORECEPTOR CELL DIFFERENTIATION	6	3.19e-02	1.91e-01	0.8260	-1.45e-02	2.75e-01	2.26e-01	-5.12e-01	5.42e-01	9.51e-01	2.44e-01	3.39e-01	3.00e-02	2.16e-02
GOMF CHOLINE TRANSMEMBRANE TRANSPORTER ACTIVITY	7	3.11e-02	1.88e-01	0.8240	4.67e-01	7.05e-02	4.18e-01	5.15e-01	-1.26e-01	3.23e-02	7.47e-01	5.53e-02	1.82e-02	5.64e-01
GOMF RECEPTOR SIGNALING PROTEIN TYROSINE KINASE ACTIVATOR ACTIVITY	5	1.09e-01	4.03e-01	0.8190	-4.85e-01	-2.94e-01	4.59e-01	2.69e-01	-2.57e-01	6.03e-02	2.56e-01	7.56e-02	2.98e-01	3.20e-01
GOBP EGG ACTIVATION	11	1.12e-03	1.68e-02	0.8180	-6.17e-01	3.78e-02	1.54e-01	4.72e-01	-2.03e-01	3.95e-04	8.28e-01	3.77e-01	6.70e-03	2.44e-01
GOBP AORTA SMOOTH MUSCLE TISSUE MORPHOGENESIS	6	3.91e-02	2.17e-01	0.8180	-5.69e-01	-1.25e-02	4.52e-01	8.45e-02	3.66e-01	1.58e-02	9.58e-01	5.53e-02	7.20e-01	1.21e-01
GOMF OPIOID RECEPTOR BINDING	7	2.88e-02	1.78e-01	0.8180	-4.67e-01	2.84e-01	5.76e-01	1.24e-01	-1.50e-01	3.26e-02	1.93e-01	8.26e-03	5.69e-01	4.93e-01
GOMF ALCOHOL TRANSMEMBRANE TRANSPORTER ACTIVITY	6	2.51e-02	1.62e-01	0.8170	-4.83e-03	5.22e-01	-1.34e-01	3.09e-01	-5.31e-01	9.84e-01	2.68e-02	5.71e-01	1.90e-01	2.42e-02
GOMF CELL ADHESIVE PROTEIN BINDING INVOLVED IN BUNDLE OF HIS CELL PURKINJE MYOCYTE COMMUNICATION	5	1.48e-01	4.72e-01	0.8170	1.94e-01	-3.78e-02	5.30e-01	5.03e-01	-3.08e-01	4.52e-01	8.84e-01	4.01e-02	5.16e-02	2.33e-01
GOCC SMAD PROTEIN COMPLEX	9	1.18e-02	9.80e-02	0.8150	1.13e-01	3.51e-01	3.97e-01	4.27e-01	-4.33e-01	5.57e-01	6.81e-02	3.92e-02	2.65e-02	2.44e-02
GOCC KAINATE SELECTIVE GLUTAMATE RECEPTOR COMPLEX	5	1.41e-01	4.62e-01	0.8140	-1.21e-02	-1.14e-02	5.04e-01	4.11e-01	-4.88e-01	9.63e-01	9.65e-01	5.10e-02	1.11e-01	5.87e-02
GOMF KAINATE SELECTIVE GLUTAMATE RECEPTOR ACTIVITY	5	1.41e-01	4.62e-01	0.8140	-1.21e-02	-1.14e-02	5.04e-01	4.11e-01	-4.88e-01	9.63e-01	9.65e-01	5.10e-02	1.11e-01	5.87e-02
GOBP PROGESTERONE BIOSYNTHETIC PROCESS	6	7.91e-02	3.39e-01	0.8130	4.08e-01	-2.85e-01	-2.62e-01	-3.67e-01	4.58e-01	8.37e-02	2.26e-01	2.66e-01	1.19e-01	5.21e-02
GOBP XYLULOSE 5 PHOSPHATE METABOLIC PROCESS	6	6.53e-02	3.01e-01	0.8130	1.93e-01	-2.64e-03	-4.72e-02	-4.32e-01	6.59e-01	4.13e-01	9.91e-01	8.41e-01	6.69e-02	5.17e-03
GOBP TELOMERASE HOLOENZYME COMPLEX ASSEMBLY	6	7.74e-02	3.33e-01	0.8120	-2.67e-01	-4.69e-01	-4.11e-01	-4.05e-01	1.87e-01	2.58e-01	4.66e-02	8.12e-02	8.58e-02	4.26e-01
GOBP REGULATION OF HIPPOCAMPAL NEURON APOPTOTIC PROCESS	5	1.04e-01	3.90e-01	0.8090	-5.08e-01	-4.50e-01	3.57e-01	2.58e-01	2.29e-02	4.92e-02	8.17e-02	1.67e-01	3.17e-01	9.29e-01
GOCC STEREOCILIUM MEMBRANE	6	8.88e-02	3.59e-01	0.8090	-3.67e-01	1.14e-01	3.70e-01	3.31e-01	-5.10e-01	1.20e-01	6.30e-01	1.16e-01	1.60e-01	3.06e-02
GOMF INOSITOL TETRAKISPHOSPHATE KINASE ACTIVITY	5	8.59e-02	3.55e-01	0.8070	1.52e-01	3.44e-01	5.30e-02	-6.56e-01	2.78e-01	5.57e-01	1.82e-01	8.38e-01	1.11e-02	2.82e-01
GOBP LIPID HYDROXYLATION	7	1.27e-02	1.04e-01	0.8060	3.96e-01	-5.08e-01	-3.29e-01	3.55e-01	-1.50e-02	6.94e-02	1.99e-02	1.31e-01	1.04e-01	9.45e-01
GOMF TYPE I INTERFERON RECEPTOR BINDING	13	5.34e-04	9.33e-03	0.8060	-1.62e-01	-3.34e-01	3.51e-01	6.06e-01	1.45e-01	3.12e-01	3.69e-02	2.85e-02	1.54e-04	3.66e-01
GOBP PERICENTRIC HETEROCHROMATIN FORMATION	5	1.87e-01	5.31e-01	0.8060	1.30e-01	-2.71e-01	-5.24e-01	-3.96e-01	3.58e-01	6.15e-01	2.94e-01	4.25e-02	1.25e-01	1.66e-01
GOBP GLUCURONATE CATABOLIC PROCESS TO XYLULOSE 5 PHOSPHATE	5	1.41e-01	4.62e-01	0.8060	2.18e-01	-1.67e-01	-1.46e-01	-4.28e-01	6.08e-01	3.98e-01	5.18e-01	5.73e-01	9.75e-02	1.86e-02
GOBP NEGATIVE REGULATION OF GLUCOCORTICOID METABOLIC PROCESS	5	1.39e-01	4.59e-01	0.8050	-5.82e-01	1.88e-01	4.73e-01	2.20e-01	-2.80e-02	2.42e-02	4.67e-01	6.68e-02	3.93e-01	9.14e-01
GOMF SPHINGOSINE 1 PHOSPHATE RECEPTOR ACTIVITY	8	3.14e-02	1.89e-01	0.8040	-8.37e-02	3.61e-02	-4.49e-01	-5.22e-01	4.06e-01	6.82e-01	8.60e-01	2.80e-02	1.06e-02	4.67e-02
GOBP REGULATION OF ENDOTHELIAL TUBE MORPHOGENESIS	6	4.41e-02	2.33e-01	0.8030	-4.46e-01	-2.00e-01	1.79e-02	6.02e-01	-2.09e-01	5.84e-02	3.96e-01	9.39e-01	1.07e-02	3.76e-01
GOBP DTMP METABOLIC PROCESS	6	5.71e-02	2.77e-01	0.8030	-2.13e-01	1.27e-01	-3.87e-01	-4.14e-01	-5.12e-01	3.66e-01	5.90e-01	1.00e-01	7.91e-02	2.98e-02
GOBP MESANGIAL CELL DEVELOPMENT	6	3.36e-02	1.97e-01	0.8030	4.39e-01	3.21e-01	-3.28e-01	-5.70e-02	4.87e-01	6.26e-02	1.74e-01	1.64e-01	8.09e-01	3.87e-02
GOBP POSITIVE REGULATION OF GONADOTROPIN SECRETION	7	1.61e-02	1.22e-01	0.8020	1.59e-01	5.14e-01	-1.28e-01	-3.57e-01	-4.58e-01	4.66e-01	1.85e-02	5.58e-01	1.02e-01	3.58e-02
GOCC 9PLUS0 MOTILE CILIUM	5	1.96e-01	5.45e-01	0.8010	-4.04e-01	1.23e-01	3.96e-01	4.88e-01	-2.62e-01	1.18e-01	6.33e-01	1.26e-01	5.87e-02	3.10e-01
GOCC NUCLEOLAR RIBONUCLEASE P COMPLEX	7	3.83e-02	2.14e-01	0.8000	3.03e-01	2.33e-02	-6.56e-01	-2.49e-01	-2.35e-01	1.65e-01	9.15e-01	2.65e-03	2.54e-01	2.83e-01
GOMF GABA GATED CHLORIDE ION CHANNEL ACTIVITY	11	2.19e-03	2.88e-02	0.8000	4.19e-01	8.22e-02	4.51e-01	3.18e-01	3.91e-01	1.61e-02	6.37e-01	9.66e-03	6.75e-02	2.49e-02
GOCC COMMITMENT COMPLEX	5	9.64e-02	3.76e-01	0.7990	-4.66e-01	3.59e-01	-6.58e-02	-5.04e-01	1.83e-01	7.12e-02	1.65e-01	7.99e-01	5.09e-02	4.78e-01
GOBP TRNA PSEUDOURIDINE SYNTHESIS	6	9.92e-02	3.81e-01	0.7970	3.55e-01	-2.36e-01	-5.22e-01	-3.87e-01	-1.76e-01	1.32e-01	3.16e-01	2.67e-02	1.01e-01	4.55e-01
GOMF C X C CHEMOKINE BINDING	5	1.78e-01	5.19e-01	0.7970	-3.62e-01	5.95e-02	2.67e-01	5.63e-01	-3.36e-01	1.61e-01	8.18e-01	3.01e-01	2.94e-02	1.94e-01
GOBP REGULATION OF ENAMEL MINERALIZATION	7	5.48e-02	2.70e-01	0.7970	-2.12e-01	-2.56e-01	2.76e-01	6.43e-01	-1.87e-01	3.32e-01	2.41e-01	2.05e-01	3.23e-03	3.93e-01
GOBP NEGATIVE REGULATION OF INTERLEUKIN 5 PRODUCTION	7	4.53e-02	2.37e-01	0.7950	1.91e-02	4.20e-01	5.35e-01	1.74e-01	3.74e-01	9.30e-01	5.46e-02	1.43e-02	4.25e-01	8.67e-02
GOBP POSITIVE REGULATION OF MONOCYTE EXTRAVASATION	5	9.48e-02	3.72e-01	0.7940	-5.70e-01	-8.11e-02	3.16e-01	1.93e-01	4.04e-01	2.74e-02	7.54e-01	2.22e-01	4.54e-01	1.18e-01
GOBP REGULATION OF AMACRINE CELL DIFFERENTIATION	6	9.68e-02	3.77e-01	0.7930	2.06e-01	2.77e-01	-2.14e-01	-6.22e-01	2.79e-01	3.82e-01	2.41e-01	3.64e-01	8.37e-03	2.36e-01
GOCC INTERPHOTORECEPTOR MATRIX	6	2.39e-02	1.58e-01	0.7930	-2.11e-01	-3.94e-01	1.90e-02	5.17e-01	4.01e-01	3.72e-01	9.46e-02	9.36e-01	2.82e-02	8.88e-02
GOBP MONOTERPENOID METABOLIC PROCESS	6	3.05e-02	1.85e-01	0.7930	2.21e-01	-2.95e-01	-7.79e-02	6.88e-01	-1.15e-01	3.48e-01	2.12e-01	7.41e-01	3.52e-03	6.26e-01
GOMF PYRIMIDINE NUCLEOTIDE BINDING	6	1.25e-01	4.35e-01	0.7920	-1.51e-01	-1.09e-01	-5.86e-01	-4.93e-01	-7.68e-02	5.22e-01	6.43e-01	1.29e-02	3.65e-02	7.45e-01
GOMF BILE ACID BINDING	10	8.26e-03	7.66e-02	0.7920	-1.74e-02	-3.70e-01	3.02e-01	5.45e-01	-3.19e-01	9.24e-01	4.27e-02	9.82e-02	2.83e-03	8.11e-02
GOMF INTRACELLULAR CGMP ACTIVATED CATION CHANNEL ACTIVITY	6	1.10e-01	4.04e-01	0.7920	-2.52e-01	2.06e-01	4.26e-01	5.83e-01	1.43e-02	2.86e-01	3.83e-01	7.09e-02	1.34e-02	9.52e-01
GOMF LIPOPEPTIDE BINDING	10	1.18e-02	9.80e-02	0.7910	7.59e-02	-1.71e-01	4.40e-01	6.28e-01	-5.47e-02	6.78e-01	3.48e-01	1.59e-02	5.84e-04	7.65e-01
GOCC GAMMA TUBULIN RING COMPLEX	7	7.91e-02	3.39e-01	0.7910	3.64e-01	-1.02e-01	-5.29e-01	-4.17e-01	1.71e-01	9.52e-02	6.41e-01	1.54e-02	5.61e-02	4.33e-01
GOMF INHIBITORY EXTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY	11	2.94e-03	3.61e-02	0.7910	1.70e-01	2.30e-01	5.77e-01	1.77e-01	4.23e-01	3.28e-01	1.86e-01	9.21e-04	3.10e-01	1.51e-02
GOBP LEUKOTRIENE CATABOLIC PROCESS	6	7.94e-02	3.39e-01	0.7900	-4.49e-02	6.51e-01	3.71e-01	2.37e-01	6.83e-02	8.49e-01	5.73e-03	1.16e-01	3.14e-01	7.72e-01
GOBP SYNAPTIC TRANSMISSION GLYCINERGIC	5	1.09e-01	4.02e-01	0.7900	-3.63e-01	5.20e-01	4.57e-01	-9.96e-02	5.45e-02	1.60e-01	4.39e-02	7.67e-02	7.00e-01	8.33e-01
GOBP PENTOSE PHOSPHATE SHUNT NON OXIDATIVE BRANCH	6	6.86e-02	3.10e-01	0.7890	4.25e-01	4.87e-01	-2.82e-01	-2.65e-01	2.34e-01	7.12e-02	3.89e-02	2.32e-01	2.60e-01	3.20e-01
GOBP TRACHEA CARTILAGE DEVELOPMENT	7	2.52e-02	1.62e-01	0.7880	-1.90e-01	6.82e-01	2.71e-01	-1.83e-01	-1.16e-01	3.85e-01	1.77e-03	2.15e-01	4.02e-01	5.96e-01
GOBP POSITIVE REGULATION OF IMMATURE T CELL PROLIFERATION	5	1.20e-01	4.24e-01	0.7880	2.84e-01	4.10e-01	1.98e-01	3.81e-02	5.76e-01	2.71e-01	1.12e-01	4.43e-01	8.83e-01	2.58e-02
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN REDUCED IRON SULFUR PROTEIN AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN	9	2.97e-02	1.82e-01	0.7880	-7.51e-02	9.48e-02	4.27e-01	5.48e-01	-3.51e-01	6.97e-01	6.22e-01	2.66e-02	4.43e-03	6.80e-02
GOBP FC RECEPTOR MEDIATED INHIBITORY SIGNALING PATHWAY	5	3.58e-02	2.05e-01	0.7870	-4.30e-01	4.82e-01	-1.45e-01	4.03e-01	-1.40e-01	9.60e-02	6.17e-02	5.76e-01	1.19e-01	5.89e-01
GOBP ARTERIAL ENDOTHELIAL CELL DIFFERENTIATION	6	8.72e-02	3.57e-01	0.7870	4.40e-01	2.31e-01	4.90e-01	3.21e-01	1.70e-01	6.19e-02	3.27e-01	3.75e-02	1.74e-01	4.72e-01
GOMF D1 DOPAMINE RECEPTOR BINDING	6	5.44e-02	2.69e-01	0.7860	-3.25e-01	4.48e-01	5.84e-02	-4.58e-01	3.15e-01	1.68e-01	5.76e-02	8.04e-01	5.23e-02	1.81e-01
GOBP POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION	6	8.16e-02	3.44e-01	0.7850	-1.49e-01	1.62e-02	5.37e-01	2.94e-01	-4.68e-01	5.29e-01	9.45e-01	2.26e-02	2.13e-01	4.72e-02
GOBP REGULATION OF XENOBIOTIC DETOXIFICATION BY TRANSMEMBRANE EXPORT ACROSS THE PLASMA MEMBRANE	12	1.99e-03	2.67e-02	0.7840	-4.01e-01	-3.22e-01	1.68e-01	5.23e-01	-2.20e-01	1.61e-02	5.33e-02	3.14e-01	1.70e-03	1.88e-01
GOBP URETER MORPHOGENESIS	7	4.60e-02	2.40e-01	0.7830	1.80e-01	9.78e-02	-9.02e-02	-6.22e-01	4.20e-01	4.10e-01	6.54e-01	6.79e-01	4.37e-03	5.45e-02
GOBP HYPOXIA INDUCIBLE FACTOR 1ALPHA SIGNALING PATHWAY	5	5.39e-02	2.67e-01	0.7820	1.57e-01	-5.74e-02	-3.94e-02	-7.63e-01	-1.46e-02	5.43e-01	8.24e-01	8.79e-01	3.13e-03	9.55e-01
GOMF DOUBLE STRANDED RNA ADENOSINE DEAMINASE ACTIVITY	6	8.96e-02	3.62e-01	0.7820	3.73e-01	4.40e-01	4.71e-01	2.29e-01	6.71e-02	1.14e-01	6.23e-02	4.55e-02	3.32e-01	7.76e-01
GOBP NEUTROPHIL MEDIATED KILLING OF GRAM NEGATIVE BACTERIUM	6	5.95e-02	2.85e-01	0.7820	-3.10e-01	4.50e-01	2.05e-02	-4.10e-01	3.80e-01	1.88e-01	5.65e-02	9.31e-01	8.20e-02	1.07e-01
GOBP SKELETAL MUSCLE SATELLITE CELL MAINTENANCE INVOLVED IN SKELETAL MUSCLE REGENERATION	5	9.11e-02	3.65e-01	0.7810	3.40e-01	1.87e-01	-3.80e-01	5.70e-02	-5.58e-01	1.88e-01	4.69e-01	1.41e-01	8.25e-01	3.06e-02
GOBP INTERLEUKIN 3 MEDIATED SIGNALING PATHWAY	6	8.19e-02	3.45e-01	0.7780	-1.82e-01	5.64e-01	4.77e-01	1.57e-02	1.59e-01	4.39e-01	1.67e-02	4.29e-02	9.47e-01	5.00e-01
GOMF THIOREDOXIN DEPENDENT PEROXIREDOXIN ACTIVITY	5	2.44e-01	6.01e-01	0.7780	1.35e-02	-2.88e-01	-4.98e-01	-4.97e-01	1.66e-01	9.58e-01	2.64e-01	5.40e-02	5.44e-02	5.22e-01
GOBP NEGATIVE REGULATION OF INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY	8	9.47e-03	8.41e-02	0.7750	-2.35e-01	-1.95e-01	1.30e-01	-2.02e-03	-7.01e-01	2.49e-01	3.41e-01	5.23e-01	9.92e-01	6.00e-04
GOBP ISOPRENOID TRANSPORT	5	4.37e-02	2.32e-01	0.7750	4.93e-02	5.30e-01	-2.66e-01	3.64e-01	-3.37e-01	8.49e-01	4.00e-02	3.02e-01	1.58e-01	1.92e-01
GOBP GLOSSOPHARYNGEAL NERVE DEVELOPMENT	5	2.16e-01	5.69e-01	0.7750	-3.37e-01	1.71e-01	5.27e-01	3.22e-01	-2.77e-01	1.92e-01	5.07e-01	4.12e-02	2.12e-01	2.84e-01
GOBP POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION OF STAT PROTEIN	16	8.57e-05	2.09e-03	0.7750	-2.10e-01	-3.78e-01	2.96e-01	5.38e-01	1.92e-01	1.46e-01	8.84e-03	4.05e-02	1.96e-04	1.84e-01
GOBP FATTY ACID OMEGA OXIDATION	5	6.61e-02	3.03e-01	0.7740	5.52e-02	3.13e-02	-5.77e-01	2.01e-01	-4.70e-01	8.31e-01	9.03e-01	2.53e-02	4.36e-01	6.85e-02
GOBP ASCENDING AORTA DEVELOPMENT	5	1.34e-01	4.53e-01	0.7730	5.23e-01	-2.03e-01	3.82e-02	-1.06e-01	5.20e-01	4.30e-02	4.31e-01	8.82e-01	6.82e-01	4.39e-02
GOBP ACTIN FILAMENT NETWORK FORMATION	8	1.65e-02	1.25e-01	0.7730	-4.44e-01	2.04e-01	6.72e-02	-3.95e-02	-5.94e-01	2.97e-02	3.17e-01	7.42e-01	8.46e-01	3.61e-03
GOBP POSITIVE REGULATION OF HEMOGLOBIN BIOSYNTHETIC PROCESS	6	1.55e-01	4.84e-01	0.7720	-9.54e-02	-7.25e-02	-5.03e-01	-5.36e-01	2.04e-01	6.86e-01	7.58e-01	3.29e-02	2.30e-02	3.86e-01
GOCC LSM1 7 PAT1 COMPLEX	5	2.44e-01	6.01e-01	0.7720	1.97e-01	1.26e-01	-3.96e-01	-5.31e-01	3.19e-01	4.45e-01	6.27e-01	1.25e-01	3.98e-02	2.17e-01
GOBP TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE PHOSPHATASE SIGNALING PATHWAY	6	1.43e-01	4.63e-01	0.7710	2.96e-02	2.94e-02	4.54e-01	6.20e-01	4.27e-02	9.00e-01	9.01e-01	5.40e-02	8.50e-03	8.56e-01
GOBP EMBRYONIC HEART TUBE LEFT RIGHT PATTERN FORMATION	5	2.10e-01	5.62e-01	0.7710	8.89e-02	3.35e-01	-4.03e-01	-5.30e-01	1.76e-01	7.31e-01	1.94e-01	1.19e-01	4.01e-02	4.94e-01
GOBP POSITIVE REGULATION OF INTERLEUKIN 1 ALPHA PRODUCTION	6	7.47e-02	3.27e-01	0.7700	-5.08e-01	4.17e-01	1.25e-01	2.22e-01	-3.09e-01	3.10e-02	7.69e-02	5.95e-01	3.47e-01	1.89e-01
GOMF ACETYLESTERASE ACTIVITY	5	1.30e-01	4.46e-01	0.7700	-6.85e-02	6.75e-01	1.44e-01	1.04e-01	-3.17e-01	7.91e-01	8.90e-03	5.77e-01	6.87e-01	2.20e-01
GOBP REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DEDIFFERENTIATION	5	6.45e-02	2.99e-01	0.7700	-2.10e-01	9.02e-02	5.03e-01	-3.36e-01	4.18e-01	4.17e-01	7.27e-01	5.14e-02	1.93e-01	1.06e-01
GOMF GLYCOLIPID MANNOSYLTRANSFERASE ACTIVITY	5	2.43e-01	6.00e-01	0.7690	1.86e-01	-4.16e-02	-3.41e-01	-5.89e-01	3.04e-01	4.71e-01	8.72e-01	1.86e-01	2.26e-02	2.39e-01
GOBP PUTRESCINE BIOSYNTHETIC PROCESS	5	1.48e-01	4.71e-01	0.7690	-4.72e-01	1.03e-01	-3.28e-01	-4.21e-01	-2.72e-01	6.78e-02	6.90e-01	2.05e-01	1.03e-01	2.93e-01
GOCC INTRACELLULAR CYCLIC NUCLEOTIDE ACTIVATED CATION CHANNEL COMPLEX	5	2.56e-01	6.13e-01	0.7680	-2.03e-01	1.22e-01	4.91e-01	5.41e-01	-1.01e-02	4.33e-01	6.37e-01	5.71e-02	3.62e-02	9.69e-01
GOMF OLFACTORY RECEPTOR ACTIVITY	337	2.73e-121	2.79e-117	0.7680	-1.64e-01	-3.88e-01	1.45e-01	6.20e-01	7.67e-02	2.13e-07	1.52e-34	4.66e-06	5.02e-86	1.55e-02
GOBP FERMENTATION	5	2.47e-01	6.04e-01	0.7680	-8.98e-03	2.29e-02	-5.64e-01	-5.16e-01	-6.58e-02	9.72e-01	9.29e-01	2.90e-02	4.56e-02	7.99e-01
GOBP PSEUDOURIDINE SYNTHESIS	17	4.37e-04	8.07e-03	0.7670	1.04e-01	-3.51e-01	-5.08e-01	-4.34e-01	9.25e-02	4.58e-01	1.21e-02	2.88e-04	1.96e-03	5.09e-01
GOMF MELANOCORTIN RECEPTOR BINDING	5	1.11e-01	4.07e-01	0.7660	-2.32e-02	1.71e-01	6.21e-01	-6.55e-02	4.10e-01	9.29e-01	5.08e-01	1.62e-02	8.00e-01	1.12e-01
GOBP SMOOTH MUSCLE ADAPTATION	5	1.26e-01	4.37e-01	0.7660	1.67e-02	6.74e-01	-1.24e-01	-2.56e-01	2.25e-01	9.48e-01	9.00e-03	6.30e-01	3.21e-01	3.84e-01
GOBP POSITIVE REGULATION OF SODIUM PROTON ANTIPORTER ACTIVITY	5	1.35e-01	4.53e-01	0.7660	-2.28e-01	4.94e-01	4.77e-01	-1.15e-01	2.21e-01	3.78e-01	5.57e-02	6.45e-02	6.55e-01	3.92e-01
GOMF DEOXYRIBONUCLEOTIDE BINDING	5	1.50e-01	4.76e-01	0.7650	-1.93e-01	2.00e-01	-6.25e-01	-3.37e-01	-5.61e-02	4.56e-01	4.39e-01	1.55e-02	1.92e-01	8.28e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON METAL IONS OXYGEN AS ACCEPTOR	5	1.77e-01	5.18e-01	0.7640	3.32e-02	-2.39e-01	4.48e-01	4.61e-01	3.35e-01	8.98e-01	3.55e-01	8.27e-02	7.45e-02	1.95e-01
GOBP NEGATIVE REGULATION OF LAMELLIPODIUM ASSEMBLY	5	1.65e-01	5.00e-01	0.7630	-5.27e-01	-3.86e-01	1.45e-01	2.20e-01	-2.93e-01	4.14e-02	1.35e-01	5.74e-01	3.95e-01	2.57e-01
GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY INTERCONVERTING ALDOSES AND KETOSES	6	1.38e-01	4.57e-01	0.7620	2.64e-01	3.10e-01	-3.45e-01	-5.25e-01	1.47e-01	2.63e-01	1.89e-01	1.44e-01	2.60e-02	5.34e-01
GOBP POSITIVE REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY	5	2.21e-01	5.76e-01	0.7620	-2.21e-01	2.45e-01	6.30e-01	2.62e-01	7.83e-02	3.93e-01	3.42e-01	1.46e-02	3.11e-01	7.62e-01
GOMF GPI LINKED EPHRIN RECEPTOR ACTIVITY	6	9.02e-02	3.63e-01	0.7620	3.89e-01	-1.12e-01	3.57e-01	4.34e-01	-3.18e-01	9.92e-02	6.34e-01	1.29e-01	6.59e-02	1.77e-01
GOMF MEMBRANE POTENTIAL DRIVEN UNIPORTER ACTIVITY	5	8.05e-02	3.42e-01	0.7620	-2.44e-01	3.10e-01	6.14e-01	-1.14e-01	-1.86e-01	3.44e-01	2.30e-01	1.74e-02	6.58e-01	4.72e-01
GOMF HISTONE DEUBIQUITINASE ACTIVITY	5	1.54e-01	4.81e-01	0.7610	5.73e-01	3.79e-01	-2.42e-01	-1.95e-01	1.05e-01	2.66e-02	1.42e-01	3.49e-01	4.51e-01	6.85e-01
GOMF C X C CHEMOKINE RECEPTOR ACTIVITY	7	8.37e-02	3.49e-01	0.7610	7.24e-02	-1.52e-02	3.72e-01	4.89e-01	-4.42e-01	7.40e-01	9.45e-01	8.80e-02	2.49e-02	4.30e-02
GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS	6	7.85e-02	3.36e-01	0.7610	1.24e-01	-4.98e-01	1.07e-01	3.42e-01	-4.32e-01	5.98e-01	3.47e-02	6.51e-01	1.46e-01	6.68e-02
GOBP IMMUNOLOGICAL MEMORY FORMATION PROCESS	14	9.90e-05	2.36e-03	0.7600	-2.80e-01	5.75e-01	1.81e-01	2.20e-01	2.97e-01	6.95e-02	1.95e-04	2.41e-01	1.55e-01	5.42e-02
GOMF TAP BINDING	7	1.18e-02	9.80e-02	0.7600	-3.80e-01	-2.59e-01	1.01e-01	-3.02e-01	-5.15e-01	8.20e-02	2.36e-01	6.43e-01	1.67e-01	1.83e-02
GOMF TRAIL BINDING	5	1.48e-01	4.71e-01	0.7600	3.22e-01	5.87e-01	3.20e-02	-3.41e-01	1.06e-01	2.12e-01	2.29e-02	9.01e-01	1.87e-01	6.82e-01
GOCC PERICILIARY MEMBRANE COMPARTMENT	5	2.29e-01	5.82e-01	0.7600	-2.63e-01	1.86e-02	2.96e-01	6.13e-01	-2.10e-01	3.09e-01	9.43e-01	2.52e-01	1.76e-02	4.15e-01
GOBP CO TRANSCRIPTIONAL MRNA 3 END PROCESSING CLEAVAGE AND POLYADENYLATION PATHWAY	5	1.48e-01	4.72e-01	0.7590	2.00e-01	1.39e-01	9.73e-02	-4.89e-01	5.18e-01	4.38e-01	5.92e-01	7.06e-01	5.81e-02	4.49e-02
GOBP CARDIAC SEPTUM CELL DIFFERENTIATION	5	1.78e-01	5.19e-01	0.7590	1.96e-01	3.87e-01	-1.44e-01	-3.24e-01	5.12e-01	4.48e-01	1.34e-01	5.76e-01	2.10e-01	4.75e-02
GOBP SPONTANEOUS NEUROTRANSMITTER SECRETION	8	1.90e-02	1.37e-01	0.7580	-1.37e-01	5.06e-01	-5.89e-03	1.10e-01	-5.37e-01	5.04e-01	1.32e-02	9.77e-01	5.89e-01	8.52e-03
GOMF LACTATE DEHYDROGENASE ACTIVITY	6	6.54e-02	3.01e-01	0.7580	5.53e-01	4.37e-01	7.07e-02	2.39e-01	1.25e-01	1.90e-02	6.39e-02	7.64e-01	3.10e-01	5.97e-01
GOCC PWP2P CONTAINING SUBCOMPLEX OF 90S PRERIBOSOME	5	1.51e-01	4.76e-01	0.7580	4.11e-01	-3.66e-01	-2.96e-01	-4.13e-01	-1.14e-01	1.11e-01	1.57e-01	2.52e-01	1.10e-01	6.59e-01
GOBP ATRIOVENTRICULAR VALVE FORMATION	8	6.41e-03	6.40e-02	0.7570	5.50e-01	1.52e-01	4.78e-01	-1.17e-01	7.55e-02	7.04e-03	4.56e-01	1.92e-02	5.68e-01	7.12e-01
GOMF GAP JUNCTION CHANNEL ACTIVITY INVOLVED IN CARDIAC CONDUCTION ELECTRICAL COUPLING	5	2.06e-01	5.57e-01	0.7570	-1.98e-01	4.11e-01	2.99e-01	3.00e-01	-4.31e-01	4.43e-01	1.11e-01	2.47e-01	2.46e-01	9.53e-02
GOMF UREA TRANSMEMBRANE TRANSPORTER ACTIVITY	7	5.42e-02	2.68e-01	0.7570	-5.74e-01	1.30e-01	8.70e-02	2.82e-01	-3.74e-01	8.59e-03	5.52e-01	6.90e-01	1.96e-01	8.68e-02
GOBP AUTOCRINE SIGNALING	6	9.29e-02	3.68e-01	0.7570	-4.93e-01	-3.42e-01	-1.42e-01	4.81e-02	-4.37e-01	3.67e-02	1.47e-01	5.47e-01	8.38e-01	6.41e-02
GOBP DNA REPLICATION DEPENDENT CHROMATIN ASSEMBLY	6	8.08e-02	3.42e-01	0.7550	-1.75e-01	3.69e-01	-5.20e-01	-3.26e-01	-1.63e-01	4.59e-01	1.17e-01	2.74e-02	1.66e-01	4.89e-01
GOBP POSITIVE REGULATION OF CHONDROCYTE PROLIFERATION	8	1.36e-02	1.09e-01	0.7550	1.05e-01	7.75e-04	1.57e-01	-5.43e-01	4.89e-01	6.07e-01	9.97e-01	4.42e-01	7.81e-03	1.65e-02
GOCC BOX H ACA RNP COMPLEX	7	4.65e-02	2.42e-01	0.7540	-4.45e-01	-2.88e-01	-1.76e-01	-4.38e-01	2.55e-01	4.13e-02	1.86e-01	4.20e-01	4.49e-02	2.43e-01
GOBP RESPONSE TO OZONE	5	1.05e-01	3.93e-01	0.7540	3.49e-01	5.96e-01	1.22e-02	2.92e-01	-7.92e-02	1.77e-01	2.10e-02	9.62e-01	2.58e-01	7.59e-01
GOMF INTERLEUKIN 1 RECEPTOR ACTIVITY	6	1.39e-01	4.59e-01	0.7540	4.70e-02	1.63e-01	2.66e-01	5.11e-01	-4.56e-01	8.42e-01	4.90e-01	2.59e-01	3.02e-02	5.30e-02
GOBP SOMATOTROPIN SECRETING CELL DIFFERENTIATION	5	1.31e-01	4.48e-01	0.7540	-6.11e-01	2.61e-01	-1.62e-01	-1.50e-01	-2.81e-01	1.81e-02	3.12e-01	5.31e-01	5.60e-01	2.76e-01
GOBP PANCREATIC A CELL DIFFERENTIATION	11	7.97e-03	7.47e-02	0.7530	2.01e-01	4.93e-02	-1.62e-01	-5.93e-01	3.84e-01	2.48e-01	7.77e-01	3.53e-01	6.64e-04	2.74e-02
GOMF UBIQUINOL CYTOCHROME C REDUCTASE ACTIVITY	5	1.72e-01	5.11e-01	0.7500	2.18e-01	1.79e-01	-3.96e-01	-4.04e-01	-4.04e-01	3.98e-01	4.88e-01	1.25e-01	1.17e-01	1.18e-01
GOBP ADULT FEEDING BEHAVIOR	9	1.09e-02	9.31e-02	0.7500	4.66e-01	2.85e-01	4.10e-01	-7.46e-02	2.99e-01	1.54e-02	1.38e-01	3.32e-02	6.98e-01	1.20e-01
GOBP POSITIVE REGULATION OF ENAMEL MINERALIZATION	5	2.34e-01	5.88e-01	0.7500	-2.34e-01	-2.42e-01	2.88e-01	5.91e-01	-1.25e-01	3.64e-01	3.48e-01	2.65e-01	2.20e-02	6.28e-01
GOBP INHIBITION OF NEUROEPITHELIAL CELL DIFFERENTIATION	5	1.27e-01	4.40e-01	0.7490	6.26e-01	-5.24e-02	3.52e-01	1.23e-01	1.66e-01	1.53e-02	8.39e-01	1.73e-01	6.33e-01	5.20e-01
GOMF CCR3 CHEMOKINE RECEPTOR BINDING	5	1.52e-01	4.78e-01	0.7480	-5.99e-01	2.25e-02	-2.32e-01	-6.93e-02	-3.77e-01	2.03e-02	9.30e-01	3.70e-01	7.88e-01	1.45e-01
GOBP CHOLINE METABOLIC PROCESS	6	3.55e-02	2.04e-01	0.7470	-7.92e-02	-4.64e-01	5.65e-01	1.09e-01	-7.13e-02	7.37e-01	4.89e-02	1.64e-02	6.43e-01	7.62e-01
GOMF ODORANT BINDING	100	1.13e-32	5.25e-30	0.7460	-5.47e-02	-3.82e-01	1.27e-01	6.25e-01	2.64e-02	3.44e-01	3.80e-11	2.85e-02	2.84e-27	6.48e-01
GOCC NUCLEAR EXOSOME RNASE COMPLEX	12	1.11e-02	9.47e-02	0.7460	-9.67e-03	-1.74e-01	-5.76e-01	-4.29e-01	9.81e-02	9.54e-01	2.97e-01	5.50e-04	1.00e-02	5.56e-01
GOMF ACETYLCHOLINE RECEPTOR INHIBITOR ACTIVITY	6	3.29e-02	1.94e-01	0.7450	1.78e-01	4.85e-01	3.75e-01	-3.53e-01	-1.53e-01	4.49e-01	3.95e-02	1.12e-01	1.34e-01	5.17e-01
GOBP NATURAL KILLER CELL CHEMOTAXIS	9	5.33e-03	5.56e-02	0.7450	-2.55e-01	-3.47e-01	1.84e-02	5.84e-01	1.71e-01	1.86e-01	7.18e-02	9.24e-01	2.42e-03	3.76e-01
GOCC HRD1P UBIQUITIN LIGASE ERAD L COMPLEX	6	4.03e-02	2.21e-01	0.7450	-2.01e-01	3.23e-02	-7.80e-02	-6.51e-01	-2.90e-01	3.94e-01	8.91e-01	7.41e-01	5.77e-03	2.19e-01
GOBP REGULATION OF PHOSPHOLIPID CATABOLIC PROCESS	7	3.94e-02	2.18e-01	0.7450	-3.57e-01	4.92e-01	-4.02e-02	-2.92e-01	3.14e-01	1.01e-01	2.42e-02	8.54e-01	1.81e-01	1.51e-01
GOBP NEGATIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL	11	2.15e-03	2.85e-02	0.7450	-2.65e-01	-3.70e-01	4.22e-01	1.76e-01	-3.72e-01	1.28e-01	3.36e-02	1.53e-02	3.13e-01	3.27e-02
GOCC ALVEOLAR LAMELLAR BODY	7	6.63e-02	3.04e-01	0.7430	-4.51e-02	4.02e-01	5.63e-01	4.73e-02	2.62e-01	8.36e-01	6.53e-02	9.91e-03	8.28e-01	2.30e-01
GOBP REGULATION OF MESONEPHROS DEVELOPMENT	5	1.79e-01	5.20e-01	0.7420	4.93e-01	1.09e-01	-1.33e-01	-5.10e-01	1.35e-01	5.60e-02	6.74e-01	6.06e-01	4.84e-02	6.00e-01
GOCC PI BODY	10	8.07e-03	7.53e-02	0.7420	-2.98e-01	2.31e-01	4.25e-01	4.22e-02	4.75e-01	1.02e-01	2.07e-01	1.98e-02	8.17e-01	9.27e-03
GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY	7	1.29e-01	4.44e-01	0.7410	-3.10e-01	1.44e-01	4.79e-01	4.31e-01	-1.30e-01	1.55e-01	5.09e-01	2.81e-02	4.83e-02	5.52e-01
GOBP TRYPTOPHAN CATABOLIC PROCESS TO KYNURENINE	5	1.52e-01	4.78e-01	0.7410	-2.70e-01	1.48e-01	1.52e-01	6.45e-01	-1.23e-01	2.95e-01	5.67e-01	5.56e-01	1.25e-02	6.34e-01
GOBP PATTERN SPECIFICATION INVOLVED IN KIDNEY DEVELOPMENT	8	1.33e-02	1.07e-01	0.7410	-3.41e-02	1.66e-01	1.16e-01	-6.52e-01	2.85e-01	8.67e-01	4.17e-01	5.71e-01	1.39e-03	1.62e-01
GOBP PURKINJE MYOCYTE TO VENTRICULAR CARDIAC MUSCLE CELL COMMUNICATION	6	9.88e-02	3.80e-01	0.7410	-2.70e-01	1.34e-01	5.91e-02	5.54e-01	-3.84e-01	2.53e-01	5.71e-01	8.02e-01	1.88e-02	1.03e-01
GOBP ERBB4 ERBB4 SIGNALING PATHWAY	6	1.07e-01	3.97e-01	0.7400	-1.40e-01	-2.26e-01	1.24e-01	6.61e-01	-1.57e-01	5.52e-01	3.38e-01	6.00e-01	5.02e-03	5.04e-01
GOMF O PALMITOYLTRANSFERASE ACTIVITY	5	2.07e-01	5.58e-01	0.7400	1.67e-01	-2.77e-01	-5.49e-01	-1.92e-01	3.24e-01	5.17e-01	2.84e-01	3.34e-02	4.57e-01	2.09e-01
GOBP FLAVIN CONTAINING COMPOUND METABOLIC PROCESS	6	1.43e-01	4.63e-01	0.7390	8.83e-02	3.58e-01	-4.40e-01	-4.38e-01	1.59e-01	7.08e-01	1.28e-01	6.19e-02	6.35e-02	4.99e-01
GOMF COPPER ION TRANSMEMBRANE TRANSPORTER ACTIVITY	6	8.26e-02	3.46e-01	0.7390	-2.72e-01	5.51e-01	1.57e-01	-3.45e-01	1.56e-01	2.48e-01	1.94e-02	5.06e-01	1.43e-01	5.08e-01
GOMF AMINE TRANSMEMBRANE TRANSPORTER ACTIVITY	6	6.41e-02	2.98e-01	0.7380	-3.17e-02	3.51e-02	2.07e-01	6.46e-01	2.87e-01	8.93e-01	8.82e-01	3.80e-01	6.15e-03	2.24e-01
GOCC MANNOSYLTRANSFERASE COMPLEX	5	3.17e-01	6.66e-01	0.7380	1.67e-01	-3.88e-02	-5.15e-01	-4.84e-01	1.24e-01	5.18e-01	8.81e-01	4.62e-02	6.09e-02	6.32e-01
GOBP MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA	16	1.46e-03	2.10e-02	0.7370	4.53e-02	-2.25e-01	-5.67e-01	-3.77e-01	1.64e-01	7.54e-01	1.19e-01	8.54e-05	9.00e-03	2.57e-01
GOBP U4 SNRNA 3 END PROCESSING	8	9.06e-02	3.63e-01	0.7360	1.09e-01	-9.22e-02	-5.57e-01	-4.40e-01	1.34e-01	5.92e-01	6.52e-01	6.33e-03	3.13e-02	5.11e-01
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY ENDOTHELIN	6	8.24e-02	3.46e-01	0.7360	7.54e-02	3.21e-01	-2.53e-01	-2.50e-01	-5.54e-01	7.49e-01	1.73e-01	2.83e-01	2.89e-01	1.88e-02
GOMF NADPLUS PROTEIN CYSTEINE ADP RIBOSYLTRANSFERASE ACTIVITY	6	8.60e-02	3.55e-01	0.7360	1.97e-01	-7.49e-02	-4.08e-01	7.05e-02	-5.71e-01	4.03e-01	7.51e-01	8.36e-02	7.65e-01	1.55e-02
GOMF CALCIUM DEPENDENT PROTEIN SERINE THREONINE PHOSPHATASE REGULATOR ACTIVITY	5	2.29e-01	5.82e-01	0.7360	-3.54e-01	-2.00e-02	1.30e-01	5.06e-01	-3.78e-01	1.70e-01	9.38e-01	6.13e-01	5.01e-02	1.44e-01
GOMF PROTEASOME ACTIVATING ACTIVITY	6	1.97e-01	5.45e-01	0.7350	3.55e-01	-1.20e-01	-3.94e-01	-4.34e-01	2.39e-01	1.32e-01	6.12e-01	9.44e-02	6.56e-02	3.11e-01
GOCC T CELL RECEPTOR COMPLEX	13	9.08e-04	1.44e-02	0.7350	1.88e-01	-1.37e-01	5.73e-01	1.54e-01	3.65e-01	2.40e-01	3.91e-01	3.43e-04	3.36e-01	2.26e-02
GOBP POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN	6	1.47e-01	4.69e-01	0.7350	3.50e-02	-3.16e-01	2.31e-01	5.91e-01	-1.90e-01	8.82e-01	1.81e-01	3.26e-01	1.22e-02	4.20e-01
GOBP COMPLEMENT RECEPTOR MEDIATED SIGNALING PATHWAY	12	6.44e-03	6.41e-02	0.7340	-4.01e-01	1.29e-01	3.12e-01	5.09e-01	-7.75e-02	1.62e-02	4.39e-01	6.12e-02	2.28e-03	6.42e-01
GOCC MEIOTIC COHESIN COMPLEX	6	5.79e-02	2.80e-01	0.7340	1.06e-01	2.28e-01	3.26e-01	-4.53e-01	4.06e-01	6.54e-01	3.34e-01	1.66e-01	5.49e-02	8.50e-02
GOBP REGULATION OF PHENOTYPIC SWITCHING	6	8.08e-02	3.42e-01	0.7330	-4.66e-01	2.36e-01	2.38e-01	-1.94e-01	4.11e-01	4.78e-02	3.16e-01	3.12e-01	4.11e-01	8.13e-02
GOBP RESPONSE TO ACTINOMYCIN D	5	3.17e-01	6.67e-01	0.7320	1.06e-01	-4.67e-02	-5.37e-01	-4.84e-01	-1.35e-02	6.81e-01	8.57e-01	3.75e-02	6.09e-02	9.58e-01
GOCC NUCLEOLAR EXOSOME RNASE COMPLEX	10	3.61e-02	2.06e-01	0.7320	-2.17e-02	-1.58e-01	-5.65e-01	-4.28e-01	8.81e-02	9.05e-01	3.87e-01	1.97e-03	1.91e-02	6.29e-01
GOBP REGULATION OF PROTEIN OLIGOMERIZATION	5	2.05e-01	5.55e-01	0.7320	-3.26e-01	-3.18e-01	-2.72e-01	-5.04e-01	1.09e-02	2.07e-01	2.19e-01	2.91e-01	5.11e-02	9.66e-01
GOBP NEGATIVE REGULATION OF CELL CYCLE CHECKPOINT	6	8.69e-02	3.56e-01	0.7310	4.38e-01	5.04e-01	-1.27e-02	-2.57e-01	-1.47e-01	6.33e-02	3.24e-02	9.57e-01	2.75e-01	5.32e-01
GOMF BENZODIAZEPINE RECEPTOR ACTIVITY	9	2.36e-02	1.57e-01	0.7300	2.88e-01	1.24e-01	4.79e-01	1.52e-01	4.27e-01	1.35e-01	5.20e-01	1.28e-02	4.29e-01	2.66e-02
GOBP NUCLEAR MRNA SURVEILLANCE	10	3.31e-02	1.94e-01	0.7300	2.59e-01	-2.07e-01	-4.37e-01	-3.69e-01	3.11e-01	1.56e-01	2.57e-01	1.67e-02	4.33e-02	8.89e-02
GOBP NEGATIVE REGULATION OF CYTOKINESIS	7	1.24e-01	4.34e-01	0.7300	-3.94e-02	6.93e-02	-5.16e-01	-4.98e-01	-1.08e-01	8.57e-01	7.51e-01	1.81e-02	2.24e-02	6.19e-01
GOCC NURF COMPLEX	5	3.06e-01	6.59e-01	0.7300	3.29e-03	-1.17e-01	-4.45e-01	-5.67e-01	9.71e-03	9.90e-01	6.49e-01	8.50e-02	2.82e-02	9.70e-01
GOMF GAMMA AMINOBUTYRIC ACID SODIUM CHLORIDE SYMPORTER ACTIVITY	5	2.06e-01	5.56e-01	0.7290	1.64e-01	1.85e-01	5.35e-01	2.70e-01	-3.35e-01	5.26e-01	4.73e-01	3.83e-02	2.96e-01	1.95e-01
GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION INDEPENDENT DECAY	7	1.31e-01	4.48e-01	0.7290	3.73e-01	-1.39e-01	-4.02e-01	-3.99e-01	2.30e-01	8.77e-02	5.24e-01	6.56e-02	6.73e-02	2.92e-01
GOBP NEGATIVE REGULATION OF CELL FATE COMMITMENT	11	3.35e-03	3.99e-02	0.7290	-1.34e-01	5.33e-01	-3.10e-02	-4.49e-01	-1.64e-01	4.42e-01	2.19e-03	8.59e-01	9.93e-03	3.45e-01
GOCC ROD PHOTORECEPTOR OUTER SEGMENT	5	1.01e-01	3.84e-01	0.7290	1.38e-01	-3.83e-01	-5.66e-01	2.08e-01	4.05e-02	5.94e-01	1.38e-01	2.83e-02	4.21e-01	8.75e-01
GOBP POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION	19	5.04e-05	1.36e-03	0.7280	-3.46e-01	-1.73e-01	2.16e-01	1.95e-01	-5.44e-01	9.11e-03	1.93e-01	1.04e-01	1.41e-01	4.01e-05
GOCC U7 SNRNP	7	9.69e-02	3.77e-01	0.7280	1.74e-01	-5.25e-01	-3.74e-01	-2.28e-01	1.79e-01	4.25e-01	1.62e-02	8.62e-02	2.96e-01	4.13e-01
GOBP ADENINE TRANSPORT	5	2.31e-01	5.84e-01	0.7270	3.44e-01	8.76e-02	-5.82e-01	-2.53e-01	-1.02e-02	1.83e-01	7.34e-01	2.42e-02	3.27e-01	9.69e-01
GOBP FOREBRAIN DORSAL VENTRAL PATTERN FORMATION	7	1.27e-01	4.40e-01	0.7260	-1.26e-02	-3.96e-02	-3.38e-01	-5.01e-01	4.00e-01	9.54e-01	8.56e-01	1.21e-01	2.16e-02	6.66e-02
GOBP NEGATIVE REGULATION OF CGMP MEDIATED SIGNALING	6	9.23e-02	3.67e-01	0.7260	3.91e-01	-4.44e-01	-2.99e-03	4.17e-01	-5.63e-02	9.70e-02	5.96e-02	9.90e-01	7.68e-02	8.11e-01
GOMF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR ACTIVITY	7	1.35e-01	4.54e-01	0.7260	6.65e-02	-7.67e-02	4.23e-01	5.38e-01	-2.20e-01	7.61e-01	7.25e-01	5.28e-02	1.36e-02	3.14e-01
GOBP POSITIVE REGULATION OF DNA CATABOLIC PROCESS	5	3.25e-02	1.93e-01	0.7260	2.38e-01	-4.41e-01	1.55e-01	-4.18e-01	-2.79e-01	3.58e-01	8.76e-02	5.49e-01	1.06e-01	2.81e-01
GOMF DIACYLGLYCEROL O ACYLTRANSFERASE ACTIVITY	5	1.75e-01	5.15e-01	0.7260	-4.36e-02	6.37e-01	1.64e-01	-2.89e-01	9.33e-02	8.66e-01	1.36e-02	5.26e-01	2.62e-01	7.18e-01
GOBP SENSORY PERCEPTION OF SMELL	363	3.48e-116	1.78e-112	0.7260	-1.60e-01	-3.61e-01	1.44e-01	5.86e-01	7.87e-02	1.64e-07	3.11e-32	2.34e-06	9.92e-83	9.99e-03
GOBP PROTEIN LOCALIZATION TO CELL LEADING EDGE	5	1.95e-01	5.43e-01	0.7250	-2.19e-01	2.45e-01	5.63e-01	1.19e-01	-2.96e-01	3.97e-01	3.43e-01	2.94e-02	6.46e-01	2.52e-01
GOBP SIRNA MEDIATED RETROTRANSPOSON SILENCING BY HETEROCHROMATIN FORMATION	11	8.08e-03	7.53e-02	0.7250	-3.35e-01	-1.30e-02	4.42e-01	2.82e-01	3.72e-01	5.45e-02	9.40e-01	1.12e-02	1.06e-01	3.24e-02
GOBP COMMA SHAPED BODY MORPHOGENESIS	5	1.55e-01	4.83e-01	0.7240	2.11e-01	1.98e-01	-6.14e-02	-6.58e-01	6.65e-02	4.13e-01	4.44e-01	8.12e-01	1.08e-02	7.97e-01
GOCC MICROTUBULE BUNDLE	6	7.65e-02	3.32e-01	0.7240	6.86e-02	3.89e-01	5.30e-01	-1.89e-01	2.28e-01	7.71e-01	9.93e-02	2.46e-02	4.22e-01	3.34e-01
GOCC GAMMA SECRETASE COMPLEX	7	1.21e-01	4.28e-01	0.7230	3.41e-01	2.33e-01	-3.78e-01	-4.26e-01	1.70e-01	1.19e-01	2.86e-01	8.34e-02	5.11e-02	4.35e-01
GOBP ETHANOL OXIDATION	9	2.47e-02	1.61e-01	0.7230	2.76e-02	-3.19e-01	-1.70e-02	4.79e-01	-4.37e-01	8.86e-01	9.80e-02	9.30e-01	1.28e-02	2.31e-02
GOBP REGULATION OF FEMALE RECEPTIVITY	7	7.73e-02	3.33e-01	0.7230	-8.97e-02	-8.49e-02	4.27e-01	3.32e-01	4.63e-01	6.81e-01	6.97e-01	5.03e-02	1.28e-01	3.38e-02
GOBP NEGATIVE REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY	6	1.71e-01	5.10e-01	0.7230	-3.58e-01	-1.79e-01	1.47e-01	4.07e-01	-4.18e-01	1.29e-01	4.49e-01	5.33e-01	8.43e-02	7.63e-02
GOMF SIGNAL RECOGNITION PARTICLE BINDING	7	1.24e-01	4.32e-01	0.7220	-1.47e-01	4.41e-02	-3.98e-01	-5.83e-01	8.26e-03	5.02e-01	8.40e-01	6.80e-02	7.58e-03	9.70e-01
GOBP HYALOID VASCULAR PLEXUS REGRESSION	7	1.26e-01	4.37e-01	0.7220	8.93e-02	1.73e-01	3.29e-01	5.49e-01	-2.71e-01	6.83e-01	4.28e-01	1.31e-01	1.18e-02	2.14e-01
GOMF CENTROMERIC DNA BINDING	6	1.34e-01	4.52e-01	0.7220	3.88e-01	-9.11e-02	-5.69e-01	-1.40e-01	-1.40e-01	1.00e-01	6.99e-01	1.58e-02	5.52e-01	5.54e-01
GOBP NEGATIVE REGULATION OF ADIPOSE TISSUE DEVELOPMENT	5	2.03e-01	5.53e-01	0.7220	5.22e-02	4.02e-01	2.67e-01	-1.12e-01	5.22e-01	8.40e-01	1.19e-01	3.01e-01	6.65e-01	4.31e-02
GOMF FIBRINOGEN BINDING	5	6.66e-02	3.05e-01	0.7220	-3.89e-02	-3.53e-01	-3.42e-01	5.26e-01	2.02e-02	8.80e-01	1.71e-01	1.85e-01	4.15e-02	9.38e-01
GOBP POSITIVE REGULATION OF PHOSPHOLIPASE A2 ACTIVITY	5	1.58e-01	4.88e-01	0.7210	3.38e-01	-3.95e-01	1.01e-02	2.25e-01	-4.47e-01	1.91e-01	1.26e-01	9.69e-01	3.84e-01	8.38e-02
GOBP POSITIVE REGULATION OF LEUKOCYTE TETHERING OR ROLLING	13	1.02e-03	1.58e-02	0.7210	-3.50e-01	4.06e-01	3.46e-01	-2.30e-01	2.46e-01	2.90e-02	1.13e-02	3.08e-02	1.51e-01	1.25e-01
GOBP POSITIVE REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY	6	1.41e-01	4.62e-01	0.7210	-3.16e-01	-3.15e-01	1.96e-01	2.55e-01	-4.67e-01	1.81e-01	1.81e-01	4.06e-01	2.80e-01	4.78e-02
GOBP REGULATION OF NEUTROPHIL MEDIATED CYTOTOXICITY	5	1.75e-01	5.16e-01	0.7210	-3.38e-01	2.99e-01	6.91e-02	-4.15e-01	3.73e-01	1.91e-01	2.47e-01	7.89e-01	1.08e-01	1.49e-01
GOBP EMBRYONIC PROCESS INVOLVED IN FEMALE PREGNANCY	6	2.07e-01	5.57e-01	0.7210	3.01e-01	-2.58e-02	-3.10e-01	-4.19e-01	3.95e-01	2.02e-01	9.13e-01	1.89e-01	7.53e-02	9.34e-02
GOMF CONNEXIN BINDING	5	3.25e-01	6.73e-01	0.7200	-2.83e-01	3.34e-02	4.55e-01	3.99e-01	-2.65e-01	2.73e-01	8.97e-01	7.78e-02	1.22e-01	3.05e-01
GOCC SHELTERIN COMPLEX	6	2.29e-01	5.83e-01	0.7190	1.85e-01	-2.62e-01	-4.88e-01	-4.16e-01	5.90e-02	4.33e-01	2.66e-01	3.85e-02	7.76e-02	8.02e-01
GOMF MHC CLASS IB RECEPTOR ACTIVITY	7	2.25e-02	1.52e-01	0.7190	-2.78e-01	-1.97e-01	3.30e-02	5.46e-01	3.19e-01	2.03e-01	3.68e-01	8.80e-01	1.23e-02	1.44e-01
GOBP EPOXIDE METABOLIC PROCESS	5	2.40e-01	5.97e-01	0.7190	9.83e-02	4.63e-01	-2.78e-01	-4.14e-01	2.10e-01	7.04e-01	7.30e-02	2.81e-01	1.09e-01	4.16e-01
GOCC SERINE PROTEASE INHIBITOR COMPLEX	6	8.61e-02	3.55e-01	0.7190	-2.50e-01	4.94e-01	3.36e-01	-1.58e-01	-2.69e-01	2.88e-01	3.63e-02	1.54e-01	5.02e-01	2.53e-01
GOBP CEREBRAL CORTEX TANGENTIAL MIGRATION	5	1.40e-01	4.60e-01	0.7190	-4.06e-01	-4.98e-01	3.09e-01	4.08e-02	-8.21e-02	1.16e-01	5.36e-02	2.32e-01	8.74e-01	7.50e-01
GOBP REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE DEPOLARIZATION	7	1.16e-01	4.16e-01	0.7180	-3.85e-01	1.51e-01	2.39e-01	3.33e-01	-4.20e-01	7.77e-02	4.88e-01	2.73e-01	1.27e-01	5.42e-02
GOCC COHESIN COMPLEX	8	1.62e-02	1.23e-01	0.7180	8.86e-02	1.51e-01	2.88e-01	-4.86e-01	4.07e-01	6.64e-01	4.60e-01	1.58e-01	1.72e-02	4.60e-02
GOBP HISTONE H3 K9 METHYLATION	5	2.94e-01	6.48e-01	0.7180	4.02e-01	-1.43e-01	-4.24e-01	-2.91e-01	2.62e-01	1.19e-01	5.80e-01	1.01e-01	2.60e-01	3.10e-01
GOBP SUCCINYL COA CATABOLIC PROCESS	6	1.32e-01	4.50e-01	0.7170	3.48e-01	-2.45e-01	-3.21e-01	-4.49e-01	-1.67e-01	1.40e-01	2.98e-01	1.73e-01	5.68e-02	4.79e-01
GOMF COMPLEMENT RECEPTOR ACTIVITY	11	1.34e-02	1.08e-01	0.7170	-3.93e-01	1.28e-01	2.88e-01	5.05e-01	-6.59e-02	2.39e-02	4.63e-01	9.76e-02	3.74e-03	7.05e-01
GOCC SMN COMPLEX	9	2.42e-02	1.59e-01	0.7150	2.92e-01	3.90e-01	-3.13e-01	-2.33e-01	3.49e-01	1.29e-01	4.26e-02	1.04e-01	2.25e-01	6.99e-02
GOBP POSITIVE REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION	5	2.95e-01	6.49e-01	0.7150	4.22e-01	-1.80e-01	-4.22e-01	-3.50e-01	2.15e-02	1.02e-01	4.86e-01	1.02e-01	1.75e-01	9.34e-01
GOMF PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ACTIVITY	9	5.25e-02	2.63e-01	0.7140	-2.28e-01	1.31e-01	2.76e-01	3.75e-01	-4.73e-01	2.35e-01	4.95e-01	1.52e-01	5.16e-02	1.40e-02
GOMF METAL ION SEQUESTERING ACTIVITY	5	2.62e-01	6.19e-01	0.7140	-4.04e-01	4.45e-02	1.21e-01	3.17e-01	-4.78e-01	1.17e-01	8.63e-01	6.38e-01	2.19e-01	6.40e-02
GOMF L LACTATE DEHYDROGENASE ACTIVITY	5	1.92e-01	5.38e-01	0.7140	4.79e-01	3.51e-01	1.54e-01	2.54e-01	2.62e-01	6.34e-02	1.75e-01	5.51e-01	3.26e-01	3.11e-01
GOBP POSITIVE REGULATION OF THE FORCE OF HEART CONTRACTION	5	1.36e-01	4.55e-01	0.7140	5.08e-01	2.72e-01	-7.56e-02	3.78e-01	-1.67e-01	4.89e-02	2.93e-01	7.70e-01	1.43e-01	5.17e-01
GOBP SOMATOSTATIN RECEPTOR SIGNALING PATHWAY	5	8.81e-02	3.59e-01	0.7130	-3.77e-01	-1.86e-01	1.43e-01	-5.50e-01	9.23e-02	1.44e-01	4.71e-01	5.80e-01	3.32e-02	7.21e-01
GOMF SOMATOSTATIN RECEPTOR ACTIVITY	5	8.81e-02	3.59e-01	0.7130	-3.77e-01	-1.86e-01	1.43e-01	-5.50e-01	9.23e-02	1.44e-01	4.71e-01	5.80e-01	3.32e-02	7.21e-01
GOBP REGULATION OF NEUTROPHIL ACTIVATION	14	2.12e-03	2.81e-02	0.7130	-3.66e-01	-1.00e-02	5.69e-01	2.05e-01	-8.88e-02	1.77e-02	9.48e-01	2.26e-04	1.83e-01	5.65e-01
GOCC SPERMATOPROTEASOME COMPLEX	5	2.07e-01	5.57e-01	0.7130	-9.73e-02	-5.26e-01	-2.68e-01	-2.84e-01	-2.63e-01	7.06e-01	4.17e-02	2.99e-01	2.71e-01	3.09e-01
GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX SUBSTRATE RELEASE	5	2.03e-01	5.53e-01	0.7120	-4.52e-01	1.33e-01	-1.11e-01	-2.85e-02	-5.22e-01	8.03e-02	6.06e-01	6.69e-01	9.12e-01	4.31e-02
GOMF RNA DIRECTED DNA POLYMERASE ACTIVITY	6	1.06e-01	3.95e-01	0.7110	-2.15e-01	-3.59e-01	-2.29e-01	-4.40e-01	-2.91e-01	3.62e-01	1.28e-01	3.31e-01	6.22e-02	2.17e-01
GOMF TELOMERASE ACTIVITY	6	1.06e-01	3.95e-01	0.7110	-2.15e-01	-3.59e-01	-2.29e-01	-4.40e-01	-2.91e-01	3.62e-01	1.28e-01	3.31e-01	6.22e-02	2.17e-01
GOBP POSITIVE REGULATION OF HEPATIC STELLATE CELL ACTIVATION	5	2.12e-01	5.65e-01	0.7110	-9.98e-02	5.16e-01	2.98e-01	2.52e-01	2.76e-01	6.99e-01	4.55e-02	2.48e-01	3.30e-01	2.84e-01
GOCC CLATHRIN SCULPTED MONOAMINE TRANSPORT VESICLE	5	1.32e-01	4.49e-01	0.7110	3.23e-01	-1.15e-01	-2.54e-01	4.49e-01	-3.48e-01	2.11e-01	6.55e-01	3.24e-01	8.20e-02	1.78e-01
GOBP POSITIVE REGULATION OF APOPTOTIC CELL CLEARANCE	8	3.34e-02	1.96e-01	0.7100	-5.38e-01	-2.68e-01	-2.85e-01	-1.47e-01	2.01e-01	8.43e-03	1.89e-01	1.62e-01	4.71e-01	3.25e-01
GOBP TRACHEA FORMATION	7	2.87e-02	1.78e-01	0.7100	-3.63e-01	5.28e-02	1.25e-01	-5.85e-01	1.12e-01	9.60e-02	8.09e-01	5.68e-01	7.40e-03	6.08e-01
GOMF GLUCURONOSYL N ACETYLGALACTOSAMINYL PROTEOGLYCAN 4 BETA N ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY	6	9.11e-02	3.65e-01	0.7100	-3.61e-01	3.01e-01	4.42e-02	-2.42e-01	-4.72e-01	1.26e-01	2.02e-01	8.51e-01	3.05e-01	4.50e-02
GOBP CELLULAR RESPONSE TO LAMINAR FLUID SHEAR STRESS	8	6.77e-02	3.07e-01	0.7090	-1.21e-01	5.76e-02	-3.87e-01	-5.22e-01	-2.50e-01	5.55e-01	7.78e-01	5.78e-02	1.06e-02	2.20e-01
GOBP PROTEIN HISTIDYL MODIFICATION TO DIPHTHAMIDE	6	1.82e-01	5.24e-01	0.7090	2.14e-01	2.77e-02	-4.78e-01	-3.73e-01	-2.96e-01	3.63e-01	9.06e-01	4.27e-02	1.13e-01	2.09e-01
GOBP HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	12	8.89e-03	8.07e-02	0.7080	-3.33e-01	4.08e-01	3.03e-01	2.06e-01	-3.01e-01	4.60e-02	1.44e-02	6.94e-02	2.16e-01	7.10e-02
GOBP GENERAL ADAPTATION SYNDROME BEHAVIORAL PROCESS	5	2.19e-01	5.73e-01	0.7080	-4.19e-01	-3.53e-01	3.70e-01	2.26e-01	1.12e-01	1.05e-01	1.72e-01	1.52e-01	3.81e-01	6.65e-01
GOBP URATE METABOLIC PROCESS	12	6.59e-03	6.52e-02	0.7070	-2.65e-01	1.02e-01	2.10e-02	3.70e-01	-5.32e-01	1.12e-01	5.41e-01	9.00e-01	2.65e-02	1.43e-03
GOBP REGULATION OF MESODERM DEVELOPMENT	6	1.08e-01	4.01e-01	0.7070	-6.05e-01	-2.12e-01	2.97e-01	1.52e-02	-1.02e-02	1.02e-02	3.69e-01	2.08e-01	9.49e-01	9.66e-01
GOBP POSITIVE REGULATION OF FERTILIZATION	5	1.57e-01	4.85e-01	0.7070	5.67e-01	-2.69e-01	1.31e-01	-1.41e-01	2.62e-01	2.81e-02	2.98e-01	6.12e-01	5.84e-01	3.10e-01
GOBP AV NODE CELL TO BUNDLE OF HIS CELL SIGNALING	11	1.12e-02	9.50e-02	0.7060	-3.60e-01	1.23e-01	8.16e-02	4.54e-01	-3.76e-01	3.86e-02	4.81e-01	6.39e-01	9.12e-03	3.09e-02
GOBP TRUNK SEGMENTATION	5	2.73e-01	6.28e-01	0.7060	1.23e-01	3.52e-01	3.03e-01	3.36e-01	-3.93e-01	6.33e-01	1.73e-01	2.40e-01	1.94e-01	1.28e-01
GOBP MATURATION OF LSU RRNA	27	1.60e-05	5.07e-04	0.7060	8.00e-02	-1.69e-01	-5.47e-01	-3.85e-01	1.24e-01	4.72e-01	1.27e-01	8.49e-07	5.35e-04	2.63e-01
GOCC MEMBRANE ATTACK COMPLEX	7	1.01e-01	3.86e-01	0.7050	-4.00e-01	-3.49e-01	9.63e-02	4.08e-01	-1.99e-01	6.67e-02	1.09e-01	6.59e-01	6.15e-02	3.62e-01
GOBP REGULATION OF ANTIMICROBIAL PEPTIDE PRODUCTION	9	4.53e-02	2.37e-01	0.7050	-3.57e-01	-3.30e-01	2.57e-01	3.37e-01	-2.85e-01	6.33e-02	8.61e-02	1.82e-01	7.99e-02	1.39e-01
GOBP MESENCHYMAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT	6	1.21e-01	4.26e-01	0.7050	2.30e-01	-1.65e-01	2.23e-02	-4.63e-01	4.50e-01	3.30e-01	4.83e-01	9.25e-01	4.94e-02	5.64e-02
GOMF 7S RNA BINDING	7	1.58e-01	4.88e-01	0.7050	-1.81e-02	-2.81e-02	-4.61e-01	-4.39e-01	2.99e-01	9.34e-01	8.98e-01	3.45e-02	4.42e-02	1.70e-01
GOBP RENAL WATER ABSORPTION	6	1.29e-01	4.45e-01	0.7040	-2.02e-01	5.06e-01	-1.82e-01	-3.99e-01	-8.31e-02	3.91e-01	3.17e-02	4.41e-01	9.09e-02	7.24e-01
GOBP REGULATION OF T CELL COSTIMULATION	5	5.17e-02	2.61e-01	0.7040	-1.85e-02	5.15e-01	-3.99e-01	2.47e-01	-9.72e-02	9.43e-01	4.59e-02	1.22e-01	3.39e-01	7.07e-01
GOBP CILIARY BODY MORPHOGENESIS	5	1.32e-01	4.48e-01	0.7040	1.75e-01	2.42e-01	-1.30e-02	-2.30e-01	-5.95e-01	4.97e-01	3.48e-01	9.60e-01	3.74e-01	2.13e-02
GOMF NEUROLIGIN FAMILY PROTEIN BINDING	5	3.11e-01	6.62e-01	0.7030	-1.19e-01	-2.21e-01	2.54e-01	4.56e-01	-3.99e-01	6.45e-01	3.91e-01	3.25e-01	7.76e-02	1.22e-01
GOBP MAINTENANCE OF ANIMAL ORGAN IDENTITY	5	2.72e-01	6.27e-01	0.7030	-2.94e-01	-3.16e-01	4.18e-01	3.28e-01	-1.63e-01	2.56e-01	2.22e-01	1.06e-01	2.03e-01	5.27e-01
GOMF INTRACELLULAR CYCLIC NUCLEOTIDE ACTIVATED MONOATOMIC CATION CHANNEL ACTIVITY	10	3.72e-02	2.10e-01	0.7030	-2.42e-01	3.26e-01	3.64e-01	4.37e-01	-7.87e-02	1.84e-01	7.44e-02	4.61e-02	1.68e-02	6.67e-01
GOBP NEGATIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS	7	6.32e-02	2.96e-01	0.7030	-5.98e-01	2.76e-01	4.29e-02	1.85e-01	-1.54e-01	6.14e-03	2.06e-01	8.44e-01	3.96e-01	4.80e-01
GOMF N ACETYLGLUCOSAMINE 6 O SULFOTRANSFERASE ACTIVITY	6	1.16e-01	4.16e-01	0.7020	2.37e-01	2.32e-01	-3.20e-01	-1.44e-01	-5.10e-01	3.15e-01	3.25e-01	1.75e-01	5.42e-01	3.05e-02
GOMF ESTROGEN 16 ALPHA HYDROXYLASE ACTIVITY	8	3.22e-02	1.92e-01	0.7020	3.68e-01	-4.36e-01	-3.55e-01	2.04e-01	1.70e-02	7.15e-02	3.27e-02	8.22e-02	3.18e-01	9.33e-01
GOBP CELLULAR RESPONSE TO OXYGEN GLUCOSE DEPRIVATION	5	2.70e-01	6.24e-01	0.7020	-2.05e-01	2.39e-01	-4.21e-01	-4.36e-01	1.62e-01	4.28e-01	3.54e-01	1.03e-01	9.11e-02	5.30e-01
GOCC MITOCHONDRIAL INTERMEMBRANE SPACE PROTEIN TRANSPORTER COMPLEX	5	3.16e-01	6.66e-01	0.7020	1.76e-01	2.49e-01	-4.40e-01	-4.53e-01	-2.22e-02	4.95e-01	3.35e-01	8.84e-02	7.96e-02	9.32e-01
GOBP SNRNA MODIFICATION	6	2.22e-01	5.76e-01	0.7010	1.15e-01	-2.62e-01	-3.90e-01	-3.32e-01	3.84e-01	6.25e-01	2.67e-01	9.82e-02	1.58e-01	1.03e-01
GOBP B CELL PROLIFERATION INVOLVED IN IMMUNE RESPONSE	6	1.92e-01	5.38e-01	0.7010	2.64e-01	3.93e-01	4.45e-01	2.40e-01	1.07e-01	2.62e-01	9.56e-02	5.92e-02	3.08e-01	6.51e-01
GOBP REGULATION OF ISOTYPE SWITCHING TO IGE ISOTYPES	6	1.55e-01	4.83e-01	0.7010	2.69e-01	3.88e-01	3.44e-01	-3.80e-02	3.85e-01	2.54e-01	9.94e-02	1.44e-01	8.72e-01	1.03e-01
GOBP SEMICIRCULAR CANAL MORPHOGENESIS	7	7.65e-02	3.32e-01	0.7000	6.42e-01	-1.97e-01	-8.53e-02	-4.37e-02	1.72e-01	3.25e-03	3.66e-01	6.96e-01	8.41e-01	4.30e-01
GOMF ALPHA 2A ADRENERGIC RECEPTOR BINDING	5	2.47e-01	6.04e-01	0.7000	-4.78e-02	1.85e-01	-1.91e-04	-4.59e-01	4.93e-01	8.53e-01	4.73e-01	9.99e-01	7.58e-02	5.62e-02
GOBP COPPER ION TRANSMEMBRANE TRANSPORT	7	5.48e-02	2.70e-01	0.7000	-2.76e-01	4.47e-01	1.98e-01	-4.07e-01	9.33e-02	2.06e-01	4.04e-02	3.64e-01	6.23e-02	6.69e-01
GOBP CORTISOL SECRETION	5	1.58e-01	4.88e-01	0.7000	5.28e-01	2.75e-01	5.29e-02	-3.56e-01	-7.28e-02	4.07e-02	2.87e-01	8.38e-01	1.68e-01	7.78e-01
GOMF INOSITOL 1 4 5 TRISPHOSPHATE 5 PHOSPHATASE ACTIVITY	6	1.04e-01	3.92e-01	0.6990	-3.40e-01	9.11e-02	1.64e-01	-6.88e-02	-5.77e-01	1.49e-01	6.99e-01	4.88e-01	7.71e-01	1.44e-02
GOBP NEGATIVE REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS	6	2.27e-01	5.80e-01	0.6970	-9.56e-02	2.04e-03	-5.60e-01	-3.91e-01	-1.04e-01	6.85e-01	9.93e-01	1.76e-02	9.75e-02	6.60e-01
GOMF VOLTAGE GATED SODIUM CHANNEL ACTIVITY INVOLVED IN CARDIAC MUSCLE CELL ACTION POTENTIAL	5	1.97e-01	5.46e-01	0.6960	-4.74e-01	1.87e-01	-2.24e-01	4.25e-02	-4.17e-01	6.65e-02	4.70e-01	3.86e-01	8.69e-01	1.06e-01
GOBP POST EMBRYONIC CAMERA TYPE EYE DEVELOPMENT	8	3.30e-02	1.94e-01	0.6960	-1.33e-01	-4.10e-01	2.26e-02	-3.84e-01	3.88e-01	5.16e-01	4.45e-02	9.12e-01	6.02e-02	5.71e-02
GOCC RIBONUCLEASE MRP COMPLEX	10	3.52e-02	2.03e-01	0.6960	2.04e-01	-6.04e-02	-6.07e-01	-2.62e-01	-4.58e-02	2.64e-01	7.41e-01	8.87e-04	1.52e-01	8.02e-01
GOBP REGULATION OF CHRONIC INFLAMMATORY RESPONSE	9	1.17e-02	9.80e-02	0.6950	1.70e-01	-3.12e-02	5.50e-02	6.69e-01	6.23e-02	3.78e-01	8.71e-01	7.75e-01	5.14e-04	7.46e-01
GOMF EPINEPHRINE BINDING	6	7.43e-02	3.26e-01	0.6950	1.84e-01	4.10e-01	3.67e-01	-3.66e-01	1.15e-01	4.34e-01	8.21e-02	1.20e-01	1.20e-01	6.27e-01
GOBP ABSCISSION	6	2.01e-01	5.50e-01	0.6950	-2.98e-01	3.78e-03	-4.78e-01	-4.04e-01	5.35e-02	2.06e-01	9.87e-01	4.26e-02	8.65e-02	8.20e-01
GOBP INTERLEUKIN 5 MEDIATED SIGNALING PATHWAY	6	2.04e-01	5.54e-01	0.6950	-5.86e-02	3.81e-01	3.38e-01	4.68e-01	-2.19e-02	8.04e-01	1.06e-01	1.52e-01	4.70e-02	9.26e-01
GOMF IMPORTIN ALPHA FAMILY PROTEIN BINDING	9	5.66e-02	2.76e-01	0.6950	1.16e-01	-1.12e-01	-3.68e-01	-5.56e-01	-1.12e-01	5.46e-01	5.62e-01	5.60e-02	3.90e-03	5.60e-01
GOMF IGG BINDING	6	1.09e-01	4.03e-01	0.6940	-2.41e-01	3.60e-01	1.53e-01	6.78e-03	5.20e-01	3.06e-01	1.26e-01	5.17e-01	9.77e-01	2.73e-02
GOMF HISTONE H3K36 TRIMETHYLTRANSFERASE ACTIVITY	5	1.96e-01	5.44e-01	0.6930	1.61e-01	1.71e-01	5.43e-01	-6.09e-02	3.57e-01	5.32e-01	5.09e-01	3.55e-02	8.14e-01	1.67e-01
GOCC DERLIN 1 RETROTRANSLOCATION COMPLEX	8	6.31e-02	2.95e-01	0.6930	-3.18e-01	5.00e-02	-1.78e-01	-5.58e-01	1.82e-01	1.19e-01	8.06e-01	3.83e-01	6.23e-03	3.72e-01
GOCC NETWORK FORMING COLLAGEN TRIMER	6	1.10e-01	4.06e-01	0.6930	3.85e-01	-4.33e-01	2.61e-01	2.63e-01	-8.34e-02	1.03e-01	6.61e-02	2.68e-01	2.64e-01	7.24e-01
GOBP POSITIVE REGULATION OF THYROID HORMONE GENERATION	5	1.77e-01	5.18e-01	0.6930	4.47e-01	2.13e-01	-5.02e-02	-1.83e-03	-4.81e-01	8.32e-02	4.08e-01	8.46e-01	9.94e-01	6.23e-02
GOBP CILIARY NEUROTROPHIC FACTOR MEDIATED SIGNALING PATHWAY	5	9.96e-02	3.82e-01	0.6930	2.04e-01	8.96e-02	5.80e-01	-2.14e-01	2.18e-01	4.30e-01	7.29e-01	2.47e-02	4.07e-01	3.98e-01
GOBP NEURON GLIAL CELL SIGNALING	5	2.64e-01	6.19e-01	0.6920	-3.86e-01	2.87e-01	3.21e-01	3.61e-01	1.25e-01	1.35e-01	2.67e-01	2.14e-01	1.62e-01	6.29e-01
GOMF BUTYRATE COA LIGASE ACTIVITY	8	5.40e-02	2.68e-01	0.6920	1.90e-01	5.76e-01	1.74e-01	2.48e-01	-1.41e-01	3.53e-01	4.78e-03	3.94e-01	2.25e-01	4.89e-01
GOCC SIGNAL PEPTIDASE COMPLEX	5	3.04e-01	6.58e-01	0.6920	-3.37e-01	-2.85e-01	-4.26e-01	-3.19e-01	-3.24e-02	1.91e-01	2.70e-01	9.91e-02	2.16e-01	9.00e-01
GOMF TRACE AMINE RECEPTOR ACTIVITY	7	9.75e-02	3.78e-01	0.6920	1.91e-01	-4.26e-01	3.28e-01	3.91e-01	1.26e-02	3.80e-01	5.11e-02	1.33e-01	7.30e-02	9.54e-01
GOBP FATTY ACYL COA CATABOLIC PROCESS	5	2.72e-01	6.27e-01	0.6920	4.39e-01	2.95e-01	-8.92e-02	-1.97e-01	3.89e-01	8.90e-02	2.53e-01	7.30e-01	4.45e-01	1.32e-01
GOMF SUMO POLYMER BINDING	5	1.63e-01	4.96e-01	0.6910	1.05e-01	-3.89e-01	-2.96e-01	4.29e-01	-2.08e-01	6.85e-01	1.32e-01	2.52e-01	9.68e-02	4.20e-01
GOMF AMINOACYL TRNA HYDROLASE ACTIVITY	5	3.75e-01	7.15e-01	0.6910	1.13e-01	-5.38e-02	-5.32e-01	-4.16e-01	-7.36e-02	6.61e-01	8.35e-01	3.94e-02	1.07e-01	7.76e-01
GOBP REGULATION OF BRANCHING MORPHOGENESIS OF A NERVE	5	2.97e-01	6.51e-01	0.6910	-5.91e-02	3.91e-01	4.65e-01	1.46e-01	2.89e-01	8.19e-01	1.30e-01	7.19e-02	5.72e-01	2.64e-01
GOBP URATE TRANSPORT	11	2.80e-02	1.76e-01	0.6910	-1.55e-01	3.29e-01	3.37e-01	4.63e-01	-1.30e-01	3.74e-01	5.89e-02	5.29e-02	7.87e-03	4.56e-01
GOBP NEGATIVE REGULATION OF LIPOPROTEIN METABOLIC PROCESS	5	2.75e-01	6.29e-01	0.6900	-2.84e-01	-5.18e-01	-3.12e-01	-1.69e-01	-3.75e-02	2.71e-01	4.50e-02	2.27e-01	5.12e-01	8.85e-01
GOCC CYCLIN CDK POSITIVE TRANSCRIPTION ELONGATION FACTOR COMPLEX	6	1.52e-01	4.80e-01	0.6890	3.38e-02	-3.17e-01	-2.79e-01	-5.22e-01	-1.52e-01	8.86e-01	1.79e-01	2.37e-01	2.68e-02	5.18e-01
GOBP REGULATION OF SNRNA TRANSCRIPTION BY RNA POLYMERASE II	5	2.50e-01	6.07e-01	0.6890	-7.98e-02	1.20e-02	-8.85e-02	-6.09e-01	2.99e-01	7.57e-01	9.63e-01	7.32e-01	1.83e-02	2.46e-01
GOBP UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY	5	3.50e-01	6.96e-01	0.6890	2.44e-01	1.19e-01	-4.30e-01	-4.62e-01	-6.18e-02	3.45e-01	6.46e-01	9.61e-02	7.39e-02	8.11e-01
GOBP MEMBRANE DEPOLARIZATION DURING AV NODE CELL ACTION POTENTIAL	6	1.75e-01	5.16e-01	0.6890	-4.99e-01	1.12e-01	1.58e-01	3.89e-01	-1.93e-01	3.44e-02	6.35e-01	5.01e-01	9.92e-02	4.13e-01
GOBP PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY	6	1.53e-01	4.81e-01	0.6890	-3.36e-01	-5.03e-01	-1.83e-01	-1.55e-01	-2.26e-01	1.55e-01	3.30e-02	4.36e-01	5.10e-01	3.37e-01
GOBP POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY	14	8.38e-03	7.74e-02	0.6880	-5.02e-02	-3.66e-01	-3.89e-01	-4.00e-01	1.60e-01	7.45e-01	1.77e-02	1.17e-02	9.58e-03	3.00e-01
GOBP NEGATIVE REGULATION OF INTERLEUKIN 4 PRODUCTION	7	7.08e-02	3.17e-01	0.6880	3.48e-01	4.80e-01	3.22e-01	-7.89e-02	-1.09e-01	1.10e-01	2.79e-02	1.41e-01	7.18e-01	6.19e-01
GOBP DETECTION OF BACTERIUM	16	1.05e-03	1.61e-02	0.6870	-4.67e-01	1.21e-01	3.84e-01	1.10e-01	-2.84e-01	1.23e-03	4.04e-01	7.88e-03	4.47e-01	4.95e-02
GOBP POSITIVE REGULATION OF T HELPER 2 CELL CYTOKINE PRODUCTION	8	7.20e-02	3.20e-01	0.6870	2.66e-02	5.35e-01	4.01e-01	1.01e-02	1.56e-01	8.96e-01	8.82e-03	4.98e-02	9.61e-01	4.45e-01
GOBP DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION	13	5.34e-03	5.56e-02	0.6870	-1.57e-01	4.71e-01	2.14e-01	3.80e-01	-1.87e-01	3.25e-01	3.30e-03	1.82e-01	1.76e-02	2.43e-01
GOBP POSITIVE REGULATION OF NEUTROPHIL ACTIVATION	6	2.05e-01	5.56e-01	0.6860	1.87e-02	1.67e-01	5.64e-01	2.65e-01	-2.33e-01	9.37e-01	4.78e-01	1.67e-02	2.61e-01	3.23e-01
GOBP PROTEIN LOCALIZATION TO GOLGI MEMBRANE	5	2.47e-01	6.04e-01	0.6860	-5.42e-01	-3.28e-01	-2.17e-01	-8.42e-02	-1.25e-01	3.60e-02	2.04e-01	4.00e-01	7.44e-01	6.28e-01
GOMF CARBOHYDRATE PROTON SYMPORTER ACTIVITY	7	1.42e-01	4.63e-01	0.6860	-1.27e-01	3.95e-01	3.79e-01	3.75e-01	1.20e-01	5.60e-01	7.03e-02	8.22e-02	8.60e-02	5.83e-01
GOCC FASCIA ADHERENS	8	1.04e-01	3.91e-01	0.6860	2.09e-01	-1.20e-02	4.68e-01	4.28e-01	-1.59e-01	3.05e-01	9.53e-01	2.20e-02	3.61e-02	4.37e-01
GOBP POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN	7	9.34e-02	3.69e-01	0.6860	2.98e-01	-1.24e-01	1.64e-01	5.83e-01	9.66e-03	1.73e-01	5.70e-01	4.52e-01	7.56e-03	9.65e-01
GOBP INTERLEUKIN 2 MEDIATED SIGNALING PATHWAY	8	4.32e-02	2.31e-01	0.6860	-2.25e-01	4.50e-01	3.32e-01	-9.01e-02	-3.15e-01	2.71e-01	2.75e-02	1.04e-01	6.59e-01	1.22e-01
GOBP C X C CHEMOKINE RECEPTOR CXCR4 SIGNALING PATHWAY	5	2.71e-01	6.25e-01	0.6860	-5.17e-01	-5.60e-02	3.76e-01	2.01e-01	1.35e-01	4.54e-02	8.28e-01	1.46e-01	4.36e-01	6.00e-01
GOCC TRANSCRIPTION FACTOR TFIIA COMPLEX	5	2.62e-01	6.19e-01	0.6850	3.94e-01	4.05e-01	3.70e-01	1.16e-01	-1.70e-03	1.27e-01	1.17e-01	1.52e-01	6.54e-01	9.95e-01
GOBP HEXOSE PHOSPHATE TRANSPORT	7	4.62e-02	2.41e-01	0.6850	-5.21e-01	-2.35e-01	-3.56e-01	7.64e-02	9.98e-02	1.69e-02	2.82e-01	1.03e-01	7.26e-01	6.47e-01
GOBP REGULATION OF LYSOSOME SIZE	8	7.19e-02	3.20e-01	0.6840	-3.16e-02	2.78e-01	-3.53e-01	-3.49e-01	3.79e-01	8.77e-01	1.74e-01	8.39e-02	8.71e-02	6.33e-02
GOCC BORC COMPLEX	8	7.19e-02	3.20e-01	0.6840	-3.16e-02	2.78e-01	-3.53e-01	-3.49e-01	3.79e-01	8.77e-01	1.74e-01	8.39e-02	8.71e-02	6.33e-02
GOCC IMMUNOGLOBULIN COMPLEX	10	2.42e-02	1.59e-01	0.6840	1.51e-01	3.12e-01	2.84e-01	6.71e-02	5.13e-01	4.09e-01	8.79e-02	1.20e-01	7.13e-01	4.93e-03
GOBP TANGENTIAL MIGRATION FROM THE SUBVENTRICULAR ZONE TO THE OLFACTORY BULB	7	1.58e-01	4.88e-01	0.6840	-2.87e-01	-3.71e-02	1.73e-01	3.79e-01	-4.59e-01	1.88e-01	8.65e-01	4.27e-01	8.22e-02	3.55e-02
GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY	5	3.10e-01	6.62e-01	0.6840	3.47e-01	2.79e-01	-1.36e-01	-4.42e-01	2.38e-01	1.79e-01	2.80e-01	6.00e-01	8.73e-02	3.57e-01
GOBP SATELLITE CELL ACTIVATION INVOLVED IN SKELETAL MUSCLE REGENERATION	5	2.69e-01	6.23e-01	0.6840	2.77e-01	5.49e-01	2.43e-01	3.13e-02	1.71e-01	2.84e-01	3.34e-02	3.47e-01	9.03e-01	5.09e-01
GOBP REGULATION OF EATING BEHAVIOR	7	2.09e-02	1.45e-01	0.6830	4.44e-02	2.05e-01	5.22e-01	-1.51e-01	-3.58e-01	8.39e-01	3.48e-01	1.68e-02	4.88e-01	1.01e-01
GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS	10	2.44e-02	1.59e-01	0.6830	-2.19e-01	3.22e-01	-3.31e-01	-3.85e-01	-2.40e-01	2.29e-01	7.76e-02	7.00e-02	3.52e-02	1.89e-01
GOMF PSEUDOURIDINE SYNTHASE ACTIVITY	12	2.59e-02	1.65e-01	0.6830	1.33e-01	-2.40e-01	-4.56e-01	-4.23e-01	-6.74e-02	4.25e-01	1.50e-01	6.29e-03	1.11e-02	6.86e-01
GOBP EOSINOPHIL ACTIVATION	8	4.90e-02	2.50e-01	0.6830	-4.54e-01	-1.24e-01	2.45e-01	2.69e-01	3.35e-01	2.61e-02	5.43e-01	2.29e-01	1.87e-01	1.01e-01
GOBP REGULATION OF THE FORCE OF HEART CONTRACTION BY CHEMICAL SIGNAL	6	1.87e-01	5.30e-01	0.6830	-2.91e-01	2.87e-01	-2.83e-01	-4.63e-01	7.35e-02	2.18e-01	2.24e-01	2.31e-01	4.97e-02	7.55e-01
GOBP REGULATION OF COMPLEMENT ACTIVATION CLASSICAL PATHWAY	9	5.33e-02	2.66e-01	0.6810	-3.96e-01	-1.83e-01	1.87e-02	3.06e-01	-4.25e-01	3.99e-02	3.41e-01	9.22e-01	1.12e-01	2.73e-02
GOMF GLUTAMATE SODIUM SYMPORTER ACTIVITY	5	2.70e-01	6.24e-01	0.6810	-2.85e-01	3.61e-01	1.24e-01	1.22e-01	-4.72e-01	2.70e-01	1.62e-01	6.32e-01	6.38e-01	6.76e-02
GOMF EXTRACELLULAR MATRIX PROTEIN BINDING	6	1.41e-01	4.61e-01	0.6810	3.45e-01	-4.48e-01	1.89e-01	2.69e-01	1.91e-01	1.43e-01	5.76e-02	4.23e-01	2.54e-01	4.19e-01
GOMF RNA POLYMERASE I GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY	5	2.07e-01	5.57e-01	0.6810	6.12e-01	-1.56e-01	-8.38e-02	-2.41e-01	-1.36e-02	1.79e-02	5.46e-01	7.45e-01	3.50e-01	9.58e-01
GOBP REGULATION OF EXTRACELLULAR MATRIX CONSTITUENT SECRETION	9	3.23e-02	1.92e-01	0.6810	-1.69e-01	2.94e-01	3.16e-01	-1.77e-01	4.66e-01	3.81e-01	1.27e-01	1.01e-01	3.58e-01	1.54e-02
GOBP MEDIUM CHAIN FATTY ACID BIOSYNTHETIC PROCESS	6	1.73e-01	5.13e-01	0.6800	-1.91e-01	5.84e-01	2.54e-01	1.35e-01	4.17e-02	4.17e-01	1.32e-02	2.80e-01	5.66e-01	8.60e-01
GOBP POSITIVE REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE	6	1.30e-01	4.47e-01	0.6790	1.54e-01	3.59e-01	-1.81e-01	-3.14e-02	-5.24e-01	5.13e-01	1.27e-01	4.41e-01	8.94e-01	2.62e-02
GOBP REGULATION OF MONOCYTE EXTRAVASATION	7	1.19e-01	4.23e-01	0.6790	-3.43e-01	-1.47e-01	3.49e-01	3.52e-01	2.75e-01	1.16e-01	5.01e-01	1.10e-01	1.07e-01	2.07e-01
GOMF OXYSTEROL BINDING	8	7.78e-02	3.35e-01	0.6790	-3.64e-01	-3.35e-01	5.69e-02	1.86e-01	-4.22e-01	7.48e-02	1.01e-01	7.81e-01	3.62e-01	3.87e-02
GOCC BASEMENT MEMBRANE COLLAGEN TRIMER	6	2.18e-01	5.72e-01	0.6790	2.11e-01	-1.53e-01	2.75e-01	4.71e-01	-3.09e-01	3.70e-01	5.18e-01	2.44e-01	4.58e-02	1.90e-01
GOBP RETINAL BIPOLAR NEURON DIFFERENTIATION	7	4.25e-02	2.28e-01	0.6780	4.72e-01	2.90e-01	-1.86e-01	3.29e-01	-1.03e-01	3.05e-02	1.84e-01	3.95e-01	1.32e-01	6.37e-01
GOMF STRUCTURAL CONSTITUENT OF PRESYNAPTIC ACTIVE ZONE	5	3.31e-01	6.79e-01	0.6780	-6.92e-03	-3.46e-01	2.79e-01	4.99e-01	-1.15e-01	9.79e-01	1.80e-01	2.81e-01	5.33e-02	6.56e-01
GOCC MHC CLASS I PEPTIDE LOADING COMPLEX	8	1.61e-02	1.22e-01	0.6780	-2.79e-01	-2.44e-01	1.48e-01	-2.30e-01	-4.97e-01	1.71e-01	2.31e-01	4.69e-01	2.60e-01	1.49e-02
GOBP INTERNEURON MIGRATION FROM THE SUBPALLIUM TO THE CORTEX	7	6.56e-02	3.02e-01	0.6780	-1.80e-01	-5.87e-01	2.24e-01	4.05e-02	1.75e-01	4.11e-01	7.11e-03	3.06e-01	8.53e-01	4.23e-01
GOCC BRISC COMPLEX	5	1.74e-01	5.14e-01	0.6780	2.76e-01	4.26e-01	-4.04e-01	-1.73e-02	-1.93e-01	2.84e-01	9.86e-02	1.17e-01	9.47e-01	4.55e-01
GOBP NUCLEAR MIGRATION ALONG MICROTUBULE	5	2.62e-01	6.19e-01	0.6780	4.18e-01	-4.71e-01	-1.88e-01	-6.76e-02	1.50e-01	1.05e-01	6.82e-02	4.66e-01	7.93e-01	5.62e-01
GOBP ISG15 PROTEIN CONJUGATION	6	1.38e-01	4.57e-01	0.6770	-3.30e-01	-2.37e-01	-8.02e-02	-5.06e-01	1.76e-01	1.62e-01	3.14e-01	7.34e-01	3.19e-02	4.55e-01
GOBP TRNA THREONYLCARBAMOYLADENOSINE MODIFICATION	5	3.62e-01	7.04e-01	0.6760	9.19e-02	9.44e-02	-5.47e-01	-3.66e-01	8.35e-02	7.22e-01	7.15e-01	3.40e-02	1.57e-01	7.46e-01
GOBP MESENCHYMAL CELL DEVELOPMENT	6	1.13e-01	4.11e-01	0.6760	3.82e-02	1.55e-01	3.11e-01	-3.77e-01	4.39e-01	8.71e-01	5.11e-01	1.87e-01	1.10e-01	6.23e-02
GOMF PROTEINASE ACTIVATED RECEPTOR ACTIVITY	5	3.71e-01	7.10e-01	0.6760	-1.31e-01	-2.65e-01	-4.05e-01	-3.87e-01	2.36e-01	6.11e-01	3.04e-01	1.16e-01	1.34e-01	3.61e-01
GOBP HEAT ACCLIMATION	5	2.45e-01	6.02e-01	0.6760	-5.23e-01	1.65e-01	-2.70e-01	-2.86e-01	-3.12e-02	4.29e-02	5.23e-01	2.95e-01	2.68e-01	9.04e-01
GOMF 3 5 RNA HELICASE ACTIVITY	6	2.55e-01	6.13e-01	0.6750	5.92e-02	-3.98e-01	-3.63e-01	-3.98e-01	6.34e-02	8.02e-01	9.14e-02	1.23e-01	9.15e-02	7.88e-01
GOCC CALCINEURIN COMPLEX	6	2.64e-01	6.19e-01	0.6750	9.03e-02	1.85e-01	3.53e-01	4.19e-01	-3.37e-01	7.02e-01	4.33e-01	1.35e-01	7.54e-02	1.53e-01
GOCC FIBRINOGEN COMPLEX	8	1.91e-02	1.37e-01	0.6750	9.92e-03	-1.81e-01	-3.89e-02	6.36e-01	1.29e-01	9.61e-01	3.76e-01	8.49e-01	1.82e-03	5.28e-01
GOBP AGGRESSIVE BEHAVIOR	7	9.65e-02	3.76e-01	0.6750	-2.67e-01	-3.01e-01	3.20e-01	2.07e-01	3.86e-01	2.22e-01	1.68e-01	1.43e-01	3.43e-01	7.67e-02
GOBP CMP METABOLIC PROCESS	8	5.03e-02	2.55e-01	0.6750	-3.02e-01	3.22e-01	4.12e-01	-1.63e-01	2.54e-01	1.38e-01	1.15e-01	4.38e-02	4.24e-01	2.13e-01
GOBP POSITIVE REGULATION OF MELANOCYTE DIFFERENTIATION	5	3.75e-01	7.15e-01	0.6750	1.08e-01	8.57e-02	3.44e-01	5.54e-01	-1.06e-01	6.75e-01	7.40e-01	1.83e-01	3.19e-02	6.82e-01
GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE INHIBITOR ACTIVITY	12	2.24e-02	1.51e-01	0.6750	4.36e-02	1.95e-01	-3.95e-01	-4.22e-01	2.85e-01	7.94e-01	2.41e-01	1.79e-02	1.14e-02	8.74e-02
GOBP VOLUNTARY SKELETAL MUSCLE CONTRACTION	5	2.46e-01	6.02e-01	0.6750	1.73e-01	3.00e-01	-2.92e-01	-1.93e-01	4.61e-01	5.03e-01	2.45e-01	2.58e-01	4.54e-01	7.43e-02
GOBP ENDOTHELIAL CELL MATRIX ADHESION	8	2.83e-02	1.77e-01	0.6740	-4.57e-01	-2.60e-01	-3.20e-01	2.56e-01	-9.97e-02	2.51e-02	2.03e-01	1.17e-01	2.10e-01	6.25e-01
GOBP PUTRESCINE METABOLIC PROCESS	7	1.30e-01	4.46e-01	0.6740	-4.07e-01	-2.92e-02	-3.83e-01	-2.92e-01	-2.35e-01	6.21e-02	8.93e-01	7.90e-02	1.81e-01	2.81e-01
GOBP RESPONSE TO L ASCORBIC ACID	6	1.56e-01	4.85e-01	0.6740	2.92e-01	5.10e-01	6.70e-02	4.01e-02	3.19e-01	2.15e-01	3.04e-02	7.76e-01	8.65e-01	1.76e-01
GOBP THYROID STIMULATING HORMONE SECRETING CELL DIFFERENTIATION	6	1.37e-01	4.55e-01	0.6740	-4.41e-01	3.98e-01	-2.02e-01	-1.90e-01	-1.55e-01	6.12e-02	9.16e-02	3.92e-01	4.21e-01	5.11e-01
GOMF LIGAND GATED MONOATOMIC ANION CHANNEL ACTIVITY	16	3.16e-03	3.82e-02	0.6740	1.09e-01	1.71e-01	4.89e-01	2.95e-01	2.95e-01	4.49e-01	2.37e-01	7.15e-04	4.14e-02	4.09e-02
GOMF GLUTAMATE GATED CALCIUM ION CHANNEL ACTIVITY	5	2.79e-01	6.33e-01	0.6730	-3.96e-01	-1.75e-01	-2.74e-01	-3.11e-01	3.06e-01	1.25e-01	4.97e-01	2.89e-01	2.28e-01	2.36e-01
GOBP CORTICOTROPIN SECRETION	7	8.00e-02	3.41e-01	0.6730	5.19e-01	2.86e-01	3.11e-01	-5.25e-02	4.09e-02	1.73e-02	1.90e-01	1.54e-01	8.10e-01	8.51e-01
GOBP NEGATIVE REGULATION OF NEURON MIGRATION	9	8.74e-02	3.57e-01	0.6730	-1.44e-01	-2.22e-01	3.25e-01	5.19e-01	-8.67e-02	4.56e-01	2.49e-01	9.09e-02	7.01e-03	6.52e-01
GOBP REGULATION OF MELANOCYTE DIFFERENTIATION	6	2.55e-01	6.12e-01	0.6730	3.56e-02	2.19e-01	3.64e-01	5.18e-01	5.16e-02	8.80e-01	3.53e-01	1.23e-01	2.81e-02	8.27e-01
GOBP CHORIONIC TROPHOBLAST CELL DIFFERENTIATION	7	1.45e-01	4.67e-01	0.6730	2.23e-01	-1.21e-02	-3.19e-01	-5.32e-01	-1.31e-01	3.06e-01	9.56e-01	1.43e-01	1.48e-02	5.49e-01
GOBP C 5 METHYLATION OF CYTOSINE	5	2.78e-01	6.32e-01	0.6720	4.34e-01	4.42e-01	2.02e-02	-2.12e-01	1.50e-01	9.28e-02	8.68e-02	9.38e-01	4.11e-01	5.60e-01
GOMF LEUKOTRIENE C4 SYNTHASE ACTIVITY	5	2.30e-01	5.83e-01	0.6720	1.07e-02	3.38e-01	-8.21e-02	-1.34e-01	5.59e-01	9.67e-01	1.90e-01	7.51e-01	6.03e-01	3.04e-02
GOMF KERATIN FILAMENT BINDING	6	1.58e-01	4.88e-01	0.6720	-4.45e-01	-3.16e-01	-1.49e-01	-3.43e-01	-1.15e-01	5.88e-02	1.80e-01	5.28e-01	1.46e-01	6.26e-01
GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE	9	9.05e-02	3.63e-01	0.6710	-1.78e-01	-2.32e-01	-4.31e-01	-4.19e-01	-5.84e-02	3.56e-01	2.29e-01	2.51e-02	2.94e-02	7.61e-01
GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED EIF2 ALPHA PHOSPHORYLATION	5	2.74e-01	6.29e-01	0.6710	-1.53e-02	5.38e-01	2.10e-01	-6.20e-02	3.36e-01	9.53e-01	3.73e-02	4.15e-01	8.10e-01	1.94e-01
GOBP POSITIVE REGULATION OF RECEPTOR CLUSTERING	6	1.84e-01	5.27e-01	0.6710	-1.75e-01	4.52e-01	3.10e-01	1.15e-01	3.26e-01	4.57e-01	5.53e-02	1.89e-01	6.25e-01	1.67e-01
GOBP POSITIVE REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION	6	2.61e-01	6.18e-01	0.6710	-1.66e-01	-2.35e-01	-4.85e-01	-3.27e-01	1.58e-01	4.82e-01	3.18e-01	3.98e-02	1.66e-01	5.03e-01
GOBP DEPYRIMIDINATION	8	1.37e-01	4.55e-01	0.6700	2.61e-01	1.77e-01	-4.12e-01	-4.20e-01	6.16e-02	2.02e-01	3.86e-01	4.35e-02	3.96e-02	7.63e-01
GOBP T HELPER 2 CELL CYTOKINE PRODUCTION	12	1.20e-02	9.95e-02	0.6700	-5.86e-02	4.06e-01	4.85e-01	6.65e-03	2.13e-01	7.25e-01	1.48e-02	3.62e-03	9.68e-01	2.01e-01
GOBP NEGATIVE REGULATION OF NEUTROPHIL MIGRATION	5	3.25e-01	6.73e-01	0.6700	-4.06e-01	1.58e-01	2.74e-01	4.28e-01	-2.92e-02	1.16e-01	5.40e-01	2.89e-01	9.78e-02	9.10e-01
GOBP PROTEIN LOCALIZATION TO NUCLEAR BODY	11	4.29e-02	2.30e-01	0.6700	-1.20e-01	-2.65e-01	-3.98e-01	-4.52e-01	3.48e-02	4.89e-01	1.28e-01	2.24e-02	9.47e-03	8.41e-01
GOBP NEGATIVE REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION	5	2.35e-01	5.91e-01	0.6690	2.97e-01	-8.96e-02	1.48e-01	5.42e-01	1.90e-01	2.51e-01	7.29e-01	5.66e-01	3.57e-02	4.63e-01
GOBP REGULATION OF TRANSCRIPTION BY GLUCOSE	8	1.63e-01	4.96e-01	0.6690	1.93e-01	-4.79e-02	-3.60e-01	-4.90e-01	1.95e-01	3.44e-01	8.14e-01	7.82e-02	1.64e-02	3.40e-01
GOBP ARTICULAR CARTILAGE DEVELOPMENT	5	2.17e-01	5.72e-01	0.6680	2.93e-01	-4.71e-01	2.16e-01	2.36e-01	-1.90e-01	2.56e-01	6.80e-02	4.02e-01	3.61e-01	4.61e-01
GOBP INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY	7	1.73e-01	5.13e-01	0.6680	3.66e-01	1.58e-01	-1.58e-01	-4.05e-01	3.15e-01	9.40e-02	4.70e-01	4.68e-01	6.34e-02	1.49e-01
GOMF COPPER CHAPERONE ACTIVITY	6	2.27e-01	5.81e-01	0.6680	-2.71e-01	1.31e-02	-4.87e-01	-3.56e-01	9.79e-02	2.50e-01	9.56e-01	3.90e-02	1.32e-01	6.78e-01
GOMF TUMOR NECROSIS FACTOR RECEPTOR ACTIVITY	8	5.98e-02	2.86e-01	0.6680	-3.02e-01	5.10e-01	-3.08e-04	-2.80e-01	1.30e-01	1.39e-01	1.25e-02	9.99e-01	1.71e-01	5.24e-01
GOBP SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION	10	3.07e-02	1.86e-01	0.6670	-1.65e-01	3.62e-01	-7.78e-02	-4.88e-01	2.07e-01	3.66e-01	4.74e-02	6.70e-01	7.54e-03	2.56e-01
GOBP RNA GUANINE N7 METHYLATION	6	3.13e-01	6.65e-01	0.6670	9.11e-02	-8.90e-02	-4.86e-01	-4.35e-01	-6.57e-02	6.99e-01	7.06e-01	3.94e-02	6.51e-02	7.81e-01
GOBP URETERIC BUD FORMATION	7	1.43e-01	4.63e-01	0.6670	4.32e-01	2.95e-03	-2.47e-01	-4.44e-01	-1.03e-02	4.78e-02	9.89e-01	2.57e-01	4.19e-02	9.62e-01
GOBP REGULATION OF CARDIAC MUSCLE CELL MEMBRANE POTENTIAL	7	8.87e-02	3.59e-01	0.6670	-4.67e-01	-1.63e-01	2.94e-03	-2.06e-01	3.97e-01	3.24e-02	4.54e-01	9.89e-01	3.45e-01	6.90e-02
GOMF SERINE TYPE CARBOXYPEPTIDASE ACTIVITY	5	2.66e-01	6.21e-01	0.6670	-2.13e-01	5.65e-01	1.48e-01	1.96e-01	-1.40e-01	4.10e-01	2.86e-02	5.67e-01	4.47e-01	5.87e-01
GOCC NLRP3 INFLAMMASOME COMPLEX	7	9.90e-02	3.81e-01	0.6670	-5.20e-02	5.92e-01	5.53e-02	-2.81e-01	-9.76e-02	8.12e-01	6.72e-03	8.00e-01	1.97e-01	6.55e-01
GOMF ICOSANOID RECEPTOR ACTIVITY	14	5.89e-03	5.99e-02	0.6670	-1.34e-01	2.83e-01	-1.59e-01	-4.46e-01	3.50e-01	3.86e-01	6.65e-02	3.04e-01	3.87e-03	2.35e-02
GOBP POSITIVE REGULATION OF AUTOPHAGOSOME MATURATION	7	1.00e-01	3.83e-01	0.6660	5.81e-01	2.30e-01	1.11e-01	-1.59e-01	1.27e-01	7.80e-03	2.92e-01	6.10e-01	4.66e-01	5.61e-01
GOBP LACTATE TRANSMEMBRANE TRANSPORT	7	1.56e-01	4.84e-01	0.6660	2.18e-01	2.30e-01	4.71e-01	2.76e-01	-2.14e-01	3.17e-01	2.93e-01	3.11e-02	2.06e-01	3.27e-01
GOMF NFAT PROTEIN BINDING	5	2.62e-01	6.19e-01	0.6660	-3.56e-02	1.02e-01	2.42e-01	-2.01e-01	5.77e-01	8.90e-01	6.94e-01	3.48e-01	4.37e-01	2.55e-02
GOBP POSITIVE REGULATION OF PROTEIN MONOUBIQUITINATION	5	2.47e-01	6.04e-01	0.6660	3.95e-01	1.96e-01	-1.37e-01	-4.62e-01	-1.28e-01	1.26e-01	4.47e-01	5.97e-01	7.36e-02	6.21e-01
GOBP HIPPOCAMPAL NEURON APOPTOTIC PROCESS	6	1.75e-01	5.15e-01	0.6660	-3.23e-01	-4.37e-01	3.00e-01	2.06e-01	1.24e-01	1.71e-01	6.39e-02	2.03e-01	3.81e-01	6.00e-01
GOMF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY INVOLVED IN VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL REPOLARIZATION	11	2.21e-03	2.90e-02	0.6660	-1.29e-01	5.60e-01	-5.11e-02	3.30e-01	2.88e-02	4.57e-01	1.29e-03	7.69e-01	5.82e-02	8.69e-01
GOBP CELL DIFFERENTIATION INVOLVED IN PHENOTYPIC SWITCHING	5	2.42e-01	6.00e-01	0.6660	-2.32e-01	3.66e-01	-1.53e-01	-2.56e-01	4.08e-01	3.68e-01	1.57e-01	5.54e-01	3.22e-01	1.14e-01
GOBP REGULATION OF GUANYLATE CYCLASE ACTIVITY	6	7.31e-02	3.23e-01	0.6650	1.67e-01	5.83e-01	-1.57e-01	1.96e-01	1.09e-01	4.80e-01	1.34e-02	5.06e-01	4.06e-01	6.44e-01
GOBP GDP MANNOSE METABOLIC PROCESS	7	2.03e-01	5.53e-01	0.6650	3.65e-02	-5.10e-02	-4.76e-01	-4.14e-01	-2.01e-01	8.67e-01	8.15e-01	2.92e-02	5.77e-02	3.58e-01
GOBP REGULATION OF SYNAPSE STRUCTURAL PLASTICITY	7	9.71e-02	3.77e-01	0.6650	-3.72e-02	-2.25e-01	-2.46e-01	3.51e-01	-4.54e-01	8.65e-01	3.02e-01	2.59e-01	1.08e-01	3.75e-02
GOMF 5 3 DNA HELICASE ACTIVITY	8	1.07e-01	3.98e-01	0.6650	1.83e-01	-2.59e-01	-4.01e-01	-3.31e-01	-2.68e-01	3.71e-01	2.05e-01	4.95e-02	1.05e-01	1.90e-01
GOBP PHENYLPROPANOID METABOLIC PROCESS	6	1.60e-01	4.92e-01	0.6650	4.34e-01	2.21e-01	1.22e-01	2.12e-01	-3.80e-01	6.54e-02	3.49e-01	6.05e-01	3.67e-01	1.07e-01
GOCC TRANSCRIPTION FACTOR AP 1 COMPLEX	5	4.07e-01	7.39e-01	0.6650	3.05e-01	3.22e-02	-4.58e-01	-3.69e-01	3.37e-02	2.37e-01	9.01e-01	7.61e-02	1.53e-01	8.96e-01
GOBP REGULATION OF VERY LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE	5	2.75e-01	6.29e-01	0.6650	-4.20e-01	-4.46e-02	-4.47e-01	-1.57e-01	-1.97e-01	1.04e-01	8.63e-01	8.34e-02	5.42e-01	4.45e-01
GOBP POSITIVE REGULATION OF STORE OPERATED CALCIUM CHANNEL ACTIVITY	5	2.84e-01	6.38e-01	0.6640	3.16e-01	5.05e-01	2.84e-01	3.70e-02	-6.43e-02	2.21e-01	5.03e-02	2.72e-01	8.86e-01	8.03e-01
GOBP POSITIVE REGULATION OF NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION	5	1.82e-01	5.25e-01	0.6640	5.01e-03	-4.34e-02	3.86e-02	6.62e-01	1.66e-02	9.85e-01	8.67e-01	8.81e-01	1.04e-02	9.49e-01
GOBP NEGATIVE REGULATION OF HORMONE BIOSYNTHETIC PROCESS	10	4.05e-02	2.22e-01	0.6640	-4.29e-01	3.50e-01	2.77e-01	2.25e-01	-8.47e-02	1.87e-02	5.52e-02	1.30e-01	2.18e-01	6.43e-01
GOBP REGULATION OF LIPOPHAGY	5	2.94e-01	6.48e-01	0.6640	4.48e-01	2.60e-01	-6.58e-02	-3.93e-01	1.21e-01	8.31e-02	3.15e-01	7.99e-01	1.28e-01	6.39e-01
GOCC STEREOCILIA COUPLING LINK	7	2.02e-01	5.52e-01	0.6640	-3.12e-01	1.32e-01	2.63e-01	3.85e-01	-3.29e-01	1.52e-01	5.45e-01	2.28e-01	7.76e-02	1.32e-01
GOCC FACIT COLLAGEN TRIMER	6	2.19e-01	5.73e-01	0.6640	-2.96e-01	-4.07e-01	9.25e-02	3.93e-01	-1.59e-01	2.10e-01	8.46e-02	6.95e-01	9.58e-02	5.01e-01
GOBP IMMUNOLOGICAL MEMORY PROCESS	17	1.74e-04	3.74e-03	0.6640	-2.63e-01	5.11e-01	1.13e-01	1.36e-01	2.82e-01	6.08e-02	2.67e-04	4.22e-01	3.30e-01	4.40e-02
GOBP NAD TRANSPORT	5	2.28e-01	5.81e-01	0.6630	-4.30e-01	-1.88e-01	4.66e-01	4.57e-02	-2.85e-02	9.60e-02	4.68e-01	7.14e-02	8.59e-01	9.12e-01
GOBP REGULATION OF MITOCHONDRIAL MRNA STABILITY	7	1.96e-01	5.45e-01	0.6630	7.95e-02	-1.22e-01	-5.70e-01	-2.88e-01	1.04e-01	7.16e-01	5.75e-01	9.07e-03	1.87e-01	6.33e-01
GOMF MUTSALPHA COMPLEX BINDING	7	1.80e-01	5.22e-01	0.6630	-2.77e-01	-2.56e-01	-3.72e-01	-3.74e-01	1.35e-01	2.04e-01	2.41e-01	8.79e-02	8.63e-02	5.37e-01
GOCC ZONA PELLUCIDA RECEPTOR COMPLEX	8	8.52e-02	3.53e-01	0.6630	3.18e-02	-4.65e-01	-2.30e-01	-4.07e-01	6.36e-02	8.76e-01	2.28e-02	2.60e-01	4.65e-02	7.55e-01
GOBP RESPONSE TO INTERLEUKIN 2	9	3.27e-02	1.93e-01	0.6630	-1.44e-01	4.42e-01	2.83e-01	-8.44e-02	-3.68e-01	4.53e-01	2.17e-02	1.41e-01	6.61e-01	5.58e-02
GOBP ROSTROCAUDAL NEURAL TUBE PATTERNING	10	5.58e-02	2.74e-01	0.6620	5.78e-02	1.34e-01	-1.63e-01	-5.07e-01	3.67e-01	7.51e-01	4.64e-01	3.72e-01	5.54e-03	4.46e-02
GOBP POSITIVE REGULATION OF CELL PROLIFERATION IN BONE MARROW	6	1.99e-01	5.48e-01	0.6620	-1.95e-01	-6.39e-02	3.89e-01	2.39e-01	4.34e-01	4.07e-01	7.87e-01	9.93e-02	3.10e-01	6.58e-02
GOMF CORTICOTROPIN RELEASING HORMONE RECEPTOR BINDING	5	2.35e-01	5.90e-01	0.6620	1.04e-01	4.73e-01	3.71e-01	-2.28e-01	1.21e-01	6.86e-01	6.72e-02	1.51e-01	3.77e-01	6.39e-01
GOBP REGULATION OF DEFENSE RESPONSE TO FUNGUS	5	2.18e-01	5.72e-01	0.6620	-5.25e-01	1.03e-01	3.25e-01	-1.80e-01	1.15e-01	4.19e-02	6.89e-01	2.08e-01	4.86e-01	6.55e-01
GOMF CARNITINE O ACYLTRANSFERASE ACTIVITY	6	2.49e-01	6.06e-01	0.6620	4.39e-01	-1.84e-01	-4.07e-01	-1.80e-01	1.17e-01	6.24e-02	4.36e-01	8.45e-02	4.45e-01	6.20e-01
GOMF INTERLEUKIN 6 RECEPTOR BINDING	7	3.92e-02	2.17e-01	0.6620	2.22e-01	3.84e-01	2.97e-01	-3.48e-01	-1.79e-01	3.08e-01	7.86e-02	1.74e-01	1.11e-01	4.12e-01
GOBP PROTEIN LOCALIZATION TO CENP A CONTAINING CHROMATIN	16	4.73e-03	5.18e-02	0.6610	9.93e-02	-4.28e-01	-3.64e-01	-3.29e-01	6.26e-02	4.92e-01	3.05e-03	1.18e-02	2.28e-02	6.64e-01
GOBP SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION	12	2.31e-02	1.55e-01	0.6610	-1.03e-01	9.93e-02	-2.18e-01	-4.74e-01	3.81e-01	5.38e-01	5.51e-01	1.92e-01	4.49e-03	2.24e-02
GOBP NEGATIVE REGULATION OF PINOCYTOSIS	5	3.45e-01	6.91e-01	0.6610	-2.60e-01	-2.33e-02	-4.81e-01	-2.93e-01	-2.26e-01	3.14e-01	9.28e-01	6.23e-02	2.56e-01	3.82e-01
GOCC LATE ENDOSOME LUMEN	8	7.26e-02	3.22e-01	0.6600	2.05e-01	4.18e-01	4.52e-01	-4.36e-02	1.12e-01	3.15e-01	4.08e-02	2.68e-02	8.31e-01	5.82e-01
GOCC DNA RECOMBINASE MEDIATOR COMPLEX	7	1.41e-01	4.62e-01	0.6600	1.64e-01	-1.27e-01	-3.18e-01	-1.77e-01	5.10e-01	4.53e-01	5.62e-01	1.45e-01	4.19e-01	1.95e-02
GOBP REGULATION OF FC GAMMA RECEPTOR SIGNALING PATHWAY INVOLVED IN PHAGOCYTOSIS	5	2.76e-01	6.30e-01	0.6600	-2.13e-01	1.22e-01	3.76e-01	-2.05e-02	4.83e-01	4.09e-01	6.37e-01	1.45e-01	9.37e-01	6.16e-02
GOMF RETINOIC ACID RESPONSIVE ELEMENT BINDING	6	1.84e-01	5.25e-01	0.6590	-6.43e-02	5.33e-01	2.90e-01	-1.89e-01	1.62e-01	7.85e-01	2.37e-02	2.19e-01	4.24e-01	4.92e-01
GOBP NEGATIVE REGULATION OF MEIOTIC CELL CYCLE PHASE TRANSITION	5	2.45e-01	6.02e-01	0.6590	2.21e-01	-5.00e-01	6.88e-02	-6.65e-02	3.55e-01	3.93e-01	5.27e-02	7.90e-01	7.97e-01	1.69e-01
GOBP CO TRANSCRIPTIONAL RNA 3 END PROCESSING CLEAVAGE AND POLYADENYLATION PATHWAY	6	2.22e-01	5.76e-01	0.6590	2.03e-01	9.25e-02	8.40e-03	-4.22e-01	4.54e-01	3.89e-01	6.95e-01	9.72e-01	7.37e-02	5.39e-02
GOBP COMMON BILE DUCT DEVELOPMENT	5	3.04e-01	6.58e-01	0.6580	-1.64e-01	2.38e-01	-1.08e-01	-5.62e-01	1.50e-01	5.25e-01	3.58e-01	6.77e-01	2.95e-02	5.62e-01
GOBP ANTIMICROBIAL PEPTIDE PRODUCTION	11	3.50e-02	2.02e-01	0.6580	-4.46e-01	-1.05e-01	3.37e-01	2.46e-01	-2.22e-01	1.04e-02	5.46e-01	5.30e-02	1.58e-01	2.03e-01
GOMF PROTEIN TYROSINE KINASE INHIBITOR ACTIVITY	6	1.41e-01	4.62e-01	0.6580	-4.34e-01	3.44e-01	-2.97e-01	-1.80e-01	-7.16e-02	6.55e-02	1.44e-01	2.08e-01	4.45e-01	7.61e-01
GOBP POSITIVE REGULATION OF ANTIBACTERIAL PEPTIDE PRODUCTION	5	3.18e-01	6.67e-01	0.6580	-5.20e-01	-2.60e-01	4.63e-02	2.14e-01	-2.16e-01	4.40e-02	3.15e-01	8.58e-01	4.08e-01	4.02e-01
GOBP AXONEMAL CENTRAL APPARATUS ASSEMBLY	6	2.19e-01	5.73e-01	0.6580	-2.97e-01	2.82e-01	8.07e-02	2.72e-01	-4.29e-01	2.08e-01	2.31e-01	7.32e-01	2.49e-01	6.89e-02
GOMF DOPAMINE NEUROTRANSMITTER RECEPTOR ACTIVITY	5	1.86e-01	5.28e-01	0.6570	2.29e-01	-3.14e-01	1.06e-01	-4.16e-01	3.11e-01	3.76e-01	2.24e-01	6.82e-01	1.08e-01	2.28e-01
GOBP BRONCHUS DEVELOPMENT	11	1.62e-02	1.23e-01	0.6560	-2.12e-01	5.21e-01	1.88e-01	-8.73e-02	-2.67e-01	2.24e-01	2.76e-03	2.80e-01	6.16e-01	1.25e-01
GOBP BLOOD VESSEL ENDOTHELIAL CELL DIFFERENTIATION	14	8.83e-03	8.04e-02	0.6560	2.46e-01	1.47e-01	4.67e-01	2.42e-01	2.68e-01	1.10e-01	3.42e-01	2.49e-03	1.17e-01	8.25e-02
GOMF ATPASE COUPLED LIPID TRANSMEMBRANE TRANSPORTER ACTIVITY	8	8.90e-02	3.59e-01	0.6560	-2.14e-01	4.44e-01	1.36e-01	2.88e-01	-2.94e-01	2.95e-01	2.96e-02	5.06e-01	1.59e-01	1.50e-01
GOBP SHORT CHAIN FATTY ACID CATABOLIC PROCESS	7	1.27e-01	4.40e-01	0.6560	3.00e-01	3.40e-01	1.27e-01	5.06e-02	4.54e-01	1.69e-01	1.20e-01	5.59e-01	8.17e-01	3.75e-02
GOCC CEREBELLAR CLIMBING FIBER TO PURKINJE CELL SYNAPSE	7	1.09e-01	4.03e-01	0.6560	-1.35e-01	3.89e-01	2.37e-01	1.72e-01	4.18e-01	5.36e-01	7.50e-02	2.77e-01	4.31e-01	5.54e-02
GOBP INTESTINAL HEXOSE ABSORPTION	5	3.50e-01	6.96e-01	0.6560	-1.97e-01	-3.84e-01	1.11e-01	4.29e-01	-2.17e-01	4.46e-01	1.37e-01	6.67e-01	9.65e-02	4.02e-01
GOBP REGULATION OF HISTAMINE SECRETION BY MAST CELL	6	2.27e-01	5.80e-01	0.6560	-1.61e-01	-5.54e-01	-2.80e-01	-1.35e-01	1.76e-02	4.94e-01	1.88e-02	2.35e-01	5.66e-01	9.40e-01
GOMF MYOSIN HEAVY CHAIN BINDING	12	4.38e-03	4.90e-02	0.6560	-1.52e-02	9.76e-02	-3.07e-01	2.77e-01	-4.99e-01	9.27e-01	5.58e-01	6.54e-02	9.62e-02	2.77e-03
GOBP OVIDUCT DEVELOPMENT	5	2.69e-01	6.24e-01	0.6560	3.30e-01	-1.81e-01	1.97e-01	-9.42e-02	4.90e-01	2.01e-01	4.84e-01	4.46e-01	7.15e-01	5.76e-02
GOMF DEATH RECEPTOR ACTIVITY	11	1.65e-02	1.25e-01	0.6560	-2.09e-01	5.03e-01	8.16e-02	-3.19e-01	1.57e-01	2.30e-01	3.86e-03	6.39e-01	6.71e-02	3.68e-01
GOMF DOLICHYL PHOSPHATE MANNOSE PROTEIN MANNOSYLTRANSFERASE ACTIVITY	8	1.41e-01	4.62e-01	0.6550	2.16e-01	-3.80e-01	-3.91e-01	-2.92e-01	-7.19e-03	2.90e-01	6.26e-02	5.53e-02	1.53e-01	9.72e-01
GOMF PRERIBOSOME BINDING	6	3.32e-01	6.80e-01	0.6550	-3.70e-02	-3.05e-02	-3.99e-01	-4.70e-01	2.17e-01	8.75e-01	8.97e-01	9.03e-02	4.63e-02	3.58e-01
GOMF 2 ACYLGLYCEROL O ACYLTRANSFERASE ACTIVITY	6	1.93e-01	5.41e-01	0.6550	-5.53e-03	5.63e-01	3.75e-03	-3.29e-01	6.09e-02	9.81e-01	1.69e-02	9.87e-01	1.62e-01	7.96e-01
GOBP EOSINOPHIL MIGRATION	28	2.75e-05	8.13e-04	0.6550	-2.56e-01	1.44e-01	2.91e-01	4.89e-01	-1.36e-01	1.91e-02	1.87e-01	7.69e-03	7.56e-06	2.12e-01
GOBP REGULATION OF PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS	5	2.81e-01	6.34e-01	0.6540	-2.21e-01	4.59e-01	1.42e-01	-2.77e-01	2.68e-01	3.92e-01	7.55e-02	5.83e-01	2.83e-01	2.99e-01
GOMF N ACETYLLACTOSAMINIDE BETA 1 3 N ACETYLGLUCOSAMINYLTRANSFERASE ACTIVITY	5	3.50e-01	6.96e-01	0.6540	-1.66e-01	3.06e-01	-2.71e-01	-4.45e-01	1.87e-01	5.19e-01	2.35e-01	2.95e-01	8.48e-02	4.69e-01
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYPOXIA	9	1.19e-01	4.23e-01	0.6540	5.70e-03	-2.13e-01	-3.50e-01	-4.81e-01	1.72e-01	9.76e-01	2.70e-01	6.93e-02	1.25e-02	3.73e-01
GOBP CHOLINE TRANSPORT	9	7.04e-02	3.15e-01	0.6540	3.84e-01	1.07e-01	4.09e-01	3.11e-01	-6.69e-02	4.61e-02	5.79e-01	3.36e-02	1.06e-01	7.28e-01
GOBP MONOACYLGLYCEROL BIOSYNTHETIC PROCESS	5	2.80e-01	6.33e-01	0.6530	-1.80e-01	5.80e-01	1.38e-01	-1.35e-01	-1.43e-01	4.87e-01	2.46e-02	5.92e-01	6.00e-01	5.79e-01
GOBP CARDIAC PACEMAKER CELL DEVELOPMENT	9	7.53e-02	3.29e-01	0.6530	4.53e-02	2.10e-01	-7.18e-02	-4.98e-01	3.57e-01	8.14e-01	2.76e-01	7.09e-01	9.74e-03	6.37e-02
GOCC METHYLOSOME	13	2.26e-02	1.52e-01	0.6520	-1.71e-01	-2.09e-01	-4.59e-01	-3.51e-01	1.36e-01	2.84e-01	1.91e-01	4.18e-03	2.83e-02	3.96e-01
GOMF RNA ENDONUCLEASE ACTIVITY PRODUCING 3 PHOSPHOMONOESTERS	7	1.37e-01	4.56e-01	0.6520	1.96e-01	-8.49e-02	-4.03e-01	-9.32e-02	-4.56e-01	3.68e-01	6.97e-01	6.47e-02	6.69e-01	3.65e-02
GOBP POSITIVE REGULATION OF CELLULAR PH REDUCTION	5	2.63e-01	6.19e-01	0.6520	-1.76e-01	-4.09e-01	3.28e-01	1.34e-01	3.19e-01	4.96e-01	1.13e-01	2.05e-01	6.04e-01	2.16e-01
GOMF NEUROTROPHIN TRK RECEPTOR BINDING	6	2.02e-01	5.53e-01	0.6520	8.33e-02	4.16e-01	4.75e-01	-3.50e-02	1.34e-01	7.24e-01	7.75e-02	4.37e-02	8.82e-01	5.71e-01
GOBP PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY	8	9.15e-02	3.66e-01	0.6520	2.53e-01	3.20e-01	2.43e-01	4.29e-01	1.27e-01	2.16e-01	1.17e-01	2.34e-01	3.58e-02	5.35e-01
GOMF COLLAGEN RECEPTOR ACTIVITY	5	3.21e-01	6.70e-01	0.6520	-9.82e-02	-2.71e-02	8.41e-02	5.75e-01	-2.78e-01	7.04e-01	9.16e-01	7.45e-01	2.61e-02	2.82e-01
GOBP PROTEIN MATURATION BY PROTEIN FOLDING	7	9.77e-02	3.78e-01	0.6510	-2.65e-01	2.03e-01	-1.06e-01	-4.01e-01	-3.76e-01	2.24e-01	3.52e-01	6.27e-01	6.64e-02	8.52e-02
GOBP RESPONSE TO COBALT ION	9	8.36e-02	3.49e-01	0.6510	-2.57e-02	-9.89e-02	-2.75e-01	-3.18e-01	4.86e-01	8.94e-01	6.07e-01	1.53e-01	9.82e-02	1.16e-02
GOBP REGULATION OF GROWTH HORMONE RECEPTOR SIGNALING PATHWAY	6	1.71e-01	5.09e-01	0.6510	5.65e-01	2.52e-01	1.43e-01	-1.29e-01	5.63e-02	1.65e-02	2.85e-01	5.43e-01	5.83e-01	8.11e-01
GOBP CD8 POSITIVE ALPHA BETA T CELL PROLIFERATION	8	6.82e-02	3.09e-01	0.6510	4.83e-01	-1.09e-01	3.66e-01	1.79e-01	1.11e-01	1.80e-02	5.94e-01	7.33e-02	3.81e-01	5.86e-01
GOBP POSITIVE REGULATION OF GASTRULATION	6	1.97e-01	5.45e-01	0.6500	-7.71e-02	1.96e-01	7.74e-02	-4.57e-01	4.05e-01	7.44e-01	4.05e-01	7.43e-01	5.27e-02	8.57e-02
GOMF LYSOZYME ACTIVITY	9	4.68e-02	2.42e-01	0.6500	7.81e-02	-1.62e-01	1.21e-02	5.80e-01	-2.30e-01	6.85e-01	4.00e-01	9.50e-01	2.58e-03	2.32e-01
GOCC ER MEMBRANE INSERTION COMPLEX	11	4.99e-02	2.54e-01	0.6500	7.34e-02	-3.14e-02	-2.99e-01	-3.70e-01	4.36e-01	6.74e-01	8.57e-01	8.62e-02	3.38e-02	1.23e-02
GOBP AUTOPHAGOSOME LYSOSOME FUSION	9	4.93e-02	2.51e-01	0.6490	1.93e-01	5.07e-01	1.92e-01	-2.69e-01	1.35e-01	3.15e-01	8.50e-03	3.19e-01	1.62e-01	4.82e-01
GOMF L GLUTAMATE TRANSMEMBRANE TRANSPORTER ACTIVITY	14	9.60e-03	8.52e-02	0.6490	-2.28e-01	4.08e-01	2.71e-01	1.83e-01	-3.09e-01	1.39e-01	8.14e-03	7.93e-02	2.36e-01	4.54e-02
GOBP DEVELOPMENT OF SECONDARY FEMALE SEXUAL CHARACTERISTICS	5	2.97e-01	6.52e-01	0.6490	1.24e-01	1.70e-01	-2.93e-01	-3.04e-01	-4.46e-01	6.32e-01	5.11e-01	2.57e-01	2.39e-01	8.42e-02
GOBP PROTEIN SULFATION	6	2.75e-01	6.30e-01	0.6490	1.09e-01	2.33e-01	2.30e-01	4.52e-01	-3.12e-01	6.44e-01	3.22e-01	3.29e-01	5.53e-02	1.85e-01
GOBP METANEPHRIC MESENCHYMAL CELL DIFFERENTIATION	5	2.03e-01	5.53e-01	0.6490	1.89e-01	-1.65e-01	2.14e-01	-3.77e-01	4.12e-01	4.64e-01	5.22e-01	4.06e-01	1.45e-01	1.10e-01
GOBP CALCITONIN FAMILY RECEPTOR SIGNALING PATHWAY	8	7.92e-02	3.39e-01	0.6490	1.65e-01	-4.54e-01	-5.72e-02	4.00e-01	-1.56e-01	4.18e-01	2.63e-02	7.79e-01	5.00e-02	4.46e-01
GOBP RESPONSE TO CELL CYCLE CHECKPOINT SIGNALING	7	2.22e-01	5.76e-01	0.6470	1.06e-01	1.12e-01	-4.76e-01	-3.88e-01	-1.34e-01	6.29e-01	6.09e-01	2.92e-02	7.51e-02	5.40e-01
GOBP LUNG LOBE DEVELOPMENT	7	1.03e-01	3.88e-01	0.6460	-3.05e-01	-2.78e-01	1.32e-01	-1.56e-01	4.54e-01	1.62e-01	2.03e-01	5.45e-01	4.75e-01	3.76e-02
GOMF INOSITOL 1 3 4 5 6 PENTAKISPHOSPHATE KINASE ACTIVITY	5	2.59e-01	6.16e-01	0.6460	5.29e-01	1.22e-01	-1.13e-01	7.41e-02	-3.23e-01	4.04e-02	6.36e-01	6.63e-01	7.74e-01	2.10e-01
GOBP ENDODERMAL CELL FATE SPECIFICATION	8	3.41e-02	1.99e-01	0.6460	-4.07e-01	8.68e-02	1.14e-01	-4.08e-01	-2.54e-01	4.60e-02	6.71e-01	5.75e-01	4.55e-02	2.14e-01
GOBP MIDBRAIN HINDBRAIN BOUNDARY DEVELOPMENT	7	2.24e-01	5.77e-01	0.6460	2.09e-01	1.37e-01	-2.12e-01	-3.97e-01	3.91e-01	3.38e-01	5.31e-01	3.31e-01	6.90e-02	7.35e-02
GOBP POSITIVE REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY	5	3.14e-01	6.65e-01	0.6460	-2.50e-01	2.15e-01	-1.58e-01	-5.31e-01	-3.81e-02	3.32e-01	4.05e-01	5.41e-01	3.97e-02	8.83e-01
GOCC PICLN SM PROTEIN COMPLEX	6	2.60e-01	6.17e-01	0.6460	-2.46e-01	-1.79e-01	-2.87e-01	-3.49e-01	3.47e-01	2.97e-01	4.47e-01	2.23e-01	1.39e-01	1.41e-01
GOBP NUCLEAR RNA SURVEILLANCE	14	2.54e-02	1.63e-01	0.6460	1.53e-01	-1.02e-01	-3.72e-01	-4.25e-01	2.54e-01	3.22e-01	5.09e-01	1.59e-02	5.88e-03	1.00e-01
GOBP POSITIVE REGULATION OF CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION	5	2.58e-01	6.14e-01	0.6460	-3.65e-01	3.72e-01	-1.80e-01	-9.39e-04	-3.37e-01	1.57e-01	1.50e-01	4.86e-01	9.97e-01	1.92e-01
GOBP MITOCHONDRIAL RNA CATABOLIC PROCESS	6	2.37e-01	5.93e-01	0.6450	-2.30e-01	-4.42e-01	-2.27e-01	-3.34e-01	7.23e-02	3.29e-01	6.08e-02	3.36e-01	1.57e-01	7.59e-01
GOBP CARDIAC FIBROBLAST CELL DIFFERENTIATION	5	2.80e-01	6.33e-01	0.6450	-3.55e-01	-7.74e-02	-4.18e-01	1.47e-02	-3.31e-01	1.69e-01	7.64e-01	1.05e-01	9.55e-01	2.00e-01
GOMF ROUNDABOUT BINDING	8	1.35e-01	4.54e-01	0.6450	-4.12e-01	-6.11e-02	2.61e-01	2.27e-01	-3.51e-01	4.36e-02	7.65e-01	2.01e-01	2.67e-01	8.54e-02
GOBP REGULATION OF TOOTH MINERALIZATION	10	9.69e-02	3.77e-01	0.6450	-1.03e-01	-1.26e-01	3.98e-01	4.70e-01	-1.01e-01	5.74e-01	4.90e-01	2.94e-02	9.99e-03	5.79e-01
GOBP AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION	14	8.72e-03	7.99e-02	0.6450	-2.51e-01	1.74e-01	9.34e-02	4.03e-01	-3.89e-01	1.04e-01	2.59e-01	5.45e-01	9.00e-03	1.17e-02
GOBP SINOATRIAL NODE CELL DEVELOPMENT	5	3.48e-01	6.95e-01	0.6450	2.48e-02	1.01e-01	-7.77e-02	-5.50e-01	3.10e-01	9.24e-01	6.95e-01	7.63e-01	3.31e-02	2.31e-01
GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 4F COMPLEX	12	9.23e-03	8.25e-02	0.6450	-2.09e-01	5.42e-01	-7.24e-02	-6.73e-02	-2.60e-01	2.10e-01	1.14e-03	6.64e-01	6.86e-01	1.18e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I	7	1.90e-01	5.35e-01	0.6440	4.90e-02	2.53e-01	5.53e-01	1.95e-01	-6.84e-02	8.22e-01	2.46e-01	1.13e-02	3.72e-01	7.54e-01
GOBP NEGATIVE REGULATION OF CELLULAR EXTRAVASATION	9	5.01e-02	2.55e-01	0.6440	4.05e-02	-1.96e-01	3.22e-01	2.35e-01	-4.64e-01	8.33e-01	3.07e-01	9.42e-02	2.22e-01	1.58e-02
GOBP POSITIVE REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY	10	2.91e-02	1.79e-01	0.6430	-3.87e-01	3.77e-01	1.01e-01	-2.63e-01	2.06e-01	3.42e-02	3.89e-02	5.80e-01	1.50e-01	2.59e-01
GOMF 1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE ACTIVITY	8	3.50e-02	2.02e-01	0.6430	4.38e-01	-5.63e-02	-5.65e-02	-3.81e-01	-2.65e-01	3.21e-02	7.83e-01	7.82e-01	6.18e-02	1.94e-01
GOBP NEURAL CREST CELL MIGRATION INVOLVED IN AUTONOMIC NERVOUS SYSTEM DEVELOPMENT	6	2.99e-01	6.53e-01	0.6430	1.50e-01	6.97e-02	2.49e-01	5.06e-01	-2.61e-01	5.26e-01	7.67e-01	2.90e-01	3.20e-02	2.68e-01
GOBP PROTEIN LOCALIZATION TO NUCLEOPLASM	13	3.15e-02	1.89e-01	0.6430	-3.67e-03	-2.28e-01	-3.92e-01	-4.55e-01	1.10e-03	9.82e-01	1.55e-01	1.43e-02	4.50e-03	9.95e-01
GOBP REGULATION OF T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL	8	8.07e-02	3.42e-01	0.6420	-5.14e-01	-1.77e-02	-3.22e-01	-2.07e-01	4.43e-02	1.19e-02	9.31e-01	1.15e-01	3.10e-01	8.28e-01
GOBP NEGATIVE REGULATION OF HAIR FOLLICLE DEVELOPMENT	5	2.71e-01	6.25e-01	0.6410	5.99e-02	5.04e-01	1.79e-01	-1.15e-01	-3.30e-01	8.17e-01	5.12e-02	4.87e-01	6.55e-01	2.01e-01
GOBP URONIC ACID METABOLIC PROCESS	23	4.53e-04	8.30e-03	0.6410	1.60e-01	2.46e-02	3.98e-01	4.71e-01	7.22e-02	1.85e-01	8.38e-01	9.55e-04	9.31e-05	5.49e-01
GOMF AMINOACYLASE ACTIVITY	6	1.69e-01	5.05e-01	0.6410	-3.78e-01	-3.54e-01	-2.64e-01	-1.01e-02	2.71e-01	1.09e-01	1.33e-01	2.63e-01	9.66e-01	2.51e-01
GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR	8	1.39e-01	4.58e-01	0.6410	-1.29e-01	2.05e-01	-2.77e-01	-4.23e-01	3.11e-01	5.28e-01	3.14e-01	1.75e-01	3.85e-02	1.28e-01
GOCC ELONGIN COMPLEX	5	3.12e-01	6.63e-01	0.6400	-2.17e-01	-1.67e-02	-2.02e-01	-5.50e-01	-1.41e-01	4.01e-01	9.48e-01	4.35e-01	3.32e-02	5.86e-01
GOMF GAP JUNCTION HEMI CHANNEL ACTIVITY	6	1.87e-01	5.30e-01	0.6400	-4.34e-01	3.92e-01	-4.88e-02	7.55e-03	-2.56e-01	6.57e-02	9.65e-02	8.36e-01	9.74e-01	2.77e-01
GOBP SENSORY PERCEPTION OF CHEMICAL STIMULUS	438	2.97e-106	7.60e-103	0.6400	-1.23e-01	-3.12e-01	1.54e-01	5.18e-01	7.20e-02	9.93e-06	3.46e-29	3.50e-08	8.19e-78	9.74e-03
GOMF TYPE 5 METABOTROPIC GLUTAMATE RECEPTOR BINDING	6	1.50e-01	4.76e-01	0.6400	4.71e-01	-4.45e-02	3.54e-01	-5.46e-02	2.40e-01	4.57e-02	8.50e-01	1.33e-01	8.17e-01	3.09e-01
GOMF BETA 2 MICROGLOBULIN BINDING	9	5.48e-02	2.70e-01	0.6400	-3.51e-01	-3.21e-01	-1.63e-01	-2.77e-01	-2.82e-01	6.79e-02	9.57e-02	3.97e-01	1.50e-01	1.43e-01
GOBP RESPONSE TO OXYGEN GLUCOSE DEPRIVATION	11	4.48e-02	2.36e-01	0.6400	-1.74e-01	4.57e-02	-2.81e-01	-4.11e-01	3.60e-01	3.18e-01	7.93e-01	1.07e-01	1.83e-02	3.89e-02
GOMF ARACHIDONIC ACID MONOOXYGENASE ACTIVITY	17	1.95e-03	2.65e-02	0.6400	3.20e-01	-1.26e-01	1.74e-01	4.92e-01	-1.36e-01	2.22e-02	3.67e-01	2.15e-01	4.49e-04	3.30e-01
GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME	11	5.04e-02	2.56e-01	0.6390	-2.32e-01	-1.92e-01	-3.37e-01	-4.53e-01	-1.08e-02	1.84e-01	2.71e-01	5.33e-02	9.31e-03	9.50e-01
GOBP POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS	12	1.46e-02	1.14e-01	0.6390	-1.01e-01	5.50e-01	2.07e-01	9.98e-02	2.07e-01	5.45e-01	9.60e-04	2.15e-01	5.49e-01	2.15e-01
GOBP NEGATIVE REGULATION OF BEHAVIOR	12	3.12e-03	3.78e-02	0.6390	1.70e-01	2.82e-01	2.07e-01	-1.57e-01	-4.82e-01	3.07e-01	9.04e-02	2.14e-01	3.46e-01	3.85e-03
GOMF TRANSCRIPTION REGULATOR ACTIVATOR ACTIVITY	5	3.52e-01	6.98e-01	0.6390	2.46e-01	9.56e-02	7.36e-02	-3.03e-01	4.92e-01	3.41e-01	7.11e-01	7.76e-01	2.41e-01	5.69e-02
GOBP NEGATIVE REGULATION OF MATRIX METALLOPEPTIDASE SECRETION	6	2.10e-01	5.62e-01	0.6390	1.89e-01	-1.05e-02	2.38e-01	-1.50e-01	5.41e-01	4.22e-01	9.64e-01	3.12e-01	5.25e-01	2.16e-02
GOBP REGULATION OF FEMALE GONAD DEVELOPMENT	7	1.67e-01	5.02e-01	0.6380	-2.23e-02	1.18e-01	5.14e-01	2.03e-01	-2.97e-01	9.19e-01	5.87e-01	1.86e-02	3.52e-01	1.74e-01
GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY	14	6.62e-03	6.54e-02	0.6380	-2.58e-01	1.36e-01	2.99e-01	3.91e-01	2.82e-01	9.46e-02	3.78e-01	5.26e-02	1.13e-02	6.74e-02
GOBP MITOCHONDRIAL RNA MODIFICATION	9	4.67e-02	2.42e-01	0.6380	6.21e-02	-5.04e-02	-1.54e-01	-6.12e-01	-4.82e-02	7.47e-01	7.93e-01	4.24e-01	1.47e-03	8.02e-01
GOCC PHAGOLYSOSOME	5	3.12e-01	6.63e-01	0.6370	7.19e-02	3.43e-01	1.40e-02	1.63e-01	-5.07e-01	7.81e-01	1.84e-01	9.57e-01	5.29e-01	4.96e-02
GOBP MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C	12	3.98e-02	2.19e-01	0.6370	9.67e-03	-1.21e-01	-4.64e-01	-3.40e-01	-2.47e-01	9.54e-01	4.69e-01	5.42e-03	4.16e-02	1.38e-01
GOBP POSITIVE REGULATION OF T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL	5	2.57e-01	6.14e-01	0.6370	-4.32e-01	-1.41e-02	-4.51e-01	-1.23e-01	3.74e-02	9.47e-02	9.56e-01	8.09e-02	6.34e-01	8.85e-01
GOBP NEGATIVE REGULATION OF CHROMATIN ORGANIZATION	5	2.61e-01	6.18e-01	0.6370	-6.29e-04	2.31e-01	5.90e-01	-2.93e-02	6.24e-02	9.98e-01	3.70e-01	2.24e-02	9.10e-01	8.09e-01
GOBP NEGATIVE REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS	6	1.21e-01	4.26e-01	0.6370	-4.00e-01	2.03e-02	4.19e-01	-2.23e-01	1.44e-01	9.00e-02	9.31e-01	7.56e-02	3.45e-01	5.42e-01
GOMF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY	23	2.66e-04	5.30e-03	0.6370	-3.25e-01	-2.89e-02	1.17e-01	4.18e-01	-3.33e-01	7.05e-03	8.10e-01	3.30e-01	5.18e-04	5.70e-03
GOBP CARDIAC PACEMAKER CELL DIFFERENTIATION	11	3.94e-02	2.18e-01	0.6370	3.09e-02	2.92e-01	-6.00e-02	-3.83e-01	4.11e-01	8.59e-01	9.39e-02	7.30e-01	2.77e-02	1.84e-02
GOBP NEURON FATE DETERMINATION	10	2.02e-02	1.42e-01	0.6360	1.90e-01	1.61e-02	2.24e-01	-3.94e-01	4.04e-01	2.98e-01	9.30e-01	2.19e-01	3.11e-02	2.70e-02
GOBP L ASCORBIC ACID METABOLIC PROCESS	9	6.42e-02	2.98e-01	0.6360	2.88e-01	3.66e-01	1.81e-01	1.82e-01	3.48e-01	1.35e-01	5.70e-02	3.46e-01	3.45e-01	7.08e-02
GOBP NEUROTRANSMITTER LOADING INTO SYNAPTIC VESICLE	7	1.41e-01	4.62e-01	0.6360	2.21e-01	4.95e-01	8.60e-02	1.41e-01	-2.88e-01	3.10e-01	2.33e-02	6.94e-01	5.19e-01	1.87e-01
GOMF BITTER TASTE RECEPTOR ACTIVITY	23	1.44e-05	4.58e-04	0.6360	1.52e-01	-4.00e-01	-2.35e-02	3.60e-01	3.03e-01	2.08e-01	9.06e-04	8.45e-01	2.84e-03	1.20e-02
GOBP NEGATIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION	7	2.42e-01	5.98e-01	0.6350	2.45e-01	1.44e-01	-4.41e-01	-3.36e-01	1.27e-01	2.63e-01	5.10e-01	4.35e-02	1.23e-01	5.61e-01
GOBP MONOCYTE EXTRAVASATION	10	4.20e-02	2.27e-01	0.6350	-2.85e-01	8.94e-02	3.42e-01	1.33e-01	4.24e-01	1.18e-01	6.25e-01	6.15e-02	4.67e-01	2.01e-02
GOBP SOFT PALATE DEVELOPMENT	5	2.69e-01	6.23e-01	0.6350	5.96e-01	1.61e-01	1.10e-01	-8.80e-02	-4.99e-02	2.10e-02	5.33e-01	6.71e-01	7.33e-01	8.47e-01
GOBP OUTER EAR MORPHOGENESIS	7	1.77e-01	5.18e-01	0.6350	3.50e-01	-8.69e-02	-3.61e-02	-3.52e-01	3.86e-01	1.09e-01	6.90e-01	8.69e-01	1.07e-01	7.73e-02
GOBP MESODERMAL CELL MIGRATION	5	2.39e-01	5.95e-01	0.6350	-5.20e-01	-1.59e-01	6.34e-03	2.36e-01	2.29e-01	4.42e-02	5.38e-01	9.80e-01	3.61e-01	3.74e-01
GOBP TELENCEPHALON REGIONALIZATION	13	1.14e-02	9.60e-02	0.6350	3.88e-02	1.96e-01	2.03e-02	-5.00e-01	3.36e-01	8.09e-01	2.22e-01	8.99e-01	1.79e-03	3.59e-02
GOBP EOSINOPHIL DIFFERENTIATION	6	1.84e-01	5.25e-01	0.6350	1.43e-01	5.21e-01	1.23e-01	2.59e-01	1.72e-01	5.44e-01	2.72e-02	6.01e-01	2.73e-01	4.67e-01
GOMF UBIQUITIN MODIFICATION DEPENDENT HISTONE BINDING	6	1.43e-01	4.63e-01	0.6350	-1.26e-01	2.55e-01	4.14e-01	-2.94e-01	2.54e-01	5.93e-01	2.79e-01	7.93e-02	2.13e-01	2.82e-01
GOBP DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION	451	2.46e-107	8.40e-104	0.6340	-1.34e-01	-3.06e-01	1.39e-01	5.19e-01	4.23e-02	1.02e-06	7.48e-29	4.40e-07	2.40e-80	1.24e-01
GOBP GALACTOSE TRANSMEMBRANE TRANSPORT	5	3.75e-01	7.15e-01	0.6340	3.98e-01	-2.75e-02	3.20e-01	3.74e-01	3.49e-02	1.23e-01	9.15e-01	2.15e-01	1.48e-01	8.92e-01
GOBP NEGATIVE REGULATION OF HORMONE METABOLIC PROCESS	12	1.79e-02	1.32e-01	0.6340	-3.86e-01	3.53e-01	1.72e-01	2.99e-01	-9.36e-02	2.05e-02	3.43e-02	3.01e-01	7.26e-02	5.74e-01
GOBP REGULATION OF HISTONE DEACETYLATION	5	4.62e-01	7.79e-01	0.6330	1.10e-01	-3.29e-01	-4.05e-01	-3.42e-01	2.07e-03	6.69e-01	2.02e-01	1.17e-01	1.85e-01	9.94e-01
GOBP NEUTROPHIL MEDIATED KILLING OF SYMBIONT CELL	12	6.64e-03	6.54e-02	0.6330	-2.23e-01	1.88e-01	2.68e-01	-3.90e-01	3.04e-01	1.82e-01	2.58e-01	1.09e-01	1.94e-02	6.87e-02
GOBP POSITIVE REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY	8	1.24e-01	4.32e-01	0.6330	-3.35e-01	2.01e-01	4.01e-01	1.22e-01	2.68e-01	1.01e-01	3.25e-01	4.93e-02	5.49e-01	1.89e-01
GOMF BETA 2 ADRENERGIC RECEPTOR BINDING	6	1.50e-01	4.76e-01	0.6330	-1.39e-01	4.59e-01	-1.43e-02	4.51e-03	4.13e-01	5.56e-01	5.17e-02	9.52e-01	9.85e-01	8.00e-02
GOMF GLUCURONOSYLTRANSFERASE ACTIVITY	32	2.26e-05	6.89e-04	0.6330	3.53e-02	6.36e-02	3.27e-01	5.07e-01	-1.76e-01	7.30e-01	5.34e-01	1.37e-03	6.85e-07	8.55e-02
GOBP SUBSTRATE INDEPENDENT TELENCEPHALIC TANGENTIAL MIGRATION	10	3.86e-02	2.15e-01	0.6320	-2.29e-01	-5.26e-01	1.91e-01	1.76e-01	-5.71e-02	2.10e-01	3.94e-03	2.96e-01	3.36e-01	7.55e-01
GOBP NEGATIVE REGULATION OF NATURAL KILLER CELL ACTIVATION	10	4.40e-02	2.33e-01	0.6320	-2.08e-01	2.85e-01	-2.92e-01	-2.70e-01	-3.42e-01	2.56e-01	1.19e-01	1.10e-01	1.39e-01	6.14e-02
GOBP MYELOID PROGENITOR CELL DIFFERENTIATION	9	4.23e-02	2.28e-01	0.6310	-4.76e-01	-1.05e-01	2.34e-01	-1.57e-01	2.85e-01	1.35e-02	5.84e-01	2.24e-01	4.16e-01	1.39e-01
GOBP L PROLINE BIOSYNTHETIC PROCESS	6	2.06e-01	5.56e-01	0.6310	-3.15e-01	2.68e-02	6.05e-03	-4.64e-01	2.87e-01	1.81e-01	9.09e-01	9.80e-01	4.90e-02	2.23e-01
GOBP SERINE PHOSPHORYLATION OF STAT PROTEIN	20	8.26e-04	1.33e-02	0.6310	-1.34e-01	-2.71e-01	2.88e-01	4.44e-01	1.63e-01	2.98e-01	3.58e-02	2.60e-02	5.93e-04	2.06e-01
GOCC PROTEASOME REGULATORY PARTICLE BASE SUBCOMPLEX	9	1.52e-01	4.78e-01	0.6300	2.49e-01	-1.65e-01	-3.36e-01	-4.09e-01	1.69e-01	1.96e-01	3.93e-01	8.13e-02	3.36e-02	3.81e-01
GOBP REGULATION OF DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION	10	7.58e-02	3.31e-01	0.6300	-1.90e-01	3.67e-01	2.62e-01	3.63e-01	-1.63e-01	2.99e-01	4.43e-02	1.52e-01	4.70e-02	3.72e-01
GOBP MESANGIAL CELL DIFFERENTIATION	7	9.23e-02	3.67e-01	0.6300	3.00e-01	3.15e-01	-2.29e-01	2.48e-02	3.93e-01	1.69e-01	1.48e-01	2.94e-01	9.09e-01	7.15e-02
GOBP NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING	11	2.68e-02	1.70e-01	0.6300	2.14e-01	6.05e-02	9.10e-02	-4.05e-01	4.19e-01	2.18e-01	7.28e-01	6.01e-01	2.01e-02	1.61e-02
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY BARORECEPTOR FEEDBACK	5	4.03e-01	7.35e-01	0.6300	-3.34e-01	8.95e-02	2.27e-01	4.67e-01	-8.82e-02	1.96e-01	7.29e-01	3.79e-01	7.06e-02	7.33e-01
GOBP MODULATION BY VIRUS OF HOST PROCESS	7	9.24e-02	3.67e-01	0.6300	5.25e-01	1.40e-01	2.52e-01	-1.80e-01	7.95e-02	1.62e-02	5.22e-01	2.47e-01	4.10e-01	7.16e-01
GOMF DNA REPLICATION ORIGIN BINDING	15	6.51e-03	6.48e-02	0.6300	-1.59e-01	-3.02e-01	-2.72e-01	-4.32e-01	-1.40e-01	2.86e-01	4.31e-02	6.78e-02	3.75e-03	3.46e-01
GOBP PHAGOSOME ACIDIFICATION	7	1.88e-01	5.33e-01	0.6300	2.04e-02	3.78e-01	4.54e-01	2.17e-02	2.17e-01	9.25e-01	8.35e-02	3.75e-02	9.21e-01	3.20e-01
GOCC GID COMPLEX	5	1.59e-01	4.89e-01	0.6300	1.27e-01	2.94e-01	1.82e-01	-4.61e-01	-2.20e-01	6.23e-01	2.54e-01	4.81e-01	7.45e-02	3.93e-01
GOBP NEGATIVE REGULATION OF GONADOTROPIN SECRETION	7	9.92e-02	3.81e-01	0.6300	-1.85e-01	1.79e-01	9.41e-02	-1.71e-01	-5.41e-01	3.97e-01	4.13e-01	6.66e-01	4.34e-01	1.33e-02
GOBP REGULATION OF OSTEOCLAST PROLIFERATION	6	2.26e-01	5.79e-01	0.6300	-2.77e-01	8.41e-02	3.57e-03	-3.08e-01	4.67e-01	2.41e-01	7.21e-01	9.88e-01	1.92e-01	4.76e-02
GOBP NEGATIVE REGULATION OF B CELL DIFFERENTIATION	6	2.38e-01	5.94e-01	0.6290	-1.92e-01	2.49e-01	-3.37e-01	-2.36e-01	-3.58e-01	4.14e-01	2.90e-01	1.53e-01	3.17e-01	1.29e-01
GOBP FATTY ACID ALPHA OXIDATION	8	7.20e-02	3.20e-01	0.6290	4.04e-01	1.28e-02	-1.66e-01	9.96e-02	4.42e-01	4.81e-02	9.50e-01	4.16e-01	6.26e-01	3.03e-02
GOBP ACYLGLYCEROL TRANSPORT	8	8.06e-02	3.42e-01	0.6290	4.35e-01	-1.31e-01	-1.02e-01	3.18e-01	-2.78e-01	3.29e-02	5.21e-01	6.16e-01	1.19e-01	1.73e-01
GOMF SMALL PROTEIN ACTIVATING ENZYME BINDING	5	4.27e-01	7.54e-01	0.6290	2.69e-01	7.99e-02	-4.40e-01	-3.12e-01	-1.61e-01	2.97e-01	7.57e-01	8.83e-02	2.28e-01	5.33e-01
GOMF EUKARYOTIC INITIATION FACTOR 4E BINDING	9	4.74e-02	2.44e-01	0.6290	-2.36e-01	3.72e-01	1.37e-01	-4.13e-01	1.10e-01	2.20e-01	5.34e-02	4.76e-01	3.19e-02	5.67e-01
GOBP TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS	15	1.37e-02	1.10e-01	0.6290	2.21e-02	3.94e-02	-3.02e-01	-5.49e-01	8.55e-03	8.82e-01	7.92e-01	4.27e-02	2.29e-04	9.54e-01
GOCC NEUROFIBRILLARY TANGLE	5	1.15e-01	4.15e-01	0.6290	-2.73e-02	4.07e-02	5.74e-01	-2.51e-01	2.39e-02	9.16e-01	8.75e-01	2.63e-02	3.31e-01	9.26e-01
GOBP REGULATION OF BLOOD VOLUME BY RENIN ANGIOTENSIN	6	3.24e-01	6.72e-01	0.6280	-8.37e-02	1.52e-01	1.84e-01	4.34e-01	-3.78e-01	7.23e-01	5.18e-01	4.34e-01	6.59e-02	1.09e-01
GOMF CARBOXYLESTERASE ACTIVITY	6	2.82e-01	6.35e-01	0.6280	-2.29e-01	2.54e-01	4.23e-01	1.22e-01	2.90e-01	3.31e-01	2.81e-01	7.29e-02	6.04e-01	2.19e-01
GOMF PYRUVATE DEHYDROGENASE ACTIVITY	5	3.21e-01	6.70e-01	0.6280	5.77e-01	-8.14e-02	1.12e-01	1.44e-01	1.48e-01	2.55e-02	7.53e-01	6.66e-01	5.77e-01	5.66e-01
GOBP POSITIVE REGULATION OF CENTRIOLE ELONGATION	5	4.65e-01	7.80e-01	0.6280	3.45e-01	-8.28e-02	-4.02e-01	-3.26e-01	6.28e-03	1.81e-01	7.48e-01	1.19e-01	2.07e-01	9.81e-01
GOBP FOLLICLE STIMULATING HORMONE SECRETION	8	9.25e-02	3.67e-01	0.6280	2.01e-01	3.71e-01	-1.41e-01	-3.58e-01	-2.62e-01	3.25e-01	6.94e-02	4.89e-01	7.99e-02	2.00e-01
GOCC MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX III	11	5.63e-02	2.75e-01	0.6280	3.44e-02	-5.35e-02	-4.52e-01	-3.06e-01	-3.04e-01	8.43e-01	7.59e-01	9.45e-03	7.87e-02	8.13e-02
GOBP CORTICOSTERONE SECRETION	5	2.92e-01	6.46e-01	0.6280	-4.60e-01	1.52e-01	-1.41e-02	-3.84e-01	-1.07e-01	7.46e-02	5.56e-01	9.56e-01	1.37e-01	6.80e-01
GOCC RNA N6 METHYLADENOSINE METHYLTRANSFERASE COMPLEX	9	1.27e-01	4.40e-01	0.6280	1.18e-01	-3.67e-01	-3.02e-01	-3.64e-01	1.47e-01	5.42e-01	5.65e-02	1.16e-01	5.88e-02	4.46e-01
GOCC CARBOXY TERMINAL DOMAIN PROTEIN KINASE COMPLEX	16	8.21e-03	7.62e-02	0.6270	1.55e-03	-2.63e-01	-2.93e-01	-4.85e-01	5.53e-02	9.91e-01	6.81e-02	4.22e-02	7.87e-04	7.02e-01
GOBP NEURAL FOLD FORMATION	7	8.85e-02	3.59e-01	0.6270	-7.77e-02	-5.01e-01	3.47e-01	4.03e-02	1.20e-01	7.22e-01	2.18e-02	1.12e-01	8.53e-01	5.83e-01
GOBP CARDIOBLAST PROLIFERATION	11	4.24e-02	2.28e-01	0.6270	3.05e-02	1.04e-01	-4.15e-02	-4.70e-01	3.99e-01	8.61e-01	5.50e-01	8.12e-01	7.00e-03	2.20e-02
GOMF TESTOSTERONE DEHYDROGENASE NADPLUS ACTIVITY	7	1.74e-01	5.14e-01	0.6270	-4.82e-01	2.79e-01	2.19e-01	1.86e-01	4.62e-03	2.72e-02	2.02e-01	3.15e-01	3.94e-01	9.83e-01
GOBP REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY	9	1.25e-01	4.36e-01	0.6270	-2.97e-01	-1.87e-01	2.05e-01	3.26e-01	-3.47e-01	1.23e-01	3.30e-01	2.86e-01	9.01e-02	7.13e-02
GOBP RESPONSE TO ERYTHROPOIETIN	7	1.31e-01	4.48e-01	0.6260	3.47e-02	1.55e-01	-1.93e-01	-3.31e-01	-4.70e-01	8.74e-01	4.79e-01	3.77e-01	1.29e-01	3.14e-02
GOMF C METHYLTRANSFERASE ACTIVITY	6	1.56e-01	4.84e-01	0.6260	3.75e-01	-1.24e-01	-1.27e-01	-4.09e-01	-2.30e-01	1.11e-01	5.99e-01	5.91e-01	8.30e-02	3.28e-01
GOBP TRANS SYNAPTIC SIGNALING BY LIPID	7	1.80e-01	5.22e-01	0.6260	-4.41e-01	-2.71e-01	-2.09e-01	-1.49e-02	-2.84e-01	4.35e-02	2.15e-01	3.38e-01	9.45e-01	1.93e-01
GOBP POSITIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT	6	2.33e-01	5.87e-01	0.6260	-1.28e-01	3.51e-01	7.54e-02	-4.15e-01	2.73e-01	5.87e-01	1.37e-01	7.49e-01	7.81e-02	2.48e-01
GOBP REGULATION OF TRANSLATIONAL TERMINATION	8	3.67e-02	2.08e-01	0.6260	-4.07e-01	5.43e-02	2.06e-01	-4.21e-01	-6.13e-02	4.63e-02	7.90e-01	3.12e-01	3.93e-02	7.64e-01
GOBP POSITIVE REGULATION OF PROTEIN GLYCOSYLATION	8	1.64e-01	4.97e-01	0.6260	4.39e-01	-9.17e-02	-3.27e-01	-1.95e-01	2.15e-01	3.17e-02	6.53e-01	1.09e-01	3.40e-01	2.93e-01
GOBP LEUKOCYTE CHEMOTAXIS INVOLVED IN INFLAMMATORY RESPONSE	8	8.40e-02	3.50e-01	0.6260	1.79e-01	1.30e-01	6.22e-02	1.07e-01	5.72e-01	3.80e-01	5.25e-01	7.61e-01	6.02e-01	5.06e-03
GOCC CARDIAC MYOFIBRIL	6	2.10e-01	5.62e-01	0.6260	4.19e-01	2.20e-01	1.54e-02	2.91e-01	-2.88e-01	7.58e-02	3.51e-01	9.48e-01	2.16e-01	2.22e-01
GOCC INSULIN LIKE GROWTH FACTOR BINDING PROTEIN COMPLEX	5	1.04e-01	3.90e-01	0.6260	7.23e-02	8.56e-02	-5.42e-01	2.83e-01	-7.24e-02	7.79e-01	7.40e-01	3.59e-02	2.73e-01	7.79e-01
GOBP REGULATION OF TETRAPYRROLE METABOLIC PROCESS	8	1.59e-01	4.89e-01	0.6250	-2.51e-02	1.21e-02	-1.77e-01	-3.61e-01	4.78e-01	9.02e-01	9.53e-01	3.86e-01	7.73e-02	1.91e-02
GOBP REGULATION OF APOPTOTIC CELL CLEARANCE	10	3.03e-02	1.85e-01	0.6250	-5.39e-01	-8.65e-02	-2.18e-01	-1.17e-01	1.78e-01	3.16e-03	6.36e-01	2.32e-01	5.23e-01	3.29e-01
GOBP PROTEIN FOLDING IN ENDOPLASMIC RETICULUM	12	1.14e-02	9.62e-02	0.6250	-2.53e-01	1.66e-01	-7.14e-02	-5.32e-01	-1.07e-01	1.30e-01	3.19e-01	6.69e-01	1.41e-03	5.22e-01
GOCC TRANSCRIPTION FACTOR TFIIH HOLO COMPLEX	10	1.02e-01	3.88e-01	0.6250	-1.78e-02	-2.31e-01	-3.02e-01	-4.62e-01	1.80e-01	9.22e-01	2.06e-01	9.83e-02	1.14e-02	3.24e-01
GOMF RNA POLYMERASE II CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING	18	2.87e-03	3.56e-02	0.6250	4.19e-01	1.63e-01	-1.23e-01	-3.52e-01	2.22e-01	2.10e-03	2.30e-01	3.68e-01	9.73e-03	1.02e-01
GOBP REGULATION OF PHOSPHOLIPASE A2 ACTIVITY	8	9.98e-02	3.83e-01	0.6240	2.39e-01	-2.54e-01	-1.31e-01	3.18e-01	-3.87e-01	2.43e-01	2.13e-01	5.21e-01	1.19e-01	5.79e-02
GOBP POSITIVE REGULATION OF BLOOD BRAIN BARRIER PERMEABILITY	5	4.34e-01	7.57e-01	0.6240	-4.23e-01	8.05e-02	1.96e-01	2.76e-01	-3.00e-01	1.01e-01	7.55e-01	4.48e-01	2.85e-01	2.45e-01
GOMF PHOSPHATIDYLINOSITOL 3 4 5 TRISPHOSPHATE 5 PHOSPHATASE ACTIVITY	6	2.14e-01	5.67e-01	0.6240	-2.25e-01	1.75e-02	-1.64e-01	-2.83e-01	-4.81e-01	3.40e-01	9.41e-01	4.87e-01	2.30e-01	4.11e-02
GOBP TRNA THIO MODIFICATION	5	4.52e-01	7.72e-01	0.6240	2.20e-01	-2.66e-01	-4.17e-01	-2.77e-01	-1.42e-01	3.95e-01	3.03e-01	1.07e-01	2.84e-01	5.84e-01
GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS	17	3.90e-03	4.48e-02	0.6240	-1.60e-01	2.24e-01	-3.34e-01	-4.10e-01	-1.82e-01	2.53e-01	1.09e-01	1.72e-02	3.39e-03	1.95e-01
GOBP OUTER MITOCHONDRIAL MEMBRANE ORGANIZATION	15	1.84e-02	1.34e-01	0.6240	-4.58e-02	-2.53e-02	-4.43e-01	-3.71e-01	2.28e-01	7.59e-01	8.65e-01	2.96e-03	1.27e-02	1.27e-01
GOCC GINS COMPLEX	5	3.56e-01	7.01e-01	0.6230	-1.16e-01	3.75e-01	8.70e-02	-3.00e-01	3.70e-01	6.53e-01	1.46e-01	7.36e-01	2.45e-01	1.52e-01
GOBP L PHENYLALANINE METABOLIC PROCESS	8	1.02e-01	3.87e-01	0.6230	-1.50e-02	5.53e-01	8.59e-02	-5.64e-02	-2.67e-01	9.41e-01	6.72e-03	6.74e-01	7.83e-01	1.91e-01
GOBP PARATHYROID GLAND DEVELOPMENT	7	5.11e-02	2.58e-01	0.6230	3.96e-01	1.77e-01	1.87e-01	-3.24e-01	-2.45e-01	6.95e-02	4.18e-01	3.93e-01	1.38e-01	2.61e-01
GOBP NEGATIVE REGULATION OF TRANSLATIONAL ELONGATION	5	4.27e-01	7.54e-01	0.6230	-1.63e-01	1.38e-02	-2.07e-01	-5.19e-01	2.22e-01	5.28e-01	9.57e-01	4.22e-01	4.46e-02	3.91e-01
GOBP L CYSTINE TRANSPORT	6	3.42e-01	6.88e-01	0.6230	1.36e-01	6.17e-02	2.67e-01	4.33e-01	-3.26e-01	5.64e-01	7.93e-01	2.58e-01	6.60e-02	1.67e-01
GOBP CEREBELLAR GRANULAR LAYER FORMATION	6	2.33e-01	5.86e-01	0.6230	1.51e-01	-3.66e-01	1.76e-01	3.13e-01	3.19e-01	5.22e-01	1.20e-01	4.56e-01	1.85e-01	1.75e-01
GOCC LAMININ COMPLEX	9	1.39e-01	4.60e-01	0.6220	-3.88e-02	-1.21e-01	2.07e-01	4.74e-01	-3.22e-01	8.40e-01	5.29e-01	2.81e-01	1.39e-02	9.42e-02
GOBP CYCLIC GMP AMP TRANSMEMBRANE IMPORT ACROSS PLASMA MEMBRANE	6	2.56e-01	6.13e-01	0.6220	2.86e-01	3.83e-01	7.87e-02	-2.12e-02	3.90e-01	2.26e-01	1.05e-01	7.38e-01	9.28e-01	9.79e-02
GOCC CALCITONIN FAMILY RECEPTOR COMPLEX	5	3.54e-01	7.00e-01	0.6220	-1.04e-01	-3.64e-01	3.30e-02	4.85e-01	-8.63e-02	6.87e-01	1.59e-01	8.98e-01	6.06e-02	7.38e-01
GOCC PRERIBOSOME LARGE SUBUNIT PRECURSOR	18	9.00e-03	8.14e-02	0.6220	6.88e-03	-1.19e-01	-4.60e-01	-3.76e-01	1.37e-01	9.60e-01	3.82e-01	7.19e-04	5.74e-03	3.15e-01
GOMF RIBOSOMAL SMALL SUBUNIT BINDING	16	1.90e-02	1.37e-01	0.6210	1.69e-01	2.50e-02	-4.19e-01	-4.11e-01	1.09e-01	2.42e-01	8.62e-01	3.70e-03	4.40e-03	4.50e-01
GOBP POSITIVE REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS	6	2.77e-01	6.31e-01	0.6210	1.10e-01	4.23e-01	6.77e-02	-2.70e-01	3.42e-01	6.41e-01	7.29e-02	7.74e-01	2.51e-01	1.47e-01
GOBP MEIOTIC DNA DOUBLE STRAND BREAK FORMATION	6	2.22e-01	5.76e-01	0.6210	-4.04e-01	-3.78e-01	-3.86e-02	-1.15e-01	2.54e-01	8.63e-02	1.09e-01	8.70e-01	6.26e-01	2.82e-01
GOMF CCR CHEMOKINE RECEPTOR BINDING	38	1.21e-06	5.24e-05	0.6210	-4.00e-01	1.00e-01	2.67e-01	3.45e-01	-1.60e-01	1.97e-05	2.86e-01	4.44e-03	2.36e-04	8.88e-02
GOMF RNA POLYMERASE I ACTIVITY	10	1.15e-01	4.13e-01	0.6200	3.23e-01	-8.92e-02	-3.48e-01	-3.80e-01	7.91e-02	7.65e-02	6.25e-01	5.64e-02	3.73e-02	6.65e-01
GOBP POSITIVE REGULATION OF TRANSMISSION OF NERVE IMPULSE	7	1.58e-01	4.88e-01	0.6200	2.30e-01	-1.70e-01	1.27e-01	1.40e-01	5.17e-01	2.92e-01	4.35e-01	5.62e-01	5.22e-01	1.79e-02
GOBP PHENOL CONTAINING COMPOUND CATABOLIC PROCESS	7	1.81e-01	5.24e-01	0.6190	-2.17e-01	1.94e-01	5.38e-01	7.37e-02	-6.28e-02	3.19e-01	3.74e-01	1.38e-02	7.36e-01	7.74e-01
GOBP SEROTONIN METABOLIC PROCESS	10	1.12e-01	4.10e-01	0.6190	-1.61e-01	4.82e-02	4.97e-01	2.97e-01	-1.39e-01	3.78e-01	7.92e-01	6.50e-03	1.04e-01	4.48e-01
GOCC EXTRINSIC COMPONENT OF MITOCHONDRIAL INNER MEMBRANE	7	2.18e-01	5.72e-01	0.6180	1.33e-01	-2.78e-01	-2.90e-01	-4.42e-01	-8.61e-02	5.43e-01	2.02e-01	1.84e-01	4.28e-02	6.93e-01
GOBP CEREBRAL CORTEX GABAERGIC INTERNEURON DEVELOPMENT	6	1.68e-01	5.04e-01	0.6180	-6.86e-02	-5.49e-01	9.44e-02	-1.77e-01	1.88e-01	7.71e-01	1.98e-02	6.89e-01	4.53e-01	4.26e-01
GOMF PORIN ACTIVITY	6	2.79e-01	6.32e-01	0.6180	-1.72e-01	-5.15e-02	-3.24e-01	-2.73e-01	4.12e-01	4.66e-01	8.27e-01	1.69e-01	2.47e-01	8.02e-02
GOBP TRANSCRIPTION ELONGATION COUPLED CHROMATIN REMODELING	7	1.91e-01	5.37e-01	0.6180	-9.36e-02	-1.12e-01	-2.42e-01	-5.35e-01	-1.23e-01	6.68e-01	6.08e-01	2.67e-01	1.42e-02	5.74e-01
GOBP RRNA 5 END PROCESSING	5	4.76e-01	7.89e-01	0.6180	3.18e-01	-3.97e-02	-4.49e-01	-2.78e-01	-1.42e-02	2.19e-01	8.78e-01	8.22e-02	2.82e-01	9.56e-01
GOCC ENDOPLASMIC RETICULUM TUBULAR NETWORK MEMBRANE	5	4.40e-01	7.63e-01	0.6170	3.96e-01	7.26e-02	-1.52e-01	-3.77e-01	2.32e-01	1.25e-01	7.79e-01	5.55e-01	1.44e-01	3.70e-01
GOBP DIADENOSINE POLYPHOSPHATE METABOLIC PROCESS	6	2.80e-01	6.33e-01	0.6170	-4.61e-01	-9.63e-02	-2.86e-01	-2.69e-01	-7.11e-02	5.05e-02	6.83e-01	2.25e-01	2.53e-01	7.63e-01
GOBP ECTODERMAL CELL DIFFERENTIATION	6	2.59e-01	6.16e-01	0.6170	-2.94e-01	3.16e-01	-1.06e-01	-4.23e-01	7.02e-02	2.13e-01	1.81e-01	6.54e-01	7.28e-02	7.66e-01
GOBP POSITIVE REGULATION OF DENDRITIC CELL DIFFERENTIATION	6	2.36e-01	5.91e-01	0.6170	-2.66e-01	2.93e-01	-3.94e-01	-2.60e-01	-3.68e-02	2.60e-01	2.13e-01	9.48e-02	2.70e-01	8.76e-01
GOBP POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS	5	3.59e-01	7.03e-01	0.6170	-2.76e-01	2.64e-01	3.07e-01	-3.10e-02	3.74e-01	2.86e-01	3.06e-01	2.35e-01	9.04e-01	1.48e-01
GOBP DISTAL CONVOLUTED TUBULE DEVELOPMENT	5	1.96e-01	5.44e-01	0.6170	5.22e-02	3.59e-01	2.76e-01	-3.96e-01	-1.27e-01	8.40e-01	1.65e-01	2.86e-01	1.25e-01	6.23e-01
GOBP PRIMARY AMINO COMPOUND BIOSYNTHETIC PROCESS	6	3.08e-01	6.60e-01	0.6170	-4.63e-01	-1.18e-01	3.28e-01	2.05e-01	-4.36e-02	4.94e-02	6.16e-01	1.64e-01	3.84e-01	8.53e-01
GOBP TRNA AMINOACYLATION FOR MITOCHONDRIAL PROTEIN TRANSLATION	8	1.96e-01	5.44e-01	0.6170	1.53e-01	-5.13e-02	-4.94e-01	-2.76e-01	-1.86e-01	4.54e-01	8.01e-01	1.56e-02	1.77e-01	3.62e-01
GOCC RNA POLYMERASE I COMPLEX	13	4.50e-02	2.37e-01	0.6170	2.52e-01	-1.28e-01	-3.61e-01	-4.11e-01	2.25e-02	1.15e-01	4.25e-01	2.41e-02	1.02e-02	8.88e-01
GOBP D ASPARTATE IMPORT ACROSS PLASMA MEMBRANE	5	3.26e-01	6.74e-01	0.6170	-5.43e-02	4.17e-01	1.35e-01	-6.43e-02	-4.25e-01	8.33e-01	1.06e-01	6.02e-01	8.03e-01	9.96e-02
GOBP DNA METHYLATION ON CYTOSINE	6	2.78e-01	6.32e-01	0.6160	4.62e-01	3.29e-01	-1.20e-02	-1.77e-01	1.63e-01	4.99e-02	1.63e-01	9.60e-01	4.54e-01	4.90e-01
GOCC BARR BODY	7	2.75e-01	6.30e-01	0.6160	1.80e-01	-6.97e-02	-2.51e-01	-5.03e-01	1.61e-01	4.10e-01	7.49e-01	2.50e-01	2.13e-02	4.60e-01
GOBP HYDROCARBON METABOLIC PROCESS	7	1.32e-01	4.49e-01	0.6150	4.01e-01	-1.38e-02	-4.14e-01	8.42e-02	-1.99e-01	6.64e-02	9.49e-01	5.78e-02	7.00e-01	3.63e-01
GOBP NEGATIVE REGULATION OF INTERLEUKIN 18 PRODUCTION	5	4.83e-01	7.93e-01	0.6150	-2.23e-01	2.69e-01	4.50e-01	2.31e-01	2.48e-02	3.88e-01	2.97e-01	8.13e-02	3.71e-01	9.24e-01
GOMF CALCIUM SENSITIVE GUANYLATE CYCLASE ACTIVATOR ACTIVITY	5	4.66e-01	7.81e-01	0.6150	5.48e-02	1.04e-01	2.65e-01	5.29e-01	-1.21e-01	8.32e-01	6.87e-01	3.04e-01	4.06e-02	6.39e-01
GOBP POSITIVE REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS	9	6.66e-02	3.05e-01	0.6150	1.09e-02	4.65e-01	-3.37e-02	-1.12e-01	3.84e-01	9.55e-01	1.56e-02	8.61e-01	5.60e-01	4.62e-02
GOBP METANEPHRIC S SHAPED BODY MORPHOGENESIS	5	1.63e-01	4.96e-01	0.6150	3.01e-01	2.28e-01	3.73e-01	-2.48e-01	-1.84e-01	2.44e-01	3.76e-01	1.48e-01	3.36e-01	4.76e-01
GOMF POTASSIUM CHANNEL INHIBITOR ACTIVITY	5	3.75e-01	7.15e-01	0.6140	-4.53e-01	-2.74e-01	1.26e-02	1.85e-02	-3.10e-01	7.91e-02	2.88e-01	9.61e-01	9.43e-01	2.30e-01
GOBP REGULATION BY VIRUS OF VIRAL PROTEIN LEVELS IN HOST CELL	7	2.30e-01	5.83e-01	0.6140	4.76e-01	-1.80e-01	-2.37e-01	-2.09e-01	1.34e-01	2.90e-02	4.10e-01	2.78e-01	3.38e-01	5.40e-01
GOBP MRNA ALTERNATIVE POLYADENYLATION	5	3.94e-01	7.29e-01	0.6140	-1.16e-01	-4.19e-01	-2.39e-01	-3.54e-01	-7.45e-02	6.55e-01	1.05e-01	3.55e-01	1.71e-01	7.73e-01
GOMF PROSTANOID RECEPTOR ACTIVITY	11	4.85e-02	2.49e-01	0.6140	-1.47e-01	1.52e-01	-1.04e-01	-5.07e-01	2.54e-01	3.98e-01	3.83e-01	5.49e-01	3.61e-03	1.45e-01
GOBP VIRAL TRANSLATIONAL TERMINATION REINITIATION	5	3.82e-01	7.20e-01	0.6140	4.25e-01	-3.85e-02	-4.30e-01	-7.89e-02	-5.73e-02	9.98e-02	8.81e-01	9.57e-02	7.60e-01	8.24e-01
GOBP TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE CLEARANCE	7	1.64e-01	4.97e-01	0.6140	-5.07e-01	2.05e-01	-1.30e-01	-2.27e-01	-9.71e-02	2.02e-02	3.49e-01	5.51e-01	2.99e-01	6.56e-01
GOMF C ACETYLTRANSFERASE ACTIVITY	7	2.70e-01	6.24e-01	0.6130	3.85e-02	5.46e-02	-5.11e-01	-3.18e-01	9.93e-02	8.60e-01	8.02e-01	1.93e-02	1.45e-01	6.49e-01
GOBP METANEPHRIC LOOP OF HENLE DEVELOPMENT	6	2.71e-01	6.25e-01	0.6130	3.57e-01	4.62e-01	5.37e-02	-1.52e-01	9.78e-02	1.30e-01	5.02e-02	8.20e-01	5.19e-01	6.78e-01
GOBP PRIMITIVE STREAK FORMATION	10	5.76e-02	2.79e-01	0.6130	2.21e-01	-1.26e-01	-2.59e-02	-4.38e-01	3.44e-01	2.26e-01	4.90e-01	8.87e-01	1.66e-02	5.93e-02
GOMF 5S RRNA BINDING	9	1.64e-01	4.97e-01	0.6120	-5.25e-02	1.47e-01	-3.38e-01	-4.71e-01	1.18e-01	7.85e-01	4.46e-01	7.87e-02	1.43e-02	5.39e-01
GOMF UBIQUINONE BINDING	5	4.78e-01	7.91e-01	0.6120	-5.77e-02	-7.98e-02	-4.77e-01	-3.15e-01	1.95e-01	8.23e-01	7.57e-01	6.47e-02	2.22e-01	4.49e-01
GOBP VITAMIN B6 METABOLIC PROCESS	5	4.07e-01	7.40e-01	0.6120	3.49e-01	3.55e-01	-2.51e-01	-2.24e-01	1.15e-01	1.77e-01	1.70e-01	3.31e-01	3.86e-01	6.56e-01
GOBP NEGATIVE REGULATION OF RESPONSE TO FOOD	10	3.51e-02	2.02e-01	0.6110	5.74e-01	6.60e-02	-2.07e-02	-1.31e-01	-1.49e-01	1.67e-03	7.18e-01	9.10e-01	4.74e-01	4.13e-01
GOMF LARGE RIBOSOMAL SUBUNIT RRNA BINDING	5	4.51e-01	7.71e-01	0.6110	-1.67e-01	1.86e-01	-3.82e-01	-3.92e-01	1.06e-01	5.17e-01	4.72e-01	1.39e-01	1.29e-01	6.81e-01
GOBP LIMB JOINT MORPHOGENESIS	5	2.30e-01	5.83e-01	0.6110	-1.46e-01	-1.60e-01	3.73e-01	-2.44e-01	3.57e-01	5.72e-01	5.35e-01	1.49e-01	3.44e-01	1.67e-01
GOBP REGULATION OF ANTIMICROBIAL HUMORAL RESPONSE	12	4.09e-02	2.23e-01	0.6100	-3.37e-01	-3.30e-01	2.11e-01	3.13e-01	-9.09e-02	4.35e-02	4.81e-02	2.06e-01	6.05e-02	5.85e-01
GOMF SPLICING FACTOR BINDING	5	4.06e-01	7.39e-01	0.6100	2.00e-01	-1.96e-02	-3.31e-01	-3.30e-01	-3.37e-01	4.38e-01	9.40e-01	1.99e-01	2.01e-01	1.92e-01
GOBP GALACTOLIPID BIOSYNTHETIC PROCESS	6	2.87e-01	6.41e-01	0.6100	-4.81e-01	-2.79e-01	1.64e-01	1.36e-01	-1.32e-01	4.11e-02	2.37e-01	4.88e-01	5.64e-01	5.75e-01
GOBP RESPONSE TO YEAST	7	1.43e-01	4.63e-01	0.6100	-4.59e-01	1.94e-01	1.30e-01	2.23e-02	3.26e-01	3.55e-02	3.74e-01	5.50e-01	9.18e-01	1.35e-01
GOMF URATE TRANSMEMBRANE TRANSPORTER ACTIVITY	9	1.54e-01	4.82e-01	0.6100	-1.96e-01	2.33e-01	2.61e-01	4.18e-01	-1.90e-01	3.08e-01	2.26e-01	1.76e-01	2.97e-02	3.23e-01
GOCC ANKYRIN 1 COMPLEX	7	2.16e-01	5.69e-01	0.6100	-5.84e-02	3.21e-01	2.59e-01	4.40e-01	6.66e-02	7.89e-01	1.41e-01	2.35e-01	4.36e-02	7.60e-01
GOMF LIPOTEICHOIC ACID BINDING	5	3.62e-01	7.04e-01	0.6100	3.36e-01	3.06e-01	-2.20e-01	-2.05e-01	-2.73e-01	1.93e-01	2.35e-01	3.95e-01	4.28e-01	2.90e-01
GOCC SEH1 ASSOCIATED COMPLEX	8	1.83e-01	5.25e-01	0.6100	3.65e-01	-2.89e-01	-3.22e-01	-2.26e-01	3.53e-03	7.35e-02	1.57e-01	1.15e-01	2.68e-01	9.86e-01
GOBP REGULATION OF INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY	11	2.29e-02	1.54e-01	0.6100	-1.81e-01	-1.52e-01	7.98e-02	-2.53e-02	-5.56e-01	2.98e-01	3.84e-01	6.47e-01	8.84e-01	1.42e-03
GOBP LEUCINE CATABOLIC PROCESS	6	3.57e-01	7.02e-01	0.6100	1.03e-01	1.08e-02	4.55e-01	3.09e-01	2.41e-01	6.61e-01	9.63e-01	5.35e-02	1.89e-01	3.08e-01
GOBP OTOLITH MORPHOGENESIS	5	5.10e-01	8.07e-01	0.6100	-2.73e-01	2.06e-01	3.40e-01	3.56e-01	-1.08e-01	2.90e-01	4.24e-01	1.88e-01	1.68e-01	6.75e-01
GOMF INSULIN BINDING	5	4.73e-01	7.86e-01	0.6090	-1.58e-01	2.81e-01	4.56e-01	1.86e-01	1.56e-01	5.40e-01	2.76e-01	7.72e-02	4.72e-01	5.45e-01
GOBP POSITIVE REGULATION OF TRANSCRIPTION BY GLUCOSE	6	4.03e-01	7.36e-01	0.6090	2.18e-01	-3.46e-02	-2.50e-01	-4.05e-01	3.09e-01	3.55e-01	8.83e-01	2.88e-01	8.55e-02	1.89e-01
GOBP TRICUSPID VALVE DEVELOPMENT	6	1.81e-01	5.23e-01	0.6090	5.70e-02	-2.44e-02	3.20e-01	-2.87e-01	4.27e-01	8.09e-01	9.17e-01	1.75e-01	2.23e-01	7.02e-02
GOMF SULFUR AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY	11	8.25e-02	3.46e-01	0.6090	-2.30e-01	3.67e-02	3.43e-01	2.77e-01	-3.49e-01	1.87e-01	8.33e-01	4.89e-02	1.11e-01	4.47e-02
GOMF L PROLINE TRANSMEMBRANE TRANSPORTER ACTIVITY	7	1.87e-01	5.30e-01	0.6090	-2.86e-01	-2.81e-01	4.23e-01	1.76e-01	-1.80e-02	1.90e-01	1.98e-01	5.28e-02	4.20e-01	9.34e-01
GOMF G RICH STRAND TELOMERIC DNA BINDING	10	1.46e-01	4.68e-01	0.6090	8.30e-02	-1.20e-01	-3.89e-01	-3.71e-01	2.47e-01	6.49e-01	5.12e-01	3.33e-02	4.24e-02	1.77e-01
GOBP POSITIVE REGULATION OF PHOSPHOLIPID TRANSLOCATION	5	4.71e-01	7.86e-01	0.6080	-1.54e-01	-2.31e-01	4.14e-01	3.48e-01	2.30e-02	5.52e-01	3.71e-01	1.09e-01	1.78e-01	9.29e-01
GOBP REGULATION OF OPSONIZATION	10	3.49e-02	2.02e-01	0.6080	-3.83e-01	1.57e-01	-5.00e-02	3.73e-01	-2.38e-01	3.59e-02	3.91e-01	7.84e-01	4.09e-02	1.92e-01
GOMF LACTATE TRANSMEMBRANE TRANSPORTER ACTIVITY	6	3.09e-01	6.62e-01	0.6080	1.71e-01	2.38e-01	3.97e-01	2.13e-01	-2.85e-01	4.67e-01	3.13e-01	9.23e-02	3.67e-01	2.27e-01
GOBP REGULATION OF CORE PROMOTER BINDING	5	3.91e-01	7.26e-01	0.6080	-8.12e-03	1.00e-01	9.57e-02	-3.05e-01	5.07e-01	9.75e-01	6.97e-01	7.11e-01	2.37e-01	4.97e-02
GOBP POSITIVE REGULATION OF T HELPER 17 CELL DIFFERENTIATION	8	1.83e-01	5.25e-01	0.6080	-4.35e-01	1.85e-01	3.27e-01	1.97e-01	-2.26e-02	3.33e-02	3.64e-01	1.10e-01	3.34e-01	9.12e-01
GOBP TOLL SIGNALING PATHWAY	10	7.16e-02	3.19e-01	0.6070	2.21e-01	3.96e-01	3.88e-01	2.34e-02	1.08e-01	2.27e-01	2.99e-02	3.37e-02	8.98e-01	5.53e-01
GOCC GEMINI OF COILED BODIES	11	4.86e-02	2.49e-01	0.6070	2.63e-01	2.13e-01	-3.46e-01	-2.00e-01	3.07e-01	1.31e-01	2.21e-01	4.71e-02	2.50e-01	7.83e-02
GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY	5	4.70e-01	7.85e-01	0.6060	3.55e-02	-3.88e-01	-2.80e-01	-3.54e-01	1.11e-01	8.91e-01	1.33e-01	2.78e-01	1.71e-01	6.68e-01
GOCC PHAGOCYTIC VESICLE LUMEN	5	2.34e-01	5.89e-01	0.6060	-4.55e-01	-1.14e-01	2.43e-01	-2.97e-01	-1.04e-02	7.80e-02	6.58e-01	3.47e-01	2.51e-01	9.68e-01
GOBP OTOLITH DEVELOPMENT	10	7.48e-02	3.28e-01	0.6060	-1.42e-01	2.99e-01	2.64e-01	4.22e-01	9.89e-02	4.37e-01	1.02e-01	1.48e-01	2.10e-02	5.88e-01
GOBP REGULATION OF MITOCHONDRIAL RNA CATABOLIC PROCESS	5	4.08e-01	7.40e-01	0.6060	-1.53e-01	-4.95e-01	-2.07e-01	-2.35e-01	-1.08e-02	5.53e-01	5.51e-02	4.24e-01	3.63e-01	9.67e-01
GOBP POSITIVE REGULATION OF MICROGLIAL CELL ACTIVATION	10	1.04e-01	3.91e-01	0.6060	-3.81e-01	-5.83e-02	3.75e-01	2.75e-01	4.69e-02	3.71e-02	7.49e-01	4.03e-02	1.32e-01	7.97e-01
GOBP METANEPHRIC PROXIMAL TUBULE DEVELOPMENT	5	3.55e-01	7.00e-01	0.6050	2.03e-01	-2.57e-01	-5.05e-01	1.01e-02	6.82e-02	4.32e-01	3.20e-01	5.06e-02	9.69e-01	7.92e-01
GOBP NEGATIVE REGULATION OF INTERLEUKIN 13 PRODUCTION	7	2.16e-01	5.70e-01	0.6050	1.81e-01	4.63e-01	2.13e-01	7.27e-02	2.62e-01	4.06e-01	3.40e-02	3.29e-01	7.39e-01	2.29e-01
GOBP DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT	7	2.15e-01	5.68e-01	0.6050	-2.43e-01	-1.57e-01	-2.00e-01	2.31e-02	-4.92e-01	2.66e-01	4.71e-01	3.60e-01	9.16e-01	2.42e-02
GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY	6	2.94e-01	6.48e-01	0.6050	-1.65e-01	4.29e-01	3.19e-01	-5.31e-02	2.24e-01	4.83e-01	6.87e-02	1.77e-01	8.22e-01	3.42e-01
GOBP CEREBRAL CORTEX REGIONALIZATION	7	1.31e-01	4.47e-01	0.6050	7.04e-02	3.71e-02	1.16e-01	-5.06e-01	3.00e-01	7.47e-01	8.65e-01	5.95e-01	2.04e-02	1.70e-01
GOMF SINGLE STRANDED DNA 3 5 DNA EXONUCLEASE ACTIVITY	5	3.47e-01	6.93e-01	0.6050	-3.12e-01	-3.98e-01	3.55e-03	-1.75e-01	2.82e-01	2.27e-01	1.23e-01	9.89e-01	4.97e-01	2.75e-01
GOMF HYDROLASE ACTIVITY ACTING ON ETHER BONDS	9	1.16e-01	4.17e-01	0.6050	1.60e-02	3.90e-01	-1.76e-01	-3.28e-01	2.73e-01	9.34e-01	4.26e-02	3.60e-01	8.85e-02	1.56e-01
GOBP REGULATION OF ENDODERMAL CELL DIFFERENTIATION	7	1.70e-01	5.08e-01	0.6040	-4.83e-01	7.93e-02	1.22e-01	-1.13e-01	-3.12e-01	2.68e-02	7.16e-01	5.77e-01	6.04e-01	1.53e-01
GOBP SEQUESTERING OF BMP IN EXTRACELLULAR MATRIX	5	2.93e-01	6.48e-01	0.6040	-4.65e-01	-2.15e-01	-3.09e-01	6.75e-02	5.24e-02	7.19e-02	4.05e-01	2.32e-01	7.94e-01	8.39e-01
GOBP REGULATION OF PROTEIN MONOUBIQUITINATION	6	2.56e-01	6.13e-01	0.6040	3.76e-01	1.36e-01	-1.02e-01	-4.39e-01	-3.53e-02	1.11e-01	5.64e-01	6.66e-01	6.23e-02	8.81e-01
GOMF ACETYL COA C ACYLTRANSFERASE ACTIVITY	7	2.58e-01	6.14e-01	0.6040	6.01e-03	1.73e-01	-4.83e-01	-3.15e-01	5.36e-02	9.78e-01	4.29e-01	2.70e-02	1.49e-01	8.06e-01
GOBP SEROTONIN UPTAKE	12	1.04e-02	9.03e-02	0.6040	4.59e-01	-6.03e-02	-3.00e-01	1.75e-01	1.70e-01	5.86e-03	7.18e-01	7.16e-02	2.93e-01	3.07e-01
GOBP SPERM MITOCHONDRIAL SHEATH ASSEMBLY	6	2.69e-01	6.24e-01	0.6040	-1.76e-01	-4.90e-01	-2.08e-01	2.02e-01	-9.32e-02	4.55e-01	3.75e-02	3.76e-01	3.92e-01	6.93e-01
GOBP RENAL RESPONSE TO BLOOD FLOW INVOLVED IN CIRCULATORY RENIN ANGIOTENSIN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE	6	2.52e-01	6.08e-01	0.6040	-1.34e-01	-4.30e-01	-5.48e-02	-6.97e-03	3.98e-01	5.71e-01	6.82e-02	8.16e-01	9.76e-01	9.11e-02
GOBP GALACTOLIPID METABOLIC PROCESS	9	1.16e-01	4.17e-01	0.6040	-5.09e-01	-1.23e-01	1.88e-01	2.28e-01	-5.72e-02	8.21e-03	5.22e-01	3.29e-01	2.37e-01	7.66e-01
GOBP AIM2 INFLAMMASOME COMPLEX ASSEMBLY	5	3.76e-01	7.15e-01	0.6040	4.91e-02	-3.97e-01	1.12e-01	4.10e-01	1.55e-01	8.49e-01	1.24e-01	6.65e-01	1.13e-01	5.49e-01
GOCC SEROTONIN ACTIVATED CATION SELECTIVE CHANNEL COMPLEX	5	4.31e-01	7.55e-01	0.6040	-3.03e-01	-4.02e-01	1.36e-01	2.85e-01	-1.06e-01	2.41e-01	1.19e-01	6.00e-01	2.69e-01	6.82e-01
GOMF SEROTONIN GATED MONOATOMIC CATION SELECTIVE CHANNEL ACTIVITY	5	4.31e-01	7.55e-01	0.6040	-3.03e-01	-4.02e-01	1.36e-01	2.85e-01	-1.06e-01	2.41e-01	1.19e-01	6.00e-01	2.69e-01	6.82e-01
GOMF MANGANESE ION TRANSMEMBRANE TRANSPORTER ACTIVITY	9	3.71e-02	2.10e-01	0.6030	-1.71e-02	1.70e-01	3.28e-01	-3.88e-01	2.78e-01	9.29e-01	3.78e-01	8.83e-02	4.39e-02	1.49e-01
GOMF CYCLASE INHIBITOR ACTIVITY	5	3.45e-01	6.91e-01	0.6030	2.22e-02	-8.45e-02	-4.46e-03	5.59e-01	-2.09e-01	9.31e-01	7.43e-01	9.86e-01	3.05e-02	4.18e-01
GOBP LYMPHOCYTE ANERGY	7	1.97e-01	5.45e-01	0.6030	2.19e-01	-3.20e-01	3.05e-01	2.59e-01	2.32e-01	3.15e-01	1.43e-01	1.63e-01	2.36e-01	2.88e-01
GOMF RS DOMAIN BINDING	5	3.25e-01	6.73e-01	0.6030	-2.83e-01	9.12e-06	-3.94e-02	-5.29e-01	4.55e-02	2.73e-01	1.00e+00	8.79e-01	4.05e-02	8.60e-01
GOMF CGMP BINDING	15	2.92e-02	1.80e-01	0.6030	-2.95e-02	-1.01e-01	3.99e-01	4.39e-01	2.27e-02	8.43e-01	5.00e-01	7.50e-03	3.24e-03	8.79e-01
GOMF MEMBRANE INSERTASE ACTIVITY	16	1.77e-02	1.31e-01	0.6030	1.93e-01	1.04e-01	-4.34e-01	-3.50e-01	-6.22e-02	1.82e-01	4.71e-01	2.63e-03	1.53e-02	6.66e-01
GOBP DE NOVO AMP BIOSYNTHETIC PROCESS	8	2.04e-01	5.54e-01	0.6020	-1.38e-01	-3.91e-01	-3.37e-01	-2.45e-01	1.30e-01	4.98e-01	5.56e-02	9.89e-02	2.30e-01	5.23e-01
GOBP REGULATION OF ENDOSOME ORGANIZATION	5	4.01e-01	7.34e-01	0.6020	-1.45e-01	4.96e-01	2.13e-01	2.15e-01	5.76e-02	5.76e-01	5.46e-02	4.10e-01	4.06e-01	8.23e-01
GOBP REGULATION OF PRO B CELL DIFFERENTIATION	8	1.97e-01	5.46e-01	0.6020	4.03e-01	-9.66e-02	-1.57e-01	-2.76e-01	2.98e-01	4.82e-02	6.36e-01	4.43e-01	1.76e-01	1.44e-01
GOBP NON CANONICAL WNT SIGNALING PATHWAY VIA JNK CASCADE	6	3.35e-01	6.82e-01	0.6020	-2.31e-01	5.58e-02	-2.73e-01	-4.62e-01	-1.32e-01	3.28e-01	8.13e-01	2.47e-01	4.99e-02	5.75e-01
GOBP MEIOTIC CHROMOSOME CONDENSATION	6	3.08e-01	6.61e-01	0.6010	4.94e-01	1.91e-01	-2.12e-01	-1.88e-01	-1.08e-02	3.60e-02	4.18e-01	3.69e-01	4.24e-01	9.64e-01
GOBP ALPHA LINOLENIC ACID METABOLIC PROCESS	9	1.72e-01	5.12e-01	0.6010	-5.05e-02	1.59e-01	-2.74e-01	-4.77e-01	1.76e-01	7.93e-01	4.08e-01	1.54e-01	1.33e-02	3.62e-01
GOBP NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC	6	3.34e-01	6.81e-01	0.6010	-4.75e-02	5.09e-01	2.75e-01	1.55e-01	2.32e-02	8.40e-01	3.10e-02	2.43e-01	5.12e-01	9.21e-01
GOBP REGULATION OF PLASMA MEMBRANE REPAIR	6	3.01e-01	6.54e-01	0.6010	-1.57e-01	2.78e-01	2.51e-02	2.33e-01	-4.52e-01	5.05e-01	2.38e-01	9.15e-01	3.24e-01	5.52e-02
GOBP REGULATION OF TOLL LIKE RECEPTOR 7 SIGNALING PATHWAY	5	4.69e-01	7.84e-01	0.6000	-1.14e-01	-2.03e-01	-2.18e-01	-4.72e-01	1.90e-01	6.60e-01	4.32e-01	3.98e-01	6.76e-02	4.63e-01
GOBP NEUTROPHIL MEDIATED CYTOTOXICITY	14	6.78e-03	6.64e-02	0.6000	-2.32e-01	2.64e-01	2.14e-01	-3.51e-01	2.60e-01	1.33e-01	8.77e-02	1.65e-01	2.29e-02	9.24e-02
GOBP REGULATION OF MUCUS SECRETION	8	1.46e-01	4.69e-01	0.6000	9.20e-02	5.62e-01	1.68e-01	-1.27e-02	-8.19e-02	6.52e-01	5.89e-03	4.10e-01	9.51e-01	6.88e-01
GOMF PEROXIREDOXIN ACTIVITY	7	3.13e-01	6.64e-01	0.5990	-5.14e-02	-1.72e-01	-3.63e-01	-4.33e-01	-8.85e-02	8.14e-01	4.31e-01	9.66e-02	4.71e-02	6.85e-01
GOBP CELLULAR RESPONSE TO INDOLE 3 METHANOL	5	3.95e-01	7.29e-01	0.5990	4.29e-01	-1.85e-01	2.06e-01	3.14e-01	-8.14e-03	9.68e-02	4.75e-01	4.24e-01	2.24e-01	9.75e-01
GOMF RNA POLYMERASE III ACTIVITY	10	1.14e-01	4.13e-01	0.5990	3.46e-01	-1.15e-01	-4.32e-01	-1.98e-01	2.22e-02	5.82e-02	5.30e-01	1.79e-02	2.79e-01	9.03e-01
GOBP OLFACTORY BULB INTERNEURON DEVELOPMENT	7	2.51e-01	6.08e-01	0.5990	-5.08e-02	-3.56e-01	2.99e-01	3.33e-01	-1.72e-01	8.16e-01	1.03e-01	1.71e-01	1.27e-01	4.32e-01
GOMF GLYCINE TRANSMEMBRANE TRANSPORTER ACTIVITY	9	1.07e-01	3.97e-01	0.5990	-2.90e-01	-4.26e-02	4.90e-01	1.24e-01	1.34e-01	1.32e-01	8.25e-01	1.09e-02	5.21e-01	4.86e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN REDUCED ASCORBATE AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN	5	4.46e-01	7.69e-01	0.5990	-1.36e-01	-3.29e-02	5.30e-01	2.19e-01	-1.06e-01	5.99e-01	8.99e-01	4.03e-02	3.97e-01	6.81e-01
GOMF ARGININE BINDING	8	1.08e-01	4.00e-01	0.5990	-1.88e-01	4.92e-01	1.26e-01	1.07e-01	2.33e-01	3.57e-01	1.59e-02	5.39e-01	6.01e-01	2.54e-01
GOBP MITOCHONDRIAL ELECTRON TRANSPORT SUCCINATE TO UBIQUINONE	5	5.19e-01	8.13e-01	0.5990	-5.36e-02	-1.32e-01	-5.00e-01	-2.91e-01	5.53e-02	8.35e-01	6.10e-01	5.28e-02	2.59e-01	8.30e-01
GOCC NUCLEAR PORE CENTRAL TRANSPORT CHANNEL	5	3.85e-01	7.23e-01	0.5980	-3.02e-01	3.85e-01	-2.55e-02	-3.24e-01	1.11e-01	2.42e-01	1.36e-01	9.21e-01	2.09e-01	6.67e-01
GOCC SODIUM CHANNEL COMPLEX	24	6.24e-04	1.04e-02	0.5980	-2.22e-01	-7.50e-03	8.88e-02	3.62e-01	-4.12e-01	6.03e-02	9.49e-01	4.51e-01	2.14e-03	4.78e-04
GOBP POSITIVE REGULATION OF INOSITOL TRISPHOSPHATE BIOSYNTHETIC PROCESS	5	5.22e-01	8.15e-01	0.5980	-2.93e-01	9.67e-02	3.42e-01	2.68e-01	-2.72e-01	2.57e-01	7.08e-01	1.86e-01	2.99e-01	2.93e-01
GOBP MICROGLIAL CELL MIGRATION	8	1.84e-01	5.26e-01	0.5980	-2.96e-01	-4.26e-02	2.86e-01	4.04e-01	1.52e-01	1.48e-01	8.35e-01	1.62e-01	4.76e-02	4.58e-01
GOBP REGULATION OF GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS	8	1.84e-01	5.25e-01	0.5970	-1.23e-01	1.51e-01	7.20e-02	3.52e-01	-4.36e-01	5.47e-01	4.61e-01	7.24e-01	8.51e-02	3.26e-02
GOBP TRNA 3 END PROCESSING	6	3.48e-01	6.95e-01	0.5970	-9.25e-03	-3.99e-01	-3.05e-01	-2.68e-01	-1.79e-01	9.69e-01	9.06e-02	1.95e-01	2.56e-01	4.48e-01
GOBP NEGATIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS	6	2.08e-01	5.59e-01	0.5970	-7.92e-03	-1.03e-01	-9.23e-02	-2.16e-01	-5.39e-01	9.73e-01	6.63e-01	6.95e-01	3.61e-01	2.22e-02
GOCC ELASTIC FIBER	5	3.21e-01	6.70e-01	0.5970	-3.00e-01	3.75e-01	1.36e-01	2.27e-01	2.34e-01	2.45e-01	1.46e-01	5.98e-01	3.79e-01	3.64e-01
GOBP POSITIVE REGULATION OF CENTRIOLE REPLICATION	9	1.63e-01	4.96e-01	0.5960	2.79e-01	-2.05e-01	-3.18e-01	-3.65e-01	-3.29e-02	1.47e-01	2.86e-01	9.86e-02	5.78e-02	8.64e-01
GOBP RENAL WATER TRANSPORT	9	8.79e-02	3.59e-01	0.5960	-1.74e-01	3.94e-01	-2.12e-01	-1.80e-01	-3.05e-01	3.66e-01	4.09e-02	2.70e-01	3.51e-01	1.13e-01
GOCC TROPONIN COMPLEX	9	9.91e-02	3.81e-01	0.5960	-3.18e-02	1.30e-02	-5.47e-01	-1.92e-01	1.33e-01	8.69e-01	9.46e-01	4.46e-03	3.18e-01	4.89e-01
GOMF SHORT CHAIN CARBOXYLESTERASE ACTIVITY	6	2.83e-01	6.36e-01	0.5960	-1.58e-01	5.42e-01	1.08e-01	9.58e-02	-1.26e-01	5.02e-01	2.15e-02	6.47e-01	6.84e-01	5.93e-01
GOBP PIRNA PROCESSING	23	5.44e-04	9.47e-03	0.5960	-3.05e-01	8.33e-02	3.83e-01	1.76e-01	2.79e-01	1.13e-02	4.89e-01	1.48e-03	1.43e-01	2.06e-02
GOBP LOW DENSITY LIPOPROTEIN PARTICLE REMODELING	16	4.95e-03	5.32e-02	0.5960	-3.55e-01	2.07e-01	3.38e-02	3.45e-01	-2.57e-01	1.38e-02	1.52e-01	8.15e-01	1.69e-02	7.53e-02
GOBP BASE EXCISION REPAIR GAP FILLING	14	4.34e-02	2.31e-01	0.5960	2.35e-01	-1.16e-01	-4.49e-01	-2.70e-01	1.12e-01	1.28e-01	4.52e-01	3.66e-03	7.99e-02	4.70e-01
GOBP POSITIVE REGULATION OF G0 TO G1 TRANSITION	5	4.54e-01	7.73e-01	0.5960	-1.25e-01	-4.00e-02	-4.04e-01	-1.94e-01	-3.70e-01	6.29e-01	8.77e-01	1.17e-01	4.53e-01	1.52e-01
GOBP MEMBRANE DEPOLARIZATION DURING SA NODE CELL ACTION POTENTIAL	5	5.12e-01	8.08e-01	0.5960	2.67e-02	1.25e-01	3.12e-01	4.92e-01	1.17e-02	9.18e-01	6.29e-01	2.28e-01	5.69e-02	9.64e-01
GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS BY CYTOCHROME C	6	3.43e-01	6.90e-01	0.5960	4.09e-01	2.60e-03	-2.31e-01	-3.67e-01	-2.03e-02	8.29e-02	9.91e-01	3.28e-01	1.20e-01	9.31e-01
GOCC PREFOLDIN COMPLEX	6	3.83e-01	7.21e-01	0.5960	2.57e-01	2.70e-01	-1.86e-01	-3.93e-01	1.64e-01	2.75e-01	2.53e-01	4.30e-01	9.53e-02	4.87e-01
GOBP 7 METHYLGUANOSINE CAP HYPERMETHYLATION	8	2.38e-01	5.94e-01	0.5960	-4.57e-02	-2.79e-01	-3.38e-01	-3.03e-01	2.63e-01	8.23e-01	1.72e-01	9.80e-02	1.38e-01	1.98e-01
GOBP OSMOSENSORY SIGNALING PATHWAY	5	3.85e-01	7.23e-01	0.5950	-2.07e-01	5.34e-01	1.33e-01	2.99e-02	8.40e-02	4.22e-01	3.86e-02	6.08e-01	9.08e-01	7.45e-01
GOMF NERVE GROWTH FACTOR BINDING	6	3.22e-01	6.71e-01	0.5940	-2.16e-01	4.16e-01	1.43e-01	2.43e-01	-2.32e-01	3.58e-01	7.77e-02	5.44e-01	3.03e-01	3.25e-01
GOBP NEGATIVE REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY	7	3.50e-01	6.96e-01	0.5940	-2.32e-01	1.61e-01	3.72e-01	3.65e-01	-3.84e-02	2.87e-01	4.62e-01	8.82e-02	9.47e-02	8.60e-01
GOBP HEMOGLOBIN BIOSYNTHETIC PROCESS	13	4.03e-02	2.21e-01	0.5940	-9.97e-02	1.48e-01	-2.56e-01	-5.05e-01	-1.78e-02	5.33e-01	3.56e-01	1.10e-01	1.62e-03	9.12e-01
GOMF ACID PHOSPHATASE ACTIVITY	9	1.27e-01	4.40e-01	0.5940	2.11e-01	2.88e-01	-3.87e-01	-2.55e-01	-1.04e-01	2.74e-01	1.35e-01	4.43e-02	1.86e-01	5.91e-01
GOBP REGULATION OF ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION	6	4.17e-01	7.46e-01	0.5940	-1.45e-01	-2.67e-02	-4.08e-01	-3.74e-01	1.58e-01	5.40e-01	9.10e-01	8.39e-02	1.12e-01	5.03e-01
GOBP AMMONIUM HOMEOSTASIS	5	4.37e-01	7.60e-01	0.5940	1.84e-01	2.96e-01	1.79e-01	-9.08e-02	4.37e-01	4.77e-01	2.52e-01	4.89e-01	7.25e-01	9.05e-02
GOBP LYMPHOCYTE MIGRATION INTO LYMPHOID ORGANS	9	1.11e-01	4.06e-01	0.5930	-3.09e-01	3.67e-01	2.49e-01	1.83e-01	1.61e-01	1.08e-01	5.65e-02	1.96e-01	3.41e-01	4.03e-01
GOBP REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY	5	4.99e-01	8.03e-01	0.5930	1.85e-01	1.00e-01	2.43e-01	4.26e-01	-2.58e-01	4.74e-01	6.98e-01	3.46e-01	9.86e-02	3.17e-01
GOCC G PROTEIN COUPLED RECEPTOR DIMERIC COMPLEX	7	3.21e-01	6.69e-01	0.5930	-2.31e-01	-8.10e-02	1.77e-01	3.89e-01	-3.30e-01	2.90e-01	7.11e-01	4.17e-01	7.45e-02	1.30e-01
GOCC CCAAT BINDING FACTOR COMPLEX	5	2.51e-01	6.07e-01	0.5930	2.97e-01	-7.85e-02	3.27e-03	-5.05e-01	-4.80e-02	2.51e-01	7.61e-01	9.90e-01	5.04e-02	8.53e-01
GOMF CILIARY NEUROTROPHIC FACTOR RECEPTOR BINDING	6	2.57e-01	6.14e-01	0.5930	1.11e-01	-4.56e-03	3.57e-01	-1.12e-01	4.47e-01	6.39e-01	9.85e-01	1.30e-01	6.35e-01	5.79e-02
GOCC CYTOSOLIC LARGE RIBOSOMAL SUBUNIT	54	2.59e-08	1.66e-06	0.5920	-1.58e-01	-7.65e-02	-4.19e-01	-3.80e-01	1.19e-02	4.47e-02	3.31e-01	9.73e-08	1.38e-06	8.80e-01
GOCC GABA RECEPTOR COMPLEX	18	1.09e-02	9.32e-02	0.5920	4.49e-02	1.22e-01	4.14e-01	3.58e-01	1.87e-01	7.42e-01	3.71e-01	2.38e-03	8.57e-03	1.70e-01
GOBP NEGATIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE	5	3.83e-01	7.21e-01	0.5920	-7.81e-02	-1.29e-01	-2.20e-01	-3.89e-01	-3.58e-01	7.62e-01	6.18e-01	3.95e-01	1.32e-01	1.66e-01
GOBP SINOATRIAL NODE CELL DIFFERENTIATION	6	3.15e-01	6.65e-01	0.5920	-1.07e-01	2.12e-01	1.02e-02	-4.33e-01	3.26e-01	6.50e-01	3.68e-01	9.66e-01	6.62e-02	1.66e-01
GOBP REGULATION OF POTASSIUM ION IMPORT	5	1.04e-01	3.92e-01	0.5920	1.57e-01	-3.23e-01	3.30e-01	-3.15e-01	-1.15e-01	5.44e-01	2.12e-01	2.01e-01	2.22e-01	6.57e-01
GOBP AMYGDALA DEVELOPMENT	5	4.21e-01	7.49e-01	0.5920	2.13e-01	-1.99e-01	-1.65e-02	-3.44e-01	3.83e-01	4.11e-01	4.41e-01	9.49e-01	1.83e-01	1.38e-01
GOBP REGULATION OF LENS FIBER CELL DIFFERENTIATION	9	1.04e-01	3.92e-01	0.5920	-1.90e-01	1.80e-01	-1.25e-01	-5.15e-01	-2.99e-02	3.25e-01	3.50e-01	5.15e-01	7.48e-03	8.77e-01
GOBP EPOXYGENASE P450 PATHWAY	17	2.82e-03	3.51e-02	0.5920	3.85e-01	-5.97e-02	9.12e-03	4.11e-01	-1.72e-01	6.05e-03	6.70e-01	9.48e-01	3.36e-03	2.19e-01
GOCC TIM22 MITOCHONDRIAL IMPORT INNER MEMBRANE INSERTION COMPLEX	7	2.53e-01	6.09e-01	0.5910	3.72e-01	6.28e-02	-2.61e-01	-3.48e-01	-1.36e-01	8.84e-02	7.74e-01	2.32e-01	1.11e-01	5.34e-01
GOBP TRANSLOCATION OF MOLECULES INTO HOST	6	3.08e-01	6.60e-01	0.5910	3.01e-02	2.78e-01	-1.77e-01	-4.57e-01	-1.75e-01	8.98e-01	2.39e-01	4.52e-01	5.25e-02	4.57e-01
GOBP NEGATIVE REGULATION OF MONOCYTE CHEMOTAXIS	6	4.52e-01	7.72e-01	0.5910	-2.67e-02	-2.49e-01	-3.83e-01	-3.53e-01	1.23e-01	9.10e-01	2.91e-01	1.05e-01	1.34e-01	6.01e-01
GOBP FLAVONOID METABOLIC PROCESS	11	9.94e-02	3.82e-01	0.5900	1.43e-01	3.92e-02	2.89e-01	3.99e-01	-2.89e-01	4.11e-01	8.22e-01	9.66e-02	2.21e-02	9.68e-02
GOBP MINERALOCORTICOID SECRETION	7	2.43e-01	6.00e-01	0.5900	-3.37e-01	1.69e-01	4.38e-02	2.97e-01	-3.40e-01	1.22e-01	4.40e-01	8.41e-01	1.74e-01	1.19e-01
GOBP REGULATION OF ACROSOME REACTION	17	1.69e-02	1.27e-01	0.5900	-3.05e-01	-4.02e-02	2.56e-01	4.00e-01	-1.68e-01	2.97e-02	7.74e-01	6.74e-02	4.32e-03	2.32e-01
GOBP GLOMERULAR EPITHELIAL CELL DEVELOPMENT	12	2.57e-02	1.65e-01	0.5900	2.20e-01	-1.80e-01	2.71e-02	1.66e-01	-4.88e-01	1.87e-01	2.79e-01	8.71e-01	3.19e-01	3.40e-03
GOMF INOSITOL POLYPHOSPHATE 5 PHOSPHATASE ACTIVITY	6	2.00e-01	5.50e-01	0.5890	-1.01e-01	2.61e-02	-9.88e-03	-2.44e-01	-5.26e-01	6.69e-01	9.12e-01	9.67e-01	3.01e-01	2.56e-02
GOMF ENONE REDUCTASE ACTIVITY	5	1.91e-01	5.38e-01	0.5890	-9.40e-02	-1.81e-01	-3.83e-01	3.92e-01	-7.20e-02	7.16e-01	4.83e-01	1.38e-01	1.29e-01	7.81e-01
GOBP APOPTOTIC PROCESS INVOLVED IN BLOOD VESSEL MORPHOGENESIS	5	3.32e-01	6.80e-01	0.5890	-2.60e-01	-7.21e-02	3.34e-01	-1.62e-01	3.70e-01	3.15e-01	7.80e-01	1.96e-01	5.31e-01	1.52e-01
GOBP OTIC VESICLE FORMATION	8	1.27e-01	4.40e-01	0.5890	-3.69e-01	-4.07e-02	8.59e-02	-1.67e-01	4.16e-01	7.04e-02	8.42e-01	6.74e-01	4.14e-01	4.13e-02
GOBP REGULATION OF ALDOSTERONE METABOLIC PROCESS	8	1.98e-01	5.47e-01	0.5890	-4.64e-01	1.29e-01	1.51e-01	1.89e-01	-2.36e-01	2.30e-02	5.26e-01	4.58e-01	3.55e-01	2.48e-01
GOBP URETER DEVELOPMENT	18	7.93e-03	7.43e-02	0.5890	4.13e-02	1.37e-02	-1.22e-01	-4.44e-01	3.64e-01	7.62e-01	9.20e-01	3.69e-01	1.11e-03	7.48e-03
GOBP REGULATION OF FAS SIGNALING PATHWAY	6	2.83e-01	6.36e-01	0.5880	-5.01e-01	1.94e-01	-5.84e-02	-2.23e-01	-6.33e-02	3.35e-02	4.09e-01	8.04e-01	3.44e-01	7.88e-01
GOBP TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION	9	1.69e-01	5.05e-01	0.5880	-1.85e-01	3.15e-02	-3.20e-01	-4.41e-01	-1.18e-01	3.37e-01	8.70e-01	9.67e-02	2.19e-02	5.41e-01
GOMF PROTEIN KINASE B BINDING	10	7.84e-02	3.36e-01	0.5880	-1.28e-01	2.73e-01	5.10e-02	-2.41e-01	4.41e-01	4.85e-01	1.35e-01	7.80e-01	1.87e-01	1.57e-02
GOMF POLYAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY	10	5.46e-02	2.69e-01	0.5880	2.58e-01	-3.20e-01	-1.70e-02	2.43e-01	3.43e-01	1.58e-01	7.93e-02	9.26e-01	1.84e-01	6.05e-02
GOCC CATALYTIC STEP 1 SPLICEOSOME	12	5.76e-02	2.79e-01	0.5880	3.80e-01	-1.71e-01	-3.08e-01	-2.66e-01	-7.89e-02	2.26e-02	3.05e-01	6.44e-02	1.10e-01	6.36e-01
GOBP NEGATIVE REGULATION OF HYPOXIA INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY	6	4.58e-01	7.76e-01	0.5880	-2.86e-03	-2.81e-02	-3.00e-01	-4.57e-01	2.16e-01	9.90e-01	9.05e-01	2.03e-01	5.28e-02	3.60e-01
GOMF AMINO ACID PROTON SYMPORTER ACTIVITY	6	3.33e-01	6.81e-01	0.5880	-2.91e-01	-2.14e-01	3.99e-01	1.92e-01	1.39e-01	2.18e-01	3.65e-01	9.07e-02	4.14e-01	5.55e-01
GOBP COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY	15	1.82e-02	1.33e-01	0.5880	-2.27e-01	-3.19e-01	4.70e-02	2.44e-01	-3.61e-01	1.28e-01	3.23e-02	7.53e-01	1.02e-01	1.55e-02
GOBP UTERUS MORPHOGENESIS	6	3.12e-01	6.64e-01	0.5880	4.15e-01	2.15e-01	1.35e-01	3.02e-01	-1.31e-01	7.82e-02	3.63e-01	5.66e-01	2.00e-01	5.78e-01
GOBP MITOCHONDRIAL DNA REPLICATION	14	4.88e-02	2.50e-01	0.5870	-2.12e-02	-7.38e-02	-4.42e-01	-3.30e-01	1.84e-01	8.91e-01	6.32e-01	4.15e-03	3.24e-02	2.33e-01
GOBP REGULATION OF ATRIAL CARDIAC MUSCLE CELL MEMBRANE DEPOLARIZATION	9	1.04e-01	3.90e-01	0.5870	-2.94e-01	2.69e-01	-7.21e-02	1.23e-01	-4.07e-01	1.27e-01	1.62e-01	7.08e-01	5.24e-01	3.47e-02
GOBP VACUOLAR PROTON TRANSPORTING V TYPE ATPASE COMPLEX ASSEMBLY	5	4.04e-01	7.37e-01	0.5870	-4.10e-01	-1.74e-01	-1.28e-01	-3.36e-01	-1.30e-01	1.13e-01	5.01e-01	6.19e-01	1.93e-01	6.15e-01
GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR	16	2.44e-02	1.59e-01	0.5870	7.13e-03	1.46e-01	-3.90e-01	-3.86e-01	1.47e-01	9.61e-01	3.12e-01	6.94e-03	7.46e-03	3.09e-01
GOBP REGULATION OF PROTEIN ADP RIBOSYLATION	8	2.79e-01	6.33e-01	0.5860	2.37e-01	-2.20e-01	-3.72e-01	-2.79e-01	1.54e-01	2.47e-01	2.81e-01	6.88e-02	1.72e-01	4.52e-01
GOBP EOSINOPHIL MEDIATED IMMUNITY	8	1.36e-01	4.55e-01	0.5860	-3.91e-01	3.75e-02	2.14e-01	1.29e-01	3.57e-01	5.53e-02	8.54e-01	2.95e-01	5.28e-01	8.07e-02
GOCC EXORIBONUCLEASE COMPLEX	18	1.69e-02	1.27e-01	0.5860	3.70e-02	-2.13e-01	-4.47e-01	-3.05e-01	6.55e-02	7.86e-01	1.18e-01	1.03e-03	2.52e-02	6.30e-01
GOBP NEGATIVE REGULATION OF LAMELLIPODIUM ORGANIZATION	7	2.55e-01	6.13e-01	0.5860	-4.60e-01	-2.09e-01	1.51e-01	1.25e-01	-2.23e-01	3.51e-02	3.38e-01	4.88e-01	5.67e-01	3.07e-01
GOBP MONOACYLGLYCEROL CATABOLIC PROCESS	7	2.28e-01	5.81e-01	0.5860	-1.68e-01	4.29e-01	2.61e-03	-3.09e-01	1.87e-01	4.42e-01	4.91e-02	9.90e-01	1.57e-01	3.91e-01
GOBP DNA DEAMINATION	13	7.08e-02	3.17e-01	0.5860	3.01e-01	-4.63e-02	-3.73e-01	-3.26e-01	6.69e-02	6.03e-02	7.72e-01	1.98e-02	4.16e-02	6.76e-01
GOBP POSTSYNAPSE TO NUCLEUS SIGNALING PATHWAY	6	3.00e-01	6.54e-01	0.5850	2.79e-01	2.12e-01	-2.47e-01	-1.09e-01	3.84e-01	2.37e-01	3.69e-01	2.94e-01	6.44e-01	1.04e-01
GOCC NUCLEAR CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX	14	2.50e-02	1.62e-01	0.5850	7.39e-02	-3.60e-01	-2.35e-01	-3.89e-01	1.97e-02	6.32e-01	1.96e-02	1.29e-01	1.16e-02	8.99e-01
GOBP LOOP OF HENLE DEVELOPMENT	12	3.39e-02	1.98e-01	0.5850	2.90e-01	3.46e-01	1.47e-01	-2.83e-01	1.92e-01	8.20e-02	3.79e-02	3.77e-01	9.00e-02	2.50e-01
GOMF ALKALINE PHOSPHATASE ACTIVITY	6	3.41e-01	6.88e-01	0.5850	1.54e-01	4.86e-01	1.97e-01	1.39e-01	-1.57e-01	5.14e-01	3.94e-02	4.03e-01	5.57e-01	5.06e-01
GOBP MALE MATING BEHAVIOR	6	1.13e-01	4.10e-01	0.5850	-1.40e-01	-1.75e-02	4.44e-01	-3.22e-01	1.48e-01	5.52e-01	9.41e-01	5.99e-02	1.73e-01	5.30e-01
GOBP RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE	9	2.07e-01	5.57e-01	0.5850	-5.49e-02	2.05e-01	3.43e-01	4.22e-01	3.30e-02	7.76e-01	2.88e-01	7.44e-02	2.84e-02	8.64e-01
GOBP PROTEIN TO MEMBRANE DOCKING	5	4.27e-01	7.54e-01	0.5850	-4.15e-01	1.02e-01	-1.32e-01	-3.72e-01	6.09e-02	1.08e-01	6.93e-01	6.09e-01	1.50e-01	8.14e-01
GOBP PYRIDINE CONTAINING COMPOUND CATABOLIC PROCESS	8	1.33e-01	4.50e-01	0.5850	5.24e-02	5.68e-02	-4.10e-02	-5.64e-01	1.29e-01	7.98e-01	7.81e-01	8.41e-01	5.77e-03	5.28e-01
GOBP MAINTENANCE OF PROTEIN LOCATION IN MITOCHONDRION	5	3.83e-01	7.21e-01	0.5850	-1.36e-01	4.39e-01	1.56e-01	-3.21e-01	5.38e-02	5.99e-01	8.91e-02	5.45e-01	2.13e-01	8.35e-01
GOBP CHRONIC INFLAMMATORY RESPONSE	18	3.38e-04	6.52e-03	0.5850	6.76e-02	-1.74e-01	-1.43e-01	5.32e-01	-6.10e-02	6.19e-01	2.01e-01	2.92e-01	9.42e-05	6.54e-01
GOBP NEGATIVE REGULATION OF INTERLEUKIN 1 ALPHA PRODUCTION	5	3.69e-01	7.09e-01	0.5850	-3.75e-01	-3.18e-01	2.89e-02	1.88e-01	2.52e-01	1.46e-01	2.18e-01	9.11e-01	4.67e-01	3.28e-01
GOBP REGULATION OF SYNAPTIC VESICLE CLUSTERING	6	3.02e-01	6.55e-01	0.5850	5.38e-01	1.14e-01	4.39e-02	-1.46e-01	1.28e-01	2.26e-02	6.30e-01	8.52e-01	5.35e-01	5.88e-01
GOBP PROTEIN TARGETING TO VACUOLE INVOLVED IN AUTOPHAGY	5	4.88e-01	7.97e-01	0.5840	1.74e-01	3.40e-01	-8.36e-02	-2.97e-01	3.17e-01	5.00e-01	1.88e-01	7.46e-01	2.50e-01	2.19e-01
GOBP POSITIVE REGULATION OF RRNA PROCESSING	10	1.17e-01	4.18e-01	0.5840	3.27e-01	7.93e-02	-2.56e-01	-1.93e-01	3.54e-01	7.35e-02	6.64e-01	1.61e-01	2.90e-01	5.24e-02
GOCC HEMOGLOBIN COMPLEX	12	8.67e-02	3.56e-01	0.5840	-8.17e-02	8.95e-02	3.22e-01	4.72e-01	1.90e-02	6.24e-01	5.91e-01	5.32e-02	4.64e-03	9.09e-01
GOCC UBIQUINONE BIOSYNTHESIS COMPLEX	6	3.56e-01	7.02e-01	0.5840	1.26e-01	-2.38e-01	-2.59e-01	-4.41e-01	-8.55e-02	5.92e-01	3.12e-01	2.71e-01	6.15e-02	7.17e-01
GOMF POTASSIUM PROTON ANTIPORTER ACTIVITY	12	2.86e-02	1.78e-01	0.5840	-1.13e-01	3.84e-01	3.84e-01	-1.48e-01	1.07e-01	4.99e-01	2.12e-02	2.11e-02	3.74e-01	5.21e-01
GOMF DEHYDROASCORBIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY	8	1.45e-01	4.66e-01	0.5840	7.80e-03	3.14e-01	2.08e-01	2.51e-01	3.69e-01	9.70e-01	1.24e-01	3.07e-01	2.18e-01	7.11e-02
GOBP PURINE NUCLEOBASE BIOSYNTHETIC PROCESS	9	2.27e-01	5.80e-01	0.5840	4.50e-02	-5.10e-02	-4.43e-01	-3.37e-01	1.64e-01	8.15e-01	7.91e-01	2.13e-02	8.04e-02	3.94e-01
GOBP RNA SURVEILLANCE	17	2.80e-02	1.76e-01	0.5840	8.93e-02	-1.83e-02	-3.74e-01	-4.10e-01	1.58e-01	5.24e-01	8.96e-01	7.62e-03	3.43e-03	2.58e-01
GOBP FOREBRAIN REGIONALIZATION	24	4.49e-04	8.27e-03	0.5840	-4.90e-03	8.27e-02	-4.74e-02	-4.87e-01	3.08e-01	9.67e-01	4.83e-01	6.88e-01	3.63e-05	9.07e-03
GOCC EQUATORIAL MICROTUBULE ORGANIZING CENTER	5	3.99e-01	7.33e-01	0.5840	5.56e-01	3.31e-02	-4.09e-02	-1.68e-01	1.18e-02	3.12e-02	8.98e-01	8.74e-01	5.15e-01	9.63e-01
GOCC LATERAL ELEMENT	14	1.85e-02	1.34e-01	0.5830	4.87e-02	2.40e-01	1.41e-01	-3.20e-01	3.98e-01	7.53e-01	1.19e-01	3.62e-01	3.83e-02	9.99e-03
GOCC PERINUCLEOLAR COMPARTMENT	5	3.99e-01	7.32e-01	0.5830	-3.54e-01	2.69e-01	3.57e-02	-1.57e-01	-3.41e-01	1.70e-01	2.97e-01	8.90e-01	5.44e-01	1.87e-01
GOMF CCR1 CHEMOKINE RECEPTOR BINDING	5	3.29e-01	6.77e-01	0.5830	-2.17e-01	1.88e-01	1.04e-01	4.90e-01	7.81e-02	4.00e-01	4.67e-01	6.87e-01	5.76e-02	7.62e-01
GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY	6	3.05e-01	6.58e-01	0.5830	6.43e-02	3.08e-01	1.57e-01	-3.54e-01	3.02e-01	7.85e-01	1.92e-01	5.05e-01	1.34e-01	2.00e-01
GOBP G QUADRUPLEX DNA UNWINDING	7	3.93e-01	7.28e-01	0.5830	3.92e-02	-1.23e-01	-4.12e-01	-3.91e-01	7.31e-03	8.57e-01	5.72e-01	5.90e-02	7.31e-02	9.73e-01
GOBP FORMATION OF ANATOMICAL BOUNDARY	7	2.63e-01	6.19e-01	0.5830	1.02e-01	4.05e-02	5.24e-03	-3.97e-01	4.13e-01	6.41e-01	8.53e-01	9.81e-01	6.92e-02	5.86e-02
GOBP RESPONSE TO PHORBOL 13 ACETATE 12 MYRISTATE	10	2.76e-02	1.74e-01	0.5830	2.36e-01	4.12e-01	-3.30e-01	6.01e-02	-3.46e-02	1.95e-01	2.40e-02	7.05e-02	7.42e-01	8.50e-01
GOBP POSITIVE REGULATION OF NUCLEASE ACTIVITY	7	3.83e-01	7.21e-01	0.5830	5.04e-02	7.53e-02	-3.60e-01	-4.40e-01	8.66e-02	8.17e-01	7.30e-01	9.87e-02	4.37e-02	6.92e-01
GOMF GLYCEROL CHANNEL ACTIVITY	5	4.16e-01	7.46e-01	0.5830	-4.43e-01	-3.86e-02	-2.48e-01	7.54e-03	-2.83e-01	8.63e-02	8.81e-01	3.37e-01	9.77e-01	2.73e-01
GOBP POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION	16	1.99e-02	1.41e-01	0.5830	4.85e-02	-1.37e-02	-2.85e-01	-5.04e-01	-4.42e-02	7.37e-01	9.24e-01	4.83e-02	4.87e-04	7.59e-01
GOCC EXTERNAL SIDE OF APICAL PLASMA MEMBRANE	6	4.19e-01	7.48e-01	0.5820	-1.42e-01	2.57e-01	4.39e-01	1.85e-01	-1.60e-01	5.46e-01	2.76e-01	6.23e-02	4.31e-01	4.98e-01
GOBP NEGATIVE REGULATION OF ATP BIOSYNTHETIC PROCESS	5	3.78e-01	7.17e-01	0.5820	4.69e-01	-7.01e-02	2.01e-01	1.83e-01	-2.02e-01	6.95e-02	7.86e-01	4.36e-01	4.79e-01	4.35e-01
GOBP ANGIOTENSIN ACTIVATED SIGNALING PATHWAY	18	7.31e-03	7.01e-02	0.5820	-4.37e-01	1.75e-01	2.78e-01	1.39e-01	-1.46e-01	1.34e-03	1.99e-01	4.14e-02	3.08e-01	2.83e-01
GOMF DNA N GLYCOSYLASE ACTIVITY	14	3.32e-02	1.95e-01	0.5820	1.59e-01	2.18e-01	-4.20e-01	-2.86e-01	8.36e-02	3.03e-01	1.57e-01	6.45e-03	6.37e-02	5.88e-01
GOBP REGULATION PROTEIN CATABOLIC PROCESS AT SYNAPSE	6	2.00e-01	5.49e-01	0.5820	-1.92e-01	1.30e-01	1.96e-01	-1.65e-01	-4.68e-01	4.16e-01	5.82e-01	4.06e-01	4.83e-01	4.70e-02
GOBP INTERLEUKIN 21 PRODUCTION	5	4.00e-01	7.33e-01	0.5820	-4.85e-02	-2.27e-01	1.43e-01	1.30e-01	-4.97e-01	8.51e-01	3.79e-01	5.79e-01	6.14e-01	5.42e-02
GOCC CYTOSKELETON OF PRESYNAPTIC ACTIVE ZONE	8	1.59e-01	4.89e-01	0.5820	1.85e-01	-4.60e-01	1.43e-01	2.69e-01	1.97e-02	3.65e-01	2.44e-02	4.84e-01	1.88e-01	9.23e-01
GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE	7	3.04e-01	6.58e-01	0.5820	-2.02e-01	1.57e-01	-3.20e-01	-3.87e-01	1.43e-01	3.54e-01	4.72e-01	1.43e-01	7.58e-02	5.12e-01
GOBP PYRIMIDINE CONTAINING COMPOUND SALVAGE	7	2.52e-01	6.09e-01	0.5810	-3.57e-01	2.86e-01	3.22e-01	2.47e-02	1.56e-01	1.02e-01	1.90e-01	1.40e-01	9.10e-01	4.74e-01
GOBP NEGATIVE REGULATION OF DENDRITIC CELL APOPTOTIC PROCESS	8	1.25e-01	4.37e-01	0.5810	9.35e-02	1.84e-01	-1.14e-01	3.33e-01	-4.14e-01	6.47e-01	3.68e-01	5.77e-01	1.03e-01	4.25e-02
GOBP RIBOSOMAL LARGE SUBUNIT BIOGENESIS	70	6.63e-10	5.51e-08	0.5810	4.21e-03	-1.38e-01	-4.10e-01	-3.70e-01	1.17e-01	9.51e-01	4.52e-02	2.92e-09	8.58e-08	9.10e-02
GOBP ESCRT COMPLEX DISASSEMBLY	10	1.96e-01	5.45e-01	0.5810	5.44e-02	-2.17e-02	-4.20e-01	-3.88e-01	8.36e-02	7.66e-01	9.05e-01	2.14e-02	3.35e-02	6.47e-01
GOCC PIP BODY	5	5.00e-01	8.03e-01	0.5810	-1.58e-01	-1.64e-01	4.24e-01	2.71e-01	1.79e-01	5.40e-01	5.24e-01	1.01e-01	2.93e-01	4.88e-01
GOBP GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS	15	1.59e-02	1.21e-01	0.5810	-2.01e-01	1.28e-01	-6.66e-02	-4.33e-01	2.98e-01	1.78e-01	3.90e-01	6.55e-01	3.71e-03	4.58e-02
GOMF HMG BOX DOMAIN BINDING	13	2.07e-02	1.45e-01	0.5810	2.79e-01	6.97e-02	1.31e-01	-3.46e-01	3.42e-01	8.15e-02	6.63e-01	4.15e-01	3.05e-02	3.25e-02
GOBP B 1 B CELL DIFFERENTIATION	5	2.14e-01	5.67e-01	0.5800	1.46e-01	-4.26e-02	5.51e-01	-9.61e-02	2.18e-02	5.72e-01	8.69e-01	3.28e-02	7.10e-01	9.33e-01
GOBP CYTOPLASMIC TRANSLATIONAL ELONGATION	5	4.80e-01	7.92e-01	0.5800	1.43e-01	2.78e-01	-1.96e-01	-2.47e-01	3.73e-01	5.79e-01	2.81e-01	4.48e-01	3.39e-01	1.49e-01
GOBP NUCLEOSIDE BISPHOSPHATE CATABOLIC PROCESS	11	1.00e-01	3.83e-01	0.5800	4.17e-01	-1.10e-01	-3.11e-01	-1.98e-01	1.21e-01	1.67e-02	5.28e-01	7.40e-02	2.55e-01	4.87e-01
GOBP REGULATION OF SECONDARY HEART FIELD CARDIOBLAST PROLIFERATION	9	1.33e-01	4.50e-01	0.5800	1.50e-01	-4.42e-03	2.87e-02	-3.83e-01	4.07e-01	4.35e-01	9.82e-01	8.82e-01	4.67e-02	3.43e-02
GOBP REGULATION OF GASTRIC ACID SECRETION	6	1.83e-01	5.25e-01	0.5790	1.27e-01	4.35e-01	-2.98e-01	1.07e-01	-1.75e-01	5.91e-01	6.52e-02	2.07e-01	6.50e-01	4.58e-01
GOMF CLASS I DNA APURINIC OR APYRIMIDINIC SITE ENDONUCLEASE ACTIVITY	8	1.55e-01	4.83e-01	0.5790	3.21e-03	1.79e-01	-4.64e-01	-2.11e-01	2.10e-01	9.87e-01	3.81e-01	2.31e-02	3.02e-01	3.04e-01
GOBP REGULATION OF RESPONSE TO DRUG	15	1.55e-02	1.19e-01	0.5790	-3.92e-01	-2.68e-01	5.48e-02	3.17e-01	-8.44e-02	8.60e-03	7.28e-02	7.13e-01	3.36e-02	5.71e-01
GOMF INTRAMOLECULAR TRANSFERASE ACTIVITY	26	1.19e-03	1.77e-02	0.5790	1.61e-01	-1.67e-01	-3.94e-01	-3.42e-01	-9.59e-02	1.54e-01	1.40e-01	5.03e-04	2.53e-03	3.98e-01
GOBP NEGATIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION	7	1.35e-01	4.54e-01	0.5790	3.01e-01	-1.16e-01	-6.81e-02	4.64e-01	1.10e-01	1.68e-01	5.95e-01	7.55e-01	3.36e-02	6.15e-01
GOBP ADENYLATE CYCLASE ACTIVATING DOPAMINE RECEPTOR SIGNALING PATHWAY	9	1.23e-01	4.32e-01	0.5790	-2.29e-01	1.24e-01	3.03e-03	-3.23e-01	4.04e-01	2.35e-01	5.18e-01	9.87e-01	9.32e-02	3.59e-02
GOBP POSITIVE REGULATION OF ANOIKIS	6	2.87e-01	6.41e-01	0.5790	5.08e-01	-2.33e-01	-8.66e-02	4.28e-02	-1.14e-01	3.10e-02	3.22e-01	7.13e-01	8.56e-01	6.29e-01
GOBP ELASTIC FIBER ASSEMBLY	9	1.12e-01	4.09e-01	0.5790	-1.16e-01	2.43e-02	4.19e-01	1.58e-03	3.81e-01	5.47e-01	9.00e-01	2.93e-02	9.93e-01	4.77e-02
GOBP RESPONSE TO PHEROMONE	7	3.12e-01	6.63e-01	0.5790	-2.03e-01	8.00e-02	4.55e-01	1.97e-01	-2.03e-01	3.52e-01	7.14e-01	3.70e-02	3.67e-01	3.52e-01
GOBP REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS	7	2.28e-01	5.82e-01	0.5790	-3.73e-01	2.30e-01	2.59e-01	-3.08e-02	2.75e-01	8.77e-02	2.92e-01	2.36e-01	8.88e-01	2.08e-01
GOBP TELOMERASE RNA LOCALIZATION	18	1.40e-02	1.12e-01	0.5790	-7.64e-02	-3.15e-01	-3.30e-01	-3.42e-01	6.29e-02	5.75e-01	2.07e-02	1.55e-02	1.19e-02	6.44e-01
GOMF POLYSOME BINDING	6	2.17e-01	5.72e-01	0.5790	-2.24e-01	-7.91e-02	3.63e-01	-5.84e-03	-3.82e-01	3.41e-01	7.37e-01	1.23e-01	9.80e-01	1.05e-01
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE	6	3.48e-01	6.94e-01	0.5780	5.30e-01	6.11e-02	-1.74e-01	-9.03e-02	1.06e-01	2.45e-02	7.96e-01	4.60e-01	7.02e-01	6.53e-01
GOCC AMPHISOME MEMBRANE	11	1.52e-01	4.78e-01	0.5780	1.38e-01	-4.62e-02	-4.35e-01	-3.52e-01	2.30e-02	4.28e-01	7.91e-01	1.25e-02	4.32e-02	8.95e-01
GOBP MONOACYLGLYCEROL METABOLIC PROCESS	12	3.75e-02	2.11e-01	0.5780	-1.73e-01	4.92e-01	5.92e-02	-2.37e-01	4.96e-02	3.00e-01	3.13e-03	7.23e-01	1.56e-01	7.66e-01
GOBP POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE REGENERATION	5	4.78e-01	7.91e-01	0.5780	2.45e-01	2.94e-01	3.99e-01	1.49e-01	-7.81e-02	3.42e-01	2.55e-01	1.22e-01	5.65e-01	7.62e-01
GOBP REGULATION OF SYNAPTIC VESICLE PRIMING	7	2.35e-01	5.90e-01	0.5780	-1.76e-01	4.10e-01	-2.36e-01	-2.74e-01	-6.15e-02	4.19e-01	6.00e-02	2.80e-01	2.09e-01	7.78e-01
GOMF SODIUM PHOSPHATE SYMPORTER ACTIVITY	13	4.24e-02	2.28e-01	0.5780	-6.01e-02	3.45e-01	1.62e-01	2.19e-01	-3.70e-01	7.07e-01	3.10e-02	3.11e-01	1.71e-01	2.10e-02
GOBP DERMATAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS	8	1.70e-01	5.09e-01	0.5780	-2.90e-01	2.85e-01	-1.91e-01	-2.66e-01	-2.47e-01	1.55e-01	1.63e-01	3.50e-01	1.93e-01	2.26e-01
GOBP NEGATIVE REGULATION OF KIDNEY DEVELOPMENT	5	4.83e-01	7.93e-01	0.5780	6.44e-02	-2.71e-01	-2.01e-01	-4.55e-01	9.29e-02	8.03e-01	2.94e-01	4.36e-01	7.80e-02	7.19e-01
GOMF GLYCOSPHINGOLIPID BINDING	10	6.82e-02	3.09e-01	0.5780	6.37e-02	2.34e-01	1.73e-01	4.78e-01	1.28e-01	7.27e-01	2.00e-01	3.43e-01	8.88e-03	4.82e-01
GOMF RAGE RECEPTOR BINDING	10	4.30e-02	2.30e-01	0.5780	-3.82e-01	3.59e-01	-6.59e-02	1.90e-01	-1.37e-01	3.66e-02	4.95e-02	7.18e-01	2.97e-01	4.54e-01
GOCC PROTEASE INHIBITOR COMPLEX	8	1.61e-01	4.93e-01	0.5770	-2.45e-02	4.70e-01	2.93e-01	-7.92e-02	-1.39e-01	9.05e-01	2.13e-02	1.51e-01	6.98e-01	4.95e-01
GOCC SARCOPLASMIC RETICULUM LUMEN	9	1.02e-01	3.87e-01	0.5770	-4.26e-01	3.35e-01	-1.49e-02	6.28e-02	-1.89e-01	2.69e-02	8.19e-02	9.38e-01	7.44e-01	3.27e-01
GOBP ACTIVATION OF JANUS KINASE ACTIVITY	12	1.11e-01	4.07e-01	0.5770	-2.11e-01	1.51e-01	4.20e-01	2.92e-01	-6.51e-02	2.07e-01	3.64e-01	1.18e-02	7.94e-02	6.96e-01
GOBP ELASTIN CATABOLIC PROCESS	5	4.19e-01	7.48e-01	0.5770	1.07e-01	-4.82e-01	-2.46e-01	1.68e-01	1.84e-02	6.77e-01	6.20e-02	3.40e-01	5.15e-01	9.43e-01
GOMF GUANYLATE CYCLASE REGULATOR ACTIVITY	8	2.06e-01	5.56e-01	0.5770	2.10e-01	1.92e-02	1.73e-01	5.01e-01	-8.94e-02	3.04e-01	9.25e-01	3.98e-01	1.42e-02	6.61e-01
GOBP DOLICHYL DIPHOSPHATE METABOLIC PROCESS	5	5.09e-01	8.07e-01	0.5770	-8.40e-02	-1.84e-02	-2.00e-01	-5.24e-01	1.07e-01	7.45e-01	9.43e-01	4.40e-01	4.26e-02	6.79e-01
GOBP NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION	14	2.40e-02	1.58e-01	0.5770	1.36e-01	2.32e-02	-3.39e-04	-4.30e-01	3.59e-01	3.79e-01	8.81e-01	9.98e-01	5.36e-03	2.00e-02
GOBP RESPONSE TO CORTICOTROPIN RELEASING HORMONE	5	4.11e-01	7.43e-01	0.5770	-2.04e-01	4.25e-01	-1.06e-01	-2.18e-01	2.26e-01	4.29e-01	9.97e-02	6.82e-01	3.98e-01	3.81e-01
GOMF ADP RIBOSE DIPHOSPHATASE ACTIVITY	6	3.31e-01	6.79e-01	0.5760	-3.39e-02	4.88e-02	-8.39e-02	-5.47e-01	1.50e-01	8.86e-01	8.36e-01	7.22e-01	2.03e-02	5.25e-01
GOCC MULTIMERIC RIBONUCLEASE P COMPLEX	10	1.66e-01	5.01e-01	0.5760	1.50e-01	2.35e-02	-4.51e-01	-3.04e-01	-1.12e-01	4.12e-01	8.98e-01	1.35e-02	9.62e-02	5.40e-01
GOMF RIBONUCLEASE P RNA BINDING	10	1.66e-01	5.01e-01	0.5760	1.50e-01	2.35e-02	-4.51e-01	-3.04e-01	-1.12e-01	4.12e-01	8.98e-01	1.35e-02	9.62e-02	5.40e-01
GOMF MHC CLASS I PROTEIN COMPLEX BINDING	6	3.04e-01	6.58e-01	0.5760	-4.98e-01	-2.00e-01	-2.65e-02	-1.75e-01	1.09e-01	3.46e-02	3.95e-01	9.11e-01	4.58e-01	6.45e-01
GOBP METANEPHRIC DISTAL TUBULE DEVELOPMENT	7	1.34e-01	4.52e-01	0.5760	2.76e-01	2.74e-01	1.40e-01	-3.95e-01	-6.16e-02	2.05e-01	2.09e-01	5.20e-01	7.01e-02	7.78e-01
GOMF CAMP DEPENDENT PROTEIN KINASE ACTIVITY	5	5.27e-01	8.18e-01	0.5760	3.11e-01	1.72e-01	-9.86e-02	-3.14e-01	3.11e-01	2.28e-01	5.06e-01	7.02e-01	2.25e-01	2.28e-01
GOBP NEGATIVE REGULATION OF CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION	5	3.82e-01	7.20e-01	0.5750	5.51e-02	4.34e-01	8.93e-03	1.78e-02	3.73e-01	8.31e-01	9.26e-02	9.72e-01	9.45e-01	1.49e-01
GOBP REGULATION OF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY	8	9.15e-02	3.66e-01	0.5750	-1.72e-01	3.03e-01	2.02e-01	-4.11e-01	-8.84e-03	4.01e-01	1.38e-01	3.23e-01	4.39e-02	9.65e-01
GOBP D AMINO ACID TRANSPORT	6	3.16e-01	6.66e-01	0.5750	-9.25e-02	4.26e-01	1.72e-01	-4.63e-02	-3.30e-01	6.95e-01	7.04e-02	4.65e-01	8.44e-01	1.62e-01
GOBP RESPONSE TO GRAM POSITIVE BACTERIUM	5	4.20e-01	7.48e-01	0.5750	-2.25e-01	4.52e-01	2.63e-03	-2.36e-01	-1.43e-01	3.84e-01	8.01e-02	9.92e-01	3.61e-01	5.79e-01
GOBP XMP METABOLIC PROCESS	7	3.64e-01	7.05e-01	0.5750	-4.69e-02	-2.86e-01	-4.36e-01	-2.36e-01	-9.63e-03	8.30e-01	1.90e-01	4.55e-02	2.79e-01	9.65e-01
GOBP FOREBRAIN NEUROBLAST DIVISION	5	4.59e-01	7.77e-01	0.5750	-1.86e-01	-1.83e-01	3.63e-01	1.82e-01	3.12e-01	4.72e-01	4.78e-01	1.60e-01	4.80e-01	2.27e-01
GOBP ACTIN MYOSIN FILAMENT SLIDING	16	9.84e-03	8.67e-02	0.5750	1.33e-01	-3.57e-01	-7.64e-02	2.53e-01	-3.40e-01	3.57e-01	1.34e-02	5.97e-01	7.96e-02	1.86e-02
GOBP PROTEIN C LINKED GLYCOSYLATION	5	2.67e-01	6.23e-01	0.5750	3.74e-02	4.86e-01	-2.73e-01	1.00e-01	-8.97e-02	8.85e-01	5.98e-02	2.90e-01	6.98e-01	7.28e-01
GOBP MRNA 3 SPLICE SITE RECOGNITION	6	4.12e-01	7.43e-01	0.5750	3.97e-01	-2.55e-02	-2.95e-01	-2.88e-01	-4.61e-02	9.23e-02	9.14e-01	2.11e-01	2.22e-01	8.45e-01
GOMF RETROMER COMPLEX BINDING	7	2.44e-01	6.01e-01	0.5740	-1.77e-01	1.98e-01	4.07e-01	-4.35e-02	3.03e-01	4.17e-01	3.65e-01	6.24e-02	8.42e-01	1.65e-01
GOBP HISTONE H3 ACETYLATION	6	3.12e-01	6.63e-01	0.5740	2.60e-02	1.88e-01	1.17e-01	2.95e-02	5.28e-01	9.12e-01	4.25e-01	6.20e-01	9.00e-01	2.50e-02
GOBP ANTIBACTERIAL PEPTIDE PRODUCTION	9	2.06e-01	5.57e-01	0.5740	-3.84e-01	6.59e-02	3.32e-01	2.29e-01	-1.24e-01	4.61e-02	7.32e-01	8.46e-02	2.34e-01	5.18e-01
GOBP LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS	6	2.96e-01	6.50e-01	0.5740	1.23e-01	2.68e-01	-9.82e-02	-5.27e-02	-4.80e-01	6.01e-01	2.56e-01	6.77e-01	8.23e-01	4.19e-02
GOMF SUPEROXIDE GENERATING NAD P H OXIDASE ACTIVITY	7	2.76e-01	6.30e-01	0.5740	1.67e-01	3.59e-01	2.35e-01	-9.37e-02	3.30e-01	4.45e-01	1.00e-01	2.81e-01	6.68e-01	1.31e-01
GOBP CELLULAR RESPONSE TO AMMONIUM ION	5	5.57e-01	8.31e-01	0.5740	-3.01e-01	1.73e-01	3.95e-01	2.27e-01	2.39e-02	2.44e-01	5.02e-01	1.26e-01	3.79e-01	9.26e-01
GOBP EQUILIBRIOCEPTION	7	3.15e-01	6.65e-01	0.5740	-3.88e-01	2.43e-01	2.60e-01	2.15e-01	-7.58e-02	7.53e-02	2.66e-01	2.33e-01	3.25e-01	7.28e-01
GOCC CHROMOSOME TELOMERIC REPEAT REGION	13	9.16e-02	3.66e-01	0.5730	1.96e-01	-1.01e-01	-4.22e-01	-3.15e-01	4.36e-02	2.20e-01	5.28e-01	8.37e-03	4.89e-02	7.85e-01
GOBP CELLULAR RESPONSE TO LEUCINE STARVATION	12	1.22e-01	4.28e-01	0.5730	5.95e-02	-1.46e-01	-4.17e-01	-3.58e-01	-3.62e-02	7.21e-01	3.80e-01	1.23e-02	3.18e-02	8.28e-01
GOCC FHF COMPLEX	5	4.84e-01	7.93e-01	0.5730	3.14e-01	3.11e-01	-6.77e-02	-1.45e-01	3.28e-01	2.24e-01	2.29e-01	7.93e-01	5.73e-01	2.05e-01
GOBP MUCOCILIARY CLEARANCE	8	1.35e-01	4.54e-01	0.5730	-1.28e-01	8.92e-02	1.31e-01	5.30e-01	7.69e-02	5.29e-01	6.62e-01	5.22e-01	9.46e-03	7.06e-01
GOCC PAM COMPLEX TIM23 ASSOCIATED IMPORT MOTOR	5	4.25e-01	7.52e-01	0.5730	-3.40e-01	3.53e-01	2.11e-01	-1.72e-01	1.16e-01	1.88e-01	1.71e-01	4.14e-01	5.05e-01	6.54e-01
GOBP ANTEROGRADE DENDRITIC TRANSPORT OF NEUROTRANSMITTER RECEPTOR COMPLEX	5	5.43e-01	8.25e-01	0.5730	-1.28e-01	3.11e-01	2.39e-01	2.60e-01	-3.01e-01	6.19e-01	2.29e-01	3.56e-01	3.13e-01	2.44e-01
GOCC EXON EXON JUNCTION COMPLEX	10	1.42e-01	4.63e-01	0.5730	1.55e-02	-3.37e-01	-3.18e-01	-3.04e-01	-1.42e-01	9.33e-01	6.49e-02	8.14e-02	9.57e-02	4.37e-01
GOMF U4 SNRNA BINDING	6	2.20e-01	5.74e-01	0.5730	2.07e-01	3.70e-01	2.43e-01	-2.79e-01	-1.03e-01	3.80e-01	1.16e-01	3.02e-01	2.36e-01	6.61e-01
GOMF ICOSANOID TRANSMEMBRANE TRANSPORTER ACTIVITY	13	6.43e-03	6.41e-02	0.5720	1.10e-01	-2.61e-01	-2.07e-01	4.52e-01	1.01e-02	4.92e-01	1.04e-01	1.95e-01	4.78e-03	9.50e-01
GOMF HISTAMINE RECEPTOR ACTIVITY	6	4.16e-01	7.46e-01	0.5720	-6.99e-02	2.45e-01	1.74e-01	3.97e-01	-2.73e-01	7.67e-01	2.99e-01	4.61e-01	9.19e-02	2.47e-01
GOBP CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION	7	2.16e-01	5.69e-01	0.5720	-5.78e-02	2.84e-01	-9.81e-02	-4.34e-01	-2.14e-01	7.91e-01	1.94e-01	6.53e-01	4.68e-02	3.28e-01
GOMF PROLINE SODIUM SYMPORTER ACTIVITY	5	4.07e-01	7.39e-01	0.5720	-6.28e-02	2.02e-01	5.22e-01	-2.24e-02	9.70e-02	8.08e-01	4.34e-01	4.32e-02	9.31e-01	7.07e-01
GOBP MAINTENANCE OF PRESYNAPTIC ACTIVE ZONE STRUCTURE	6	3.90e-01	7.26e-01	0.5720	2.70e-03	-3.87e-01	1.77e-01	3.73e-01	-8.06e-02	9.91e-01	1.01e-01	4.52e-01	1.13e-01	7.32e-01
GOMF FK506 BINDING	10	1.20e-01	4.25e-01	0.5720	-2.14e-02	2.36e-01	-3.27e-01	-3.27e-01	-2.39e-01	9.07e-01	1.96e-01	7.35e-02	7.37e-02	1.90e-01
GOCC CYTOPLASMIC EXOSOME RNASE COMPLEX	15	5.62e-02	2.75e-01	0.5720	4.26e-02	-1.64e-01	-4.35e-01	-3.30e-01	2.68e-02	7.75e-01	2.73e-01	3.56e-03	2.71e-02	8.57e-01
GOBP PLASMA MEMBRANE TO ENDOSOME TRANSPORT	8	1.79e-01	5.20e-01	0.5720	3.25e-01	4.64e-01	-2.34e-02	-6.86e-02	3.03e-02	1.12e-01	2.31e-02	9.09e-01	7.37e-01	8.82e-01
GOCC MITOCHONDRIAL PROTON TRANSPORTING ATP SYNTHASE COMPLEX COUPLING FACTOR F O	10	1.82e-01	5.25e-01	0.5720	-1.13e-01	5.30e-02	-3.57e-01	-4.23e-01	6.82e-02	5.34e-01	7.72e-01	5.09e-02	2.04e-02	7.09e-01
GOBP MITOCHONDRIAL RIBOSOME ASSEMBLY	10	1.38e-01	4.57e-01	0.5710	-9.01e-02	1.12e-01	-2.80e-01	-4.60e-01	-1.26e-01	6.22e-01	5.38e-01	1.25e-01	1.18e-02	4.91e-01
GOBP ENDOCARDIAL CELL DIFFERENTIATION	6	1.30e-01	4.46e-01	0.5710	2.37e-01	9.74e-02	4.54e-01	-1.37e-01	-1.90e-01	3.15e-01	6.80e-01	5.43e-02	5.60e-01	4.20e-01
GOMF NUCLEAR VITAMIN D RECEPTOR BINDING	13	9.63e-02	3.76e-01	0.5710	8.83e-02	-2.14e-01	-4.00e-01	-3.26e-01	8.23e-02	5.81e-01	1.81e-01	1.26e-02	4.20e-02	6.08e-01
GOBP MIDBODY ABSCISSION	17	2.88e-02	1.78e-01	0.5710	2.58e-01	-2.97e-02	-3.89e-01	-3.22e-01	6.15e-02	6.58e-02	8.32e-01	5.48e-03	2.16e-02	6.61e-01
GOBP COPI COATED VESICLE BUDDING	6	4.54e-01	7.73e-01	0.5710	2.16e-01	1.79e-01	-1.79e-01	-4.02e-01	2.31e-01	3.59e-01	4.46e-01	4.47e-01	8.83e-02	3.27e-01
GOCC PROTEASOME CORE COMPLEX BETA SUBUNIT COMPLEX	11	1.20e-01	4.24e-01	0.5710	-7.74e-02	-1.61e-02	-4.82e-01	-2.92e-01	4.92e-02	6.57e-01	9.26e-01	5.66e-03	9.37e-02	7.78e-01
GOBP REGULATION OF PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY	6	2.29e-01	5.82e-01	0.5710	4.09e-01	2.52e-01	1.52e-01	-2.36e-01	-1.26e-01	8.26e-02	2.84e-01	5.19e-01	3.17e-01	5.93e-01
GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS	7	1.36e-01	4.55e-01	0.5710	1.49e-01	8.60e-02	-5.02e-01	-1.24e-02	2.09e-01	4.95e-01	6.93e-01	2.14e-02	9.55e-01	3.37e-01
GOBP ROUNDABOUT SIGNALING PATHWAY	5	5.10e-01	8.07e-01	0.5700	-1.85e-01	-7.10e-02	6.87e-03	2.47e-01	-4.75e-01	4.74e-01	7.83e-01	9.79e-01	3.40e-01	6.61e-02
GOBP VACUOLE FUSION	12	1.35e-01	4.53e-01	0.5700	1.24e-01	-8.41e-02	-3.92e-01	-3.79e-01	7.15e-02	4.57e-01	6.14e-01	1.86e-02	2.31e-02	6.68e-01
GOBP POLE PLASM ASSEMBLY	6	3.94e-01	7.29e-01	0.5700	-1.94e-01	3.66e-01	3.89e-01	4.60e-02	8.69e-03	4.10e-01	1.20e-01	9.93e-02	8.45e-01	9.71e-01
GOMF ANGIOTENSIN RECEPTOR BINDING	9	1.99e-01	5.48e-01	0.5700	-2.37e-01	2.49e-01	3.88e-01	1.86e-01	1.49e-01	2.19e-01	1.96e-01	4.40e-02	3.34e-01	4.39e-01
GOBP CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION	10	1.12e-01	4.10e-01	0.5700	-6.43e-03	-1.83e-01	-8.70e-02	-4.27e-01	3.19e-01	9.72e-01	3.16e-01	6.34e-01	1.95e-02	8.10e-02
GOBP PROTEIN DNA COVALENT CROSS LINKING REPAIR	6	4.87e-01	7.95e-01	0.5700	2.39e-01	-1.76e-01	-3.12e-01	-3.54e-01	1.20e-01	3.11e-01	4.55e-01	1.86e-01	1.34e-01	6.11e-01
GOBP CONSTITUTIVE SECRETORY PATHWAY	7	2.22e-01	5.76e-01	0.5700	-2.21e-01	-1.30e-01	-2.09e-01	-1.35e-01	4.44e-01	3.12e-01	5.53e-01	3.39e-01	5.35e-01	4.18e-02
GOMF TRANSMEMBRANE RECEPTOR PROTEIN PHOSPHATASE ACTIVITY	17	2.24e-02	1.51e-01	0.5700	-2.16e-01	-6.23e-02	2.64e-01	4.49e-01	-5.41e-02	1.24e-01	6.56e-01	5.97e-02	1.35e-03	7.00e-01
GOBP RESPONSE TO CGMP	8	2.29e-01	5.83e-01	0.5700	-5.68e-02	4.79e-01	2.38e-01	1.35e-01	-1.32e-01	7.81e-01	1.90e-02	2.45e-01	5.09e-01	5.18e-01
GOCC PARASPECKLES	7	2.83e-01	6.37e-01	0.5690	1.21e-02	2.24e-01	-2.02e-01	-4.64e-01	-1.33e-01	9.56e-01	3.05e-01	3.55e-01	3.34e-02	5.42e-01
GOBP REGULATION OF RESPONSE TO FOOD	14	2.70e-02	1.71e-01	0.5690	4.71e-01	1.17e-01	-9.86e-02	-2.73e-01	6.93e-02	2.30e-03	4.50e-01	5.23e-01	7.68e-02	6.53e-01
GOBP NEGATIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE	7	1.69e-01	5.05e-01	0.5690	2.35e-01	4.10e-01	-2.73e-01	3.63e-02	-1.57e-01	2.82e-01	6.02e-02	2.10e-01	8.68e-01	4.73e-01
GOBP ASPARTATE METABOLIC PROCESS	8	1.71e-01	5.09e-01	0.5690	-4.06e-01	-3.47e-01	-1.36e-01	1.39e-01	-3.11e-02	4.70e-02	8.88e-02	5.06e-01	4.96e-01	8.79e-01
GOCC DEUTEROSOME	6	3.54e-01	7.00e-01	0.5690	-1.21e-02	-2.95e-01	-2.48e-01	-2.55e-01	-3.33e-01	9.59e-01	2.11e-01	2.93e-01	2.80e-01	1.58e-01
GOMF 1 ACYLGLYCEROPHOSPHOCHOLINE O ACYLTRANSFERASE ACTIVITY	7	2.28e-01	5.81e-01	0.5690	1.59e-01	1.37e-01	-1.50e-01	1.02e-01	-4.97e-01	4.67e-01	5.29e-01	4.93e-01	6.41e-01	2.28e-02
GOBP RESPIRATORY CHAIN COMPLEX III ASSEMBLY	12	4.78e-02	2.46e-01	0.5690	2.03e-01	4.00e-01	6.54e-03	-3.46e-01	5.05e-02	2.24e-01	1.63e-02	9.69e-01	3.82e-02	7.62e-01
GOCC CHROMOSOME CENTROMERIC CORE DOMAIN	17	2.20e-02	1.50e-01	0.5680	6.19e-02	-3.55e-01	-3.21e-01	-2.98e-01	3.98e-02	6.59e-01	1.12e-02	2.21e-02	3.34e-02	7.76e-01
GOMF INTRACELLULAR CAMP ACTIVATED CATION CHANNEL ACTIVITY	8	3.22e-01	6.70e-01	0.5680	-1.54e-01	2.11e-01	3.71e-01	3.42e-01	1.15e-03	4.50e-01	3.01e-01	6.91e-02	9.40e-02	9.96e-01
GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS	6	4.47e-01	7.70e-01	0.5680	-3.66e-02	1.06e-01	-2.56e-01	-4.94e-01	2.29e-02	8.77e-01	6.52e-01	2.78e-01	3.61e-02	9.23e-01
GOBP CELLULAR RESPONSE TO ELECTRICAL STIMULUS	13	1.35e-02	1.09e-01	0.5680	-3.29e-01	2.50e-01	1.99e-01	-3.35e-01	-1.00e-02	4.00e-02	1.19e-01	2.15e-01	3.63e-02	9.50e-01
GOBP REGULATION OF MITOTIC SPINDLE ASSEMBLY	22	8.11e-03	7.56e-02	0.5680	1.73e-01	-5.58e-02	-3.21e-01	-4.10e-01	1.35e-01	1.61e-01	6.51e-01	9.08e-03	8.63e-04	2.74e-01
GOMF G PROTEIN COUPLED RECEPTOR KINASE ACTIVITY	7	3.04e-01	6.58e-01	0.5680	4.97e-02	3.69e-01	3.01e-01	4.81e-02	3.02e-01	8.20e-01	9.10e-02	1.68e-01	8.25e-01	1.67e-01
GOBP POSITIVE REGULATION OF INTERLEUKIN 23 PRODUCTION	7	2.56e-01	6.13e-01	0.5680	-4.64e-01	3.65e-03	-2.55e-01	-1.53e-01	-1.36e-01	3.35e-02	9.87e-01	2.42e-01	4.82e-01	5.34e-01
GOBP NEGATIVE REGULATION OF MEGAKARYOCYTE DIFFERENTIATION	18	6.62e-03	6.54e-02	0.5680	-8.51e-02	-3.68e-01	-2.12e-01	-3.64e-01	-4.18e-02	5.32e-01	6.85e-03	1.20e-01	7.45e-03	7.59e-01
GOBP POSITIVE REGULATION OF DNA TEMPLATED DNA REPLICATION	12	1.34e-01	4.53e-01	0.5680	1.72e-01	-8.44e-02	-3.68e-01	-3.80e-01	7.46e-02	3.03e-01	6.13e-01	2.72e-02	2.27e-02	6.55e-01
GOBP INHIBITORY POSTSYNAPTIC POTENTIAL	16	4.16e-03	4.70e-02	0.5680	1.71e-01	2.95e-01	4.34e-01	-1.19e-01	5.92e-02	2.35e-01	4.11e-02	2.66e-03	4.10e-01	6.82e-01
GOBP ANDROGEN CATABOLIC PROCESS	5	5.39e-01	8.22e-01	0.5680	-1.84e-01	2.19e-01	1.74e-01	3.86e-01	-2.46e-01	4.75e-01	3.97e-01	5.01e-01	1.35e-01	3.40e-01
GOMF CALCIUM ACTIVATED POTASSIUM CHANNEL ACTIVITY	13	4.67e-02	2.42e-01	0.5670	-3.68e-01	6.94e-02	1.53e-01	3.82e-01	-1.12e-01	2.16e-02	6.65e-01	3.39e-01	1.71e-02	4.86e-01
GOBP ENDOCANNABINOID SIGNALING PATHWAY	5	4.40e-01	7.62e-01	0.5670	-5.52e-01	6.94e-02	-1.56e-02	1.16e-02	-1.08e-01	3.24e-02	7.88e-01	9.52e-01	9.64e-01	6.75e-01
GOCC RNA POLYMERASE III COMPLEX	18	1.44e-02	1.14e-01	0.5670	2.93e-01	2.18e-02	-4.04e-01	-2.27e-01	1.43e-01	3.14e-02	8.73e-01	2.97e-03	9.55e-02	2.94e-01
GOBP DE NOVO CENTRIOLE ASSEMBLY INVOLVED IN MULTI CILIATED EPITHELIAL CELL DIFFERENTIATION	5	4.26e-01	7.53e-01	0.5670	7.52e-02	-3.19e-01	-1.90e-01	-1.89e-01	-3.77e-01	7.71e-01	2.16e-01	4.61e-01	4.65e-01	1.44e-01
GOMF GUANYLYLTRANSFERASE ACTIVITY	7	3.65e-01	7.05e-01	0.5670	-9.78e-02	-1.41e-01	-3.34e-01	-4.10e-01	-1.14e-01	6.54e-01	5.19e-01	1.26e-01	6.04e-02	6.01e-01
GOMF NMDA GLUTAMATE RECEPTOR ACTIVITY	8	2.08e-01	5.59e-01	0.5670	-2.87e-01	-5.10e-02	-2.62e-01	-2.69e-01	3.09e-01	1.60e-01	8.03e-01	1.99e-01	1.88e-01	1.30e-01
GOBP GLYCEROL TRANSMEMBRANE TRANSPORT	7	2.08e-01	5.59e-01	0.5670	-4.19e-01	1.24e-01	-1.19e-01	2.13e-01	-2.66e-01	5.50e-02	5.71e-01	5.86e-01	3.28e-01	2.22e-01
GOMF GLYCEROL TRANSMEMBRANE TRANSPORTER ACTIVITY	7	2.08e-01	5.59e-01	0.5670	-4.19e-01	1.24e-01	-1.19e-01	2.13e-01	-2.66e-01	5.50e-02	5.71e-01	5.86e-01	3.28e-01	2.22e-01
GOCC CCR4 NOT CORE COMPLEX	6	4.07e-01	7.40e-01	0.5660	3.08e-01	-2.36e-01	-2.13e-01	-3.47e-01	6.77e-02	1.91e-01	3.17e-01	3.66e-01	1.42e-01	7.74e-01
GOCC CUL4B RING E3 UBIQUITIN LIGASE COMPLEX	5	5.46e-01	8.26e-01	0.5660	-1.52e-01	1.92e-01	-2.58e-01	-4.21e-01	1.29e-01	5.57e-01	4.56e-01	3.18e-01	1.03e-01	6.18e-01
GOBP ADENOSINE TRANSPORT	5	4.60e-01	7.77e-01	0.5660	2.71e-01	1.48e-01	-2.75e-01	-1.79e-01	-3.44e-01	2.95e-01	5.66e-01	2.87e-01	4.88e-01	1.83e-01
GOMF AROMATASE ACTIVITY	26	1.14e-04	2.64e-03	0.5660	2.56e-01	-3.13e-02	7.78e-02	4.97e-01	-2.46e-02	2.40e-02	7.83e-01	4.92e-01	1.12e-05	8.28e-01
GOBP PANCREATIC JUICE SECRETION	11	3.68e-02	2.08e-01	0.5660	-1.26e-01	4.75e-01	-2.16e-01	-1.22e-01	1.32e-01	4.71e-01	6.39e-03	2.14e-01	4.83e-01	4.48e-01
GOBP OPTIC CUP MORPHOGENESIS INVOLVED IN CAMERA TYPE EYE DEVELOPMENT	7	2.46e-01	6.02e-01	0.5660	2.33e-01	-6.57e-02	3.21e-01	3.29e-03	3.98e-01	2.86e-01	7.63e-01	1.42e-01	9.88e-01	6.79e-02
GOMF 1 4 ALPHA OLIGOGLUCAN PHOSPHORYLASE ACTIVITY	5	4.71e-01	7.86e-01	0.5660	-1.88e-01	5.79e-02	-2.01e-01	-4.46e-01	-2.04e-01	4.66e-01	8.23e-01	4.36e-01	8.41e-02	4.29e-01
GOBP TRACHEA MORPHOGENESIS	11	2.84e-02	1.77e-01	0.5660	-2.40e-01	2.75e-01	2.80e-01	-3.27e-01	2.47e-02	1.68e-01	1.14e-01	1.07e-01	6.01e-02	8.87e-01
GOBP PROTEIN SIDE CHAIN DEGLUTAMYLATION	5	4.33e-01	7.57e-01	0.5650	-1.79e-01	-2.45e-01	1.78e-01	2.18e-01	3.85e-01	4.88e-01	3.43e-01	4.91e-01	3.99e-01	1.36e-01
GOBP ER TO GOLGI CERAMIDE TRANSPORT	5	4.14e-01	7.45e-01	0.5650	-1.10e-01	4.74e-01	5.54e-02	-1.07e-02	2.83e-01	6.71e-01	6.67e-02	8.30e-01	9.67e-01	2.72e-01
GOBP TYPE II PNEUMOCYTE DIFFERENTIATION	6	4.32e-01	7.56e-01	0.5650	-6.56e-02	-4.02e-01	-2.81e-01	-2.73e-01	-1.49e-02	7.81e-01	8.80e-02	2.33e-01	2.47e-01	9.50e-01
GOBP REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY	10	1.19e-01	4.23e-01	0.5650	-3.51e-01	1.34e-01	3.25e-01	1.37e-01	2.34e-01	5.49e-02	4.64e-01	7.55e-02	4.54e-01	2.00e-01
GOBP REGULATION OF SYNAPTIC VESICLE MEMBRANE ORGANIZATION	12	2.82e-02	1.76e-01	0.5650	8.91e-02	1.17e-01	4.63e-02	-3.16e-02	-5.43e-01	5.93e-01	4.81e-01	7.81e-01	8.49e-01	1.13e-03
GOBP REGULATION OF CELL PROLIFERATION IN BONE MARROW	8	2.39e-01	5.95e-01	0.5650	-1.14e-01	7.73e-02	3.68e-01	2.05e-01	3.50e-01	5.75e-01	7.05e-01	7.14e-02	3.15e-01	8.61e-02
GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION	9	1.21e-01	4.26e-01	0.5650	3.91e-01	-2.58e-02	2.35e-01	-7.30e-02	3.25e-01	4.24e-02	8.93e-01	2.22e-01	7.05e-01	9.16e-02
GOCC EARLY ENDOSOME LUMEN	5	2.31e-01	5.84e-01	0.5640	-1.96e-01	-6.09e-02	3.59e-01	-1.77e-01	-3.41e-01	4.47e-01	8.13e-01	1.64e-01	4.93e-01	1.87e-01
GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5	12	1.38e-01	4.58e-01	0.5640	1.65e-01	-1.14e-01	-3.85e-01	-3.31e-01	1.42e-01	3.21e-01	4.94e-01	2.08e-02	4.70e-02	3.96e-01
GOMF CELL MATRIX ADHESION MEDIATOR ACTIVITY	7	1.47e-01	4.69e-01	0.5640	-8.66e-02	4.84e-01	7.86e-03	2.51e-01	1.19e-01	6.91e-01	2.67e-02	9.71e-01	2.50e-01	5.87e-01
GOMF INOSITOL BISPHOSPHATE PHOSPHATASE ACTIVITY	5	5.58e-01	8.32e-01	0.5640	-1.42e-01	2.22e-01	2.58e-01	2.24e-01	-3.64e-01	5.81e-01	3.91e-01	3.18e-01	3.85e-01	1.59e-01
GOBP REGULATION OF CALCIUM ION EXPORT ACROSS PLASMA MEMBRANE	5	4.12e-01	7.43e-01	0.5640	-4.44e-01	2.02e-01	2.04e-01	-1.95e-01	2.43e-03	8.55e-02	4.33e-01	4.29e-01	4.50e-01	9.92e-01
GOBP DENTINOGENESIS	6	3.61e-01	7.04e-01	0.5640	-5.70e-03	-1.42e-01	3.22e-02	1.57e-01	-5.22e-01	9.81e-01	5.48e-01	8.91e-01	5.05e-01	2.69e-02
GOMF UBIQUITIN LIKE MODIFIER ACTIVATING ENZYME ACTIVITY	9	1.87e-01	5.30e-01	0.5640	2.20e-01	2.97e-01	-2.46e-01	-3.41e-01	-6.67e-02	2.53e-01	1.23e-01	2.02e-01	7.64e-02	7.29e-01
GOBP CELLULAR RESPONSE TO CGMP	7	3.07e-01	6.60e-01	0.5640	-1.90e-01	4.58e-01	2.35e-01	8.39e-02	-1.01e-01	3.85e-01	3.60e-02	2.81e-01	7.01e-01	6.44e-01
GOMF CALCIUM CHANNEL INHIBITOR ACTIVITY	12	5.98e-02	2.86e-01	0.5640	1.21e-01	3.77e-01	-8.74e-02	-3.92e-01	1.28e-02	4.70e-01	2.37e-02	6.00e-01	1.89e-02	9.39e-01
GOBP POSITIVE REGULATION OF TAU PROTEIN KINASE ACTIVITY	8	8.52e-02	3.53e-01	0.5640	1.77e-02	9.77e-02	-4.84e-03	-5.01e-01	-2.39e-01	9.31e-01	6.32e-01	9.81e-01	1.42e-02	2.42e-01
GOBP REGULATION OF T CIRCLE FORMATION	5	4.69e-01	7.84e-01	0.5640	-1.95e-01	3.25e-01	-2.69e-01	-2.52e-01	-1.97e-01	4.50e-01	2.09e-01	2.98e-01	3.30e-01	4.46e-01
GOBP REGULATION OF MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL	6	3.95e-01	7.29e-01	0.5640	-2.78e-01	1.08e-01	4.01e-01	1.14e-01	-2.34e-01	2.38e-01	6.46e-01	8.91e-02	6.29e-01	3.20e-01
GOMF MIRNA INHIBITOR ACTIVITY VIA BASE PAIRING	8	1.59e-01	4.89e-01	0.5640	-2.57e-01	2.23e-01	-1.29e-02	-2.17e-01	-3.93e-01	2.07e-01	2.75e-01	9.50e-01	2.87e-01	5.43e-02
GOBP NON LYTIC VIRAL RELEASE	14	8.16e-02	3.44e-01	0.5640	9.42e-02	4.50e-02	-3.86e-01	-3.93e-01	5.41e-02	5.42e-01	7.70e-01	1.23e-02	1.09e-02	7.26e-01
GOBP SPLICEOSOMAL CONFORMATIONAL CHANGES TO GENERATE CATALYTIC CONFORMATION	5	5.06e-01	8.06e-01	0.5640	2.87e-01	-2.54e-01	-1.91e-01	-3.59e-01	7.31e-02	2.67e-01	3.25e-01	4.60e-01	1.64e-01	7.77e-01
GOBP MICROGLIAL CELL PROLIFERATION	8	3.07e-01	6.60e-01	0.5630	-1.22e-02	-1.88e-01	3.20e-01	4.22e-01	-3.88e-02	9.52e-01	3.57e-01	1.17e-01	3.89e-02	8.49e-01
GOBP ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE	8	1.69e-01	5.07e-01	0.5630	-3.17e-01	2.28e-01	-3.52e-02	-4.01e-01	-5.50e-02	1.20e-01	2.64e-01	8.63e-01	4.97e-02	7.88e-01
GOBP COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY	8	3.30e-01	6.77e-01	0.5630	-2.80e-02	-8.30e-02	2.79e-01	4.29e-01	-2.19e-01	8.91e-01	6.84e-01	1.72e-01	3.58e-02	2.83e-01
GOMF CALCIUM DEPENDENT PHOSPHOLIPASE A2 ACTIVITY	17	7.38e-03	7.05e-02	0.5630	-2.08e-01	-1.48e-01	2.61e-02	4.79e-01	-1.48e-01	1.37e-01	2.90e-01	8.52e-01	6.34e-04	2.90e-01
GOBP REGULATION OF EXCRETION	11	1.16e-01	4.16e-01	0.5630	-2.00e-02	-1.15e-01	1.50e-01	3.23e-01	-4.20e-01	9.09e-01	5.11e-01	3.89e-01	6.35e-02	1.59e-02
GOMF CADMIUM ION BINDING	5	4.22e-01	7.49e-01	0.5620	-1.12e-01	2.41e-01	-4.56e-01	-1.92e-01	2.67e-02	6.63e-01	3.51e-01	7.74e-02	4.56e-01	9.18e-01
GOBP CARDIOLIPIN ACYL CHAIN REMODELING	5	4.59e-01	7.77e-01	0.5620	-1.53e-01	5.19e-01	1.29e-01	7.92e-02	9.64e-03	5.53e-01	4.43e-02	6.18e-01	7.59e-01	9.70e-01
GOBP POST TRANSLATIONAL PROTEIN TARGETING TO MEMBRANE TRANSLOCATION	8	1.06e-01	3.96e-01	0.5620	2.34e-01	1.86e-01	7.07e-04	-4.41e-01	-1.81e-01	2.52e-01	3.62e-01	9.97e-01	3.09e-02	3.75e-01
GOBP RHOMBOMERE DEVELOPMENT	8	2.59e-01	6.16e-01	0.5620	2.66e-01	-1.10e-01	-1.03e-01	-2.17e-01	4.19e-01	1.92e-01	5.89e-01	6.13e-01	2.87e-01	4.03e-02
GOBP POSITIVE REGULATION OF DNA DEMETHYLATION	8	3.09e-01	6.61e-01	0.5620	-2.31e-01	2.78e-01	3.24e-01	2.75e-01	-7.16e-02	2.58e-01	1.74e-01	1.12e-01	1.79e-01	7.26e-01
GOBP INDUCTION OF BACTERIAL AGGLUTINATION	6	3.78e-01	7.17e-01	0.5620	-3.13e-01	-1.88e-01	1.70e-01	3.80e-01	9.52e-02	1.84e-01	4.25e-01	4.71e-01	1.07e-01	6.86e-01
GOCC LAMIN FILAMENT	5	5.78e-01	8.42e-01	0.5620	6.28e-02	1.93e-01	-3.50e-01	-3.87e-01	-5.14e-02	8.08e-01	4.55e-01	1.76e-01	1.34e-01	8.42e-01
GOCC SMN SM PROTEIN COMPLEX	16	3.10e-02	1.87e-01	0.5620	1.27e-01	4.86e-02	-3.16e-01	-2.84e-01	3.42e-01	3.80e-01	7.37e-01	2.84e-02	4.92e-02	1.79e-02
GOBP CELLULAR RESPONSE TO UV B	12	5.85e-02	2.82e-01	0.5620	1.27e-02	3.70e-01	1.33e-01	-1.22e-01	3.83e-01	9.39e-01	2.66e-02	4.23e-01	4.63e-01	2.17e-02
GOBP REGULATION OF NK T CELL DIFFERENTIATION	6	2.89e-01	6.43e-01	0.5620	-2.10e-01	2.59e-02	3.01e-01	-2.04e-01	3.73e-01	3.74e-01	9.12e-01	2.01e-01	3.86e-01	1.14e-01
GOMF LIPASE BINDING	7	3.40e-01	6.87e-01	0.5620	-2.36e-01	-1.94e-01	-4.18e-01	-1.90e-01	-1.06e-01	2.80e-01	3.73e-01	5.53e-02	3.83e-01	6.26e-01
GOMF MISFOLDED PROTEIN BINDING	19	9.98e-03	8.76e-02	0.5620	-1.35e-01	1.06e-01	-2.84e-01	-4.45e-01	-8.45e-02	3.10e-01	4.23e-01	3.18e-02	7.75e-04	5.24e-01
GOBP CARDIAC MUSCLE TISSUE REGENERATION	8	1.90e-01	5.36e-01	0.5620	2.45e-01	-4.19e-01	-6.58e-02	-1.72e-01	2.13e-01	2.30e-01	4.00e-02	7.47e-01	4.00e-01	2.97e-01
GOBP DOUBLE STRAND BREAK REPAIR VIA CLASSICAL NONHOMOLOGOUS END JOINING	6	3.76e-01	7.15e-01	0.5610	-1.77e-01	-1.38e-01	-2.30e-01	-3.87e-01	-2.50e-01	4.54e-01	5.59e-01	3.28e-01	1.01e-01	2.89e-01
GOBP CEREBELLAR PURKINJE CELL GRANULE CELL PRECURSOR CELL SIGNALING INVOLVED IN REGULATION OF GRANULE CELL PRECURSOR CELL PROLIFERATION	5	5.75e-01	8.40e-01	0.5610	1.59e-01	-5.32e-02	-1.69e-01	-4.31e-01	2.69e-01	5.37e-01	8.37e-01	5.13e-01	9.47e-02	2.98e-01
GOBP OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS	20	1.12e-02	9.53e-02	0.5610	2.05e-01	-1.27e-01	-3.24e-01	-3.88e-01	-3.02e-02	1.13e-01	3.24e-01	1.20e-02	2.65e-03	8.15e-01
GOBP REGULATION OF SODIUM DEPENDENT PHOSPHATE TRANSPORT	5	3.56e-01	7.01e-01	0.5610	-4.75e-02	3.34e-01	-4.29e-01	-7.82e-02	-1.02e-01	8.54e-01	1.95e-01	9.66e-02	7.62e-01	6.93e-01
GOMF HYDROXYMETHYL FORMYL AND RELATED TRANSFERASE ACTIVITY	8	1.88e-01	5.32e-01	0.5610	1.47e-02	-6.64e-03	-4.38e-01	-1.62e-01	3.11e-01	9.42e-01	9.74e-01	3.21e-02	4.27e-01	1.28e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION	12	9.39e-02	3.71e-01	0.5610	-1.73e-01	-2.03e-01	-3.09e-01	-3.63e-01	-1.26e-01	2.99e-01	2.22e-01	6.41e-02	2.94e-02	4.52e-01
GOBP NUCLEAR MEMBRANE REASSEMBLY	25	4.34e-03	4.87e-02	0.5610	1.36e-01	-1.33e-01	-3.83e-01	-3.34e-01	1.42e-01	2.38e-01	2.51e-01	9.29e-04	3.85e-03	2.19e-01
GOMF GABA RECEPTOR ACTIVITY	19	1.48e-02	1.15e-01	0.5600	5.53e-02	1.39e-01	3.60e-01	3.76e-01	1.44e-01	6.76e-01	2.95e-01	6.61e-03	4.55e-03	2.76e-01
GOBP DENDRITE SELF AVOIDANCE	14	2.96e-02	1.81e-01	0.5600	-7.51e-02	-2.15e-01	6.04e-02	4.94e-01	-1.20e-01	6.27e-01	1.64e-01	6.96e-01	1.38e-03	4.37e-01
GOBP NEURAL CREST CELL FATE COMMITMENT	6	4.27e-01	7.54e-01	0.5600	1.95e-01	1.83e-01	3.35e-01	1.67e-01	3.19e-01	4.08e-01	4.37e-01	1.55e-01	4.80e-01	1.76e-01
GOMF LIPOPOLYSACCHARIDE IMMUNE RECEPTOR ACTIVITY	6	2.82e-01	6.35e-01	0.5600	2.36e-01	3.88e-01	1.30e-01	-2.07e-01	-2.18e-01	3.17e-01	9.97e-02	5.81e-01	3.81e-01	3.55e-01
GOBP NEGATIVE REGULATION OF ASTROCYTE ACTIVATION	5	5.17e-01	8.11e-01	0.5600	-2.88e-01	-3.14e-01	-3.34e-01	-1.36e-01	3.29e-02	2.64e-01	2.24e-01	1.95e-01	5.99e-01	8.99e-01
GOBP ADHESION OF SYMBIONT TO HOST	12	3.37e-02	1.97e-01	0.5600	-5.04e-01	4.01e-03	1.58e-01	-1.85e-01	-1.88e-02	2.50e-03	9.81e-01	3.45e-01	2.68e-01	9.10e-01
GOBP RESPONSE TO ZINC ION STARVATION	9	1.46e-01	4.67e-01	0.5600	-2.18e-01	2.92e-01	2.48e-01	2.08e-03	-3.46e-01	2.58e-01	1.30e-01	1.98e-01	9.91e-01	7.27e-02
GOBP DUCTUS ARTERIOSUS CLOSURE	5	6.24e-01	8.66e-01	0.5590	-4.42e-03	-1.91e-01	-4.27e-01	-3.01e-01	5.51e-02	9.86e-01	4.59e-01	9.79e-02	2.44e-01	8.31e-01
GOMF GAP JUNCTION CHANNEL ACTIVITY INVOLVED IN CELL COMMUNICATION BY ELECTRICAL COUPLING	8	2.62e-01	6.19e-01	0.5590	-7.30e-02	2.39e-01	2.14e-01	2.00e-01	-4.06e-01	7.21e-01	2.42e-01	2.94e-01	3.27e-01	4.70e-02
GOMF DOUBLE STRANDED DNA EXODEOXYRIBONUCLEASE ACTIVITY	6	4.75e-01	7.88e-01	0.5590	3.53e-02	1.69e-01	-4.11e-01	-3.38e-01	9.36e-03	8.81e-01	4.73e-01	8.14e-02	1.52e-01	9.68e-01
GOBP INTERKINETIC NUCLEAR MIGRATION	5	5.02e-01	8.03e-01	0.5590	2.94e-01	5.37e-02	9.81e-02	-2.02e-01	4.16e-01	2.55e-01	8.35e-01	7.04e-01	4.34e-01	1.07e-01
GOBP POSITIVE REGULATION OF SARCOMERE ORGANIZATION	6	3.14e-01	6.65e-01	0.5590	-3.13e-02	-1.59e-01	1.18e-01	4.86e-01	1.90e-01	8.94e-01	5.00e-01	6.18e-01	3.91e-02	4.20e-01
GOMF SODIUM INDEPENDENT ORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY	16	1.27e-02	1.04e-01	0.5590	-3.65e-02	-3.28e-01	2.15e-02	4.45e-01	-7.49e-02	8.00e-01	2.32e-02	8.82e-01	2.08e-03	6.04e-01
GOBP MALE SEX DETERMINATION	11	3.51e-02	2.02e-01	0.5580	-6.33e-02	2.89e-01	1.63e-01	-4.41e-01	6.03e-02	7.16e-01	9.71e-02	3.49e-01	1.14e-02	7.29e-01
GOBP PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT	17	8.12e-03	7.56e-02	0.5580	4.12e-01	2.79e-01	2.48e-01	4.38e-02	-2.31e-02	3.28e-03	4.62e-02	7.67e-02	7.55e-01	8.69e-01
GOBP B CELL CHEMOTAXIS	6	3.17e-01	6.66e-01	0.5580	-3.91e-02	2.64e-01	-2.04e-01	9.27e-02	-4.36e-01	8.68e-01	2.63e-01	3.86e-01	6.94e-01	6.46e-02
GOBP RESPONSE TO MERCURY ION	10	1.08e-01	4.00e-01	0.5580	-2.26e-02	3.83e-01	3.59e-02	1.55e-01	-3.72e-01	9.02e-01	3.59e-02	8.44e-01	3.96e-01	4.14e-02
GOBP MESONEPHRIC TUBULE FORMATION	10	1.41e-01	4.62e-01	0.5580	3.23e-01	-9.07e-02	-1.85e-01	-4.01e-01	6.13e-02	7.71e-02	6.20e-01	3.10e-01	2.81e-02	7.37e-01
GOMF I SMAD BINDING	16	1.59e-02	1.21e-01	0.5580	1.55e-01	3.36e-01	3.40e-01	1.04e-01	-2.19e-01	2.83e-01	2.00e-02	1.86e-02	4.70e-01	1.29e-01
GOMF RETINOL BINDING	16	7.25e-03	6.96e-02	0.5580	-3.24e-01	-3.44e-02	-3.98e-01	3.77e-03	-2.15e-01	2.49e-02	8.12e-01	5.81e-03	9.79e-01	1.36e-01
GOMF BETA GALACTOSIDASE ACTIVITY	5	4.40e-01	7.63e-01	0.5580	3.78e-02	-2.67e-01	1.05e-01	1.30e-01	-4.59e-01	8.84e-01	3.01e-01	6.84e-01	6.15e-01	7.57e-02
GOBP REGULATION OF MESENCHYMAL STEM CELL DIFFERENTIATION	8	2.24e-01	5.77e-01	0.5580	1.25e-01	1.73e-01	4.58e-01	1.59e-01	-1.72e-01	5.40e-01	3.96e-01	2.48e-02	4.36e-01	3.98e-01
GOBP NEGATIVE REGULATION OF NEUROBLAST PROLIFERATION	11	6.87e-02	3.10e-01	0.5570	2.95e-01	-1.08e-01	2.24e-01	-5.03e-02	3.99e-01	9.02e-02	5.34e-01	1.98e-01	7.73e-01	2.19e-02
GOBP INTERLEUKIN 18 MEDIATED SIGNALING PATHWAY	9	1.95e-01	5.44e-01	0.5570	3.05e-01	2.44e-01	3.09e-01	1.53e-01	1.98e-01	1.13e-01	2.05e-01	1.08e-01	4.28e-01	3.04e-01
GOBP ENDONUCLEOLYTIC CLEAVAGE IN 5 ETS OF TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA	8	3.01e-01	6.55e-01	0.5570	2.25e-01	3.67e-02	-4.33e-01	-2.43e-01	1.12e-01	2.71e-01	8.57e-01	3.41e-02	2.35e-01	5.84e-01
GOBP TRNA 5 LEADER REMOVAL	13	9.44e-02	3.72e-01	0.5570	1.05e-01	-1.26e-01	-4.61e-01	-2.49e-01	-9.16e-02	5.12e-01	4.31e-01	3.99e-03	1.19e-01	5.68e-01
GOBP NEGATIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS	6	3.44e-01	6.90e-01	0.5570	4.72e-01	-4.36e-02	3.73e-02	2.51e-01	-1.44e-01	4.51e-02	8.53e-01	8.74e-01	2.88e-01	5.41e-01
GOBP PROLACTIN SECRETION	5	5.82e-01	8.44e-01	0.5570	9.25e-03	4.23e-02	1.82e-01	3.78e-01	-3.64e-01	9.71e-01	8.70e-01	4.81e-01	1.44e-01	1.59e-01
GOMF PHOSPHATIDIC ACID TRANSFER ACTIVITY	7	3.17e-01	6.67e-01	0.5570	-1.85e-01	2.81e-01	-2.88e-01	-3.33e-01	-5.69e-02	3.97e-01	1.98e-01	1.87e-01	1.27e-01	7.94e-01
GOBP CALCIUM ACTIVATED PHOSPHOLIPID SCRAMBLING	5	5.33e-01	8.20e-01	0.5560	9.07e-03	2.80e-01	1.71e-01	2.10e-01	-3.98e-01	9.72e-01	2.79e-01	5.09e-01	4.17e-01	1.23e-01
GOMF CALCITONIN FAMILY RECEPTOR ACTIVITY	6	3.71e-01	7.10e-01	0.5560	-8.78e-02	-2.80e-01	1.03e-01	4.58e-01	5.64e-02	7.09e-01	2.35e-01	6.63e-01	5.21e-02	8.11e-01
GOBP REGULATION OF CARDIOBLAST DIFFERENTIATION	5	6.01e-01	8.53e-01	0.5560	2.66e-01	1.58e-01	-2.92e-01	-3.23e-01	1.53e-01	3.02e-01	5.41e-01	2.57e-01	2.10e-01	5.54e-01
GOBP FC GAMMA RECEPTOR SIGNALING PATHWAY	31	1.10e-04	2.58e-03	0.5560	-1.12e-01	3.05e-01	3.64e-01	4.90e-02	2.63e-01	2.79e-01	3.29e-03	4.59e-04	6.37e-01	1.14e-02
GOBP POSITIVE REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE	11	1.11e-01	4.07e-01	0.5560	1.80e-01	-1.99e-01	2.67e-01	3.92e-01	1.12e-01	3.01e-01	2.54e-01	1.25e-01	2.45e-02	5.19e-01
GOBP MACROPHAGE INFLAMMATORY PROTEIN 1 ALPHA PRODUCTION	6	3.62e-01	7.04e-01	0.5560	-4.49e-01	1.33e-01	-9.89e-03	1.90e-01	-2.31e-01	5.68e-02	5.73e-01	9.67e-01	4.19e-01	3.27e-01
GOBP REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA SIGNALING PATHWAY	5	5.06e-01	8.06e-01	0.5560	2.96e-01	-3.29e-01	-3.29e-01	2.42e-03	7.26e-02	2.52e-01	2.03e-01	2.03e-01	9.93e-01	7.79e-01
GOBP L ASPARTATE IMPORT ACROSS PLASMA MEMBRANE	6	3.73e-01	7.12e-01	0.5550	-3.58e-01	2.60e-01	-2.03e-02	2.32e-02	-3.34e-01	1.28e-01	2.70e-01	9.31e-01	9.22e-01	1.56e-01
GOBP MATURATION OF 5 8S RRNA	35	1.58e-04	3.45e-03	0.5550	1.75e-02	-1.16e-01	-4.60e-01	-2.80e-01	6.49e-02	8.58e-01	2.34e-01	2.44e-06	4.12e-03	5.06e-01
GOBP MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY	25	3.90e-03	4.48e-02	0.5550	2.31e-01	5.03e-02	-2.95e-01	-3.85e-01	1.29e-01	4.58e-02	6.63e-01	1.06e-02	8.48e-04	2.63e-01
GOBP PURINE NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS	5	5.56e-01	8.31e-01	0.5550	1.53e-01	2.59e-01	-2.53e-01	-2.76e-01	2.78e-01	5.54e-01	3.17e-01	3.26e-01	2.85e-01	2.82e-01
GOBP SEMICIRCULAR CANAL DEVELOPMENT	9	1.71e-01	5.10e-01	0.5550	5.00e-01	-1.25e-01	-1.46e-01	-9.28e-02	1.12e-01	9.40e-03	5.16e-01	4.48e-01	6.30e-01	5.61e-01
GOMF ARACHIDONATE COA LIGASE ACTIVITY	10	1.05e-01	3.94e-01	0.5550	-1.89e-01	4.90e-01	8.32e-02	-1.09e-01	-1.15e-01	3.01e-01	7.27e-03	6.49e-01	5.50e-01	5.28e-01
GOBP POSITIVE REGULATION OF COA TRANSFERASE ACTIVITY	8	2.07e-01	5.57e-01	0.5550	-2.66e-01	2.16e-02	-1.46e-01	2.03e-01	-4.18e-01	1.93e-01	9.16e-01	4.75e-01	3.20e-01	4.08e-02
GOBP NEGATIVE REGULATION OF OXIDATIVE PHOSPHORYLATION	8	1.77e-01	5.18e-01	0.5550	-2.83e-01	1.56e-01	-2.38e-01	-2.13e-01	3.19e-01	1.66e-01	4.45e-01	2.44e-01	2.97e-01	1.18e-01
GOBP REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL	12	1.09e-01	4.03e-01	0.5550	7.55e-03	-8.85e-02	1.72e-01	4.50e-01	-2.60e-01	9.64e-01	5.96e-01	3.03e-01	6.89e-03	1.19e-01
GOBP PROSTHETIC GROUP METABOLIC PROCESS	6	4.21e-01	7.48e-01	0.5550	2.54e-01	-3.32e-01	-2.46e-01	-2.64e-01	-5.26e-02	2.81e-01	1.59e-01	2.97e-01	2.62e-01	8.23e-01
GOBP TRICUSPID VALVE MORPHOGENESIS	5	4.19e-01	7.48e-01	0.5550	1.90e-01	-1.32e-01	2.53e-01	-1.60e-01	4.05e-01	4.61e-01	6.10e-01	3.27e-01	5.35e-01	1.16e-01
GOBP COMPLEMENT ACTIVATION LECTIN PATHWAY	11	7.54e-02	3.29e-01	0.5540	-1.34e-01	-1.60e-01	3.49e-02	4.97e-01	-1.22e-01	4.41e-01	3.58e-01	8.41e-01	4.28e-03	4.85e-01
GOBP REGULATION OF MITOCHONDRIAL TRANSCRIPTION	5	6.41e-01	8.75e-01	0.5540	1.34e-01	-9.73e-02	-3.35e-01	-3.37e-01	2.32e-01	6.05e-01	7.06e-01	1.95e-01	1.92e-01	3.69e-01
GOMF RIBOSOMAL PROTEIN S6 KINASE ACTIVITY	5	5.19e-01	8.13e-01	0.5540	1.80e-01	1.53e-01	1.21e-01	-1.28e-01	4.69e-01	4.86e-01	5.54e-01	6.40e-01	6.21e-01	6.91e-02
GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX COUPLING FACTOR F O	12	1.23e-01	4.32e-01	0.5540	-8.58e-02	1.20e-01	-3.15e-01	-4.11e-01	1.28e-01	6.07e-01	4.71e-01	5.84e-02	1.36e-02	4.43e-01
GOCC TUBULAR ENDOSOME	5	5.30e-01	8.19e-01	0.5540	-1.63e-01	1.91e-01	-3.98e-01	-2.84e-01	-6.38e-02	5.27e-01	4.59e-01	1.23e-01	2.71e-01	8.05e-01
GOBP SENSORY PERCEPTION OF SOUR TASTE	9	1.42e-01	4.63e-01	0.5540	2.18e-01	2.97e-01	3.39e-01	6.99e-02	-2.24e-01	2.57e-01	1.22e-01	7.79e-02	7.17e-01	2.44e-01
GOCC MPP7 DLG1 LIN7 COMPLEX	5	5.08e-01	8.07e-01	0.5540	-1.14e-02	4.87e-01	2.33e-01	-3.87e-03	-1.23e-01	9.65e-01	5.95e-02	3.67e-01	9.88e-01	6.33e-01
GOMF ATP DEPENDENT PROTEIN BINDING	6	2.73e-01	6.28e-01	0.5540	2.45e-01	2.35e-01	1.37e-01	-4.08e-01	7.88e-02	3.00e-01	3.19e-01	5.60e-01	8.37e-02	7.38e-01
GOBP MITOCHONDRIAL ATP TRANSMEMBRANE TRANSPORT	6	3.56e-01	7.01e-01	0.5540	5.31e-01	1.28e-01	-6.94e-02	5.46e-02	2.39e-03	2.42e-02	5.89e-01	7.68e-01	8.17e-01	9.92e-01
GOMF 4 GALACTOSYL N ACETYLGLUCOSAMINIDE 3 ALPHA L FUCOSYLTRANSFERASE ACTIVITY	6	2.30e-01	5.83e-01	0.5530	-2.33e-01	3.82e-01	1.29e-02	1.81e-01	2.70e-01	3.23e-01	1.05e-01	9.56e-01	4.43e-01	2.52e-01
GOBP COMMON MYELOID PROGENITOR CELL PROLIFERATION	9	1.66e-01	5.02e-01	0.5530	3.16e-01	1.60e-01	7.67e-02	-3.01e-01	2.90e-01	1.00e-01	4.06e-01	6.90e-01	1.17e-01	1.32e-01
GOBP CYTOPLASMIC SEQUESTERING OF NF KAPPAB	5	4.98e-01	8.02e-01	0.5530	-6.26e-02	4.02e-01	-1.63e-02	-2.23e-01	3.01e-01	8.08e-01	1.20e-01	9.50e-01	3.88e-01	2.43e-01
GOMF CARNITINE TRANSMEMBRANE TRANSPORTER ACTIVITY	5	3.29e-01	6.77e-01	0.5530	3.34e-01	4.62e-02	-3.27e-01	1.39e-01	2.58e-01	1.96e-01	8.58e-01	2.06e-01	5.92e-01	3.18e-01
GOCC U2 TYPE CATALYTIC STEP 2 SPLICEOSOME	30	7.07e-04	1.16e-02	0.5530	1.39e-01	-2.72e-01	-2.93e-01	-3.20e-01	1.56e-01	1.86e-01	9.94e-03	5.48e-03	2.41e-03	1.38e-01
GOBP POSITIVE REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS	6	3.84e-01	7.22e-01	0.5530	4.54e-02	1.49e-01	5.09e-01	1.22e-01	-9.08e-02	8.47e-01	5.28e-01	3.10e-02	6.05e-01	7.00e-01
GOBP REGULATION OF PROTEIN K48 LINKED UBIQUITINATION	6	4.15e-01	7.45e-01	0.5530	3.93e-01	-1.31e-01	-1.60e-01	-3.20e-01	8.04e-02	9.57e-02	5.80e-01	4.97e-01	1.74e-01	7.33e-01
GOBP REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS	13	3.85e-02	2.15e-01	0.5530	-1.91e-01	1.34e-01	-9.09e-02	2.54e-01	-4.23e-01	2.32e-01	4.02e-01	5.70e-01	1.13e-01	8.33e-03
GOBP SIGNAL COMPLEX ASSEMBLY	8	2.22e-01	5.76e-01	0.5530	3.27e-01	2.08e-01	1.75e-01	2.94e-01	1.96e-01	1.09e-01	3.09e-01	3.92e-01	1.49e-01	3.36e-01
GOBP REGULATION OF COLLAGEN FIBRIL ORGANIZATION	8	1.25e-01	4.36e-01	0.5530	1.99e-01	8.67e-02	3.47e-01	-2.39e-01	2.85e-01	3.31e-01	6.71e-01	8.93e-02	2.43e-01	1.62e-01
GOBP CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS	9	1.59e-01	4.90e-01	0.5530	2.00e-01	-4.88e-02	3.00e-01	2.38e-01	-3.41e-01	2.98e-01	8.00e-01	1.19e-01	2.16e-01	7.68e-02
GOMF LAMININ 1 BINDING	7	3.06e-01	6.60e-01	0.5530	5.02e-02	-3.51e-01	3.03e-01	2.80e-01	-9.76e-02	8.18e-01	1.08e-01	1.65e-01	2.00e-01	6.55e-01
GOMF MRF BINDING	5	5.15e-01	8.10e-01	0.5530	-1.82e-01	1.92e-01	-3.17e-01	-2.42e-01	-2.75e-01	4.80e-01	4.56e-01	2.19e-01	3.48e-01	2.87e-01
GOBP NEGATIVE REGULATION OF SOMATIC STEM CELL POPULATION MAINTENANCE	5	1.49e-01	4.74e-01	0.5530	-5.00e-02	-1.03e-01	3.89e-01	-3.45e-01	-1.49e-01	8.46e-01	6.91e-01	1.32e-01	1.82e-01	5.65e-01
GOMF FERROUS IRON TRANSMEMBRANE TRANSPORTER ACTIVITY	5	3.94e-01	7.28e-01	0.5520	3.65e-01	1.24e-01	-4.93e-02	-3.32e-01	-2.09e-01	1.57e-01	6.31e-01	8.49e-01	1.98e-01	4.19e-01
GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT CONFERRING COMPRESSION RESISTANCE	19	1.99e-02	1.40e-01	0.5520	-2.98e-01	-6.01e-02	3.06e-01	3.08e-01	-1.56e-01	2.46e-02	6.50e-01	2.10e-02	2.02e-02	2.39e-01
GOBP POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR	16	1.81e-02	1.33e-01	0.5520	-1.15e-01	-3.31e-01	-2.13e-01	-1.35e-01	3.44e-01	4.26e-01	2.19e-02	1.41e-01	3.49e-01	1.71e-02
GOCC MITOTIC SPINDLE MICROTUBULE	13	9.26e-02	3.67e-01	0.5520	1.82e-01	2.03e-01	-3.32e-01	-3.39e-01	7.45e-02	2.57e-01	2.05e-01	3.81e-02	3.45e-02	6.42e-01
GOMF LIPOPROTEIN LIPASE ACTIVITY	9	1.33e-01	4.50e-01	0.5520	-1.53e-01	-1.62e-01	3.47e-01	2.17e-02	3.67e-01	4.28e-01	3.99e-01	7.16e-02	9.10e-01	5.68e-02
GOCC MITOCHONDRIAL PYRUVATE DEHYDROGENASE COMPLEX	7	2.62e-01	6.19e-01	0.5520	5.14e-01	-1.12e-02	1.29e-01	-2.32e-02	1.51e-01	1.84e-02	9.59e-01	5.56e-01	9.15e-01	4.89e-01
GOCC INNER ACROSOMAL MEMBRANE	5	4.71e-01	7.86e-01	0.5520	-2.87e-01	4.22e-01	5.13e-02	-1.79e-01	-9.68e-02	2.67e-01	1.02e-01	8.43e-01	4.87e-01	7.08e-01
GOCC CORTICAL GRANULE	6	3.85e-01	7.23e-01	0.5520	-3.40e-01	2.63e-01	2.47e-01	-1.93e-02	-2.41e-01	1.49e-01	2.65e-01	2.94e-01	9.35e-01	3.07e-01
GOBP TYROSINE CATABOLIC PROCESS	6	3.66e-01	7.06e-01	0.5510	-6.29e-02	5.01e-01	8.65e-02	-1.47e-01	-1.41e-01	7.90e-01	3.36e-02	7.14e-01	5.32e-01	5.50e-01
GOBP HINDBRAIN TANGENTIAL CELL MIGRATION	5	6.41e-01	8.75e-01	0.5510	-6.34e-02	2.21e-01	4.04e-01	2.89e-01	-6.63e-02	8.06e-01	3.91e-01	1.18e-01	2.64e-01	7.97e-01
GOBP PROTEIN DE ADP RIBOSYLATION	5	5.06e-01	8.06e-01	0.5510	-9.75e-02	-2.44e-01	-1.75e-01	-2.76e-02	-4.51e-01	7.06e-01	3.45e-01	4.99e-01	9.15e-01	8.05e-02
GOBP BRUSH BORDER ASSEMBLY	7	4.47e-01	7.70e-01	0.5510	-6.28e-02	1.08e-02	3.95e-01	3.76e-01	5.32e-02	7.74e-01	9.61e-01	7.07e-02	8.50e-02	8.07e-01
GOMF PROTEIN CARBOXYL O METHYLTRANSFERASE ACTIVITY	6	4.20e-01	7.48e-01	0.5510	-3.55e-01	-2.24e-01	-2.59e-01	-2.20e-01	1.09e-01	1.32e-01	3.42e-01	2.72e-01	3.52e-01	6.45e-01
GOMF MOLECULAR TAG ACTIVITY	13	1.04e-01	3.91e-01	0.5510	4.64e-02	-1.34e-01	-3.21e-01	-4.24e-01	-1.98e-02	7.72e-01	4.02e-01	4.48e-02	8.13e-03	9.02e-01
GOBP CELLULAR RESPONSE TO ZINC ION	23	6.03e-04	1.03e-02	0.5510	-1.38e-01	3.80e-01	6.58e-02	-3.68e-01	-2.38e-03	2.51e-01	1.60e-03	5.85e-01	2.23e-03	9.84e-01
GOBP REGULATION OF LEUKOCYTE TETHERING OR ROLLING	18	8.96e-03	8.11e-02	0.5510	-2.65e-01	2.77e-01	3.93e-01	-4.02e-03	5.19e-02	5.20e-02	4.21e-02	3.91e-03	9.76e-01	7.03e-01
GOBP REGULATION OF RIBONUCLEASE ACTIVITY	9	2.87e-01	6.40e-01	0.5510	5.10e-02	1.31e-01	-3.24e-01	-4.15e-01	7.56e-02	7.91e-01	4.95e-01	9.21e-02	3.10e-02	6.95e-01
GOCC SMOOTH ENDOPLASMIC RETICULUM MEMBRANE	7	2.22e-01	5.76e-01	0.5500	-2.76e-01	2.53e-01	1.37e-01	3.42e-01	1.65e-01	2.06e-01	2.47e-01	5.30e-01	1.17e-01	4.49e-01
GOBP NEGATIVE REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE	12	4.58e-02	2.39e-01	0.5500	1.49e-03	5.39e-01	-7.60e-02	-7.57e-02	-2.57e-02	9.93e-01	1.22e-03	6.48e-01	6.50e-01	8.78e-01
GOCC PLATELET DENSE GRANULE MEMBRANE	5	4.01e-01	7.34e-01	0.5500	-3.90e-01	1.69e-01	-3.21e-01	-4.16e-02	-1.29e-01	1.31e-01	5.12e-01	2.13e-01	8.72e-01	6.16e-01
GOBP NEGATIVE REGULATION OF CELLULAR RESPIRATION	10	1.51e-01	4.78e-01	0.5500	-1.37e-01	1.58e-01	-2.98e-01	-3.07e-01	2.75e-01	4.53e-01	3.88e-01	1.03e-01	9.23e-02	1.33e-01
GOCC GROWTH FACTOR COMPLEX	8	3.82e-02	2.14e-01	0.5500	1.25e-01	8.92e-02	-4.54e-01	2.32e-01	1.38e-01	5.41e-01	6.62e-01	2.62e-02	2.56e-01	5.00e-01
GOBP REGULATION OF HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE	10	1.28e-01	4.41e-01	0.5490	7.96e-02	-3.17e-01	1.31e-01	2.52e-01	-3.38e-01	6.63e-01	8.21e-02	4.72e-01	1.68e-01	6.43e-02
GOBP PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING	6	3.46e-01	6.93e-01	0.5490	-1.59e-01	4.25e-01	6.94e-02	-2.57e-01	-1.57e-01	4.99e-01	7.13e-02	7.69e-01	2.75e-01	5.06e-01
GOMF DNA METHYLTRANSFERASE ACTIVITY	7	3.28e-01	6.76e-01	0.5490	4.55e-01	1.41e-01	-1.58e-02	-1.69e-01	2.14e-01	3.70e-02	5.19e-01	9.42e-01	4.38e-01	3.26e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OR CH2 GROUPS DISULFIDE AS ACCEPTOR	5	4.83e-01	7.93e-01	0.5490	-3.43e-01	2.83e-01	-1.17e-01	-1.75e-01	-2.43e-01	1.84e-01	2.73e-01	6.51e-01	4.99e-01	3.47e-01
GOBP GLIAL CELL FATE SPECIFICATION	7	3.96e-01	7.30e-01	0.5490	-1.38e-01	1.40e-01	-2.81e-01	-4.27e-01	3.20e-02	5.28e-01	5.22e-01	1.98e-01	5.03e-02	8.83e-01
GOBP NEGATIVE REGULATION OF INTERFERON ALPHA PRODUCTION	6	4.62e-01	7.78e-01	0.5490	1.00e-01	3.05e-02	-3.23e-01	-2.37e-01	3.60e-01	6.71e-01	8.97e-01	1.71e-01	3.14e-01	1.27e-01
GOBP POSITIVE REGULATION OF T HELPER 2 CELL DIFFERENTIATION	7	2.64e-01	6.19e-01	0.5480	-1.89e-01	4.60e-01	1.33e-01	1.55e-01	1.07e-01	3.87e-01	3.49e-02	5.43e-01	4.78e-01	6.24e-01
GOBP CELL FATE COMMITMENT INVOLVED IN PATTERN SPECIFICATION	11	1.41e-01	4.62e-01	0.5480	3.96e-02	1.85e-01	-2.85e-01	-4.16e-01	-1.04e-01	8.20e-01	2.89e-01	1.02e-01	1.68e-02	5.51e-01
GOBP POSITIVE REGULATION OF TOOTH MINERALIZATION	7	4.62e-01	7.78e-01	0.5480	-6.21e-02	-4.19e-03	3.95e-01	3.53e-01	-1.27e-01	7.76e-01	9.85e-01	7.05e-02	1.05e-01	5.60e-01
GOBP REGULATION OF CELLULAR RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR STIMULUS	6	5.36e-01	8.21e-01	0.5480	-1.42e-01	1.98e-01	4.03e-01	2.78e-01	4.47e-02	5.48e-01	4.01e-01	8.77e-02	2.38e-01	8.50e-01
GOBP RETROTRANSPOSON SILENCING BY HETEROCHROMATIN FORMATION	15	3.17e-02	1.90e-01	0.5480	-3.40e-01	-8.37e-02	3.81e-01	1.50e-01	1.02e-01	2.27e-02	5.75e-01	1.07e-02	3.15e-01	4.93e-01
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE	17	3.66e-02	2.08e-01	0.5480	-1.15e-01	-2.23e-01	-3.22e-01	-3.56e-01	8.05e-02	4.10e-01	1.11e-01	2.13e-02	1.11e-02	5.65e-01
GOBP TRNA 5 END PROCESSING	15	6.73e-02	3.06e-01	0.5480	1.32e-01	-1.22e-01	-4.32e-01	-2.74e-01	-8.25e-02	3.78e-01	4.14e-01	3.80e-03	6.66e-02	5.80e-01
GOBP RESPONSE TO INDOLE 3 METHANOL	6	3.74e-01	7.13e-01	0.5480	4.73e-01	-1.42e-01	1.03e-01	1.92e-01	9.60e-02	4.50e-02	5.48e-01	6.63e-01	4.16e-01	6.84e-01
GOBP ANTIBACTERIAL INNATE IMMUNE RESPONSE	6	3.24e-01	6.72e-01	0.5480	6.89e-02	1.90e-01	1.44e-01	2.92e-01	3.92e-01	7.70e-01	4.20e-01	5.41e-01	2.16e-01	9.67e-02
GOBP REGULATION OF CYTOCHROME C OXIDASE ACTIVITY	5	6.18e-01	8.62e-01	0.5480	3.44e-02	1.53e-01	-2.30e-01	-4.44e-01	1.58e-01	8.94e-01	5.53e-01	3.72e-01	8.54e-02	5.41e-01
GOMF GLUTATHIONE DISULFIDE OXIDOREDUCTASE ACTIVITY	5	5.07e-01	8.07e-01	0.5470	1.29e-01	5.02e-01	3.28e-02	-1.08e-01	1.34e-01	6.17e-01	5.17e-02	8.99e-01	6.77e-01	6.03e-01
GOBP PARAXIAL MESODERM FORMATION	7	4.31e-01	7.56e-01	0.5470	4.29e-02	-9.12e-02	-2.25e-01	-4.05e-01	2.73e-01	8.44e-01	6.76e-01	3.02e-01	6.32e-02	2.11e-01
GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX RECEPTOR RECYCLING	6	4.24e-01	7.51e-01	0.5470	-2.96e-01	9.01e-03	-2.67e-01	-1.99e-01	-3.18e-01	2.10e-01	9.70e-01	2.57e-01	3.99e-01	1.77e-01
GOBP UDP GLUCOSE METABOLIC PROCESS	6	5.10e-01	8.07e-01	0.5470	-1.20e-01	6.60e-02	-3.01e-01	-3.88e-01	1.99e-01	6.10e-01	7.80e-01	2.02e-01	1.00e-01	3.97e-01
GOMF BH3 DOMAIN BINDING	6	5.02e-01	8.03e-01	0.5470	2.95e-02	1.98e-01	-2.35e-01	-4.43e-01	8.84e-02	9.00e-01	4.01e-01	3.19e-01	6.03e-02	7.08e-01
GOBP NEGATIVE REGULATION OF MYOBLAST PROLIFERATION	9	1.76e-01	5.16e-01	0.5470	-1.50e-01	-3.65e-01	1.17e-01	3.46e-01	9.87e-02	4.36e-01	5.79e-02	5.44e-01	7.19e-02	6.08e-01
GOBP MATERNAL PROCESS INVOLVED IN PARTURITION	5	4.58e-01	7.77e-01	0.5470	4.60e-01	1.76e-01	-6.27e-02	-9.32e-02	-2.08e-01	7.46e-02	4.95e-01	8.08e-01	7.18e-01	4.20e-01
GOBP MRNA 3 END PROCESSING BY STEM LOOP BINDING AND CLEAVAGE	6	5.14e-01	8.09e-01	0.5470	-4.22e-02	-2.67e-01	-3.18e-01	-3.53e-01	-1.74e-02	8.58e-01	2.57e-01	1.77e-01	1.35e-01	9.41e-01
GOMF PEPTIDOGLYCAN MURALYTIC ACTIVITY	13	7.15e-02	3.19e-01	0.5470	-2.02e-01	-2.13e-02	2.51e-02	3.07e-01	-4.04e-01	2.08e-01	8.94e-01	8.75e-01	5.54e-02	1.17e-02
GOBP REGULATION OF LEUKOCYTE ADHESION TO ARTERIAL ENDOTHELIAL CELL	5	4.78e-01	7.91e-01	0.5470	-3.35e-01	-1.30e-01	-3.45e-01	-1.43e-01	1.73e-01	1.95e-01	6.13e-01	1.81e-01	5.80e-01	5.03e-01
GOBP HYPOTHALAMUS GONADOTROPHIN RELEASING HORMONE NEURON DIFFERENTIATION	7	3.41e-01	6.88e-01	0.5470	1.97e-01	2.58e-01	3.66e-01	1.67e-01	-1.79e-01	3.67e-01	2.38e-01	9.34e-02	4.45e-01	4.13e-01
GOBP POSITIVE REGULATION OF MUCUS SECRETION	5	5.09e-01	8.07e-01	0.5470	2.80e-02	5.10e-01	1.34e-01	1.29e-01	-5.76e-02	9.14e-01	4.82e-02	6.04e-01	6.18e-01	8.23e-01
GOMF GAMMA CATENIN BINDING	12	5.32e-02	2.66e-01	0.5460	1.81e-01	-2.19e-01	4.10e-01	2.16e-01	-5.67e-02	2.78e-01	1.89e-01	1.39e-02	1.96e-01	7.34e-01
GOBP ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA	10	2.41e-01	5.98e-01	0.5460	1.07e-01	1.08e-01	-3.66e-01	-3.63e-01	9.65e-02	5.60e-01	5.54e-01	4.49e-02	4.67e-02	5.97e-01
GOBP NEGATIVE REGULATION OF AMYLOID BETA CLEARANCE	11	1.02e-01	3.87e-01	0.5460	-2.87e-01	-3.52e-01	-2.99e-01	-4.14e-02	-2.70e-02	9.92e-02	4.32e-02	8.58e-02	8.12e-01	8.77e-01
GOBP IMP BIOSYNTHETIC PROCESS	10	2.18e-01	5.72e-01	0.5460	-1.35e-01	-2.21e-01	-3.06e-01	-3.51e-01	1.19e-01	4.60e-01	2.26e-01	9.35e-02	5.47e-02	5.13e-01
GOMF CARBOHYDRATE MONOATOMIC CATION SYMPORTER ACTIVITY	16	4.52e-02	2.37e-01	0.5460	8.97e-02	2.85e-01	3.26e-01	3.20e-01	1.71e-02	5.34e-01	4.82e-02	2.39e-02	2.68e-02	9.06e-01
GOBP REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH	12	7.70e-02	3.33e-01	0.5460	-1.05e-01	4.32e-01	2.70e-01	1.23e-02	-1.67e-01	5.28e-01	9.60e-03	1.06e-01	9.41e-01	3.17e-01
GOBP T CELL PROLIFERATION INVOLVED IN IMMUNE RESPONSE	5	4.07e-01	7.39e-01	0.5460	-1.38e-01	4.87e-01	-1.17e-01	6.57e-02	-1.55e-01	5.93e-01	5.93e-02	6.52e-01	7.99e-01	5.48e-01
GOMF SINGLE STRANDED DNA 5 3 DNA EXONUCLEASE ACTIVITY	5	5.38e-01	8.22e-01	0.5460	3.42e-01	3.00e-01	9.04e-02	-8.81e-02	2.73e-01	1.85e-01	2.45e-01	7.26e-01	7.33e-01	2.91e-01
GOBP DENDRITE ARBORIZATION	10	2.01e-01	5.50e-01	0.5460	-1.19e-01	-2.71e-01	2.45e-01	3.67e-01	-1.25e-01	5.15e-01	1.38e-01	1.81e-01	4.43e-02	4.93e-01
GOCC LEWY BODY	8	2.83e-01	6.36e-01	0.5460	-3.25e-02	7.28e-02	-2.95e-01	-3.77e-01	-2.49e-01	8.74e-01	7.21e-01	1.49e-01	6.47e-02	2.22e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS IB	18	3.94e-04	7.41e-03	0.5450	-1.67e-01	-2.86e-01	1.13e-01	-2.94e-01	-2.98e-01	2.19e-01	3.60e-02	4.07e-01	3.08e-02	2.86e-02
GOMF GANGLIOSIDE BINDING	5	2.77e-01	6.31e-01	0.5450	2.50e-01	-3.01e-02	-2.09e-01	4.28e-01	8.14e-02	3.33e-01	9.07e-01	4.18e-01	9.72e-02	7.53e-01
GOBP PROTEIN RETENTION IN GOLGI APPARATUS	5	3.57e-01	7.02e-01	0.5450	-3.01e-01	1.07e-01	3.18e-01	-2.88e-01	1.04e-01	2.43e-01	6.79e-01	2.18e-01	2.65e-01	6.86e-01
GOBP DETECTION OF VIRUS	6	3.98e-01	7.31e-01	0.5450	1.58e-01	3.81e-01	-4.30e-02	-1.08e-01	3.37e-01	5.02e-01	1.06e-01	8.55e-01	6.48e-01	1.53e-01
GOBP CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS	20	7.88e-03	7.40e-02	0.5450	-4.59e-02	5.52e-02	-6.04e-02	-3.72e-01	3.87e-01	7.22e-01	6.69e-01	6.40e-01	3.98e-03	2.74e-03
GOBP POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN TRANSCRIPTION OF P21 CLASS MEDIATOR	5	4.13e-01	7.44e-01	0.5450	-3.03e-01	-2.14e-01	-3.05e-01	-8.56e-03	2.57e-01	2.41e-01	4.08e-01	2.38e-01	9.74e-01	3.20e-01
GOCC INNER DYNEIN ARM	5	4.62e-01	7.78e-01	0.5440	2.58e-01	3.57e-01	7.97e-02	2.16e-01	2.22e-01	3.18e-01	1.66e-01	7.58e-01	4.03e-01	3.91e-01
GOBP NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS	14	4.91e-02	2.51e-01	0.5440	-2.36e-01	1.53e-01	-1.92e-01	-3.54e-01	2.35e-01	1.27e-01	3.22e-01	2.12e-01	2.19e-02	1.28e-01
GOBP MITOCHONDRION ENDOPLASMIC RETICULUM MEMBRANE TETHERING	7	2.77e-01	6.31e-01	0.5440	-4.09e-01	3.16e-01	7.12e-02	-1.27e-01	8.99e-02	6.12e-02	1.47e-01	7.44e-01	5.61e-01	6.80e-01
GOBP POSITIVE REGULATION OF DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION	7	3.38e-01	6.85e-01	0.5440	-2.36e-01	3.85e-01	1.67e-01	2.23e-01	-1.22e-01	2.80e-01	7.80e-02	4.43e-01	3.08e-01	5.76e-01
GOBP REGULATION OF HEXOKINASE ACTIVITY	7	3.50e-01	6.96e-01	0.5440	2.34e-01	9.86e-02	-2.96e-01	-2.90e-01	-2.44e-01	2.83e-01	6.51e-01	1.75e-01	1.84e-01	2.64e-01
GOBP HIS PURKINJE SYSTEM DEVELOPMENT	7	3.48e-01	6.95e-01	0.5440	4.71e-01	1.08e-01	-1.25e-01	-1.76e-01	1.26e-01	3.09e-02	6.20e-01	5.67e-01	4.21e-01	5.64e-01
GOBP POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY	12	6.38e-02	2.97e-01	0.5440	-4.02e-01	-2.27e-01	1.05e-01	9.47e-03	-2.67e-01	1.58e-02	1.74e-01	5.30e-01	9.55e-01	1.09e-01
GOMF MHC CLASS IB PROTEIN BINDING	7	1.78e-01	5.19e-01	0.5440	-1.05e-01	-1.22e-01	-2.66e-01	3.76e-01	-2.40e-01	6.31e-01	5.75e-01	2.23e-01	8.47e-02	2.72e-01
GOBP NEGATIVE REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION	5	5.58e-01	8.32e-01	0.5440	-8.47e-02	-9.08e-02	-9.86e-02	-3.08e-01	4.19e-01	7.43e-01	7.25e-01	7.03e-01	2.33e-01	1.04e-01
GOBP BRONCHIOLE DEVELOPMENT	5	4.80e-01	7.92e-01	0.5430	1.91e-01	-3.12e-01	2.85e-01	2.33e-01	-1.60e-01	4.60e-01	2.27e-01	2.70e-01	3.67e-01	5.34e-01
GOBP POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST	14	3.84e-02	2.15e-01	0.5430	-1.30e-01	2.89e-01	-3.30e-01	-2.73e-01	1.05e-01	4.01e-01	6.15e-02	3.24e-02	7.68e-02	4.95e-01
GOBP DTTP METABOLIC PROCESS	5	5.56e-01	8.31e-01	0.5430	1.21e-01	-1.70e-02	-1.52e-01	-4.96e-01	1.04e-01	6.39e-01	9.47e-01	5.56e-01	5.48e-02	6.86e-01
GOBP OLFACTORY NERVE DEVELOPMENT	6	4.13e-01	7.44e-01	0.5430	2.58e-01	4.58e-01	1.31e-01	3.35e-02	-7.67e-03	2.73e-01	5.20e-02	5.78e-01	8.87e-01	9.74e-01
GOBP REGULATION OF T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL	6	4.78e-01	7.91e-01	0.5430	7.88e-02	2.89e-01	-2.96e-01	-3.11e-01	1.44e-01	7.38e-01	2.21e-01	2.09e-01	1.87e-01	5.42e-01
GOBP ENDONUCLEOLYTIC CLEAVAGE OF TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA	17	4.60e-02	2.40e-01	0.5430	1.80e-01	3.62e-02	-3.89e-01	-3.14e-01	1.05e-01	1.98e-01	7.96e-01	5.49e-03	2.50e-02	4.54e-01
GOBP TAURINE TRANSPORT	8	2.54e-01	6.11e-01	0.5430	2.71e-01	3.02e-01	3.53e-01	7.01e-02	1.95e-02	1.84e-01	1.39e-01	8.40e-02	7.31e-01	9.24e-01
GOBP REGULATION OF ANTIBACTERIAL PEPTIDE PRODUCTION	7	4.29e-01	7.54e-01	0.5430	-2.53e-01	-1.75e-01	2.28e-01	3.42e-01	-1.78e-01	2.47e-01	4.23e-01	2.97e-01	1.18e-01	4.16e-01
GOBP S SHAPED BODY MORPHOGENESIS	7	1.90e-01	5.36e-01	0.5420	3.46e-01	1.82e-01	1.19e-01	-3.57e-01	-1.45e-02	1.13e-01	4.03e-01	5.86e-01	1.02e-01	9.47e-01
GOBP TENDON DEVELOPMENT	5	5.90e-01	8.47e-01	0.5420	1.45e-02	1.34e-01	-1.46e-01	-4.72e-01	1.80e-01	9.55e-01	6.04e-01	5.72e-01	6.78e-02	4.86e-01
GOBP RETINAL PIGMENT EPITHELIUM DEVELOPMENT	6	4.49e-01	7.70e-01	0.5420	-9.65e-02	-3.48e-01	-2.07e-01	-3.46e-01	3.37e-02	6.82e-01	1.40e-01	3.80e-01	1.42e-01	8.86e-01
GOBP CELLULAR RESPONSE TO THYROID HORMONE STIMULUS	16	2.09e-02	1.45e-01	0.5420	-2.55e-01	-3.13e-02	-2.07e-01	-3.43e-01	-2.59e-01	7.68e-02	8.28e-01	1.52e-01	1.75e-02	7.28e-02
GOBP REVERSIBLE DIFFERENTIATION	11	7.68e-02	3.33e-01	0.5420	-2.80e-01	1.63e-01	1.96e-01	-2.13e-01	3.24e-01	1.08e-01	3.49e-01	2.60e-01	2.20e-01	6.29e-02
GOBP ISOPENTENYL DIPHOSPHATE BIOSYNTHETIC PROCESS	5	3.94e-01	7.29e-01	0.5420	8.32e-03	-4.44e-02	-2.95e-02	-5.39e-01	-5.94e-03	9.74e-01	8.64e-01	9.09e-01	3.67e-02	9.82e-01
GOBP IMMUNE RESPONSE INHIBITING CELL SURFACE RECEPTOR SIGNALING PATHWAY	9	2.18e-01	5.72e-01	0.5420	-3.61e-01	-6.38e-02	8.63e-02	3.44e-01	-1.85e-01	6.09e-02	7.40e-01	6.54e-01	7.42e-02	3.37e-01
GOBP ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY	9	2.25e-01	5.79e-01	0.5420	-8.21e-02	-2.80e-01	2.74e-01	3.41e-01	1.32e-01	6.70e-01	1.46e-01	1.55e-01	7.67e-02	4.94e-01
GOMF G PROTEIN COUPLED GLUTAMATE RECEPTOR ACTIVITY	9	2.25e-01	5.79e-01	0.5420	-8.21e-02	-2.80e-01	2.74e-01	3.41e-01	1.32e-01	6.70e-01	1.46e-01	1.55e-01	7.67e-02	4.94e-01
GOBP NEGATIVE REGULATION OF T HELPER 2 CELL DIFFERENTIATION	5	4.18e-01	7.48e-01	0.5420	2.63e-01	2.56e-01	-3.04e-01	7.16e-02	-2.47e-01	3.09e-01	3.22e-01	2.39e-01	7.82e-01	3.38e-01
GOBP REGULATION OF RENAL SODIUM EXCRETION	8	2.31e-01	5.85e-01	0.5420	2.15e-01	-9.93e-02	5.87e-02	2.28e-01	-4.26e-01	2.92e-01	6.27e-01	7.74e-01	2.64e-01	3.69e-02
GOMF POLYOL TRANSMEMBRANE TRANSPORTER ACTIVITY	11	1.10e-01	4.04e-01	0.5410	-3.47e-01	1.14e-01	-2.67e-02	1.18e-01	-3.81e-01	4.63e-02	5.11e-01	8.78e-01	4.98e-01	2.87e-02
GOBP EXTRACELLULAR MATRIX CONSTITUENT SECRETION	13	5.26e-02	2.63e-01	0.5410	-1.12e-01	2.40e-01	2.30e-01	-8.97e-02	4.02e-01	4.83e-01	1.34e-01	1.52e-01	5.75e-01	1.20e-02
GOBP EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS	10	1.13e-01	4.10e-01	0.5410	-3.88e-01	2.60e-01	1.61e-01	-1.67e-01	1.45e-01	3.36e-02	1.55e-01	3.77e-01	3.61e-01	4.29e-01
GOBP DETECTION OF OTHER ORGANISM	19	1.44e-02	1.14e-01	0.5410	-3.90e-01	1.05e-01	2.59e-01	1.47e-01	-2.02e-01	3.22e-03	4.29e-01	5.11e-02	2.68e-01	1.27e-01
GOBP REGULATION OF GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT	9	1.19e-01	4.23e-01	0.5410	-2.54e-01	3.06e-01	2.99e-01	-1.93e-01	-9.11e-02	1.87e-01	1.12e-01	1.21e-01	3.16e-01	6.36e-01
GOMF VOLTAGE GATED SODIUM CHANNEL ACTIVITY	23	2.34e-03	3.06e-02	0.5410	-2.32e-01	6.47e-02	7.15e-03	3.34e-01	-3.50e-01	5.42e-02	5.91e-01	9.53e-01	5.49e-03	3.66e-03
GOBP REGULATION OF GLIAL CELL APOPTOTIC PROCESS	10	2.37e-01	5.92e-01	0.5410	-2.63e-01	-8.12e-04	3.85e-01	2.71e-01	-3.68e-02	1.50e-01	9.96e-01	3.50e-02	1.37e-01	8.40e-01
GOMF MITOCHONDRION TARGETING SEQUENCE BINDING	5	5.64e-01	8.34e-01	0.5400	1.71e-01	2.66e-01	-3.60e-01	-2.42e-01	5.77e-02	5.08e-01	3.03e-01	1.63e-01	3.48e-01	8.23e-01
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY NOREPINEPHRINE EPINEPHRINE	8	1.28e-01	4.42e-01	0.5400	-2.53e-02	-4.64e-02	2.82e-01	-3.15e-01	3.33e-01	9.01e-01	8.20e-01	1.68e-01	1.23e-01	1.03e-01
GOBP INTERNEURON MIGRATION	14	1.36e-02	1.09e-01	0.5400	1.01e-01	-2.52e-01	2.74e-01	-1.46e-01	3.48e-01	5.12e-01	1.02e-01	7.56e-02	3.44e-01	2.41e-02
GOMF RNA POLYMERASE II ACTIVITY	9	2.67e-01	6.23e-01	0.5400	3.61e-01	-1.33e-01	-3.07e-01	-2.07e-01	8.20e-02	6.08e-02	4.88e-01	1.11e-01	2.83e-01	6.70e-01
GOBP DNA REPLICATION SYNTHESIS OF RNA PRIMER	6	4.83e-01	7.93e-01	0.5400	3.09e-01	-1.08e-01	-3.39e-01	-2.13e-01	-1.54e-01	1.89e-01	6.47e-01	1.50e-01	3.66e-01	5.13e-01
GOBP POSITIVE REGULATION OF DNA LIGATION	5	5.81e-01	8.43e-01	0.5400	1.65e-02	2.94e-01	-3.19e-01	-3.15e-01	6.14e-02	9.49e-01	2.55e-01	2.16e-01	2.23e-01	8.12e-01
GOBP POSITIVE REGULATION OF INTERLEUKIN 18 PRODUCTION	8	3.20e-01	6.69e-01	0.5400	-4.71e-02	-1.08e-01	1.29e-01	4.55e-01	-2.31e-01	8.18e-01	5.98e-01	5.29e-01	2.57e-02	2.58e-01
GOMF FUCOSE BINDING	8	2.52e-01	6.09e-01	0.5400	-4.05e-01	-4.29e-02	-2.21e-01	-8.41e-02	-2.63e-01	4.73e-02	8.33e-01	2.79e-01	6.81e-01	1.97e-01
GOMF CHONDROITIN SULFATE BINDING	10	2.72e-02	1.72e-01	0.5390	7.22e-02	5.64e-03	-1.20e-01	3.43e-01	3.93e-01	6.93e-01	9.75e-01	5.12e-01	6.07e-02	3.16e-02
GOBP REGULATION OF THYROID HORMONE GENERATION	7	2.79e-01	6.32e-01	0.5390	2.89e-01	2.53e-01	-1.24e-01	-1.94e-01	-3.01e-01	1.85e-01	2.47e-01	5.70e-01	3.74e-01	1.68e-01
GOMF NADPLUS NUCLEOSIDASE ACTIVITY	14	7.97e-02	3.40e-01	0.5390	-2.47e-03	3.28e-01	2.72e-01	3.12e-01	-1.09e-01	9.87e-01	3.35e-02	7.76e-02	4.35e-02	4.78e-01
GOBP NEGATIVE REGULATION OF LENS FIBER CELL DIFFERENTIATION	6	3.99e-01	7.32e-01	0.5390	-1.37e-01	1.80e-01	-3.86e-02	-4.75e-01	1.13e-01	5.60e-01	4.46e-01	8.70e-01	4.40e-02	6.31e-01
GOBP NOREPINEPHRINE UPTAKE	8	2.36e-01	5.91e-01	0.5390	3.40e-01	-3.31e-01	-7.67e-02	5.83e-02	2.38e-01	9.60e-02	1.05e-01	7.07e-01	7.75e-01	2.45e-01
GOBP REGULATION OF ENDOSOME SIZE	13	5.37e-02	2.67e-01	0.5390	1.52e-01	1.92e-01	-3.92e-01	-1.83e-01	2.09e-01	3.44e-01	2.32e-01	1.43e-02	2.54e-01	1.91e-01
GOBP CRANIAL SUTURE MORPHOGENESIS	8	2.98e-01	6.52e-01	0.5390	-1.45e-02	-2.38e-01	-2.38e-01	-4.20e-01	-2.73e-02	9.43e-01	2.44e-01	2.43e-01	3.96e-02	8.93e-01
GOCC CATENIN COMPLEX	31	2.20e-04	4.55e-03	0.5390	7.59e-02	-2.88e-01	3.08e-01	3.18e-01	7.67e-02	4.65e-01	5.57e-03	3.00e-03	2.17e-03	4.60e-01
GOBP POSITIVE REGULATION OF ACTION POTENTIAL	8	1.46e-01	4.67e-01	0.5390	-2.05e-01	-2.88e-01	-1.42e-01	3.81e-01	1.06e-02	3.15e-01	1.58e-01	4.88e-01	6.22e-02	9.59e-01
GOBP MAST CELL CYTOKINE PRODUCTION	6	3.80e-01	7.18e-01	0.5390	-2.42e-01	1.65e-01	-1.02e-01	-2.70e-01	-3.48e-01	3.05e-01	4.84e-01	6.67e-01	2.52e-01	1.40e-01
GOBP GLYCOSYLCERAMIDE BIOSYNTHETIC PROCESS	8	2.50e-01	6.07e-01	0.5380	-4.58e-01	-2.12e-01	6.26e-03	-6.90e-03	-1.86e-01	2.48e-02	3.00e-01	9.76e-01	9.73e-01	3.61e-01
GOBP MOTOR LEARNING	7	3.46e-01	6.93e-01	0.5380	1.89e-01	4.13e-01	2.31e-01	-6.30e-02	1.62e-01	3.87e-01	5.88e-02	2.89e-01	7.73e-01	4.58e-01
GOBP RETROGRADE TRANS SYNAPTIC SIGNALING BY LIPID	5	5.18e-01	8.12e-01	0.5380	-4.29e-01	-4.74e-02	-2.12e-01	-1.64e-02	-2.41e-01	9.66e-02	8.54e-01	4.12e-01	9.49e-01	3.51e-01
GOBP NEGATIVE REGULATION OF INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY	7	3.33e-01	6.80e-01	0.5380	-4.61e-01	-4.23e-02	-6.61e-02	3.92e-02	-2.64e-01	3.47e-02	8.46e-01	7.62e-01	8.57e-01	2.27e-01
GOBP AMACRINE CELL DIFFERENTIATION	12	1.06e-01	3.96e-01	0.5380	1.41e-01	1.19e-01	-2.76e-02	-3.67e-01	3.46e-01	3.97e-01	4.76e-01	8.68e-01	2.76e-02	3.79e-02
GOBP NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT	6	4.32e-01	7.56e-01	0.5380	3.45e-03	4.50e-01	-7.44e-02	-2.70e-01	9.31e-02	9.88e-01	5.64e-02	7.52e-01	2.53e-01	6.93e-01
GOMF ASPARTIC ENDOPEPTIDASE ACTIVITY INTRAMEMBRANE CLEAVING	8	2.63e-01	6.19e-01	0.5380	-1.80e-01	2.92e-01	-9.95e-02	-3.98e-01	6.12e-02	3.78e-01	1.53e-01	6.26e-01	5.15e-02	7.64e-01
GOBP PEPTIDYL ARGININE METHYLATION	7	3.92e-01	7.27e-01	0.5380	-8.24e-02	-2.12e-01	-2.12e-01	-4.29e-01	9.22e-02	7.06e-01	3.32e-01	3.30e-01	4.94e-02	6.73e-01
GOBP LNCRNA MEDIATED POST TRANSCRIPTIONAL GENE SILENCING	9	1.51e-01	4.77e-01	0.5380	-2.02e-01	1.84e-01	-7.45e-02	-2.46e-01	-3.85e-01	2.94e-01	3.40e-01	6.99e-01	2.01e-01	4.53e-02
GOBP NEGATIVE REGULATION OF TRANSMISSION OF NERVE IMPULSE	6	3.90e-01	7.26e-01	0.5380	9.17e-02	-2.25e-01	1.10e-01	1.11e-01	4.53e-01	6.97e-01	3.39e-01	6.41e-01	6.38e-01	5.46e-02
GOCC CIA COMPLEX	5	5.74e-01	8.40e-01	0.5380	7.83e-02	3.49e-01	-5.09e-02	-3.23e-01	2.33e-01	7.62e-01	1.77e-01	8.44e-01	2.11e-01	3.68e-01
GOBP REGULATION OF MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL	5	4.28e-01	7.54e-01	0.5370	-2.15e-01	-4.24e-03	3.98e-01	8.52e-03	-2.90e-01	4.05e-01	9.87e-01	1.23e-01	9.74e-01	2.61e-01
GOBP POSITIVE REGULATION OF DENDRITIC SPINE MAINTENANCE	5	4.56e-01	7.75e-01	0.5370	-6.54e-02	4.59e-01	6.34e-02	2.61e-01	-3.80e-02	8.00e-01	7.54e-02	8.06e-01	3.12e-01	8.83e-01
GOBP TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION	10	2.00e-01	5.50e-01	0.5370	-3.20e-01	-2.97e-02	1.57e-01	1.95e-01	-3.50e-01	7.96e-02	8.71e-01	3.90e-01	2.85e-01	5.54e-02
GOBP POST CHAPERONIN TUBULIN FOLDING PATHWAY	6	4.75e-01	7.88e-01	0.5370	4.10e-01	-1.13e-01	-1.34e-01	-1.77e-01	2.41e-01	8.16e-02	6.33e-01	5.69e-01	4.53e-01	3.07e-01
GOCC SORTING ENDOSOME	6	4.10e-01	7.42e-01	0.5370	-2.21e-01	1.10e-01	-3.78e-02	-3.25e-02	-4.75e-01	3.49e-01	6.41e-01	8.73e-01	8.90e-01	4.41e-02
GOMF PHOSPHATE ION TRANSMEMBRANE TRANSPORTER ACTIVITY	11	8.18e-02	3.44e-01	0.5370	-2.70e-01	2.60e-01	2.79e-01	-1.76e-01	1.98e-01	1.21e-01	1.36e-01	1.10e-01	3.11e-01	2.55e-01
GOBP BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION	15	7.81e-02	3.35e-01	0.5370	-3.49e-03	4.29e-02	2.88e-01	3.53e-01	-2.81e-01	9.81e-01	7.74e-01	5.37e-02	1.78e-02	5.96e-02
GOBP REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS	17	4.11e-02	2.24e-01	0.5370	-1.75e-01	2.06e-01	3.31e-01	3.20e-01	5.92e-02	2.12e-01	1.42e-01	1.81e-02	2.23e-02	6.73e-01
GOBP REGULATION OF GLYCOGEN STARCH SYNTHASE ACTIVITY	5	5.37e-01	8.22e-01	0.5370	1.31e-01	-9.02e-02	-2.69e-01	-2.50e-01	-3.57e-01	6.11e-01	7.27e-01	2.97e-01	3.33e-01	1.66e-01
GOBP POSITIVE REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS	14	9.94e-02	3.82e-01	0.5370	-1.79e-01	1.86e-01	3.55e-01	3.07e-01	3.60e-02	2.47e-01	2.27e-01	2.15e-02	4.68e-02	8.16e-01
GOCC ARP2 3 PROTEIN COMPLEX	9	2.77e-01	6.31e-01	0.5370	-1.07e-01	1.33e-03	-3.83e-01	-3.11e-01	-1.82e-01	5.78e-01	9.94e-01	4.64e-02	1.07e-01	3.43e-01
GOMF HETEROTRIMERIC G PROTEIN BINDING	5	5.23e-01	8.15e-01	0.5370	2.00e-01	-3.61e-01	-1.95e-01	9.76e-03	-2.82e-01	4.39e-01	1.62e-01	4.51e-01	9.70e-01	2.74e-01
GOBP INTRACELLULAR WATER HOMEOSTASIS	6	3.43e-01	6.90e-01	0.5370	3.29e-01	3.79e-01	-5.69e-02	1.69e-01	-6.87e-02	1.63e-01	1.08e-01	8.09e-01	4.73e-01	7.71e-01
GOBP XENOBIOTIC EXPORT FROM CELL	26	9.87e-04	1.53e-02	0.5360	-2.30e-01	-1.03e-01	3.11e-02	4.10e-01	-2.35e-01	4.21e-02	3.65e-01	7.84e-01	2.96e-04	3.80e-02
GOBP RESPIRATORY CHAIN COMPLEX IV ASSEMBLY	29	2.02e-03	2.71e-02	0.5360	2.32e-01	1.50e-02	-2.79e-01	-3.79e-01	1.10e-01	3.09e-02	8.89e-01	9.30e-03	4.07e-04	3.06e-01
GOCC BASAL DENDRITE	6	4.94e-01	7.99e-01	0.5360	-7.27e-02	-3.06e-01	2.75e-01	3.25e-01	-8.37e-02	7.58e-01	1.94e-01	2.43e-01	1.68e-01	7.23e-01
GOBP CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES	47	6.98e-06	2.41e-04	0.5360	-1.13e-01	-1.14e-02	2.16e-01	4.47e-01	-1.67e-01	1.79e-01	8.92e-01	1.04e-02	1.11e-07	4.81e-02
GOBP U2 TYPE PRESPLICEOSOME ASSEMBLY	22	1.69e-02	1.27e-01	0.5360	9.21e-02	-1.82e-01	-3.71e-01	-3.22e-01	6.53e-02	4.55e-01	1.40e-01	2.58e-03	8.91e-03	5.96e-01
GOBP TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR	10	2.19e-01	5.74e-01	0.5360	-2.77e-02	-2.03e-01	-2.60e-01	-4.20e-01	3.65e-02	8.80e-01	2.67e-01	1.54e-01	2.16e-02	8.42e-01
GOBP NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM	9	2.50e-01	6.07e-01	0.5360	-1.43e-01	-3.62e-01	-3.07e-01	-1.31e-01	-1.56e-01	4.57e-01	6.02e-02	1.11e-01	4.96e-01	4.18e-01
GOBP LACRIMAL GLAND DEVELOPMENT	7	4.41e-01	7.63e-01	0.5360	2.00e-02	-6.24e-02	-2.07e-01	-4.48e-01	1.97e-01	9.27e-01	7.75e-01	3.43e-01	3.99e-02	3.67e-01
GOBP NEGATIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION	8	2.52e-01	6.08e-01	0.5360	-1.72e-01	1.66e-01	-1.81e-01	-3.72e-01	-2.43e-01	3.99e-01	4.17e-01	3.75e-01	6.88e-02	2.35e-01
GOCC ZONULA ADHERENS	8	3.03e-01	6.57e-01	0.5350	7.94e-02	2.02e-01	1.73e-01	4.29e-01	-1.59e-01	6.97e-01	3.22e-01	3.97e-01	3.55e-02	4.35e-01
GOCC TRANSCRIPTION EXPORT COMPLEX	8	3.53e-01	6.98e-01	0.5350	1.85e-01	1.48e-01	-2.84e-01	-3.85e-01	-4.01e-02	3.64e-01	4.69e-01	1.64e-01	5.94e-02	8.44e-01
GOMF LEUCINE BINDING	6	4.78e-01	7.91e-01	0.5350	-2.04e-03	9.86e-02	-3.25e-01	-2.63e-01	3.19e-01	9.93e-01	6.76e-01	1.68e-01	2.65e-01	1.76e-01
GOMF KINETOCHORE BINDING	6	3.63e-01	7.05e-01	0.5350	4.88e-01	-1.84e-01	-4.07e-02	-1.08e-01	-3.02e-02	3.85e-02	4.34e-01	8.63e-01	6.46e-01	8.98e-01
GOBP UTP METABOLIC PROCESS	12	8.10e-02	3.42e-01	0.5350	2.26e-01	4.55e-01	-4.02e-02	-1.60e-01	3.04e-02	1.76e-01	6.32e-03	8.10e-01	3.37e-01	8.55e-01
GOCC NLS DEPENDENT PROTEIN NUCLEAR IMPORT COMPLEX	10	1.81e-01	5.24e-01	0.5350	8.34e-02	-1.12e-01	-3.36e-01	-2.00e-01	-3.37e-01	6.48e-01	5.41e-01	6.59e-02	2.73e-01	6.46e-02
GOBP DETECTION OF STIMULUS	571	1.12e-92	2.29e-89	0.5350	-1.16e-01	-2.37e-01	1.45e-01	4.41e-01	2.40e-02	2.02e-06	2.77e-22	3.28e-09	3.72e-73	3.28e-01
GOBP MONOUBIQUITINATED PROTEIN DEUBIQUITINATION	7	3.43e-01	6.90e-01	0.5350	8.80e-02	2.08e-01	-1.47e-01	-4.56e-01	-7.15e-02	6.87e-01	3.41e-01	5.02e-01	3.66e-02	7.43e-01
GOBP CRANIAL NERVE FORMATION	10	1.65e-01	5.00e-01	0.5350	2.78e-01	-1.02e-01	8.49e-03	-1.18e-01	4.29e-01	1.28e-01	5.76e-01	9.63e-01	5.17e-01	1.88e-02
GOBP CARBOHYDRATE IMPORT ACROSS PLASMA MEMBRANE	6	4.28e-01	7.54e-01	0.5340	1.59e-01	-3.04e-03	1.31e-01	4.92e-01	-3.22e-02	5.00e-01	9.90e-01	5.78e-01	3.69e-02	8.91e-01
GOBP MICROGLIAL CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE	5	5.66e-01	8.35e-01	0.5340	-3.38e-01	-2.64e-01	2.50e-01	1.97e-01	1.65e-02	1.90e-01	3.07e-01	3.34e-01	4.47e-01	9.49e-01
GOBP POSITIVE REGULATION OF GAMMA DELTA T CELL ACTIVATION	9	2.10e-01	5.61e-01	0.5340	2.24e-01	3.82e-01	1.78e-01	1.47e-01	-1.90e-01	2.44e-01	4.74e-02	3.55e-01	4.46e-01	3.24e-01
GOCC POSTSYNAPTIC RECYCLING ENDOSOME	7	4.34e-01	7.57e-01	0.5340	-1.16e-01	-1.97e-01	-2.45e-01	-3.90e-01	1.45e-01	5.95e-01	3.66e-01	2.63e-01	7.39e-02	5.08e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A HEME GROUP OF DONORS	11	1.93e-01	5.41e-01	0.5340	6.88e-02	-8.69e-02	-3.10e-01	-4.16e-01	-6.02e-02	6.93e-01	6.18e-01	7.52e-02	1.68e-02	7.30e-01
GOBP PHOTORECEPTOR CELL MORPHOGENESIS	5	5.13e-01	8.08e-01	0.5340	8.80e-02	1.18e-01	-2.76e-01	-2.96e-02	-4.32e-01	7.33e-01	6.49e-01	2.86e-01	9.09e-01	9.44e-02
GOMF PROCOLLAGEN PROLINE 4 DIOXYGENASE ACTIVITY	5	4.36e-01	7.59e-01	0.5340	-1.62e-01	3.52e-01	2.60e-01	-2.44e-01	-8.68e-02	5.31e-01	1.73e-01	3.14e-01	3.44e-01	7.37e-01
GOBP POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS	10	1.51e-01	4.76e-01	0.5340	4.72e-01	8.90e-02	-2.33e-02	6.88e-03	2.32e-01	9.76e-03	6.26e-01	8.98e-01	9.70e-01	2.05e-01
GOBP NEGATIVE REGULATION OF IMMATURE T CELL PROLIFERATION	5	3.60e-01	7.04e-01	0.5340	2.37e-02	1.57e-01	5.51e-02	-4.88e-01	-1.37e-01	9.27e-01	5.44e-01	8.31e-01	5.89e-02	5.97e-01
GOBP HEMIDESMOSOME ASSEMBLY	6	4.52e-01	7.72e-01	0.5340	-1.23e-01	-2.34e-01	-9.07e-02	2.85e-01	-3.55e-01	6.03e-01	3.22e-01	7.00e-01	2.27e-01	1.33e-01
GOBP DETOXIFICATION OF COPPER ION	15	2.51e-02	1.62e-01	0.5330	-2.47e-01	2.15e-01	-4.64e-02	-4.19e-01	2.09e-03	9.80e-02	1.50e-01	7.56e-01	5.00e-03	9.89e-01
GOMF INTRAMOLECULAR TRANSFERASE ACTIVITY PHOSPHOTRANSFERASES	10	1.78e-01	5.19e-01	0.5330	1.26e-01	-6.89e-02	-2.91e-01	-3.25e-01	-2.72e-01	4.92e-01	7.06e-01	1.11e-01	7.55e-02	1.37e-01
GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE 5 PHOSPHATASE ACTIVITY	5	5.63e-01	8.34e-01	0.5330	-3.77e-01	-1.66e-01	-2.07e-01	-1.86e-01	-1.93e-01	1.45e-01	5.19e-01	4.22e-01	4.71e-01	4.56e-01
GOBP PROTEIN UNFOLDING	5	6.42e-01	8.75e-01	0.5330	-1.68e-01	-5.88e-02	-3.88e-01	-3.17e-01	4.01e-02	5.16e-01	8.20e-01	1.33e-01	2.20e-01	8.76e-01
GOCC ENDOPLASMIC RETICULUM QUALITY CONTROL COMPARTMENT	15	9.60e-03	8.52e-02	0.5330	-2.64e-01	8.55e-02	3.28e-02	-3.54e-01	-2.84e-01	7.66e-02	5.66e-01	8.26e-01	1.75e-02	5.68e-02
GOBP MINERALOCORTICOID BIOSYNTHETIC PROCESS	11	1.68e-01	5.05e-01	0.5330	-3.38e-01	-3.33e-02	1.27e-01	2.48e-01	-3.02e-01	5.22e-02	8.48e-01	4.65e-01	1.54e-01	8.31e-02
GOMF HEPARAN SULFATE GLUCOSAMINE 3 SULFOTRANSFERASE 1 ACTIVITY	7	2.77e-01	6.31e-01	0.5330	-1.78e-01	-6.69e-02	4.32e-01	-1.57e-03	2.47e-01	4.15e-01	7.59e-01	4.76e-02	9.94e-01	2.59e-01
GOBP RESPONSE TO PROSTAGLANDIN D	5	5.10e-01	8.07e-01	0.5330	-3.86e-01	-2.35e-01	1.78e-01	7.07e-02	2.07e-01	1.35e-01	3.63e-01	4.90e-01	7.84e-01	4.22e-01
GOBP IMMUNE RESPONSE INHIBITING SIGNAL TRANSDUCTION	11	1.21e-01	4.26e-01	0.5330	-3.72e-01	-1.43e-02	-3.84e-02	2.18e-01	-3.10e-01	3.24e-02	9.34e-01	8.25e-01	2.11e-01	7.51e-02
GOBP STEM CELL FATE COMMITMENT	10	8.11e-02	3.43e-01	0.5330	1.69e-01	2.99e-01	3.03e-01	-2.54e-01	9.96e-02	3.56e-01	1.01e-01	9.70e-02	1.65e-01	5.86e-01
GOBP SPINAL CORD OLIGODENDROCYTE CELL DIFFERENTIATION	5	5.93e-01	8.47e-01	0.5330	3.13e-01	1.50e-01	-2.82e-01	-2.68e-01	-1.09e-01	2.25e-01	5.61e-01	2.75e-01	2.99e-01	6.72e-01
GOBP REGULATION OF NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION	11	8.62e-02	3.55e-01	0.5330	-1.23e-02	-1.36e-01	1.13e-01	4.88e-01	1.21e-01	9.44e-01	4.35e-01	5.17e-01	5.11e-03	4.87e-01
GOCC PROTEASOME CORE COMPLEX ALPHA SUBUNIT COMPLEX	8	1.98e-01	5.47e-01	0.5330	1.99e-01	-3.33e-02	-1.28e-01	-4.56e-01	-1.36e-01	3.30e-01	8.70e-01	5.29e-01	2.56e-02	5.04e-01
GOBP TELOMERIC D LOOP DISASSEMBLY	7	3.42e-01	6.88e-01	0.5320	-1.44e-01	2.82e-03	-1.99e-01	-4.33e-01	-1.88e-01	5.10e-01	9.90e-01	3.62e-01	4.71e-02	3.89e-01
GOBP REGULATION OF SUPEROXIDE DISMUTASE ACTIVITY	7	3.38e-01	6.85e-01	0.5320	1.06e-01	-3.23e-01	-1.36e-01	1.83e-01	-3.40e-01	6.27e-01	1.38e-01	5.34e-01	4.01e-01	1.19e-01
GOBP HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES	164	2.78e-21	6.32e-19	0.5320	9.21e-02	-3.40e-02	3.43e-01	3.93e-01	-3.48e-02	4.17e-02	4.53e-01	3.18e-14	3.30e-18	4.42e-01
GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION	12	8.02e-02	3.41e-01	0.5320	-3.21e-01	3.40e-01	2.45e-01	-6.44e-02	-1.98e-02	5.41e-02	4.14e-02	1.42e-01	6.99e-01	9.06e-01
GOBP REGULATION OF WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT	9	1.84e-01	5.27e-01	0.5320	-3.64e-01	2.41e-01	-7.50e-02	-2.96e-01	9.27e-04	5.90e-02	2.11e-01	6.97e-01	1.25e-01	9.96e-01
GOMF INTERLEUKIN 17 RECEPTOR ACTIVITY	8	2.87e-01	6.41e-01	0.5320	2.09e-01	3.92e-01	4.08e-02	-2.14e-01	1.96e-01	3.05e-01	5.51e-02	8.42e-01	2.94e-01	3.38e-01
GOBP QUINOLINATE METABOLIC PROCESS	5	4.78e-01	7.91e-01	0.5320	-4.02e-01	-7.79e-02	9.13e-02	5.36e-02	3.23e-01	1.20e-01	7.63e-01	7.24e-01	8.36e-01	2.12e-01
GOCC HAUS COMPLEX	7	4.56e-01	7.74e-01	0.5320	8.99e-02	9.63e-02	-4.14e-01	-3.03e-01	-4.18e-02	6.80e-01	6.59e-01	5.79e-02	1.64e-01	8.48e-01
GOBP SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE	14	7.73e-02	3.33e-01	0.5310	3.59e-02	1.44e-01	1.61e-01	3.93e-01	-2.83e-01	8.16e-01	3.51e-01	2.97e-01	1.09e-02	6.67e-02
GOBP POSITIVE REGULATION OF CARDIAC MUSCLE ADAPTATION	9	6.99e-02	3.14e-01	0.5310	-1.68e-01	-1.25e-02	3.28e-01	-3.23e-01	2.04e-01	3.82e-01	9.48e-01	8.84e-02	9.29e-02	2.89e-01
GOBP POSITIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION	9	2.42e-01	5.99e-01	0.5310	-3.36e-01	2.85e-01	1.86e-01	1.88e-01	-1.35e-01	8.12e-02	1.39e-01	3.34e-01	3.28e-01	4.82e-01
GOBP POSITIVE REGULATION OF COMPLEMENT ACTIVATION	6	4.60e-01	7.78e-01	0.5310	8.66e-04	-3.65e-01	2.63e-01	2.82e-01	-1.77e-02	9.97e-01	1.21e-01	2.65e-01	2.31e-01	9.40e-01
GOMF MORPHOGEN ACTIVITY	8	3.22e-01	6.70e-01	0.5310	-2.21e-01	-2.43e-01	-2.18e-01	-3.02e-01	1.88e-01	2.79e-01	2.34e-01	2.86e-01	1.39e-01	3.57e-01
GOBP NEUROTRANSMITTER CATABOLIC PROCESS	8	3.60e-01	7.04e-01	0.5310	3.05e-02	2.79e-01	3.96e-01	1.90e-01	-9.98e-02	8.81e-01	1.72e-01	5.22e-02	3.52e-01	6.25e-01
GOBP GABAERGIC NEURON DIFFERENTIATION	19	6.91e-03	6.73e-02	0.5310	1.66e-02	-4.69e-02	3.20e-02	-4.11e-01	3.31e-01	9.00e-01	7.23e-01	8.09e-01	1.94e-03	1.26e-02
GOBP POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE	18	3.40e-02	1.98e-01	0.5300	-2.57e-01	-1.46e-01	2.83e-01	3.35e-01	-4.02e-02	5.93e-02	2.83e-01	3.77e-02	1.38e-02	7.68e-01
GOBP ASYMMETRIC NEUROBLAST DIVISION	5	6.36e-01	8.72e-01	0.5300	-2.72e-01	1.53e-01	2.11e-01	2.30e-01	-2.94e-01	2.93e-01	5.52e-01	4.14e-01	3.73e-01	2.55e-01
GOMF CYSTEINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY	34	3.23e-04	6.28e-03	0.5300	-1.48e-01	-2.32e-01	2.19e-01	3.34e-01	-2.15e-01	1.36e-01	1.94e-02	2.69e-02	7.54e-04	3.02e-02
GOMF ACYLGLYCEROL LIPASE ACTIVITY	15	2.90e-02	1.79e-01	0.5300	-1.96e-01	4.27e-01	1.11e-01	-9.77e-02	1.97e-01	1.88e-01	4.21e-03	4.57e-01	5.12e-01	1.87e-01
GOCC GLYCINERGIC SYNAPSE	7	3.18e-01	6.67e-01	0.5300	-2.75e-01	3.99e-01	8.84e-02	-1.93e-01	2.41e-02	2.07e-01	6.75e-02	6.85e-01	3.76e-01	9.12e-01
GOBP REGULATION OF LUTEINIZING HORMONE SECRETION	6	3.62e-01	7.04e-01	0.5300	1.86e-01	8.32e-02	2.55e-01	9.70e-02	-4.06e-01	4.30e-01	7.24e-01	2.79e-01	6.81e-01	8.53e-02
GOBP DETECTION OF TEMPERATURE STIMULUS INVOLVED IN THERMOCEPTION	5	5.15e-01	8.10e-01	0.5300	3.41e-01	-7.18e-02	6.85e-02	3.93e-01	2.05e-02	1.87e-01	7.81e-01	7.91e-01	1.28e-01	9.37e-01
GOBP POSITIVE REGULATION OF HAIR FOLLICLE MATURATION	5	4.37e-01	7.60e-01	0.5300	1.99e-01	-2.95e-01	1.49e-01	-2.10e-01	2.96e-01	4.40e-01	2.53e-01	5.65e-01	4.17e-01	2.52e-01
GOBP RESPONSE TO AMMONIUM ION	6	5.09e-01	8.07e-01	0.5300	-3.88e-01	7.75e-02	3.03e-01	1.80e-01	-4.83e-03	9.99e-02	7.42e-01	1.99e-01	4.45e-01	9.84e-01
GOBP NEGATIVE REGULATION OF TYPE B PANCREATIC CELL APOPTOTIC PROCESS	6	4.63e-01	7.79e-01	0.5300	-9.85e-02	3.56e-01	-1.28e-01	-3.55e-01	4.37e-02	6.76e-01	1.32e-01	5.89e-01	1.32e-01	8.53e-01
GOBP VERY LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE	7	3.18e-01	6.67e-01	0.5300	-2.06e-01	1.31e-01	-4.29e-01	-1.77e-01	-7.25e-02	3.46e-01	5.47e-01	4.93e-02	4.17e-01	7.40e-01
GOBP REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN	6	1.99e-01	5.48e-01	0.5290	-1.09e-01	-2.71e-01	2.21e-01	-3.59e-01	1.29e-01	6.43e-01	2.50e-01	3.48e-01	1.28e-01	5.83e-01
GOCC POLYSOMAL RIBOSOME	28	4.96e-04	8.81e-03	0.5290	-2.48e-01	-1.74e-01	-1.88e-01	-3.70e-01	-1.27e-01	2.34e-02	1.10e-01	8.47e-02	6.95e-04	2.45e-01
GOBP DESMOSOME ORGANIZATION	10	2.42e-01	5.98e-01	0.5290	3.41e-02	1.81e-01	2.73e-01	2.87e-01	-2.98e-01	8.52e-01	3.21e-01	1.35e-01	1.16e-01	1.02e-01
GOMF PROTEIN BINDING INVOLVED IN HETEROTYPIC CELL CELL ADHESION	12	1.45e-01	4.67e-01	0.5290	-2.11e-01	-1.70e-01	3.55e-01	2.76e-01	-5.93e-02	2.06e-01	3.06e-01	3.30e-02	9.73e-02	7.22e-01
GOBP NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT	11	1.97e-01	5.45e-01	0.5290	-2.42e-01	1.79e-01	3.57e-01	2.39e-01	6.84e-02	1.64e-01	3.05e-01	4.06e-02	1.70e-01	6.95e-01
GOMF CDP ALCOHOL PHOSPHATIDYLTRANSFERASE ACTIVITY	8	3.01e-01	6.55e-01	0.5290	-2.15e-01	-4.68e-02	-2.45e-01	-3.38e-01	-2.38e-01	2.92e-01	8.19e-01	2.31e-01	9.78e-02	2.43e-01
GOBP PEPTIDYL ARGININE MODIFICATION	10	1.86e-01	5.30e-01	0.5290	-2.90e-02	-1.91e-01	-2.16e-01	-4.42e-01	-2.69e-02	8.74e-01	2.97e-01	2.38e-01	1.56e-02	8.83e-01
GOBP ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE	9	2.01e-01	5.50e-01	0.5290	4.29e-01	1.64e-02	8.06e-02	-1.42e-01	2.61e-01	2.58e-02	9.32e-01	6.76e-01	4.61e-01	1.74e-01
GOCC ATG1 ULK1 KINASE COMPLEX	6	4.53e-01	7.72e-01	0.5280	-1.13e-01	-8.45e-02	-2.59e-02	-2.71e-01	4.30e-01	6.32e-01	7.20e-01	9.12e-01	2.50e-01	6.81e-02
GOMF 1 PHOSPHATIDYLINOSITOL 4 PHOSPHATE 5 KINASE ACTIVITY	9	2.01e-01	5.50e-01	0.5280	-2.99e-01	2.58e-01	-1.91e-01	-2.49e-01	-1.57e-01	1.20e-01	1.80e-01	3.20e-01	1.96e-01	4.15e-01
GOBP POSITIVE REGULATION OF BLOOD VESSEL REMODELING	6	3.96e-01	7.29e-01	0.5280	-3.64e-01	1.48e-01	2.67e-01	-1.21e-01	1.96e-01	1.22e-01	5.30e-01	2.57e-01	6.07e-01	4.06e-01
GOBP RESPONSE TO INSECTICIDE	6	3.64e-01	7.05e-01	0.5280	2.18e-01	2.11e-01	-2.20e-01	1.13e-01	-3.54e-01	3.54e-01	3.71e-01	3.51e-01	6.31e-01	1.33e-01
GOBP MAINTENANCE OF CENTROSOME LOCATION	6	4.82e-01	7.93e-01	0.5280	3.04e-01	-2.62e-01	-1.70e-01	-8.94e-02	2.84e-01	1.97e-01	2.67e-01	4.72e-01	7.05e-01	2.28e-01
GOBP POSITIVE REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY	5	5.54e-01	8.30e-01	0.5280	-1.80e-02	-3.32e-01	-2.15e-01	-2.96e-01	-1.85e-01	9.45e-01	1.98e-01	4.06e-01	2.52e-01	4.74e-01
GOBP PEPTIDYL LYSINE OXIDATION	5	6.58e-01	8.80e-01	0.5280	-1.60e-01	-5.12e-02	-3.30e-01	-3.76e-01	-1.00e-02	5.36e-01	8.43e-01	2.01e-01	1.46e-01	9.69e-01
GOMF PROTEIN LYSINE 6 OXIDASE ACTIVITY	5	6.58e-01	8.80e-01	0.5280	-1.60e-01	-5.12e-02	-3.30e-01	-3.76e-01	-1.00e-02	5.36e-01	8.43e-01	2.01e-01	1.46e-01	9.69e-01
GOBP PARALLEL ACTIN FILAMENT BUNDLE ASSEMBLY	7	3.08e-01	6.60e-01	0.5280	-3.24e-01	3.90e-01	-2.46e-02	-1.45e-01	1.72e-02	1.38e-01	7.41e-02	9.10e-01	5.08e-01	9.37e-01
GOBP SUGAR MEDIATED SIGNALING PATHWAY	9	2.82e-01	6.36e-01	0.5280	2.68e-01	3.78e-02	-9.80e-02	-3.22e-01	3.04e-01	1.64e-01	8.44e-01	6.11e-01	9.47e-02	1.14e-01
GOMF VOLUME SENSITIVE ANION CHANNEL ACTIVITY	9	2.01e-01	5.50e-01	0.5280	-4.87e-02	1.29e-01	2.66e-01	-9.30e-02	4.24e-01	8.00e-01	5.03e-01	1.67e-01	6.29e-01	2.75e-02
GOBP PROLINE TRANSMEMBRANE TRANSPORT	9	2.34e-01	5.89e-01	0.5280	-1.97e-01	-1.47e-01	4.28e-01	1.83e-01	3.58e-02	3.07e-01	4.46e-01	2.62e-02	3.41e-01	8.53e-01
GOBP LEUCINE METABOLIC PROCESS	8	3.13e-01	6.64e-01	0.5280	1.98e-01	-1.79e-02	3.75e-01	1.99e-01	2.42e-01	3.32e-01	9.30e-01	6.65e-02	3.29e-01	2.35e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS DISULFIDE AS ACCEPTOR	7	2.92e-01	6.46e-01	0.5280	3.55e-01	-4.45e-02	-1.72e-01	1.92e-01	-2.89e-01	1.04e-01	8.39e-01	4.29e-01	3.78e-01	1.85e-01
GOCC ELONGATOR HOLOENZYME COMPLEX	6	5.17e-01	8.11e-01	0.5280	-2.95e-02	5.01e-02	-3.10e-01	-3.64e-01	-2.15e-01	9.00e-01	8.32e-01	1.88e-01	1.23e-01	3.61e-01
GOBP THYROID HORMONE MEDIATED SIGNALING PATHWAY	8	2.53e-01	6.09e-01	0.5270	-4.65e-01	7.26e-02	1.18e-01	2.04e-01	3.48e-02	2.27e-02	7.22e-01	5.63e-01	3.18e-01	8.65e-01
GOBP REGULATION OF PHOSPHOLIPID TRANSLOCATION	6	4.83e-01	7.93e-01	0.5270	-2.52e-01	-7.66e-02	4.18e-01	1.62e-01	9.07e-02	2.85e-01	7.45e-01	7.65e-02	4.93e-01	7.01e-01
GOMF NUCLEOSIDE KINASE ACTIVITY	9	1.63e-01	4.97e-01	0.5270	-2.73e-01	1.31e-01	1.65e-01	-2.74e-01	2.90e-01	1.56e-01	4.98e-01	3.93e-01	1.54e-01	1.32e-01
GOBP MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS	13	1.36e-01	4.55e-01	0.5270	3.40e-02	1.10e-02	-2.83e-01	-4.43e-01	1.41e-02	8.32e-01	9.45e-01	7.71e-02	5.66e-03	9.30e-01
GOCC U2 SNRNP	24	1.08e-02	9.28e-02	0.5270	1.59e-01	-1.97e-01	-3.43e-01	-3.05e-01	5.54e-02	1.77e-01	9.46e-02	3.64e-03	9.65e-03	6.38e-01
GOBP REGULATION OF LIPID TRANSPORTER ACTIVITY	6	4.79e-01	7.91e-01	0.5270	-1.27e-01	3.45e-01	3.02e-01	3.01e-02	2.25e-01	5.89e-01	1.43e-01	2.00e-01	8.99e-01	3.41e-01
GOBP UV DAMAGE EXCISION REPAIR	12	1.37e-01	4.56e-01	0.5270	-9.94e-02	-5.51e-02	-3.51e-01	-2.73e-01	2.60e-01	5.51e-01	7.41e-01	3.54e-02	1.02e-01	1.19e-01
GOBP POSITIVE REGULATION OF OPSONIZATION	8	1.72e-01	5.11e-01	0.5270	-2.63e-01	1.46e-01	-6.13e-02	3.86e-01	-1.86e-01	1.98e-01	4.76e-01	7.64e-01	5.88e-02	3.61e-01
GOBP ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT	11	1.51e-01	4.76e-01	0.5270	-2.09e-01	-3.62e-01	-2.78e-01	-1.38e-01	8.05e-02	2.30e-01	3.78e-02	1.10e-01	4.27e-01	6.44e-01
GOMF CALCIUM POTASSIUM SODIUM ANTIPORTER ACTIVITY	5	4.66e-01	7.82e-01	0.5270	-2.80e-01	-2.60e-02	-1.87e-02	4.33e-01	-1.04e-01	2.78e-01	9.20e-01	9.42e-01	9.40e-02	6.86e-01
GOCC SNO S RNA CONTAINING RIBONUCLEOPROTEIN COMPLEX	27	4.99e-03	5.35e-02	0.5270	-6.30e-02	-1.55e-01	-3.45e-01	-3.59e-01	3.45e-02	5.71e-01	1.63e-01	1.89e-03	1.24e-03	7.56e-01
GOBP L ALANINE TRANSPORT	10	1.60e-01	4.92e-01	0.5270	-3.75e-01	-3.49e-01	5.10e-02	8.68e-02	-6.78e-02	3.99e-02	5.61e-02	7.80e-01	6.34e-01	7.10e-01
GOCC POLE PLASM	24	1.76e-03	2.44e-02	0.5270	-3.13e-01	-3.24e-02	3.48e-01	6.54e-02	2.29e-01	7.89e-03	7.83e-01	3.14e-03	5.79e-01	5.20e-02
GOBP PHOSPHATIDYLSERINE EXPOSURE ON APOPTOTIC CELL SURFACE	8	2.69e-01	6.24e-01	0.5270	2.50e-01	-1.87e-01	3.40e-01	2.11e-01	1.42e-01	2.21e-01	3.59e-01	9.63e-02	3.02e-01	4.88e-01
GOBP NEURONAL ACTION POTENTIAL PROPAGATION	9	2.77e-01	6.31e-01	0.5260	-2.39e-01	-2.32e-01	2.21e-01	2.47e-01	-2.36e-01	2.14e-01	2.27e-01	2.51e-01	2.00e-01	2.19e-01
GOCC PROTEASOME REGULATORY PARTICLE	19	3.76e-02	2.12e-01	0.5260	1.64e-01	-1.40e-01	-2.70e-01	-3.51e-01	1.85e-01	2.16e-01	2.91e-01	4.18e-02	8.13e-03	1.62e-01
GOBP MRNA POLYADENYLATION	24	4.16e-03	4.70e-02	0.5260	-1.44e-01	-1.48e-01	-1.65e-01	-3.99e-01	2.17e-01	2.23e-01	2.09e-01	1.62e-01	7.08e-04	6.53e-02
GOCC NUCLEOCYTOPLASMIC TRANSPORT COMPLEX	12	9.37e-02	3.70e-01	0.5260	1.35e-01	-9.71e-02	-2.73e-01	-1.28e-01	-3.97e-01	4.19e-01	5.60e-01	1.01e-01	4.42e-01	1.72e-02
GOBP WYBUTOSINE METABOLIC PROCESS	6	4.79e-01	7.91e-01	0.5260	-4.33e-03	2.66e-01	-3.44e-01	-2.59e-01	-1.43e-01	9.85e-01	2.60e-01	1.45e-01	2.72e-01	5.44e-01
GOBP NEGATIVE REGULATION OF MUSCLE ORGAN DEVELOPMENT	9	1.83e-01	5.25e-01	0.5250	-9.11e-02	2.83e-01	1.43e-01	-3.31e-01	2.39e-01	6.36e-01	1.41e-01	4.58e-01	8.51e-02	2.14e-01
GOBP DORSAL SPINAL CORD DEVELOPMENT	20	1.05e-02	9.10e-02	0.5250	1.58e-02	6.51e-02	-2.50e-03	-3.62e-01	3.74e-01	9.03e-01	6.14e-01	9.85e-01	5.09e-03	3.75e-03
GOBP SMOOTH MUSCLE CELL CHEMOTAXIS	9	2.66e-01	6.22e-01	0.5250	-3.66e-01	1.69e-01	2.76e-01	1.87e-01	4.16e-02	5.72e-02	3.79e-01	1.52e-01	3.31e-01	8.29e-01
GOBP ERK5 CASCADE	5	3.29e-01	6.77e-01	0.5240	-4.91e-02	-3.48e-01	2.07e-01	-1.08e-01	-3.12e-01	8.49e-01	1.78e-01	4.24e-01	6.75e-01	2.27e-01
GOCC RIBONUCLEASE P COMPLEX	13	1.52e-01	4.78e-01	0.5240	1.29e-01	-1.39e-01	-4.05e-01	-2.69e-01	-5.28e-02	4.20e-01	3.84e-01	1.15e-02	9.37e-02	7.42e-01
GOBP CYTOPLASM ORGANIZATION	15	5.20e-02	2.62e-01	0.5240	-6.91e-02	4.15e-01	2.60e-01	1.08e-01	1.36e-01	6.43e-01	5.37e-03	8.11e-02	4.70e-01	3.61e-01
GOBP PROTEIN GERANYLGERANYLATION	6	3.95e-01	7.29e-01	0.5240	1.83e-02	-4.56e-01	-8.54e-02	-2.43e-01	2.27e-02	9.38e-01	5.32e-02	7.17e-01	3.03e-01	9.23e-01
GOMF MONOCARBOXYLATE SODIUM SYMPORTER ACTIVITY	13	4.86e-02	2.49e-01	0.5240	6.32e-02	1.73e-01	4.54e-01	6.70e-02	-1.76e-01	6.93e-01	2.81e-01	4.63e-03	6.76e-01	2.72e-01
GOBP REGULATION OF RRNA PROCESSING	16	4.92e-02	2.51e-01	0.5240	2.83e-01	6.81e-02	-1.10e-01	-2.12e-01	3.65e-01	4.96e-02	6.37e-01	4.47e-01	1.43e-01	1.15e-02
GOBP LEUCINE TRANSPORT	10	1.72e-01	5.10e-01	0.5240	-3.41e-01	1.37e-01	2.69e-01	1.18e-01	2.30e-01	6.17e-02	4.53e-01	1.41e-01	5.18e-01	2.07e-01
GOMF BETA GALACTOSIDE CMP ALPHA 2 3 SIALYLTRANSFERASE ACTIVITY	7	3.57e-01	7.02e-01	0.5240	-1.70e-01	3.90e-01	1.92e-01	-2.44e-02	2.37e-01	4.35e-01	7.42e-02	3.78e-01	9.11e-01	2.78e-01
GOBP POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS	20	1.93e-02	1.38e-01	0.5240	-2.17e-01	3.15e-01	2.94e-01	1.81e-01	-9.43e-02	9.35e-02	1.46e-02	2.28e-02	1.62e-01	4.65e-01
GOBP NOTOCHORD MORPHOGENESIS	8	2.68e-01	6.23e-01	0.5240	7.52e-02	2.35e-01	-1.61e-01	-3.74e-01	-2.17e-01	7.13e-01	2.49e-01	4.30e-01	6.69e-02	2.87e-01
GOBP CYCLIC NUCLEOTIDE TRANSPORT	9	2.32e-01	5.86e-01	0.5230	2.54e-01	3.24e-01	8.46e-02	-3.51e-02	3.10e-01	1.87e-01	9.21e-02	6.60e-01	8.55e-01	1.08e-01
GOMF ALPHA CATENIN BINDING	10	2.43e-01	6.00e-01	0.5230	1.19e-01	-1.15e-01	2.50e-01	3.74e-01	-2.10e-01	5.14e-01	5.28e-01	1.71e-01	4.07e-02	2.50e-01
GOCC DENSE BODY	5	4.20e-01	7.48e-01	0.5230	-3.03e-01	1.41e-01	2.08e-01	-3.42e-01	4.56e-02	2.40e-01	5.85e-01	4.21e-01	1.86e-01	8.60e-01
GOBP REGULATION OF PANCREATIC JUICE SECRETION	7	3.58e-01	7.03e-01	0.5230	-1.74e-01	3.32e-01	-2.14e-01	-2.72e-01	1.17e-01	4.27e-01	1.29e-01	3.26e-01	2.12e-01	5.91e-01
GOCC PROCENTRIOLE REPLICATION COMPLEX	6	4.49e-01	7.70e-01	0.5230	3.02e-01	-3.66e-01	-1.84e-01	-7.42e-02	-9.59e-02	2.00e-01	1.21e-01	4.35e-01	7.53e-01	6.84e-01
GOBP REGULATION OF BONE MINERALIZATION INVOLVED IN BONE MATURATION	7	3.19e-01	6.67e-01	0.5230	-4.44e-01	5.50e-02	1.24e-02	-2.12e-01	1.69e-01	4.21e-02	8.01e-01	9.55e-01	3.32e-01	4.38e-01
GOBP INTERLEUKIN 18 PRODUCTION	14	1.30e-01	4.46e-01	0.5230	-5.47e-02	9.62e-02	3.00e-01	4.06e-01	-7.87e-02	7.23e-01	5.33e-01	5.20e-02	8.51e-03	6.10e-01
GOBP VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION	13	1.14e-01	4.12e-01	0.5230	1.87e-02	2.28e-01	-2.75e-01	-3.78e-01	-5.49e-02	9.07e-01	1.54e-01	8.65e-02	1.84e-02	7.32e-01
GOCC BRCA1 A COMPLEX	7	3.75e-01	7.15e-01	0.5230	3.75e-01	2.97e-01	-1.45e-01	-1.38e-01	6.55e-02	8.57e-02	1.74e-01	5.05e-01	5.27e-01	7.64e-01
GOMF WD40 REPEAT DOMAIN BINDING	5	6.12e-01	8.58e-01	0.5220	-2.08e-01	6.20e-02	-2.11e-01	-4.25e-01	-1.82e-02	4.20e-01	8.10e-01	4.13e-01	9.98e-02	9.44e-01
GOBP POSITIVE REGULATION OF CYTOPLASMIC MRNA PROCESSING BODY ASSEMBLY	6	5.32e-01	8.20e-01	0.5220	3.46e-01	-1.83e-01	-2.21e-01	-2.41e-01	1.11e-01	1.42e-01	4.36e-01	3.49e-01	3.06e-01	6.38e-01
GOBP REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT	5	5.13e-01	8.09e-01	0.5220	-4.18e-03	2.52e-01	8.71e-02	5.28e-02	4.46e-01	9.87e-01	3.29e-01	7.36e-01	8.38e-01	8.43e-02
GOBP RIBOFLAVIN TRANSPORT	6	4.39e-01	7.61e-01	0.5220	-3.76e-01	2.11e-01	-1.05e-01	-2.73e-01	3.19e-02	1.11e-01	3.70e-01	6.55e-01	2.47e-01	8.92e-01
GOMF RIBOFLAVIN TRANSMEMBRANE TRANSPORTER ACTIVITY	6	4.39e-01	7.61e-01	0.5220	-3.76e-01	2.11e-01	-1.05e-01	-2.73e-01	3.19e-02	1.11e-01	3.70e-01	6.55e-01	2.47e-01	8.92e-01
GOBP CHITIN METABOLIC PROCESS	6	5.38e-01	8.22e-01	0.5220	1.26e-01	-1.65e-01	2.35e-01	3.78e-01	-1.78e-01	5.93e-01	4.83e-01	3.19e-01	1.09e-01	4.51e-01
GOMF CHITINASE ACTIVITY	6	5.38e-01	8.22e-01	0.5220	1.26e-01	-1.65e-01	2.35e-01	3.78e-01	-1.78e-01	5.93e-01	4.83e-01	3.19e-01	1.09e-01	4.51e-01
GOBP POSITIVE REGULATION OF INTERLEUKIN 5 PRODUCTION	10	1.65e-01	5.00e-01	0.5220	7.21e-02	4.91e-01	1.24e-01	-2.28e-02	-1.03e-01	6.93e-01	7.21e-03	4.97e-01	9.00e-01	5.72e-01
GOBP XENOBIOTIC TRANSPORT ACROSS BLOOD BRAIN BARRIER	6	4.73e-01	7.87e-01	0.5220	2.02e-01	-1.48e-01	1.92e-01	3.81e-01	1.65e-01	3.91e-01	5.30e-01	4.15e-01	1.06e-01	4.85e-01
GOBP PROTEIN DEPALMITOYLATION	8	1.80e-01	5.22e-01	0.5220	-3.75e-01	1.19e-01	2.15e-01	-2.19e-01	-1.52e-01	6.62e-02	5.61e-01	2.92e-01	2.83e-01	4.58e-01
GOMF ACIDIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY	18	2.97e-02	1.82e-01	0.5220	-2.30e-01	2.87e-01	2.46e-01	1.47e-01	-2.34e-01	9.11e-02	3.47e-02	7.10e-02	2.82e-01	8.61e-02
GOCC CBM COMPLEX	5	5.47e-01	8.27e-01	0.5210	1.64e-01	4.84e-01	-4.15e-02	-9.42e-02	-9.60e-03	5.26e-01	6.09e-02	8.72e-01	7.15e-01	9.70e-01
GOBP REGULATION OF INOSITOL 1 4 5 TRISPHOSPHATE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY	5	5.92e-01	8.47e-01	0.5210	3.66e-01	1.55e-01	-4.30e-02	-8.16e-02	3.24e-01	1.56e-01	5.49e-01	8.68e-01	7.52e-01	2.09e-01
GOBP REGULATION OF SERINE TYPE PEPTIDASE ACTIVITY	6	5.54e-01	8.30e-01	0.5210	1.66e-01	-4.71e-02	2.48e-01	4.03e-01	-1.34e-01	4.82e-01	8.42e-01	2.93e-01	8.76e-02	5.69e-01
GOCC SPERM PLASMA MEMBRANE	14	5.35e-02	2.66e-01	0.5210	-5.78e-02	-3.00e-01	3.12e-02	4.15e-01	-6.98e-02	7.08e-01	5.21e-02	8.40e-01	7.18e-03	6.51e-01
GOCC HISTONE PRE MRNA 3 END PROCESSING COMPLEX	6	4.98e-01	8.02e-01	0.5210	-1.04e-01	-4.78e-02	-2.52e-01	-3.84e-01	-2.17e-01	6.58e-01	8.39e-01	2.85e-01	1.03e-01	3.58e-01
GOBP MATURE CONVENTIONAL DENDRITIC CELL DIFFERENTIATION	5	5.74e-01	8.40e-01	0.5210	-1.06e-01	1.98e-01	-3.63e-01	-2.52e-01	1.59e-01	6.83e-01	4.43e-01	1.59e-01	3.30e-01	5.39e-01
GOBP RETINAL CELL PROGRAMMED CELL DEATH	6	2.30e-01	5.84e-01	0.5210	2.26e-01	-1.06e-01	4.14e-01	-1.44e-01	1.28e-01	3.37e-01	6.54e-01	7.90e-02	5.42e-01	5.87e-01
GOMF LYSOPHOSPHATIDIC ACID PHOSPHATASE ACTIVITY	6	2.31e-01	5.84e-01	0.5200	-2.69e-02	1.25e-01	3.66e-01	-3.30e-01	1.07e-01	9.09e-01	5.95e-01	1.20e-01	1.61e-01	6.51e-01
GOBP REGULATION OF CENTROMERE COMPLEX ASSEMBLY	6	4.99e-01	8.03e-01	0.5200	1.76e-01	-2.63e-01	-1.55e-01	-3.52e-01	1.51e-01	4.55e-01	2.64e-01	5.10e-01	1.36e-01	5.21e-01
GOMF INTERLEUKIN 12 RECEPTOR BINDING	5	5.63e-01	8.34e-01	0.5200	-2.05e-01	2.57e-01	2.32e-01	1.85e-01	2.73e-01	4.27e-01	3.20e-01	3.68e-01	4.73e-01	2.91e-01
GOBP INOSITOL TRISPHOSPHATE BIOSYNTHETIC PROCESS	8	3.83e-01	7.21e-01	0.5200	-9.22e-02	3.05e-01	3.10e-01	1.84e-01	-1.97e-01	6.52e-01	1.35e-01	1.29e-01	3.68e-01	3.34e-01
GOMF RIBONUCLEASE P ACTIVITY	12	1.83e-01	5.25e-01	0.5200	1.32e-01	-8.93e-02	-4.32e-01	-2.37e-01	-4.66e-02	4.29e-01	5.92e-01	9.53e-03	1.55e-01	7.80e-01
GOBP SNRNA 3 END PROCESSING	20	3.75e-02	2.11e-01	0.5200	3.51e-02	-7.26e-02	-3.97e-01	-3.21e-01	5.61e-02	7.86e-01	5.74e-01	2.12e-03	1.30e-02	6.64e-01
GOCC PROTON TRANSPORTING V TYPE ATPASE V1 DOMAIN	11	2.07e-01	5.58e-01	0.5200	1.46e-01	-1.16e-01	-1.63e-01	-3.59e-01	2.82e-01	4.03e-01	5.04e-01	3.48e-01	3.92e-02	1.05e-01
GOBP TRACHEA DEVELOPMENT	18	5.51e-03	5.70e-02	0.5200	-1.96e-01	2.69e-01	1.71e-01	-3.56e-01	5.69e-02	1.50e-01	4.84e-02	2.10e-01	8.90e-03	6.76e-01
GOBP POSITIVE REGULATION OF CELL FATE COMMITMENT	13	5.62e-02	2.75e-01	0.5190	-4.07e-01	6.03e-02	2.87e-01	-6.19e-02	1.19e-01	1.10e-02	7.06e-01	7.32e-02	6.99e-01	4.57e-01
GOMF ALPHA GLUCOSIDASE ACTIVITY	5	5.24e-01	8.16e-01	0.5190	-4.99e-01	1.00e-01	-2.88e-02	-8.67e-02	4.64e-02	5.33e-02	6.97e-01	9.11e-01	7.37e-01	8.57e-01
GOMF UDP GALACTOSE BETA N ACETYLGLUCOSAMINE BETA 1 3 GALACTOSYLTRANSFERASE ACTIVITY	12	8.12e-02	3.43e-01	0.5190	-2.76e-01	3.85e-01	-4.10e-02	-7.64e-02	-1.93e-01	9.73e-02	2.09e-02	8.06e-01	6.47e-01	2.47e-01
GOCC ER UBIQUITIN LIGASE COMPLEX	9	1.19e-01	4.24e-01	0.5190	-8.43e-02	1.41e-01	-2.48e-03	-4.52e-01	-1.96e-01	6.62e-01	4.63e-01	9.90e-01	1.89e-02	3.09e-01
GOBP CGMP CATABOLIC PROCESS	5	5.71e-01	8.38e-01	0.5190	-8.53e-02	-3.04e-01	2.79e-02	4.04e-01	-7.51e-02	7.41e-01	2.39e-01	9.14e-01	1.18e-01	7.71e-01
GOBP REGULATION OF CD4 POSITIVE CD25 POSITIVE ALPHA BETA REGULATORY T CELL DIFFERENTIATION	5	3.34e-01	6.81e-01	0.5190	-1.95e-01	-3.02e-02	-1.50e-01	1.94e-01	4.12e-01	4.50e-01	9.07e-01	5.61e-01	4.52e-01	1.10e-01
GOBP CELLULAR RESPONSE TO UV C	5	6.37e-01	8.73e-01	0.5190	3.09e-01	-2.63e-01	-2.70e-01	-1.71e-01	5.09e-02	2.32e-01	3.08e-01	2.96e-01	5.08e-01	8.44e-01
GOBP POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS	9	2.62e-01	6.19e-01	0.5190	5.17e-02	4.48e-01	2.16e-01	1.36e-01	1.51e-02	7.88e-01	1.98e-02	2.62e-01	4.81e-01	9.37e-01
GOCC PLATELET DENSE TUBULAR NETWORK MEMBRANE	9	1.76e-01	5.18e-01	0.5190	1.77e-02	3.59e-01	-1.06e-01	1.02e-01	-3.44e-01	9.27e-01	6.24e-02	5.82e-01	5.94e-01	7.39e-02
GOCC CYTOPLASMIC SIDE OF LYSOSOMAL MEMBRANE	13	1.22e-01	4.28e-01	0.5190	-1.13e-01	7.27e-02	-3.89e-01	-3.00e-01	9.54e-02	4.80e-01	6.50e-01	1.50e-02	6.09e-02	5.52e-01
GOBP LIPOXIN METABOLIC PROCESS	5	5.43e-01	8.25e-01	0.5190	5.61e-02	2.06e-01	9.75e-03	-4.53e-01	1.35e-01	8.28e-01	4.26e-01	9.70e-01	7.95e-02	6.01e-01
GOBP POSITIVE REGULATION OF MITOCHONDRIAL DEPOLARIZATION	9	1.97e-01	5.46e-01	0.5180	-4.56e-01	-2.50e-02	8.58e-02	-9.86e-02	-2.07e-01	1.78e-02	8.97e-01	6.56e-01	6.08e-01	2.81e-01
GOBP LYSINE METABOLIC PROCESS	8	4.07e-01	7.39e-01	0.5180	-2.85e-01	-8.37e-03	2.22e-01	2.62e-01	-2.63e-01	1.63e-01	9.67e-01	2.78e-01	1.99e-01	1.97e-01
GOBP GLUCOSE IMPORT ACROSS PLASMA MEMBRANE	5	5.02e-01	8.03e-01	0.5180	1.54e-01	-7.18e-02	2.76e-02	4.88e-01	-2.65e-02	5.50e-01	7.81e-01	9.15e-01	5.89e-02	9.18e-01
GOBP MEIOTIC SISTER CHROMATID COHESION	13	6.24e-02	2.94e-01	0.5180	1.16e-01	7.73e-02	7.21e-02	-3.94e-01	2.97e-01	4.67e-01	6.29e-01	6.53e-01	1.39e-02	6.35e-02
GOBP NEGATIVE REGULATION OF RESPONSE TO TYPE II INTERFERON	7	3.18e-01	6.67e-01	0.5180	-9.71e-03	2.88e-02	8.50e-02	7.63e-02	5.04e-01	9.65e-01	8.95e-01	6.97e-01	7.27e-01	2.10e-02
GOBP REGULATION OF PROTEIN KINASE C ACTIVITY	5	5.50e-01	8.28e-01	0.5180	2.38e-01	-3.44e-01	1.76e-01	2.37e-01	-7.63e-02	3.56e-01	1.83e-01	4.95e-01	3.59e-01	7.68e-01
GOBP GASTRIC MOTILITY	5	4.65e-01	7.81e-01	0.5170	-3.06e-02	2.89e-01	5.87e-02	-4.10e-01	-1.09e-01	9.06e-01	2.63e-01	8.20e-01	1.13e-01	6.73e-01
GOBP PROTEIN HEXAMERIZATION	9	2.66e-01	6.21e-01	0.5170	4.15e-01	8.01e-02	-6.38e-02	-2.13e-01	1.98e-01	3.10e-02	6.77e-01	7.40e-01	2.68e-01	3.05e-01
GOBP POSITIVE REGULATION OF SKELETAL MUSCLE FIBER DEVELOPMENT	9	2.41e-01	5.98e-01	0.5170	1.83e-02	4.07e-01	1.58e-01	-1.30e-01	2.43e-01	9.24e-01	3.43e-02	4.10e-01	4.99e-01	2.07e-01
GOMF HISTONE H3K27 METHYLTRANSFERASE ACTIVITY	6	5.11e-01	8.08e-01	0.5170	3.23e-01	1.78e-01	2.80e-01	1.63e-01	1.61e-01	1.70e-01	4.50e-01	2.34e-01	4.88e-01	4.95e-01
GOBP REGULATION OF ASTROCYTE ACTIVATION	8	3.53e-01	6.99e-01	0.5170	-1.35e-01	-2.26e-01	-2.51e-01	-3.54e-01	-1.02e-01	5.10e-01	2.68e-01	2.20e-01	8.34e-02	6.17e-01
GOCC 90S PRERIBOSOME	28	5.24e-03	5.52e-02	0.5170	2.15e-01	-7.61e-02	-3.37e-01	-2.86e-01	1.42e-01	4.90e-02	4.86e-01	2.03e-03	8.87e-03	1.94e-01
GOBP L METHIONINE SALVAGE FROM METHYLTHIOADENOSINE	5	5.37e-01	8.22e-01	0.5170	1.81e-01	3.11e-01	1.77e-01	-2.75e-01	1.76e-01	4.83e-01	2.29e-01	4.94e-01	2.86e-01	4.95e-01
GOMF STEROL ESTERASE ACTIVITY	7	2.04e-01	5.53e-01	0.5170	1.84e-01	2.33e-01	1.23e-01	-3.81e-01	-1.35e-01	3.98e-01	2.87e-01	5.73e-01	8.05e-02	5.37e-01
GOMF APOLIPOPROTEIN A I BINDING	5	5.35e-01	8.21e-01	0.5170	-4.32e-01	-1.59e-01	-2.09e-01	4.77e-02	-9.51e-02	9.44e-02	5.39e-01	4.17e-01	8.53e-01	7.13e-01
GOBP RIBOSOME ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS	7	4.21e-01	7.48e-01	0.5170	2.45e-01	1.23e-01	-2.16e-01	-1.67e-01	3.42e-01	2.61e-01	5.74e-01	3.22e-01	4.44e-01	1.17e-01
GOBP FORMATE METABOLIC PROCESS	6	3.32e-01	6.80e-01	0.5170	-4.01e-01	-1.35e-01	-6.19e-02	2.49e-01	1.48e-01	8.89e-02	5.67e-01	7.93e-01	2.90e-01	5.31e-01
GOBP OMEGA HYDROXYLASE P450 PATHWAY	11	1.31e-01	4.48e-01	0.5160	2.46e-01	-2.11e-01	1.20e-01	3.70e-01	9.97e-02	1.57e-01	2.26e-01	4.91e-01	3.35e-02	5.67e-01
GOBP DELAMINATION	7	3.49e-01	6.95e-01	0.5160	-2.48e-01	4.45e-01	7.34e-02	-3.70e-02	-1.64e-02	2.55e-01	4.16e-02	7.37e-01	8.65e-01	9.40e-01
GOBP SPINDLE MIDZONE ASSEMBLY	13	7.64e-02	3.32e-01	0.5160	-9.55e-02	-3.85e-01	-8.57e-02	-1.21e-01	2.94e-01	5.51e-01	1.62e-02	5.92e-01	4.48e-01	6.62e-02
GOBP POSITIVE REGULATION OF MESENCHYMAL STEM CELL PROLIFERATION	6	4.55e-01	7.74e-01	0.5160	2.49e-01	-4.01e-02	9.36e-02	1.13e-01	4.25e-01	2.90e-01	8.65e-01	6.91e-01	6.32e-01	7.12e-02
GOBP COPPER ION IMPORT	6	4.38e-01	7.60e-01	0.5160	-3.70e-01	2.08e-01	7.69e-03	-2.67e-01	1.18e-01	1.16e-01	3.76e-01	9.74e-01	2.57e-01	6.18e-01
GOBP NEGATIVE REGULATION OF PROTEIN KINASE ACTIVITY BY REGULATION OF PROTEIN PHOSPHORYLATION	6	4.64e-01	7.80e-01	0.5160	2.31e-01	4.35e-01	5.17e-02	1.52e-03	1.43e-01	3.27e-01	6.49e-02	8.27e-01	9.95e-01	5.45e-01
GOMF GTPASE ACTIVATING PROTEIN BINDING	12	9.54e-02	3.73e-01	0.5160	9.26e-02	4.69e-01	1.14e-01	-6.35e-02	-1.43e-01	5.79e-01	4.91e-03	4.96e-01	7.03e-01	3.91e-01
GOBP GROWTH PLATE CARTILAGE CHONDROCYTE DEVELOPMENT	5	5.62e-01	8.33e-01	0.5160	-3.09e-01	2.93e-01	-7.22e-02	-2.82e-01	2.36e-03	2.32e-01	2.57e-01	7.80e-01	2.75e-01	9.93e-01
GOBP PROTEIN LOCALIZATION TO BASOLATERAL PLASMA MEMBRANE	7	3.27e-01	6.76e-01	0.5160	-2.61e-01	1.13e-01	-7.40e-02	-4.03e-01	-1.32e-01	2.32e-01	6.06e-01	7.35e-01	6.50e-02	5.47e-01
GOCC TRNA SPLICING LIGASE COMPLEX	8	3.83e-01	7.21e-01	0.5150	-7.92e-02	5.28e-02	-2.10e-01	-4.56e-01	7.04e-02	6.98e-01	7.96e-01	3.04e-01	2.56e-02	7.30e-01
GOBP NEGATIVE REGULATION OF FIBROBLAST MIGRATION	10	1.45e-01	4.66e-01	0.5150	-1.86e-01	3.85e-01	1.34e-01	-2.55e-01	-2.33e-03	3.09e-01	3.52e-02	4.64e-01	1.62e-01	9.90e-01
GOBP POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION	14	3.60e-02	2.06e-01	0.5150	8.41e-02	1.00e-01	1.26e-01	4.63e-01	1.34e-01	5.86e-01	5.17e-01	4.15e-01	2.67e-03	3.86e-01
GOBP POSITIVE REGULATION OF T CELL TOLERANCE INDUCTION	8	3.33e-01	6.81e-01	0.5150	-3.17e-03	-2.75e-01	2.48e-01	3.18e-01	1.65e-01	9.88e-01	1.79e-01	2.24e-01	1.19e-01	4.20e-01
GOBP PARANODAL JUNCTION ASSEMBLY	6	4.77e-01	7.90e-01	0.5150	3.03e-01	-1.29e-01	1.19e-01	3.77e-01	-2.75e-02	1.99e-01	5.85e-01	6.13e-01	1.10e-01	9.07e-01
GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL	5	5.78e-01	8.42e-01	0.5150	3.68e-01	-2.14e-01	-2.11e-02	-1.32e-01	2.58e-01	1.55e-01	4.07e-01	9.35e-01	6.10e-01	3.17e-01
GOBP TETRAHYDROBIOPTERIN METABOLIC PROCESS	8	3.10e-01	6.62e-01	0.5150	-1.98e-01	-1.27e-02	-2.18e-01	-7.31e-02	-4.16e-01	3.31e-01	9.50e-01	2.85e-01	7.20e-01	4.17e-02
GOBP RETINAL CONE CELL DEVELOPMENT	11	1.87e-01	5.31e-01	0.5150	1.50e-01	-1.01e-01	2.52e-01	3.24e-01	-2.54e-01	3.88e-01	5.63e-01	1.49e-01	6.30e-02	1.45e-01
GOBP CHONDROBLAST DIFFERENTIATION	5	5.28e-01	8.18e-01	0.5150	9.43e-02	2.55e-01	1.61e-01	-3.43e-01	2.20e-01	7.15e-01	3.24e-01	5.34e-01	1.85e-01	3.95e-01
GOBP LUNG VASCULATURE DEVELOPMENT	8	3.06e-01	6.60e-01	0.5150	-3.74e-02	2.96e-02	-3.81e-02	-4.47e-01	2.49e-01	8.55e-01	8.85e-01	8.52e-01	2.87e-02	2.23e-01
GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY	13	7.27e-02	3.22e-01	0.5150	1.81e-01	2.70e-01	1.69e-01	-2.53e-01	2.58e-01	2.58e-01	9.14e-02	2.91e-01	1.15e-01	1.07e-01
GOCC NODE OF RANVIER	16	4.35e-02	2.31e-01	0.5150	-2.61e-01	-2.36e-01	-7.71e-02	1.76e-01	-3.23e-01	7.05e-02	1.03e-01	5.93e-01	2.24e-01	2.52e-02
GOMF G PROTEIN COUPLED SEROTONIN RECEPTOR ACTIVITY	21	1.35e-02	1.09e-01	0.5150	2.73e-01	2.23e-01	3.08e-01	1.84e-01	1.09e-01	3.03e-02	7.75e-02	1.45e-02	1.43e-01	3.87e-01
GOBP COBALAMIN TRANSPORT	8	3.13e-01	6.64e-01	0.5150	-4.27e-02	4.78e-01	1.77e-01	-5.81e-03	5.79e-02	8.35e-01	1.92e-02	3.87e-01	9.77e-01	7.77e-01
GOBP REGULATION OF PLASMA CELL DIFFERENTIATION	5	5.01e-01	8.03e-01	0.5150	-3.72e-01	3.45e-01	1.91e-03	8.23e-02	-1.42e-02	1.49e-01	1.81e-01	9.94e-01	7.50e-01	9.56e-01
GOBP TELOMERIC LOOP DISASSEMBLY	9	2.53e-01	6.10e-01	0.5140	-1.25e-01	8.82e-02	-1.79e-01	-4.49e-01	-8.89e-02	5.18e-01	6.47e-01	3.53e-01	1.97e-02	6.44e-01
GOBP IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN PHAGOCYTOSIS	25	3.96e-03	4.53e-02	0.5140	-1.43e-01	2.78e-01	3.09e-01	1.42e-01	2.26e-01	2.15e-01	1.62e-02	7.47e-03	2.20e-01	5.03e-02
GOBP REGULATION OF GLUCOCORTICOID SECRETION	10	1.16e-01	4.16e-01	0.5140	1.88e-01	3.53e-01	1.95e-01	-2.57e-01	-1.42e-02	3.04e-01	5.30e-02	2.85e-01	1.60e-01	9.38e-01
GOBP RESPONSE TO INTERLEUKIN 18	11	1.82e-01	5.24e-01	0.5140	1.92e-01	2.06e-01	2.84e-01	1.89e-01	2.63e-01	2.70e-01	2.38e-01	1.03e-01	2.77e-01	1.31e-01
GOCC TRAPPIII PROTEIN COMPLEX	11	2.57e-01	6.14e-01	0.5140	-3.47e-02	9.84e-03	-3.04e-01	-4.08e-01	6.31e-02	8.42e-01	9.55e-01	8.08e-02	1.91e-02	7.17e-01
GOBP LUNG SACCULE DEVELOPMENT	10	2.93e-01	6.47e-01	0.5140	2.04e-01	3.57e-02	-1.90e-01	-3.62e-01	2.33e-01	2.65e-01	8.45e-01	2.98e-01	4.76e-02	2.01e-01
GOBP SYNAPTIC VESICLE UNCOATING	6	4.21e-01	7.49e-01	0.5140	4.03e-01	-1.06e-01	-1.11e-01	2.13e-01	-1.81e-01	8.71e-02	6.53e-01	6.38e-01	3.67e-01	4.43e-01
GOMF D LOOP DNA BINDING	5	6.79e-01	8.87e-01	0.5140	1.38e-01	5.12e-02	-1.88e-01	-4.24e-01	1.66e-01	5.93e-01	8.43e-01	4.67e-01	1.01e-01	5.21e-01
GOBP NEGATIVE REGULATION OF GLUCOSE IMPORT	16	2.76e-02	1.74e-01	0.5140	1.80e-01	-3.15e-01	-2.67e-01	1.54e-01	-1.92e-01	2.13e-01	2.90e-02	6.42e-02	2.87e-01	1.83e-01
GOBP REGULATION OF HEPATIC STELLATE CELL ACTIVATION	7	3.44e-01	6.91e-01	0.5140	-1.39e-01	4.54e-01	1.14e-01	7.63e-02	1.40e-01	5.23e-01	3.75e-02	6.02e-01	7.27e-01	5.23e-01
GOBP NEGATIVE REGULATION OF DENDRITE DEVELOPMENT	8	2.84e-01	6.37e-01	0.5140	-2.14e-01	2.98e-01	-4.25e-02	-4.26e-02	-3.54e-01	2.94e-01	1.44e-01	8.35e-01	8.35e-01	8.32e-02
GOBP CELLULAR RESPONSE TO LUTEINIZING HORMONE STIMULUS	5	5.60e-01	8.33e-01	0.5130	3.15e-01	-1.65e-01	5.72e-02	2.38e-01	-2.77e-01	2.22e-01	5.24e-01	8.25e-01	3.56e-01	2.83e-01
GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND	14	6.63e-02	3.04e-01	0.5130	-2.49e-01	-8.52e-02	2.43e-01	1.18e-01	-3.48e-01	1.06e-01	5.81e-01	1.15e-01	4.45e-01	2.43e-02
GOBP REGULATION OF DNA STRAND ELONGATION	17	4.07e-02	2.22e-01	0.5130	3.03e-01	-5.52e-02	-7.01e-02	-1.96e-01	3.53e-01	3.05e-02	6.94e-01	6.17e-01	1.61e-01	1.16e-02
GOBP EMBRYONIC SKELETAL JOINT MORPHOGENESIS	11	9.85e-02	3.79e-01	0.5130	1.97e-01	8.29e-02	3.70e-03	-4.55e-01	1.04e-01	2.58e-01	6.34e-01	9.83e-01	9.05e-03	5.49e-01
GOCC WEIBEL PALADE BODY	5	4.94e-01	8.00e-01	0.5130	1.73e-01	7.78e-02	-2.25e-01	2.23e-01	-3.56e-01	5.04e-01	7.63e-01	3.84e-01	3.87e-01	1.68e-01
GOBP PYRIMIDINE DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS	6	5.79e-01	8.43e-01	0.5130	7.01e-02	1.56e-01	-2.66e-01	-4.04e-01	-1.84e-02	7.66e-01	5.09e-01	2.60e-01	8.69e-02	9.38e-01
GOMF PLATELET DERIVED GROWTH FACTOR RECEPTOR BINDING	13	2.39e-02	1.58e-01	0.5130	-2.44e-01	2.63e-01	2.55e-02	3.55e-01	8.83e-02	1.28e-01	1.00e-01	8.74e-01	2.68e-02	5.81e-01
GOBP REGULATION OF PHOSPHATIDYLCHOLINE METABOLIC PROCESS	10	1.45e-01	4.66e-01	0.5130	-3.24e-01	2.31e-01	6.73e-02	-3.10e-01	6.28e-02	7.58e-02	2.05e-01	7.12e-01	9.00e-02	7.31e-01
GOCC KERATIN FILAMENT	90	1.08e-10	1.01e-08	0.5130	-2.17e-01	-1.31e-01	2.33e-01	3.66e-01	-1.03e-01	3.82e-04	3.23e-02	1.36e-04	1.85e-09	9.08e-02
GOMF AXON GUIDANCE RECEPTOR ACTIVITY	10	3.04e-01	6.58e-01	0.5130	-5.84e-02	-9.34e-02	2.31e-01	3.90e-01	-2.13e-01	7.49e-01	6.09e-01	2.05e-01	3.27e-02	2.44e-01
GOCC KNL1 SPC105 COMPLEX	6	5.69e-01	8.37e-01	0.5130	2.35e-01	3.79e-02	-3.49e-01	-2.64e-01	-1.21e-01	3.19e-01	8.72e-01	1.39e-01	2.63e-01	6.07e-01
GOBP MESENCHYME MIGRATION	5	5.62e-01	8.34e-01	0.5130	2.16e-01	3.12e-01	4.03e-02	-3.35e-01	7.14e-02	4.03e-01	2.28e-01	8.76e-01	1.95e-01	7.82e-01
GOCC DYNEIN AXONEMAL PARTICLE	20	4.06e-02	2.22e-01	0.5130	2.38e-02	-1.36e-01	-3.15e-01	-3.32e-01	1.85e-01	8.54e-01	2.93e-01	1.48e-02	1.01e-02	1.52e-01
GOBP PROTEIN IMPORT	7	4.40e-01	7.63e-01	0.5120	-8.21e-02	1.85e-01	-3.17e-01	-2.96e-01	1.83e-01	7.07e-01	3.98e-01	1.46e-01	1.75e-01	4.01e-01
GOBP POSITIVE REGULATION OF T HELPER 1 CELL DIFFERENTIATION	6	3.28e-01	6.76e-01	0.5120	-1.51e-02	7.61e-02	-1.86e-01	3.74e-01	-2.87e-01	9.49e-01	7.47e-01	4.30e-01	1.13e-01	2.23e-01
GOBP CELLULAR RESPONSE TO HEPARIN	5	5.60e-01	8.32e-01	0.5120	-4.75e-01	-1.37e-01	-1.00e-01	5.02e-02	-7.65e-02	6.61e-02	5.97e-01	6.97e-01	8.46e-01	7.67e-01
GOCC JUNCTIONAL SARCOPLASMIC RETICULUM MEMBRANE	9	2.99e-01	6.53e-01	0.5120	-5.71e-02	-1.99e-01	1.88e-01	4.29e-01	5.11e-03	7.67e-01	3.01e-01	3.28e-01	2.59e-02	9.79e-01
GOMF SPHINGOSINE 1 PHOSPHATE PHOSPHATASE ACTIVITY	7	2.47e-01	6.04e-01	0.5120	5.78e-02	-2.08e-03	5.08e-01	1.61e-02	-2.64e-02	7.91e-01	9.92e-01	2.00e-02	9.41e-01	9.04e-01
GOBP TRANSITION BETWEEN FAST AND SLOW FIBER	9	1.02e-01	3.87e-01	0.5120	8.02e-02	-1.74e-02	-4.17e-01	3.96e-02	2.83e-01	6.77e-01	9.28e-01	3.04e-02	8.37e-01	1.41e-01
GOBP TRYPTOPHAN CATABOLIC PROCESS	9	2.91e-01	6.45e-01	0.5120	-3.48e-01	6.03e-02	1.40e-01	3.13e-01	-1.41e-01	7.10e-02	7.54e-01	4.67e-01	1.04e-01	4.63e-01
GOBP POSITIVE REGULATION OF SPINDLE ASSEMBLY	8	4.29e-01	7.54e-01	0.5120	2.57e-01	-9.99e-02	-3.56e-01	-2.42e-01	-1.02e-02	2.08e-01	6.25e-01	8.09e-02	2.35e-01	9.60e-01
GOBP CARDIAC VENTRICLE FORMATION	8	3.49e-01	6.95e-01	0.5120	1.02e-01	3.43e-01	-3.55e-02	-2.99e-01	2.08e-01	6.18e-01	9.28e-02	8.62e-01	1.43e-01	3.09e-01
GOBP UREA TRANSMEMBRANE TRANSPORT	9	2.48e-01	6.05e-01	0.5120	-3.20e-01	2.58e-01	6.49e-02	1.85e-01	-2.32e-01	9.64e-02	1.80e-01	7.36e-01	3.35e-01	2.27e-01
GOBP NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN	10	2.20e-01	5.74e-01	0.5120	-2.08e-01	-1.39e-02	-2.23e-02	2.10e-01	-4.17e-01	2.54e-01	9.39e-01	9.03e-01	2.51e-01	2.25e-02
GOCC SPERM FIBROUS SHEATH	6	2.26e-01	5.79e-01	0.5110	-8.90e-02	-1.90e-01	-2.43e-01	3.80e-01	1.18e-01	7.06e-01	4.20e-01	3.02e-01	1.07e-01	6.15e-01
GOBP PROXIMAL TUBULE DEVELOPMENT	10	1.63e-01	4.96e-01	0.5110	3.31e-01	-6.88e-03	-3.50e-01	2.75e-03	-1.70e-01	6.96e-02	9.70e-01	5.51e-02	9.88e-01	3.53e-01
GOBP NEGATIVE REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY	9	2.58e-01	6.16e-01	0.5110	-8.12e-02	3.10e-01	-2.61e-03	-2.96e-01	2.66e-01	6.73e-01	1.07e-01	9.89e-01	1.24e-01	1.67e-01
GOBP EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS	17	3.18e-02	1.90e-01	0.5110	1.00e-01	-1.83e-01	-4.48e-02	-3.14e-01	3.43e-01	4.75e-01	1.92e-01	7.49e-01	2.52e-02	1.44e-02
GOBP NEGATIVE REGULATION OF RESPONSE TO TUMOR CELL	5	6.95e-01	8.93e-01	0.5110	1.62e-01	1.56e-01	-3.07e-01	-3.34e-01	6.90e-02	5.30e-01	5.46e-01	2.35e-01	1.95e-01	7.89e-01
GOBP TRNA WOBBLE BASE MODIFICATION	20	2.90e-02	1.79e-01	0.5110	3.31e-02	-1.83e-01	-3.48e-01	-2.78e-01	-1.69e-01	7.98e-01	1.56e-01	7.07e-03	3.15e-02	1.92e-01
GOBP ACINAR CELL DIFFERENTIATION	5	3.32e-01	6.80e-01	0.5110	3.06e-02	-3.59e-01	2.97e-01	-1.82e-01	9.96e-02	9.06e-01	1.64e-01	2.51e-01	4.81e-01	7.00e-01
GOBP NEGATIVE REGULATION OF ERAD PATHWAY	6	4.26e-01	7.53e-01	0.5110	2.40e-01	4.12e-01	-8.05e-02	3.97e-02	-1.60e-01	3.09e-01	8.07e-02	7.33e-01	8.66e-01	4.96e-01
GOBP NEGATIVE REGULATION OF PLASMINOGEN ACTIVATION	8	2.22e-01	5.76e-01	0.5110	-3.31e-01	1.32e-01	3.30e-01	-1.49e-01	5.12e-02	1.05e-01	5.17e-01	1.06e-01	4.67e-01	8.02e-01
GOMF RIBOSOMAL LARGE SUBUNIT BINDING	14	8.89e-02	3.59e-01	0.5110	1.76e-01	-7.74e-02	-1.49e-01	-4.28e-01	1.34e-01	2.54e-01	6.16e-01	3.33e-01	5.51e-03	3.85e-01
GOBP CENTROMERE COMPLEX ASSEMBLY	28	2.91e-03	3.58e-02	0.5110	2.24e-01	-1.88e-01	-2.28e-01	-3.44e-01	6.99e-02	3.99e-02	8.57e-02	3.64e-02	1.65e-03	5.22e-01
GOBP BASE EXCISION REPAIR AP SITE FORMATION	12	1.73e-01	5.12e-01	0.5100	9.65e-02	1.92e-01	-3.49e-01	-2.88e-01	9.57e-02	5.63e-01	2.50e-01	3.61e-02	8.38e-02	5.66e-01
GOBP NEGATIVE REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS	5	5.34e-01	8.21e-01	0.5100	-3.54e-01	-7.07e-02	1.48e-01	-1.34e-01	3.01e-01	1.71e-01	7.84e-01	5.67e-01	6.05e-01	2.44e-01
GOBP DE NOVO NAD BIOSYNTHETIC PROCESS	8	1.80e-01	5.22e-01	0.5100	-1.64e-01	2.52e-01	4.97e-02	4.05e-01	5.70e-02	4.23e-01	2.17e-01	8.08e-01	4.71e-02	7.80e-01
GOMF SULFATIDE BINDING	6	4.28e-01	7.54e-01	0.5100	-3.79e-01	-2.63e-01	-1.46e-01	1.17e-02	1.60e-01	1.08e-01	2.65e-01	5.35e-01	9.60e-01	4.97e-01
GOCC G PROTEIN COUPLED RECEPTOR COMPLEX	11	1.15e-01	4.14e-01	0.5100	-7.19e-02	-2.45e-01	-1.68e-02	4.36e-01	-6.80e-02	6.79e-01	1.60e-01	9.23e-01	1.23e-02	6.96e-01
GOBP HEART VALVE FORMATION	15	2.82e-02	1.76e-01	0.5100	1.89e-01	2.71e-01	3.29e-01	-1.50e-01	1.41e-01	2.05e-01	6.90e-02	2.72e-02	3.16e-01	3.45e-01
GOBP NLS BEARING PROTEIN IMPORT INTO NUCLEUS	18	2.41e-02	1.59e-01	0.5100	-2.00e-02	-4.22e-01	-2.67e-01	-1.66e-02	9.90e-02	8.83e-01	1.93e-03	5.02e-02	9.03e-01	4.67e-01
GOBP INTERLEUKIN 1 ALPHA PRODUCTION	11	1.37e-01	4.56e-01	0.5100	-4.48e-01	8.29e-02	8.16e-02	2.06e-01	-5.41e-02	1.01e-02	6.34e-01	6.39e-01	2.36e-01	7.56e-01
GOBP MACROPHAGE FUSION	6	4.10e-01	7.42e-01	0.5090	-3.18e-01	-1.05e-01	3.61e-01	-2.20e-02	1.29e-01	1.77e-01	6.57e-01	1.26e-01	9.26e-01	5.84e-01
GOBP NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS	10	4.57e-02	2.39e-01	0.5090	1.39e-01	1.62e-01	3.73e-01	-2.74e-01	-6.32e-03	4.47e-01	3.75e-01	4.11e-02	1.34e-01	9.72e-01
GOMF ARYLESTERASE ACTIVITY	6	5.96e-01	8.50e-01	0.5090	1.02e-01	1.40e-01	3.35e-01	2.87e-01	-1.87e-01	6.65e-01	5.53e-01	1.56e-01	2.23e-01	4.27e-01
GOCC X CHROMOSOME	11	2.15e-01	5.69e-01	0.5090	2.52e-01	-6.77e-02	-1.92e-01	-3.77e-01	1.13e-01	1.48e-01	6.97e-01	2.71e-01	3.04e-02	5.18e-01
GOMF CROSSOVER JUNCTION DNA ENDONUCLEASE ACTIVITY	7	2.99e-01	6.53e-01	0.5090	-1.29e-01	1.96e-01	-4.02e-01	-1.49e-01	1.45e-01	5.56e-01	3.69e-01	6.58e-02	4.95e-01	5.07e-01
GOMF G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR ACTIVITY	7	3.87e-01	7.24e-01	0.5090	2.35e-01	6.04e-02	9.81e-02	4.24e-01	-1.08e-01	2.82e-01	7.82e-01	6.53e-01	5.23e-02	6.22e-01
GOBP NEGATIVE REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT	6	2.64e-01	6.19e-01	0.5090	2.49e-01	-1.07e-01	1.25e-01	-1.23e-01	-3.93e-01	2.90e-01	6.49e-01	5.95e-01	6.01e-01	9.52e-02
GOBP POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE	22	1.45e-02	1.14e-01	0.5090	-8.98e-02	-2.42e-01	1.64e-01	3.87e-01	-1.24e-01	4.66e-01	4.91e-02	1.83e-01	1.66e-03	3.13e-01
GOBP FAT SOLUBLE VITAMIN CATABOLIC PROCESS	11	1.34e-01	4.52e-01	0.5090	1.71e-02	1.98e-01	1.67e-01	1.04e-01	4.25e-01	9.22e-01	2.55e-01	3.37e-01	5.51e-01	1.46e-02
GOBP NEGATIVE REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE	8	3.80e-01	7.18e-01	0.5090	-2.13e-01	9.66e-02	2.21e-01	3.95e-01	1.37e-03	2.97e-01	6.36e-01	2.80e-01	5.33e-02	9.95e-01
GOCC CYTOPLASMIC UBIQUITIN LIGASE COMPLEX	13	3.10e-02	1.87e-01	0.5090	-4.23e-02	1.83e-01	1.33e-02	-3.92e-01	-2.65e-01	7.92e-01	2.54e-01	9.34e-01	1.45e-02	9.85e-02
GOBP FAT PAD DEVELOPMENT	8	3.53e-01	6.99e-01	0.5090	3.02e-01	-4.89e-03	-3.86e-01	-1.24e-01	5.80e-02	1.39e-01	9.81e-01	5.89e-02	5.44e-01	7.76e-01
GOBP POSITIVE REGULATION OF CHROMATIN ORGANIZATION	14	9.59e-02	3.75e-01	0.5090	2.76e-01	-2.24e-01	-1.95e-01	-2.93e-01	9.34e-02	7.35e-02	1.48e-01	2.07e-01	5.78e-02	5.45e-01
GOBP NORADRENERGIC NEURON DIFFERENTIATION	10	2.26e-01	5.80e-01	0.5090	3.22e-01	2.33e-01	9.52e-03	-2.07e-01	2.41e-01	7.82e-02	2.03e-01	9.58e-01	2.56e-01	1.87e-01
GOBP SPONTANEOUS SYNAPTIC TRANSMISSION	14	5.28e-02	2.64e-01	0.5080	-6.87e-02	4.10e-01	-3.07e-02	9.21e-03	-2.91e-01	6.56e-01	7.91e-03	8.42e-01	9.52e-01	5.96e-02
GOBP REGULATION OF CYTOPLASMIC MRNA PROCESSING BODY ASSEMBLY	7	3.42e-01	6.88e-01	0.5080	4.18e-01	-2.74e-01	-5.10e-02	-7.98e-02	1.32e-03	5.56e-02	2.10e-01	8.15e-01	7.15e-01	9.95e-01
GOBP EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT	10	2.03e-01	5.53e-01	0.5080	2.01e-02	3.01e-01	6.12e-02	-3.16e-01	2.52e-01	9.12e-01	9.93e-02	7.37e-01	8.37e-02	1.67e-01
GOBP NEUROENDOCRINE CELL DIFFERENTIATION	16	6.34e-02	2.96e-01	0.5080	-1.26e-01	1.48e-01	-2.32e-01	-4.08e-01	-1.23e-02	3.84e-01	3.05e-01	1.09e-01	4.69e-03	9.32e-01
GOBP CD4 POSITIVE CD25 POSITIVE ALPHA BETA REGULATORY T CELL DIFFERENTIATION	8	1.12e-01	4.09e-01	0.5080	-2.36e-01	5.07e-03	-6.86e-02	3.28e-01	3.00e-01	2.48e-01	9.80e-01	7.37e-01	1.08e-01	1.41e-01
GOBP NEPHRON TUBULE FORMATION	20	2.68e-03	3.37e-02	0.5080	1.12e-01	3.19e-02	6.07e-02	-4.74e-01	1.26e-01	3.87e-01	8.05e-01	6.39e-01	2.42e-04	3.28e-01
GOCC TORC1 COMPLEX	6	6.37e-01	8.73e-01	0.5080	1.39e-01	-8.86e-02	-2.74e-01	-3.40e-01	1.99e-01	5.54e-01	7.07e-01	2.45e-01	1.49e-01	4.00e-01
GOBP POSITIVE REGULATION OF VASCULAR WOUND HEALING	5	6.86e-01	8.89e-01	0.5070	1.71e-01	9.97e-02	-2.35e-01	-2.69e-01	3.01e-01	5.09e-01	6.99e-01	3.63e-01	2.98e-01	2.43e-01
GOBP POLY N ACETYLLACTOSAMINE METABOLIC PROCESS	7	4.25e-01	7.52e-01	0.5070	1.37e-01	3.37e-01	-2.06e-01	-2.20e-01	1.84e-01	5.29e-01	1.22e-01	3.44e-01	3.13e-01	4.00e-01
GOBP PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION	15	1.26e-01	4.39e-01	0.5070	1.12e-01	-7.69e-04	-2.48e-01	-3.81e-01	1.95e-01	4.54e-01	9.96e-01	9.61e-02	1.06e-02	1.91e-01
GOBP NEGATIVE REGULATION OF DEFENSE RESPONSE TO BACTERIUM	5	5.55e-01	8.30e-01	0.5070	3.52e-01	-2.23e-01	2.05e-01	1.96e-01	-5.71e-02	1.73e-01	3.88e-01	4.27e-01	4.47e-01	8.25e-01
GOCC CALCIUM AND CALMODULIN DEPENDENT PROTEIN KINASE COMPLEX	5	6.11e-01	8.58e-01	0.5070	3.50e-01	1.21e-01	-2.90e-01	-1.37e-01	-1.32e-01	1.75e-01	6.40e-01	2.62e-01	5.96e-01	6.08e-01
GOBP PYRUVATE FAMILY AMINO ACID METABOLIC PROCESS	5	6.76e-01	8.85e-01	0.5070	-2.59e-01	-1.18e-01	3.31e-01	2.34e-01	-1.10e-01	3.16e-01	6.47e-01	2.00e-01	3.65e-01	6.69e-01
GOBP POSITIVE REGULATION OF GAMMA DELTA T CELL DIFFERENTIATION	7	4.13e-01	7.44e-01	0.5070	1.86e-01	3.61e-01	2.74e-01	6.51e-02	-1.15e-01	3.95e-01	9.83e-02	2.10e-01	7.65e-01	5.98e-01
GOMF EPOXIDE HYDROLASE ACTIVITY	6	5.02e-01	8.03e-01	0.5070	-1.52e-01	3.46e-01	-9.79e-02	-3.14e-01	7.27e-02	5.18e-01	1.42e-01	6.78e-01	1.82e-01	7.58e-01
GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION	6	5.03e-01	8.03e-01	0.5070	3.02e-01	3.71e-01	4.18e-02	-1.29e-01	9.79e-02	2.00e-01	1.16e-01	8.59e-01	5.84e-01	6.78e-01
GOBP POSITIVE REGULATION OF GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT	5	6.06e-01	8.56e-01	0.5070	4.23e-02	4.12e-01	2.45e-01	-9.33e-02	1.28e-01	8.70e-01	1.11e-01	3.43e-01	7.18e-01	6.19e-01
GOBP GOLGI VESICLE BUDDING	10	2.78e-01	6.31e-01	0.5060	2.07e-01	1.82e-01	-1.45e-01	-3.63e-01	1.67e-01	2.56e-01	3.19e-01	4.28e-01	4.70e-02	3.61e-01
GOBP DEHYDROASCORBIC ACID TRANSPORT	9	1.73e-01	5.13e-01	0.5060	-1.44e-02	2.80e-01	9.18e-02	1.73e-01	3.73e-01	9.41e-01	1.46e-01	6.33e-01	3.69e-01	5.24e-02
GOCC EMC COMPLEX	9	3.68e-01	7.08e-01	0.5060	8.67e-02	1.58e-01	-3.34e-01	-3.35e-01	1.42e-02	6.52e-01	4.12e-01	8.30e-02	8.22e-02	9.41e-01
GOBP CANONICAL WNT SIGNALING PATHWAY INVOLVED IN OSTEOBLAST DIFFERENTIATION	7	3.44e-01	6.90e-01	0.5060	-2.20e-01	-2.11e-01	3.61e-01	9.71e-02	-1.52e-01	3.13e-01	3.34e-01	9.77e-02	6.57e-01	4.87e-01
GOMF U1 SNRNP BINDING	6	5.88e-01	8.46e-01	0.5060	-1.82e-03	-2.47e-01	-3.46e-01	-1.98e-01	1.89e-01	9.94e-01	2.94e-01	1.42e-01	4.02e-01	4.22e-01
GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY	9	3.89e-01	7.25e-01	0.5060	-2.18e-01	-2.52e-02	2.37e-01	3.21e-01	-2.19e-01	2.57e-01	8.96e-01	2.18e-01	9.51e-02	2.55e-01
GOMF ALPHA N ACETYLGALACTOSAMINIDE ALPHA 2 6 SIALYLTRANSFERASE ACTIVITY	6	4.48e-01	7.70e-01	0.5060	-1.22e-01	3.02e-01	1.96e-01	-5.61e-02	-3.29e-01	6.04e-01	2.01e-01	4.06e-01	8.12e-01	1.63e-01
GOCC JUNCTIONAL MEMBRANE COMPLEX	6	4.37e-01	7.60e-01	0.5060	-5.89e-02	-2.39e-01	1.02e-01	2.55e-01	3.45e-01	8.03e-01	3.10e-01	6.65e-01	2.79e-01	1.43e-01
GOBP REGULATION OF SPINDLE ASSEMBLY	32	3.13e-03	3.79e-02	0.5050	1.66e-01	-7.80e-02	-3.18e-01	-3.38e-01	7.84e-02	1.04e-01	4.45e-01	1.84e-03	9.27e-04	4.43e-01
GOBP HINDBRAIN MATURATION	5	6.75e-01	8.85e-01	0.5050	3.06e-01	-1.59e-01	-2.49e-01	-1.66e-01	2.17e-01	2.36e-01	5.39e-01	3.35e-01	5.20e-01	4.02e-01
GOMF FATTY ACID LIGASE ACTIVITY	20	1.19e-02	9.86e-02	0.5050	2.68e-02	4.72e-01	1.34e-01	-3.21e-02	-1.11e-01	8.36e-01	2.54e-04	2.98e-01	8.04e-01	3.92e-01
GOCC NUCLEAR LAMINA	10	2.45e-01	6.02e-01	0.5050	4.34e-02	2.94e-01	-2.66e-01	-3.05e-01	-5.49e-02	8.12e-01	1.08e-01	1.45e-01	9.51e-02	7.64e-01
GOMF INTERLEUKIN 1 RECEPTOR BINDING	17	8.89e-02	3.59e-01	0.5050	-1.56e-01	1.12e-01	2.97e-01	3.45e-01	-1.04e-01	2.66e-01	4.26e-01	3.41e-02	1.37e-02	4.56e-01
GOBP POSITIVE REGULATION OF GONAD DEVELOPMENT	8	1.61e-01	4.93e-01	0.5050	-7.10e-02	2.53e-01	3.42e-01	-2.60e-01	-3.40e-02	7.28e-01	2.15e-01	9.40e-02	2.02e-01	8.68e-01
GOBP REGULATION OF SPONTANEOUS SYNAPTIC TRANSMISSION	6	4.68e-01	7.84e-01	0.5050	-6.12e-02	4.46e-01	-5.36e-03	-1.32e-01	-1.88e-01	7.95e-01	5.88e-02	9.82e-01	5.76e-01	4.25e-01
GOBP ANTEROGRADE NEURONAL DENSE CORE VESICLE TRANSPORT	6	3.97e-01	7.31e-01	0.5050	-1.83e-02	-1.86e-01	-1.81e-02	1.50e-01	4.44e-01	9.38e-01	4.31e-01	9.39e-01	5.26e-01	5.95e-02
GOBP PHOSPHATIDYLSERINE ACYL CHAIN REMODELING	9	2.88e-01	6.42e-01	0.5050	-1.58e-01	6.29e-02	1.69e-02	3.09e-01	-3.60e-01	4.10e-01	7.44e-01	9.30e-01	1.08e-01	6.13e-02
GOBP INTERLEUKIN 11 MEDIATED SIGNALING PATHWAY	6	4.39e-01	7.61e-01	0.5050	2.50e-01	1.72e-01	-1.19e-01	-2.76e-01	-2.68e-01	2.88e-01	4.65e-01	6.14e-01	2.41e-01	2.56e-01
GOBP NEGATIVE REGULATION OF AMINE METABOLIC PROCESS	6	5.58e-01	8.32e-01	0.5050	-1.92e-01	1.21e-01	1.11e-01	3.55e-01	-2.55e-01	4.15e-01	6.07e-01	6.37e-01	1.33e-01	2.80e-01
GOBP REGULATION OF NATURAL KILLER CELL PROLIFERATION	12	1.34e-01	4.53e-01	0.5050	1.36e-01	1.14e-01	4.39e-01	1.08e-01	1.36e-01	4.15e-01	4.93e-01	8.45e-03	5.16e-01	4.14e-01
GOMF S ADENOSYL L METHIONINE BINDING	19	3.78e-02	2.13e-01	0.5050	2.18e-01	-1.31e-01	-3.78e-01	-1.71e-01	1.35e-01	1.01e-01	3.22e-01	4.38e-03	1.97e-01	3.09e-01
GOCC ROUGH ENDOPLASMIC RETICULUM MEMBRANE	22	1.93e-02	1.38e-01	0.5050	2.64e-01	-8.74e-02	-2.28e-01	-3.44e-01	8.25e-02	3.23e-02	4.78e-01	6.35e-02	5.21e-03	5.03e-01
GOCC TRAPPII PROTEIN COMPLEX	11	2.32e-01	5.85e-01	0.5040	-1.72e-02	1.82e-01	-2.48e-01	-4.00e-01	-7.34e-04	9.21e-01	2.96e-01	1.55e-01	2.18e-02	9.97e-01
GOBP TRANS SYNAPTIC SIGNALING BY TRANS SYNAPTIC COMPLEX	6	6.13e-01	8.58e-01	0.5040	-8.87e-02	1.26e-01	3.14e-01	2.47e-01	-2.66e-01	7.07e-01	5.94e-01	1.83e-01	2.94e-01	2.58e-01
GOBP NEGATIVE REGULATION OF RIG I SIGNALING PATHWAY	8	3.75e-01	7.14e-01	0.5040	2.85e-01	-2.25e-02	-2.85e-01	-1.32e-01	2.72e-01	1.63e-01	9.12e-01	1.63e-01	5.17e-01	1.82e-01
GOBP RRNA TRANSPORT	5	5.48e-01	8.27e-01	0.5040	-2.97e-01	-1.05e-01	-5.77e-02	-3.89e-01	-7.67e-03	2.51e-01	6.85e-01	8.23e-01	1.32e-01	9.76e-01
GOCC LARGE RIBOSOMAL SUBUNIT	111	3.93e-12	4.19e-10	0.5040	-3.94e-02	-7.95e-02	-3.54e-01	-3.48e-01	-8.79e-03	4.74e-01	1.48e-01	1.16e-10	2.47e-10	8.73e-01
GOBP POSITIVE REGULATION OF PROTEIN K63 LINKED UBIQUITINATION	7	4.03e-01	7.36e-01	0.5040	1.18e-01	3.72e-01	2.71e-01	-1.02e-01	1.35e-01	5.89e-01	8.85e-02	2.15e-01	6.41e-01	5.35e-01
GOBP REGULATION OF KIDNEY SIZE	5	2.51e-01	6.08e-01	0.5040	2.76e-02	-1.95e-01	3.96e-01	-2.03e-01	-1.29e-01	9.15e-01	4.51e-01	1.25e-01	4.31e-01	6.18e-01
GOBP REGULATION OF CIRCADIAN SLEEP WAKE CYCLE NON REM SLEEP	5	5.43e-01	8.25e-01	0.5040	1.16e-01	3.44e-01	1.68e-01	-2.95e-01	8.19e-02	6.54e-01	1.83e-01	5.16e-01	2.53e-01	7.51e-01
GOBP POSITIVE REGULATION OF ER ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS	5	5.66e-01	8.35e-01	0.5040	-4.46e-01	-1.65e-01	1.72e-02	-1.05e-01	1.25e-01	8.39e-02	5.23e-01	9.47e-01	6.83e-01	6.28e-01
GOBP REGULATION OF PRIMARY MIRNA PROCESSING	5	4.73e-01	7.86e-01	0.5040	6.44e-02	7.96e-02	-3.48e-02	-2.60e-01	-4.18e-01	8.03e-01	7.58e-01	8.93e-01	3.14e-01	1.06e-01
GOBP MESONEPHRIC DUCT DEVELOPMENT	8	4.10e-01	7.42e-01	0.5030	1.84e-01	-2.48e-01	-2.29e-01	-3.18e-01	6.53e-02	3.67e-01	2.24e-01	2.61e-01	1.20e-01	7.49e-01
GOMF LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY INVOLVED IN REGULATION OF PRESYNAPTIC MEMBRANE POTENTIAL	14	1.30e-01	4.46e-01	0.5030	-2.55e-01	9.78e-02	3.76e-01	1.92e-01	-3.17e-03	9.79e-02	5.26e-01	1.47e-02	2.14e-01	9.84e-01
GOBP EARLY ENDOSOME TO RECYCLING ENDOSOME TRANSPORT	6	5.39e-01	8.23e-01	0.5030	2.14e-01	-2.53e-01	-2.81e-01	-1.44e-01	-2.09e-01	3.64e-01	2.83e-01	2.33e-01	5.43e-01	3.76e-01
GOBP ALDITOL BIOSYNTHETIC PROCESS	5	6.09e-01	8.58e-01	0.5030	2.51e-01	3.00e-01	1.02e-01	5.38e-02	2.94e-01	3.31e-01	2.45e-01	6.93e-01	8.35e-01	2.55e-01
GOBP DCMP CATABOLIC PROCESS	6	4.78e-01	7.91e-01	0.5030	-1.51e-01	2.62e-01	3.29e-01	2.37e-03	-2.32e-01	5.22e-01	2.67e-01	1.63e-01	9.92e-01	3.26e-01
GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION	10	1.27e-01	4.40e-01	0.5030	2.08e-01	5.45e-02	2.29e-01	6.74e-02	-3.87e-01	2.54e-01	7.66e-01	2.10e-01	7.12e-01	3.43e-02
GOBP PRONEPHROS DEVELOPMENT	9	9.35e-02	3.70e-01	0.5030	1.51e-01	-5.50e-02	1.96e-01	-4.02e-01	1.62e-01	4.33e-01	7.75e-01	3.09e-01	3.66e-02	3.99e-01
GOBP INTERLEUKIN 5 PRODUCTION	19	2.35e-02	1.56e-01	0.5030	8.57e-02	4.33e-01	2.07e-01	6.91e-02	1.00e-01	5.18e-01	1.07e-03	1.19e-01	6.02e-01	4.49e-01
GOMF ATP DEPENDENT PROTEIN FOLDING CHAPERONE	35	1.03e-03	1.59e-02	0.5020	-1.40e-01	-1.26e-01	-3.24e-01	-3.23e-01	8.64e-02	1.52e-01	1.96e-01	9.18e-04	9.25e-04	3.77e-01
GOBP CARDIAC VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION	10	2.10e-01	5.61e-01	0.5020	-1.86e-01	6.96e-02	3.36e-01	4.45e-02	3.13e-01	3.07e-01	7.03e-01	6.57e-02	8.08e-01	8.68e-02
GOBP DEDIFFERENTIATION	11	6.57e-02	3.02e-01	0.5020	-1.40e-01	-8.73e-02	3.42e-01	-1.95e-01	2.65e-01	4.20e-01	6.16e-01	4.98e-02	2.63e-01	1.28e-01
GOBP POSITIVE REGULATION OF PLATELET ACTIVATION	9	2.27e-01	5.80e-01	0.5020	-1.24e-01	4.36e-01	1.09e-01	5.33e-02	1.78e-01	5.19e-01	2.34e-02	5.71e-01	7.82e-01	3.56e-01
GOMF HIGH DENSITY LIPOPROTEIN PARTICLE BINDING	13	7.92e-02	3.39e-01	0.5020	-3.43e-01	-3.50e-01	3.61e-02	1.88e-03	1.01e-01	3.21e-02	2.88e-02	8.21e-01	9.91e-01	5.30e-01
GOBP REGULATION OF SEROTONIN SECRETION	6	5.40e-01	8.23e-01	0.5020	3.78e-01	8.85e-02	-1.85e-01	-1.09e-01	2.35e-01	1.09e-01	7.07e-01	4.32e-01	6.45e-01	3.19e-01
GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYDROGEN PEROXIDE	6	5.27e-01	8.17e-01	0.5020	-1.73e-01	2.70e-01	-1.24e-01	-3.61e-01	5.23e-02	4.63e-01	2.51e-01	6.00e-01	1.25e-01	8.24e-01
GOCC HAPTOGLOBIN HEMOGLOBIN COMPLEX	11	2.10e-01	5.61e-01	0.5010	-9.24e-02	-1.56e-02	2.59e-01	3.87e-01	1.60e-01	5.96e-01	9.29e-01	1.36e-01	2.64e-02	3.59e-01
GOBP GASTRIC ACID SECRETION	13	5.34e-02	2.66e-01	0.5010	2.02e-02	3.73e-01	-7.78e-02	2.01e-01	-2.54e-01	9.00e-01	1.97e-02	6.27e-01	2.09e-01	1.12e-01
GOBP MACROMOLECULE DEPALMITOYLATION	11	1.02e-01	3.87e-01	0.5010	-3.80e-01	1.47e-01	1.72e-01	-2.34e-01	-1.48e-02	2.89e-02	3.99e-01	3.23e-01	1.78e-01	9.32e-01
GOMF PALMITOYL HYDROLASE ACTIVITY	11	1.02e-01	3.87e-01	0.5010	-3.80e-01	1.47e-01	1.72e-01	-2.34e-01	-1.48e-02	2.89e-02	3.99e-01	3.23e-01	1.78e-01	9.32e-01
GOBP DE NOVO CENTRIOLE ASSEMBLY	6	4.61e-01	7.78e-01	0.5010	-4.60e-02	-1.84e-01	-1.55e-01	-2.06e-01	-3.85e-01	8.45e-01	4.36e-01	5.11e-01	3.82e-01	1.02e-01
GOBP ETHANOLAMINE CONTAINING COMPOUND METABOLIC PROCESS	8	4.43e-01	7.66e-01	0.5010	-7.73e-02	3.12e-01	3.21e-01	1.90e-01	-9.47e-02	7.05e-01	1.27e-01	1.16e-01	3.53e-01	6.43e-01
GOBP EMBRYONIC FORELIMB MORPHOGENESIS	33	8.40e-04	1.35e-02	0.5010	7.90e-02	1.37e-01	-7.60e-02	-3.67e-01	2.92e-01	4.32e-01	1.74e-01	4.50e-01	2.65e-04	3.67e-03
GOBP CARDIAC CHAMBER FORMATION	12	1.19e-01	4.24e-01	0.5010	3.10e-02	3.55e-01	1.30e-01	-2.67e-01	1.88e-01	8.52e-01	3.31e-02	4.34e-01	1.10e-01	2.60e-01
GOCC POSTSYNAPTIC ENDOCYTIC ZONE	5	4.49e-01	7.70e-01	0.5000	-2.64e-01	2.06e-01	7.87e-03	1.49e-01	3.40e-01	3.06e-01	4.26e-01	9.76e-01	5.63e-01	1.87e-01
GOCC CORVET COMPLEX	7	4.02e-01	7.35e-01	0.5000	4.31e-01	1.68e-01	-1.51e-02	-1.86e-01	4.43e-02	4.85e-02	4.42e-01	9.45e-01	3.93e-01	8.39e-01
GOBP INTRACELLULAR SPHINGOLIPID HOMEOSTASIS	5	6.30e-01	8.69e-01	0.5000	1.14e-01	2.33e-01	-3.29e-01	-2.05e-01	-1.82e-01	6.60e-01	3.68e-01	2.03e-01	4.27e-01	4.80e-01
GOBP NEUTROPHIL EXTRAVASATION	11	1.63e-01	4.96e-01	0.5000	-2.70e-01	3.26e-01	2.54e-01	-5.65e-02	5.79e-02	1.22e-01	6.13e-02	1.44e-01	7.46e-01	7.39e-01
GOBP HOST MEDIATED REGULATION OF INTESTINAL MICROBIOTA COMPOSITION	9	2.60e-01	6.17e-01	0.5000	-2.14e-01	2.46e-01	3.16e-01	9.23e-03	-2.09e-01	2.67e-01	2.02e-01	1.01e-01	9.62e-01	2.77e-01
GOBP PULMONARY ARTERY MORPHOGENESIS	6	4.72e-01	7.86e-01	0.5000	2.56e-01	9.98e-02	-3.42e-02	1.57e-01	-3.85e-01	2.77e-01	6.72e-01	8.85e-01	5.06e-01	1.02e-01
GOMF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY INVOLVED IN CARDIAC MUSCLE CELL ACTION POTENTIAL REPOLARIZATION	14	2.40e-02	1.58e-01	0.5000	-6.08e-02	4.64e-01	-8.23e-02	1.53e-01	-2.50e-02	6.94e-01	2.65e-03	5.94e-01	3.22e-01	8.72e-01
GOBP MALE MEIOSIS I	27	1.11e-03	1.67e-02	0.5000	5.15e-02	-6.11e-02	1.78e-01	-1.55e-01	4.33e-01	6.43e-01	5.83e-01	1.09e-01	1.64e-01	9.80e-05
GOBP RRNA BASE METHYLATION	9	2.05e-01	5.55e-01	0.4990	1.04e-01	1.23e-01	-1.02e-01	-4.26e-01	-1.77e-01	5.90e-01	5.24e-01	5.95e-01	2.67e-02	3.58e-01
GOBP REGULATION OF VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING	6	4.30e-01	7.55e-01	0.4990	-4.20e-01	-1.17e-01	-1.60e-01	1.58e-01	-9.04e-02	7.45e-02	6.20e-01	4.98e-01	5.01e-01	7.02e-01
GOBP RESPONSE TO INCREASED OXYGEN LEVELS	24	2.14e-02	1.48e-01	0.4990	1.16e-01	-9.92e-02	-2.82e-01	-3.68e-01	1.06e-01	3.24e-01	4.00e-01	1.69e-02	1.81e-03	3.68e-01
GOCC OUTER MITOCHONDRIAL MEMBRANE PROTEIN COMPLEX	21	2.87e-02	1.78e-01	0.4990	2.36e-02	1.67e-01	-2.65e-01	-3.33e-01	1.99e-01	8.51e-01	1.84e-01	3.55e-02	8.33e-03	1.14e-01
GOMF CYTOSKELETON NUCLEAR MEMBRANE ANCHOR ACTIVITY	5	6.31e-01	8.70e-01	0.4990	3.90e-01	7.20e-02	3.15e-02	-3.68e-02	2.98e-01	1.31e-01	7.81e-01	9.03e-01	8.87e-01	2.48e-01
GOBP NEGATIVE REGULATION OF MONOCYTE DIFFERENTIATION	8	3.18e-01	6.67e-01	0.4990	8.90e-03	1.28e-01	2.35e-02	7.17e-02	-4.76e-01	9.65e-01	5.31e-01	9.08e-01	7.26e-01	1.97e-02
GOBP HEPOXILIN METABOLIC PROCESS	9	1.35e-01	4.54e-01	0.4980	2.28e-02	8.06e-02	7.01e-02	-4.85e-01	3.11e-02	9.06e-01	6.75e-01	7.16e-01	1.17e-02	8.72e-01
GOBP NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 1 SIGNALING PATHWAY	7	4.51e-01	7.71e-01	0.4980	-8.48e-02	2.35e-01	-1.61e-01	-2.74e-01	2.92e-01	6.98e-01	2.83e-01	4.61e-01	2.10e-01	1.81e-01
GOBP MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS	11	8.69e-02	3.56e-01	0.4980	2.57e-01	-2.21e-01	4.49e-02	-3.29e-01	1.51e-01	1.39e-01	2.04e-01	7.97e-01	5.92e-02	3.86e-01
GOMF SIALIC ACID BINDING	22	1.07e-04	2.52e-03	0.4980	-3.07e-01	1.47e-01	-1.60e-01	2.70e-01	1.85e-01	1.28e-02	2.32e-01	1.95e-01	2.86e-02	1.34e-01
GOBP LYSOSOMAL MEMBRANE ORGANIZATION	14	1.33e-01	4.50e-01	0.4980	1.27e-01	-8.74e-02	-4.33e-01	-1.84e-01	-4.96e-02	4.10e-01	5.71e-01	4.98e-03	2.34e-01	7.48e-01
GOBP REGULATION OF ARACHIDONIC ACID SECRETION	7	4.55e-01	7.74e-01	0.4980	-2.82e-01	-2.59e-01	-2.89e-01	-1.32e-01	1.76e-02	1.97e-01	2.36e-01	1.85e-01	5.45e-01	9.36e-01
GOBP REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN	11	3.14e-01	6.65e-01	0.4980	-8.50e-02	1.80e-02	2.93e-01	3.64e-01	-1.47e-01	6.26e-01	9.18e-01	9.22e-02	3.64e-02	4.00e-01
GOBP L ASPARTATE TRANSMEMBRANE TRANSPORT	11	1.93e-01	5.41e-01	0.4980	-3.55e-01	2.32e-01	1.39e-01	9.53e-02	-1.98e-01	4.14e-02	1.82e-01	4.23e-01	5.84e-01	2.56e-01
GOBP REGULATION OF GONADOTROPIN SECRETION	11	9.74e-02	3.78e-01	0.4980	3.24e-02	2.33e-01	1.18e-01	-1.08e-01	-4.08e-01	8.52e-01	1.81e-01	4.97e-01	5.35e-01	1.91e-02
GOBP REGULATION OF MACROPHAGE FUSION	5	5.49e-01	8.28e-01	0.4970	-3.00e-01	-1.48e-01	3.56e-01	4.44e-03	9.31e-02	2.46e-01	5.66e-01	1.68e-01	9.86e-01	7.19e-01
GOMF RRNA BINDING	62	7.87e-07	3.61e-05	0.4970	-6.38e-02	1.16e-01	-3.14e-01	-3.61e-01	-2.92e-02	3.85e-01	1.15e-01	1.93e-05	8.48e-07	6.91e-01
GOBP RNA 5 END PROCESSING	21	3.58e-02	2.05e-01	0.4970	1.37e-01	-1.42e-01	-3.77e-01	-2.45e-01	-8.03e-02	2.78e-01	2.62e-01	2.80e-03	5.19e-02	5.24e-01
GOBP POSITIVE REGULATION OF I KAPPAB PHOSPHORYLATION	6	5.81e-01	8.43e-01	0.4970	-1.95e-01	-2.81e-01	1.75e-01	3.10e-01	-6.25e-02	4.08e-01	2.34e-01	4.58e-01	1.89e-01	7.91e-01
GOBP CELLULAR RESPONSE TO IRON ION	8	1.82e-01	5.24e-01	0.4970	-1.01e-01	2.27e-01	1.35e-01	-3.16e-01	-2.59e-01	6.21e-01	2.66e-01	5.10e-01	1.22e-01	2.04e-01
GOBP REGULATION OF GAMMA DELTA T CELL DIFFERENTIATION	9	2.41e-01	5.98e-01	0.4970	2.06e-01	3.67e-01	2.16e-01	-1.47e-01	4.80e-02	2.86e-01	5.69e-02	2.62e-01	4.46e-01	8.03e-01
GOBP GENERAL ADAPTATION SYNDROME	6	5.01e-01	8.03e-01	0.4970	-4.43e-01	-1.37e-01	1.74e-01	2.58e-02	-3.71e-02	6.03e-02	5.62e-01	4.61e-01	9.13e-01	8.75e-01
GOBP DNA CYTOSINE DEAMINATION	9	3.54e-01	7.00e-01	0.4970	3.33e-01	-1.76e-02	-2.58e-01	-2.63e-01	-1.42e-02	8.34e-02	9.27e-01	1.80e-01	1.73e-01	9.41e-01
GOCC PROTEASOME CORE COMPLEX	20	4.89e-02	2.50e-01	0.4970	7.89e-03	-1.61e-02	-3.25e-01	-3.74e-01	-3.69e-02	9.51e-01	9.01e-01	1.18e-02	3.82e-03	7.75e-01
GOBP MAINTENANCE OF PROTEIN LOCATION IN EXTRACELLULAR REGION	8	2.45e-01	6.02e-01	0.4970	-4.35e-01	-5.99e-02	-3.25e-02	2.24e-01	5.51e-02	3.32e-02	7.69e-01	8.74e-01	2.73e-01	7.87e-01
GOBP MESENCHYMAL STEM CELL MAINTENANCE INVOLVED IN NEPHRON MORPHOGENESIS	6	3.14e-01	6.65e-01	0.4970	2.84e-01	-3.14e-01	3.93e-02	-2.10e-01	-1.49e-01	2.29e-01	1.83e-01	8.67e-01	3.72e-01	5.28e-01
GOBP ESTROGEN BIOSYNTHETIC PROCESS	11	1.54e-01	4.82e-01	0.4970	-1.69e-01	4.31e-01	9.79e-02	-6.43e-02	1.36e-01	3.31e-01	1.33e-02	5.74e-01	7.12e-01	4.33e-01
GOBP CELL PROLIFERATION IN MIDBRAIN	8	3.18e-01	6.67e-01	0.4970	-1.13e-01	-1.70e-01	-1.00e-02	-3.43e-01	2.96e-01	5.81e-01	4.06e-01	9.61e-01	9.32e-02	1.47e-01
GOBP PERIPHERAL NERVOUS SYSTEM AXON REGENERATION	8	3.42e-01	6.88e-01	0.4970	-2.10e-01	-3.53e-01	-2.79e-01	-9.00e-04	1.65e-02	3.04e-01	8.37e-02	1.73e-01	9.96e-01	9.35e-01
GOBP PROSTATE GLAND GROWTH	10	2.51e-01	6.07e-01	0.4960	-1.89e-01	-9.24e-02	3.73e-01	1.68e-01	1.87e-01	3.00e-01	6.13e-01	4.12e-02	3.58e-01	3.06e-01
GOBP AXON CHOICE POINT RECOGNITION	7	3.77e-01	7.16e-01	0.4960	6.04e-03	3.59e-02	4.60e-01	2.90e-02	1.80e-01	9.78e-01	8.69e-01	3.50e-02	8.94e-01	4.08e-01
GOBP PERICYTE CELL DIFFERENTIATION	11	1.26e-01	4.39e-01	0.4960	5.29e-03	4.30e-01	-2.33e-02	-3.39e-02	2.45e-01	9.76e-01	1.36e-02	8.93e-01	8.46e-01	1.60e-01
GOCC NEUROFILAMENT	9	4.15e-02	2.26e-01	0.4960	6.34e-02	5.18e-03	3.58e-01	-2.75e-01	-1.96e-01	7.42e-01	9.79e-01	6.32e-02	1.52e-01	3.09e-01
GOCC KINETOCHORE MICROTUBULE	20	5.31e-02	2.65e-01	0.4960	1.94e-01	-9.74e-02	-3.44e-01	-2.71e-01	8.60e-02	1.33e-01	4.51e-01	7.76e-03	3.60e-02	5.06e-01
GOBP OBSERVATIONAL LEARNING	7	5.22e-01	8.14e-01	0.4960	-5.42e-02	1.18e-01	1.78e-01	3.97e-01	-2.00e-01	8.04e-01	5.88e-01	4.16e-01	6.89e-02	3.60e-01
GOBP ADHESION OF SYMBIONT TO HOST CELL	8	2.89e-01	6.43e-01	0.4960	-4.05e-01	1.63e-01	9.16e-02	-2.09e-01	-5.26e-02	4.71e-02	4.24e-01	6.54e-01	3.05e-01	7.97e-01
GOBP RNA IMPORT INTO MITOCHONDRION	5	5.08e-01	8.07e-01	0.4960	-2.08e-01	7.39e-02	-2.74e-05	-4.28e-01	-1.18e-01	4.20e-01	7.75e-01	1.00e+00	9.77e-02	6.47e-01
GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION CHOLINERGIC	6	3.44e-01	6.90e-01	0.4960	-1.12e-01	-3.07e-01	3.40e-01	1.27e-02	-1.51e-01	6.33e-01	1.93e-01	1.49e-01	9.57e-01	5.21e-01
GOBP REGULATION OF CD40 SIGNALING PATHWAY	6	5.15e-01	8.10e-01	0.4960	-5.54e-02	-4.79e-01	-9.98e-02	5.03e-02	2.86e-02	8.14e-01	4.22e-02	6.72e-01	8.31e-01	9.03e-01
GOBP PROTEIN LOCALIZATION TO CYTOPLASMIC STRESS GRANULE	7	4.82e-01	7.93e-01	0.4960	1.52e-01	-1.39e-01	-2.91e-01	-2.58e-01	-2.27e-01	4.86e-01	5.24e-01	1.82e-01	2.36e-01	2.98e-01
GOMF SINGLE STRANDED DNA HELICASE ACTIVITY	23	2.20e-02	1.50e-01	0.4960	-1.17e-01	-7.94e-02	-2.99e-01	-3.69e-01	-8.42e-03	3.30e-01	5.10e-01	1.32e-02	2.16e-03	9.44e-01
GOBP POSITIVE THYMIC T CELL SELECTION	14	4.40e-02	2.33e-01	0.4960	6.25e-02	3.30e-02	3.92e-01	-8.75e-02	2.82e-01	6.86e-01	8.31e-01	1.11e-02	5.71e-01	6.77e-02
GOMF TOLL LIKE RECEPTOR 4 BINDING	5	6.25e-01	8.66e-01	0.4960	-2.82e-01	3.49e-02	-1.26e-01	-5.21e-02	-3.83e-01	2.75e-01	8.93e-01	6.27e-01	8.40e-01	1.38e-01
GOBP FORMATION OF TRANSLATION PREINITIATION COMPLEX	7	5.27e-01	8.17e-01	0.4960	-3.74e-02	-1.43e-01	-3.31e-01	-2.41e-01	2.37e-01	8.64e-01	5.13e-01	1.29e-01	2.69e-01	2.78e-01
GOCC SAGA COMPLEX	23	2.15e-02	1.48e-01	0.4950	2.46e-01	7.48e-02	-3.11e-01	-2.87e-01	2.10e-02	4.15e-02	5.35e-01	9.83e-03	1.72e-02	8.62e-01
GOMF NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY	11	1.21e-01	4.27e-01	0.4950	-1.26e-01	9.51e-02	-8.79e-02	-4.20e-01	-1.90e-01	4.70e-01	5.85e-01	6.14e-01	1.59e-02	2.74e-01
GOBP CELL PROLIFERATION IN BONE MARROW	10	2.43e-01	6.00e-01	0.4950	-1.25e-01	-7.29e-02	3.28e-01	1.67e-01	2.98e-01	4.94e-01	6.90e-01	7.27e-02	3.62e-01	1.02e-01
GOBP THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY	13	9.77e-02	3.78e-01	0.4950	-1.85e-01	-1.36e-01	-1.94e-01	-1.56e-01	3.61e-01	2.47e-01	3.97e-01	2.26e-01	3.31e-01	2.42e-02
GOBP POSITIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	6	5.25e-01	8.16e-01	0.4950	1.89e-01	1.81e-01	3.94e-01	4.95e-02	1.38e-01	4.23e-01	4.42e-01	9.50e-02	8.34e-01	5.57e-01
GOMF DESUMOYLASE ACTIVITY	7	4.92e-01	7.98e-01	0.4950	1.13e-01	-6.63e-02	-4.05e-01	-1.47e-01	-2.06e-01	6.06e-01	7.61e-01	6.38e-02	5.00e-01	3.45e-01
GOCC RNA POLYMERASE I TRANSCRIPTION REGULATOR COMPLEX	6	6.17e-01	8.62e-01	0.4950	-1.61e-03	9.92e-02	-3.34e-01	-3.29e-01	-1.24e-01	9.95e-01	6.74e-01	1.57e-01	1.63e-01	5.98e-01
GOMF POLY A RNA POLYMERASE ACTIVITY	11	1.64e-01	4.98e-01	0.4940	-1.91e-01	-1.01e-01	-1.16e-01	-4.28e-01	3.73e-02	2.73e-01	5.61e-01	5.05e-01	1.40e-02	8.31e-01
GOBP ATRIOVENTRICULAR NODE DEVELOPMENT	9	3.27e-01	6.76e-01	0.4940	2.78e-01	1.05e-01	1.46e-03	-1.79e-01	3.52e-01	1.49e-01	5.87e-01	9.94e-01	3.52e-01	6.73e-02
GOBP REGULATION OF TESTOSTERONE BIOSYNTHETIC PROCESS	7	3.20e-01	6.69e-01	0.4940	-2.97e-01	-2.25e-01	-9.76e-02	3.09e-01	1.52e-02	1.74e-01	3.02e-01	6.55e-01	1.56e-01	9.44e-01
GOBP BUNDLE OF HIS CELL TO PURKINJE MYOCYTE SIGNALING	7	4.32e-01	7.56e-01	0.4940	-1.23e-01	2.52e-01	8.33e-02	3.39e-01	-2.09e-01	5.73e-01	2.47e-01	7.03e-01	1.21e-01	3.39e-01
GOBP REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION	10	2.84e-01	6.38e-01	0.4940	-1.83e-01	-2.67e-01	1.63e-01	3.31e-01	-5.63e-02	3.18e-01	1.44e-01	3.73e-01	6.96e-02	7.58e-01
GOMF HISTONE H3K9ME2 H3K9ME3 DEMETHYLASE ACTIVITY	5	5.73e-01	8.39e-01	0.4940	3.93e-01	-4.60e-02	-2.77e-01	6.16e-02	8.11e-02	1.28e-01	8.59e-01	2.83e-01	8.11e-01	7.54e-01
GOBP REGULATION OF DENDRITIC CELL DIFFERENTIATION	13	1.36e-01	4.54e-01	0.4940	-2.59e-02	2.26e-01	-3.45e-01	-2.63e-01	-5.65e-02	8.71e-01	1.57e-01	3.11e-02	1.00e-01	7.24e-01
GOBP PROTEIN INSERTION INTO MITOCHONDRIAL INNER MEMBRANE	12	2.40e-01	5.96e-01	0.4940	8.11e-02	8.29e-02	-2.29e-01	-4.08e-01	1.08e-01	6.27e-01	6.19e-01	1.69e-01	1.45e-02	5.17e-01
GOBP MACROPINOCYTOSIS	10	2.00e-01	5.49e-01	0.4940	-2.13e-01	3.80e-01	-5.79e-03	-2.17e-01	-8.50e-02	2.44e-01	3.77e-02	9.75e-01	2.35e-01	6.42e-01
GOCC SYMMETRIC SYNAPSE	8	1.73e-01	5.13e-01	0.4940	6.08e-02	2.52e-01	3.12e-01	-2.82e-01	-1.01e-02	7.66e-01	2.18e-01	1.27e-01	1.68e-01	9.61e-01
GOBP KERATINIZATION	75	5.98e-08	3.54e-06	0.4940	-2.44e-01	-8.30e-02	2.66e-01	3.07e-01	-1.11e-01	2.64e-04	2.14e-01	6.66e-05	4.36e-06	9.58e-02
GOBP POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY	15	4.22e-02	2.28e-01	0.4940	2.11e-01	-9.27e-02	2.81e-01	-4.47e-02	3.31e-01	1.57e-01	5.34e-01	5.92e-02	7.64e-01	2.66e-02
GOBP GRANZYME MEDIATED PROGRAMMED CELL DEATH SIGNALING PATHWAY	8	3.09e-01	6.62e-01	0.4930	-8.11e-02	-4.06e-02	2.20e-01	-1.15e-01	4.17e-01	6.91e-01	8.42e-01	2.82e-01	5.72e-01	4.13e-02
GOMF EUKARYOTIC TRANSLATION INITIATION FACTOR 2ALPHA KINASE ACTIVITY	6	4.60e-01	7.78e-01	0.4930	-7.20e-02	4.48e-02	3.92e-01	7.54e-02	-2.77e-01	7.60e-01	8.49e-01	9.60e-02	7.49e-01	2.41e-01
GOBP SYNAPTIC VESICLE DOCKING	10	2.32e-01	5.85e-01	0.4930	-4.03e-01	-1.11e-01	-1.85e-01	-1.77e-01	-5.30e-02	2.72e-02	5.44e-01	3.12e-01	3.32e-01	7.72e-01
GOBP REGULATION OF CHAPERONE MEDIATED AUTOPHAGY	8	4.59e-01	7.77e-01	0.4930	1.09e-01	-1.25e-01	-4.25e-01	-1.88e-01	8.82e-03	5.94e-01	5.41e-01	3.74e-02	3.58e-01	9.66e-01
GOMF L ASPARTATE TRANSMEMBRANE TRANSPORTER ACTIVITY	9	3.03e-01	6.57e-01	0.4930	-4.27e-01	1.38e-01	1.47e-01	8.13e-02	-1.16e-01	2.65e-02	4.74e-01	4.44e-01	6.73e-01	5.47e-01
GOMF LYSOPHOSPHATIDIC ACID BINDING	7	3.64e-01	7.05e-01	0.4930	-1.54e-01	-3.09e-01	1.73e-02	3.06e-01	1.73e-01	4.79e-01	1.58e-01	9.37e-01	1.60e-01	4.29e-01
GOBP AXON MIDLINE CHOICE POINT RECOGNITION	5	6.11e-01	8.58e-01	0.4930	1.56e-01	1.12e-02	4.03e-01	6.87e-02	2.27e-01	5.46e-01	9.65e-01	1.19e-01	7.90e-01	3.80e-01
GOMF OPSONIN RECEPTOR ACTIVITY	5	6.05e-01	8.55e-01	0.4930	-3.50e-01	3.09e-01	1.24e-01	-7.46e-02	6.24e-02	1.75e-01	2.32e-01	6.31e-01	7.73e-01	8.09e-01
GOBP ENDOTHELIAL CELL MORPHOGENESIS	9	3.20e-01	6.69e-01	0.4930	-3.38e-01	-2.40e-01	2.98e-02	1.93e-01	-1.82e-01	7.91e-02	2.13e-01	8.77e-01	3.17e-01	3.44e-01
GOMF SNRNP BINDING	9	3.87e-01	7.24e-01	0.4930	5.62e-02	-1.70e-01	-3.15e-01	-2.17e-01	2.54e-01	7.70e-01	3.78e-01	1.02e-01	2.60e-01	1.87e-01
GOCC UNIPLEX COMPLEX	6	3.43e-01	6.90e-01	0.4930	1.99e-01	2.56e-01	2.05e-01	-2.96e-01	-8.86e-02	3.99e-01	2.77e-01	3.84e-01	2.09e-01	7.07e-01
GOBP G PROTEIN COUPLED SEROTONIN RECEPTOR SIGNALING PATHWAY	22	1.80e-02	1.32e-01	0.4930	2.59e-01	1.95e-01	2.99e-01	2.00e-01	9.08e-02	3.55e-02	1.14e-01	1.53e-02	1.04e-01	4.61e-01
GOMF PROTEIN GLUTAMIC ACID LIGASE ACTIVITY	10	2.54e-01	6.12e-01	0.4930	-2.89e-01	3.05e-01	2.05e-01	1.55e-01	3.91e-03	1.13e-01	9.49e-02	2.62e-01	3.97e-01	9.83e-01
GOBP NEGATIVE REGULATION OF NOREPINEPHRINE SECRETION	5	3.60e-01	7.04e-01	0.4930	2.09e-01	-1.25e-02	1.48e-01	-4.18e-01	-4.69e-02	4.19e-01	9.62e-01	5.68e-01	1.05e-01	8.56e-01
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE	37	1.27e-03	1.87e-02	0.4930	-5.95e-02	-7.52e-02	-3.09e-01	-3.61e-01	8.50e-02	5.31e-01	4.29e-01	1.12e-03	1.44e-04	3.71e-01
GOBP DISTAL TUBULE DEVELOPMENT	12	1.06e-01	3.96e-01	0.4920	2.32e-01	3.11e-01	1.08e-01	-2.78e-01	5.55e-02	1.63e-01	6.21e-02	5.18e-01	9.58e-02	7.39e-01
GOBP PLASMA CELL DIFFERENTIATION	8	3.05e-01	6.58e-01	0.4920	-3.16e-01	3.52e-01	-5.99e-02	-1.22e-01	-3.02e-02	1.22e-01	8.51e-02	7.69e-01	5.51e-01	8.82e-01
GOBP SODIUM DEPENDENT PHOSPHATE TRANSPORT	12	1.28e-01	4.42e-01	0.4920	8.99e-02	3.43e-01	3.32e-02	1.28e-01	-3.14e-01	5.90e-01	3.94e-02	8.42e-01	4.42e-01	5.94e-02
GOBP PEPTIDE CROSS LINKING	26	9.30e-03	8.30e-02	0.4920	-2.10e-01	-8.49e-02	1.50e-01	3.69e-01	-1.80e-01	6.32e-02	4.53e-01	1.84e-01	1.13e-03	1.13e-01
GOBP TAIL ANCHORED MEMBRANE PROTEIN INSERTION INTO ER MEMBRANE	15	1.32e-01	4.49e-01	0.4920	1.77e-01	1.37e-01	-2.58e-01	-3.50e-01	5.62e-02	2.34e-01	3.58e-01	8.41e-02	1.89e-02	7.06e-01
GOBP NEGATIVE REGULATION OF T CELL CYTOKINE PRODUCTION	9	2.19e-01	5.73e-01	0.4920	-3.25e-01	-4.51e-02	3.12e-01	-6.47e-02	1.81e-01	9.11e-02	8.15e-01	1.05e-01	7.37e-01	3.47e-01
GOBP SECRETION OF LYSOSOMAL ENZYMES	7	5.77e-01	8.42e-01	0.4920	1.88e-03	-1.56e-01	-3.29e-01	-3.29e-01	-3.04e-02	9.93e-01	4.74e-01	1.31e-01	1.31e-01	8.89e-01
GOCC WASH COMPLEX	8	2.93e-01	6.48e-01	0.4920	-6.46e-02	-1.13e-03	-1.25e-01	-2.33e-01	-4.10e-01	7.52e-01	9.96e-01	5.39e-01	2.54e-01	4.47e-02
GOMF HEXOKINASE ACTIVITY	5	7.11e-01	8.99e-01	0.4920	5.10e-02	1.85e-01	2.58e-01	2.62e-01	-2.65e-01	8.43e-01	4.74e-01	3.19e-01	3.10e-01	3.05e-01
GOBP MANGANESE ION TRANSPORT	11	7.63e-02	3.32e-01	0.4920	5.74e-02	8.25e-02	3.05e-01	-2.84e-01	2.40e-01	7.41e-01	6.35e-01	7.94e-02	1.03e-01	1.68e-01
GOBP REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS	13	1.61e-01	4.93e-01	0.4920	3.47e-03	2.56e-01	-2.44e-01	-3.21e-01	1.19e-01	9.83e-01	1.11e-01	1.28e-01	4.52e-02	4.57e-01
GOBP NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS	9	3.16e-01	6.66e-01	0.4920	1.00e-02	1.35e-01	4.21e-01	7.68e-02	2.00e-01	9.59e-01	4.82e-01	2.87e-02	6.90e-01	2.98e-01
GOMF BIOTIN BINDING	5	6.79e-01	8.87e-01	0.4910	3.95e-02	3.86e-01	2.49e-01	1.27e-01	-1.15e-01	8.78e-01	1.35e-01	3.36e-01	6.23e-01	6.55e-01
GOCC TELOMERASE HOLOENZYME COMPLEX	20	5.92e-02	2.84e-01	0.4910	-2.32e-02	-1.40e-01	-3.24e-01	-3.33e-01	7.59e-02	8.57e-01	2.80e-01	1.21e-02	1.00e-02	5.57e-01
GOBP POLYOL TRANSMEMBRANE TRANSPORT	10	2.13e-01	5.66e-01	0.4910	-3.52e-01	1.88e-01	-8.60e-02	-8.83e-02	-2.59e-01	5.40e-02	3.04e-01	6.38e-01	6.29e-01	1.56e-01
GOMF GUANYLATE CYCLASE ACTIVITY	7	3.35e-01	6.82e-01	0.4910	1.55e-01	2.43e-01	4.46e-02	3.95e-01	-8.00e-03	4.76e-01	2.65e-01	8.38e-01	7.05e-02	9.71e-01
GOBP BRANCHED CHAIN AMINO ACID BIOSYNTHETIC PROCESS	5	5.74e-01	8.40e-01	0.4910	4.79e-01	6.47e-04	1.07e-01	-4.80e-03	9.58e-03	6.35e-02	9.98e-01	6.78e-01	9.85e-01	9.70e-01
GOBP POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING	22	3.10e-02	1.87e-01	0.4910	4.75e-02	-1.27e-01	-2.16e-01	-3.68e-01	2.02e-01	7.00e-01	3.04e-01	7.94e-02	2.81e-03	1.01e-01
GOBP NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION	18	1.32e-02	1.07e-01	0.4910	7.93e-02	4.53e-01	-1.64e-01	-2.95e-02	-4.21e-02	5.60e-01	8.74e-04	2.29e-01	8.29e-01	7.57e-01
GOMF DNA APURINIC OR APYRIMIDINIC SITE ENDONUCLEASE ACTIVITY	12	1.83e-01	5.25e-01	0.4910	1.59e-01	1.64e-01	-3.56e-01	-2.16e-01	1.25e-01	3.42e-01	3.24e-01	3.29e-02	1.94e-01	4.54e-01
GOBP POSITIVE REGULATION OF BLOOD PRESSURE BY EPINEPHRINE NOREPINEPHRINE	6	4.18e-01	7.48e-01	0.4910	2.84e-02	-1.23e-01	2.89e-01	-1.50e-01	3.45e-01	9.04e-01	6.01e-01	2.21e-01	5.24e-01	1.43e-01
GOBP REGULATION OF DNA TEMPLATED DNA REPLICATION INITIATION	15	9.23e-02	3.67e-01	0.4910	-2.87e-01	1.51e-02	-2.45e-01	-3.11e-01	4.12e-02	5.44e-02	9.19e-01	1.00e-01	3.71e-02	7.82e-01
GOBP MESENDODERM DEVELOPMENT	9	2.58e-01	6.15e-01	0.4900	3.04e-02	-4.04e-01	-2.18e-02	-1.45e-01	2.34e-01	8.75e-01	3.57e-02	9.10e-01	4.50e-01	2.25e-01
GOCC ENDOPLASMIC RETICULUM PALMITOYLTRANSFERASE COMPLEX	8	3.96e-01	7.29e-01	0.4900	3.10e-01	1.22e-01	-2.93e-01	-1.76e-01	-1.13e-01	1.29e-01	5.49e-01	1.51e-01	3.90e-01	5.79e-01
GOBP NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION	19	4.56e-02	2.39e-01	0.4900	-9.06e-03	3.46e-01	2.66e-01	1.81e-01	-1.30e-01	9.46e-01	9.06e-03	4.43e-02	1.71e-01	3.27e-01
GOBP POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN WOUND HEALING	10	1.85e-01	5.28e-01	0.4900	-3.41e-01	-5.07e-03	1.48e-01	1.41e-01	2.87e-01	6.17e-02	9.78e-01	4.19e-01	4.41e-01	1.16e-01
GOCC CYTOSOLIC RIBOSOME	107	6.05e-12	6.25e-10	0.4900	-1.58e-01	1.01e-02	-3.44e-01	-3.11e-01	-3.89e-03	4.81e-03	8.57e-01	7.63e-10	2.59e-08	9.45e-01
GOMF SERINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY	94	9.66e-10	7.72e-08	0.4900	-8.04e-02	-1.64e-02	2.40e-01	3.98e-01	-1.33e-01	1.78e-01	7.84e-01	5.57e-05	2.66e-11	2.57e-02
GOBP RESPONSE TO NEMATODE	7	4.90e-01	7.98e-01	0.4900	8.96e-03	-1.95e-02	-3.94e-01	-1.51e-01	-2.49e-01	9.67e-01	9.29e-01	7.11e-02	4.90e-01	2.54e-01
GOBP IRIS MORPHOGENESIS	10	1.19e-01	4.23e-01	0.4900	3.17e-02	2.02e-01	8.57e-02	-4.37e-01	-1.73e-02	8.62e-01	2.69e-01	6.39e-01	1.68e-02	9.24e-01
GOBP BEHAVIORAL RESPONSE TO NICOTINE	9	4.06e-01	7.39e-01	0.4900	-8.23e-02	-2.51e-01	-3.11e-01	-2.51e-01	1.01e-01	6.69e-01	1.92e-01	1.06e-01	1.92e-01	6.01e-01
GOCC INO80 COMPLEX	15	9.06e-02	3.63e-01	0.4900	2.60e-01	-1.21e-01	-5.79e-02	-1.84e-01	3.47e-01	8.08e-02	4.15e-01	6.98e-01	2.18e-01	2.00e-02
GOBP LIPOPHAGY	7	4.54e-01	7.73e-01	0.4900	2.51e-01	2.74e-01	-3.62e-02	-3.10e-01	6.65e-02	2.50e-01	2.09e-01	8.68e-01	1.56e-01	7.61e-01
GOBP POSITIVE REGULATION OF GLIAL CELL MIGRATION	11	2.14e-01	5.67e-01	0.4900	-2.36e-01	-2.30e-01	1.89e-01	2.97e-01	8.54e-02	1.75e-01	1.87e-01	2.78e-01	8.78e-02	6.24e-01
GOMF RETINAL DEHYDROGENASE ACTIVITY	8	3.26e-01	6.74e-01	0.4900	-6.34e-02	-8.86e-02	-1.28e-02	4.36e-01	-1.95e-01	7.56e-01	6.64e-01	9.50e-01	3.29e-02	3.40e-01
GOMF GLUCOSYLTRANSFERASE ACTIVITY	19	3.69e-02	2.09e-01	0.4890	2.70e-01	-1.73e-01	-3.48e-01	-9.34e-02	8.16e-02	4.15e-02	1.93e-01	8.55e-03	4.81e-01	5.38e-01
GOBP NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH	12	1.66e-01	5.02e-01	0.4890	2.45e-01	1.76e-01	1.52e-02	-3.01e-01	2.41e-01	1.42e-01	2.90e-01	9.27e-01	7.15e-02	1.48e-01
GOBP NEGATIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY	9	3.35e-01	6.82e-01	0.4890	1.62e-01	-1.01e-01	2.55e-01	3.10e-01	2.04e-01	3.99e-01	6.01e-01	1.85e-01	1.07e-01	2.89e-01
GOBP OOCYTE CONSTRUCTION	8	3.62e-01	7.04e-01	0.4890	-2.55e-01	3.59e-01	2.07e-01	-4.50e-02	-3.08e-02	2.12e-01	7.90e-02	3.11e-01	8.26e-01	8.80e-01
GOBP POSITIVE REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY	5	5.60e-01	8.33e-01	0.4890	4.75e-02	-1.73e-01	1.60e-01	-2.20e-01	3.64e-01	8.54e-01	5.03e-01	5.35e-01	3.93e-01	1.58e-01
GOCC CYTOSOLIC SMALL RIBOSOMAL SUBUNIT	36	4.65e-04	8.41e-03	0.4890	-2.03e-01	1.04e-01	-3.16e-01	-2.86e-01	-7.63e-02	3.54e-02	2.81e-01	1.05e-03	2.97e-03	4.28e-01
GOBP REGULATION OF ANGIOTENSIN LEVELS IN BLOOD	8	4.27e-01	7.54e-01	0.4890	8.39e-02	-9.00e-02	2.63e-01	2.81e-01	-2.75e-01	6.81e-01	6.59e-01	1.98e-01	1.68e-01	1.78e-01
GOBP REGULATION OF IRON ION TRANSPORT	7	3.72e-01	7.11e-01	0.4890	-3.52e-01	7.78e-02	2.72e-01	-1.25e-01	1.39e-01	1.07e-01	7.21e-01	2.13e-01	5.66e-01	5.24e-01
GOBP POSITIVE REGULATION OF RESPONSE TO TYPE II INTERFERON	6	5.63e-01	8.34e-01	0.4880	4.37e-01	-4.28e-02	-1.69e-01	-1.04e-01	8.07e-02	6.38e-02	8.56e-01	4.75e-01	6.59e-01	7.32e-01
GOBP IMP CATABOLIC PROCESS	5	5.90e-01	8.47e-01	0.4880	9.37e-02	1.95e-01	-1.26e-01	-2.31e-01	-3.50e-01	7.17e-01	4.51e-01	6.25e-01	3.70e-01	1.76e-01
GOBP PHOSPHATIDYLGLYCEROL BIOSYNTHETIC PROCESS	9	4.43e-01	7.66e-01	0.4880	-4.27e-02	-1.87e-02	-3.54e-01	-3.32e-01	2.86e-02	8.25e-01	9.23e-01	6.60e-02	8.45e-02	8.82e-01
GOBP POSITIVE REGULATION OF NEUROTRANSMITTER UPTAKE	6	5.63e-01	8.34e-01	0.4880	-4.22e-02	3.43e-01	1.47e-01	1.13e-01	-2.91e-01	8.58e-01	1.46e-01	5.32e-01	6.31e-01	2.18e-01
GOBP REDUCTION OF FOOD INTAKE IN RESPONSE TO DIETARY EXCESS	5	7.33e-01	9.08e-01	0.4880	6.65e-02	1.20e-01	3.74e-01	2.55e-01	1.21e-01	7.97e-01	6.42e-01	1.48e-01	3.23e-01	6.41e-01
GOBP MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA	25	1.93e-02	1.38e-01	0.4880	-3.29e-03	-6.48e-02	-4.00e-01	-2.72e-01	1.34e-02	9.77e-01	5.75e-01	5.40e-04	1.84e-02	9.07e-01
GOMF GLYCINE BINDING	10	2.22e-01	5.76e-01	0.4880	-1.96e-01	2.61e-01	-9.05e-02	-2.29e-01	2.67e-01	2.83e-01	1.52e-01	6.20e-01	2.11e-01	1.44e-01
GOMF INTERLEUKIN 2 RECEPTOR BINDING	5	6.67e-01	8.82e-01	0.4880	6.05e-02	1.89e-01	3.72e-01	4.58e-02	2.41e-01	8.15e-01	4.63e-01	1.50e-01	8.59e-01	3.50e-01
GOBP VITAMIN A METABOLIC PROCESS	8	3.69e-01	7.09e-01	0.4880	-2.00e-01	-4.18e-01	-1.35e-01	6.46e-02	-3.68e-02	3.28e-01	4.08e-02	5.08e-01	7.52e-01	8.57e-01
GOBP WOUND HEALING INVOLVED IN INFLAMMATORY RESPONSE	8	3.61e-01	7.04e-01	0.4880	4.88e-02	3.05e-01	3.17e-02	-9.97e-02	3.63e-01	8.11e-01	1.35e-01	8.76e-01	6.25e-01	7.55e-02
GOBP MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM	12	1.15e-01	4.14e-01	0.4880	-1.05e-01	1.23e-01	-1.22e-01	-3.55e-01	-2.66e-01	5.28e-01	4.60e-01	4.64e-01	3.31e-02	1.11e-01
GOBP REGULATION OF SYNAPTIC VESICLE TRANSPORT	5	6.46e-01	8.76e-01	0.4880	9.02e-02	2.59e-01	2.05e-01	2.50e-01	2.41e-01	7.27e-01	3.15e-01	4.27e-01	3.33e-01	3.52e-01
GOBP SIRNA PROCESSING	9	3.89e-01	7.25e-01	0.4880	1.85e-01	-4.26e-02	-3.08e-01	-1.99e-01	2.60e-01	3.38e-01	8.25e-01	1.10e-01	3.01e-01	1.77e-01
GOBP REGULATION OF RESPIRATORY GASEOUS EXCHANGE	21	5.15e-03	5.46e-02	0.4870	-4.95e-03	2.37e-01	8.29e-02	-4.13e-01	6.07e-02	9.69e-01	6.03e-02	5.11e-01	1.05e-03	6.30e-01
GOMF PRIMARY MIRNA BINDING	9	3.29e-01	6.77e-01	0.4870	1.27e-01	1.90e-01	-3.18e-01	-2.13e-01	-1.96e-01	5.09e-01	3.24e-01	9.86e-02	2.67e-01	3.08e-01
GOMF PROTEIN HORMONE RECEPTOR ACTIVITY	20	6.15e-02	2.91e-01	0.4870	-1.65e-01	2.92e-02	3.30e-01	2.78e-01	-1.52e-01	2.00e-01	8.21e-01	1.07e-02	3.14e-02	2.39e-01
GOMF RNA POLYMERASE III TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING	9	3.64e-01	7.05e-01	0.4870	2.09e-01	-1.71e-01	-1.14e-01	-2.39e-01	3.07e-01	2.78e-01	3.73e-01	5.55e-01	2.15e-01	1.11e-01
GOBP NEGATIVE REGULATION OF SEQUESTERING OF TRIGLYCERIDE	6	4.70e-01	7.85e-01	0.4870	-3.04e-01	-5.38e-02	1.06e-01	8.76e-02	3.51e-01	1.97e-01	8.20e-01	6.53e-01	7.10e-01	1.37e-01
GOBP NADH DEHYDROGENASE COMPLEX ASSEMBLY	52	3.78e-05	1.06e-03	0.4870	5.80e-02	-1.62e-01	-2.55e-01	-3.53e-01	1.34e-01	4.69e-01	4.39e-02	1.45e-03	1.08e-05	9.38e-02
GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION	34	2.18e-03	2.88e-02	0.4870	2.65e-01	-1.28e-01	-2.92e-01	-2.44e-01	7.42e-02	7.51e-03	1.95e-01	3.17e-03	1.39e-02	4.54e-01
GOBP REGULATION OF BILE ACID SECRETION	6	6.14e-01	8.60e-01	0.4870	-3.25e-01	-8.76e-02	2.07e-01	1.89e-01	-2.12e-01	1.68e-01	7.10e-01	3.80e-01	4.23e-01	3.69e-01
GOBP POSITIVE REGULATION OF VASCULAR PERMEABILITY	18	3.58e-02	2.05e-01	0.4870	-1.57e-01	1.46e-01	-4.13e-03	2.46e-01	-3.61e-01	2.49e-01	2.85e-01	9.76e-01	7.10e-02	7.94e-03
GOMF HISTONE DEACETYLASE REGULATOR ACTIVITY	6	3.38e-01	6.85e-01	0.4870	3.66e-01	-2.09e-01	1.08e-01	-1.06e-01	-1.91e-01	1.20e-01	3.76e-01	6.46e-01	6.54e-01	4.19e-01
GOBP N TERMINAL PEPTIDYL METHIONINE ACETYLATION	6	6.05e-01	8.55e-01	0.4870	1.50e-01	1.94e-01	-6.28e-02	-3.34e-01	2.47e-01	5.24e-01	4.11e-01	7.90e-01	1.57e-01	2.94e-01
GOMF PEPTIDOGLYCAN BINDING	18	5.79e-02	2.80e-01	0.4870	-2.86e-01	-5.93e-04	9.46e-02	2.50e-01	-2.90e-01	3.59e-02	9.97e-01	4.87e-01	6.67e-02	3.34e-02
GOBP REGULATION OF FOREBRAIN NEURON DIFFERENTIATION	5	6.55e-01	8.80e-01	0.4870	1.68e-01	-8.62e-02	-4.13e-02	-3.61e-01	2.63e-01	5.14e-01	7.39e-01	8.73e-01	1.63e-01	3.08e-01
GOBP LUNG ASSOCIATED MESENCHYME DEVELOPMENT	8	2.88e-01	6.41e-01	0.4870	-3.25e-01	-3.31e-01	1.20e-01	-7.84e-02	2.62e-02	1.11e-01	1.05e-01	5.56e-01	7.01e-01	8.98e-01
GOBP NEURAL PLATE ANTERIOR POSTERIOR REGIONALIZATION	5	6.78e-01	8.87e-01	0.4860	7.87e-03	2.41e-01	-1.72e-01	-3.83e-01	-4.56e-02	9.76e-01	3.51e-01	5.06e-01	1.38e-01	8.60e-01
GOBP POSITIVE REGULATION OF TRIGLYCERIDE LIPASE ACTIVITY	9	1.68e-01	5.05e-01	0.4860	-3.01e-01	-1.98e-01	-1.83e-01	1.04e-01	2.50e-01	1.18e-01	3.03e-01	3.42e-01	5.88e-01	1.94e-01
GOCC SPECTRIN ASSOCIATED CYTOSKELETON	9	3.87e-01	7.24e-01	0.4860	5.44e-02	2.75e-01	2.24e-01	3.05e-01	-1.20e-01	7.77e-01	1.53e-01	2.44e-01	1.13e-01	5.34e-01
GOMF FRUCTOSE TRANSMEMBRANE TRANSPORTER ACTIVITY	9	4.11e-01	7.43e-01	0.4860	9.95e-02	2.38e-01	3.26e-01	2.43e-01	7.07e-02	6.05e-01	2.17e-01	9.04e-02	2.07e-01	7.13e-01
GOBP R LOOP PROCESSING	6	5.32e-01	8.20e-01	0.4860	2.71e-01	-3.56e-03	2.48e-02	4.37e-02	4.01e-01	2.51e-01	9.88e-01	9.16e-01	8.53e-01	8.92e-02
GOBP MULTINUCLEAR OSTEOCLAST DIFFERENTIATION	8	3.22e-01	6.70e-01	0.4860	-4.13e-01	1.24e-01	1.74e-01	-1.10e-01	-8.89e-02	4.28e-02	5.45e-01	3.94e-01	5.92e-01	6.63e-01
GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS	15	3.90e-02	2.17e-01	0.4860	-2.73e-01	9.78e-02	8.88e-02	7.15e-02	3.73e-01	6.67e-02	5.12e-01	5.52e-01	6.31e-01	1.24e-02
GOBP NEGATIVE REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS	5	6.29e-01	8.68e-01	0.4860	-3.83e-01	-7.05e-02	-1.31e-01	1.10e-01	-2.36e-01	1.38e-01	7.85e-01	6.11e-01	6.70e-01	3.62e-01
GOMF GPI ANCHOR BINDING	7	5.70e-01	8.38e-01	0.4860	1.11e-01	1.47e-01	-3.07e-01	-3.06e-01	1.20e-01	6.11e-01	5.00e-01	1.60e-01	1.61e-01	5.82e-01
GOBP POSITIVE REGULATION OF SEQUESTERING OF TRIGLYCERIDE	9	2.63e-01	6.19e-01	0.4860	-6.44e-02	1.38e-01	-2.62e-02	-4.53e-01	8.53e-02	7.38e-01	4.73e-01	8.92e-01	1.87e-02	6.58e-01
GOBP RECOGNITION OF APOPTOTIC CELL	7	3.29e-01	6.77e-01	0.4860	-3.95e-01	-5.10e-02	-5.00e-02	6.44e-02	2.65e-01	7.01e-02	8.15e-01	8.19e-01	7.68e-01	2.24e-01
GOBP REGULATION OF INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION	9	2.61e-01	6.18e-01	0.4860	3.11e-01	1.17e-01	1.60e-01	-2.06e-01	2.40e-01	1.07e-01	5.43e-01	4.05e-01	2.85e-01	2.12e-01
GOBP POSITIVE REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING SIGNALING PATHWAY	7	4.60e-01	7.78e-01	0.4860	-1.26e-01	2.10e-01	1.10e-02	-3.20e-01	2.71e-01	5.65e-01	3.35e-01	9.60e-01	1.43e-01	2.14e-01
GOBP REGULATION OF NUCLEASE ACTIVITY	22	2.48e-02	1.61e-01	0.4860	4.10e-02	1.93e-01	-2.39e-01	-3.73e-01	-3.41e-02	7.39e-01	1.17e-01	5.26e-02	2.49e-03	7.82e-01
GOMF STRUCTURAL MOLECULE ACTIVITY CONFERRING ELASTICITY	12	1.28e-01	4.41e-01	0.4860	-1.33e-01	3.34e-01	1.47e-01	2.84e-01	6.69e-02	4.23e-01	4.52e-02	3.78e-01	8.90e-02	6.88e-01
GOBP REGULATION OF T HELPER 1 CELL DIFFERENTIATION	11	9.57e-02	3.74e-01	0.4850	-2.52e-02	3.13e-01	-2.96e-01	3.94e-02	-2.20e-01	8.85e-01	7.25e-02	8.95e-02	8.21e-01	2.07e-01
GOCC NUCLEAR INCLUSION BODY	12	2.57e-01	6.14e-01	0.4850	-1.09e-01	-1.64e-01	-2.89e-01	-3.30e-01	6.56e-02	5.13e-01	3.24e-01	8.34e-02	4.76e-02	6.94e-01
GOMF N ACYLSPHINGOSINE AMIDOHYDROLASE ACTIVITY	7	4.29e-01	7.54e-01	0.4850	-1.20e-01	-4.25e-01	-5.96e-02	1.93e-02	1.92e-01	5.81e-01	5.16e-02	7.85e-01	9.30e-01	3.80e-01
GOBP AXONOGENESIS INVOLVED IN INNERVATION	9	3.87e-01	7.24e-01	0.4850	-1.20e-01	1.91e-01	1.63e-01	3.27e-01	-2.26e-01	5.32e-01	3.21e-01	3.97e-01	8.97e-02	2.39e-01
GOBP MESENCHYMAL STEM CELL DIFFERENTIATION	12	5.16e-02	2.60e-01	0.4850	-4.29e-02	-5.82e-02	4.00e-01	-6.08e-04	-2.65e-01	7.97e-01	7.27e-01	1.63e-02	9.97e-01	1.13e-01
GOBP REGULATION OF HOMOPHILIC CELL ADHESION	5	7.26e-01	9.05e-01	0.4850	8.98e-02	-3.45e-02	3.83e-01	2.80e-01	2.64e-02	7.28e-01	8.94e-01	1.38e-01	2.78e-01	9.18e-01
GOMF K48 LINKED POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING	10	3.16e-01	6.66e-01	0.4850	-2.57e-02	1.74e-01	-3.48e-01	-2.88e-01	2.14e-02	8.88e-01	3.41e-01	5.70e-02	1.15e-01	9.07e-01
GOBP TRANSCRIPTION DEPENDENT TETHERING OF RNA POLYMERASE II GENE DNA AT NUCLEAR PERIPHERY	7	5.90e-01	8.47e-01	0.4850	1.42e-01	-1.40e-01	-3.39e-01	-2.81e-01	-4.46e-02	5.16e-01	5.20e-01	1.21e-01	1.99e-01	8.38e-01
GOMF NADPLUS PROTEIN LYSINE ADP RIBOSYLTRANSFERASE ACTIVITY	5	7.38e-01	9.11e-01	0.4850	4.82e-02	-1.69e-01	-4.05e-01	-1.99e-01	2.36e-02	8.52e-01	5.12e-01	1.17e-01	4.40e-01	9.27e-01
GOBP NEGATIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT	6	4.65e-01	7.81e-01	0.4850	1.76e-01	-1.96e-01	-1.05e-01	-3.90e-01	-5.15e-02	4.55e-01	4.06e-01	6.57e-01	9.81e-02	8.27e-01
GOBP POSITIVE REGULATION OF NECROPTOTIC PROCESS	7	3.12e-01	6.63e-01	0.4850	4.35e-01	3.71e-04	7.82e-02	-1.13e-01	-1.63e-01	4.61e-02	9.99e-01	7.20e-01	6.04e-01	4.56e-01
GOBP POLYPRENOL METABOLIC PROCESS	23	3.29e-02	1.94e-01	0.4850	1.58e-01	-1.14e-01	-3.50e-01	-2.71e-01	-3.00e-02	1.88e-01	3.46e-01	3.71e-03	2.42e-02	8.03e-01
GOBP NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION	8	3.23e-01	6.71e-01	0.4850	2.42e-01	1.54e-01	1.12e-02	-3.82e-01	8.25e-02	2.36e-01	4.52e-01	9.56e-01	6.16e-02	6.86e-01
GOBP REGULATION OF ISOMERASE ACTIVITY	8	4.01e-01	7.34e-01	0.4840	4.08e-02	4.00e-01	2.52e-01	3.61e-02	-9.03e-02	8.41e-01	5.00e-02	2.18e-01	8.60e-01	6.58e-01
GOMF MINUS END DIRECTED MICROTUBULE MOTOR ACTIVITY	17	9.49e-02	3.72e-01	0.4840	1.18e-01	-3.20e-03	2.61e-01	3.85e-01	-6.64e-02	4.00e-01	9.82e-01	6.28e-02	5.98e-03	6.35e-01
GOCC ENDOPLASMIC RETICULUM PLASMA MEMBRANE CONTACT SITE	12	1.77e-01	5.18e-01	0.4840	-8.93e-03	3.70e-01	2.25e-01	3.59e-02	2.14e-01	9.57e-01	2.66e-02	1.77e-01	8.30e-01	1.99e-01
GOBP NEGATIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY	12	1.75e-01	5.15e-01	0.4840	1.47e-01	-1.63e-01	-2.89e-02	-2.42e-01	3.56e-01	3.78e-01	3.29e-01	8.63e-01	1.47e-01	3.25e-02
GOBP POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY	9	3.01e-01	6.55e-01	0.4840	2.37e-01	1.87e-01	-1.54e-01	-3.11e-01	-1.51e-01	2.19e-01	3.31e-01	4.24e-01	1.06e-01	4.33e-01
GOBP PEPTIDYL HISTIDINE MODIFICATION	8	4.30e-01	7.55e-01	0.4840	1.44e-01	3.62e-02	-2.57e-01	-3.38e-01	-1.78e-01	4.82e-01	8.59e-01	2.08e-01	9.75e-02	3.83e-01
GOBP MITOTIC NUCLEAR MEMBRANE ORGANIZATION	10	3.88e-01	7.25e-01	0.4840	1.30e-01	-1.09e-01	-2.46e-01	-3.20e-01	2.07e-01	4.78e-01	5.52e-01	1.79e-01	7.99e-02	2.57e-01
GOBP REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE	16	6.64e-02	3.04e-01	0.4840	6.80e-02	-1.54e-01	2.01e-01	3.58e-01	1.93e-01	6.38e-01	2.86e-01	1.65e-01	1.32e-02	1.82e-01
GOMF GLUCOSE SODIUM SYMPORTER ACTIVITY	7	4.73e-01	7.86e-01	0.4840	1.70e-01	1.96e-02	2.43e-01	2.19e-01	-3.12e-01	4.35e-01	9.29e-01	2.66e-01	3.15e-01	1.53e-01
GOBP REGULATION OF LYSOSOME ORGANIZATION	12	2.52e-01	6.08e-01	0.4830	2.35e-01	-2.93e-02	-3.01e-01	-2.17e-01	1.99e-01	1.58e-01	8.60e-01	7.09e-02	1.92e-01	2.33e-01
GOBP NEPHRIC DUCT FORMATION	5	4.44e-01	7.67e-01	0.4830	2.07e-01	-2.20e-01	6.51e-02	-3.71e-01	2.78e-02	4.24e-01	3.94e-01	8.01e-01	1.51e-01	9.14e-01
GOMF PYRUVATE DEHYDROGENASE LIPOAMIDE PHOSPHATASE ACTIVITY	5	6.69e-01	8.83e-01	0.4830	-3.39e-01	-2.26e-01	-1.92e-01	-1.71e-01	-3.06e-02	1.89e-01	3.81e-01	4.57e-01	5.09e-01	9.06e-01
GOBP ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY	8	4.34e-01	7.57e-01	0.4830	1.26e-01	5.22e-02	1.70e-01	4.22e-01	-8.60e-02	5.37e-01	7.98e-01	4.06e-01	3.86e-02	6.74e-01
GOBP RESPONSE TO SORBITOL	6	5.55e-01	8.31e-01	0.4830	1.70e-01	1.35e-01	3.23e-02	-4.82e-02	4.27e-01	4.71e-01	5.67e-01	8.91e-01	8.38e-01	6.98e-02
GOBP REGULATION OF HEMOGLOBIN BIOSYNTHETIC PROCESS	8	5.35e-01	8.21e-01	0.4830	7.60e-02	2.03e-02	-3.20e-01	-3.22e-01	1.45e-01	7.10e-01	9.21e-01	1.18e-01	1.15e-01	4.76e-01
GOBP METANEPHRIC GLOMERULAR MESANGIUM DEVELOPMENT	5	7.07e-01	8.97e-01	0.4830	4.23e-02	3.71e-01	2.44e-01	1.80e-01	-4.34e-02	8.70e-01	1.51e-01	3.45e-01	4.86e-01	8.67e-01
GOBP ISOLEUCINE METABOLIC PROCESS	6	5.71e-01	8.38e-01	0.4830	4.01e-01	-8.95e-02	-2.18e-01	-1.15e-01	-5.77e-02	8.88e-02	7.04e-01	3.55e-01	6.27e-01	8.07e-01
GOBP SNRNA PROCESSING	25	2.50e-02	1.62e-01	0.4830	4.42e-02	-7.25e-02	-3.76e-01	-2.91e-01	-1.45e-02	7.02e-01	5.30e-01	1.15e-03	1.19e-02	9.00e-01
GOBP INTERLEUKIN 4 PRODUCTION	32	9.43e-04	1.48e-02	0.4830	1.44e-01	4.22e-01	1.56e-01	6.89e-02	6.74e-02	1.57e-01	3.52e-05	1.27e-01	5.00e-01	5.10e-01
GOBP POSITIVE REGULATION OF AXON GUIDANCE	5	6.32e-01	8.70e-01	0.4830	-2.44e-01	-1.71e-01	-9.87e-02	-3.63e-01	5.28e-02	3.44e-01	5.08e-01	7.02e-01	1.60e-01	8.38e-01
GOCC ANNULATE LAMELLAE	5	7.09e-01	8.98e-01	0.4830	-1.79e-01	6.37e-02	-2.18e-01	-3.36e-01	1.91e-01	4.89e-01	8.05e-01	3.99e-01	1.93e-01	4.60e-01
GOBP T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL	10	1.80e-01	5.23e-01	0.4830	-1.09e-01	4.28e-01	-1.18e-01	-9.93e-02	1.20e-01	5.51e-01	1.92e-02	5.20e-01	5.87e-01	5.11e-01
GOCC MITOCHONDRIAL SMALL RIBOSOMAL SUBUNIT	32	3.68e-03	4.28e-02	0.4820	1.66e-01	6.33e-02	-3.18e-01	-3.09e-01	-6.89e-02	1.03e-01	5.36e-01	1.85e-03	2.51e-03	5.00e-01
GOBP REGULATION OF RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE	6	3.38e-01	6.85e-01	0.4820	1.01e-01	1.53e-01	-4.83e-02	2.72e-01	3.50e-01	6.69e-01	5.17e-01	8.38e-01	2.48e-01	1.37e-01
GOBP GLYCOLIPID TRANSPORT	8	3.58e-01	7.03e-01	0.4820	-2.01e-01	3.24e-01	8.20e-02	-2.22e-01	1.77e-01	3.25e-01	1.13e-01	6.88e-01	2.76e-01	3.87e-01
GOMF L ALANINE TRANSMEMBRANE TRANSPORTER ACTIVITY	9	3.07e-01	6.60e-01	0.4820	-3.24e-01	-2.88e-01	1.66e-01	1.27e-01	3.52e-02	9.25e-02	1.35e-01	3.87e-01	5.10e-01	8.55e-01
GOMF HYDROPEROXY ICOSATETRAENOATE DEHYDRATASE ACTIVITY	7	4.45e-01	7.68e-01	0.4820	2.98e-01	-8.89e-02	-3.67e-01	-1.37e-02	-3.66e-02	1.72e-01	6.84e-01	9.29e-02	9.50e-01	8.67e-01
GOBP POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS	13	1.19e-01	4.23e-01	0.4820	-1.39e-01	4.32e-01	9.89e-02	7.67e-02	-1.05e-01	3.87e-01	7.00e-03	5.37e-01	6.32e-01	5.11e-01
GOCC SPERM CONNECTING PIECE	9	2.42e-01	5.99e-01	0.4820	-2.74e-01	2.26e-01	2.45e-01	-1.12e-01	-1.85e-01	1.55e-01	2.41e-01	2.03e-01	5.61e-01	3.36e-01
GOBP REGULATION OF REMOVAL OF SUPEROXIDE RADICALS	9	2.72e-01	6.26e-01	0.4820	1.97e-01	-2.34e-01	7.10e-02	1.74e-01	-3.22e-01	3.07e-01	2.25e-01	7.12e-01	3.65e-01	9.43e-02
GOBP POSITIVE REGULATION OF MITOTIC CYTOKINESIS	8	4.84e-01	7.93e-01	0.4820	-8.05e-03	-1.88e-01	-2.52e-01	-3.65e-01	1.18e-02	9.69e-01	3.56e-01	2.18e-01	7.37e-02	9.54e-01
GOBP ESTABLISHMENT OF LEFT RIGHT ASYMMETRY	6	5.29e-01	8.19e-01	0.4820	-1.93e-01	-2.58e-01	-2.31e-02	-1.92e-01	3.02e-01	4.12e-01	2.73e-01	9.22e-01	4.16e-01	2.01e-01
GOBP LIPOXYGENASE PATHWAY	11	2.14e-01	5.67e-01	0.4820	-1.65e-01	1.60e-01	-2.00e-01	-3.12e-01	-2.05e-01	3.42e-01	3.58e-01	2.51e-01	7.30e-02	2.40e-01
GOBP CELLULAR HYPOTONIC RESPONSE	11	1.96e-01	5.45e-01	0.4820	-3.59e-01	2.85e-01	1.37e-01	2.47e-03	-5.67e-02	3.91e-02	1.02e-01	4.32e-01	9.89e-01	7.45e-01
GOBP SERTOLI CELL PROLIFERATION	5	5.02e-01	8.03e-01	0.4820	3.42e-01	-2.63e-01	1.93e-01	-6.25e-02	6.93e-02	1.85e-01	3.09e-01	4.56e-01	8.09e-01	7.88e-01
GOMF HEME TRANSMEMBRANE TRANSPORTER ACTIVITY	8	4.30e-01	7.55e-01	0.4820	2.83e-01	-7.92e-02	-1.48e-01	-1.13e-01	3.33e-01	1.65e-01	6.98e-01	4.68e-01	5.79e-01	1.03e-01
GOBP INTESTINAL EPITHELIAL STRUCTURE MAINTENANCE	8	4.22e-01	7.49e-01	0.4820	-1.60e-01	1.79e-01	-1.24e-01	-3.30e-01	2.24e-01	4.33e-01	3.81e-01	5.43e-01	1.06e-01	2.73e-01
GOBP NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION	13	1.99e-01	5.47e-01	0.4820	-2.11e-02	2.84e-01	3.16e-01	1.96e-01	1.15e-01	8.95e-01	7.67e-02	4.89e-02	2.21e-01	4.73e-01
GOMF FRUCTOSE BINDING	6	4.78e-01	7.91e-01	0.4820	2.47e-01	6.37e-03	3.77e-01	1.16e-01	-1.23e-01	2.94e-01	9.78e-01	1.10e-01	6.23e-01	6.02e-01
GOBP FAS SIGNALING PATHWAY	8	3.03e-01	6.57e-01	0.4820	-4.57e-01	6.61e-02	-1.22e-01	-4.35e-02	4.47e-02	2.52e-02	7.46e-01	5.51e-01	8.31e-01	8.27e-01
GOMF STRUCTURAL CONSTITUENT OF RIBOSOME	155	4.01e-16	5.40e-14	0.4810	-5.89e-02	1.01e-02	-3.43e-01	-3.31e-01	-3.10e-02	2.06e-01	8.28e-01	1.72e-13	1.07e-12	5.05e-01
GOBP METANEPHRIC NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION	6	3.02e-01	6.55e-01	0.4810	-1.07e-01	-3.22e-01	3.11e-01	-1.39e-01	2.24e-02	6.49e-01	1.72e-01	1.87e-01	5.56e-01	9.24e-01
GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 3 COMPLEX	15	1.59e-01	4.90e-01	0.4810	1.14e-01	-2.09e-01	-3.61e-01	-2.11e-01	7.31e-03	4.47e-01	1.61e-01	1.54e-02	1.57e-01	9.61e-01
GOBP POSITIVE REGULATION OF MRNA 3 END PROCESSING	6	6.34e-01	8.71e-01	0.4810	1.02e-01	-3.20e-02	-1.63e-01	-2.41e-01	3.68e-01	6.64e-01	8.92e-01	4.91e-01	3.06e-01	1.18e-01
GOBP FORELIMB MORPHOGENESIS	39	2.25e-04	4.61e-03	0.4810	8.06e-02	1.69e-01	6.16e-03	-2.97e-01	3.29e-01	3.84e-01	6.84e-02	9.47e-01	1.35e-03	3.70e-04
GOBP PROTEIN INSERTION INTO ER MEMBRANE	27	1.42e-02	1.12e-01	0.4810	5.00e-02	1.16e-01	-2.54e-01	-3.54e-01	1.60e-01	6.53e-01	2.96e-01	2.25e-02	1.43e-03	1.51e-01
GOBP POST TRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE	15	8.42e-02	3.50e-01	0.4810	2.43e-01	1.11e-01	-1.35e-01	-3.75e-01	-3.36e-02	1.03e-01	4.55e-01	3.64e-01	1.20e-02	8.22e-01
GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE REGULATOR ACTIVITY	47	1.86e-04	3.93e-03	0.4810	7.44e-03	1.66e-02	-2.65e-01	-3.50e-01	1.96e-01	9.30e-01	8.44e-01	1.65e-03	3.32e-05	2.03e-02
GOMF PHOTORECEPTOR ACTIVITY	13	1.20e-01	4.24e-01	0.4810	3.08e-01	-1.73e-01	9.25e-02	3.12e-01	1.38e-02	5.41e-02	2.80e-01	5.64e-01	5.13e-02	9.32e-01
GOBP N TERMINAL PROTEIN LIPIDATION	6	5.76e-01	8.41e-01	0.4810	2.07e-02	1.40e-01	1.87e-01	1.55e-01	-3.90e-01	9.30e-01	5.52e-01	4.28e-01	5.12e-01	9.79e-02
GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION	20	2.28e-02	1.53e-01	0.4810	-1.31e-01	3.65e-01	2.31e-01	-7.28e-02	1.49e-01	3.11e-01	4.73e-03	7.38e-02	5.73e-01	2.47e-01
GOBP TRANSLATIONAL TERMINATION	15	3.92e-02	2.17e-01	0.4810	-5.64e-02	-1.72e-01	-7.69e-02	-4.36e-01	-4.53e-02	7.05e-01	2.48e-01	6.06e-01	3.44e-03	7.61e-01
GOBP ISOTYPE SWITCHING TO IGA ISOTYPES	8	4.91e-01	7.98e-01	0.4810	-1.11e-01	-2.02e-01	-3.46e-01	-2.26e-01	8.56e-02	5.86e-01	3.22e-01	9.06e-02	2.68e-01	6.75e-01
GOBP SYNAPSE PRUNING	14	1.73e-01	5.13e-01	0.4810	-2.75e-01	-3.58e-02	3.08e-01	2.42e-01	-1.84e-02	7.47e-02	8.17e-01	4.57e-02	1.17e-01	9.05e-01
GOMF DEUBIQUITINASE ACTIVATOR ACTIVITY	5	5.50e-01	8.28e-01	0.4800	-4.79e-02	-1.62e-01	-2.33e-01	2.31e-02	3.84e-01	8.53e-01	5.31e-01	3.67e-01	9.29e-01	1.37e-01
GOBP MITOTIC SPINDLE ELONGATION	11	1.85e-01	5.28e-01	0.4800	-1.11e-01	-3.63e-01	-4.55e-02	-6.37e-02	2.84e-01	5.25e-01	3.69e-02	7.94e-01	7.14e-01	1.03e-01
GOBP GLANDULAR EPITHELIAL CELL MATURATION	9	3.50e-01	6.96e-01	0.4800	2.31e-01	-1.34e-01	-9.69e-02	-3.29e-01	2.05e-01	2.30e-01	4.86e-01	6.15e-01	8.74e-02	2.88e-01
GOBP MRNA 3 END PROCESSING	49	8.29e-05	2.04e-03	0.4800	2.16e-02	-9.84e-02	-2.24e-01	-3.88e-01	1.43e-01	7.93e-01	2.33e-01	6.74e-03	2.68e-06	8.39e-02
GOMF OPSONIN BINDING	19	3.00e-02	1.83e-01	0.4800	-2.49e-01	-2.95e-01	-4.48e-02	2.48e-01	-1.35e-01	6.01e-02	2.61e-02	7.35e-01	6.09e-02	3.10e-01
GOBP VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS	14	8.70e-02	3.56e-01	0.4800	3.69e-01	2.29e-01	2.84e-02	1.10e-01	1.70e-01	1.68e-02	1.37e-01	8.54e-01	4.75e-01	2.72e-01
GOBP NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION	6	5.27e-01	8.17e-01	0.4800	-2.78e-01	3.53e-01	2.16e-02	-1.66e-01	-5.06e-03	2.37e-01	1.34e-01	9.27e-01	4.81e-01	9.83e-01
GOBP RADIAL GLIA GUIDED PYRAMIDAL NEURON MIGRATION	6	5.26e-01	8.17e-01	0.4800	-4.28e-01	-8.93e-02	-5.18e-03	-1.41e-01	-1.40e-01	6.95e-02	7.05e-01	9.82e-01	5.50e-01	5.53e-01
GOBP MDA 5 SIGNALING PATHWAY	11	1.86e-01	5.30e-01	0.4800	1.77e-01	2.71e-01	-3.25e-01	-1.43e-01	5.06e-04	3.10e-01	1.20e-01	6.21e-02	4.13e-01	9.98e-01
GOBP NEGATIVE REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION	14	1.11e-01	4.07e-01	0.4800	-3.93e-02	5.70e-03	2.46e-03	-2.27e-01	4.21e-01	7.99e-01	9.71e-01	9.87e-01	1.42e-01	6.36e-03
GOBP POSITIVE REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION	6	5.36e-01	8.21e-01	0.4800	3.56e-01	2.97e-01	8.30e-02	-9.14e-02	-2.48e-03	1.31e-01	2.08e-01	7.25e-01	6.98e-01	9.92e-01
GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION	11	1.98e-01	5.47e-01	0.4800	3.47e-01	2.28e-01	-1.82e-01	-7.48e-02	1.37e-01	4.62e-02	1.90e-01	2.95e-01	6.67e-01	4.32e-01
GOMF 3 HYDROXYACYL COA DEHYDROGENASE ACTIVITY	6	4.56e-01	7.75e-01	0.4800	3.87e-03	4.44e-01	-1.27e-01	3.43e-02	-1.25e-01	9.87e-01	5.97e-02	5.89e-01	8.84e-01	5.97e-01
GOMF AMINE BINDING	11	1.45e-01	4.66e-01	0.4800	2.73e-01	1.06e-01	2.45e-01	-1.72e-01	2.33e-01	1.16e-01	5.44e-01	1.60e-01	3.23e-01	1.80e-01
GOBP ENDOSOMAL LUMEN ACIDIFICATION	12	2.21e-01	5.76e-01	0.4800	2.58e-01	-2.57e-03	-1.34e-01	-1.72e-01	3.40e-01	1.21e-01	9.88e-01	4.23e-01	3.03e-01	4.12e-02
GOCC PRP19 COMPLEX	12	2.62e-01	6.19e-01	0.4800	1.26e-01	-1.89e-01	-2.37e-01	-3.35e-01	9.89e-02	4.50e-01	2.57e-01	1.54e-01	4.45e-02	5.53e-01
GOBP 4FE 4S CLUSTER ASSEMBLY	5	6.29e-01	8.68e-01	0.4800	2.80e-01	2.74e-02	-2.38e-01	-4.88e-03	-3.07e-01	2.79e-01	9.16e-01	3.58e-01	9.85e-01	2.34e-01
GOBP FUNGIFORM PAPILLA MORPHOGENESIS	5	5.08e-01	8.07e-01	0.4790	2.11e-01	-2.00e-02	1.51e-01	-3.58e-01	1.85e-01	4.13e-01	9.38e-01	5.59e-01	1.66e-01	4.74e-01
GOBP SUCCINYL COA METABOLIC PROCESS	10	3.55e-01	7.00e-01	0.4790	6.60e-02	-1.38e-01	-3.42e-01	-2.38e-01	-1.82e-01	7.18e-01	4.49e-01	6.15e-02	1.93e-01	3.18e-01
GOBP SNRNA TRANSPORT	6	4.97e-01	8.01e-01	0.4790	-8.89e-02	1.36e-01	-9.89e-02	-3.72e-01	-2.34e-01	7.06e-01	5.64e-01	6.75e-01	1.14e-01	3.20e-01
GOMF MHC CLASS I RECEPTOR ACTIVITY	13	1.03e-01	3.88e-01	0.4790	-3.66e-01	-2.37e-01	-1.85e-01	-2.00e-03	7.04e-02	2.22e-02	1.39e-01	2.48e-01	9.90e-01	6.60e-01
GOBP RESPONSE TO HEPARIN	7	4.36e-01	7.60e-01	0.4790	-4.29e-01	1.99e-02	-1.43e-01	-1.49e-02	-1.56e-01	4.94e-02	9.27e-01	5.12e-01	9.46e-01	4.75e-01
GOMF INOSITOL TRISPHOSPHATE PHOSPHATASE ACTIVITY	11	1.78e-01	5.19e-01	0.4790	-1.10e-01	1.94e-01	1.32e-01	-1.37e-04	-4.03e-01	5.27e-01	2.66e-01	4.50e-01	9.99e-01	2.06e-02
GOBP CAMP BIOSYNTHETIC PROCESS	10	3.54e-01	7.00e-01	0.4790	-2.77e-01	-1.23e-01	2.55e-01	2.59e-01	-7.57e-02	1.30e-01	5.02e-01	1.63e-01	1.56e-01	6.79e-01
GOCC PROTEASOME ACCESSORY COMPLEX	23	4.21e-02	2.28e-01	0.4790	1.11e-01	-1.04e-01	-2.84e-01	-3.35e-01	1.16e-01	3.59e-01	3.89e-01	1.84e-02	5.40e-03	3.35e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON OTHER NITROGENOUS COMPOUNDS AS DONORS	10	2.65e-01	6.19e-01	0.4790	-1.87e-01	1.83e-01	2.57e-01	5.61e-02	3.02e-01	3.05e-01	3.17e-01	1.59e-01	7.59e-01	9.76e-02
GOBP NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION	13	7.69e-02	3.33e-01	0.4790	2.36e-01	-5.02e-02	3.16e-01	1.26e-01	-2.35e-01	1.41e-01	7.54e-01	4.85e-02	4.33e-01	1.42e-01
GOBP CENTRIOLE ELONGATION	8	5.08e-01	8.07e-01	0.4790	2.93e-01	-4.26e-02	-2.62e-01	-2.53e-01	9.28e-02	1.51e-01	8.35e-01	1.99e-01	2.16e-01	6.49e-01
GOBP REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY	22	1.55e-02	1.19e-01	0.4790	-2.80e-01	2.62e-01	2.41e-01	4.78e-02	1.46e-01	2.28e-02	3.34e-02	5.00e-02	6.98e-01	2.37e-01
GOMF 3 HYDROXYACYL COA DEHYDRATASE ACTIVITY	7	5.18e-01	8.12e-01	0.4790	1.33e-01	-3.50e-02	-3.60e-01	-1.41e-01	-2.46e-01	5.41e-01	8.73e-01	9.91e-02	5.18e-01	2.60e-01
GOCC PHOTORECEPTOR RIBBON SYNAPSE	10	2.47e-01	6.04e-01	0.4790	-1.99e-01	1.50e-01	3.28e-01	4.40e-02	-2.41e-01	2.77e-01	4.12e-01	7.29e-02	8.09e-01	1.88e-01
GOBP N ACETYLNEURAMINATE CATABOLIC PROCESS	6	5.55e-01	8.31e-01	0.4780	-7.98e-02	4.35e-01	1.23e-01	-3.46e-02	-1.31e-01	7.35e-01	6.52e-02	6.02e-01	8.83e-01	5.78e-01
GOBP PROXIMAL DISTAL PATTERN FORMATION	34	6.23e-04	1.04e-02	0.4780	1.65e-01	4.85e-02	3.54e-02	-3.05e-01	3.24e-01	9.60e-02	6.25e-01	7.21e-01	2.06e-03	1.09e-03
GOBP TRNA SURVEILLANCE	8	5.01e-01	8.03e-01	0.4780	-1.21e-01	-5.24e-03	-3.61e-01	-2.87e-01	-3.84e-02	5.52e-01	9.80e-01	7.73e-02	1.60e-01	8.51e-01
GOCC BBAF COMPLEX	10	8.86e-02	3.59e-01	0.4780	2.24e-01	-8.92e-02	2.59e-01	-2.73e-01	1.70e-01	2.21e-01	6.25e-01	1.56e-01	1.35e-01	3.52e-01
GOCC CORE MEDIATOR COMPLEX	25	1.86e-02	1.35e-01	0.4780	5.93e-02	-3.40e-02	-3.65e-01	-2.54e-01	-1.61e-01	6.08e-01	7.69e-01	1.58e-03	2.81e-02	1.62e-01
GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT KINASE ACTIVITY	10	1.39e-01	4.59e-01	0.4780	2.53e-02	3.38e-02	-4.87e-02	-4.26e-01	-2.07e-01	8.90e-01	8.53e-01	7.90e-01	1.96e-02	2.58e-01
GOBP PLUS END DIRECTED ORGANELLE TRANSPORT ALONG MICROTUBULE	7	5.87e-01	8.45e-01	0.4780	-7.86e-02	2.20e-01	3.56e-01	2.00e-01	8.19e-02	7.19e-01	3.13e-01	1.03e-01	3.58e-01	7.08e-01
GOBP GOLGI VESICLE FUSION TO TARGET MEMBRANE	5	6.20e-01	8.64e-01	0.4780	3.00e-02	3.81e-01	2.26e-01	-1.73e-01	2.65e-02	9.07e-01	1.40e-01	3.81e-01	5.02e-01	9.18e-01
GOBP NEGATIVE REGULATION OF OSTEOCLAST DEVELOPMENT	5	6.48e-01	8.77e-01	0.4780	7.58e-02	-1.41e-01	2.30e-01	8.32e-02	3.78e-01	7.69e-01	5.84e-01	3.72e-01	7.47e-01	1.44e-01
GOBP POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY	7	4.51e-01	7.71e-01	0.4780	-1.20e-01	-2.36e-01	-8.45e-02	-9.06e-02	3.78e-01	5.83e-01	2.80e-01	6.99e-01	6.78e-01	8.33e-02
GOBP TERPENOID CATABOLIC PROCESS	8	3.43e-01	6.90e-01	0.4780	1.10e-01	2.65e-01	-7.34e-02	-5.35e-02	3.71e-01	5.91e-01	1.94e-01	7.19e-01	7.93e-01	6.92e-02
GOMF XMP 5 NUCLEOSIDASE ACTIVITY	6	5.10e-01	8.07e-01	0.4780	-3.09e-01	-1.79e-02	3.11e-01	-3.81e-02	1.85e-01	1.90e-01	9.40e-01	1.87e-01	8.72e-01	4.33e-01
GOBP REGULATION OF HEART RATE BY CHEMICAL SIGNAL	7	6.21e-01	8.64e-01	0.4780	-1.63e-01	8.03e-02	2.74e-01	2.99e-01	-1.75e-01	4.55e-01	7.13e-01	2.09e-01	1.71e-01	4.24e-01
GOBP DETOXIFICATION OF INORGANIC COMPOUND	21	1.55e-02	1.19e-01	0.4780	-2.26e-01	2.24e-01	-5.20e-02	-3.51e-01	3.17e-02	7.34e-02	7.60e-02	6.80e-01	5.29e-03	8.01e-01
GOBP T CELL TOLERANCE INDUCTION	14	1.47e-01	4.70e-01	0.4780	-1.19e-01	-1.81e-01	3.44e-01	2.42e-01	6.52e-02	4.41e-01	2.41e-01	2.58e-02	1.17e-01	6.73e-01
GOBP MITOCHONDRIAL RNA 3 END PROCESSING	5	6.44e-01	8.75e-01	0.4780	-7.38e-02	-3.80e-01	-1.42e-01	-1.94e-01	-1.44e-01	7.75e-01	1.42e-01	5.82e-01	4.52e-01	5.78e-01
GOCC DESMOSOME	25	2.41e-02	1.58e-01	0.4780	3.28e-02	-2.25e-02	3.57e-01	3.12e-01	-3.55e-02	7.77e-01	8.45e-01	1.98e-03	6.86e-03	7.58e-01
GOBP THROMBOPOIETIN MEDIATED SIGNALING PATHWAY	5	5.66e-01	8.35e-01	0.4780	-1.16e-01	-1.05e-01	-2.17e-02	-1.63e-01	-4.20e-01	6.53e-01	6.83e-01	9.33e-01	5.28e-01	1.04e-01
GOCC ORIGIN RECOGNITION COMPLEX	9	2.50e-01	6.07e-01	0.4780	-1.01e-01	-2.14e-01	-3.45e-03	-3.67e-01	1.93e-01	5.98e-01	2.67e-01	9.86e-01	5.64e-02	3.16e-01
GOMF CHLORIDE CHANNEL INHIBITOR ACTIVITY	6	5.21e-01	8.14e-01	0.4770	-3.19e-01	1.55e-01	8.43e-02	-1.34e-01	2.78e-01	1.76e-01	5.12e-01	7.21e-01	5.70e-01	2.38e-01
GOMF MRNA 5 PHOSPHATASE ACTIVITY	11	2.82e-01	6.36e-01	0.4770	1.49e-01	-3.61e-02	-1.48e-01	-3.95e-01	1.63e-01	3.93e-01	8.36e-01	3.95e-01	2.33e-02	3.49e-01
GOBP ZYMOGEN INHIBITION	7	4.33e-01	7.57e-01	0.4770	1.14e-01	3.79e-01	-2.52e-02	-1.33e-01	-2.29e-01	6.00e-01	8.24e-02	9.08e-01	5.42e-01	2.93e-01
GOCC RIBOSOMAL SUBUNIT	177	5.97e-18	1.04e-15	0.4770	-4.08e-02	-9.01e-03	-3.37e-01	-3.34e-01	-2.97e-02	3.49e-01	8.36e-01	1.02e-14	1.83e-14	4.96e-01
GOBP NEGATIVE REGULATION OF CELL VOLUME	5	6.64e-01	8.81e-01	0.4770	-3.92e-01	-8.21e-02	1.84e-01	4.36e-02	-1.76e-01	1.29e-01	7.50e-01	4.76e-01	8.66e-01	4.97e-01
GOBP RETINAL ROD CELL DEVELOPMENT	8	3.67e-01	7.07e-01	0.4770	9.64e-02	-3.35e-01	-8.19e-02	6.44e-02	-3.08e-01	6.37e-01	1.01e-01	6.88e-01	7.52e-01	1.32e-01
GOMF BH DOMAIN BINDING	9	2.99e-01	6.53e-01	0.4770	1.01e-01	2.45e-01	8.90e-02	-3.32e-01	1.98e-01	6.00e-01	2.03e-01	6.44e-01	8.48e-02	3.05e-01
GOBP POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION	24	7.25e-03	6.96e-02	0.4770	2.13e-01	-3.89e-02	3.38e-01	9.01e-02	2.41e-01	7.06e-02	7.41e-01	4.19e-03	4.45e-01	4.09e-02
GOBP HEPATIC STELLATE CELL ACTIVATION	9	2.73e-01	6.28e-01	0.4770	-2.07e-01	3.79e-01	1.08e-01	8.28e-02	1.49e-01	2.82e-01	4.89e-02	5.76e-01	6.67e-01	4.40e-01
GOCC SPECTRIN	9	2.99e-01	6.53e-01	0.4760	3.40e-01	1.61e-01	5.76e-02	2.48e-01	-1.44e-01	7.72e-02	4.03e-01	7.65e-01	1.98e-01	4.55e-01
GOBP BRANCHED CHAIN AMINO ACID TRANSPORT	13	1.12e-01	4.09e-01	0.4760	-2.87e-01	1.58e-01	1.73e-01	4.41e-02	2.96e-01	7.33e-02	3.25e-01	2.80e-01	7.83e-01	6.43e-02
GOMF SEMAPHORIN RECEPTOR ACTIVITY	10	2.92e-01	6.46e-01	0.4760	-1.32e-01	1.76e-01	1.26e-01	3.75e-01	-1.49e-01	4.70e-01	3.35e-01	4.90e-01	4.01e-02	4.16e-01
GOBP CELL DIFFERENTIATION IN SPINAL CORD	49	2.32e-05	7.00e-04	0.4760	1.03e-01	1.40e-01	-2.28e-02	-3.25e-01	3.01e-01	2.12e-01	8.92e-02	7.82e-01	8.41e-05	2.65e-04
GOBP PROTEIN DEMETHYLATION	9	3.82e-01	7.20e-01	0.4760	1.73e-01	2.42e-01	-8.75e-02	-2.18e-01	2.89e-01	3.69e-01	2.08e-01	6.49e-01	2.58e-01	1.33e-01
GOCC EPSILON DNA POLYMERASE COMPLEX	5	6.38e-01	8.73e-01	0.4760	3.25e-01	1.19e-01	-1.16e-01	6.08e-03	3.06e-01	2.08e-01	6.44e-01	6.54e-01	9.81e-01	2.37e-01
GOMF TRNA SPECIFIC RIBONUCLEASE ACTIVITY	16	1.49e-01	4.74e-01	0.4760	1.19e-01	-5.86e-02	-3.44e-01	-2.97e-01	-5.22e-02	4.11e-01	6.85e-01	1.71e-02	4.00e-02	7.18e-01
GOBP ENDOTHELIN RECEPTOR SIGNALING PATHWAY	10	2.49e-01	6.06e-01	0.4760	2.61e-01	2.26e-01	8.07e-02	1.00e-01	3.01e-01	1.53e-01	2.16e-01	6.59e-01	5.84e-01	9.88e-02
GOBP MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL	22	1.76e-02	1.30e-01	0.4760	-3.12e-01	8.82e-02	2.74e-02	2.28e-01	-2.62e-01	1.12e-02	4.74e-01	8.24e-01	6.46e-02	3.31e-02
GOBP REGULATION OF MICROVILLUS ASSEMBLY	6	3.10e-01	6.62e-01	0.4760	-2.30e-01	1.73e-01	-1.31e-01	3.54e-01	-3.37e-02	3.29e-01	4.62e-01	5.77e-01	1.33e-01	8.86e-01
GOBP BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR SIGNALING PATHWAY	6	4.49e-01	7.70e-01	0.4760	-3.18e-01	-2.46e-01	9.75e-02	-2.24e-01	7.34e-02	1.77e-01	2.98e-01	6.79e-01	3.43e-01	7.56e-01
GOBP REGULATION OF GAMMA DELTA T CELL ACTIVATION	11	2.04e-01	5.53e-01	0.4760	2.33e-01	3.83e-01	1.48e-01	-4.14e-02	-4.28e-02	1.80e-01	2.80e-02	3.95e-01	8.12e-01	8.06e-01
GOBP MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL	15	3.03e-02	1.85e-01	0.4760	-1.73e-01	3.35e-01	2.27e-02	2.88e-01	2.72e-02	2.46e-01	2.46e-02	8.79e-01	5.38e-02	8.55e-01
GOBP CELLULAR RESPONSE TO MURAMYL DIPEPTIDE	8	4.10e-01	7.42e-01	0.4760	5.05e-02	3.77e-01	8.38e-02	-1.81e-01	2.05e-01	8.05e-01	6.49e-02	6.82e-01	3.76e-01	3.16e-01
GOCC TRNA METHYLTRANSFERASE COMPLEX	6	6.56e-01	8.80e-01	0.4760	4.90e-02	-1.47e-01	-2.81e-01	-3.36e-01	-1.03e-01	8.35e-01	5.32e-01	2.33e-01	1.55e-01	6.63e-01
GOBP REGULATION OF CALCIDIOL 1 MONOOXYGENASE ACTIVITY	7	2.48e-01	6.06e-01	0.4760	-4.85e-02	1.58e-01	-2.49e-03	3.77e-01	2.38e-01	8.24e-01	4.68e-01	9.91e-01	8.42e-02	2.76e-01
GOBP PYRIMIDINE NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS	6	6.77e-01	8.86e-01	0.4750	2.02e-01	-1.94e-01	-2.66e-01	-2.64e-01	8.62e-02	3.92e-01	4.11e-01	2.59e-01	2.62e-01	7.15e-01
GOBP POSITIVE REGULATION OF VITAMIN D RECEPTOR SIGNALING PATHWAY	6	4.93e-01	7.99e-01	0.4750	3.73e-02	3.04e-01	3.12e-02	5.72e-02	3.58e-01	8.74e-01	1.98e-01	8.95e-01	8.08e-01	1.29e-01
GOMF SPHINGOSINE N ACYLTRANSFERASE ACTIVITY	7	4.64e-01	7.80e-01	0.4750	2.05e-01	3.88e-01	1.32e-01	-1.25e-01	1.36e-02	3.48e-01	7.53e-02	5.46e-01	5.68e-01	9.50e-01
GOBP NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS	16	6.60e-02	3.03e-01	0.4750	-2.55e-01	2.59e-01	-1.31e-01	-2.73e-01	3.91e-02	7.75e-02	7.27e-02	3.64e-01	5.84e-02	7.86e-01
GOBP SEROTONIN SECRETION	9	3.07e-01	6.60e-01	0.4750	4.04e-01	1.61e-01	-6.10e-02	3.55e-02	1.76e-01	3.56e-02	4.03e-01	7.51e-01	8.54e-01	3.61e-01
GOBP PROTEIN K6 LINKED UBIQUITINATION	11	2.43e-01	6.00e-01	0.4750	7.76e-02	-6.42e-02	-2.65e-01	-2.48e-01	-2.88e-01	6.56e-01	7.12e-01	1.28e-01	1.54e-01	9.76e-02
GOCC MYOSIN II COMPLEX	26	4.40e-03	4.91e-02	0.4750	-1.85e-02	-2.65e-01	-1.07e-01	2.94e-01	-2.39e-01	8.70e-01	1.94e-02	3.43e-01	9.49e-03	3.50e-02
GOBP ESTABLISHMENT OF CENTROSOME LOCALIZATION	10	3.58e-01	7.03e-01	0.4750	-1.55e-01	3.72e-02	2.47e-01	2.08e-01	-3.09e-01	3.97e-01	8.39e-01	1.76e-01	2.55e-01	9.05e-02
GOBP MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL	28	2.80e-03	3.49e-02	0.4740	-2.20e-01	1.20e-01	1.31e-02	3.05e-01	-2.62e-01	4.36e-02	2.73e-01	9.05e-01	5.17e-03	1.62e-02
GOMF STRUCTURAL CONSTITUENT OF SKIN EPIDERMIS	34	2.04e-03	2.73e-02	0.4740	-2.26e-01	-3.69e-02	1.92e-01	3.65e-01	-4.75e-02	2.26e-02	7.10e-01	5.28e-02	2.30e-04	6.32e-01
GOMF NAD DEPENDENT HISTONE DEACETYLASE ACTIVITY	5	7.19e-01	9.02e-01	0.4740	2.44e-01	1.44e-01	-5.62e-02	-2.00e-01	3.18e-01	3.45e-01	5.76e-01	8.28e-01	4.40e-01	2.18e-01
GOCC CHROMATIN SILENCING COMPLEX	12	2.14e-01	5.67e-01	0.4740	2.00e-01	-7.52e-02	-1.76e-01	-3.84e-01	2.51e-02	2.30e-01	6.52e-01	2.90e-01	2.14e-02	8.80e-01
GOMF BRANCHED CHAIN AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY	9	2.82e-01	6.36e-01	0.4740	-2.06e-01	1.79e-02	1.38e-01	2.65e-02	4.03e-01	2.85e-01	9.26e-01	4.74e-01	8.91e-01	3.65e-02
GOBP POINTED END ACTIN FILAMENT CAPPING	7	6.25e-01	8.66e-01	0.4740	-6.09e-02	1.31e-01	3.16e-01	2.71e-01	-1.73e-01	7.80e-01	5.48e-01	1.47e-01	2.14e-01	4.27e-01
GOMF STRUCTURAL CONSTITUENT OF MYELIN SHEATH	9	3.37e-01	6.84e-01	0.4740	-1.20e-01	2.91e-01	2.21e-01	-4.21e-02	2.74e-01	5.34e-01	1.31e-01	2.51e-01	8.27e-01	1.55e-01
GOBP NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR PRODUCTION	5	6.18e-01	8.62e-01	0.4740	-3.65e-01	-2.18e-02	-8.47e-03	-2.19e-01	-2.06e-01	1.57e-01	9.33e-01	9.74e-01	3.97e-01	4.24e-01
GOBP REGULATION OF TAU PROTEIN KINASE ACTIVITY	13	2.36e-02	1.57e-01	0.4740	-1.47e-01	-3.45e-02	1.63e-01	-4.16e-01	-3.96e-02	3.58e-01	8.29e-01	3.10e-01	9.32e-03	8.05e-01
GOMF S METHYLTRANSFERASE ACTIVITY	8	2.76e-01	6.30e-01	0.4740	3.22e-01	-3.35e-01	6.69e-02	-6.02e-02	-6.46e-03	1.15e-01	1.00e-01	7.43e-01	7.68e-01	9.75e-01
GOBP POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE	13	1.31e-01	4.47e-01	0.4740	-1.96e-01	3.55e-01	1.49e-01	-5.87e-02	1.85e-01	2.20e-01	2.67e-02	3.53e-01	7.14e-01	2.49e-01
GOBP CELL CELL JUNCTION DISASSEMBLY	5	6.40e-01	8.74e-01	0.4740	4.59e-01	8.54e-02	-8.98e-03	7.15e-02	-3.68e-02	7.57e-02	7.41e-01	9.72e-01	7.82e-01	8.87e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OR CH2 GROUPS	11	1.66e-01	5.01e-01	0.4740	-5.79e-03	9.72e-02	-8.64e-02	3.21e-01	-3.23e-01	9.73e-01	5.77e-01	6.20e-01	6.54e-02	6.35e-02
GOBP REGULATION OF STORE OPERATED CALCIUM ENTRY	15	1.14e-01	4.13e-01	0.4730	2.36e-01	2.60e-01	2.80e-01	9.99e-02	1.12e-01	1.14e-01	8.14e-02	6.00e-02	5.03e-01	4.54e-01
GOBP MAINTENANCE OF APICAL BASAL CELL POLARITY	10	2.35e-01	5.90e-01	0.4730	1.06e-01	3.70e-01	5.32e-02	-2.69e-01	-2.46e-02	5.63e-01	4.27e-02	7.71e-01	1.40e-01	8.93e-01
GOBP VESICLE MEDIATED CHOLESTEROL TRANSPORT	9	2.99e-01	6.53e-01	0.4730	-2.48e-01	1.82e-01	1.12e-01	-1.90e-01	2.84e-01	1.97e-01	3.43e-01	5.60e-01	3.24e-01	1.40e-01
GOBP RRNA 3 END PROCESSING	10	3.89e-01	7.25e-01	0.4730	-1.13e-01	-6.16e-02	-3.53e-01	-2.81e-01	-5.96e-02	5.36e-01	7.36e-01	5.30e-02	1.24e-01	7.44e-01
GOBP POSITIVE REGULATION OF ODONTOGENESIS	7	4.11e-01	7.43e-01	0.4730	7.36e-02	4.42e-01	-2.94e-02	9.59e-02	-1.13e-01	7.36e-01	4.28e-02	8.93e-01	6.60e-01	6.03e-01
GOBP STRAND INVASION	6	6.95e-01	8.94e-01	0.4730	9.03e-02	-2.62e-02	-2.19e-01	-3.26e-01	2.46e-01	7.02e-01	9.12e-01	3.54e-01	1.66e-01	2.97e-01
GOBP REGULATION OF COMPLEMENT DEPENDENT CYTOTOXICITY	11	7.98e-02	3.40e-01	0.4730	2.68e-01	2.14e-01	-1.29e-01	2.96e-01	4.32e-02	1.24e-01	2.19e-01	4.59e-01	8.94e-02	8.04e-01
GOBP GAP JUNCTION ASSEMBLY	16	9.96e-02	3.82e-01	0.4730	6.83e-02	1.63e-01	3.14e-01	1.87e-01	-2.43e-01	6.36e-01	2.59e-01	2.98e-02	1.96e-01	9.20e-02
GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN CELL CYCLE ARREST	18	8.02e-02	3.41e-01	0.4730	2.50e-01	-2.70e-02	-2.57e-01	-3.03e-01	-4.59e-02	6.58e-02	8.43e-01	5.90e-02	2.60e-02	7.36e-01
GOMF PHOSPHATIDYLINOSITOL 3 4 5 TRISPHOSPHATE 3 PHOSPHATASE ACTIVITY	5	6.44e-01	8.75e-01	0.4730	2.02e-01	-3.83e-01	1.33e-02	6.68e-02	1.78e-01	4.35e-01	1.38e-01	9.59e-01	7.96e-01	4.90e-01
GOCC TRANSLATION PREINITIATION COMPLEX	18	1.06e-01	3.95e-01	0.4730	1.26e-01	-1.52e-01	-3.63e-01	-2.21e-01	6.21e-02	3.53e-01	2.63e-01	7.73e-03	1.04e-01	6.48e-01
GOBP KILLING BY HOST OF SYMBIONT CELLS	25	1.67e-03	2.35e-02	0.4720	-3.29e-01	-2.46e-01	1.71e-01	-1.35e-01	8.48e-02	4.43e-03	3.33e-02	1.39e-01	2.42e-01	4.63e-01
GOBP MYCOTOXIN METABOLIC PROCESS	6	5.44e-01	8.25e-01	0.4720	3.03e-01	-2.86e-01	1.05e-01	1.65e-01	1.07e-01	1.99e-01	2.24e-01	6.57e-01	4.83e-01	6.51e-01
GOBP KETONE BODY BIOSYNTHETIC PROCESS	6	5.71e-01	8.38e-01	0.4720	-1.54e-01	-3.05e-01	2.58e-01	1.69e-01	1.06e-01	5.13e-01	1.96e-01	2.73e-01	4.74e-01	6.54e-01
GOBP THREONINE METABOLIC PROCESS	5	6.36e-01	8.72e-01	0.4720	1.31e-01	-4.34e-01	4.82e-03	9.39e-02	-9.49e-02	6.12e-01	9.31e-02	9.85e-01	7.16e-01	7.13e-01
GOBP REGULATION OF BLOOD BRAIN BARRIER PERMEABILITY	9	3.91e-01	7.26e-01	0.4720	-2.15e-01	6.55e-02	1.01e-01	3.44e-01	-2.10e-01	2.64e-01	7.34e-01	6.01e-01	7.41e-02	2.76e-01
GOMF ARYL SULFOTRANSFERASE ACTIVITY	7	5.46e-01	8.26e-01	0.4720	-3.65e-01	7.34e-03	2.44e-01	1.37e-01	-1.04e-01	9.42e-02	9.73e-01	2.63e-01	5.30e-01	6.34e-01
GOBP ORGANELLE INHERITANCE	15	7.68e-02	3.33e-01	0.4720	4.38e-02	-6.65e-02	-5.24e-02	-4.33e-01	1.62e-01	7.69e-01	6.56e-01	7.25e-01	3.70e-03	2.76e-01
GOMF C PALMITOYLTRANSFERASE ACTIVITY	5	6.44e-01	8.75e-01	0.4720	4.48e-01	1.36e-01	5.94e-03	-5.13e-02	-3.12e-02	8.29e-02	5.97e-01	9.82e-01	8.42e-01	9.04e-01
GOCC INTERCELLULAR CANALICULUS	6	6.28e-01	8.68e-01	0.4720	-3.67e-02	6.69e-02	7.06e-02	3.09e-01	-3.41e-01	8.76e-01	7.77e-01	7.65e-01	1.90e-01	1.48e-01
GOBP NEURON FATE COMMITMENT	73	2.39e-08	1.55e-06	0.4720	1.17e-01	1.32e-01	1.55e-02	-3.24e-01	2.93e-01	8.33e-02	5.03e-02	8.18e-01	1.72e-06	1.45e-05
GOBP CYTOLYSIS	7	4.33e-01	7.57e-01	0.4720	2.40e-01	-3.99e-01	1.94e-02	5.81e-02	3.47e-02	2.71e-01	6.72e-02	9.29e-01	7.90e-01	8.74e-01
GOBP POSITIVE REGULATION OF 3 UTR MEDIATED MRNA STABILIZATION	5	6.29e-01	8.68e-01	0.4720	-4.09e-01	2.11e-02	1.62e-01	-8.82e-02	-1.45e-01	1.14e-01	9.35e-01	5.32e-01	7.33e-01	5.74e-01
GOBP PRIMARY AMINO COMPOUND METABOLIC PROCESS	13	2.25e-01	5.79e-01	0.4710	-2.20e-01	1.19e-02	3.65e-01	1.99e-01	-3.20e-02	1.70e-01	9.41e-01	2.27e-02	2.14e-01	8.42e-01
GOBP SKELETAL MUSCLE SATELLITE CELL ACTIVATION	8	4.26e-01	7.53e-01	0.4710	2.26e-01	3.62e-01	1.53e-01	1.22e-01	4.36e-02	2.69e-01	7.62e-02	4.53e-01	5.51e-01	8.31e-01
GOBP POSITIVE REGULATION OF DOPAMINE SECRETION	6	5.49e-01	8.28e-01	0.4710	2.95e-01	-2.54e-03	4.16e-03	2.09e-01	-3.02e-01	2.10e-01	9.91e-01	9.86e-01	3.74e-01	2.01e-01
GOBP GROWTH PLATE CARTILAGE CHONDROCYTE DIFFERENTIATION	10	3.98e-01	7.31e-01	0.4710	-3.15e-03	1.32e-01	-2.75e-01	-3.43e-01	1.06e-01	9.86e-01	4.70e-01	1.32e-01	6.06e-02	5.60e-01
GOBP RIGHTING REFLEX	8	3.31e-01	6.79e-01	0.4710	-3.55e-01	1.52e-01	2.10e-01	-1.46e-01	-8.24e-02	8.17e-02	4.57e-01	3.03e-01	4.74e-01	6.86e-01
GOMF ADP PHOSPHATASE ACTIVITY	5	6.66e-01	8.82e-01	0.4710	-1.96e-01	2.02e-01	-1.23e-01	-3.24e-01	-1.51e-01	4.48e-01	4.35e-01	6.34e-01	2.10e-01	5.58e-01
GOBP PROTEIN K27 LINKED UBIQUITINATION	7	4.25e-01	7.52e-01	0.4710	3.95e-02	-1.27e-01	-1.56e-01	-2.75e-01	-3.22e-01	8.57e-01	5.62e-01	4.73e-01	2.07e-01	1.40e-01
GOBP UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE C END DEGRON RULE PATHWAY	12	1.38e-01	4.57e-01	0.4710	-1.11e-01	1.25e-02	-8.75e-02	-4.46e-01	-5.47e-02	5.06e-01	9.40e-01	6.00e-01	7.53e-03	7.43e-01
GOBP REGULATION OF ARTERY MORPHOGENESIS	11	1.39e-01	4.60e-01	0.4710	-1.98e-01	-2.98e-01	-1.62e-01	2.58e-01	2.08e-02	2.54e-01	8.66e-02	3.53e-01	1.39e-01	9.05e-01
GOMF RNA DNA HYBRID RIBONUCLEASE ACTIVITY	6	5.67e-01	8.36e-01	0.4700	2.81e-01	-4.12e-02	-2.40e-01	-5.53e-02	-2.83e-01	2.34e-01	8.61e-01	3.09e-01	8.15e-01	2.30e-01
GOBP REGULATION OF COA TRANSFERASE ACTIVITY	10	2.21e-01	5.76e-01	0.4700	-2.97e-01	5.40e-02	-1.98e-01	1.11e-01	-2.80e-01	1.04e-01	7.67e-01	2.79e-01	5.43e-01	1.25e-01
GOBP NEGATIVE REGULATION OF NUCLEASE ACTIVITY	7	3.81e-01	7.19e-01	0.4700	2.21e-01	1.78e-01	-3.56e-02	-2.69e-01	-2.58e-01	3.11e-01	4.15e-01	8.70e-01	2.18e-01	2.37e-01
GOBP NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN	12	2.80e-01	6.33e-01	0.4700	7.08e-02	-1.65e-01	-2.89e-01	-3.14e-01	-8.23e-02	6.71e-01	3.22e-01	8.35e-02	5.99e-02	6.22e-01
GOMF AP 1 ADAPTOR COMPLEX BINDING	5	4.69e-01	7.84e-01	0.4700	2.42e-01	1.60e-01	2.49e-01	-2.71e-01	-3.39e-02	3.48e-01	5.35e-01	3.35e-01	2.94e-01	8.96e-01
GOBP NEGATIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY	9	2.68e-01	6.23e-01	0.4700	-2.77e-01	-1.21e-01	2.71e-01	-5.00e-02	2.31e-01	1.51e-01	5.28e-01	1.59e-01	7.95e-01	2.30e-01
GOMF METALLOCHAPERONE ACTIVITY	12	3.27e-01	6.75e-01	0.4700	-1.63e-02	-8.24e-02	-3.20e-01	-3.31e-01	4.06e-02	9.22e-01	6.21e-01	5.47e-02	4.74e-02	8.08e-01
GOMF ALPHA N ACETYLNEURAMINATE ALPHA 2 8 SIALYLTRANSFERASE ACTIVITY	6	5.91e-01	8.47e-01	0.4690	9.97e-03	-2.58e-01	-1.47e-01	1.16e-01	-3.44e-01	9.66e-01	2.74e-01	5.32e-01	6.22e-01	1.44e-01
GOCC MICOS COMPLEX	6	6.10e-01	8.58e-01	0.4690	9.38e-02	3.25e-01	-8.90e-02	-3.11e-01	3.84e-02	6.91e-01	1.68e-01	7.06e-01	1.87e-01	8.71e-01
GOBP RESPONSE TO FOLIC ACID	10	1.74e-01	5.14e-01	0.4690	-2.18e-01	1.83e-01	7.22e-02	-2.79e-01	-2.37e-01	2.32e-01	3.17e-01	6.92e-01	1.27e-01	1.94e-01
GOBP LIPID TRANSPORT ACROSS BLOOD BRAIN BARRIER	6	5.58e-01	8.32e-01	0.4690	-2.65e-01	2.09e-01	-1.73e-01	-1.03e-01	-2.57e-01	2.60e-01	3.76e-01	4.63e-01	6.63e-01	2.76e-01
GOBP NUCLEOLAR CHROMATIN ORGANIZATION	9	4.25e-01	7.52e-01	0.4690	2.28e-01	2.12e-02	-2.52e-01	-3.13e-01	-7.89e-02	2.37e-01	9.12e-01	1.91e-01	1.03e-01	6.82e-01
GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DEVELOPMENT	12	1.68e-01	5.04e-01	0.4690	1.53e-01	6.93e-02	1.37e-01	-2.36e-01	3.43e-01	3.58e-01	6.77e-01	4.10e-01	1.57e-01	3.98e-02
GOBP REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION	6	5.83e-01	8.45e-01	0.4690	2.46e-01	2.59e-01	1.74e-02	-2.02e-02	3.03e-01	2.97e-01	2.71e-01	9.41e-01	9.32e-01	1.99e-01
GOBP REGULATION OF PROTEIN COMPLEX STABILITY	14	2.04e-01	5.53e-01	0.4690	7.79e-02	-3.38e-03	-3.72e-01	-2.41e-01	1.31e-01	6.14e-01	9.83e-01	1.58e-02	1.18e-01	3.97e-01
GOBP IMMUNOLOGICAL SYNAPSE FORMATION	15	7.42e-02	3.26e-01	0.4690	-6.95e-02	4.16e-01	-2.84e-02	-2.83e-02	-2.00e-01	6.41e-01	5.22e-03	8.49e-01	8.50e-01	1.79e-01
GOBP NEGATIVE REGULATION OF RECEPTOR RECYCLING	5	5.54e-01	8.30e-01	0.4690	2.35e-01	-2.08e-01	1.55e-01	6.20e-02	-3.06e-01	3.63e-01	4.21e-01	5.49e-01	8.10e-01	2.35e-01
GOBP NEGATIVE REGULATION OF MACROPHAGE CYTOKINE PRODUCTION	12	1.14e-01	4.12e-01	0.4690	1.64e-01	4.23e-01	-7.04e-02	7.44e-02	5.96e-02	3.26e-01	1.12e-02	6.73e-01	6.55e-01	7.21e-01
GOBP RIBOSOMAL LARGE SUBUNIT ASSEMBLY	24	3.80e-02	2.13e-01	0.4690	-6.96e-02	-1.14e-01	-3.11e-01	-3.17e-01	6.78e-02	5.55e-01	3.32e-01	8.44e-03	7.14e-03	5.66e-01
GOMF CHEMOKINE ACTIVITY	45	1.84e-04	3.90e-03	0.4690	-2.50e-01	7.90e-02	1.30e-01	2.78e-01	-2.39e-01	3.77e-03	3.59e-01	1.31e-01	1.28e-03	5.54e-03
GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE 5 PHOSPHATASE ACTIVITY	9	3.21e-01	6.69e-01	0.4680	-2.75e-01	6.92e-02	-9.70e-02	-1.93e-01	-3.04e-01	1.54e-01	7.19e-01	6.14e-01	3.17e-01	1.15e-01
GOMF NATURAL KILLER CELL LECTIN LIKE RECEPTOR BINDING	8	4.30e-01	7.55e-01	0.4680	9.28e-02	-1.95e-01	-2.26e-01	-2.73e-01	-2.17e-01	6.49e-01	3.41e-01	2.69e-01	1.82e-01	2.87e-01
GOMF MAP KINASE TYROSINE SERINE THREONINE PHOSPHATASE ACTIVITY	11	2.08e-01	5.59e-01	0.4680	4.55e-02	2.29e-01	-2.55e-02	-4.03e-01	4.00e-02	7.94e-01	1.89e-01	8.84e-01	2.07e-02	8.19e-01
GOBP POSITIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS	5	6.74e-01	8.85e-01	0.4680	4.15e-02	2.36e-01	9.40e-02	-3.03e-01	2.47e-01	8.72e-01	3.61e-01	7.16e-01	2.41e-01	3.39e-01
GOBP MITOCHONDRIAL RNA METABOLIC PROCESS	51	1.45e-04	3.20e-03	0.4680	5.53e-04	-1.26e-01	-2.97e-01	-3.38e-01	5.63e-03	9.95e-01	1.20e-01	2.41e-04	2.91e-05	9.45e-01
GOMF PHOSPHOLIPASE D ACTIVITY	6	6.78e-01	8.87e-01	0.4680	1.76e-01	1.12e-01	2.91e-01	2.89e-01	-8.34e-02	4.56e-01	6.33e-01	2.17e-01	2.21e-01	7.23e-01
GOMF COMPLEMENT COMPONENT C1Q COMPLEX BINDING	8	4.50e-01	7.71e-01	0.4670	-2.92e-01	-1.80e-01	-2.33e-01	-8.54e-02	-1.98e-01	1.53e-01	3.77e-01	2.54e-01	6.76e-01	3.31e-01
GOCC MCM COMPLEX	8	4.11e-01	7.43e-01	0.4670	-1.77e-01	-1.66e-01	-1.58e-01	-3.51e-01	-1.06e-01	3.87e-01	4.17e-01	4.39e-01	8.52e-02	6.03e-01
GOBP PROTEIN LOCALIZATION TO NUCLEAR ENVELOPE	13	2.55e-01	6.12e-01	0.4670	-1.08e-02	7.28e-02	-2.42e-01	-3.87e-01	6.63e-02	9.46e-01	6.49e-01	1.31e-01	1.56e-02	6.79e-01
GOBP MITOCHONDRIAL RNA PROCESSING	20	7.33e-02	3.23e-01	0.4670	3.45e-02	-1.52e-01	-2.79e-01	-3.40e-01	-1.75e-02	7.89e-01	2.38e-01	3.05e-02	8.48e-03	8.92e-01
GOBP INTESTINAL CHOLESTEROL ABSORPTION	18	4.23e-02	2.28e-01	0.4670	2.20e-01	-1.39e-01	2.01e-02	3.55e-01	-1.55e-01	1.07e-01	3.07e-01	8.82e-01	9.10e-03	2.54e-01
GOBP CLEARANCE OF FOREIGN INTRACELLULAR NUCLEIC ACIDS	6	5.32e-01	8.20e-01	0.4670	2.59e-01	3.26e-01	-1.71e-01	-2.10e-02	-1.23e-01	2.72e-01	1.66e-01	4.69e-01	9.29e-01	6.03e-01
GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION	18	8.47e-02	3.51e-01	0.4670	-1.54e-01	-7.18e-02	-3.56e-01	-2.41e-01	6.90e-02	2.59e-01	5.98e-01	8.97e-03	7.70e-02	6.12e-01
GOBP NUCLEAR PORE LOCALIZATION	5	5.39e-01	8.23e-01	0.4670	-3.20e-01	2.18e-01	-2.43e-01	-4.18e-02	8.32e-02	2.15e-01	3.99e-01	3.46e-01	8.72e-01	7.47e-01
GOBP LEUKOTRIENE TRANSPORT	7	2.63e-01	6.19e-01	0.4670	6.72e-02	9.02e-02	-3.47e-01	2.28e-01	-1.81e-01	7.58e-01	6.79e-01	1.12e-01	2.97e-01	4.06e-01
GOBP MEIOTIC CHROMOSOME SEPARATION	8	4.90e-01	7.98e-01	0.4670	3.16e-01	-1.48e-01	-2.63e-01	-1.22e-01	1.11e-01	1.22e-01	4.69e-01	1.97e-01	5.50e-01	5.88e-01
GOBP SPINAL CORD MOTOR NEURON DIFFERENTIATION	28	7.66e-03	7.25e-02	0.4670	7.20e-02	1.86e-01	-5.25e-02	-3.36e-01	2.50e-01	5.10e-01	8.89e-02	6.31e-01	2.06e-03	2.23e-02
GOBP INTESTINAL EPITHELIAL CELL MATURATION	6	2.51e-01	6.07e-01	0.4670	7.62e-02	-1.68e-01	3.51e-01	-2.43e-01	3.76e-02	7.47e-01	4.75e-01	1.37e-01	3.03e-01	8.73e-01
GOBP NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT	11	1.76e-01	5.16e-01	0.4660	-1.22e-01	1.79e-01	-4.46e-02	-3.92e-01	-1.23e-01	4.84e-01	3.04e-01	7.98e-01	2.45e-02	4.81e-01
GOBP REGULATION OF CHROMOSOME CONDENSATION	13	2.36e-01	5.91e-01	0.4660	2.84e-01	8.78e-02	-1.78e-01	-2.71e-01	1.53e-01	7.58e-02	5.84e-01	2.68e-01	9.03e-02	3.38e-01
GOBP INTERLEUKIN 17A MEDIATED SIGNALING PATHWAY	6	5.89e-01	8.47e-01	0.4660	-6.96e-02	1.09e-01	-1.77e-02	-1.67e-01	4.15e-01	7.68e-01	6.43e-01	9.40e-01	4.80e-01	7.82e-02
GOMF SCAVENGER RECEPTOR ACTIVITY	27	5.12e-03	5.46e-02	0.4660	-1.14e-01	1.30e-01	1.96e-02	3.24e-01	-2.86e-01	3.05e-01	2.43e-01	8.60e-01	3.55e-03	1.01e-02
GOBP RNA CAPPING	35	5.44e-03	5.66e-02	0.4660	5.82e-02	-9.83e-02	-3.52e-01	-2.82e-01	2.25e-02	5.51e-01	3.14e-01	3.10e-04	3.87e-03	8.18e-01
GOBP POSITIVE REGULATION OF VESICLE FUSION	11	1.61e-01	4.93e-01	0.4660	1.57e-01	2.49e-01	-1.60e-01	1.27e-01	-2.98e-01	3.68e-01	1.53e-01	3.57e-01	4.65e-01	8.70e-02
GOBP TRANSEPITHELIAL CHLORIDE TRANSPORT	8	2.36e-01	5.91e-01	0.4660	-4.83e-02	1.98e-01	-3.45e-01	-4.16e-02	2.34e-01	8.13e-01	3.33e-01	9.10e-02	8.38e-01	2.51e-01
GOMF BMP RECEPTOR BINDING	11	2.61e-01	6.18e-01	0.4660	-3.24e-01	2.43e-01	1.65e-01	1.52e-01	-5.27e-02	6.31e-02	1.63e-01	3.42e-01	3.81e-01	7.62e-01
GOMF PROTEIN SERINE THREONINE KINASE BINDING	6	5.35e-01	8.21e-01	0.4660	-3.26e-01	-1.91e-01	6.24e-02	1.78e-01	1.97e-01	1.67e-01	4.18e-01	7.91e-01	4.50e-01	4.04e-01
GOBP RESPONSE TO SELENIUM ION	8	5.43e-01	8.25e-01	0.4660	7.42e-03	-9.23e-02	-2.61e-01	-3.75e-01	-4.06e-03	9.71e-01	6.51e-01	2.02e-01	6.63e-02	9.84e-01
GOBP STORE OPERATED CALCIUM ENTRY	21	2.46e-02	1.60e-01	0.4660	2.70e-01	2.82e-01	2.48e-01	1.75e-02	5.64e-02	3.24e-02	2.54e-02	4.92e-02	8.90e-01	6.55e-01
GOCC R2TP COMPLEX	5	7.19e-01	9.02e-01	0.4660	8.46e-02	-1.91e-01	-1.38e-01	-3.64e-01	1.49e-01	7.43e-01	4.60e-01	5.93e-01	1.59e-01	5.64e-01
GOBP POSITIVE REGULATION OF CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION	9	3.75e-01	7.14e-01	0.4660	2.74e-01	2.24e-01	4.25e-02	-6.01e-02	2.94e-01	1.55e-01	2.45e-01	8.25e-01	7.55e-01	1.27e-01
GOMF HAPTOGLOBIN BINDING	10	3.53e-01	6.98e-01	0.4660	-1.75e-02	-4.58e-02	2.21e-01	3.98e-01	8.76e-02	9.24e-01	8.02e-01	2.27e-01	2.95e-02	6.31e-01
GOBP GOLGI DISASSEMBLY	6	5.34e-01	8.20e-01	0.4660	1.70e-01	-4.41e-02	2.80e-02	-3.75e-01	2.11e-01	4.70e-01	8.52e-01	9.05e-01	1.12e-01	3.72e-01
GOBP RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION	14	2.00e-01	5.50e-01	0.4660	-5.95e-02	6.68e-02	-2.24e-01	-3.96e-01	3.92e-02	7.00e-01	6.65e-01	1.46e-01	1.03e-02	8.00e-01
GOBP PROTEIN LOCALIZATION TO PLASMA MEMBRANE RAFT	5	6.50e-01	8.78e-01	0.4660	-3.44e-01	3.75e-02	-3.40e-02	-3.10e-01	4.62e-03	1.83e-01	8.84e-01	8.95e-01	2.30e-01	9.86e-01
GOBP METANEPHRIC NEPHRON TUBULE MORPHOGENESIS	8	3.60e-01	7.04e-01	0.4650	5.69e-03	8.17e-02	3.23e-02	-4.23e-01	1.73e-01	9.78e-01	6.89e-01	8.74e-01	3.82e-02	3.98e-01
GOBP HYPOTONIC RESPONSE	13	1.34e-01	4.53e-01	0.4650	-3.82e-01	2.47e-01	9.53e-02	-3.00e-03	2.22e-02	1.72e-02	1.23e-01	5.52e-01	9.85e-01	8.90e-01
GOMF STRUCTURAL CONSTITUENT OF CHROMATIN	78	1.53e-07	8.50e-06	0.4650	7.24e-02	-2.74e-01	-3.04e-01	-1.79e-01	1.10e-01	2.69e-01	2.94e-05	3.49e-06	6.38e-03	9.42e-02
GOCC HOPS COMPLEX	9	3.97e-01	7.31e-01	0.4650	3.92e-01	7.05e-02	-1.60e-01	-1.67e-01	6.47e-02	4.19e-02	7.14e-01	4.06e-01	3.86e-01	7.37e-01
GOBP POSTSYNAPTIC MEMBRANE ASSEMBLY	7	5.98e-01	8.51e-01	0.4650	2.54e-02	7.37e-02	2.16e-01	4.01e-01	-4.53e-02	9.07e-01	7.36e-01	3.22e-01	6.60e-02	8.36e-01
GOBP INDOLE CONTAINING COMPOUND METABOLIC PROCESS	22	4.81e-02	2.47e-01	0.4650	-2.74e-01	4.03e-02	2.18e-01	2.30e-01	-1.97e-01	2.63e-02	7.44e-01	7.65e-02	6.20e-02	1.09e-01
GOMF HISTONE H3K36 METHYLTRANSFERASE ACTIVITY	13	1.13e-01	4.11e-01	0.4640	2.37e-01	6.62e-02	3.86e-01	4.95e-02	6.00e-02	1.40e-01	6.79e-01	1.59e-02	7.57e-01	7.08e-01
GOBP NEGATIVE REGULATION OF TROPHOBLAST CELL MIGRATION	7	4.43e-01	7.66e-01	0.4640	-2.14e-01	1.09e-01	2.59e-01	-1.51e-01	2.62e-01	3.28e-01	6.16e-01	2.36e-01	4.90e-01	2.31e-01
GOBP ADENOSINE TO INOSINE EDITING	7	5.79e-01	8.43e-01	0.4640	2.04e-01	1.55e-01	2.54e-01	2.77e-01	9.32e-02	3.50e-01	4.78e-01	2.44e-01	2.05e-01	6.69e-01
GOBP POSITIVE REGULATION OF BONE RESORPTION	18	2.64e-02	1.68e-01	0.4640	1.11e-01	2.35e-01	2.57e-01	-2.13e-03	-2.86e-01	4.16e-01	8.39e-02	5.94e-02	9.88e-01	3.54e-02
GOBP ANDROGEN BIOSYNTHETIC PROCESS	10	2.82e-01	6.35e-01	0.4640	-1.96e-01	-2.31e-01	-6.57e-02	2.97e-01	-1.76e-01	2.83e-01	2.06e-01	7.19e-01	1.03e-01	3.36e-01
GOBP NOREPINEPHRINE BIOSYNTHETIC PROCESS	8	3.40e-01	6.87e-01	0.4640	-2.19e-01	2.69e-01	2.54e-01	-1.63e-01	-6.30e-02	2.84e-01	1.87e-01	2.13e-01	4.26e-01	7.58e-01
GOBP REGULATION OF ENDODEOXYRIBONUCLEASE ACTIVITY	8	4.49e-01	7.70e-01	0.4640	-1.24e-01	1.93e-01	-1.37e-01	-3.78e-01	-3.38e-02	5.45e-01	3.44e-01	5.01e-01	6.42e-02	8.69e-01
GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I	11	3.17e-01	6.66e-01	0.4640	2.94e-01	2.82e-02	-2.51e-01	-2.53e-01	-3.91e-02	9.16e-02	8.71e-01	1.50e-01	1.47e-01	8.22e-01
GOBP POSITIVE REGULATION OF GLUTAMATE SECRETION	11	3.37e-01	6.84e-01	0.4640	-1.65e-01	9.26e-02	3.86e-01	1.73e-01	1.94e-02	3.44e-01	5.95e-01	2.66e-02	3.21e-01	9.11e-01
GOMF ALKANESULFONATE TRANSMEMBRANE TRANSPORTER ACTIVITY	5	6.53e-01	8.79e-01	0.4640	1.47e-01	1.76e-01	3.51e-01	7.36e-02	-1.83e-01	5.70e-01	4.96e-01	1.74e-01	7.76e-01	4.78e-01
GOBP PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM EXIT SITE	6	6.45e-01	8.75e-01	0.4640	1.83e-01	2.85e-01	2.11e-01	2.34e-01	2.97e-02	4.38e-01	2.27e-01	3.70e-01	3.21e-01	9.00e-01
GOBP NEGATIVE REGULATION OF WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT	7	4.79e-01	7.91e-01	0.4630	-3.37e-01	1.37e-01	-4.65e-02	-2.83e-01	-8.33e-03	1.22e-01	5.30e-01	8.31e-01	1.95e-01	9.70e-01
GOBP RESOLUTION OF RECOMBINATION INTERMEDIATES	6	5.77e-01	8.42e-01	0.4630	-6.35e-02	6.94e-02	1.05e-01	-2.60e-01	3.57e-01	7.88e-01	7.68e-01	6.57e-01	2.70e-01	1.30e-01
GOBP NEGATIVE REGULATION OF CENTRIOLE REPLICATION	7	3.85e-01	7.23e-01	0.4630	1.35e-01	3.64e-01	-3.27e-02	1.18e-01	2.21e-01	5.36e-01	9.55e-02	8.81e-01	5.87e-01	3.12e-01
GOBP MYOBLAST FATE COMMITMENT	6	6.49e-01	8.77e-01	0.4630	-2.17e-02	2.31e-01	-2.91e-01	-2.75e-01	1.20e-02	9.27e-01	3.28e-01	2.17e-01	2.43e-01	9.59e-01
GOBP PROTEIN INSERTION INTO ER MEMBRANE BY STOP TRANSFER MEMBRANE ANCHOR SEQUENCE	10	3.85e-01	7.23e-01	0.4630	5.14e-02	2.20e-01	-2.60e-01	-3.07e-01	3.73e-02	7.78e-01	2.29e-01	1.55e-01	9.24e-02	8.38e-01
GOMF BHLH TRANSCRIPTION FACTOR BINDING	31	5.02e-03	5.37e-02	0.4630	8.75e-03	2.15e-01	-1.18e-01	-3.37e-01	2.01e-01	9.33e-01	3.83e-02	2.57e-01	1.17e-03	5.23e-02
GOBP POSITIVE REGULATION OF METALLOENDOPEPTIDASE ACTIVITY	7	1.90e-01	5.36e-01	0.4630	-2.40e-01	5.94e-02	-1.94e-01	3.00e-01	1.60e-01	2.72e-01	7.85e-01	3.74e-01	1.69e-01	4.63e-01
GOBP CELLULAR RESPONSE TO GONADOTROPIN STIMULUS	17	2.46e-02	1.60e-01	0.4630	1.71e-01	-7.51e-02	2.23e-01	7.04e-02	-3.52e-01	2.22e-01	5.92e-01	1.11e-01	6.15e-01	1.19e-02
GOBP POLYAMINE BIOSYNTHETIC PROCESS	12	1.57e-01	4.86e-01	0.4620	-9.62e-02	1.56e-01	-9.95e-02	-3.45e-01	-2.26e-01	5.64e-01	3.51e-01	5.51e-01	3.84e-02	1.75e-01
GOMF SECONDARY ACTIVE MONOCARBOXYLATE TRANSMEMBRANE TRANSPORTER ACTIVITY	17	5.65e-02	2.76e-01	0.4620	1.19e-01	1.44e-01	3.94e-01	9.67e-02	-1.20e-01	3.94e-01	3.05e-01	4.97e-03	4.90e-01	3.92e-01
GOMF C ACYLTRANSFERASE ACTIVITY	19	2.83e-02	1.77e-01	0.4620	2.53e-01	3.42e-01	-1.63e-01	-4.86e-02	-6.24e-02	5.66e-02	9.85e-03	2.20e-01	7.14e-01	6.38e-01
GOBP POSITIVE REGULATION OF MITOPHAGY	7	5.66e-01	8.36e-01	0.4620	2.16e-01	2.77e-01	-1.39e-01	-2.54e-01	7.87e-02	3.23e-01	2.05e-01	5.25e-01	2.44e-01	7.18e-01
GOMF NAD RETINOL DEHYDROGENASE ACTIVITY	21	3.26e-02	1.93e-01	0.4620	-1.12e-01	-7.11e-02	9.27e-02	4.17e-01	-1.15e-01	3.76e-01	5.73e-01	4.62e-01	9.33e-04	3.64e-01
GOCC INTERSTITIAL MATRIX	11	3.36e-01	6.83e-01	0.4620	-2.62e-01	8.24e-02	3.30e-01	1.70e-01	-8.91e-04	1.32e-01	6.36e-01	5.83e-02	3.28e-01	9.96e-01
GOBP RETINAL BLOOD VESSEL MORPHOGENESIS	5	7.18e-01	9.02e-01	0.4620	2.89e-02	-9.52e-02	2.28e-01	3.18e-01	2.24e-01	9.11e-01	7.12e-01	3.77e-01	2.18e-01	3.86e-01
GOMF LYSINE N ACETYLTRANSFERASE ACTIVITY ACTING ON ACETYL PHOSPHATE AS DONOR	6	6.45e-01	8.76e-01	0.4620	-1.62e-01	9.47e-02	4.04e-01	1.17e-01	-3.74e-02	4.92e-01	6.88e-01	8.69e-02	6.19e-01	8.74e-01
GOMF MANNOSYLTRANSFERASE ACTIVITY	24	4.72e-02	2.44e-01	0.4620	1.37e-01	-9.10e-02	-3.26e-01	-2.81e-01	1.97e-02	2.45e-01	4.40e-01	5.63e-03	1.71e-02	8.67e-01
GOBP FUNGIFORM PAPILLA DEVELOPMENT	6	4.52e-01	7.71e-01	0.4620	7.47e-02	-1.02e-02	1.52e-01	-3.70e-01	2.18e-01	7.51e-01	9.66e-01	5.18e-01	1.17e-01	3.56e-01
GOMF HEPARAN SULFATE SULFOTRANSFERASE ACTIVITY	14	1.27e-01	4.40e-01	0.4620	-1.08e-01	-1.36e-01	2.62e-01	1.28e-01	3.13e-01	4.86e-01	3.77e-01	8.96e-02	4.06e-01	4.28e-02
GOBP PROTEIN PEPTIDYL PROLYL ISOMERIZATION	18	7.78e-02	3.35e-01	0.4620	2.32e-01	4.26e-02	-2.01e-01	-3.39e-01	-4.93e-02	8.89e-02	7.55e-01	1.41e-01	1.28e-02	7.17e-01
GOBP REGULATION OF TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY	10	2.42e-01	5.99e-01	0.4610	-2.88e-01	2.42e-01	8.63e-02	-1.21e-02	2.52e-01	1.14e-01	1.86e-01	6.37e-01	9.47e-01	1.67e-01
GOBP POSITIVE REGULATION OF RESPIRATORY BURST	7	2.05e-01	5.55e-01	0.4610	-2.66e-02	1.05e-01	-4.12e-01	1.24e-01	1.26e-01	9.03e-01	6.30e-01	5.90e-02	5.70e-01	5.63e-01
GOBP ETHANOL METABOLIC PROCESS	19	6.17e-02	2.92e-01	0.4610	-1.45e-01	-2.38e-01	3.88e-02	2.96e-01	-2.14e-01	2.73e-01	7.31e-02	7.70e-01	2.53e-02	1.06e-01
GOMF TELETHONIN BINDING	7	3.93e-01	7.27e-01	0.4610	-3.17e-01	9.15e-02	-8.79e-02	2.71e-01	-1.51e-01	1.47e-01	6.75e-01	6.87e-01	2.14e-01	4.89e-01
GOMF G PROTEIN COUPLED CHEMOATTRACTANT RECEPTOR ACTIVITY	25	3.17e-02	1.90e-01	0.4610	-1.64e-01	-4.95e-02	1.80e-01	3.21e-01	-2.19e-01	1.56e-01	6.68e-01	1.19e-01	5.49e-03	5.79e-02
GOBP AGGRESOME ASSEMBLY	5	6.20e-01	8.63e-01	0.4610	2.10e-01	-1.60e-01	-2.28e-01	2.34e-01	-1.89e-01	4.15e-01	5.35e-01	3.77e-01	3.65e-01	4.63e-01
GOMF SNORNA BINDING	31	1.41e-02	1.12e-01	0.4610	1.14e-01	-9.51e-02	-2.97e-01	-3.00e-01	1.12e-01	2.71e-01	3.60e-01	4.24e-03	3.85e-03	2.82e-01
GOBP SNO S RNA METABOLIC PROCESS	15	1.97e-01	5.45e-01	0.4610	2.20e-01	-3.45e-02	-1.98e-01	-2.93e-01	1.94e-01	1.39e-01	8.17e-01	1.83e-01	4.97e-02	1.93e-01
GOBP PH REDUCTION	6	6.42e-01	8.75e-01	0.4610	-1.04e-01	1.09e-01	3.65e-01	1.33e-01	-1.96e-01	6.58e-01	6.44e-01	1.21e-01	5.71e-01	4.06e-01
GOBP NEUTROPHIL DEGRANULATION	13	1.61e-01	4.93e-01	0.4610	-3.37e-01	3.53e-02	3.10e-01	3.58e-02	-5.01e-03	3.52e-02	8.25e-01	5.30e-02	8.23e-01	9.75e-01
GOBP NEGATIVE REGULATION OF THYMOCYTE APOPTOTIC PROCESS	10	6.41e-02	2.98e-01	0.4610	5.55e-02	-4.10e-02	2.69e-01	-3.65e-01	4.69e-02	7.61e-01	8.22e-01	1.40e-01	4.59e-02	7.97e-01
GOBP REGULATION OF RETINAL GANGLION CELL AXON GUIDANCE	6	5.44e-01	8.25e-01	0.4610	-2.55e-01	-3.44e-01	1.66e-01	2.30e-02	2.60e-02	2.80e-01	1.44e-01	4.81e-01	9.22e-01	9.12e-01
GOBP FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX	16	1.61e-01	4.93e-01	0.4610	1.19e-01	-1.42e-01	-3.75e-01	-1.88e-01	4.25e-02	4.11e-01	3.25e-01	9.33e-03	1.94e-01	7.69e-01
GOMF FOLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY	5	6.97e-01	8.94e-01	0.4610	2.53e-01	1.66e-01	1.36e-01	-1.69e-01	2.70e-01	3.26e-01	5.20e-01	5.98e-01	5.13e-01	2.95e-01
GOCC AMPHISOME	13	2.95e-01	6.49e-01	0.4610	1.18e-01	1.04e-02	-3.21e-01	-3.09e-01	-2.97e-03	4.61e-01	9.48e-01	4.53e-02	5.40e-02	9.85e-01
GOBP LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR	11	2.44e-01	6.02e-01	0.4610	-5.29e-02	-1.95e-01	-8.12e-02	5.01e-02	-4.03e-01	7.61e-01	2.64e-01	6.41e-01	7.73e-01	2.07e-02
GOBP CELLULAR RESPONSE TO GLUCAGON STIMULUS	11	2.62e-01	6.19e-01	0.4610	-1.61e-02	3.04e-01	1.84e-01	2.86e-01	6.37e-02	9.26e-01	8.12e-02	2.91e-01	1.01e-01	7.14e-01
GOBP ENDOCARDIAL CUSHION TO MESENCHYMAL TRANSITION	6	6.45e-01	8.76e-01	0.4600	8.08e-03	1.32e-01	-4.91e-02	-2.49e-01	3.60e-01	9.73e-01	5.75e-01	8.35e-01	2.90e-01	1.26e-01
GOBP MAST CELL PROLIFERATION	7	4.91e-01	7.98e-01	0.4600	-3.38e-01	2.33e-01	1.70e-01	-7.73e-02	9.46e-02	1.22e-01	2.87e-01	4.37e-01	7.23e-01	6.65e-01
GOBP VIRAL RELEASE FROM HOST CELL	28	1.44e-02	1.14e-01	0.4600	1.77e-01	1.55e-02	-1.65e-01	-3.62e-01	1.49e-01	1.06e-01	8.87e-01	1.30e-01	9.10e-04	1.74e-01
GOBP KINETOCHORE ORGANIZATION	20	4.36e-02	2.32e-01	0.4600	2.18e-01	-1.74e-01	-1.65e-01	-3.25e-01	3.76e-02	9.16e-02	1.77e-01	2.02e-01	1.19e-02	7.71e-01
GOBP GOLGI LUMEN ACIDIFICATION	10	3.51e-01	6.97e-01	0.4600	1.78e-01	8.80e-02	-5.92e-02	-3.55e-01	2.07e-01	3.28e-01	6.30e-01	7.46e-01	5.21e-02	2.56e-01
GOBP RRNA CATABOLIC PROCESS	21	4.64e-02	2.41e-01	0.4600	8.18e-02	1.55e-01	-1.54e-01	-3.93e-01	5.59e-02	5.17e-01	2.18e-01	2.23e-01	1.82e-03	6.58e-01
GOBP REGULATION OF MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS	7	2.83e-01	6.36e-01	0.4600	1.88e-01	-2.40e-01	2.52e-01	-1.80e-01	1.50e-01	3.89e-01	2.71e-01	2.48e-01	4.09e-01	4.92e-01
GOBP REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS	10	2.23e-01	5.77e-01	0.4600	2.12e-01	2.47e-01	1.29e-01	-2.90e-01	7.28e-02	2.45e-01	1.76e-01	4.79e-01	1.13e-01	6.90e-01
GOCC RNA POLYMERASE II CORE COMPLEX	13	2.25e-01	5.79e-01	0.4600	2.26e-01	-1.96e-01	-2.03e-01	-2.79e-01	5.16e-02	1.57e-01	2.20e-01	2.04e-01	8.14e-02	7.47e-01
GOBP CELLULAR RESPONSE TO X RAY	11	1.87e-01	5.30e-01	0.4600	3.70e-01	2.06e-01	8.33e-02	-1.54e-01	-4.01e-02	3.37e-02	2.36e-01	6.32e-01	3.75e-01	8.18e-01
GOMF MOLYBDOPTERIN COFACTOR BINDING	6	5.90e-01	8.47e-01	0.4600	-2.59e-01	-9.14e-02	2.24e-01	1.06e-01	2.73e-01	2.72e-01	6.98e-01	3.41e-01	6.53e-01	2.46e-01
GOMF 5ALPHA ANDROSTANE 3BETA 17BETA DIOL DEHYDROGENASE ACTIVITY	6	6.40e-01	8.74e-01	0.4600	-2.00e-01	5.43e-02	1.05e-01	3.67e-01	-1.51e-01	3.96e-01	8.18e-01	6.57e-01	1.19e-01	5.22e-01
GOMF TASTE RECEPTOR ACTIVITY	29	1.61e-03	2.28e-02	0.4600	1.43e-01	-1.79e-01	6.48e-02	3.37e-01	2.03e-01	1.82e-01	9.53e-02	5.46e-01	1.67e-03	5.87e-02
GOBP INTERLEUKIN 23 PRODUCTION	9	3.36e-01	6.84e-01	0.4600	-4.03e-01	1.09e-01	-1.12e-01	-1.01e-01	-1.21e-01	3.64e-02	5.72e-01	5.60e-01	5.98e-01	5.30e-01
GOMF RACEMASE AND EPIMERASE ACTIVITY ACTING ON CARBOHYDRATES AND DERIVATIVES	10	2.80e-01	6.33e-01	0.4600	3.35e-01	2.94e-01	-1.38e-02	-8.83e-02	-7.03e-02	6.70e-02	1.07e-01	9.40e-01	6.29e-01	7.00e-01
GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT CONFERRING TENSILE STRENGTH	42	4.43e-04	8.17e-03	0.4600	-1.13e-01	-2.39e-01	1.29e-01	3.34e-01	-1.16e-01	2.07e-01	7.48e-03	1.48e-01	1.78e-04	1.91e-01
GOMF CARBON SULFUR LYASE ACTIVITY	12	2.22e-01	5.76e-01	0.4600	9.45e-02	1.18e-01	-6.58e-02	-1.43e-01	4.05e-01	5.71e-01	4.79e-01	6.93e-01	3.92e-01	1.52e-02
GOCC VCP NPL4 UFD1 AAA ATPASE COMPLEX	8	5.54e-01	8.30e-01	0.4600	1.85e-01	-2.52e-02	-3.15e-01	-2.13e-01	1.78e-01	3.65e-01	9.02e-01	1.22e-01	2.97e-01	3.83e-01
GOMF S100 PROTEIN BINDING	14	1.13e-01	4.11e-01	0.4600	-9.74e-02	2.34e-01	9.16e-02	3.60e-01	-9.54e-02	5.28e-01	1.29e-01	5.53e-01	1.97e-02	5.36e-01
GOCC RAGULATOR COMPLEX	5	7.79e-01	9.28e-01	0.4600	2.24e-01	-3.38e-02	-1.85e-01	-3.18e-01	1.57e-01	3.87e-01	8.96e-01	4.73e-01	2.18e-01	5.44e-01
GOBP REGULATION OF CGMP MEDIATED SIGNALING	11	2.15e-01	5.69e-01	0.4600	3.53e-01	-2.33e-01	-9.72e-02	1.49e-01	-2.85e-02	4.27e-02	1.81e-01	5.77e-01	3.93e-01	8.70e-01
GOCC RNA POLYMERASE III TRANSCRIPTION REGULATOR COMPLEX	9	3.80e-01	7.18e-01	0.4590	8.23e-02	-9.34e-02	-6.79e-02	-3.86e-01	2.05e-01	6.69e-01	6.28e-01	7.24e-01	4.51e-02	2.86e-01
GOBP SUBTELOMERIC HETEROCHROMATIN FORMATION	8	5.02e-01	8.03e-01	0.4590	2.70e-01	1.10e-01	-4.92e-02	-1.90e-01	2.96e-01	1.86e-01	5.90e-01	8.10e-01	3.51e-01	1.48e-01
GOBP MESENCHYMAL CELL PROLIFERATION INVOLVED IN LUNG DEVELOPMENT	6	4.97e-01	8.02e-01	0.4590	-2.37e-01	-3.05e-01	2.31e-01	-3.74e-02	8.61e-02	3.15e-01	1.96e-01	3.27e-01	8.74e-01	7.15e-01
GOBP SULFATION	20	8.99e-02	3.62e-01	0.4590	-1.27e-01	1.58e-01	2.44e-01	2.81e-01	-1.79e-01	3.27e-01	2.23e-01	5.94e-02	2.99e-02	1.65e-01
GOMF ANAPHASE PROMOTING COMPLEX BINDING	9	3.87e-01	7.24e-01	0.4590	1.33e-01	3.32e-01	-1.81e-01	-2.20e-01	-3.62e-02	4.89e-01	8.41e-02	3.47e-01	2.52e-01	8.51e-01
GOMF PRE MRNA 5 SPLICE SITE BINDING	6	6.13e-01	8.59e-01	0.4590	-1.60e-01	1.20e-02	-3.97e-01	-1.61e-01	-3.42e-02	4.97e-01	9.59e-01	9.18e-02	4.94e-01	8.85e-01
GOBP UREA TRANSPORT	11	2.41e-01	5.98e-01	0.4590	-2.57e-01	3.09e-01	4.06e-02	7.84e-02	-2.04e-01	1.41e-01	7.60e-02	8.16e-01	6.53e-01	2.42e-01
GOBP CONNECTIVE TISSUE REPLACEMENT INVOLVED IN INFLAMMATORY RESPONSE WOUND HEALING	6	6.23e-01	8.66e-01	0.4590	1.09e-01	2.12e-01	1.70e-02	-1.16e-01	3.74e-01	6.44e-01	3.69e-01	9.43e-01	6.24e-01	1.12e-01
GOBP CLATHRIN COATED VESICLE CARGO LOADING	7	5.21e-01	8.13e-01	0.4590	1.07e-01	-2.37e-01	-1.77e-01	-3.27e-01	-7.10e-02	6.24e-01	2.79e-01	4.18e-01	1.34e-01	7.45e-01
GOBP NEGATIVE REGULATION OF TELOMERASE ACTIVITY	10	4.38e-01	7.60e-01	0.4590	5.42e-02	-7.94e-02	-3.20e-01	-2.98e-01	-1.00e-01	7.66e-01	6.64e-01	8.02e-02	1.02e-01	5.84e-01
GOBP MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA	34	5.59e-03	5.76e-02	0.4590	2.15e-01	5.50e-02	-3.02e-01	-2.56e-01	6.37e-02	3.03e-02	5.79e-01	2.27e-03	9.67e-03	5.20e-01
GOMF G PROTEIN COUPLED ADENOSINE RECEPTOR ACTIVITY	5	6.15e-01	8.60e-01	0.4590	1.14e-01	2.99e-01	2.98e-01	-1.37e-01	-2.60e-02	6.60e-01	2.47e-01	2.49e-01	5.97e-01	9.20e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB	25	7.08e-04	1.16e-02	0.4580	-1.16e-01	-3.18e-01	2.28e-01	-6.71e-02	-1.98e-01	3.17e-01	5.95e-03	4.84e-02	5.62e-01	8.59e-02
GOBP UTP BIOSYNTHETIC PROCESS	10	2.88e-01	6.42e-01	0.4580	1.31e-01	4.11e-01	-4.39e-02	-1.25e-01	-7.97e-02	4.73e-01	2.43e-02	8.10e-01	4.95e-01	6.63e-01
GOBP LIPID GLYCOSYLATION	12	5.54e-02	2.72e-01	0.4580	9.02e-02	1.14e-01	2.61e-01	-3.40e-01	7.24e-02	5.88e-01	4.95e-01	1.17e-01	4.15e-02	6.64e-01
GOCC IRON SULFUR CLUSTER ASSEMBLY COMPLEX	10	3.28e-01	6.76e-01	0.4580	1.42e-01	-1.19e-01	-2.80e-01	-8.59e-02	-3.00e-01	4.36e-01	5.15e-01	1.25e-01	6.38e-01	1.01e-01
GOBP ALPHA KETOGLUTARATE TRANSPORT	7	2.63e-01	6.19e-01	0.4580	7.82e-02	-1.12e-01	-1.79e-01	3.85e-01	1.07e-01	7.20e-01	6.09e-01	4.12e-01	7.79e-02	6.25e-01
GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE ADAPTATION	8	4.78e-01	7.91e-01	0.4580	-1.64e-01	6.42e-02	3.93e-01	1.18e-01	-1.03e-01	4.21e-01	7.53e-01	5.42e-02	5.64e-01	6.15e-01
GOBP POSITIVE REGULATION OF HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE	7	5.49e-01	8.28e-01	0.4580	1.06e-01	-1.44e-01	3.33e-01	2.37e-01	-1.04e-01	6.27e-01	5.10e-01	1.27e-01	2.79e-01	6.32e-01
GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 SIGNALING PATHWAY	6	5.92e-01	8.47e-01	0.4580	1.89e-01	-1.91e-01	1.95e-01	1.03e-01	2.99e-01	4.22e-01	4.18e-01	4.08e-01	6.64e-01	2.05e-01
GOBP REGULATION OF MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON	5	7.57e-01	9.19e-01	0.4580	-1.18e-01	1.08e-02	9.06e-02	3.34e-01	-2.76e-01	6.48e-01	9.67e-01	7.26e-01	1.96e-01	2.85e-01
GOBP REGULATION OF GENE EXPRESSION BY GENOMIC IMPRINTING	10	1.58e-01	4.88e-01	0.4580	3.16e-01	2.92e-02	2.98e-02	-3.07e-01	-1.18e-01	8.33e-02	8.73e-01	8.70e-01	9.32e-02	5.18e-01
GOBP BILE ACID SIGNALING PATHWAY	11	2.24e-01	5.77e-01	0.4580	-2.84e-01	7.53e-02	3.89e-02	3.25e-01	-1.26e-01	1.02e-01	6.65e-01	8.23e-01	6.17e-02	4.71e-01
GOBP T HELPER 17 CELL LINEAGE COMMITMENT	16	6.56e-02	3.02e-01	0.4580	-9.30e-02	3.67e-01	1.92e-01	-1.37e-01	-1.04e-01	5.19e-01	1.10e-02	1.85e-01	3.44e-01	4.73e-01
GOBP REGULATION OF CILIUM BEAT FREQUENCY INVOLVED IN CILIARY MOTILITY	9	3.75e-01	7.15e-01	0.4580	-8.87e-02	-5.10e-02	-1.23e-01	4.94e-02	-4.26e-01	6.45e-01	7.91e-01	5.22e-01	7.98e-01	2.69e-02
GOCC NEURONAL DENSE CORE VESICLE MEMBRANE	5	6.95e-01	8.94e-01	0.4580	-3.84e-01	-1.13e-01	-9.93e-02	8.63e-02	-1.78e-01	1.37e-01	6.62e-01	7.00e-01	7.38e-01	4.90e-01
GOMF IMMUNOGLOBULIN BINDING	19	5.21e-02	2.62e-01	0.4580	-3.15e-02	2.28e-01	2.16e-01	2.77e-01	1.81e-01	8.12e-01	8.55e-02	1.03e-01	3.63e-02	1.72e-01
GOBP HAIR CYCLE PHASE	9	2.86e-01	6.40e-01	0.4580	3.22e-01	-1.46e-01	1.95e-01	-4.84e-02	2.09e-01	9.41e-02	4.47e-01	3.10e-01	8.02e-01	2.78e-01
GOBP ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT	27	9.83e-03	8.67e-02	0.4570	-1.67e-01	-4.08e-03	-1.85e-01	-3.78e-01	-6.84e-02	1.33e-01	9.71e-01	9.66e-02	6.82e-04	5.38e-01
GOBP NEGATIVE REGULATION OF DENDRITIC CELL DIFFERENTIATION	5	7.49e-01	9.15e-01	0.4570	3.35e-01	1.84e-02	-2.43e-01	-1.93e-01	-2.26e-02	1.94e-01	9.43e-01	3.47e-01	4.56e-01	9.30e-01
GOBP POSITIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE	7	5.05e-01	8.05e-01	0.4570	-3.67e-01	2.20e-01	1.46e-01	-1.93e-02	6.48e-02	9.25e-02	3.13e-01	5.05e-01	9.30e-01	7.67e-01
GOBP MITOCHONDRIAL TRNA PROCESSING	13	1.22e-01	4.30e-01	0.4570	-6.86e-02	-1.65e-01	-1.03e-01	-4.05e-01	-5.36e-02	6.68e-01	3.04e-01	5.22e-01	1.15e-02	7.38e-01
GOMF SEQUENCE SPECIFIC SINGLE STRANDED DNA BINDING	14	2.57e-01	6.14e-01	0.4570	4.00e-02	-1.38e-01	-2.51e-01	-3.30e-01	1.28e-01	7.95e-01	3.71e-01	1.04e-01	3.25e-02	4.07e-01
GOMF INOSITOL TETRAKISPHOSPHATE PHOSPHATASE ACTIVITY	7	4.62e-01	7.79e-01	0.4570	-1.64e-01	2.33e-01	2.06e-01	-6.47e-02	-2.85e-01	4.54e-01	2.85e-01	3.46e-01	7.67e-01	1.91e-01
GOBP TRNA TRANSCRIPTION	11	3.16e-01	6.66e-01	0.4570	2.12e-01	-9.44e-03	-9.49e-02	-3.39e-01	2.01e-01	2.25e-01	9.57e-01	5.86e-01	5.18e-02	2.47e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS WITH A FLAVIN AS ACCEPTOR	12	2.89e-01	6.43e-01	0.4570	2.17e-01	1.81e-01	-2.31e-01	-2.74e-01	2.09e-02	1.92e-01	2.78e-01	1.66e-01	9.99e-02	9.00e-01
GOBP CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION	18	8.68e-02	3.56e-01	0.4570	-2.86e-02	2.13e-01	3.57e-01	8.82e-02	1.65e-01	8.34e-01	1.17e-01	8.72e-03	5.17e-01	2.25e-01
GOCC INNER KINETOCHORE	17	1.46e-01	4.67e-01	0.4570	1.38e-01	-3.84e-02	-2.44e-01	-3.57e-01	2.79e-02	3.23e-01	7.84e-01	8.12e-02	1.07e-02	8.42e-01
GOBP FATTY ACID ELONGATION SATURATED FATTY ACID	7	5.68e-01	8.37e-01	0.4570	-1.52e-01	1.70e-01	-1.31e-01	-3.58e-01	1.06e-01	4.86e-01	4.36e-01	5.48e-01	1.01e-01	6.26e-01
GOMF FATTY ACID ELONGASE ACTIVITY	7	5.68e-01	8.37e-01	0.4570	-1.52e-01	1.70e-01	-1.31e-01	-3.58e-01	1.06e-01	4.86e-01	4.36e-01	5.48e-01	1.01e-01	6.26e-01
GOBP REGULATION OF DEOXYRIBONUCLEASE ACTIVITY	10	3.09e-01	6.61e-01	0.4570	-2.01e-03	3.16e-01	-1.10e-01	-2.90e-01	-1.12e-01	9.91e-01	8.34e-02	5.49e-01	1.13e-01	5.39e-01
GOBP SYNAPTIC VESICLE COATING	5	6.87e-01	8.90e-01	0.4570	1.39e-01	-1.99e-01	-1.86e-01	-2.79e-01	-1.92e-01	5.90e-01	4.41e-01	4.73e-01	2.79e-01	4.57e-01
GOCC LAMELLAR BODY	17	8.29e-02	3.47e-01	0.4570	-1.37e-02	1.67e-01	2.38e-01	1.13e-01	3.33e-01	9.22e-01	2.32e-01	8.99e-02	4.18e-01	1.75e-02
GOBP REGULATION OF ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS	5	7.17e-01	9.02e-01	0.4560	7.91e-02	3.57e-01	-1.44e-01	-2.32e-01	-1.13e-02	7.59e-01	1.67e-01	5.77e-01	3.69e-01	9.65e-01
GOBP AMMONIUM ION METABOLIC PROCESS	22	5.36e-02	2.66e-01	0.4560	-8.36e-02	-4.45e-02	3.75e-01	2.38e-01	-4.92e-02	4.97e-01	7.18e-01	2.34e-03	5.37e-02	6.90e-01
GOBP GLIAL CELL FATE COMMITMENT	13	2.24e-01	5.77e-01	0.4560	-8.37e-02	1.37e-01	-1.38e-01	-3.87e-01	1.17e-01	6.01e-01	3.91e-01	3.89e-01	1.57e-02	4.67e-01
GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 3 COMPLEX EIF3M	7	6.47e-01	8.77e-01	0.4560	2.14e-01	-1.18e-02	-2.50e-01	-3.12e-01	5.09e-02	3.26e-01	9.57e-01	2.52e-01	1.53e-01	8.16e-01
GOBP REGULATION OF ODONTOBLAST DIFFERENTIATION	5	6.74e-01	8.85e-01	0.4560	3.19e-01	-2.73e-01	6.17e-02	1.67e-01	-6.04e-03	2.16e-01	2.90e-01	8.11e-01	5.18e-01	9.81e-01
GOBP REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY	6	5.47e-01	8.27e-01	0.4560	2.22e-01	-1.37e-01	3.46e-01	1.40e-01	-2.80e-02	3.46e-01	5.61e-01	1.42e-01	5.53e-01	9.06e-01
GOBP REGULATION OF APPETITE	19	3.26e-02	1.93e-01	0.4560	4.30e-01	1.01e-01	7.79e-02	-7.45e-02	4.00e-02	1.19e-03	4.44e-01	5.56e-01	5.74e-01	7.63e-01
GOBP RESPONSE TO FORSKOLIN	14	2.12e-01	5.65e-01	0.4560	-2.21e-01	-7.80e-02	3.03e-01	2.39e-01	6.49e-02	1.52e-01	6.14e-01	4.98e-02	1.21e-01	6.74e-01
GOMF ADENYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY	15	2.37e-01	5.93e-01	0.4560	8.88e-02	-1.37e-01	-3.10e-01	-2.83e-01	7.14e-02	5.52e-01	3.59e-01	3.74e-02	5.80e-02	6.32e-01
GOBP CELLULAR RESPONSE TO ETHER	6	6.12e-01	8.58e-01	0.4560	-1.26e-01	3.24e-01	1.06e-01	1.08e-02	-2.74e-01	5.93e-01	1.69e-01	6.52e-01	9.63e-01	2.44e-01
GOBP MYELOID DENDRITIC CELL CHEMOTAXIS	5	6.28e-01	8.68e-01	0.4560	-1.12e-01	2.66e-01	4.04e-02	3.41e-01	-8.23e-02	6.65e-01	3.03e-01	8.76e-01	1.87e-01	7.50e-01
GOBP POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE	17	9.66e-02	3.76e-01	0.4560	-6.95e-04	3.75e-01	2.03e-01	1.59e-01	2.29e-02	9.96e-01	7.42e-03	1.47e-01	2.55e-01	8.70e-01
GOBP SEROTONIN TRANSPORT	20	2.35e-02	1.56e-01	0.4560	3.89e-01	-2.96e-02	-1.11e-01	1.12e-01	1.75e-01	2.58e-03	8.19e-01	3.90e-01	3.87e-01	1.75e-01
GOBP EMBRYONIC CAMERA TYPE EYE FORMATION	11	2.60e-01	6.17e-01	0.4560	2.89e-01	4.95e-02	2.36e-01	3.50e-02	2.54e-01	9.65e-02	7.76e-01	1.75e-01	8.41e-01	1.45e-01
GOBP REGULATION OF PIGMENT CELL DIFFERENTIATION	8	5.16e-01	8.10e-01	0.4560	5.95e-02	1.24e-01	2.13e-01	3.77e-01	3.59e-02	7.71e-01	5.43e-01	2.97e-01	6.50e-02	8.60e-01
GOMF DNA ENDONUCLEASE ACTIVITY PRODUCING 3 PHOSPHOMONOESTERS	9	2.82e-01	6.36e-01	0.4550	-1.31e-01	8.58e-02	-3.75e-01	-1.20e-01	1.68e-01	4.97e-01	6.56e-01	5.15e-02	5.34e-01	3.83e-01
GOBP POSITIVE REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY	7	4.06e-01	7.39e-01	0.4550	-2.57e-01	-1.64e-01	2.95e-01	-1.28e-02	-1.65e-01	2.39e-01	4.53e-01	1.76e-01	9.53e-01	4.50e-01
GOBP ACTIN CROSSLINK FORMATION	12	1.95e-01	5.43e-01	0.4550	-2.77e-01	3.17e-01	1.29e-01	-1.01e-01	5.35e-02	9.65e-02	5.72e-02	4.37e-01	5.44e-01	7.48e-01
GOCC SMALL RIBOSOMAL SUBUNIT	70	2.05e-06	8.37e-05	0.4550	-3.60e-02	8.84e-02	-3.14e-01	-3.09e-01	-6.49e-02	6.03e-01	2.01e-01	5.50e-06	7.98e-06	3.48e-01
GOBP RIBOSOME BIOGENESIS	303	2.35e-27	8.59e-25	0.4550	5.90e-02	-5.54e-02	-3.01e-01	-3.29e-01	4.22e-02	7.74e-02	9.69e-02	2.00e-19	5.79e-23	2.07e-01
GOMF MACROLIDE BINDING	12	2.50e-01	6.07e-01	0.4550	-6.81e-02	6.07e-02	-3.12e-01	-1.83e-01	-2.61e-01	6.83e-01	7.16e-01	6.13e-02	2.72e-01	1.18e-01
GOBP POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION	11	2.76e-01	6.30e-01	0.4550	-3.89e-01	-4.19e-02	1.79e-02	4.45e-02	-2.28e-01	2.56e-02	8.10e-01	9.18e-01	7.98e-01	1.90e-01
GOMF 5 3 EXONUCLEASE ACTIVITY	19	6.89e-02	3.11e-01	0.4550	3.45e-01	9.41e-02	-9.80e-02	-2.21e-01	1.45e-01	9.24e-03	4.78e-01	4.59e-01	9.58e-02	2.75e-01
GOBP CYTOCHROME COMPLEX ASSEMBLY	38	2.07e-03	2.76e-02	0.4550	1.82e-01	9.98e-02	-1.85e-01	-3.51e-01	8.23e-02	5.18e-02	2.87e-01	4.86e-02	1.84e-04	3.80e-01
GOBP AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS	16	9.50e-02	3.73e-01	0.4550	-1.57e-01	3.20e-01	8.99e-02	2.03e-01	-1.75e-01	2.78e-01	2.65e-02	5.34e-01	1.60e-01	2.25e-01
GOBP EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT	10	1.87e-01	5.31e-01	0.4550	-3.77e-02	-3.39e-01	2.69e-01	-1.06e-02	1.34e-01	8.36e-01	6.31e-02	1.41e-01	9.54e-01	4.65e-01
GOBP REGULATION OF SYNAPTIC VESICLE CYCLE	12	1.75e-01	5.15e-01	0.4550	-3.71e-01	2.01e-01	-6.01e-02	2.64e-02	-1.57e-01	2.60e-02	2.29e-01	7.18e-01	8.74e-01	3.46e-01
GOBP DITERPENOID BIOSYNTHETIC PROCESS	10	1.97e-01	5.46e-01	0.4550	5.43e-02	-4.37e-02	-2.04e-01	3.07e-01	-2.57e-01	7.66e-01	8.11e-01	2.64e-01	9.25e-02	1.59e-01
GOCC EUKARYOTIC 48S PREINITIATION COMPLEX	16	1.66e-01	5.02e-01	0.4550	1.22e-01	-1.59e-01	-3.65e-01	-1.70e-01	6.38e-02	4.00e-01	2.69e-01	1.14e-02	2.40e-01	6.58e-01
GOBP CAMP METABOLIC PROCESS	23	3.51e-02	2.02e-01	0.4540	-3.20e-01	7.81e-02	2.52e-01	1.84e-01	1.65e-02	7.80e-03	5.17e-01	3.65e-02	1.26e-01	8.91e-01
GOBP LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT	18	7.01e-02	3.15e-01	0.4540	1.75e-01	1.26e-01	-4.86e-03	-3.34e-01	2.20e-01	1.98e-01	3.57e-01	9.72e-01	1.42e-02	1.06e-01
GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT POSTSYNAPTIC ENDOSOME TO LYSOSOME	7	4.53e-01	7.72e-01	0.4540	1.42e-01	-1.86e-01	-5.48e-02	-3.78e-01	7.35e-02	5.15e-01	3.94e-01	8.02e-01	8.30e-02	7.36e-01
GOCC BOX C D RNP COMPLEX	6	5.53e-01	8.30e-01	0.4540	-2.79e-02	5.16e-02	-1.06e-01	-4.00e-01	-1.78e-01	9.06e-01	8.27e-01	6.53e-01	8.98e-02	4.50e-01
GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING TO IGG ISOTYPES	11	2.81e-01	6.34e-01	0.4540	9.98e-02	3.33e-01	1.67e-01	-9.73e-02	2.19e-01	5.67e-01	5.57e-02	3.37e-01	5.77e-01	2.09e-01
GOBP REGULATION OF STORE OPERATED CALCIUM CHANNEL ACTIVITY	6	6.55e-01	8.80e-01	0.4540	1.67e-01	3.33e-01	2.45e-01	6.16e-02	5.82e-02	4.80e-01	1.57e-01	2.98e-01	7.94e-01	8.05e-01
GOBP INTESTINAL STEM CELL HOMEOSTASIS	6	5.98e-01	8.51e-01	0.4540	-3.19e-01	-1.33e-01	-5.43e-02	2.45e-01	-1.53e-01	1.76e-01	5.72e-01	8.18e-01	2.98e-01	5.17e-01
GOMF BICARBONATE MONOATOMIC ANION ANTIPORTER ACTIVITY	12	1.93e-01	5.41e-01	0.4540	1.52e-01	-1.38e-01	-1.40e-01	4.25e-02	-3.78e-01	3.63e-01	4.09e-01	3.99e-01	7.99e-01	2.35e-02
GOCC PROTEIN COMPLEX INVOLVED IN CELL MATRIX ADHESION	17	1.12e-01	4.08e-01	0.4540	-2.72e-01	4.73e-02	2.53e-01	2.36e-01	9.89e-02	5.19e-02	7.36e-01	7.05e-02	9.19e-02	4.80e-01
GOMF CLATHRIN LIGHT CHAIN BINDING	7	5.99e-01	8.51e-01	0.4540	5.13e-03	3.36e-01	2.05e-01	1.99e-01	-1.08e-01	9.81e-01	1.24e-01	3.49e-01	3.62e-01	6.21e-01
GOCC SEMAPHORIN RECEPTOR COMPLEX	9	4.22e-01	7.49e-01	0.4540	-6.16e-02	2.17e-01	1.30e-01	3.36e-01	-1.58e-01	7.49e-01	2.59e-01	5.00e-01	8.06e-02	4.11e-01
GOBP REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY	10	3.15e-01	6.65e-01	0.4540	-2.80e-01	1.86e-01	3.05e-01	-8.44e-03	-1.18e-02	1.25e-01	3.10e-01	9.53e-02	9.63e-01	9.48e-01
GOBP HISTONE MRNA METABOLIC PROCESS	24	3.29e-02	1.94e-01	0.4540	-2.22e-02	-2.16e-01	-2.18e-01	-3.31e-01	4.41e-02	8.51e-01	6.71e-02	6.46e-02	5.03e-03	7.08e-01
GOBP POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE	17	1.32e-01	4.49e-01	0.4540	-1.52e-01	1.74e-01	2.92e-01	2.36e-01	1.09e-01	2.78e-01	2.14e-01	3.73e-02	9.25e-02	4.37e-01
GOBP FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY	31	4.68e-03	5.14e-02	0.4540	-1.72e-01	2.72e-01	2.84e-01	5.54e-02	1.37e-01	9.84e-02	8.76e-03	6.23e-03	5.94e-01	1.86e-01
GOBP POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION	25	1.06e-02	9.16e-02	0.4540	2.20e-02	-1.34e-01	1.67e-02	-2.75e-01	3.34e-01	8.49e-01	2.46e-01	8.85e-01	1.72e-02	3.88e-03
GOBP REGULATION OF RIBOSOME BIOGENESIS	9	2.81e-01	6.34e-01	0.4540	1.31e-01	9.85e-02	6.98e-02	-3.96e-01	1.31e-01	4.97e-01	6.09e-01	7.17e-01	3.96e-02	4.97e-01
GOBP CELLULAR RESPONSE TO MINERALOCORTICOID STIMULUS	11	2.09e-01	5.61e-01	0.4540	2.84e-01	1.86e-01	2.66e-01	4.18e-02	-1.35e-01	1.03e-01	2.84e-01	1.27e-01	8.10e-01	4.39e-01
GOBP CARDIAC RIGHT VENTRICLE MORPHOGENESIS	21	3.08e-02	1.86e-01	0.4530	1.17e-01	2.39e-01	9.55e-02	-2.64e-01	2.36e-01	3.55e-01	5.79e-02	4.49e-01	3.59e-02	6.08e-02
GOBP SULFUR AMINO ACID CATABOLIC PROCESS	10	3.39e-01	6.86e-01	0.4530	3.09e-02	1.01e-01	2.43e-01	6.83e-02	3.61e-01	8.66e-01	5.80e-01	1.83e-01	7.08e-01	4.79e-02
GOBP REGULATION OF NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE	8	3.25e-01	6.73e-01	0.4530	3.20e-01	1.32e-01	2.78e-01	-9.03e-02	2.18e-02	1.17e-01	5.19e-01	1.74e-01	6.58e-01	9.15e-01
GOCC FANCONI ANAEMIA NUCLEAR COMPLEX	11	3.38e-01	6.85e-01	0.4530	6.21e-02	-1.62e-01	-1.97e-01	-3.67e-01	4.36e-02	7.21e-01	3.52e-01	2.57e-01	3.52e-02	8.02e-01
GOMF PRE MRNA BINDING	39	1.37e-03	1.99e-02	0.4530	-1.26e-01	4.23e-02	-2.50e-01	-3.46e-01	-7.68e-02	1.75e-01	6.47e-01	6.87e-03	1.88e-04	4.06e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN REDUCED PTERIDINE AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN	7	5.70e-01	8.38e-01	0.4530	-1.41e-01	1.68e-01	1.02e-01	3.30e-01	-1.95e-01	5.19e-01	4.40e-01	6.41e-01	1.30e-01	3.73e-01
GOBP DEOXYRIBONUCLEOSIDE CATABOLIC PROCESS	6	6.56e-01	8.80e-01	0.4530	-1.08e-02	2.20e-01	1.20e-01	3.25e-01	-1.92e-01	9.64e-01	3.51e-01	6.10e-01	1.68e-01	4.16e-01
GOBP REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS	32	4.80e-03	5.21e-02	0.4530	-3.99e-02	2.13e-01	-2.50e-01	-3.02e-01	-6.63e-02	6.96e-01	3.71e-02	1.43e-02	3.07e-03	5.16e-01
GOCC RPAP3 R2TP PREFOLDIN LIKE COMPLEX	10	3.63e-01	7.05e-01	0.4530	2.70e-01	-4.05e-02	-1.39e-01	-3.27e-01	6.45e-02	1.39e-01	8.25e-01	4.45e-01	7.33e-02	7.24e-01
GOMF TRNA SPECIFIC ADENOSINE DEAMINASE ACTIVITY	8	5.31e-01	8.20e-01	0.4530	1.23e-01	1.40e-01	2.84e-01	2.13e-01	2.10e-01	5.46e-01	4.92e-01	1.64e-01	2.96e-01	3.03e-01
GOBP NEGATIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS	5	4.78e-01	7.91e-01	0.4530	1.85e-02	3.60e-02	3.58e-01	-2.50e-01	1.12e-01	9.43e-01	8.89e-01	1.65e-01	3.33e-01	6.64e-01
GOBP REGULATION OF NEUTROPHIL EXTRAVASATION	5	6.22e-01	8.65e-01	0.4530	-6.28e-02	4.17e-01	-2.95e-02	1.43e-01	-7.70e-02	8.08e-01	1.06e-01	9.09e-01	5.81e-01	7.66e-01
GOBP PYRIMIDINE DIMER REPAIR	9	5.10e-01	8.07e-01	0.4530	-4.97e-02	-1.13e-01	-2.36e-01	-3.55e-01	8.98e-02	7.96e-01	5.58e-01	2.21e-01	6.48e-02	6.41e-01
GOBP OXYGEN METABOLIC PROCESS	5	7.37e-01	9.10e-01	0.4530	-2.34e-01	-1.20e-01	-1.75e-01	-2.42e-01	2.16e-01	3.66e-01	6.41e-01	4.97e-01	3.49e-01	4.03e-01
GOBP NATURAL KILLER CELL CYTOKINE PRODUCTION	9	3.21e-01	6.69e-01	0.4520	-3.27e-01	-9.76e-02	2.93e-01	2.53e-05	-4.68e-02	8.91e-02	6.12e-01	1.28e-01	1.00e+00	8.08e-01
GOCC CHAPERONIN CONTAINING T COMPLEX	10	4.30e-01	7.55e-01	0.4520	-1.66e-01	-4.61e-02	-2.92e-01	-2.93e-01	6.12e-02	3.62e-01	8.01e-01	1.10e-01	1.08e-01	7.37e-01
GOCC CORNIFIED ENVELOPE	55	5.10e-05	1.38e-03	0.4520	-1.80e-01	-2.19e-02	1.99e-01	3.61e-01	-3.88e-02	2.07e-02	7.78e-01	1.08e-02	3.55e-06	6.19e-01
GOBP PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS	17	8.12e-02	3.43e-01	0.4520	9.32e-02	4.03e-01	4.62e-02	-1.36e-01	1.13e-01	5.06e-01	4.04e-03	7.41e-01	3.30e-01	4.20e-01
GOBP CELLULAR RESPONSE TO PEPTIDOGLYCAN	6	6.77e-01	8.86e-01	0.4520	-6.29e-02	2.49e-01	1.48e-01	2.83e-01	-1.90e-01	7.90e-01	2.91e-01	5.30e-01	2.29e-01	4.20e-01
GOCC CUL2 RING UBIQUITIN LIGASE COMPLEX	23	1.47e-02	1.15e-01	0.4520	-1.15e-01	5.60e-02	-1.13e-01	-4.07e-01	-9.81e-02	3.41e-01	6.42e-01	3.50e-01	7.26e-04	4.16e-01
GOBP MUSCULAR SEPTUM MORPHOGENESIS	5	4.00e-01	7.33e-01	0.4520	1.04e-01	-5.47e-02	2.41e-01	-3.64e-01	2.01e-03	6.87e-01	8.32e-01	3.51e-01	1.59e-01	9.94e-01
GOBP MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY	92	7.94e-08	4.57e-06	0.4520	1.00e-01	-5.44e-02	-2.52e-01	-3.44e-01	9.71e-02	9.70e-02	3.67e-01	2.96e-05	1.16e-08	1.07e-01
GOBP MITOCHONDRIAL DNA METABOLIC PROCESS	23	6.30e-02	2.95e-01	0.4520	3.68e-02	1.24e-02	-3.31e-01	-2.85e-01	1.08e-01	7.60e-01	9.18e-01	6.02e-03	1.79e-02	3.70e-01
GOMF DELTA CATENIN BINDING	9	3.41e-01	6.88e-01	0.4520	-1.15e-01	1.09e-01	-1.68e-03	3.61e-01	-2.21e-01	5.49e-01	5.70e-01	9.93e-01	6.10e-02	2.52e-01
GOBP REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING	8	5.54e-01	8.30e-01	0.4520	4.43e-03	1.68e-01	-2.38e-01	-3.45e-01	-8.65e-03	9.83e-01	4.11e-01	2.45e-01	9.08e-02	9.66e-01
GOBP REGULATION OF SKELETAL MUSCLE TISSUE REGENERATION	8	4.17e-01	7.46e-01	0.4520	1.83e-01	3.50e-01	1.86e-01	-8.40e-02	-7.73e-02	3.70e-01	8.62e-02	3.62e-01	6.81e-01	7.05e-01
GOBP NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE	5	6.79e-01	8.87e-01	0.4510	3.99e-01	1.23e-01	-9.58e-02	6.88e-02	1.26e-01	1.23e-01	6.35e-01	7.11e-01	7.90e-01	6.26e-01
GOMF CARDIOLIPIN BINDING	11	2.66e-01	6.21e-01	0.4510	-6.30e-02	2.01e-01	9.46e-02	-2.47e-01	2.99e-01	7.17e-01	2.47e-01	5.87e-01	1.57e-01	8.62e-02
GOBP CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS	10	4.90e-01	7.97e-01	0.4510	3.93e-02	-1.96e-03	-2.94e-01	-3.34e-01	6.51e-02	8.30e-01	9.91e-01	1.08e-01	6.76e-02	7.21e-01
GOMF BETA 1 3 GALACTOSYLTRANSFERASE ACTIVITY	14	1.29e-01	4.43e-01	0.4510	-2.90e-01	3.36e-01	5.78e-02	1.45e-03	-5.65e-02	6.04e-02	2.95e-02	7.08e-01	9.92e-01	7.14e-01
GOCC CELL TIP	5	7.12e-01	9.00e-01	0.4510	3.42e-01	-1.39e-01	1.15e-02	-9.27e-02	2.41e-01	1.85e-01	5.91e-01	9.64e-01	7.20e-01	3.50e-01
GOBP CHONDROCYTE HYPERTROPHY	6	6.11e-01	8.58e-01	0.4510	-9.77e-02	3.67e-01	4.69e-02	-2.32e-01	5.19e-02	6.79e-01	1.19e-01	8.42e-01	3.24e-01	8.26e-01
GOCC HFE TRANSFERRIN RECEPTOR COMPLEX	8	2.41e-01	5.98e-01	0.4510	-1.47e-01	9.86e-02	1.62e-01	-2.71e-01	-2.69e-01	4.73e-01	6.29e-01	4.27e-01	1.85e-01	1.88e-01
GOBP RESPIRATORY BURST INVOLVED IN DEFENSE RESPONSE	15	5.72e-02	2.78e-01	0.4510	-3.35e-01	2.92e-03	8.14e-03	9.88e-02	2.85e-01	2.48e-02	9.84e-01	9.56e-01	5.08e-01	5.62e-02
GOMF GAMMA AMINOBUTYRIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY	8	5.64e-01	8.34e-01	0.4510	5.26e-02	2.17e-01	3.53e-01	1.67e-01	2.51e-03	7.97e-01	2.87e-01	8.34e-02	4.12e-01	9.90e-01
GOMF HISTONE H3K36 DEMETHYLASE ACTIVITY	9	5.53e-01	8.30e-01	0.4500	6.94e-02	9.61e-03	-2.84e-01	-3.17e-01	1.29e-01	7.18e-01	9.60e-01	1.39e-01	9.99e-02	5.03e-01
GOBP PHAGOLYSOSOME ASSEMBLY	17	5.50e-02	2.70e-01	0.4500	-1.41e-01	2.88e-01	5.22e-02	-3.12e-01	-3.71e-03	3.16e-01	3.98e-02	7.09e-01	2.59e-02	9.79e-01
GOBP THYMOCYTE MIGRATION	6	6.41e-01	8.75e-01	0.4500	-3.96e-01	-1.48e-01	5.28e-02	1.06e-01	-1.01e-01	9.30e-02	5.31e-01	8.23e-01	6.53e-01	6.69e-01
GOCC U4 SNRNP	10	3.64e-01	7.05e-01	0.4500	9.58e-02	-1.91e-01	-7.36e-02	-2.71e-01	2.79e-01	6.00e-01	2.95e-01	6.87e-01	1.37e-01	1.26e-01
GOBP REGULATION OF TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE	19	8.76e-02	3.58e-01	0.4500	2.41e-01	-4.82e-02	-1.25e-01	-1.87e-01	3.03e-01	6.95e-02	7.16e-01	3.45e-01	1.59e-01	2.21e-02
GOBP NEUTROPHIL DIFFERENTIATION	11	2.93e-01	6.47e-01	0.4500	5.10e-02	2.91e-01	-2.23e-01	-2.31e-01	-1.08e-01	7.70e-01	9.44e-02	1.99e-01	1.84e-01	5.37e-01
GOCC N TERMINAL PROTEIN ACETYLTRANSFERASE COMPLEX	9	4.87e-01	7.95e-01	0.4500	1.90e-01	1.62e-01	-2.51e-01	-2.78e-01	-1.03e-02	3.23e-01	4.00e-01	1.93e-01	1.49e-01	9.57e-01
GOBP REGULATION OF MATRIX METALLOPEPTIDASE SECRETION	10	2.76e-01	6.30e-01	0.4500	1.09e-01	9.86e-02	2.47e-01	-1.63e-01	3.05e-01	5.50e-01	5.89e-01	1.75e-01	3.71e-01	9.51e-02
GOMF MELANOCORTIN RECEPTOR ACTIVITY	6	5.87e-01	8.45e-01	0.4500	-3.69e-02	-3.38e-01	4.57e-03	1.10e-01	2.73e-01	8.76e-01	1.51e-01	9.85e-01	6.39e-01	2.47e-01
GOBP REGULATION OF MITOPHAGY	15	1.83e-01	5.25e-01	0.4500	2.79e-01	1.54e-01	-1.73e-01	-2.17e-01	1.55e-01	6.17e-02	3.03e-01	2.46e-01	1.45e-01	2.97e-01
GOBP POSITIVE REGULATION OF SYNAPTIC VESICLE RECYCLING	8	3.84e-01	7.22e-01	0.4500	9.04e-02	-3.56e-03	4.32e-01	8.10e-02	-2.47e-02	6.58e-01	9.86e-01	3.42e-02	6.92e-01	9.04e-01
GOBP SEQUESTERING OF ACTIN MONOMERS	6	6.51e-01	8.79e-01	0.4500	2.13e-01	-3.97e-03	-1.62e-01	-9.79e-02	3.48e-01	3.67e-01	9.87e-01	4.92e-01	6.78e-01	1.40e-01
GOBP POSITIVE REGULATION OF FEAR RESPONSE	6	5.57e-01	8.32e-01	0.4500	3.48e-02	7.21e-02	4.27e-01	5.80e-02	-1.01e-01	8.83e-01	7.60e-01	7.02e-02	8.06e-01	6.67e-01
GOBP LEUKOTRIENE D4 METABOLIC PROCESS	7	6.20e-01	8.63e-01	0.4500	2.29e-01	5.08e-02	-2.15e-01	-1.80e-01	2.61e-01	2.94e-01	8.16e-01	3.24e-01	4.09e-01	2.31e-01
GOBP POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE	19	6.73e-02	3.06e-01	0.4500	-3.13e-01	2.00e-01	1.32e-01	1.74e-01	-1.31e-01	1.83e-02	1.32e-01	3.21e-01	1.90e-01	3.24e-01
GOBP SERTOLI CELL DIFFERENTIATION	17	7.27e-02	3.22e-01	0.4500	9.04e-02	2.99e-01	1.31e-01	-2.40e-01	1.74e-01	5.19e-01	3.30e-02	3.51e-01	8.68e-02	2.15e-01
GOBP PROTEIN PROCESSING INVOLVED IN PROTEIN TARGETING TO MITOCHONDRION	7	4.57e-01	7.75e-01	0.4500	3.54e-01	9.17e-02	-2.39e-01	7.91e-02	-7.25e-02	1.05e-01	6.74e-01	2.73e-01	7.17e-01	7.40e-01
GOMF RNA POLYMERASE II C TERMINAL DOMAIN BINDING	10	3.74e-01	7.14e-01	0.4500	9.49e-02	3.03e-01	-5.40e-02	-2.40e-01	2.01e-01	6.03e-01	9.67e-02	7.68e-01	1.88e-01	2.70e-01
GOBP GRANULOCYTE COLONY STIMULATING FACTOR PRODUCTION	5	5.61e-01	8.33e-01	0.4500	-9.07e-02	3.60e-01	-1.18e-01	4.16e-02	2.20e-01	7.26e-01	1.63e-01	6.49e-01	8.72e-01	3.94e-01
GOBP PHOSPHATE ION TRANSMEMBRANE TRANSPORT	17	6.63e-02	3.04e-01	0.4500	-2.71e-01	2.82e-01	9.83e-02	-1.62e-01	1.15e-01	5.29e-02	4.41e-02	4.83e-01	2.48e-01	4.13e-01
GOBP PROTEIN LOCALIZATION TO CILIARY MEMBRANE	11	1.95e-01	5.44e-01	0.4500	1.02e-01	-2.64e-01	-1.18e-01	-2.72e-01	-1.85e-01	5.60e-01	1.30e-01	4.97e-01	1.19e-01	2.87e-01
GOBP MITOCHONDRIAL TRANSLATION	130	2.06e-11	2.02e-09	0.4500	1.06e-01	-4.56e-02	-2.93e-01	-3.19e-01	-3.47e-02	3.77e-02	3.69e-01	7.58e-09	3.42e-10	4.94e-01
GOBP REGULATION OF SMOOTH MUSCLE CELL CHEMOTAXIS	7	5.95e-01	8.49e-01	0.4490	-2.99e-01	2.03e-01	2.35e-01	8.78e-02	-9.05e-02	1.71e-01	3.52e-01	2.81e-01	6.87e-01	6.78e-01
GOBP DNA TEMPLATED TRANSCRIPTION TERMINATION	24	5.05e-02	2.56e-01	0.4490	1.06e-01	1.01e-01	-2.49e-01	-2.96e-01	1.75e-01	3.70e-01	3.91e-01	3.44e-02	1.20e-02	1.39e-01
GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC	20	9.53e-02	3.73e-01	0.4490	1.90e-01	-1.61e-01	-2.43e-01	-2.74e-01	7.56e-02	1.42e-01	2.13e-01	5.97e-02	3.37e-02	5.58e-01
GOMF NEUROTROPHIN RECEPTOR ACTIVITY	5	7.88e-01	9.30e-01	0.4490	1.11e-01	-1.54e-02	3.42e-01	2.67e-01	-2.97e-02	6.67e-01	9.53e-01	1.86e-01	3.01e-01	9.09e-01
GOBP POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION	24	2.04e-02	1.43e-01	0.4490	1.32e-01	3.81e-01	1.55e-01	7.32e-02	9.76e-02	2.64e-01	1.22e-03	1.88e-01	5.35e-01	4.08e-01
GOBP CDP CHOLINE PATHWAY	6	5.96e-01	8.50e-01	0.4490	-4.38e-02	2.86e-03	-7.74e-02	-4.39e-01	3.49e-02	8.53e-01	9.90e-01	7.43e-01	6.26e-02	8.82e-01
GOBP TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY	11	2.22e-01	5.76e-01	0.4490	-2.54e-01	2.05e-01	3.78e-02	-3.06e-01	1.64e-02	1.45e-01	2.39e-01	8.28e-01	7.89e-02	9.25e-01
GOMF WNT RECEPTOR ACTIVITY	17	5.36e-02	2.66e-01	0.4490	-4.05e-02	-3.25e-01	-3.12e-02	-2.71e-01	1.41e-01	7.72e-01	2.04e-02	8.24e-01	5.28e-02	3.14e-01
GOMF AMINO ACID SODIUM SYMPORTER ACTIVITY	21	4.63e-02	2.41e-01	0.4490	-1.56e-01	2.15e-01	2.71e-01	8.21e-02	-2.26e-01	2.16e-01	8.82e-02	3.16e-02	5.15e-01	7.33e-02
GOMF OXO ACID LYASE ACTIVITY	7	5.07e-01	8.07e-01	0.4490	-3.06e-01	7.30e-02	1.31e-01	2.72e-01	1.08e-01	1.61e-01	7.38e-01	5.49e-01	2.13e-01	6.20e-01
GOBP DETECTION OF MUSCLE STRETCH	7	6.30e-01	8.69e-01	0.4490	-6.11e-02	-1.81e-01	2.16e-01	2.75e-01	-2.06e-01	7.80e-01	4.06e-01	3.22e-01	2.07e-01	3.46e-01
GOBP REGULATION OF SKELETAL MUSCLE ADAPTATION	14	2.21e-02	1.50e-01	0.4490	6.51e-05	9.10e-02	-4.08e-01	9.86e-02	1.30e-01	1.00e+00	5.56e-01	8.23e-03	5.23e-01	3.98e-01
GOBP SENSORY PERCEPTION OF BITTER TASTE	44	8.75e-05	2.13e-03	0.4490	3.12e-02	-3.07e-01	8.09e-02	2.87e-01	1.31e-01	7.21e-01	4.34e-04	3.53e-01	9.70e-04	1.32e-01
GOBP POLAR BODY EXTRUSION AFTER MEIOTIC DIVISIONS	5	5.80e-01	8.43e-01	0.4490	-1.14e-01	-1.48e-01	7.91e-02	-1.33e-01	-3.77e-01	6.59e-01	5.66e-01	7.59e-01	6.07e-01	1.44e-01
GOBP RESPONSE TO UV B	21	3.66e-02	2.08e-01	0.4490	2.03e-03	2.46e-01	2.28e-02	-1.51e-01	3.43e-01	9.87e-01	5.06e-02	8.56e-01	2.32e-01	6.58e-03
GOCC ENDONUCLEASE COMPLEX	37	5.14e-03	5.46e-02	0.4480	1.35e-01	6.52e-03	-3.34e-01	-2.67e-01	-3.53e-03	1.56e-01	9.45e-01	4.43e-04	4.92e-03	9.70e-01
GOMF NUCLEOSIDE TRIPHOSPHATE DIPHOSPHATASE ACTIVITY	9	3.72e-01	7.12e-01	0.4480	-4.53e-02	1.42e-01	-3.31e-01	-1.78e-01	1.95e-01	8.14e-01	4.62e-01	8.60e-02	3.56e-01	3.11e-01
GOBP GTP BIOSYNTHETIC PROCESS	11	2.35e-01	5.90e-01	0.4480	1.02e-01	4.07e-01	-1.22e-01	-8.06e-02	-5.76e-02	5.59e-01	1.94e-02	4.83e-01	6.44e-01	7.41e-01
GOBP UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS	14	1.21e-01	4.27e-01	0.4480	2.99e-01	2.11e-01	-4.83e-02	-2.18e-01	-1.30e-01	5.27e-02	1.72e-01	7.54e-01	1.58e-01	3.99e-01
GOMF NETRIN RECEPTOR ACTIVITY	5	7.93e-01	9.31e-01	0.4480	-3.20e-02	-1.01e-01	1.99e-01	2.93e-01	-2.53e-01	9.02e-01	6.97e-01	4.41e-01	2.56e-01	3.27e-01
GOBP INOSINE METABOLIC PROCESS	5	6.87e-01	8.90e-01	0.4480	9.95e-02	2.51e-01	-2.00e-03	2.52e-01	-2.53e-01	7.00e-01	3.30e-01	9.94e-01	3.30e-01	3.27e-01
GOCC CAMP DEPENDENT PROTEIN KINASE COMPLEX	7	5.70e-01	8.38e-01	0.4480	7.82e-02	3.31e-01	4.52e-02	-1.65e-01	2.35e-01	7.20e-01	1.29e-01	8.36e-01	4.50e-01	2.81e-01
GOBP REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY	16	1.27e-01	4.40e-01	0.4480	-1.36e-01	2.15e-01	-1.28e-01	-3.03e-01	1.67e-01	3.47e-01	1.37e-01	3.75e-01	3.59e-02	2.48e-01
GOCC CLATHRIN SCULPTED GAMMA AMINOBUTYRIC ACID TRANSPORT VESICLE	8	4.49e-01	7.70e-01	0.4480	1.76e-01	-2.89e-01	1.06e-02	-9.15e-02	2.78e-01	3.88e-01	1.57e-01	9.59e-01	6.54e-01	1.73e-01
GOCC NUCLEOTIDE EXCISION REPAIR COMPLEX	10	4.46e-01	7.69e-01	0.4480	1.04e-01	-7.69e-02	-3.81e-01	-1.87e-01	-5.85e-02	5.70e-01	6.74e-01	3.69e-02	3.05e-01	7.49e-01
GOBP RESPONSE TO ACIDIC PH	28	9.72e-03	8.59e-02	0.4470	-6.12e-02	2.76e-01	2.85e-01	6.81e-02	-1.86e-01	5.75e-01	1.15e-02	9.08e-03	5.33e-01	8.85e-02
GOCC MCRD MEDIATED MRNA STABILITY COMPLEX	5	6.23e-01	8.65e-01	0.4470	-1.49e-01	1.14e-01	1.69e-02	-3.99e-01	-7.22e-02	5.64e-01	6.58e-01	9.48e-01	1.22e-01	7.80e-01
GOBP MITOTIC G1 S TRANSITION CHECKPOINT SIGNALING	29	2.52e-02	1.62e-01	0.4470	1.57e-01	-3.35e-02	-2.98e-01	-2.91e-01	2.43e-02	1.43e-01	7.55e-01	5.46e-03	6.63e-03	8.21e-01
GOBP NOREPINEPHRINE METABOLIC PROCESS	12	2.70e-01	6.24e-01	0.4470	-9.34e-02	2.88e-01	2.81e-01	6.61e-02	-1.57e-01	5.75e-01	8.41e-02	9.13e-02	6.92e-01	3.45e-01
GOBP CARNITINE METABOLIC PROCESS	11	3.15e-01	6.65e-01	0.4470	3.67e-01	-1.17e-01	-1.96e-01	-8.10e-02	8.23e-02	3.50e-02	5.02e-01	2.61e-01	6.42e-01	6.36e-01
GOBP NEGATIVE REGULATION OF GENE EXPRESSION VIA CPG ISLAND METHYLATION	7	6.67e-01	8.82e-01	0.4470	1.51e-01	-7.77e-02	-2.81e-01	-2.21e-01	2.08e-01	4.88e-01	7.22e-01	1.97e-01	3.12e-01	3.41e-01
GOMF THYROID HORMONE BINDING	6	7.40e-01	9.11e-01	0.4470	-1.27e-01	1.96e-01	2.59e-01	2.71e-01	-7.25e-02	5.90e-01	4.07e-01	2.72e-01	2.51e-01	7.58e-01
GOBP OTIC VESICLE MORPHOGENESIS	10	2.98e-01	6.52e-01	0.4470	-1.40e-01	-6.38e-02	1.02e-01	-4.76e-02	4.04e-01	4.42e-01	7.27e-01	5.76e-01	7.94e-01	2.69e-02
GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX	20	9.45e-02	3.72e-01	0.4470	-7.34e-02	-3.12e-02	-2.57e-01	-3.56e-01	-2.46e-02	5.70e-01	8.09e-01	4.63e-02	5.88e-03	8.49e-01
GOBP REGULATION OF ODONTOGENESIS	18	6.24e-02	2.94e-01	0.4470	-8.72e-02	4.10e-01	1.08e-01	-1.01e-01	-4.81e-02	5.22e-01	2.61e-03	4.29e-01	4.59e-01	7.24e-01
GOMF SUMO LIGASE ACTIVITY	13	3.01e-01	6.54e-01	0.4470	1.36e-01	-1.36e-01	-2.25e-01	-2.23e-01	2.49e-01	3.96e-01	3.94e-01	1.59e-01	1.63e-01	1.21e-01
GOMF HISTONE H4K16 ACETYLTRANSFERASE ACTIVITY	8	5.14e-01	8.09e-01	0.4470	-7.23e-03	2.01e-01	-7.32e-02	-3.67e-01	1.39e-01	9.72e-01	3.26e-01	7.20e-01	7.25e-02	4.96e-01
GOMF ACYLTRANSFERASE ACTIVITY ACYL GROUPS CONVERTED INTO ALKYL ON TRANSFER	5	6.82e-01	8.88e-01	0.4470	4.54e-02	1.66e-01	1.41e-01	2.39e-01	3.05e-01	8.61e-01	5.20e-01	5.85e-01	3.54e-01	2.38e-01
GOBP REGULATION OF CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION	8	4.89e-01	7.97e-01	0.4460	-1.39e-01	-6.27e-02	-2.02e-01	-2.26e-01	-2.90e-01	4.97e-01	7.59e-01	3.23e-01	2.68e-01	1.55e-01
GOBP REGULATION OF MAST CELL CHEMOTAXIS	7	6.08e-01	8.58e-01	0.4460	6.69e-03	3.06e-01	2.68e-01	8.35e-02	1.64e-01	9.76e-01	1.61e-01	2.19e-01	7.02e-01	4.53e-01
GOBP SYNAPTIC VESICLE LUMEN ACIDIFICATION	14	2.22e-01	5.76e-01	0.4460	8.88e-02	-1.05e-01	-1.07e-01	-2.97e-01	2.84e-01	5.65e-01	4.96e-01	4.87e-01	5.46e-02	6.57e-02
GOMF INOSITOL 1 3 4 5 TETRAKISPHOSPHATE BINDING	5	7.12e-01	9.00e-01	0.4460	-7.21e-02	-5.77e-02	1.54e-01	1.04e-01	-3.95e-01	7.80e-01	8.23e-01	5.52e-01	6.86e-01	1.26e-01
GOMF PRIMARY AMINE OXIDASE ACTIVITY	7	4.13e-01	7.44e-01	0.4460	-2.10e-01	-3.11e-02	-6.73e-03	3.92e-01	2.15e-02	3.36e-01	8.87e-01	9.75e-01	7.27e-02	9.21e-01
GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE PHOSPHATASE ACTIVITY	11	2.76e-01	6.30e-01	0.4460	-3.49e-01	-2.36e-01	-8.54e-02	-1.14e-01	-3.25e-02	4.50e-02	1.74e-01	6.24e-01	5.13e-01	8.52e-01
GOBP NEGATIVE REGULATION OF GLIAL CELL MIGRATION	6	6.64e-01	8.82e-01	0.4460	-8.49e-02	3.24e-01	2.87e-01	1.19e-03	6.57e-02	7.19e-01	1.69e-01	2.24e-01	9.96e-01	7.80e-01
GOBP REGULATION OF DNA TOPOISOMERASE ATP HYDROLYZING ACTIVITY	5	7.23e-01	9.04e-01	0.4460	2.48e-01	3.10e-01	-8.43e-03	-2.03e-01	1.20e-02	3.37e-01	2.31e-01	9.74e-01	4.32e-01	9.63e-01
GOCC CHROMOSOME PASSENGER COMPLEX	6	6.04e-01	8.55e-01	0.4460	2.58e-01	-3.33e-01	1.90e-02	5.27e-02	1.33e-01	2.73e-01	1.57e-01	9.36e-01	8.23e-01	5.73e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS DISULFIDE AS ACCEPTOR	8	3.93e-01	7.27e-01	0.4460	-2.87e-01	1.62e-01	-2.30e-01	-1.41e-01	1.32e-01	1.60e-01	4.28e-01	2.61e-01	4.89e-01	5.18e-01
GOBP POSITIVE REGULATION OF DEOXYRIBONUCLEASE ACTIVITY	5	8.01e-01	9.34e-01	0.4460	5.63e-02	9.19e-02	-2.29e-01	-3.66e-01	1.44e-02	8.28e-01	7.22e-01	3.75e-01	1.56e-01	9.55e-01
GOBP GERMINAL CENTER B CELL DIFFERENTIATION	9	3.48e-01	6.95e-01	0.4460	-2.85e-01	-2.50e-01	1.89e-01	1.64e-02	1.37e-01	1.39e-01	1.93e-01	3.25e-01	9.32e-01	4.77e-01
GOBP SKELETAL MUSCLE FIBER DIFFERENTIATION	8	2.57e-01	6.14e-01	0.4460	1.77e-02	1.95e-01	2.19e-01	-3.34e-01	-2.28e-02	9.31e-01	3.39e-01	2.84e-01	1.01e-01	9.11e-01
GOBP RESPONSE TO BILE ACID	7	6.51e-01	8.78e-01	0.4460	-2.22e-01	1.72e-01	2.45e-01	2.42e-01	-3.11e-02	3.09e-01	4.30e-01	2.61e-01	2.68e-01	8.87e-01
GOBP BLOOD COAGULATION INTRINSIC PATHWAY	6	5.50e-01	8.28e-01	0.4460	-1.95e-01	3.71e-01	-1.24e-01	-7.50e-02	4.28e-02	4.08e-01	1.16e-01	6.00e-01	7.51e-01	8.56e-01
GOCC NUCLEAR STRESS GRANULE	6	6.34e-01	8.71e-01	0.4450	2.83e-01	-2.48e-01	-9.96e-02	-1.98e-01	8.67e-02	2.30e-01	2.92e-01	6.73e-01	4.01e-01	7.13e-01
GOBP REGULATION OF RECEPTOR CATABOLIC PROCESS	11	2.51e-01	6.08e-01	0.4450	4.40e-02	1.42e-01	-1.02e-01	-2.09e-02	-4.07e-01	8.00e-01	4.16e-01	5.56e-01	9.05e-01	1.95e-02
GOBP MRNA 5 SPLICE SITE RECOGNITION	10	4.25e-01	7.52e-01	0.4450	-1.10e-01	8.47e-03	-3.45e-01	-2.43e-01	8.75e-02	5.47e-01	9.63e-01	5.88e-02	1.82e-01	6.32e-01
GOCC OMEGASOME	5	7.06e-01	8.97e-01	0.4450	3.92e-01	1.87e-01	-6.45e-02	-3.16e-02	-6.90e-02	1.29e-01	4.70e-01	8.03e-01	9.03e-01	7.89e-01
GOBP DETECTION OF BIOTIC STIMULUS	37	1.67e-03	2.35e-02	0.4450	-3.65e-01	8.66e-02	1.81e-01	1.05e-01	-1.16e-01	1.20e-04	3.62e-01	5.73e-02	2.68e-01	2.22e-01
GOMF EXTRACELLULAR MATRIX CONSTITUENT CONFERRING ELASTICITY	10	3.13e-01	6.65e-01	0.4450	-9.84e-02	3.10e-01	1.51e-01	2.38e-01	1.15e-01	5.90e-01	8.99e-02	4.09e-01	1.93e-01	5.30e-01
GOCC PLATELET DENSE TUBULAR NETWORK	11	2.45e-01	6.02e-01	0.4450	6.96e-02	3.01e-01	-6.72e-02	3.77e-02	-3.11e-01	6.90e-01	8.40e-02	7.00e-01	8.29e-01	7.45e-02
GOCC MITOCHONDRIAL LARGE RIBOSOMAL SUBUNIT	56	1.57e-04	3.43e-03	0.4450	8.17e-02	-8.70e-02	-2.95e-01	-3.10e-01	-2.99e-02	2.90e-01	2.60e-01	1.37e-04	6.11e-05	6.99e-01
GOBP ADIPONECTIN ACTIVATED SIGNALING PATHWAY	7	5.64e-01	8.34e-01	0.4450	1.26e-01	2.94e-01	-1.43e-01	-1.56e-01	2.26e-01	5.65e-01	1.78e-01	5.14e-01	4.75e-01	3.01e-01
GOBP REGULATION OF 3 UTR MEDIATED MRNA STABILIZATION	6	6.24e-01	8.66e-01	0.4450	-3.70e-01	1.06e-01	1.23e-01	-4.87e-02	-1.79e-01	1.17e-01	6.52e-01	6.02e-01	8.36e-01	4.48e-01
GOCC CUTICULAR PLATE	8	4.62e-01	7.79e-01	0.4450	3.78e-01	2.05e-01	-3.13e-02	-1.06e-01	-2.01e-02	6.38e-02	3.16e-01	8.78e-01	6.05e-01	9.22e-01
GOBP REGULATION OF INOSITOL TRISPHOSPHATE BIOSYNTHETIC PROCESS	6	7.17e-01	9.02e-01	0.4450	-1.58e-01	1.92e-01	1.88e-01	1.96e-01	-2.49e-01	5.03e-01	4.15e-01	4.25e-01	4.06e-01	2.91e-01
GOBP BLOOD VESSEL MATURATION	8	4.43e-01	7.66e-01	0.4450	-2.65e-01	-1.55e-01	-3.17e-01	-5.50e-02	9.16e-03	1.94e-01	4.47e-01	1.21e-01	7.88e-01	9.64e-01
GOCC RESPIRASOME	85	5.87e-07	2.80e-05	0.4440	6.17e-02	-1.05e-01	-2.70e-01	-3.28e-01	4.63e-02	3.25e-01	9.55e-02	1.63e-05	1.71e-07	4.60e-01
GOBP RESPONSE TO LITHIUM ION	15	1.51e-01	4.78e-01	0.4440	-1.14e-02	3.22e-01	2.10e-01	-7.01e-03	2.22e-01	9.39e-01	3.09e-02	1.59e-01	9.63e-01	1.36e-01
GOMF DEOXYNUCLEOSIDE KINASE ACTIVITY	5	6.56e-01	8.80e-01	0.4440	-2.38e-01	1.53e-01	2.18e-01	-2.17e-01	1.51e-01	3.57e-01	5.53e-01	3.98e-01	4.02e-01	5.59e-01
GOBP PROTON TRANSPORTING V TYPE ATPASE COMPLEX ASSEMBLY	7	5.56e-01	8.31e-01	0.4440	-3.44e-01	-6.63e-02	-1.13e-01	-2.44e-01	4.99e-02	1.15e-01	7.61e-01	6.04e-01	2.64e-01	8.19e-01
GOBP POSITIVE REGULATION OF CARDIAC MUSCLE CONTRACTION	8	4.57e-01	7.75e-01	0.4440	-2.29e-01	-1.95e-01	1.79e-01	7.63e-02	-2.63e-01	2.63e-01	3.40e-01	3.81e-01	7.09e-01	1.97e-01
GOBP LUNG GROWTH	6	5.91e-01	8.47e-01	0.4440	-3.47e-01	1.60e-01	2.43e-03	-1.14e-01	1.94e-01	1.41e-01	4.97e-01	9.92e-01	6.29e-01	4.10e-01
GOMF PROTEIN FOLDING CHAPERONE	61	7.86e-05	1.95e-03	0.4440	-1.17e-02	-2.72e-02	-2.90e-01	-3.23e-01	8.84e-02	8.75e-01	7.14e-01	8.85e-05	1.29e-05	2.32e-01
GOBP POSITIVE REGULATION OF RECEPTOR BINDING	6	5.04e-01	8.05e-01	0.4440	-3.35e-01	-1.18e-01	2.19e-01	-1.43e-01	-4.84e-02	1.55e-01	6.16e-01	3.52e-01	5.45e-01	8.37e-01
GOBP CARBON CATABOLITE REGULATION OF TRANSCRIPTION	7	6.54e-01	8.79e-01	0.4440	1.12e-01	-3.25e-02	-1.52e-01	-2.54e-01	3.09e-01	6.07e-01	8.82e-01	4.85e-01	2.45e-01	1.57e-01
GOCC CATALYTIC STEP 2 SPLICEOSOME	87	3.55e-07	1.85e-05	0.4440	1.19e-01	-8.28e-02	-2.34e-01	-3.28e-01	1.16e-01	5.60e-02	1.82e-01	1.57e-04	1.23e-07	6.08e-02
GOBP REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN	17	1.14e-01	4.12e-01	0.4440	5.10e-05	-5.93e-02	5.45e-02	3.64e-01	-2.41e-01	1.00e+00	6.72e-01	6.97e-01	9.44e-03	8.50e-02
GOBP CELLULAR RESPONSE TO UV A	10	3.05e-01	6.58e-01	0.4440	9.48e-02	-4.02e-01	4.26e-02	6.55e-02	1.43e-01	6.04e-01	2.78e-02	8.16e-01	7.20e-01	4.34e-01
GOBP SENSORY PERCEPTION OF UMAMI TASTE	7	4.20e-01	7.48e-01	0.4430	-3.08e-01	-5.23e-02	2.55e-01	-1.61e-01	9.18e-02	1.59e-01	8.11e-01	2.43e-01	4.60e-01	6.74e-01
GOBP SKELETAL MUSCLE THIN FILAMENT ASSEMBLY	7	5.27e-01	8.17e-01	0.4430	-1.50e-01	1.56e-01	3.02e-01	-8.16e-02	2.27e-01	4.91e-01	4.75e-01	1.66e-01	7.09e-01	2.98e-01
GOBP REGULATION OF AXON GUIDANCE	13	1.68e-01	5.04e-01	0.4430	-7.49e-02	-1.38e-01	-7.61e-04	-3.35e-01	2.44e-01	6.40e-01	3.90e-01	9.96e-01	3.62e-02	1.28e-01
GOBP NETRIN ACTIVATED SIGNALING PATHWAY	9	5.10e-01	8.07e-01	0.4430	-4.40e-02	-2.01e-01	2.25e-01	3.08e-01	-9.39e-02	8.19e-01	2.96e-01	2.43e-01	1.09e-01	6.26e-01
GOBP CILIUM DISASSEMBLY	5	7.83e-01	9.28e-01	0.4430	2.12e-01	1.63e-01	2.73e-01	2.15e-01	6.55e-02	4.12e-01	5.29e-01	2.90e-01	4.05e-01	8.00e-01
GOMF CYSTEINE TYPE EXOPEPTIDASE ACTIVITY	7	6.16e-01	8.60e-01	0.4430	2.25e-02	1.20e-01	-3.13e-01	-2.27e-01	1.79e-01	9.18e-01	5.81e-01	1.52e-01	2.98e-01	4.11e-01
GOBP INTRACELLULAR NITROGEN HOMEOSTASIS	5	7.32e-01	9.08e-01	0.4430	-1.37e-01	-2.54e-01	1.42e-01	1.36e-01	-2.72e-01	5.95e-01	3.25e-01	5.82e-01	5.98e-01	2.92e-01
GOBP ANTRAL OVARIAN FOLLICLE GROWTH	11	2.72e-01	6.26e-01	0.4430	-1.75e-01	9.95e-02	1.97e-01	1.65e-01	3.00e-01	3.15e-01	5.68e-01	2.58e-01	3.43e-01	8.54e-02
GOBP TRNA TRANSPORT	6	6.68e-01	8.83e-01	0.4430	2.09e-02	1.10e-01	-3.07e-01	-1.69e-01	-2.47e-01	9.29e-01	6.40e-01	1.92e-01	4.74e-01	2.96e-01
GOBP PROGESTERONE METABOLIC PROCESS	16	9.35e-02	3.70e-01	0.4430	1.65e-01	-3.43e-01	-3.94e-02	2.22e-01	1.72e-02	2.54e-01	1.74e-02	7.85e-01	1.24e-01	9.05e-01
GOBP OPTIC NERVE MORPHOGENESIS	6	5.97e-01	8.51e-01	0.4430	-3.05e-01	4.37e-02	2.91e-01	-1.89e-02	-1.26e-01	1.95e-01	8.53e-01	2.17e-01	9.36e-01	5.92e-01
GOBP THYROID HORMONE TRANSPORT	10	1.71e-01	5.09e-01	0.4430	2.72e-01	1.67e-01	-1.61e-01	2.60e-01	-2.51e-02	1.37e-01	3.61e-01	3.78e-01	1.54e-01	8.91e-01
GOBP FACIAL NERVE STRUCTURAL ORGANIZATION	7	6.37e-01	8.73e-01	0.4430	1.60e-01	1.80e-01	2.53e-01	2.30e-01	-1.46e-01	4.64e-01	4.10e-01	2.47e-01	2.92e-01	5.05e-01
GOBP MIDDLE EAR MORPHOGENESIS	20	9.23e-02	3.67e-01	0.4430	2.28e-01	-9.04e-03	-1.41e-01	-2.24e-01	2.72e-01	7.73e-02	9.44e-01	2.76e-01	8.29e-02	3.54e-02
GOBP POSITIVE REGULATION OF CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS	5	6.83e-01	8.88e-01	0.4430	-2.51e-01	1.11e-01	-2.43e-01	-1.58e-01	1.90e-01	3.31e-01	6.67e-01	3.46e-01	5.40e-01	4.61e-01
GOBP HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING	16	9.86e-02	3.80e-01	0.4420	-1.64e-01	1.69e-01	-1.25e-01	1.43e-02	-3.53e-01	2.55e-01	2.43e-01	3.87e-01	9.21e-01	1.46e-02
GOMF LONG CHAIN FATTY ACID COA LIGASE ACTIVITY	14	1.39e-01	4.59e-01	0.4420	-2.13e-02	3.83e-01	1.48e-01	-1.30e-01	-9.85e-02	8.90e-01	1.31e-02	3.37e-01	3.99e-01	5.23e-01
GOMF RNA POLYMERASE III TYPE 3 PROMOTER SEQUENCE SPECIFIC DNA BINDING	7	6.05e-01	8.55e-01	0.4420	3.22e-01	-1.39e-01	-1.38e-01	-9.87e-02	2.10e-01	1.40e-01	5.25e-01	5.28e-01	6.51e-01	3.37e-01
GOBP POSITIVE REGULATION OF TELOMERE CAPPING	17	1.13e-01	4.11e-01	0.4420	1.06e-02	-8.82e-02	-6.25e-02	-3.28e-01	2.76e-01	9.40e-01	5.29e-01	6.55e-01	1.92e-02	4.87e-02
GOBP POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE	13	1.28e-01	4.41e-01	0.4420	1.61e-01	3.89e-01	-5.38e-02	7.82e-02	9.72e-02	3.15e-01	1.52e-02	7.37e-01	6.25e-01	5.44e-01
GOBP POLYAMINE METABOLIC PROCESS	15	1.57e-01	4.85e-01	0.4420	-5.42e-02	8.48e-02	-2.17e-01	-2.89e-01	-2.34e-01	7.16e-01	5.69e-01	1.45e-01	5.30e-02	1.16e-01
GOBP INHIBITORY SYNAPSE ASSEMBLY	18	7.67e-02	3.33e-01	0.4420	1.31e-01	2.43e-01	2.21e-01	-9.98e-02	2.46e-01	3.35e-01	7.45e-02	1.05e-01	4.64e-01	7.07e-02
GOBP POSITIVE REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I	10	2.81e-01	6.34e-01	0.4420	6.24e-02	-3.73e-01	-8.87e-02	-1.91e-01	-9.12e-02	7.33e-01	4.13e-02	6.27e-01	2.96e-01	6.18e-01
GOMF PROTEIN TYROSINE THREONINE PHOSPHATASE ACTIVITY	9	4.01e-01	7.34e-01	0.4420	1.28e-01	1.98e-01	-6.35e-02	-3.69e-01	-2.48e-03	5.06e-01	3.04e-01	7.42e-01	5.56e-02	9.90e-01
GOBP PEPTIDYL LYSINE HYDROXYLATION	8	6.34e-01	8.71e-01	0.4420	4.62e-02	-1.89e-03	-3.24e-01	-2.88e-01	7.34e-02	8.21e-01	9.93e-01	1.12e-01	1.59e-01	7.19e-01
GOBP CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE	52	5.36e-05	1.44e-03	0.4420	-1.06e-01	-5.91e-02	1.14e-01	4.02e-01	-7.96e-02	1.88e-01	4.61e-01	1.57e-01	5.31e-07	3.21e-01
GOMF POLY ADP D RIBOSE BINDING	5	7.22e-01	9.03e-01	0.4420	2.62e-01	-1.80e-01	-1.39e-01	-2.72e-01	-3.53e-02	3.11e-01	4.85e-01	5.91e-01	2.93e-01	8.91e-01
GOBP COP9 SIGNALOSOME ASSEMBLY	5	6.93e-01	8.93e-01	0.4420	3.21e-01	-9.46e-02	-1.21e-01	-2.25e-01	-1.34e-01	2.13e-01	7.14e-01	6.40e-01	3.84e-01	6.04e-01
GOBP REGULATION OF FOCAL ADHESION DISASSEMBLY	6	6.58e-01	8.80e-01	0.4420	3.74e-02	2.18e-01	1.26e-01	-1.64e-01	3.22e-01	8.74e-01	3.56e-01	5.94e-01	4.86e-01	1.72e-01
GOBP LIPID DROPLET DISASSEMBLY	6	6.93e-01	8.93e-01	0.4420	-1.12e-01	1.45e-01	-1.14e-01	-3.25e-01	2.08e-01	6.35e-01	5.40e-01	6.29e-01	1.68e-01	3.78e-01
GOMF ADENOSINE 3 5 BISPHOSPHATE TRANSMEMBRANE TRANSPORTER ACTIVITY	5	6.95e-01	8.93e-01	0.4420	-1.05e-01	-1.41e-01	-8.14e-02	-3.96e-01	3.03e-02	6.85e-01	5.84e-01	7.53e-01	1.26e-01	9.06e-01
GOMF 5 3 DNA EXONUCLEASE ACTIVITY	9	4.83e-01	7.93e-01	0.4420	2.92e-01	1.41e-01	-8.39e-02	-1.98e-01	2.09e-01	1.29e-01	4.64e-01	6.63e-01	3.03e-01	2.79e-01
GOBP RESPONSE TO SODIUM ARSENITE	6	7.57e-01	9.19e-01	0.4420	9.71e-02	8.78e-03	-3.14e-01	-2.92e-01	-3.94e-02	6.80e-01	9.70e-01	1.83e-01	2.16e-01	8.67e-01
GOCC HIPPOCAMPAL MOSSY FIBER	5	5.05e-01	8.06e-01	0.4410	-4.28e-02	3.36e-01	-1.47e-01	2.41e-01	-1.74e-02	8.68e-01	1.93e-01	5.68e-01	3.51e-01	9.46e-01
GOBP 2FE 2S CLUSTER ASSEMBLY	9	4.42e-01	7.64e-01	0.4410	1.05e-01	-2.07e-02	-2.67e-01	-1.55e-01	-2.97e-01	5.87e-01	9.14e-01	1.66e-01	4.21e-01	1.22e-01
GOBP PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION	38	2.89e-03	3.57e-02	0.4410	1.75e-01	-2.52e-01	-2.27e-01	-2.13e-01	5.89e-02	6.17e-02	7.29e-03	1.55e-02	2.28e-02	5.30e-01
GOCC NASCENT POLYPEPTIDE ASSOCIATED COMPLEX	5	7.41e-01	9.12e-01	0.4410	-2.96e-01	1.30e-02	-1.85e-01	-1.14e-01	-2.43e-01	2.51e-01	9.60e-01	4.74e-01	6.60e-01	3.46e-01
GOBP ENUCLEATE ERYTHROCYTE DIFFERENTIATION	10	3.76e-01	7.15e-01	0.4410	1.62e-01	-1.49e-01	-4.77e-02	-2.75e-01	2.61e-01	3.74e-01	4.13e-01	7.94e-01	1.32e-01	1.54e-01
GOBP REGULATION OF G2 MI TRANSITION OF MEIOTIC CELL CYCLE	5	7.06e-01	8.97e-01	0.4410	9.23e-02	1.67e-01	-1.41e-01	-1.07e-01	-3.56e-01	7.21e-01	5.19e-01	5.86e-01	6.77e-01	1.68e-01
GOBP POSITIVE REGULATION OF PROTEIN NEDDYLATION	5	7.67e-01	9.23e-01	0.4410	-1.27e-01	-2.45e-01	-1.54e-01	-2.81e-01	1.25e-01	6.23e-01	3.43e-01	5.51e-01	2.76e-01	6.29e-01
GOBP CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION	10	2.39e-01	5.95e-01	0.4410	-1.55e-01	4.03e-01	-8.54e-02	8.43e-03	1.82e-02	3.96e-01	2.73e-02	6.40e-01	9.63e-01	9.21e-01
GOBP ESTABLISHMENT OR MAINTENANCE OF CYTOSKELETON POLARITY	7	6.10e-01	8.58e-01	0.4410	2.12e-01	2.53e-01	2.02e-01	1.86e-01	1.00e-01	3.31e-01	2.47e-01	3.56e-01	3.94e-01	6.46e-01
GOCC MITOCHONDRIAL PERMEABILITY TRANSITION PORE COMPLEX	6	7.24e-01	9.04e-01	0.4410	-9.15e-02	-1.05e-01	-3.70e-01	-1.94e-01	8.36e-04	6.98e-01	6.56e-01	1.16e-01	4.10e-01	9.97e-01
GOCC U2 TYPE SPLICEOSOMAL COMPLEX	88	4.12e-07	2.06e-05	0.4410	1.44e-01	-1.37e-01	-2.75e-01	-2.49e-01	1.32e-01	1.97e-02	2.68e-02	8.42e-06	5.39e-05	3.23e-02
GOBP PROPIONATE METABOLIC PROCESS	5	6.11e-01	8.58e-01	0.4410	5.32e-02	6.85e-02	-1.77e-01	3.51e-02	3.92e-01	8.37e-01	7.91e-01	4.93e-01	8.92e-01	1.29e-01
GOMF SUMO TRANSFERASE ACTIVITY	25	3.83e-02	2.14e-01	0.4410	1.35e-01	-9.18e-02	-2.21e-01	-1.92e-01	2.86e-01	2.43e-01	4.27e-01	5.61e-02	9.73e-02	1.32e-02
GOBP DE NOVO PYRIMIDINE NUCLEOBASE BIOSYNTHETIC PROCESS	6	6.60e-01	8.80e-01	0.4400	1.29e-01	-3.79e-01	-1.76e-01	1.73e-02	-4.62e-02	5.84e-01	1.08e-01	4.56e-01	9.42e-01	8.44e-01
GOBP SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION	10	3.02e-01	6.55e-01	0.4400	-7.90e-02	2.75e-01	2.30e-01	-1.91e-01	1.51e-01	6.65e-01	1.32e-01	2.07e-01	2.97e-01	4.09e-01
GOBP NEGATIVE REGULATION OF VASOCONSTRICTION	8	4.11e-01	7.43e-01	0.4400	2.60e-02	-4.13e-01	5.84e-02	-4.47e-02	1.30e-01	8.99e-01	4.29e-02	7.75e-01	8.27e-01	5.25e-01
GOBP REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS	15	2.01e-01	5.50e-01	0.4400	-3.17e-01	-1.71e-02	2.16e-01	1.58e-01	-1.45e-01	3.34e-02	9.09e-01	1.47e-01	2.89e-01	3.30e-01
GOBP PROTEIN LOCALIZATION TO AXON	9	4.82e-01	7.93e-01	0.4400	2.60e-02	-2.42e-01	1.37e-01	3.10e-01	-1.40e-01	8.93e-01	2.09e-01	4.75e-01	1.07e-01	4.67e-01
GOMF INORGANIC DIPHOSPHATE PHOSPHATASE ACTIVITY	5	7.51e-01	9.16e-01	0.4400	3.25e-01	1.74e-01	1.89e-01	1.42e-01	4.03e-02	2.08e-01	5.01e-01	4.64e-01	5.82e-01	8.76e-01
GOBP SULFUR AMINO ACID TRANSPORT	12	3.66e-01	7.05e-01	0.4400	-4.58e-02	1.10e-01	2.95e-01	2.19e-01	-2.10e-01	7.83e-01	5.08e-01	7.64e-02	1.90e-01	2.07e-01
GOBP POSITIVE REGULATION OF RNA EXPORT FROM NUCLEUS	5	7.83e-01	9.28e-01	0.4400	1.40e-01	-3.33e-03	-5.70e-02	-2.51e-01	3.28e-01	5.88e-01	9.90e-01	8.25e-01	3.30e-01	2.04e-01
GOBP NEURON FATE SPECIFICATION	34	3.86e-03	4.45e-02	0.4390	8.77e-02	2.11e-01	-3.06e-02	-3.18e-01	1.97e-01	3.76e-01	3.33e-02	7.58e-01	1.32e-03	4.72e-02
GOBP CADMIUM ION TRANSMEMBRANE TRANSPORT	6	5.11e-01	8.08e-01	0.4390	1.51e-01	2.26e-01	3.09e-01	-1.52e-01	-1.68e-02	5.22e-01	3.37e-01	1.90e-01	5.20e-01	9.43e-01
GOBP REGULATION OF ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE	8	6.13e-01	8.59e-01	0.4390	1.71e-01	-1.44e-01	-2.42e-01	-2.14e-01	1.98e-01	4.04e-01	4.82e-01	2.37e-01	2.96e-01	3.31e-01
GOBP FUSED ANTRUM STAGE	6	5.57e-01	8.32e-01	0.4390	-2.66e-01	1.28e-01	9.53e-02	2.29e-01	2.11e-01	2.60e-01	5.88e-01	6.86e-01	3.31e-01	3.71e-01
GOMF ATPASE INHIBITOR ACTIVITY	5	7.88e-01	9.30e-01	0.4390	-3.51e-02	9.46e-02	-1.31e-01	-2.87e-01	2.89e-01	8.92e-01	7.14e-01	6.13e-01	2.67e-01	2.63e-01
GOBP POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION	17	1.37e-01	4.57e-01	0.4390	3.16e-01	-6.07e-02	-1.16e-01	-1.78e-01	2.10e-01	2.41e-02	6.65e-01	4.07e-01	2.03e-01	1.34e-01
GOBP POSITIVE REGULATION OF ATP METABOLIC PROCESS	10	2.69e-01	6.24e-01	0.4390	2.66e-01	-1.62e-01	-1.49e-01	1.45e-01	2.29e-01	1.46e-01	3.74e-01	4.13e-01	4.27e-01	2.09e-01
GOMF SUPERCOILED DNA BINDING	6	6.70e-01	8.83e-01	0.4390	-1.18e-01	2.34e-01	-2.59e-01	-2.37e-01	-1.90e-02	6.16e-01	3.20e-01	2.71e-01	3.15e-01	9.36e-01
GOCC ENDOPLASMIC RETICULUM CHAPERONE COMPLEX	11	3.07e-01	6.60e-01	0.4390	-2.86e-01	1.46e-01	-1.47e-01	-2.61e-01	1.49e-02	1.01e-01	4.03e-01	3.97e-01	1.34e-01	9.32e-01
GOBP POSITIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION	8	2.89e-01	6.43e-01	0.4390	8.37e-02	-2.69e-01	2.70e-01	2.37e-02	-2.00e-01	6.82e-01	1.88e-01	1.86e-01	9.07e-01	3.28e-01
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR	43	2.44e-03	3.15e-02	0.4390	3.58e-02	6.10e-02	-2.49e-01	-3.29e-01	1.31e-01	6.84e-01	4.89e-01	4.69e-03	1.89e-04	1.37e-01
GOBP MONOCYTE ACTIVATION	12	1.95e-01	5.44e-01	0.4390	-3.07e-01	6.64e-02	1.26e-01	-2.02e-01	1.92e-01	6.52e-02	6.90e-01	4.50e-01	2.25e-01	2.50e-01
GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING	15	1.24e-02	1.02e-01	0.4390	1.91e-01	-1.33e-01	1.99e-01	-3.09e-01	-5.55e-02	2.01e-01	3.73e-01	1.83e-01	3.80e-02	7.10e-01
GOMF MYOSIN LIGHT CHAIN BINDING	8	5.11e-01	8.08e-01	0.4380	-2.74e-01	-1.76e-01	-1.47e-01	-1.36e-01	-2.14e-01	1.79e-01	3.89e-01	4.72e-01	5.05e-01	2.94e-01
GOMF DNA POLYMERASE BINDING	22	7.01e-02	3.15e-01	0.4380	-1.17e-01	7.13e-02	-2.45e-01	-3.14e-01	1.22e-01	3.43e-01	5.63e-01	4.64e-02	1.09e-02	3.22e-01
GOBP PURINE NUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS	5	6.53e-01	8.79e-01	0.4380	-3.49e-01	5.75e-03	9.78e-02	-2.43e-01	-4.44e-02	1.77e-01	9.82e-01	7.05e-01	3.47e-01	8.63e-01
GOBP NEGATIVE REGULATION OF MYOFIBROBLAST DIFFERENTIATION	6	5.88e-01	8.46e-01	0.4380	-6.11e-02	-1.24e-01	2.96e-02	-3.51e-01	2.22e-01	7.95e-01	5.99e-01	9.00e-01	1.37e-01	3.47e-01
GOBP G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY	21	4.38e-02	2.32e-01	0.4380	7.38e-02	3.34e-01	1.57e-01	1.98e-01	1.07e-01	5.58e-01	8.08e-03	2.12e-01	1.17e-01	3.98e-01
GOBP REGULATION OF EXIT FROM MITOSIS	17	1.17e-01	4.17e-01	0.4380	5.73e-02	1.68e-01	-1.28e-01	-3.80e-01	-1.00e-02	6.83e-01	2.30e-01	3.61e-01	6.74e-03	9.43e-01
GOBP RESPONSE TO WATER DEPRIVATION	5	7.19e-01	9.02e-01	0.4380	1.56e-01	6.06e-02	1.42e-01	2.79e-01	2.57e-01	5.46e-01	8.14e-01	5.83e-01	2.81e-01	3.19e-01
GOBP NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY	14	1.75e-01	5.15e-01	0.4380	-1.87e-01	6.08e-02	-1.01e-01	-6.48e-03	-3.79e-01	2.27e-01	6.94e-01	5.13e-01	9.67e-01	1.42e-02
GOBP LIPID DIGESTION	21	2.50e-02	1.62e-01	0.4380	8.49e-02	-8.23e-02	2.55e-02	4.19e-01	-3.62e-02	5.01e-01	5.14e-01	8.39e-01	8.74e-04	7.74e-01
GOBP REGULATION OF PROSTAGLANDIN SECRETION	13	2.78e-01	6.31e-01	0.4380	1.20e-01	2.81e-01	2.31e-01	1.81e-01	-1.13e-01	4.53e-01	7.98e-02	1.50e-01	2.58e-01	4.81e-01
GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE 3 PHOSPHATASE ACTIVITY	8	4.53e-01	7.72e-01	0.4380	-3.37e-01	-2.51e-01	2.19e-02	-8.07e-02	9.34e-02	9.91e-02	2.20e-01	9.15e-01	6.93e-01	6.47e-01
GOBP NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS	12	2.48e-01	6.05e-01	0.4380	-1.13e-01	2.75e-01	-1.36e-01	-2.11e-01	2.00e-01	4.97e-01	9.86e-02	4.15e-01	2.06e-01	2.29e-01
GOBP PEPTIDYL PROLINE HYDROXYLATION TO 4 HYDROXY L PROLINE	8	4.00e-01	7.33e-01	0.4380	-1.48e-01	2.74e-01	1.49e-01	-1.74e-01	-2.06e-01	4.69e-01	1.80e-01	4.65e-01	3.94e-01	3.12e-01
GOMF PEPTIDYL PROLINE 4 DIOXYGENASE ACTIVITY	8	4.00e-01	7.33e-01	0.4380	-1.48e-01	2.74e-01	1.49e-01	-1.74e-01	-2.06e-01	4.69e-01	1.80e-01	4.65e-01	3.94e-01	3.12e-01
GOBP POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL	25	1.08e-02	9.28e-02	0.4380	-2.32e-01	2.38e-01	1.23e-01	-2.30e-01	1.15e-01	4.50e-02	3.94e-02	2.86e-01	4.63e-02	3.18e-01
GOCC SM LIKE PROTEIN FAMILY COMPLEX	89	4.50e-07	2.23e-05	0.4380	1.63e-01	-4.56e-02	-2.91e-01	-2.50e-01	1.25e-01	7.69e-03	4.57e-01	2.06e-06	4.51e-05	4.14e-02
GOMF TYPE 2 FIBROBLAST GROWTH FACTOR RECEPTOR BINDING	5	7.39e-01	9.11e-01	0.4380	-1.51e-01	2.88e-01	-9.33e-02	-2.75e-01	-4.12e-02	5.59e-01	2.64e-01	7.18e-01	2.88e-01	8.73e-01
GOMF ALPHA KETOGLUTARATE TRANSMEMBRANE TRANSPORTER ACTIVITY	6	4.79e-01	7.91e-01	0.4380	1.79e-01	-8.09e-02	-1.20e-01	3.71e-01	2.67e-02	4.48e-01	7.32e-01	6.11e-01	1.15e-01	9.10e-01
GOMF G PROTEIN COUPLED RECEPTOR ACTIVITY	741	1.78e-78	3.03e-75	0.4380	-9.38e-02	-1.89e-01	1.48e-01	3.48e-01	5.96e-02	1.37e-05	1.55e-18	5.80e-12	5.33e-59	5.73e-03
GOBP MITOCHONDRIAL GENE EXPRESSION	162	2.05e-13	2.50e-11	0.4380	8.13e-02	-5.86e-02	-2.88e-01	-3.13e-01	-1.65e-02	7.42e-02	1.98e-01	2.46e-10	5.75e-12	7.16e-01
GOBP INNER CELL MASS CELL PROLIFERATION	14	2.28e-01	5.81e-01	0.4380	-1.85e-01	2.38e-02	-1.66e-01	-3.48e-01	8.88e-02	2.30e-01	8.77e-01	2.83e-01	2.41e-02	5.65e-01
GOBP ACETYL COA BIOSYNTHETIC PROCESS	16	1.55e-01	4.83e-01	0.4380	2.76e-01	-8.41e-02	-6.25e-02	-1.76e-01	2.71e-01	5.61e-02	5.60e-01	6.65e-01	2.22e-01	6.08e-02
GOMF PEPTIDE ALPHA N ACETYLTRANSFERASE ACTIVITY	7	6.40e-01	8.74e-01	0.4380	1.13e-01	-7.00e-02	-1.43e-01	-3.71e-01	1.26e-01	6.06e-01	7.49e-01	5.11e-01	8.94e-02	5.64e-01
GOBP MATURATION OF SSU RRNA	51	6.97e-04	1.15e-02	0.4370	1.56e-01	-2.26e-02	-2.90e-01	-2.77e-01	7.37e-02	5.40e-02	7.80e-01	3.33e-04	6.17e-04	3.62e-01
GOBP EPINEPHRINE TRANSPORT	11	2.80e-01	6.33e-01	0.4370	3.56e-01	-1.67e-01	1.40e-02	1.23e-01	1.47e-01	4.11e-02	3.37e-01	9.36e-01	4.81e-01	3.98e-01
GOBP DENSE CORE GRANULE EXOCYTOSIS	10	4.45e-01	7.68e-01	0.4370	-2.20e-01	-2.02e-01	1.46e-01	2.57e-01	-1.20e-01	2.28e-01	2.68e-01	4.26e-01	1.59e-01	5.11e-01
GOBP METANEPHRIC GLOMERULUS VASCULATURE DEVELOPMENT	9	4.72e-01	7.86e-01	0.4370	1.36e-03	3.27e-01	2.55e-01	2.53e-02	1.36e-01	9.94e-01	8.91e-02	1.85e-01	8.95e-01	4.80e-01
GOBP ADENOHYPOPHYSIS DEVELOPMENT	16	9.83e-02	3.79e-01	0.4370	-3.90e-01	1.02e-01	-1.15e-01	-1.17e-01	-4.55e-02	6.98e-03	4.79e-01	4.25e-01	4.19e-01	7.52e-01
GOBP LATE NUCLEOPHAGY	8	5.39e-01	8.23e-01	0.4370	1.54e-01	-5.99e-02	-3.59e-01	-9.67e-02	-1.59e-01	4.50e-01	7.69e-01	7.86e-02	6.36e-01	4.36e-01
GOBP CARNITINE TRANSMEMBRANE TRANSPORT	6	4.45e-01	7.67e-01	0.4370	2.50e-01	1.46e-01	-2.30e-01	1.71e-01	1.58e-01	2.88e-01	5.36e-01	3.30e-01	4.69e-01	5.01e-01
GOBP PML BODY ORGANIZATION	7	4.44e-01	7.66e-01	0.4370	-2.16e-01	1.39e-01	1.47e-01	-3.17e-01	5.57e-02	3.23e-01	5.24e-01	5.00e-01	1.47e-01	7.99e-01
GOBP CHEMOREPULSION OF AXON	6	4.77e-01	7.90e-01	0.4370	-2.69e-01	2.80e-02	-2.26e-02	1.98e-01	2.79e-01	2.54e-01	9.06e-01	9.24e-01	4.02e-01	2.36e-01
GOMF P TYPE POTASSIUM TRANSMEMBRANE TRANSPORTER ACTIVITY	7	6.02e-01	8.54e-01	0.4370	-3.75e-02	-3.76e-01	-1.49e-01	-1.45e-01	7.15e-02	8.64e-01	8.52e-02	4.95e-01	5.07e-01	7.43e-01
GOBP VENOUS BLOOD VESSEL MORPHOGENESIS	9	4.16e-01	7.46e-01	0.4370	1.45e-01	7.00e-02	3.13e-01	4.92e-03	2.59e-01	4.51e-01	7.16e-01	1.04e-01	9.80e-01	1.79e-01
GOMF ADRENERGIC RECEPTOR ACTIVITY	9	4.00e-01	7.33e-01	0.4370	-1.33e-01	1.53e-01	7.56e-02	-2.88e-01	2.47e-01	4.90e-01	4.27e-01	6.95e-01	1.35e-01	1.99e-01
GOCC PRERIBOSOME SMALL SUBUNIT PRECURSOR	15	1.94e-01	5.42e-01	0.4370	2.41e-01	-5.93e-02	-3.04e-01	-1.18e-01	1.50e-01	1.07e-01	6.91e-01	4.14e-02	4.27e-01	3.14e-01
GOBP IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE	20	4.50e-02	2.37e-01	0.4360	-2.58e-01	1.06e-01	-6.65e-02	-3.28e-01	-2.36e-02	4.56e-02	4.11e-01	6.07e-01	1.11e-02	8.55e-01
GOMF CATALYTIC ACTIVITY ACTING ON A RRNA	23	2.75e-02	1.74e-01	0.4360	1.32e-01	7.96e-02	-1.44e-01	-3.67e-01	-1.05e-01	2.73e-01	5.09e-01	2.31e-01	2.30e-03	3.81e-01
GOBP NEGATIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION	22	3.40e-02	1.98e-01	0.4360	-2.84e-01	2.76e-01	1.76e-01	-3.15e-02	4.52e-02	2.13e-02	2.50e-02	1.54e-01	7.98e-01	7.13e-01
GOBP POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION	12	1.69e-01	5.07e-01	0.4360	-2.16e-01	-2.19e-01	1.32e-01	-1.70e-01	2.22e-01	1.94e-01	1.90e-01	4.27e-01	3.09e-01	1.82e-01
GOBP DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS	8	5.88e-01	8.46e-01	0.4360	2.21e-02	8.52e-02	-2.03e-01	-2.56e-01	2.75e-01	9.14e-01	6.76e-01	3.21e-01	2.09e-01	1.78e-01
GOCC PROTEIN FOLDING CHAPERONE COMPLEX	40	4.96e-03	5.32e-02	0.4360	6.96e-02	5.36e-02	-2.81e-01	-3.08e-01	9.43e-02	4.46e-01	5.58e-01	2.14e-03	7.42e-04	3.02e-01
GOCC PEPTIDASE INHIBITOR COMPLEX	11	2.92e-01	6.46e-01	0.4360	-3.60e-02	3.42e-01	2.50e-01	-9.09e-02	3.42e-02	8.36e-01	4.95e-02	1.51e-01	6.02e-01	8.44e-01
GOBP REGULATION OF CAVEOLIN MEDIATED ENDOCYTOSIS	6	6.92e-01	8.92e-01	0.4360	-1.77e-01	-1.06e-01	-2.52e-03	1.29e-01	-3.62e-01	4.52e-01	6.52e-01	9.91e-01	5.84e-01	1.25e-01
GOBP ICOSANOID CATABOLIC PROCESS	9	4.10e-01	7.42e-01	0.4360	-7.19e-02	4.00e-01	5.33e-02	-5.92e-02	-1.36e-01	7.09e-01	3.76e-02	7.82e-01	7.58e-01	4.81e-01
GOBP POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION	22	3.43e-02	1.99e-01	0.4360	-2.03e-01	2.61e-01	1.07e-01	2.50e-01	-8.20e-02	9.98e-02	3.44e-02	3.84e-01	4.21e-02	5.06e-01
GOBP SODIUM INDEPENDENT ORGANIC ANION TRANSPORT	15	1.68e-01	5.04e-01	0.4350	-1.32e-01	-2.46e-01	3.82e-02	3.18e-01	-9.58e-02	3.77e-01	9.89e-02	7.98e-01	3.30e-02	5.21e-01
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME	27	3.07e-02	1.86e-01	0.4350	-7.95e-02	-1.56e-01	-2.27e-01	-3.27e-01	1.88e-02	4.75e-01	1.60e-01	4.10e-02	3.28e-03	8.66e-01
GOBP GEPHYRIN CLUSTERING INVOLVED IN POSTSYNAPTIC DENSITY ASSEMBLY	5	7.41e-01	9.12e-01	0.4350	1.30e-01	3.28e-02	2.22e-01	-3.83e-02	3.48e-01	6.14e-01	8.99e-01	3.90e-01	8.82e-01	1.78e-01
GOMF GALACTOSIDASE ACTIVITY	6	5.82e-01	8.43e-01	0.4350	3.94e-02	-2.48e-01	6.76e-02	4.08e-02	-3.47e-01	8.67e-01	2.93e-01	7.74e-01	8.62e-01	1.42e-01
GOBP ISOCITRATE METABOLIC PROCESS	5	7.74e-01	9.25e-01	0.4350	3.55e-03	1.34e-01	-2.19e-01	-2.15e-01	2.78e-01	9.89e-01	6.04e-01	3.96e-01	4.05e-01	2.82e-01
GOBP POSITIVE REGULATION OF CALCIUM ION IMPORT	14	1.60e-01	4.92e-01	0.4350	-1.20e-01	2.43e-01	8.84e-02	3.15e-01	-9.33e-02	4.36e-01	1.16e-01	5.67e-01	4.11e-02	5.46e-01
GOBP AMYLIN RECEPTOR SIGNALING PATHWAY	6	6.33e-01	8.71e-01	0.4350	1.16e-01	-3.39e-01	-9.45e-02	2.24e-01	-3.71e-02	6.22e-01	1.50e-01	6.89e-01	3.42e-01	8.75e-01
GOBP DENSE CORE GRANULE LOCALIZATION	10	4.31e-01	7.55e-01	0.4350	-6.31e-02	-1.55e-01	2.01e-01	3.36e-01	8.93e-02	7.30e-01	3.97e-01	2.70e-01	6.58e-02	6.25e-01
GOBP REGULATION OF CELL FATE SPECIFICATION	24	1.78e-02	1.31e-01	0.4350	-1.36e-01	1.25e-01	-7.36e-02	-3.84e-01	-4.47e-02	2.47e-01	2.87e-01	5.32e-01	1.13e-03	7.05e-01
GOBP REGULATION OF LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR	5	6.58e-01	8.80e-01	0.4350	4.44e-02	-9.97e-02	-8.04e-02	-2.03e-01	-3.60e-01	8.64e-01	7.00e-01	7.56e-01	4.32e-01	1.64e-01
GOBP POSITIVE REGULATION OF VIRAL LIFE CYCLE	23	2.70e-02	1.71e-01	0.4350	-1.41e-01	3.10e-01	-1.69e-01	-2.12e-01	-4.90e-03	2.43e-01	1.02e-02	1.61e-01	7.82e-02	9.68e-01
GOBP POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY	7	4.88e-01	7.97e-01	0.4350	2.51e-01	-1.27e-01	-3.15e-01	8.88e-02	5.65e-02	2.51e-01	5.60e-01	1.50e-01	6.84e-01	7.96e-01
GOMF DOUBLE STRANDED METHYLATED DNA BINDING	5	6.11e-01	8.58e-01	0.4350	9.51e-02	1.24e-01	2.90e-01	-3.93e-02	-2.81e-01	7.13e-01	6.31e-01	2.61e-01	8.79e-01	2.77e-01
GOBP REGULATION OF GAP JUNCTION ASSEMBLY	9	3.89e-01	7.25e-01	0.4350	1.08e-01	1.27e-01	3.05e-01	8.94e-02	-2.45e-01	5.74e-01	5.09e-01	1.13e-01	6.43e-01	2.04e-01
GOBP POSITIVE REGULATION OF PROTEIN DEACETYLATION	10	3.78e-01	7.17e-01	0.4350	2.21e-01	-3.00e-01	-1.27e-01	-1.74e-01	6.21e-02	2.27e-01	1.01e-01	4.86e-01	3.41e-01	7.34e-01
GOMF ALL TRANS RETINAL BINDING	5	6.30e-01	8.69e-01	0.4350	-1.39e-01	-1.10e-01	-3.45e-01	1.37e-01	-1.40e-01	5.89e-01	6.69e-01	1.82e-01	5.95e-01	5.88e-01
GOCC ORGANELLAR RIBOSOME	89	3.83e-07	1.94e-05	0.4350	9.68e-02	-3.16e-02	-2.85e-01	-3.09e-01	-4.60e-02	1.15e-01	6.06e-01	3.48e-06	4.71e-07	4.53e-01
GOMF PRE MRNA INTRONIC BINDING	12	3.63e-01	7.05e-01	0.4350	-1.55e-01	-3.27e-02	-2.44e-01	-3.23e-01	8.47e-03	3.53e-01	8.45e-01	1.43e-01	5.29e-02	9.59e-01
GOBP REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING SIGNALING PATHWAY	14	2.06e-01	5.56e-01	0.4350	1.76e-01	1.65e-01	1.05e-01	-1.09e-01	3.28e-01	2.53e-01	2.86e-01	4.94e-01	4.79e-01	3.37e-02
GOBP RENAL VESICLE FORMATION	8	4.80e-01	7.92e-01	0.4340	-2.25e-01	1.62e-01	3.01e-01	-5.12e-02	1.36e-01	2.71e-01	4.28e-01	1.40e-01	8.02e-01	5.05e-01
GOMF NADPLUS PROTEIN ARGININE ADP RIBOSYLTRANSFERASE ACTIVITY	6	6.11e-01	8.58e-01	0.4340	-1.12e-01	-3.88e-01	-1.33e-02	-5.71e-02	-1.49e-01	6.35e-01	9.99e-02	9.55e-01	8.09e-01	5.27e-01
GOBP POSITIVE REGULATION OF TELOMERASE ACTIVITY	33	5.73e-03	5.86e-02	0.4340	-1.13e-01	-2.25e-01	-1.43e-01	-2.90e-01	1.45e-01	2.63e-01	2.54e-02	1.54e-01	4.00e-03	1.50e-01
GOBP TOLL LIKE RECEPTOR 7 SIGNALING PATHWAY	9	3.99e-01	7.33e-01	0.4340	-2.54e-01	1.35e-01	-4.66e-02	-1.74e-01	2.71e-01	1.88e-01	4.84e-01	8.09e-01	3.66e-01	1.59e-01
GOBP MELANOCYTE PROLIFERATION	5	7.65e-01	9.22e-01	0.4340	-1.23e-01	-3.03e-01	1.99e-01	2.02e-01	-2.68e-02	6.33e-01	2.40e-01	4.41e-01	4.35e-01	9.17e-01
GOBP KINETOCHORE ASSEMBLY	16	1.28e-01	4.42e-01	0.4340	2.11e-01	-2.03e-01	-1.50e-01	-2.82e-01	-1.53e-02	1.44e-01	1.59e-01	2.99e-01	5.07e-02	9.16e-01
GOBP CARBON DIOXIDE TRANSPORT	15	1.08e-01	4.00e-01	0.4340	-2.43e-01	5.84e-02	7.82e-02	3.45e-01	2.76e-02	1.03e-01	6.95e-01	6.00e-01	2.08e-02	8.53e-01
GOMF SODIUM CHANNEL ACTIVITY	42	1.78e-03	2.45e-02	0.4340	-5.80e-02	8.17e-02	1.38e-01	2.66e-01	-2.97e-01	5.15e-01	3.59e-01	1.21e-01	2.83e-03	8.64e-04
GOBP DETECTION OF EXTERNAL BIOTIC STIMULUS	26	1.96e-02	1.39e-01	0.4340	-3.75e-01	1.18e-01	1.33e-01	7.18e-02	-1.06e-01	9.45e-04	2.99e-01	2.40e-01	5.26e-01	3.50e-01
GOBP REGULATION OF GERMINAL CENTER FORMATION	8	3.56e-01	7.01e-01	0.4340	-1.11e-01	3.94e-01	-1.16e-01	6.63e-02	-4.77e-02	5.87e-01	5.34e-02	5.68e-01	7.45e-01	8.15e-01
GOMF L LEUCINE TRANSMEMBRANE TRANSPORTER ACTIVITY	6	6.35e-01	8.71e-01	0.4340	-2.87e-01	1.20e-01	1.57e-01	6.05e-02	2.51e-01	2.23e-01	6.11e-01	5.05e-01	7.97e-01	2.88e-01
GOBP GONADOTROPIN SECRETION	17	7.62e-02	3.31e-01	0.4340	5.06e-02	1.25e-01	-3.95e-02	-3.20e-02	-4.09e-01	7.18e-01	3.72e-01	7.78e-01	8.20e-01	3.50e-03
GOMF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY	27	1.47e-02	1.15e-01	0.4340	-3.67e-02	3.63e-01	2.33e-01	-2.94e-02	2.88e-03	7.41e-01	1.10e-03	3.62e-02	7.92e-01	9.79e-01
GOBP PHENOTYPIC SWITCHING	16	1.01e-01	3.84e-01	0.4340	-3.23e-01	9.13e-02	1.34e-01	-5.84e-02	2.32e-01	2.53e-02	5.27e-01	3.53e-01	6.86e-01	1.08e-01
GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY	15	2.57e-01	6.14e-01	0.4340	3.16e-02	-5.38e-02	-1.90e-01	-2.88e-01	2.55e-01	8.32e-01	7.18e-01	2.03e-01	5.35e-02	8.70e-02
GOBP REGULATION OF MITOCHONDRIAL GENE EXPRESSION	30	2.52e-02	1.62e-01	0.4330	6.26e-02	-6.58e-02	-2.44e-01	-3.45e-01	2.57e-02	5.53e-01	5.33e-01	2.06e-02	1.06e-03	8.07e-01
GOBP POSITIVE REGULATION OF HORMONE BIOSYNTHETIC PROCESS	9	3.98e-01	7.31e-01	0.4330	-3.63e-01	-1.05e-01	1.89e-01	-6.91e-03	-9.70e-02	5.94e-02	5.84e-01	3.27e-01	9.71e-01	6.14e-01
GOBP CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS	8	4.71e-01	7.85e-01	0.4330	2.65e-01	-2.85e-01	6.08e-02	1.67e-01	-6.74e-02	1.94e-01	1.63e-01	7.66e-01	4.12e-01	7.41e-01
GOMF SUPEROXIDE GENERATING NADPH OXIDASE ACTIVATOR ACTIVITY	7	5.75e-01	8.40e-01	0.4330	1.86e-02	2.63e-01	4.59e-02	6.54e-02	-3.34e-01	9.32e-01	2.28e-01	8.34e-01	7.65e-01	1.26e-01
GOBP NEGATIVE REGULATION OF FATTY ACID TRANSPORT	7	5.23e-01	8.15e-01	0.4330	-5.27e-02	-3.57e-01	6.29e-02	-8.12e-02	2.16e-01	8.09e-01	1.02e-01	7.73e-01	7.10e-01	3.22e-01
GOBP DETECTION OF CELL DENSITY	9	5.02e-01	8.03e-01	0.4330	-2.80e-01	1.65e-03	2.38e-01	1.26e-01	-1.90e-01	1.45e-01	9.93e-01	2.15e-01	5.11e-01	3.24e-01
GOBP REGULATION OF KILLING OF CELLS OF ANOTHER ORGANISM	11	2.75e-01	6.30e-01	0.4330	-2.51e-01	1.68e-01	2.30e-01	-1.17e-01	1.72e-01	1.49e-01	3.33e-01	1.87e-01	5.03e-01	3.24e-01
GOBP REGULATION OF INTRACELLULAR LIPID TRANSPORT	10	3.60e-01	7.04e-01	0.4330	9.74e-02	3.78e-01	1.63e-01	-9.25e-02	-1.89e-02	5.94e-01	3.87e-02	3.73e-01	6.12e-01	9.18e-01
GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY	12	3.40e-01	6.87e-01	0.4330	1.61e-01	-2.36e-01	-3.00e-01	-9.55e-02	7.92e-02	3.34e-01	1.57e-01	7.18e-02	5.67e-01	6.35e-01
GOMF RNA POLYMERASE ACTIVITY	31	1.56e-02	1.20e-01	0.4330	2.18e-01	-3.97e-02	-3.30e-01	-1.72e-01	1.69e-04	3.58e-02	7.02e-01	1.49e-03	9.82e-02	9.99e-01
GOBP POSITIVE REGULATION OF AMYLOID FIBRIL FORMATION	5	7.29e-01	9.06e-01	0.4330	-5.24e-02	4.02e-01	-7.12e-02	-1.33e-01	-9.45e-03	8.39e-01	1.20e-01	7.83e-01	6.06e-01	9.71e-01
GOBP REGULATION OF MEMBRANE INVAGINATION	15	1.67e-01	5.03e-01	0.4320	-3.04e-01	6.96e-02	2.92e-01	4.76e-02	4.60e-02	4.15e-02	6.41e-01	5.01e-02	7.49e-01	7.58e-01
GOMF 2 ACYLGLYCEROL 3 PHOSPHATE O ACYLTRANSFERASE ACTIVITY	9	3.96e-01	7.30e-01	0.4320	8.89e-02	1.33e-01	-1.92e-01	2.17e-02	-3.52e-01	6.44e-01	4.90e-01	3.20e-01	9.10e-01	6.71e-02
GOBP HISTIDINE CATABOLIC PROCESS	8	2.78e-01	6.31e-01	0.4320	-1.39e-01	5.16e-02	-2.96e-01	2.20e-01	-1.70e-01	4.97e-01	8.00e-01	1.47e-01	2.80e-01	4.06e-01
GOMF HISTONE H4K20 MONOMETHYLTRANSFERASE ACTIVITY	6	4.68e-01	7.83e-01	0.4320	2.21e-01	-2.15e-02	6.46e-02	-3.63e-01	-3.67e-02	3.49e-01	9.27e-01	7.84e-01	1.23e-01	8.76e-01
GOBP NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS	11	4.19e-01	7.48e-01	0.4320	-1.49e-01	-1.78e-01	1.39e-01	2.83e-01	-1.82e-01	3.92e-01	3.06e-01	4.23e-01	1.05e-01	2.95e-01
GOCC CENTRAL ELEMENT	7	5.41e-01	8.24e-01	0.4320	2.99e-01	-1.08e-02	4.06e-02	2.12e-01	2.25e-01	1.71e-01	9.61e-01	8.52e-01	3.31e-01	3.02e-01
GOCC MHC PROTEIN COMPLEX	24	3.17e-03	3.83e-02	0.4320	-2.54e-01	-1.91e-01	1.20e-01	-2.32e-01	-1.32e-01	3.10e-02	1.06e-01	3.10e-01	4.95e-02	2.61e-01
GOBP NEGATIVE REGULATION OF VASCULAR WOUND HEALING	7	5.91e-01	8.47e-01	0.4320	-2.27e-03	-2.75e-01	-3.43e-02	2.92e-01	-1.56e-01	9.92e-01	2.07e-01	8.75e-01	1.81e-01	4.76e-01
GOBP POSITIVE REGULATION OF MIRNA PROCESSING	5	8.18e-01	9.41e-01	0.4310	1.79e-01	-1.92e-01	-2.61e-01	-2.21e-01	-1.66e-02	4.87e-01	4.57e-01	3.12e-01	3.93e-01	9.49e-01
GOBP INTERSTRAND CROSS LINK REPAIR	37	8.81e-03	8.04e-02	0.4310	1.47e-01	-1.47e-01	-2.61e-01	-2.62e-01	7.80e-02	1.23e-01	1.21e-01	6.05e-03	5.78e-03	4.11e-01
GOCC VACUOLAR PROTON TRANSPORTING V TYPE ATPASE V0 DOMAIN	9	3.52e-01	6.97e-01	0.4310	1.39e-01	2.63e-01	1.28e-01	-2.81e-01	4.55e-02	4.69e-01	1.72e-01	5.05e-01	1.45e-01	8.13e-01
GOBP INDOLALKYLAMINE METABOLIC PROCESS	11	3.61e-01	7.04e-01	0.4310	-3.31e-01	-3.24e-02	3.76e-02	1.83e-01	-2.01e-01	5.74e-02	8.52e-01	8.29e-01	2.94e-01	2.47e-01
GOBP POSITIVE REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION	11	2.58e-01	6.15e-01	0.4310	2.46e-01	-2.39e-01	-8.87e-02	-2.44e-01	-3.07e-02	1.58e-01	1.70e-01	6.10e-01	1.61e-01	8.60e-01
GOBP NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY	28	1.87e-02	1.35e-01	0.4310	1.35e-01	2.23e-01	-3.96e-02	-2.04e-01	2.74e-01	2.17e-01	4.13e-02	7.17e-01	6.19e-02	1.22e-02
GOBP REGULATION OF LYMPHOID PROGENITOR CELL DIFFERENTIATION	12	4.02e-01	7.35e-01	0.4310	1.92e-01	-1.04e-01	-2.52e-01	-2.09e-01	1.75e-01	2.50e-01	5.35e-01	1.30e-01	2.09e-01	2.93e-01
GOCC CYTOCHROME COMPLEX	34	1.15e-02	9.65e-02	0.4310	1.01e-01	-1.28e-01	-2.62e-01	-2.97e-01	-4.74e-02	3.08e-01	1.95e-01	8.18e-03	2.73e-03	6.33e-01
GOBP CLUSTERING OF VOLTAGE GATED SODIUM CHANNELS	6	6.54e-01	8.79e-01	0.4310	-3.38e-01	9.45e-02	-1.37e-01	-5.30e-02	-2.03e-01	1.52e-01	6.89e-01	5.62e-01	8.22e-01	3.88e-01
GOBP TRANSFERRIN TRANSPORT	10	3.01e-01	6.55e-01	0.4310	1.23e-01	1.43e-01	-5.63e-02	-3.66e-01	-1.15e-01	5.01e-01	4.33e-01	7.58e-01	4.52e-02	5.29e-01
GOBP MITOCHONDRIAL ELECTRON TRANSPORT CYTOCHROME C TO OXYGEN	19	1.07e-01	3.98e-01	0.4310	1.24e-01	-2.66e-01	-1.63e-01	-2.40e-01	1.24e-01	3.50e-01	4.50e-02	2.18e-01	7.00e-02	3.48e-01
GOMF RETINYL PALMITATE ESTERASE ACTIVITY	6	7.43e-01	9.13e-01	0.4310	6.06e-02	2.11e-01	2.26e-01	2.94e-01	5.26e-03	7.97e-01	3.71e-01	3.37e-01	2.13e-01	9.82e-01
GOBP NEGATIVE REGULATION OF SYNAPSE ASSEMBLY	8	3.87e-01	7.24e-01	0.4310	1.25e-01	-3.61e-01	4.38e-02	-1.69e-02	-1.94e-01	5.40e-01	7.74e-02	8.30e-01	9.34e-01	3.41e-01
GOBP POSITIVE REGULATION OF ACROSOME REACTION	11	4.15e-01	7.46e-01	0.4310	-1.63e-01	-1.74e-01	1.26e-01	2.51e-01	-2.24e-01	3.49e-01	3.18e-01	4.71e-01	1.50e-01	1.98e-01
GOBP GLYCINE TRANSPORT	14	2.49e-01	6.06e-01	0.4310	-2.38e-01	1.17e-01	3.20e-01	1.06e-01	3.77e-02	1.22e-01	4.49e-01	3.83e-02	4.90e-01	8.07e-01
GOMF CARBON NITROGEN LIGASE ACTIVITY WITH GLUTAMINE AS AMIDO N DONOR	10	3.77e-01	7.17e-01	0.4310	3.10e-01	1.04e-01	-2.08e-01	-1.04e-01	-1.58e-01	8.99e-02	5.71e-01	2.56e-01	5.69e-01	3.87e-01
GOCC DYSTROPHIN ASSOCIATED GLYCOPROTEIN COMPLEX	17	1.65e-01	5.00e-01	0.4310	1.32e-01	1.20e-01	2.83e-01	2.17e-01	-1.62e-01	3.45e-01	3.92e-01	4.32e-02	1.21e-01	2.49e-01
GOBP PURINE NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS	6	7.04e-01	8.97e-01	0.4310	2.90e-01	1.76e-01	-1.52e-01	-2.16e-01	-1.77e-02	2.19e-01	4.54e-01	5.19e-01	3.59e-01	9.40e-01
GOBP NEURONAL DENSE CORE VESICLE EXOCYTOSIS	7	6.15e-01	8.60e-01	0.4300	-2.63e-01	-1.64e-01	5.90e-02	2.83e-01	-7.52e-02	2.29e-01	4.52e-01	7.87e-01	1.95e-01	7.31e-01
GOMF PHOSPHATIDYLCHOLINE STEROL O ACYLTRANSFERASE ACTIVATOR ACTIVITY	6	6.73e-01	8.84e-01	0.4300	-3.55e-01	-1.00e-01	-6.32e-02	-7.40e-02	-1.98e-01	1.32e-01	6.70e-01	7.89e-01	7.54e-01	4.01e-01
GOCC BCL 2 FAMILY PROTEIN COMPLEX	10	3.07e-01	6.60e-01	0.4300	-9.93e-02	7.74e-02	1.32e-01	-2.95e-01	2.55e-01	5.87e-01	6.72e-01	4.71e-01	1.06e-01	1.63e-01
GOBP COLLAGEN ACTIVATED SIGNALING PATHWAY	13	3.15e-01	6.65e-01	0.4300	-1.67e-01	3.40e-02	1.35e-01	3.34e-01	-1.62e-01	2.96e-01	8.32e-01	4.01e-01	3.72e-02	3.11e-01
GOMF NITRIC OXIDE SYNTHASE REGULATOR ACTIVITY	6	6.28e-01	8.68e-01	0.4300	-2.67e-01	-3.00e-01	1.43e-01	1.99e-02	-5.11e-02	2.57e-01	2.03e-01	5.44e-01	9.33e-01	8.28e-01
GOBP REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY	15	1.41e-01	4.62e-01	0.4300	-8.30e-02	2.68e-01	-1.28e-02	-3.25e-01	1.52e-03	5.78e-01	7.20e-02	9.31e-01	2.92e-02	9.92e-01
GOMF BMP BINDING	19	7.56e-02	3.30e-01	0.4300	-2.27e-02	3.07e-01	1.24e-01	-4.76e-02	2.68e-01	8.64e-01	2.03e-02	3.50e-01	7.19e-01	4.28e-02
GOBP ENDOSOME TO LYSOSOME TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY	17	2.19e-01	5.74e-01	0.4300	1.09e-01	4.70e-02	-2.75e-01	-2.72e-01	1.45e-01	4.35e-01	7.37e-01	4.95e-02	5.25e-02	3.00e-01
GOMF BETA GLUCOSIDASE ACTIVITY	6	6.78e-01	8.86e-01	0.4300	8.02e-02	-2.92e-01	1.77e-01	2.20e-01	-1.15e-01	7.34e-01	2.16e-01	4.52e-01	3.51e-01	6.25e-01
GOMF THIOL OXIDASE ACTIVITY	6	7.14e-01	9.01e-01	0.4300	-6.68e-02	4.89e-02	-6.77e-02	-3.22e-01	2.64e-01	7.77e-01	8.36e-01	7.74e-01	1.72e-01	2.63e-01
GOBP PURINE NUCLEOTIDE SALVAGE	10	2.86e-01	6.40e-01	0.4300	-6.36e-02	-6.96e-02	1.11e-01	-3.02e-01	2.69e-01	7.28e-01	7.03e-01	5.42e-01	9.87e-02	1.41e-01
GOBP POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE	5	7.34e-01	9.09e-01	0.4300	-2.48e-01	2.07e-01	-1.75e-01	-1.10e-01	-1.92e-01	3.36e-01	4.22e-01	4.97e-01	6.70e-01	4.57e-01
GOBP REGULATION OF SOMITOGENESIS	6	6.31e-01	8.69e-01	0.4290	1.18e-01	2.04e-01	2.48e-01	-1.59e-01	2.05e-01	6.16e-01	3.87e-01	2.93e-01	5.00e-01	3.83e-01
GOCC MYOSIN FILAMENT	24	4.17e-02	2.26e-01	0.4290	8.22e-02	3.25e-02	1.26e-01	3.78e-01	-1.34e-01	4.86e-01	7.83e-01	2.83e-01	1.35e-03	2.57e-01
GOBP 5S CLASS RRNA TRANSCRIPTION BY RNA POLYMERASE III	6	5.75e-01	8.40e-01	0.4290	5.39e-02	-7.69e-02	-4.79e-03	-4.11e-01	8.15e-02	8.19e-01	7.44e-01	9.84e-01	8.12e-02	7.29e-01
GOCC TRANSCRIPTION FACTOR TFIIIC COMPLEX	6	5.75e-01	8.40e-01	0.4290	5.39e-02	-7.69e-02	-4.79e-03	-4.11e-01	8.15e-02	8.19e-01	7.44e-01	9.84e-01	8.12e-02	7.29e-01
GOMF INTERLEUKIN 1 BINDING	9	3.71e-01	7.10e-01	0.4290	-3.77e-02	-2.05e-01	4.58e-02	3.38e-01	1.58e-01	8.45e-01	2.87e-01	8.12e-01	7.94e-02	4.12e-01
GOBP POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION	15	1.79e-01	5.20e-01	0.4290	-1.95e-01	2.68e-01	2.10e-01	9.18e-02	1.49e-01	1.91e-01	7.28e-02	1.59e-01	5.38e-01	3.19e-01
GOBP NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS	18	1.25e-01	4.36e-01	0.4290	-2.57e-01	2.45e-01	2.09e-01	9.92e-02	-6.55e-02	5.88e-02	7.19e-02	1.24e-01	4.66e-01	6.30e-01
GOMF LIGASE ACTIVITY FORMING CARBON CARBON BONDS	7	6.91e-01	8.92e-01	0.4290	8.46e-02	1.56e-01	3.21e-01	1.97e-01	1.00e-01	6.98e-01	4.73e-01	1.41e-01	3.66e-01	6.46e-01
GOBP PROTEIN O LINKED MANNOSYLATION	17	7.72e-02	3.33e-01	0.4290	3.44e-01	-2.32e-01	-2.88e-02	2.71e-02	-9.98e-02	1.39e-02	9.83e-02	8.37e-01	8.47e-01	4.76e-01
GOBP GAP JUNCTION MEDIATED INTERCELLULAR TRANSPORT	6	6.84e-01	8.88e-01	0.4290	1.17e-01	-1.78e-01	-7.11e-03	2.73e-01	-2.53e-01	6.21e-01	4.50e-01	9.76e-01	2.47e-01	2.83e-01
GOBP REGULATION OF TRANSLATIONAL FIDELITY	18	1.66e-01	5.01e-01	0.4290	1.83e-01	1.14e-01	-1.90e-01	-3.09e-01	7.63e-02	1.79e-01	4.01e-01	1.62e-01	2.34e-02	5.75e-01
GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE SPINDLE ASSEMBLY CHECKPOINT	12	3.69e-01	7.09e-01	0.4290	9.39e-02	-2.25e-01	-3.29e-01	-1.19e-01	3.91e-02	5.73e-01	1.76e-01	4.84e-02	4.75e-01	8.15e-01
GOBP RESPONSE TO HYPEROXIA	18	1.90e-01	5.36e-01	0.4290	8.54e-02	-1.16e-01	-2.28e-01	-3.17e-01	1.03e-01	5.30e-01	3.96e-01	9.36e-02	1.99e-02	4.52e-01
GOBP RESPONSE TO MURAMYL DIPEPTIDE	20	8.28e-02	3.47e-01	0.4290	1.04e-01	2.86e-01	-3.11e-02	-2.28e-01	1.95e-01	4.20e-01	2.69e-02	8.10e-01	7.71e-02	1.31e-01
GOBP INSULIN PROCESSING	8	3.81e-01	7.19e-01	0.4280	-6.50e-02	-3.04e-01	2.17e-01	-7.07e-02	1.86e-01	7.50e-01	1.36e-01	2.89e-01	7.29e-01	3.63e-01
GOBP REGULATION OF SARCOMERE ORGANIZATION	9	5.21e-01	8.14e-01	0.4280	1.15e-01	-1.70e-01	2.03e-01	3.15e-01	-2.21e-02	5.51e-01	3.77e-01	2.92e-01	1.02e-01	9.09e-01
GOBP RRNA MODIFICATION	32	1.55e-02	1.19e-01	0.4280	6.87e-02	-7.66e-02	-2.26e-01	-3.48e-01	-1.75e-02	5.01e-01	4.53e-01	2.67e-02	6.60e-04	8.64e-01
GOBP ER OVERLOAD RESPONSE	11	3.66e-01	7.06e-01	0.4280	-1.66e-01	1.47e-01	-2.00e-01	-2.79e-01	-1.27e-01	3.41e-01	4.00e-01	2.52e-01	1.09e-01	4.65e-01
GOBP SEQUESTERING OF IRON ION	6	4.52e-01	7.72e-01	0.4280	-5.10e-02	7.79e-02	-2.53e-01	5.89e-02	3.27e-01	8.29e-01	7.41e-01	2.84e-01	8.03e-01	1.65e-01
GOMF N ACETYLGALACTOSAMINE 4 O SULFOTRANSFERASE ACTIVITY	5	8.07e-01	9.36e-01	0.4280	2.88e-01	1.31e-01	-1.62e-01	-1.95e-01	1.38e-01	2.66e-01	6.12e-01	5.30e-01	4.51e-01	5.94e-01
GOBP NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR	14	2.97e-01	6.52e-01	0.4280	1.32e-01	1.38e-01	-2.12e-01	-3.17e-01	2.62e-02	3.91e-01	3.70e-01	1.70e-01	3.98e-02	8.65e-01
GOBP CELLULAR RESPONSE TO COCAINE	8	5.06e-01	8.06e-01	0.4280	1.93e-01	2.23e-01	1.67e-01	8.82e-02	-2.46e-01	3.46e-01	2.76e-01	4.13e-01	6.66e-01	2.29e-01
GOMF CERAMIDE 1 PHOSPHATE BINDING	7	5.50e-01	8.28e-01	0.4280	-4.09e-02	4.25e-01	1.02e-02	1.07e-02	1.87e-02	8.51e-01	5.16e-02	9.63e-01	9.61e-01	9.32e-01
GOMF PHOSPHATIDYLETHANOLAMINE FLIPPASE ACTIVITY	5	7.82e-01	9.28e-01	0.4270	1.22e-01	2.73e-01	1.63e-01	2.58e-01	-7.85e-03	6.37e-01	2.90e-01	5.28e-01	3.18e-01	9.76e-01
GOBP LEUCINE IMPORT ACROSS PLASMA MEMBRANE	5	7.57e-01	9.19e-01	0.4270	-2.40e-01	7.08e-02	2.11e-01	1.13e-01	2.50e-01	3.52e-01	7.84e-01	4.14e-01	6.62e-01	3.33e-01
GOMF BIOACTIVE LIPID RECEPTOR ACTIVITY	14	2.67e-01	6.23e-01	0.4270	-1.50e-02	-2.37e-01	-1.70e-01	-2.15e-01	2.26e-01	9.23e-01	1.25e-01	2.71e-01	1.63e-01	1.43e-01
GOBP REGULATION OF PROTEIN FOLDING	8	6.53e-01	8.79e-01	0.4270	4.29e-02	-5.92e-02	-2.80e-01	-3.10e-01	-5.03e-02	8.34e-01	7.72e-01	1.70e-01	1.29e-01	8.05e-01
GOBP TRANSLATIONAL READTHROUGH	9	4.27e-01	7.54e-01	0.4270	4.99e-02	-2.29e-01	6.01e-02	-5.48e-03	3.52e-01	7.96e-01	2.35e-01	7.55e-01	9.77e-01	6.72e-02
GOBP ANTERIOR HEAD DEVELOPMENT	7	5.86e-01	8.45e-01	0.4270	6.06e-02	1.37e-01	1.80e-01	-1.69e-01	3.15e-01	7.81e-01	5.31e-01	4.09e-01	4.39e-01	1.50e-01
GOBP POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS	12	2.73e-01	6.28e-01	0.4270	2.22e-01	3.61e-01	4.48e-02	9.92e-03	2.02e-02	1.83e-01	3.01e-02	7.88e-01	9.53e-01	9.04e-01
GOMF BUBBLE DNA BINDING	8	4.95e-01	8.00e-01	0.4270	-2.96e-01	1.74e-01	-1.95e-02	-2.52e-01	1.79e-02	1.46e-01	3.95e-01	9.24e-01	2.17e-01	9.30e-01
GOBP DIAPEDESIS	6	6.58e-01	8.80e-01	0.4270	-2.32e-01	4.82e-02	1.83e-01	2.87e-02	3.03e-01	3.25e-01	8.38e-01	4.39e-01	9.03e-01	1.98e-01
GOBP POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION	65	7.59e-05	1.90e-03	0.4270	6.34e-02	-6.07e-02	-3.22e-01	-2.61e-01	-5.21e-02	3.77e-01	3.97e-01	6.99e-06	2.77e-04	4.68e-01
GOBP INTERLEUKIN 4 MEDIATED SIGNALING PATHWAY	9	4.68e-01	7.83e-01	0.4270	2.16e-01	3.04e-01	3.82e-02	-4.51e-02	2.00e-01	2.62e-01	1.15e-01	8.43e-01	8.15e-01	3.00e-01
GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS	14	1.11e-01	4.07e-01	0.4270	-1.02e-01	-3.51e-02	-3.76e-01	-4.96e-02	1.62e-01	5.10e-01	8.20e-01	1.47e-02	7.48e-01	2.93e-01
GOBP MRNA MODIFICATION	31	1.60e-02	1.22e-01	0.4270	1.13e-01	-2.50e-01	-2.14e-01	-2.46e-01	2.74e-02	2.77e-01	1.60e-02	3.95e-02	1.78e-02	7.91e-01
GOBP LYSOSOMAL PROTEIN CATABOLIC PROCESS	19	1.53e-01	4.81e-01	0.4270	-3.04e-02	-1.52e-01	-2.33e-01	-3.19e-01	4.61e-02	8.18e-01	2.53e-01	7.91e-02	1.60e-02	7.28e-01
GOCC NSL COMPLEX	9	4.74e-01	7.87e-01	0.4270	1.59e-01	8.89e-02	1.24e-01	-9.87e-02	3.52e-01	4.10e-01	6.44e-01	5.18e-01	6.08e-01	6.77e-02
GOBP REGULATION OF DNA LIGATION	6	7.56e-01	9.18e-01	0.4270	8.75e-02	1.85e-01	-2.43e-01	-2.75e-01	7.13e-02	7.11e-01	4.31e-01	3.03e-01	2.43e-01	7.62e-01
GOBP MESENCHYMAL STEM CELL PROLIFERATION	10	3.37e-01	6.84e-01	0.4260	7.55e-02	-1.75e-01	1.89e-02	1.08e-01	3.65e-01	6.79e-01	3.39e-01	9.18e-01	5.54e-01	4.54e-02
GOMF CO RECEPTOR BINDING	13	1.10e-01	4.04e-01	0.4260	-1.98e-01	1.42e-01	1.32e-01	-2.72e-01	-1.75e-01	2.16e-01	3.76e-01	4.09e-01	8.91e-02	2.75e-01
GOBP RIBONUCLEOPROTEIN COMPLEX BIOGENESIS	449	1.31e-35	6.70e-33	0.4260	6.81e-02	-5.12e-02	-2.82e-01	-3.04e-01	4.42e-02	1.34e-02	6.30e-02	9.86e-25	1.88e-28	1.09e-01
GOBP NEGATIVE REGULATION OF BONE MINERALIZATION	18	8.74e-02	3.57e-01	0.4260	-2.19e-01	9.11e-02	2.17e-01	-8.03e-03	2.80e-01	1.08e-01	5.03e-01	1.11e-01	9.53e-01	4.00e-02
GOBP POLYADENYLATION DEPENDENT SNORNA 3 END PROCESSING	8	6.62e-01	8.81e-01	0.4260	7.82e-03	-1.40e-02	-3.35e-01	-2.63e-01	2.56e-03	9.69e-01	9.45e-01	1.01e-01	1.99e-01	9.90e-01
GOBP REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY	31	9.18e-03	8.24e-02	0.4260	-3.63e-02	2.07e-01	2.28e-01	6.55e-02	2.84e-01	7.27e-01	4.64e-02	2.82e-02	5.28e-01	6.13e-03
GOBP INTESTINE SMOOTH MUSCLE CONTRACTION	8	5.33e-01	8.20e-01	0.4250	7.76e-02	2.83e-01	2.77e-01	3.99e-02	-1.29e-01	7.04e-01	1.65e-01	1.75e-01	8.45e-01	5.29e-01
GOMF LOW DENSITY LIPOPROTEIN PARTICLE BINDING	17	1.74e-01	5.14e-01	0.4250	-4.91e-02	-7.53e-02	7.87e-02	3.02e-01	-2.74e-01	7.26e-01	5.91e-01	5.74e-01	3.09e-02	5.01e-02
GOBP NEGATIVE REGULATION OF MIRNA PROCESSING	9	3.80e-01	7.18e-01	0.4250	4.23e-02	-1.02e-01	-7.61e-02	-9.80e-02	-3.92e-01	8.26e-01	5.98e-01	6.93e-01	6.11e-01	4.18e-02
GOBP POSITIVE REGULATION OF HEPATOCYTE PROLIFERATION	10	2.73e-01	6.27e-01	0.4250	-2.37e-01	-1.83e-01	-2.84e-01	1.01e-01	-1.10e-02	1.94e-01	3.15e-01	1.20e-01	5.81e-01	9.52e-01
GOMF U2 SNRNA BINDING	6	6.92e-01	8.92e-01	0.4250	-1.58e-01	-3.31e-01	-1.15e-01	-1.63e-01	8.09e-02	5.03e-01	1.60e-01	6.27e-01	4.90e-01	7.32e-01
GOBP RIBOSOME ASSEMBLY	58	3.32e-04	6.42e-03	0.4250	-2.24e-02	-6.77e-02	-2.95e-01	-2.98e-01	1.64e-02	7.68e-01	3.73e-01	1.03e-04	8.76e-05	8.29e-01
GOCC CHITOSOME	19	8.34e-02	3.48e-01	0.4250	-2.12e-01	1.98e-01	1.80e-01	2.26e-01	1.14e-01	1.09e-01	1.34e-01	1.75e-01	8.80e-02	3.90e-01
GOMF THYROID HORMONE TRANSMEMBRANE TRANSPORTER ACTIVITY	7	4.29e-01	7.54e-01	0.4250	1.89e-01	7.14e-02	-4.12e-02	3.64e-01	7.57e-02	3.87e-01	7.44e-01	8.50e-01	9.52e-02	7.29e-01
GOBP ACETYLCHOLINE SECRETION	5	6.14e-01	8.59e-01	0.4250	2.15e-01	-8.19e-02	1.31e-01	-3.06e-01	1.30e-01	4.05e-01	7.51e-01	6.11e-01	2.36e-01	6.15e-01
GOMF DENEDDYLASE ACTIVITY	6	7.51e-01	9.16e-01	0.4250	-3.83e-02	6.72e-03	-3.67e-01	-2.08e-01	-3.11e-02	8.71e-01	9.77e-01	1.19e-01	3.78e-01	8.95e-01
GOBP REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA	10	4.93e-01	7.99e-01	0.4250	-4.67e-02	4.88e-02	-2.05e-01	-3.66e-01	-7.11e-04	7.98e-01	7.89e-01	2.62e-01	4.49e-02	9.97e-01
GOBP GLYCOSIDE TRANSPORT	5	7.29e-01	9.07e-01	0.4250	1.66e-01	7.20e-02	-7.07e-02	2.39e-01	-2.93e-01	5.21e-01	7.80e-01	7.84e-01	3.55e-01	2.56e-01
GOBP G2 MI TRANSITION OF MEIOTIC CELL CYCLE	7	6.53e-01	8.79e-01	0.4250	1.24e-01	4.51e-02	-2.49e-01	-2.50e-01	-1.97e-01	5.69e-01	8.36e-01	2.54e-01	2.53e-01	3.67e-01
GOBP ACETATE ESTER METABOLIC PROCESS	6	4.10e-01	7.42e-01	0.4250	-5.21e-02	-1.99e-01	1.13e-01	-2.63e-01	-2.38e-01	8.25e-01	4.00e-01	6.32e-01	2.64e-01	3.14e-01
GOBP BRANCHING MORPHOGENESIS OF A NERVE	10	4.16e-01	7.46e-01	0.4250	-1.51e-01	3.96e-02	2.26e-01	2.08e-01	2.49e-01	4.09e-01	8.28e-01	2.17e-01	2.54e-01	1.73e-01
GOBP POSITIVE REGULATION OF TISSUE REMODELING	23	3.67e-02	2.08e-01	0.4250	-2.41e-01	2.75e-02	3.43e-01	5.18e-02	3.48e-02	4.50e-02	8.20e-01	4.44e-03	6.67e-01	7.73e-01
GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS	5	5.35e-01	8.21e-01	0.4250	-5.76e-02	7.99e-02	2.58e-01	-2.07e-01	-2.47e-01	8.24e-01	7.57e-01	3.17e-01	4.24e-01	3.38e-01
GOBP NEUTROPHIL APOPTOTIC PROCESS	8	3.96e-01	7.29e-01	0.4250	1.68e-01	6.36e-02	1.87e-01	8.95e-03	-3.36e-01	4.11e-01	7.55e-01	3.60e-01	9.65e-01	9.96e-02
GOBP AMP BIOSYNTHETIC PROCESS	12	3.58e-01	7.03e-01	0.4250	-8.17e-02	-2.62e-01	-2.09e-01	-1.76e-01	1.74e-01	6.24e-01	1.16e-01	2.10e-01	2.91e-01	2.97e-01
GOMF GUANINE NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY	5	7.69e-01	9.24e-01	0.4240	1.11e-01	1.81e-01	6.98e-02	-2.67e-01	2.42e-01	6.68e-01	4.82e-01	7.87e-01	3.01e-01	3.48e-01
GOBP CARDIAC MUSCLE MYOBLAST PROLIFERATION	7	5.80e-01	8.43e-01	0.4240	-2.14e-01	-3.01e-01	-6.81e-03	2.01e-01	5.69e-02	3.26e-01	1.68e-01	9.75e-01	3.57e-01	7.94e-01
GOBP RRNA METABOLIC PROCESS	253	9.55e-20	1.95e-17	0.4240	1.00e-01	-3.78e-02	-2.67e-01	-3.09e-01	4.24e-02	6.04e-03	3.01e-01	2.56e-13	2.33e-17	2.45e-01
GOBP IMMATURE T CELL PROLIFERATION	12	2.95e-01	6.49e-01	0.4240	4.91e-02	3.56e-01	1.51e-01	-1.17e-01	1.22e-01	7.68e-01	3.30e-02	3.65e-01	4.83e-01	4.66e-01
GOBP POSITIVE REGULATION OF DENDRITIC CELL CYTOKINE PRODUCTION	13	2.20e-01	5.75e-01	0.4240	-2.58e-01	2.52e-01	-5.25e-02	-5.41e-02	-2.10e-01	1.07e-01	1.16e-01	7.43e-01	7.36e-01	1.89e-01
GOMF PHOSPHATIDYLINOSITOL 3 4 BISPHOSPHATE BINDING	25	4.67e-02	2.42e-01	0.4240	7.40e-02	3.03e-01	2.48e-01	1.40e-01	3.43e-02	5.22e-01	8.68e-03	3.17e-02	2.24e-01	7.67e-01
GOBP NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS	5	7.65e-01	9.22e-01	0.4240	4.08e-02	-2.45e-02	-3.27e-01	-1.26e-01	2.34e-01	8.75e-01	9.25e-01	2.05e-01	6.27e-01	3.64e-01
GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT MODIFYING ACTIVITY	17	4.47e-02	2.36e-01	0.4240	5.52e-02	4.44e-02	-3.79e-02	-3.21e-01	-2.65e-01	6.93e-01	7.52e-01	7.87e-01	2.19e-02	5.84e-02
GOMF PROCOLLAGEN PROLINE DIOXYGENASE ACTIVITY	8	4.76e-01	7.89e-01	0.4240	-7.68e-02	2.93e-01	1.61e-02	-1.72e-01	-2.42e-01	7.07e-01	1.52e-01	9.37e-01	4.00e-01	2.36e-01
GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING TO IGA ISOTYPES	6	7.70e-01	9.24e-01	0.4240	-3.80e-02	-9.11e-02	-1.86e-01	-3.29e-01	1.67e-01	8.72e-01	6.99e-01	4.31e-01	1.63e-01	4.80e-01
GOMF MAP KINASE PHOSPHATASE ACTIVITY	14	2.21e-01	5.76e-01	0.4240	2.45e-02	1.99e-01	-8.35e-02	-3.63e-01	2.17e-02	8.74e-01	1.97e-01	5.88e-01	1.86e-02	8.88e-01
GOBP REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS INVOLVED IN CHOLESTEROL TRANSPORT	6	6.62e-01	8.81e-01	0.4240	2.62e-01	2.77e-01	1.26e-01	9.92e-03	-1.34e-01	2.66e-01	2.39e-01	5.92e-01	9.66e-01	5.69e-01
GOMF HISTONE H3K4 DEMETHYLASE ACTIVITY	6	6.91e-01	8.92e-01	0.4240	1.70e-01	-4.09e-02	-2.27e-01	-1.20e-01	-2.88e-01	4.71e-01	8.62e-01	3.35e-01	6.12e-01	2.21e-01
GOBP PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS	29	3.47e-02	2.01e-01	0.4240	4.46e-02	9.86e-02	-2.98e-01	-2.75e-01	5.68e-02	6.78e-01	3.58e-01	5.49e-03	1.03e-02	5.96e-01
GOMF URIDYLYLTRANSFERASE ACTIVITY	7	5.04e-01	8.04e-01	0.4240	-1.38e-01	-8.52e-02	-2.29e-03	-3.87e-01	5.54e-02	5.26e-01	6.96e-01	9.92e-01	7.61e-02	7.99e-01
GOBP RNA 3 END PROCESSING	90	5.98e-07	2.84e-05	0.4240	1.15e-02	-1.26e-01	-2.25e-01	-3.28e-01	7.08e-02	8.50e-01	3.81e-02	2.22e-04	7.46e-08	2.46e-01
GOBP CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR	11	3.70e-01	7.10e-01	0.4230	1.27e-01	2.81e-01	-8.36e-02	-2.77e-01	1.15e-02	4.67e-01	1.06e-01	6.31e-01	1.11e-01	9.47e-01
GOBP CORNIFIED ENVELOPE ASSEMBLY	6	5.62e-01	8.34e-01	0.4230	-6.44e-02	1.54e-01	3.82e-02	-3.76e-01	-9.31e-02	7.85e-01	5.13e-01	8.71e-01	1.11e-01	6.93e-01
GOCC STEREOCILIUM BASE	5	7.98e-01	9.33e-01	0.4230	-1.22e-01	8.12e-02	-2.66e-01	-2.23e-01	-1.93e-01	6.36e-01	7.53e-01	3.03e-01	3.88e-01	4.54e-01
GOBP POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY	19	1.36e-01	4.55e-01	0.4230	8.98e-02	1.24e-01	-2.09e-01	-3.32e-01	-4.20e-02	4.98e-01	3.49e-01	1.14e-01	1.23e-02	7.51e-01
GOCC CCR4 NOT COMPLEX	14	2.96e-01	6.49e-01	0.4230	1.40e-01	-1.76e-01	-1.87e-01	-2.92e-01	9.18e-02	3.64e-01	2.55e-01	2.25e-01	5.86e-02	5.52e-01
GOBP ENDOSOMAL VESICLE FUSION	12	3.15e-01	6.65e-01	0.4230	3.56e-01	1.18e-01	-4.10e-02	-1.57e-01	1.10e-01	3.28e-02	4.77e-01	8.06e-01	3.46e-01	5.10e-01
GOMF STEROID HYDROXYLASE ACTIVITY	25	1.90e-02	1.37e-01	0.4230	1.57e-01	-2.00e-01	-2.79e-02	3.17e-01	-1.13e-01	1.73e-01	8.28e-02	8.09e-01	6.07e-03	3.27e-01
GOBP POSITIVE REGULATION OF CHROMOSOME CONDENSATION	8	5.86e-01	8.45e-01	0.4230	2.31e-01	1.99e-01	-1.29e-01	-2.62e-01	2.09e-02	2.57e-01	3.30e-01	5.26e-01	1.99e-01	9.18e-01
GOCC CONDENSIN COMPLEX	8	5.86e-01	8.45e-01	0.4230	2.31e-01	1.99e-01	-1.29e-01	-2.62e-01	2.09e-02	2.57e-01	3.30e-01	5.26e-01	1.99e-01	9.18e-01
GOBP INTERMEDIATE FILAMENT ORGANIZATION	71	1.60e-05	5.07e-04	0.4230	-2.14e-01	-8.16e-02	1.99e-01	2.84e-01	-7.59e-02	1.78e-03	2.34e-01	3.70e-03	3.40e-05	2.69e-01
GOBP REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT	14	8.30e-02	3.48e-01	0.4230	3.11e-02	-2.55e-01	1.69e-01	-2.10e-01	2.00e-01	8.40e-01	9.80e-02	2.75e-01	1.74e-01	1.94e-01
GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS	8	4.96e-01	8.01e-01	0.4230	-2.47e-01	1.99e-01	-1.28e-02	-2.76e-01	-4.28e-02	2.26e-01	3.29e-01	9.50e-01	1.77e-01	8.34e-01
GOBP NEGATIVE REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY	10	4.71e-01	7.86e-01	0.4230	-4.38e-02	1.43e-01	2.23e-01	3.10e-01	1.03e-01	8.11e-01	4.34e-01	2.21e-01	8.99e-02	5.72e-01
GOCC MYELIN SHEATH ADAXONAL REGION	6	5.53e-01	8.30e-01	0.4230	1.14e-01	1.77e-01	-2.51e-01	-4.70e-03	2.67e-01	6.29e-01	4.52e-01	2.86e-01	9.84e-01	2.57e-01
GOBP REGULATION OF LUNG BLOOD PRESSURE	5	7.09e-01	8.98e-01	0.4230	3.73e-01	-5.01e-02	1.38e-01	-7.17e-02	1.13e-01	1.48e-01	8.46e-01	5.93e-01	7.81e-01	6.62e-01
GOBP LEUKOCYTE ADHESION TO ARTERIAL ENDOTHELIAL CELL	6	6.71e-01	8.83e-01	0.4230	-2.63e-01	-1.26e-01	-2.75e-01	-1.01e-01	8.99e-02	2.64e-01	5.93e-01	2.44e-01	6.69e-01	7.03e-01
GOBP PROTON MOTIVE FORCE DRIVEN ATP SYNTHESIS	65	1.11e-04	2.60e-03	0.4230	4.32e-02	-7.92e-02	-2.54e-01	-3.20e-01	6.08e-02	5.47e-01	2.69e-01	3.98e-04	8.14e-06	3.96e-01
GOBP POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS	26	2.26e-02	1.52e-01	0.4230	-1.01e-02	3.52e-01	9.28e-02	1.05e-01	-1.86e-01	9.29e-01	1.87e-03	4.13e-01	3.55e-01	9.98e-02
GOCC PRECATALYTIC SPLICEOSOME	50	1.50e-03	2.15e-02	0.4230	1.15e-01	-1.32e-01	-2.78e-01	-2.46e-01	1.01e-01	1.60e-01	1.08e-01	6.82e-04	2.56e-03	2.15e-01
GOBP MESENCHYMAL CELL APOPTOTIC PROCESS	15	7.76e-02	3.34e-01	0.4230	8.63e-02	7.89e-02	2.54e-01	-2.42e-01	2.04e-01	5.63e-01	5.97e-01	8.81e-02	1.04e-01	1.72e-01
GOBP PARKIN MEDIATED STIMULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION	5	7.46e-01	9.14e-01	0.4220	-3.10e-01	2.31e-01	6.39e-03	-1.63e-01	-4.86e-02	2.30e-01	3.71e-01	9.80e-01	5.28e-01	8.51e-01
GOBP RETINAL CONE CELL DIFFERENTIATION	13	2.94e-01	6.48e-01	0.4220	1.20e-01	-2.05e-02	3.30e-01	2.07e-01	-1.07e-01	4.53e-01	8.98e-01	3.92e-02	1.96e-01	5.03e-01
GOMF NF KAPPAB INDUCING KINASE ACTIVITY	5	7.15e-01	9.01e-01	0.4220	9.78e-02	2.69e-01	4.09e-02	-1.12e-01	-2.87e-01	7.05e-01	2.98e-01	8.74e-01	6.65e-01	2.67e-01
GOBP MICTURITION	8	3.42e-01	6.89e-01	0.4220	1.98e-03	-1.73e-01	-1.01e-01	3.56e-01	1.06e-01	9.92e-01	3.97e-01	6.19e-01	8.12e-02	6.02e-01
GOBP REGULATION OF CHLORIDE TRANSPORT	6	7.64e-01	9.22e-01	0.4220	-2.09e-01	-1.22e-02	2.60e-01	2.50e-01	6.77e-02	3.74e-01	9.59e-01	2.71e-01	2.90e-01	7.74e-01
GOBP NEGATIVE REGULATION OF RIBOSOME BIOGENESIS	7	4.37e-01	7.60e-01	0.4220	5.18e-02	-7.16e-02	3.97e-02	-4.08e-01	4.53e-02	8.13e-01	7.43e-01	8.56e-01	6.13e-02	8.36e-01
GOBP NEGATIVE REGULATION OF SKELETAL MUSCLE CELL PROLIFERATION	5	7.14e-01	9.01e-01	0.4220	5.30e-03	-2.25e-03	-4.60e-02	-4.19e-01	1.67e-02	9.84e-01	9.93e-01	8.59e-01	1.05e-01	9.48e-01
GOBP DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS	11	3.65e-01	7.05e-01	0.4220	-1.53e-01	1.84e-01	-1.51e-01	-2.95e-01	-1.04e-01	3.80e-01	2.90e-01	3.86e-01	9.03e-02	5.50e-01
GOBP ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE	21	8.92e-02	3.60e-01	0.4220	1.72e-01	-2.11e-01	-1.30e-01	-2.17e-01	2.00e-01	1.72e-01	9.35e-02	3.03e-01	8.54e-02	1.13e-01
GOBP RESPONSE TO HYDROXYUREA	11	4.53e-01	7.72e-01	0.4220	-3.51e-02	-1.22e-01	-2.07e-01	-3.42e-01	4.55e-02	8.40e-01	4.83e-01	2.35e-01	4.95e-02	7.94e-01
GOCC INO80 TYPE COMPLEX	26	4.96e-02	2.52e-01	0.4220	1.94e-01	-4.45e-02	-1.32e-01	-2.36e-01	2.55e-01	8.66e-02	6.94e-01	2.44e-01	3.75e-02	2.43e-02
GOBP CYCLOOXYGENASE PATHWAY	9	2.08e-01	5.59e-01	0.4220	-2.40e-01	1.28e-02	-3.21e-01	1.24e-01	4.44e-02	2.13e-01	9.47e-01	9.59e-02	5.20e-01	8.17e-01
GOBP REGULATION OF STEM CELL DIVISION	11	2.66e-01	6.21e-01	0.4210	-7.33e-02	2.86e-01	1.24e-01	-2.74e-01	8.33e-03	6.74e-01	1.00e-01	4.75e-01	1.16e-01	9.62e-01
GOBP MUSCLE CELL FATE COMMITMENT	20	6.66e-02	3.05e-01	0.4210	3.07e-01	2.35e-01	-3.20e-02	-1.63e-01	-2.15e-02	1.75e-02	6.84e-02	8.05e-01	2.07e-01	8.68e-01
GOBP PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS	12	3.45e-01	6.91e-01	0.4210	-2.09e-01	-1.04e-01	-2.11e-01	-2.16e-01	-1.79e-01	2.10e-01	5.33e-01	2.06e-01	1.96e-01	2.83e-01
GOMF DOPAMINE BINDING	6	4.83e-01	7.93e-01	0.4210	2.22e-01	-9.27e-02	2.84e-01	-1.56e-01	1.20e-01	3.45e-01	6.94e-01	2.28e-01	5.08e-01	6.09e-01
GOBP REGULATION OF MITOCHONDRIAL TRANSLATION	25	6.16e-02	2.92e-01	0.4210	4.83e-02	-5.95e-02	-2.26e-01	-3.47e-01	-1.56e-02	6.76e-01	6.07e-01	5.06e-02	2.67e-03	8.93e-01
GOBP INTRACELLULAR AMINO ACID HOMEOSTASIS	8	5.64e-01	8.34e-01	0.4210	-2.52e-01	-2.12e-03	-1.19e-01	-2.85e-01	1.38e-01	2.18e-01	9.92e-01	5.59e-01	1.63e-01	5.00e-01
GOMF TRANSFERRIN RECEPTOR BINDING	10	2.56e-01	6.13e-01	0.4210	-6.53e-02	1.45e-01	1.88e-01	-3.18e-01	1.24e-01	7.21e-01	4.26e-01	3.03e-01	8.17e-02	4.96e-01
GOBP CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS	25	1.52e-02	1.18e-01	0.4210	-1.57e-01	-1.89e-01	-9.62e-02	-3.01e-01	-1.30e-01	1.75e-01	1.02e-01	4.05e-01	9.13e-03	2.59e-01
GOBP REGULATION OF B CELL APOPTOTIC PROCESS	20	6.12e-02	2.91e-01	0.4210	-2.18e-01	2.88e-01	-7.42e-02	-1.94e-01	6.39e-02	9.16e-02	2.60e-02	5.66e-01	1.34e-01	6.21e-01
GOMF C C CHEMOKINE BINDING	23	8.75e-02	3.57e-01	0.4210	-1.81e-01	-2.48e-02	1.69e-01	2.29e-01	-2.51e-01	1.33e-01	8.37e-01	1.60e-01	5.76e-02	3.73e-02
GOBP REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY	83	3.56e-06	1.34e-04	0.4210	2.40e-02	-3.90e-02	-2.10e-01	-3.40e-01	1.25e-01	7.05e-01	5.39e-01	9.67e-04	8.58e-08	4.86e-02
GOBP REGULATION OF TELOMERASE ACTIVITY	48	6.58e-04	1.10e-02	0.4210	-9.00e-02	-1.88e-01	-1.77e-01	-3.10e-01	7.84e-02	2.81e-01	2.46e-02	3.38e-02	1.98e-04	3.47e-01
GOBP NEGATIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION	5	7.88e-01	9.30e-01	0.4210	-6.16e-02	-2.27e-01	-2.82e-01	7.74e-03	-2.06e-01	8.11e-01	3.80e-01	2.75e-01	9.76e-01	4.25e-01
GOBP NEGATIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS	6	7.45e-01	9.14e-01	0.4210	-2.08e-01	9.79e-02	2.42e-01	2.27e-01	1.19e-01	3.77e-01	6.78e-01	3.05e-01	3.36e-01	6.14e-01
GOBP CELLULAR RESPONSE TO L GLUTAMATE	5	7.89e-01	9.30e-01	0.4210	-1.63e-03	1.82e-01	2.15e-01	1.69e-01	2.63e-01	9.95e-01	4.82e-01	4.04e-01	5.14e-01	3.08e-01
GOBP POSITIVE REGULATION OF AXON EXTENSION INVOLVED IN AXON GUIDANCE	7	6.48e-01	8.77e-01	0.4210	-5.11e-02	-2.26e-01	1.51e-02	2.98e-01	-1.85e-01	8.15e-01	3.01e-01	9.45e-01	1.72e-01	3.96e-01
GOBP MESODERMAL CELL FATE SPECIFICATION	12	2.27e-01	5.80e-01	0.4210	1.37e-01	-2.20e-01	8.90e-02	-1.76e-01	2.66e-01	4.10e-01	1.87e-01	5.94e-01	2.92e-01	1.10e-01
GOBP AUTOPHAGY OF PEROXISOME	10	5.40e-01	8.23e-01	0.4210	-9.81e-02	-5.34e-02	-2.50e-01	-3.05e-01	9.67e-02	5.91e-01	7.70e-01	1.72e-01	9.52e-02	5.97e-01
GOMF MICROFILAMENT MOTOR ACTIVITY	37	1.00e-02	8.79e-02	0.4210	-5.68e-02	-1.03e-02	1.68e-01	3.11e-01	-2.21e-01	5.50e-01	9.13e-01	7.70e-02	1.07e-03	2.00e-02
GOBP PROSTAGLANDIN SECRETION	17	1.72e-01	5.12e-01	0.4210	1.39e-01	2.91e-01	2.29e-01	1.38e-01	-4.25e-02	3.21e-01	3.80e-02	1.03e-01	3.26e-01	7.62e-01
GOBP REGULATION OF RAB PROTEIN SIGNAL TRANSDUCTION	7	6.47e-01	8.76e-01	0.4200	1.49e-01	1.50e-01	3.33e-01	7.93e-02	1.21e-01	4.96e-01	4.91e-01	1.27e-01	7.16e-01	5.80e-01
GOBP T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL	9	4.66e-01	7.81e-01	0.4200	-3.50e-01	-1.25e-01	-1.77e-01	-7.32e-02	-4.69e-02	6.94e-02	5.17e-01	3.57e-01	7.04e-01	8.08e-01
GOMF NAD DEPENDENT PROTEIN DEACETYLASE ACTIVITY	7	6.36e-01	8.72e-01	0.4200	2.35e-01	2.21e-01	-1.50e-01	-1.18e-01	1.90e-01	2.82e-01	3.10e-01	4.93e-01	5.87e-01	3.84e-01
GOBP CANONICAL WNT SIGNALING PATHWAY INVOLVED IN REGULATION OF CELL PROLIFERATION	6	5.40e-01	8.23e-01	0.4200	-1.45e-01	-2.99e-01	2.02e-01	-1.20e-01	1.04e-01	5.38e-01	2.04e-01	3.92e-01	6.11e-01	6.60e-01
GOBP PHAGOSOME LYSOSOME FUSION	13	2.19e-01	5.73e-01	0.4200	-8.81e-02	2.44e-01	3.32e-02	-3.23e-01	6.06e-02	5.82e-01	1.28e-01	8.36e-01	4.36e-02	7.05e-01
GOBP AMINO ACID BETAINE METABOLIC PROCESS	16	1.31e-01	4.47e-01	0.4200	3.30e-01	-2.46e-01	-5.44e-02	-4.23e-02	4.56e-02	2.22e-02	8.86e-02	7.06e-01	7.70e-01	7.52e-01
GOBP PROTEIN MATURATION BY 4FE 4S CLUSTER TRANSFER	7	7.17e-01	9.02e-01	0.4200	-1.07e-01	-8.81e-02	-3.17e-01	-2.32e-01	-4.95e-02	6.24e-01	6.87e-01	1.46e-01	2.87e-01	8.21e-01
GOBP MELANOCYTE DIFFERENTIATION	24	4.94e-02	2.52e-01	0.4200	-2.23e-01	-1.24e-01	1.33e-01	3.06e-01	-1.32e-02	5.91e-02	2.95e-01	2.60e-01	9.44e-03	9.11e-01
GOBP PURINE NUCLEOSIDE TRANSMEMBRANE TRANSPORT	5	7.40e-01	9.11e-01	0.4200	3.62e-01	-7.57e-04	-1.37e-04	2.06e-01	5.75e-02	1.62e-01	9.98e-01	1.00e+00	4.26e-01	8.24e-01
GOMF TESTOSTERONE DEHYDROGENASE NAD P ACTIVITY	10	5.32e-01	8.20e-01	0.4200	-1.28e-01	-3.53e-02	2.12e-01	3.36e-01	-2.39e-02	4.84e-01	8.47e-01	2.46e-01	6.56e-02	8.96e-01
GOBP DGMP METABOLIC PROCESS	5	6.38e-01	8.73e-01	0.4200	4.40e-03	9.75e-02	1.20e-01	-1.44e-01	-3.63e-01	9.86e-01	7.06e-01	6.41e-01	5.78e-01	1.60e-01
GOMF CHEMOKINE RECEPTOR BINDING	62	7.04e-05	1.81e-03	0.4200	-2.34e-01	1.19e-01	1.56e-01	2.28e-01	-1.74e-01	1.41e-03	1.05e-01	3.34e-02	1.86e-03	1.77e-02
GOBP INOSITOL TRISPHOSPHATE METABOLIC PROCESS	12	3.19e-01	6.68e-01	0.4200	1.82e-02	3.06e-01	2.55e-01	3.36e-02	-1.25e-01	9.13e-01	6.64e-02	1.25e-01	8.40e-01	4.53e-01
GOBP RESPONSE TO LUTEINIZING HORMONE	7	7.05e-01	8.97e-01	0.4200	2.41e-02	-2.20e-02	1.49e-01	3.48e-01	-1.78e-01	9.12e-01	9.20e-01	4.94e-01	1.11e-01	4.16e-01
GOBP MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION	7	6.19e-01	8.63e-01	0.4200	-2.98e-01	1.84e-01	1.33e-01	1.89e-01	1.33e-02	1.73e-01	3.99e-01	5.44e-01	3.86e-01	9.51e-01
GOCC RNA POLYMERASE TRANSCRIPTION FACTOR SL1 COMPLEX	5	7.98e-01	9.32e-01	0.4190	-3.30e-02	1.33e-01	-2.39e-01	-2.34e-01	-2.13e-01	8.98e-01	6.08e-01	3.55e-01	3.65e-01	4.09e-01
GOMF POLY A SPECIFIC RIBONUCLEASE ACTIVITY	13	4.14e-01	7.44e-01	0.4190	1.32e-01	-2.70e-03	-2.46e-01	-3.01e-01	8.38e-02	4.11e-01	9.87e-01	1.24e-01	6.00e-02	6.01e-01
GOBP ZYGOTIC DETERMINATION OF ANTERIOR POSTERIOR AXIS EMBRYO	6	6.75e-01	8.85e-01	0.4190	-5.34e-02	1.36e-01	7.17e-02	3.71e-01	-1.07e-01	8.21e-01	5.64e-01	7.61e-01	1.15e-01	6.51e-01
GOMF LIGASE ACTIVITY FORMING PHOSPHORIC ESTER BONDS	5	7.64e-01	9.22e-01	0.4190	7.13e-02	3.47e-01	-7.58e-02	-1.74e-01	-1.20e-01	7.82e-01	1.79e-01	7.69e-01	5.01e-01	6.41e-01
GOCC EARLY PHAGOSOME	12	3.05e-01	6.58e-01	0.4190	-3.03e-01	2.44e-01	1.52e-01	-1.12e-02	-3.54e-02	6.94e-02	1.44e-01	3.60e-01	9.46e-01	8.32e-01
GOBP REGULATION OF MITOCHONDRIAL ATP SYNTHESIS COUPLED ELECTRON TRANSPORT	7	5.59e-01	8.32e-01	0.4190	3.90e-02	-1.56e-01	2.13e-01	-5.38e-02	3.18e-01	8.58e-01	4.75e-01	3.28e-01	8.05e-01	1.45e-01
GOMF ATP DEPENDENT PEPTIDASE ACTIVITY	7	7.10e-01	8.98e-01	0.4190	1.18e-01	-1.58e-01	-1.66e-01	-2.29e-01	2.38e-01	5.90e-01	4.69e-01	4.47e-01	2.94e-01	2.76e-01
GOBP REGULATION OF POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE	8	4.62e-01	7.79e-01	0.4180	-3.44e-01	1.85e-01	-9.73e-02	4.28e-02	-1.07e-01	9.24e-02	3.64e-01	6.34e-01	8.34e-01	6.01e-01
GOBP PROTEIN EXIT FROM ENDOPLASMIC RETICULUM	48	1.29e-03	1.89e-02	0.4180	-9.07e-02	-5.59e-02	-2.36e-01	-3.28e-01	-2.09e-02	2.77e-01	5.02e-01	4.70e-03	8.39e-05	8.02e-01
GOMF DNA DNA ANNEALING ACTIVITY	7	7.23e-01	9.03e-01	0.4180	-2.43e-02	-9.94e-03	-2.29e-01	-3.49e-01	8.92e-03	9.11e-01	9.64e-01	2.94e-01	1.10e-01	9.67e-01
GOCC AUTOLYSOSOME	11	2.73e-01	6.28e-01	0.4180	2.37e-02	1.95e-01	2.05e-01	-2.44e-01	1.86e-01	8.92e-01	2.62e-01	2.39e-01	1.61e-01	2.85e-01
GOBP TUBULIN COMPLEX ASSEMBLY	8	5.74e-01	8.40e-01	0.4180	3.30e-01	-2.23e-02	-5.05e-02	-1.96e-01	1.58e-01	1.06e-01	9.13e-01	8.05e-01	3.38e-01	4.40e-01
GOBP REGULATION OF SKELETAL MUSCLE CONTRACTION BY CALCIUM ION SIGNALING	6	6.87e-01	8.90e-01	0.4180	2.94e-01	1.95e-01	-1.23e-01	-1.27e-01	-1.38e-01	2.12e-01	4.07e-01	6.03e-01	5.89e-01	5.59e-01
GOBP LYMPHATIC ENDOTHELIAL CELL DIFFERENTIATION	8	3.30e-01	6.77e-01	0.4180	2.12e-01	-1.75e-01	4.94e-02	-3.11e-01	-1.53e-02	2.98e-01	3.90e-01	8.09e-01	1.28e-01	9.40e-01
GOBP RESPONSE TO MUSCLE INACTIVITY	9	2.46e-01	6.02e-01	0.4180	2.16e-01	2.14e-01	-1.75e-01	2.00e-01	1.07e-01	2.61e-01	2.66e-01	3.63e-01	2.98e-01	5.79e-01
GOBP CILIARY BASAL BODY ORGANIZATION	5	7.06e-01	8.97e-01	0.4180	3.12e-01	2.07e-01	-7.50e-02	1.41e-01	9.74e-02	2.28e-01	4.22e-01	7.72e-01	5.86e-01	7.06e-01
GOCC COPI VESICLE COAT	13	3.33e-01	6.80e-01	0.4180	2.63e-01	3.62e-02	-1.56e-01	-2.79e-01	4.91e-02	1.01e-01	8.21e-01	3.31e-01	8.13e-02	7.59e-01
GOBP N ACETYLGLUCOSAMINE METABOLIC PROCESS	16	1.20e-01	4.24e-01	0.4180	2.12e-01	2.22e-01	-5.72e-02	-6.25e-02	-2.71e-01	1.43e-01	1.24e-01	6.92e-01	6.65e-01	6.04e-02
GOBP SIGNAL PEPTIDE PROCESSING	13	3.05e-01	6.58e-01	0.4180	-2.57e-01	-8.43e-02	-2.47e-01	-1.62e-01	-1.19e-01	1.09e-01	5.99e-01	1.23e-01	3.11e-01	4.56e-01
GOBP POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY	11	2.57e-01	6.14e-01	0.4180	1.47e-01	1.67e-01	-3.14e-02	-1.94e-01	-2.94e-01	3.97e-01	3.36e-01	8.57e-01	2.66e-01	9.13e-02
GOCC TRANSCRIPTION FACTOR TFIID COMPLEX	30	3.26e-02	1.93e-01	0.4180	1.06e-01	-2.03e-01	-2.32e-01	-2.53e-01	6.77e-02	3.16e-01	5.46e-02	2.80e-02	1.64e-02	5.21e-01
GOMF RRNA ADENINE METHYLTRANSFERASE ACTIVITY	8	6.83e-01	8.88e-01	0.4180	8.25e-02	-1.18e-01	-3.19e-01	-2.27e-01	-2.29e-02	6.86e-01	5.65e-01	1.18e-01	2.66e-01	9.11e-01
GOBP CEREBRAL CORTEX NEURON DIFFERENTIATION	24	1.32e-02	1.07e-01	0.4180	6.18e-03	-8.57e-02	4.40e-02	-3.68e-01	1.73e-01	9.58e-01	4.68e-01	7.09e-01	1.80e-03	1.43e-01
GOMF NAADP SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY	5	7.95e-01	9.32e-01	0.4180	1.28e-01	9.94e-02	-2.96e-01	-1.56e-01	1.91e-01	6.19e-01	7.00e-01	2.52e-01	5.46e-01	4.60e-01
GOBP VESTIBULOCOCHLEAR NERVE DEVELOPMENT	11	4.05e-01	7.38e-01	0.4180	-5.01e-03	9.06e-02	2.23e-01	2.80e-01	1.95e-01	9.77e-01	6.03e-01	2.00e-01	1.07e-01	2.64e-01
GOBP REGULATION OF MIRNA CATABOLIC PROCESS	9	3.65e-01	7.05e-01	0.4180	-5.63e-02	-3.52e-02	-7.73e-02	-3.12e-01	-2.59e-01	7.70e-01	8.55e-01	6.88e-01	1.05e-01	1.79e-01
GOBP RESPONSE TO PROTOZOAN	31	4.73e-03	5.18e-02	0.4180	-1.58e-01	-8.89e-02	6.65e-02	-2.36e-01	2.86e-01	1.29e-01	3.92e-01	5.21e-01	2.30e-02	5.90e-03
GOBP CHEMOKINE C X C MOTIF LIGAND 12 SIGNALING PATHWAY	7	6.25e-01	8.66e-01	0.4180	-2.91e-01	-2.76e-01	4.62e-02	5.82e-02	-9.05e-02	1.82e-01	2.07e-01	8.32e-01	7.90e-01	6.79e-01
GOBP DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION	12	3.44e-01	6.90e-01	0.4180	-2.69e-02	-5.46e-02	-1.77e-01	-3.66e-01	-7.34e-02	8.72e-01	7.43e-01	2.89e-01	2.81e-02	6.60e-01
GOCC TRICARBOXYLIC ACID CYCLE ENZYME COMPLEX	14	2.09e-01	5.61e-01	0.4180	1.68e-01	-6.41e-02	-1.95e-01	-6.25e-02	-3.17e-01	2.78e-01	6.78e-01	2.06e-01	6.86e-01	4.03e-02
GOCC B WICH COMPLEX	7	7.16e-01	9.01e-01	0.4180	1.48e-01	-2.10e-01	-2.65e-01	-1.57e-01	1.15e-01	4.97e-01	3.36e-01	2.25e-01	4.72e-01	5.97e-01
GOMF VITAMIN D BINDING	6	7.41e-01	9.12e-01	0.4170	-1.88e-01	1.63e-02	-2.89e-01	-1.96e-01	-1.29e-01	4.24e-01	9.45e-01	2.20e-01	4.07e-01	5.86e-01
GOBP NEGATIVE REGULATION OF PLATELET AGGREGATION	10	4.50e-01	7.71e-01	0.4170	-2.79e-02	3.08e-01	2.68e-01	-5.46e-03	8.23e-02	8.79e-01	9.21e-02	1.42e-01	9.76e-01	6.52e-01
GOBP REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING	37	5.27e-03	5.54e-02	0.4170	6.05e-02	-5.46e-02	-9.35e-02	-3.43e-01	2.03e-01	5.24e-01	5.66e-01	3.25e-01	3.07e-04	3.24e-02
GOBP HEMOGLOBIN METABOLIC PROCESS	17	1.42e-01	4.63e-01	0.4170	-1.29e-01	2.11e-01	-1.26e-01	-3.04e-01	-6.93e-02	3.58e-01	1.32e-01	3.67e-01	3.01e-02	6.21e-01
GOBP TRICARBOXYLIC ACID METABOLIC PROCESS	14	1.40e-01	4.61e-01	0.4170	-8.38e-03	3.74e-01	-9.94e-02	-3.04e-02	1.52e-01	9.57e-01	1.53e-02	5.19e-01	8.44e-01	3.25e-01
GOBP CELLULAR RESPONSE TO NICOTINE	8	5.25e-01	8.16e-01	0.4170	-3.82e-02	1.87e-01	-1.31e-01	-5.38e-02	-3.43e-01	8.52e-01	3.59e-01	5.20e-01	7.92e-01	9.33e-02
GOBP NUCLEOLUS ORGANIZATION	16	2.23e-01	5.76e-01	0.4170	2.05e-01	4.98e-02	-1.01e-01	-3.05e-01	1.62e-01	1.57e-01	7.30e-01	4.83e-01	3.46e-02	2.61e-01
GOMF UBIQUITIN LIKE PROTEIN SPECIFIC ENDOPEPTIDASE ACTIVITY	5	7.90e-01	9.31e-01	0.4170	3.09e-02	-3.56e-01	-2.14e-01	2.36e-02	-1.51e-02	9.05e-01	1.69e-01	4.07e-01	9.27e-01	9.53e-01
GOBP REGULATION OF PROSTATIC BUD FORMATION	5	7.43e-01	9.13e-01	0.4170	1.67e-01	-1.53e-01	-2.46e-02	-3.17e-01	1.48e-01	5.19e-01	5.53e-01	9.24e-01	2.20e-01	5.67e-01
GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE PHOSPHATASE ACTIVITY	11	3.70e-01	7.10e-01	0.4170	-2.62e-01	9.32e-02	-1.55e-01	-2.19e-01	-1.56e-01	1.32e-01	5.93e-01	3.74e-01	2.08e-01	3.69e-01
GOBP POSITIVE REGULATION OF STEROID HORMONE SECRETION	11	2.06e-01	5.57e-01	0.4170	2.12e-01	1.41e-01	1.09e-01	-1.16e-01	-2.89e-01	2.24e-01	4.20e-01	5.32e-01	5.04e-01	9.64e-02
GOMF CUPRIC ION BINDING	5	7.19e-01	9.02e-01	0.4170	6.16e-02	3.95e-02	6.41e-02	-2.84e-03	-4.05e-01	8.12e-01	8.78e-01	8.04e-01	9.91e-01	1.17e-01
GOCC SPLICEOSOMAL SNRNP COMPLEX	70	7.09e-05	1.81e-03	0.4170	1.34e-01	-9.99e-02	-2.75e-01	-2.54e-01	7.70e-02	5.29e-02	1.48e-01	7.04e-05	2.41e-04	2.65e-01
GOBP GOLGI TO VACUOLE TRANSPORT	20	1.15e-01	4.15e-01	0.4170	7.88e-02	-2.26e-01	-1.76e-01	-1.44e-01	2.54e-01	5.42e-01	8.08e-02	1.73e-01	2.64e-01	4.88e-02
GOBP REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY	12	3.80e-01	7.18e-01	0.4170	-1.66e-01	1.97e-01	2.96e-01	9.42e-02	1.04e-01	3.21e-01	2.38e-01	7.58e-02	5.72e-01	5.32e-01
GOMF CHONDROITIN SULFOTRANSFERASE ACTIVITY	5	7.51e-01	9.16e-01	0.4160	1.66e-01	1.16e-01	-1.35e-01	-7.17e-02	-3.30e-01	5.20e-01	6.52e-01	6.02e-01	7.81e-01	2.01e-01
GOCC RIBOSOME	224	2.62e-17	4.18e-15	0.4160	-5.54e-02	-2.36e-02	-2.80e-01	-3.01e-01	-1.74e-02	1.53e-01	5.43e-01	4.65e-13	7.45e-15	6.54e-01
GOMF RETINAL BINDING	19	3.80e-02	2.13e-01	0.4160	-1.20e-01	-4.19e-02	-2.81e-01	1.68e-01	-2.23e-01	3.66e-01	7.52e-01	3.39e-02	2.05e-01	9.17e-02
GOBP REGULATION OF ADIPONECTIN SECRETION	7	7.24e-01	9.04e-01	0.4160	4.09e-02	1.29e-01	2.98e-01	2.25e-01	1.23e-01	8.51e-01	5.54e-01	1.71e-01	3.03e-01	5.74e-01
GOBP DNA REPAIR DEPENDENT CHROMATIN REMODELING	19	9.14e-02	3.66e-01	0.4160	2.39e-01	1.76e-01	-1.46e-01	-1.96e-01	-1.58e-01	7.13e-02	1.83e-01	2.71e-01	1.38e-01	2.33e-01
GOMF MUTLALPHA COMPLEX BINDING	7	6.09e-01	8.58e-01	0.4160	8.66e-02	1.92e-01	-3.18e-01	-1.42e-01	8.61e-02	6.91e-01	3.80e-01	1.45e-01	5.16e-01	6.93e-01
GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS	37	4.03e-03	4.60e-02	0.4160	-5.44e-02	2.34e-01	-1.81e-01	-2.74e-01	-8.86e-02	5.67e-01	1.37e-02	5.74e-02	3.98e-03	3.51e-01
GOBP SPLICEOSOMAL SNRNP ASSEMBLY	43	5.50e-03	5.69e-02	0.4160	1.30e-01	1.00e-02	-2.80e-01	-2.48e-01	1.27e-01	1.39e-01	9.09e-01	1.49e-03	4.91e-03	1.50e-01
GOBP TRANSCRIPTION BY RNA POLYMERASE I	67	5.56e-05	1.48e-03	0.4160	1.68e-01	-9.14e-02	-2.42e-01	-2.78e-01	-1.48e-02	1.71e-02	1.96e-01	6.05e-04	8.30e-05	8.34e-01
GOBP RESPONSE TO TYPE III INTERFERON	11	3.47e-01	6.93e-01	0.4160	7.88e-05	1.30e-01	1.06e-01	-2.51e-01	2.86e-01	1.00e+00	4.56e-01	5.41e-01	1.49e-01	1.01e-01
GOBP RESPONSE TO CHEMOKINE	93	2.46e-07	1.31e-05	0.4160	-2.29e-01	5.18e-04	1.16e-01	2.35e-01	-2.27e-01	1.32e-04	9.93e-01	5.24e-02	9.06e-05	1.54e-04
GOCC SYNAPTOBREVIN 2 SNAP 25 SYNTAXIN 1A COMPLEX	5	6.66e-01	8.82e-01	0.4160	-2.09e-01	1.12e-01	-7.39e-02	2.25e-02	3.32e-01	4.17e-01	6.65e-01	7.75e-01	9.31e-01	1.98e-01
GOBP POSITIVE REGULATION OF TRANSCRIPTION ELONGATION BY RNA POLYMERASE II	48	1.84e-03	2.53e-02	0.4160	2.90e-02	-2.91e-02	-2.69e-01	-3.06e-01	-7.25e-02	7.28e-01	7.27e-01	1.27e-03	2.46e-04	3.85e-01
GOBP MEIOTIC CELL CYCLE CHECKPOINT SIGNALING	8	5.04e-01	8.04e-01	0.4160	1.37e-02	-4.08e-01	-3.27e-02	-6.65e-02	-1.35e-02	9.47e-01	4.55e-02	8.73e-01	7.45e-01	9.47e-01
GOBP PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE	15	2.62e-01	6.19e-01	0.4160	4.28e-02	1.67e-01	-1.33e-01	-2.50e-01	2.50e-01	7.74e-01	2.63e-01	3.74e-01	9.32e-02	9.32e-02
GOBP ASTROCYTE CELL MIGRATION	9	4.95e-01	8.00e-01	0.4150	-9.68e-02	-1.85e-01	2.34e-01	1.61e-01	2.20e-01	6.15e-01	3.36e-01	2.24e-01	4.02e-01	2.54e-01
GOCC U12 TYPE SPLICEOSOMAL COMPLEX	25	9.47e-02	3.72e-01	0.4150	5.24e-04	-6.57e-02	-2.82e-01	-2.94e-01	4.57e-02	9.96e-01	5.69e-01	1.47e-02	1.08e-02	6.92e-01
GOMF PROTEIN SERINE THREONINE PHOSPHATASE INHIBITOR ACTIVITY	11	3.34e-01	6.82e-01	0.4150	2.76e-01	1.44e-01	-1.75e-01	-5.15e-02	-2.05e-01	1.12e-01	4.09e-01	3.14e-01	7.68e-01	2.39e-01
GOCC DNA REPLICATION PREINITIATION COMPLEX	13	2.84e-01	6.37e-01	0.4150	-5.69e-02	1.84e-02	-8.86e-02	-3.89e-01	9.71e-02	7.22e-01	9.08e-01	5.80e-01	1.50e-02	5.44e-01
GOBP REGULATION OF NADP METABOLIC PROCESS	9	5.46e-01	8.26e-01	0.4150	3.33e-02	-9.93e-02	-3.55e-01	-1.04e-01	-1.57e-01	8.63e-01	6.06e-01	6.49e-02	5.90e-01	4.16e-01
GOBP POSITIVE REGULATION OF MAST CELL ACTIVATION	18	9.09e-02	3.64e-01	0.4150	6.23e-02	3.92e-01	5.71e-02	8.05e-02	7.32e-02	6.47e-01	4.00e-03	6.75e-01	5.55e-01	5.91e-01
GOBP PRIMITIVE HEMOPOIESIS	8	5.55e-01	8.30e-01	0.4150	1.62e-01	2.67e-01	-1.48e-01	-1.20e-01	1.97e-01	4.29e-01	1.90e-01	4.69e-01	5.57e-01	3.36e-01
GOBP CENTRAL NERVOUS SYSTEM MYELIN FORMATION	8	5.44e-01	8.25e-01	0.4150	-1.37e-02	-3.36e-01	1.74e-01	1.68e-01	-2.48e-02	9.46e-01	1.00e-01	3.94e-01	4.10e-01	9.03e-01
GOBP TYPE 2 IMMUNE RESPONSE	41	2.54e-03	3.25e-02	0.4150	-4.14e-02	3.13e-01	2.54e-01	5.00e-02	7.18e-02	6.47e-01	5.15e-04	4.91e-03	5.80e-01	4.26e-01
GOMF PYRIMIDINE NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY	9	5.33e-01	8.20e-01	0.4140	-5.55e-02	6.81e-02	-1.90e-01	-3.31e-01	-1.34e-01	7.73e-01	7.23e-01	3.24e-01	8.51e-02	4.85e-01
GOBP TESTOSTERONE BIOSYNTHETIC PROCESS	11	3.18e-01	6.67e-01	0.4140	-1.48e-03	-2.78e-01	-1.76e-02	3.04e-01	3.60e-02	9.93e-01	1.10e-01	9.20e-01	8.07e-02	8.36e-01
GOBP NEGATIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	9	5.02e-01	8.03e-01	0.4140	-6.96e-02	2.55e-01	4.77e-02	1.09e-01	-2.96e-01	7.18e-01	1.85e-01	8.04e-01	5.73e-01	1.24e-01
GOMF PYRIMIDINE NUCLEOBASE TRANSMEMBRANE TRANSPORTER ACTIVITY	7	7.04e-01	8.97e-01	0.4140	-1.18e-01	-1.05e-01	1.39e-01	2.13e-01	-2.86e-01	5.90e-01	6.32e-01	5.26e-01	3.29e-01	1.90e-01
GOBP REGULATION OF MICROVILLUS LENGTH	7	6.61e-01	8.81e-01	0.4140	-2.38e-01	-1.34e-01	1.19e-01	2.87e-01	1.11e-02	2.76e-01	5.39e-01	5.85e-01	1.88e-01	9.59e-01
GOBP MACROPHAGE PROLIFERATION	12	3.35e-01	6.82e-01	0.4140	3.08e-02	-2.43e-01	2.56e-01	2.04e-01	6.33e-02	8.53e-01	1.45e-01	1.24e-01	2.21e-01	7.04e-01
GOBP PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS	23	5.45e-02	2.69e-01	0.4140	5.94e-02	3.25e-01	-3.26e-02	-2.30e-01	8.96e-02	6.22e-01	6.89e-03	7.87e-01	5.63e-02	4.57e-01
GOBP POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION	61	1.16e-04	2.67e-03	0.4140	1.98e-02	-1.15e-02	-2.39e-01	-3.22e-01	-1.01e-01	7.89e-01	8.77e-01	1.24e-03	1.39e-05	1.72e-01
GOCC HEMIDESMOSOME	8	5.73e-01	8.39e-01	0.4140	-9.53e-03	-2.44e-01	-1.04e-01	1.02e-01	-3.01e-01	9.63e-01	2.32e-01	6.10e-01	6.16e-01	1.41e-01
GOCC NUCLEAR PORE OUTER RING	9	6.35e-01	8.72e-01	0.4140	5.88e-02	-1.39e-01	-2.41e-01	-2.84e-01	9.97e-02	7.60e-01	4.70e-01	2.11e-01	1.40e-01	6.05e-01
GOBP REGULATION OF LYMPHANGIOGENESIS	6	6.88e-01	8.90e-01	0.4140	-2.47e-01	-8.04e-02	2.19e-01	3.54e-02	2.33e-01	2.95e-01	7.33e-01	3.53e-01	8.81e-01	3.22e-01
GOBP HINDGUT DEVELOPMENT	8	6.12e-01	8.58e-01	0.4140	8.20e-03	-1.49e-01	-3.66e-01	-1.13e-01	4.81e-02	9.68e-01	4.65e-01	7.31e-02	5.80e-01	8.14e-01
GOMF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 BINDING	9	3.70e-01	7.10e-01	0.4140	-1.72e-01	-4.34e-02	-3.65e-01	-3.69e-02	7.24e-02	3.72e-01	8.22e-01	5.80e-02	8.48e-01	7.07e-01
GOCC CYTOLYTIC GRANULE	13	2.34e-01	5.89e-01	0.4140	-3.10e-01	2.36e-01	3.99e-02	-1.03e-01	8.65e-02	5.32e-02	1.41e-01	8.03e-01	5.21e-01	5.89e-01
GOBP POSITIVE REGULATION OF B CELL DIFFERENTIATION	14	1.63e-01	4.97e-01	0.4140	-3.17e-01	2.51e-01	-4.07e-02	-4.29e-02	6.28e-02	3.98e-02	1.04e-01	7.92e-01	7.81e-01	6.84e-01
GOBP UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS	9	4.49e-01	7.70e-01	0.4140	2.91e-01	1.70e-01	-6.64e-02	-1.87e-01	-1.36e-01	1.31e-01	3.77e-01	7.30e-01	3.32e-01	4.81e-01
GOBP ALDITOL CATABOLIC PROCESS	6	7.55e-01	9.17e-01	0.4140	3.00e-01	-8.65e-03	-8.59e-02	-1.50e-01	2.26e-01	2.03e-01	9.71e-01	7.16e-01	5.25e-01	3.38e-01
GOBP INTERLEUKIN 13 PRODUCTION	21	7.93e-02	3.39e-01	0.4130	1.39e-01	3.03e-01	9.93e-02	-7.01e-02	2.12e-01	2.69e-01	1.62e-02	4.31e-01	5.78e-01	9.29e-02
GOMF AMINO ACID MONOATOMIC CATION SYMPORTER ACTIVITY	27	3.73e-02	2.10e-01	0.4130	-1.86e-01	1.20e-01	2.99e-01	1.07e-01	-1.45e-01	9.45e-02	2.82e-01	7.07e-03	3.37e-01	1.93e-01
GOBP REGULATION OF BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS	19	9.99e-02	3.83e-01	0.4130	-8.85e-03	3.55e-02	-8.79e-02	-3.98e-01	5.84e-02	9.47e-01	7.89e-01	5.07e-01	2.67e-03	6.59e-01
GOBP CYTOPLASMIC TRANSLATION	142	2.32e-11	2.26e-09	0.4130	-1.59e-01	1.20e-02	-2.65e-01	-2.74e-01	1.14e-02	1.07e-03	8.05e-01	4.90e-08	1.74e-08	8.15e-01
GOBP POSITIVE REGULATION BY HOST OF VIRAL GENOME REPLICATION	10	5.86e-01	8.45e-01	0.4130	4.59e-02	-1.37e-02	-2.51e-01	-3.20e-01	5.49e-02	8.02e-01	9.40e-01	1.69e-01	7.96e-02	7.64e-01
GOCC LSM2 8 COMPLEX	7	7.15e-01	9.01e-01	0.4130	2.57e-01	-1.20e-01	-2.18e-01	-2.02e-01	3.97e-02	2.39e-01	5.81e-01	3.17e-01	3.55e-01	8.56e-01
GOBP REGULATION OF BASEMENT MEMBRANE ORGANIZATION	11	4.81e-01	7.92e-01	0.4130	-4.28e-02	-8.91e-02	2.83e-01	2.41e-01	-1.50e-01	8.06e-01	6.09e-01	1.04e-01	1.66e-01	3.90e-01
GOBP REPLICATIVE SENESCENCE	17	2.29e-01	5.82e-01	0.4130	-1.85e-02	-2.26e-01	-2.98e-01	-1.63e-01	6.07e-02	8.95e-01	1.06e-01	3.32e-02	2.45e-01	6.65e-01
GOBP POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL	10	5.18e-01	8.12e-01	0.4130	2.22e-01	5.68e-02	-1.01e-01	-1.93e-01	2.65e-01	2.24e-01	7.56e-01	5.79e-01	2.90e-01	1.46e-01
GOBP REGULATION OF TYPE 2 IMMUNE RESPONSE	33	1.21e-02	1.00e-01	0.4130	2.51e-02	3.08e-01	2.54e-01	5.17e-02	8.77e-02	8.03e-01	2.16e-03	1.16e-02	6.07e-01	3.83e-01
GOBP SMOOTH MUSCLE TISSUE DEVELOPMENT	27	1.63e-02	1.24e-01	0.4130	-1.99e-01	1.45e-01	1.03e-01	-8.53e-02	3.03e-01	7.33e-02	1.91e-01	3.54e-01	4.43e-01	6.42e-03
GOCC MYOSIN COMPLEX	56	1.23e-04	2.80e-03	0.4130	-4.54e-02	-7.17e-02	1.66e-02	2.90e-01	-2.81e-01	5.57e-01	3.53e-01	8.30e-01	1.72e-04	2.78e-04
GOBP FACIAL NERVE MORPHOGENESIS	9	5.09e-01	8.07e-01	0.4130	2.31e-01	2.52e-01	1.19e-01	1.75e-01	-9.31e-02	2.30e-01	1.91e-01	5.35e-01	3.63e-01	6.29e-01
GOBP HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS	14	2.89e-01	6.43e-01	0.4130	3.03e-01	-1.47e-01	-1.94e-01	-1.35e-01	3.62e-02	5.00e-02	3.40e-01	2.09e-01	3.82e-01	8.15e-01
GOMF ICOSANOID BINDING	8	5.71e-01	8.38e-01	0.4130	-2.60e-01	1.69e-01	1.01e-01	2.40e-01	-7.89e-02	2.03e-01	4.08e-01	6.19e-01	2.39e-01	6.99e-01
GOMF UDP GLUCOSYLTRANSFERASE ACTIVITY	10	3.19e-01	6.68e-01	0.4130	9.42e-02	6.11e-02	-3.75e-01	-4.42e-02	1.24e-01	6.06e-01	7.38e-01	4.02e-02	8.09e-01	4.97e-01
GOCC MITOCHONDRIA ASSOCIATED ENDOPLASMIC RETICULUM MEMBRANE	18	1.70e-01	5.09e-01	0.4130	-1.46e-01	9.95e-02	-1.75e-01	-3.09e-01	1.13e-01	2.84e-01	4.65e-01	1.99e-01	2.31e-02	4.06e-01
GOMF VINCULIN BINDING	11	3.63e-01	7.05e-01	0.4130	1.75e-01	3.12e-01	9.91e-02	1.79e-01	2.38e-02	3.15e-01	7.32e-02	5.69e-01	3.05e-01	8.91e-01
GOBP REGULATION OF MESODERMAL CELL FATE SPECIFICATION	5	7.35e-01	9.09e-01	0.4120	-7.96e-02	5.59e-03	-7.00e-02	-3.91e-01	-7.74e-02	7.58e-01	9.83e-01	7.86e-01	1.30e-01	7.64e-01
GOBP NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS	19	1.36e-01	4.55e-01	0.4120	1.25e-01	8.66e-02	-2.17e-01	-2.83e-01	-1.40e-01	3.45e-01	5.13e-01	1.02e-01	3.25e-02	2.91e-01
GOBP PENILE ERECTION	7	5.49e-01	8.28e-01	0.4120	-1.42e-01	-2.73e-01	1.48e-01	-8.29e-02	2.16e-01	5.17e-01	2.12e-01	4.97e-01	7.04e-01	3.22e-01
GOBP REGULATION OF STEROID HORMONE SECRETION	22	4.28e-02	2.29e-01	0.4120	8.03e-02	2.30e-01	2.06e-01	2.61e-02	-2.59e-01	5.14e-01	6.17e-02	9.41e-02	8.32e-01	3.51e-02
GOMF DOLICHYL DIPHOSPHOOLIGOSACCHARIDE PROTEIN GLYCOTRANSFERASE ACTIVITY	5	7.62e-01	9.20e-01	0.4120	2.89e-01	2.25e-01	-3.49e-02	-1.35e-01	-1.27e-01	2.63e-01	3.83e-01	8.93e-01	6.01e-01	6.24e-01
GOBP NEGATIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY	8	5.85e-01	8.45e-01	0.4120	3.12e-02	-3.28e-01	-1.01e-01	-1.24e-01	1.89e-01	8.78e-01	1.08e-01	6.20e-01	5.44e-01	3.55e-01
GOBP RESPONSE TO PARATHYROID HORMONE	10	4.08e-01	7.41e-01	0.4120	-1.28e-01	2.51e-01	1.54e-01	1.21e-01	2.28e-01	4.84e-01	1.69e-01	3.98e-01	5.07e-01	2.13e-01
GOBP MITOCHONDRIAL FRAGMENTATION INVOLVED IN APOPTOTIC PROCESS	10	4.12e-01	7.43e-01	0.4120	-6.12e-02	-3.23e-01	-1.18e-01	-2.09e-01	-6.55e-02	7.37e-01	7.71e-02	5.19e-01	2.53e-01	7.20e-01
GOBP FREE UBIQUITIN CHAIN POLYMERIZATION	9	5.16e-01	8.11e-01	0.4120	-2.63e-01	7.85e-02	-2.16e-01	-2.18e-01	1.48e-02	1.71e-01	6.84e-01	2.63e-01	2.58e-01	9.39e-01
GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION	34	1.02e-02	8.87e-02	0.4120	-1.01e-01	-5.90e-02	1.04e-01	1.66e-01	-3.43e-01	3.08e-01	5.52e-01	2.93e-01	9.37e-02	5.45e-04
GOBP DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE	46	5.76e-04	9.90e-03	0.4120	4.08e-02	-1.82e-01	1.35e-01	3.23e-01	1.08e-01	6.33e-01	3.23e-02	1.13e-01	1.47e-04	2.04e-01
GOMF PHOSPHATIDYLCHOLINE TRANSFER ACTIVITY	5	7.43e-01	9.13e-01	0.4120	-2.08e-01	-2.98e-01	1.42e-01	-8.25e-03	1.31e-01	4.22e-01	2.48e-01	5.82e-01	9.75e-01	6.13e-01
GOBP REGULATION OF LYMPHOCYTE CHEMOTAXIS	25	2.13e-02	1.47e-01	0.4120	-1.11e-01	-1.10e-01	4.82e-02	3.77e-01	1.24e-02	3.37e-01	3.41e-01	6.77e-01	1.08e-03	9.14e-01
GOBP TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING	12	2.08e-01	5.59e-01	0.4110	-2.79e-01	1.30e-01	-2.04e-01	7.36e-02	-1.65e-01	9.41e-02	4.35e-01	2.20e-01	6.59e-01	3.22e-01
GOMF ENDODEOXYRIBONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS	11	4.29e-01	7.54e-01	0.4110	1.57e-01	1.95e-02	-2.94e-01	-1.42e-01	1.93e-01	3.67e-01	9.11e-01	9.08e-02	4.15e-01	2.67e-01
GOBP LIPID DROPLET FORMATION	13	1.69e-01	5.05e-01	0.4110	-3.33e-02	-5.18e-02	-2.98e-02	-1.77e-01	-3.65e-01	8.35e-01	7.46e-01	8.52e-01	2.69e-01	2.27e-02
GOBP SYNAPTIC SIGNALING VIA NEUROPEPTIDE	6	7.29e-01	9.07e-01	0.4110	-3.05e-01	-1.48e-02	2.08e-01	1.28e-01	1.26e-01	1.95e-01	9.50e-01	3.77e-01	5.86e-01	5.93e-01
GOBP RENAL WATER HOMEOSTASIS	24	4.09e-02	2.23e-01	0.4110	-1.07e-01	3.54e-01	9.75e-02	1.17e-01	-9.69e-02	3.62e-01	2.70e-03	4.08e-01	3.23e-01	4.11e-01
GOMF PROTEIN CARRIER CHAPERONE	33	1.81e-02	1.32e-01	0.4110	1.01e-01	1.07e-01	-3.09e-01	-2.22e-01	-4.91e-02	3.16e-01	2.86e-01	2.11e-03	2.70e-02	6.26e-01
GOBP CITRATE TRANSPORT	5	5.54e-01	8.30e-01	0.4110	4.61e-02	2.87e-01	-1.77e-01	2.29e-01	3.44e-02	8.58e-01	2.67e-01	4.94e-01	3.75e-01	8.94e-01
GOCC NUCLEAR PORE NUCLEAR BASKET	11	4.85e-01	7.94e-01	0.4110	8.61e-03	-2.35e-01	-2.93e-01	-1.48e-01	7.76e-02	9.61e-01	1.77e-01	9.26e-02	3.94e-01	6.56e-01
GOBP DERMATAN SULFATE BIOSYNTHETIC PROCESS	5	7.74e-01	9.25e-01	0.4110	-2.08e-01	2.19e-01	-6.92e-02	-1.48e-01	-2.25e-01	4.20e-01	3.95e-01	7.89e-01	5.67e-01	3.83e-01
GOBP RESPONSE TO UV A	13	2.48e-01	6.05e-01	0.4110	8.50e-02	-3.54e-01	7.11e-02	1.09e-01	1.40e-01	5.96e-01	2.72e-02	6.57e-01	4.95e-01	3.82e-01
GOMF SOLUTE POTASSIUM ANTIPORTER ACTIVITY	17	1.73e-01	5.13e-01	0.4110	-1.62e-01	2.64e-01	2.66e-01	2.27e-02	4.48e-02	2.47e-01	5.99e-02	5.77e-02	8.71e-01	7.49e-01
GOBP CENTROMERIC SISTER CHROMATID COHESION	10	3.01e-01	6.54e-01	0.4110	2.86e-01	4.06e-02	1.55e-02	-2.87e-01	-5.36e-02	1.18e-01	8.24e-01	9.33e-01	1.16e-01	7.69e-01
GOBP N ACYLETHANOLAMINE METABOLIC PROCESS	5	7.01e-01	8.96e-01	0.4110	3.95e-02	3.28e-01	2.03e-02	1.62e-01	1.81e-01	8.79e-01	2.03e-01	9.37e-01	5.30e-01	4.83e-01
GOMF UNIPORTER ACTIVITY	8	4.94e-01	7.99e-01	0.4110	-4.98e-02	2.40e-01	3.17e-01	-7.26e-02	-5.19e-02	8.07e-01	2.40e-01	1.20e-01	7.22e-01	7.99e-01
GOBP POSITIVE REGULATION OF CGMP MEDIATED SIGNALING	5	8.28e-01	9.44e-01	0.4110	3.07e-01	2.06e-02	-2.10e-01	-1.73e-01	4.73e-03	2.35e-01	9.36e-01	4.16e-01	5.02e-01	9.85e-01
GOBP REGULATION OF DEVELOPMENT HETEROCHRONIC	12	2.55e-01	6.13e-01	0.4110	2.66e-01	9.38e-02	1.11e-01	-2.33e-01	1.49e-01	1.10e-01	5.74e-01	5.04e-01	1.62e-01	3.71e-01
GOBP POLY A PLUS MRNA EXPORT FROM NUCLEUS	18	1.93e-01	5.39e-01	0.4110	1.33e-01	4.22e-02	-3.32e-01	-1.91e-01	-4.92e-02	3.29e-01	7.57e-01	1.47e-02	1.60e-01	7.18e-01
GOBP CONSTITUTIVE HETEROCHROMATIN FORMATION	11	4.49e-01	7.70e-01	0.4110	7.98e-02	9.07e-03	-1.30e-01	-1.84e-01	3.34e-01	6.47e-01	9.58e-01	4.56e-01	2.91e-01	5.52e-02
GOCC PHOTORECEPTOR DISC MEMBRANE	19	1.54e-01	4.82e-01	0.4100	1.95e-01	1.86e-01	2.30e-01	2.07e-01	-1.17e-02	1.41e-01	1.61e-01	8.29e-02	1.18e-01	9.30e-01
GOBP PURINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS	6	7.61e-01	9.20e-01	0.4100	2.55e-01	1.43e-01	-6.86e-02	-1.59e-01	2.30e-01	2.79e-01	5.45e-01	7.71e-01	5.00e-01	3.29e-01
GOBP DE NOVO PROTEIN FOLDING	41	6.75e-03	6.62e-02	0.4100	-3.36e-02	4.05e-02	-2.35e-01	-3.32e-01	-4.00e-04	7.10e-01	6.54e-01	9.10e-03	2.33e-04	9.96e-01
GOBP BIOLOGICAL PHASE	11	2.90e-01	6.43e-01	0.4100	2.64e-01	5.92e-03	1.56e-01	-1.83e-01	2.02e-01	1.29e-01	9.73e-01	3.70e-01	2.93e-01	2.47e-01
GOBP ISOLEUCINE TRANSPORT	5	7.62e-01	9.20e-01	0.4100	-2.22e-01	2.37e-02	1.35e-01	3.63e-02	3.15e-01	3.90e-01	9.27e-01	6.01e-01	8.88e-01	2.23e-01
GOBP REGULATION OF TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION	12	3.28e-01	6.76e-01	0.4100	7.69e-02	1.94e-01	2.90e-01	8.24e-02	-1.85e-01	6.45e-01	2.46e-01	8.23e-02	6.21e-01	2.67e-01
GOBP ENDOCARDIUM MORPHOGENESIS	6	4.10e-01	7.42e-01	0.4100	4.56e-02	-2.81e-02	2.70e-01	-3.02e-01	3.02e-02	8.47e-01	9.05e-01	2.52e-01	1.99e-01	8.98e-01
GOBP POLYOL CATABOLIC PROCESS	9	4.74e-01	7.87e-01	0.4100	4.81e-02	2.03e-01	-5.45e-02	-3.46e-01	-4.46e-02	8.03e-01	2.91e-01	7.77e-01	7.22e-02	8.17e-01
GOBP RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE	8	4.83e-01	7.93e-01	0.4100	-7.57e-02	-4.60e-03	1.07e-02	4.82e-02	4.00e-01	7.11e-01	9.82e-01	9.58e-01	8.13e-01	5.01e-02
GOBP TRYPTOPHAN METABOLIC PROCESS	10	4.82e-01	7.93e-01	0.4100	-3.04e-01	-1.80e-02	4.78e-02	2.01e-01	-1.81e-01	9.64e-02	9.22e-01	7.93e-01	2.71e-01	3.20e-01
GOBP HEME TRANSPORT	9	5.10e-01	8.08e-01	0.4100	2.83e-01	-1.75e-01	-2.72e-02	-4.47e-02	2.34e-01	1.41e-01	3.63e-01	8.88e-01	8.16e-01	2.25e-01
GOBP KETONE BODY METABOLIC PROCESS	9	5.09e-01	8.07e-01	0.4100	-1.31e-01	-2.62e-01	1.25e-01	2.30e-01	1.18e-01	4.98e-01	1.74e-01	5.15e-01	2.32e-01	5.39e-01
GOBP RESPONSE TO ANGIOTENSIN	35	5.74e-03	5.86e-02	0.4100	-3.30e-01	1.26e-01	2.04e-01	2.27e-02	-3.92e-02	7.39e-04	1.96e-01	3.71e-02	8.17e-01	6.88e-01
GOBP EMBRYONIC NEUROCRANIUM MORPHOGENESIS	8	5.14e-01	8.09e-01	0.4100	-1.89e-02	-7.69e-02	-3.97e-01	-2.22e-02	-5.98e-02	9.26e-01	7.06e-01	5.18e-02	9.13e-01	7.69e-01
GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX	14	3.12e-01	6.63e-01	0.4100	-1.21e-01	-3.18e-02	-3.00e-01	-1.82e-01	-1.70e-01	4.32e-01	8.37e-01	5.18e-02	2.38e-01	2.70e-01
GOBP REGULATION OF T HELPER CELL DIFFERENTIATION	42	2.76e-04	5.47e-03	0.4100	-1.78e-01	3.45e-01	-6.77e-02	3.56e-02	-1.06e-01	4.55e-02	1.09e-04	4.48e-01	6.90e-01	2.35e-01
GOBP POSITIVE REGULATION OF NATURAL KILLER CELL PROLIFERATION	10	4.46e-01	7.69e-01	0.4100	1.37e-03	2.72e-02	3.93e-01	9.98e-02	5.42e-02	9.94e-01	8.82e-01	3.16e-02	5.85e-01	7.67e-01
GOBP RESPONSE TO LAMINAR FLUID SHEAR STRESS	14	3.13e-01	6.64e-01	0.4090	-3.46e-02	-8.31e-03	-2.82e-01	-2.05e-01	-2.12e-01	8.23e-01	9.57e-01	6.77e-02	1.84e-01	1.70e-01
GOBP REGULATION OF RETROGRADE TRANSPORT ENDOSOME TO GOLGI	7	6.79e-01	8.87e-01	0.4090	-2.01e-01	-5.54e-02	2.12e-01	1.22e-01	-2.54e-01	3.58e-01	8.00e-01	3.31e-01	5.77e-01	2.45e-01
GOCC SWR1 COMPLEX	13	4.38e-01	7.61e-01	0.4090	1.41e-01	-1.16e-02	-2.17e-01	-2.89e-01	1.30e-01	3.79e-01	9.43e-01	1.76e-01	7.08e-02	4.17e-01
GOBP RIBOSOMAL SMALL SUBUNIT BIOGENESIS	100	6.76e-07	3.14e-05	0.4090	3.17e-02	8.48e-03	-2.74e-01	-3.02e-01	1.91e-02	5.84e-01	8.83e-01	2.25e-06	1.78e-07	7.41e-01
GOBP PLATELET DENSE GRANULE ORGANIZATION	24	7.30e-02	3.23e-01	0.4090	-1.12e-01	-2.68e-02	-1.57e-01	-2.73e-01	2.34e-01	3.43e-01	8.20e-01	1.82e-01	2.04e-02	4.72e-02
GOBP ANAGEN	5	7.95e-01	9.32e-01	0.4090	1.74e-01	-7.15e-02	2.28e-01	9.99e-02	2.65e-01	5.01e-01	7.82e-01	3.76e-01	6.99e-01	3.05e-01
GOBP PLASMA MEMBRANE TUBULATION	19	1.04e-01	3.91e-01	0.4090	2.15e-02	3.73e-01	5.65e-02	-1.49e-01	5.21e-02	8.71e-01	4.92e-03	6.70e-01	2.61e-01	6.94e-01
GOBP SMOOTHENED SIGNALING PATHWAY INVOLVED IN VENTRAL SPINAL CORD PATTERNING	8	5.70e-01	8.38e-01	0.4090	-1.73e-01	-5.54e-02	-2.48e-01	4.73e-03	-2.69e-01	3.97e-01	7.86e-01	2.24e-01	9.82e-01	1.87e-01
GOCC CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX	50	2.42e-03	3.12e-02	0.4090	4.33e-02	-5.41e-02	-2.26e-01	-3.18e-01	1.03e-01	5.96e-01	5.08e-01	5.77e-03	1.02e-04	2.06e-01
GOMF CIS TRANS ISOMERASE ACTIVITY	38	1.56e-02	1.20e-01	0.4090	1.44e-02	8.59e-03	-2.64e-01	-3.10e-01	3.73e-02	8.78e-01	9.27e-01	4.89e-03	9.45e-04	6.90e-01
GOBP HISTONE MRNA CATABOLIC PROCESS	15	2.96e-01	6.50e-01	0.4090	-2.86e-02	-2.20e-01	-1.99e-01	-2.71e-01	7.13e-02	8.48e-01	1.40e-01	1.83e-01	6.94e-02	6.32e-01
GOCC CTF18 RFC LIKE COMPLEX	7	7.02e-01	8.96e-01	0.4090	-1.64e-01	1.06e-02	-1.78e-01	-3.29e-01	1.38e-02	4.53e-01	9.61e-01	4.15e-01	1.32e-01	9.50e-01
GOBP POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS	16	2.40e-01	5.96e-01	0.4090	2.01e-02	-9.04e-02	2.19e-01	3.13e-01	1.13e-01	8.89e-01	5.31e-01	1.29e-01	3.03e-02	4.36e-01
GOBP POSITIVE REGULATION OF HELICASE ACTIVITY	6	7.45e-01	9.14e-01	0.4090	2.74e-01	-1.18e-01	-1.03e-01	-6.23e-02	2.52e-01	2.45e-01	6.17e-01	6.64e-01	7.92e-01	2.85e-01
GOCC CUL4A RING E3 UBIQUITIN LIGASE COMPLEX	12	4.93e-01	7.99e-01	0.4090	3.31e-02	1.15e-02	-2.54e-01	-2.90e-01	1.30e-01	8.42e-01	9.45e-01	1.27e-01	8.18e-02	4.34e-01
GOBP POSITIVE REGULATION OF MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION	15	1.22e-01	4.30e-01	0.4090	-4.49e-02	3.88e-01	-1.17e-01	-1.47e-02	2.36e-02	7.63e-01	9.27e-03	4.33e-01	9.22e-01	8.74e-01
GOBP CHORION DEVELOPMENT	10	5.40e-01	8.23e-01	0.4090	5.14e-02	3.22e-02	-2.11e-01	-3.42e-01	-4.56e-02	7.78e-01	8.60e-01	2.48e-01	6.14e-02	8.03e-01
GOBP SCHWANN CELL PROLIFERATION	9	5.66e-01	8.35e-01	0.4090	2.55e-01	1.13e-01	-2.48e-01	-1.53e-01	6.67e-02	1.85e-01	5.57e-01	1.98e-01	4.28e-01	7.29e-01
GOBP POSITIVE REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT	8	6.05e-01	8.55e-01	0.4080	-1.11e-01	-2.79e-01	-2.70e-01	-2.60e-02	-5.29e-02	5.87e-01	1.71e-01	1.86e-01	8.99e-01	7.96e-01
GOBP CELLULAR RESPONSE TO NITROGEN STARVATION	12	2.57e-01	6.14e-01	0.4080	-2.02e-01	8.00e-02	-2.95e-01	-1.93e-02	-1.80e-01	2.26e-01	6.31e-01	7.68e-02	9.08e-01	2.81e-01
GOBP REGULATION OF ATRIAL CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION	6	6.41e-01	8.75e-01	0.4080	2.25e-03	-2.42e-01	3.16e-01	9.16e-02	-1.90e-03	9.92e-01	3.04e-01	1.80e-01	6.97e-01	9.94e-01
GOMF PHOSPHODIESTERASE I ACTIVITY	5	6.11e-01	8.58e-01	0.4080	2.12e-01	1.17e-01	-2.82e-01	1.68e-01	1.85e-02	4.11e-01	6.50e-01	2.75e-01	5.15e-01	9.43e-01
GOBP ADP BIOSYNTHETIC PROCESS	5	8.04e-01	9.34e-01	0.4080	2.22e-01	2.82e-01	-1.26e-01	-1.41e-01	4.37e-02	3.91e-01	2.74e-01	6.25e-01	5.84e-01	8.66e-01
GOMF MISMATCH REPAIR COMPLEX BINDING	11	5.30e-01	8.19e-01	0.4080	-7.45e-02	-7.53e-02	-2.79e-01	-2.69e-01	7.36e-02	6.69e-01	6.65e-01	1.09e-01	1.23e-01	6.72e-01
GOBP LUTEOLYSIS	6	7.11e-01	8.99e-01	0.4080	2.17e-01	-2.56e-01	1.04e-01	2.09e-01	-4.51e-03	3.57e-01	2.78e-01	6.60e-01	3.76e-01	9.85e-01
GOBP FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS	11	3.90e-01	7.26e-01	0.4080	2.25e-01	2.73e-01	1.16e-01	1.11e-01	-1.26e-01	1.96e-01	1.17e-01	5.07e-01	5.23e-01	4.69e-01
GOBP EPITHELIAL CILIUM MOVEMENT INVOLVED IN DETERMINATION OF LEFT RIGHT ASYMMETRY	12	3.19e-01	6.68e-01	0.4080	-3.58e-01	-9.42e-02	-1.73e-02	-8.18e-02	-1.50e-01	3.16e-02	5.72e-01	9.17e-01	6.24e-01	3.69e-01
GOBP NEGATIVE REGULATION OF MRNA PROCESSING	22	7.63e-02	3.32e-01	0.4080	7.47e-05	1.45e-01	-1.34e-01	-3.55e-01	-4.53e-02	1.00e+00	2.38e-01	2.78e-01	3.99e-03	7.13e-01
GOBP FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE	12	3.53e-01	6.99e-01	0.4080	2.48e-01	2.60e-01	-1.81e-02	-1.80e-01	6.94e-02	1.37e-01	1.18e-01	9.13e-01	2.81e-01	6.77e-01
GOBP REGULATION OF HELICASE ACTIVITY	10	5.19e-01	8.13e-01	0.4080	2.35e-01	-1.26e-01	-1.98e-01	-1.15e-01	2.08e-01	1.98e-01	4.89e-01	2.79e-01	5.30e-01	2.55e-01
GOBP PHOSPHOLIPASE C ACTIVATING DOPAMINE RECEPTOR SIGNALING PATHWAY	9	3.27e-01	6.75e-01	0.4080	-1.21e-01	1.67e-01	-4.80e-02	8.20e-02	3.39e-01	5.29e-01	3.86e-01	8.03e-01	6.70e-01	7.82e-02
GOBP ADENOSINE METABOLIC PROCESS	10	4.25e-01	7.52e-01	0.4080	-2.40e-01	1.68e-01	2.73e-01	-4.11e-02	6.79e-02	1.89e-01	3.59e-01	1.35e-01	8.22e-01	7.10e-01
GOMF MALATE DEHYDROGENASE ACTIVITY	8	5.27e-01	8.17e-01	0.4080	-1.16e-01	-2.84e-01	1.23e-02	-8.13e-03	-2.68e-01	5.69e-01	1.64e-01	9.52e-01	9.68e-01	1.89e-01
GOCC DYSTROGLYCAN COMPLEX	7	6.76e-01	8.85e-01	0.4080	2.63e-01	1.78e-01	2.15e-01	8.76e-02	1.08e-01	2.29e-01	4.15e-01	3.24e-01	6.88e-01	6.19e-01
GOBP SPHINGOSINE 1 PHOSPHATE RECEPTOR SIGNALING PATHWAY	15	2.90e-01	6.44e-01	0.4080	-8.16e-02	-1.88e-01	-1.75e-01	-2.57e-01	1.67e-01	5.84e-01	2.07e-01	2.41e-01	8.51e-02	2.64e-01
GOBP REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION	22	9.89e-02	3.80e-01	0.4080	-1.04e-01	1.95e-01	1.74e-01	2.90e-01	-5.33e-02	3.96e-01	1.13e-01	1.57e-01	1.85e-02	6.65e-01
GOCC NMDA SELECTIVE GLUTAMATE RECEPTOR COMPLEX	9	4.97e-01	8.02e-01	0.4080	-1.82e-01	9.67e-03	-2.22e-01	-1.68e-01	2.35e-01	3.44e-01	9.60e-01	2.49e-01	3.82e-01	2.22e-01
GOBP POSITIVE REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS	8	5.86e-01	8.45e-01	0.4080	1.99e-01	-8.35e-02	9.07e-02	3.31e-01	-4.46e-02	3.29e-01	6.83e-01	6.57e-01	1.05e-01	8.27e-01
GOMF FERRIC IRON BINDING	9	4.84e-01	7.94e-01	0.4080	-6.03e-02	3.07e-01	-9.30e-02	-1.48e-01	-1.95e-01	7.54e-01	1.11e-01	6.29e-01	4.43e-01	3.11e-01
GOCC RNA CAP BINDING COMPLEX	19	9.22e-02	3.67e-01	0.4080	-7.50e-02	3.55e-01	-7.36e-02	-1.36e-01	-1.03e-01	5.72e-01	7.39e-03	5.79e-01	3.05e-01	4.37e-01
GOBP FEMALE MEIOSIS CHROMOSOME SEGREGATION	6	7.58e-01	9.19e-01	0.4070	3.14e-01	-7.19e-03	-1.99e-01	-1.61e-01	-4.19e-02	1.83e-01	9.76e-01	3.98e-01	4.96e-01	8.59e-01
GOBP EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS	26	2.88e-02	1.78e-01	0.4070	2.74e-01	6.15e-02	9.14e-02	-1.55e-01	2.34e-01	1.57e-02	5.87e-01	4.20e-01	1.72e-01	3.85e-02
GOBP NEURAL PLATE MORPHOGENESIS	5	8.35e-01	9.45e-01	0.4070	2.32e-03	-1.45e-01	-3.10e-01	-1.09e-01	-1.92e-01	9.93e-01	5.75e-01	2.30e-01	6.72e-01	4.57e-01
GOMF OXIDOREDUCTION DRIVEN ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY	53	9.43e-04	1.48e-02	0.4070	7.59e-02	-1.73e-02	-2.21e-01	-3.32e-01	-1.69e-02	3.39e-01	8.28e-01	5.33e-03	2.83e-05	8.32e-01
GOCC MISMATCH REPAIR COMPLEX	8	5.72e-01	8.39e-01	0.4070	3.89e-02	-3.07e-01	-1.23e-01	-2.34e-01	6.84e-03	8.49e-01	1.32e-01	5.48e-01	2.52e-01	9.73e-01
GOMF MITOCHONDRIAL RIBOSOME BINDING	9	4.85e-01	7.94e-01	0.4070	2.64e-01	-1.73e-02	-7.54e-02	-3.00e-01	1.73e-02	1.71e-01	9.28e-01	6.95e-01	1.19e-01	9.28e-01
GOBP REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY	18	2.00e-01	5.49e-01	0.4070	-1.12e-01	-2.96e-03	2.55e-01	2.68e-01	1.28e-01	4.11e-01	9.83e-01	6.15e-02	4.90e-02	3.46e-01
GOBP SEX DETERMINATION	18	6.97e-02	3.14e-01	0.4070	-1.47e-03	1.70e-01	3.61e-02	-3.68e-01	-3.77e-03	9.91e-01	2.13e-01	7.91e-01	6.86e-03	9.78e-01
GOBP REGULATION OF I KAPPAB PHOSPHORYLATION	8	5.87e-01	8.45e-01	0.4070	-2.57e-01	-1.96e-01	1.42e-01	1.74e-01	1.04e-01	2.09e-01	3.37e-01	4.87e-01	3.95e-01	6.09e-01
GOBP ESTABLISHMENT OF MITOTIC SISTER CHROMATID COHESION	5	6.59e-01	8.80e-01	0.4070	2.50e-01	7.84e-02	2.19e-01	-2.11e-01	6.67e-02	3.33e-01	7.62e-01	3.97e-01	4.13e-01	7.96e-01
GOMF PATCHED BINDING	8	6.30e-01	8.69e-01	0.4070	5.61e-03	-2.13e-01	-1.10e-01	-2.20e-01	2.44e-01	9.78e-01	2.98e-01	5.91e-01	2.81e-01	2.32e-01
GOBP NEGATIVE REGULATION OF ACTION POTENTIAL	6	5.95e-01	8.49e-01	0.4070	-3.53e-02	-2.17e-02	2.82e-02	2.50e-01	3.17e-01	8.81e-01	9.27e-01	9.05e-01	2.89e-01	1.79e-01
GOBP SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE	20	1.03e-01	3.88e-01	0.4070	2.51e-01	-1.70e-01	-1.55e-01	-2.21e-01	-2.83e-02	5.17e-02	1.89e-01	2.31e-01	8.77e-02	8.27e-01
GOBP ESTABLISHMENT OF MEIOTIC SPINDLE LOCALIZATION	6	7.98e-01	9.32e-01	0.4060	-7.85e-02	-1.41e-02	1.76e-01	2.32e-01	-2.72e-01	7.39e-01	9.52e-01	4.55e-01	3.25e-01	2.49e-01
GOBP CALCIUM ION EXPORT ACROSS PLASMA MEMBRANE	9	4.62e-01	7.78e-01	0.4060	-2.99e-01	1.93e-01	9.00e-02	-1.73e-01	-1.99e-02	1.20e-01	3.15e-01	6.40e-01	3.69e-01	9.18e-01
GOBP MEIOTIC CYTOKINESIS	8	5.88e-01	8.46e-01	0.4060	-3.59e-01	-5.93e-03	8.38e-02	1.36e-02	-1.70e-01	7.86e-02	9.77e-01	6.82e-01	9.47e-01	4.05e-01
GOBP ACTIVATION OF PROTEIN KINASE C ACTIVITY	5	8.47e-01	9.49e-01	0.4060	-9.48e-02	2.30e-01	2.39e-01	1.40e-01	-1.63e-01	7.13e-01	3.73e-01	3.55e-01	5.88e-01	5.28e-01
GOBP REGULATION OF THYMOCYTE APOPTOTIC PROCESS	14	7.84e-02	3.36e-01	0.4060	1.48e-01	3.34e-02	1.73e-01	-3.28e-01	6.69e-02	3.38e-01	8.29e-01	2.62e-01	3.36e-02	6.65e-01
GOBP MITOCHONDRIAL TRANSCRIPTION	19	2.03e-01	5.53e-01	0.4060	-4.14e-02	-7.75e-02	-2.11e-01	-3.27e-01	7.48e-02	7.55e-01	5.58e-01	1.11e-01	1.36e-02	5.72e-01
GOCC OUTER DYNEIN ARM	11	1.63e-01	4.96e-01	0.4060	-2.56e-02	-5.08e-02	-8.21e-02	3.75e-01	1.19e-01	8.83e-01	7.70e-01	6.37e-01	3.12e-02	4.94e-01
GOBP DENDRITIC CELL CYTOKINE PRODUCTION	19	1.19e-01	4.23e-01	0.4060	-2.56e-01	2.60e-01	9.93e-02	6.41e-02	-1.32e-01	5.31e-02	4.94e-02	4.54e-01	6.29e-01	3.20e-01
GOBP VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL	34	9.22e-03	8.25e-02	0.4060	-7.98e-02	1.20e-01	1.00e-01	3.42e-01	-1.30e-01	4.21e-01	2.25e-01	3.12e-01	5.50e-04	1.91e-01
GOBP NUCLEOBASE BIOSYNTHETIC PROCESS	16	2.87e-01	6.41e-01	0.4060	6.59e-02	-1.86e-01	-2.93e-01	-1.62e-01	1.15e-01	6.48e-01	1.97e-01	4.22e-02	2.61e-01	4.24e-01
GOBP REGULATION OF WNT PROTEIN SECRETION	5	7.90e-01	9.31e-01	0.4060	-1.70e-01	1.04e-01	2.29e-01	3.86e-02	-2.67e-01	5.11e-01	6.86e-01	3.75e-01	8.81e-01	3.02e-01
GOBP WNT PROTEIN SECRETION	5	7.90e-01	9.31e-01	0.4060	-1.70e-01	1.04e-01	2.29e-01	3.86e-02	-2.67e-01	5.11e-01	6.86e-01	3.75e-01	8.81e-01	3.02e-01
GOBP CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE	20	7.12e-02	3.18e-01	0.4060	-1.48e-01	1.16e-01	3.16e-01	-5.41e-02	1.63e-01	2.53e-01	3.68e-01	1.44e-02	6.75e-01	2.08e-01
GOBP NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION	21	4.86e-02	2.49e-01	0.4060	-2.48e-01	-1.43e-01	8.61e-03	2.85e-01	3.57e-02	4.89e-02	2.56e-01	9.46e-01	2.38e-02	7.77e-01
GOBP CARDIOLIPIN BIOSYNTHETIC PROCESS	7	7.30e-01	9.07e-01	0.4060	3.91e-02	1.17e-01	-3.07e-01	-2.33e-01	2.31e-02	8.58e-01	5.92e-01	1.59e-01	2.85e-01	9.16e-01
GOBP NEUTROPHIL CLEARANCE	6	5.27e-01	8.18e-01	0.4060	-1.79e-01	3.06e-01	-1.04e-01	1.67e-01	2.61e-02	4.49e-01	1.95e-01	6.60e-01	4.79e-01	9.12e-01
GOMF TOXIN TRANSMEMBRANE TRANSPORTER ACTIVITY	9	4.33e-01	7.57e-01	0.4060	4.39e-02	-2.89e-01	-6.06e-02	2.46e-01	1.22e-01	8.20e-01	1.33e-01	7.53e-01	2.01e-01	5.28e-01
GOBP CEREBROSPINAL FLUID CIRCULATION	15	1.99e-01	5.47e-01	0.4060	-7.94e-02	2.04e-01	1.29e-01	3.15e-01	2.84e-02	5.94e-01	1.71e-01	3.87e-01	3.48e-02	8.49e-01
GOBP AMYLOID BETA CLEARANCE BY TRANSCYTOSIS	7	7.54e-01	9.17e-01	0.4050	-2.80e-02	-1.85e-01	-2.96e-01	-2.01e-01	-3.77e-02	8.98e-01	3.97e-01	1.75e-01	3.56e-01	8.63e-01
GOBP PROSTATIC BUD FORMATION	8	5.90e-01	8.47e-01	0.4050	1.36e-01	-2.88e-01	-1.31e-01	-2.13e-01	2.44e-02	5.06e-01	1.59e-01	5.21e-01	2.96e-01	9.05e-01
GOBP RIBOSOMAL LARGE SUBUNIT EXPORT FROM NUCLEUS	7	6.31e-01	8.70e-01	0.4050	-1.39e-02	-2.02e-01	-1.25e-01	-3.26e-01	-4.37e-02	9.49e-01	3.56e-01	5.68e-01	1.36e-01	8.41e-01
GOBP REGULATION OF T HELPER 17 CELL DIFFERENTIATION	21	5.21e-02	2.62e-01	0.4050	-2.18e-01	3.37e-01	-8.27e-03	1.40e-02	-5.33e-02	8.43e-02	7.43e-03	9.48e-01	9.12e-01	6.72e-01
GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT PHOSPHATASE ACTIVITY	7	5.33e-01	8.20e-01	0.4050	9.79e-02	5.93e-02	-2.24e-02	-1.71e-01	-3.48e-01	6.54e-01	7.86e-01	9.18e-01	4.34e-01	1.10e-01
GOBP RRNA TRANSCRIPTION	37	4.10e-03	4.65e-02	0.4050	1.85e-01	-7.82e-02	-1.33e-01	-3.25e-01	-1.89e-02	5.15e-02	4.11e-01	1.61e-01	6.18e-04	8.43e-01
GOBP ACROSOMAL VESICLE EXOCYTOSIS	9	4.36e-01	7.59e-01	0.4050	3.36e-02	-1.98e-01	-1.29e-01	2.95e-01	-1.41e-01	8.61e-01	3.03e-01	5.02e-01	1.25e-01	4.63e-01
GOBP NEGATIVE REGULATION OF RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE	5	7.10e-01	8.99e-01	0.4050	6.12e-02	1.17e-01	3.56e-02	1.98e-01	3.26e-01	8.13e-01	6.50e-01	8.90e-01	4.42e-01	2.07e-01
GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ADAPTOR ACTIVITY	17	1.50e-01	4.75e-01	0.4050	1.54e-01	3.03e-01	2.12e-01	-5.18e-02	2.77e-02	2.72e-01	3.03e-02	1.30e-01	7.11e-01	8.43e-01
GOBP AMELOBLAST DIFFERENTIATION	5	7.02e-01	8.96e-01	0.4050	1.72e-01	5.28e-02	1.33e-01	-1.77e-02	-3.37e-01	5.05e-01	8.38e-01	6.07e-01	9.45e-01	1.92e-01
GOBP REGULATION OF SNARE COMPLEX ASSEMBLY	14	2.00e-01	5.50e-01	0.4050	3.04e-01	2.43e-01	-6.20e-02	8.51e-02	-4.11e-02	4.89e-02	1.16e-01	6.88e-01	5.81e-01	7.90e-01
GOBP REGULATION OF GLUCAGON SECRETION	8	5.69e-01	8.37e-01	0.4050	1.79e-01	2.23e-01	1.29e-01	-1.91e-01	1.70e-01	3.81e-01	2.74e-01	5.27e-01	3.50e-01	4.05e-01
GOCC APOLIPOPROTEIN B MRNA EDITING ENZYME COMPLEX	5	7.98e-01	9.33e-01	0.4050	1.86e-01	2.37e-02	7.26e-02	3.37e-01	-1.01e-01	4.72e-01	9.27e-01	7.79e-01	1.92e-01	6.96e-01
GOBP MAMMARY GLAND INVOLUTION	8	5.52e-01	8.29e-01	0.4050	-2.63e-01	3.96e-02	-2.74e-01	-9.06e-02	-9.91e-02	1.98e-01	8.46e-01	1.79e-01	6.57e-01	6.27e-01
GOBP PEPTIDYL LYSINE MONOMETHYLATION	9	3.41e-01	6.88e-01	0.4050	-1.46e-01	-7.37e-03	3.52e-02	-3.69e-01	-7.05e-02	4.48e-01	9.69e-01	8.55e-01	5.52e-02	7.14e-01
GOBP GLYCINE IMPORT ACROSS PLASMA MEMBRANE	5	7.97e-01	9.32e-01	0.4050	-8.64e-02	3.55e-01	1.43e-01	-5.05e-02	-8.45e-02	7.38e-01	1.69e-01	5.80e-01	8.45e-01	7.44e-01
GOBP EARLY ENDOSOME TO GOLGI TRANSPORT	13	3.91e-01	7.26e-01	0.4040	-7.67e-02	8.94e-02	-1.81e-01	-2.87e-01	1.86e-01	6.32e-01	5.77e-01	2.59e-01	7.31e-02	2.45e-01
GOMF PYRIMIDINE NUCLEOSIDE TRANSMEMBRANE TRANSPORTER ACTIVITY	8	5.72e-01	8.39e-01	0.4040	1.88e-01	-2.71e-01	4.83e-03	2.18e-01	-8.50e-02	3.58e-01	1.84e-01	9.81e-01	2.86e-01	6.77e-01
GOBP BUD ELONGATION INVOLVED IN LUNG BRANCHING	7	7.16e-01	9.01e-01	0.4040	-6.74e-02	-2.62e-01	-2.10e-01	-2.06e-01	-5.94e-02	7.57e-01	2.30e-01	3.35e-01	3.45e-01	7.85e-01
GOBP DEVELOPMENT OF SECONDARY SEXUAL CHARACTERISTICS	8	5.51e-01	8.28e-01	0.4040	-9.41e-02	7.72e-02	-8.29e-02	-1.20e-01	-3.57e-01	6.45e-01	7.05e-01	6.85e-01	5.56e-01	8.05e-02
GOBP CELLULAR RESPONSE TO MANGANESE ION	10	4.52e-01	7.71e-01	0.4040	-2.32e-01	1.65e-01	3.93e-02	-1.71e-02	-2.84e-01	2.04e-01	3.67e-01	8.29e-01	9.25e-01	1.20e-01
GOBP CEREBELLAR GRANULAR LAYER MORPHOGENESIS	8	5.87e-01	8.45e-01	0.4040	3.16e-03	-2.37e-01	1.27e-01	2.59e-01	1.55e-01	9.88e-01	2.46e-01	5.34e-01	2.04e-01	4.48e-01
GOBP REGULATION OF ENTRY OF BACTERIUM INTO HOST CELL	7	6.43e-01	8.75e-01	0.4040	1.44e-01	-2.54e-01	2.01e-02	-2.72e-03	2.78e-01	5.10e-01	2.44e-01	9.26e-01	9.90e-01	2.02e-01
GOBP HEMATOPOIETIC STEM CELL MIGRATION	8	4.88e-01	7.97e-01	0.4040	-9.94e-02	-7.32e-02	3.66e-01	-1.60e-04	1.17e-01	6.26e-01	7.20e-01	7.28e-02	9.99e-01	5.65e-01
GOBP TONGUE MORPHOGENESIS	10	2.16e-01	5.70e-01	0.4040	1.42e-01	2.08e-02	2.20e-01	-2.90e-01	1.00e-01	4.36e-01	9.09e-01	2.29e-01	1.12e-01	5.83e-01
GOBP REGULATION OF NOREPINEPHRINE SECRETION	13	3.17e-01	6.67e-01	0.4040	1.27e-01	2.09e-01	-3.92e-02	-3.10e-01	7.48e-02	4.29e-01	1.91e-01	8.06e-01	5.29e-02	6.41e-01
GOMF SYNDECAN BINDING	5	8.52e-01	9.51e-01	0.4040	-1.27e-01	-1.45e-01	1.11e-01	2.70e-01	-2.03e-01	6.24e-01	5.75e-01	6.69e-01	2.96e-01	4.32e-01
GOBP POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY	12	3.80e-01	7.18e-01	0.4040	-2.23e-01	2.13e-01	2.59e-01	2.71e-02	1.91e-02	1.81e-01	2.02e-01	1.20e-01	8.71e-01	9.09e-01
GOBP ALLANTOIN METABOLIC PROCESS	9	4.30e-01	7.55e-01	0.4040	1.89e-01	-8.47e-02	-9.17e-02	-1.19e-01	-3.12e-01	3.26e-01	6.60e-01	6.34e-01	5.37e-01	1.05e-01
GOBP MYOBLAST MIGRATION	13	3.66e-01	7.06e-01	0.4040	2.70e-01	1.34e-01	-1.43e-01	-2.22e-01	4.51e-02	9.18e-02	4.02e-01	3.71e-01	1.65e-01	7.78e-01
GOBP VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION	27	2.10e-02	1.46e-01	0.4040	-1.35e-01	2.17e-01	8.74e-02	2.94e-01	-6.06e-02	2.25e-01	5.06e-02	4.32e-01	8.27e-03	5.86e-01
GOBP NEGATIVE REGULATION OF RNA SPLICING	25	6.98e-02	3.14e-01	0.4040	1.57e-02	1.69e-01	-1.55e-01	-3.30e-01	3.62e-02	8.92e-01	1.44e-01	1.80e-01	4.31e-03	7.54e-01
GOBP SPINDLE ELONGATION	13	3.00e-01	6.54e-01	0.4040	-7.75e-02	-3.48e-01	-8.38e-02	-1.10e-01	1.28e-01	6.29e-01	2.96e-02	6.01e-01	4.93e-01	4.25e-01
GOBP POSITIVE REGULATION OF FATTY ACID BETA OXIDATION	10	4.90e-01	7.97e-01	0.4030	2.33e-01	1.64e-01	-2.42e-01	-1.33e-01	7.37e-02	2.02e-01	3.69e-01	1.85e-01	4.66e-01	6.87e-01
GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION	22	4.13e-02	2.25e-01	0.4030	5.40e-02	3.59e-01	-1.59e-01	-6.43e-02	-4.08e-02	6.61e-01	3.57e-03	1.97e-01	6.02e-01	7.40e-01
GOBP RENAL SODIUM ION TRANSPORT	15	1.70e-01	5.09e-01	0.4030	-2.42e-02	3.45e-01	8.20e-02	1.67e-01	9.02e-02	8.71e-01	2.05e-02	5.82e-01	2.63e-01	5.45e-01
GOBP NEGATIVE REGULATION OF PROTEIN K63 LINKED UBIQUITINATION	5	8.68e-01	9.56e-01	0.4030	1.11e-01	-1.91e-01	-2.52e-01	-1.96e-01	1.10e-01	6.69e-01	4.60e-01	3.30e-01	4.47e-01	6.70e-01
GOBP ANTIFUNGAL INNATE IMMUNE RESPONSE	19	1.33e-01	4.50e-01	0.4030	-2.25e-01	2.24e-01	1.60e-01	1.90e-01	1.43e-02	8.97e-02	9.10e-02	2.28e-01	1.51e-01	9.14e-01
GOBP NAIL DEVELOPMENT	11	2.03e-01	5.53e-01	0.4030	-7.13e-02	4.49e-02	1.31e-01	-3.67e-01	5.86e-02	6.82e-01	7.97e-01	4.50e-01	3.51e-02	7.37e-01
GOBP CENP A CONTAINING CHROMATIN ASSEMBLY	9	6.32e-01	8.70e-01	0.4030	1.14e-01	-1.37e-01	-1.90e-01	-2.93e-01	9.22e-02	5.54e-01	4.78e-01	3.23e-01	1.28e-01	6.32e-01
GOCC GRANULAR COMPONENT	7	6.76e-01	8.85e-01	0.4030	-5.30e-02	2.84e-01	-1.01e-01	-2.14e-01	1.51e-01	8.08e-01	1.93e-01	6.42e-01	3.27e-01	4.90e-01
GOBP REFLEX	21	7.38e-02	3.25e-01	0.4030	-3.21e-01	6.91e-03	2.25e-01	8.48e-03	-9.18e-02	1.08e-02	9.56e-01	7.46e-02	9.46e-01	4.66e-01
GOBP REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE	9	5.33e-01	8.20e-01	0.4030	4.53e-02	-2.45e-01	-4.67e-02	-1.86e-01	2.53e-01	8.14e-01	2.04e-01	8.08e-01	3.35e-01	1.89e-01
GOBP CELLULAR RESPONSE TO HYDROPEROXIDE	8	6.85e-01	8.89e-01	0.4030	-2.38e-01	-3.58e-02	1.87e-01	1.93e-01	-1.78e-01	2.43e-01	8.61e-01	3.60e-01	3.44e-01	3.82e-01
GOBP MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS	23	1.11e-01	4.06e-01	0.4030	1.23e-01	-7.49e-02	-2.29e-01	-2.94e-01	-5.38e-02	3.07e-01	5.34e-01	5.76e-02	1.48e-02	6.55e-01
GOMF SEMAPHORIN RECEPTOR BINDING	23	5.83e-02	2.82e-01	0.4030	-3.15e-01	1.24e-01	9.77e-02	1.90e-01	-3.83e-02	8.85e-03	3.01e-01	4.17e-01	1.14e-01	7.51e-01
GOBP METANEPHRIC RENAL VESICLE MORPHOGENESIS	14	1.55e-01	4.83e-01	0.4030	1.88e-01	-1.45e-01	1.09e-01	-2.28e-01	2.04e-01	2.24e-01	3.47e-01	4.79e-01	1.39e-01	1.85e-01
GOCC MITOCHONDRIAL CRISTA	8	5.91e-01	8.47e-01	0.4030	-5.12e-02	2.93e-01	2.51e-01	-6.34e-02	8.22e-02	8.02e-01	1.51e-01	2.19e-01	7.56e-01	6.87e-01
GOBP TYPE I PNEUMOCYTE DIFFERENTIATION	8	5.14e-01	8.09e-01	0.4030	-2.51e-01	2.99e-01	3.28e-02	4.75e-02	7.96e-02	2.19e-01	1.43e-01	8.72e-01	8.16e-01	6.97e-01
GOBP NEGATIVE REGULATION OF EPINEPHRINE SECRETION	5	8.36e-01	9.46e-01	0.4030	2.95e-01	4.62e-02	-2.22e-01	-1.54e-01	-1.63e-02	2.54e-01	8.58e-01	3.91e-01	5.51e-01	9.50e-01
GOBP MARGINAL ZONE B CELL DIFFERENTIATION	8	5.62e-01	8.34e-01	0.4030	1.56e-01	3.35e-01	-5.03e-02	-6.29e-02	-1.36e-01	4.44e-01	1.00e-01	8.06e-01	7.58e-01	5.04e-01
GOBP NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS	13	3.57e-01	7.02e-01	0.4020	2.88e-01	6.35e-02	-1.77e-01	-2.05e-01	-3.49e-02	7.19e-02	6.92e-01	2.69e-01	2.00e-01	8.28e-01
GOBP REGULATION OF DNA DIRECTED DNA POLYMERASE ACTIVITY	9	6.19e-01	8.63e-01	0.4020	-7.05e-02	9.13e-02	-2.71e-01	-2.69e-01	-4.94e-02	7.14e-01	6.35e-01	1.59e-01	1.62e-01	7.97e-01
GOBP ALDITOL PHOSPHATE METABOLIC PROCESS	9	4.05e-01	7.38e-01	0.4020	1.52e-01	1.42e-01	8.57e-02	-3.27e-01	6.60e-02	4.29e-01	4.61e-01	6.56e-01	8.96e-02	7.32e-01
GOCC MIB COMPLEX	11	4.17e-01	7.47e-01	0.4020	3.96e-02	3.07e-01	-3.29e-02	-2.52e-01	3.82e-02	8.20e-01	7.79e-02	8.50e-01	1.48e-01	8.26e-01
GOBP EXOCRINE PANCREAS DEVELOPMENT	7	6.65e-01	8.82e-01	0.4020	1.35e-01	3.37e-01	-7.40e-02	-1.25e-01	9.26e-02	5.38e-01	1.22e-01	7.35e-01	5.66e-01	6.71e-01
GOBP POSITIVE REGULATION OF NEURON PROJECTION REGENERATION	10	3.22e-01	6.70e-01	0.4020	1.41e-03	-2.07e-01	3.28e-01	1.94e-02	1.05e-01	9.94e-01	2.57e-01	7.26e-02	9.15e-01	5.65e-01
GOCC RISC LOADING COMPLEX	8	6.41e-01	8.75e-01	0.4020	-4.88e-02	8.49e-02	-1.50e-01	-3.60e-01	-1.06e-02	8.11e-01	6.78e-01	4.63e-01	7.80e-02	9.59e-01
GOBP MITOCHONDRIAL PROTEIN CATABOLIC PROCESS	6	5.86e-01	8.45e-01	0.4020	-1.52e-01	-3.12e-01	1.31e-01	-1.54e-01	2.39e-02	5.20e-01	1.86e-01	5.80e-01	5.14e-01	9.19e-01
GOBP POSITIVE REGULATION OF CELL MATURATION	7	6.74e-01	8.85e-01	0.4020	-1.49e-01	3.12e-01	2.02e-01	-2.48e-02	-1.63e-02	4.95e-01	1.53e-01	3.54e-01	9.09e-01	9.40e-01
GOMF DINUCLEOTIDE PHOSPHATASE ACTIVITY	8	4.39e-01	7.61e-01	0.4020	1.38e-01	1.03e-01	1.66e-01	-2.96e-01	1.28e-01	4.98e-01	6.13e-01	4.15e-01	1.47e-01	5.30e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO LYSOSOME	5	8.35e-01	9.45e-01	0.4020	-1.85e-01	1.73e-01	2.57e-01	1.05e-01	1.44e-01	4.75e-01	5.04e-01	3.20e-01	6.86e-01	5.78e-01
GOBP PROTEIN INSERTION INTO MEMBRANE	72	1.13e-04	2.63e-03	0.4020	-1.77e-04	-6.45e-03	-2.58e-01	-2.88e-01	1.08e-01	9.98e-01	9.25e-01	1.51e-04	2.35e-05	1.15e-01
GOBP VOCALIZATION BEHAVIOR	15	3.16e-01	6.66e-01	0.4020	-1.24e-01	-1.37e-01	9.81e-02	2.73e-01	-2.07e-01	4.05e-01	3.59e-01	5.11e-01	6.68e-02	1.65e-01
GOMF PROTON TRANSPORTING ATP SYNTHASE ACTIVITY ROTATIONAL MECHANISM	16	2.71e-01	6.25e-01	0.4010	3.69e-03	-1.75e-02	-2.39e-01	-2.91e-01	-1.39e-01	9.80e-01	9.04e-01	9.83e-02	4.42e-02	3.35e-01
GOBP DEOXYRIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS	5	6.84e-01	8.88e-01	0.4010	-3.35e-02	3.69e-02	-1.49e-03	-2.98e-01	-2.64e-01	8.97e-01	8.86e-01	9.95e-01	2.48e-01	3.07e-01
GOBP CELLULAR RESPONSE TO STEROL	25	3.54e-02	2.03e-01	0.4010	-1.91e-01	-2.54e-01	2.04e-01	9.95e-02	-9.45e-02	9.84e-02	2.81e-02	7.81e-02	3.89e-01	4.13e-01
GOBP NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY	11	3.61e-01	7.04e-01	0.4010	-9.93e-03	3.39e-01	1.11e-01	-1.78e-01	-4.34e-02	9.55e-01	5.16e-02	5.24e-01	3.06e-01	8.03e-01
GOBP MEIOTIC TELOMERE CLUSTERING	10	4.34e-01	7.58e-01	0.4010	-1.05e-01	-3.42e-01	-3.15e-02	-1.14e-01	1.37e-01	5.66e-01	6.09e-02	8.63e-01	5.33e-01	4.52e-01
GOBP VENTRAL MIDLINE DEVELOPMENT	6	7.73e-01	9.25e-01	0.4010	2.92e-03	-1.95e-01	-2.72e-01	-1.15e-01	1.89e-01	9.90e-01	4.09e-01	2.48e-01	6.25e-01	4.22e-01
GOCC MESSENGER RIBONUCLEOPROTEIN COMPLEX	12	3.73e-01	7.13e-01	0.4010	-2.57e-02	3.68e-01	1.58e-01	-6.95e-03	-1.73e-03	8.78e-01	2.74e-02	3.43e-01	9.67e-01	9.92e-01
GOBP NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION	14	1.94e-01	5.42e-01	0.4010	-2.43e-01	-9.60e-02	-3.64e-02	-1.66e-02	3.02e-01	1.15e-01	5.34e-01	8.13e-01	9.14e-01	5.07e-02
GOMF TPR DOMAIN BINDING	7	6.14e-01	8.60e-01	0.4010	-7.35e-02	3.47e-01	-7.47e-02	-9.54e-02	1.43e-01	7.36e-01	1.12e-01	7.32e-01	6.62e-01	5.12e-01
GOCC FILTRATION DIAPHRAGM	8	4.38e-01	7.61e-01	0.4010	1.70e-01	-2.43e-01	1.65e-01	4.27e-02	-2.09e-01	4.06e-01	2.33e-01	4.18e-01	8.34e-01	3.07e-01
GOBP REGULATION OF TRANSMISSION OF NERVE IMPULSE	15	2.28e-01	5.81e-01	0.4010	1.04e-01	-6.86e-02	2.61e-01	8.11e-02	2.65e-01	4.85e-01	6.45e-01	7.97e-02	5.87e-01	7.56e-02
GOCC ISWI TYPE COMPLEX	12	4.87e-01	7.95e-01	0.4010	1.78e-01	-5.23e-02	-2.30e-01	-2.71e-01	1.16e-02	2.87e-01	7.54e-01	1.68e-01	1.04e-01	9.45e-01
GOCC PRE SNORNP COMPLEX	7	7.26e-01	9.05e-01	0.4010	-1.44e-01	-1.05e-01	-2.54e-01	-1.86e-01	-1.71e-01	5.10e-01	6.30e-01	2.44e-01	3.93e-01	4.33e-01
GOBP APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS	27	4.23e-02	2.28e-01	0.4010	8.79e-02	1.79e-02	-3.62e-02	-3.07e-01	2.39e-01	4.29e-01	8.72e-01	7.45e-01	5.79e-03	3.16e-02
GOCC PRESYNAPTIC CYTOSKELETON	11	3.80e-01	7.18e-01	0.4010	1.51e-01	-3.38e-01	1.02e-02	9.59e-02	1.20e-01	3.86e-01	5.25e-02	9.53e-01	5.82e-01	4.89e-01
GOCC PRERIBOSOME	104	9.33e-07	4.19e-05	0.4010	3.87e-02	-2.99e-02	-2.75e-01	-2.85e-01	3.68e-02	4.96e-01	5.98e-01	1.22e-06	5.27e-07	5.17e-01
GOCC SIN3 TYPE COMPLEX	20	1.84e-01	5.26e-01	0.4010	1.24e-01	3.82e-02	-1.62e-01	-3.25e-01	1.09e-01	3.37e-01	7.67e-01	2.10e-01	1.19e-02	3.98e-01
GOBP MEMBRANE RAFT LOCALIZATION	8	4.58e-01	7.77e-01	0.4010	2.25e-01	1.78e-01	2.56e-01	-1.05e-01	-3.63e-02	2.70e-01	3.82e-01	2.10e-01	6.07e-01	8.59e-01
GOBP NECROPTOTIC SIGNALING PATHWAY	8	6.32e-01	8.70e-01	0.4000	8.35e-02	-2.22e-01	9.21e-02	2.95e-01	-9.24e-02	6.83e-01	2.76e-01	6.52e-01	1.49e-01	6.51e-01
GOBP REGULATION OF BRANCHING INVOLVED IN LUNG MORPHOGENESIS	6	7.20e-01	9.02e-01	0.4000	-1.28e-01	1.32e-01	-4.95e-02	-3.52e-01	1.14e-02	5.89e-01	5.77e-01	8.34e-01	1.35e-01	9.61e-01
GOBP GAMMA AMINOBUTYRIC ACID SECRETION	12	4.17e-01	7.47e-01	0.4000	-3.92e-02	2.51e-01	3.03e-01	5.71e-02	2.24e-02	8.14e-01	1.32e-01	6.92e-02	7.32e-01	8.93e-01
GOCC TETRASPANIN ENRICHED MICRODOMAIN	10	4.41e-01	7.63e-01	0.4000	-1.76e-01	2.90e-01	6.48e-02	-9.42e-02	1.79e-01	3.35e-01	1.13e-01	7.23e-01	6.06e-01	3.27e-01
GOBP REGULATION OF HUMORAL IMMUNE RESPONSE	45	2.18e-03	2.88e-02	0.4000	-6.33e-02	-1.53e-01	5.56e-02	3.16e-01	-1.73e-01	4.62e-01	7.54e-02	5.19e-01	2.49e-04	4.48e-02
GOBP SNO S RNA PROCESSING	12	4.98e-01	8.02e-01	0.4000	1.42e-01	-1.32e-01	-2.05e-01	-2.43e-01	1.46e-01	3.95e-01	4.28e-01	2.20e-01	1.45e-01	3.81e-01
GOBP CYTOKINETIC PROCESS	42	9.42e-03	8.38e-02	0.4000	6.19e-03	5.81e-02	-2.60e-01	-2.98e-01	-2.56e-03	9.45e-01	5.15e-01	3.53e-03	8.32e-04	9.77e-01
GOBP VENTRAL SPINAL CORD DEVELOPMENT	45	2.36e-03	3.08e-02	0.4000	8.98e-02	1.05e-01	-4.87e-02	-3.05e-01	2.13e-01	2.97e-01	2.24e-01	5.72e-01	4.02e-04	1.33e-02
GOBP COMPLEMENT ACTIVATION	56	7.25e-05	1.84e-03	0.4000	-2.45e-01	-5.70e-02	-1.05e-02	2.76e-01	-1.43e-01	1.52e-03	4.61e-01	8.92e-01	3.60e-04	6.37e-02
GOBP FRUCTOSE TRANSMEMBRANE TRANSPORT	10	5.76e-01	8.41e-01	0.4000	1.28e-01	1.23e-01	2.94e-01	2.04e-01	-1.57e-02	4.85e-01	4.99e-01	1.07e-01	2.64e-01	9.32e-01
GOBP GMP BIOSYNTHETIC PROCESS	13	4.18e-01	7.48e-01	0.4000	-9.93e-02	-1.59e-01	-2.77e-01	-1.97e-01	9.69e-02	5.35e-01	3.21e-01	8.40e-02	2.20e-01	5.45e-01
GOMF PROTEIN TRANSMEMBRANE TRANSPORTER ACTIVITY	26	1.02e-01	3.87e-01	0.4000	3.25e-02	2.25e-02	-2.90e-01	-2.69e-01	3.85e-02	7.74e-01	8.43e-01	1.05e-02	1.74e-02	7.34e-01
GOBP POSITIVE REGULATION OF PLATELET AGGREGATION	11	2.85e-01	6.39e-01	0.4000	7.24e-02	2.29e-01	1.60e-01	-2.73e-01	4.45e-02	6.78e-01	1.89e-01	3.59e-01	1.17e-01	7.98e-01
GOBP ORNITHINE TRANSPORT	6	8.18e-01	9.41e-01	0.4000	2.35e-02	-7.73e-02	2.12e-01	2.97e-01	-1.43e-01	9.21e-01	7.43e-01	3.69e-01	2.08e-01	5.44e-01
GOBP NEGATIVE REGULATION OF MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION	6	6.44e-01	8.75e-01	0.4000	4.13e-02	-3.52e-01	1.67e-01	4.88e-02	-6.24e-02	8.61e-01	1.36e-01	4.79e-01	8.36e-01	7.91e-01
GOCC ATG12 ATG5 ATG16 COMPLEX	5	6.93e-01	8.93e-01	0.4000	-1.88e-01	-1.77e-01	2.60e-02	-2.80e-01	-1.18e-01	4.66e-01	4.93e-01	9.20e-01	2.78e-01	6.49e-01
GOCC SPLICEOSOMAL TRI SNRNP COMPLEX	39	1.40e-02	1.12e-01	0.4000	1.50e-01	-1.25e-01	-2.01e-01	-2.23e-01	1.77e-01	1.04e-01	1.76e-01	3.00e-02	1.60e-02	5.56e-02
GOBP GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION	18	2.31e-01	5.84e-01	0.4000	-1.32e-01	2.02e-01	2.79e-01	1.48e-01	3.93e-02	3.31e-01	1.38e-01	4.02e-02	2.78e-01	7.73e-01
GOBP METAPHASE ANAPHASE TRANSITION OF MEIOTIC CELL CYCLE	5	8.03e-01	9.34e-01	0.4000	3.00e-01	-2.17e-01	-1.40e-01	3.88e-02	3.55e-02	2.45e-01	4.00e-01	5.88e-01	8.80e-01	8.91e-01
GOBP POST EMBRYONIC EYE MORPHOGENESIS	7	5.86e-01	8.45e-01	0.3990	-1.40e-01	-2.52e-01	1.03e-01	-1.39e-01	2.15e-01	5.20e-01	2.48e-01	6.37e-01	5.24e-01	3.24e-01
GOMF INORGANIC PHOSPHATE TRANSMEMBRANE TRANSPORTER ACTIVITY	8	5.27e-01	8.17e-01	0.3990	9.01e-02	2.54e-01	4.35e-02	-2.89e-01	-3.90e-02	6.59e-01	2.14e-01	8.31e-01	1.57e-01	8.49e-01
GOBP POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY	10	4.79e-01	7.91e-01	0.3990	7.38e-02	8.24e-02	1.55e-01	-6.81e-02	3.44e-01	6.86e-01	6.52e-01	3.96e-01	7.09e-01	5.93e-02
GOBP HEPARAN SULFATE PROTEOGLYCAN CATABOLIC PROCESS	8	6.48e-01	8.77e-01	0.3990	3.01e-01	-2.47e-02	-2.37e-01	-1.09e-01	3.31e-03	1.40e-01	9.04e-01	2.46e-01	5.92e-01	9.87e-01
GOBP REGULATION OF CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION	8	6.21e-01	8.64e-01	0.3990	3.92e-02	-2.51e-03	1.82e-02	-2.34e-01	3.21e-01	8.48e-01	9.90e-01	9.29e-01	2.51e-01	1.16e-01
GOBP REGULATION OF T HELPER 2 CELL DIFFERENTIATION	12	2.38e-01	5.94e-01	0.3990	-7.07e-04	3.75e-01	-4.93e-02	1.20e-01	-4.07e-02	9.97e-01	2.44e-02	7.67e-01	4.71e-01	8.07e-01
GOBP REGULATION OF SYNAPTIC ASSEMBLY AT NEUROMUSCULAR JUNCTION	6	7.38e-01	9.10e-01	0.3990	1.68e-01	3.51e-01	2.55e-03	-8.86e-02	1.98e-02	4.75e-01	1.37e-01	9.91e-01	7.07e-01	9.33e-01
GOBP B CELL RECEPTOR SIGNALING PATHWAY	60	1.12e-04	2.60e-03	0.3990	-1.72e-01	2.25e-01	2.54e-01	4.12e-02	1.13e-01	2.11e-02	2.53e-03	6.70e-04	5.81e-01	1.30e-01
GOBP NEGATIVE REGULATION OF MEIOTIC CELL CYCLE	17	2.04e-01	5.53e-01	0.3990	-1.57e-02	-2.17e-01	-9.42e-02	-2.21e-01	2.33e-01	9.11e-01	1.22e-01	5.01e-01	1.15e-01	9.60e-02
GOBP IMP METABOLIC PROCESS	17	2.59e-01	6.16e-01	0.3990	-1.27e-01	-1.34e-01	-2.25e-01	-2.73e-01	-5.77e-03	3.63e-01	3.38e-01	1.09e-01	5.14e-02	9.67e-01
GOBP AMINO ACID BETAINE BIOSYNTHETIC PROCESS	5	7.14e-01	9.01e-01	0.3990	2.36e-01	-2.61e-01	1.66e-01	4.34e-02	-7.58e-02	3.61e-01	3.12e-01	5.19e-01	8.67e-01	7.69e-01
GOMF PROTEIN TRANSPORTER ACTIVITY	38	1.75e-02	1.30e-01	0.3990	2.16e-02	2.00e-02	-2.97e-01	-2.61e-01	-4.61e-02	8.18e-01	8.31e-01	1.52e-03	5.44e-03	6.23e-01
GOBP POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION	10	3.66e-01	7.06e-01	0.3990	5.21e-02	1.04e-01	1.48e-01	-2.92e-01	1.96e-01	7.75e-01	5.68e-01	4.19e-01	1.10e-01	2.83e-01
GOMF MONOAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY	12	3.46e-01	6.93e-01	0.3990	3.56e-01	-1.26e-01	-1.25e-01	2.65e-02	1.17e-02	3.27e-02	4.49e-01	4.54e-01	8.74e-01	9.44e-01
GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX CATALYTIC CORE F 1	7	6.43e-01	8.75e-01	0.3990	-1.15e-01	-1.94e-01	-9.09e-02	-1.09e-01	-2.97e-01	5.97e-01	3.75e-01	6.77e-01	6.18e-01	1.74e-01
GOMF CAMP RESPONSE ELEMENT BINDING PROTEIN BINDING	9	5.86e-01	8.45e-01	0.3990	2.11e-01	1.60e-02	-1.13e-01	-3.09e-01	7.52e-02	2.73e-01	9.34e-01	5.57e-01	1.08e-01	6.96e-01
GOCC AMINOACYL TRNA SYNTHETASE MULTIENZYME COMPLEX	10	4.38e-01	7.60e-01	0.3990	5.93e-02	-3.75e-01	-3.67e-02	-7.12e-02	9.03e-02	7.45e-01	3.99e-02	8.41e-01	6.96e-01	6.21e-01
GOBP GLUCOCORTICOID SECRETION	12	2.26e-01	5.79e-01	0.3980	1.18e-01	2.34e-01	1.04e-01	-2.67e-01	-8.87e-02	4.77e-01	1.61e-01	5.34e-01	1.09e-01	5.95e-01
GOBP RNA 3 URIDYLATION	5	5.71e-01	8.38e-01	0.3980	-1.34e-02	-5.28e-02	3.55e-01	-1.30e-01	-1.14e-01	9.59e-01	8.38e-01	1.70e-01	6.14e-01	6.60e-01
GOBP REGULATION OF T CELL CHEMOTAXIS	15	3.18e-01	6.67e-01	0.3980	-1.06e-01	-1.33e-01	1.25e-01	3.23e-01	-9.87e-02	4.76e-01	3.74e-01	4.00e-01	3.04e-02	5.08e-01
GOBP MULTICELLULAR ORGANISMAL LEVEL WATER HOMEOSTASIS	33	1.55e-02	1.19e-01	0.3980	-1.27e-01	2.99e-01	1.51e-01	1.65e-01	-5.31e-02	2.05e-01	2.93e-03	1.34e-01	1.00e-01	5.97e-01
GOMF SEROTONIN RECEPTOR ACTIVITY	26	7.32e-02	3.23e-01	0.3980	1.62e-01	1.02e-01	2.75e-01	2.04e-01	6.77e-02	1.52e-01	3.66e-01	1.52e-02	7.20e-02	5.50e-01
GOMF ACTIVIN RECEPTOR ACTIVITY	9	3.97e-01	7.31e-01	0.3980	-5.25e-02	-3.93e-02	7.92e-02	-3.52e-01	1.55e-01	7.85e-01	8.38e-01	6.81e-01	6.72e-02	4.22e-01
GOBP REGULATION OF DOSAGE COMPENSATION BY INACTIVATION OF X CHROMOSOME	9	5.82e-01	8.44e-01	0.3980	2.37e-01	2.16e-01	-3.52e-02	-1.57e-01	1.72e-01	2.18e-01	2.61e-01	8.55e-01	4.15e-01	3.72e-01
GOBP DEFENSE RESPONSE TO TUMOR CELL	13	2.97e-01	6.51e-01	0.3980	-1.44e-01	5.90e-02	-2.57e-02	-1.43e-01	3.37e-01	3.69e-01	7.12e-01	8.72e-01	3.73e-01	3.56e-02
GOBP DIRECT OSSIFICATION	7	6.95e-01	8.94e-01	0.3980	-1.89e-01	-3.45e-02	2.88e-01	1.06e-01	1.66e-01	3.86e-01	8.74e-01	1.88e-01	6.29e-01	4.46e-01
GOBP REGULATION OF SYNAPSE PRUNING	6	7.67e-01	9.23e-01	0.3980	-2.32e-01	1.46e-01	2.00e-01	1.75e-01	1.13e-01	3.26e-01	5.36e-01	3.97e-01	4.57e-01	6.31e-01
GOMF MACROMOLECULE TRANSMEMBRANE TRANSPORTER ACTIVITY	31	5.16e-02	2.60e-01	0.3980	3.37e-02	8.17e-04	-2.39e-01	-3.16e-01	1.68e-02	7.45e-01	9.94e-01	2.13e-02	2.33e-03	8.71e-01
GOBP ANGIOGENESIS INVOLVED IN CORONARY VASCULAR MORPHOGENESIS	5	8.55e-01	9.52e-01	0.3980	-1.67e-01	1.23e-01	1.33e-01	1.75e-01	-2.59e-01	5.18e-01	6.34e-01	6.07e-01	4.98e-01	3.16e-01
GOMF ADENYLATE CYCLASE ACTIVITY	15	3.56e-01	7.01e-01	0.3980	-1.77e-01	3.88e-02	1.90e-01	2.88e-01	-7.90e-02	2.35e-01	7.95e-01	2.03e-01	5.31e-02	5.96e-01
GOBP METANEPHRIC PART OF URETERIC BUD DEVELOPMENT	6	6.46e-01	8.76e-01	0.3980	1.91e-01	2.13e-01	2.44e-01	-8.36e-02	-9.77e-02	4.17e-01	3.66e-01	3.00e-01	7.23e-01	6.79e-01
GOBP BLEB ASSEMBLY	11	3.44e-01	6.91e-01	0.3980	-2.85e-01	2.27e-01	-3.16e-02	1.00e-01	-1.19e-01	1.01e-01	1.91e-01	8.56e-01	5.66e-01	4.95e-01
GOCC AP 3 ADAPTOR COMPLEX	9	5.75e-01	8.40e-01	0.3980	8.85e-02	-1.71e-01	-1.53e-01	-3.12e-01	1.59e-02	6.46e-01	3.74e-01	4.26e-01	1.05e-01	9.34e-01
GOMF NAD P H DEHYDROGENASE QUINONE ACTIVITY	37	2.41e-02	1.59e-01	0.3980	9.75e-02	-6.11e-02	-2.23e-01	-2.97e-01	8.23e-02	3.05e-01	5.20e-01	1.87e-02	1.76e-03	3.86e-01
GOBP DOPAMINERGIC NEURON DIFFERENTIATION	40	1.10e-03	1.66e-02	0.3980	1.41e-02	8.48e-02	8.35e-02	-3.22e-01	2.00e-01	8.77e-01	3.53e-01	3.61e-01	4.24e-04	2.85e-02
GOBP RESPONSE TO BACTERIAL LIPOPROTEIN	10	3.46e-01	6.93e-01	0.3980	6.87e-03	2.72e-01	1.79e-01	-1.72e-01	-1.51e-01	9.70e-01	1.37e-01	3.28e-01	3.45e-01	4.10e-01
GOBP PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE	8	6.80e-01	8.87e-01	0.3980	7.33e-02	-1.20e-01	-3.49e-01	-1.27e-01	2.05e-03	7.20e-01	5.56e-01	8.70e-02	5.34e-01	9.92e-01
GOBP GAMMA AMINOBUTYRIC ACID TRANSPORT	19	1.78e-01	5.19e-01	0.3980	4.21e-03	2.51e-01	2.97e-01	7.87e-02	2.28e-02	9.75e-01	5.78e-02	2.51e-02	5.53e-01	8.63e-01
GOBP ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS	12	4.69e-01	7.84e-01	0.3970	8.37e-02	1.04e-01	-2.77e-01	-2.19e-01	1.24e-01	6.16e-01	5.33e-01	9.64e-02	1.89e-01	4.59e-01
GOBP MALATE METABOLIC PROCESS	9	5.29e-01	8.19e-01	0.3970	7.90e-02	-1.87e-01	-1.60e-01	-6.61e-02	-2.94e-01	6.81e-01	3.30e-01	4.06e-01	7.31e-01	1.27e-01
GOBP CHIASMA ASSEMBLY	6	6.47e-01	8.77e-01	0.3970	9.68e-02	2.71e-01	-2.13e-01	-3.69e-02	1.67e-01	6.81e-01	2.50e-01	3.65e-01	8.75e-01	4.78e-01
GOBP PURINE NUCLEOBASE TRANSMEMBRANE TRANSPORT	8	6.85e-01	8.89e-01	0.3970	-4.69e-02	-3.62e-02	1.13e-01	2.42e-01	-2.88e-01	8.18e-01	8.59e-01	5.78e-01	2.35e-01	1.59e-01
GOBP REGULATION OF CATECHOLAMINE METABOLIC PROCESS	18	3.65e-02	2.08e-01	0.3970	5.56e-03	1.27e-01	3.36e-01	-1.68e-01	-7.24e-03	9.67e-01	3.50e-01	1.35e-02	2.16e-01	9.58e-01
GOBP ZINC ION IMPORT ACROSS PLASMA MEMBRANE	9	4.36e-01	7.60e-01	0.3970	-1.25e-01	2.22e-01	1.92e-01	-1.18e-01	-2.05e-01	5.15e-01	2.49e-01	3.18e-01	5.41e-01	2.87e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN ANOTHER COMPOUND AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN	6	5.87e-01	8.45e-01	0.3970	1.24e-01	3.97e-02	-4.07e-02	2.48e-01	2.79e-01	5.99e-01	8.66e-01	8.63e-01	2.94e-01	2.37e-01
GOBP POSITIVE REGULATION OF METALLOPEPTIDASE ACTIVITY	10	2.53e-01	6.10e-01	0.3970	-3.04e-01	1.04e-03	-1.70e-01	1.90e-01	2.32e-02	9.63e-02	9.95e-01	3.51e-01	2.99e-01	8.99e-01
GOCC SPERM MITOCHONDRIAL SHEATH	5	7.98e-01	9.32e-01	0.3970	2.39e-01	-9.97e-02	7.72e-03	2.74e-01	-1.24e-01	3.55e-01	6.99e-01	9.76e-01	2.88e-01	6.31e-01
GOBP SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY	12	3.90e-01	7.26e-01	0.3970	1.91e-01	-2.12e-01	-1.57e-01	-2.26e-01	-2.58e-02	2.52e-01	2.04e-01	3.47e-01	1.75e-01	8.77e-01
GOCC CYTOPLASMIC SIDE OF ENDOSOME MEMBRANE	6	7.61e-01	9.20e-01	0.3970	-2.70e-02	-3.95e-02	-3.59e-01	-9.21e-02	-1.35e-01	9.09e-01	8.67e-01	1.28e-01	6.96e-01	5.67e-01
GOBP MULTI CILIATED EPITHELIAL CELL DIFFERENTIATION	9	5.04e-01	8.05e-01	0.3970	5.69e-02	-5.45e-02	-1.45e-01	-3.09e-01	-1.87e-01	7.67e-01	7.77e-01	4.50e-01	1.09e-01	3.33e-01
GOBP FOREBRAIN RADIAL GLIAL CELL DIFFERENTIATION	7	7.84e-01	9.28e-01	0.3970	9.88e-02	-1.10e-01	-2.16e-01	-2.73e-01	1.18e-01	6.51e-01	6.15e-01	3.22e-01	2.10e-01	5.88e-01
GOCC INTERMEDIATE FILAMENT CYTOSKELETON	232	1.94e-16	2.64e-14	0.3970	-1.75e-01	-7.54e-02	1.89e-01	2.67e-01	-1.17e-01	4.27e-06	4.78e-02	6.69e-07	2.31e-12	2.19e-03
GOBP PHOSPHATE ION HOMEOSTASIS	20	1.49e-01	4.74e-01	0.3970	1.90e-02	2.95e-01	1.81e-01	1.92e-01	-8.58e-03	8.83e-01	2.22e-02	1.62e-01	1.37e-01	9.47e-01
GOBP REGULATION OF OXIDATIVE PHOSPHORYLATION	21	1.45e-01	4.66e-01	0.3970	1.17e-01	5.20e-02	-1.92e-01	-1.83e-01	2.65e-01	3.52e-01	6.80e-01	1.28e-01	1.46e-01	3.52e-02
GOBP NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS	7	5.38e-01	8.22e-01	0.3960	8.90e-02	1.79e-01	1.72e-01	-2.87e-01	7.21e-02	6.84e-01	4.13e-01	4.31e-01	1.88e-01	7.41e-01
GOBP UMP CATABOLIC PROCESS	5	7.01e-01	8.96e-01	0.3960	-4.06e-02	2.16e-01	2.65e-01	-1.63e-01	-1.10e-01	8.75e-01	4.03e-01	3.04e-01	5.28e-01	6.71e-01
GOBP DETECTION OF MOLECULE OF BACTERIAL ORIGIN	13	3.38e-01	6.85e-01	0.3960	-2.23e-01	2.74e-01	1.79e-01	7.02e-03	1.83e-02	1.64e-01	8.75e-02	2.63e-01	9.65e-01	9.09e-01
GOBP HYALURONAN BIOSYNTHETIC PROCESS	14	2.77e-01	6.31e-01	0.3960	2.80e-01	2.69e-01	-1.04e-02	-3.63e-02	6.95e-02	6.94e-02	8.17e-02	9.46e-01	8.14e-01	6.53e-01
GOBP CELL MIGRATION INVOLVED IN METANEPHROS DEVELOPMENT	5	6.54e-01	8.79e-01	0.3960	7.41e-02	1.31e-01	-2.54e-01	5.52e-02	2.58e-01	7.74e-01	6.13e-01	3.25e-01	8.31e-01	3.17e-01
GOCC AXON INITIAL SEGMENT	21	1.07e-01	3.97e-01	0.3960	-2.60e-01	-1.17e-01	9.19e-02	2.59e-01	-1.54e-02	3.89e-02	3.54e-01	4.66e-01	4.02e-02	9.03e-01
GOBP POSITIVE REGULATION OF PLASMINOGEN ACTIVATION	8	5.76e-01	8.40e-01	0.3960	-5.81e-02	2.05e-01	-5.14e-02	1.52e-01	-2.93e-01	7.76e-01	3.16e-01	8.01e-01	4.58e-01	1.51e-01
GOBP VERY LONG CHAIN FATTY ACID CATABOLIC PROCESS	6	7.40e-01	9.11e-01	0.3960	3.70e-01	-7.73e-02	-2.88e-02	-5.67e-02	9.90e-02	1.16e-01	7.43e-01	9.03e-01	8.10e-01	6.75e-01
GOBP ERBB3 SIGNALING PATHWAY	5	8.14e-01	9.39e-01	0.3960	3.61e-02	1.77e-01	1.73e-02	1.36e-01	-3.25e-01	8.89e-01	4.94e-01	9.46e-01	5.98e-01	2.09e-01
GOBP REGULATION OF MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE	6	7.36e-01	9.09e-01	0.3960	-1.38e-01	2.42e-01	-4.88e-02	-1.71e-01	2.18e-01	5.57e-01	3.05e-01	8.36e-01	4.69e-01	3.55e-01
GOBP MOTOR NEURON MIGRATION	13	2.68e-01	6.23e-01	0.3960	-2.07e-01	6.34e-02	2.21e-01	-1.04e-01	2.25e-01	1.97e-01	6.92e-01	1.68e-01	5.17e-01	1.61e-01
GOBP PROLINE METABOLIC PROCESS	10	5.02e-01	8.03e-01	0.3960	-1.67e-01	-8.70e-02	-7.82e-02	-2.83e-01	1.88e-01	3.61e-01	6.34e-01	6.68e-01	1.22e-01	3.04e-01
GOBP MITOCHONDRIAL GENOME MAINTENANCE	31	5.89e-02	2.83e-01	0.3960	7.30e-02	-1.03e-03	-2.93e-01	-2.54e-01	3.17e-02	4.82e-01	9.92e-01	4.74e-03	1.45e-02	7.60e-01
GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVATOR ACTIVITY	17	2.30e-01	5.84e-01	0.3960	-1.62e-02	-2.32e-01	1.98e-01	2.42e-01	-7.12e-02	9.08e-01	9.78e-02	1.58e-01	8.47e-02	6.11e-01
GOCC TRANSCRIPTION FACTOR TFTC COMPLEX	17	2.52e-01	6.08e-01	0.3960	2.78e-01	5.58e-02	-1.83e-01	-1.63e-01	1.26e-01	4.68e-02	6.90e-01	1.92e-01	2.44e-01	3.69e-01
GOMF ORGANIC HYDROXY COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY	50	5.90e-04	1.01e-02	0.3960	-3.60e-02	1.82e-01	3.41e-02	1.99e-01	-2.85e-01	6.59e-01	2.57e-02	6.76e-01	1.51e-02	4.83e-04
GOBP AMINO ACID SALVAGE	7	5.35e-01	8.21e-01	0.3950	2.73e-01	5.53e-02	1.10e-01	-2.55e-01	3.97e-02	2.10e-01	8.00e-01	6.15e-01	2.43e-01	8.56e-01
GOBP NEGATIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY	9	5.50e-01	8.28e-01	0.3950	-2.49e-01	1.30e-01	-1.11e-01	-2.54e-01	-2.23e-02	1.95e-01	4.99e-01	5.62e-01	1.88e-01	9.08e-01
GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY	19	1.53e-01	4.80e-01	0.3950	-4.12e-03	1.44e-01	1.61e-02	-2.31e-01	2.86e-01	9.75e-01	2.77e-01	9.03e-01	8.12e-02	3.08e-02
GOMF NEDD8 TRANSFERASE ACTIVITY	7	7.09e-01	8.98e-01	0.3950	-3.18e-02	2.37e-01	-2.20e-01	-2.25e-01	-1.50e-02	8.84e-01	2.79e-01	3.13e-01	3.02e-01	9.45e-01
GOBP CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE	17	2.48e-01	6.05e-01	0.3950	1.04e-02	1.96e-01	-1.77e-01	-2.94e-01	2.12e-02	9.41e-01	1.62e-01	2.08e-01	3.61e-02	8.80e-01
GOBP REGULATION OF MICROVILLUS ORGANIZATION	13	2.18e-01	5.72e-01	0.3950	-2.34e-01	7.75e-03	3.52e-03	3.18e-01	-9.56e-03	1.44e-01	9.61e-01	9.82e-01	4.70e-02	9.52e-01
GOMF TRNA GUANINE METHYLTRANSFERASE ACTIVITY	11	5.11e-01	8.08e-01	0.3950	-6.88e-02	-2.13e-02	-1.31e-01	-2.80e-01	2.36e-01	6.93e-01	9.03e-01	4.51e-01	1.08e-01	1.75e-01
GOBP REGULATION OF SENSORY PERCEPTION	17	1.38e-01	4.57e-01	0.3950	-2.87e-01	-1.72e-01	-3.33e-02	2.08e-01	-1.51e-03	4.05e-02	2.20e-01	8.12e-01	1.38e-01	9.91e-01
GOBP FOREBRAIN MORPHOGENESIS	13	3.50e-01	6.96e-01	0.3950	-2.02e-01	7.03e-02	-1.05e-01	-2.54e-01	1.88e-01	2.08e-01	6.61e-01	5.13e-01	1.13e-01	2.41e-01
GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY	20	4.35e-02	2.32e-01	0.3950	-1.47e-01	1.62e-01	2.65e-01	-1.91e-01	4.60e-02	2.56e-01	2.11e-01	4.05e-02	1.39e-01	7.22e-01
GOBP PROTEIN POLYUFMYLATION	5	7.92e-01	9.31e-01	0.3950	3.18e-01	5.56e-02	-1.15e-01	-3.70e-02	-1.93e-01	2.18e-01	8.29e-01	6.55e-01	8.86e-01	4.55e-01
GOMF CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING	39	8.76e-03	8.00e-02	0.3950	2.56e-01	8.63e-02	-8.66e-02	-2.28e-01	1.53e-01	5.59e-03	3.51e-01	3.49e-01	1.35e-02	9.90e-02
GOCC MRNA CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR COMPLEX	14	4.26e-01	7.52e-01	0.3950	1.58e-01	-1.12e-01	-2.33e-01	-2.45e-01	6.39e-02	3.05e-01	4.69e-01	1.31e-01	1.12e-01	6.79e-01
GOMF PHOSPHATIDYLGLYCEROL BINDING	15	1.90e-01	5.36e-01	0.3950	-1.46e-01	1.51e-01	1.84e-01	-1.89e-01	2.06e-01	3.29e-01	3.12e-01	2.16e-01	2.05e-01	1.67e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH OXIDATION OF A PAIR OF DONORS RESULTING IN THE REDUCTION OF MOLECULAR OXYGEN TO TWO MOLECULES OF WATER	10	5.00e-01	8.03e-01	0.3950	-1.66e-01	-9.42e-02	-1.57e-01	-2.73e-01	-1.43e-01	3.63e-01	6.06e-01	3.88e-01	1.35e-01	4.34e-01
GOMF INHIBITORY MHC CLASS I RECEPTOR ACTIVITY	9	3.61e-01	7.04e-01	0.3950	-2.11e-01	-1.70e-01	-1.22e-01	1.96e-01	1.70e-01	2.72e-01	3.76e-01	5.25e-01	3.10e-01	3.76e-01
GOBP REPLICATION BORN DOUBLE STRAND BREAK REPAIR VIA SISTER CHROMATID EXCHANGE	6	7.37e-01	9.09e-01	0.3950	1.96e-01	2.13e-01	1.49e-02	1.92e-02	2.68e-01	4.07e-01	3.66e-01	9.50e-01	9.35e-01	2.56e-01
GOBP NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION	9	6.07e-01	8.57e-01	0.3950	-1.16e-01	-1.41e-01	-1.34e-01	-2.70e-01	1.77e-01	5.48e-01	4.62e-01	4.85e-01	1.60e-01	3.58e-01
GOCC CELL BODY FIBER	7	7.81e-01	9.28e-01	0.3950	8.70e-02	-1.36e-02	-2.85e-01	-2.20e-01	1.36e-01	6.90e-01	9.50e-01	1.91e-01	3.14e-01	5.34e-01
GOMF MAP KINASE SCAFFOLD ACTIVITY	11	4.28e-01	7.54e-01	0.3950	1.81e-01	2.40e-01	1.23e-01	1.69e-01	1.46e-01	2.99e-01	1.67e-01	4.80e-01	3.31e-01	4.01e-01
GOCC DIHYDROLIPOYL DEHYDROGENASE COMPLEX	8	6.06e-01	8.55e-01	0.3950	6.28e-02	1.06e-01	-1.91e-02	1.45e-01	-3.45e-01	7.58e-01	6.03e-01	9.25e-01	4.77e-01	9.10e-02
GOBP ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS	24	1.17e-01	4.18e-01	0.3950	1.22e-01	1.20e-01	-1.66e-01	-3.01e-01	9.23e-02	3.01e-01	3.10e-01	1.59e-01	1.08e-02	4.34e-01
GOBP OTIC VESICLE DEVELOPMENT	15	2.47e-01	6.04e-01	0.3950	4.16e-02	7.59e-02	1.40e-01	-1.00e-01	3.44e-01	7.80e-01	6.11e-01	3.50e-01	5.00e-01	2.09e-02
GOBP NEUROBLAST MIGRATION	6	7.92e-01	9.31e-01	0.3940	1.71e-01	-2.87e-02	-1.32e-01	-1.33e-01	3.01e-01	4.69e-01	9.03e-01	5.76e-01	5.72e-01	2.02e-01
GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE	37	2.21e-02	1.50e-01	0.3940	7.86e-02	5.64e-02	-2.27e-01	-3.08e-01	8.97e-03	4.08e-01	5.53e-01	1.71e-02	1.19e-03	9.25e-01
GOBP PURINE NUCLEOSIDE CATABOLIC PROCESS	8	6.30e-01	8.69e-01	0.3940	1.40e-02	1.72e-01	8.17e-02	3.02e-01	-1.67e-01	9.45e-01	4.00e-01	6.89e-01	1.39e-01	4.13e-01
GOBP VITAMIN CATABOLIC PROCESS	14	2.59e-01	6.16e-01	0.3940	5.39e-02	1.47e-01	6.55e-02	1.97e-02	3.55e-01	7.27e-01	3.40e-01	6.71e-01	8.98e-01	2.13e-02
GOBP NEGATIVE REGULATION OF MACROPHAGE DIFFERENTIATION	8	5.35e-01	8.21e-01	0.3940	6.73e-02	2.70e-01	-1.50e-01	4.44e-02	-2.31e-01	7.42e-01	1.86e-01	4.63e-01	8.28e-01	2.57e-01
GOCC PLATELET DENSE GRANULE LUMEN	14	2.37e-01	5.93e-01	0.3940	2.66e-02	-1.91e-01	-8.51e-02	2.98e-01	-1.49e-01	8.63e-01	2.17e-01	5.81e-01	5.36e-02	3.34e-01
GOBP FIBROBLAST GROWTH FACTOR PRODUCTION	9	3.67e-01	7.07e-01	0.3940	-2.14e-01	6.08e-02	1.97e-01	-2.55e-01	4.41e-02	2.66e-01	7.52e-01	3.05e-01	1.86e-01	8.19e-01
GOBP REGULATION OF METAPHASE PLATE CONGRESSION	13	4.72e-01	7.86e-01	0.3940	1.90e-01	-1.95e-02	-2.11e-01	-2.31e-01	1.45e-01	2.36e-01	9.03e-01	1.88e-01	1.49e-01	3.65e-01
GOBP BASOLATERAL PROTEIN SECRETION	5	8.08e-01	9.37e-01	0.3940	-1.17e-02	2.51e-01	1.49e-01	-1.85e-01	1.88e-01	9.64e-01	3.30e-01	5.65e-01	4.73e-01	4.66e-01
GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT ENDOSOME TO POSTSYNAPTIC MEMBRANE	10	4.89e-01	7.97e-01	0.3940	1.52e-02	-3.22e-01	-1.45e-01	1.21e-01	-1.24e-01	9.34e-01	7.78e-02	4.26e-01	5.07e-01	4.96e-01
GOBP NEGATIVE CHEMOTAXIS	46	4.78e-03	5.21e-02	0.3940	-1.92e-01	-2.74e-02	1.50e-01	2.80e-01	-1.28e-01	2.40e-02	7.48e-01	7.74e-02	1.01e-03	1.34e-01
GOBP MITOTIC CYTOKINETIC PROCESS	26	1.07e-01	3.97e-01	0.3940	9.66e-02	4.43e-02	-2.41e-01	-2.92e-01	1.47e-02	3.94e-01	6.96e-01	3.33e-02	9.86e-03	8.97e-01
GOBP B CELL APOPTOTIC PROCESS	26	3.38e-02	1.98e-01	0.3940	-2.16e-01	2.72e-01	-3.44e-02	-1.69e-01	6.66e-02	5.61e-02	1.63e-02	7.61e-01	1.35e-01	5.56e-01
GOCC ANAPHASE PROMOTING COMPLEX	21	1.66e-01	5.01e-01	0.3940	2.37e-01	8.69e-02	-1.62e-01	-2.32e-01	1.08e-01	6.02e-02	4.90e-01	2.00e-01	6.60e-02	3.93e-01
GOBP PYRIMIDINE NUCLEOBASE BIOSYNTHETIC PROCESS	7	6.77e-01	8.86e-01	0.3940	9.26e-02	-3.60e-01	-1.01e-01	6.19e-02	5.31e-02	6.71e-01	9.89e-02	6.45e-01	7.77e-01	8.08e-01
GOBP PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS	14	2.87e-01	6.41e-01	0.3940	1.70e-02	3.64e-01	4.85e-02	-1.15e-01	8.09e-02	9.12e-01	1.84e-02	7.53e-01	4.55e-01	6.00e-01
GOBP NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVITY	24	1.36e-01	4.55e-01	0.3930	8.95e-03	-9.91e-02	-2.03e-01	-2.93e-01	1.34e-01	9.39e-01	4.01e-01	8.59e-02	1.29e-02	2.56e-01
GOBP EMBRYONIC CAMERA TYPE EYE DEVELOPMENT	37	9.64e-03	8.54e-02	0.3930	2.12e-01	4.62e-02	-4.16e-03	-2.13e-01	2.50e-01	2.56e-02	6.27e-01	9.65e-01	2.52e-02	8.57e-03
GOBP DNA PROTECTION	6	6.97e-01	8.94e-01	0.3930	4.09e-03	3.31e-02	-2.43e-01	-7.68e-02	2.98e-01	9.86e-01	8.88e-01	3.03e-01	7.45e-01	2.06e-01
GOMF HISTONE H4K20 METHYLTRANSFERASE ACTIVITY	10	2.42e-01	5.99e-01	0.3930	1.56e-01	1.26e-01	1.53e-01	-2.83e-01	-1.03e-01	3.93e-01	4.89e-01	4.02e-01	1.21e-01	5.73e-01
GOCC F ACTIN CAPPING PROTEIN COMPLEX	8	6.87e-01	8.90e-01	0.3930	7.63e-02	2.76e-01	2.33e-01	1.36e-01	-1.35e-02	7.08e-01	1.77e-01	2.54e-01	5.07e-01	9.47e-01
GOCC AXOLEMMA	15	2.86e-01	6.40e-01	0.3930	1.61e-01	-5.24e-02	2.87e-01	2.01e-01	-5.61e-02	2.80e-01	7.25e-01	5.46e-02	1.77e-01	7.07e-01
GOBP NEGATIVE REGULATION OF MUSCLE ADAPTATION	10	5.38e-01	8.22e-01	0.3930	-2.54e-01	1.74e-01	2.06e-01	6.18e-02	-1.17e-01	1.64e-01	3.42e-01	2.59e-01	7.35e-01	5.23e-01
GOBP AMINO ACID NEUROTRANSMITTER REUPTAKE	10	5.91e-01	8.47e-01	0.3930	1.08e-02	1.60e-01	2.85e-01	1.68e-01	-1.41e-01	9.53e-01	3.82e-01	1.19e-01	3.59e-01	4.41e-01
GOBP SEPTUM PRIMUM DEVELOPMENT	5	7.97e-01	9.32e-01	0.3930	2.81e-01	6.47e-04	1.24e-01	-1.18e-01	2.16e-01	2.77e-01	9.98e-01	6.31e-01	6.49e-01	4.03e-01
GOBP NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT	21	9.78e-02	3.78e-01	0.3930	1.23e-01	-2.36e-01	-2.25e-01	6.54e-02	-1.70e-01	3.29e-01	6.12e-02	7.49e-02	6.04e-01	1.78e-01
GOBP COMMISSURAL NEURON AXON GUIDANCE	12	4.81e-01	7.92e-01	0.3930	-7.49e-02	-9.41e-02	2.29e-01	2.86e-01	7.54e-02	6.53e-01	5.72e-01	1.70e-01	8.61e-02	6.51e-01
GOBP PHOSPHOLIPID HOMEOSTASIS	16	2.31e-01	5.85e-01	0.3930	-2.11e-01	-7.36e-02	-1.79e-01	-1.28e-02	-2.69e-01	1.44e-01	6.10e-01	2.14e-01	9.29e-01	6.29e-02
GOBP TRNA PROCESSING	126	6.06e-08	3.54e-06	0.3930	7.17e-02	-8.56e-02	-2.74e-01	-2.57e-01	3.08e-02	1.64e-01	9.68e-02	1.11e-07	6.34e-07	5.51e-01
GOMF INSULIN RECEPTOR SUBSTRATE BINDING	13	2.68e-01	6.23e-01	0.3930	-1.55e-01	2.30e-01	2.56e-01	-1.08e-01	-4.98e-03	3.33e-01	1.50e-01	1.10e-01	5.02e-01	9.75e-01
GOBP PROTEIN K29 LINKED UBIQUITINATION	7	6.57e-01	8.80e-01	0.3930	1.71e-01	-1.26e-01	-1.40e-01	-4.98e-02	-2.95e-01	4.34e-01	5.62e-01	5.20e-01	8.20e-01	1.77e-01
GOBP NEGATIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY	12	2.50e-01	6.07e-01	0.3930	-1.09e-01	-5.46e-02	-4.19e-02	-3.32e-01	-1.66e-01	5.12e-01	7.43e-01	8.02e-01	4.66e-02	3.20e-01
GOBP PROTEIN POLYGLUTAMYLATION	12	3.94e-01	7.29e-01	0.3930	-2.54e-01	2.54e-01	1.50e-01	5.05e-02	9.36e-03	1.28e-01	1.28e-01	3.68e-01	7.62e-01	9.55e-01
GOBP REGULATION OF SPINDLE ORGANIZATION	46	6.41e-03	6.40e-02	0.3930	8.32e-02	-3.92e-03	-2.25e-01	-3.11e-01	4.33e-03	3.29e-01	9.63e-01	8.36e-03	2.62e-04	9.59e-01
GOBP TELOMERE TETHERING AT NUCLEAR PERIPHERY	6	7.22e-01	9.03e-01	0.3930	1.10e-01	-2.84e-01	8.48e-02	5.76e-03	2.33e-01	6.39e-01	2.29e-01	7.19e-01	9.81e-01	3.23e-01
GOBP INTRACELLULAR PH ELEVATION	7	6.98e-01	8.94e-01	0.3930	1.30e-01	9.92e-02	3.37e-01	1.12e-01	-3.62e-02	5.51e-01	6.49e-01	1.23e-01	6.07e-01	8.68e-01
GOBP GLUTATHIONE CATABOLIC PROCESS	6	7.29e-01	9.07e-01	0.3930	2.76e-01	9.60e-03	-2.75e-01	-1.22e-02	4.42e-02	2.42e-01	9.68e-01	2.43e-01	9.59e-01	8.51e-01
GOBP MULTICELLULAR ORGANISMAL LEVEL IRON ION HOMEOSTASIS	25	5.47e-02	2.69e-01	0.3920	-1.43e-01	3.38e-01	1.30e-01	5.72e-03	-4.97e-02	2.15e-01	3.46e-03	2.60e-01	9.61e-01	6.67e-01
GOBP NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE	16	1.98e-01	5.47e-01	0.3920	2.08e-01	-1.27e-01	-1.35e-01	-2.63e-01	-8.29e-02	1.49e-01	3.77e-01	3.51e-01	6.81e-02	5.66e-01
GOBP MEDIUM CHAIN FATTY ACYL COA METABOLIC PROCESS	5	8.55e-01	9.52e-01	0.3920	2.60e-01	7.96e-02	-7.43e-02	-1.66e-01	2.17e-01	3.14e-01	7.58e-01	7.73e-01	5.20e-01	4.02e-01
GOBP SYNAPTONEMAL COMPLEX ORGANIZATION	25	3.62e-02	2.06e-01	0.3920	-3.55e-02	-1.93e-01	1.27e-01	-3.56e-02	3.13e-01	7.58e-01	9.55e-02	2.70e-01	7.58e-01	6.74e-03
GOBP PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION	28	7.30e-02	3.23e-01	0.3920	-7.88e-02	-1.68e-01	-2.22e-01	-2.55e-01	7.00e-02	4.71e-01	1.23e-01	4.16e-02	1.96e-02	5.22e-01
GOMF PURINE RIBONUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY	19	1.83e-01	5.25e-01	0.3920	1.40e-01	1.10e-01	-1.30e-01	-3.23e-01	2.39e-02	2.91e-01	4.05e-01	3.27e-01	1.46e-02	8.57e-01
GOBP COMPLEMENT DEPENDENT CYTOTOXICITY	13	1.79e-01	5.20e-01	0.3920	1.60e-01	2.19e-01	-1.96e-02	2.47e-01	1.38e-01	3.19e-01	1.72e-01	9.03e-01	1.23e-01	3.88e-01
GOBP POSITIVE REGULATION OF DNA RECOMBINATION	67	1.64e-04	3.54e-03	0.3920	2.53e-01	-1.74e-02	-1.64e-01	-2.17e-01	1.25e-01	3.37e-04	8.05e-01	2.03e-02	2.17e-03	7.79e-02
GOBP MITOCHONDRIAL PROTEIN PROCESSING	13	3.87e-01	7.24e-01	0.3920	2.61e-01	8.49e-03	-2.71e-01	-1.06e-01	3.17e-02	1.04e-01	9.58e-01	9.07e-02	5.06e-01	8.43e-01
GOBP STOMACH DEVELOPMENT	5	8.28e-01	9.44e-01	0.3920	1.09e-01	7.84e-02	-3.41e-01	-1.16e-01	-7.70e-02	6.73e-01	7.62e-01	1.87e-01	6.54e-01	7.66e-01
GOBP MEIOTIC ATTACHMENT OF TELOMERE TO NUCLEAR ENVELOPE	5	8.02e-01	9.34e-01	0.3920	4.98e-02	-2.27e-01	1.12e-01	3.28e-02	2.93e-01	8.47e-01	3.79e-01	6.64e-01	8.99e-01	2.56e-01
GOBP PROTEIN LOCALIZATION TO CILIARY TRANSITION ZONE	8	6.50e-01	8.78e-01	0.3920	1.36e-01	1.98e-01	-1.88e-01	-2.14e-01	-1.21e-01	5.06e-01	3.31e-01	3.57e-01	2.95e-01	5.53e-01
GOBP SINOATRIAL NODE DEVELOPMENT	12	3.54e-01	7.00e-01	0.3920	3.23e-02	1.58e-01	9.92e-02	-2.63e-01	2.20e-01	8.47e-01	3.44e-01	5.52e-01	1.14e-01	1.86e-01
GOBP COPULATION	19	1.33e-01	4.50e-01	0.3920	-1.30e-01	-1.09e-01	1.45e-01	2.72e-01	1.73e-01	3.26e-01	4.13e-01	2.75e-01	4.03e-02	1.92e-01
GOBP COPPER ION HOMEOSTASIS	17	1.58e-01	4.88e-01	0.3920	-1.82e-01	2.85e-01	-1.23e-01	-1.54e-01	2.10e-02	1.95e-01	4.20e-02	3.79e-01	2.72e-01	8.81e-01
GOCC RETROMER COMPLEX	11	3.51e-01	6.97e-01	0.3920	-1.18e-01	7.12e-02	4.32e-02	-3.46e-01	1.14e-01	4.99e-01	6.83e-01	8.04e-01	4.71e-02	5.11e-01
GOCC ARYL HYDROCARBON RECEPTOR COMPLEX	8	5.98e-01	8.51e-01	0.3920	-3.57e-01	-5.63e-02	1.50e-01	-9.94e-03	-1.99e-02	8.05e-02	7.83e-01	4.63e-01	9.61e-01	9.22e-01
GOBP FUCOSE CATABOLIC PROCESS	9	3.94e-01	7.29e-01	0.3920	-1.97e-01	9.41e-02	-9.70e-02	9.23e-03	3.10e-01	3.06e-01	6.25e-01	6.14e-01	9.62e-01	1.07e-01
GOBP POSITIVE REGULATION OF MAST CELL CHEMOTAXIS	5	8.79e-01	9.61e-01	0.3920	-4.41e-02	1.95e-01	2.48e-01	2.27e-01	1.90e-02	8.64e-01	4.50e-01	3.36e-01	3.80e-01	9.41e-01
GOBP NATURAL KILLER CELL PROLIFERATION	14	3.31e-01	6.79e-01	0.3920	1.06e-01	9.46e-02	3.09e-01	8.10e-02	1.76e-01	4.93e-01	5.40e-01	4.52e-02	6.00e-01	2.54e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN	25	1.98e-02	1.40e-01	0.3910	-1.69e-01	-9.13e-02	7.29e-03	-1.71e-01	-2.95e-01	1.44e-01	4.30e-01	9.50e-01	1.38e-01	1.07e-02
GOBP POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION	13	3.87e-01	7.24e-01	0.3910	6.34e-02	6.72e-02	-8.48e-02	-1.66e-01	3.31e-01	6.92e-01	6.75e-01	5.97e-01	2.99e-01	3.85e-02
GOBP BASE EXCISION REPAIR	42	8.17e-03	7.60e-02	0.3910	7.38e-02	-3.90e-02	-3.26e-01	-1.71e-01	1.02e-01	4.08e-01	6.62e-01	2.52e-04	5.55e-02	2.52e-01
GOBP POSITIVE REGULATION OF NEUTROPHIL MIGRATION	29	2.11e-02	1.46e-01	0.3910	-6.56e-02	3.67e-01	5.11e-02	6.59e-02	-8.43e-02	5.41e-01	6.23e-04	6.34e-01	5.39e-01	4.32e-01
GOMF DEATH DOMAIN BINDING	11	3.24e-01	6.72e-01	0.3910	-4.58e-02	1.20e-01	-7.88e-03	-3.60e-01	-8.30e-02	7.93e-01	4.89e-01	9.64e-01	3.88e-02	6.33e-01
GOMF CATECHOLAMINE BINDING	12	1.99e-01	5.48e-01	0.3910	1.68e-01	3.84e-02	2.23e-01	-2.34e-01	1.37e-01	3.13e-01	8.18e-01	1.81e-01	1.61e-01	4.10e-01
GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA SIGNALING PATHWAY	7	6.72e-01	8.84e-01	0.3910	1.99e-01	-2.15e-01	-2.49e-01	4.24e-02	5.55e-02	3.62e-01	3.24e-01	2.53e-01	8.46e-01	7.99e-01
GOBP SEROTONIN RECEPTOR SIGNALING PATHWAY	27	7.53e-02	3.29e-01	0.3910	1.55e-01	8.43e-02	2.69e-01	2.16e-01	5.44e-02	1.64e-01	4.48e-01	1.57e-02	5.18e-02	6.24e-01
GOMF CO SMAD BINDING	9	5.78e-01	8.42e-01	0.3910	8.97e-02	3.00e-01	2.31e-01	1.91e-02	-3.39e-02	6.41e-01	1.19e-01	2.30e-01	9.21e-01	8.60e-01
GOBP FC RECEPTOR SIGNALING PATHWAY	52	6.33e-04	1.06e-02	0.3910	-3.74e-02	1.71e-01	2.97e-01	2.04e-02	1.84e-01	6.41e-01	3.32e-02	2.15e-04	7.99e-01	2.18e-02
GOBP NEGATIVE REGULATION OF MEMBRANE DEPOLARIZATION	7	7.08e-01	8.97e-01	0.3910	2.11e-01	1.27e-01	2.78e-01	8.07e-02	9.23e-02	3.33e-01	5.62e-01	2.03e-01	7.11e-01	6.72e-01
GOMF UBIQUITIN LIGASE COMPLEX SCAFFOLD ACTIVITY	6	5.56e-01	8.31e-01	0.3910	-6.19e-02	7.46e-02	2.09e-01	-1.67e-01	-2.68e-01	7.93e-01	7.52e-01	3.74e-01	4.79e-01	2.56e-01
GOBP MONOCYTE CHEMOTAXIS	66	1.33e-04	3.01e-03	0.3910	-1.88e-01	1.71e-01	1.38e-01	2.06e-01	-1.64e-01	8.35e-03	1.61e-02	5.24e-02	3.87e-03	2.15e-02
GOMF ACTIVIN RECEPTOR ACTIVITY TYPE I	5	7.53e-01	9.17e-01	0.3910	-8.79e-02	3.12e-02	3.96e-02	-3.68e-01	8.42e-02	7.33e-01	9.04e-01	8.78e-01	1.54e-01	7.44e-01
GOBP POST EMBRYONIC ANIMAL MORPHOGENESIS	16	1.75e-01	5.16e-01	0.3910	3.85e-03	-2.61e-01	2.14e-01	7.33e-02	1.82e-01	9.79e-01	7.06e-02	1.38e-01	6.12e-01	2.07e-01
GOCC U6 SNRNP	8	5.94e-01	8.48e-01	0.3910	2.69e-01	9.51e-03	-8.87e-02	-2.63e-01	-5.26e-02	1.87e-01	9.63e-01	6.64e-01	1.97e-01	7.97e-01
GOMF COLLAGEN BINDING INVOLVED IN CELL MATRIX ADHESION	5	7.00e-01	8.96e-01	0.3910	-1.64e-01	3.02e-01	-3.38e-02	1.71e-01	6.56e-02	5.26e-01	2.43e-01	8.96e-01	5.08e-01	7.99e-01
GOBP POSITIVE REGULATION OF AMINE METABOLIC PROCESS	6	6.81e-01	8.88e-01	0.3900	-7.46e-03	-6.63e-02	2.09e-01	5.05e-02	-3.19e-01	9.75e-01	7.79e-01	3.76e-01	8.30e-01	1.76e-01
GOBP NEURONAL ION CHANNEL CLUSTERING	12	3.89e-01	7.25e-01	0.3900	-2.53e-01	7.49e-02	-7.29e-02	1.28e-02	-2.78e-01	1.29e-01	6.53e-01	6.62e-01	9.39e-01	9.56e-02
GOBP REGULATION OF POLYAMINE TRANSMEMBRANE TRANSPORT	5	7.99e-01	9.33e-01	0.3900	-7.95e-02	2.69e-01	6.75e-02	-8.09e-02	-2.50e-01	7.58e-01	2.98e-01	7.94e-01	7.54e-01	3.32e-01
GOMF ORNITHINE DECARBOXYLASE REGULATOR ACTIVITY	5	7.99e-01	9.33e-01	0.3900	-7.95e-02	2.69e-01	6.75e-02	-8.09e-02	-2.50e-01	7.58e-01	2.98e-01	7.94e-01	7.54e-01	3.32e-01
GOBP POSITIVE REGULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION	8	6.42e-01	8.75e-01	0.3900	-8.69e-02	2.21e-01	-2.22e-01	-2.11e-01	4.58e-02	6.71e-01	2.79e-01	2.78e-01	3.01e-01	8.22e-01
GOBP REGULATION OF WOUND HEALING SPREADING OF EPIDERMAL CELLS	8	6.46e-01	8.76e-01	0.3900	2.03e-01	2.20e-01	1.45e-01	1.48e-01	1.40e-01	3.20e-01	2.81e-01	4.77e-01	4.67e-01	4.93e-01
GOBP NEGATIVE REGULATION OF TUBULIN DEACETYLATION	5	8.06e-01	9.36e-01	0.3900	2.93e-01	6.60e-02	1.70e-01	-5.43e-02	1.73e-01	2.56e-01	7.98e-01	5.09e-01	8.33e-01	5.04e-01
GOMF PROFILIN BINDING	10	5.11e-01	8.08e-01	0.3900	2.99e-01	2.10e-01	-2.17e-02	-1.21e-01	5.77e-02	1.01e-01	2.50e-01	9.05e-01	5.08e-01	7.52e-01
GOCC GAMMA TUBULIN COMPLEX	16	3.32e-01	6.80e-01	0.3900	2.29e-01	-4.19e-02	-2.53e-01	-1.77e-01	4.90e-02	1.13e-01	7.71e-01	7.92e-02	2.20e-01	7.34e-01
GOCC BASEMENT MEMBRANE	85	9.20e-06	3.09e-04	0.3900	-1.17e-01	-6.15e-02	1.19e-01	3.09e-01	-1.57e-01	6.19e-02	3.27e-01	5.84e-02	8.16e-07	1.23e-02
GOBP REGULATION OF MITOCHONDRIAL DNA METABOLIC PROCESS	8	6.99e-01	8.95e-01	0.3900	2.43e-01	5.39e-02	-2.47e-01	-1.68e-01	2.76e-02	2.34e-01	7.92e-01	2.26e-01	4.11e-01	8.92e-01
GOCC U5 SNRNP	22	1.43e-01	4.63e-01	0.3900	5.06e-02	-1.87e-01	-1.57e-01	-1.86e-01	2.35e-01	6.81e-01	1.29e-01	2.02e-01	1.32e-01	5.64e-02
GOBP METANEPHRIC TUBULE FORMATION	6	6.09e-01	8.58e-01	0.3900	-1.20e-01	1.29e-01	2.98e-01	-1.78e-01	3.28e-03	6.11e-01	5.84e-01	2.06e-01	4.49e-01	9.89e-01
GOBP MIRNA CATABOLIC PROCESS	18	6.72e-02	3.06e-01	0.3900	-9.32e-02	1.94e-01	1.30e-01	-2.23e-01	-1.98e-01	4.94e-01	1.55e-01	3.40e-01	1.02e-01	1.46e-01
GOBP MEMBRANOUS SEPTUM MORPHOGENESIS	8	3.73e-01	7.13e-01	0.3900	-1.22e-01	-8.27e-02	1.46e-01	-3.29e-01	3.00e-02	5.51e-01	6.85e-01	4.75e-01	1.07e-01	8.83e-01
GOBP REGULATION OF GLOMERULUS DEVELOPMENT	5	6.59e-01	8.80e-01	0.3900	-8.98e-02	-1.34e-01	5.97e-02	-2.55e-01	-2.39e-01	7.28e-01	6.03e-01	8.17e-01	3.23e-01	3.55e-01
GOBP FATTY ACID ELONGATION	12	4.82e-01	7.93e-01	0.3890	-4.76e-02	-1.43e-02	-1.98e-01	-3.29e-01	-4.08e-02	7.75e-01	9.32e-01	2.35e-01	4.84e-02	8.07e-01
GOBP NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION	16	9.06e-02	3.63e-01	0.3890	3.11e-01	1.68e-02	1.85e-01	-6.17e-02	-1.29e-01	3.12e-02	9.08e-01	2.01e-01	6.69e-01	3.73e-01
GOBP CELL MOTILITY INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION	7	6.72e-01	8.84e-01	0.3890	1.74e-01	-1.02e-01	-3.63e-02	2.64e-01	-2.00e-01	4.24e-01	6.40e-01	8.68e-01	2.27e-01	3.60e-01
GOMF 11 CIS RETINAL BINDING	7	6.70e-01	8.83e-01	0.3890	-1.48e-01	-5.73e-02	-1.73e-01	1.32e-01	-2.81e-01	4.98e-01	7.93e-01	4.27e-01	5.45e-01	1.98e-01
GOMF LNCRNA BINDING	18	1.33e-01	4.50e-01	0.3890	2.68e-01	-1.07e-01	1.10e-01	1.47e-01	-1.86e-01	4.89e-02	4.31e-01	4.20e-01	2.80e-01	1.73e-01
GOBP POSITIVE REGULATION OF PROTEIN KINASE A SIGNALING	12	3.86e-01	7.24e-01	0.3890	-1.32e-01	-3.53e-01	1.35e-02	9.75e-02	-1.26e-02	4.30e-01	3.45e-02	9.35e-01	5.59e-01	9.40e-01
GOBP DICARBOXYLIC ACID CATABOLIC PROCESS	18	1.35e-01	4.54e-01	0.3890	-2.57e-01	-1.86e-01	5.20e-03	-1.53e-01	1.66e-01	5.95e-02	1.73e-01	9.70e-01	2.60e-01	2.22e-01
GOCC DENTATE GYRUS MOSSY FIBER	6	5.61e-01	8.33e-01	0.3890	9.09e-02	2.63e-01	-8.60e-02	2.39e-01	9.76e-02	7.00e-01	2.64e-01	7.15e-01	3.12e-01	6.79e-01
GOBP ATRIAL SEPTUM MORPHOGENESIS	15	2.45e-01	6.02e-01	0.3890	1.91e-01	1.31e-01	4.63e-02	-2.63e-01	1.62e-01	2.01e-01	3.79e-01	7.56e-01	7.76e-02	2.76e-01
GOBP RESPONSE TO AMPHETAMINE	29	8.00e-03	7.49e-02	0.3890	1.51e-01	2.20e-01	1.86e-01	-8.78e-02	-1.94e-01	1.58e-01	4.03e-02	8.24e-02	4.13e-01	7.06e-02
GOCC MRNA CLEAVAGE FACTOR COMPLEX	19	2.26e-01	5.79e-01	0.3890	1.71e-01	-7.97e-02	-1.70e-01	-2.85e-01	7.44e-02	1.98e-01	5.48e-01	2.00e-01	3.12e-02	5.75e-01
GOBP SNORNA LOCALIZATION	6	8.12e-01	9.38e-01	0.3890	2.47e-02	7.09e-02	-3.23e-01	-1.99e-01	4.42e-02	9.17e-01	7.64e-01	1.71e-01	3.99e-01	8.51e-01
GOBP NEGATIVE REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY	35	2.14e-02	1.48e-01	0.3890	3.18e-02	-8.09e-02	-1.90e-01	-1.77e-01	2.76e-01	7.45e-01	4.08e-01	5.18e-02	7.01e-02	4.66e-03
GOMF ALPHA ACTININ BINDING	28	1.02e-01	3.87e-01	0.3890	-3.04e-02	4.15e-02	2.82e-01	2.59e-01	-4.10e-02	7.81e-01	7.04e-01	9.68e-03	1.76e-02	7.07e-01
GOCC EXOCYST	14	2.81e-01	6.34e-01	0.3890	1.74e-01	4.51e-02	3.30e-01	8.37e-02	5.79e-02	2.60e-01	7.70e-01	3.27e-02	5.88e-01	7.08e-01
GOCC RESPIRATORY CHAIN COMPLEX IV	22	1.67e-01	5.03e-01	0.3890	1.25e-01	-1.23e-01	-1.90e-01	-2.81e-01	7.39e-02	3.09e-01	3.18e-01	1.23e-01	2.26e-02	5.48e-01
GOMF GROWTH HORMONE RECEPTOR BINDING	7	7.84e-01	9.28e-01	0.3890	1.45e-01	-7.87e-02	-2.47e-01	-1.82e-01	1.73e-01	5.06e-01	7.18e-01	2.59e-01	4.03e-01	4.28e-01
GOBP MINERALOCORTICOID METABOLIC PROCESS	13	4.34e-01	7.57e-01	0.3890	-2.27e-01	-1.27e-01	1.14e-01	2.26e-01	-1.39e-01	1.57e-01	4.28e-01	4.76e-01	1.58e-01	3.84e-01
GOBP ATRIOVENTRICULAR VALVE DEVELOPMENT	29	9.01e-03	8.14e-02	0.3890	1.45e-01	2.02e-01	2.40e-01	-1.65e-01	6.64e-02	1.77e-01	5.99e-02	2.53e-02	1.23e-01	5.36e-01
GOBP DOUBLE STRAND BREAK REPAIR VIA SYNTHESIS DEPENDENT STRAND ANNEALING	8	6.62e-01	8.81e-01	0.3890	-3.79e-02	2.04e-02	-3.06e-02	-2.66e-01	2.78e-01	8.53e-01	9.20e-01	8.81e-01	1.92e-01	1.73e-01
GOBP NEURON CELL CELL ADHESION	13	4.67e-01	7.82e-01	0.3890	-6.35e-02	-1.13e-01	2.41e-01	2.76e-01	1.32e-02	6.92e-01	4.82e-01	1.33e-01	8.48e-02	9.34e-01
GOBP REGULATION OF B CELL DIFFERENTIATION	31	1.29e-02	1.05e-01	0.3890	-2.50e-01	2.31e-01	-1.31e-01	-1.21e-01	-5.66e-02	1.61e-02	2.59e-02	2.06e-01	2.43e-01	5.85e-01
GOBP REGULATION OF RESPONSE TO TYPE II INTERFERON	14	3.07e-01	6.60e-01	0.3880	2.27e-01	9.69e-03	-7.23e-02	-2.82e-02	3.05e-01	1.42e-01	9.50e-01	6.40e-01	8.55e-01	4.78e-02
GOBP PEPTIDYL LYSINE DEACETYLATION	6	7.55e-01	9.17e-01	0.3880	2.58e-01	2.65e-01	-5.81e-02	-9.02e-02	-5.04e-02	2.74e-01	2.61e-01	8.05e-01	7.02e-01	8.31e-01
GOCC NUCLEOSOME	114	1.39e-07	7.84e-06	0.3880	8.40e-02	-1.97e-01	-2.74e-01	-1.50e-01	8.44e-02	1.21e-01	2.82e-04	4.21e-07	5.56e-03	1.19e-01
GOBP STRESS INDUCED PREMATURE SENESCENCE	8	7.20e-01	9.02e-01	0.3880	-5.27e-02	-1.45e-01	-1.93e-01	-2.38e-01	1.81e-01	7.96e-01	4.77e-01	3.44e-01	2.43e-01	3.75e-01
GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS	10	4.13e-01	7.44e-01	0.3880	-2.43e-01	4.38e-02	2.74e-02	1.07e-02	2.98e-01	1.83e-01	8.11e-01	8.81e-01	9.53e-01	1.03e-01
GOBP FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE	12	3.64e-01	7.05e-01	0.3880	1.63e-02	1.83e-01	-3.00e-01	-1.12e-01	-1.19e-01	9.22e-01	2.72e-01	7.18e-02	5.02e-01	4.76e-01
GOBP NEGATIVE REGULATION OF CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION	5	8.51e-01	9.50e-01	0.3880	1.98e-01	-2.51e-01	-1.43e-01	-9.62e-02	1.34e-01	4.42e-01	3.31e-01	5.79e-01	7.09e-01	6.03e-01
GOBP INSEMINATION	12	3.42e-01	6.88e-01	0.3880	-1.55e-01	5.78e-02	1.18e-01	3.06e-01	1.24e-01	3.52e-01	7.29e-01	4.79e-01	6.64e-02	4.59e-01
GOBP NEGATIVE REGULATION OF MEMBRANE PERMEABILITY	19	8.57e-02	3.54e-01	0.3880	1.29e-01	-1.30e-01	1.10e-01	-2.12e-01	2.45e-01	3.32e-01	3.28e-01	4.06e-01	1.10e-01	6.49e-02
GOBP RELAXATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE	6	6.60e-01	8.80e-01	0.3880	-2.29e-01	-9.58e-02	-2.65e-01	1.07e-01	-8.30e-02	3.31e-01	6.84e-01	2.61e-01	6.50e-01	7.25e-01
GOBP DORSAL AORTA MORPHOGENESIS	8	6.80e-01	8.87e-01	0.3870	1.53e-01	1.53e-01	-9.54e-02	-1.54e-01	2.66e-01	4.54e-01	4.55e-01	6.40e-01	4.52e-01	1.92e-01
GOCC SYNAPTONEMAL STRUCTURE	35	1.85e-02	1.34e-01	0.3870	4.99e-02	8.61e-02	-6.75e-02	-1.95e-01	3.13e-01	6.09e-01	3.78e-01	4.90e-01	4.61e-02	1.37e-03
GOBP CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT	26	6.02e-02	2.87e-01	0.3870	-9.23e-03	3.69e-02	-5.76e-02	-3.43e-01	1.66e-01	9.35e-01	7.45e-01	6.11e-01	2.46e-03	1.42e-01
GOBP MECHANOSENSORY BEHAVIOR	14	2.21e-01	5.76e-01	0.3870	-4.93e-02	1.00e-01	-1.93e-02	3.34e-01	-1.59e-01	7.49e-01	5.16e-01	9.01e-01	3.03e-02	3.02e-01
GOBP REGULATION OF MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL	5	7.89e-01	9.30e-01	0.3870	-3.07e-01	-5.24e-02	6.42e-02	1.51e-01	1.61e-01	2.34e-01	8.39e-01	8.04e-01	5.60e-01	5.32e-01
GOBP CARDIAC CONDUCTION SYSTEM DEVELOPMENT	37	5.29e-03	5.55e-02	0.3870	1.70e-01	1.29e-01	1.99e-01	-1.12e-01	2.28e-01	7.28e-02	1.75e-01	3.58e-02	2.40e-01	1.62e-02
GOMF CALCIUM DEPENDENT PHOSPHOLIPID BINDING	54	4.16e-04	7.76e-03	0.3870	-1.71e-01	2.12e-01	4.64e-02	1.54e-01	-2.23e-01	2.94e-02	6.99e-03	5.55e-01	5.04e-02	4.57e-03
GOBP REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS	39	4.19e-03	4.72e-02	0.3870	-2.07e-01	2.44e-01	-1.26e-03	-1.64e-02	-2.18e-01	2.54e-02	8.48e-03	9.89e-01	8.59e-01	1.84e-02
GOBP TYPE II INTERFERON MEDIATED SIGNALING PATHWAY	26	3.70e-02	2.09e-01	0.3870	2.64e-01	-6.39e-02	-7.45e-02	6.08e-02	2.59e-01	2.00e-02	5.73e-01	5.11e-01	5.91e-01	2.22e-02
GOMF SULFURTRANSFERASE ACTIVITY	11	4.98e-01	8.02e-01	0.3870	9.68e-02	-1.23e-01	-1.78e-01	-3.00e-01	-6.12e-02	5.78e-01	4.80e-01	3.07e-01	8.49e-02	7.25e-01
GOBP REGULATION OF XENOPHAGY	9	5.92e-01	8.47e-01	0.3870	1.57e-01	1.16e-01	-1.93e-01	-1.23e-01	2.43e-01	4.14e-01	5.47e-01	3.16e-01	5.24e-01	2.06e-01
GOBP BLOOD COAGULATION FIBRIN CLOT FORMATION	14	1.01e-01	3.86e-01	0.3870	-2.52e-01	-5.20e-02	-2.19e-01	1.79e-01	6.11e-02	1.02e-01	7.36e-01	1.56e-01	2.48e-01	6.92e-01
GOMF ORGANIC ACID SODIUM SYMPORTER ACTIVITY	34	2.55e-02	1.63e-01	0.3870	-5.42e-02	2.31e-01	2.76e-01	9.72e-02	-8.92e-02	5.85e-01	1.99e-02	5.36e-03	3.26e-01	3.68e-01
GOBP MANNOSE METABOLIC PROCESS	9	6.74e-01	8.85e-01	0.3870	2.13e-01	1.76e-02	-2.47e-01	-2.07e-01	1.43e-02	2.69e-01	9.27e-01	1.99e-01	2.83e-01	9.41e-01
GOBP POSITIVE REGULATION OF GAP JUNCTION ASSEMBLY	6	6.54e-01	8.79e-01	0.3870	-1.46e-01	-1.43e-02	2.61e-01	-3.31e-02	-2.42e-01	5.35e-01	9.52e-01	2.68e-01	8.88e-01	3.04e-01
GOCC COPII VESICLE COAT	16	3.12e-01	6.64e-01	0.3870	2.36e-01	9.33e-03	-2.60e-01	-1.59e-01	-2.63e-02	1.01e-01	9.48e-01	7.17e-02	2.72e-01	8.55e-01
GOMF WATER TRANSMEMBRANE TRANSPORTER ACTIVITY	18	2.15e-01	5.69e-01	0.3870	3.60e-02	-4.79e-03	6.36e-02	3.06e-01	-2.24e-01	7.91e-01	9.72e-01	6.40e-01	2.44e-02	9.98e-02
GOBP NEUROBLAST DIVISION	13	4.72e-01	7.86e-01	0.3870	-1.74e-01	3.90e-02	2.95e-01	1.71e-01	-3.27e-02	2.76e-01	8.08e-01	6.51e-02	2.87e-01	8.38e-01
GOBP NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS	24	1.38e-01	4.58e-01	0.3870	-3.45e-02	-6.21e-02	-2.22e-01	-2.40e-01	1.94e-01	7.70e-01	5.98e-01	6.01e-02	4.18e-02	1.00e-01
GOMF O ACETYLTRANSFERASE ACTIVITY	8	5.74e-01	8.40e-01	0.3860	2.43e-01	-3.61e-02	7.96e-03	6.86e-02	-2.90e-01	2.34e-01	8.60e-01	9.69e-01	7.37e-01	1.55e-01
GOBP LATERAL SPROUTING FROM AN EPITHELIUM	10	4.50e-01	7.71e-01	0.3860	9.72e-02	-3.66e-01	-1.12e-02	-5.69e-02	5.30e-02	5.95e-01	4.52e-02	9.51e-01	7.55e-01	7.72e-01
GOBP POSITIVE REGULATION OF LAMELLIPODIUM MORPHOGENESIS	7	7.69e-01	9.24e-01	0.3860	-3.32e-02	2.35e-01	2.80e-01	1.13e-01	-3.60e-02	8.79e-01	2.81e-01	1.99e-01	6.03e-01	8.69e-01
GOMF PEPTIDYL PROLINE DIOXYGENASE ACTIVITY	12	3.25e-01	6.74e-01	0.3860	-1.26e-01	1.62e-01	-1.61e-02	-1.96e-01	-2.62e-01	4.49e-01	3.31e-01	9.23e-01	2.40e-01	1.16e-01
GOBP RETROGRADE TRANS SYNAPTIC SIGNALING	10	5.06e-01	8.06e-01	0.3860	-1.36e-01	1.21e-01	1.44e-03	2.39e-01	-2.43e-01	4.56e-01	5.08e-01	9.94e-01	1.91e-01	1.83e-01
GOBP CELLULAR RESPONSE TO POTASSIUM ION	12	3.78e-01	7.17e-01	0.3860	-8.20e-02	-2.58e-01	2.21e-01	1.35e-01	-9.47e-02	6.23e-01	1.22e-01	1.84e-01	4.19e-01	5.70e-01
GOBP REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II	5	7.08e-01	8.98e-01	0.3860	-1.29e-03	-3.21e-01	2.09e-01	-1.71e-02	-4.91e-02	9.96e-01	2.14e-01	4.19e-01	9.47e-01	8.49e-01
GOBP POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY	7	6.72e-01	8.84e-01	0.3860	1.97e-01	-1.57e-01	1.77e-02	1.36e-01	-2.59e-01	3.66e-01	4.73e-01	9.36e-01	5.34e-01	2.36e-01
GOMF TYPE 1 ANGIOTENSIN RECEPTOR BINDING	6	8.19e-01	9.41e-01	0.3860	-1.08e-01	1.20e-01	2.88e-01	1.38e-01	1.45e-01	6.45e-01	6.12e-01	2.22e-01	5.57e-01	5.39e-01
GOBP CELLULAR RESPONSE TO ETHANOL	11	4.19e-01	7.48e-01	0.3860	-1.21e-01	3.33e-01	-8.44e-03	-6.23e-03	-1.52e-01	4.86e-01	5.55e-02	9.61e-01	9.71e-01	3.83e-01
GOBP AMINE CATABOLIC PROCESS	15	3.10e-01	6.62e-01	0.3860	-2.75e-02	-8.38e-02	2.37e-01	1.76e-01	-2.33e-01	8.54e-01	5.74e-01	1.12e-01	2.37e-01	1.19e-01
GOBP TELOMERE CAPPING	39	2.27e-02	1.53e-01	0.3860	7.20e-02	-9.14e-02	-2.00e-01	-2.42e-01	1.92e-01	4.37e-01	3.23e-01	3.03e-02	8.93e-03	3.84e-02
GOBP NEURONAL STEM CELL POPULATION MAINTENANCE	23	5.72e-02	2.78e-01	0.3860	2.30e-01	1.02e-02	2.26e-01	-4.14e-02	2.08e-01	5.64e-02	9.33e-01	6.08e-02	7.31e-01	8.42e-02
GOBP GRANULOCYTE ACTIVATION	48	2.18e-03	2.88e-02	0.3860	-2.60e-01	1.13e-01	2.30e-01	1.03e-01	6.76e-02	1.81e-03	1.76e-01	5.75e-03	2.18e-01	4.18e-01
GOMF CELL CELL ADHESION MEDIATOR ACTIVITY	51	3.94e-03	4.51e-02	0.3860	-9.58e-02	-9.25e-02	2.06e-01	2.92e-01	-5.65e-02	2.36e-01	2.53e-01	1.08e-02	3.09e-04	4.85e-01
GOBP POSITIVE REGULATION OF CHOLESTEROL STORAGE	8	6.34e-01	8.71e-01	0.3860	8.49e-02	-1.24e-01	2.83e-02	1.49e-01	-3.21e-01	6.78e-01	5.43e-01	8.90e-01	4.65e-01	1.16e-01
GOBP REGULATION OF NATURAL KILLER CELL DIFFERENTIATION	12	3.62e-01	7.04e-01	0.3860	-1.78e-01	1.97e-01	-3.07e-02	-1.65e-01	-2.24e-01	2.86e-01	2.38e-01	8.54e-01	3.21e-01	1.80e-01
GOBP NEGATIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT	26	4.73e-02	2.44e-01	0.3850	-1.08e-01	9.54e-02	1.92e-01	-2.61e-02	3.00e-01	3.42e-01	4.00e-01	9.00e-02	8.18e-01	8.00e-03
GOBP POSITIVE REGULATION OF INTEGRIN ACTIVATION	11	5.30e-01	8.19e-01	0.3850	-1.84e-01	-5.63e-02	1.08e-01	2.99e-01	-1.03e-01	2.90e-01	7.47e-01	5.34e-01	8.64e-02	5.56e-01
GOBP POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION	6	8.12e-01	9.38e-01	0.3850	1.25e-02	1.41e-01	-9.59e-02	-3.20e-01	1.29e-01	9.58e-01	5.50e-01	6.84e-01	1.74e-01	5.84e-01
GOCC RNA POLYMERASE COMPLEX	97	4.25e-06	1.57e-04	0.3850	1.91e-01	-8.77e-02	-2.43e-01	-1.92e-01	9.34e-02	1.15e-03	1.36e-01	3.61e-05	1.11e-03	1.12e-01
GOBP SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION	22	4.48e-02	2.36e-01	0.3850	-2.37e-01	8.45e-02	2.19e-01	-1.70e-01	9.13e-02	5.39e-02	4.93e-01	7.58e-02	1.68e-01	4.58e-01
GOBP MHC CLASS II BIOSYNTHETIC PROCESS	20	1.06e-01	3.95e-01	0.3850	-2.36e-01	6.98e-02	6.25e-02	-1.88e-01	2.20e-01	6.74e-02	5.89e-01	6.28e-01	1.45e-01	8.87e-02
GOBP WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY	5	8.60e-01	9.53e-01	0.3850	-1.18e-01	-1.49e-01	-2.10e-01	-1.88e-01	-1.80e-01	6.46e-01	5.64e-01	4.16e-01	4.67e-01	4.85e-01
GOBP REGULATION OF VESICLE FUSION	24	6.22e-02	2.93e-01	0.3850	2.54e-02	8.99e-02	-6.87e-02	8.01e-02	-3.58e-01	8.29e-01	4.46e-01	5.60e-01	4.97e-01	2.38e-03
GOBP RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME	13	2.68e-01	6.23e-01	0.3850	-1.42e-01	2.69e-01	-3.43e-03	2.03e-01	-1.20e-01	3.75e-01	9.29e-02	9.83e-01	2.05e-01	4.53e-01
GOMF ARMADILLO REPEAT DOMAIN BINDING	8	6.72e-01	8.84e-01	0.3850	5.89e-02	1.53e-02	3.48e-03	-2.16e-01	3.13e-01	7.73e-01	9.40e-01	9.86e-01	2.89e-01	1.26e-01
GOBP OLIGOSACCHARIDE BIOSYNTHETIC PROCESS	29	1.54e-02	1.19e-01	0.3850	-2.65e-01	2.47e-01	3.14e-02	1.24e-01	-2.69e-03	1.34e-02	2.11e-02	7.70e-01	2.46e-01	9.80e-01
GOCC COMPACT MYELIN	14	2.76e-01	6.30e-01	0.3850	-9.26e-02	3.07e-01	8.09e-02	1.38e-02	1.96e-01	5.49e-01	4.67e-02	6.00e-01	9.29e-01	2.04e-01
GOBP CELLULAR DETOXIFICATION OF ALDEHYDE	9	4.64e-01	7.80e-01	0.3850	1.57e-01	-2.15e-01	-1.54e-01	2.31e-01	1.53e-02	4.14e-01	2.65e-01	4.22e-01	2.31e-01	9.37e-01
GOBP PYRAMIDAL NEURON DEVELOPMENT	9	5.64e-01	8.35e-01	0.3850	-3.33e-01	-1.96e-02	1.15e-01	1.26e-01	8.57e-02	8.35e-02	9.19e-01	5.50e-01	5.11e-01	6.56e-01
GOBP UV PROTECTION	12	4.46e-01	7.69e-01	0.3850	-1.78e-02	-4.87e-02	-3.54e-01	-1.07e-01	-9.30e-02	9.15e-01	7.70e-01	3.38e-02	5.22e-01	5.77e-01
GOCC FLOTILLIN COMPLEX	9	5.95e-01	8.49e-01	0.3850	2.31e-01	-5.55e-02	2.20e-01	1.59e-01	1.32e-01	2.29e-01	7.73e-01	2.53e-01	4.09e-01	4.93e-01
GOBP APOLIPOPROTEIN A I MEDIATED SIGNALING PATHWAY	7	7.37e-01	9.09e-01	0.3850	-6.83e-02	-2.00e-01	-2.25e-01	-1.17e-01	1.96e-01	7.54e-01	3.59e-01	3.02e-01	5.91e-01	3.69e-01
GOBP NEGATIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS	10	4.50e-01	7.71e-01	0.3840	1.88e-01	2.03e-01	6.35e-02	-2.56e-01	3.85e-02	3.03e-01	2.65e-01	7.28e-01	1.62e-01	8.33e-01
GOBP REGULATION OF OOCYTE MATURATION	7	7.02e-01	8.96e-01	0.3840	1.26e-01	3.54e-01	6.19e-02	1.56e-02	4.69e-02	5.62e-01	1.05e-01	7.77e-01	9.43e-01	8.30e-01
GOCC GOLGI MEDIAL CISTERNA	11	3.80e-01	7.18e-01	0.3840	3.60e-01	-8.71e-02	1.01e-01	1.88e-02	8.16e-03	3.89e-02	6.17e-01	5.62e-01	9.14e-01	9.63e-01
GOBP CALCIUM IMPORT INTO THE MITOCHONDRION	12	3.27e-01	6.76e-01	0.3840	7.99e-02	1.75e-01	-8.06e-03	-3.29e-01	-4.83e-02	6.32e-01	2.95e-01	9.61e-01	4.84e-02	7.72e-01
GOBP COLLECTING DUCT DEVELOPMENT	15	2.11e-01	5.63e-01	0.3840	1.94e-01	1.31e-01	2.47e-01	-9.49e-02	1.50e-01	1.94e-01	3.79e-01	9.75e-02	5.25e-01	3.14e-01
GOBP CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES	268	1.18e-17	1.98e-15	0.3840	2.98e-02	-3.01e-02	2.69e-01	2.71e-01	6.36e-03	4.01e-01	3.97e-01	3.35e-14	2.33e-14	8.58e-01
GOBP NCRNA EXPORT FROM NUCLEUS	9	7.13e-01	9.00e-01	0.3840	-9.59e-03	-7.60e-02	-2.80e-01	-2.52e-01	-2.25e-03	9.60e-01	6.93e-01	1.46e-01	1.91e-01	9.91e-01
GOBP PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER	15	2.87e-01	6.41e-01	0.3840	3.39e-02	1.46e-01	-8.67e-02	-3.43e-01	-2.47e-03	8.20e-01	3.29e-01	5.61e-01	2.16e-02	9.87e-01
GOCC CRD MEDIATED MRNA STABILITY COMPLEX	6	6.56e-01	8.80e-01	0.3840	-2.30e-01	1.43e-02	6.51e-02	-2.50e-01	-1.66e-01	3.29e-01	9.52e-01	7.82e-01	2.89e-01	4.82e-01
GOBP PROTEIN ACTIVATION CASCADE	17	1.00e-01	3.83e-01	0.3830	-2.77e-01	-4.80e-02	-1.15e-01	2.28e-01	-5.30e-02	4.84e-02	7.32e-01	4.11e-01	1.03e-01	7.05e-01
GOCC GLYCOPROTEIN COMPLEX	21	1.55e-01	4.83e-01	0.3830	1.13e-01	2.33e-01	2.27e-01	1.23e-01	-1.15e-01	3.71e-01	6.49e-02	7.13e-02	3.29e-01	3.61e-01
GOCC CELL POLE	7	7.01e-01	8.96e-01	0.3830	3.37e-01	-7.01e-02	3.11e-02	-1.63e-02	1.65e-01	1.23e-01	7.48e-01	8.87e-01	9.41e-01	4.50e-01
GOBP AMINO SUGAR BIOSYNTHETIC PROCESS	11	3.96e-01	7.30e-01	0.3830	2.86e-01	1.79e-01	6.16e-03	-1.50e-01	-1.03e-01	1.00e-01	3.05e-01	9.72e-01	3.90e-01	5.52e-01
GOBP POSITIVE REGULATION OF GRANULOCYTE DIFFERENTIATION	9	5.73e-01	8.39e-01	0.3830	3.49e-01	9.72e-02	8.79e-02	4.56e-02	7.61e-02	6.98e-02	6.14e-01	6.48e-01	8.13e-01	6.93e-01
GOBP SUPPRESSION OF VIRAL RELEASE BY HOST	15	3.61e-01	7.04e-01	0.3830	5.16e-02	6.42e-02	-2.71e-01	-2.13e-01	-1.45e-01	7.29e-01	6.67e-01	6.89e-02	1.52e-01	3.32e-01
GOMF HISTONE H3K9 METHYLTRANSFERASE ACTIVITY	12	4.03e-01	7.36e-01	0.3830	1.37e-01	-2.26e-01	-5.98e-03	-2.29e-02	2.76e-01	4.11e-01	1.74e-01	9.71e-01	8.91e-01	9.78e-02
GOBP BOX C D SNORNP ASSEMBLY	10	4.80e-01	7.92e-01	0.3830	2.38e-01	-1.42e-01	-1.24e-01	-2.00e-01	-1.21e-01	1.93e-01	4.38e-01	4.95e-01	2.73e-01	5.06e-01
GOBP LEUKOTRIENE METABOLIC PROCESS	29	3.62e-02	2.07e-01	0.3830	7.61e-02	2.26e-01	1.59e-01	1.74e-01	1.85e-01	4.78e-01	3.54e-02	1.37e-01	1.05e-01	8.44e-02
GOMF TRIGLYCERIDE LIPASE ACTIVITY	24	1.44e-01	4.65e-01	0.3830	2.55e-02	-4.33e-03	2.47e-01	2.81e-01	7.58e-02	8.29e-01	9.71e-01	3.63e-02	1.70e-02	5.20e-01
GOMF CYTOSKELETAL ANCHOR ACTIVITY	23	1.54e-01	4.82e-01	0.3830	-5.83e-02	1.45e-01	3.05e-01	1.41e-01	9.41e-02	6.28e-01	2.28e-01	1.12e-02	2.43e-01	4.35e-01
GOBP PROTEIN DESUMOYLATION	8	6.40e-01	8.74e-01	0.3830	1.14e-01	-1.65e-01	-3.01e-01	2.00e-02	-1.22e-01	5.77e-01	4.18e-01	1.40e-01	9.22e-01	5.49e-01
GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS	12	4.17e-01	7.46e-01	0.3830	2.47e-01	1.75e-01	-7.32e-02	-4.82e-02	2.17e-01	1.39e-01	2.94e-01	6.60e-01	7.73e-01	1.93e-01
GOBP MITOTIC SPINDLE ASSEMBLY	67	4.04e-04	7.56e-03	0.3820	1.16e-01	-1.23e-01	-1.82e-01	-2.65e-01	1.22e-01	1.02e-01	8.16e-02	1.02e-02	1.80e-04	8.53e-02
GOBP TYROSINE METABOLIC PROCESS	17	2.49e-01	6.06e-01	0.3820	-1.63e-02	3.02e-01	1.48e-01	9.43e-02	-1.55e-01	9.07e-01	3.14e-02	2.90e-01	5.01e-01	2.67e-01
GOMF MAGNESIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY	14	2.86e-01	6.40e-01	0.3820	-1.09e-01	-1.33e-01	-1.88e-02	-6.00e-02	3.35e-01	4.78e-01	3.88e-01	9.03e-01	6.98e-01	2.98e-02
GOBP SUCCINATE TRANSMEMBRANE TRANSPORT	6	7.61e-01	9.20e-01	0.3820	1.76e-01	2.43e-01	8.01e-02	1.11e-01	1.94e-01	4.56e-01	3.03e-01	7.34e-01	6.37e-01	4.11e-01
GOMF SUCCINATE TRANSMEMBRANE TRANSPORTER ACTIVITY	6	7.61e-01	9.20e-01	0.3820	1.76e-01	2.43e-01	8.01e-02	1.11e-01	1.94e-01	4.56e-01	3.03e-01	7.34e-01	6.37e-01	4.11e-01
GOBP RESPONSE TO INTERFERON ALPHA	17	2.31e-01	5.85e-01	0.3820	6.20e-02	-2.32e-02	1.36e-03	-1.17e-01	3.58e-01	6.58e-01	8.68e-01	9.92e-01	4.03e-01	1.07e-02
GOBP NADH OXIDATION	6	6.39e-01	8.74e-01	0.3820	1.67e-01	2.78e-02	3.18e-01	-1.72e-03	-1.29e-01	4.80e-01	9.06e-01	1.78e-01	9.94e-01	5.85e-01
GOBP GLUTAMATERGIC NEURON DIFFERENTIATION	15	1.98e-01	5.47e-01	0.3820	2.96e-01	1.18e-02	-6.05e-02	1.65e-01	1.66e-01	4.71e-02	9.37e-01	6.85e-01	2.70e-01	2.66e-01
GOBP NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION	7	5.29e-01	8.19e-01	0.3820	6.96e-03	-4.29e-02	-2.18e-01	7.70e-02	3.01e-01	9.75e-01	8.44e-01	3.18e-01	7.24e-01	1.68e-01
GOBP CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING	32	6.44e-02	2.99e-01	0.3820	-2.46e-02	1.92e-02	-2.56e-01	-2.77e-01	5.32e-02	8.10e-01	8.51e-01	1.22e-02	6.72e-03	6.02e-01
GOBP POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS	26	4.10e-02	2.24e-01	0.3820	-3.00e-02	3.20e-01	5.69e-02	-1.12e-01	-1.63e-01	7.91e-01	4.70e-03	6.15e-01	3.24e-01	1.49e-01
GOBP CUT CATABOLIC PROCESS	5	8.85e-01	9.62e-01	0.3820	-1.26e-01	-9.05e-03	-2.38e-01	-2.71e-01	1.01e-02	6.26e-01	9.72e-01	3.57e-01	2.94e-01	9.69e-01
GOBP S ADENOSYLMETHIONINE METABOLIC PROCESS	15	3.31e-01	6.79e-01	0.3820	1.94e-01	2.35e-01	-6.46e-02	-1.80e-01	1.29e-01	1.94e-01	1.15e-01	6.65e-01	2.28e-01	3.88e-01
GOCC ENZYME ACTIVATOR COMPLEX	16	3.88e-01	7.25e-01	0.3820	8.13e-02	7.73e-02	-2.07e-01	-2.82e-01	1.05e-01	5.74e-01	5.92e-01	1.52e-01	5.11e-02	4.68e-01
GOMF ERBB 3 CLASS RECEPTOR BINDING	5	8.36e-01	9.46e-01	0.3820	8.62e-02	2.67e-01	6.64e-02	9.09e-02	-2.33e-01	7.39e-01	3.02e-01	7.97e-01	7.25e-01	3.67e-01
GOBP REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY	36	1.67e-02	1.26e-01	0.3820	-7.77e-02	9.23e-02	-1.59e-01	-3.18e-01	-6.84e-02	4.20e-01	3.38e-01	9.85e-02	9.64e-04	4.78e-01
GOBP AXONAL FASCICULATION	21	2.26e-01	5.80e-01	0.3810	3.71e-02	-7.58e-03	2.70e-01	2.66e-01	2.06e-02	7.69e-01	9.52e-01	3.24e-02	3.47e-02	8.70e-01
GOBP MEIOTIC CELL CYCLE PROCESS INVOLVED IN OOCYTE MATURATION	6	7.61e-01	9.20e-01	0.3810	2.27e-01	2.43e-01	5.01e-02	7.48e-02	-1.64e-01	3.35e-01	3.03e-01	8.32e-01	7.51e-01	4.87e-01
GOBP AMP CATABOLIC PROCESS	5	8.30e-01	9.44e-01	0.3810	-1.98e-01	2.94e-01	1.07e-01	-7.46e-02	-4.81e-02	4.42e-01	2.54e-01	6.78e-01	7.73e-01	8.52e-01
GOMF GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE NADPLUS NON PHOSPHORYLATING ACTIVITY	7	7.22e-01	9.03e-01	0.3810	-2.35e-01	-2.72e-01	-4.75e-02	8.23e-02	-8.36e-02	2.82e-01	2.12e-01	8.28e-01	7.06e-01	7.02e-01
GOBP REGULATION OF AUTOPHAGY OF MITOCHONDRION	38	2.20e-02	1.50e-01	0.3810	2.04e-01	4.00e-02	-1.77e-01	-2.62e-01	4.75e-02	2.93e-02	6.70e-01	5.94e-02	5.24e-03	6.12e-01
GOBP POSITIVE REGULATION OF INTERFERON BETA PRODUCTION	37	2.08e-02	1.45e-01	0.3810	6.89e-02	4.87e-02	-3.24e-01	-1.80e-01	2.74e-02	4.68e-01	6.08e-01	6.50e-04	5.83e-02	7.73e-01
GOBP RESPONSE TO HUMAN CHORIONIC GONADOTROPIN	5	8.34e-01	9.45e-01	0.3810	6.58e-02	1.32e-01	2.87e-02	2.74e-01	-2.18e-01	7.99e-01	6.09e-01	9.12e-01	2.89e-01	3.98e-01
GOMF TRANSLATION ELONGATION FACTOR ACTIVITY	19	1.98e-01	5.47e-01	0.3810	6.21e-02	7.26e-02	-1.72e-01	-3.09e-01	-1.06e-01	6.39e-01	5.84e-01	1.95e-01	1.99e-02	4.23e-01
GOMF RECEPTOR ANTAGONIST ACTIVITY	16	2.31e-01	5.85e-01	0.3810	-2.93e-01	1.35e-01	-6.41e-02	-1.16e-01	-1.53e-01	4.25e-02	3.49e-01	6.57e-01	4.23e-01	2.89e-01
GOMF PHOSPHATIDYL PHOSPHOLIPASE B ACTIVITY	11	4.21e-01	7.49e-01	0.3810	1.38e-01	-7.85e-02	3.24e-01	9.64e-02	7.41e-02	4.27e-01	6.52e-01	6.28e-02	5.80e-01	6.70e-01
GOBP ETHER BIOSYNTHETIC PROCESS	12	3.84e-01	7.23e-01	0.3810	3.63e-01	2.90e-02	-7.70e-03	1.06e-01	2.90e-02	2.93e-02	8.62e-01	9.63e-01	5.24e-01	8.62e-01
GOMF PROTEIN PRENYLTRANSFERASE ACTIVITY	6	8.28e-01	9.44e-01	0.3810	-1.25e-01	-1.77e-01	-2.37e-01	-1.73e-01	-1.07e-01	5.95e-01	4.52e-01	3.14e-01	4.63e-01	6.50e-01
GOBP ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION	20	2.59e-01	6.16e-01	0.3810	7.11e-02	6.42e-02	-2.29e-01	-2.87e-01	2.90e-02	5.82e-01	6.19e-01	7.58e-02	2.63e-02	8.23e-01
GOMF INTERMEDIATE FILAMENT BINDING	10	4.74e-01	7.87e-01	0.3810	-3.54e-01	-1.33e-02	8.64e-02	-1.08e-01	1.21e-02	5.24e-02	9.42e-01	6.36e-01	5.55e-01	9.47e-01
GOBP RESPONSE TO VITAMIN A	15	3.28e-01	6.76e-01	0.3810	-1.19e-01	-4.90e-02	-1.07e-01	-3.20e-01	1.19e-01	4.24e-01	7.42e-01	4.73e-01	3.19e-02	4.23e-01
GOBP NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION	22	1.90e-01	5.36e-01	0.3800	1.44e-01	4.37e-02	-1.93e-01	-2.90e-01	2.72e-02	2.43e-01	7.23e-01	1.18e-01	1.84e-02	8.25e-01
GOBP REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION	13	3.02e-01	6.55e-01	0.3800	-1.20e-01	-1.57e-02	3.59e-01	3.51e-02	-8.98e-03	4.52e-01	9.22e-01	2.51e-02	8.26e-01	9.55e-01
GOBP MEIOTIC SPINDLE ORGANIZATION	18	2.79e-01	6.32e-01	0.3800	2.52e-01	-5.17e-02	-1.98e-01	-1.94e-01	4.46e-02	6.46e-02	7.04e-01	1.47e-01	1.54e-01	7.43e-01
GOBP POSITIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY	10	5.64e-01	8.35e-01	0.3800	-1.45e-01	2.03e-01	1.39e-01	6.67e-02	-2.43e-01	4.28e-01	2.67e-01	4.45e-01	7.15e-01	1.84e-01
GOBP PROTEIN CONTAINING COMPLEX REMODELING	36	1.14e-02	9.60e-02	0.3800	-2.65e-01	6.92e-02	-1.59e-02	1.43e-01	-2.21e-01	5.88e-03	4.72e-01	8.69e-01	1.36e-01	2.20e-02
GOBP GDP METABOLIC PROCESS	9	4.50e-01	7.71e-01	0.3800	4.10e-02	1.29e-01	2.65e-01	-2.68e-02	-2.35e-01	8.31e-01	5.03e-01	1.68e-01	8.89e-01	2.22e-01
GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT	156	1.47e-10	1.31e-08	0.3800	-1.34e-01	-8.44e-02	1.49e-01	3.08e-01	-5.15e-02	3.78e-03	6.90e-02	1.32e-03	3.30e-11	2.67e-01
GOBP REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I	44	1.06e-02	9.12e-02	0.3800	1.50e-01	-1.17e-01	-2.14e-01	-2.50e-01	4.12e-03	8.43e-02	1.79e-01	1.42e-02	4.10e-03	9.62e-01
GOBP FIBROBLAST ACTIVATION	15	2.35e-01	5.90e-01	0.3800	-2.53e-01	2.62e-01	4.63e-02	-1.28e-02	9.89e-02	9.00e-02	7.92e-02	7.56e-01	9.32e-01	5.07e-01
GOBP REGULATION OF GLYCOGEN CATABOLIC PROCESS	7	6.33e-01	8.70e-01	0.3800	2.46e-02	3.54e-01	-1.14e-01	1.13e-02	-7.30e-02	9.10e-01	1.05e-01	6.02e-01	9.59e-01	7.38e-01
GOBP POLARIZED EPITHELIAL CELL DIFFERENTIATION	25	6.43e-02	2.98e-01	0.3800	-1.67e-01	-9.18e-02	1.79e-01	1.50e-01	2.31e-01	1.47e-01	4.27e-01	1.22e-01	1.94e-01	4.54e-02
GOBP GOLGI TO LYSOSOME TRANSPORT	12	4.28e-01	7.54e-01	0.3800	6.59e-02	-2.16e-01	-7.44e-02	-5.36e-02	2.91e-01	6.93e-01	1.95e-01	6.55e-01	7.48e-01	8.06e-02
GOMF 3 5 EXONUCLEASE ACTIVITY	54	3.32e-03	3.96e-02	0.3800	-3.81e-03	-3.59e-02	-2.15e-01	-3.10e-01	2.48e-02	9.61e-01	6.48e-01	6.29e-03	8.05e-05	7.52e-01
GOBP NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY	38	9.85e-03	8.67e-02	0.3800	1.04e-01	2.52e-01	6.30e-03	-2.37e-01	1.16e-01	2.65e-01	7.21e-03	9.46e-01	1.13e-02	2.15e-01
GOCC FIBRILLAR COLLAGEN TRIMER	12	4.47e-01	7.70e-01	0.3800	-1.36e-01	-2.73e-01	-1.03e-02	1.94e-01	-1.16e-01	4.15e-01	1.02e-01	9.51e-01	2.44e-01	4.86e-01
GOBP POSITIVE REGULATION OF SYNAPTIC PLASTICITY	10	3.81e-01	7.19e-01	0.3800	3.02e-01	4.48e-02	1.51e-01	-2.70e-02	-1.66e-01	9.83e-02	8.06e-01	4.08e-01	8.83e-01	3.64e-01
GOBP VESTIBULOCOCHLEAR NERVE MORPHOGENESIS	7	7.51e-01	9.16e-01	0.3800	1.48e-01	-1.23e-02	1.53e-01	3.13e-01	3.08e-02	4.98e-01	9.55e-01	4.83e-01	1.52e-01	8.88e-01
GOBP MYELOID DENDRITIC CELL CYTOKINE PRODUCTION	8	6.69e-01	8.83e-01	0.3800	1.52e-02	1.63e-01	-2.16e-01	-1.72e-01	-2.02e-01	9.41e-01	4.24e-01	2.90e-01	4.00e-01	3.22e-01
GOMF NUCLEAR IMPORT SIGNAL RECEPTOR ACTIVITY	20	2.19e-01	5.73e-01	0.3800	9.48e-02	-8.87e-02	-3.00e-01	-1.45e-01	-1.26e-01	4.63e-01	4.92e-01	2.00e-02	2.61e-01	3.28e-01
GOMF CYSTEINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS	17	1.47e-01	4.70e-01	0.3800	-8.20e-02	-6.37e-02	4.99e-02	1.17e-01	3.42e-01	5.58e-01	6.49e-01	7.21e-01	4.03e-01	1.46e-02
GOBP RESPONSE TO UV C	14	3.47e-01	6.93e-01	0.3800	-8.32e-02	-4.46e-02	-7.36e-02	-3.33e-01	1.38e-01	5.90e-01	7.73e-01	6.34e-01	3.11e-02	3.72e-01
GOMF GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY	49	4.84e-03	5.24e-02	0.3790	1.67e-01	-1.27e-01	-1.63e-01	-2.43e-01	1.20e-01	4.28e-02	1.25e-01	4.89e-02	3.25e-03	1.45e-01
GOBP KERATAN SULFATE METABOLIC PROCESS	18	1.98e-01	5.47e-01	0.3790	-3.53e-02	3.12e-01	-6.09e-02	-1.97e-01	5.62e-02	7.95e-01	2.21e-02	6.55e-01	1.48e-01	6.80e-01
GOBP PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS	23	1.43e-01	4.63e-01	0.3790	7.24e-02	1.03e-01	-1.94e-01	-2.92e-01	-6.97e-02	5.48e-01	3.93e-01	1.07e-01	1.52e-02	5.63e-01
GOBP NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT	8	5.80e-01	8.43e-01	0.3790	-9.57e-02	3.33e-01	-2.00e-02	-2.10e-02	1.51e-01	6.39e-01	1.03e-01	9.22e-01	9.18e-01	4.60e-01
GOBP CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION	18	2.11e-01	5.64e-01	0.3790	2.35e-01	1.07e-01	2.18e-01	6.13e-02	1.60e-01	8.38e-02	4.33e-01	1.09e-01	6.52e-01	2.40e-01
GOBP CHAPERONE MEDIATED PROTEIN FOLDING	74	2.51e-04	5.07e-03	0.3790	3.10e-02	4.61e-02	-2.50e-01	-2.79e-01	1.96e-02	6.45e-01	4.93e-01	2.02e-04	3.33e-05	7.70e-01
GOCC PROTEASOME REGULATORY PARTICLE LID SUBCOMPLEX	7	7.96e-01	9.32e-01	0.3790	2.32e-01	7.80e-03	-1.87e-01	-2.20e-01	7.95e-02	2.88e-01	9.72e-01	3.92e-01	3.13e-01	7.16e-01
GOBP SODIUM ION EXPORT ACROSS PLASMA MEMBRANE	15	2.26e-01	5.79e-01	0.3790	-1.84e-01	-2.86e-01	1.43e-04	-1.58e-01	5.66e-02	2.17e-01	5.55e-02	9.99e-01	2.90e-01	7.04e-01
GOCC NADPH OXIDASE COMPLEX	13	2.60e-01	6.16e-01	0.3790	1.74e-02	2.24e-01	2.11e-01	-2.10e-01	6.86e-02	9.13e-01	1.63e-01	1.88e-01	1.90e-01	6.68e-01
GOBP PEROXISOME FISSION	9	6.42e-01	8.75e-01	0.3790	1.38e-01	2.10e-01	-2.11e-01	-1.87e-01	3.87e-02	4.75e-01	2.76e-01	2.74e-01	3.32e-01	8.40e-01
GOBP REGULATION OF GLUCOCORTICOID RECEPTOR SIGNALING PATHWAY	7	6.96e-01	8.94e-01	0.3790	3.67e-01	3.68e-02	6.44e-03	-8.02e-02	3.74e-02	9.31e-02	8.66e-01	9.76e-01	7.13e-01	8.64e-01
GOBP REGULATION OF PROTEIN GLYCOSYLATION	12	4.19e-01	7.48e-01	0.3790	3.63e-01	5.41e-02	-6.07e-02	-6.95e-02	1.83e-02	2.95e-02	7.46e-01	7.16e-01	6.77e-01	9.13e-01
GOMF RNA ENDONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS	31	6.53e-02	3.01e-01	0.3790	1.53e-01	-7.47e-02	-2.42e-01	-2.32e-01	-4.51e-02	1.39e-01	4.72e-01	1.98e-02	2.53e-02	6.64e-01
GOBP POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY	21	1.98e-01	5.47e-01	0.3790	-1.42e-01	3.79e-02	2.43e-01	1.56e-01	-1.97e-01	2.61e-01	7.64e-01	5.39e-02	2.17e-01	1.19e-01
GOBP CONVERGENT EXTENSION INVOLVED IN AXIS ELONGATION	6	7.66e-01	9.23e-01	0.3790	-9.64e-02	-7.52e-02	-1.08e-01	-3.38e-01	-5.09e-02	6.83e-01	7.50e-01	6.48e-01	1.52e-01	8.29e-01
GOBP POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS	19	1.78e-01	5.19e-01	0.3790	-6.72e-02	-5.14e-03	8.93e-02	3.57e-01	-6.08e-02	6.12e-01	9.69e-01	5.01e-01	7.12e-03	6.46e-01
GOBP POST FERTILIZATION EPIGENETIC REGULATION OF GENE EXPRESSION	13	4.12e-01	7.43e-01	0.3790	2.71e-01	-6.89e-02	-6.64e-02	-6.45e-02	2.38e-01	9.08e-02	6.67e-01	6.79e-01	6.87e-01	1.37e-01
GOCC CHOLINERGIC SYNAPSE	11	5.31e-01	8.19e-01	0.3790	1.57e-01	-1.22e-01	1.52e-01	2.68e-01	-9.20e-02	3.67e-01	4.82e-01	3.82e-01	1.23e-01	5.97e-01
GOBP GLYOXYLATE METABOLIC PROCESS	8	6.32e-01	8.70e-01	0.3790	-2.65e-01	2.28e-01	5.79e-02	1.19e-01	-6.20e-02	1.94e-01	2.65e-01	7.77e-01	5.61e-01	7.61e-01
GOMF PROTEIN DISULFIDE REDUCTASE ACTIVITY	27	8.08e-02	3.42e-01	0.3790	-1.15e-01	1.28e-01	-1.66e-01	-2.76e-01	9.93e-02	3.02e-01	2.48e-01	1.34e-01	1.31e-02	3.72e-01
GOMF NEUROPEPTIDE Y RECEPTOR ACTIVITY	10	5.43e-01	8.25e-01	0.3780	2.27e-02	2.09e-01	3.46e-02	-1.00e-01	2.96e-01	9.01e-01	2.52e-01	8.50e-01	5.82e-01	1.05e-01
GOBP MITOCHONDRIAL TRANSLATIONAL ELONGATION	5	8.65e-01	9.55e-01	0.3780	3.08e-02	-2.16e-01	-1.80e-01	-2.45e-01	-5.92e-02	9.05e-01	4.03e-01	4.87e-01	3.44e-01	8.19e-01
GOBP RRNA METHYLATION	24	8.25e-02	3.46e-01	0.3780	1.23e-01	2.08e-02	-1.41e-01	-3.13e-01	-9.80e-02	2.97e-01	8.60e-01	2.31e-01	7.91e-03	4.06e-01
GOBP REGULATION OF CELLULAR PH REDUCTION	7	6.62e-01	8.81e-01	0.3780	-1.04e-01	-1.77e-01	2.68e-01	2.80e-02	1.69e-01	6.34e-01	4.17e-01	2.20e-01	8.98e-01	4.39e-01
GOBP REGULATION OF SREBP SIGNALING PATHWAY	8	6.72e-01	8.84e-01	0.3780	-2.56e-01	-3.71e-02	-1.15e-01	-2.46e-01	4.85e-02	2.10e-01	8.56e-01	5.73e-01	2.28e-01	8.12e-01
GOBP ETHANOL CATABOLIC PROCESS	10	5.54e-01	8.30e-01	0.3780	-3.01e-01	-1.64e-01	8.90e-02	1.32e-01	-1.33e-02	9.95e-02	3.68e-01	6.26e-01	4.70e-01	9.42e-01
GOBP RECEPTOR MEDIATED ENDOCYTOSIS OF VIRUS BY HOST CELL	10	4.57e-01	7.75e-01	0.3780	-2.70e-01	-1.24e-01	-1.86e-03	-1.78e-01	-1.51e-01	1.39e-01	4.97e-01	9.92e-01	3.29e-01	4.08e-01
GOBP REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT	13	3.83e-01	7.21e-01	0.3780	3.38e-02	7.73e-02	-3.92e-02	-3.46e-01	1.20e-01	8.33e-01	6.30e-01	8.07e-01	3.06e-02	4.53e-01
GOMF VASOPRESSIN RECEPTOR ACTIVITY	6	7.50e-01	9.16e-01	0.3780	-1.51e-01	-4.51e-02	-5.64e-03	-6.58e-02	-3.37e-01	5.22e-01	8.48e-01	9.81e-01	7.80e-01	1.53e-01
GOMF GLUTAMATE RECEPTOR ACTIVITY	26	8.78e-02	3.58e-01	0.3780	-1.42e-01	-9.20e-02	2.06e-01	2.40e-01	1.21e-01	2.11e-01	4.17e-01	6.94e-02	3.43e-02	2.86e-01
GOBP CIRCADIAN SLEEP WAKE CYCLE NON REM SLEEP	6	7.34e-01	9.09e-01	0.3780	6.51e-02	2.64e-01	1.81e-01	-1.82e-01	5.60e-02	7.82e-01	2.63e-01	4.42e-01	4.40e-01	8.12e-01
GOBP HYPOTHALAMUS CELL MIGRATION	6	8.64e-01	9.54e-01	0.3780	-3.06e-02	4.47e-02	2.56e-01	2.73e-01	1.37e-02	8.97e-01	8.50e-01	2.78e-01	2.48e-01	9.54e-01
GOBP INNER CELL MASS CELL DIFFERENTIATION	8	7.08e-01	8.97e-01	0.3780	-6.16e-02	-1.86e-01	-1.83e-01	-2.59e-01	-5.95e-02	7.63e-01	3.62e-01	3.69e-01	2.04e-01	7.71e-01
GOBP REGULATION OF CELL FATE COMMITMENT	41	2.08e-03	2.77e-02	0.3780	-1.89e-01	1.85e-01	5.94e-02	-2.62e-01	2.20e-02	3.61e-02	3.99e-02	5.10e-01	3.69e-03	8.07e-01
GOBP TRNA METABOLIC PROCESS	188	3.25e-11	3.09e-09	0.3780	9.38e-02	-5.86e-02	-2.50e-01	-2.58e-01	3.76e-02	2.66e-02	1.66e-01	3.25e-09	1.04e-09	3.74e-01
GOCC DENDRITIC GROWTH CONE	8	6.50e-01	8.78e-01	0.3780	1.13e-01	-1.63e-01	2.25e-01	1.23e-01	1.95e-01	5.80e-01	4.26e-01	2.71e-01	5.47e-01	3.40e-01
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CHROMATIN	6	8.54e-01	9.51e-01	0.3780	7.01e-02	-1.89e-01	-2.19e-01	-2.00e-01	1.20e-01	7.66e-01	4.23e-01	3.54e-01	3.96e-01	6.12e-01
GOBP PROTEIN REPAIR	7	7.08e-01	8.98e-01	0.3780	-2.64e-01	2.01e-01	1.49e-03	-4.81e-02	-1.74e-01	2.26e-01	3.58e-01	9.95e-01	8.26e-01	4.26e-01
GOBP SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY	19	3.04e-01	6.57e-01	0.3780	7.78e-02	-6.68e-02	-1.95e-01	-2.81e-01	1.22e-01	5.57e-01	6.14e-01	1.41e-01	3.39e-02	3.56e-01
GOBP REGULATION OF SECONDARY METABOLIC PROCESS	15	2.73e-01	6.28e-01	0.3780	-5.35e-02	2.65e-01	2.95e-02	-7.97e-02	2.50e-01	7.20e-01	7.57e-02	8.43e-01	5.93e-01	9.38e-02
GOBP POSITIVE REGULATION OF TOLERANCE INDUCTION	11	5.63e-01	8.34e-01	0.3780	5.53e-02	-5.52e-02	2.06e-01	2.95e-01	8.57e-02	7.51e-01	7.51e-01	2.38e-01	9.05e-02	6.22e-01
GOBP GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT	11	3.16e-01	6.66e-01	0.3780	1.45e-01	-1.85e-01	6.34e-02	-2.58e-02	-2.88e-01	4.05e-01	2.88e-01	7.16e-01	8.82e-01	9.87e-02
GOMF IRON ION TRANSMEMBRANE TRANSPORTER ACTIVITY	8	5.30e-01	8.19e-01	0.3780	2.16e-01	7.47e-02	8.66e-02	-2.82e-01	5.93e-02	2.91e-01	7.15e-01	6.71e-01	1.67e-01	7.71e-01
GOBP NEGATIVE REGULATION OF VITAMIN D BIOSYNTHETIC PROCESS	5	8.91e-01	9.63e-01	0.3780	7.98e-02	1.14e-01	-2.47e-01	-2.49e-01	-1.21e-02	7.57e-01	6.59e-01	3.40e-01	3.34e-01	9.63e-01
GOBP PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS	18	2.02e-01	5.52e-01	0.3770	5.03e-02	3.06e-01	3.59e-02	-1.92e-01	8.86e-02	7.12e-01	2.44e-02	7.92e-01	1.58e-01	5.15e-01
GOBP CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY	21	1.81e-01	5.23e-01	0.3770	-1.27e-01	-2.00e-01	-2.05e-01	-1.86e-01	-9.93e-02	3.15e-01	1.12e-01	1.05e-01	1.40e-01	4.31e-01
GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR	34	2.84e-02	1.77e-01	0.3770	-8.33e-02	1.08e-01	-2.20e-01	-2.25e-01	1.57e-01	4.01e-01	2.76e-01	2.61e-02	2.33e-02	1.12e-01
GOBP POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL	13	2.21e-01	5.76e-01	0.3770	-2.45e-01	-1.60e-01	2.09e-01	-1.12e-01	1.59e-02	1.26e-01	3.17e-01	1.92e-01	4.83e-01	9.21e-01
GOBP POSITIVE REGULATION OF TRANSLATIONAL INITIATION	24	9.39e-02	3.71e-01	0.3770	1.74e-01	-2.82e-01	-1.34e-01	-1.17e-01	2.83e-02	1.39e-01	1.69e-02	2.57e-01	3.20e-01	8.10e-01
GOCC COMPLEX OF COLLAGEN TRIMERS	19	1.77e-01	5.18e-01	0.3770	3.00e-02	-3.00e-01	7.02e-02	1.78e-01	-1.22e-01	8.21e-01	2.35e-02	5.96e-01	1.80e-01	3.58e-01
GOBP CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER	21	1.26e-01	4.39e-01	0.3770	-2.89e-01	9.25e-03	-1.29e-01	-3.36e-02	-2.02e-01	2.19e-02	9.41e-01	3.05e-01	7.90e-01	1.09e-01
GOBP NEGATIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION	7	7.39e-01	9.11e-01	0.3770	-1.72e-01	-6.05e-02	-1.62e-01	-1.54e-01	-2.43e-01	4.31e-01	7.82e-01	4.58e-01	4.81e-01	2.65e-01
GOBP CENTRAL NERVOUS SYSTEM MATURATION	6	8.10e-01	9.38e-01	0.3770	1.71e-01	-1.22e-01	-1.71e-01	-7.68e-02	2.51e-01	4.68e-01	6.06e-01	4.69e-01	7.45e-01	2.87e-01
GOBP REGULATION OF FEAR RESPONSE	9	6.26e-01	8.67e-01	0.3770	1.32e-01	5.05e-02	2.31e-01	1.67e-01	-2.01e-01	4.92e-01	7.93e-01	2.29e-01	3.85e-01	2.96e-01
GOMF PHOSPHATIDIC ACID BINDING	23	8.32e-02	3.48e-01	0.3770	3.75e-02	2.89e-01	2.03e-01	-1.06e-01	6.54e-02	7.56e-01	1.63e-02	9.21e-02	3.77e-01	5.87e-01
GOBP NEURONAL ACTION POTENTIAL	32	5.56e-02	2.73e-01	0.3770	6.37e-03	-6.58e-02	2.72e-01	2.40e-01	7.55e-02	9.50e-01	5.20e-01	7.70e-03	1.86e-02	4.60e-01
GOBP FEVER GENERATION	11	5.32e-01	8.20e-01	0.3770	2.21e-01	7.07e-02	1.87e-01	1.95e-01	1.21e-01	2.03e-01	6.85e-01	2.83e-01	2.62e-01	4.86e-01
GOMF MICROTUBULE SEVERING ATPASE ACTIVITY	9	5.79e-01	8.42e-01	0.3770	-2.11e-01	-2.61e-01	-8.12e-02	-2.99e-02	1.48e-01	2.74e-01	1.76e-01	6.73e-01	8.77e-01	4.41e-01
GOBP DENDRITIC TRANSPORT OF RIBONUCLEOPROTEIN COMPLEX	5	8.45e-01	9.49e-01	0.3770	2.43e-01	2.72e-01	3.18e-02	-8.33e-02	2.75e-02	3.46e-01	2.93e-01	9.02e-01	7.47e-01	9.15e-01
GOBP REGULATION OF KERATINOCYTE MIGRATION	14	3.91e-01	7.26e-01	0.3760	-7.54e-02	6.82e-02	-2.34e-01	-2.04e-01	1.87e-01	6.25e-01	6.58e-01	1.30e-01	1.85e-01	2.25e-01
GOBP PEPTIDYL TYROSINE DEPHOSPHORYLATION INVOLVED IN INACTIVATION OF PROTEIN KINASE ACTIVITY	8	6.99e-01	8.95e-01	0.3760	1.21e-01	-1.65e-01	2.08e-01	2.35e-01	3.52e-02	5.52e-01	4.18e-01	3.08e-01	2.51e-01	8.63e-01
GOBP POLYKETIDE METABOLIC PROCESS	10	5.16e-01	8.11e-01	0.3760	1.09e-01	-1.89e-01	7.89e-02	2.57e-01	1.46e-01	5.49e-01	3.00e-01	6.66e-01	1.59e-01	4.22e-01
GOBP REGULATION OF NEUTROPHIL CHEMOTAXIS	30	3.48e-02	2.01e-01	0.3760	-1.54e-01	2.89e-01	8.48e-02	1.13e-01	-1.19e-01	1.44e-01	6.12e-03	4.21e-01	2.83e-01	2.59e-01
GOCC MITOCHONDRIAL PROTEIN CONTAINING COMPLEX	271	1.12e-16	1.61e-14	0.3760	7.01e-02	-3.24e-02	-2.41e-01	-2.78e-01	8.27e-04	4.69e-02	3.58e-01	7.66e-12	3.09e-15	9.81e-01
GOMF CYTOCHROME B5 REDUCTASE ACTIVITY ACTING ON NAD P H	6	7.52e-01	9.16e-01	0.3760	3.07e-01	-1.55e-02	-4.80e-02	7.09e-02	-1.99e-01	1.92e-01	9.48e-01	8.39e-01	7.64e-01	3.99e-01
GOBP COENZYME A BIOSYNTHETIC PROCESS	11	5.71e-01	8.38e-01	0.3760	-9.98e-02	-3.97e-02	-2.57e-01	-2.00e-01	-1.54e-01	5.66e-01	8.20e-01	1.40e-01	2.50e-01	3.76e-01
GOCC SIGNAL RECOGNITION PARTICLE	8	7.48e-01	9.15e-01	0.3760	-2.05e-02	-1.35e-01	-2.91e-01	-1.69e-01	9.83e-02	9.20e-01	5.09e-01	1.54e-01	4.08e-01	6.30e-01
GOBP REGULATION OF SKELETAL MUSCLE FIBER DEVELOPMENT	11	5.07e-01	8.07e-01	0.3760	6.69e-02	2.37e-01	2.55e-01	-1.37e-02	1.26e-01	7.01e-01	1.74e-01	1.43e-01	9.37e-01	4.71e-01
GOBP POSITIVE REGULATION OF MEGAKARYOCYTE DIFFERENTIATION	10	5.63e-01	8.34e-01	0.3760	1.69e-01	1.86e-01	9.94e-03	-6.47e-02	2.72e-01	3.55e-01	3.09e-01	9.57e-01	7.23e-01	1.36e-01
GOBP POSITIVE REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS	8	3.92e-01	7.27e-01	0.3760	-1.05e-01	-8.93e-02	-1.88e-01	1.93e-01	2.23e-01	6.08e-01	6.62e-01	3.57e-01	3.44e-01	2.75e-01
GOBP SENSORY PERCEPTION	862	3.64e-66	5.32e-63	0.3760	-7.74e-02	-1.69e-01	1.15e-01	3.06e-01	1.91e-02	1.15e-04	4.18e-17	9.65e-09	1.26e-52	3.40e-01
GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION	8	6.62e-01	8.81e-01	0.3760	3.11e-01	-1.74e-02	-6.85e-02	1.27e-02	1.98e-01	1.28e-01	9.32e-01	7.37e-01	9.51e-01	3.31e-01
GOCC POST MRNA RELEASE SPLICEOSOMAL COMPLEX	10	6.44e-01	8.75e-01	0.3760	6.65e-02	-1.75e-01	-2.48e-01	-1.50e-01	1.51e-01	7.16e-01	3.39e-01	1.75e-01	4.12e-01	4.10e-01
GOMF G QUADRUPLEX RNA BINDING	5	8.46e-01	9.49e-01	0.3760	3.03e-01	-1.20e-01	-1.50e-01	7.65e-03	1.10e-01	2.40e-01	6.42e-01	5.62e-01	9.76e-01	6.69e-01
GOBP RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION	13	2.38e-01	5.94e-01	0.3760	7.48e-02	1.72e-01	7.31e-03	3.26e-01	8.87e-03	6.40e-01	2.84e-01	9.64e-01	4.21e-02	9.56e-01
GOBP INTRACELLULAR POTASSIUM ION HOMEOSTASIS	15	3.93e-01	7.27e-01	0.3760	-3.88e-02	-2.58e-01	-2.17e-01	-1.59e-01	-1.14e-02	7.95e-01	8.31e-02	1.45e-01	2.85e-01	9.39e-01
GOBP RESPONSE TO FUNGUS	62	1.50e-04	3.30e-03	0.3760	-3.29e-01	6.33e-02	1.43e-01	7.46e-02	5.28e-02	7.35e-06	3.89e-01	5.17e-02	3.10e-01	4.72e-01
GOBP NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION	11	4.83e-01	7.93e-01	0.3760	9.57e-02	2.61e-02	6.52e-02	-3.63e-03	3.56e-01	5.83e-01	8.81e-01	7.08e-01	9.83e-01	4.07e-02
GOMF ALDEHYDE LYASE ACTIVITY	9	5.38e-01	8.22e-01	0.3760	-4.06e-02	-2.00e-01	-3.12e-01	4.60e-02	-8.36e-03	8.33e-01	2.98e-01	1.06e-01	8.11e-01	9.65e-01
GOBP RENAL TUBULAR SECRETION	19	2.22e-01	5.76e-01	0.3760	-8.93e-02	-1.83e-02	1.80e-01	1.47e-01	-2.81e-01	5.00e-01	8.90e-01	1.75e-01	2.68e-01	3.42e-02
GOBP ALPHA BETA T CELL PROLIFERATION	41	6.56e-03	6.50e-02	0.3760	2.02e-01	5.84e-02	2.74e-01	9.12e-02	1.16e-01	2.49e-02	5.17e-01	2.43e-03	3.12e-01	1.99e-01
GOCC TRAPP COMPLEX	16	3.59e-01	7.04e-01	0.3750	-4.50e-02	1.00e-01	-1.83e-01	-3.09e-01	1.13e-02	7.55e-01	4.89e-01	2.05e-01	3.26e-02	9.37e-01
GOMF PHOSPHOSERINE RESIDUE BINDING	10	4.89e-01	7.97e-01	0.3750	-7.97e-03	1.78e-01	-2.88e-02	-3.25e-01	-5.12e-02	9.65e-01	3.31e-01	8.75e-01	7.48e-02	7.79e-01
GOMF HISTONE METHYLTRANSFERASE BINDING	15	3.94e-01	7.29e-01	0.3750	1.86e-01	-3.29e-02	-1.67e-01	-2.76e-01	3.19e-02	2.12e-01	8.25e-01	2.63e-01	6.38e-02	8.31e-01
GOBP REGULATION OF GAMMA AMINOBUTYRIC ACID SECRETION	8	6.36e-01	8.72e-01	0.3750	1.99e-02	2.58e-01	2.02e-01	-1.37e-01	1.20e-01	9.22e-01	2.06e-01	3.23e-01	5.03e-01	5.56e-01
GOBP NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION	14	4.01e-01	7.34e-01	0.3750	1.27e-01	-5.65e-02	2.18e-01	2.24e-01	1.54e-01	4.09e-01	7.15e-01	1.57e-01	1.47e-01	3.19e-01
GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING	28	6.72e-02	3.06e-01	0.3750	1.81e-01	2.14e-01	-3.61e-02	-1.77e-01	1.72e-01	9.79e-02	4.98e-02	7.41e-01	1.04e-01	1.16e-01
GOBP TYPE III INTERFERON PRODUCTION	5	8.58e-01	9.53e-01	0.3750	1.75e-01	6.30e-02	1.63e-01	6.51e-02	2.74e-01	4.99e-01	8.07e-01	5.27e-01	8.01e-01	2.88e-01
GOBP POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING	36	4.25e-02	2.28e-01	0.3750	1.63e-02	-3.19e-02	-1.76e-01	-2.97e-01	1.43e-01	8.65e-01	7.41e-01	6.76e-02	2.07e-03	1.38e-01
GOCC NUCLEOID	43	2.07e-02	1.45e-01	0.3750	-1.15e-02	-6.61e-02	-2.82e-01	-2.33e-01	4.45e-02	8.96e-01	4.54e-01	1.36e-03	8.18e-03	6.13e-01
GOBP POSITIVE REGULATION OF FOCAL ADHESION ASSEMBLY	26	9.53e-02	3.73e-01	0.3750	-2.86e-01	8.78e-02	1.51e-01	1.16e-01	-1.21e-01	1.15e-02	4.39e-01	1.83e-01	3.05e-01	2.85e-01
GOMF ABC TYPE GLUTATHIONE S CONJUGATE TRANSPORTER ACTIVITY	8	4.21e-01	7.49e-01	0.3750	1.13e-01	5.39e-02	-2.96e-01	1.79e-01	-6.94e-02	5.80e-01	7.92e-01	1.47e-01	3.79e-01	7.34e-01
GOBP DORSAL ROOT GANGLION DEVELOPMENT	7	6.69e-01	8.83e-01	0.3750	1.58e-01	1.66e-01	2.88e-01	3.07e-03	-7.04e-02	4.70e-01	4.47e-01	1.87e-01	9.89e-01	7.47e-01
GOBP NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT	14	2.98e-01	6.53e-01	0.3750	3.44e-01	-1.32e-02	9.70e-02	-3.71e-02	1.07e-01	2.60e-02	9.32e-01	5.30e-01	8.10e-01	4.90e-01
GOBP FOLIC ACID CONTAINING COMPOUND BIOSYNTHETIC PROCESS	7	6.80e-01	8.87e-01	0.3750	-1.52e-01	-2.55e-01	-3.25e-02	-2.20e-01	5.32e-02	4.87e-01	2.43e-01	8.81e-01	3.13e-01	8.07e-01
GOBP PRIMARY ALCOHOL CATABOLIC PROCESS	13	3.32e-01	6.80e-01	0.3750	-1.96e-01	-1.84e-01	2.19e-02	2.50e-01	7.16e-02	2.22e-01	2.51e-01	8.91e-01	1.18e-01	6.55e-01
GOBP ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM	16	5.06e-02	2.56e-01	0.3750	1.79e-01	-1.70e-01	2.20e-01	-1.75e-01	-1.69e-02	2.14e-01	2.39e-01	1.28e-01	2.25e-01	9.07e-01
GOBP EPIDERMAL CELL FATE SPECIFICATION	5	6.40e-01	8.74e-01	0.3740	2.17e-01	-1.36e-01	1.97e-01	-1.87e-01	-3.37e-02	4.01e-01	6.00e-01	4.47e-01	4.69e-01	8.96e-01
GOMF PROTEIN SEQUESTERING ACTIVITY	23	6.47e-02	2.99e-01	0.3740	-1.67e-01	6.35e-02	5.11e-02	-2.95e-01	1.36e-01	1.64e-01	5.98e-01	6.71e-01	1.44e-02	2.58e-01
GOBP COMPLEMENT ACTIVATION CLASSICAL PATHWAY	34	1.42e-02	1.13e-01	0.3740	-2.15e-01	-6.71e-02	-6.06e-02	2.26e-01	-1.86e-01	2.98e-02	4.98e-01	5.41e-01	2.23e-02	6.12e-02
GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I	36	1.06e-03	1.61e-02	0.3740	-1.35e-01	-7.59e-02	7.31e-02	-1.99e-01	-2.67e-01	1.60e-01	4.31e-01	4.48e-01	3.90e-02	5.58e-03
GOBP POSITIVE REGULATION OF HEAT GENERATION	9	6.64e-01	8.82e-01	0.3740	2.17e-02	2.05e-01	2.10e-01	1.82e-01	1.43e-01	9.10e-01	2.86e-01	2.76e-01	3.43e-01	4.58e-01
GOCC BRUSH BORDER MEMBRANE	57	2.39e-03	3.09e-02	0.3740	-5.62e-02	9.93e-02	2.07e-01	2.01e-01	-2.10e-01	4.63e-01	1.95e-01	6.97e-03	8.60e-03	6.18e-03
GOBP PURINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS	6	7.58e-01	9.19e-01	0.3740	2.20e-01	6.96e-02	2.84e-02	7.80e-02	-2.83e-01	3.51e-01	7.68e-01	9.04e-01	7.41e-01	2.30e-01
GOBP TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE	29	1.00e-01	3.84e-01	0.3740	1.56e-01	-8.86e-02	-1.86e-01	-2.26e-01	1.49e-01	1.45e-01	4.09e-01	8.32e-02	3.53e-02	1.64e-01
GOBP REGULATION OF REGULATORY NCRNA PROCESSING	16	2.88e-01	6.42e-01	0.3740	7.76e-02	-1.17e-01	-1.90e-01	-2.14e-01	-1.96e-01	5.91e-01	4.16e-01	1.88e-01	1.39e-01	1.75e-01
GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN	15	2.68e-01	6.23e-01	0.3740	1.25e-01	-4.01e-02	-1.13e-01	1.70e-01	-2.85e-01	4.01e-01	7.88e-01	4.48e-01	2.55e-01	5.62e-02
GOMF HISTONE H3K4 MONOMETHYLTRANSFERASE ACTIVITY	8	5.56e-01	8.31e-01	0.3740	2.24e-01	1.49e-01	3.89e-02	-1.24e-01	-2.25e-01	2.72e-01	4.67e-01	8.49e-01	5.45e-01	2.70e-01
GOMF PHOSPHORUS OXYGEN LYASE ACTIVITY	22	1.37e-01	4.56e-01	0.3740	-9.69e-02	1.66e-03	1.09e-01	3.42e-01	-4.29e-02	4.31e-01	9.89e-01	3.78e-01	5.49e-03	7.28e-01
GOCC U1 SNRNP	19	2.11e-01	5.63e-01	0.3740	-9.20e-02	-9.27e-02	-2.46e-01	-1.50e-01	2.00e-01	4.88e-01	4.84e-01	6.37e-02	2.58e-01	1.31e-01
GOBP REGULATION OF PROTEIN AUTOUBIQUITINATION	5	8.83e-01	9.61e-01	0.3740	-2.03e-01	1.61e-01	2.24e-01	9.92e-02	-1.12e-01	4.32e-01	5.32e-01	3.86e-01	7.01e-01	6.63e-01
GOBP UBIQUITIN RECYCLING	13	3.91e-01	7.26e-01	0.3740	-2.43e-01	-4.53e-03	-6.57e-02	-2.46e-01	1.26e-01	1.29e-01	9.77e-01	6.81e-01	1.25e-01	4.32e-01
GOBP STRIATUM DEVELOPMENT	20	2.53e-01	6.10e-01	0.3740	-1.72e-01	-5.59e-02	1.52e-01	2.07e-01	-2.03e-01	1.82e-01	6.65e-01	2.39e-01	1.10e-01	1.16e-01
GOBP SOMATIC STEM CELL DIVISION	11	5.53e-01	8.30e-01	0.3740	1.11e-01	9.31e-02	-1.21e-01	-3.21e-01	3.28e-02	5.25e-01	5.93e-01	4.89e-01	6.50e-02	8.51e-01
GOBP NEGATIVE REGULATION OF RUFFLE ASSEMBLY	7	6.73e-01	8.84e-01	0.3740	-3.04e-01	1.94e-01	-1.70e-02	-4.26e-02	8.50e-02	1.63e-01	3.74e-01	9.38e-01	8.45e-01	6.97e-01
GOMF IMMUNOGLOBULIN RECEPTOR BINDING	7	7.99e-01	9.33e-01	0.3740	-8.97e-03	-6.97e-02	-2.05e-01	-3.02e-01	-3.81e-02	9.67e-01	7.49e-01	3.47e-01	1.67e-01	8.61e-01
GOBP CELLULAR RESPONSE TO SODIUM ARSENITE	5	8.68e-01	9.56e-01	0.3740	-2.81e-02	9.58e-02	-2.00e-01	-2.37e-01	-1.84e-01	9.13e-01	7.11e-01	4.40e-01	3.59e-01	4.77e-01
GOMF NEUROTROPHIN RECEPTOR BINDING	11	5.00e-01	8.03e-01	0.3740	-9.86e-03	2.83e-01	1.33e-01	-1.19e-01	1.66e-01	9.55e-01	1.04e-01	4.45e-01	4.94e-01	3.40e-01
GOBP LEUKOTRIENE BIOSYNTHETIC PROCESS	16	2.21e-01	5.76e-01	0.3740	3.81e-03	1.44e-01	1.26e-01	2.27e-01	2.27e-01	9.79e-01	3.20e-01	3.83e-01	1.16e-01	1.16e-01
GOMF EPHRIN RECEPTOR BINDING	26	4.56e-02	2.38e-01	0.3740	-1.69e-01	1.63e-01	2.60e-01	-8.48e-02	9.86e-02	1.37e-01	1.50e-01	2.17e-02	4.54e-01	3.84e-01
GOMF EXTRACELLULARLY ATP GATED MONOATOMIC CATION CHANNEL ACTIVITY	7	7.03e-01	8.96e-01	0.3740	3.75e-02	2.06e-01	2.57e-01	-9.36e-02	1.45e-01	8.64e-01	3.45e-01	2.40e-01	6.68e-01	5.07e-01
GOMF U3 SNORNA BINDING	10	6.16e-01	8.61e-01	0.3740	2.71e-01	2.75e-02	-1.51e-01	-2.03e-01	3.12e-02	1.37e-01	8.80e-01	4.07e-01	2.66e-01	8.64e-01
GOBP HISTONE H4 K16 ACETYLATION	6	7.93e-01	9.31e-01	0.3730	1.22e-01	2.91e-01	-1.40e-01	-1.42e-01	-1.57e-02	6.05e-01	2.17e-01	5.53e-01	5.47e-01	9.47e-01
GOBP GLYCOSIDE CATABOLIC PROCESS	8	5.42e-01	8.24e-01	0.3730	2.27e-01	-6.86e-02	-4.68e-02	-1.94e-01	-2.08e-01	2.66e-01	7.37e-01	8.19e-01	3.42e-01	3.07e-01
GOBP TRNA MODIFICATION	87	7.50e-05	1.89e-03	0.3730	1.06e-01	-7.46e-02	-2.63e-01	-2.29e-01	3.03e-02	8.83e-02	2.29e-01	2.23e-05	2.16e-04	6.26e-01
GOBP REGULATION OF GLOMERULAR FILTRATION	8	4.08e-01	7.40e-01	0.3730	-1.24e-01	2.05e-01	-2.74e-01	4.97e-02	6.55e-02	5.44e-01	3.14e-01	1.80e-01	8.08e-01	7.48e-01
GOBP PRO B CELL DIFFERENTIATION	12	4.82e-01	7.93e-01	0.3730	1.96e-01	-7.71e-02	-1.83e-02	-1.46e-01	2.71e-01	2.40e-01	6.44e-01	9.13e-01	3.82e-01	1.04e-01
GOBP RECEPTOR GUANYLYL CYCLASE SIGNALING PATHWAY	10	5.57e-01	8.32e-01	0.3730	1.26e-01	4.52e-02	1.40e-01	9.55e-02	3.04e-01	4.89e-01	8.05e-01	4.42e-01	6.01e-01	9.60e-02
GOBP REGULATION OF CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION	12	4.65e-01	7.81e-01	0.3730	3.00e-01	1.35e-01	-8.77e-02	-6.71e-02	1.38e-01	7.22e-02	4.17e-01	5.99e-01	6.87e-01	4.09e-01
GOCC AZUROPHIL GRANULE LUMEN	88	5.25e-07	2.55e-05	0.3730	-1.85e-01	4.29e-02	1.16e-02	-2.83e-01	1.51e-01	2.74e-03	4.86e-01	8.50e-01	4.37e-06	1.41e-02
GOMF PHOSPHATIDYLINOSITOL PHOSPHATE 5 PHOSPHATASE ACTIVITY	12	3.17e-01	6.66e-01	0.3730	-1.59e-01	-1.44e-02	-1.21e-02	-2.35e-01	-2.42e-01	3.39e-01	9.31e-01	9.42e-01	1.60e-01	1.47e-01
GOBP INTRACELLULAR TRANSPORT OF VIRUS	10	5.18e-01	8.12e-01	0.3730	-3.22e-01	1.10e-02	-1.86e-02	-1.82e-01	4.45e-02	7.83e-02	9.52e-01	9.19e-01	3.19e-01	8.07e-01
GOCC COPI COATED VESICLE	25	1.17e-01	4.19e-01	0.3730	1.02e-01	1.88e-01	-1.26e-01	-2.75e-01	4.14e-02	3.75e-01	1.04e-01	2.76e-01	1.72e-02	7.20e-01
GOBP LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE	19	7.80e-02	3.35e-01	0.3730	-2.49e-01	1.97e-02	1.24e-02	2.30e-01	1.53e-01	6.01e-02	8.82e-01	9.26e-01	8.27e-02	2.48e-01
GOBP MEMBRANE HYPERPOLARIZATION	10	5.20e-01	8.13e-01	0.3730	6.03e-02	2.38e-01	2.59e-01	-1.08e-03	-1.08e-01	7.41e-01	1.93e-01	1.56e-01	9.95e-01	5.56e-01
GOMF CHEMOREPELLENT ACTIVITY	28	7.35e-02	3.24e-01	0.3730	-2.37e-01	7.63e-02	9.64e-02	2.19e-01	-1.39e-01	2.96e-02	4.85e-01	3.77e-01	4.46e-02	2.04e-01
GOBP PHOSPHATIDYLCHOLINE CATABOLIC PROCESS	16	3.49e-01	6.95e-01	0.3730	-2.12e-01	1.96e-01	1.87e-01	1.31e-01	-5.90e-02	1.42e-01	1.75e-01	1.96e-01	3.65e-01	6.83e-01
GOBP POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION	8	6.18e-01	8.62e-01	0.3720	3.13e-01	-1.38e-01	-4.97e-02	3.24e-03	-1.39e-01	1.26e-01	4.98e-01	8.08e-01	9.87e-01	4.96e-01
GOBP NEGATIVE REGULATION OF SCHWANN CELL PROLIFERATION	8	7.07e-01	8.97e-01	0.3720	1.92e-01	2.18e-01	-1.63e-01	-1.61e-01	4.52e-02	3.47e-01	2.86e-01	4.25e-01	4.30e-01	8.25e-01
GOBP REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS	16	2.73e-01	6.28e-01	0.3720	5.36e-02	3.51e-01	8.53e-02	1.37e-02	7.28e-02	7.10e-01	1.51e-02	5.55e-01	9.24e-01	6.14e-01
GOBP NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION	17	2.75e-01	6.30e-01	0.3720	2.87e-01	8.99e-02	-4.27e-02	-1.76e-01	1.24e-01	4.07e-02	5.21e-01	7.60e-01	2.08e-01	3.74e-01
GOBP REELIN MEDIATED SIGNALING PATHWAY	7	5.92e-01	8.47e-01	0.3720	-8.67e-02	-5.22e-02	3.05e-01	-1.08e-01	1.53e-01	6.91e-01	8.11e-01	1.62e-01	6.20e-01	4.83e-01
GOBP PROTEIN UFMYLATION	6	7.84e-01	9.28e-01	0.3720	2.59e-01	1.31e-01	-1.51e-01	-8.44e-02	-1.56e-01	2.72e-01	5.77e-01	5.22e-01	7.20e-01	5.08e-01
GOBP INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY	25	1.91e-02	1.37e-01	0.3720	-3.86e-02	-5.10e-02	2.22e-01	-2.56e-02	-2.91e-01	7.38e-01	6.59e-01	5.48e-02	8.24e-01	1.18e-02
GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING	14	5.01e-01	8.03e-01	0.3720	1.73e-02	-8.73e-02	-2.65e-01	-2.41e-01	-4.83e-02	9.11e-01	5.72e-01	8.63e-02	1.18e-01	7.54e-01
GOBP TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION	15	3.85e-01	7.23e-01	0.3720	-6.23e-02	1.84e-01	3.04e-01	8.73e-02	-2.82e-02	6.76e-01	2.17e-01	4.16e-02	5.58e-01	8.50e-01
GOMF RACEMASE AND EPIMERASE ACTIVITY	17	2.23e-01	5.76e-01	0.3720	2.19e-01	2.53e-01	-3.22e-02	-1.39e-01	-7.80e-02	1.19e-01	7.06e-02	8.18e-01	3.20e-01	5.78e-01
GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE II PROMOTER	95	2.65e-05	7.89e-04	0.3720	5.93e-02	-6.72e-02	-2.69e-01	-2.41e-01	-1.10e-02	3.18e-01	2.57e-01	5.90e-06	4.99e-05	8.53e-01
GOBP POSITIVE REGULATION OF HIPPO SIGNALING	10	6.17e-01	8.62e-01	0.3720	-1.07e-01	-2.13e-01	8.35e-02	2.05e-01	-1.80e-01	5.57e-01	2.43e-01	6.47e-01	2.61e-01	3.25e-01
GOBP NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE	15	3.14e-01	6.65e-01	0.3720	1.02e-03	1.94e-01	3.00e-01	-1.02e-02	1.05e-01	9.95e-01	1.94e-01	4.44e-02	9.45e-01	4.83e-01
GOBP TOLERANCE INDUCTION DEPENDENT UPON IMMUNE RESPONSE	5	8.10e-01	9.38e-01	0.3720	-3.20e-01	1.85e-01	-3.48e-02	-1.61e-03	1.35e-02	2.15e-01	4.73e-01	8.93e-01	9.95e-01	9.58e-01
GOBP REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN TRANSCRIPTION OF P21 CLASS MEDIATOR	6	7.08e-01	8.97e-01	0.3720	-2.59e-01	-9.15e-02	-2.33e-01	1.16e-02	9.10e-02	2.71e-01	6.98e-01	3.23e-01	9.61e-01	6.99e-01
GOMF ALPHA 1 3 FUCOSYLTRANSFERASE ACTIVITY	8	5.43e-01	8.25e-01	0.3720	-2.00e-01	2.60e-01	1.32e-02	1.29e-01	1.19e-01	3.27e-01	2.04e-01	9.48e-01	5.29e-01	5.59e-01
GOBP DOUBLE STRAND BREAK REPAIR VIA SINGLE STRAND ANNEALING	6	8.19e-01	9.41e-01	0.3720	-1.40e-01	1.28e-01	-1.01e-01	-2.71e-01	1.37e-01	5.54e-01	5.88e-01	6.69e-01	2.50e-01	5.60e-01
GOBP NEGATIVE REGULATION OF CHROMOSOME SEGREGATION	50	4.60e-03	5.06e-02	0.3720	2.26e-01	-1.18e-01	-2.12e-01	-1.68e-01	-3.03e-03	5.61e-03	1.48e-01	9.62e-03	3.97e-02	9.70e-01
GOBP POSITIVE REGULATION OF SPROUTING ANGIOGENESIS	28	6.34e-02	2.96e-01	0.3720	-2.87e-01	1.13e-01	1.77e-01	4.82e-02	-9.47e-02	8.46e-03	2.99e-01	1.04e-01	6.59e-01	3.86e-01
GOCC GTPASE ACTIVATOR COMPLEX	11	5.97e-01	8.51e-01	0.3720	9.19e-02	1.72e-01	-1.56e-01	-2.57e-01	9.91e-02	5.98e-01	3.23e-01	3.69e-01	1.40e-01	5.69e-01
GOMF MITOGEN ACTIVATED PROTEIN KINASE KINASE BINDING	9	6.01e-01	8.53e-01	0.3720	2.83e-01	5.53e-02	-4.53e-02	-2.28e-01	3.27e-02	1.41e-01	7.74e-01	8.14e-01	2.37e-01	8.65e-01
GOMF QUATERNARY AMMONIUM GROUP TRANSMEMBRANE TRANSPORTER ACTIVITY	19	1.86e-01	5.30e-01	0.3720	2.25e-01	2.09e-02	1.22e-01	2.22e-01	1.51e-01	8.94e-02	8.75e-01	3.57e-01	9.37e-02	2.53e-01
GOMF SMALL RIBOSOMAL SUBUNIT RRNA BINDING	8	7.06e-01	8.97e-01	0.3720	1.12e-02	1.98e-01	-2.18e-01	-1.97e-01	1.11e-01	9.56e-01	3.31e-01	2.85e-01	3.35e-01	5.87e-01
GOCC ESCRT I COMPLEX	11	5.82e-01	8.43e-01	0.3720	-1.80e-01	-4.49e-02	2.65e-01	1.70e-01	7.10e-02	3.01e-01	7.97e-01	1.29e-01	3.30e-01	6.84e-01
GOBP SPHINGOMYELIN CATABOLIC PROCESS	8	4.70e-01	7.85e-01	0.3720	-1.60e-02	9.00e-02	1.50e-01	-3.25e-01	3.99e-02	9.37e-01	6.59e-01	4.62e-01	1.11e-01	8.45e-01
GOBP STEROID HORMONE SECRETION	27	3.94e-02	2.18e-01	0.3720	-3.21e-02	2.09e-01	6.99e-02	-4.77e-02	-2.94e-01	7.72e-01	6.05e-02	5.29e-01	6.68e-01	8.20e-03
GOBP POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION	39	9.07e-03	8.18e-02	0.3720	-1.35e-01	3.12e-01	1.42e-01	-3.72e-02	-2.95e-02	1.44e-01	7.44e-04	1.24e-01	6.87e-01	7.50e-01
GOBP REGULATION OF INTESTINAL ABSORPTION	12	3.59e-01	7.04e-01	0.3720	2.82e-02	1.80e-01	8.00e-02	3.05e-01	7.39e-02	8.66e-01	2.81e-01	6.31e-01	6.72e-02	6.58e-01
GOBP PEPTIDYL PROLINE MODIFICATION	32	3.39e-02	1.98e-01	0.3710	6.97e-02	1.38e-01	-1.40e-01	-2.93e-01	-9.48e-02	4.95e-01	1.77e-01	1.71e-01	4.17e-03	3.53e-01
GOBP L SERINE CATABOLIC PROCESS	5	7.72e-01	9.25e-01	0.3710	1.98e-01	-2.21e-02	-9.13e-02	2.96e-01	-5.21e-02	4.44e-01	9.32e-01	7.24e-01	2.52e-01	8.40e-01
GOBP REGULATION OF NODAL SIGNALING PATHWAY INVOLVED IN DETERMINATION OF LEFT RIGHT ASYMMETRY	5	8.61e-01	9.53e-01	0.3710	-1.61e-01	-2.03e-01	2.15e-01	1.42e-01	6.77e-02	5.34e-01	4.31e-01	4.06e-01	5.82e-01	7.93e-01
GOCC PROTON TRANSPORTING V TYPE ATPASE COMPLEX	25	6.45e-02	2.99e-01	0.3710	1.53e-01	-1.09e-02	-2.81e-02	-3.19e-01	1.08e-01	1.86e-01	9.25e-01	8.08e-01	5.69e-03	3.50e-01
GOBP NEUTROPHIL CHEMOTAXIS	99	9.26e-07	4.17e-05	0.3710	-2.33e-01	1.82e-01	1.09e-01	1.43e-01	-1.34e-01	6.00e-05	1.72e-03	6.06e-02	1.42e-02	2.09e-02
GOCC CHLORIDE CHANNEL COMPLEX	50	4.57e-03	5.04e-02	0.3710	-1.12e-01	1.73e-01	2.32e-01	1.79e-01	9.82e-02	1.70e-01	3.47e-02	4.59e-03	2.83e-02	2.29e-01
GOCC POSTSYNAPTIC CYTOSKELETON	10	3.26e-01	6.74e-01	0.3710	1.01e-01	1.20e-01	1.28e-01	-3.08e-01	-4.54e-02	5.79e-01	5.12e-01	4.82e-01	9.20e-02	8.04e-01
GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION	27	5.19e-02	2.61e-01	0.3710	4.76e-02	2.64e-01	-2.13e-01	-1.36e-01	-4.85e-02	6.68e-01	1.77e-02	5.57e-02	2.23e-01	6.63e-01
GOBP NEGATIVE REGULATION OF MYELINATION	9	6.24e-01	8.66e-01	0.3710	-1.55e-01	-2.13e-01	-2.03e-01	4.67e-02	-1.57e-01	4.19e-01	2.68e-01	2.92e-01	8.08e-01	4.14e-01
GOBP NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY	18	2.85e-01	6.39e-01	0.3710	3.13e-02	1.49e-01	-7.76e-02	-2.65e-01	1.95e-01	8.18e-01	2.74e-01	5.69e-01	5.15e-02	1.51e-01
GOBP PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS	21	1.87e-01	5.30e-01	0.3710	2.91e-02	1.53e-01	-1.88e-01	-2.60e-01	-1.01e-01	8.18e-01	2.23e-01	1.35e-01	3.92e-02	4.22e-01
GOBP GANGLIOSIDE CATABOLIC PROCESS	7	6.63e-01	8.81e-01	0.3710	-4.33e-02	-2.21e-01	-8.26e-03	-2.76e-01	1.02e-01	8.43e-01	3.11e-01	9.70e-01	2.06e-01	6.39e-01
GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS	31	1.90e-02	1.37e-01	0.3710	-2.51e-01	2.23e-01	3.27e-02	-4.26e-02	1.48e-01	1.55e-02	3.17e-02	7.53e-01	6.82e-01	1.54e-01
GOMF OXALATE TRANSMEMBRANE TRANSPORTER ACTIVITY	10	5.85e-01	8.45e-01	0.3710	-6.31e-02	-1.68e-02	1.96e-02	1.21e-01	-3.44e-01	7.30e-01	9.27e-01	9.14e-01	5.09e-01	5.97e-02
GOBP POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION	15	3.17e-01	6.66e-01	0.3710	1.29e-01	3.29e-01	8.57e-03	-7.27e-02	8.54e-02	3.89e-01	2.74e-02	9.54e-01	6.26e-01	5.67e-01
GOBP REGULATION OF PROTEIN DEUBIQUITINATION	10	5.90e-01	8.47e-01	0.3710	-1.70e-02	2.11e-02	-1.82e-01	-2.68e-01	-1.78e-01	9.26e-01	9.08e-01	3.19e-01	1.42e-01	3.29e-01
GOBP VITAMIN D3 METABOLIC PROCESS	6	8.29e-01	9.44e-01	0.3710	2.20e-01	1.38e-01	2.09e-01	1.62e-01	1.11e-02	3.50e-01	5.59e-01	3.76e-01	4.93e-01	9.62e-01
GOBP RESPONSE TO SYMBIONT	6	8.56e-01	9.52e-01	0.3710	-1.41e-01	1.96e-01	2.04e-01	1.75e-01	-8.20e-02	5.50e-01	4.07e-01	3.87e-01	4.57e-01	7.28e-01
GOMF 3 5 CYCLIC GMP PHOSPHODIESTERASE ACTIVITY	16	4.39e-01	7.61e-01	0.3700	7.79e-03	2.30e-02	2.65e-01	2.55e-01	-3.62e-02	9.57e-01	8.73e-01	6.67e-02	7.69e-02	8.02e-01
GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I	32	6.87e-02	3.10e-01	0.3700	7.72e-02	-1.68e-01	-2.03e-01	-2.46e-01	4.23e-02	4.50e-01	1.01e-01	4.73e-02	1.62e-02	6.79e-01
GOBP REGULATION OF TRANSLATION AT SYNAPSE	6	7.39e-01	9.11e-01	0.3700	4.84e-02	-2.07e-01	-2.59e-01	1.37e-01	-7.99e-02	8.37e-01	3.81e-01	2.72e-01	5.61e-01	7.35e-01
GOCC PRC1 COMPLEX	16	3.70e-01	7.10e-01	0.3700	1.61e-01	8.45e-03	-9.83e-02	-1.81e-01	2.62e-01	2.65e-01	9.53e-01	4.96e-01	2.11e-01	6.91e-02
GOBP NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT	24	1.63e-01	4.96e-01	0.3700	2.94e-02	-1.60e-01	-1.98e-01	-2.67e-01	3.25e-03	8.03e-01	1.76e-01	9.31e-02	2.33e-02	9.78e-01
GOCC SPLICEOSOMAL COMPLEX	184	1.33e-10	1.19e-08	0.3700	6.80e-02	-6.17e-02	-2.12e-01	-2.76e-01	8.52e-02	1.12e-01	1.49e-01	6.69e-07	1.00e-10	4.63e-02
GOBP PROTEIN RETENTION IN ER LUMEN	8	6.57e-01	8.80e-01	0.3700	-4.64e-02	1.33e-01	-8.90e-02	-3.13e-01	-1.07e-01	8.20e-01	5.15e-01	6.63e-01	1.25e-01	6.01e-01
GOBP HISTAMINE METABOLIC PROCESS	6	6.40e-01	8.74e-01	0.3700	4.15e-02	2.21e-01	-2.03e-02	2.67e-01	1.22e-01	8.60e-01	3.49e-01	9.31e-01	2.58e-01	6.05e-01
GOCC CANONICAL INFLAMMASOME COMPLEX	16	3.46e-01	6.93e-01	0.3700	-5.47e-02	2.45e-01	2.60e-01	6.79e-02	-4.05e-02	7.05e-01	8.99e-02	7.13e-02	6.38e-01	7.79e-01
GOBP MRNA EXPORT FROM NUCLEUS	61	1.83e-03	2.52e-02	0.3700	3.98e-02	4.45e-02	-2.18e-01	-2.93e-01	-6.96e-03	5.90e-01	5.48e-01	3.21e-03	7.59e-05	9.25e-01
GOBP POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION	14	3.29e-01	6.77e-01	0.3700	1.53e-01	1.05e-01	-2.49e-02	-3.15e-01	5.06e-02	3.21e-01	4.95e-01	8.72e-01	4.13e-02	7.43e-01
GOBP TERMINAL BUTTON ORGANIZATION	6	7.94e-01	9.32e-01	0.3700	1.73e-01	4.83e-02	1.74e-01	-5.61e-02	2.67e-01	4.64e-01	8.38e-01	4.60e-01	8.12e-01	2.58e-01
GOMF DEATH RECEPTOR BINDING	19	1.63e-01	4.96e-01	0.3700	-7.81e-02	-1.10e-01	2.92e-02	-2.26e-01	2.58e-01	5.55e-01	4.08e-01	8.26e-01	8.77e-02	5.13e-02
GOCC COLLAGEN TRIMER	83	2.86e-05	8.39e-04	0.3700	-1.59e-01	-1.56e-01	8.35e-02	2.55e-01	-1.22e-01	1.24e-02	1.39e-02	1.89e-01	5.78e-05	5.39e-02
GOBP TROPHOBLAST GIANT CELL DIFFERENTIATION	12	5.68e-01	8.37e-01	0.3700	2.34e-01	-1.94e-02	-1.79e-01	-1.98e-01	1.02e-01	1.61e-01	9.07e-01	2.83e-01	2.35e-01	5.41e-01
GOBP NEGATIVE REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION	5	8.49e-01	9.49e-01	0.3700	-4.33e-02	2.70e-02	-6.63e-02	-3.56e-01	5.04e-02	8.67e-01	9.17e-01	7.98e-01	1.68e-01	8.45e-01
GOBP NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL	10	5.50e-01	8.28e-01	0.3700	1.97e-01	1.34e-01	1.63e-01	-1.02e-01	2.07e-01	2.82e-01	4.61e-01	3.72e-01	5.77e-01	2.57e-01
GOBP EXONUCLEOLYTIC CATABOLISM OF DEADENYLATED MRNA	13	4.96e-01	8.00e-01	0.3690	1.31e-01	-1.58e-01	-1.98e-01	-2.33e-01	-3.02e-02	4.14e-01	3.25e-01	2.16e-01	1.45e-01	8.51e-01
GOBP G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY	10	5.70e-01	8.38e-01	0.3690	-1.51e-01	2.55e-01	1.56e-01	9.66e-02	1.23e-01	4.09e-01	1.63e-01	3.92e-01	5.97e-01	5.02e-01
GOMF G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR ACTIVITY	10	5.70e-01	8.38e-01	0.3690	-1.51e-01	2.55e-01	1.56e-01	9.66e-02	1.23e-01	4.09e-01	1.63e-01	3.92e-01	5.97e-01	5.02e-01
GOBP REGULATION OF HEART RATE BY CARDIAC CONDUCTION	37	1.58e-02	1.21e-01	0.3690	-1.46e-01	1.83e-01	1.03e-01	2.53e-01	-8.58e-02	1.25e-01	5.45e-02	2.78e-01	7.76e-03	3.67e-01
GOBP PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX	19	2.50e-01	6.07e-01	0.3690	-9.05e-02	1.20e-01	-1.23e-01	-2.65e-01	1.68e-01	4.95e-01	3.64e-01	3.53e-01	4.54e-02	2.05e-01
GOCC SMALL SUBUNIT PROCESSOME	70	5.95e-04	1.01e-02	0.3690	1.01e-02	-1.76e-02	-2.33e-01	-2.84e-01	-3.38e-02	8.83e-01	8.00e-01	7.61e-04	3.96e-05	6.25e-01
GOBP NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT	11	5.07e-01	8.07e-01	0.3690	2.95e-01	5.24e-02	-5.01e-02	-2.05e-01	4.48e-02	9.03e-02	7.63e-01	7.74e-01	2.39e-01	7.97e-01
GOBP FOREBRAIN NEURON DIFFERENTIATION	42	2.09e-03	2.78e-02	0.3690	7.64e-03	8.05e-02	1.64e-01	-2.21e-01	2.32e-01	9.32e-01	3.66e-01	6.57e-02	1.32e-02	9.15e-03
GOBP MITOTIC CHROMOSOME CONDENSATION	19	3.22e-01	6.71e-01	0.3690	1.55e-01	-4.08e-05	-2.03e-01	-2.60e-01	5.72e-02	2.42e-01	1.00e+00	1.25e-01	4.96e-02	6.66e-01
GOCC SPERM HEAD	17	2.96e-01	6.50e-01	0.3690	-9.33e-02	-1.12e-01	6.75e-02	3.13e-01	-1.12e-01	5.05e-01	4.22e-01	6.30e-01	2.56e-02	4.23e-01
GOBP LEUKOTRIENE D4 BIOSYNTHETIC PROCESS	5	8.82e-01	9.61e-01	0.3690	8.59e-02	-2.27e-01	-2.05e-01	-8.65e-02	1.67e-01	7.39e-01	3.79e-01	4.28e-01	7.38e-01	5.18e-01
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION	19	2.26e-01	5.79e-01	0.3690	-3.06e-01	9.40e-02	1.53e-01	9.78e-02	-3.26e-02	2.11e-02	4.78e-01	2.49e-01	4.61e-01	8.05e-01
GOBP LEYDIG CELL DIFFERENTIATION	9	6.44e-01	8.75e-01	0.3690	-3.42e-02	1.89e-01	-4.62e-02	-2.97e-01	9.44e-02	8.59e-01	3.25e-01	8.10e-01	1.23e-01	6.24e-01
GOBP RENAL VESICLE DEVELOPMENT	18	1.39e-01	4.59e-01	0.3690	5.65e-02	-3.82e-02	1.05e-01	-2.64e-01	2.25e-01	6.78e-01	7.79e-01	4.39e-01	5.24e-02	9.84e-02
GOCC PROTEIN PHOSPHATASE 4 COMPLEX	5	8.63e-01	9.54e-01	0.3690	8.81e-02	-1.48e-01	-1.83e-01	-1.91e-01	-1.90e-01	7.33e-01	5.65e-01	4.78e-01	4.59e-01	4.62e-01
GOBP MALE MEIOTIC NUCLEAR DIVISION	54	4.59e-04	8.37e-03	0.3690	-8.86e-02	-3.44e-02	1.25e-01	-9.89e-02	3.19e-01	2.60e-01	6.62e-01	1.13e-01	2.09e-01	5.00e-05
GOBP NEGATIVE REGULATION OF CALCIUM ION IMPORT	10	5.72e-01	8.38e-01	0.3690	1.71e-02	4.60e-02	1.53e-01	3.06e-01	1.29e-01	9.25e-01	8.01e-01	4.03e-01	9.39e-02	4.79e-01
GOBP REGULATION OF NODAL SIGNALING PATHWAY	9	5.77e-01	8.42e-01	0.3690	4.65e-02	-2.56e-01	1.44e-01	4.73e-02	2.13e-01	8.09e-01	1.84e-01	4.55e-01	8.06e-01	2.68e-01
GOBP PROTEIN CATABOLIC PROCESS IN THE VACUOLE	22	2.30e-01	5.84e-01	0.3690	-1.99e-02	-1.17e-01	-2.04e-01	-2.79e-01	4.68e-02	8.72e-01	3.41e-01	9.70e-02	2.35e-02	7.04e-01
GOMF TRANSCRIPTION REGULATOR INHIBITOR ACTIVITY	21	1.89e-01	5.34e-01	0.3690	1.91e-01	8.59e-02	-1.23e-01	-2.77e-01	1.04e-02	1.30e-01	4.96e-01	3.30e-01	2.79e-02	9.34e-01
GOBP REGULATION OF PRESYNAPTIC MEMBRANE POTENTIAL	28	8.25e-02	3.46e-01	0.3690	-2.00e-01	1.19e-01	2.73e-01	8.16e-02	-2.07e-02	6.73e-02	2.74e-01	1.24e-02	4.55e-01	8.49e-01
GOBP REGULATION OF ELECTRON TRANSFER ACTIVITY	6	8.35e-01	9.45e-01	0.3690	5.08e-02	8.28e-02	-1.12e-01	-3.32e-01	5.89e-02	8.29e-01	7.25e-01	6.34e-01	1.59e-01	8.03e-01
GOBP POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT	6	6.35e-01	8.72e-01	0.3680	9.88e-02	-1.14e-01	1.86e-01	-2.33e-01	1.56e-01	6.75e-01	6.28e-01	4.31e-01	3.24e-01	5.08e-01
GOCC PRESYNAPTIC ACTIVE ZONE CYTOPLASMIC COMPONENT	18	2.33e-01	5.86e-01	0.3680	7.22e-03	-2.73e-01	1.43e-01	1.95e-01	4.81e-02	9.58e-01	4.47e-02	2.92e-01	1.52e-01	7.24e-01
GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE I PROMOTER	11	3.37e-01	6.84e-01	0.3680	3.00e-01	-6.86e-02	3.14e-02	-1.33e-01	-1.49e-01	8.48e-02	6.93e-01	8.57e-01	4.45e-01	3.92e-01
GOBP TROPHECTODERMAL CELL DIFFERENTIATION	19	1.41e-01	4.62e-01	0.3680	1.84e-01	-2.23e-01	-2.30e-02	-2.06e-01	9.57e-02	1.65e-01	9.27e-02	8.62e-01	1.19e-01	4.70e-01
GOMF TELOMERIC DNA BINDING	38	3.91e-02	2.17e-01	0.3680	3.09e-02	5.04e-02	-2.56e-01	-2.57e-01	-2.17e-02	7.42e-01	5.91e-01	6.33e-03	6.04e-03	8.17e-01
GOMF ADENYLATE CYCLASE BINDING	12	5.26e-01	8.17e-01	0.3680	-1.30e-01	-1.14e-01	2.33e-01	1.97e-01	1.11e-01	4.35e-01	4.95e-01	1.62e-01	2.36e-01	5.04e-01
GOMF TESTOSTERONE 17 BETA DEHYDROGENASE NADPPLUS ACTIVITY	9	6.14e-01	8.60e-01	0.3680	1.24e-01	-1.09e-01	2.00e-01	1.68e-01	-2.00e-01	5.20e-01	5.72e-01	2.99e-01	3.83e-01	2.98e-01
GOBP CHONDROCYTE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS	8	7.00e-01	8.96e-01	0.3680	-1.95e-01	1.30e-01	-1.74e-01	-2.01e-01	-1.00e-01	3.40e-01	5.26e-01	3.94e-01	3.25e-01	6.24e-01
GOBP REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY	7	7.48e-01	9.15e-01	0.3680	-1.11e-02	1.82e-01	-3.89e-02	-1.35e-01	2.87e-01	9.59e-01	4.03e-01	8.58e-01	5.36e-01	1.89e-01
GOBP MONOCYTE AGGREGATION	5	8.32e-01	9.45e-01	0.3680	2.87e-01	1.31e-01	1.40e-02	1.60e-01	1.01e-01	2.67e-01	6.13e-01	9.57e-01	5.36e-01	6.95e-01
GOBP VESTIBULOCOCHLEAR NERVE FORMATION	5	8.27e-01	9.44e-01	0.3680	1.19e-01	-1.42e-01	1.97e-02	1.54e-01	2.77e-01	6.46e-01	5.82e-01	9.39e-01	5.50e-01	2.83e-01
GOMF POTASSIUM CHLORIDE SYMPORTER ACTIVITY	9	6.03e-01	8.55e-01	0.3680	-2.98e-01	-3.57e-02	-5.13e-02	-1.61e-01	-1.28e-01	1.21e-01	8.53e-01	7.90e-01	4.04e-01	5.05e-01
GOBP CARNITINE TRANSPORT	8	4.13e-01	7.44e-01	0.3680	1.28e-01	1.94e-01	-1.55e-01	2.10e-01	1.15e-01	5.31e-01	3.42e-01	4.48e-01	3.04e-01	5.73e-01
GOBP LUTEINIZATION	12	4.04e-01	7.36e-01	0.3680	-1.46e-01	1.91e-01	3.14e-02	-1.17e-01	-2.51e-01	3.83e-01	2.52e-01	8.51e-01	4.81e-01	1.32e-01
GOBP NEURON RECOGNITION	45	1.85e-02	1.34e-01	0.3680	-5.50e-02	-5.74e-02	2.23e-01	2.78e-01	-4.36e-02	5.23e-01	5.06e-01	9.76e-03	1.23e-03	6.13e-01
GOBP MEDIUM CHAIN FATTY ACID METABOLIC PROCESS	15	2.86e-01	6.40e-01	0.3680	6.30e-02	1.64e-01	3.18e-01	-1.12e-02	5.62e-02	6.73e-01	2.72e-01	3.29e-02	9.40e-01	7.06e-01
GOBP NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY	15	3.13e-01	6.64e-01	0.3680	-2.24e-01	1.52e-01	-7.45e-02	-2.29e-01	-6.38e-02	1.34e-01	3.07e-01	6.17e-01	1.25e-01	6.69e-01
GOMF STRUCTURAL CONSTITUENT OF EYE LENS	23	9.16e-02	3.66e-01	0.3680	2.63e-01	-1.10e-01	-1.70e-02	1.50e-01	-1.77e-01	2.93e-02	3.63e-01	8.88e-01	2.12e-01	1.41e-01
GOBP UBIQUINONE METABOLIC PROCESS	19	2.59e-01	6.16e-01	0.3680	1.50e-01	4.30e-02	-1.84e-01	-2.67e-01	-7.36e-02	2.58e-01	7.46e-01	1.65e-01	4.36e-02	5.78e-01
GOBP POSITIVE REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS	14	3.18e-01	6.67e-01	0.3680	-1.32e-01	1.15e-01	-9.53e-02	-1.17e-01	2.86e-01	3.94e-01	4.58e-01	5.37e-01	4.50e-01	6.37e-02
GOBP EMBRYONIC VISCEROCRANIUM MORPHOGENESIS	10	5.13e-01	8.08e-01	0.3670	2.80e-01	1.47e-01	-1.22e-01	2.49e-02	1.39e-01	1.25e-01	4.21e-01	5.03e-01	8.92e-01	4.46e-01
GOCC ENDOPLASMIC RETICULUM TUBULAR NETWORK	26	1.06e-01	3.95e-01	0.3670	2.55e-01	1.45e-01	-1.38e-01	-1.60e-01	6.53e-02	2.44e-02	2.00e-01	2.25e-01	1.57e-01	5.65e-01
GOBP INTRACELLULAR MONOATOMIC ANION HOMEOSTASIS	10	4.84e-01	7.94e-01	0.3670	-2.01e-01	2.62e-01	-6.79e-03	-3.00e-02	1.59e-01	2.72e-01	1.52e-01	9.70e-01	8.70e-01	3.85e-01
GOBP VITAMIN K METABOLIC PROCESS	10	6.12e-01	8.58e-01	0.3670	-4.67e-02	3.00e-01	1.45e-01	1.34e-01	-6.16e-02	7.98e-01	1.00e-01	4.29e-01	4.63e-01	7.36e-01
GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE	29	8.58e-02	3.54e-01	0.3670	1.52e-01	3.12e-02	-1.88e-01	-2.71e-01	-4.61e-02	1.57e-01	7.71e-01	7.92e-02	1.16e-02	6.67e-01
GOCC PERICENTRIC HETEROCHROMATIN	29	7.91e-02	3.39e-01	0.3670	2.65e-01	6.16e-02	-1.66e-01	-1.38e-01	1.20e-01	1.37e-02	5.66e-01	1.22e-01	1.98e-01	2.63e-01
GOBP DETECTION OF MECHANICAL STIMULUS	52	2.88e-03	3.57e-02	0.3670	2.76e-03	-1.92e-02	1.61e-01	1.82e-01	-2.75e-01	9.73e-01	8.11e-01	4.48e-02	2.33e-02	6.05e-04
GOCC STEREOCILIUM TIP	19	2.21e-01	5.76e-01	0.3670	-3.44e-02	1.83e-01	8.69e-02	2.65e-01	-1.50e-01	7.95e-01	1.68e-01	5.12e-01	4.56e-02	2.58e-01
GOBP SPHINGOLIPID TRANSLOCATION	5	9.08e-01	9.70e-01	0.3670	-4.17e-02	-4.08e-02	2.76e-01	2.32e-01	3.11e-02	8.72e-01	8.75e-01	2.85e-01	3.68e-01	9.04e-01
GOBP NUCLEOTIDE SALVAGE	17	2.03e-01	5.53e-01	0.3670	-1.69e-01	1.13e-01	1.80e-01	-1.49e-01	1.97e-01	2.26e-01	4.20e-01	2.00e-01	2.89e-01	1.60e-01
GOMF LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR ACTIVITY	15	3.98e-01	7.31e-01	0.3670	-2.15e-01	3.72e-02	9.07e-02	2.38e-01	-1.49e-01	1.50e-01	8.03e-01	5.43e-01	1.10e-01	3.19e-01
GOBP REGULATION OF CALCIUM ION IMPORT	31	4.80e-02	2.47e-01	0.3670	-6.59e-02	8.98e-02	1.40e-01	3.20e-01	-3.18e-03	5.25e-01	3.87e-01	1.76e-01	2.03e-03	9.76e-01
GOCC LUMENAL SIDE OF ENDOPLASMIC RETICULUM MEMBRANE	26	3.77e-02	2.12e-01	0.3670	-2.72e-01	2.15e-02	4.74e-02	-1.87e-01	-1.52e-01	1.64e-02	8.50e-01	6.76e-01	9.86e-02	1.81e-01
GOBP REGULATION OF INWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY	7	7.90e-01	9.31e-01	0.3670	-1.92e-01	-1.51e-01	-2.12e-01	-1.52e-01	-8.05e-02	3.78e-01	4.90e-01	3.30e-01	4.85e-01	7.12e-01
GOMF 3 5 DNA EXONUCLEASE ACTIVITY	13	5.48e-01	8.27e-01	0.3670	9.94e-03	-1.11e-01	-1.79e-01	-2.58e-01	1.53e-01	9.50e-01	4.88e-01	2.63e-01	1.07e-01	3.38e-01
GOBP SPLICEOSOMAL COMPLEX ASSEMBLY	75	5.29e-04	9.30e-03	0.3670	5.53e-02	6.14e-03	-2.52e-01	-2.60e-01	2.84e-02	4.08e-01	9.27e-01	1.64e-04	1.02e-04	6.71e-01
GOBP CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS	15	4.37e-01	7.60e-01	0.3670	7.38e-02	1.46e-02	-1.82e-01	-3.10e-01	1.37e-04	6.21e-01	9.22e-01	2.23e-01	3.79e-02	9.99e-01
GOBP REGULATION OF GERM CELL PROLIFERATION	7	7.53e-01	9.16e-01	0.3670	-5.24e-02	2.82e-01	2.27e-01	-2.63e-02	-6.82e-03	8.10e-01	1.96e-01	2.99e-01	9.04e-01	9.75e-01
GOBP PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY	23	1.02e-01	3.87e-01	0.3660	-1.45e-01	2.96e-01	1.39e-02	-1.59e-01	-9.63e-03	2.29e-01	1.40e-02	9.08e-01	1.86e-01	9.36e-01
GOBP SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION	13	5.03e-01	8.03e-01	0.3660	2.16e-01	-8.02e-02	-1.12e-01	-2.06e-01	1.61e-01	1.78e-01	6.17e-01	4.83e-01	1.98e-01	3.14e-01
GOBP POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS	6	6.14e-01	8.60e-01	0.3660	-6.48e-02	-1.95e-01	2.59e-01	-1.36e-01	7.73e-02	7.83e-01	4.08e-01	2.71e-01	5.63e-01	7.43e-01
GOCC DNA REPLICATION FACTOR C COMPLEX	5	8.40e-01	9.47e-01	0.3660	-2.56e-01	6.97e-02	-7.85e-03	-1.22e-01	2.20e-01	3.22e-01	7.87e-01	9.76e-01	6.35e-01	3.94e-01
GOMF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE BINDING	19	2.76e-01	6.30e-01	0.3660	-1.74e-01	1.91e-01	1.52e-01	1.64e-01	-1.30e-01	1.89e-01	1.49e-01	2.51e-01	2.17e-01	3.25e-01
GOBP DIET INDUCED THERMOGENESIS	13	5.38e-01	8.22e-01	0.3660	9.28e-02	8.24e-02	-1.44e-01	-2.92e-01	1.11e-01	5.62e-01	6.07e-01	3.68e-01	6.81e-02	4.89e-01
GOCC MEDIATOR COMPLEX	34	5.36e-02	2.66e-01	0.3660	1.70e-02	-1.43e-02	-2.55e-01	-2.26e-01	-1.32e-01	8.64e-01	8.86e-01	1.02e-02	2.26e-02	1.82e-01
GOBP OXIDATIVE RNA DEMETHYLATION	5	8.53e-01	9.51e-01	0.3660	-2.29e-01	-9.84e-02	-9.58e-02	-1.34e-01	2.11e-01	3.75e-01	7.03e-01	7.11e-01	6.04e-01	4.14e-01
GOMF OXIDATIVE RNA DEMETHYLASE ACTIVITY	5	8.53e-01	9.51e-01	0.3660	-2.29e-01	-9.84e-02	-9.58e-02	-1.34e-01	2.11e-01	3.75e-01	7.03e-01	7.11e-01	6.04e-01	4.14e-01
GOMF GLUTATHIONE BINDING	10	5.19e-01	8.13e-01	0.3660	1.89e-02	9.54e-03	8.65e-02	-2.57e-01	2.44e-01	9.18e-01	9.58e-01	6.36e-01	1.59e-01	1.81e-01
GOBP CELL MIGRATION INVOLVED IN GASTRULATION	13	2.76e-01	6.30e-01	0.3660	-2.61e-01	-1.36e-01	1.51e-01	-1.47e-01	5.32e-02	1.04e-01	3.97e-01	3.45e-01	3.59e-01	7.40e-01
GOMF ENDONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 3 PHOSPHOMONOESTERS	17	2.68e-01	6.23e-01	0.3660	7.11e-04	2.63e-02	-3.35e-01	-9.72e-02	-1.06e-01	9.96e-01	8.51e-01	1.68e-02	4.88e-01	4.48e-01
GOMF DAMAGED DNA BINDING	70	4.52e-04	8.30e-03	0.3660	6.25e-02	-1.99e-02	-3.04e-01	-1.72e-01	8.75e-02	3.66e-01	7.73e-01	1.12e-05	1.30e-02	2.06e-01
GOBP CELLULAR RESPONSE TO FLUID SHEAR STRESS	21	1.85e-01	5.28e-01	0.3660	7.42e-02	3.06e-02	-1.60e-01	-3.05e-01	-9.13e-02	5.56e-01	8.08e-01	2.04e-01	1.54e-02	4.69e-01
GOBP PEPTIDE MODIFICATION	5	8.33e-01	9.45e-01	0.3650	4.54e-02	-1.29e-01	-1.17e-01	-2.84e-01	-1.44e-01	8.60e-01	6.19e-01	6.50e-01	2.72e-01	5.77e-01
GOBP HYPOTHALAMUS CELL DIFFERENTIATION	12	4.40e-01	7.62e-01	0.3650	1.16e-01	2.81e-01	1.71e-01	-1.02e-01	3.86e-02	4.87e-01	9.17e-02	3.06e-01	5.40e-01	8.17e-01
GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS	11	4.58e-01	7.76e-01	0.3650	-1.42e-01	1.22e-01	-2.87e-03	-1.29e-01	-2.85e-01	4.14e-01	4.82e-01	9.87e-01	4.57e-01	1.01e-01
GOCC NUCLEAR REPLICATION FORK	32	7.29e-02	3.23e-01	0.3650	2.14e-01	5.17e-02	-1.76e-01	-2.21e-01	7.46e-02	3.65e-02	6.13e-01	8.48e-02	3.08e-02	4.65e-01
GOBP REGULATION OF HISTONE H3 K4 METHYLATION	11	5.24e-01	8.15e-01	0.3650	2.04e-01	1.94e-01	8.31e-02	6.98e-02	2.06e-01	2.40e-01	2.65e-01	6.33e-01	6.89e-01	2.37e-01
GOMF TFIID CLASS TRANSCRIPTION FACTOR COMPLEX BINDING	10	5.64e-01	8.34e-01	0.3650	6.56e-02	-1.03e-01	-3.40e-01	-4.51e-02	2.94e-02	7.19e-01	5.71e-01	6.27e-02	8.05e-01	8.72e-01
GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY	62	1.61e-03	2.28e-02	0.3650	-4.89e-02	-7.49e-02	1.78e-01	2.32e-01	-2.00e-01	5.05e-01	3.08e-01	1.54e-02	1.56e-03	6.54e-03
GOBP ISOTYPE SWITCHING TO IGG ISOTYPES	15	2.39e-01	5.95e-01	0.3650	-9.39e-03	2.28e-01	2.01e-01	-1.90e-01	6.91e-02	9.50e-01	1.26e-01	1.78e-01	2.02e-01	6.43e-01
GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO OXIDATIVE STRESS	8	7.73e-01	9.25e-01	0.3650	-1.15e-01	-9.17e-02	1.46e-01	2.21e-01	-2.03e-01	5.73e-01	6.53e-01	4.74e-01	2.78e-01	3.20e-01
GOMF NUCLEAR GLUCOCORTICOID RECEPTOR BINDING	12	5.02e-01	8.03e-01	0.3650	1.58e-01	2.49e-01	-1.12e-01	-1.45e-01	1.13e-01	3.42e-01	1.36e-01	5.00e-01	3.85e-01	4.98e-01
GOBP MAGNESIUM ION TRANSPORT	16	2.57e-01	6.14e-01	0.3650	-4.85e-02	-1.70e-01	-5.28e-02	-1.61e-02	3.15e-01	7.37e-01	2.38e-01	7.15e-01	9.11e-01	2.94e-02
GOBP NEGATIVE REGULATION OF ATP DEPENDENT ACTIVITY	17	3.26e-01	6.74e-01	0.3650	-3.41e-02	-1.75e-01	-1.18e-01	-2.08e-01	2.10e-01	8.08e-01	2.11e-01	3.98e-01	1.38e-01	1.33e-01
GOCC UBIQUITIN CONJUGATING ENZYME COMPLEX	7	6.77e-01	8.86e-01	0.3650	2.95e-02	1.30e-01	-1.74e-02	-3.32e-01	-7.18e-02	8.92e-01	5.52e-01	9.36e-01	1.29e-01	7.42e-01
GOBP POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL	7	7.48e-01	9.15e-01	0.3650	-3.20e-01	1.29e-01	8.59e-02	-6.02e-03	-8.35e-02	1.43e-01	5.56e-01	6.94e-01	9.78e-01	7.02e-01
GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT	35	2.52e-02	1.62e-01	0.3650	-1.66e-01	-8.76e-02	1.81e-01	1.05e-01	-2.32e-01	8.87e-02	3.70e-01	6.32e-02	2.84e-01	1.74e-02
GOMF CAMP DEPENDENT PROTEIN KINASE INHIBITOR ACTIVITY	10	6.82e-01	8.88e-01	0.3650	-1.22e-01	1.66e-01	1.80e-01	1.94e-01	-1.43e-01	5.05e-01	3.62e-01	3.23e-01	2.88e-01	4.35e-01
GOCC MKS COMPLEX	13	4.73e-01	7.87e-01	0.3650	7.71e-02	2.92e-02	-5.94e-02	-3.08e-01	1.68e-01	6.30e-01	8.55e-01	7.11e-01	5.48e-02	2.96e-01
GOBP SURFACTANT HOMEOSTASIS	17	2.75e-01	6.30e-01	0.3650	-2.31e-01	-2.07e-01	1.03e-02	4.23e-02	-1.87e-01	9.91e-02	1.39e-01	9.42e-01	7.62e-01	1.83e-01
GOBP PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS	5	8.59e-01	9.53e-01	0.3650	-2.25e-01	1.47e-01	-5.82e-02	-2.34e-01	5.24e-02	3.83e-01	5.70e-01	8.22e-01	3.66e-01	8.39e-01
GOMF STRUCTURAL CONSTITUENT OF NUCLEAR PORE	23	9.65e-02	3.76e-01	0.3650	-1.26e-01	-1.59e-01	-3.85e-02	-2.75e-01	1.22e-01	2.96e-01	1.87e-01	7.49e-01	2.24e-02	3.12e-01
GOBP PYRIMIDINE NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS	9	7.44e-01	9.14e-01	0.3650	1.56e-01	-1.05e-02	-2.12e-01	-2.51e-01	2.99e-02	4.18e-01	9.57e-01	2.71e-01	1.93e-01	8.77e-01
GOBP SEBACEOUS GLAND DEVELOPMENT	10	4.53e-01	7.72e-01	0.3650	-2.23e-01	-1.29e-01	-7.91e-03	2.01e-01	1.62e-01	2.23e-01	4.79e-01	9.65e-01	2.70e-01	3.76e-01
GOBP NEURAL TUBE PATTERNING	39	1.45e-02	1.14e-01	0.3650	-3.78e-02	9.04e-02	-5.34e-02	-3.23e-01	1.26e-01	6.83e-01	3.29e-01	5.64e-01	4.75e-04	1.72e-01
GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY	12	4.94e-01	7.99e-01	0.3650	1.29e-01	2.79e-01	7.82e-02	-7.31e-02	1.65e-01	4.40e-01	9.44e-02	6.39e-01	6.61e-01	3.23e-01
GOBP NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY	12	3.66e-01	7.06e-01	0.3650	-1.52e-01	-4.35e-03	-3.66e-02	-3.09e-01	-1.15e-01	3.63e-01	9.79e-01	8.26e-01	6.40e-02	4.90e-01
GOMF POLYSACCHARIDE BINDING	21	1.40e-01	4.60e-01	0.3650	-2.06e-01	2.25e-01	4.91e-02	1.61e-01	-1.08e-01	1.03e-01	7.41e-02	6.97e-01	2.03e-01	3.89e-01
GOCC CHROMATOID BODY	13	5.06e-01	8.06e-01	0.3640	-1.95e-01	1.02e-01	2.67e-01	1.09e-01	3.45e-02	2.23e-01	5.24e-01	9.59e-02	4.94e-01	8.29e-01
GOMF HISTONE CHAPERONE ACTIVITY	12	4.94e-01	7.99e-01	0.3640	-1.55e-02	1.03e-01	-3.04e-01	-1.41e-01	-9.71e-02	9.26e-01	5.36e-01	6.82e-02	3.96e-01	5.60e-01
GOBP EPITHELIAL CELL PROLIFERATION INVOLVED IN SALIVARY GLAND MORPHOGENESIS	5	8.85e-01	9.62e-01	0.3640	-5.29e-02	-2.88e-01	-1.99e-01	-5.94e-02	-6.30e-02	8.38e-01	2.65e-01	4.40e-01	8.18e-01	8.07e-01
GOMF LONG CHAIN FATTY ACID BINDING	17	2.01e-01	5.50e-01	0.3640	-1.09e-01	3.13e-01	4.26e-02	1.45e-01	-2.02e-02	4.36e-01	2.57e-02	7.61e-01	3.02e-01	8.85e-01
GOCC ENDOLYSOSOME LUMEN	5	8.53e-01	9.51e-01	0.3640	1.46e-01	1.21e-01	-7.18e-02	-2.99e-01	-4.40e-02	5.71e-01	6.39e-01	7.81e-01	2.47e-01	8.65e-01
GOBP POSITIVE REGULATION OF DENDRITE DEVELOPMENT	15	4.16e-01	7.46e-01	0.3640	-9.37e-02	-1.59e-01	2.40e-01	2.02e-01	6.20e-03	5.30e-01	2.86e-01	1.07e-01	1.76e-01	9.67e-01
GOBP REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION	13	5.08e-01	8.07e-01	0.3640	1.19e-01	1.07e-01	-7.64e-02	-2.74e-01	1.61e-01	4.56e-01	5.03e-01	6.33e-01	8.75e-02	3.13e-01
GOBP CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION	51	6.60e-03	6.52e-02	0.3640	-1.34e-01	6.18e-02	1.37e-01	2.70e-01	-1.37e-01	9.68e-02	4.45e-01	9.15e-02	8.35e-04	8.94e-02
GOBP RESPONSE TO INACTIVITY	12	1.90e-01	5.36e-01	0.3640	8.95e-02	2.37e-01	-1.83e-01	1.75e-01	6.33e-02	5.91e-01	1.55e-01	2.72e-01	2.94e-01	7.04e-01
GOBP HINDLIMB MORPHOGENESIS	35	2.13e-02	1.47e-01	0.3640	9.02e-02	5.53e-03	8.11e-02	-1.57e-01	3.05e-01	3.56e-01	9.55e-01	4.07e-01	1.08e-01	1.78e-03
GOBP PYRIMIDINE RIBONUCLEOTIDE CATABOLIC PROCESS	8	6.07e-01	8.57e-01	0.3640	-1.34e-03	2.68e-01	1.27e-01	-1.86e-01	-9.95e-02	9.95e-01	1.89e-01	5.35e-01	3.63e-01	6.26e-01
GOBP L SERINE BIOSYNTHETIC PROCESS	5	8.67e-01	9.55e-01	0.3640	1.06e-01	8.28e-02	8.17e-02	-1.40e-02	3.28e-01	6.83e-01	7.49e-01	7.52e-01	9.57e-01	2.04e-01
GOBP REGULATION OF CDC42 PROTEIN SIGNAL TRANSDUCTION	8	5.58e-01	8.32e-01	0.3640	2.37e-02	-1.49e-01	-1.78e-01	2.63e-01	-9.24e-02	9.07e-01	4.65e-01	3.83e-01	1.98e-01	6.51e-01
GOBP ATTACHMENT OF GPI ANCHOR TO PROTEIN	6	8.65e-01	9.55e-01	0.3640	-8.71e-02	-4.48e-02	-2.21e-01	-2.29e-01	1.47e-01	7.12e-01	8.49e-01	3.49e-01	3.32e-01	5.34e-01
GOBP REGULATION OF NEUTROPHIL MIGRATION	39	1.04e-02	9.03e-02	0.3640	-1.09e-01	3.21e-01	8.16e-02	8.81e-02	-5.52e-02	2.39e-01	5.25e-04	3.78e-01	3.41e-01	5.51e-01
GOBP ESTABLISHMENT OF SISTER CHROMATID COHESION	8	5.10e-01	8.07e-01	0.3640	1.72e-01	-3.82e-02	1.48e-01	-2.55e-01	1.19e-01	3.98e-01	8.52e-01	4.69e-01	2.11e-01	5.62e-01
GOMF AMP ACTIVATED PROTEIN KINASE ACTIVITY	8	6.62e-01	8.81e-01	0.3640	-7.80e-02	4.51e-02	-3.52e-02	-7.54e-02	3.42e-01	7.02e-01	8.25e-01	8.63e-01	7.12e-01	9.36e-02
GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA	5	8.84e-01	9.61e-01	0.3640	-1.85e-01	-7.60e-02	-1.47e-01	-2.20e-01	1.49e-01	4.74e-01	7.68e-01	5.70e-01	3.94e-01	5.63e-01
GOBP MITOTIC METAPHASE CHROMOSOME ALIGNMENT	58	4.06e-03	4.63e-02	0.3640	1.20e-01	-3.80e-02	-1.71e-01	-2.64e-01	1.32e-01	1.13e-01	6.17e-01	2.42e-02	5.13e-04	8.21e-02
GOBP INTESTINAL LIPID ABSORPTION	22	1.05e-01	3.92e-01	0.3630	1.47e-01	-1.97e-02	9.66e-04	3.15e-01	-1.05e-01	2.32e-01	8.73e-01	9.94e-01	1.06e-02	3.92e-01
GOCC PROTEASOME COMPLEX	59	4.79e-03	5.21e-02	0.3630	4.07e-02	-1.24e-02	-2.27e-01	-2.68e-01	8.22e-02	5.88e-01	8.69e-01	2.54e-03	3.69e-04	2.75e-01
GOBP POSITIVE REGULATION OF PROTEIN KINASE C SIGNALING	9	6.02e-01	8.53e-01	0.3630	-3.40e-01	-1.66e-02	-9.02e-02	-7.86e-02	4.07e-02	7.72e-02	9.31e-01	6.39e-01	6.83e-01	8.32e-01
GOBP POSITIVE REGULATION OF PROTEIN SUMOYLATION	12	5.13e-01	8.08e-01	0.3630	2.58e-01	1.82e-01	-6.51e-02	-1.52e-01	7.20e-02	1.22e-01	2.75e-01	6.96e-01	3.63e-01	6.66e-01
GOBP GLUTAMATE SECRETION NEUROTRANSMISSION	8	6.71e-01	8.83e-01	0.3630	2.12e-01	1.86e-01	7.06e-02	2.14e-01	3.81e-02	2.99e-01	3.61e-01	7.29e-01	2.95e-01	8.52e-01
GOBP IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY	22	1.73e-01	5.13e-01	0.3630	-2.10e-01	8.09e-02	2.12e-01	1.34e-01	1.36e-01	8.80e-02	5.11e-01	8.53e-02	2.77e-01	2.71e-01
GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION	77	3.77e-04	7.19e-03	0.3630	7.66e-02	-2.95e-02	-2.89e-01	-2.03e-01	-1.57e-02	2.45e-01	6.55e-01	1.15e-05	2.04e-03	8.12e-01
GOMF MINOR GROOVE OF ADENINE THYMINE RICH DNA BINDING	10	5.27e-01	8.18e-01	0.3630	-3.00e-01	-1.64e-01	3.77e-02	-1.10e-01	3.76e-02	1.00e-01	3.70e-01	8.37e-01	5.48e-01	8.37e-01
GOMF CARBOHYDRATE TRANSMEMBRANE TRANSPORTER ACTIVITY	41	4.53e-03	5.03e-02	0.3630	-1.32e-01	2.07e-01	6.31e-02	2.55e-01	-4.65e-02	1.43e-01	2.16e-02	4.85e-01	4.68e-03	6.06e-01
GOBP NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING	7	7.91e-01	9.31e-01	0.3630	-7.06e-02	1.09e-01	-7.41e-02	-2.63e-01	2.01e-01	7.46e-01	6.17e-01	7.34e-01	2.29e-01	3.57e-01
GOBP ZINC ION IMPORT INTO ORGANELLE	9	6.37e-01	8.73e-01	0.3630	-9.15e-02	-2.49e-01	-9.35e-02	-6.71e-02	2.20e-01	6.35e-01	1.96e-01	6.27e-01	7.27e-01	2.54e-01
GOBP EMBRYONIC BRAIN DEVELOPMENT	16	1.78e-01	5.19e-01	0.3630	-4.39e-02	-1.16e-02	1.01e-01	-3.04e-01	1.64e-01	7.61e-01	9.36e-01	4.84e-01	3.51e-02	2.56e-01
GOBP SNRNA METABOLIC PROCESS	53	9.88e-03	8.69e-02	0.3630	1.20e-02	-6.82e-02	-2.39e-01	-2.57e-01	6.02e-02	8.80e-01	3.90e-01	2.61e-03	1.20e-03	4.48e-01
GOBP ENTRY OF BACTERIUM INTO HOST CELL	9	6.37e-01	8.73e-01	0.3630	1.92e-01	-1.32e-01	2.74e-02	1.50e-03	2.77e-01	3.18e-01	4.94e-01	8.87e-01	9.94e-01	1.51e-01
GOBP REGULATION OF PROTON TRANSPORT	16	3.08e-01	6.60e-01	0.3630	-6.50e-02	1.97e-01	5.80e-02	-1.80e-01	2.30e-01	6.53e-01	1.72e-01	6.88e-01	2.12e-01	1.12e-01
GOMF DNA EXONUCLEASE ACTIVITY	23	2.37e-01	5.93e-01	0.3630	7.14e-02	-8.96e-03	-1.69e-01	-2.68e-01	1.61e-01	5.54e-01	9.41e-01	1.61e-01	2.59e-02	1.82e-01
GOBP AMINOACYL TRNA METABOLISM INVOLVED IN TRANSLATIONAL FIDELITY	13	5.51e-01	8.28e-01	0.3630	1.93e-01	4.22e-02	-2.24e-01	-2.03e-01	3.74e-02	2.29e-01	7.92e-01	1.62e-01	2.05e-01	8.15e-01
GOMF AMINOACYL TRNA EDITING ACTIVITY	13	5.51e-01	8.28e-01	0.3630	1.93e-01	4.22e-02	-2.24e-01	-2.03e-01	3.74e-02	2.29e-01	7.92e-01	1.62e-01	2.05e-01	8.15e-01
GOBP RESPONSE TO STILBENOID	8	6.98e-01	8.94e-01	0.3630	-1.39e-02	-1.69e-01	-8.72e-02	2.04e-01	-2.31e-01	9.46e-01	4.08e-01	6.69e-01	3.18e-01	2.57e-01
GOBP EMBRYONIC CLEAVAGE	8	5.54e-01	8.30e-01	0.3620	1.58e-01	-6.22e-02	6.78e-02	-2.97e-01	9.93e-02	4.38e-01	7.61e-01	7.40e-01	1.46e-01	6.27e-01
GOCC IKAPPAB KINASE COMPLEX	6	7.76e-01	9.26e-01	0.3620	-1.04e-01	2.61e-01	7.07e-02	-1.42e-01	-1.64e-01	6.61e-01	2.68e-01	7.64e-01	5.46e-01	4.85e-01
GOBP NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE	29	7.11e-02	3.17e-01	0.3620	-1.22e-01	-8.40e-02	1.56e-01	2.78e-01	8.84e-02	2.54e-01	4.34e-01	1.47e-01	9.60e-03	4.10e-01
GOBP LUTEINIZING HORMONE SECRETION	10	5.43e-01	8.25e-01	0.3620	1.21e-01	3.13e-02	5.71e-03	6.44e-02	-3.34e-01	5.07e-01	8.64e-01	9.75e-01	7.24e-01	6.75e-02
GOBP POSITIVE REGULATION OF PHAGOCYTOSIS	66	8.38e-05	2.05e-03	0.3620	-3.22e-01	1.35e-01	7.46e-02	-4.32e-02	4.43e-02	6.01e-06	5.84e-02	2.95e-01	5.43e-01	5.34e-01
GOBP POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION	66	1.25e-03	1.86e-02	0.3620	3.77e-02	7.53e-02	-2.53e-01	-2.29e-01	8.68e-02	5.96e-01	2.90e-01	3.72e-04	1.29e-03	2.23e-01
GOBP INTERLEUKIN 10 PRODUCTION	57	1.14e-03	1.72e-02	0.3620	-9.45e-02	3.09e-01	1.55e-01	4.26e-02	-2.73e-02	2.17e-01	5.40e-05	4.25e-02	5.78e-01	7.21e-01
GOBP ACTIN FILAMENT BASED TRANSPORT	21	2.89e-01	6.43e-01	0.3620	-4.42e-02	4.89e-02	1.87e-01	2.88e-01	-9.35e-02	7.26e-01	6.98e-01	1.38e-01	2.22e-02	4.58e-01
GOBP REGULATION OF RIG I SIGNALING PATHWAY	20	2.26e-01	5.79e-01	0.3620	2.58e-01	1.54e-01	-5.08e-02	-1.54e-01	1.21e-01	4.61e-02	2.33e-01	6.94e-01	2.34e-01	3.48e-01
GOMF PROTEIN LYSINE DEACETYLASE ACTIVITY	21	2.17e-01	5.72e-01	0.3620	2.43e-01	8.34e-02	-9.34e-02	-2.18e-01	9.36e-02	5.37e-02	5.08e-01	4.59e-01	8.40e-02	4.58e-01
GOBP POSITIVE REGULATION OF MUSCLE ADAPTATION	13	3.53e-01	6.98e-01	0.3620	-1.95e-01	7.92e-02	1.93e-01	-1.39e-01	1.73e-01	2.23e-01	6.21e-01	2.29e-01	3.85e-01	2.79e-01
GOMF PEROXISOME TARGETING SEQUENCE BINDING	5	8.81e-01	9.61e-01	0.3620	1.35e-02	6.57e-02	3.40e-01	1.03e-01	1.97e-02	9.58e-01	7.99e-01	1.88e-01	6.91e-01	9.39e-01
GOBP PROTEIN LOCALIZATION TO NON MOTILE CILIUM	12	5.42e-01	8.24e-01	0.3620	4.86e-02	-2.86e-01	-2.00e-01	-7.65e-02	-2.67e-02	7.71e-01	8.57e-02	2.30e-01	6.46e-01	8.73e-01
GOMF ADENYLATE CYCLASE REGULATOR ACTIVITY	8	6.96e-01	8.94e-01	0.3620	-1.93e-01	2.82e-01	1.13e-01	9.12e-04	3.59e-02	3.44e-01	1.67e-01	5.80e-01	9.96e-01	8.60e-01
GOBP NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS	36	6.15e-02	2.91e-01	0.3620	1.17e-01	-8.09e-02	-2.48e-01	-2.21e-01	-1.31e-02	2.23e-01	4.01e-01	9.89e-03	2.20e-02	8.92e-01
GOBP REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING	16	3.57e-01	7.02e-01	0.3620	-1.94e-01	2.31e-01	1.57e-01	1.20e-01	-3.29e-02	1.80e-01	1.09e-01	2.78e-01	4.07e-01	8.20e-01
GOBP PROTEASOME ASSEMBLY	11	5.97e-01	8.51e-01	0.3620	-4.37e-02	6.64e-02	-2.98e-01	-1.88e-01	2.42e-02	8.02e-01	7.03e-01	8.71e-02	2.81e-01	8.90e-01
GOBP NEGATIVE REGULATION OF METALLOENDOPEPTIDASE ACTIVITY	8	7.09e-01	8.98e-01	0.3620	-1.38e-01	-2.09e-02	-8.07e-02	1.87e-02	-3.23e-01	4.98e-01	9.18e-01	6.93e-01	9.27e-01	1.14e-01
GOBP PROTEIN RNA COMPLEX ORGANIZATION	207	3.27e-11	3.09e-09	0.3620	6.36e-02	-4.10e-02	-2.39e-01	-2.56e-01	5.17e-02	1.14e-01	3.09e-01	3.11e-09	2.31e-10	1.99e-01
GOMF AZOLE TRANSMEMBRANE TRANSPORTER ACTIVITY	12	5.08e-01	8.07e-01	0.3620	-8.01e-02	-2.50e-01	-5.16e-02	1.20e-01	-2.12e-01	6.31e-01	1.34e-01	7.57e-01	4.73e-01	2.04e-01
GOBP REGULATION OF PLASMA MEMBRANE ORGANIZATION	16	3.35e-01	6.82e-01	0.3620	-9.59e-02	2.86e-01	1.63e-01	6.97e-02	9.19e-02	5.07e-01	4.76e-02	2.60e-01	6.29e-01	5.25e-01
GOBP PRENYLATION	11	3.95e-01	7.29e-01	0.3620	7.98e-02	-2.73e-01	-1.27e-02	-2.23e-01	6.73e-03	6.47e-01	1.17e-01	9.42e-01	2.00e-01	9.69e-01
GOBP PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE	7	6.67e-01	8.82e-01	0.3610	1.33e-02	1.12e-01	9.01e-02	-3.16e-01	1.01e-01	9.51e-01	6.09e-01	6.80e-01	1.48e-01	6.42e-01
GOCC MITOCHONDRIAL TRICARBOXYLIC ACID CYCLE ENZYME COMPLEX	9	6.64e-01	8.82e-01	0.3610	1.81e-01	-8.69e-02	-2.43e-01	-5.21e-02	-1.70e-01	3.47e-01	6.52e-01	2.07e-01	7.87e-01	3.78e-01
GOBP REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT	10	5.13e-01	8.08e-01	0.3610	-1.19e-01	-1.52e-01	-7.84e-02	-2.56e-01	-1.46e-01	5.13e-01	4.04e-01	6.68e-01	1.61e-01	4.24e-01
GOMF ALPHA ADRENERGIC RECEPTOR ACTIVITY	6	8.19e-01	9.41e-01	0.3610	-1.70e-01	2.24e-01	1.79e-01	-7.42e-03	1.40e-01	4.72e-01	3.43e-01	4.47e-01	9.75e-01	5.52e-01
GOBP NEGATIVE REGULATION OF STEM CELL POPULATION MAINTENANCE	24	1.42e-01	4.63e-01	0.3610	1.04e-01	-3.05e-02	-7.58e-02	-3.03e-01	1.46e-01	3.76e-01	7.96e-01	5.20e-01	1.02e-02	2.15e-01
GOMF METALLOENDOPEPTIDASE INHIBITOR ACTIVITY	15	4.49e-01	7.70e-01	0.3610	-1.64e-01	-2.44e-02	1.45e-01	2.79e-01	-6.55e-02	2.73e-01	8.70e-01	3.32e-01	6.11e-02	6.61e-01
GOCC PROXIMAL DENDRITE	6	8.74e-01	9.59e-01	0.3610	4.63e-03	1.71e-01	2.06e-01	2.05e-01	-1.31e-01	9.84e-01	4.68e-01	3.83e-01	3.85e-01	5.79e-01
GOBP OSTEOBLAST DEVELOPMENT	17	1.93e-01	5.41e-01	0.3610	-1.53e-01	-1.39e-01	-1.45e-01	-1.05e-02	2.58e-01	2.75e-01	3.20e-01	3.02e-01	9.40e-01	6.55e-02
GOMF FOLIC ACID BINDING	13	4.50e-01	7.71e-01	0.3610	8.69e-02	2.68e-01	1.11e-01	1.39e-02	1.97e-01	5.88e-01	9.48e-02	4.89e-01	9.31e-01	2.19e-01
GOBP CELL FATE SPECIFICATION	107	2.13e-08	1.40e-06	0.3610	6.56e-02	1.02e-01	9.68e-03	-3.32e-01	7.48e-02	2.41e-01	6.77e-02	8.63e-01	3.07e-09	1.81e-01
GOBP POSITIVE REGULATION OF CHEMOKINE C X C MOTIF LIGAND 1 PRODUCTION	5	8.29e-01	9.44e-01	0.3610	-2.51e-01	-1.45e-01	4.09e-02	-1.05e-01	-1.84e-01	3.31e-01	5.75e-01	8.74e-01	6.86e-01	4.76e-01
GOCC TERTIARY GRANULE MEMBRANE	69	8.38e-05	2.05e-03	0.3610	-2.48e-01	1.80e-01	1.60e-01	-2.89e-02	9.84e-02	3.66e-04	9.53e-03	2.13e-02	6.78e-01	1.57e-01
GOCC BBSOME	8	7.32e-01	9.08e-01	0.3610	-1.23e-01	-2.02e-01	-1.64e-01	-1.65e-01	-1.42e-01	5.47e-01	3.22e-01	4.21e-01	4.20e-01	4.88e-01
GOBP APOPTOTIC CHROMOSOME CONDENSATION	6	8.04e-01	9.34e-01	0.3610	-1.54e-01	1.55e-01	1.15e-01	-7.55e-02	2.52e-01	5.14e-01	5.11e-01	6.25e-01	7.49e-01	2.85e-01
GOBP ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS	17	3.41e-01	6.88e-01	0.3610	-4.60e-02	-1.38e-01	5.73e-02	2.74e-01	-1.74e-01	7.43e-01	3.24e-01	6.83e-01	5.01e-02	2.13e-01
GOBP TONIC SMOOTH MUSCLE CONTRACTION	11	4.61e-01	7.78e-01	0.3610	1.82e-01	-2.59e-02	-9.26e-02	2.26e-01	-1.92e-01	2.95e-01	8.82e-01	5.95e-01	1.95e-01	2.71e-01
GOBP RESPONSE TO DISACCHARIDE	7	7.45e-01	9.14e-01	0.3610	2.03e-01	-2.34e-01	-1.68e-01	7.39e-02	2.14e-02	3.53e-01	2.83e-01	4.42e-01	7.35e-01	9.22e-01
GOBP REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY	18	2.71e-01	6.25e-01	0.3610	-6.25e-03	1.59e-01	-1.33e-01	-2.82e-01	-8.66e-02	9.63e-01	2.44e-01	3.30e-01	3.81e-02	5.25e-01
GOBP INTRACELLULAR DISTRIBUTION OF MITOCHONDRIA	7	7.42e-01	9.13e-01	0.3610	3.00e-01	-1.20e-01	-2.11e-02	9.39e-02	1.28e-01	1.69e-01	5.84e-01	9.23e-01	6.67e-01	5.58e-01
GOBP PHAGOSOME MATURATION	28	3.95e-02	2.18e-01	0.3610	-7.66e-02	2.63e-01	8.53e-02	-2.17e-01	-2.48e-02	4.83e-01	1.61e-02	4.34e-01	4.65e-02	8.20e-01
GOBP CANONICAL WNT SIGNALING PATHWAY INVOLVED IN CARDIAC MUSCLE CELL FATE COMMITMENT	5	9.07e-01	9.69e-01	0.3610	-1.07e-01	2.67e-02	-2.09e-01	-2.62e-01	7.67e-02	6.80e-01	9.18e-01	4.19e-01	3.11e-01	7.66e-01
GOBP RESPONSE TO INTERLEUKIN 9	5	7.64e-01	9.22e-01	0.3610	1.62e-01	3.31e-02	1.61e-02	-2.92e-01	-1.31e-01	5.32e-01	8.98e-01	9.50e-01	2.58e-01	6.12e-01
GOMF L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY	62	1.94e-03	2.63e-02	0.3610	-1.48e-01	1.46e-01	2.60e-01	1.34e-01	-3.59e-02	4.42e-02	4.72e-02	3.94e-04	6.81e-02	6.25e-01
GOBP RISC COMPLEX ASSEMBLY	10	6.47e-01	8.76e-01	0.3610	2.30e-02	8.30e-02	-8.32e-02	-3.16e-01	1.25e-01	9.00e-01	6.49e-01	6.49e-01	8.32e-02	4.94e-01
GOBP ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE	49	7.77e-03	7.32e-02	0.3610	1.65e-01	-1.64e-01	-1.41e-01	-1.94e-01	1.34e-01	4.54e-02	4.65e-02	8.77e-02	1.85e-02	1.04e-01
GOBP RESPONSE TO THYROGLOBULIN TRIIODOTHYRONINE	5	8.41e-01	9.48e-01	0.3600	-1.74e-01	2.25e-01	-5.66e-03	1.63e-01	-1.50e-01	5.01e-01	3.84e-01	9.83e-01	5.27e-01	5.61e-01
GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY	8	6.52e-01	8.79e-01	0.3600	-1.84e-02	1.23e-01	5.53e-02	-3.07e-01	1.31e-01	9.28e-01	5.48e-01	7.87e-01	1.32e-01	5.22e-01
GOBP PROTOPORPHYRINOGEN IX BIOSYNTHETIC PROCESS	8	7.84e-01	9.28e-01	0.3600	2.89e-02	1.23e-01	-1.99e-01	-2.47e-01	1.15e-01	8.88e-01	5.45e-01	3.29e-01	2.27e-01	5.74e-01
GOBP REGULATION OF TRANSCRIPTION ELONGATION BY RNA POLYMERASE II	85	1.45e-04	3.20e-03	0.3600	7.62e-02	-1.40e-02	-2.37e-01	-2.57e-01	-3.93e-02	2.25e-01	8.24e-01	1.57e-04	4.21e-05	5.31e-01
GOMF INTERFERON RECEPTOR ACTIVITY	5	8.43e-01	9.48e-01	0.3600	-3.00e-01	-4.66e-02	6.84e-02	9.30e-02	1.56e-01	2.46e-01	8.57e-01	7.91e-01	7.19e-01	5.45e-01
GOBP TETRAPYRROLE BIOSYNTHETIC PROCESS	31	1.13e-01	4.11e-01	0.3600	1.02e-01	4.35e-02	-1.99e-01	-2.55e-01	1.13e-01	3.25e-01	6.75e-01	5.48e-02	1.41e-02	2.77e-01
GOBP NEGATIVE REGULATION OF DNA REPAIR	33	6.20e-02	2.93e-01	0.3600	-1.06e-01	4.64e-02	-2.07e-01	-2.66e-01	-5.25e-02	2.91e-01	6.45e-01	3.99e-02	8.19e-03	6.01e-01
GOMF DNA DEMETHYLASE ACTIVITY	5	8.82e-01	9.61e-01	0.3600	1.40e-01	-2.54e-01	-2.03e-01	-2.02e-02	6.21e-02	5.87e-01	3.25e-01	4.32e-01	9.38e-01	8.10e-01
GOBP POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY	39	4.87e-03	5.27e-02	0.3600	-2.57e-01	-4.43e-02	1.85e-01	-4.28e-02	-1.59e-01	5.50e-03	6.32e-01	4.51e-02	6.43e-01	8.49e-02
GOMF THIOREDOXIN DISULFIDE REDUCTASE NADP ACTIVITY	7	7.72e-01	9.25e-01	0.3600	2.49e-01	3.74e-03	1.07e-01	2.33e-01	-3.68e-02	2.53e-01	9.86e-01	6.23e-01	2.85e-01	8.66e-01
GOMF NEUROTROPHIN BINDING	10	6.31e-01	8.69e-01	0.3600	-1.23e-01	1.58e-01	6.10e-02	1.88e-01	-2.23e-01	4.99e-01	3.86e-01	7.39e-01	3.02e-01	2.21e-01
GOBP CELLULAR RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR STIMULUS	13	5.78e-01	8.42e-01	0.3600	3.32e-02	1.40e-01	2.63e-01	1.96e-01	-3.56e-02	8.36e-01	3.82e-01	1.00e-01	2.22e-01	8.24e-01
GOBP POSITIVE REGULATION OF TELOMERE MAINTENANCE	66	1.68e-03	2.36e-02	0.3600	6.92e-02	-9.77e-02	-1.74e-01	-2.50e-01	1.50e-01	3.31e-01	1.70e-01	1.46e-02	4.47e-04	3.51e-02
GOBP RESPONSE TO FOLLICLE STIMULATING HORMONE	15	3.41e-01	6.88e-01	0.3600	1.59e-01	-7.65e-02	1.55e-01	1.66e-01	-2.16e-01	2.87e-01	6.08e-01	2.98e-01	2.66e-01	1.47e-01
GOBP DORSAL AORTA DEVELOPMENT	10	6.25e-01	8.66e-01	0.3600	1.27e-01	2.66e-01	-6.90e-02	-1.84e-01	6.27e-02	4.87e-01	1.45e-01	7.05e-01	3.13e-01	7.31e-01
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE	101	1.65e-05	5.20e-04	0.3600	1.60e-02	7.05e-02	-1.88e-01	-2.89e-01	7.27e-02	7.80e-01	2.21e-01	1.09e-03	5.21e-07	2.07e-01
GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION	31	2.73e-02	1.72e-01	0.3600	-2.22e-01	2.22e-01	3.41e-02	1.58e-01	-6.79e-02	3.21e-02	3.27e-02	7.43e-01	1.28e-01	5.13e-01
GOBP TOOTH MINERALIZATION	28	1.64e-01	4.98e-01	0.3600	-5.31e-02	-5.50e-03	2.39e-01	2.58e-01	-5.53e-02	6.27e-01	9.60e-01	2.88e-02	1.82e-02	6.13e-01
GOMF ENDOPEPTIDASE ACTIVATOR ACTIVITY	15	3.98e-01	7.31e-01	0.3600	7.23e-02	6.20e-02	-1.26e-01	-3.23e-01	-1.04e-02	6.28e-01	6.78e-01	3.98e-01	3.04e-02	9.44e-01
GOBP NCRNA CATABOLIC PROCESS	54	1.10e-03	1.66e-02	0.3600	2.63e-02	1.61e-01	-7.94e-02	-3.05e-01	-5.94e-02	7.38e-01	4.05e-02	3.13e-01	1.08e-04	4.50e-01
GOCC SEX CHROMOSOME	33	7.72e-02	3.33e-01	0.3600	1.30e-01	1.58e-02	-1.27e-01	-2.39e-01	1.98e-01	1.98e-01	8.75e-01	2.07e-01	1.76e-02	4.92e-02
GOMF CHITIN BINDING	8	7.69e-01	9.24e-01	0.3590	1.71e-02	-1.41e-01	1.27e-01	2.61e-01	-1.58e-01	9.33e-01	4.91e-01	5.33e-01	2.02e-01	4.39e-01
GOBP REGULATION OF ASYMMETRIC CELL DIVISION	5	8.49e-01	9.49e-01	0.3590	1.52e-01	-1.06e-01	6.72e-02	2.33e-01	1.90e-01	5.57e-01	6.80e-01	7.95e-01	3.67e-01	4.62e-01
GOMF ACID AMINO ACID LIGASE ACTIVITY	23	1.12e-01	4.09e-01	0.3590	-1.91e-01	2.49e-01	-7.08e-02	-1.54e-01	4.35e-02	1.12e-01	3.87e-02	5.56e-01	2.02e-01	7.18e-01
GOBP PROTEIN LOCALIZATION TO CONDENSED CHROMOSOME	15	4.24e-01	7.51e-01	0.3590	1.65e-01	-2.20e-01	-2.15e-01	-7.54e-02	3.99e-02	2.69e-01	1.41e-01	1.49e-01	6.13e-01	7.89e-01
GOBP NEGATIVE REGULATION OF AXON EXTENSION INVOLVED IN AXON GUIDANCE	26	8.63e-02	3.55e-01	0.3590	-3.22e-01	1.00e-01	7.33e-02	8.84e-02	-4.68e-02	4.49e-03	3.76e-01	5.17e-01	4.35e-01	6.80e-01
GOBP NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION	13	5.20e-01	8.13e-01	0.3590	2.07e-01	-1.51e-01	-1.77e-01	-1.05e-01	1.45e-01	1.97e-01	3.45e-01	2.69e-01	5.13e-01	3.66e-01
GOBP RESPONSE TO POTASSIUM ION	17	1.83e-01	5.25e-01	0.3590	-5.57e-02	-1.80e-01	1.60e-01	3.76e-02	-2.58e-01	6.91e-01	1.98e-01	2.54e-01	7.89e-01	6.55e-02
GOCC GOLGI TRANS CISTERNA	9	6.21e-01	8.64e-01	0.3590	-7.66e-02	2.67e-01	3.37e-02	-2.25e-01	1.25e-03	6.91e-01	1.65e-01	8.61e-01	2.43e-01	9.95e-01
GOMF RIBONUCLEOPROTEIN COMPLEX BINDING	156	7.52e-09	5.42e-07	0.3590	5.90e-02	-9.22e-03	-1.74e-01	-3.03e-01	5.54e-02	2.03e-01	8.42e-01	1.81e-04	5.97e-11	2.32e-01
GOBP CELLULAR RESPONSE TO TESTOSTERONE STIMULUS	8	6.42e-01	8.75e-01	0.3590	-2.49e-01	-1.22e-01	4.50e-03	-1.52e-01	-1.69e-01	2.22e-01	5.50e-01	9.82e-01	4.57e-01	4.07e-01
GOBP REGULATION OF ESTABLISHMENT OF T CELL POLARITY	6	7.38e-01	9.10e-01	0.3590	-5.47e-03	3.26e-01	-5.84e-02	3.13e-02	1.36e-01	9.81e-01	1.67e-01	8.04e-01	8.94e-01	5.65e-01
GOMF LIPOPROTEIN PARTICLE RECEPTOR ACTIVITY	18	2.56e-01	6.13e-01	0.3590	-2.24e-01	6.12e-02	9.84e-02	2.54e-01	-2.12e-02	1.00e-01	6.53e-01	4.70e-01	6.16e-02	8.76e-01
GOBP EMBRYONIC DIGIT MORPHOGENESIS	57	7.35e-04	1.20e-02	0.3590	9.98e-02	-4.61e-02	-2.75e-02	-3.00e-01	1.61e-01	1.92e-01	5.47e-01	7.20e-01	9.00e-05	3.54e-02
GOBP WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT	12	4.66e-01	7.82e-01	0.3590	-2.53e-01	7.96e-02	-2.46e-02	-2.26e-01	8.16e-02	1.29e-01	6.33e-01	8.82e-01	1.76e-01	6.24e-01
GOBP POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS	27	1.60e-01	4.91e-01	0.3590	-1.83e-01	6.32e-02	1.84e-01	2.06e-01	-1.21e-01	9.90e-02	5.70e-01	9.83e-02	6.34e-02	2.77e-01
GOMF PROTEIN PHOSPHATASE ACTIVATOR ACTIVITY	15	4.92e-01	7.99e-01	0.3590	9.57e-02	-4.31e-02	-2.02e-01	-2.77e-01	1.37e-02	5.21e-01	7.73e-01	1.77e-01	6.32e-02	9.27e-01
GOBP NEGATIVE REGULATION OF LOW DENSITY LIPOPROTEIN RECEPTOR ACTIVITY	10	6.05e-01	8.55e-01	0.3590	-1.64e-01	-1.49e-01	-9.73e-02	-4.97e-02	-2.60e-01	3.69e-01	4.13e-01	5.94e-01	7.86e-01	1.55e-01
GOMF RNA POLYMERASE II GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY	36	6.27e-02	2.94e-01	0.3590	9.61e-02	-1.41e-01	-1.96e-01	-2.09e-01	1.32e-01	3.18e-01	1.45e-01	4.22e-02	2.98e-02	1.70e-01
GOBP GLOMERULAR MESANGIAL CELL PROLIFERATION	13	5.00e-01	8.03e-01	0.3580	-1.79e-01	-1.50e-01	7.00e-02	1.34e-01	-2.26e-01	2.62e-01	3.49e-01	6.62e-01	4.04e-01	1.59e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H HEME PROTEIN AS ACCEPTOR	10	5.64e-01	8.34e-01	0.3580	2.44e-01	9.24e-02	-1.14e-01	-1.07e-01	-1.89e-01	1.82e-01	6.13e-01	5.31e-01	5.58e-01	3.00e-01
GOBP NEGATIVE REGULATION OF BONE REMODELING	18	2.98e-01	6.53e-01	0.3580	-1.04e-01	1.87e-01	2.82e-01	4.57e-02	3.19e-02	4.44e-01	1.70e-01	3.83e-02	7.37e-01	8.15e-01
GOCC NURD COMPLEX	15	3.71e-01	7.10e-01	0.3580	1.56e-02	1.63e-01	-3.20e-02	-3.04e-01	9.24e-02	9.17e-01	2.75e-01	8.30e-01	4.18e-02	5.35e-01
GOBP XENOPHAGY	14	4.85e-01	7.94e-01	0.3580	8.78e-02	6.90e-02	-1.33e-01	-1.82e-01	2.55e-01	5.70e-01	6.55e-01	3.88e-01	2.40e-01	9.82e-02
GOMF COMPLEMENT BINDING	24	1.21e-01	4.26e-01	0.3580	-1.88e-01	-1.66e-01	-5.39e-02	1.94e-01	-1.59e-01	1.12e-01	1.59e-01	6.48e-01	1.01e-01	1.78e-01
GOMF MISMATCHED DNA BINDING	14	5.41e-01	8.24e-01	0.3580	6.40e-02	-1.23e-01	-2.75e-01	-1.71e-01	6.50e-02	6.78e-01	4.25e-01	7.46e-02	2.69e-01	6.74e-01
GOBP SPHINGOSINE BIOSYNTHETIC PROCESS	14	4.34e-01	7.57e-01	0.3580	5.78e-02	-9.92e-02	-1.63e-01	-1.02e-01	2.79e-01	7.08e-01	5.20e-01	2.90e-01	5.10e-01	7.02e-02
GOBP RNA SECONDARY STRUCTURE UNWINDING	8	5.81e-01	8.43e-01	0.3580	9.67e-02	1.43e-01	1.65e-02	-2.21e-01	-2.22e-01	6.36e-01	4.83e-01	9.35e-01	2.80e-01	2.77e-01
GOBP 7 METHYLGUANOSINE RNA CAPPING	8	7.43e-01	9.14e-01	0.3580	-1.15e-01	1.66e-01	-1.69e-01	-2.41e-01	-2.89e-02	5.72e-01	4.17e-01	4.08e-01	2.38e-01	8.87e-01
GOCC MANCHETTE	16	3.49e-01	6.96e-01	0.3580	-1.95e-01	-1.77e-01	1.24e-02	7.68e-02	-2.30e-01	1.78e-01	2.22e-01	9.32e-01	5.95e-01	1.11e-01
GOCC CELL TRAILING EDGE	13	2.31e-01	5.85e-01	0.3580	-1.31e-01	2.27e-01	-5.57e-02	1.03e-01	2.14e-01	4.15e-01	1.56e-01	7.28e-01	5.20e-01	1.82e-01
GOMF INSULIN LIKE GROWTH FACTOR II BINDING	8	4.93e-01	7.99e-01	0.3580	-6.34e-02	2.54e-01	-1.68e-01	4.53e-02	1.70e-01	7.56e-01	2.13e-01	4.10e-01	8.24e-01	4.05e-01
GOMF G QUADRUPLEX DNA BINDING	11	6.51e-01	8.78e-01	0.3580	1.44e-02	7.92e-02	-2.54e-01	-2.34e-01	-4.38e-02	9.34e-01	6.49e-01	1.44e-01	1.78e-01	8.01e-01
GOMF DNA DAMAGE SENSOR ACTIVITY	21	2.31e-01	5.85e-01	0.3580	1.06e-01	-1.15e-01	-1.80e-01	-1.16e-01	2.40e-01	4.01e-01	3.63e-01	1.53e-01	3.57e-01	5.66e-02
GOBP REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION	41	1.31e-02	1.06e-01	0.3580	-5.93e-02	2.32e-01	1.83e-01	-4.52e-03	1.93e-01	5.11e-01	1.02e-02	4.27e-02	9.60e-01	3.26e-02
GOBP POSITIVE REGULATION OF CELL CYCLE CHECKPOINT	18	3.32e-01	6.80e-01	0.3580	1.20e-01	-2.11e-01	-2.10e-01	-9.91e-02	1.24e-01	3.79e-01	1.21e-01	1.24e-01	4.66e-01	3.63e-01
GOBP T HELPER CELL LINEAGE COMMITMENT	20	1.47e-01	4.69e-01	0.3580	2.40e-02	2.89e-01	1.43e-01	-1.43e-01	-5.40e-02	8.52e-01	2.52e-02	2.69e-01	2.68e-01	6.76e-01
GOBP SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION	11	6.05e-01	8.55e-01	0.3580	3.41e-02	2.51e-01	1.95e-01	1.04e-01	-1.23e-01	8.45e-01	1.50e-01	2.63e-01	5.49e-01	4.81e-01
GOBP NEGATIVE REGULATION OF COLLATERAL SPROUTING	10	5.90e-01	8.47e-01	0.3580	2.48e-01	6.72e-02	5.71e-02	1.95e-01	-1.43e-01	1.74e-01	7.13e-01	7.55e-01	2.86e-01	4.34e-01
GOBP CARDIAC MUSCLE CELL FATE COMMITMENT	11	6.44e-01	8.75e-01	0.3570	1.93e-01	7.37e-02	-1.48e-01	-2.39e-01	7.69e-02	2.68e-01	6.72e-01	3.94e-01	1.70e-01	6.59e-01
GOBP TERMINATION OF RNA POLYMERASE II TRANSCRIPTION	10	5.23e-01	8.15e-01	0.3570	-2.10e-02	7.63e-02	-2.62e-02	-3.47e-01	-1.36e-02	9.08e-01	6.76e-01	8.86e-01	5.72e-02	9.41e-01
GOBP CARTILAGE MORPHOGENESIS	10	5.86e-01	8.45e-01	0.3570	-5.20e-02	2.04e-01	-1.85e-02	-2.87e-01	3.41e-02	7.76e-01	2.65e-01	9.19e-01	1.17e-01	8.52e-01
GOBP PROTEIN SIALYLATION	5	8.02e-01	9.34e-01	0.3570	-2.30e-01	9.33e-02	1.94e-01	-1.59e-01	-5.93e-02	3.73e-01	7.18e-01	4.54e-01	5.39e-01	8.18e-01
GOBP SERTOLI CELL DEVELOPMENT	12	4.85e-01	7.94e-01	0.3570	6.88e-02	2.25e-01	6.01e-02	-2.30e-01	1.26e-01	6.80e-01	1.76e-01	7.18e-01	1.68e-01	4.50e-01
GOBP TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY	55	1.37e-03	1.99e-02	0.3570	7.26e-03	2.01e-01	1.02e-01	-5.02e-02	2.73e-01	9.26e-01	1.00e-02	1.89e-01	5.19e-01	4.72e-04
GOBP NEGATIVE REGULATION OF MICROGLIAL CELL ACTIVATION	8	6.69e-01	8.83e-01	0.3570	-3.31e-01	9.14e-03	4.20e-02	-1.18e-02	1.27e-01	1.05e-01	9.64e-01	8.37e-01	9.54e-01	5.35e-01
GOBP PRESYNAPTIC ACTIVE ZONE ORGANIZATION	8	7.46e-01	9.14e-01	0.3570	1.45e-01	-1.41e-01	1.46e-01	2.47e-01	-6.44e-02	4.78e-01	4.90e-01	4.74e-01	2.26e-01	7.53e-01
GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS ENZYMATIC MODIFICATION	11	4.98e-01	8.02e-01	0.3570	-1.02e-01	-8.81e-02	2.10e-01	-1.38e-02	2.55e-01	5.56e-01	6.13e-01	2.29e-01	9.37e-01	1.43e-01
GOMF UNMETHYLATED CPG BINDING	9	6.57e-01	8.80e-01	0.3570	-4.24e-03	2.62e-01	1.63e-01	-1.03e-01	1.46e-01	9.82e-01	1.73e-01	3.96e-01	5.93e-01	4.47e-01
GOBP REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS	21	1.85e-01	5.28e-01	0.3570	-3.03e-02	-3.00e-01	-6.19e-02	1.19e-01	-1.38e-01	8.10e-01	1.74e-02	6.24e-01	3.47e-01	2.75e-01
GOBP ESTABLISHMENT OF GOLGI LOCALIZATION	8	6.71e-01	8.83e-01	0.3570	6.91e-02	1.42e-01	1.80e-01	-1.66e-01	2.06e-01	7.35e-01	4.86e-01	3.77e-01	4.17e-01	3.12e-01
GOBP NEURAL PLATE REGIONALIZATION	6	8.75e-01	9.59e-01	0.3570	2.99e-02	1.05e-01	-1.69e-01	-2.91e-01	4.49e-02	8.99e-01	6.55e-01	4.72e-01	2.17e-01	8.49e-01
GOBP TRANSCRIPTION BY RNA POLYMERASE III	59	6.02e-03	6.10e-02	0.3570	1.03e-01	-4.50e-02	-2.17e-01	-2.33e-01	1.14e-01	1.73e-01	5.50e-01	3.88e-03	1.92e-03	1.29e-01
GOMF CALCIUM ACTIVATED CATION CHANNEL ACTIVITY	26	9.47e-02	3.72e-01	0.3570	-2.80e-01	-2.77e-02	5.15e-02	2.04e-01	-6.20e-02	1.34e-02	8.07e-01	6.49e-01	7.19e-02	5.84e-01
GOMF PHOSPHOLIPASE C ACTIVITY	29	1.31e-01	4.47e-01	0.3570	1.23e-03	-3.04e-02	1.79e-01	2.52e-01	-1.76e-01	9.91e-01	7.77e-01	9.50e-02	1.89e-02	1.02e-01
GOBP GANGLIOSIDE BIOSYNTHETIC PROCESS VIA LACTOSYLCERAMIDE	6	7.66e-01	9.23e-01	0.3570	3.67e-02	3.25e-01	1.98e-02	1.26e-01	6.29e-02	8.76e-01	1.68e-01	9.33e-01	5.92e-01	7.90e-01
GOBP PURINE DEOXYRIBONUCLEOSIDE METABOLIC PROCESS	5	8.92e-01	9.64e-01	0.3570	7.56e-02	8.87e-02	1.15e-01	3.03e-01	-9.41e-02	7.70e-01	7.31e-01	6.55e-01	2.41e-01	7.15e-01
GOBP REGULATION OF RHODOPSIN MEDIATED SIGNALING PATHWAY	9	6.86e-01	8.89e-01	0.3570	5.92e-02	2.49e-01	1.60e-01	4.32e-02	1.85e-01	7.59e-01	1.96e-01	4.05e-01	8.22e-01	3.36e-01
GOMF DYSTROGLYCAN BINDING	10	6.61e-01	8.81e-01	0.3570	1.67e-01	1.80e-01	1.74e-01	1.91e-01	-1.42e-02	3.60e-01	3.25e-01	3.41e-01	2.95e-01	9.38e-01
GOBP FOREGUT MORPHOGENESIS	10	3.90e-01	7.26e-01	0.3570	8.65e-02	2.69e-02	1.47e-01	-2.96e-01	9.93e-02	6.36e-01	8.83e-01	4.22e-01	1.05e-01	5.87e-01
GOBP 3 UTR MEDIATED MRNA DESTABILIZATION	19	3.20e-01	6.68e-01	0.3570	1.39e-02	-5.91e-02	-2.08e-01	-1.80e-01	2.19e-01	9.16e-01	6.55e-01	1.16e-01	1.75e-01	9.88e-02
GOBP POSITIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY	8	4.88e-01	7.97e-01	0.3570	2.32e-01	-1.45e-03	1.81e-01	-2.01e-01	1.57e-02	2.56e-01	9.94e-01	3.74e-01	3.26e-01	9.39e-01
GOBP GLUTAMATE CATABOLIC PROCESS	7	7.95e-01	9.32e-01	0.3570	-6.63e-02	-6.33e-02	-8.42e-02	-2.99e-01	1.49e-01	7.61e-01	7.72e-01	7.00e-01	1.70e-01	4.96e-01
GOMF LYSOPHOSPHOLIPASE ACTIVITY	26	1.27e-01	4.39e-01	0.3570	1.18e-02	2.77e-01	1.87e-01	8.78e-02	8.66e-02	9.17e-01	1.44e-02	9.93e-02	4.39e-01	4.45e-01
GOBP INTRACELLULAR OXYGEN HOMEOSTASIS	7	7.05e-01	8.97e-01	0.3560	-2.64e-02	2.49e-01	1.06e-01	-2.30e-01	-1.26e-02	9.04e-01	2.55e-01	6.28e-01	2.91e-01	9.54e-01
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMATIN	9	6.30e-01	8.69e-01	0.3560	5.94e-02	-1.25e-01	-1.37e-01	-2.53e-01	-1.60e-01	7.58e-01	5.17e-01	4.78e-01	1.90e-01	4.07e-01
GOBP PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS	20	2.87e-01	6.41e-01	0.3560	-9.50e-02	-1.43e-01	-1.78e-01	-2.10e-01	1.48e-01	4.62e-01	2.68e-01	1.69e-01	1.04e-01	2.53e-01
GOBP DEFENSE RESPONSE TO FUNGUS	52	2.05e-03	2.73e-02	0.3560	-3.29e-01	-4.08e-03	1.27e-01	4.59e-02	2.00e-02	4.08e-05	9.59e-01	1.12e-01	5.67e-01	8.03e-01
GOBP NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I	21	1.08e-01	3.99e-01	0.3560	1.69e-01	-1.55e-01	-7.67e-02	-2.41e-01	-1.01e-01	1.80e-01	2.18e-01	5.43e-01	5.60e-02	4.21e-01
GOBP BRADYKININ CATABOLIC PROCESS	7	6.34e-01	8.71e-01	0.3560	-2.55e-01	-5.73e-02	1.67e-01	-1.67e-01	-5.39e-02	2.42e-01	7.93e-01	4.45e-01	4.45e-01	8.05e-01
GOMF MRNA 3 UTR AU RICH REGION BINDING	28	1.44e-01	4.65e-01	0.3560	-8.15e-02	-1.31e-01	-2.14e-01	-2.37e-01	3.33e-02	4.56e-01	2.31e-01	4.97e-02	3.02e-02	7.60e-01
GOBP REGULATION OF VITAMIN METABOLIC PROCESS	12	1.92e-01	5.38e-01	0.3560	1.70e-02	-6.39e-02	-2.54e-01	2.13e-01	1.12e-01	9.19e-01	7.02e-01	1.28e-01	2.02e-01	5.01e-01
GOBP CRANIAL NERVE STRUCTURAL ORGANIZATION	9	7.04e-01	8.97e-01	0.3560	6.53e-02	1.42e-01	3.02e-01	1.02e-01	-1.83e-02	7.34e-01	4.60e-01	1.16e-01	5.97e-01	9.24e-01
GOBP GROOMING BEHAVIOR	17	2.67e-01	6.23e-01	0.3560	-6.66e-02	-1.81e-01	2.56e-01	9.93e-02	1.18e-01	6.34e-01	1.96e-01	6.72e-02	4.78e-01	4.01e-01
GOBP PROGESTERONE RECEPTOR SIGNALING PATHWAY	11	5.38e-01	8.22e-01	0.3560	-2.15e-01	5.66e-02	1.70e-01	4.68e-02	2.15e-01	2.17e-01	7.45e-01	3.30e-01	7.88e-01	2.17e-01
GOMF PRE MIRNA BINDING	9	7.20e-01	9.02e-01	0.3560	2.06e-01	-8.94e-02	-2.53e-01	-1.04e-01	-3.44e-02	2.84e-01	6.43e-01	1.88e-01	5.90e-01	8.58e-01
GOMF PHOSPHATIDYLINOSITOL MONOPHOSPHATE PHOSPHATASE ACTIVITY	11	4.80e-01	7.92e-01	0.3560	-1.79e-01	-2.24e-01	6.20e-02	-1.07e-01	1.71e-01	3.03e-01	1.99e-01	7.22e-01	5.40e-01	3.26e-01
GOCC RNA POLYMERASE II TRANSCRIPTION REPRESSOR COMPLEX	15	3.91e-01	7.26e-01	0.3560	-3.18e-02	1.56e-01	-4.41e-03	-1.77e-01	2.64e-01	8.31e-01	2.96e-01	9.76e-01	2.34e-01	7.65e-02
GOBP CAMP CATABOLIC PROCESS	9	6.49e-01	8.77e-01	0.3560	-3.15e-01	1.07e-01	1.17e-01	9.64e-03	4.20e-02	1.01e-01	5.77e-01	5.43e-01	9.60e-01	8.27e-01
GOBP NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION	15	4.22e-01	7.49e-01	0.3560	2.04e-01	1.61e-01	-1.11e-01	-2.15e-01	2.23e-02	1.71e-01	2.80e-01	4.57e-01	1.50e-01	8.81e-01
GOBP GLUCOSE IMPORT IN RESPONSE TO INSULIN STIMULUS	6	8.52e-01	9.51e-01	0.3560	-1.14e-01	6.32e-02	-1.12e-01	-2.37e-01	2.01e-01	6.29e-01	7.89e-01	6.33e-01	3.14e-01	3.93e-01
GOBP SPHINGOLIPID MEDIATED SIGNALING PATHWAY	18	3.51e-01	6.96e-01	0.3560	-9.85e-02	-1.94e-01	-2.02e-01	-1.76e-01	8.71e-02	4.70e-01	1.55e-01	1.38e-01	1.97e-01	5.22e-01
GOMF 1 PHOSPHATIDYLINOSITOL 4 PHOSPHATE 3 KINASE ACTIVITY	7	7.02e-01	8.96e-01	0.3560	-5.10e-02	-1.06e-01	2.93e-01	6.94e-02	-1.49e-01	8.15e-01	6.29e-01	1.80e-01	7.51e-01	4.96e-01
GOBP REGULATION OF MACROPHAGE PROLIFERATION	7	7.94e-01	9.31e-01	0.3560	3.45e-02	-1.77e-01	2.30e-01	1.88e-01	7.40e-02	8.75e-01	4.17e-01	2.92e-01	3.88e-01	7.35e-01
GOBP NEGATIVE REGULATION OF PROTEIN SUMOYLATION	8	7.37e-01	9.09e-01	0.3560	1.32e-01	-8.54e-02	-3.12e-01	-6.36e-02	1.05e-02	5.18e-01	6.76e-01	1.26e-01	7.55e-01	9.59e-01
GOBP NADPH OXIDATION	5	8.54e-01	9.51e-01	0.3560	-1.33e-01	-1.88e-02	1.23e-01	2.17e-01	2.15e-01	6.06e-01	9.42e-01	6.33e-01	4.01e-01	4.06e-01
GOBP NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION	19	3.46e-01	6.92e-01	0.3550	1.84e-02	1.11e-01	-2.22e-01	-2.53e-01	2.44e-02	8.90e-01	4.03e-01	9.41e-02	5.65e-02	8.54e-01
GOBP DENDRITIC CELL APOPTOTIC PROCESS	11	5.35e-01	8.21e-01	0.3550	4.23e-02	1.10e-01	-1.03e-02	2.24e-01	-2.50e-01	8.08e-01	5.29e-01	9.53e-01	1.99e-01	1.52e-01
GOBP POSITIVE REGULATION OF PROTEIN DEUBIQUITINATION	5	9.08e-01	9.70e-01	0.3550	-8.25e-03	-1.58e-01	-1.62e-01	-1.86e-01	2.02e-01	9.75e-01	5.41e-01	5.32e-01	4.72e-01	4.35e-01
GOBP NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS	8	7.98e-01	9.32e-01	0.3550	9.32e-02	1.15e-01	-1.88e-01	-2.59e-01	4.01e-02	6.48e-01	5.74e-01	3.56e-01	2.04e-01	8.44e-01
GOMF METALLOCARBOXYPEPTIDASE ACTIVITY	29	1.06e-01	3.95e-01	0.3550	-2.15e-01	-2.69e-02	2.22e-01	1.68e-01	4.34e-02	4.55e-02	8.02e-01	3.82e-02	1.18e-01	6.86e-01
GOBP NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	12	3.38e-01	6.85e-01	0.3550	-2.13e-01	2.12e-01	-1.02e-01	-1.09e-02	1.59e-01	2.02e-01	2.04e-01	5.40e-01	9.48e-01	3.39e-01
GOBP NEUTROPHIL ACTIVATION INVOLVED IN IMMUNE RESPONSE	20	1.85e-01	5.27e-01	0.3550	-1.96e-01	1.28e-01	2.34e-01	-4.47e-02	1.20e-01	1.29e-01	3.22e-01	6.98e-02	7.30e-01	3.52e-01
GOBP METANEPHRIC COLLECTING DUCT DEVELOPMENT	10	3.72e-01	7.12e-01	0.3550	-3.88e-03	1.52e-01	1.86e-01	-2.55e-01	-5.98e-02	9.83e-01	4.06e-01	3.09e-01	1.63e-01	7.43e-01
GOMF PROMOTER SPECIFIC CHROMATIN BINDING	63	1.68e-03	2.35e-02	0.3550	1.52e-01	4.30e-03	-1.50e-01	-2.80e-01	4.17e-02	3.71e-02	9.53e-01	3.89e-02	1.18e-04	5.67e-01
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS	10	5.13e-01	8.09e-01	0.3550	-2.86e-01	-5.16e-02	4.75e-02	-1.93e-01	-4.36e-02	1.17e-01	7.78e-01	7.95e-01	2.90e-01	8.11e-01
GOBP REGULATION OF BILE ACID BIOSYNTHETIC PROCESS	12	4.64e-01	7.80e-01	0.3550	-2.69e-02	-2.75e-01	1.07e-01	7.18e-02	1.81e-01	8.72e-01	9.89e-02	5.19e-01	6.67e-01	2.77e-01
GOBP PROTEIN MONOUBIQUITINATION	41	2.04e-02	1.43e-01	0.3550	2.11e-01	-5.51e-03	-1.46e-01	-2.45e-01	-8.08e-03	1.92e-02	9.51e-01	1.05e-01	6.72e-03	9.29e-01
GOMF GALACTOSYLTRANSFERASE ACTIVITY	31	3.96e-02	2.19e-01	0.3550	-2.87e-01	1.83e-01	7.77e-02	-6.55e-02	-7.53e-03	5.74e-03	7.81e-02	4.54e-01	5.28e-01	9.42e-01
GOBP DEVELOPMENTAL INDUCTION	33	4.36e-02	2.32e-01	0.3550	6.22e-02	1.27e-01	-5.97e-02	-3.13e-01	6.67e-02	5.37e-01	2.08e-01	5.53e-01	1.85e-03	5.07e-01
GOBP POSITIVE REGULATION OF ADIPOSE TISSUE DEVELOPMENT	10	6.11e-01	8.58e-01	0.3550	-2.97e-01	5.53e-02	1.76e-01	2.85e-02	4.98e-02	1.03e-01	7.62e-01	3.35e-01	8.76e-01	7.85e-01
GOBP POSITIVE REGULATION OF CELL MATRIX ADHESION	56	3.94e-03	4.51e-02	0.3550	-1.33e-01	7.73e-02	9.75e-02	2.29e-01	-2.01e-01	8.47e-02	3.17e-01	2.07e-01	3.03e-03	9.41e-03
GOBP REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE	21	2.79e-01	6.33e-01	0.3550	1.28e-01	-1.08e-01	-1.34e-01	-2.22e-01	1.75e-01	3.09e-01	3.93e-01	2.86e-01	7.84e-02	1.66e-01
GOCC NADH DEHYDROGENASE COMPLEX	40	4.37e-02	2.32e-01	0.3550	5.01e-02	-6.88e-02	-1.77e-01	-2.80e-01	9.43e-02	5.84e-01	4.52e-01	5.34e-02	2.16e-03	3.02e-01
GOBP RESPONSE TO EPIDERMAL GROWTH FACTOR	44	2.40e-02	1.58e-01	0.3550	-2.72e-02	-1.48e-01	-2.21e-01	-2.29e-01	-4.17e-02	7.55e-01	8.86e-02	1.12e-02	8.54e-03	6.32e-01
GOBP TONGUE DEVELOPMENT	20	8.97e-02	3.62e-01	0.3550	-7.66e-02	9.35e-02	1.28e-01	-2.98e-01	7.79e-02	5.53e-01	4.69e-01	3.22e-01	2.10e-02	5.47e-01
GOBP AXIAL MESODERM DEVELOPMENT	8	7.06e-01	8.97e-01	0.3550	1.75e-01	2.63e-01	5.52e-02	1.26e-01	-8.45e-02	3.92e-01	1.98e-01	7.87e-01	5.38e-01	6.79e-01
GOMF NOTCH BINDING	23	1.48e-01	4.72e-01	0.3550	2.02e-01	1.24e-01	2.10e-01	1.15e-01	-1.10e-01	9.28e-02	3.02e-01	8.18e-02	3.38e-01	3.62e-01
GOMF CYCLASE ACTIVATOR ACTIVITY	11	6.29e-01	8.68e-01	0.3550	2.23e-03	2.58e-01	2.10e-01	1.11e-01	5.62e-02	9.90e-01	1.39e-01	2.28e-01	5.25e-01	7.47e-01
GOCC INTRACILIARY TRANSPORT PARTICLE B	15	5.02e-01	8.03e-01	0.3550	1.32e-01	6.91e-03	-1.95e-01	-1.94e-01	1.80e-01	3.75e-01	9.63e-01	1.91e-01	1.93e-01	2.27e-01
GOCC SAGA TYPE COMPLEX	35	7.15e-02	3.19e-01	0.3540	1.96e-01	-7.36e-03	-1.87e-01	-2.17e-01	6.96e-02	4.42e-02	9.40e-01	5.54e-02	2.64e-02	4.76e-01
GOBP NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING	11	5.36e-01	8.21e-01	0.3540	6.33e-02	1.73e-01	1.50e-01	5.51e-02	-2.57e-01	7.16e-01	3.20e-01	3.90e-01	7.52e-01	1.40e-01
GOMF BILE ACID SODIUM SYMPORTER ACTIVITY	5	8.35e-01	9.45e-01	0.3540	4.03e-02	4.36e-02	3.06e-01	5.06e-02	-1.60e-01	8.76e-01	8.66e-01	2.36e-01	8.45e-01	5.35e-01
GOBP DORSAL VENTRAL AXIS SPECIFICATION	12	2.69e-01	6.24e-01	0.3540	-1.41e-02	9.90e-03	3.04e-01	-1.54e-01	9.50e-02	9.32e-01	9.53e-01	6.79e-02	3.57e-01	5.69e-01
GOBP EPITHELIAL FLUID TRANSPORT	11	4.64e-01	7.80e-01	0.3540	-9.37e-02	2.58e-01	1.90e-02	2.11e-01	-7.23e-02	5.90e-01	1.38e-01	9.13e-01	2.25e-01	6.78e-01
GOBP REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR	37	6.68e-02	3.05e-01	0.3540	-6.84e-03	-8.05e-02	-2.03e-01	-2.53e-01	1.18e-01	9.43e-01	3.97e-01	3.28e-02	7.84e-03	2.13e-01
GOBP CELLULAR RESPONSE TO EXOGENOUS DSRNA	16	3.51e-01	6.97e-01	0.3540	9.37e-02	1.52e-01	-2.65e-01	-1.41e-01	5.75e-02	5.16e-01	2.93e-01	6.63e-02	3.29e-01	6.90e-01
GOMF TRANSLATION INITIATION FACTOR ACTIVITY	46	1.95e-02	1.38e-01	0.3540	2.61e-02	3.82e-02	-2.83e-01	-2.06e-01	-3.21e-02	7.60e-01	6.54e-01	9.14e-04	1.58e-02	7.07e-01
GOMF PH DOMAIN BINDING	8	7.19e-01	9.02e-01	0.3540	4.45e-02	1.02e-01	1.87e-01	9.74e-02	-2.61e-01	8.28e-01	6.18e-01	3.59e-01	6.33e-01	2.01e-01
GOBP REACTIVE GLIOSIS	6	8.02e-01	9.34e-01	0.3540	2.51e-01	1.01e-01	-1.20e-01	1.41e-02	-1.93e-01	2.86e-01	6.69e-01	6.09e-01	9.52e-01	4.13e-01
GOBP CANNABINOID SIGNALING PATHWAY	9	6.49e-01	8.77e-01	0.3540	-3.38e-01	-8.93e-03	7.38e-02	6.50e-02	3.61e-02	7.91e-02	9.63e-01	7.01e-01	7.36e-01	8.51e-01
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYDROGEN PEROXIDE	9	7.25e-01	9.05e-01	0.3540	1.98e-02	1.99e-02	-9.62e-02	-3.09e-01	1.41e-01	9.18e-01	9.18e-01	6.17e-01	1.09e-01	4.64e-01
GOBP RNA DECAPPING	19	1.90e-01	5.36e-01	0.3540	2.20e-01	-1.24e-02	-2.55e-02	-2.70e-01	5.61e-02	9.69e-02	9.26e-01	8.47e-01	4.17e-02	6.72e-01
GOBP REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION	54	7.05e-03	6.82e-02	0.3540	1.88e-01	-8.17e-02	-2.11e-01	-1.96e-01	-1.60e-03	1.68e-02	2.99e-01	7.21e-03	1.26e-02	9.84e-01
GOMF ATP DEPENDENT PROTEIN DISAGGREGASE ACTIVITY	6	8.39e-01	9.47e-01	0.3540	-5.37e-02	-3.91e-02	-9.45e-02	-1.45e-01	3.01e-01	8.20e-01	8.68e-01	6.89e-01	5.38e-01	2.01e-01
GOBP ALDITOL METABOLIC PROCESS	21	1.92e-01	5.38e-01	0.3540	2.86e-01	1.47e-01	7.15e-02	-3.33e-02	1.26e-01	2.34e-02	2.45e-01	5.71e-01	7.92e-01	3.18e-01
GOBP CORNIFICATION	9	5.92e-01	8.47e-01	0.3540	-2.81e-01	-1.53e-01	5.98e-02	-1.34e-01	3.58e-02	1.45e-01	4.25e-01	7.56e-01	4.85e-01	8.52e-01
GOBP OXIDATIVE PHOSPHORYLATION	126	1.64e-06	6.85e-05	0.3540	6.16e-02	-9.81e-02	-2.17e-01	-2.52e-01	3.33e-02	2.32e-01	5.71e-02	2.62e-05	1.02e-06	5.18e-01
GOMF CALCIUM DEPENDENT CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY	16	9.55e-02	3.74e-01	0.3540	-1.56e-01	-4.31e-02	-2.34e-01	1.33e-01	1.64e-01	2.81e-01	7.65e-01	1.05e-01	3.59e-01	2.57e-01
GOMF NEUROPEPTIDE ACTIVITY	29	3.93e-02	2.18e-01	0.3540	4.84e-03	1.44e-01	2.39e-01	-1.27e-01	1.76e-01	9.64e-01	1.80e-01	2.61e-02	2.36e-01	1.00e-01
GOBP MHC CLASS I BIOSYNTHETIC PROCESS	8	7.08e-01	8.97e-01	0.3540	-2.02e-02	-1.82e-01	2.72e-01	1.32e-01	4.84e-03	9.21e-01	3.73e-01	1.83e-01	5.17e-01	9.81e-01
GOBP REGULATION OF DNA TEMPLATED DNA REPLICATION	46	2.47e-02	1.61e-01	0.3530	-1.36e-03	-1.10e-02	-2.23e-01	-2.74e-01	-5.80e-04	9.87e-01	8.97e-01	8.93e-03	1.30e-03	9.95e-01
GOMF GLYCOGEN BINDING	7	8.25e-01	9.44e-01	0.3530	-8.65e-02	1.26e-01	2.78e-01	1.05e-01	1.15e-01	6.92e-01	5.63e-01	2.03e-01	6.29e-01	5.98e-01
GOMF PHOSPHATIDYLINOSITOL TRANSFER ACTIVITY	10	6.89e-01	8.91e-01	0.3530	6.56e-02	1.92e-01	2.56e-01	1.27e-01	-4.94e-02	7.19e-01	2.94e-01	1.62e-01	4.88e-01	7.87e-01
GOCC CASPASE COMPLEX	10	6.46e-01	8.76e-01	0.3530	-2.68e-02	9.67e-03	-3.26e-01	-1.29e-01	-3.46e-02	8.83e-01	9.58e-01	7.44e-02	4.80e-01	8.50e-01
GOBP EMBRYONIC HINDLIMB MORPHOGENESIS	27	1.01e-01	3.86e-01	0.3530	3.60e-02	-3.96e-02	-1.07e-02	-2.35e-01	2.58e-01	7.46e-01	7.22e-01	9.24e-01	3.49e-02	2.01e-02
GOBP CAP DEPENDENT TRANSLATIONAL INITIATION	7	7.91e-01	9.31e-01	0.3530	-8.79e-02	2.19e-01	-8.80e-02	-2.46e-01	2.52e-02	6.87e-01	3.15e-01	6.87e-01	2.59e-01	9.08e-01
GOBP LYMPHOCYTE CHEMOTAXIS	59	3.31e-03	3.95e-02	0.3530	-2.25e-01	1.86e-02	1.37e-01	2.03e-01	-1.17e-01	2.75e-03	8.05e-01	6.83e-02	7.03e-03	1.21e-01
GOCC L TYPE VOLTAGE GATED CALCIUM CHANNEL COMPLEX	12	5.02e-01	8.03e-01	0.3530	-3.11e-01	7.55e-02	1.34e-01	2.84e-02	5.90e-02	6.22e-02	6.51e-01	4.20e-01	8.65e-01	7.23e-01
GOBP REGULATION OF MESENCHYMAL CELL PROLIFERATION	32	4.13e-02	2.25e-01	0.3530	-3.19e-02	-1.15e-01	-2.35e-02	-2.61e-01	2.04e-01	7.55e-01	2.59e-01	8.18e-01	1.06e-02	4.56e-02
GOBP AMINO ACID BETAINE TRANSPORT	13	3.00e-01	6.53e-01	0.3530	5.25e-02	2.82e-01	-7.05e-03	1.80e-01	9.97e-02	7.43e-01	7.84e-02	9.65e-01	2.61e-01	5.34e-01
GOBP AUDITORY RECEPTOR CELL DEVELOPMENT	23	2.14e-01	5.67e-01	0.3530	-1.85e-01	-1.61e-02	7.30e-02	2.05e-01	-2.07e-01	1.25e-01	8.94e-01	5.44e-01	8.90e-02	8.58e-02
GOCC CHECKPOINT CLAMP COMPLEX	5	7.59e-01	9.19e-01	0.3530	-1.56e-01	-6.93e-02	1.94e-01	-2.25e-01	8.46e-02	5.46e-01	7.89e-01	4.53e-01	3.83e-01	7.43e-01
GOBP NEGATIVE REGULATION OF HEPATOCYTE APOPTOTIC PROCESS	7	7.83e-01	9.28e-01	0.3530	9.24e-02	-1.60e-01	-1.70e-02	-7.56e-02	2.91e-01	6.72e-01	4.63e-01	9.38e-01	7.29e-01	1.83e-01
GOBP REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION	33	6.12e-02	2.91e-01	0.3530	-1.76e-01	-4.90e-02	3.06e-02	1.56e-01	-2.57e-01	7.95e-02	6.26e-01	7.61e-01	1.22e-01	1.07e-02
GOBP ION CHANNEL MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY	8	6.67e-01	8.82e-01	0.3530	-3.03e-02	2.70e-01	7.77e-02	2.01e-01	6.53e-02	8.82e-01	1.86e-01	7.03e-01	3.24e-01	7.49e-01
GOBP PYRIMIDINE NUCLEOSIDE TRANSPORT	6	8.46e-01	9.49e-01	0.3530	-2.67e-02	-1.13e-01	3.42e-02	1.47e-01	-2.97e-01	9.10e-01	6.32e-01	8.85e-01	5.33e-01	2.07e-01
GOMF IONOTROPIC GLUTAMATE RECEPTOR ACTIVITY	18	3.36e-01	6.83e-01	0.3530	-1.74e-01	-1.12e-02	2.02e-01	2.06e-01	1.04e-01	2.00e-01	9.34e-01	1.39e-01	1.30e-01	4.47e-01
GOBP GLUTATHIONE TRANSPORT	9	6.26e-01	8.67e-01	0.3530	-1.56e-01	2.81e-01	3.34e-02	1.18e-01	-7.92e-02	4.18e-01	1.45e-01	8.62e-01	5.40e-01	6.81e-01
GOMF ADP D RIBOSE MODIFICATION DEPENDENT PROTEIN BINDING	6	8.24e-01	9.43e-01	0.3530	8.41e-02	1.07e-01	-1.74e-01	-1.03e-01	2.55e-01	7.21e-01	6.51e-01	4.60e-01	6.62e-01	2.79e-01
GOMF ADRENERGIC RECEPTOR BINDING	18	2.84e-01	6.37e-01	0.3530	-9.30e-02	1.22e-01	-6.51e-03	-2.37e-01	2.12e-01	4.94e-01	3.72e-01	9.62e-01	8.18e-02	1.20e-01
GOBP POSITIVE REGULATION OF PROGRAMMED NECROTIC CELL DEATH	10	5.52e-01	8.29e-01	0.3530	1.25e-01	1.25e-01	-6.05e-02	-2.72e-01	-1.23e-01	4.94e-01	4.93e-01	7.40e-01	1.36e-01	4.99e-01
GOBP MITOCHONDRIAL DNA REPAIR	5	8.79e-01	9.61e-01	0.3530	-1.34e-01	1.66e-01	-1.66e-01	-1.85e-01	1.31e-01	6.05e-01	5.20e-01	5.20e-01	4.75e-01	6.11e-01
GOMF STEROID HORMONE BINDING	6	8.19e-01	9.41e-01	0.3530	-1.94e-01	-1.23e-01	2.53e-01	6.71e-02	5.69e-02	4.11e-01	6.00e-01	2.84e-01	7.76e-01	8.09e-01
GOBP SKELETAL MUSCLE TISSUE GROWTH	9	6.39e-01	8.74e-01	0.3530	-2.08e-01	1.79e-01	-3.42e-02	-1.43e-01	1.65e-01	2.79e-01	3.51e-01	8.59e-01	4.58e-01	3.91e-01
GOMF TRANSLATION ACTIVATOR ACTIVITY	9	6.78e-01	8.87e-01	0.3530	-1.76e-02	-1.64e-01	-4.25e-02	-2.19e-01	2.18e-01	9.27e-01	3.96e-01	8.25e-01	2.55e-01	2.57e-01
GOCC CUL3 RING UBIQUITIN LIGASE COMPLEX	35	2.97e-02	1.82e-01	0.3530	-1.04e-03	1.33e-02	-9.40e-02	-3.39e-01	8.09e-03	9.92e-01	8.91e-01	3.36e-01	5.09e-04	9.34e-01
GOBP INTERFERON ALPHA PRODUCTION	27	1.68e-01	5.04e-01	0.3520	-4.13e-02	1.80e-02	-2.02e-01	-2.42e-01	1.51e-01	7.10e-01	8.72e-01	6.90e-02	2.95e-02	1.75e-01
GOBP MESENCHYMAL CELL PROLIFERATION	43	1.57e-02	1.20e-01	0.3520	-2.89e-02	-5.79e-02	-6.56e-02	-2.60e-01	2.19e-01	7.43e-01	5.11e-01	4.57e-01	3.17e-03	1.28e-02
GOBP NEURON REMODELING	15	4.61e-01	7.78e-01	0.3520	8.68e-03	-4.39e-02	3.00e-01	1.74e-01	4.23e-02	9.54e-01	7.69e-01	4.40e-02	2.44e-01	7.76e-01
GOBP NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY	14	3.16e-01	6.66e-01	0.3520	-5.73e-02	6.51e-02	7.30e-02	1.52e-01	2.97e-01	7.11e-01	6.73e-01	6.36e-01	3.23e-01	5.46e-02
GOCC NUCLEAR UBIQUITIN LIGASE COMPLEX	42	2.83e-02	1.77e-01	0.3520	1.88e-01	9.15e-02	-1.24e-01	-1.97e-01	1.62e-01	3.49e-02	3.05e-01	1.66e-01	2.74e-02	6.86e-02
GOBP POSITIVE REGULATION OF SUPEROXIDE ANION GENERATION	16	3.37e-01	6.84e-01	0.3520	-1.28e-01	2.61e-01	1.09e-01	-1.43e-02	-1.65e-01	3.76e-01	7.02e-02	4.49e-01	9.21e-01	2.53e-01
GOBP AZOLE TRANSMEMBRANE TRANSPORT	13	4.94e-01	7.99e-01	0.3520	-1.06e-01	-2.51e-01	-2.65e-02	1.20e-01	-1.87e-01	5.07e-01	1.18e-01	8.68e-01	4.54e-01	2.44e-01
GOMF PHOSPHOFRUCTOKINASE ACTIVITY	6	8.06e-01	9.36e-01	0.3520	2.34e-01	-1.81e-01	1.41e-02	-1.19e-01	1.49e-01	3.21e-01	4.43e-01	9.52e-01	6.13e-01	5.27e-01
GOMF MIRNA BINDING	39	1.20e-02	9.94e-02	0.3520	-1.47e-01	1.26e-01	-7.33e-02	-2.29e-01	-1.69e-01	1.11e-01	1.74e-01	4.28e-01	1.32e-02	6.80e-02
GOMF ATP DEPENDENT ACTIVITY ACTING ON RNA	73	3.33e-04	6.42e-03	0.3520	8.11e-02	-8.50e-02	-1.70e-01	-2.83e-01	-3.94e-02	2.31e-01	2.09e-01	1.22e-02	2.98e-05	5.60e-01
GOBP CELLULAR RESPONSE TO MAGNESIUM ION	7	8.39e-01	9.47e-01	0.3520	-5.34e-02	-2.02e-02	1.77e-01	1.98e-01	-2.23e-01	8.07e-01	9.26e-01	4.17e-01	3.64e-01	3.06e-01
GOBP CARBOHYDRATE MEDIATED SIGNALING	11	6.71e-01	8.83e-01	0.3520	1.12e-01	1.09e-01	-2.00e-01	-2.15e-01	1.16e-01	5.20e-01	5.32e-01	2.51e-01	2.17e-01	5.07e-01
GOCC PALMITOYLTRANSFERASE COMPLEX	10	6.91e-01	8.92e-01	0.3520	1.38e-01	6.65e-02	-2.05e-01	-2.29e-01	-7.74e-02	4.50e-01	7.16e-01	2.62e-01	2.10e-01	6.72e-01
GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX	46	1.53e-02	1.18e-01	0.3520	3.29e-02	-3.40e-02	-1.40e-01	-3.13e-01	6.40e-02	6.99e-01	6.90e-01	1.01e-01	2.40e-04	4.53e-01
GOBP METANEPHRIC MESENCHYME DEVELOPMENT	14	2.71e-01	6.25e-01	0.3520	2.38e-01	-2.74e-02	1.26e-01	-1.92e-01	1.18e-01	1.23e-01	8.59e-01	4.15e-01	2.14e-01	4.45e-01
GOMF CD4 RECEPTOR BINDING	8	7.31e-01	9.08e-01	0.3520	-1.28e-01	1.72e-01	-1.25e-01	-1.91e-01	1.61e-01	5.31e-01	4.00e-01	5.41e-01	3.49e-01	4.31e-01
GOBP REGULATION OF SOMATIC STEM CELL POPULATION MAINTENANCE	12	2.48e-01	6.05e-01	0.3520	1.86e-03	-1.40e-01	6.40e-02	-3.14e-01	-4.04e-02	9.91e-01	4.01e-01	7.01e-01	5.98e-02	8.09e-01
GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION	11	5.67e-01	8.36e-01	0.3520	2.97e-01	1.48e-01	-6.03e-02	-1.00e-01	-2.61e-04	8.80e-02	3.97e-01	7.29e-01	5.65e-01	9.99e-01
GOMF LIGAND GATED SODIUM CHANNEL ACTIVITY	11	5.24e-01	8.16e-01	0.3520	1.64e-01	2.41e-01	1.22e-01	-7.35e-03	-1.54e-01	3.47e-01	1.66e-01	4.84e-01	9.66e-01	3.76e-01
GOMF FLAP ENDONUCLEASE ACTIVITY	6	8.34e-01	9.45e-01	0.3520	1.14e-01	4.80e-03	-2.89e-01	-9.22e-02	1.38e-01	6.30e-01	9.84e-01	2.21e-01	6.96e-01	5.59e-01
GOCC PROTON TRANSPORTING V TYPE ATPASE V0 DOMAIN	11	4.17e-01	7.46e-01	0.3520	1.58e-01	1.48e-01	2.02e-01	-1.77e-01	6.67e-02	3.63e-01	3.95e-01	2.46e-01	3.09e-01	7.02e-01
GOBP THERMOCEPTION	8	6.62e-01	8.81e-01	0.3520	2.57e-01	4.45e-02	1.78e-01	6.28e-02	-1.42e-01	2.08e-01	8.27e-01	3.83e-01	7.58e-01	4.88e-01
GOBP NEGATIVE REGULATION OF TRANSLATIONAL INITIATION	21	2.71e-01	6.25e-01	0.3520	3.40e-02	1.39e-03	-3.08e-01	-1.56e-01	-5.82e-02	7.87e-01	9.91e-01	1.46e-02	2.16e-01	6.44e-01
GOBP REGULATION OF PENTOSE PHOSPHATE SHUNT	7	8.21e-01	9.42e-01	0.3510	-3.91e-02	-7.16e-02	-3.13e-01	-1.20e-01	-6.95e-02	8.58e-01	7.43e-01	1.52e-01	5.83e-01	7.50e-01
GOBP RESPONSE TO SODIUM PHOSPHATE	7	7.50e-01	9.16e-01	0.3510	-1.74e-01	-1.99e-01	7.91e-02	2.20e-02	2.17e-01	4.26e-01	3.62e-01	7.17e-01	9.20e-01	3.20e-01
GOMF PROTEIN ARGININE N METHYLTRANSFERASE ACTIVITY	12	6.53e-01	8.79e-01	0.3510	-2.46e-02	-2.46e-02	-2.02e-01	-2.68e-01	9.85e-02	8.83e-01	8.83e-01	2.25e-01	1.08e-01	5.55e-01
GOBP NEGATIVE REGULATION OF VIRAL TRANSCRIPTION	14	3.23e-01	6.71e-01	0.3510	1.90e-01	-1.11e-01	-4.51e-02	-2.70e-01	-9.85e-03	2.19e-01	4.73e-01	7.70e-01	8.00e-02	9.49e-01
GOBP SPHINGOMYELIN BIOSYNTHETIC PROCESS	11	5.35e-01	8.21e-01	0.3510	1.55e-02	2.92e-01	-3.62e-02	-9.19e-02	-1.69e-01	9.29e-01	9.41e-02	8.35e-01	5.98e-01	3.33e-01
GOBP NCRNA PROCESSING	415	7.35e-22	1.83e-19	0.3510	6.10e-02	-4.94e-02	-2.31e-01	-2.48e-01	4.79e-02	3.30e-02	8.46e-02	6.22e-16	4.12e-18	9.42e-02
GOBP RNA MODIFICATION	168	1.33e-08	9.26e-07	0.3510	9.26e-02	-8.88e-02	-2.23e-01	-2.35e-01	4.42e-02	3.84e-02	4.71e-02	6.24e-07	1.42e-07	3.23e-01
GOBP TETRAHYDROFOLATE BIOSYNTHETIC PROCESS	5	9.04e-01	9.68e-01	0.3510	-2.87e-02	-2.69e-01	-1.68e-01	-1.46e-01	2.89e-02	9.11e-01	2.98e-01	5.16e-01	5.71e-01	9.11e-01
GOBP PERK MEDIATED UNFOLDED PROTEIN RESPONSE	18	2.23e-01	5.76e-01	0.3510	-2.11e-01	1.33e-01	1.86e-02	-2.46e-01	1.53e-02	1.20e-01	3.30e-01	8.91e-01	7.11e-02	9.10e-01
GOCC INNER MITOCHONDRIAL MEMBRANE PROTEIN COMPLEX	135	3.66e-07	1.89e-05	0.3510	3.91e-02	-3.33e-02	-1.90e-01	-2.90e-01	2.04e-02	4.33e-01	5.05e-01	1.34e-04	6.11e-09	6.82e-01
GOBP REGULATION OF PLATELET AGGREGATION	27	8.52e-02	3.53e-01	0.3510	1.31e-02	2.62e-01	2.30e-01	-2.80e-02	-2.54e-02	9.06e-01	1.85e-02	3.84e-02	8.01e-01	8.19e-01
GOBP CAMKK AMPK SIGNALING CASCADE	9	7.44e-01	9.14e-01	0.3510	1.95e-01	3.09e-02	-1.48e-01	-2.47e-01	4.03e-02	3.12e-01	8.72e-01	4.43e-01	2.00e-01	8.34e-01
GOBP CELLULAR RESPONSE TO COPPER ION	25	1.44e-01	4.65e-01	0.3510	-1.71e-01	1.15e-01	-1.49e-01	-2.41e-01	-2.65e-03	1.38e-01	3.18e-01	1.96e-01	3.69e-02	9.82e-01
GOMF PATTERN RECOGNITION RECEPTOR ACTIVITY	32	5.75e-02	2.79e-01	0.3510	-1.98e-01	2.20e-01	1.09e-01	5.44e-02	-1.43e-01	5.28e-02	3.11e-02	2.84e-01	5.94e-01	1.60e-01
GOMF U1 SNRNA BINDING	8	7.45e-01	9.14e-01	0.3510	-1.81e-01	9.08e-02	-2.18e-01	-1.85e-01	1.37e-02	3.75e-01	6.57e-01	2.85e-01	3.66e-01	9.46e-01
GOBP GLOMERULAR EPITHELIAL CELL DIFFERENTIATION	21	2.10e-01	5.62e-01	0.3510	1.14e-01	-1.63e-01	9.95e-02	2.01e-01	-1.82e-01	3.65e-01	1.97e-01	4.30e-01	1.10e-01	1.49e-01
GOMF RNA EXONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS	39	5.37e-02	2.67e-01	0.3510	-2.62e-02	-7.44e-02	-2.17e-01	-2.64e-01	-5.28e-03	7.77e-01	4.21e-01	1.88e-02	4.36e-03	9.55e-01
GOBP MITOTIC SISTER CHROMATID SEPARATION	62	1.37e-03	1.99e-02	0.3510	2.09e-01	-8.68e-02	-1.71e-01	-2.00e-01	-4.94e-02	4.43e-03	2.37e-01	1.95e-02	6.44e-03	5.01e-01
GOBP PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY	29	8.83e-02	3.59e-01	0.3510	-5.08e-02	2.15e-01	2.59e-01	1.61e-02	8.18e-02	6.36e-01	4.52e-02	1.56e-02	8.81e-01	4.46e-01
GOBP GERM CELL PROLIFERATION	10	4.75e-01	7.88e-01	0.3510	-6.40e-02	1.73e-01	2.38e-01	-1.76e-01	3.64e-02	7.26e-01	3.44e-01	1.92e-01	3.36e-01	8.42e-01
GOCC INTRACILIARY TRANSPORT PARTICLE A	8	7.79e-01	9.28e-01	0.3510	7.43e-03	5.30e-03	-2.10e-01	-1.73e-01	2.21e-01	9.71e-01	9.79e-01	3.05e-01	3.96e-01	2.79e-01
GOBP NADH METABOLIC PROCESS	11	3.78e-01	7.17e-01	0.3510	7.29e-02	-8.55e-02	-2.33e-02	-3.04e-01	-1.33e-01	6.76e-01	6.23e-01	8.94e-01	8.13e-02	4.46e-01
GOBP REGULATION OF RESPIRATORY SYSTEM PROCESS	13	3.20e-01	6.68e-01	0.3510	9.42e-02	1.61e-01	1.55e-01	-2.44e-01	6.64e-02	5.57e-01	3.14e-01	3.33e-01	1.27e-01	6.78e-01
GOBP NEGATIVE REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS	5	8.79e-01	9.61e-01	0.3510	-3.65e-02	-7.88e-02	2.74e-02	-1.23e-01	3.15e-01	8.88e-01	7.60e-01	9.15e-01	6.34e-01	2.22e-01
GOBP NEGATIVE REGULATION OF CELL ADHESION MOLECULE PRODUCTION	10	4.15e-01	7.45e-01	0.3510	1.03e-02	-1.49e-01	-1.05e-01	2.64e-01	1.41e-01	9.55e-01	4.14e-01	5.67e-01	1.48e-01	4.41e-01
GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX PROTON TRANSPORTING DOMAIN	23	1.90e-01	5.36e-01	0.3500	3.11e-02	1.33e-01	-6.80e-02	-3.00e-01	9.86e-02	7.97e-01	2.68e-01	5.72e-01	1.29e-02	4.13e-01
GOBP POSITIVE REGULATION OF MYOBLAST FUSION	16	3.14e-01	6.65e-01	0.3500	-2.00e-02	3.46e-01	1.36e-02	-3.93e-02	3.09e-02	8.90e-01	1.65e-02	9.25e-01	7.85e-01	8.30e-01
GOBP PLACENTA BLOOD VESSEL DEVELOPMENT	30	1.02e-01	3.87e-01	0.3500	1.25e-01	9.31e-02	-1.39e-01	-2.81e-01	1.47e-02	2.37e-01	3.78e-01	1.88e-01	7.68e-03	8.89e-01
GOCC ENDOPLASMIC RETICULUM PROTEIN CONTAINING COMPLEX	121	1.74e-06	7.23e-05	0.3500	-1.05e-02	7.90e-04	-1.94e-01	-2.92e-01	-1.09e-02	8.42e-01	9.88e-01	2.29e-04	3.01e-08	8.36e-01
GOBP REGULATION OF SEQUESTERING OF TRIGLYCERIDE	15	3.57e-01	7.02e-01	0.3500	-1.60e-01	6.14e-02	2.67e-02	-2.37e-01	1.91e-01	2.82e-01	6.81e-01	8.58e-01	1.13e-01	1.99e-01
GOMF SPHINGOLIPID TRANSFER ACTIVITY	9	6.51e-01	8.79e-01	0.3500	-8.81e-02	2.54e-01	-9.50e-02	-1.41e-01	1.47e-01	6.47e-01	1.87e-01	6.22e-01	4.64e-01	4.44e-01
GOBP MITOCHONDRIAL PROTON TRANSPORTING ATP SYNTHASE COMPLEX ASSEMBLY	8	7.56e-01	9.18e-01	0.3500	5.01e-02	2.52e-01	-1.30e-01	-1.92e-01	5.55e-02	8.06e-01	2.17e-01	5.23e-01	3.48e-01	7.86e-01
GOMF C3HC4 TYPE RING FINGER DOMAIN BINDING	6	7.48e-01	9.15e-01	0.3500	7.83e-02	1.96e-01	-1.04e-01	3.13e-02	2.58e-01	7.40e-01	4.07e-01	6.59e-01	8.94e-01	2.74e-01
GOBP REGULATION OF ISOTYPE SWITCHING	37	3.22e-02	1.92e-01	0.3500	1.22e-01	2.09e-01	-3.82e-02	-2.36e-01	8.43e-02	1.97e-01	2.79e-02	6.88e-01	1.31e-02	3.75e-01
GOBP MATING BEHAVIOR	36	3.83e-02	2.14e-01	0.3500	-6.69e-02	-2.20e-02	2.34e-01	1.36e-01	2.10e-01	4.87e-01	8.19e-01	1.50e-02	1.57e-01	2.89e-02
GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND	10	6.23e-01	8.65e-01	0.3500	-1.97e-01	-1.53e-01	-7.58e-02	-6.53e-02	-2.24e-01	2.81e-01	4.01e-01	6.78e-01	7.21e-01	2.19e-01
GOBP POSITIVE REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY	8	6.58e-01	8.80e-01	0.3500	-2.09e-01	-8.99e-02	4.58e-02	-9.67e-02	-2.43e-01	3.05e-01	6.60e-01	8.23e-01	6.36e-01	2.33e-01
GOBP ATP SYNTHESIS COUPLED ELECTRON TRANSPORT	85	2.36e-04	4.81e-03	0.3500	6.49e-02	-1.19e-01	-1.92e-01	-2.56e-01	4.40e-02	3.01e-01	5.89e-02	2.15e-03	4.63e-05	4.83e-01
GOBP PHOSPHOLIPID EFFLUX	14	3.99e-01	7.32e-01	0.3500	-2.60e-01	-1.52e-01	-1.76e-01	-4.67e-03	-2.60e-02	9.20e-02	3.24e-01	2.54e-01	9.76e-01	8.66e-01
GOBP MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE	41	1.71e-02	1.28e-01	0.3500	5.65e-03	6.78e-02	-1.35e-01	-3.05e-01	-8.37e-02	9.50e-01	4.52e-01	1.36e-01	7.39e-04	3.54e-01
GOBP NEGATIVE REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY	5	8.57e-01	9.53e-01	0.3500	-1.69e-02	-1.61e-01	-3.09e-01	2.18e-02	-9.25e-03	9.48e-01	5.32e-01	2.31e-01	9.33e-01	9.71e-01
GOMF OLIGOSACCHARIDE BINDING	15	3.75e-01	7.15e-01	0.3500	-1.71e-01	-1.08e-01	5.13e-02	2.81e-01	-1.74e-02	2.52e-01	4.70e-01	7.31e-01	5.99e-02	9.07e-01
GOMF ANNEALING ACTIVITY	8	7.86e-01	9.29e-01	0.3500	-8.76e-02	4.64e-02	-1.32e-01	-2.91e-01	1.02e-01	6.68e-01	8.20e-01	5.19e-01	1.54e-01	6.17e-01
GOBP MAMMALIAN OOGENESIS STAGE	12	4.53e-01	7.72e-01	0.3500	-1.94e-01	-2.74e-02	-1.06e-01	-7.82e-02	2.58e-01	2.44e-01	8.69e-01	5.24e-01	6.39e-01	1.22e-01
GOBP REGULATION OF GLIAL CELL MIGRATION	19	3.53e-01	6.99e-01	0.3500	-1.41e-01	-6.43e-02	2.29e-01	2.10e-01	4.45e-02	2.89e-01	6.28e-01	8.38e-02	1.14e-01	7.37e-01
GOBP PURINE RIBONUCLEOSIDE CATABOLIC PROCESS	6	7.83e-01	9.28e-01	0.3500	-6.02e-03	1.54e-01	-8.75e-02	1.90e-01	-2.33e-01	9.80e-01	5.12e-01	7.11e-01	4.19e-01	3.23e-01
GOBP COBALAMIN METABOLIC PROCESS	9	5.00e-01	8.03e-01	0.3490	6.58e-02	9.21e-02	1.69e-01	-2.67e-01	9.54e-02	7.32e-01	6.32e-01	3.79e-01	1.65e-01	6.20e-01
GOBP N TERMINAL PROTEIN AMINO ACID ACETYLATION	15	4.60e-01	7.77e-01	0.3490	1.78e-01	1.55e-01	-8.05e-02	-2.22e-01	1.03e-01	2.32e-01	2.99e-01	5.89e-01	1.37e-01	4.90e-01
GOBP EMBRYONIC SKELETAL JOINT DEVELOPMENT	15	4.34e-01	7.58e-01	0.3490	1.62e-01	2.82e-02	-1.01e-01	-2.87e-01	4.63e-02	2.78e-01	8.50e-01	4.97e-01	5.39e-02	7.56e-01
GOMF HISTONE H3K4 METHYLTRANSFERASE ACTIVITY	19	1.60e-01	4.91e-01	0.3490	2.30e-01	5.29e-02	2.38e-01	3.42e-02	-9.14e-02	8.20e-02	6.90e-01	7.27e-02	7.96e-01	4.90e-01
GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN EXECUTION PHASE OF APOPTOSIS	5	8.84e-01	9.61e-01	0.3490	-1.63e-01	-3.24e-02	-6.98e-02	-1.67e-01	2.48e-01	5.27e-01	9.00e-01	7.87e-01	5.18e-01	3.37e-01
GOBP REGULATION OF LIPOPROTEIN METABOLIC PROCESS	17	3.34e-01	6.81e-01	0.3490	-1.08e-01	-2.41e-01	-9.81e-02	-1.77e-01	1.05e-01	4.41e-01	8.49e-02	4.84e-01	2.06e-01	4.53e-01
GOBP REGULATION OF ICOSANOID SECRETION	20	3.29e-01	6.77e-01	0.3490	9.08e-03	1.91e-01	2.09e-01	1.66e-01	-1.19e-01	9.44e-01	1.39e-01	1.05e-01	1.99e-01	3.59e-01
GOCC CDC73 PAF1 COMPLEX	7	7.52e-01	9.16e-01	0.3490	-5.13e-02	-2.58e-01	-2.14e-01	8.00e-02	1.42e-02	8.14e-01	2.36e-01	3.26e-01	7.14e-01	9.48e-01
GOBP FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA	13	5.17e-01	8.11e-01	0.3490	-2.01e-01	6.59e-02	-1.70e-01	-2.19e-01	1.81e-02	2.10e-01	6.81e-01	2.89e-01	1.71e-01	9.10e-01
GOBP NUCLEAR MEMBRANE ORGANIZATION	42	4.72e-02	2.44e-01	0.3490	6.06e-02	-2.84e-02	-2.08e-01	-2.67e-01	5.17e-02	4.97e-01	7.50e-01	1.97e-02	2.71e-03	5.62e-01
GOBP RIBONUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS	8	7.10e-01	8.99e-01	0.3490	-1.54e-01	3.96e-02	-5.08e-02	-3.06e-01	1.77e-02	4.50e-01	8.46e-01	8.03e-01	1.34e-01	9.31e-01
GOBP NEGATIVE REGULATION OF PHOSPHATASE ACTIVITY	24	1.13e-01	4.11e-01	0.3490	9.15e-02	2.41e-01	-1.78e-02	1.66e-02	-2.34e-01	4.38e-01	4.10e-02	8.80e-01	8.88e-01	4.73e-02
GOMF ENDOPEPTIDASE REGULATOR ACTIVITY	173	4.29e-09	3.21e-07	0.3490	-1.01e-01	-7.02e-02	1.73e-01	2.64e-01	-8.24e-02	2.20e-02	1.11e-01	8.65e-05	1.95e-09	6.15e-02
GOBP METAPHASE CHROMOSOME ALIGNMENT	97	9.32e-05	2.24e-03	0.3490	1.22e-01	-6.65e-02	-2.00e-01	-2.22e-01	1.14e-01	3.79e-02	2.58e-01	6.54e-04	1.58e-04	5.23e-02
GOMF ACTIVIN RECEPTOR BINDING	8	7.82e-01	9.28e-01	0.3490	3.14e-02	1.20e-01	1.34e-01	1.79e-01	-2.37e-01	8.78e-01	5.56e-01	5.12e-01	3.81e-01	2.46e-01
GOBP POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT	23	1.85e-01	5.27e-01	0.3490	8.10e-02	2.31e-01	1.94e-01	-5.07e-03	1.53e-01	5.01e-01	5.46e-02	1.07e-01	9.66e-01	2.03e-01
GOCC REPLICATION FORK	64	2.96e-03	3.62e-02	0.3480	1.57e-01	5.08e-02	-2.15e-01	-1.89e-01	1.12e-01	3.01e-02	4.83e-01	2.95e-03	9.07e-03	1.21e-01
GOBP CELL CELL ADHESION MEDIATED BY CADHERIN	47	9.78e-03	8.63e-02	0.3480	-2.18e-02	-1.62e-01	2.03e-01	1.96e-01	1.23e-01	7.96e-01	5.49e-02	1.59e-02	2.03e-02	1.46e-01
GOBP BRANCH ELONGATION OF AN EPITHELIUM	18	4.05e-01	7.38e-01	0.3480	-5.03e-02	-1.52e-01	-2.04e-01	-2.31e-01	1.87e-02	7.12e-01	2.63e-01	1.33e-01	8.93e-02	8.91e-01
GOBP NEGATIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY	20	1.89e-01	5.35e-01	0.3480	6.98e-02	1.74e-01	-8.11e-02	-5.46e-02	-2.77e-01	5.89e-01	1.78e-01	5.30e-01	6.72e-01	3.21e-02
GOBP ECTODERM DEVELOPMENT	21	2.17e-01	5.71e-01	0.3480	1.06e-01	2.12e-01	2.09e-02	-2.17e-01	1.32e-01	3.99e-01	9.20e-02	8.68e-01	8.50e-02	2.96e-01
GOBP POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY	14	4.38e-01	7.61e-01	0.3480	1.84e-01	-1.39e-01	1.19e-01	2.04e-01	1.11e-01	2.34e-01	3.69e-01	4.39e-01	1.86e-01	4.70e-01
GOBP CALCIUM ION IMPORT	46	2.01e-02	1.41e-01	0.3480	-6.61e-02	7.83e-02	1.60e-01	2.87e-01	-5.19e-02	4.38e-01	3.58e-01	6.12e-02	7.42e-04	5.43e-01
GOMF RNA EXONUCLEASE ACTIVITY	44	3.65e-02	2.08e-01	0.3480	-3.52e-02	-6.46e-02	-2.31e-01	-2.50e-01	5.86e-03	6.87e-01	4.58e-01	7.92e-03	4.18e-03	9.46e-01
GOMF OLIGOSACCHARYL TRANSFERASE ACTIVITY	6	8.26e-01	9.44e-01	0.3480	2.36e-01	1.44e-01	-7.05e-02	-1.79e-01	-8.72e-02	3.17e-01	5.40e-01	7.65e-01	4.48e-01	7.12e-01
GOBP ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE	13	1.41e-01	4.62e-01	0.3480	1.12e-01	-1.33e-01	2.05e-01	-2.18e-01	-3.31e-02	4.83e-01	4.07e-01	2.00e-01	1.73e-01	8.36e-01
GOMF R SMAD BINDING	25	1.23e-01	4.32e-01	0.3480	6.69e-02	3.01e-01	1.04e-01	-1.07e-01	6.05e-02	5.62e-01	9.13e-03	3.68e-01	3.56e-01	6.01e-01
GOBP RESPONSE TO AMINO ACID STARVATION	53	8.58e-03	7.88e-02	0.3480	-2.21e-02	-1.70e-01	-1.88e-01	-2.38e-01	-1.05e-03	7.81e-01	3.23e-02	1.82e-02	2.75e-03	9.89e-01
GOBP SKELETAL MUSCLE ATROPHY	5	8.64e-01	9.54e-01	0.3480	-2.92e-01	-1.24e-01	-1.37e-01	-1.22e-02	4.22e-02	2.59e-01	6.32e-01	5.95e-01	9.62e-01	8.70e-01
GOBP REGULATION OF CILIUM BEAT FREQUENCY	17	3.37e-01	6.84e-01	0.3480	-2.10e-01	-9.20e-02	-1.27e-01	1.64e-02	-2.28e-01	1.34e-01	5.11e-01	3.65e-01	9.07e-01	1.03e-01
GOMF NUCLEOSIDE TRANSMEMBRANE TRANSPORTER ACTIVITY	10	5.97e-01	8.51e-01	0.3480	2.21e-01	-1.78e-01	-3.75e-02	1.82e-01	-7.79e-02	2.27e-01	3.30e-01	8.37e-01	3.19e-01	6.70e-01
GOBP INTRACILIARY ANTEROGRADE TRANSPORT	17	4.31e-01	7.55e-01	0.3480	1.90e-01	3.99e-02	-1.77e-01	-1.70e-01	1.52e-01	1.76e-01	7.76e-01	2.06e-01	2.25e-01	2.77e-01
GOBP REGULATION OF HEPATOCYTE APOPTOTIC PROCESS	10	6.48e-01	8.77e-01	0.3480	2.11e-01	-5.48e-02	1.63e-02	-1.10e-01	2.47e-01	2.47e-01	7.64e-01	9.29e-01	5.46e-01	1.77e-01
GOBP NEGATIVE REGULATION OF AUTOPHAGOSOME MATURATION	5	8.79e-01	9.61e-01	0.3480	-8.52e-02	2.00e-01	-1.96e-01	-1.31e-01	-1.36e-01	7.41e-01	4.39e-01	4.49e-01	6.12e-01	5.99e-01
GOBP REGULATION OF ENDOCRINE PROCESS	39	6.13e-03	6.20e-02	0.3480	9.84e-02	1.66e-01	1.75e-01	-2.81e-02	-2.29e-01	2.88e-01	7.28e-02	5.88e-02	7.62e-01	1.34e-02
GOBP REGULATION OF NMDA RECEPTOR ACTIVITY	17	3.49e-01	6.95e-01	0.3480	-1.53e-02	-1.08e-01	9.81e-02	3.15e-01	-4.16e-03	9.13e-01	4.41e-01	4.84e-01	2.44e-02	9.76e-01
GOBP REGULATION OF CARDIAC MUSCLE ADAPTATION	17	2.72e-01	6.26e-01	0.3480	-1.74e-01	4.11e-02	2.62e-01	-3.02e-02	1.38e-01	2.14e-01	7.69e-01	6.10e-02	8.29e-01	3.24e-01
GOBP T CELL CHEMOTAXIS	26	1.23e-01	4.31e-01	0.3480	-2.91e-01	-1.22e-01	9.92e-02	1.05e-01	-1.86e-02	1.01e-02	2.83e-01	3.81e-01	3.54e-01	8.70e-01
GOBP NUCLEAR ENVELOPE ORGANIZATION	52	1.74e-02	1.29e-01	0.3480	2.34e-02	-2.09e-02	-2.39e-01	-2.51e-01	7.64e-03	7.70e-01	7.95e-01	2.90e-03	1.77e-03	9.24e-01
GOBP KIDNEY MESENCHYME DEVELOPMENT	16	3.05e-01	6.58e-01	0.3480	2.26e-01	-2.78e-02	2.26e-03	-2.40e-01	1.08e-01	1.18e-01	8.47e-01	9.87e-01	9.71e-02	4.55e-01
GOMF IODIDE TRANSMEMBRANE TRANSPORTER ACTIVITY	5	8.36e-01	9.46e-01	0.3480	-1.59e-01	6.29e-02	3.35e-03	-2.90e-01	-8.65e-02	5.38e-01	8.08e-01	9.90e-01	2.61e-01	7.38e-01
GOBP PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE	35	6.33e-02	2.96e-01	0.3480	-1.29e-01	5.54e-02	-2.11e-01	-2.38e-01	-9.98e-03	1.87e-01	5.71e-01	3.10e-02	1.48e-02	9.19e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS NAD OR NADP AS ACCEPTOR	32	1.30e-01	4.45e-01	0.3470	8.40e-02	-1.09e-01	-2.55e-01	-1.84e-01	5.52e-02	4.11e-01	2.87e-01	1.26e-02	7.16e-02	5.89e-01
GOCC SPHERICAL HIGH DENSITY LIPOPROTEIN PARTICLE	8	7.74e-01	9.25e-01	0.3470	4.30e-02	1.50e-01	9.52e-02	2.09e-01	-2.08e-01	8.33e-01	4.61e-01	6.41e-01	3.05e-01	3.08e-01
GOBP SEGMENT SPECIFICATION	16	3.65e-01	7.05e-01	0.3470	1.05e-01	-2.04e-02	5.71e-02	-1.41e-01	2.94e-01	4.68e-01	8.87e-01	6.92e-01	3.30e-01	4.21e-02
GOMF DIPEPTIDYL PEPTIDASE ACTIVITY	12	5.28e-01	8.18e-01	0.3470	-2.83e-01	4.35e-02	1.37e-01	3.79e-03	-1.41e-01	8.98e-02	7.94e-01	4.12e-01	9.82e-01	3.97e-01
GOMF THIAMINE PYROPHOSPHATE BINDING	7	8.00e-01	9.33e-01	0.3470	2.03e-01	1.09e-01	-5.55e-02	-5.58e-02	2.48e-01	3.52e-01	6.18e-01	7.99e-01	7.98e-01	2.57e-01
GOMF LIGASE ACTIVITY FORMING CARBON SULFUR BONDS	38	1.70e-02	1.27e-01	0.3470	1.11e-01	2.58e-01	-3.76e-02	-1.60e-01	-1.22e-01	2.36e-01	6.01e-03	6.88e-01	8.70e-02	1.95e-01
GOBP VESICLE UNCOATING	8	6.88e-01	8.90e-01	0.3470	2.93e-01	-6.92e-02	-1.30e-01	1.11e-01	-1.75e-02	1.51e-01	7.35e-01	5.23e-01	5.88e-01	9.32e-01
GOMF NUCLEOBASE TRANSMEMBRANE TRANSPORTER ACTIVITY	10	6.93e-01	8.93e-01	0.3470	6.81e-02	4.82e-02	1.04e-01	2.52e-01	-1.97e-01	7.09e-01	7.92e-01	5.68e-01	1.67e-01	2.80e-01
GOBP RESPONSE TO THYROID HORMONE	28	8.43e-02	3.50e-01	0.3470	-1.69e-01	-3.26e-02	-1.21e-01	-2.20e-01	-1.67e-01	1.21e-01	7.65e-01	2.69e-01	4.42e-02	1.26e-01
GOBP REGULATION OF MYELOID DENDRITIC CELL ACTIVATION	5	9.06e-01	9.69e-01	0.3470	1.07e-01	2.11e-01	-8.43e-02	-2.28e-01	7.49e-02	6.79e-01	4.14e-01	7.44e-01	3.78e-01	7.72e-01
GOCC BETA CATENIN DESTRUCTION COMPLEX	11	3.05e-01	6.58e-01	0.3470	1.79e-01	-8.05e-03	1.25e-01	-2.69e-01	-2.33e-02	3.05e-01	9.63e-01	4.73e-01	1.23e-01	8.93e-01
GOBP ENDOPLASMIC RETICULUM TUBULAR NETWORK FORMATION	5	8.68e-01	9.56e-01	0.3470	1.87e-01	2.79e-01	-6.20e-02	1.81e-03	-5.90e-02	4.69e-01	2.79e-01	8.10e-01	9.94e-01	8.19e-01
GOBP POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION	14	4.72e-01	7.86e-01	0.3470	1.18e-01	2.23e-01	4.24e-02	-1.42e-01	1.86e-01	4.44e-01	1.49e-01	7.84e-01	3.59e-01	2.27e-01
GOBP MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER	13	4.06e-01	7.39e-01	0.3470	-9.43e-02	2.32e-01	2.07e-01	-1.02e-01	-6.60e-02	5.56e-01	1.47e-01	1.97e-01	5.24e-01	6.80e-01
GOBP RNA SPLICING VIA TRANSESTERIFICATION REACTIONS	286	6.60e-15	8.34e-13	0.3470	8.88e-02	-3.14e-02	-1.87e-01	-2.67e-01	7.07e-02	9.80e-03	3.61e-01	5.21e-08	7.48e-15	3.97e-02
GOBP ANTEROGRADE AXONAL TRANSPORT OF MITOCHONDRION	6	8.49e-01	9.49e-01	0.3470	8.32e-02	3.66e-02	1.63e-01	1.77e-01	2.32e-01	7.24e-01	8.77e-01	4.90e-01	4.53e-01	3.24e-01
GOMF DNA CLAMP LOADER ACTIVITY	9	6.96e-01	8.94e-01	0.3470	-2.19e-01	-2.10e-02	-8.47e-02	-2.33e-01	1.01e-01	2.55e-01	9.13e-01	6.60e-01	2.26e-01	6.01e-01
GOBP GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY	27	1.88e-01	5.32e-01	0.3470	2.10e-02	1.24e-01	2.67e-01	1.70e-01	6.23e-02	8.50e-01	2.64e-01	1.63e-02	1.26e-01	5.75e-01
GOMF NF KAPPAB BINDING	28	1.42e-01	4.63e-01	0.3470	1.41e-01	1.56e-01	-1.40e-01	-2.31e-01	5.28e-02	1.96e-01	1.53e-01	1.98e-01	3.44e-02	6.28e-01
GOBP HARD PALATE DEVELOPMENT	8	6.24e-01	8.66e-01	0.3460	3.15e-01	-1.69e-02	8.47e-02	-1.15e-01	-1.97e-02	1.23e-01	9.34e-01	6.78e-01	5.75e-01	9.23e-01
GOBP REGULATION OF MRNA EXPORT FROM NUCLEUS	7	7.66e-01	9.23e-01	0.3460	-2.19e-01	5.84e-02	-4.96e-02	-1.81e-01	-1.82e-01	3.15e-01	7.89e-01	8.20e-01	4.07e-01	4.03e-01
GOBP DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS	14	4.77e-01	7.90e-01	0.3460	-3.10e-02	5.08e-02	-1.31e-01	-3.12e-01	-4.72e-02	8.41e-01	7.42e-01	3.97e-01	4.36e-02	7.60e-01
GOBP RESPONSE TO MISFOLDED PROTEIN	23	1.74e-01	5.14e-01	0.3460	-2.34e-02	1.98e-01	-1.57e-01	-1.70e-01	1.63e-01	8.46e-01	1.00e-01	1.93e-01	1.57e-01	1.76e-01
GOMF HISTONE H3K9 DEMETHYLASE ACTIVITY	12	5.31e-01	8.19e-01	0.3460	3.21e-01	9.19e-02	-7.43e-02	-4.72e-02	1.54e-02	5.39e-02	5.82e-01	6.56e-01	7.77e-01	9.26e-01
GOMF CYTIDYLYLTRANSFERASE ACTIVITY	9	5.62e-01	8.33e-01	0.3460	9.71e-02	-2.38e-01	-4.15e-02	-1.71e-01	-1.51e-01	6.14e-01	2.17e-01	8.29e-01	3.74e-01	4.33e-01
GOBP POSITIVE REGULATION OF DNA BINDING	41	3.58e-02	2.05e-01	0.3460	3.53e-02	-1.01e-01	-1.17e-01	-2.16e-01	2.19e-01	6.96e-01	2.63e-01	1.94e-01	1.66e-02	1.54e-02
GOCC PARALLEL FIBER TO PURKINJE CELL SYNAPSE	17	2.94e-01	6.48e-01	0.3460	-2.15e-01	-8.15e-02	1.43e-02	2.52e-01	-5.40e-02	1.24e-01	5.61e-01	9.18e-01	7.17e-02	7.00e-01
GOMF PHOSPHATIDYLSERINE BINDING	61	1.39e-03	2.01e-02	0.3460	-2.26e-01	1.68e-01	9.85e-02	1.49e-01	-9.17e-02	2.29e-03	2.30e-02	1.83e-01	4.35e-02	2.16e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS NAD P AS ACCEPTOR	11	5.47e-01	8.27e-01	0.3460	3.27e-01	3.11e-02	-1.07e-02	1.05e-01	-2.08e-02	6.01e-02	8.58e-01	9.51e-01	5.48e-01	9.05e-01
GOBP POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR	30	1.04e-01	3.91e-01	0.3460	-9.16e-02	-1.22e-01	-1.72e-01	-1.72e-01	1.93e-01	3.85e-01	2.48e-01	1.03e-01	1.03e-01	6.78e-02
GOBP POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS	68	2.40e-03	3.10e-02	0.3460	-2.83e-02	-7.64e-02	-1.87e-01	-2.70e-01	7.15e-02	6.87e-01	2.76e-01	7.67e-03	1.19e-04	3.08e-01
GOBP REGULATION OF DNA CATABOLIC PROCESS	11	3.10e-01	6.62e-01	0.3460	1.41e-01	-2.11e-01	7.17e-02	-1.85e-01	-1.26e-01	4.18e-01	2.26e-01	6.80e-01	2.89e-01	4.70e-01
GOBP REGULATION OF INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY	10	6.77e-01	8.86e-01	0.3460	-2.31e-01	-3.73e-02	3.25e-02	9.52e-02	-2.34e-01	2.06e-01	8.38e-01	8.59e-01	6.02e-01	2.01e-01
GOBP NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT	13	5.46e-01	8.26e-01	0.3460	1.05e-01	1.43e-01	-5.82e-02	-2.66e-01	1.17e-01	5.12e-01	3.71e-01	7.16e-01	9.67e-02	4.66e-01
GOBP MESODERMAL CELL FATE COMMITMENT	17	2.88e-01	6.41e-01	0.3460	1.82e-02	-1.67e-01	-2.53e-02	-2.58e-01	1.55e-01	8.97e-01	2.33e-01	8.57e-01	6.54e-02	2.70e-01
GOBP SPERM EJACULATION	5	8.01e-01	9.34e-01	0.3460	-2.48e-01	1.16e-01	-1.91e-01	-6.37e-03	9.06e-02	3.38e-01	6.53e-01	4.60e-01	9.80e-01	7.26e-01
GOBP RESPONSE TO FLUID SHEAR STRESS	34	6.87e-02	3.10e-01	0.3450	5.64e-02	4.37e-02	-1.94e-01	-2.52e-01	-1.15e-01	5.69e-01	6.59e-01	5.07e-02	1.11e-02	2.44e-01
GOBP HISTIDINE METABOLIC PROCESS	10	3.86e-01	7.24e-01	0.3450	-9.69e-02	1.54e-02	-2.52e-01	1.87e-01	-1.06e-01	5.96e-01	9.33e-01	1.68e-01	3.05e-01	5.62e-01
GOBP RENAL PROTEIN ABSORPTION	7	7.84e-01	9.28e-01	0.3450	3.07e-01	-2.85e-02	-8.05e-02	2.94e-02	1.29e-01	1.59e-01	8.96e-01	7.12e-01	8.93e-01	5.56e-01
GOBP RADIAL GLIAL CELL DIFFERENTIATION	14	5.12e-01	8.08e-01	0.3450	1.06e-01	-2.32e-01	-2.05e-01	-9.02e-02	-6.35e-02	4.92e-01	1.33e-01	1.85e-01	5.59e-01	6.81e-01
GOMF ESTROGEN RESPONSE ELEMENT BINDING	10	7.26e-01	9.05e-01	0.3450	-2.13e-01	-2.54e-02	1.88e-01	1.90e-01	-4.27e-02	2.43e-01	8.89e-01	3.03e-01	2.99e-01	8.15e-01
GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION	66	4.09e-03	4.65e-02	0.3450	1.25e-01	-4.55e-02	-2.23e-01	-2.05e-01	9.76e-02	7.95e-02	5.23e-01	1.70e-03	3.93e-03	1.70e-01
GOBP MAMMARY GLAND FORMATION	7	7.48e-01	9.15e-01	0.3450	-5.41e-02	-2.95e-01	-5.05e-02	-1.29e-01	-9.99e-02	8.04e-01	1.76e-01	8.17e-01	5.55e-01	6.47e-01
GOBP NUCLEOTIDE SUGAR METABOLIC PROCESS	37	6.30e-02	2.95e-01	0.3450	1.25e-01	1.16e-02	-2.02e-01	-2.45e-01	-4.80e-02	1.89e-01	9.03e-01	3.32e-02	9.84e-03	6.14e-01
GOMF OXYGEN SENSOR ACTIVITY	5	8.85e-01	9.61e-01	0.3450	-8.30e-02	1.78e-01	1.09e-01	-1.40e-01	2.22e-01	7.48e-01	4.91e-01	6.73e-01	5.89e-01	3.90e-01
GOBP NEGATIVE REGULATION OF RELAXATION OF MUSCLE	7	7.07e-01	8.97e-01	0.3450	-1.69e-01	1.68e-01	3.91e-02	9.49e-02	2.28e-01	4.39e-01	4.42e-01	8.58e-01	6.64e-01	2.97e-01
GOBP ANTERIOR COMMISSURE MORPHOGENESIS	7	7.16e-01	9.01e-01	0.3450	-1.69e-01	7.05e-02	1.33e-01	-2.27e-01	1.28e-01	4.40e-01	7.47e-01	5.44e-01	2.97e-01	5.59e-01
GOMF E BOX BINDING	58	2.70e-03	3.39e-02	0.3450	6.79e-02	4.20e-02	-2.57e-02	-2.59e-01	2.12e-01	3.71e-01	5.80e-01	7.35e-01	6.42e-04	5.28e-03
GOBP REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE	14	3.89e-01	7.25e-01	0.3450	-2.06e-01	2.23e-02	-4.65e-02	-2.58e-01	-8.56e-02	1.83e-01	8.85e-01	7.63e-01	9.43e-02	5.79e-01
GOBP PONS DEVELOPMENT	11	6.10e-01	8.58e-01	0.3450	1.93e-01	1.59e-02	-7.97e-02	-2.68e-01	5.74e-02	2.68e-01	9.27e-01	6.47e-01	1.24e-01	7.42e-01
GOBP OPSONIZATION	16	1.21e-01	4.26e-01	0.3450	-2.12e-01	1.08e-01	-1.10e-01	2.19e-01	4.46e-02	1.41e-01	4.54e-01	4.46e-01	1.29e-01	7.57e-01
GOBP REGULATION OF ATPASE COUPLED CALCIUM TRANSMEMBRANE TRANSPORTER ACTIVITY	6	8.37e-01	9.46e-01	0.3450	-4.05e-02	3.10e-02	1.59e-01	7.78e-02	-2.92e-01	8.64e-01	8.95e-01	5.00e-01	7.41e-01	2.16e-01
GOBP CORNEA DEVELOPMENT IN CAMERA TYPE EYE	12	5.44e-01	8.25e-01	0.3450	2.03e-01	1.31e-01	2.32e-01	8.05e-02	-1.88e-02	2.24e-01	4.31e-01	1.65e-01	6.29e-01	9.10e-01
GOCC PRESYNAPTIC CYTOSOL	12	5.25e-01	8.16e-01	0.3450	-8.08e-02	3.13e-01	7.29e-02	-6.19e-02	-7.15e-02	6.28e-01	6.04e-02	6.62e-01	7.10e-01	6.68e-01
GOCC PSEUDOPODIUM	16	3.36e-01	6.83e-01	0.3450	-9.80e-02	2.71e-01	-1.20e-01	-1.43e-01	3.02e-02	4.97e-01	6.05e-02	4.07e-01	3.22e-01	8.34e-01
GOBP CIRCADIAN SLEEP WAKE CYCLE SLEEP	16	3.52e-01	6.97e-01	0.3450	1.93e-02	2.85e-01	-4.37e-02	-1.72e-01	-7.49e-02	8.94e-01	4.84e-02	7.62e-01	2.33e-01	6.04e-01
GOBP REGULATION OF RECEPTOR CLUSTERING	13	4.90e-01	7.98e-01	0.3450	-4.92e-02	1.92e-01	7.90e-02	-9.16e-02	2.55e-01	7.59e-01	2.31e-01	6.22e-01	5.67e-01	1.12e-01
GOBP INNER MITOCHONDRIAL MEMBRANE ORGANIZATION	36	6.26e-02	2.94e-01	0.3450	8.57e-02	4.57e-02	-1.34e-01	-2.98e-01	4.78e-02	3.74e-01	6.35e-01	1.63e-01	1.95e-03	6.20e-01
GOBP DIACYLGLYCEROL CATABOLIC PROCESS	5	8.82e-01	9.61e-01	0.3450	-1.08e-01	3.00e-01	9.49e-02	6.58e-02	6.05e-02	6.77e-01	2.45e-01	7.13e-01	7.99e-01	8.15e-01
GOBP T HELPER 2 CELL DIFFERENTIATION	19	2.15e-01	5.68e-01	0.3450	-3.70e-03	3.41e-01	1.64e-02	4.38e-02	4.61e-03	9.78e-01	1.00e-02	9.01e-01	7.41e-01	9.72e-01
GOBP NEGATIVE REGULATION OF NUCLEAR DIVISION	63	2.90e-03	3.57e-02	0.3440	1.76e-01	-8.68e-02	-2.08e-01	-1.87e-01	-4.23e-02	1.54e-02	2.33e-01	4.25e-03	1.04e-02	5.62e-01
GOMF PEPTIDE HORMONE RECEPTOR BINDING	19	3.73e-01	7.12e-01	0.3440	3.21e-03	1.70e-01	2.47e-01	1.43e-01	9.08e-02	9.81e-01	1.99e-01	6.21e-02	2.81e-01	4.93e-01
GOCC CYTOPLASMIC DYNEIN COMPLEX	22	2.18e-01	5.73e-01	0.3440	2.38e-01	-8.80e-02	-1.65e-01	-1.47e-01	-7.40e-02	5.38e-02	4.75e-01	1.81e-01	2.31e-01	5.48e-01
GOMF SNRNA BINDING	48	2.58e-02	1.65e-01	0.3440	3.99e-02	-9.42e-02	-2.15e-01	-2.49e-01	1.05e-03	6.33e-01	2.59e-01	1.01e-02	2.85e-03	9.90e-01
GOBP SHORT CHAIN FATTY ACID METABOLIC PROCESS	16	2.05e-01	5.55e-01	0.3440	8.88e-02	2.20e-01	-1.13e-01	5.06e-02	2.16e-01	5.38e-01	1.28e-01	4.32e-01	7.26e-01	1.34e-01
GOBP C TERMINAL PROTEIN LIPIDATION	5	9.00e-01	9.67e-01	0.3440	2.38e-03	1.81e-01	-9.62e-02	-2.76e-01	-1.52e-02	9.93e-01	4.83e-01	7.10e-01	2.85e-01	9.53e-01
GOBP RNA TEMPLATED DNA BIOSYNTHETIC PROCESS	68	2.19e-03	2.88e-02	0.3440	-2.56e-02	-8.37e-02	-1.66e-01	-2.70e-01	1.03e-01	7.15e-01	2.33e-01	1.79e-02	1.21e-04	1.43e-01
GOBP POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY	27	2.06e-01	5.56e-01	0.3440	-6.87e-02	1.12e-01	2.06e-01	1.90e-01	-1.50e-01	5.37e-01	3.12e-01	6.33e-02	8.76e-02	1.78e-01
GOBP SMOOTH MUSCLE CELL APOPTOTIC PROCESS	32	1.39e-02	1.11e-01	0.3440	-1.83e-01	-9.51e-03	-1.41e-01	6.52e-03	2.55e-01	7.30e-02	9.26e-01	1.67e-01	9.49e-01	1.26e-02
GOCC GLYCOGEN GRANULE	7	7.59e-01	9.19e-01	0.3440	1.06e-01	2.52e-01	-1.33e-01	-6.26e-02	1.50e-01	6.27e-01	2.49e-01	5.44e-01	7.74e-01	4.93e-01
GOBP NEUTROPHIL MIGRATION	118	4.71e-07	2.33e-05	0.3440	-1.97e-01	2.10e-01	1.08e-01	1.23e-01	-9.37e-02	2.25e-04	7.97e-05	4.29e-02	2.10e-02	7.87e-02
GOBP POSITIVE REGULATION OF LONG TERM SYNAPTIC DEPRESSION	6	7.54e-01	9.17e-01	0.3440	-6.39e-02	1.43e-01	2.31e-02	3.04e-01	3.05e-02	7.86e-01	5.44e-01	9.22e-01	1.97e-01	8.97e-01
GOBP NEGATIVE REGULATION OF DOPAMINE SECRETION	5	7.89e-01	9.30e-01	0.3440	-4.20e-02	-5.13e-03	-2.43e-02	3.30e-01	8.55e-02	8.71e-01	9.84e-01	9.25e-01	2.02e-01	7.41e-01
GOBP ENDOTHELIAL CELL FATE COMMITMENT	8	7.35e-01	9.09e-01	0.3440	2.41e-01	9.89e-03	4.88e-02	9.25e-02	2.21e-01	2.37e-01	9.61e-01	8.11e-01	6.50e-01	2.78e-01
GOBP CALCIUM ION IMPORT INTO SARCOPLASMIC RETICULUM	5	9.14e-01	9.72e-01	0.3440	5.50e-02	-4.05e-02	-6.99e-02	-2.10e-01	2.54e-01	8.31e-01	8.75e-01	7.87e-01	4.17e-01	3.24e-01
GOBP ALKALOID METABOLIC PROCESS	7	7.60e-01	9.20e-01	0.3440	1.71e-01	-1.50e-01	2.30e-01	1.15e-01	1.44e-02	4.32e-01	4.92e-01	2.91e-01	5.99e-01	9.47e-01
GOBP PROTEIN HETEROTETRAMERIZATION	15	5.59e-01	8.32e-01	0.3440	2.22e-02	-4.24e-02	-2.66e-01	-2.03e-01	6.35e-02	8.82e-01	7.76e-01	7.43e-02	1.74e-01	6.70e-01
GOBP GOLGI RIBBON FORMATION	10	5.46e-01	8.26e-01	0.3440	-2.03e-01	1.11e-01	-2.13e-01	-9.13e-02	1.04e-01	2.67e-01	5.42e-01	2.43e-01	6.17e-01	5.70e-01
GOMF ALDITOL NADPPLUS 1 OXIDOREDUCTASE ACTIVITY	12	5.18e-01	8.12e-01	0.3440	8.28e-02	-1.98e-01	-4.55e-02	2.38e-01	-1.15e-01	6.19e-01	2.34e-01	7.85e-01	1.54e-01	4.89e-01
GOMF SIGNALING RECEPTOR INHIBITOR ACTIVITY	27	7.02e-02	3.15e-01	0.3440	-1.38e-01	1.80e-01	3.61e-02	-1.27e-01	-2.22e-01	2.16e-01	1.06e-01	7.46e-01	2.53e-01	4.57e-02
GOBP RESPONSE TO BLUE LIGHT	6	8.96e-01	9.66e-01	0.3440	-1.67e-01	1.06e-01	2.20e-01	1.75e-01	-1.01e-02	4.79e-01	6.54e-01	3.52e-01	4.57e-01	9.66e-01
GOBP ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY	15	3.38e-01	6.85e-01	0.3440	5.31e-03	2.14e-01	2.54e-01	-8.32e-02	3.06e-02	9.72e-01	1.52e-01	8.87e-02	5.77e-01	8.37e-01
GOBP RESPONSE TO ISOQUINOLINE ALKALOID	11	6.67e-01	8.82e-01	0.3440	-7.39e-02	2.25e-01	2.00e-01	1.42e-01	4.10e-02	6.71e-01	1.96e-01	2.50e-01	4.15e-01	8.14e-01
GOBP REGULATION OF PROTEIN NEDDYLATION	19	3.45e-01	6.92e-01	0.3440	4.59e-02	-7.85e-02	-1.99e-01	-2.40e-01	-1.13e-01	7.29e-01	5.54e-01	1.33e-01	7.04e-02	3.96e-01
GOBP SEMAPHORIN PLEXIN SIGNALING PATHWAY	41	2.44e-02	1.59e-01	0.3440	-2.13e-01	1.38e-01	1.06e-01	1.89e-01	-8.09e-02	1.81e-02	1.27e-01	2.40e-01	3.60e-02	3.70e-01
GOBP S ADENOSYLMETHIONINE CYCLE	7	8.25e-01	9.43e-01	0.3430	6.03e-02	2.18e-01	-3.65e-02	-2.01e-01	1.59e-01	7.82e-01	3.18e-01	8.67e-01	3.58e-01	4.67e-01
GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS POLYSACCHARIDE CHAIN BIOSYNTHETIC PROCESS	8	7.74e-01	9.25e-01	0.3430	-3.55e-02	-1.10e-01	8.00e-02	3.07e-01	-6.06e-02	8.62e-01	5.91e-01	6.95e-01	1.32e-01	7.67e-01
GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC PROTEIN COMPLEX	18	1.63e-01	4.97e-01	0.3430	-2.39e-01	-4.41e-02	9.28e-02	-1.72e-01	-1.44e-01	7.98e-02	7.46e-01	4.95e-01	2.07e-01	2.89e-01
GOBP PYRIMIDINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS	11	5.68e-01	8.37e-01	0.3430	-2.14e-01	1.37e-01	1.96e-01	-5.43e-02	1.09e-01	2.19e-01	4.31e-01	2.60e-01	7.55e-01	5.30e-01
GOMF AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY	80	2.91e-04	5.75e-03	0.3430	-1.32e-01	1.43e-01	2.65e-01	9.17e-02	-3.91e-02	4.16e-02	2.75e-02	4.16e-05	1.56e-01	5.46e-01
GOBP NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION	13	2.46e-01	6.03e-01	0.3430	1.50e-02	-2.24e-01	1.95e-01	-1.42e-01	9.52e-02	9.25e-01	1.62e-01	2.23e-01	3.75e-01	5.52e-01
GOMF UBIQUITIN PROTEIN TRANSFERASE INHIBITOR ACTIVITY	11	5.87e-01	8.45e-01	0.3430	-1.78e-01	6.71e-03	-1.03e-01	-2.58e-01	-9.40e-02	3.06e-01	9.69e-01	5.55e-01	1.39e-01	5.89e-01
GOBP POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS	13	5.25e-01	8.16e-01	0.3430	-5.52e-02	1.77e-01	-1.77e-01	-1.88e-01	1.28e-01	7.31e-01	2.70e-01	2.68e-01	2.40e-01	4.23e-01
GOMF GLUTATHIONE TRANSMEMBRANE TRANSPORTER ACTIVITY	5	9.02e-01	9.68e-01	0.3430	1.80e-03	3.04e-01	1.36e-01	5.22e-02	-6.11e-02	9.94e-01	2.38e-01	5.99e-01	8.40e-01	8.13e-01
GOBP NEGATIVE REGULATION OF DNA BINDING	33	8.85e-02	3.59e-01	0.3430	2.11e-01	1.25e-02	-9.84e-02	-1.54e-01	1.99e-01	3.63e-02	9.01e-01	3.28e-01	1.27e-01	4.74e-02
GOBP MALONYL COA METABOLIC PROCESS	6	8.59e-01	9.53e-01	0.3430	1.09e-01	4.95e-02	3.70e-02	-1.79e-01	2.64e-01	6.43e-01	8.34e-01	8.75e-01	4.49e-01	2.62e-01
GOBP REGULATION OF STRESS GRANULE ASSEMBLY	8	7.35e-01	9.09e-01	0.3430	-1.64e-01	1.82e-01	-1.05e-01	-1.20e-01	-1.79e-01	4.21e-01	3.71e-01	6.07e-01	5.57e-01	3.82e-01
GOMF MAP KINASE KINASE KINASE KINASE ACTIVITY	5	8.99e-01	9.67e-01	0.3430	5.68e-02	1.96e-01	1.23e-01	-5.14e-02	2.41e-01	8.26e-01	4.49e-01	6.33e-01	8.42e-01	3.50e-01
GOBP CELLULAR RESPONSE TO CHOLESTEROL	20	1.72e-01	5.11e-01	0.3430	-8.43e-02	-2.66e-01	1.90e-01	5.50e-02	1.92e-02	5.14e-01	3.94e-02	1.41e-01	6.70e-01	8.82e-01
GOBP REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY	15	4.03e-01	7.36e-01	0.3430	1.05e-01	-1.60e-01	-1.36e-01	5.50e-02	-2.43e-01	4.81e-01	2.84e-01	3.62e-01	7.12e-01	1.03e-01
GOMF NUCLEOTIDE RECEPTOR ACTIVITY	17	3.74e-01	7.13e-01	0.3430	-7.34e-02	2.35e-01	1.98e-01	1.83e-02	1.32e-01	6.01e-01	9.37e-02	1.58e-01	8.96e-01	3.47e-01
GOBP KERATINOCYTE APOPTOTIC PROCESS	7	8.44e-01	9.49e-01	0.3430	6.04e-02	-1.64e-01	-2.25e-01	-1.13e-01	1.52e-01	7.82e-01	4.52e-01	3.02e-01	6.06e-01	4.85e-01
GOMF OXIDIZED DNA BINDING	11	6.66e-01	8.82e-01	0.3420	-1.98e-02	9.61e-02	-2.51e-01	-1.98e-01	7.34e-02	9.10e-01	5.81e-01	1.49e-01	2.55e-01	6.73e-01
GOMF PROTEIN PHOSPHATASE 2B BINDING	6	7.69e-01	9.24e-01	0.3420	-3.68e-02	-1.41e-01	-1.92e-01	4.79e-02	2.38e-01	8.76e-01	5.50e-01	4.14e-01	8.39e-01	3.12e-01
GOBP DRINKING BEHAVIOR	8	7.06e-01	8.97e-01	0.3420	2.42e-01	1.99e-01	5.57e-02	-5.13e-02	-1.15e-01	2.35e-01	3.30e-01	7.85e-01	8.02e-01	5.74e-01
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME	7	6.61e-01	8.81e-01	0.3420	6.50e-02	1.91e-01	1.75e-01	-1.83e-01	-1.12e-01	7.66e-01	3.81e-01	4.23e-01	4.03e-01	6.08e-01
GOMF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY	27	2.17e-01	5.72e-01	0.3420	8.01e-02	-8.67e-02	-2.43e-01	-2.08e-01	-2.68e-02	4.71e-01	4.36e-01	2.88e-02	6.12e-02	8.10e-01
GOMF TORC2 COMPLEX BINDING	5	8.13e-01	9.39e-01	0.3420	-9.87e-02	7.16e-02	-3.18e-01	-1.84e-02	2.71e-02	7.02e-01	7.81e-01	2.18e-01	9.43e-01	9.17e-01
GOBP POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS	11	5.72e-01	8.38e-01	0.3420	1.20e-01	-2.46e-01	8.02e-02	1.18e-01	1.48e-01	4.91e-01	1.58e-01	6.45e-01	4.97e-01	3.96e-01
GOBP CRANIAL GANGLION DEVELOPMENT	5	8.35e-01	9.46e-01	0.3420	2.35e-01	8.52e-02	1.77e-01	-9.00e-03	-1.51e-01	3.62e-01	7.41e-01	4.93e-01	9.72e-01	5.58e-01
GOBP T CELL EXTRAVASATION	10	6.02e-01	8.54e-01	0.3420	-2.50e-01	2.59e-02	7.18e-03	-1.23e-01	-1.97e-01	1.71e-01	8.87e-01	9.69e-01	5.02e-01	2.81e-01
GOMF CALCIUM INDEPENDENT PHOSPHOLIPASE A2 ACTIVITY	9	7.67e-01	9.23e-01	0.3420	-8.97e-03	1.35e-01	2.92e-01	1.15e-01	9.56e-03	9.63e-01	4.83e-01	1.29e-01	5.50e-01	9.60e-01
GOMF TELOMERASE RNA BINDING	21	3.40e-01	6.87e-01	0.3420	1.75e-02	-1.78e-01	-1.95e-01	-2.01e-01	8.09e-02	8.89e-01	1.57e-01	1.22e-01	1.11e-01	5.21e-01
GOMF LIM DOMAIN BINDING	5	8.78e-01	9.60e-01	0.3420	2.99e-01	-2.14e-02	-1.51e-01	3.88e-02	5.42e-02	2.48e-01	9.34e-01	5.59e-01	8.81e-01	8.34e-01
GOMF UBIQUITIN LIGASE INHIBITOR ACTIVITY	8	6.97e-01	8.94e-01	0.3420	-2.30e-01	9.45e-02	1.58e-02	-1.87e-01	-1.40e-01	2.59e-01	6.44e-01	9.39e-01	3.60e-01	4.94e-01
GOMF ENOYL COA HYDRATASE ACTIVITY	11	6.22e-01	8.65e-01	0.3420	8.55e-02	1.69e-01	-2.21e-01	-1.50e-01	-9.74e-02	6.24e-01	3.31e-01	2.05e-01	3.89e-01	5.76e-01
GOCC COPI COATED VESICLE MEMBRANE	18	3.62e-01	7.04e-01	0.3420	1.75e-01	1.05e-01	-1.01e-01	-2.53e-01	3.29e-02	1.99e-01	4.41e-01	4.57e-01	6.35e-02	8.09e-01
GOBP SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL SIGNALING	9	7.41e-01	9.12e-01	0.3420	1.42e-01	2.04e-01	1.89e-01	1.20e-01	-7.00e-02	4.62e-01	2.90e-01	3.26e-01	5.32e-01	7.16e-01
GOBP NEGATIVE REGULATION OF DNA RECOMBINATION	45	3.15e-02	1.89e-01	0.3420	-6.24e-02	-5.82e-02	-2.72e-01	-1.86e-01	2.95e-02	4.69e-01	4.99e-01	1.61e-03	3.07e-02	7.32e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO CHROMATIN	10	7.19e-01	9.02e-01	0.3410	1.00e-02	-1.51e-01	-1.27e-01	-2.02e-01	1.92e-01	9.56e-01	4.09e-01	4.88e-01	2.69e-01	2.92e-01
GOBP REGULATION OF ADIPOSE TISSUE DEVELOPMENT	16	3.64e-01	7.05e-01	0.3410	-1.83e-01	1.59e-01	1.56e-01	-3.03e-02	1.80e-01	2.06e-01	2.70e-01	2.80e-01	8.34e-01	2.11e-01
GOBP CELLULAR RESPONSE TO NITROSATIVE STRESS	6	8.15e-01	9.40e-01	0.3410	4.88e-02	7.53e-02	8.11e-02	2.01e-02	-3.19e-01	8.36e-01	7.49e-01	7.31e-01	9.32e-01	1.76e-01
GOBP POSITIVE REGULATION OF CAMP MEDIATED SIGNALING	15	4.33e-01	7.57e-01	0.3410	-1.70e-01	1.03e-01	2.74e-01	3.71e-02	-2.66e-02	2.54e-01	4.90e-01	6.65e-02	8.04e-01	8.59e-01
GOBP I KAPPAB PHOSPHORYLATION	15	5.02e-01	8.03e-01	0.3410	-5.91e-02	-9.41e-03	2.27e-01	2.02e-01	1.43e-01	6.92e-01	9.50e-01	1.28e-01	1.76e-01	3.36e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H OXYGEN AS ACCEPTOR	12	5.59e-01	8.32e-01	0.3410	9.49e-02	2.78e-01	9.44e-02	2.55e-02	1.43e-01	5.69e-01	9.51e-02	5.71e-01	8.78e-01	3.91e-01
GOBP AMIDE CATABOLIC PROCESS	20	2.73e-01	6.28e-01	0.3410	-2.00e-01	-2.01e-01	6.00e-02	1.78e-01	-2.78e-02	1.22e-01	1.19e-01	6.42e-01	1.69e-01	8.29e-01
GOBP CELLULAR RESPONSE TO ANTIBIOTIC	11	5.86e-01	8.45e-01	0.3410	1.61e-01	2.50e-01	-1.05e-01	-1.01e-01	-8.25e-02	3.55e-01	1.51e-01	5.46e-01	5.62e-01	6.36e-01
GOBP REGULATION OF RELAXATION OF CARDIAC MUSCLE	6	8.06e-01	9.36e-01	0.3410	-1.06e-01	-4.73e-02	2.28e-01	-6.22e-02	2.17e-01	6.52e-01	8.41e-01	3.33e-01	7.92e-01	3.58e-01
GOBP QUATERNARY AMMONIUM GROUP TRANSPORT	29	1.24e-01	4.32e-01	0.3410	1.82e-01	1.41e-01	1.90e-01	1.50e-01	7.09e-02	9.00e-02	1.89e-01	7.69e-02	1.63e-01	5.09e-01
GOMF LEUCINE ZIPPER DOMAIN BINDING	11	6.55e-01	8.80e-01	0.3410	-6.98e-02	-1.76e-01	-1.23e-01	-2.20e-01	1.31e-01	6.88e-01	3.13e-01	4.82e-01	2.06e-01	4.52e-01
GOBP REGULATION OF PHOSPHOLIPID METABOLIC PROCESS	32	4.61e-02	2.40e-01	0.3410	-1.37e-01	2.87e-01	3.26e-02	-6.52e-02	1.00e-01	1.81e-01	4.98e-03	7.49e-01	5.23e-01	3.26e-01
GOMF UBIQUITIN UBIQUITIN LIGASE ACTIVITY	14	4.62e-01	7.78e-01	0.3410	-5.64e-02	1.16e-01	1.63e-02	-2.53e-01	1.88e-01	7.15e-01	4.53e-01	9.16e-01	1.01e-01	2.23e-01
GOBP DETERMINATION OF DIGESTIVE TRACT LEFT RIGHT ASYMMETRY	6	8.61e-01	9.53e-01	0.3410	-8.81e-02	-5.28e-02	-1.37e-01	-2.87e-01	-6.71e-02	7.09e-01	8.23e-01	5.62e-01	2.23e-01	7.76e-01
GOCC BASAL CORTEX	5	9.25e-01	9.75e-01	0.3410	1.36e-01	7.68e-02	2.24e-01	2.04e-01	-1.56e-02	5.99e-01	7.66e-01	3.85e-01	4.30e-01	9.52e-01
GOBP EYELID DEVELOPMENT IN CAMERA TYPE EYE	13	4.04e-01	7.37e-01	0.3410	7.30e-02	2.10e-01	1.52e-01	-1.99e-01	6.25e-02	6.48e-01	1.90e-01	3.42e-01	2.13e-01	6.96e-01
GOMF DOPAMINE RECEPTOR BINDING	14	4.26e-01	7.52e-01	0.3410	-2.25e-01	1.42e-01	3.08e-02	-1.65e-01	1.32e-01	1.45e-01	3.58e-01	8.42e-01	2.85e-01	3.93e-01
GOBP REGULATION OF MICROGLIAL CELL ACTIVATION	20	2.47e-01	6.04e-01	0.3410	-2.66e-01	-5.28e-02	2.00e-01	4.69e-02	2.85e-02	3.97e-02	6.83e-01	1.22e-01	7.17e-01	8.26e-01
GOMF EXONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 5 PHOSPHOMONOESTERS	58	1.13e-02	9.57e-02	0.3410	4.45e-02	-2.98e-02	-2.08e-01	-2.62e-01	3.62e-02	5.57e-01	6.95e-01	6.07e-03	5.55e-04	6.33e-01
GOBP NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION	8	7.80e-01	9.28e-01	0.3410	-2.81e-02	-2.45e-01	-1.13e-01	-1.68e-01	1.20e-01	8.90e-01	2.30e-01	5.81e-01	4.10e-01	5.56e-01
GOCC MATRIX SIDE OF MITOCHONDRIAL INNER MEMBRANE	6	8.44e-01	9.49e-01	0.3410	-1.31e-03	2.69e-01	-1.51e-01	-1.43e-01	2.50e-02	9.96e-01	2.54e-01	5.22e-01	5.44e-01	9.15e-01
GOBP POSITIVE REGULATION OF BASEMENT MEMBRANE ASSEMBLY INVOLVED IN EMBRYONIC BODY MORPHOGENESIS	5	9.22e-01	9.74e-01	0.3410	1.34e-01	1.12e-01	2.05e-01	1.91e-01	-8.43e-02	6.03e-01	6.64e-01	4.27e-01	4.60e-01	7.44e-01
GOBP REGULATION OF GLUCOCORTICOID BIOSYNTHETIC PROCESS	9	7.69e-01	9.24e-01	0.3410	-1.92e-01	9.40e-02	2.38e-01	1.17e-01	-5.02e-04	3.18e-01	6.25e-01	2.16e-01	5.42e-01	9.98e-01
GOBP SULFUR COMPOUND CATABOLIC PROCESS	35	6.23e-02	2.94e-01	0.3410	2.18e-01	7.53e-02	-9.41e-02	-1.10e-01	2.04e-01	2.54e-02	4.41e-01	3.35e-01	2.60e-01	3.63e-02
GOBP ENDOTHELIAL CELL ACTIVATION	11	5.44e-01	8.25e-01	0.3410	3.17e-01	8.68e-03	1.20e-01	1.15e-02	3.18e-02	6.86e-02	9.60e-01	4.92e-01	9.47e-01	8.55e-01
GOBP KYNURENINE METABOLIC PROCESS	11	5.78e-01	8.42e-01	0.3410	-8.49e-02	-9.10e-02	3.04e-02	3.11e-01	-5.47e-02	6.26e-01	6.01e-01	8.62e-01	7.42e-02	7.53e-01
GOBP LIPID PHOSPHORYLATION	10	6.39e-01	8.73e-01	0.3410	4.47e-02	-1.05e-01	3.82e-02	-2.55e-02	3.17e-01	8.07e-01	5.64e-01	8.34e-01	8.89e-01	8.21e-02
GOMF ATP DEPENDENT DIACYLGLYCEROL KINASE ACTIVITY	10	6.39e-01	8.73e-01	0.3410	4.47e-02	-1.05e-01	3.82e-02	-2.55e-02	3.17e-01	8.07e-01	5.64e-01	8.34e-01	8.89e-01	8.21e-02
GOBP REGULATION OF PHAGOCYTOSIS	94	3.44e-06	1.30e-04	0.3410	-2.88e-01	1.61e-01	4.85e-02	-5.32e-02	4.70e-02	1.44e-06	6.99e-03	4.16e-01	3.72e-01	4.31e-01
GOBP REGULATION OF MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION	5	8.87e-01	9.62e-01	0.3410	2.24e-01	2.35e-01	3.02e-03	-9.65e-02	-3.97e-02	3.87e-01	3.63e-01	9.91e-01	7.09e-01	8.78e-01
GOMF ENDONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 5 PHOSPHOMONOESTERS	37	8.68e-02	3.56e-01	0.3410	1.44e-01	-4.85e-02	-2.35e-01	-1.94e-01	1.58e-02	1.30e-01	6.10e-01	1.36e-02	4.09e-02	8.68e-01
GOBP GLYCEROL 3 PHOSPHATE METABOLIC PROCESS	6	7.39e-01	9.11e-01	0.3410	9.38e-02	1.02e-01	2.37e-01	-1.80e-01	8.86e-02	6.91e-01	6.64e-01	3.14e-01	4.45e-01	7.07e-01
GOBP REGULATION OF CORTICOSTEROID HORMONE SECRETION	16	3.80e-01	7.18e-01	0.3410	2.78e-02	2.37e-01	1.97e-01	2.46e-02	-1.40e-01	8.47e-01	1.01e-01	1.72e-01	8.65e-01	3.32e-01
GOMF POTASSIUM CHANNEL ACTIVATOR ACTIVITY	5	8.39e-01	9.47e-01	0.3400	-1.19e-01	8.67e-02	1.45e-01	-8.51e-02	-2.57e-01	6.45e-01	7.37e-01	5.74e-01	7.42e-01	3.20e-01
GOBP PROTEIN K11 LINKED UBIQUITINATION	28	1.93e-01	5.39e-01	0.3400	1.29e-01	-1.58e-02	-1.51e-01	-2.49e-01	1.19e-01	2.36e-01	8.85e-01	1.66e-01	2.28e-02	2.75e-01
GOBP POSITIVE REGULATION OF CORTICOSTEROID HORMONE SECRETION	7	7.52e-01	9.16e-01	0.3400	3.01e-01	-3.88e-02	-2.27e-02	-1.47e-01	-3.96e-02	1.67e-01	8.59e-01	9.17e-01	5.02e-01	8.56e-01
GOBP REGULATION OF GLUTAMATE SECRETION NEUROTRANSMISSION	5	9.18e-01	9.74e-01	0.3400	1.34e-01	1.29e-01	1.57e-01	2.30e-01	-5.88e-02	6.03e-01	6.17e-01	5.42e-01	3.73e-01	8.20e-01
GOBP POSITIVE REGULATION OF UTERINE SMOOTH MUSCLE CONTRACTION	7	7.35e-01	9.09e-01	0.3400	-8.46e-02	2.06e-01	1.61e-01	-1.09e-01	-1.68e-01	6.98e-01	3.44e-01	4.60e-01	6.17e-01	4.43e-01
GOBP REGULATION OF HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS	7	7.79e-01	9.28e-01	0.3400	2.83e-01	-3.95e-02	-7.91e-02	-1.52e-01	-6.77e-02	1.94e-01	8.56e-01	7.17e-01	4.86e-01	7.57e-01
GOMF CALCIUM SODIUM ANTIPORTER ACTIVITY	10	5.55e-01	8.30e-01	0.3400	-1.04e-01	1.66e-01	2.24e-02	2.72e-01	-5.38e-02	5.70e-01	3.63e-01	9.03e-01	1.36e-01	7.68e-01
GOBP PROTEIN IMPORT INTO PEROXISOME MEMBRANE	6	7.64e-01	9.22e-01	0.3400	9.70e-02	1.47e-01	3.00e-02	-2.12e-01	-1.97e-01	6.81e-01	5.34e-01	8.99e-01	3.68e-01	4.03e-01
GOBP REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL	38	1.05e-02	9.10e-02	0.3400	-2.27e-01	5.77e-02	2.30e-01	-8.87e-02	1.22e-02	1.54e-02	5.38e-01	1.43e-02	3.44e-01	8.96e-01
GOCC CONTRACTILE RING	10	6.83e-01	8.88e-01	0.3400	1.89e-01	1.81e-01	-1.21e-01	-1.79e-01	-2.62e-02	3.01e-01	3.21e-01	5.08e-01	3.28e-01	8.86e-01
GOMF AROMATIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY	8	6.55e-01	8.80e-01	0.3400	-1.36e-01	-2.57e-01	1.90e-02	-1.38e-01	-1.09e-01	5.04e-01	2.09e-01	9.26e-01	4.99e-01	5.94e-01
GOMF CUPROUS ION BINDING	8	8.23e-01	9.42e-01	0.3400	-3.08e-02	-1.99e-01	-2.22e-01	-1.52e-01	4.83e-02	8.80e-01	3.29e-01	2.76e-01	4.55e-01	8.13e-01
GOBP RESPONSE TO INTERLEUKIN 15	11	5.51e-01	8.28e-01	0.3400	-1.33e-02	2.69e-02	-1.04e-01	-2.48e-01	-2.06e-01	9.39e-01	8.77e-01	5.52e-01	1.54e-01	2.37e-01
GOBP NEGATIVE REGULATION OF CELL DIVISION	17	4.71e-01	7.86e-01	0.3400	-7.52e-02	-6.59e-02	-1.96e-01	-2.29e-01	1.21e-01	5.92e-01	6.38e-01	1.61e-01	1.02e-01	3.90e-01
GOBP CRISTAE FORMATION	15	4.95e-01	8.00e-01	0.3400	7.10e-02	4.06e-02	-1.43e-01	-2.97e-01	-1.04e-02	6.34e-01	7.86e-01	3.37e-01	4.64e-02	9.45e-01
GOBP DOSAGE COMPENSATION	27	1.82e-01	5.24e-01	0.3400	2.11e-01	-1.98e-02	-1.24e-01	-1.55e-01	1.76e-01	5.71e-02	8.58e-01	2.63e-01	1.63e-01	1.14e-01
GOBP POSITIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS	10	5.95e-01	8.49e-01	0.3400	8.28e-02	4.41e-02	2.56e-01	-5.24e-02	1.96e-01	6.50e-01	8.09e-01	1.61e-01	7.74e-01	2.83e-01
GOBP RENAL SODIUM ION ABSORPTION	12	4.87e-01	7.96e-01	0.3400	7.52e-04	2.90e-01	5.55e-02	1.67e-01	2.15e-02	9.96e-01	8.17e-02	7.39e-01	3.18e-01	8.97e-01
GOBP RESPONSE TO X RAY	28	1.98e-01	5.47e-01	0.3400	1.69e-01	9.87e-03	-1.88e-01	-2.08e-01	8.95e-02	1.21e-01	9.28e-01	8.53e-02	5.64e-02	4.12e-01
GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE	19	4.15e-01	7.45e-01	0.3400	7.63e-02	8.34e-02	-2.03e-01	-2.47e-01	2.43e-02	5.65e-01	5.29e-01	1.26e-01	6.25e-02	8.54e-01
GOBP BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS	13	4.78e-01	7.91e-01	0.3400	-1.91e-01	1.52e-01	9.50e-02	-8.99e-02	1.97e-01	2.34e-01	3.42e-01	5.53e-01	5.75e-01	2.19e-01
GOBP RETINOIC ACID METABOLIC PROCESS	33	4.53e-02	2.37e-01	0.3400	-6.79e-02	3.34e-02	1.82e-02	2.97e-01	-1.45e-01	4.99e-01	7.40e-01	8.56e-01	3.13e-03	1.50e-01
GOMF ATP GATED ION CHANNEL ACTIVITY	9	6.93e-01	8.93e-01	0.3400	-3.05e-02	1.82e-01	2.46e-01	-5.28e-02	1.34e-01	8.74e-01	3.44e-01	2.01e-01	7.84e-01	4.86e-01
GOBP NEGATIVE REGULATION OF GLUTAMATE SECRETION	6	6.29e-01	8.69e-01	0.3400	-1.41e-02	-4.20e-02	-1.87e-01	2.63e-01	9.68e-02	9.52e-01	8.59e-01	4.28e-01	2.65e-01	6.81e-01
GOBP ADP TRANSPORT	10	7.02e-01	8.96e-01	0.3400	2.03e-01	1.04e-01	-1.29e-01	-2.15e-01	-5.84e-03	2.65e-01	5.67e-01	4.81e-01	2.38e-01	9.75e-01
GOBP T HELPER 17 CELL DIFFERENTIATION	32	5.30e-02	2.65e-01	0.3390	-1.18e-01	2.82e-01	3.56e-02	-5.50e-02	-1.31e-01	2.47e-01	5.71e-03	7.28e-01	5.90e-01	1.98e-01
GOBP PHAGOCYTOSIS ENGULFMENT	46	2.61e-02	1.66e-01	0.3390	-1.17e-01	1.73e-02	2.64e-01	1.57e-01	8.30e-02	1.70e-01	8.39e-01	1.94e-03	6.55e-02	3.30e-01
GOCC VARICOSITY	8	7.68e-01	9.24e-01	0.3390	1.87e-01	1.53e-01	2.01e-01	1.92e-02	1.27e-01	3.61e-01	4.52e-01	3.25e-01	9.25e-01	5.35e-01
GOBP GAMMA DELTA T CELL DIFFERENTIATION	13	4.06e-01	7.39e-01	0.3390	1.25e-01	1.92e-01	2.19e-01	-4.00e-02	-1.16e-01	4.35e-01	2.32e-01	1.72e-01	8.03e-01	4.69e-01
GOBP POSITIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	8	8.11e-01	9.38e-01	0.3390	1.04e-01	5.24e-02	1.43e-01	2.56e-01	-1.26e-01	6.12e-01	7.98e-01	4.85e-01	2.10e-01	5.37e-01
GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS	17	1.70e-01	5.09e-01	0.3390	-8.17e-02	6.12e-02	-1.91e-01	1.17e-03	2.61e-01	5.60e-01	6.62e-01	1.73e-01	9.93e-01	6.20e-02
GOBP SHORT TERM MEMORY	10	6.42e-01	8.75e-01	0.3390	-2.65e-01	1.85e-01	5.14e-02	-2.66e-02	-8.46e-02	1.46e-01	3.12e-01	7.78e-01	8.84e-01	6.43e-01
GOBP POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS	18	2.04e-01	5.53e-01	0.3390	2.11e-01	6.30e-02	-2.11e-01	3.32e-02	1.45e-01	1.21e-01	6.43e-01	1.22e-01	8.08e-01	2.87e-01
GOCC RNA POLYMERASE II HOLOENZYME	67	2.60e-03	3.29e-02	0.3390	1.80e-01	-1.23e-01	-1.72e-01	-1.81e-01	6.97e-02	1.09e-02	8.11e-02	1.47e-02	1.03e-02	3.24e-01
GOBP CELL MIGRATION INVOLVED IN KIDNEY DEVELOPMENT	6	7.33e-01	9.08e-01	0.3390	9.77e-02	5.98e-02	-2.62e-01	3.89e-02	1.77e-01	6.79e-01	8.00e-01	2.66e-01	8.69e-01	4.52e-01
GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY	21	1.74e-01	5.14e-01	0.3390	-1.63e-01	-1.92e-01	8.97e-02	5.81e-03	-2.08e-01	1.95e-01	1.27e-01	4.77e-01	9.63e-01	9.95e-02
GOCC ACTIVIN RECEPTOR COMPLEX	6	8.30e-01	9.44e-01	0.3390	1.54e-01	7.37e-02	1.13e-01	-1.85e-01	1.97e-01	5.14e-01	7.55e-01	6.33e-01	4.33e-01	4.02e-01
GOBP REGULATION OF VESICLE SIZE	19	3.15e-01	6.65e-01	0.3390	9.52e-02	1.37e-01	-1.82e-01	-1.38e-01	1.87e-01	4.72e-01	3.02e-01	1.70e-01	2.99e-01	1.58e-01
GOMF ATP TRANSMEMBRANE TRANSPORTER ACTIVITY	11	6.32e-01	8.70e-01	0.3390	2.28e-01	8.16e-02	-1.09e-01	-2.09e-01	-2.65e-02	1.91e-01	6.39e-01	5.30e-01	2.30e-01	8.79e-01
GOBP FATTY ACID DERIVATIVE CATABOLIC PROCESS	16	3.80e-01	7.18e-01	0.3390	1.24e-01	2.95e-01	-4.83e-02	-8.79e-02	4.48e-02	3.89e-01	4.08e-02	7.38e-01	5.43e-01	7.56e-01
GOCC SECONDARY LYSOSOME	16	3.29e-01	6.77e-01	0.3390	5.80e-02	2.38e-01	1.93e-01	-1.18e-01	5.64e-02	6.88e-01	9.87e-02	1.81e-01	4.12e-01	6.96e-01
GOBP POSITIVE REGULATION OF KIDNEY DEVELOPMENT	9	7.10e-01	8.99e-01	0.3390	-1.78e-01	9.85e-03	-1.19e-01	-2.23e-01	-1.38e-01	3.55e-01	9.59e-01	5.37e-01	2.47e-01	4.73e-01
GOBP MRNA PROCESSING	449	7.30e-23	1.97e-20	0.3390	5.99e-02	-4.29e-02	-1.79e-01	-2.69e-01	6.82e-02	2.97e-02	1.19e-01	6.99e-11	1.31e-22	1.32e-02
GOBP POSITIVE REGULATION OF CELLULAR SENESCENCE	17	3.65e-01	7.05e-01	0.3390	-6.52e-03	1.11e-01	1.67e-01	5.34e-02	2.67e-01	9.63e-01	4.27e-01	2.33e-01	7.03e-01	5.63e-02
GOBP PROTEIN DEUBIQUITINATION INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS	5	8.65e-01	9.55e-01	0.3380	8.21e-05	-1.19e-03	-3.98e-03	3.26e-01	-9.25e-02	1.00e+00	9.96e-01	9.88e-01	2.07e-01	7.20e-01
GOBP NADPH REGENERATION	21	2.22e-01	5.76e-01	0.3380	7.55e-02	2.17e-01	-2.01e-01	-1.28e-01	7.15e-02	5.49e-01	8.57e-02	1.10e-01	3.11e-01	5.70e-01
GOMF 5 DEOXYRIBOSE 5 PHOSPHATE LYASE ACTIVITY	6	8.46e-01	9.49e-01	0.3380	9.88e-02	-1.13e-01	-2.98e-01	-5.20e-03	-5.78e-02	6.75e-01	6.32e-01	2.06e-01	9.82e-01	8.06e-01
GOBP PROTEIN LOCALIZATION TO PERINUCLEAR REGION OF CYTOPLASM	9	7.25e-01	9.04e-01	0.3380	6.49e-02	7.55e-02	-1.35e-02	-9.94e-02	3.08e-01	7.36e-01	6.95e-01	9.44e-01	6.05e-01	1.10e-01
GOBP TERPENOID BIOSYNTHETIC PROCESS	16	2.96e-01	6.50e-01	0.3380	1.03e-01	-1.12e-01	-1.45e-01	2.10e-01	-1.62e-01	4.74e-01	4.39e-01	3.14e-01	1.46e-01	2.62e-01
GOBP BLASTOCYST FORMATION	45	2.26e-02	1.52e-01	0.3380	8.56e-02	-6.46e-02	-9.95e-02	-2.78e-01	1.26e-01	3.21e-01	4.54e-01	2.48e-01	1.25e-03	1.44e-01
GOBP POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT	32	1.97e-02	1.39e-01	0.3380	-8.84e-02	1.03e-01	3.27e-02	-2.98e-01	-7.88e-02	3.87e-01	3.14e-01	7.49e-01	3.53e-03	4.40e-01
GOBP TRANSLATIONAL INITIATION	110	3.41e-05	9.66e-04	0.3380	1.03e-02	4.07e-03	-2.62e-01	-2.14e-01	-3.75e-03	8.52e-01	9.41e-01	2.09e-06	1.05e-04	9.46e-01
GOBP PHOTOTRANSDUCTION VISIBLE LIGHT	18	4.20e-01	7.48e-01	0.3380	3.70e-02	1.64e-01	1.87e-01	2.25e-01	1.63e-02	7.86e-01	2.27e-01	1.69e-01	9.84e-02	9.05e-01
GOMF CYCLOSPORIN A BINDING	17	4.28e-01	7.54e-01	0.3380	1.15e-01	-1.33e-01	-1.37e-01	-2.47e-01	6.16e-02	4.10e-01	3.42e-01	3.28e-01	7.83e-02	6.60e-01
GOBP INTERFERON BETA PRODUCTION	56	1.18e-02	9.80e-02	0.3380	8.33e-02	7.28e-02	-2.38e-01	-2.11e-01	3.07e-02	2.81e-01	3.46e-01	2.08e-03	6.21e-03	6.91e-01
GOBP POSITIVE REGULATION OF GLOMERULAR MESANGIAL CELL PROLIFERATION	7	7.91e-01	9.31e-01	0.3380	-2.53e-01	-1.67e-01	-7.28e-02	1.16e-01	-6.04e-02	2.46e-01	4.44e-01	7.39e-01	5.95e-01	7.82e-01
GOBP POSITIVE REGULATION OF HISTONE METHYLATION	14	4.74e-01	7.87e-01	0.3380	2.46e-01	1.28e-01	-8.67e-02	-4.00e-02	1.69e-01	1.11e-01	4.06e-01	5.75e-01	7.96e-01	2.75e-01
GOBP BLASTOCYST GROWTH	21	3.67e-01	7.07e-01	0.3380	-5.14e-02	-4.40e-02	-2.40e-01	-2.16e-01	7.32e-02	6.83e-01	7.27e-01	5.68e-02	8.71e-02	5.62e-01
GOBP ISOPRENOID CATABOLIC PROCESS	10	6.24e-01	8.66e-01	0.3380	1.43e-01	1.02e-01	-1.48e-01	-4.72e-02	2.43e-01	4.34e-01	5.78e-01	4.19e-01	7.96e-01	1.83e-01
GOMF DEAD H BOX RNA HELICASE BINDING	8	7.43e-01	9.13e-01	0.3380	7.01e-02	2.83e-01	5.06e-02	1.39e-01	-8.55e-02	7.32e-01	1.66e-01	8.04e-01	4.95e-01	6.75e-01
GOMF DNA HELICASE ACTIVITY	57	1.20e-02	9.96e-02	0.3380	1.19e-02	-8.62e-02	-2.23e-01	-2.36e-01	-3.13e-02	8.77e-01	2.60e-01	3.65e-03	2.01e-03	6.83e-01
GOMF SODIUM PROTON ANTIPORTER ACTIVITY	13	4.01e-01	7.34e-01	0.3380	-1.46e-01	1.69e-01	1.78e-01	-1.76e-01	3.52e-02	3.62e-01	2.91e-01	2.67e-01	2.71e-01	8.26e-01
GOBP DETERMINATION OF DORSAL VENTRAL ASYMMETRY	11	4.50e-01	7.71e-01	0.3380	-7.98e-02	-7.37e-02	6.92e-02	-2.94e-01	1.05e-01	6.47e-01	6.72e-01	6.91e-01	9.13e-02	5.48e-01
GOBP MESENCHYMAL EPITHELIAL CELL SIGNALING	7	8.61e-01	9.53e-01	0.3370	-9.37e-02	1.88e-01	2.26e-01	1.15e-01	-7.30e-02	6.68e-01	3.89e-01	3.00e-01	5.99e-01	7.38e-01
GOBP EMBRYONIC EYE MORPHOGENESIS	35	4.02e-02	2.21e-01	0.3370	2.50e-01	2.73e-02	7.88e-02	-1.01e-01	1.86e-01	1.06e-02	7.80e-01	4.20e-01	3.03e-01	5.74e-02
GOCC SEX CHROMATIN	6	8.65e-01	9.55e-01	0.3370	1.09e-01	1.16e-01	-1.18e-01	-2.64e-01	-7.11e-02	6.45e-01	6.23e-01	6.17e-01	2.63e-01	7.63e-01
GOBP TELOMERE LOCALIZATION	12	4.97e-01	8.02e-01	0.3370	-5.79e-02	-2.51e-01	4.84e-02	-9.72e-02	1.89e-01	7.29e-01	1.33e-01	7.72e-01	5.60e-01	2.57e-01
GOMF GDP DISSOCIATION INHIBITOR ACTIVITY	14	4.24e-01	7.51e-01	0.3370	-1.80e-01	2.02e-01	6.82e-02	-1.86e-01	3.69e-02	2.44e-01	1.92e-01	6.58e-01	2.28e-01	8.11e-01
GOBP MUCOSA ASSOCIATED LYMPHOID TISSUE DEVELOPMENT	8	6.74e-01	8.85e-01	0.3370	-4.44e-02	9.44e-02	3.18e-01	-4.24e-02	1.17e-02	8.28e-01	6.44e-01	1.20e-01	8.35e-01	9.54e-01
GOBP COPPER ION TRANSPORT	15	4.21e-01	7.48e-01	0.3370	-6.63e-02	1.37e-01	3.85e-02	-2.38e-01	1.80e-01	6.57e-01	3.58e-01	7.96e-01	1.10e-01	2.29e-01
GOBP SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING	13	5.46e-01	8.26e-01	0.3370	-1.40e-01	2.48e-02	-8.14e-02	-2.79e-01	9.45e-02	3.82e-01	8.77e-01	6.12e-01	8.16e-02	5.55e-01
GOBP AROMATIC AMINO ACID METABOLIC PROCESS	31	1.20e-01	4.25e-01	0.3370	-1.54e-01	1.50e-01	1.21e-01	1.76e-01	-1.47e-01	1.38e-01	1.49e-01	2.43e-01	8.92e-02	1.56e-01
GOBP URINARY BLADDER SMOOTH MUSCLE CONTRACTION	7	5.85e-01	8.45e-01	0.3370	1.65e-02	1.36e-02	-2.88e-01	1.70e-01	-3.18e-02	9.40e-01	9.50e-01	1.86e-01	4.36e-01	8.84e-01
GOBP REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY	10	6.44e-01	8.75e-01	0.3370	1.62e-02	9.05e-02	1.49e-01	-1.25e-01	2.59e-01	9.29e-01	6.20e-01	4.14e-01	4.93e-01	1.56e-01
GOBP PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS	10	6.24e-01	8.66e-01	0.3370	-1.63e-01	1.86e-01	2.80e-02	-2.25e-01	2.80e-02	3.72e-01	3.07e-01	8.78e-01	2.18e-01	8.78e-01
GOBP REGULATION OF MONOCYTE CHEMOTAXIS	27	1.56e-01	4.84e-01	0.3370	-1.89e-01	2.09e-01	1.62e-01	7.86e-02	-4.34e-02	8.90e-02	6.05e-02	1.46e-01	4.80e-01	6.97e-01
GOBP DIACYLGLYCEROL BIOSYNTHETIC PROCESS	9	6.79e-01	8.87e-01	0.3370	-1.71e-01	1.62e-01	1.26e-01	-1.43e-01	1.47e-01	3.74e-01	4.00e-01	5.13e-01	4.59e-01	4.44e-01
GOCC TORC2 COMPLEX	9	7.27e-01	9.05e-01	0.3370	6.65e-03	2.08e-01	4.07e-02	-1.75e-01	1.94e-01	9.72e-01	2.79e-01	8.33e-01	3.63e-01	3.13e-01
GOBP REGULATION OF PRE MIRNA PROCESSING	6	8.66e-01	9.55e-01	0.3370	-8.36e-03	-2.07e-01	-3.54e-02	1.44e-01	-2.20e-01	9.72e-01	3.80e-01	8.81e-01	5.42e-01	3.50e-01
GOBP REGULATION OF INFLAMMATORY RESPONSE TO WOUNDING	12	4.69e-01	7.84e-01	0.3370	-2.12e-01	-9.07e-02	2.40e-03	2.41e-01	4.39e-02	2.03e-01	5.86e-01	9.89e-01	1.48e-01	7.92e-01
GOBP PEPTIDYL METHIONINE MODIFICATION	12	6.10e-01	8.58e-01	0.3370	4.71e-02	2.26e-01	-9.76e-02	-2.21e-01	3.86e-02	7.77e-01	1.75e-01	5.58e-01	1.84e-01	8.17e-01
GOBP CYTOPLASMIC TRANSLATIONAL INITIATION	36	1.07e-01	3.97e-01	0.3370	4.02e-02	-9.11e-02	-2.65e-01	-1.79e-01	3.74e-02	6.76e-01	3.44e-01	6.01e-03	6.30e-02	6.98e-01
GOBP PRIMARY MIRNA PROCESSING	18	3.55e-01	7.01e-01	0.3370	1.12e-01	1.07e-01	-1.57e-01	-2.20e-01	-1.28e-01	4.10e-01	4.34e-01	2.49e-01	1.06e-01	3.48e-01
GOBP CITRATE METABOLIC PROCESS	5	9.16e-01	9.73e-01	0.3370	-1.86e-02	2.30e-01	2.20e-01	3.49e-02	1.01e-01	9.43e-01	3.73e-01	3.94e-01	8.92e-01	6.95e-01
GOMF SIRNA BINDING	7	8.61e-01	9.53e-01	0.3370	-1.56e-02	1.68e-02	-1.24e-01	-2.89e-01	1.18e-01	9.43e-01	9.39e-01	5.70e-01	1.85e-01	5.90e-01
GOMF CARBOHYDRATE PHOSPHATASE ACTIVITY	9	5.90e-01	8.47e-01	0.3370	-1.26e-01	-2.17e-02	-3.11e-01	-2.46e-03	8.47e-03	5.13e-01	9.10e-01	1.06e-01	9.90e-01	9.65e-01
GOBP POSITIVE REGULATION OF MEMBRANE POTENTIAL	15	4.48e-01	7.70e-01	0.3370	1.78e-01	1.74e-01	6.25e-02	4.53e-03	2.18e-01	2.32e-01	2.44e-01	6.75e-01	9.76e-01	1.44e-01
GOBP REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION	26	2.49e-01	6.06e-01	0.3370	-8.06e-02	1.14e-01	2.06e-01	2.26e-01	-1.75e-02	4.77e-01	3.13e-01	6.96e-02	4.60e-02	8.77e-01
GOBP REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE	17	2.13e-01	5.66e-01	0.3370	2.48e-01	1.17e-01	1.52e-01	-8.67e-02	-8.78e-02	7.72e-02	4.03e-01	2.79e-01	5.36e-01	5.31e-01
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEOLUS	6	7.73e-01	9.25e-01	0.3360	2.80e-03	-2.87e-01	3.63e-03	-1.46e-01	-9.77e-02	9.91e-01	2.23e-01	9.88e-01	5.36e-01	6.79e-01
GOBP VESICLE TETHERING TO GOLGI	5	9.20e-01	9.74e-01	0.3360	3.09e-02	9.61e-02	-9.97e-02	-1.85e-01	2.43e-01	9.05e-01	7.10e-01	6.99e-01	4.75e-01	3.47e-01
GOBP POSITIVE REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY	11	6.61e-01	8.81e-01	0.3360	-2.28e-01	1.23e-01	1.25e-01	7.69e-02	-1.57e-01	1.91e-01	4.79e-01	4.72e-01	6.59e-01	3.69e-01
GOBP NEGATIVE REGULATION OF VITAMIN METABOLIC PROCESS	7	6.80e-01	8.87e-01	0.3360	8.36e-03	1.86e-01	-2.76e-01	1.34e-02	-4.81e-02	9.69e-01	3.94e-01	2.06e-01	9.51e-01	8.26e-01
GOBP CELLULAR RESPONSE TO GLUCOSE STARVATION	49	2.24e-02	1.52e-01	0.3360	-1.01e-01	3.10e-03	-1.89e-01	-2.51e-01	6.42e-02	2.20e-01	9.70e-01	2.22e-02	2.35e-03	4.37e-01
GOBP DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM	82	2.38e-05	7.17e-04	0.3360	-2.92e-01	-1.41e-02	1.56e-01	-4.30e-02	-3.86e-02	4.73e-06	8.25e-01	1.49e-02	5.01e-01	5.45e-01
GOBP ACTIVATION INDUCED CELL DEATH OF T CELLS	8	7.57e-01	9.19e-01	0.3360	-2.41e-01	6.81e-02	-8.58e-02	-1.76e-01	-1.11e-01	2.39e-01	7.39e-01	6.74e-01	3.89e-01	5.87e-01
GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE	15	3.55e-01	7.00e-01	0.3360	-7.65e-02	2.37e-02	-6.84e-02	-2.88e-01	-1.38e-01	6.08e-01	8.74e-01	6.46e-01	5.33e-02	3.55e-01
GOMF MOLECULAR CONDENSATE SCAFFOLD ACTIVITY	27	1.40e-01	4.60e-01	0.3360	-8.13e-03	1.90e-01	-8.97e-02	-2.62e-01	-1.12e-02	9.42e-01	8.71e-02	4.20e-01	1.85e-02	9.20e-01
GOBP FATTY ACID HOMEOSTASIS	16	4.14e-01	7.44e-01	0.3360	-1.18e-01	1.34e-01	-2.07e-01	-1.81e-01	7.53e-02	4.12e-01	3.53e-01	1.53e-01	2.11e-01	6.02e-01
GOBP MAGNESIUM ION HOMEOSTASIS	10	6.99e-01	8.95e-01	0.3360	1.29e-02	-1.16e-01	2.59e-01	1.70e-01	-5.69e-02	9.44e-01	5.24e-01	1.56e-01	3.52e-01	7.56e-01
GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION	102	4.83e-05	1.32e-03	0.3360	6.36e-02	-1.08e-02	-1.87e-01	-2.69e-01	-3.87e-02	2.67e-01	8.50e-01	1.11e-03	2.64e-06	4.99e-01
GOBP DENDRITIC CELL MIGRATION	32	8.98e-02	3.62e-01	0.3360	-1.44e-01	1.71e-01	1.17e-01	2.09e-01	-7.13e-02	1.57e-01	9.35e-02	2.51e-01	4.03e-02	4.85e-01
GOBP REGULATION OF FEEDING BEHAVIOR	27	6.89e-02	3.11e-01	0.3360	8.96e-02	8.01e-02	3.11e-01	1.78e-02	-3.59e-02	4.20e-01	4.71e-01	5.12e-03	8.73e-01	7.47e-01
GOCC ATP BINDING CASSETTE ABC TRANSPORTER COMPLEX	6	8.72e-01	9.58e-01	0.3360	1.34e-01	-2.72e-02	-1.39e-01	-8.38e-02	2.60e-01	5.68e-01	9.08e-01	5.56e-01	7.22e-01	2.70e-01
GOBP PROTEIN NEDDYLATION	28	1.51e-01	4.77e-01	0.3360	-3.49e-02	3.67e-02	-1.68e-01	-2.72e-01	-8.89e-02	7.49e-01	7.37e-01	1.24e-01	1.26e-02	4.16e-01
GOMF PROTEIN ARGININE OMEGA N ASYMMETRIC METHYLTRANSFERASE ACTIVITY	7	8.31e-01	9.44e-01	0.3360	-2.08e-01	4.32e-02	-1.37e-01	-2.19e-01	3.23e-02	3.41e-01	8.43e-01	5.32e-01	3.15e-01	8.82e-01
GOBP L GLUTAMATE TRANSMEMBRANE TRANSPORT	28	1.45e-01	4.66e-01	0.3360	-8.42e-02	2.12e-01	1.35e-01	9.23e-02	-1.84e-01	4.40e-01	5.23e-02	2.16e-01	3.98e-01	9.13e-02
GOBP NEGATIVE REGULATION OF LYASE ACTIVITY	18	3.08e-01	6.60e-01	0.3360	-1.70e-01	1.67e-03	-1.53e-01	-1.36e-01	2.05e-01	2.12e-01	9.90e-01	2.60e-01	3.18e-01	1.33e-01
GOCC MITOCHONDRIAL ALPHA KETOGLUTARATE DEHYDROGENASE COMPLEX	5	8.82e-01	9.61e-01	0.3360	1.49e-01	4.64e-02	-1.25e-01	7.49e-02	-2.59e-01	5.63e-01	8.57e-01	6.28e-01	7.72e-01	3.16e-01
GOBP MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION	17	2.36e-01	5.91e-01	0.3360	3.34e-02	-2.37e-02	-7.00e-03	-3.33e-01	1.59e-02	8.12e-01	8.66e-01	9.60e-01	1.76e-02	9.10e-01
GOBP POSITIVE REGULATION OF MACROPHAGE ACTIVATION	30	1.14e-01	4.12e-01	0.3360	-5.23e-02	1.60e-01	1.91e-01	1.46e-01	1.63e-01	6.20e-01	1.28e-01	7.08e-02	1.68e-01	1.22e-01
GOMF CYCLIN BINDING	34	9.62e-02	3.76e-01	0.3360	-6.41e-02	1.01e-01	-1.76e-01	-2.59e-01	1.23e-02	5.18e-01	3.09e-01	7.59e-02	8.88e-03	9.01e-01
GOBP RESPONSE TO CORTICOSTERONE	12	5.63e-01	8.34e-01	0.3360	4.80e-02	1.52e-01	8.80e-02	1.41e-02	2.81e-01	7.74e-01	3.62e-01	5.98e-01	9.33e-01	9.14e-02
GOMF HISTONE H4 ACETYLTRANSFERASE ACTIVITY	21	3.35e-01	6.83e-01	0.3360	1.11e-01	1.07e-01	-1.03e-01	-2.03e-01	1.92e-01	3.79e-01	3.96e-01	4.12e-01	1.08e-01	1.27e-01
GOMF DEOXYCYTIDINE DEAMINASE ACTIVITY	9	7.52e-01	9.16e-01	0.3350	2.71e-01	6.58e-02	-1.25e-01	-1.01e-01	9.49e-02	1.60e-01	7.33e-01	5.14e-01	6.00e-01	6.22e-01
GOMF ATPASE COUPLED INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY	10	5.88e-01	8.46e-01	0.3350	-4.00e-02	-2.05e-02	-8.70e-02	2.59e-01	-1.90e-01	8.26e-01	9.11e-01	6.34e-01	1.56e-01	2.99e-01
GOBP CHROMOSOME SEPARATION	81	3.10e-04	6.08e-03	0.3350	2.08e-01	-6.04e-02	-1.63e-01	-1.96e-01	-2.80e-02	1.23e-03	3.47e-01	1.10e-02	2.34e-03	6.64e-01
GOMF LBD DOMAIN BINDING	6	8.04e-01	9.35e-01	0.3350	-2.87e-01	1.48e-01	-6.61e-02	4.88e-02	-3.73e-02	2.23e-01	5.29e-01	7.79e-01	8.36e-01	8.74e-01
GOMF EXONUCLEASE ACTIVITY	81	1.21e-03	1.80e-02	0.3350	3.23e-02	8.07e-03	-1.98e-01	-2.64e-01	5.00e-02	6.15e-01	9.00e-01	2.09e-03	3.93e-05	4.37e-01
GOBP POSITIVE T CELL SELECTION	39	7.62e-03	7.22e-02	0.3350	5.11e-02	1.09e-01	2.60e-01	-1.25e-01	1.20e-01	5.81e-01	2.37e-01	4.94e-03	1.75e-01	1.93e-01
GOBP RESPONSE TO VITAMIN E	8	7.55e-01	9.17e-01	0.3350	-1.30e-01	1.10e-01	-7.57e-02	-2.69e-01	-7.04e-02	5.23e-01	5.89e-01	7.11e-01	1.87e-01	7.30e-01
GOBP ACTIN POLYMERIZATION DEPENDENT CELL MOTILITY	7	8.16e-01	9.41e-01	0.3350	-7.68e-02	2.00e-01	4.61e-02	4.29e-02	-2.50e-01	7.25e-01	3.60e-01	8.33e-01	8.44e-01	2.52e-01
GOBP POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION	24	2.03e-01	5.53e-01	0.3350	9.45e-02	1.29e-01	2.30e-01	3.33e-02	1.81e-01	4.23e-01	2.73e-01	5.16e-02	7.77e-01	1.24e-01
GOBP EMBRYONIC DIGESTIVE TRACT DEVELOPMENT	33	9.45e-02	3.72e-01	0.3350	1.55e-01	-9.74e-02	-9.41e-02	-1.26e-01	2.32e-01	1.24e-01	3.33e-01	3.50e-01	2.10e-01	2.08e-02
GOCC PARANODAL JUNCTION	8	7.02e-01	8.96e-01	0.3350	-1.94e-01	1.94e-01	6.56e-02	9.89e-02	1.51e-01	3.42e-01	3.42e-01	7.48e-01	6.28e-01	4.59e-01
GOBP RESPONSE TO CORTISOL	6	8.52e-01	9.51e-01	0.3350	-1.32e-01	2.88e-02	-2.58e-02	2.25e-01	-2.07e-01	5.76e-01	9.03e-01	9.13e-01	3.40e-01	3.80e-01
GOCC CMG COMPLEX	11	6.68e-01	8.83e-01	0.3350	-4.63e-02	2.23e-02	-1.22e-01	-3.07e-01	2.42e-02	7.90e-01	8.98e-01	4.85e-01	7.80e-02	8.89e-01
GOBP POSITIVE REGULATION OF PROSTAGLANDIN BIOSYNTHETIC PROCESS	7	7.98e-01	9.33e-01	0.3350	1.22e-01	2.20e-02	8.92e-02	2.90e-01	6.86e-02	5.75e-01	9.20e-01	6.83e-01	1.84e-01	7.53e-01
GOBP MAINTENANCE OF ORGANELLE LOCATION	13	3.88e-01	7.25e-01	0.3350	2.13e-01	-2.48e-01	4.85e-02	-4.05e-02	-3.28e-02	1.83e-01	1.22e-01	7.62e-01	8.01e-01	8.38e-01
GOBP CORONARY ARTERY MORPHOGENESIS	9	7.08e-01	8.97e-01	0.3350	2.42e-01	2.19e-01	5.20e-02	3.92e-02	-3.44e-02	2.08e-01	2.56e-01	7.87e-01	8.39e-01	8.58e-01
GOBP REGULATION OF HEMATOPOIETIC STEM CELL PROLIFERATION	15	5.28e-01	8.18e-01	0.3350	-1.22e-01	-8.62e-02	-1.56e-01	-2.47e-01	6.74e-02	4.12e-01	5.63e-01	2.96e-01	9.83e-02	6.51e-01
GOBP NEGATIVE REGULATION OF COMPLEMENT ACTIVATION	12	5.82e-01	8.43e-01	0.3350	-7.39e-02	-2.73e-02	-1.52e-02	2.43e-01	-2.16e-01	6.57e-01	8.70e-01	9.28e-01	1.46e-01	1.95e-01
GOBP POSITIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY	15	3.52e-01	6.98e-01	0.3350	1.77e-01	-1.57e-01	-7.42e-02	-2.12e-01	-7.44e-02	2.36e-01	2.93e-01	6.19e-01	1.55e-01	6.18e-01
GOBP REGULATION OF MEGAKARYOCYTE DIFFERENTIATION	35	4.63e-02	2.41e-01	0.3350	1.26e-02	-1.87e-01	-7.25e-02	-2.47e-01	1.02e-01	8.97e-01	5.52e-02	4.58e-01	1.14e-02	2.96e-01
GOBP SYNAPTIC ASSEMBLY AT NEUROMUSCULAR JUNCTION	10	6.54e-01	8.79e-01	0.3350	2.46e-02	3.12e-01	7.69e-02	7.23e-02	5.60e-02	8.93e-01	8.80e-02	6.74e-01	6.92e-01	7.59e-01
GOBP DNA STRAND ELONGATION	36	6.87e-02	3.10e-01	0.3350	1.79e-01	-7.88e-02	-8.82e-02	-1.21e-01	2.26e-01	6.30e-02	4.13e-01	3.60e-01	2.09e-01	1.88e-02
GOBP HAIR FOLLICLE MATURATION	15	3.13e-01	6.64e-01	0.3340	2.39e-01	-1.39e-01	1.25e-01	-7.45e-02	1.18e-01	1.09e-01	3.50e-01	4.02e-01	6.17e-01	4.28e-01
GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY	19	3.10e-01	6.62e-01	0.3340	-1.73e-01	7.98e-02	-1.20e-01	-2.20e-01	-1.12e-01	1.91e-01	5.47e-01	3.65e-01	9.68e-02	3.98e-01
GOBP ERBB4 SIGNALING PATHWAY	10	5.58e-01	8.32e-01	0.3340	-8.42e-03	-1.03e-01	-4.58e-02	3.13e-01	-3.59e-02	9.63e-01	5.71e-01	8.02e-01	8.70e-02	8.44e-01
GOBP POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION	11	6.25e-01	8.66e-01	0.3340	-2.06e-01	-8.26e-02	1.32e-01	1.74e-01	1.22e-01	2.36e-01	6.35e-01	4.47e-01	3.19e-01	4.85e-01
GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS	8	6.52e-01	8.79e-01	0.3340	-2.00e-01	7.20e-02	1.03e-01	-2.34e-01	-3.29e-02	3.26e-01	7.24e-01	6.15e-01	2.52e-01	8.72e-01
GOMF PEPTIDE ANTIGEN BINDING	35	1.46e-02	1.15e-01	0.3340	-2.61e-01	-6.16e-02	1.13e-01	-1.50e-01	-6.93e-02	7.57e-03	5.29e-01	2.49e-01	1.25e-01	4.78e-01
GOBP POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION	15	4.03e-01	7.36e-01	0.3340	3.44e-02	2.82e-01	1.24e-01	-7.01e-02	-1.02e-01	8.17e-01	5.82e-02	4.04e-01	6.38e-01	4.94e-01
GOBP REGULATION OF MITOTIC CELL CYCLE SPINDLE ASSEMBLY CHECKPOINT	21	3.16e-01	6.66e-01	0.3340	1.42e-01	-1.41e-01	-2.55e-01	-7.85e-02	-1.77e-02	2.61e-01	2.63e-01	4.27e-02	5.33e-01	8.88e-01
GOBP POSITIVE REGULATION OF DENDRITIC CELL CHEMOTAXIS	9	7.21e-01	9.03e-01	0.3340	-2.14e-01	-1.33e-02	-2.08e-01	-7.80e-02	-1.28e-01	2.67e-01	9.45e-01	2.79e-01	6.85e-01	5.05e-01
GOBP CHEMOKINE C X C MOTIF LIGAND 1 PRODUCTION	6	8.19e-01	9.41e-01	0.3340	-1.71e-01	-1.04e-01	-4.13e-02	-1.94e-01	-1.80e-01	4.67e-01	6.58e-01	8.61e-01	4.12e-01	4.46e-01
GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION	12	6.37e-01	8.73e-01	0.3340	-2.54e-01	-3.82e-02	1.10e-01	1.25e-01	-1.35e-01	1.28e-01	8.19e-01	5.11e-01	4.55e-01	4.19e-01
GOBP DNA DEALKYLATION INVOLVED IN DNA REPAIR	9	7.34e-01	9.09e-01	0.3340	1.00e-01	-1.75e-01	-1.78e-01	-4.13e-02	1.94e-01	6.02e-01	3.64e-01	3.56e-01	8.30e-01	3.13e-01
GOBP TAURINE METABOLIC PROCESS	9	6.76e-01	8.85e-01	0.3340	-5.54e-02	9.01e-02	1.04e-01	2.80e-01	1.06e-01	7.74e-01	6.40e-01	5.89e-01	1.46e-01	5.83e-01
GOMF CADHERIN BINDING INVOLVED IN CELL CELL ADHESION	18	4.52e-01	7.72e-01	0.3340	-5.84e-02	1.25e-01	1.53e-01	2.40e-01	-1.07e-01	6.68e-01	3.58e-01	2.61e-01	7.79e-02	4.33e-01
GOBP SUCKLING BEHAVIOR	12	6.53e-01	8.79e-01	0.3340	9.77e-02	5.60e-02	-1.35e-01	-2.83e-01	2.51e-02	5.58e-01	7.37e-01	4.18e-01	9.00e-02	8.80e-01
GOBP RESPONSE TO GONADOTROPIN	27	1.14e-01	4.12e-01	0.3340	4.12e-02	3.81e-03	1.39e-01	1.01e-01	-2.83e-01	7.11e-01	9.73e-01	2.11e-01	3.64e-01	1.09e-02
GOMF MICROTUBULE MINUS END BINDING	13	4.79e-01	7.91e-01	0.3340	2.46e-01	1.45e-01	6.23e-02	-1.54e-01	4.72e-02	1.24e-01	3.65e-01	6.98e-01	3.37e-01	7.68e-01
GOBP PARENTAL BEHAVIOR	10	5.94e-01	8.48e-01	0.3340	-8.60e-02	-1.83e-01	2.55e-01	6.44e-02	-4.05e-02	6.38e-01	3.17e-01	1.63e-01	7.24e-01	8.24e-01
GOMF SINGLE STRANDED DNA BINDING	114	2.49e-05	7.48e-04	0.3340	3.76e-02	-1.52e-02	-1.63e-01	-2.78e-01	7.79e-02	4.88e-01	7.79e-01	2.65e-03	2.99e-07	1.51e-01
GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO WOUNDING	9	7.16e-01	9.01e-01	0.3340	-2.10e-01	-7.16e-03	1.09e-01	2.26e-01	6.59e-02	2.76e-01	9.70e-01	5.72e-01	2.40e-01	7.32e-01
GOBP REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE	11	5.34e-01	8.20e-01	0.3340	-1.01e-01	2.25e-01	9.86e-02	-1.84e-01	-8.49e-02	5.63e-01	1.97e-01	5.71e-01	2.92e-01	6.26e-01
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS BY VEGF ACTIVATED VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	5	9.25e-01	9.76e-01	0.3340	1.21e-02	-1.48e-01	-2.31e-01	-1.19e-01	1.49e-01	9.63e-01	5.67e-01	3.72e-01	6.46e-01	5.65e-01
GOBP MELANOSOME ASSEMBLY	18	3.51e-01	6.97e-01	0.3340	-5.86e-02	3.72e-02	9.02e-04	-1.83e-01	2.70e-01	6.67e-01	7.85e-01	9.95e-01	1.78e-01	4.74e-02
GOMF ACYL COA BINDING	19	4.21e-01	7.49e-01	0.3340	4.84e-02	7.60e-02	-2.19e-01	-2.32e-01	-4.08e-02	7.15e-01	5.66e-01	9.91e-02	8.04e-02	7.58e-01
GOBP INTRACELLULAR TRIGLYCERIDE HOMEOSTASIS	7	7.91e-01	9.31e-01	0.3330	-2.25e-01	1.12e-01	-1.69e-01	-1.28e-01	5.32e-02	3.02e-01	6.07e-01	4.38e-01	5.59e-01	8.08e-01
GOBP CELL FATE DETERMINATION	42	1.26e-02	1.03e-01	0.3330	6.11e-02	5.18e-02	3.34e-02	-2.85e-01	1.50e-01	4.93e-01	5.61e-01	7.08e-01	1.41e-03	9.20e-02
GOBP SECONDARY HEART FIELD SPECIFICATION	11	5.89e-01	8.47e-01	0.3330	-9.55e-02	2.31e-01	6.09e-02	-6.95e-02	-2.00e-01	5.84e-01	1.84e-01	7.26e-01	6.90e-01	2.51e-01
GOMF VOLTAGE GATED MONOATOMIC ION CHANNEL ACTIVITY INVOLVED IN REGULATION OF PRESYNAPTIC MEMBRANE POTENTIAL	12	5.23e-01	8.15e-01	0.3330	-1.01e-01	1.16e-01	2.86e-01	-1.95e-03	-7.43e-02	5.43e-01	4.87e-01	8.61e-02	9.91e-01	6.56e-01
GOBP NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE	12	4.63e-01	7.79e-01	0.3330	1.28e-01	2.54e-01	-1.23e-02	1.73e-01	-1.13e-02	4.43e-01	1.28e-01	9.41e-01	2.99e-01	9.46e-01
GOBP DENDRITIC CELL CHEMOTAXIS	25	1.79e-01	5.20e-01	0.3330	-2.59e-01	7.49e-02	7.53e-02	1.61e-01	-8.27e-02	2.51e-02	5.17e-01	5.15e-01	1.63e-01	4.74e-01
GOMF MYOSIN II BINDING	12	4.26e-01	7.53e-01	0.3330	-1.05e-01	1.11e-01	-2.89e-01	-4.93e-02	4.13e-02	5.28e-01	5.06e-01	8.30e-02	7.68e-01	8.04e-01
GOMF BMP RECEPTOR ACTIVITY	7	5.97e-01	8.51e-01	0.3330	-1.04e-01	1.25e-02	1.78e-01	-2.50e-01	-7.57e-02	6.33e-01	9.54e-01	4.15e-01	2.51e-01	7.29e-01
GOBP REGULATION OF MESODERMAL CELL DIFFERENTIATION	9	6.59e-01	8.80e-01	0.3330	-1.49e-01	1.39e-01	1.03e-02	-2.57e-01	-5.68e-02	4.38e-01	4.70e-01	9.57e-01	1.82e-01	7.68e-01
GOBP LENS FIBER CELL DEVELOPMENT	14	4.22e-01	7.49e-01	0.3330	2.40e-02	2.51e-01	1.38e-01	-6.88e-02	-1.54e-01	8.77e-01	1.03e-01	3.73e-01	6.56e-01	3.20e-01
GOBP REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	23	1.81e-01	5.24e-01	0.3330	-9.09e-02	2.56e-01	-1.49e-04	1.45e-03	-1.92e-01	4.50e-01	3.34e-02	9.99e-01	9.90e-01	1.10e-01
GOBP SKELETAL MYOFIBRIL ASSEMBLY	10	5.52e-01	8.29e-01	0.3330	-2.12e-01	-2.27e-02	1.38e-01	-1.85e-01	1.10e-01	2.46e-01	9.01e-01	4.49e-01	3.11e-01	5.47e-01
GOBP NEGATIVE REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY	15	5.42e-01	8.24e-01	0.3330	-8.42e-04	-7.67e-02	-1.17e-01	-2.13e-01	2.14e-01	9.95e-01	6.07e-01	4.34e-01	1.53e-01	1.51e-01
GOBP REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY	11	6.69e-01	8.83e-01	0.3330	-7.83e-02	-1.50e-01	2.31e-01	1.64e-01	4.69e-02	6.53e-01	3.88e-01	1.85e-01	3.48e-01	7.88e-01
GOBP NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS	22	2.02e-01	5.51e-01	0.3330	-2.64e-02	-8.78e-02	-8.55e-02	2.11e-01	-2.25e-01	8.30e-01	4.76e-01	4.88e-01	8.69e-02	6.77e-02
GOBP CHAPERONE MEDIATED AUTOPHAGY	14	5.22e-01	8.14e-01	0.3330	5.03e-02	-1.42e-02	-3.05e-01	-1.08e-01	5.53e-02	7.44e-01	9.26e-01	4.79e-02	4.82e-01	7.20e-01
GOBP PRIMARY ALCOHOL BIOSYNTHETIC PROCESS	14	5.54e-01	8.30e-01	0.3330	-1.93e-01	-7.73e-02	3.82e-02	1.43e-01	-2.13e-01	2.10e-01	6.17e-01	8.04e-01	3.55e-01	1.67e-01
GOBP NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	13	3.77e-01	7.16e-01	0.3330	-2.21e-01	-5.62e-03	-1.52e-01	-9.80e-03	1.97e-01	1.68e-01	9.72e-01	3.42e-01	9.51e-01	2.19e-01
GOCC POLAR MICROTUBULE	5	8.58e-01	9.53e-01	0.3330	2.68e-01	3.39e-02	1.45e-01	-1.06e-01	7.38e-02	2.99e-01	8.96e-01	5.73e-01	6.83e-01	7.75e-01
GOBP REGULATION OF METANEPHROS DEVELOPMENT	5	9.21e-01	9.74e-01	0.3330	-1.09e-01	-1.36e-01	1.46e-01	1.52e-01	-1.90e-01	6.73e-01	5.99e-01	5.71e-01	5.56e-01	4.63e-01
GOBP POSITIVE REGULATION OF HEMATOPOIETIC STEM CELL PROLIFERATION	9	7.35e-01	9.09e-01	0.3330	-2.30e-01	-4.08e-02	-1.08e-01	-1.88e-01	9.74e-02	2.33e-01	8.32e-01	5.76e-01	3.30e-01	6.13e-01
GOBP INTERCELLULAR TRANSPORT	10	6.82e-01	8.88e-01	0.3330	8.08e-02	-1.56e-01	8.07e-02	1.66e-01	-2.14e-01	6.58e-01	3.92e-01	6.58e-01	3.65e-01	2.41e-01
GOBP ERBB2 EGFR SIGNALING PATHWAY	7	6.79e-01	8.87e-01	0.3330	-1.20e-01	-6.80e-02	-5.57e-02	2.91e-01	6.16e-02	5.82e-01	7.56e-01	7.99e-01	1.82e-01	7.78e-01
GOMF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY	51	1.41e-02	1.12e-01	0.3330	-2.35e-01	-7.17e-02	8.26e-02	1.63e-01	-1.30e-01	3.69e-03	3.76e-01	3.07e-01	4.40e-02	1.09e-01
GOBP RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR	17	4.90e-01	7.97e-01	0.3320	6.46e-03	7.83e-02	1.40e-01	2.54e-01	-1.43e-01	9.63e-01	5.76e-01	3.17e-01	7.03e-02	3.07e-01
GOMF FOUR WAY JUNCTION HELICASE ACTIVITY	6	8.09e-01	9.37e-01	0.3320	-6.42e-02	8.08e-02	-2.28e-02	-2.97e-01	-1.05e-01	7.85e-01	7.32e-01	9.23e-01	2.08e-01	6.56e-01
GOMF AMIDE TRANSMEMBRANE TRANSPORTER ACTIVITY	44	1.92e-02	1.37e-01	0.3320	-2.28e-01	1.80e-01	9.68e-02	2.44e-02	-1.28e-01	8.86e-03	3.93e-02	2.66e-01	7.79e-01	1.43e-01
GOMF POTASSIUM ION LEAK CHANNEL ACTIVITY	16	4.61e-01	7.78e-01	0.3320	1.26e-01	3.96e-02	2.12e-01	1.66e-01	-1.44e-01	3.84e-01	7.84e-01	1.42e-01	2.51e-01	3.19e-01
GOBP REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS	21	2.67e-01	6.23e-01	0.3320	-5.62e-02	1.73e-01	1.10e-03	-1.86e-01	2.07e-01	6.56e-01	1.70e-01	9.93e-01	1.40e-01	1.01e-01
GOBP POSITIVE REGULATION OF RIG I SIGNALING PATHWAY	10	6.24e-01	8.66e-01	0.3320	1.77e-01	1.92e-01	1.09e-02	-1.98e-01	-5.21e-02	3.33e-01	2.93e-01	9.52e-01	2.77e-01	7.76e-01
GOMF PLATELET DERIVED GROWTH FACTOR BINDING	11	5.13e-01	8.08e-01	0.3320	5.09e-02	-1.21e-01	1.96e-03	2.09e-01	2.22e-01	7.70e-01	4.88e-01	9.91e-01	2.29e-01	2.02e-01
GOBP CDP DIACYLGLYCEROL BIOSYNTHETIC PROCESS	11	5.42e-01	8.24e-01	0.3320	9.48e-02	-3.08e-02	-8.41e-02	-2.69e-01	-1.45e-01	5.86e-01	8.60e-01	6.29e-01	1.22e-01	4.07e-01
GOBP CELLULAR RESPONSE TO INTERFERON ALPHA	7	8.26e-01	9.44e-01	0.3320	-1.04e-01	-2.06e-01	-8.73e-02	-1.12e-01	1.92e-01	6.34e-01	3.45e-01	6.89e-01	6.08e-01	3.80e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN	32	4.29e-02	2.30e-01	0.3320	-1.34e-01	-1.11e-01	1.07e-01	4.05e-03	-2.61e-01	1.88e-01	2.75e-01	2.95e-01	9.68e-01	1.05e-02
GOBP REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL	12	6.04e-01	8.55e-01	0.3320	-1.35e-01	5.91e-02	-1.10e-01	-2.75e-01	-2.66e-02	4.17e-01	7.23e-01	5.10e-01	9.88e-02	8.73e-01
GOBP NEUROFILAMENT CYTOSKELETON ORGANIZATION	10	6.53e-01	8.79e-01	0.3320	-4.79e-02	-2.57e-01	-2.68e-02	-1.35e-01	1.52e-01	7.93e-01	1.59e-01	8.83e-01	4.61e-01	4.07e-01
GOBP METHYLGLYOXAL METABOLIC PROCESS	6	8.44e-01	9.49e-01	0.3320	8.30e-02	-2.05e-01	-7.71e-02	-2.34e-01	1.84e-02	7.25e-01	3.84e-01	7.44e-01	3.20e-01	9.38e-01
GOBP REGULATION OF CORTISOL BIOSYNTHETIC PROCESS	7	8.32e-01	9.45e-01	0.3320	-1.38e-01	2.30e-01	1.31e-01	1.44e-01	1.54e-02	5.27e-01	2.92e-01	5.47e-01	5.09e-01	9.44e-01
GOMF BILE ACID TRANSMEMBRANE TRANSPORTER ACTIVITY	18	3.93e-01	7.27e-01	0.3320	-2.31e-02	7.22e-02	8.40e-02	2.80e-01	-1.37e-01	8.65e-01	5.96e-01	5.37e-01	3.96e-02	3.13e-01
GOBP POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY	26	1.44e-01	4.65e-01	0.3320	-5.43e-02	2.41e-01	7.74e-02	-1.46e-01	1.47e-01	6.32e-01	3.32e-02	4.95e-01	1.96e-01	1.95e-01
GOCC CUL4 RING E3 UBIQUITIN LIGASE COMPLEX	32	1.61e-01	4.93e-01	0.3320	1.74e-02	5.65e-02	-2.15e-01	-2.43e-01	3.35e-02	8.64e-01	5.80e-01	3.51e-02	1.73e-02	7.43e-01
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR	82	9.66e-04	1.51e-02	0.3320	7.37e-03	3.22e-02	-1.56e-01	-2.48e-01	1.51e-01	9.08e-01	6.14e-01	1.44e-02	1.01e-04	1.81e-02
GOBP MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON	11	6.21e-01	8.64e-01	0.3320	4.15e-02	-6.52e-02	-1.29e-01	5.65e-02	-2.90e-01	8.12e-01	7.08e-01	4.60e-01	7.46e-01	9.55e-02
GOBP NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION	21	1.81e-01	5.23e-01	0.3320	-1.49e-02	-6.25e-02	-4.32e-02	2.99e-01	-1.21e-01	9.06e-01	6.20e-01	7.32e-01	1.77e-02	3.37e-01
GOMF MUSCLE ALPHA ACTININ BINDING	15	5.92e-01	8.47e-01	0.3320	3.74e-03	7.50e-02	1.76e-01	2.44e-01	-1.17e-01	9.80e-01	6.15e-01	2.37e-01	1.02e-01	4.33e-01
GOCC SPINDLE POLE CENTROSOME	13	5.72e-01	8.39e-01	0.3320	-4.32e-02	-1.72e-01	-1.07e-01	-2.46e-01	7.82e-02	7.87e-01	2.82e-01	5.02e-01	1.24e-01	6.25e-01
GOBP NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION	11	5.06e-01	8.06e-01	0.3320	-2.08e-01	-3.33e-02	1.38e-01	-1.78e-01	1.22e-01	2.33e-01	8.48e-01	4.27e-01	3.07e-01	4.84e-01
GOBP ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY	6	9.03e-01	9.68e-01	0.3310	7.80e-02	-2.05e-02	1.78e-01	2.68e-01	6.69e-04	7.41e-01	9.31e-01	4.51e-01	2.56e-01	9.98e-01
GOMF 3 CHLOROALLYL ALDEHYDE DEHYDROGENASE ACTIVITY	5	8.89e-01	9.63e-01	0.3310	1.53e-01	-1.66e-01	-3.78e-02	2.32e-01	-6.03e-02	5.54e-01	5.19e-01	8.84e-01	3.69e-01	8.15e-01
GOBP REGULATION OF FIBRINOLYSIS	18	3.70e-01	7.10e-01	0.3310	-6.52e-02	-2.45e-01	1.09e-01	1.57e-01	-9.55e-02	6.32e-01	7.20e-02	4.25e-01	2.49e-01	4.83e-01
GOBP SPLEEN DEVELOPMENT	38	8.25e-02	3.46e-01	0.3310	2.93e-02	3.11e-02	-1.30e-01	-2.75e-01	1.23e-01	7.55e-01	7.40e-01	1.66e-01	3.31e-03	1.88e-01
GOBP CELL REDOX HOMEOSTASIS	38	7.20e-02	3.20e-01	0.3310	-2.82e-02	7.84e-02	-2.49e-01	-2.01e-01	2.07e-02	7.63e-01	4.03e-01	7.88e-03	3.24e-02	8.25e-01
GOBP VALINE METABOLIC PROCESS	7	8.32e-01	9.45e-01	0.3310	1.68e-01	1.47e-01	1.96e-02	-4.28e-02	2.40e-01	4.41e-01	5.01e-01	9.28e-01	8.44e-01	2.72e-01
GOBP VIRAL RNA GENOME REPLICATION	29	8.56e-02	3.54e-01	0.3310	1.24e-01	-1.40e-01	-9.93e-02	-2.51e-01	-3.84e-02	2.46e-01	1.91e-01	3.55e-01	1.92e-02	7.20e-01
GOBP MITOPHAGY	34	1.09e-01	4.03e-01	0.3310	9.59e-02	1.19e-01	-2.02e-01	-1.89e-01	9.75e-02	3.33e-01	2.29e-01	4.15e-02	5.59e-02	3.25e-01
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE	34	3.97e-02	2.19e-01	0.3310	-1.65e-01	1.41e-01	2.34e-01	-3.73e-02	-8.08e-02	9.65e-02	1.55e-01	1.82e-02	7.06e-01	4.15e-01
GOBP ENAMEL MINERALIZATION	19	4.38e-01	7.60e-01	0.3310	-2.56e-02	-9.19e-02	1.58e-01	2.59e-01	-9.13e-02	8.47e-01	4.88e-01	2.33e-01	5.05e-02	4.91e-01
GOBP VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY	12	5.31e-01	8.19e-01	0.3310	2.75e-01	3.12e-02	-3.55e-02	4.17e-02	-1.72e-01	9.86e-02	8.52e-01	8.31e-01	8.02e-01	3.01e-01
GOBP REGULATION OF INTESTINAL LIPID ABSORPTION	10	5.79e-01	8.42e-01	0.3310	1.61e-01	5.18e-02	6.76e-03	2.83e-01	2.63e-02	3.79e-01	7.77e-01	9.70e-01	1.21e-01	8.85e-01
GOMF MYOSIN V BINDING	16	2.64e-01	6.19e-01	0.3310	-1.89e-01	-8.67e-02	-2.47e-01	6.85e-02	-2.46e-02	1.90e-01	5.48e-01	8.74e-02	6.35e-01	8.65e-01
GOBP SYMPATHETIC GANGLION DEVELOPMENT	9	7.72e-01	9.25e-01	0.3310	-9.71e-02	1.09e-01	2.11e-01	9.81e-02	-1.85e-01	6.14e-01	5.73e-01	2.73e-01	6.10e-01	3.37e-01
GOMF 1 PHOSPHATIDYLINOSITOL 3 KINASE REGULATOR ACTIVITY	15	4.03e-01	7.36e-01	0.3310	-1.14e-01	2.50e-01	-1.42e-01	-1.18e-01	-2.52e-04	4.45e-01	9.41e-02	3.41e-01	4.28e-01	9.99e-01
GOBP UTERINE SMOOTH MUSCLE CONTRACTION	9	5.36e-01	8.22e-01	0.3310	-5.15e-02	4.40e-02	9.34e-02	-1.76e-01	-2.55e-01	7.89e-01	8.19e-01	6.27e-01	3.62e-01	1.84e-01
GOMF THREONINE TYPE PEPTIDASE ACTIVITY	16	5.45e-01	8.26e-01	0.3310	-1.35e-02	-1.29e-01	-2.47e-01	-1.66e-01	-6.11e-02	9.26e-01	3.71e-01	8.66e-02	2.50e-01	6.72e-01
GOBP RNA METHYLATION	84	8.41e-04	1.35e-02	0.3310	6.24e-02	-1.03e-01	-1.84e-01	-2.44e-01	3.70e-02	3.23e-01	1.02e-01	3.53e-03	1.10e-04	5.58e-01
GOBP VOLUNTARY MUSCULOSKELETAL MOVEMENT	7	8.32e-01	9.45e-01	0.3310	1.67e-01	2.20e-01	1.17e-01	-5.17e-02	1.29e-01	4.44e-01	3.14e-01	5.91e-01	8.13e-01	5.54e-01
GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE METABOLIC PROCESS	5	8.82e-01	9.61e-01	0.3310	-1.97e-01	1.53e-01	3.44e-02	-2.07e-01	-5.16e-02	4.45e-01	5.53e-01	8.94e-01	4.22e-01	8.42e-01
GOMF PHOSPHATIDYLINOSITOL 3 4 5 TRISPHOSPHATE BINDING	34	9.76e-02	3.78e-01	0.3310	-7.37e-02	1.48e-01	1.20e-01	2.33e-01	-1.16e-01	4.57e-01	1.35e-01	2.26e-01	1.88e-02	2.43e-01
GOBP ACTIVATION OF MEIOSIS	6	7.33e-01	9.08e-01	0.3310	1.20e-01	6.02e-02	-1.79e-01	1.06e-01	2.19e-01	6.11e-01	7.98e-01	4.46e-01	6.52e-01	3.54e-01
GOBP POSITIVE REGULATION OF ERAD PATHWAY	13	6.45e-01	8.75e-01	0.3310	-9.39e-02	-1.46e-01	-2.14e-01	-1.83e-01	-1.47e-02	5.58e-01	3.63e-01	1.82e-01	2.55e-01	9.27e-01
GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION	29	1.02e-01	3.87e-01	0.3310	1.30e-01	9.92e-02	1.09e-01	-1.47e-01	2.22e-01	2.24e-01	3.55e-01	3.12e-01	1.72e-01	3.89e-02
GOBP NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION	15	4.96e-01	8.00e-01	0.3300	-6.69e-02	-8.33e-02	1.62e-01	2.32e-01	1.33e-01	6.54e-01	5.76e-01	2.76e-01	1.20e-01	3.71e-01
GOBP DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING	65	8.62e-03	7.91e-02	0.3300	9.86e-02	2.83e-03	-2.10e-01	-2.27e-01	6.21e-02	1.69e-01	9.68e-01	3.41e-03	1.55e-03	3.86e-01
GOBP ADULT HEART DEVELOPMENT	13	4.32e-01	7.56e-01	0.3300	-1.66e-01	1.23e-01	4.01e-02	5.55e-02	2.49e-01	3.00e-01	4.43e-01	8.02e-01	7.29e-01	1.21e-01
GOBP MORPHOGENESIS OF AN EPITHELIAL FOLD	23	9.73e-02	3.78e-01	0.3300	4.18e-02	-1.99e-01	8.11e-02	-1.96e-01	1.50e-01	7.29e-01	9.81e-02	5.01e-01	1.03e-01	2.12e-01
GOBP POSITIVE REGULATION OF MACROPHAGE MIGRATION	26	1.37e-01	4.56e-01	0.3300	-1.57e-01	5.44e-02	1.44e-01	1.49e-01	1.97e-01	1.65e-01	6.31e-01	2.04e-01	1.90e-01	8.26e-02
GOBP GLYCINE BIOSYNTHETIC PROCESS	7	8.14e-01	9.39e-01	0.3300	-1.06e-01	-1.74e-01	2.56e-02	2.58e-01	-7.83e-03	6.28e-01	4.24e-01	9.07e-01	2.36e-01	9.71e-01
GOMF GLUTAMATE BINDING	8	7.74e-01	9.25e-01	0.3300	-2.89e-01	-1.31e-01	-6.92e-02	-1.01e-02	-6.00e-02	1.57e-01	5.21e-01	7.35e-01	9.60e-01	7.69e-01
GOBP ANTEROGRADE DENDRITIC TRANSPORT	9	7.45e-01	9.14e-01	0.3300	9.58e-02	2.47e-01	9.84e-02	1.08e-01	-1.32e-01	6.19e-01	1.99e-01	6.09e-01	5.76e-01	4.94e-01
GOBP POSITIVE REGULATION OF CILIUM MOVEMENT	11	6.34e-01	8.71e-01	0.3300	-1.02e-01	-2.19e-01	-8.14e-02	-3.77e-02	-2.06e-01	5.56e-01	2.08e-01	6.40e-01	8.28e-01	2.38e-01
GOMF INTRONIC TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING	11	6.54e-01	8.79e-01	0.3300	8.59e-02	5.99e-02	-4.27e-03	-2.56e-01	1.80e-01	6.22e-01	7.31e-01	9.80e-01	1.41e-01	3.02e-01
GOBP DOPAMINE METABOLIC PROCESS	35	4.23e-02	2.28e-01	0.3300	4.50e-04	7.47e-02	2.94e-01	6.19e-02	-1.14e-01	9.96e-01	4.45e-01	2.60e-03	5.26e-01	2.44e-01
GOBP NEUROBLAST DIFFERENTIATION	8	7.64e-01	9.22e-01	0.3300	-5.02e-02	-2.79e-02	-9.88e-03	-2.80e-01	1.64e-01	8.06e-01	8.91e-01	9.61e-01	1.70e-01	4.22e-01
GOBP GLUCOSYLCERAMIDE METABOLIC PROCESS	7	8.52e-01	9.51e-01	0.3300	-1.74e-01	-1.72e-01	-1.78e-01	-1.17e-01	-5.92e-02	4.24e-01	4.30e-01	4.15e-01	5.93e-01	7.86e-01
GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX CLASS I	9	6.82e-01	8.88e-01	0.3300	-2.59e-01	6.17e-02	1.83e-01	-6.81e-02	7.57e-03	1.79e-01	7.48e-01	3.42e-01	7.23e-01	9.69e-01
GOMF PYRUVATE TRANSMEMBRANE TRANSPORTER ACTIVITY	5	9.36e-01	9.80e-01	0.3300	-4.03e-02	-1.19e-01	-2.15e-01	-1.70e-01	1.33e-01	8.76e-01	6.45e-01	4.06e-01	5.10e-01	6.05e-01
GOMF C X3 C CHEMOKINE BINDING	5	8.65e-01	9.55e-01	0.3300	-5.60e-02	1.26e-02	-1.14e-01	-1.69e-02	3.04e-01	8.28e-01	9.61e-01	6.60e-01	9.48e-01	2.40e-01
GOBP PROTEIN LOCALIZATION TO MEMBRANE RAFT	9	7.17e-01	9.02e-01	0.3300	-1.03e-01	8.15e-02	-5.81e-02	-2.97e-01	-2.01e-03	5.94e-01	6.72e-01	7.63e-01	1.23e-01	9.92e-01
GOBP GUANINE NUCLEOTIDE TRANSPORT	9	7.35e-01	9.09e-01	0.3300	1.20e-01	1.46e-01	9.84e-02	-1.45e-01	2.06e-01	5.31e-01	4.50e-01	6.09e-01	4.53e-01	2.85e-01
GOMF PROTEIN CONTAINING COMPLEX DESTABILIZING ACTIVITY	15	4.41e-01	7.63e-01	0.3300	-1.48e-01	-1.72e-01	-8.65e-02	-7.60e-02	2.10e-01	3.21e-01	2.49e-01	5.62e-01	6.10e-01	1.60e-01
GOBP REGULATION OF DNA DEMETHYLATION	11	7.45e-01	9.14e-01	0.3300	-9.09e-02	1.05e-01	2.43e-01	1.72e-01	2.94e-02	6.02e-01	5.46e-01	1.63e-01	3.23e-01	8.66e-01
GOMF 3 5 DNA HELICASE ACTIVITY	15	3.91e-01	7.26e-01	0.3300	-1.63e-02	9.23e-02	-3.72e-02	-3.12e-01	-3.54e-02	9.13e-01	5.36e-01	8.03e-01	3.65e-02	8.12e-01
GOMF 7SK SNRNA BINDING	9	7.97e-01	9.32e-01	0.3300	-3.22e-03	-1.18e-01	-1.52e-01	-2.61e-01	5.78e-02	9.87e-01	5.38e-01	4.29e-01	1.76e-01	7.64e-01
GOBP MAMMARY GLAND BRANCHING INVOLVED IN PREGNANCY	6	7.92e-01	9.31e-01	0.3290	-2.36e-01	8.26e-02	-8.43e-02	1.76e-01	-9.06e-02	3.18e-01	7.26e-01	7.21e-01	4.56e-01	7.01e-01
GOBP MITOCHONDRION MORPHOGENESIS	20	2.83e-01	6.36e-01	0.3290	2.23e-02	-2.33e-01	-1.19e-01	-5.54e-02	-1.91e-01	8.63e-01	7.18e-02	3.55e-01	6.68e-01	1.39e-01
GOBP PERICARDIUM MORPHOGENESIS	8	7.01e-01	8.96e-01	0.3290	6.49e-03	-2.05e-01	1.55e-01	-5.75e-02	1.98e-01	9.75e-01	3.15e-01	4.49e-01	7.78e-01	3.32e-01
GOBP NEGATIVE REGULATION OF VASCULAR PERMEABILITY	18	3.73e-01	7.13e-01	0.3290	1.56e-01	1.68e-01	1.88e-01	9.67e-02	-1.06e-01	2.53e-01	2.18e-01	1.67e-01	4.78e-01	4.36e-01
GOMF G PROTEIN COUPLED NEUROTRANSMITTER RECEPTOR ACTIVITY	11	5.93e-01	8.47e-01	0.3290	1.29e-01	2.38e-02	7.15e-02	2.85e-01	6.91e-02	4.58e-01	8.91e-01	6.81e-01	1.02e-01	6.91e-01
GOBP PLASMA MEMBRANE FUSION	30	1.82e-01	5.25e-01	0.3290	-4.73e-02	-8.96e-02	1.68e-01	2.22e-01	-1.44e-01	6.54e-01	3.95e-01	1.11e-01	3.57e-02	1.72e-01
GOBP C21 STEROID HORMONE METABOLIC PROCESS	36	7.66e-02	3.32e-01	0.3290	-2.68e-02	-1.36e-01	7.78e-02	2.69e-01	-1.03e-01	7.81e-01	1.59e-01	4.19e-01	5.19e-03	2.83e-01
GOMF MONOATOMIC ANION SODIUM SYMPORTER ACTIVITY	17	4.13e-01	7.44e-01	0.3290	7.24e-02	6.45e-02	6.94e-02	1.57e-01	-2.63e-01	6.05e-01	6.45e-01	6.21e-01	2.61e-01	6.02e-02
GOBP RENAL SODIUM EXCRETION	11	5.70e-01	8.38e-01	0.3290	1.40e-01	-4.97e-02	2.16e-02	4.56e-02	-2.89e-01	4.23e-01	7.75e-01	9.01e-01	7.93e-01	9.65e-02
GOBP POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT	19	3.40e-01	6.87e-01	0.3290	7.06e-02	2.15e-01	1.46e-01	-5.75e-02	1.80e-01	5.94e-01	1.05e-01	2.69e-01	6.65e-01	1.75e-01
GOBP REGULATION OF DNA BIOSYNTHETIC PROCESS	117	3.39e-05	9.63e-04	0.3290	8.68e-03	-7.30e-02	-1.95e-01	-2.52e-01	3.49e-02	8.71e-01	1.73e-01	2.68e-04	2.47e-06	5.14e-01
GOBP EXTRACELLULAR EXOSOME ASSEMBLY	7	8.05e-01	9.35e-01	0.3290	-2.20e-01	1.26e-01	3.50e-03	-2.06e-01	3.47e-02	3.13e-01	5.64e-01	9.87e-01	3.44e-01	8.74e-01
GOBP BEHAVIORAL RESPONSE TO ETHANOL	10	5.95e-01	8.50e-01	0.3290	5.08e-02	6.48e-02	2.85e-01	3.14e-02	-1.39e-01	7.81e-01	7.23e-01	1.19e-01	8.63e-01	4.47e-01
GOBP TRYPTOPHAN TRANSPORT	5	9.12e-01	9.71e-01	0.3290	6.00e-02	1.18e-01	1.29e-01	-5.48e-02	2.66e-01	8.16e-01	6.48e-01	6.17e-01	8.32e-01	3.02e-01
GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX CATALYTIC DOMAIN	19	4.26e-01	7.52e-01	0.3290	-2.28e-03	-1.74e-01	-1.58e-01	-2.10e-01	9.25e-02	9.86e-01	1.89e-01	2.32e-01	1.13e-01	4.85e-01
GOBP NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY	10	7.20e-01	9.02e-01	0.3290	4.57e-02	7.19e-02	-5.71e-02	-1.38e-01	2.80e-01	8.03e-01	6.94e-01	7.54e-01	4.48e-01	1.25e-01
GOMF SECONDARY ACTIVE SULFATE TRANSMEMBRANE TRANSPORTER ACTIVITY	11	6.96e-01	8.94e-01	0.3290	-7.27e-02	-1.10e-01	2.17e-01	1.64e-01	-1.29e-01	6.76e-01	5.28e-01	2.13e-01	3.46e-01	4.58e-01
GOBP VESICLE TETHERING	31	1.73e-01	5.13e-01	0.3290	9.69e-02	3.31e-02	-1.28e-01	-2.43e-01	1.49e-01	3.50e-01	7.50e-01	2.17e-01	1.92e-02	1.52e-01
GOBP GRANULOCYTE CHEMOTAXIS	122	1.33e-06	5.72e-05	0.3290	-1.70e-01	1.93e-01	1.02e-01	1.54e-01	-8.92e-02	1.21e-03	2.35e-04	5.28e-02	3.25e-03	8.87e-02
GOBP ERBB2 SIGNALING PATHWAY	17	2.64e-01	6.19e-01	0.3290	-1.69e-01	1.18e-01	-4.93e-02	2.18e-01	-1.25e-01	2.29e-01	4.00e-01	7.25e-01	1.19e-01	3.73e-01
GOBP T TUBULE ORGANIZATION	6	9.16e-01	9.73e-01	0.3290	-7.09e-02	-9.51e-03	1.78e-01	2.66e-01	-2.51e-02	7.64e-01	9.68e-01	4.51e-01	2.60e-01	9.15e-01
GOBP POSITIVE REGULATION OF CELL KILLING	73	6.06e-04	1.03e-02	0.3290	-2.52e-01	-6.46e-02	1.85e-01	7.09e-02	-3.53e-02	1.98e-04	3.40e-01	6.37e-03	2.95e-01	6.02e-01
GOMF DNA NUCLEASE ACTIVITY	58	1.22e-02	1.01e-01	0.3290	6.46e-02	1.04e-02	-2.46e-01	-1.75e-01	1.12e-01	3.95e-01	8.91e-01	1.18e-03	2.15e-02	1.40e-01
GOCC INTRACILIARY TRANSPORT PARTICLE	22	3.68e-01	7.09e-01	0.3290	8.70e-02	-1.76e-03	-1.87e-01	-1.90e-01	1.70e-01	4.80e-01	9.89e-01	1.28e-01	1.22e-01	1.66e-01
GOBP INTERMEDIATE FILAMENT BASED PROCESS	93	2.37e-04	4.83e-03	0.3280	-1.80e-01	-7.13e-02	1.59e-01	2.07e-01	-4.89e-02	2.69e-03	2.35e-01	8.24e-03	5.57e-04	4.15e-01
GOMF UBIQUITINATION LIKE MODIFICATION DEPENDENT PROTEIN BINDING	20	2.66e-01	6.21e-01	0.3280	6.37e-02	7.67e-02	-6.34e-02	-3.06e-01	-1.33e-02	6.22e-01	5.53e-01	6.24e-01	1.78e-02	9.18e-01
GOBP AMYLOID BETA CLEARANCE BY CELLULAR CATABOLIC PROCESS	8	7.86e-01	9.29e-01	0.3280	-2.72e-01	-1.10e-01	-8.29e-02	-1.56e-02	-1.22e-01	1.83e-01	5.90e-01	6.85e-01	9.39e-01	5.51e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS	60	1.26e-02	1.03e-01	0.3280	9.83e-02	-5.38e-02	-2.59e-01	-1.68e-01	1.63e-02	1.88e-01	4.71e-01	5.28e-04	2.47e-02	8.27e-01
GOBP TYPE I INTERFERON PRODUCTION	115	3.08e-05	8.93e-04	0.3280	3.63e-02	7.46e-02	-2.02e-01	-2.18e-01	1.11e-01	5.02e-01	1.67e-01	1.80e-04	5.20e-05	3.92e-02
GOBP POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY	32	1.10e-01	4.03e-01	0.3280	-1.90e-01	-1.06e-01	1.35e-01	2.03e-01	3.11e-02	6.25e-02	3.00e-01	1.87e-01	4.69e-02	7.61e-01
GOMF AP 2 ADAPTOR COMPLEX BINDING	10	6.25e-01	8.66e-01	0.3280	7.84e-02	2.03e-01	2.24e-01	-8.99e-02	4.17e-02	6.68e-01	2.65e-01	2.19e-01	6.23e-01	8.19e-01
GOBP NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY	26	1.37e-01	4.57e-01	0.3280	-8.94e-02	-2.54e-01	1.36e-01	9.39e-02	8.87e-02	4.30e-01	2.50e-02	2.30e-01	4.07e-01	4.34e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE	18	2.86e-01	6.40e-01	0.3280	3.02e-01	5.52e-02	7.45e-02	-8.00e-02	3.26e-02	2.63e-02	6.85e-01	5.84e-01	5.57e-01	8.11e-01
GOBP RNA SPLICING	420	1.28e-19	2.51e-17	0.3280	7.29e-02	-2.55e-02	-1.78e-01	-2.53e-01	7.81e-02	1.04e-02	3.69e-01	4.01e-10	6.22e-19	6.02e-03
GOMF DNA ENDONUCLEASE ACTIVITY	38	5.85e-02	2.82e-01	0.3280	9.58e-02	1.01e-02	-2.80e-01	-1.18e-01	7.60e-02	3.07e-01	9.14e-01	2.82e-03	2.07e-01	4.17e-01
GOBP REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS	13	3.24e-01	6.72e-01	0.3280	-2.12e-01	-8.21e-02	-1.66e-01	1.61e-01	4.66e-02	1.86e-01	6.08e-01	2.99e-01	3.14e-01	7.71e-01
GOMF CATALYTIC ACTIVITY ACTING ON A TRNA	125	1.67e-05	5.24e-04	0.3280	1.40e-01	-3.37e-02	-2.18e-01	-1.94e-01	4.11e-02	6.83e-03	5.15e-01	2.62e-05	1.82e-04	4.27e-01
GOBP FARNESYL DIPHOSPHATE METABOLIC PROCESS	6	7.36e-01	9.09e-01	0.3280	1.43e-01	-1.84e-01	1.85e-01	-1.12e-01	7.88e-02	5.44e-01	4.35e-01	4.32e-01	6.36e-01	7.38e-01
GOBP HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY	13	5.69e-01	8.37e-01	0.3280	1.92e-01	7.47e-02	-1.04e-01	-2.29e-01	-4.05e-02	2.30e-01	6.41e-01	5.18e-01	1.53e-01	8.00e-01
GOBP NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION	15	5.35e-01	8.21e-01	0.3270	1.14e-01	2.10e-01	1.59e-01	1.50e-01	-4.92e-02	4.44e-01	1.59e-01	2.85e-01	3.15e-01	7.41e-01
GOBP MRNA METHYLATION	17	4.49e-01	7.70e-01	0.3270	-4.76e-02	-1.48e-01	-1.49e-01	-2.45e-01	-2.59e-02	7.34e-01	2.90e-01	2.88e-01	7.99e-02	8.53e-01
GOBP RESPONSE TO GLUCAGON	20	3.39e-01	6.86e-01	0.3270	1.30e-01	1.87e-01	1.52e-01	1.39e-01	1.13e-01	3.13e-01	1.47e-01	2.39e-01	2.82e-01	3.82e-01
GOBP LYMPH NODE DEVELOPMENT	18	3.28e-01	6.76e-01	0.3270	2.38e-01	-1.94e-01	-3.44e-02	-7.52e-02	7.76e-02	8.06e-02	1.54e-01	8.00e-01	5.81e-01	5.69e-01
GOBP GLUTATHIONE TRANSMEMBRANE TRANSPORT	7	8.15e-01	9.41e-01	0.3270	-2.91e-02	2.60e-01	3.02e-03	-5.96e-03	-1.96e-01	8.94e-01	2.33e-01	9.89e-01	9.78e-01	3.68e-01
GOBP RESPONSE TO INTERLEUKIN 3	6	8.54e-01	9.51e-01	0.3270	1.00e-02	2.81e-01	9.79e-02	-8.73e-02	-1.04e-01	9.66e-01	2.33e-01	6.78e-01	7.11e-01	6.59e-01
GOBP CARDIOBLAST DIFFERENTIATION	17	3.56e-01	7.01e-01	0.3270	6.86e-02	1.31e-01	-5.43e-02	-2.82e-01	-5.01e-02	6.24e-01	3.48e-01	6.98e-01	4.41e-02	7.20e-01
GOBP INOSITOL METABOLIC PROCESS	8	6.66e-01	8.82e-01	0.3270	1.77e-01	1.10e-01	3.38e-02	-2.13e-01	-1.31e-01	3.87e-01	5.89e-01	8.68e-01	2.98e-01	5.20e-01
GOBP REGULATION OF AEROBIC RESPIRATION	30	1.70e-01	5.09e-01	0.3270	5.64e-02	7.60e-02	-9.18e-02	-2.20e-01	2.03e-01	5.93e-01	4.71e-01	3.84e-01	3.73e-02	5.40e-02
GOBP DETECTION OF LIPOPOLYSACCHARIDE	5	8.92e-01	9.63e-01	0.3270	-2.55e-01	1.30e-01	-7.45e-02	-1.09e-01	8.65e-02	3.23e-01	6.15e-01	7.73e-01	6.74e-01	7.38e-01
GOBP NEPHRIC DUCT MORPHOGENESIS	10	5.99e-01	8.52e-01	0.3270	6.31e-02	-1.84e-01	1.08e-02	-2.35e-01	1.16e-01	7.30e-01	3.13e-01	9.53e-01	1.98e-01	5.24e-01
GOBP POSITIVE REGULATION OF RECEPTOR CATABOLIC PROCESS	7	8.12e-01	9.38e-01	0.3270	3.94e-02	3.37e-02	-8.44e-02	-1.72e-02	-3.11e-01	8.57e-01	8.77e-01	6.99e-01	9.37e-01	1.54e-01
GOMF POTASSIUM CHANNEL REGULATOR ACTIVITY	46	2.13e-02	1.47e-01	0.3270	-1.40e-01	1.80e-01	2.26e-01	2.92e-02	-5.34e-02	9.94e-02	3.51e-02	7.93e-03	7.32e-01	5.31e-01
GOMF CYCLASE REGULATOR ACTIVITY	16	5.00e-01	8.03e-01	0.3270	8.47e-03	1.51e-01	1.43e-01	2.51e-01	-2.68e-02	9.53e-01	2.97e-01	3.23e-01	8.23e-02	8.53e-01
GOBP MACROPHAGE COLONY STIMULATING FACTOR SIGNALING PATHWAY	7	8.56e-01	9.52e-01	0.3270	-8.13e-02	1.96e-01	1.76e-01	1.44e-01	1.00e-01	7.10e-01	3.70e-01	4.19e-01	5.09e-01	6.46e-01
GOBP DNA TEMPLATED TRANSCRIPTION ELONGATION	132	2.59e-06	1.01e-04	0.3270	5.03e-02	-3.93e-02	-1.91e-01	-2.47e-01	-7.00e-02	3.19e-01	4.36e-01	1.46e-04	9.21e-07	1.65e-01
GOBP REGULATION OF SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING	11	5.67e-01	8.36e-01	0.3270	-1.52e-01	1.19e-01	3.04e-02	-2.62e-01	2.79e-03	3.83e-01	4.93e-01	8.62e-01	1.33e-01	9.87e-01
GOBP REPRODUCTIVE BEHAVIOR	42	4.16e-02	2.26e-01	0.3270	-5.95e-02	-2.80e-02	2.61e-01	1.28e-01	1.33e-01	5.05e-01	7.54e-01	3.40e-03	1.50e-01	1.35e-01
GOBP RIG I SIGNALING PATHWAY	28	1.73e-01	5.13e-01	0.3270	1.56e-01	1.84e-01	-1.28e-01	-1.74e-01	3.99e-02	1.52e-01	9.11e-02	2.41e-01	1.11e-01	7.14e-01
GOMF G PROTEIN BETA SUBUNIT BINDING	21	2.79e-01	6.32e-01	0.3270	6.25e-02	2.27e-01	-8.25e-02	-2.02e-01	-5.71e-02	6.20e-01	7.11e-02	5.13e-01	1.08e-01	6.51e-01
GOBP EMBRYONIC CRANIAL SKELETON MORPHOGENESIS	44	3.43e-02	1.99e-01	0.3270	1.64e-01	9.43e-02	-5.47e-02	-1.28e-01	2.27e-01	6.02e-02	2.79e-01	5.30e-01	1.41e-01	9.14e-03
GOMF G PROTEIN COUPLED AMINE RECEPTOR ACTIVITY	38	5.60e-02	2.74e-01	0.3270	1.58e-01	7.24e-02	2.33e-01	9.42e-02	1.16e-01	9.29e-02	4.40e-01	1.29e-02	3.15e-01	2.16e-01
GOBP REGULATION OF PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION	5	8.92e-01	9.63e-01	0.3270	-1.23e-01	1.44e-01	-1.40e-01	-1.20e-01	1.93e-01	6.35e-01	5.78e-01	5.88e-01	6.42e-01	4.56e-01
GOCC TRANSCRIPTION PREINITIATION COMPLEX	13	5.62e-01	8.33e-01	0.3270	-5.57e-02	1.26e-01	1.06e-02	-1.39e-01	2.61e-01	7.28e-01	4.32e-01	9.47e-01	3.85e-01	1.03e-01
GOBP DENTATE GYRUS DEVELOPMENT	23	2.82e-02	1.76e-01	0.3260	4.09e-02	-1.05e-01	2.54e-01	-1.71e-01	1.57e-02	7.34e-01	3.83e-01	3.53e-02	1.55e-01	8.96e-01
GOMF NEUTRAL L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY	44	2.35e-02	1.56e-01	0.3260	-2.41e-01	5.63e-02	2.05e-01	3.47e-02	-4.58e-02	5.63e-03	5.18e-01	1.88e-02	6.90e-01	5.99e-01
GOBP RESPONSE TO IRON II ION	6	8.87e-01	9.62e-01	0.3260	9.13e-03	2.37e-01	1.75e-01	7.90e-03	1.40e-01	9.69e-01	3.14e-01	4.59e-01	9.73e-01	5.53e-01
GOCC NUCLEAR PORE	89	9.00e-04	1.43e-02	0.3260	-3.96e-04	-9.46e-02	-2.16e-01	-2.23e-01	3.30e-02	9.95e-01	1.23e-01	4.18e-04	2.78e-04	5.91e-01
GOMF ATP DEPENDENT DNA DAMAGE SENSOR ACTIVITY	17	4.49e-01	7.70e-01	0.3260	3.05e-02	-1.15e-01	-1.76e-01	-1.08e-01	2.22e-01	8.28e-01	4.12e-01	2.08e-01	4.39e-01	1.12e-01
GOBP NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY	33	7.69e-02	3.33e-01	0.3260	-3.08e-02	5.63e-02	-9.24e-02	-3.05e-01	-2.24e-02	7.59e-01	5.76e-01	3.59e-01	2.39e-03	8.23e-01
GOBP ANDROGEN METABOLIC PROCESS	29	1.39e-01	4.59e-01	0.3260	-1.15e-01	7.10e-02	3.49e-02	2.22e-01	-1.94e-01	2.86e-01	5.08e-01	7.45e-01	3.83e-02	7.06e-02
GOBP STABILIZATION OF MEMBRANE POTENTIAL	17	5.42e-01	8.24e-01	0.3260	3.59e-02	1.11e-01	2.14e-01	2.06e-01	-6.70e-02	7.98e-01	4.28e-01	1.27e-01	1.41e-01	6.32e-01
GOBP FOREBRAIN GENERATION OF NEURONS	51	3.18e-03	3.83e-02	0.3260	1.69e-03	4.30e-02	1.37e-01	-1.96e-01	2.17e-01	9.83e-01	5.95e-01	9.06e-02	1.52e-02	7.32e-03
GOBP TRANSFORMING GROWTH FACTOR BETA ACTIVATION	13	6.11e-01	8.58e-01	0.3260	-1.77e-01	1.64e-01	2.02e-01	7.19e-02	4.75e-02	2.69e-01	3.06e-01	2.08e-01	6.53e-01	7.67e-01
GOBP PIGMENT CATABOLIC PROCESS	11	3.74e-01	7.14e-01	0.3260	-1.12e-01	2.03e-01	-6.82e-02	1.93e-01	1.02e-01	5.19e-01	2.43e-01	6.95e-01	2.67e-01	5.60e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME	12	6.34e-01	8.71e-01	0.3260	2.11e-01	-8.04e-02	-9.64e-02	-2.06e-01	5.93e-02	2.05e-01	6.30e-01	5.63e-01	2.17e-01	7.22e-01
GOBP POSITIVE REGULATION OF FATTY ACID TRANSPORT	23	2.75e-01	6.29e-01	0.3260	-5.31e-03	2.44e-01	1.60e-01	8.63e-02	-1.17e-01	9.65e-01	4.28e-02	1.85e-01	4.74e-01	3.30e-01
GOBP TOOTH ERUPTION	5	8.92e-01	9.63e-01	0.3260	-6.12e-02	-1.96e-01	1.02e-01	-3.14e-02	2.29e-01	8.13e-01	4.47e-01	6.92e-01	9.03e-01	3.75e-01
GOBP NEPHRIC DUCT DEVELOPMENT	14	5.01e-01	8.03e-01	0.3260	9.35e-02	-1.86e-01	-9.55e-02	-2.31e-01	1.56e-02	5.45e-01	2.29e-01	5.36e-01	1.34e-01	9.20e-01
GOBP VESICLE COATING	38	6.33e-02	2.96e-01	0.3260	1.42e-01	2.75e-02	-1.23e-01	-2.65e-01	2.09e-04	1.31e-01	7.69e-01	1.91e-01	4.72e-03	9.98e-01
GOBP NEGATIVE REGULATION OF B CELL PROLIFERATION	15	5.74e-01	8.40e-01	0.3260	-1.65e-01	-4.96e-02	1.93e-01	1.95e-01	2.74e-02	2.68e-01	7.40e-01	1.95e-01	1.90e-01	8.54e-01
GOBP CELL CYCLE DNA REPLICATION	42	7.39e-02	3.25e-01	0.3260	1.48e-02	3.34e-02	-1.83e-01	-2.64e-01	3.88e-02	8.68e-01	7.08e-01	4.04e-02	3.06e-03	6.64e-01
GOBP SPINDLE ASSEMBLY INVOLVED IN FEMALE MEIOSIS	9	7.56e-01	9.18e-01	0.3260	8.07e-02	1.59e-01	-2.36e-01	-1.35e-01	-4.63e-03	6.75e-01	4.08e-01	2.20e-01	4.83e-01	9.81e-01
GOCC MRNA EDITING COMPLEX	15	5.81e-01	8.43e-01	0.3250	1.19e-01	-1.81e-01	-1.84e-01	-1.42e-01	6.89e-02	4.25e-01	2.24e-01	2.17e-01	3.40e-01	6.44e-01
GOBP NEGATIVE ADAPTATION OF SIGNALING PATHWAY	18	3.40e-01	6.87e-01	0.3250	-1.17e-01	1.41e-01	2.64e-01	-2.02e-02	4.50e-02	3.90e-01	3.00e-01	5.23e-02	8.82e-01	7.41e-01
GOBP REGULATION OF GRANULOCYTE CHEMOTAXIS	49	1.68e-02	1.27e-01	0.3250	-7.65e-02	2.50e-01	1.21e-01	1.40e-01	-5.78e-02	3.54e-01	2.47e-03	1.42e-01	9.05e-02	4.84e-01
GOBP CANONICAL WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT	6	8.84e-01	9.61e-01	0.3250	-1.35e-01	-7.24e-02	-1.02e-01	-2.65e-01	3.96e-02	5.67e-01	7.59e-01	6.65e-01	2.60e-01	8.67e-01
GOBP REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III	28	2.45e-01	6.02e-01	0.3250	8.14e-02	-6.52e-02	-1.72e-01	-2.47e-01	6.38e-02	4.56e-01	5.50e-01	1.15e-01	2.34e-02	5.59e-01
GOMF FIBROBLAST GROWTH FACTOR BINDING	23	1.14e-01	4.12e-01	0.3250	-1.56e-01	-1.23e-01	-5.98e-02	2.49e-01	2.27e-02	1.95e-01	3.07e-01	6.19e-01	3.84e-02	8.50e-01
GOMF NUCLEAR THYROID HORMONE RECEPTOR BINDING	28	2.69e-01	6.23e-01	0.3250	6.31e-02	-6.22e-02	-2.10e-01	-2.26e-01	5.03e-02	5.64e-01	5.69e-01	5.45e-02	3.81e-02	6.45e-01
GOBP REGULATION OF GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY	7	8.01e-01	9.34e-01	0.3250	-2.70e-01	1.43e-01	-1.24e-02	-7.40e-02	8.37e-02	2.17e-01	5.13e-01	9.55e-01	7.35e-01	7.02e-01
GOMF CYCLIC NUCLEOTIDE BINDING	37	7.76e-02	3.34e-01	0.3250	-8.49e-02	1.53e-01	1.71e-01	2.06e-01	5.63e-02	3.71e-01	1.07e-01	7.18e-02	3.02e-02	5.54e-01
GOBP SMOOTH MUSCLE CELL MATRIX ADHESION	6	8.61e-01	9.53e-01	0.3250	-2.39e-01	-3.35e-02	-5.53e-02	-1.19e-01	1.73e-01	3.10e-01	8.87e-01	8.15e-01	6.15e-01	4.63e-01
GOBP REGULATION OF CAMP MEDIATED SIGNALING	29	1.30e-01	4.46e-01	0.3250	-1.13e-01	1.36e-01	2.32e-01	4.16e-02	-1.36e-01	2.90e-01	2.05e-01	3.04e-02	6.98e-01	2.06e-01
GOMF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR BINDING	11	6.27e-01	8.67e-01	0.3250	2.47e-02	3.16e-01	-1.47e-02	-5.61e-02	-3.85e-02	8.87e-01	6.94e-02	9.33e-01	7.47e-01	8.25e-01
GOCC CAJAL BODY	77	1.95e-03	2.65e-02	0.3250	1.62e-01	-9.30e-02	-1.49e-01	-1.80e-01	1.26e-01	1.41e-02	1.58e-01	2.35e-02	6.26e-03	5.63e-02
GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY	1133	1.65e-61	1.88e-58	0.3250	-9.47e-02	-9.96e-02	1.40e-01	2.54e-01	4.79e-02	7.49e-08	1.53e-08	1.85e-15	2.10e-47	6.48e-03
GOBP REGULATION OF HISTONE METHYLATION	16	4.51e-01	7.71e-01	0.3250	2.51e-01	8.35e-02	-6.76e-02	-3.29e-02	1.73e-01	8.24e-02	5.63e-01	6.39e-01	8.20e-01	2.32e-01
GOBP URINARY TRACT SMOOTH MUSCLE CONTRACTION	9	6.09e-01	8.58e-01	0.3250	1.10e-01	-4.45e-03	-3.00e-01	5.63e-02	-7.63e-03	5.68e-01	9.82e-01	1.19e-01	7.70e-01	9.68e-01
GOBP RESPONSE TO PH	41	4.48e-02	2.36e-01	0.3250	-2.93e-02	2.49e-01	1.79e-01	5.27e-02	-8.70e-02	7.46e-01	5.80e-03	4.71e-02	5.59e-01	3.35e-01
GOBP REGULATION OF NON MOTILE CILIUM ASSEMBLY	11	7.23e-01	9.04e-01	0.3250	1.54e-01	-1.78e-01	-1.90e-01	-1.16e-01	1.72e-02	3.77e-01	3.06e-01	2.74e-01	5.06e-01	9.21e-01
GOBP REGULATION OF VOLTAGE GATED SODIUM CHANNEL ACTIVITY	8	7.27e-01	9.05e-01	0.3240	1.93e-01	3.97e-02	2.56e-01	2.84e-02	-6.94e-03	3.45e-01	8.46e-01	2.10e-01	8.90e-01	9.73e-01
GOBP POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION	27	1.34e-01	4.52e-01	0.3240	-1.42e-01	1.99e-01	5.26e-02	-1.71e-01	1.16e-01	2.02e-01	7.41e-02	6.36e-01	1.24e-01	2.96e-01
GOBP NEGATIVE REGULATION OF CIRCADIAN RHYTHM	11	5.70e-01	8.38e-01	0.3240	1.99e-01	1.94e-01	9.39e-02	-1.26e-01	-5.60e-02	2.53e-01	2.64e-01	5.90e-01	4.71e-01	7.48e-01
GOMF NEUROTRANSMITTER BINDING	16	4.56e-01	7.75e-01	0.3240	-1.82e-01	-5.52e-02	-1.28e-01	-1.57e-01	1.68e-01	2.08e-01	7.02e-01	3.76e-01	2.78e-01	2.44e-01
GOBP POSITIVE REGULATION OF KILLING OF CELLS OF ANOTHER ORGANISM	8	7.65e-01	9.22e-01	0.3240	-2.81e-01	3.99e-02	8.92e-02	-1.35e-02	1.29e-01	1.69e-01	8.45e-01	6.62e-01	9.47e-01	5.29e-01
GOBP MYOSIN FILAMENT ORGANIZATION	6	9.13e-01	9.71e-01	0.3240	-2.58e-02	9.34e-02	-1.90e-01	-2.24e-01	9.63e-02	9.13e-01	6.92e-01	4.20e-01	3.41e-01	6.83e-01
GOBP GENOMIC IMPRINTING	18	3.19e-01	6.68e-01	0.3240	2.55e-01	-8.16e-02	1.57e-01	9.10e-02	2.28e-02	6.10e-02	5.49e-01	2.49e-01	5.04e-01	8.67e-01
GOMF REGULATORY RNA BINDING	49	5.47e-03	5.67e-02	0.3240	-2.04e-01	1.26e-01	1.96e-02	-1.79e-01	-1.23e-01	1.36e-02	1.26e-01	8.13e-01	3.03e-02	1.35e-01
GOBP MITOTIC SPINDLE ORGANIZATION	125	1.04e-05	3.47e-04	0.3240	1.21e-01	-6.27e-02	-1.45e-01	-2.43e-01	7.78e-02	1.93e-02	2.26e-01	5.00e-03	2.57e-06	1.33e-01
GOCC CD95 DEATH INDUCING SIGNALING COMPLEX	6	8.39e-01	9.47e-01	0.3240	-1.73e-01	2.82e-02	8.62e-02	-2.08e-01	1.54e-01	4.63e-01	9.05e-01	7.15e-01	3.78e-01	5.13e-01
GOBP REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR	104	1.43e-04	3.18e-03	0.3240	-1.95e-02	2.10e-02	-1.60e-01	-2.50e-01	1.27e-01	7.31e-01	7.11e-01	4.82e-03	1.06e-05	2.52e-02
GOMF UBIQUITIN SPECIFIC PROTEASE BINDING	21	2.93e-01	6.48e-01	0.3240	-2.12e-02	1.59e-01	-1.41e-01	-1.97e-01	-1.44e-01	8.66e-01	2.07e-01	2.64e-01	1.19e-01	2.52e-01
GOCC BLOC COMPLEX	14	5.20e-01	8.13e-01	0.3240	-1.63e-01	1.32e-01	-6.31e-02	-1.80e-01	1.57e-01	2.92e-01	3.94e-01	6.82e-01	2.42e-01	3.09e-01
GOBP ENGULFMENT OF APOPTOTIC CELL	15	3.26e-01	6.74e-01	0.3240	-1.73e-02	-2.82e-01	1.25e-01	2.77e-04	-9.82e-02	9.07e-01	5.88e-02	4.02e-01	9.99e-01	5.10e-01
GOBP PURINE DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS	10	6.34e-01	8.71e-01	0.3240	1.81e-01	1.54e-01	8.86e-03	-5.25e-02	-2.14e-01	3.22e-01	3.99e-01	9.61e-01	7.74e-01	2.41e-01
GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION	19	2.76e-01	6.30e-01	0.3240	1.04e-01	8.42e-02	7.56e-02	1.67e-01	2.31e-01	4.33e-01	5.25e-01	5.68e-01	2.07e-01	8.14e-02
GOBP GLIAL CELL ACTIVATION	57	8.35e-03	7.73e-02	0.3240	-7.80e-02	7.60e-02	2.37e-01	8.83e-02	1.71e-01	3.08e-01	3.21e-01	2.01e-03	2.49e-01	2.55e-02
GOCC SCHMIDT LANTERMAN INCISURE	11	6.30e-01	8.69e-01	0.3240	-6.20e-03	2.42e-01	1.07e-02	-5.23e-02	2.08e-01	9.72e-01	1.65e-01	9.51e-01	7.64e-01	2.32e-01
GOBP REGULATION OF PODOSOME ASSEMBLY	13	2.55e-01	6.13e-01	0.3240	5.06e-02	1.97e-01	-2.11e-01	1.30e-01	3.98e-02	7.52e-01	2.18e-01	1.87e-01	4.16e-01	8.04e-01
GOBP REGULATION OF MALE GONAD DEVELOPMENT	8	7.36e-01	9.09e-01	0.3240	-4.50e-03	2.03e-01	2.33e-01	-9.45e-02	1.59e-02	9.82e-01	3.20e-01	2.54e-01	6.43e-01	9.38e-01
GOBP NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION	6	8.41e-01	9.48e-01	0.3240	-1.75e-02	2.92e-01	-1.23e-01	-5.52e-02	-2.91e-02	9.41e-01	2.15e-01	6.03e-01	8.15e-01	9.02e-01
GOCC PERICENTRIOLAR MATERIAL	22	1.51e-01	4.77e-01	0.3240	2.34e-01	-2.13e-02	8.60e-02	-1.78e-01	1.01e-01	5.71e-02	8.63e-01	4.85e-01	1.48e-01	4.12e-01
GOBP GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS	23	1.80e-01	5.22e-01	0.3230	1.94e-01	1.03e-01	-1.06e-02	2.28e-02	-2.36e-01	1.07e-01	3.90e-01	9.30e-01	8.50e-01	5.01e-02
GOCC PRESPLICEOSOME	16	5.56e-01	8.31e-01	0.3230	5.48e-02	8.76e-02	-1.74e-01	-2.01e-01	1.52e-01	7.04e-01	5.44e-01	2.28e-01	1.64e-01	2.91e-01
GOBP RENAL ABSORPTION	32	3.12e-02	1.88e-01	0.3230	5.20e-03	2.71e-01	-3.57e-02	1.64e-01	-5.33e-02	9.59e-01	7.93e-03	7.26e-01	1.08e-01	6.02e-01
GOBP REGULATION OF DNA DAMAGE CHECKPOINT	23	2.99e-01	6.53e-01	0.3230	1.26e-01	9.92e-02	-5.56e-02	-2.33e-01	1.46e-01	2.96e-01	4.10e-01	6.45e-01	5.26e-02	2.27e-01
GOMF FIBROBLAST GROWTH FACTOR RECEPTOR ACTIVITY	5	9.08e-01	9.69e-01	0.3230	-1.90e-02	-2.71e-01	-1.61e-01	6.17e-02	2.96e-02	9.41e-01	2.93e-01	5.34e-01	8.11e-01	9.09e-01
GOMF HISTONE KINASE ACTIVITY	20	3.59e-01	7.03e-01	0.3230	1.99e-01	6.63e-02	-1.37e-01	-9.56e-02	1.80e-01	1.23e-01	6.08e-01	2.88e-01	4.59e-01	1.63e-01
GOCC FICOLIN 1 RICH GRANULE MEMBRANE	59	5.56e-03	5.74e-02	0.3230	-1.84e-01	1.78e-01	1.91e-01	3.50e-02	3.60e-02	1.47e-02	1.77e-02	1.13e-02	6.42e-01	6.32e-01
GOBP ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE	77	3.92e-04	7.39e-03	0.3230	-1.67e-01	-1.65e-01	1.28e-01	8.45e-02	-1.61e-01	1.15e-02	1.21e-02	5.22e-02	2.00e-01	1.48e-02
GOBP NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE	15	5.20e-01	8.13e-01	0.3230	2.26e-02	-1.75e-02	3.25e-02	2.52e-01	-1.98e-01	8.80e-01	9.07e-01	8.27e-01	9.14e-02	1.85e-01
GOBP LACTATE METABOLIC PROCESS	18	4.49e-01	7.70e-01	0.3230	1.18e-01	1.54e-01	-8.33e-02	-2.29e-01	8.66e-02	3.88e-01	2.59e-01	5.41e-01	9.28e-02	5.25e-01
GOBP THIAMINE CONTAINING COMPOUND METABOLIC PROCESS	6	8.93e-01	9.64e-01	0.3230	-2.17e-01	3.49e-02	1.37e-01	6.16e-02	-1.83e-01	3.58e-01	8.82e-01	5.62e-01	7.94e-01	4.37e-01
GOBP T CELL CYTOKINE PRODUCTION	35	8.10e-02	3.42e-01	0.3230	-2.49e-02	1.13e-01	2.38e-01	3.49e-02	1.82e-01	7.99e-01	2.45e-01	1.50e-02	7.21e-01	6.26e-02
GOBP MAINTENANCE OF CELL POLARITY	17	3.81e-01	7.19e-01	0.3230	2.37e-02	2.93e-01	5.75e-02	-8.95e-02	-8.14e-02	8.66e-01	3.66e-02	6.81e-01	5.23e-01	5.61e-01
GOBP INNATE IMMUNE RESPONSE IN MUCOSA	26	1.56e-01	4.84e-01	0.3230	-1.49e-01	-2.59e-01	-4.27e-02	-8.78e-02	7.26e-02	1.88e-01	2.22e-02	7.07e-01	4.39e-01	5.22e-01
GOBP HEAT GENERATION	17	4.33e-01	7.57e-01	0.3230	1.63e-01	1.01e-01	1.07e-01	-2.35e-02	2.35e-01	2.44e-01	4.70e-01	4.46e-01	8.67e-01	9.33e-02
GOBP MEIOTIC SPINDLE ASSEMBLY	12	7.34e-01	9.09e-01	0.3230	1.37e-01	3.27e-04	-1.96e-01	-2.09e-01	5.73e-02	4.11e-01	9.98e-01	2.40e-01	2.09e-01	7.31e-01
GOMF MRNA REGULATORY ELEMENT BINDING TRANSLATION REPRESSOR ACTIVITY	15	4.71e-01	7.86e-01	0.3230	1.65e-02	2.87e-01	-1.89e-02	-1.38e-01	-4.16e-02	9.12e-01	5.39e-02	8.99e-01	3.54e-01	7.80e-01
GOBP REGULATION OF PHOSPHATE TRANSPORT	6	8.31e-01	9.45e-01	0.3230	-1.78e-01	1.51e-01	-1.97e-01	-8.65e-02	5.76e-02	4.49e-01	5.21e-01	4.04e-01	7.14e-01	8.07e-01
GOBP TRNA CATABOLIC PROCESS	16	5.59e-01	8.32e-01	0.3220	2.08e-02	7.24e-02	-2.22e-01	-2.16e-01	-4.92e-02	8.85e-01	6.16e-01	1.24e-01	1.35e-01	7.33e-01
GOBP POSITIVE REGULATION OF RESPONSE TO TUMOR CELL	15	4.14e-01	7.44e-01	0.3220	-2.83e-01	8.88e-02	-9.31e-02	1.26e-02	-8.58e-02	5.81e-02	5.51e-01	5.33e-01	9.32e-01	5.65e-01
GOMF RNA POLYMERASE III GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY	12	5.54e-01	8.30e-01	0.3220	1.71e-01	-8.02e-02	-4.01e-02	-2.55e-01	3.98e-02	3.05e-01	6.31e-01	8.10e-01	1.26e-01	8.11e-01
GOBP PROTEIN DENEDDYLATION	11	7.03e-01	8.97e-01	0.3220	9.87e-02	-7.03e-03	-1.06e-01	-2.84e-01	4.65e-02	5.71e-01	9.68e-01	5.42e-01	1.03e-01	7.89e-01
GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN LINEAR AMIDINES	11	6.71e-01	8.84e-01	0.3220	-1.79e-01	-1.68e-01	-8.05e-02	1.10e-01	-1.59e-01	3.04e-01	3.35e-01	6.44e-01	5.29e-01	3.63e-01
GOBP REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE	30	1.00e-01	3.83e-01	0.3220	-6.53e-02	2.37e-01	6.69e-02	1.85e-01	-6.96e-02	5.36e-01	2.49e-02	5.26e-01	7.92e-02	5.10e-01
GOBP CARDIAC ATRIUM MORPHOGENESIS	29	1.34e-01	4.53e-01	0.3220	9.98e-02	1.09e-01	7.30e-02	-1.61e-01	2.25e-01	3.52e-01	3.10e-01	4.96e-01	1.34e-01	3.58e-02
GOCC TIM23 MITOCHONDRIAL IMPORT INNER MEMBRANE TRANSLOCASE COMPLEX	14	4.48e-01	7.70e-01	0.3220	-1.18e-01	1.37e-01	5.50e-02	-2.54e-01	5.90e-02	4.44e-01	3.75e-01	7.22e-01	9.97e-02	7.02e-01
GOBP REGULATION OF VIRAL TRANSCRIPTION	18	3.52e-01	6.98e-01	0.3220	1.11e-01	-1.24e-01	-1.08e-01	-2.48e-01	-5.20e-02	4.15e-01	3.63e-01	4.27e-01	6.83e-02	7.02e-01
GOBP REGULATION OF AUTOPHAGOSOME MATURATION	16	4.17e-01	7.46e-01	0.3220	2.24e-01	1.82e-01	4.25e-02	-1.34e-01	2.06e-02	1.20e-01	2.06e-01	7.69e-01	3.54e-01	8.86e-01
GOBP DNA TEMPLATED TRANSCRIPTION INITIATION	134	1.12e-05	3.69e-04	0.3220	6.63e-02	-4.91e-02	-2.20e-01	-2.19e-01	-1.63e-02	1.85e-01	3.26e-01	1.07e-05	1.15e-05	7.44e-01
GOBP THYMOCYTE APOPTOTIC PROCESS	20	1.53e-01	4.80e-01	0.3220	5.80e-02	1.86e-02	5.83e-02	-3.08e-01	3.95e-02	6.53e-01	8.85e-01	6.52e-01	1.71e-02	7.60e-01
GOBP NEGATIVE REGULATION OF CYTOPLASMIC TRANSLATION	8	7.84e-01	9.28e-01	0.3220	-1.37e-01	2.04e-01	1.17e-01	4.36e-02	1.67e-01	5.03e-01	3.18e-01	5.68e-01	8.31e-01	4.14e-01
GOBP ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION	40	8.38e-02	3.49e-01	0.3220	1.69e-01	-1.74e-02	-2.02e-01	-1.83e-01	-1.46e-02	6.41e-02	8.49e-01	2.70e-02	4.51e-02	8.73e-01
GOBP RESPONSE TO LEUCINE	15	5.75e-01	8.40e-01	0.3220	1.80e-01	7.72e-02	-1.70e-01	-1.43e-01	1.25e-01	2.28e-01	6.04e-01	2.53e-01	3.37e-01	4.03e-01
GOBP BONE MINERALIZATION INVOLVED IN BONE MATURATION	13	5.92e-01	8.47e-01	0.3220	-8.54e-02	-2.27e-02	-3.15e-02	-1.97e-01	2.37e-01	5.94e-01	8.88e-01	8.44e-01	2.20e-01	1.40e-01
GOBP CELLULAR RESPONSE TO COLD	13	6.17e-01	8.62e-01	0.3220	9.21e-02	1.36e-01	-1.32e-01	-2.36e-01	-5.84e-02	5.65e-01	3.97e-01	4.12e-01	1.40e-01	7.15e-01
GOBP POSITIVE REGULATION OF TRANSLATION IN RESPONSE TO STRESS	6	8.72e-01	9.58e-01	0.3210	4.51e-02	1.20e-01	2.84e-01	4.96e-02	-6.18e-02	8.48e-01	6.11e-01	2.28e-01	8.33e-01	7.93e-01
GOBP RETINOIC ACID RECEPTOR SIGNALING PATHWAY	32	8.29e-02	3.47e-01	0.3210	-1.16e-01	2.32e-01	-4.22e-03	-1.29e-01	1.38e-01	2.55e-01	2.29e-02	9.67e-01	2.08e-01	1.75e-01
GOBP FRUCTOSE METABOLIC PROCESS	13	6.92e-01	8.92e-01	0.3210	1.41e-02	-3.60e-02	-1.49e-01	-2.45e-01	1.39e-01	9.30e-01	8.22e-01	3.51e-01	1.26e-01	3.85e-01
GOBP MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS	158	6.01e-07	2.84e-05	0.3210	1.27e-01	-5.32e-02	-1.66e-01	-2.30e-01	6.25e-02	5.76e-03	2.49e-01	3.08e-04	6.34e-07	1.75e-01
GOBP HEPARIN BIOSYNTHETIC PROCESS	11	5.80e-01	8.43e-01	0.3210	2.10e-02	3.42e-02	-8.52e-03	3.03e-01	-1.00e-01	9.04e-01	8.44e-01	9.61e-01	8.23e-02	5.65e-01
GOBP RNA EXPORT FROM NUCLEUS	82	1.25e-03	1.86e-02	0.3210	1.75e-02	3.77e-03	-1.76e-01	-2.67e-01	-2.41e-02	7.85e-01	9.53e-01	5.80e-03	2.90e-05	7.05e-01
GOBP NEGATIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS	9	7.87e-01	9.29e-01	0.3210	-1.28e-02	7.13e-02	-1.40e-01	-2.73e-01	-6.40e-02	9.47e-01	7.11e-01	4.67e-01	1.57e-01	7.39e-01
GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING	26	3.02e-01	6.55e-01	0.3210	2.39e-02	-1.12e-01	-2.14e-01	-2.09e-01	-2.23e-02	8.33e-01	3.21e-01	5.92e-02	6.47e-02	8.44e-01
GOBP FIBRINOLYSIS	27	1.90e-01	5.36e-01	0.3210	-1.29e-01	-9.61e-02	7.62e-02	2.64e-01	-4.45e-02	2.46e-01	3.87e-01	4.93e-01	1.77e-02	6.89e-01
GOBP AUTOPHAGOSOME MATURATION	60	1.34e-02	1.08e-01	0.3210	1.06e-01	9.16e-02	-1.64e-01	-2.34e-01	4.58e-02	1.56e-01	2.20e-01	2.85e-02	1.72e-03	5.39e-01
GOBP REGULATION OF COMPLEMENT ACTIVATION	21	3.73e-01	7.12e-01	0.3210	-6.76e-02	-6.86e-02	5.97e-02	2.25e-01	-1.99e-01	5.92e-01	5.86e-01	6.36e-01	7.39e-02	1.15e-01
GOBP RESPONSE TO IMMOBILIZATION STRESS	21	2.54e-01	6.10e-01	0.3210	1.33e-01	2.90e-01	-3.14e-02	-1.40e-02	1.58e-02	2.90e-01	2.16e-02	8.03e-01	9.12e-01	9.00e-01
GOBP LIGAND GATED ION CHANNEL SIGNALING PATHWAY	31	1.38e-01	4.57e-01	0.3210	-9.77e-02	8.35e-02	1.74e-01	2.06e-01	1.17e-01	3.47e-01	4.21e-01	9.28e-02	4.71e-02	2.59e-01
GOBP CELLULAR RESPONSE TO DSRNA	22	2.41e-01	5.98e-01	0.3210	-6.45e-02	2.11e-01	-1.77e-01	-1.41e-01	5.51e-02	6.01e-01	8.70e-02	1.51e-01	2.51e-01	6.54e-01
GOMF FATTY ACID TRANSMEMBRANE TRANSPORTER ACTIVITY	10	6.89e-01	8.91e-01	0.3210	-1.88e-01	1.74e-01	1.56e-01	-7.28e-02	8.70e-02	3.03e-01	3.40e-01	3.94e-01	6.90e-01	6.34e-01
GOMF PHOSPHOLIPID SCRAMBLASE ACTIVITY	15	5.25e-01	8.16e-01	0.3210	2.04e-02	-4.14e-03	-2.22e-01	-8.88e-02	-2.13e-01	8.91e-01	9.78e-01	1.37e-01	5.51e-01	1.53e-01
GOBP NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL	11	6.14e-01	8.60e-01	0.3210	3.53e-02	2.94e-01	-6.25e-02	-4.95e-02	9.24e-02	8.39e-01	9.09e-02	7.19e-01	7.76e-01	5.96e-01
GOBP REGULATION OF APOPTOTIC DNA FRAGMENTATION	10	4.22e-01	7.49e-01	0.3210	1.14e-01	-1.70e-01	8.88e-02	-1.86e-01	-1.35e-01	5.31e-01	3.52e-01	6.27e-01	3.07e-01	4.60e-01
GOBP PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING	11	6.48e-01	8.77e-01	0.3210	8.09e-02	-1.16e-01	-1.81e-01	6.97e-02	-2.13e-01	6.42e-01	5.07e-01	3.00e-01	6.89e-01	2.21e-01
GOMF SINGLE STRANDED DNA ENDODEOXYRIBONUCLEASE ACTIVITY	10	7.14e-01	9.01e-01	0.3200	2.89e-01	2.13e-02	-1.40e-02	-9.51e-02	9.73e-02	1.14e-01	9.07e-01	9.39e-01	6.03e-01	5.94e-01
GOBP RIBOSOMAL SMALL SUBUNIT ASSEMBLY	18	5.01e-01	8.03e-01	0.3200	7.98e-02	-2.66e-02	-2.66e-01	-1.49e-01	5.34e-02	5.58e-01	8.45e-01	5.08e-02	2.75e-01	6.95e-01
GOBP POSITIVE REGULATION OF AMYLOID BETA FORMATION	20	9.84e-02	3.79e-01	0.3200	-1.91e-01	-6.84e-04	-9.90e-02	2.21e-01	8.71e-02	1.40e-01	9.96e-01	4.43e-01	8.68e-02	5.00e-01
GOCC GABA ERGIC SYNAPSE	73	2.61e-03	3.30e-02	0.3200	1.81e-02	4.29e-02	2.67e-01	1.36e-01	1.05e-01	7.90e-01	5.26e-01	8.16e-05	4.45e-02	1.23e-01
GOBP SPERM DNA CONDENSATION	17	3.84e-01	7.22e-01	0.3200	-1.74e-01	-5.33e-02	-1.80e-02	-1.04e-01	2.42e-01	2.13e-01	7.04e-01	8.98e-01	4.59e-01	8.47e-02
GOMF PHOSPHOTYROSINE RESIDUE BINDING	46	2.37e-02	1.57e-01	0.3200	-8.57e-02	2.41e-01	1.59e-01	-9.07e-04	1.08e-01	3.15e-01	4.60e-03	6.25e-02	9.92e-01	2.03e-01
GOBP REGULATION OF PROTEIN LIPIDATION	11	6.49e-01	8.77e-01	0.3200	-1.68e-01	-1.29e-01	-6.79e-02	-2.29e-01	2.55e-02	3.36e-01	4.59e-01	6.97e-01	1.88e-01	8.83e-01
GOBP CELLULAR RESPONSE TO ESTROGEN STIMULUS	18	3.67e-01	7.07e-01	0.3200	-1.90e-02	1.67e-01	2.00e-01	-7.57e-02	1.69e-01	8.89e-01	2.19e-01	1.42e-01	5.78e-01	2.15e-01
GOCC CALYX OF HELD	19	1.64e-01	4.97e-01	0.3200	-3.64e-02	2.70e-02	1.57e-01	-2.51e-01	1.12e-01	7.84e-01	8.39e-01	2.35e-01	5.80e-02	3.97e-01
GOBP POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION	21	4.06e-01	7.39e-01	0.3200	-8.18e-02	1.44e-02	-1.68e-01	-2.43e-01	9.10e-02	5.16e-01	9.09e-01	1.84e-01	5.37e-02	4.70e-01
GOBP LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE	52	1.68e-02	1.26e-01	0.3200	-8.05e-02	5.36e-02	2.26e-01	1.06e-01	1.76e-01	3.16e-01	5.04e-01	4.83e-03	1.86e-01	2.85e-02
GOBP REGULATION OF SUPEROXIDE ANION GENERATION	19	3.34e-01	6.82e-01	0.3200	-8.71e-02	2.81e-01	6.63e-02	-5.96e-02	-8.75e-02	5.11e-01	3.37e-02	6.17e-01	6.53e-01	5.09e-01
GOMF MONOATOMIC ANION CHANNEL ACTIVITY	86	5.43e-04	9.46e-03	0.3200	-1.22e-01	1.04e-01	1.74e-01	2.08e-01	5.32e-02	5.02e-02	9.40e-02	5.23e-03	8.49e-04	3.94e-01
GOBP REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT	8	7.60e-01	9.20e-01	0.3200	1.55e-01	1.90e-01	1.27e-01	-1.47e-01	6.31e-02	4.47e-01	3.51e-01	5.33e-01	4.70e-01	7.57e-01
GOBP PLANAR CELL POLARITY PATHWAY INVOLVED IN AXIS ELONGATION	6	7.06e-01	8.97e-01	0.3200	-2.25e-02	-1.52e-01	2.19e-01	-9.18e-02	-1.49e-01	9.24e-01	5.19e-01	3.52e-01	6.97e-01	5.28e-01
GOBP NEGATIVE REGULATION OF MEMBRANE POTENTIAL	12	6.69e-01	8.83e-01	0.3200	-1.67e-02	-1.64e-01	-9.88e-02	-1.49e-01	2.07e-01	9.20e-01	3.25e-01	5.53e-01	3.71e-01	2.14e-01
GOMF SNAP RECEPTOR ACTIVITY	36	1.13e-01	4.11e-01	0.3200	-6.72e-03	7.17e-02	-1.05e-01	-2.43e-01	1.64e-01	9.44e-01	4.57e-01	2.77e-01	1.15e-02	8.87e-02
GOBP CARDIAC LEFT VENTRICLE MORPHOGENESIS	16	3.87e-01	7.24e-01	0.3200	2.69e-01	-4.33e-02	3.69e-02	-1.36e-01	8.89e-02	6.20e-02	7.64e-01	7.98e-01	3.48e-01	5.38e-01
GOBP MRNA SPLICE SITE RECOGNITION	35	1.32e-01	4.50e-01	0.3190	-2.60e-03	1.91e-02	-1.80e-01	-2.61e-01	-3.37e-02	9.79e-01	8.45e-01	6.55e-02	7.50e-03	7.30e-01
GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION	21	2.75e-01	6.30e-01	0.3190	-5.49e-02	-2.73e-01	9.81e-02	1.06e-01	6.05e-02	6.63e-01	3.04e-02	4.37e-01	4.00e-01	6.31e-01
GOBP THIAMINE DIPHOSPHATE METABOLIC PROCESS	5	9.06e-01	9.69e-01	0.3190	-2.49e-01	1.42e-02	5.64e-02	-5.95e-02	-1.82e-01	3.35e-01	9.56e-01	8.27e-01	8.18e-01	4.81e-01
GOMF ACTIVIN BINDING	11	6.53e-01	8.79e-01	0.3190	-5.23e-02	2.10e-01	1.49e-01	-1.15e-01	1.40e-01	7.64e-01	2.27e-01	3.93e-01	5.08e-01	4.22e-01
GOBP RESCUE OF STALLED RIBOSOME	29	2.05e-01	5.55e-01	0.3190	1.28e-02	7.47e-02	-2.53e-01	-1.79e-01	1.75e-02	9.05e-01	4.86e-01	1.85e-02	9.50e-02	8.70e-01
GOBP SMOOTH MUSCLE CELL DIFFERENTIATION	72	9.41e-04	1.48e-02	0.3190	1.87e-02	1.68e-01	1.59e-01	-7.00e-02	2.08e-01	7.84e-01	1.37e-02	2.00e-02	3.04e-01	2.25e-03
GOMF CAMP BINDING	22	2.91e-01	6.45e-01	0.3190	-6.91e-02	2.56e-01	1.11e-01	1.35e-01	-3.15e-02	5.75e-01	3.74e-02	3.68e-01	2.74e-01	7.98e-01
GOBP POSITIVE REGULATION OF DEFENSE RESPONSE TO BACTERIUM	14	3.47e-01	6.94e-01	0.3190	-2.25e-01	-6.13e-02	-1.84e-01	1.16e-01	-7.31e-03	1.45e-01	6.91e-01	2.32e-01	4.52e-01	9.62e-01
GOCC DYNACTIN COMPLEX	8	6.82e-01	8.88e-01	0.3190	2.17e-01	-6.00e-03	4.54e-03	-2.02e-01	-1.19e-01	2.89e-01	9.77e-01	9.82e-01	3.24e-01	5.58e-01
GOBP REGULATION OF FERTILIZATION	17	5.30e-01	8.19e-01	0.3190	-7.26e-02	-8.79e-02	9.65e-02	2.28e-01	-1.66e-01	6.04e-01	5.30e-01	4.91e-01	1.04e-01	2.35e-01
GOBP PEPTIDYL PROLINE HYDROXYLATION	11	6.03e-01	8.54e-01	0.3190	-8.33e-02	1.42e-01	2.57e-03	-1.27e-01	-2.42e-01	6.33e-01	4.15e-01	9.88e-01	4.65e-01	1.65e-01
GOBP REGULATION OF TORC2 SIGNALING	6	8.86e-01	9.62e-01	0.3190	-1.24e-01	1.75e-01	3.19e-02	4.02e-02	-2.31e-01	6.00e-01	4.59e-01	8.92e-01	8.65e-01	3.27e-01
GOMF MAP KINASE KINASE KINASE ACTIVITY	24	2.41e-01	5.98e-01	0.3190	6.38e-02	1.77e-01	1.39e-01	-5.67e-02	2.10e-01	5.88e-01	1.34e-01	2.39e-01	6.30e-01	7.53e-02
GOBP CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION	32	1.49e-01	4.73e-01	0.3190	-1.67e-01	1.45e-01	1.38e-01	1.07e-01	-1.50e-01	1.03e-01	1.55e-01	1.77e-01	2.96e-01	1.42e-01
GOMF LYSOPHOSPHOLIPID ACYLTRANSFERASE ACTIVITY	19	3.33e-01	6.81e-01	0.3190	2.21e-01	1.36e-01	-1.07e-01	-8.04e-02	-1.29e-01	9.60e-02	3.04e-01	4.18e-01	5.44e-01	3.32e-01
GOCC BRAHMA COMPLEX	14	2.66e-01	6.21e-01	0.3190	1.10e-01	6.20e-03	2.55e-01	-1.49e-01	4.96e-02	4.78e-01	9.68e-01	9.87e-02	3.34e-01	7.48e-01
GOBP REGULATION OF MDA 5 SIGNALING PATHWAY	7	7.87e-01	9.30e-01	0.3190	1.36e-01	2.59e-01	-8.67e-02	6.13e-02	-6.99e-02	5.33e-01	2.36e-01	6.91e-01	7.79e-01	7.49e-01
GOBP PIGMENT GRANULE MATURATION	10	7.07e-01	8.97e-01	0.3190	2.20e-02	2.27e-01	-1.03e-01	-1.49e-01	-1.30e-01	9.04e-01	2.13e-01	5.73e-01	4.16e-01	4.78e-01
GOBP RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE	22	2.92e-01	6.45e-01	0.3190	-1.03e-01	1.32e-01	9.65e-02	2.47e-01	-5.76e-02	4.03e-01	2.83e-01	4.33e-01	4.50e-02	6.40e-01
GOBP AUDITORY RECEPTOR CELL MORPHOGENESIS	19	4.02e-01	7.35e-01	0.3190	-1.63e-01	2.77e-02	2.56e-02	1.85e-01	-1.99e-01	2.17e-01	8.34e-01	8.47e-01	1.64e-01	1.34e-01
GOBP REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION	53	3.67e-03	4.27e-02	0.3190	-1.59e-01	2.59e-01	-4.77e-02	8.81e-03	-8.34e-02	4.53e-02	1.11e-03	5.48e-01	9.12e-01	2.94e-01
GOMF GLUTATHIONE TRANSFERASE ACTIVITY	22	2.65e-01	6.20e-01	0.3190	-2.32e-02	6.95e-02	1.45e-01	-4.88e-02	2.70e-01	8.50e-01	5.73e-01	2.39e-01	6.92e-01	2.85e-02
GOBP MITOTIC CELL CYCLE CHECKPOINT SIGNALING	139	6.68e-06	2.33e-04	0.3190	1.43e-01	-1.55e-02	-2.06e-01	-1.96e-01	1.30e-02	3.66e-03	7.52e-01	2.83e-05	6.54e-05	7.91e-01
GOBP INTRACELLULAR PROTEIN TRANSMEMBRANE TRANSPORT	52	2.15e-02	1.48e-01	0.3190	-7.65e-02	6.81e-02	-1.57e-01	-2.56e-01	-2.86e-02	3.40e-01	3.95e-01	5.06e-02	1.39e-03	7.21e-01
GOBP METANEPHRIC NEPHRON MORPHOGENESIS	24	1.34e-01	4.52e-01	0.3190	1.41e-01	-1.55e-02	7.99e-02	-2.31e-01	1.48e-01	2.33e-01	8.96e-01	4.98e-01	5.05e-02	2.09e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN REDUCED FLAVIN OR FLAVOPROTEIN AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN	42	2.79e-02	1.75e-01	0.3190	5.66e-02	3.01e-02	8.36e-02	3.00e-01	1.21e-02	5.25e-01	7.36e-01	3.48e-01	7.54e-04	8.92e-01
GOCC REPLISOME	13	5.83e-01	8.44e-01	0.3190	1.82e-01	7.68e-02	-2.25e-01	-7.29e-02	8.11e-02	2.56e-01	6.31e-01	1.60e-01	6.49e-01	6.13e-01
GOBP CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES	22	3.10e-01	6.62e-01	0.3190	-1.29e-01	-1.36e-01	1.98e-01	1.42e-01	8.19e-02	2.93e-01	2.68e-01	1.08e-01	2.49e-01	5.06e-01
GOBP L GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE	17	3.98e-01	7.31e-01	0.3180	-8.43e-02	2.54e-01	-5.49e-03	-1.36e-02	-1.72e-01	5.48e-01	6.98e-02	9.69e-01	9.23e-01	2.19e-01
GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS	8	7.34e-01	9.09e-01	0.3180	-9.73e-02	6.48e-02	1.45e-01	-3.75e-02	-2.55e-01	6.34e-01	7.51e-01	4.77e-01	8.54e-01	2.11e-01
GOBP POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM	12	6.80e-01	8.87e-01	0.3180	-5.54e-02	-3.87e-02	-9.06e-02	-2.66e-01	1.34e-01	7.40e-01	8.17e-01	5.87e-01	1.11e-01	4.22e-01
GOMF VERY LONG CHAIN FATTY ACID COA LIGASE ACTIVITY	9	7.03e-01	8.96e-01	0.3180	-1.01e-01	2.13e-01	9.55e-02	-1.92e-01	-5.55e-03	6.00e-01	2.69e-01	6.20e-01	3.20e-01	9.77e-01
GOBP NEGATIVE REGULATION OF MYOSIN LIGHT CHAIN PHOSPHATASE ACTIVITY	5	9.02e-01	9.68e-01	0.3180	-1.91e-01	-1.13e-01	-1.39e-01	1.23e-01	-1.33e-01	4.59e-01	6.63e-01	5.89e-01	6.34e-01	6.07e-01
GOBP PEROXISOMAL TRANSPORT	22	3.64e-01	7.05e-01	0.3180	4.36e-02	-1.24e-01	-2.08e-01	-1.64e-01	-1.16e-01	7.23e-01	3.15e-01	9.06e-02	1.82e-01	3.44e-01
GOBP KERATINOCYTE MIGRATION	20	2.14e-01	5.67e-01	0.3180	-6.18e-02	2.28e-01	-1.42e-01	-6.23e-02	1.47e-01	6.32e-01	7.80e-02	2.70e-01	6.30e-01	2.56e-01
GOMF AMMONIA LYASE ACTIVITY	5	9.36e-01	9.80e-01	0.3180	7.02e-02	1.33e-01	1.20e-01	1.79e-01	-1.80e-01	7.86e-01	6.07e-01	6.43e-01	4.88e-01	4.86e-01
GOCC AXON HILLOCK	7	8.29e-01	9.44e-01	0.3180	-1.54e-01	1.53e-01	7.85e-02	-4.46e-02	2.14e-01	4.79e-01	4.83e-01	7.19e-01	8.38e-01	3.27e-01
GOMF U6 SNRNA BINDING	14	5.80e-01	8.43e-01	0.3180	2.35e-01	4.71e-02	-1.44e-01	-1.42e-01	-5.21e-02	1.28e-01	7.60e-01	3.51e-01	3.56e-01	7.36e-01
GOBP REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION	18	2.69e-01	6.23e-01	0.3180	1.54e-01	-1.33e-01	-2.04e-02	-2.43e-01	1.09e-02	2.57e-01	3.29e-01	8.81e-01	7.45e-02	9.36e-01
GOBP REGULATION OF TRANSFORMING GROWTH FACTOR BETA ACTIVATION	10	7.82e-01	9.28e-01	0.3180	-1.82e-01	9.88e-02	1.92e-01	1.06e-01	-9.99e-02	3.19e-01	5.88e-01	2.93e-01	5.62e-01	5.84e-01
GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS	14	4.94e-01	7.99e-01	0.3180	-1.09e-02	9.94e-02	1.14e-01	2.05e-02	-2.79e-01	9.44e-01	5.20e-01	4.61e-01	8.94e-01	7.12e-02
GOBP EYE PIGMENTATION	5	9.12e-01	9.71e-01	0.3180	-1.34e-01	-2.25e-01	-2.28e-02	-5.03e-02	1.72e-01	6.05e-01	3.84e-01	9.30e-01	8.46e-01	5.06e-01
GOBP POSITIVE REGULATION OF HEART RATE BY EPINEPHRINE NOREPINEPHRINE	5	9.16e-01	9.73e-01	0.3180	-7.45e-02	-1.16e-03	2.14e-01	1.53e-02	2.22e-01	7.73e-01	9.96e-01	4.08e-01	9.53e-01	3.89e-01
GOBP PROTEIN TRANSMEMBRANE TRANSPORT	64	1.11e-02	9.47e-02	0.3180	-4.06e-02	1.69e-02	-1.90e-01	-2.51e-01	7.89e-03	5.74e-01	8.16e-01	8.65e-03	5.20e-04	9.13e-01
GOBP CYTIDINE METABOLIC PROCESS	12	6.70e-01	8.83e-01	0.3180	2.65e-01	-5.52e-02	-1.11e-01	-9.65e-02	7.59e-02	1.11e-01	7.41e-01	5.05e-01	5.63e-01	6.49e-01
GOMF CYTIDINE DEAMINASE ACTIVITY	12	6.70e-01	8.83e-01	0.3180	2.65e-01	-5.52e-02	-1.11e-01	-9.65e-02	7.59e-02	1.11e-01	7.41e-01	5.05e-01	5.63e-01	6.49e-01
GOMF DYNEIN COMPLEX BINDING	23	1.30e-01	4.46e-01	0.3180	-3.75e-03	-3.31e-02	8.68e-02	-2.66e-01	1.46e-01	9.75e-01	7.83e-01	4.71e-01	2.71e-02	2.25e-01
GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING	12	5.99e-01	8.52e-01	0.3180	7.93e-02	1.56e-01	3.30e-02	-2.47e-01	8.93e-02	6.34e-01	3.50e-01	8.43e-01	1.38e-01	5.92e-01
GOCC DENDRITE TERMINUS	12	5.10e-01	8.08e-01	0.3170	1.54e-01	-1.78e-01	1.35e-01	-6.30e-02	1.52e-01	3.55e-01	2.87e-01	4.17e-01	7.06e-01	3.62e-01
GOBP RESPONSE TO MANGANESE ION	17	3.69e-01	7.09e-01	0.3170	-1.07e-01	1.16e-01	-4.86e-02	-1.94e-01	-1.90e-01	4.47e-01	4.09e-01	7.29e-01	1.67e-01	1.74e-01
GOMF INTRACELLULAR CHLORIDE CHANNEL ACTIVITY	19	4.65e-01	7.80e-01	0.3170	1.03e-04	3.17e-03	2.05e-01	2.18e-01	1.05e-01	9.99e-01	9.81e-01	1.22e-01	9.92e-02	4.29e-01
GOCC AXONAL GROWTH CONE	25	3.09e-01	6.61e-01	0.3170	-1.40e-02	-5.69e-02	1.38e-01	2.11e-01	-1.84e-01	9.04e-01	6.22e-01	2.31e-01	6.82e-02	1.12e-01
GOBP VESICLE FUSION TO PLASMA MEMBRANE	24	1.61e-01	4.93e-01	0.3170	7.39e-02	1.59e-01	3.18e-03	-7.93e-02	-2.53e-01	5.31e-01	1.78e-01	9.78e-01	5.01e-01	3.22e-02
GOBP GAMMA AMINOBUTYRIC ACID IMPORT	6	9.00e-01	9.67e-01	0.3170	-4.42e-02	5.36e-02	2.47e-01	6.82e-02	1.74e-01	8.51e-01	8.20e-01	2.95e-01	7.72e-01	4.60e-01
GOBP ATRIAL CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION	9	8.35e-01	9.45e-01	0.3170	-9.53e-02	-6.71e-02	2.19e-01	1.84e-01	-7.37e-02	6.20e-01	7.28e-01	2.56e-01	3.39e-01	7.02e-01
GOBP SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS	47	1.00e-02	8.79e-02	0.3170	-7.53e-02	1.22e-01	-1.42e-02	-2.81e-01	-2.41e-02	3.72e-01	1.47e-01	8.66e-01	8.43e-04	7.75e-01
GOBP LEUKOCYTE TETHERING OR ROLLING	34	9.78e-02	3.78e-01	0.3170	-8.43e-02	2.68e-01	1.37e-01	4.49e-02	2.92e-02	3.95e-01	6.85e-03	1.67e-01	6.51e-01	7.68e-01
GOMF UBIQUITIN LIGASE ACTIVATOR ACTIVITY	7	8.31e-01	9.45e-01	0.3170	1.12e-01	2.33e-01	-7.57e-02	-7.45e-02	-1.49e-01	6.08e-01	2.85e-01	7.29e-01	7.33e-01	4.95e-01
GOCC CILIARY ROOTLET	15	5.09e-01	8.07e-01	0.3170	-1.01e-01	1.90e-01	-2.68e-02	-2.21e-01	6.80e-02	5.00e-01	2.02e-01	8.58e-01	1.38e-01	6.48e-01
GOBP NEGATIVE REGULATION OF OSSIFICATION	37	4.40e-02	2.33e-01	0.3170	-1.80e-01	1.66e-01	1.01e-01	6.05e-02	1.63e-01	5.83e-02	8.03e-02	2.86e-01	5.24e-01	8.64e-02
GOBP REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY	8	8.51e-01	9.50e-01	0.3170	-1.14e-01	4.33e-02	-1.61e-01	-2.29e-01	8.48e-02	5.75e-01	8.32e-01	4.32e-01	2.62e-01	6.78e-01
GOBP SKIN MORPHOGENESIS	13	5.93e-01	8.47e-01	0.3170	-1.26e-01	1.26e-01	-1.73e-01	-1.65e-01	1.07e-01	4.32e-01	4.32e-01	2.80e-01	3.02e-01	5.04e-01
GOBP THORAX AND ANTERIOR ABDOMEN DETERMINATION	5	9.02e-01	9.68e-01	0.3170	4.91e-02	5.49e-02	5.49e-02	3.03e-01	-3.53e-03	8.49e-01	8.32e-01	8.32e-01	2.40e-01	9.89e-01
GOBP B CELL LINEAGE COMMITMENT	6	8.58e-01	9.53e-01	0.3170	1.33e-01	-1.74e-01	-5.73e-02	1.13e-01	1.91e-01	5.73e-01	4.61e-01	8.08e-01	6.33e-01	4.17e-01
GOBP RESPONSE TO AMYLOID BETA	54	2.84e-02	1.77e-01	0.3170	-8.99e-02	-7.31e-02	1.28e-01	2.23e-01	-1.44e-01	2.53e-01	3.53e-01	1.04e-01	4.54e-03	6.69e-02
GOMF CELL ADHESION MEDIATOR ACTIVITY	64	8.25e-03	7.65e-02	0.3170	-6.83e-02	1.95e-02	1.53e-01	2.68e-01	8.51e-04	3.45e-01	7.87e-01	3.41e-02	2.10e-04	9.91e-01
GOCC APICOLATERAL PLASMA MEMBRANE	22	2.41e-01	5.98e-01	0.3170	-6.85e-02	-1.33e-01	2.16e-01	9.36e-02	-1.49e-01	5.78e-01	2.79e-01	7.90e-02	4.47e-01	2.27e-01
GOCC MITOTIC SPINDLE MIDZONE	13	6.58e-01	8.80e-01	0.3160	-1.02e-01	-3.72e-02	-1.76e-01	-1.83e-01	1.54e-01	5.23e-01	8.17e-01	2.71e-01	2.53e-01	3.36e-01
GOBP NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION	14	6.68e-01	8.83e-01	0.3160	-1.31e-01	6.06e-02	1.62e-01	2.20e-01	-6.91e-02	3.95e-01	6.94e-01	2.95e-01	1.54e-01	6.54e-01
GOBP POSITIVE REGULATION OF PSEUDOPODIUM ASSEMBLY	12	6.50e-01	8.78e-01	0.3160	-9.38e-02	2.03e-01	-8.38e-02	-2.01e-01	5.24e-02	5.74e-01	2.23e-01	6.15e-01	2.28e-01	7.53e-01
GOBP NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING	34	3.63e-02	2.07e-01	0.3160	1.45e-01	-9.04e-02	-2.50e-02	-2.65e-01	2.56e-03	1.44e-01	3.62e-01	8.01e-01	7.45e-03	9.79e-01
GOBP PRESYNAPTIC MEMBRANE ORGANIZATION	6	7.92e-01	9.31e-01	0.3160	-1.09e-01	1.23e-01	1.82e-02	2.01e-01	1.79e-01	6.43e-01	6.02e-01	9.39e-01	3.94e-01	4.46e-01
GOBP GLOMERULUS MORPHOGENESIS	9	7.84e-01	9.28e-01	0.3160	9.66e-02	6.89e-02	2.61e-01	1.13e-01	-7.04e-02	6.16e-01	7.21e-01	1.75e-01	5.57e-01	7.14e-01
GOMF NUCLEAR ANDROGEN RECEPTOR BINDING	25	2.57e-01	6.14e-01	0.3160	-6.88e-03	7.96e-02	-1.40e-01	-2.63e-01	-6.86e-02	9.53e-01	4.91e-01	2.26e-01	2.26e-02	5.53e-01
GOBP REGULATION OF BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS	5	8.12e-01	9.38e-01	0.3160	-6.11e-04	-8.80e-02	1.36e-01	-1.08e-01	-2.49e-01	9.98e-01	7.33e-01	5.99e-01	6.77e-01	3.34e-01
GOMF CLATHRIN BINDING	68	4.11e-03	4.65e-02	0.3160	-1.00e-01	2.20e-01	1.39e-01	1.19e-01	-8.99e-02	1.54e-01	1.71e-03	4.74e-02	8.98e-02	2.00e-01
GOBP POST ANAL TAIL MORPHOGENESIS	18	3.74e-01	7.14e-01	0.3160	-1.08e-01	6.73e-02	1.40e-01	-6.33e-02	2.45e-01	4.26e-01	6.21e-01	3.04e-01	6.42e-01	7.19e-02
GOBP ATRIAL CARDIAC MUSCLE TISSUE DEVELOPMENT	21	3.54e-01	6.99e-01	0.3160	4.92e-02	1.01e-01	-1.00e-02	-1.53e-01	2.52e-01	6.96e-01	4.21e-01	9.37e-01	2.25e-01	4.52e-02
GOBP PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS	30	1.24e-01	4.35e-01	0.3160	-1.08e-02	2.72e-01	1.24e-01	-8.83e-02	5.16e-02	9.18e-01	9.93e-03	2.41e-01	4.03e-01	6.25e-01
GOMF GUANYLATE KINASE ACTIVITY	7	7.80e-01	9.28e-01	0.3160	1.74e-01	5.08e-02	2.29e-01	2.38e-02	-1.17e-01	4.24e-01	8.16e-01	2.94e-01	9.13e-01	5.90e-01
GOBP EPITHELIAL MESENCHYMAL CELL SIGNALING	6	8.49e-01	9.49e-01	0.3160	1.06e-02	8.93e-02	-1.59e-02	-3.01e-01	-3.08e-02	9.64e-01	7.05e-01	9.46e-01	2.02e-01	8.96e-01
GOBP PLASMA MEMBRANE REPAIR	27	1.96e-01	5.45e-01	0.3160	-1.56e-02	1.62e-01	-2.03e-01	-1.57e-01	-8.55e-02	8.89e-01	1.45e-01	6.78e-02	1.57e-01	4.42e-01
GOMF COBALAMIN BINDING	9	6.85e-01	8.89e-01	0.3160	-1.34e-01	2.38e-01	-1.21e-01	-6.54e-02	7.97e-02	4.86e-01	2.17e-01	5.30e-01	7.34e-01	6.79e-01
GOBP LENS FIBER CELL DIFFERENTIATION	37	5.51e-02	2.71e-01	0.3160	5.64e-03	2.31e-01	-3.67e-02	-2.05e-01	-5.50e-02	9.53e-01	1.50e-02	6.99e-01	3.10e-02	5.62e-01
GOBP POSITIVE REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS	10	7.07e-01	8.97e-01	0.3160	-7.58e-02	-7.14e-02	1.78e-02	2.81e-02	-2.96e-01	6.78e-01	6.96e-01	9.22e-01	8.78e-01	1.05e-01
GOBP POSITIVE REGULATION OF ERBB SIGNALING PATHWAY	29	1.53e-01	4.81e-01	0.3160	9.47e-02	2.30e-01	1.83e-01	2.93e-02	-5.85e-02	3.77e-01	3.19e-02	8.80e-02	7.85e-01	5.86e-01
GOBP HUMORAL IMMUNE RESPONSE	232	1.15e-10	1.06e-08	0.3160	-1.48e-01	-1.02e-01	1.10e-01	2.14e-01	-9.83e-02	1.06e-04	7.43e-03	3.79e-03	2.02e-08	9.90e-03
GOBP SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR	11	5.29e-01	8.19e-01	0.3160	-2.52e-01	2.28e-02	-1.96e-02	1.60e-01	9.88e-02	1.48e-01	8.96e-01	9.11e-01	3.58e-01	5.71e-01
GOBP HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION	8	6.77e-01	8.86e-01	0.3160	7.95e-02	-2.26e-01	8.37e-02	-3.20e-02	-1.85e-01	6.97e-01	2.68e-01	6.82e-01	8.76e-01	3.65e-01
GOBP REGULATION OF GONAD DEVELOPMENT	12	5.13e-01	8.08e-01	0.3160	-1.49e-03	1.46e-01	2.64e-01	-5.41e-02	-7.63e-02	9.93e-01	3.82e-01	1.13e-01	7.45e-01	6.47e-01
GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL MATURATION	13	4.10e-01	7.42e-01	0.3160	1.65e-01	-1.01e-01	5.97e-02	-2.32e-01	6.64e-02	3.02e-01	5.27e-01	7.10e-01	1.47e-01	6.79e-01
GOBP G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY	14	5.98e-01	8.51e-01	0.3150	-5.99e-02	-1.05e-01	1.70e-01	2.00e-01	1.26e-01	6.98e-01	4.97e-01	2.72e-01	1.94e-01	4.13e-01
GOMF DISULFIDE OXIDOREDUCTASE ACTIVITY	34	1.14e-01	4.12e-01	0.3150	-7.27e-02	1.63e-01	-1.12e-01	-2.14e-01	9.69e-02	4.63e-01	1.01e-01	2.58e-01	3.08e-02	3.28e-01
GOMF MHC CLASS I PROTEIN BINDING	18	2.80e-01	6.33e-01	0.3150	-2.73e-01	3.82e-02	9.63e-05	8.22e-02	1.29e-01	4.46e-02	7.79e-01	9.99e-01	5.46e-01	3.45e-01
GOBP CELL SURFACE PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY	70	1.60e-03	2.27e-02	0.3150	-1.64e-02	1.89e-01	1.29e-01	-9.50e-03	2.16e-01	8.12e-01	6.30e-03	6.25e-02	8.91e-01	1.74e-03
GOBP PHARYNGEAL ARCH ARTERY MORPHOGENESIS	10	6.75e-01	8.85e-01	0.3150	2.27e-01	-3.58e-02	-1.22e-01	1.06e-01	-1.44e-01	2.14e-01	8.45e-01	5.06e-01	5.62e-01	4.31e-01
GOBP RESPONSE TO FOOD	35	8.08e-02	3.42e-01	0.3150	2.75e-01	3.36e-02	-1.12e-01	-9.02e-02	-4.19e-02	4.80e-03	7.31e-01	2.52e-01	3.56e-01	6.68e-01
GOCC NPBAF COMPLEX	14	3.45e-01	6.92e-01	0.3150	1.28e-01	4.87e-02	2.12e-01	-1.64e-01	9.40e-02	4.06e-01	7.52e-01	1.70e-01	2.88e-01	5.43e-01
GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSPORT	41	5.01e-02	2.55e-01	0.3150	-1.33e-01	-4.63e-02	1.48e-01	9.16e-02	-2.22e-01	1.40e-01	6.08e-01	1.01e-01	3.10e-01	1.40e-02
GOBP OLFACTORY BULB INTERNEURON DIFFERENTIATION	12	5.96e-01	8.50e-01	0.3150	3.01e-03	-2.22e-01	1.76e-01	8.43e-02	1.10e-01	9.86e-01	1.83e-01	2.92e-01	6.13e-01	5.11e-01
GOBP NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION	89	1.29e-03	1.89e-02	0.3150	1.42e-01	-4.17e-02	-2.03e-01	-1.90e-01	1.25e-02	2.09e-02	4.96e-01	9.45e-04	1.90e-03	8.39e-01
GOBP NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION	31	2.22e-01	5.76e-01	0.3150	-1.30e-01	-3.20e-02	2.03e-01	2.00e-01	-1.62e-02	2.10e-01	7.58e-01	5.07e-02	5.42e-02	8.76e-01
GOBP CDC42 PROTEIN SIGNAL TRANSDUCTION	16	4.10e-01	7.42e-01	0.3150	-8.45e-02	1.21e-03	2.37e-02	2.97e-01	-5.64e-02	5.59e-01	9.93e-01	8.70e-01	3.96e-02	6.96e-01
GOMF STRUCTURAL CONSTITUENT OF POSTSYNAPTIC ACTIN CYTOSKELETON	6	8.91e-01	9.63e-01	0.3150	-1.18e-01	8.56e-02	2.06e-01	9.10e-03	1.88e-01	6.17e-01	7.16e-01	3.83e-01	9.69e-01	4.24e-01
GOBP POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA	25	2.48e-01	6.05e-01	0.3150	-8.11e-02	6.44e-02	-9.78e-02	-2.80e-01	1.70e-02	4.83e-01	5.77e-01	3.97e-01	1.53e-02	8.83e-01
GOBP DISACCHARIDE METABOLIC PROCESS	11	6.88e-01	8.90e-01	0.3150	-2.24e-01	2.17e-02	8.34e-03	1.65e-01	-1.44e-01	1.97e-01	9.01e-01	9.62e-01	3.43e-01	4.07e-01
GOBP RNA POLYMERASE I PREINITIATION COMPLEX ASSEMBLY	8	7.50e-01	9.16e-01	0.3150	2.72e-01	1.25e-02	-1.23e-02	-1.32e-01	-8.40e-02	1.82e-01	9.51e-01	9.52e-01	5.17e-01	6.81e-01
GOMF CHLORIDE CHANNEL REGULATOR ACTIVITY	13	5.65e-01	8.35e-01	0.3150	-1.87e-01	2.10e-01	8.77e-02	2.90e-02	1.06e-01	2.43e-01	1.89e-01	5.84e-01	8.56e-01	5.09e-01
GOBP PYRIMIDINE RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS	15	4.81e-01	7.92e-01	0.3150	-1.17e-01	1.64e-01	2.12e-01	-6.80e-02	9.36e-02	4.31e-01	2.72e-01	1.55e-01	6.48e-01	5.30e-01
GOBP THYMUS DEVELOPMENT	49	1.46e-02	1.14e-01	0.3140	8.97e-03	2.42e-02	-6.34e-02	-3.06e-01	2.81e-02	9.13e-01	7.70e-01	4.43e-01	2.14e-04	7.34e-01
GOBP REGULATION OF AMINO ACID TRANSMEMBRANE TRANSPORT	14	5.41e-01	8.24e-01	0.3140	-8.27e-02	2.01e-01	-6.74e-03	3.20e-02	-2.24e-01	5.92e-01	1.92e-01	9.65e-01	8.36e-01	1.46e-01
GOBP CYTOPLASMIC SEQUESTERING OF PROTEIN	18	4.16e-01	7.46e-01	0.3140	1.77e-01	1.78e-01	-1.07e-01	-1.38e-01	-7.16e-02	1.94e-01	1.90e-01	4.31e-01	3.10e-01	5.99e-01
GOBP RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY	53	4.33e-02	2.31e-01	0.3140	6.80e-02	-5.74e-02	-2.20e-01	-2.06e-01	4.11e-04	3.92e-01	4.70e-01	5.53e-03	9.54e-03	9.96e-01
GOCC LUMENAL SIDE OF MEMBRANE	35	5.25e-02	2.63e-01	0.3140	-2.28e-01	8.60e-02	1.21e-02	-1.62e-01	-1.13e-01	1.96e-02	3.79e-01	9.01e-01	9.63e-02	2.47e-01
GOBP TYPE B PANCREATIC CELL APOPTOTIC PROCESS	10	6.84e-01	8.88e-01	0.3140	5.32e-02	6.69e-02	-4.53e-02	-2.98e-01	-2.12e-02	7.71e-01	7.14e-01	8.04e-01	1.03e-01	9.08e-01
GOBP OXALOACETATE METABOLIC PROCESS	9	8.49e-01	9.49e-01	0.3140	-3.91e-02	-5.77e-02	-1.92e-01	-2.37e-01	2.24e-02	8.39e-01	7.64e-01	3.18e-01	2.18e-01	9.08e-01
GOBP STRIATED MUSCLE ATROPHY	7	6.33e-01	8.70e-01	0.3140	-6.49e-03	7.25e-02	-1.75e-01	1.39e-01	2.09e-01	9.76e-01	7.40e-01	4.23e-01	5.24e-01	3.39e-01
GOBP MITOTIC DNA REPLICATION	15	6.12e-01	8.58e-01	0.3140	2.17e-02	1.17e-01	-1.37e-01	-2.52e-01	4.53e-02	8.84e-01	4.31e-01	3.59e-01	9.08e-02	7.61e-01
GOBP PROSTAGLANDIN TRANSPORT	28	1.37e-01	4.55e-01	0.3140	1.34e-01	4.20e-02	5.85e-02	2.74e-01	-7.07e-03	2.18e-01	7.00e-01	5.92e-01	1.20e-02	9.48e-01
GOMF ACYLGLYCEROL O ACYLTRANSFERASE ACTIVITY	25	2.02e-01	5.51e-01	0.3140	1.12e-01	2.61e-01	1.99e-02	-1.28e-01	-2.98e-02	3.31e-01	2.38e-02	8.63e-01	2.67e-01	7.96e-01
GOCC HISTONE DEACETYLASE COMPLEX	76	2.75e-03	3.44e-02	0.3140	1.00e-01	8.59e-02	-1.07e-01	-2.52e-01	8.00e-02	1.31e-01	1.95e-01	1.06e-01	1.49e-04	2.28e-01
GOBP GAMMA AMINOBUTYRIC ACID BIOSYNTHETIC PROCESS	6	8.86e-01	9.62e-01	0.3140	4.10e-02	2.17e-01	1.44e-01	2.40e-02	-1.69e-01	8.62e-01	3.58e-01	5.40e-01	9.19e-01	4.74e-01
GOMF ARYL HYDROCARBON RECEPTOR BINDING	8	7.89e-01	9.30e-01	0.3140	1.34e-02	1.35e-01	2.01e-01	3.30e-02	-1.97e-01	9.48e-01	5.08e-01	3.25e-01	8.72e-01	3.36e-01
GOBP NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM	10	7.27e-01	9.05e-01	0.3140	-1.58e-01	6.42e-03	-9.35e-02	-2.48e-01	-5.90e-02	3.87e-01	9.72e-01	6.09e-01	1.75e-01	7.46e-01
GOCC SUMO LIGASE COMPLEX	13	5.10e-01	8.07e-01	0.3140	4.23e-02	-2.74e-01	2.04e-02	-1.09e-01	9.69e-02	7.92e-01	8.73e-02	8.99e-01	4.95e-01	5.45e-01
GOBP MRNA CIS SPLICING VIA SPLICEOSOME	26	3.34e-01	6.82e-01	0.3140	1.11e-01	-5.44e-02	-2.34e-01	-1.63e-01	4.49e-02	3.25e-01	6.31e-01	3.92e-02	1.51e-01	6.92e-01
GOBP RECEPTOR DIFFUSION TRAPPING	10	7.86e-01	9.29e-01	0.3140	-1.46e-03	-2.20e-01	-1.66e-01	-1.23e-01	8.58e-02	9.94e-01	2.28e-01	3.64e-01	5.01e-01	6.38e-01
GOBP PROTEIN TARGETING TO MITOCHONDRION	101	4.63e-04	8.40e-03	0.3140	1.03e-02	4.70e-02	-1.93e-01	-2.41e-01	3.03e-02	8.57e-01	4.14e-01	8.07e-04	2.89e-05	5.99e-01
GOCC CHROMOSOME TELOMERIC REGION	164	1.18e-06	5.17e-05	0.3140	4.21e-02	-6.09e-02	-1.74e-01	-2.39e-01	7.57e-02	3.52e-01	1.78e-01	1.25e-04	1.29e-07	9.44e-02
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY	29	9.17e-02	3.66e-01	0.3140	-2.35e-01	8.14e-02	1.58e-01	-9.94e-02	-3.82e-02	2.83e-02	4.48e-01	1.40e-01	3.54e-01	7.22e-01
GOMF TUMOR NECROSIS FACTOR BINDING	7	8.48e-01	9.49e-01	0.3140	1.46e-01	-2.40e-02	2.05e-01	4.56e-02	1.80e-01	5.02e-01	9.13e-01	3.48e-01	8.35e-01	4.11e-01
GOBP LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS	26	1.82e-01	5.24e-01	0.3130	3.04e-01	4.71e-02	8.54e-03	4.61e-02	3.78e-02	7.28e-03	6.78e-01	9.40e-01	6.84e-01	7.39e-01
GOMF K63 LINKED POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING	24	3.31e-01	6.79e-01	0.3130	-8.36e-02	7.34e-02	-1.65e-01	-2.28e-01	8.02e-02	4.78e-01	5.34e-01	1.62e-01	5.27e-02	4.96e-01
GOMF VIRION BINDING	13	6.09e-01	8.58e-01	0.3130	-1.61e-01	7.33e-02	-2.75e-03	2.23e-02	-2.58e-01	3.14e-01	6.47e-01	9.86e-01	8.90e-01	1.08e-01
GOBP PROTEIN FOLDING	208	1.48e-08	1.01e-06	0.3130	3.02e-02	2.64e-02	-1.88e-01	-2.44e-01	3.81e-02	4.53e-01	5.11e-01	2.83e-06	1.25e-09	3.43e-01
GOBP DNA TOPOLOGICAL CHANGE	9	7.70e-01	9.24e-01	0.3130	5.74e-02	1.85e-01	4.33e-02	-2.09e-01	1.22e-01	7.66e-01	3.36e-01	8.22e-01	2.77e-01	5.25e-01
GOBP PROTEIN TARGETING TO PEROXISOME	19	4.82e-01	7.93e-01	0.3130	-3.36e-02	-6.86e-02	-2.21e-01	-1.69e-01	-1.22e-01	8.00e-01	6.05e-01	9.56e-02	2.02e-01	3.56e-01
GOMF UBIQUITIN PROTEIN TRANSFERASE REGULATOR ACTIVITY	27	1.53e-01	4.81e-01	0.3130	-6.60e-02	1.27e-01	-4.22e-02	-2.73e-01	-3.69e-02	5.53e-01	2.54e-01	7.04e-01	1.41e-02	7.40e-01
GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS	14	5.19e-01	8.13e-01	0.3130	-2.24e-01	1.67e-01	6.87e-02	-1.23e-01	7.56e-03	1.46e-01	2.80e-01	6.56e-01	4.26e-01	9.61e-01
GOMF ATPASE COUPLED ION TRANSMEMBRANE TRANSPORTER ACTIVITY	24	2.12e-01	5.65e-01	0.3130	1.52e-01	-4.00e-02	2.31e-02	-2.11e-01	1.69e-01	1.98e-01	7.35e-01	8.45e-01	7.40e-02	1.52e-01
GOBP SPINDLE ASSEMBLY	125	5.71e-05	1.52e-03	0.3130	1.24e-01	-5.20e-02	-1.79e-01	-2.01e-01	8.82e-02	1.68e-02	3.15e-01	5.52e-04	1.07e-04	8.84e-02
GOBP ENDOCRINE HORMONE SECRETION	56	4.79e-03	5.21e-02	0.3130	7.84e-02	1.46e-01	9.40e-02	3.13e-02	-2.46e-01	3.10e-01	5.79e-02	2.24e-01	6.85e-01	1.44e-03
GOBP POSITIVE REGULATION OF GLUCONEOGENESIS	21	3.17e-01	6.66e-01	0.3130	2.02e-01	-2.05e-02	1.34e-01	3.55e-02	1.94e-01	1.10e-01	8.71e-01	2.88e-01	7.78e-01	1.24e-01
GOBP REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS	7	8.59e-01	9.53e-01	0.3130	-1.24e-01	1.30e-01	-3.54e-02	-1.87e-01	1.72e-01	5.70e-01	5.53e-01	8.71e-01	3.92e-01	4.31e-01
GOBP GERMINAL CENTER FORMATION	14	3.90e-01	7.26e-01	0.3130	-7.61e-02	1.87e-01	-2.26e-01	4.56e-03	-7.95e-02	6.22e-01	2.27e-01	1.44e-01	9.76e-01	6.07e-01
GOBP DOUBLE STRAND BREAK REPAIR INVOLVED IN MEIOTIC RECOMBINATION	11	7.01e-01	8.96e-01	0.3130	1.04e-01	4.85e-02	2.75e-01	8.95e-02	3.32e-02	5.51e-01	7.80e-01	1.14e-01	6.07e-01	8.49e-01
GOBP NEGATIVE T CELL SELECTION	13	5.97e-01	8.51e-01	0.3130	1.81e-01	1.89e-02	2.29e-01	7.49e-02	8.18e-02	2.58e-01	9.06e-01	1.53e-01	6.40e-01	6.09e-01
GOCC GPI ANCHOR TRANSAMIDASE COMPLEX	5	9.46e-01	9.82e-01	0.3130	-5.13e-02	2.97e-02	-1.33e-01	-2.71e-01	5.82e-02	8.42e-01	9.08e-01	6.06e-01	2.95e-01	8.22e-01
GOBP INTRACELLULAR MRNA LOCALIZATION	13	5.91e-01	8.47e-01	0.3130	2.42e-01	-1.59e-01	-2.58e-02	-3.87e-02	1.09e-01	1.31e-01	3.21e-01	8.72e-01	8.09e-01	4.96e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH GROUP OF DONORS NAD OR NADP AS ACCEPTOR	17	4.13e-01	7.44e-01	0.3130	-1.97e-01	1.76e-01	9.99e-02	-1.02e-01	8.73e-02	1.59e-01	2.10e-01	4.76e-01	4.66e-01	5.33e-01
GOBP GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT	39	3.22e-02	1.92e-01	0.3130	-2.14e-01	1.23e-01	3.18e-02	-1.80e-01	-5.90e-02	2.08e-02	1.85e-01	7.31e-01	5.15e-02	5.24e-01
GOBP EXCRETION	29	2.28e-01	5.82e-01	0.3130	-1.25e-01	-1.05e-01	1.06e-01	1.71e-01	-1.75e-01	2.45e-01	3.29e-01	3.21e-01	1.11e-01	1.02e-01
GOCC CUL5 RING UBIQUITIN LIGASE COMPLEX	9	7.72e-01	9.25e-01	0.3130	-1.22e-01	1.18e-01	-6.46e-03	-2.26e-01	1.34e-01	5.26e-01	5.41e-01	9.73e-01	2.41e-01	4.86e-01
GOBP INTERLEUKIN 17 MEDIATED SIGNALING PATHWAY	11	4.10e-01	7.42e-01	0.3130	-9.86e-02	-1.03e-01	2.30e-01	-1.56e-01	1.47e-02	5.71e-01	5.54e-01	1.87e-01	3.70e-01	9.33e-01
GOBP TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING	77	5.06e-03	5.41e-02	0.3120	6.13e-03	-4.02e-02	-1.67e-01	-2.43e-01	9.43e-02	9.26e-01	5.42e-01	1.11e-02	2.26e-04	1.53e-01
GOBP NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS	12	5.59e-01	8.32e-01	0.3120	2.08e-01	7.97e-02	1.99e-01	-5.42e-02	7.34e-02	2.12e-01	6.33e-01	2.32e-01	7.45e-01	6.60e-01
GOBP REGULATION OF LIPOPROTEIN LIPASE ACTIVITY	16	3.73e-01	7.13e-01	0.3120	-1.54e-01	-1.56e-01	-1.11e-01	3.95e-02	1.89e-01	2.87e-01	2.79e-01	4.43e-01	7.84e-01	1.91e-01
GOMF DIHYDROPYRIMIDINASE ACTIVITY	6	8.09e-01	9.37e-01	0.3120	-1.85e-01	-9.13e-02	-1.68e-01	1.61e-01	-3.21e-02	4.34e-01	6.99e-01	4.77e-01	4.94e-01	8.92e-01
GOBP NEGATIVE REGULATION OF GLUCONEOGENESIS	18	1.81e-01	5.23e-01	0.3120	1.47e-01	1.68e-01	-1.74e-01	1.31e-01	2.35e-02	2.81e-01	2.18e-01	2.02e-01	3.37e-01	8.63e-01
GOBP REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL	28	2.82e-01	6.35e-01	0.3120	-6.24e-03	-7.78e-02	1.91e-01	2.30e-01	-4.25e-02	9.54e-01	4.76e-01	8.01e-02	3.48e-02	6.97e-01
GOBP OLIGOPEPTIDE TRANSMEMBRANE TRANSPORT	9	8.12e-01	9.39e-01	0.3120	-9.36e-02	-7.94e-03	-2.45e-01	-1.30e-01	-1.09e-01	6.27e-01	9.67e-01	2.03e-01	5.01e-01	5.72e-01
GOMF DOUBLE STRANDED RNA BINDING	71	3.57e-03	4.18e-02	0.3120	1.01e-01	1.84e-01	-1.22e-01	-1.89e-01	5.41e-02	1.42e-01	7.26e-03	7.54e-02	6.01e-03	4.31e-01
GOBP LIPID EXPORT FROM CELL	47	2.18e-02	1.49e-01	0.3120	1.03e-02	2.41e-01	1.12e-01	1.35e-02	-1.63e-01	9.03e-01	4.28e-03	1.83e-01	8.73e-01	5.30e-02
GOBP GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION	12	5.52e-01	8.29e-01	0.3120	1.88e-01	1.64e-01	1.43e-01	-4.52e-02	-1.13e-01	2.60e-01	3.25e-01	3.90e-01	7.86e-01	4.98e-01
GOBP POSITIVE REGULATION OF LIPID CATABOLIC PROCESS	26	1.16e-01	4.16e-01	0.3120	6.49e-02	2.01e-01	-5.37e-02	2.83e-02	2.21e-01	5.67e-01	7.55e-02	6.36e-01	8.03e-01	5.07e-02
GOBP GRANULOCYTE MIGRATION	145	3.68e-07	1.89e-05	0.3120	-1.45e-01	2.05e-01	1.06e-01	1.41e-01	-5.63e-02	2.63e-03	1.94e-05	2.76e-02	3.36e-03	2.42e-01
GOBP EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS	93	2.00e-04	4.17e-03	0.3120	1.84e-01	8.91e-02	8.51e-03	-1.58e-01	1.75e-01	2.13e-03	1.37e-01	8.87e-01	8.41e-03	3.62e-03
GOBP PARAXIAL MESODERM MORPHOGENESIS	10	8.05e-01	9.35e-01	0.3120	9.75e-02	1.23e-02	-9.61e-02	-2.24e-01	1.68e-01	5.93e-01	9.46e-01	5.99e-01	2.20e-01	3.57e-01
GOMF RIBOSOME BINDING	101	1.12e-04	2.61e-03	0.3120	7.20e-02	5.57e-03	-1.08e-01	-2.82e-01	3.08e-02	2.11e-01	9.23e-01	6.09e-02	9.73e-07	5.93e-01
GOBP COCHLEA MORPHOGENESIS	23	2.20e-01	5.74e-01	0.3120	2.27e-01	-1.35e-02	9.42e-02	-1.07e-01	1.59e-01	5.99e-02	9.11e-01	4.34e-01	3.75e-01	1.86e-01
GOCC NUCLEAR CHROMOSOME	213	1.75e-09	1.37e-07	0.3120	8.29e-02	-6.33e-03	-8.89e-02	-2.33e-01	1.67e-01	3.71e-02	8.74e-01	2.54e-02	4.23e-09	2.62e-05
GOBP NEUTROPHIL MEDIATED IMMUNITY	36	2.84e-02	1.77e-01	0.3120	-1.69e-01	9.63e-02	1.74e-01	-1.62e-01	5.27e-02	7.95e-02	3.18e-01	7.01e-02	9.28e-02	5.84e-01
GOBP SECRETORY GRANULE LOCALIZATION	13	6.51e-01	8.78e-01	0.3120	-2.00e-02	-7.84e-02	1.72e-01	2.03e-01	1.41e-01	9.01e-01	6.25e-01	2.84e-01	2.04e-01	3.80e-01
GOBP BILE ACID SECRETION	12	7.51e-01	9.16e-01	0.3120	-1.48e-01	7.43e-02	1.59e-01	1.85e-01	-1.02e-01	3.73e-01	6.56e-01	3.41e-01	2.68e-01	5.42e-01
GOBP ASPARTATE TRANSMEMBRANE TRANSPORT	19	4.46e-01	7.69e-01	0.3120	-9.28e-02	2.31e-01	1.46e-01	8.28e-02	-8.29e-02	4.84e-01	8.07e-02	2.71e-01	5.32e-01	5.32e-01
GOBP REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE	30	1.22e-01	4.30e-01	0.3120	-1.30e-01	1.39e-01	-4.11e-03	-2.39e-01	6.16e-02	2.17e-01	1.89e-01	9.69e-01	2.34e-02	5.59e-01
GOBP REGULATION OF MEMBRANE REPOLARIZATION	36	1.80e-01	5.22e-01	0.3120	-8.96e-02	5.20e-02	2.07e-01	2.05e-01	-3.57e-02	3.52e-01	5.89e-01	3.13e-02	3.30e-02	7.11e-01
GOBP NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS	49	3.24e-02	1.93e-01	0.3120	-3.96e-02	-2.30e-02	-1.50e-01	-1.60e-01	2.16e-01	6.32e-01	7.80e-01	6.84e-02	5.29e-02	8.76e-03
GOMF ADENYLYLTRANSFERASE ACTIVITY	29	2.50e-01	6.07e-01	0.3120	-7.50e-02	7.55e-03	-1.75e-01	-2.23e-01	1.05e-01	4.84e-01	9.44e-01	1.04e-01	3.74e-02	3.27e-01
GOBP SULFUR AMINO ACID BIOSYNTHETIC PROCESS	16	3.33e-01	6.80e-01	0.3120	1.21e-01	4.31e-02	1.44e-01	-2.04e-01	1.34e-01	4.02e-01	7.65e-01	3.17e-01	1.57e-01	3.52e-01
GOBP PEROXISOME ORGANIZATION	34	1.93e-01	5.41e-01	0.3120	2.18e-02	-3.61e-02	-2.24e-01	-2.08e-01	-4.44e-02	8.26e-01	7.16e-01	2.40e-02	3.58e-02	6.54e-01
GOBP NEGATIVE REGULATION OF MAST CELL ACTIVATION	12	5.29e-01	8.19e-01	0.3120	1.53e-02	-1.29e-02	1.15e-02	1.35e-01	2.80e-01	9.27e-01	9.38e-01	9.45e-01	4.17e-01	9.35e-02
GOMF OXYGEN CARRIER ACTIVITY	14	6.03e-01	8.54e-01	0.3120	-4.97e-02	-9.13e-03	1.14e-01	2.85e-01	1.26e-02	7.47e-01	9.53e-01	4.59e-01	6.48e-02	9.35e-01
GOBP T HELPER 1 CELL CYTOKINE PRODUCTION	7	8.16e-01	9.41e-01	0.3110	5.68e-02	-1.62e-02	6.91e-02	2.38e-01	1.79e-01	7.95e-01	9.41e-01	7.52e-01	2.75e-01	4.12e-01
GOBP ATP BIOSYNTHETIC PROCESS	89	2.25e-03	2.94e-02	0.3110	7.11e-02	-5.00e-02	-1.90e-01	-2.17e-01	7.71e-02	2.46e-01	4.15e-01	1.92e-03	3.91e-04	2.09e-01
GOBP PROTEIN OXIDATION	13	6.81e-01	8.88e-01	0.3110	-9.11e-02	-3.67e-03	-2.22e-01	-1.69e-01	-1.04e-01	5.70e-01	9.82e-01	1.66e-01	2.92e-01	5.15e-01
GOBP COLLATERAL SPROUTING IN ABSENCE OF INJURY	5	9.09e-01	9.70e-01	0.3110	-1.17e-01	1.78e-02	2.85e-01	2.26e-02	-3.19e-02	6.50e-01	9.45e-01	2.69e-01	9.30e-01	9.02e-01
GOBP NEGATIVE REGULATION OF PROTEIN POLYUBIQUITINATION	8	8.46e-01	9.49e-01	0.3110	2.40e-01	3.12e-02	-6.37e-02	-1.46e-01	1.13e-01	2.39e-01	8.79e-01	7.55e-01	4.74e-01	5.81e-01
GOBP CELLULAR RESPONSE TO IONIZING RADIATION	68	7.53e-03	7.15e-02	0.3110	3.31e-02	3.88e-02	-9.36e-02	-2.38e-01	1.69e-01	6.37e-01	5.80e-01	1.82e-01	6.70e-04	1.58e-02
GOBP REGULATION OF MEMBRANE TUBULATION	5	9.30e-01	9.78e-01	0.3110	-3.42e-02	1.98e-01	1.64e-01	-3.06e-02	1.69e-01	8.95e-01	4.43e-01	5.24e-01	9.06e-01	5.13e-01
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN	14	5.80e-01	8.43e-01	0.3110	-9.33e-03	-2.36e-01	1.27e-01	1.58e-01	1.37e-02	9.52e-01	1.27e-01	4.11e-01	3.06e-01	9.29e-01
GOCC HIPPOCAMPAL MOSSY FIBER TO CA3 SYNAPSE	42	6.41e-02	2.98e-01	0.3110	-1.96e-01	1.44e-01	1.70e-01	9.43e-02	5.62e-03	2.82e-02	1.07e-01	5.62e-02	2.90e-01	9.50e-01
GOBP PHAGOCYTOSIS RECOGNITION	27	5.40e-02	2.68e-01	0.3110	-2.44e-01	3.39e-02	-1.19e-01	1.47e-01	1.55e-02	2.80e-02	7.60e-01	2.86e-01	1.86e-01	8.89e-01
GOBP HORMONE CATABOLIC PROCESS	11	7.58e-01	9.19e-01	0.3110	-1.51e-01	2.90e-02	2.33e-01	1.12e-01	-7.92e-02	3.86e-01	8.68e-01	1.81e-01	5.19e-01	6.49e-01
GOMF ACID THIOL LIGASE ACTIVITY	29	1.19e-01	4.23e-01	0.3110	7.70e-02	2.45e-01	2.71e-02	-1.04e-01	-1.39e-01	4.73e-01	2.24e-02	8.01e-01	3.31e-01	1.97e-01
GOBP EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION	18	4.00e-01	7.33e-01	0.3110	1.01e-01	2.47e-02	3.85e-02	-2.19e-01	1.91e-01	4.60e-01	8.56e-01	7.77e-01	1.08e-01	1.60e-01
GOMF MOLECULAR TRANSDUCER ACTIVITY	1357	3.65e-65	4.66e-62	0.3110	-9.36e-02	-7.34e-02	1.37e-01	2.52e-01	1.95e-02	7.17e-09	5.70e-06	2.91e-17	5.90e-55	2.28e-01
GOBP NEGATIVE REGULATION OF MAST CELL DEGRANULATION	5	9.10e-01	9.70e-01	0.3110	4.30e-02	-2.41e-01	2.00e-02	-1.03e-01	1.60e-01	8.68e-01	3.51e-01	9.38e-01	6.90e-01	5.34e-01
GOBP TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY	17	3.62e-01	7.04e-01	0.3110	-2.04e-01	1.75e-01	1.94e-02	-3.78e-04	1.55e-01	1.45e-01	2.12e-01	8.90e-01	9.98e-01	2.69e-01
GOBP SYNAPTIC VESICLE CLUSTERING	15	5.01e-01	8.03e-01	0.3110	2.39e-01	-1.11e-01	5.07e-02	1.44e-01	-6.14e-02	1.09e-01	4.57e-01	7.34e-01	3.34e-01	6.81e-01
GOBP MODULATION OF INHIBITORY POSTSYNAPTIC POTENTIAL	7	8.81e-01	9.61e-01	0.3110	5.20e-02	2.02e-01	2.02e-01	3.62e-02	1.03e-01	8.12e-01	3.54e-01	3.54e-01	8.68e-01	6.36e-01
GOBP ASYMMETRIC CELL DIVISION	18	4.64e-01	7.80e-01	0.3110	-2.31e-01	1.25e-01	1.07e-01	1.08e-01	-6.62e-02	8.95e-02	3.60e-01	4.32e-01	4.27e-01	6.27e-01
GOBP ELASTIN METABOLIC PROCESS	8	8.17e-01	9.41e-01	0.3110	1.28e-01	-1.91e-01	-1.62e-02	-1.98e-02	2.07e-01	5.29e-01	3.51e-01	9.37e-01	9.23e-01	3.10e-01
GOBP CARDIAC CELL FATE COMMITMENT	16	5.58e-01	8.32e-01	0.3110	-9.85e-03	1.55e-01	-8.15e-02	-2.32e-01	1.09e-01	9.46e-01	2.84e-01	5.73e-01	1.08e-01	4.49e-01
GOMF INITIATOR METHIONYL AMINOPEPTIDASE ACTIVITY	5	9.15e-01	9.72e-01	0.3110	1.88e-01	1.05e-01	-1.70e-01	-3.29e-02	1.42e-01	4.66e-01	6.85e-01	5.11e-01	8.99e-01	5.82e-01
GOBP L SERINE TRANSPORT	7	8.84e-01	9.61e-01	0.3110	-1.81e-01	-8.08e-03	1.64e-01	1.79e-01	6.93e-02	4.08e-01	9.70e-01	4.53e-01	4.11e-01	7.51e-01
GOMF L SERINE TRANSMEMBRANE TRANSPORTER ACTIVITY	7	8.84e-01	9.61e-01	0.3110	-1.81e-01	-8.08e-03	1.64e-01	1.79e-01	6.93e-02	4.08e-01	9.70e-01	4.53e-01	4.11e-01	7.51e-01
GOBP PEPTIDYL GLUTAMIC ACID MODIFICATION	26	1.89e-01	5.35e-01	0.3110	-1.56e-01	2.46e-01	7.47e-02	-2.51e-02	7.46e-02	1.69e-01	3.01e-02	5.10e-01	8.25e-01	5.10e-01
GOBP PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS	28	1.20e-01	4.24e-01	0.3100	-4.16e-02	2.41e-01	1.01e-01	-1.33e-01	-9.28e-02	7.03e-01	2.71e-02	3.55e-01	2.24e-01	3.95e-01
GOBP POSITIVE REGULATION OF GROWTH HORMONE SECRETION	9	7.73e-01	9.25e-01	0.3100	7.85e-02	7.88e-02	2.01e-03	1.97e-01	-2.13e-01	6.84e-01	6.82e-01	9.92e-01	3.07e-01	2.69e-01
GOBP SISTER CHROMATID COHESION	52	2.47e-03	3.17e-02	0.3100	1.08e-01	1.49e-02	3.52e-02	-2.85e-01	4.08e-02	1.77e-01	8.52e-01	6.61e-01	3.69e-04	6.11e-01
GOBP SEQUESTERING OF METAL ION	10	4.63e-01	7.79e-01	0.3100	-1.16e-01	-2.59e-02	-1.23e-01	2.43e-01	8.82e-02	5.26e-01	8.87e-01	5.00e-01	1.83e-01	6.29e-01
GOBP DIAPHRAGM DEVELOPMENT	8	7.81e-01	9.28e-01	0.3100	1.54e-01	1.86e-01	-7.76e-03	-1.52e-01	-1.22e-01	4.50e-01	3.64e-01	9.70e-01	4.56e-01	5.50e-01
GOBP RESPONSE TO WATER	13	7.04e-01	8.97e-01	0.3100	9.74e-02	5.67e-02	2.19e-01	1.81e-01	-5.25e-02	5.43e-01	7.23e-01	1.71e-01	2.59e-01	7.43e-01
GOBP HYPEROSMOTIC SALINITY RESPONSE	10	7.18e-01	9.02e-01	0.3100	-3.95e-02	2.47e-01	9.43e-02	8.27e-02	1.34e-01	8.29e-01	1.76e-01	6.05e-01	6.51e-01	4.65e-01
GOBP TORC2 SIGNALING	12	6.58e-01	8.80e-01	0.3100	-5.77e-02	2.89e-01	9.50e-02	-8.85e-03	-1.90e-03	7.29e-01	8.26e-02	5.69e-01	9.58e-01	9.91e-01
GOBP NEGATIVE REGULATION OF GLYCOLYTIC PROCESS	17	5.31e-01	8.20e-01	0.3100	-4.82e-03	-2.37e-02	-7.91e-02	-2.52e-01	1.61e-01	9.73e-01	8.65e-01	5.72e-01	7.24e-02	2.50e-01
GOCC CONE PHOTORECEPTOR OUTER SEGMENT	8	6.85e-01	8.89e-01	0.3100	8.56e-02	1.52e-01	-7.08e-02	1.14e-01	2.18e-01	6.75e-01	4.57e-01	7.29e-01	5.76e-01	2.85e-01
GOBP NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION	27	2.43e-01	6.00e-01	0.3100	5.58e-03	-7.29e-02	-7.69e-02	-2.49e-01	1.50e-01	9.60e-01	5.12e-01	4.89e-01	2.49e-02	1.77e-01
GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR	70	1.15e-02	9.65e-02	0.3100	9.17e-03	-4.54e-02	-1.91e-01	-2.36e-01	3.68e-02	8.94e-01	5.11e-01	5.66e-03	6.22e-04	5.94e-01
GOBP CERAMIDE 1 PHOSPHATE TRANSPORT	7	8.23e-01	9.43e-01	0.3100	3.51e-02	2.47e-01	-1.18e-01	-6.24e-02	1.27e-01	8.72e-01	2.58e-01	5.89e-01	7.75e-01	5.62e-01
GOMF CERAMIDE 1 PHOSPHATE TRANSFER ACTIVITY	7	8.23e-01	9.43e-01	0.3100	3.51e-02	2.47e-01	-1.18e-01	-6.24e-02	1.27e-01	8.72e-01	2.58e-01	5.89e-01	7.75e-01	5.62e-01
GOBP MEIOTIC CELL CYCLE PHASE TRANSITION	13	6.56e-01	8.80e-01	0.3100	1.76e-01	-1.02e-01	-1.56e-01	-1.60e-01	-6.66e-02	2.71e-01	5.24e-01	3.29e-01	3.18e-01	6.78e-01
GOMF MICROFIBRIL BINDING	5	9.33e-01	9.79e-01	0.3100	-1.71e-01	1.42e-02	-2.93e-02	5.45e-02	-2.51e-01	5.09e-01	9.56e-01	9.10e-01	8.33e-01	3.32e-01
GOMF TRNA BINDING	73	6.32e-03	6.33e-02	0.3100	9.22e-02	-1.10e-01	-2.12e-01	-1.67e-01	-4.78e-02	1.73e-01	1.05e-01	1.71e-03	1.35e-02	4.80e-01
GOBP OXALATE TRANSPORT	12	6.98e-01	8.94e-01	0.3100	-1.09e-01	-1.25e-02	1.01e-02	1.41e-01	-2.53e-01	5.14e-01	9.40e-01	9.52e-01	3.98e-01	1.29e-01
GOBP SPINAL CORD PATTERNING	21	4.11e-01	7.43e-01	0.3090	-1.15e-02	8.31e-02	-1.81e-01	-2.18e-01	-9.12e-02	9.28e-01	5.10e-01	1.51e-01	8.31e-02	4.70e-01
GOBP POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY	19	4.47e-01	7.69e-01	0.3090	-1.33e-01	9.79e-02	-1.62e-01	-2.03e-01	2.99e-02	3.16e-01	4.60e-01	2.21e-01	1.25e-01	8.22e-01
GOMF HSP90 PROTEIN BINDING	40	8.69e-02	3.56e-01	0.3090	5.52e-02	-1.42e-01	-2.13e-01	-9.77e-02	-1.32e-01	5.46e-01	1.20e-01	1.96e-02	2.85e-01	1.47e-01
GOBP REGULATION OF GASTRULATION	16	4.64e-01	7.80e-01	0.3090	1.16e-01	2.18e-01	1.33e-01	-1.11e-01	6.77e-02	4.21e-01	1.31e-01	3.56e-01	4.43e-01	6.39e-01
GOBP GLUTAMATE RECEPTOR SIGNALING PATHWAY	47	6.22e-02	2.93e-01	0.3090	-1.20e-01	5.01e-02	2.22e-01	1.62e-01	5.63e-02	1.55e-01	5.52e-01	8.38e-03	5.44e-02	5.04e-01
GOCC JUXTAPARANODE REGION OF AXON	12	7.28e-01	9.06e-01	0.3090	-1.67e-01	3.39e-02	2.32e-01	1.13e-01	3.79e-03	3.17e-01	8.39e-01	1.63e-01	4.98e-01	9.82e-01
GOBP NEGATIVE REGULATION OF CHOLESTEROL METABOLIC PROCESS	10	6.72e-01	8.84e-01	0.3090	-7.11e-02	2.15e-01	9.31e-02	-1.34e-01	-1.33e-01	6.97e-01	2.38e-01	6.10e-01	4.63e-01	4.67e-01
GOBP BONE MARROW DEVELOPMENT	9	5.89e-01	8.47e-01	0.3090	-1.40e-01	-7.44e-02	1.43e-01	-2.21e-01	3.19e-02	4.66e-01	6.99e-01	4.58e-01	2.50e-01	8.68e-01
GOBP RESPONSE TO PEPTIDOGLYCAN	13	5.19e-01	8.13e-01	0.3090	-1.05e-01	1.99e-01	9.99e-02	-1.76e-01	-6.38e-02	5.14e-01	2.13e-01	5.33e-01	2.73e-01	6.90e-01
GOBP RESPONSE TO INTERLEUKIN 12	12	6.20e-01	8.63e-01	0.3090	-1.85e-01	1.14e-01	8.85e-02	-1.51e-02	2.01e-01	2.67e-01	4.93e-01	5.96e-01	9.28e-01	2.29e-01
GOBP POSITIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION	5	9.09e-01	9.70e-01	0.3090	-1.11e-01	-1.97e-01	4.10e-02	-7.98e-03	-2.07e-01	6.66e-01	4.46e-01	8.74e-01	9.75e-01	4.23e-01
GOMF P TYPE CALCIUM TRANSPORTER ACTIVITY	8	8.08e-01	9.37e-01	0.3090	2.24e-01	1.61e-01	8.47e-02	4.43e-02	-1.02e-01	2.73e-01	4.30e-01	6.78e-01	8.28e-01	6.19e-01
GOBP INSULIN METABOLIC PROCESS	16	4.70e-01	7.84e-01	0.3090	2.20e-02	7.00e-02	1.08e-01	-1.58e-01	2.31e-01	8.79e-01	6.28e-01	4.55e-01	2.73e-01	1.09e-01
GOBP POSITIVE REGULATION OF RUFFLE ASSEMBLY	15	5.18e-01	8.12e-01	0.3090	1.43e-01	2.37e-03	-1.41e-01	-8.62e-02	-2.18e-01	3.36e-01	9.87e-01	3.44e-01	5.63e-01	1.43e-01
GOBP REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY	11	5.90e-01	8.47e-01	0.3090	-3.66e-02	-2.26e-02	3.05e-01	1.35e-02	-1.72e-02	8.34e-01	8.97e-01	7.96e-02	9.38e-01	9.21e-01
GOBP HYPERSENSITIVITY	10	7.79e-01	9.28e-01	0.3090	1.65e-02	2.34e-01	1.42e-01	1.42e-01	9.45e-03	9.28e-01	2.01e-01	4.37e-01	4.35e-01	9.59e-01
GOBP NEGATIVE REGULATION BY HOST OF VIRAL GENOME REPLICATION	9	7.76e-01	9.26e-01	0.3090	1.25e-01	-2.29e-02	-1.33e-02	1.81e-01	-2.15e-01	5.16e-01	9.05e-01	9.45e-01	3.47e-01	2.64e-01
GOBP DUMP METABOLIC PROCESS	7	7.78e-01	9.27e-01	0.3090	-6.44e-02	1.64e-01	9.18e-02	-1.93e-01	-1.37e-01	7.68e-01	4.52e-01	6.74e-01	3.77e-01	5.30e-01
GOBP REGULATION OF MITOTIC RECOMBINATION	7	8.84e-01	9.61e-01	0.3090	1.12e-01	-1.26e-01	-2.36e-01	-5.52e-02	-8.96e-02	6.08e-01	5.63e-01	2.79e-01	8.00e-01	6.81e-01
GOBP POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION	21	2.57e-01	6.14e-01	0.3090	-2.79e-01	4.87e-02	2.36e-02	2.76e-02	1.19e-01	2.71e-02	6.99e-01	8.51e-01	8.27e-01	3.46e-01
GOCC INTERCALATED DISC	49	4.75e-02	2.45e-01	0.3090	-4.59e-02	-1.90e-02	1.98e-01	1.64e-01	-1.64e-01	5.78e-01	8.18e-01	1.65e-02	4.71e-02	4.75e-02
GOBP NEGATIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS	7	8.49e-01	9.49e-01	0.3090	-8.43e-02	-1.28e-01	1.76e-01	5.37e-02	1.95e-01	6.99e-01	5.58e-01	4.20e-01	8.06e-01	3.71e-01
GOBP PURINE DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS	5	8.09e-01	9.37e-01	0.3090	-5.45e-02	1.01e-03	2.28e-01	-2.00e-01	1.36e-02	8.33e-01	9.97e-01	3.77e-01	4.38e-01	9.58e-01
GOMF SOLUTE SODIUM SYMPORTER ACTIVITY	77	3.40e-03	4.03e-02	0.3090	-2.31e-03	1.30e-01	1.59e-01	1.53e-01	-1.72e-01	9.72e-01	4.89e-02	1.60e-02	2.01e-02	8.92e-03
GOCC CIS GOLGI NETWORK MEMBRANE	10	7.60e-01	9.20e-01	0.3090	5.29e-02	6.06e-02	3.95e-02	-1.41e-01	2.60e-01	7.72e-01	7.40e-01	8.29e-01	4.41e-01	1.55e-01
GOMF NUCLEAR EXPORT SIGNAL RECEPTOR ACTIVITY	12	6.25e-01	8.66e-01	0.3090	1.21e-02	2.01e-01	1.44e-02	-2.72e-02	-2.32e-01	9.42e-01	2.28e-01	9.31e-01	8.70e-01	1.64e-01
GOBP POSITIVE REGULATION OF CHROMOSOME ORGANIZATION	104	3.21e-04	6.26e-03	0.3090	1.03e-01	-5.55e-02	-1.28e-01	-2.32e-01	1.07e-01	6.94e-02	3.28e-01	2.43e-02	4.42e-05	5.92e-02
GOBP AXIS ELONGATION	27	2.19e-01	5.73e-01	0.3090	-8.74e-02	-1.85e-01	-1.20e-01	-1.95e-01	-3.22e-02	4.32e-01	9.67e-02	2.81e-01	7.94e-02	7.72e-01
GOCC POLYSOME	60	3.55e-03	4.17e-02	0.3090	-9.38e-02	-3.03e-02	-8.19e-02	-2.66e-01	-9.04e-02	2.09e-01	6.85e-01	2.72e-01	3.72e-04	2.26e-01
GOBP POSITIVE REGULATION OF FEEDING BEHAVIOR	10	7.06e-01	8.97e-01	0.3080	-6.97e-02	8.84e-02	2.64e-01	-3.08e-02	1.09e-01	7.03e-01	6.28e-01	1.48e-01	8.66e-01	5.51e-01
GOCC RSC TYPE COMPLEX	15	3.78e-01	7.17e-01	0.3080	1.60e-01	-6.10e-02	4.79e-02	-2.41e-01	7.25e-02	2.83e-01	6.82e-01	7.48e-01	1.06e-01	6.27e-01
GOCC SERINE TYPE ENDOPEPTIDASE COMPLEX	11	6.70e-01	8.83e-01	0.3080	-1.84e-01	-1.16e-01	-6.12e-02	1.82e-01	-1.06e-01	2.92e-01	5.05e-01	7.25e-01	2.97e-01	5.44e-01
GOBP NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION	28	1.47e-01	4.70e-01	0.3080	-3.69e-02	1.43e-01	-2.05e-02	-5.34e-02	-2.64e-01	7.35e-01	1.89e-01	8.51e-01	6.25e-01	1.55e-02
GOMF MHC CLASS II PROTEIN BINDING	7	8.13e-01	9.39e-01	0.3080	1.35e-01	2.30e-01	-1.15e-01	-1.48e-03	1.04e-01	5.37e-01	2.92e-01	5.98e-01	9.95e-01	6.35e-01
GOMF HISTONE H2A UBIQUITIN LIGASE ACTIVITY	5	9.32e-01	9.79e-01	0.3080	1.69e-01	-1.54e-02	-2.09e-02	-2.14e-01	1.42e-01	5.13e-01	9.52e-01	9.36e-01	4.08e-01	5.83e-01
GOBP PROTEIN KINASE C SIGNALING	35	8.24e-02	3.46e-01	0.3080	-2.12e-01	1.80e-01	1.10e-01	-3.30e-02	6.84e-02	3.03e-02	6.56e-02	2.61e-01	7.35e-01	4.84e-01
GOCC PEPTIDASE COMPLEX	116	2.42e-04	4.92e-03	0.3080	3.11e-02	-1.91e-02	-2.20e-01	-2.09e-01	3.79e-02	5.63e-01	7.22e-01	4.12e-05	1.02e-04	4.81e-01
GOBP SKELETAL MUSCLE ADAPTATION	25	6.22e-02	2.93e-01	0.3080	-1.38e-01	1.72e-03	-2.20e-01	5.29e-02	1.57e-01	2.33e-01	9.88e-01	5.69e-02	6.47e-01	1.73e-01
GOCC CELL BODY MEMBRANE	32	8.63e-02	3.55e-01	0.3080	5.05e-02	-5.28e-02	2.59e-01	2.51e-02	1.48e-01	6.21e-01	6.05e-01	1.12e-02	8.06e-01	1.49e-01
GOBP POSITIVE REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE	11	7.50e-01	9.16e-01	0.3080	6.59e-02	1.57e-01	1.43e-01	1.38e-01	-1.62e-01	7.05e-01	3.67e-01	4.12e-01	4.29e-01	3.51e-01
GOBP THYROID GLAND DEVELOPMENT	31	1.25e-01	4.36e-01	0.3080	2.40e-02	2.85e-01	3.42e-02	-1.02e-01	-3.35e-02	8.17e-01	5.96e-03	7.41e-01	3.24e-01	7.47e-01
GOBP POLYADENYLATION DEPENDENT RNA CATABOLIC PROCESS	8	8.92e-01	9.63e-01	0.3080	2.55e-02	-3.75e-03	-2.21e-01	-2.12e-01	-1.49e-02	9.01e-01	9.85e-01	2.79e-01	2.99e-01	9.42e-01
GOBP CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT	25	1.68e-01	5.04e-01	0.3080	-1.94e-02	2.23e-01	1.38e-01	-1.60e-01	1.13e-02	8.67e-01	5.34e-02	2.34e-01	1.67e-01	9.22e-01
GOBP OXIDATIVE DEMETHYLATION	14	4.87e-01	7.96e-01	0.3080	5.63e-02	-2.13e-01	-6.55e-02	1.80e-01	9.74e-02	7.15e-01	1.68e-01	6.71e-01	2.42e-01	5.28e-01
GOBP NEGATIVE REGULATION OF TISSUE REMODELING	21	3.87e-01	7.24e-01	0.3080	-1.14e-01	1.25e-01	2.51e-01	4.72e-02	2.14e-02	3.64e-01	3.20e-01	4.63e-02	7.08e-01	8.65e-01
GOBP DUMP CATABOLIC PROCESS	6	7.50e-01	9.16e-01	0.3080	6.23e-02	7.10e-02	2.36e-01	-1.44e-01	-9.57e-02	7.91e-01	7.63e-01	3.17e-01	5.41e-01	6.85e-01
GOCC ATPASE COMPLEX	140	4.97e-06	1.79e-04	0.3080	8.31e-02	-2.00e-02	-1.03e-01	-2.58e-01	9.94e-02	8.94e-02	6.83e-01	3.47e-02	1.31e-07	4.23e-02
GOMF ASPARTIC TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY	7	8.68e-01	9.56e-01	0.3080	1.75e-02	2.33e-01	-7.47e-02	-1.81e-01	-3.77e-02	9.36e-01	2.85e-01	7.32e-01	4.06e-01	8.63e-01
GOCC CHROMOCENTER	13	6.52e-01	8.79e-01	0.3080	2.13e-01	7.55e-02	-1.48e-02	-1.62e-01	1.31e-01	1.84e-01	6.38e-01	9.26e-01	3.12e-01	4.14e-01
GOBP POSTSYNAPTIC SIGNAL TRANSDUCTION	38	7.45e-02	3.27e-01	0.3070	4.90e-02	2.21e-01	1.05e-01	2.35e-02	1.78e-01	6.01e-01	1.86e-02	2.61e-01	8.02e-01	5.73e-02
GOBP LONG CHAIN FATTY ACYL COA METABOLIC PROCESS	24	2.35e-01	5.91e-01	0.3070	-1.66e-02	2.54e-01	1.11e-01	-1.27e-01	3.67e-02	8.88e-01	3.15e-02	3.47e-01	2.80e-01	7.56e-01
GOCC CATSPER COMPLEX	14	4.59e-01	7.77e-01	0.3070	-6.85e-02	-1.27e-01	4.52e-02	-2.33e-01	1.33e-01	6.57e-01	4.11e-01	7.70e-01	1.32e-01	3.90e-01
GOBP TRANSEPITHELIAL TRANSPORT	34	4.39e-02	2.32e-01	0.3070	-1.70e-01	2.41e-01	-1.92e-02	8.48e-02	2.41e-03	8.67e-02	1.50e-02	8.47e-01	3.92e-01	9.81e-01
GOBP CELL CELL ADHESION MEDIATED BY INTEGRIN	17	5.78e-01	8.42e-01	0.3070	-1.10e-01	6.98e-02	1.26e-01	2.26e-01	-1.01e-01	4.31e-01	6.18e-01	3.68e-01	1.06e-01	4.69e-01
GOBP REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION	23	3.39e-01	6.86e-01	0.3070	-6.76e-02	2.13e-01	1.80e-01	5.18e-02	9.71e-02	5.75e-01	7.76e-02	1.34e-01	6.67e-01	4.20e-01
GOBP GAMMA DELTA T CELL ACTIVATION	23	2.47e-01	6.04e-01	0.3070	1.86e-01	7.68e-02	2.28e-01	4.51e-02	-1.79e-03	1.23e-01	5.24e-01	5.86e-02	7.08e-01	9.88e-01
GOMF RNA 7 METHYLGUANOSINE CAP BINDING	13	6.01e-01	8.53e-01	0.3070	-4.58e-02	2.97e-01	5.51e-02	3.46e-02	-7.89e-04	7.75e-01	6.40e-02	7.31e-01	8.29e-01	9.96e-01
GOBP POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY	16	5.23e-01	8.15e-01	0.3070	4.66e-02	2.01e-01	1.68e-01	5.32e-02	-1.44e-01	7.47e-01	1.63e-01	2.46e-01	7.12e-01	3.20e-01
GOBP CELL CYCLE CHECKPOINT SIGNALING	188	1.94e-07	1.07e-05	0.3070	1.31e-01	-6.75e-03	-1.91e-01	-2.00e-01	2.66e-02	2.01e-03	8.73e-01	6.39e-06	2.23e-06	5.30e-01
GOBP NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION	10	7.63e-01	9.22e-01	0.3070	-1.91e-01	-9.01e-02	-1.38e-01	-2.95e-02	-1.73e-01	2.97e-01	6.22e-01	4.50e-01	8.72e-01	3.44e-01
GOBP INTRACELLULAR GLUTAMATE HOMEOSTASIS	5	9.12e-01	9.71e-01	0.3070	-2.08e-01	-6.72e-02	3.92e-02	-1.67e-01	1.30e-01	4.21e-01	7.95e-01	8.79e-01	5.18e-01	6.15e-01
GOCC MITOTIC SPINDLE ASTRAL MICROTUBULE	7	8.63e-01	9.54e-01	0.3070	3.35e-02	8.91e-02	-1.01e-01	-2.56e-01	-9.66e-02	8.78e-01	6.83e-01	6.42e-01	2.41e-01	6.58e-01
GOBP DECIDUALIZATION	24	2.64e-01	6.19e-01	0.3070	1.90e-01	1.86e-01	6.74e-02	-1.06e-01	8.82e-02	1.08e-01	1.15e-01	5.68e-01	3.68e-01	4.55e-01
GOMF 3 5 CYCLIC AMP PHOSPHODIESTERASE ACTIVITY	17	5.38e-01	8.22e-01	0.3070	-2.09e-01	6.97e-02	1.54e-01	1.46e-01	1.72e-02	1.35e-01	6.19e-01	2.72e-01	2.98e-01	9.02e-01
GOBP STRESS GRANULE DISASSEMBLY	5	9.41e-01	9.82e-01	0.3070	-5.79e-03	8.89e-02	-1.78e-01	-1.59e-01	1.71e-01	9.82e-01	7.31e-01	4.92e-01	5.39e-01	5.07e-01
GOBP RIBOSOMAL SUBUNIT EXPORT FROM NUCLEUS	14	6.58e-01	8.80e-01	0.3070	1.07e-01	-1.02e-01	-1.24e-01	-2.29e-01	6.46e-02	4.87e-01	5.07e-01	4.23e-01	1.38e-01	6.76e-01
GOCC CULLIN RING UBIQUITIN LIGASE COMPLEX	174	7.06e-08	4.08e-06	0.3070	9.95e-03	8.44e-02	-1.03e-01	-2.74e-01	3.36e-02	8.21e-01	5.47e-02	1.93e-02	4.48e-10	4.44e-01
GOMF PROTEIN TYROSINE SERINE THREONINE PHOSPHATASE ACTIVITY	39	5.70e-02	2.77e-01	0.3060	1.32e-01	2.41e-01	5.00e-02	-1.25e-01	1.71e-02	1.55e-01	9.10e-03	5.89e-01	1.77e-01	8.53e-01
GOMF SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY	30	1.05e-01	3.94e-01	0.3060	-8.40e-03	1.94e-01	4.18e-02	2.29e-01	-4.72e-02	9.37e-01	6.59e-02	6.92e-01	3.03e-02	6.54e-01
GOBP CEREBELLAR PURKINJE CELL LAYER FORMATION	14	5.21e-01	8.13e-01	0.3060	-6.60e-02	-2.43e-01	3.26e-03	-1.33e-01	1.14e-01	6.69e-01	1.16e-01	9.83e-01	3.90e-01	4.61e-01
GOBP PODOCYTE CELL MIGRATION	7	8.63e-01	9.54e-01	0.3060	-2.69e-01	-4.91e-02	-7.58e-02	-1.05e-01	-5.12e-02	2.19e-01	8.22e-01	7.28e-01	6.30e-01	8.15e-01
GOBP NCRNA METABOLIC PROCESS	603	9.56e-25	2.96e-22	0.3060	5.90e-02	-1.46e-02	-1.77e-01	-2.39e-01	3.87e-02	1.33e-02	5.40e-01	1.04e-13	9.13e-24	1.05e-01
GOBP NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION	14	2.73e-01	6.27e-01	0.3060	5.35e-02	1.19e-01	-2.21e-01	1.02e-01	1.34e-01	7.29e-01	4.42e-01	1.53e-01	5.10e-01	3.87e-01
GOBP REGULATION OF DNA METHYLATION	20	3.08e-01	6.61e-01	0.3060	2.26e-01	-1.20e-01	-6.60e-02	-1.42e-01	-6.06e-02	8.01e-02	3.52e-01	6.09e-01	2.71e-01	6.39e-01
GOBP REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I	15	3.50e-01	6.96e-01	0.3060	1.89e-01	-1.33e-01	1.09e-02	-1.90e-01	-6.35e-02	2.05e-01	3.73e-01	9.41e-01	2.02e-01	6.70e-01
GOBP PLATELET MORPHOGENESIS	22	3.12e-01	6.63e-01	0.3060	3.70e-03	1.03e-01	-2.19e-01	-8.44e-02	-1.68e-01	9.76e-01	4.05e-01	7.56e-02	4.93e-01	1.72e-01
GOCC MLL3 4 COMPLEX	10	8.36e-01	9.46e-01	0.3060	5.19e-02	-1.84e-03	-1.84e-01	-2.39e-01	1.51e-02	7.76e-01	9.92e-01	3.15e-01	1.91e-01	9.34e-01
GOBP NEGATIVE REGULATION OF GLIOGENESIS	44	5.72e-02	2.78e-01	0.3060	8.35e-02	1.77e-02	-5.83e-02	-2.56e-01	1.31e-01	3.38e-01	8.39e-01	5.03e-01	3.24e-03	1.32e-01
GOBP DNA TEMPLATED DNA REPLICATION	158	6.00e-06	2.11e-04	0.3060	6.74e-02	-9.30e-03	-2.05e-01	-2.15e-01	2.98e-02	1.44e-01	8.40e-01	9.01e-06	3.04e-06	5.18e-01
GOBP LYMPHANGIOGENESIS	18	2.75e-01	6.30e-01	0.3060	1.44e-01	-2.22e-01	1.30e-01	-4.00e-02	7.19e-02	2.90e-01	1.03e-01	3.41e-01	7.69e-01	5.98e-01
GOMF ATP DEPENDENT CHROMATIN REMODELER ACTIVITY	33	1.04e-01	3.90e-01	0.3060	1.57e-01	-1.60e-01	1.16e-02	-9.81e-02	1.83e-01	1.19e-01	1.11e-01	9.09e-01	3.30e-01	6.86e-02
GOMF POTASSIUM ION BINDING	13	4.69e-01	7.84e-01	0.3060	-2.12e-01	-5.77e-02	1.31e-01	-1.63e-01	4.20e-02	1.86e-01	7.19e-01	4.14e-01	3.09e-01	7.93e-01
GOBP POSITIVE REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT	9	7.75e-01	9.26e-01	0.3060	-2.36e-01	-9.83e-02	-9.64e-02	7.94e-02	-1.13e-01	2.21e-01	6.10e-01	6.16e-01	6.80e-01	5.57e-01
GOBP POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT	21	3.64e-01	7.05e-01	0.3060	-1.54e-01	1.21e-01	-7.96e-02	-2.04e-01	8.34e-02	2.21e-01	3.37e-01	5.28e-01	1.05e-01	5.08e-01
GOBP CELLULAR RESPONSE TO ACIDIC PH	16	5.84e-01	8.45e-01	0.3060	8.85e-02	1.85e-01	1.93e-01	1.09e-01	-4.93e-02	5.40e-01	2.00e-01	1.81e-01	4.52e-01	7.33e-01
GOMF STRUCTURAL CONSTITUENT OF SYNAPSE	23	2.68e-01	6.23e-01	0.3060	-6.40e-02	-1.03e-01	2.52e-01	7.17e-02	1.02e-01	5.95e-01	3.94e-01	3.66e-02	5.52e-01	3.98e-01
GOBP POSITIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY	8	8.25e-01	9.43e-01	0.3060	-1.40e-01	1.08e-01	2.34e-01	-9.49e-03	8.56e-02	4.92e-01	5.97e-01	2.52e-01	9.63e-01	6.75e-01
GOBP LEPTIN MEDIATED SIGNALING PATHWAY	10	8.34e-01	9.45e-01	0.3060	1.19e-01	-1.98e-02	-2.26e-01	-1.67e-01	1.16e-02	5.14e-01	9.14e-01	2.17e-01	3.61e-01	9.49e-01
GOBP REGULATION OF TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY	12	6.93e-01	8.93e-01	0.3060	-6.53e-02	6.33e-02	-2.40e-02	-2.03e-01	2.08e-01	6.95e-01	7.04e-01	8.85e-01	2.23e-01	2.12e-01
GOMF OMEGA PEPTIDASE ACTIVITY	13	6.79e-01	8.87e-01	0.3060	8.27e-02	-1.16e-01	-1.85e-01	-1.38e-01	-1.41e-01	6.06e-01	4.70e-01	2.47e-01	3.89e-01	3.80e-01
GOMF RETINOIC ACID 4 HYDROXYLASE ACTIVITY	10	6.13e-01	8.58e-01	0.3060	3.92e-02	5.99e-02	-1.19e-01	4.20e-02	2.69e-01	8.30e-01	7.43e-01	5.15e-01	8.18e-01	1.41e-01
GOBP RESPONSE TO ZINC ION	48	2.32e-02	1.55e-01	0.3060	-1.11e-01	2.25e-01	-2.75e-02	-1.72e-01	1.49e-02	1.83e-01	7.07e-03	7.42e-01	3.94e-02	8.58e-01
GOBP TOLERANCE INDUCTION	29	2.32e-01	5.85e-01	0.3060	-7.86e-02	-8.97e-05	2.17e-01	1.41e-01	1.42e-01	4.64e-01	9.99e-01	4.31e-02	1.90e-01	1.84e-01
GOMF RNA POLYMERASE II INTRONIC TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING	8	8.19e-01	9.41e-01	0.3050	1.75e-01	1.99e-02	6.17e-02	-1.56e-01	1.84e-01	3.91e-01	9.23e-01	7.62e-01	4.43e-01	3.67e-01
GOBP DORSAL VENTRAL NEURAL TUBE PATTERNING	24	2.45e-01	6.02e-01	0.3050	-5.45e-02	8.78e-02	-6.92e-04	-2.69e-01	1.01e-01	6.44e-01	4.57e-01	9.95e-01	2.24e-02	3.93e-01
GOBP GOLGI TO ENDOSOME TRANSPORT	17	4.54e-01	7.73e-01	0.3050	-1.88e-01	4.74e-02	-1.55e-02	-2.09e-01	1.09e-01	1.79e-01	7.35e-01	9.12e-01	1.36e-01	4.36e-01
GOBP NK T CELL DIFFERENTIATION	11	6.43e-01	8.75e-01	0.3050	-1.10e-01	-5.68e-04	7.76e-02	-2.10e-01	1.77e-01	5.28e-01	9.97e-01	6.56e-01	2.29e-01	3.10e-01
GOMF UBIQUITIN PROTEIN TRANSFERASE ACTIVATOR ACTIVITY	13	5.47e-01	8.27e-01	0.3050	-7.53e-02	1.80e-01	6.07e-02	-2.27e-01	2.13e-03	6.38e-01	2.61e-01	7.05e-01	1.56e-01	9.89e-01
GOBP REGULATION OF TELOMERE CAPPING	26	3.05e-01	6.58e-01	0.3050	-2.59e-02	-7.00e-02	-9.94e-02	-2.32e-01	1.54e-01	8.19e-01	5.37e-01	3.80e-01	4.04e-02	1.73e-01
GOBP SYNAPTIC VESICLE MEMBRANE ORGANIZATION	27	1.26e-01	4.39e-01	0.3050	1.99e-02	1.55e-01	1.98e-02	-1.26e-01	-2.29e-01	8.58e-01	1.65e-01	8.58e-01	2.57e-01	3.91e-02
GOBP POSITIVE REGULATION OF VASOCONSTRICTION	30	1.36e-01	4.55e-01	0.3050	-2.40e-01	5.47e-03	-1.47e-02	1.54e-01	-1.08e-01	2.29e-02	9.59e-01	8.89e-01	1.44e-01	3.08e-01
GOBP POSITIVE REGULATION OF DNA DAMAGE CHECKPOINT	5	9.46e-01	9.83e-01	0.3050	1.68e-01	-6.62e-02	-9.93e-02	-9.92e-02	2.02e-01	5.15e-01	7.98e-01	7.01e-01	7.01e-01	4.34e-01
GOBP ACID SECRETION	43	5.43e-02	2.68e-01	0.3050	-7.86e-02	2.23e-01	1.02e-01	1.52e-01	-6.19e-02	3.73e-01	1.14e-02	2.49e-01	8.48e-02	4.83e-01
GOBP RESPONSE TO LECTIN	21	2.90e-01	6.43e-01	0.3050	-7.64e-02	-1.43e-01	6.29e-02	1.46e-01	2.04e-01	5.45e-01	2.57e-01	6.18e-01	2.47e-01	1.06e-01
GOBP PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX ASSEMBLY	15	5.95e-01	8.50e-01	0.3050	-1.34e-01	1.03e-01	-1.22e-01	-2.16e-01	5.29e-02	3.70e-01	4.88e-01	4.12e-01	1.47e-01	7.23e-01
GOBP RESPONSE TO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR	9	8.36e-01	9.46e-01	0.3050	1.32e-01	-3.66e-02	-1.69e-01	-2.04e-01	-6.46e-02	4.92e-01	8.49e-01	3.80e-01	2.90e-01	7.37e-01
GOBP ENDOPLASMIC RETICULUM MEMBRANE ORGANIZATION	12	7.77e-01	9.26e-01	0.3050	6.44e-02	7.05e-03	-1.79e-01	-1.93e-01	1.41e-01	6.99e-01	9.66e-01	2.84e-01	2.48e-01	3.97e-01
GOBP CORTISOL METABOLIC PROCESS	12	7.22e-01	9.03e-01	0.3050	-1.12e-02	5.22e-02	6.10e-02	1.95e-01	-2.20e-01	9.46e-01	7.54e-01	7.15e-01	2.42e-01	1.87e-01
GOMF LIPASE ACTIVATOR ACTIVITY	17	3.91e-01	7.26e-01	0.3050	-2.36e-01	-1.22e-03	7.32e-03	-4.69e-03	1.93e-01	9.21e-02	9.93e-01	9.58e-01	9.73e-01	1.68e-01
GOBP SUBSTANTIA NIGRA DEVELOPMENT	40	4.20e-02	2.27e-01	0.3050	-1.73e-01	1.19e-01	-1.17e-02	-2.19e-01	-3.16e-02	5.83e-02	1.94e-01	8.98e-01	1.66e-02	7.29e-01
GOBP NEUTRAL AMINO ACID TRANSPORT	54	2.18e-02	1.49e-01	0.3050	-1.75e-01	1.19e-01	2.07e-01	5.01e-02	-5.38e-02	2.63e-02	1.31e-01	8.47e-03	5.24e-01	4.94e-01
GOBP ACTIVATION OF ADENYLATE CYCLASE ACTIVITY	25	3.28e-01	6.76e-01	0.3050	3.36e-02	5.18e-02	2.29e-01	1.26e-01	1.45e-01	7.71e-01	6.54e-01	4.75e-02	2.77e-01	2.10e-01
GOBP AMINE BIOSYNTHETIC PROCESS	37	5.68e-02	2.77e-01	0.3050	-1.40e-01	1.73e-01	1.40e-02	-1.28e-01	-1.64e-01	1.40e-01	6.83e-02	8.83e-01	1.79e-01	8.50e-02
GOBP REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION	10	6.61e-01	8.81e-01	0.3050	-1.08e-01	-1.03e-01	2.59e-01	-5.47e-04	6.02e-02	5.54e-01	5.72e-01	1.56e-01	9.98e-01	7.42e-01
GOBP EPITHELIAL CELL FATE COMMITMENT	14	5.45e-01	8.26e-01	0.3050	1.32e-01	1.46e-01	1.08e-01	-1.63e-01	1.25e-01	3.93e-01	3.43e-01	4.83e-01	2.90e-01	4.18e-01
GOBP NEGATIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS	7	7.87e-01	9.30e-01	0.3050	-1.43e-01	1.13e-01	1.07e-01	-2.17e-01	-3.43e-02	5.13e-01	6.05e-01	6.24e-01	3.20e-01	8.75e-01
GOBP PULMONARY VALVE MORPHOGENESIS	19	4.32e-01	7.56e-01	0.3050	1.23e-01	1.28e-01	2.21e-01	8.46e-02	-7.22e-02	3.52e-01	3.35e-01	9.50e-02	5.23e-01	5.86e-01
GOBP RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE	18	5.98e-01	8.51e-01	0.3050	-1.08e-01	2.91e-02	1.78e-01	1.94e-01	-1.06e-01	4.27e-01	8.31e-01	1.92e-01	1.55e-01	4.37e-01
GOBP INTRACILIARY RETROGRADE TRANSPORT	14	6.55e-01	8.80e-01	0.3050	1.71e-01	-1.68e-01	-1.45e-01	-1.00e-01	6.55e-02	2.69e-01	2.76e-01	3.48e-01	5.16e-01	6.71e-01
GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION	12	5.78e-01	8.42e-01	0.3050	1.48e-01	-1.34e-02	2.02e-02	2.35e-01	1.23e-01	3.76e-01	9.36e-01	9.04e-01	1.59e-01	4.60e-01
GOBP NOTCH RECEPTOR PROCESSING	9	8.27e-01	9.44e-01	0.3050	1.04e-01	1.41e-01	-1.67e-01	-1.75e-01	-5.90e-02	5.89e-01	4.65e-01	3.86e-01	3.62e-01	7.59e-01
GOBP REGULATION OF SKELETAL MUSCLE TISSUE GROWTH	6	9.09e-01	9.70e-01	0.3050	1.70e-02	2.25e-01	-6.94e-02	-1.47e-01	1.24e-01	9.42e-01	3.39e-01	7.69e-01	5.33e-01	6.00e-01
GOBP CHOLESTEROL IMPORT	9	7.47e-01	9.14e-01	0.3050	2.89e-02	-8.33e-02	-2.34e-01	7.43e-02	-1.57e-01	8.81e-01	6.65e-01	2.24e-01	7.00e-01	4.14e-01
GOBP RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES	15	5.86e-01	8.45e-01	0.3040	-4.70e-02	-2.24e-02	-1.42e-01	-2.40e-01	-1.11e-01	7.53e-01	8.81e-01	3.41e-01	1.08e-01	4.58e-01
GOCC ORGANELLE INNER MEMBRANE	512	2.41e-21	5.74e-19	0.3040	4.37e-02	2.12e-02	-1.73e-01	-2.46e-01	4.33e-03	9.03e-02	4.11e-01	2.24e-11	1.48e-21	8.67e-01
GOBP PYRIMIDINE RIBONUCLEOTIDE BIOSYNTHETIC PROCESS	22	3.28e-01	6.76e-01	0.3040	-9.01e-02	2.49e-01	1.35e-01	-4.55e-02	4.57e-02	4.64e-01	4.31e-02	2.72e-01	7.12e-01	7.10e-01
GOBP RESPONSE TO INTERLEUKIN 4	32	1.81e-01	5.24e-01	0.3040	5.93e-02	1.81e-01	-1.16e-01	-2.05e-01	2.55e-02	5.61e-01	7.62e-02	2.57e-01	4.44e-02	8.03e-01
GOMF MAP KINASE KINASE ACTIVITY	17	4.68e-01	7.83e-01	0.3040	-1.88e-02	-1.67e-01	-7.02e-03	-1.36e-01	2.14e-01	8.93e-01	2.33e-01	9.60e-01	3.33e-01	1.27e-01
GOBP ORGAN INDUCTION	22	3.32e-01	6.79e-01	0.3040	6.24e-02	2.71e-02	-1.13e-01	-2.63e-01	-7.73e-02	6.12e-01	8.26e-01	3.58e-01	3.28e-02	5.30e-01
GOBP SIALYLATION	8	7.98e-01	9.33e-01	0.3040	-1.82e-01	-1.95e-01	1.41e-01	1.63e-02	3.53e-02	3.73e-01	3.39e-01	4.91e-01	9.36e-01	8.63e-01
GOBP PROTEIN REFOLDING	27	3.36e-01	6.83e-01	0.3040	3.62e-02	4.88e-02	-2.00e-01	-2.20e-01	-2.10e-02	7.44e-01	6.61e-01	7.17e-02	4.81e-02	8.50e-01
GOBP REGULATION OF GROWTH RATE	5	9.03e-01	9.68e-01	0.3040	-2.81e-02	1.83e-01	1.87e-01	-1.44e-01	4.88e-02	9.13e-01	4.77e-01	4.70e-01	5.76e-01	8.50e-01
GOCC MULTIVESICULAR BODY INTERNAL VESICLE	6	8.90e-01	9.63e-01	0.3040	1.35e-01	2.57e-01	-6.11e-02	-3.21e-02	-5.85e-02	5.67e-01	2.76e-01	7.96e-01	8.92e-01	8.04e-01
GOBP REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING	57	3.41e-02	1.99e-01	0.3040	1.05e-03	1.92e-02	-1.51e-01	-2.55e-01	6.60e-02	9.89e-01	8.02e-01	4.80e-02	8.85e-04	3.89e-01
GOBP CELLULAR RESPONSE TO INSULIN LIKE GROWTH FACTOR STIMULUS	7	8.44e-01	9.49e-01	0.3040	-1.96e-02	4.51e-02	-3.76e-02	-6.11e-02	-2.91e-01	9.28e-01	8.36e-01	8.63e-01	7.79e-01	1.82e-01
GOBP DISRUPTION OF ANATOMICAL STRUCTURE IN ANOTHER ORGANISM	94	1.44e-04	3.19e-03	0.3040	-2.23e-01	-1.55e-01	1.16e-01	5.39e-02	-4.69e-02	1.85e-04	9.33e-03	5.19e-02	3.66e-01	4.32e-01
GOBP WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION	12	6.30e-01	8.69e-01	0.3040	3.29e-02	-1.22e-01	1.14e-02	-2.15e-01	1.73e-01	8.43e-01	4.64e-01	9.46e-01	1.97e-01	2.98e-01
GOBP INNERVATION	26	1.41e-01	4.62e-01	0.3040	-1.05e-01	2.64e-01	-1.93e-02	1.22e-02	1.05e-01	3.54e-01	1.98e-02	8.65e-01	9.14e-01	3.53e-01
GOBP REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY	23	3.25e-01	6.73e-01	0.3040	1.64e-02	2.55e-01	1.31e-01	-1.72e-02	9.86e-02	8.92e-01	3.46e-02	2.76e-01	8.86e-01	4.13e-01
GOBP CELLULAR RESPONSE TO GAMMA RADIATION	26	3.60e-01	7.04e-01	0.3040	-2.29e-02	-7.89e-02	-1.80e-01	-1.90e-01	1.31e-01	8.40e-01	4.86e-01	1.13e-01	9.41e-02	2.46e-01
GOBP POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT	18	4.22e-01	7.49e-01	0.3040	1.92e-02	-1.76e-01	2.59e-02	-7.48e-02	2.34e-01	8.88e-01	1.97e-01	8.49e-01	5.83e-01	8.57e-02
GOBP REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION	40	9.13e-02	3.65e-01	0.3040	-4.55e-02	-5.18e-03	-8.91e-02	-1.79e-01	2.24e-01	6.19e-01	9.55e-01	3.29e-01	4.99e-02	1.43e-02
GOBP TRANSDIFFERENTIATION	7	8.22e-01	9.42e-01	0.3040	1.11e-02	1.19e-01	4.46e-02	-2.72e-01	4.51e-02	9.60e-01	5.87e-01	8.38e-01	2.13e-01	8.36e-01
GOBP NEGATIVE REGULATION OF SYNAPSE ORGANIZATION	11	4.89e-01	7.97e-01	0.3040	6.83e-02	-1.46e-01	1.01e-01	-7.62e-02	-2.24e-01	6.95e-01	4.02e-01	5.60e-01	6.62e-01	1.99e-01
GOBP NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS	16	4.54e-01	7.73e-01	0.3040	1.11e-01	-1.30e-01	-1.99e-01	9.82e-02	-1.18e-01	4.41e-01	3.69e-01	1.69e-01	4.96e-01	4.14e-01
GOMF ER RETENTION SEQUENCE BINDING	5	9.19e-01	9.74e-01	0.3040	5.29e-02	2.17e-01	9.02e-03	-8.73e-02	-1.86e-01	8.38e-01	4.00e-01	9.72e-01	7.35e-01	4.72e-01
GOMF TRANSLATION INITIATION FACTOR BINDING	31	2.09e-01	5.61e-01	0.3040	1.19e-02	2.23e-02	-1.21e-01	-2.76e-01	2.55e-02	9.08e-01	8.30e-01	2.45e-01	7.78e-03	8.06e-01
GOBP DOPAMINE RECEPTOR SIGNALING PATHWAY	37	7.62e-02	3.31e-01	0.3030	-6.97e-02	1.97e-01	1.95e-01	-5.96e-02	8.32e-02	4.63e-01	3.86e-02	4.01e-02	5.30e-01	3.81e-01
GOBP AEROBIC RESPIRATION	170	1.14e-06	5.04e-05	0.3030	6.87e-02	-5.70e-02	-1.72e-01	-2.33e-01	8.67e-03	1.22e-01	2.00e-01	1.07e-04	1.59e-07	8.45e-01
GOBP REGULATION OF MRNA 3 END PROCESSING	12	7.57e-01	9.19e-01	0.3030	2.55e-02	-1.01e-02	-1.16e-01	-2.58e-01	1.07e-01	8.79e-01	9.52e-01	4.88e-01	1.22e-01	5.22e-01
GOBP POSITIVE REGULATION OF FATTY ACID OXIDATION	14	6.63e-01	8.81e-01	0.3030	2.08e-01	6.69e-02	-1.25e-01	-1.20e-01	1.19e-01	1.78e-01	6.65e-01	4.16e-01	4.38e-01	4.40e-01
GOBP CARDIOLIPIN METABOLIC PROCESS	14	5.30e-01	8.19e-01	0.3030	-1.29e-01	2.64e-01	-4.39e-02	-5.42e-02	2.88e-02	4.03e-01	8.76e-02	7.76e-01	7.25e-01	8.52e-01
GOBP REGULATION OF ATP METABOLIC PROCESS	22	3.99e-01	7.33e-01	0.3030	2.11e-01	-1.05e-01	-1.40e-01	-8.84e-02	9.39e-02	8.65e-02	3.92e-01	2.56e-01	4.73e-01	4.46e-01
GOBP REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS	28	1.94e-01	5.41e-01	0.3030	2.47e-01	1.18e-01	-5.78e-02	-1.13e-01	-2.45e-02	2.35e-02	2.80e-01	5.97e-01	2.99e-01	8.23e-01
GOBP NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING	7	8.85e-01	9.62e-01	0.3030	-1.50e-01	-1.55e-01	-1.31e-01	-1.09e-01	-1.28e-01	4.93e-01	4.79e-01	5.48e-01	6.18e-01	5.56e-01
GOMF TRANSLATION FACTOR ACTIVITY RNA BINDING	78	5.67e-03	5.81e-02	0.3030	4.13e-02	4.04e-02	-2.05e-01	-2.12e-01	-3.89e-02	5.28e-01	5.37e-01	1.78e-03	1.17e-03	5.53e-01
GOBP INTRACELLULAR ZINC ION HOMEOSTASIS	36	7.32e-02	3.23e-01	0.3030	-1.48e-01	1.17e-01	1.08e-02	-2.27e-01	6.74e-02	1.26e-01	2.23e-01	9.11e-01	1.83e-02	4.84e-01
GOBP NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT	33	1.04e-01	3.91e-01	0.3030	-2.23e-02	-1.64e-01	-1.08e-01	-1.72e-01	-1.53e-01	8.24e-01	1.03e-01	2.84e-01	8.81e-02	1.28e-01
GOBP REGULATION OF MEIOTIC CELL CYCLE PHASE TRANSITION	10	7.20e-01	9.02e-01	0.3030	2.28e-01	-1.54e-01	-6.65e-02	-9.02e-02	-5.92e-02	2.12e-01	3.98e-01	7.16e-01	6.21e-01	7.46e-01
GOMF ATP ACTIVATED INWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY	6	8.92e-01	9.63e-01	0.3030	2.14e-01	9.54e-02	1.10e-01	7.18e-02	-1.40e-01	3.64e-01	6.86e-01	6.42e-01	7.61e-01	5.53e-01
GOBP NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS	28	1.67e-01	5.03e-01	0.3030	-2.30e-01	1.88e-01	1.10e-02	-5.30e-02	-2.33e-02	3.50e-02	8.53e-02	9.20e-01	6.27e-01	8.31e-01
GOBP VESICLE TARGETING TO FROM OR WITHIN GOLGI	32	1.88e-01	5.31e-01	0.3030	1.17e-01	8.19e-02	-1.01e-01	-2.45e-01	2.85e-02	2.52e-01	4.23e-01	3.21e-01	1.63e-02	7.81e-01
GOMF PROTEIN ARGININE OMEGA N MONOMETHYLTRANSFERASE ACTIVITY	6	9.19e-01	9.74e-01	0.3030	-1.12e-01	8.37e-02	-1.28e-01	-2.33e-01	-3.61e-02	6.34e-01	7.23e-01	5.86e-01	3.23e-01	8.78e-01
GOBP NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS	14	2.89e-01	6.43e-01	0.3030	-1.16e-01	1.97e-01	-1.33e-01	1.30e-01	7.07e-02	4.54e-01	2.02e-01	3.89e-01	4.01e-01	6.47e-01
GOBP NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS	48	1.05e-02	9.10e-02	0.3030	-1.67e-01	1.09e-01	8.01e-02	-2.11e-01	3.12e-02	4.57e-02	1.91e-01	3.37e-01	1.14e-02	7.09e-01
GOBP DNA REPLICATION INITIATION	35	2.14e-01	5.67e-01	0.3030	-1.70e-02	-3.19e-02	-1.83e-01	-2.21e-01	9.01e-02	8.62e-01	7.44e-01	6.15e-02	2.37e-02	3.56e-01
GOBP POSITIVE REGULATION OF SODIUM ION TRANSPORT	29	1.72e-01	5.11e-01	0.3030	-1.50e-01	1.92e-01	1.75e-01	-3.69e-02	-2.00e-02	1.63e-01	7.39e-02	1.03e-01	7.31e-01	8.52e-01
GOBP CRD MEDIATED MRNA STABILIZATION	11	6.56e-01	8.80e-01	0.3030	-2.31e-01	8.01e-02	4.83e-02	-1.62e-01	-5.37e-02	1.84e-01	6.45e-01	7.81e-01	3.51e-01	7.58e-01
GOBP NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION	7	8.75e-01	9.59e-01	0.3030	3.27e-02	-1.99e-01	-1.04e-01	5.72e-02	-1.92e-01	8.81e-01	3.63e-01	6.35e-01	7.93e-01	3.78e-01
GOMF PHOSPHATASE ACTIVATOR ACTIVITY	18	5.57e-01	8.31e-01	0.3020	1.35e-01	3.41e-02	-1.42e-01	-2.27e-01	1.69e-02	3.23e-01	8.02e-01	2.96e-01	9.50e-02	9.01e-01
GOBP POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN	11	6.97e-01	8.94e-01	0.3020	-9.72e-03	-1.77e-01	2.62e-03	-1.48e-01	1.96e-01	9.55e-01	3.11e-01	9.88e-01	3.95e-01	2.61e-01
GOBP SNRNA TRANSCRIPTION	19	4.33e-01	7.57e-01	0.3020	-3.04e-03	-5.05e-02	-4.13e-02	-2.58e-01	1.44e-01	9.82e-01	7.03e-01	7.55e-01	5.16e-02	2.78e-01
GOMF HELICASE ACTIVITY	148	5.71e-06	2.02e-04	0.3020	6.48e-02	-8.00e-02	-1.47e-01	-2.41e-01	3.24e-02	1.74e-01	9.28e-02	1.98e-03	4.17e-07	4.97e-01
GOBP RESPONSE TO STEROL	35	1.39e-01	4.59e-01	0.3020	-1.96e-01	-8.89e-02	1.73e-01	1.08e-01	-5.63e-02	4.43e-02	3.63e-01	7.59e-02	2.68e-01	5.64e-01
GOBP REGULATION OF HETEROCHROMATIN ORGANIZATION	23	2.34e-01	5.89e-01	0.3020	1.92e-01	-3.48e-02	-1.79e-02	-2.27e-01	3.61e-02	1.10e-01	7.73e-01	8.82e-01	5.96e-02	7.64e-01
GOBP REGULATION OF L GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE	8	7.19e-01	9.02e-01	0.3020	1.66e-02	1.46e-01	-2.20e-01	6.92e-02	-1.28e-01	9.35e-01	4.73e-01	2.81e-01	7.35e-01	5.32e-01
GOBP POSITIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE	15	3.31e-01	6.79e-01	0.3020	1.50e-01	-1.88e-02	2.90e-02	-1.72e-01	-1.95e-01	3.13e-01	9.00e-01	8.46e-01	2.50e-01	1.91e-01
GOBP PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY	26	2.67e-01	6.23e-01	0.3020	9.13e-02	1.12e-01	2.38e-01	4.60e-02	1.07e-01	4.20e-01	3.23e-01	3.53e-02	6.85e-01	3.45e-01
GOBP CYCLIC NUCLEOTIDE METABOLIC PROCESS	40	1.10e-01	4.05e-01	0.3020	-1.64e-01	4.73e-03	1.79e-01	1.72e-01	5.30e-02	7.29e-02	9.59e-01	5.04e-02	5.95e-02	5.62e-01
GOBP HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS	15	5.39e-01	8.23e-01	0.3020	-5.10e-02	-3.60e-03	9.87e-02	-9.24e-03	2.81e-01	7.32e-01	9.81e-01	5.08e-01	9.51e-01	5.98e-02
GOBP REGULATION OF CELLULAR EXTRAVASATION	38	7.25e-02	3.22e-01	0.3020	-1.45e-01	1.68e-01	1.98e-01	-2.05e-02	-4.70e-02	1.22e-01	7.28e-02	3.46e-02	8.27e-01	6.16e-01
GOBP NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS	35	5.65e-02	2.76e-01	0.3020	-2.07e-01	7.69e-02	1.15e-01	-1.60e-01	5.87e-02	3.37e-02	4.31e-01	2.37e-01	1.02e-01	5.48e-01
GOBP IRON IMPORT INTO CELL	10	5.83e-01	8.44e-01	0.3020	5.31e-02	5.52e-02	8.80e-02	-2.78e-01	1.05e-02	7.71e-01	7.63e-01	6.30e-01	1.28e-01	9.54e-01
GOBP ENDOPLASMIC RETICULUM PLASMA MEMBRANE TETHERING	6	9.18e-01	9.74e-01	0.3020	1.49e-01	1.46e-01	-1.13e-01	-1.82e-01	-3.91e-02	5.26e-01	5.35e-01	6.31e-01	4.41e-01	8.68e-01
GOBP NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR	32	2.16e-01	5.70e-01	0.3020	7.59e-02	1.39e-01	-1.45e-01	-2.08e-01	4.09e-02	4.57e-01	1.73e-01	1.55e-01	4.19e-02	6.89e-01
GOBP REGULATION OF POSITIVE CHEMOTAXIS	25	2.76e-01	6.30e-01	0.3020	1.21e-01	-2.43e-03	1.57e-01	6.27e-02	2.19e-01	2.95e-01	9.83e-01	1.74e-01	5.87e-01	5.86e-02
GOCC CONDENSED NUCLEAR CHROMOSOME	74	4.68e-03	5.14e-02	0.3020	3.07e-02	2.60e-02	-5.43e-02	-1.97e-01	2.19e-01	6.48e-01	6.99e-01	4.19e-01	3.45e-03	1.14e-03
GOBP RESPONSE TO ETHER	11	7.18e-01	9.02e-01	0.3020	-1.43e-01	1.02e-01	1.54e-01	2.00e-02	-1.90e-01	4.11e-01	5.56e-01	3.77e-01	9.08e-01	2.76e-01
GOBP ENDOCARDIUM DEVELOPMENT	12	3.56e-01	7.02e-01	0.3020	5.06e-02	-9.34e-02	2.58e-01	-1.05e-01	-4.33e-02	7.61e-01	5.75e-01	1.21e-01	5.27e-01	7.95e-01
GOCC VOLTAGE GATED CALCIUM CHANNEL COMPLEX	54	2.56e-02	1.64e-01	0.3020	-2.30e-01	-6.50e-02	8.14e-02	9.47e-02	-1.35e-01	3.45e-03	4.09e-01	3.01e-01	2.28e-01	8.62e-02
GOBP METHIONINE METABOLIC PROCESS	15	5.96e-01	8.50e-01	0.3020	1.88e-01	1.19e-01	1.21e-02	-1.41e-01	1.46e-01	2.07e-01	4.26e-01	9.35e-01	3.43e-01	3.28e-01
GOBP REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY	13	6.41e-01	8.75e-01	0.3010	-1.50e-01	-1.58e-01	5.11e-02	4.80e-02	-1.97e-01	3.50e-01	3.25e-01	7.50e-01	7.64e-01	2.20e-01
GOBP POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION	42	6.47e-02	2.99e-01	0.3010	-1.18e-01	1.71e-01	1.49e-01	1.19e-01	1.07e-01	1.85e-01	5.55e-02	9.53e-02	1.83e-01	2.31e-01
GOBP POSITIVE REGULATION OF STEM CELL POPULATION MAINTENANCE	46	3.87e-02	2.15e-01	0.3010	4.24e-02	-8.91e-02	-2.36e-02	-2.18e-01	1.82e-01	6.19e-01	2.96e-01	7.81e-01	1.07e-02	3.27e-02
GOBP HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES	50	3.85e-02	2.15e-01	0.3010	1.16e-02	-8.93e-02	1.79e-01	1.87e-01	1.26e-01	8.87e-01	2.75e-01	2.86e-02	2.25e-02	1.24e-01
GOBP PROTEIN LOCALIZATION TO MITOCHONDRION	126	7.25e-05	1.84e-03	0.3010	-3.99e-03	1.98e-02	-1.70e-01	-2.48e-01	-7.68e-03	9.38e-01	7.01e-01	9.70e-04	1.59e-06	8.82e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS OXYGEN AS ACCEPTOR	11	7.62e-01	9.21e-01	0.3010	-9.91e-02	5.38e-02	-1.26e-01	-1.90e-01	1.61e-01	5.69e-01	7.57e-01	4.70e-01	2.75e-01	3.54e-01
GOMF NUCLEOSIDE DIPHOSPHATE PHOSPHATASE ACTIVITY	17	4.91e-01	7.98e-01	0.3010	-3.30e-04	1.93e-01	-2.53e-02	-2.29e-01	2.04e-02	9.98e-01	1.68e-01	8.57e-01	1.02e-01	8.84e-01
GOMF OUTWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY	26	3.28e-01	6.76e-01	0.3010	-2.62e-02	5.66e-02	2.48e-01	1.27e-01	-9.55e-02	8.17e-01	6.17e-01	2.86e-02	2.62e-01	3.99e-01
GOBP CELLULAR RESPONSE TO WATER STIMULUS	6	8.80e-01	9.61e-01	0.3010	1.92e-01	-1.72e-01	4.88e-02	-7.70e-02	1.26e-01	4.15e-01	4.66e-01	8.36e-01	7.44e-01	5.92e-01
GOMF TOLL LIKE RECEPTOR BINDING	14	7.14e-01	9.01e-01	0.3010	-7.10e-02	9.96e-02	1.63e-01	1.64e-01	-1.50e-01	6.45e-01	5.19e-01	2.92e-01	2.89e-01	3.31e-01
GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS	127	4.26e-05	1.18e-03	0.3010	4.85e-02	-5.64e-02	-1.48e-01	-2.51e-01	8.79e-03	3.45e-01	2.72e-01	3.91e-03	1.02e-06	8.64e-01
GOBP PEPTIDYL TYROSINE AUTOPHOSPHORYLATION	18	2.25e-01	5.79e-01	0.3010	-2.26e-02	-1.87e-01	7.01e-02	-1.15e-01	-1.92e-01	8.68e-01	1.69e-01	6.06e-01	3.97e-01	1.59e-01
GOBP MITOTIC G2 DNA DAMAGE CHECKPOINT SIGNALING	34	1.83e-01	5.25e-01	0.3010	2.00e-01	6.31e-02	-1.10e-01	-1.52e-01	1.07e-01	4.37e-02	5.24e-01	2.67e-01	1.24e-01	2.82e-01
GOMF NUCLEOSOMAL DNA BINDING	39	1.62e-01	4.94e-01	0.3010	-6.09e-03	-9.73e-02	-1.73e-01	-2.07e-01	9.11e-02	9.48e-01	2.93e-01	6.18e-02	2.53e-02	3.25e-01
GOBP REGULATION OF MEMBRANE REPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL	6	8.88e-01	9.62e-01	0.3010	-9.62e-02	-1.79e-01	-5.74e-02	1.28e-02	2.13e-01	6.83e-01	4.47e-01	8.08e-01	9.57e-01	3.66e-01
GOBP GPI ANCHOR METABOLIC PROCESS	31	2.79e-01	6.32e-01	0.3000	4.21e-02	-4.80e-02	-1.47e-01	-2.33e-01	1.02e-01	6.85e-01	6.44e-01	1.57e-01	2.50e-02	3.23e-01
GOBP NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION	28	2.17e-01	5.72e-01	0.3000	-4.47e-03	1.69e-01	1.19e-01	2.13e-01	4.35e-02	9.67e-01	1.22e-01	2.74e-01	5.08e-02	6.90e-01
GOBP L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT	65	9.12e-03	8.21e-02	0.3000	-1.40e-01	1.83e-01	1.78e-01	4.31e-02	-6.08e-02	5.09e-02	1.09e-02	1.30e-02	5.48e-01	3.96e-01
GOCC GLYCOSYLPHOSPHATIDYLINOSITOL N ACETYLGLUCOSAMINYLTRANSFERASE GPI GNT COMPLEX	6	9.21e-01	9.74e-01	0.3000	-8.58e-02	-9.66e-03	-1.40e-01	-1.56e-01	1.97e-01	7.16e-01	9.67e-01	5.52e-01	5.08e-01	4.04e-01
GOMF C4 DICARBOXYLATE TRANSMEMBRANE TRANSPORTER ACTIVITY	15	5.93e-01	8.47e-01	0.3000	-1.86e-01	1.80e-01	1.20e-01	9.33e-02	7.93e-03	2.12e-01	2.28e-01	4.19e-01	5.32e-01	9.58e-01
GOMF PHOSPHATIDYLETHANOLAMINE BINDING	13	6.34e-01	8.71e-01	0.3000	-2.40e-01	5.14e-02	-1.20e-01	-1.23e-01	-9.54e-03	1.34e-01	7.48e-01	4.53e-01	4.42e-01	9.53e-01
GOBP LATE ENDOSOME TO LYSOSOME TRANSPORT	21	4.20e-01	7.48e-01	0.3000	1.28e-01	9.36e-02	-1.10e-01	-2.29e-01	-2.17e-02	3.09e-01	4.58e-01	3.81e-01	6.98e-02	8.63e-01
GOCC ACETYLTRANSFERASE COMPLEX	90	1.86e-03	2.53e-02	0.3000	1.73e-01	-1.33e-02	-1.33e-01	-1.91e-01	7.67e-02	4.64e-03	8.27e-01	2.87e-02	1.74e-03	2.08e-01
GOBP CELLULAR LIPID BIOSYNTHETIC PROCESS	12	6.57e-01	8.80e-01	0.3000	2.72e-01	-6.26e-02	7.42e-02	5.75e-02	5.67e-02	1.02e-01	7.07e-01	6.56e-01	7.30e-01	7.34e-01
GOBP POSITIVE REGULATION OF TORC1 SIGNALING	50	6.87e-02	3.10e-01	0.3000	7.07e-02	2.66e-02	-1.74e-01	-2.32e-01	3.60e-03	3.87e-01	7.45e-01	3.31e-02	4.47e-03	9.65e-01
GOBP ENTERIC NERVOUS SYSTEM DEVELOPMENT	12	6.87e-01	8.90e-01	0.3000	2.17e-01	-4.20e-02	5.48e-02	-7.45e-04	1.95e-01	1.92e-01	8.01e-01	7.42e-01	9.96e-01	2.43e-01
GOBP INTESTINAL ABSORPTION	41	6.46e-02	2.99e-01	0.3000	5.20e-02	6.80e-02	5.06e-02	2.55e-01	-1.22e-01	5.65e-01	4.51e-01	5.75e-01	4.66e-03	1.77e-01
GOBP REGULATION OF ER ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS	7	8.51e-01	9.50e-01	0.3000	-2.67e-01	8.57e-02	3.18e-02	-1.86e-02	9.91e-02	2.21e-01	6.95e-01	8.84e-01	9.32e-01	6.50e-01
GOMF GDP BINDING	69	2.82e-03	3.51e-02	0.3000	-8.55e-02	1.23e-01	-8.02e-02	-2.24e-01	-1.05e-01	2.19e-01	7.81e-02	2.49e-01	1.32e-03	1.31e-01
GOBP NUCLEOBASE CATABOLIC PROCESS	10	7.46e-01	9.14e-01	0.3000	-1.41e-01	1.17e-02	-1.25e-02	2.22e-01	-1.44e-01	4.41e-01	9.49e-01	9.46e-01	2.25e-01	4.31e-01
GOBP DIPEPTIDE TRANSMEMBRANE TRANSPORT	7	8.97e-01	9.66e-01	0.3000	-1.34e-01	2.98e-02	-1.75e-01	-1.71e-01	-1.04e-01	5.40e-01	8.92e-01	4.22e-01	4.32e-01	6.32e-01
GOBP FOREBRAIN NEURON DEVELOPMENT	23	2.68e-01	6.23e-01	0.3000	-6.94e-02	1.92e-02	2.53e-01	-1.00e-02	1.43e-01	5.65e-01	8.73e-01	3.57e-02	9.34e-01	2.35e-01
GOCC HETEROCHROMATIN	76	7.47e-03	7.13e-02	0.3000	1.47e-01	2.28e-02	-1.21e-01	-1.94e-01	1.25e-01	2.68e-02	7.31e-01	6.84e-02	3.53e-03	5.97e-02
GOBP NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY	21	1.89e-01	5.35e-01	0.3000	-1.87e-01	-5.12e-03	1.45e-01	-1.82e-01	1.30e-02	1.37e-01	9.68e-01	2.49e-01	1.48e-01	9.18e-01
GOMF CCR5 CHEMOKINE RECEPTOR BINDING	7	8.14e-01	9.40e-01	0.3000	-9.85e-02	2.02e-01	2.12e-02	7.71e-02	1.81e-01	6.52e-01	3.55e-01	9.23e-01	7.24e-01	4.06e-01
GOBP POSITIVE REGULATION OF FILOPODIUM ASSEMBLY	28	2.36e-01	5.92e-01	0.3000	-1.12e-01	1.63e-01	7.36e-02	1.76e-01	-1.20e-01	3.06e-01	1.36e-01	5.00e-01	1.07e-01	2.73e-01
GOBP REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC	9	8.03e-01	9.34e-01	0.3000	-1.58e-01	1.60e-01	1.63e-01	-2.95e-02	1.09e-01	4.11e-01	4.07e-01	3.99e-01	8.78e-01	5.71e-01
GOBP NEGATIVE REGULATION OF MAP KINASE ACTIVITY	49	3.69e-02	2.09e-01	0.3000	-6.10e-02	1.85e-01	2.08e-01	5.89e-03	9.24e-02	4.60e-01	2.49e-02	1.19e-02	9.43e-01	2.63e-01
GOBP CORTICOSTEROID HORMONE SECRETION	19	3.80e-01	7.18e-01	0.2990	-4.95e-02	2.10e-01	8.17e-02	-5.96e-02	-1.82e-01	7.08e-01	1.13e-01	5.38e-01	6.53e-01	1.71e-01
GOBP NEGATIVE REGULATION OF ATP METABOLIC PROCESS	7	7.81e-01	9.28e-01	0.2990	2.41e-01	-8.61e-02	4.21e-02	-1.11e-01	-9.87e-02	2.69e-01	6.93e-01	8.47e-01	6.10e-01	6.51e-01
GOMF 1 PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE 3 KINASE ACTIVITY	7	8.23e-01	9.42e-01	0.2990	-1.99e-01	3.37e-02	1.83e-01	-6.76e-02	-1.05e-01	3.62e-01	8.77e-01	4.03e-01	7.57e-01	6.32e-01
GOBP G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY	12	6.73e-01	8.84e-01	0.2990	2.94e-02	1.21e-01	2.71e-01	2.21e-02	1.19e-02	8.60e-01	4.69e-01	1.04e-01	8.94e-01	9.43e-01
GOBP POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION	13	5.83e-01	8.44e-01	0.2990	-2.28e-01	5.70e-02	9.15e-02	-8.96e-02	-1.33e-01	1.54e-01	7.22e-01	5.68e-01	5.76e-01	4.06e-01
GOMF HISTONE DEACETYLASE BINDING	109	1.48e-04	3.26e-03	0.2990	1.97e-02	4.09e-02	-7.32e-02	-2.64e-01	1.10e-01	7.22e-01	4.61e-01	1.87e-01	1.84e-06	4.69e-02
GOBP REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE	21	3.38e-01	6.85e-01	0.2990	-2.48e-02	1.69e-01	-2.13e-01	-9.99e-02	-6.98e-02	8.44e-01	1.79e-01	9.15e-02	4.28e-01	5.80e-01
GOMF UBIQUITIN LIGASE SUBSTRATE ADAPTOR ACTIVITY	50	4.52e-02	2.37e-01	0.2990	1.01e-02	7.72e-02	-9.23e-02	-2.66e-01	6.36e-02	9.01e-01	3.45e-01	2.59e-01	1.13e-03	4.37e-01
GOBP AORTIC VALVE MORPHOGENESIS	38	2.81e-02	1.76e-01	0.2990	1.04e-01	5.41e-02	1.65e-01	-1.75e-01	1.33e-01	2.66e-01	5.64e-01	7.85e-02	6.19e-02	1.56e-01
GOBP GTP METABOLIC PROCESS	24	2.98e-01	6.52e-01	0.2990	1.49e-01	2.46e-01	3.51e-02	-6.23e-02	3.50e-02	2.05e-01	3.67e-02	7.66e-01	5.98e-01	7.66e-01
GOCC EXTRINSIC COMPONENT OF ORGANELLE MEMBRANE	26	3.25e-01	6.73e-01	0.2990	1.11e-01	-1.63e-02	-1.45e-01	-2.35e-01	-2.87e-02	3.29e-01	8.86e-01	2.01e-01	3.84e-02	8.00e-01
GOBP MISMATCH REPAIR	32	2.11e-01	5.63e-01	0.2990	-4.02e-03	9.22e-02	-7.85e-02	-2.06e-01	1.80e-01	9.69e-01	3.67e-01	4.42e-01	4.38e-02	7.88e-02
GOBP EMBRYONIC APPENDAGE MORPHOGENESIS	119	2.12e-05	6.50e-04	0.2990	1.13e-01	1.25e-02	-1.25e-03	-2.11e-01	1.79e-01	3.26e-02	8.13e-01	9.81e-01	7.20e-05	7.65e-04
GOMF UNFOLDED PROTEIN BINDING	115	2.04e-04	4.26e-03	0.2990	-5.30e-02	-3.13e-02	-1.61e-01	-2.44e-01	9.84e-03	3.26e-01	5.61e-01	2.92e-03	6.14e-06	8.55e-01
GOCC NUCLEAR PROTEIN CONTAINING COMPLEX	1135	3.24e-44	2.21e-41	0.2990	8.36e-02	-2.29e-03	-1.64e-01	-2.27e-01	6.31e-02	2.01e-06	8.96e-01	9.96e-21	4.77e-38	3.36e-04
GOBP REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS	17	5.08e-01	8.07e-01	0.2990	-3.71e-02	2.39e-02	-2.53e-02	-2.61e-01	1.35e-01	7.91e-01	8.65e-01	8.57e-01	6.22e-02	3.34e-01
GOMF MONOCARBOXYLIC ACID BINDING	84	4.56e-03	5.04e-02	0.2990	-4.07e-02	9.72e-02	1.61e-01	2.20e-01	-5.92e-02	5.19e-01	1.24e-01	1.07e-02	4.77e-04	3.48e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO NUCLEOLUS	10	7.43e-01	9.14e-01	0.2990	1.43e-01	-2.15e-01	-7.17e-02	-1.32e-01	-8.08e-03	4.34e-01	2.40e-01	6.94e-01	4.69e-01	9.65e-01
GOBP CORTISOL BIOSYNTHETIC PROCESS	10	8.37e-01	9.46e-01	0.2990	-9.73e-02	2.08e-02	1.11e-01	2.22e-01	-1.33e-01	5.94e-01	9.09e-01	5.45e-01	2.23e-01	4.68e-01
GOBP RELAXATION OF SMOOTH MUSCLE	9	6.97e-01	8.94e-01	0.2980	-1.87e-01	1.06e-01	-7.90e-02	1.68e-01	-9.21e-02	3.32e-01	5.83e-01	6.82e-01	3.82e-01	6.33e-01
GOMF OLEATE TRANSMEMBRANE TRANSPORTER ACTIVITY	6	9.04e-01	9.68e-01	0.2980	-2.33e-01	1.30e-01	9.07e-03	-5.40e-02	-1.23e-01	3.23e-01	5.82e-01	9.69e-01	8.19e-01	6.03e-01
GOBP VITAMIN D METABOLIC PROCESS	20	3.94e-01	7.29e-01	0.2980	5.11e-02	-1.87e-01	-7.90e-02	1.51e-01	-1.49e-01	6.92e-01	1.48e-01	5.41e-01	2.42e-01	2.47e-01
GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CONTRACTION	7	8.74e-01	9.58e-01	0.2980	1.06e-01	-2.35e-01	-4.34e-02	1.45e-02	1.43e-01	6.26e-01	2.81e-01	8.42e-01	9.47e-01	5.14e-01
GOBP POSITIVE REGULATION OF PINOCYTOSIS	7	8.83e-01	9.61e-01	0.2980	-7.74e-03	1.49e-01	1.44e-01	-4.21e-02	2.10e-01	9.72e-01	4.95e-01	5.09e-01	8.47e-01	3.36e-01
GOBP LAYER FORMATION IN CEREBRAL CORTEX	14	4.09e-01	7.42e-01	0.2980	-5.05e-02	-8.14e-02	2.55e-01	-7.80e-02	9.33e-02	7.43e-01	5.98e-01	9.86e-02	6.13e-01	5.45e-01
GOBP PINOCYTOSIS	22	3.05e-01	6.58e-01	0.2980	-1.70e-01	2.09e-01	-7.21e-02	-1.05e-01	-2.56e-03	1.68e-01	8.93e-02	5.58e-01	3.92e-01	9.83e-01
GOBP ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY	17	5.02e-01	8.03e-01	0.2980	-1.68e-01	-2.27e-02	1.47e-01	1.01e-01	1.69e-01	2.29e-01	8.71e-01	2.95e-01	4.72e-01	2.29e-01
GOBP NEGATIVE REGULATION OF LIPOPROTEIN LIPASE ACTIVITY	8	8.30e-01	9.44e-01	0.2980	6.09e-02	-1.92e-01	7.74e-02	7.63e-02	1.91e-01	7.66e-01	3.47e-01	7.05e-01	7.09e-01	3.49e-01
GOMF IMMUNE RECEPTOR ACTIVITY	130	6.75e-05	1.73e-03	0.2980	-1.18e-01	6.06e-02	1.59e-01	2.12e-01	-3.03e-02	1.97e-02	2.33e-01	1.77e-03	2.94e-05	5.51e-01
GOBP ARACHIDONIC ACID SECRETION	31	1.09e-01	4.02e-01	0.2980	-5.88e-02	-1.36e-01	-5.68e-02	2.42e-01	-7.02e-02	5.71e-01	1.89e-01	5.84e-01	1.96e-02	4.99e-01
GOBP REGULATION OF BILE ACID METABOLIC PROCESS	15	5.83e-01	8.44e-01	0.2980	-1.75e-01	-2.05e-01	9.12e-02	8.34e-02	-3.36e-02	2.42e-01	1.70e-01	5.41e-01	5.76e-01	8.22e-01
GOBP REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY	26	3.36e-01	6.83e-01	0.2980	9.61e-03	-3.70e-02	-1.14e-01	-2.63e-01	7.10e-02	9.32e-01	7.44e-01	3.16e-01	2.01e-02	5.31e-01
GOBP POSITIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY	18	5.26e-01	8.17e-01	0.2980	-1.15e-01	7.54e-02	-2.01e-01	-1.70e-01	-2.04e-02	3.97e-01	5.80e-01	1.40e-01	2.11e-01	8.81e-01
GOBP REGULATION OF TRANSLATIONAL ELONGATION	12	7.64e-01	9.22e-01	0.2980	-2.34e-03	-1.81e-02	-9.50e-02	-2.35e-01	1.55e-01	9.89e-01	9.14e-01	5.69e-01	1.58e-01	3.52e-01
GOBP PLANAR CELL POLARITY PATHWAY INVOLVED IN NEURAL TUBE CLOSURE	11	4.01e-01	7.34e-01	0.2980	1.12e-01	-6.37e-02	1.67e-01	-2.04e-01	-5.08e-02	5.21e-01	7.14e-01	3.39e-01	2.40e-01	7.71e-01
GOBP COENZYME A METABOLIC PROCESS	19	5.45e-01	8.26e-01	0.2980	3.94e-02	-1.62e-01	-1.67e-01	-1.82e-01	-5.16e-04	7.67e-01	2.22e-01	2.08e-01	1.70e-01	9.97e-01
GOBP REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION	13	7.41e-01	9.12e-01	0.2980	-2.95e-02	8.56e-02	-1.51e-01	-2.31e-01	6.48e-02	8.54e-01	5.93e-01	3.47e-01	1.48e-01	6.86e-01
GOBP ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL COMMUNICATION	17	5.73e-01	8.39e-01	0.2980	-1.32e-01	6.83e-02	5.66e-02	1.64e-01	-1.91e-01	3.46e-01	6.26e-01	6.86e-01	2.42e-01	1.73e-01
GOBP VAGINA DEVELOPMENT	10	7.19e-01	9.02e-01	0.2980	-1.68e-01	7.21e-02	-1.79e-01	4.52e-03	-1.52e-01	3.56e-01	6.93e-01	3.28e-01	9.80e-01	4.06e-01
GOBP ECTODERMAL PLACODE DEVELOPMENT	13	3.63e-01	7.05e-01	0.2970	1.28e-01	2.45e-02	2.15e-01	-1.59e-01	-1.24e-02	4.24e-01	8.78e-01	1.80e-01	3.22e-01	9.38e-01
GOBP MRNA TRANSPORT	112	2.18e-04	4.50e-03	0.2970	-8.39e-03	-3.54e-03	-1.39e-01	-2.63e-01	1.35e-02	8.78e-01	9.48e-01	1.13e-02	1.56e-06	8.04e-01
GOBP REGULATION OF BONE DEVELOPMENT	9	7.84e-01	9.28e-01	0.2970	-1.20e-01	-8.08e-02	2.28e-02	-4.24e-02	2.55e-01	5.33e-01	6.75e-01	9.06e-01	8.26e-01	1.85e-01
GOBP RIBONUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS	9	8.50e-01	9.50e-01	0.2970	2.10e-01	2.93e-02	-1.44e-01	-1.50e-01	1.23e-02	2.75e-01	8.79e-01	4.55e-01	4.36e-01	9.49e-01
GOBP POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS	34	1.43e-01	4.64e-01	0.2970	8.88e-02	1.42e-01	-9.98e-02	-2.16e-01	-6.18e-02	3.70e-01	1.53e-01	3.14e-01	2.92e-02	5.33e-01
GOBP OSTEOCLAST FUSION	6	9.01e-01	9.68e-01	0.2970	-2.55e-01	-2.08e-02	1.55e-02	-7.44e-02	-1.31e-01	2.80e-01	9.30e-01	9.48e-01	7.52e-01	5.77e-01
GOMF PHOSPHOLIPASE A1 ACTIVITY	18	5.13e-01	8.08e-01	0.2970	-2.07e-01	1.08e-01	1.50e-01	9.27e-02	5.19e-02	1.28e-01	4.30e-01	2.72e-01	4.96e-01	7.03e-01
GOMF CERAMIDE BINDING	19	2.38e-01	5.93e-01	0.2970	3.45e-02	2.58e-01	-1.12e-01	6.71e-02	5.72e-02	7.95e-01	5.11e-02	3.99e-01	6.13e-01	6.66e-01
GOBP DNA CONFORMATION CHANGE	87	4.42e-03	4.92e-02	0.2970	1.11e-02	-2.00e-02	-1.92e-01	-2.25e-01	-5.21e-03	8.58e-01	7.47e-01	1.92e-03	2.84e-04	9.33e-01
GOMF ACTININ BINDING	35	2.49e-01	6.06e-01	0.2970	-4.48e-02	5.00e-02	1.97e-01	2.00e-01	-6.89e-02	6.47e-01	6.08e-01	4.35e-02	4.04e-02	4.80e-01
GOMF FMN BINDING	15	4.89e-01	7.97e-01	0.2970	6.37e-02	2.29e-01	-1.10e-01	-3.32e-02	1.36e-01	6.69e-01	1.24e-01	4.62e-01	8.24e-01	3.63e-01
GOMF SPHINGOMYELIN PHOSPHODIESTERASE ACTIVITY	7	7.21e-01	9.02e-01	0.2970	8.80e-02	3.54e-03	1.10e-01	-2.61e-01	-1.57e-02	6.87e-01	9.87e-01	6.16e-01	2.31e-01	9.43e-01
GOBP MITOTIC SISTER CHROMATID SEGREGATION	180	3.71e-07	1.90e-05	0.2970	1.15e-01	-5.97e-02	-1.26e-01	-2.27e-01	6.39e-02	7.81e-03	1.67e-01	3.61e-03	1.48e-07	1.39e-01
GOBP GROWTH HORMONE SECRETION	13	6.59e-01	8.80e-01	0.2970	4.92e-02	1.93e-01	4.15e-02	1.13e-01	-1.85e-01	7.59e-01	2.28e-01	7.96e-01	4.82e-01	2.49e-01
GOBP ODONTOBLAST DIFFERENTIATION	11	7.06e-01	8.97e-01	0.2970	2.03e-01	-6.65e-02	-3.19e-02	1.16e-01	-1.67e-01	2.43e-01	7.03e-01	8.55e-01	5.05e-01	3.38e-01
GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS	23	2.44e-01	6.00e-01	0.2970	-1.25e-01	1.51e-01	6.31e-02	-1.17e-01	-1.79e-01	3.00e-01	2.10e-01	6.01e-01	3.31e-01	1.37e-01
GOBP DENDRITIC TRANSPORT	12	6.85e-01	8.89e-01	0.2970	7.30e-02	2.61e-01	5.28e-02	-3.72e-04	-1.09e-01	6.61e-01	1.18e-01	7.51e-01	9.98e-01	5.13e-01
GOBP LIMB BUD FORMATION	9	7.54e-01	9.17e-01	0.2970	-1.99e-01	1.81e-02	1.02e-01	-1.55e-01	1.17e-01	3.01e-01	9.25e-01	5.95e-01	4.21e-01	5.44e-01
GOBP RESPONSE TO THYROXINE	5	9.37e-01	9.80e-01	0.2970	-1.55e-01	7.83e-03	-3.60e-02	-1.48e-01	2.02e-01	5.49e-01	9.76e-01	8.89e-01	5.66e-01	4.34e-01
GOBP REGULATION OF PROTEIN SUMOYLATION	21	4.65e-01	7.81e-01	0.2970	1.83e-01	9.36e-02	-1.54e-01	-1.45e-01	3.04e-02	1.46e-01	4.58e-01	2.22e-01	2.49e-01	8.10e-01
GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE TRANSLOCATION	8	8.98e-01	9.67e-01	0.2970	7.52e-02	5.83e-02	-1.87e-01	-2.09e-01	-1.71e-02	7.13e-01	7.75e-01	3.59e-01	3.07e-01	9.33e-01
GOBP MAST CELL CHEMOTAXIS	10	6.96e-01	8.94e-01	0.2970	-6.98e-02	1.80e-01	1.96e-01	-1.08e-01	-2.67e-02	7.02e-01	3.25e-01	2.83e-01	5.54e-01	8.84e-01
GOBP POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION	14	6.31e-01	8.69e-01	0.2970	-1.23e-01	5.66e-02	-1.12e-01	-2.10e-01	-1.15e-01	4.26e-01	7.14e-01	4.68e-01	1.74e-01	4.57e-01
GOBP POST EMBRYONIC ANIMAL ORGAN MORPHOGENESIS	11	6.96e-01	8.94e-01	0.2970	-4.77e-02	-1.30e-01	1.52e-01	3.03e-04	2.14e-01	7.84e-01	4.57e-01	3.84e-01	9.99e-01	2.19e-01
GOBP CGMP METABOLIC PROCESS	16	5.74e-01	8.40e-01	0.2960	2.44e-02	-9.86e-02	1.07e-01	2.51e-01	5.57e-02	8.66e-01	4.95e-01	4.61e-01	8.18e-02	7.00e-01
GOCC MLL1 2 COMPLEX	29	2.61e-01	6.18e-01	0.2960	1.99e-01	1.01e-01	-7.36e-02	-1.56e-01	9.12e-02	6.36e-02	3.49e-01	4.93e-01	1.45e-01	3.95e-01
GOBP LYSOSOMAL LUMEN ACIDIFICATION	20	5.10e-01	8.07e-01	0.2960	-6.25e-03	-3.39e-03	-1.06e-01	-1.89e-01	2.02e-01	9.61e-01	9.79e-01	4.10e-01	1.43e-01	1.19e-01
GOBP REGULATION OF EOSINOPHIL MIGRATION	6	9.27e-01	9.76e-01	0.2960	1.40e-01	1.71e-01	1.72e-01	6.85e-02	6.79e-02	5.53e-01	4.67e-01	4.66e-01	7.71e-01	7.73e-01
GOMF NEUROPEPTIDE BINDING	31	1.43e-01	4.64e-01	0.2960	6.78e-02	-9.47e-02	1.36e-01	-8.67e-03	2.36e-01	5.14e-01	3.62e-01	1.90e-01	9.33e-01	2.30e-02
GOMF PHOSPHOTRANSFERASE ACTIVITY FOR OTHER SUBSTITUTED PHOSPHATE GROUPS	22	3.20e-01	6.68e-01	0.2960	-7.12e-02	8.59e-02	-7.50e-02	-1.29e-01	-2.30e-01	5.63e-01	4.85e-01	5.43e-01	2.93e-01	6.17e-02
GOCC AXONEMAL DYNEIN COMPLEX	22	1.55e-01	4.83e-01	0.2960	-1.27e-02	9.07e-03	-1.25e-02	2.43e-01	1.69e-01	9.18e-01	9.41e-01	9.19e-01	4.89e-02	1.71e-01
GOBP POSITIVE REGULATION OF ACTIN NUCLEATION	14	6.19e-01	8.63e-01	0.2960	1.93e-01	1.37e-02	8.75e-02	1.38e-01	1.54e-01	2.11e-01	9.29e-01	5.71e-01	3.72e-01	3.19e-01
GOBP NEGATIVE REGULATION OF DEPHOSPHORYLATION	35	1.05e-01	3.92e-01	0.2960	1.09e-02	1.65e-01	3.81e-02	2.11e-02	-2.41e-01	9.11e-01	9.03e-02	6.97e-01	8.29e-01	1.34e-02
GOBP HISTONE DEACETYLATION	19	4.82e-01	7.93e-01	0.2960	1.64e-01	6.46e-02	-5.84e-02	-2.22e-01	6.09e-02	2.15e-01	6.26e-01	6.59e-01	9.36e-02	6.46e-01
GOCC SUPER ELONGATION COMPLEX	5	9.39e-01	9.81e-01	0.2960	2.43e-01	1.45e-01	7.52e-02	4.34e-02	1.63e-02	3.47e-01	5.75e-01	7.71e-01	8.67e-01	9.50e-01
GOBP REGULATION OF PROTEIN KINASE C SIGNALING	18	4.41e-01	7.63e-01	0.2960	-2.87e-01	5.16e-02	-2.54e-02	-5.78e-03	-4.70e-02	3.53e-02	7.05e-01	8.52e-01	9.66e-01	7.30e-01
GOBP NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS	18	4.83e-01	7.93e-01	0.2960	-6.16e-02	-2.41e-01	-1.43e-01	5.15e-02	-5.27e-02	6.51e-01	7.71e-02	2.93e-01	7.05e-01	6.99e-01
GOMF CHANNEL ACTIVATOR ACTIVITY	6	9.09e-01	9.70e-01	0.2960	-1.56e-01	1.79e-01	4.48e-02	-2.57e-02	-1.69e-01	5.07e-01	4.47e-01	8.49e-01	9.13e-01	4.75e-01
GOBP GAMMA AMINOBUTYRIC ACID METABOLIC PROCESS	8	8.99e-01	9.67e-01	0.2960	-1.22e-02	1.32e-01	1.99e-01	1.44e-01	-9.81e-02	9.52e-01	5.19e-01	3.30e-01	4.80e-01	6.31e-01
GOBP POSITIVE REGULATION OF CHROMOSOME SEPARATION	29	1.92e-01	5.38e-01	0.2960	1.72e-01	1.47e-02	-9.60e-02	-2.09e-01	-7.09e-02	1.10e-01	8.91e-01	3.71e-01	5.15e-02	5.09e-01
GOBP CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER	32	9.67e-02	3.76e-01	0.2960	-4.85e-02	-1.33e-01	-2.04e-02	-2.53e-01	5.77e-02	6.35e-01	1.94e-01	8.42e-01	1.34e-02	5.72e-01
GOBP PROSTATE GLANDULAR ACINUS MORPHOGENESIS	6	9.12e-01	9.71e-01	0.2960	4.81e-02	-7.49e-02	2.51e-01	1.00e-01	8.08e-02	8.38e-01	7.51e-01	2.87e-01	6.70e-01	7.32e-01
GOBP NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY	24	3.19e-01	6.67e-01	0.2960	1.37e-01	1.72e-01	7.15e-02	2.24e-02	1.82e-01	2.44e-01	1.44e-01	5.44e-01	8.49e-01	1.22e-01
GOMF SEQUENCE SPECIFIC MRNA BINDING	12	6.57e-01	8.80e-01	0.2960	-1.88e-01	-1.22e-01	-4.26e-02	-1.66e-01	-8.84e-02	2.59e-01	4.66e-01	7.99e-01	3.20e-01	5.96e-01
GOBP REGULATION OF SALIVA SECRETION	7	8.65e-01	9.55e-01	0.2950	9.73e-02	-8.48e-02	-3.31e-02	2.32e-01	-1.26e-01	6.56e-01	6.98e-01	8.79e-01	2.88e-01	5.64e-01
GOBP REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY	53	1.81e-02	1.32e-01	0.2950	-1.13e-01	1.87e-01	1.09e-01	-1.04e-01	1.30e-01	1.53e-01	1.87e-02	1.68e-01	1.92e-01	1.03e-01
GOBP POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS	13	4.66e-01	7.81e-01	0.2950	1.72e-01	6.80e-02	-1.19e-01	1.36e-01	1.42e-01	2.82e-01	6.71e-01	4.58e-01	3.95e-01	3.75e-01
GOBP RETROGRADE TRANSPORT VESICLE RECYCLING WITHIN GOLGI	9	8.35e-01	9.45e-01	0.2950	1.97e-01	-6.12e-02	-1.23e-01	-1.69e-01	-2.56e-02	3.05e-01	7.51e-01	5.21e-01	3.79e-01	8.94e-01
GOBP CELLULAR RESPONSE TO CADMIUM ION	34	1.23e-01	4.30e-01	0.2950	-1.61e-01	1.46e-02	-3.68e-02	-2.33e-01	7.55e-02	1.05e-01	8.83e-01	7.10e-01	1.89e-02	4.46e-01
GOCC ORGANELLE ENVELOPE LUMEN	86	2.36e-03	3.08e-02	0.2950	-4.78e-02	-1.31e-02	-1.53e-01	-2.44e-01	-4.27e-02	4.44e-01	8.33e-01	1.45e-02	9.06e-05	4.93e-01
GOBP REGULATION OF ANTIGEN PROCESSING AND PRESENTATION	18	5.47e-01	8.27e-01	0.2950	-1.63e-01	1.62e-01	1.35e-01	7.75e-02	-9.97e-02	2.30e-01	2.35e-01	3.20e-01	5.69e-01	4.64e-01
GOMF GTPASE INHIBITOR ACTIVITY	12	7.17e-01	9.02e-01	0.2950	-4.25e-02	-2.47e-01	-9.94e-02	3.02e-02	-1.17e-01	7.99e-01	1.39e-01	5.51e-01	8.56e-01	4.83e-01
GOBP NEGATIVE REGULATION OF PHAGOCYTOSIS	20	3.67e-01	7.07e-01	0.2950	-2.68e-01	1.01e-01	-1.04e-02	-6.21e-02	3.55e-02	3.81e-02	4.36e-01	9.36e-01	6.31e-01	7.83e-01
GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION	30	1.22e-01	4.29e-01	0.2950	-1.89e-02	1.49e-01	-1.60e-02	-2.07e-01	-1.46e-01	8.58e-01	1.58e-01	8.79e-01	4.96e-02	1.65e-01
GOBP SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE	182	1.64e-06	6.85e-05	0.2950	7.73e-02	2.20e-02	-1.68e-01	-2.22e-01	5.51e-02	7.20e-02	6.09e-01	9.15e-05	2.36e-07	2.00e-01
GOBP COPII COATED VESICLE BUDDING	42	9.49e-02	3.72e-01	0.2950	1.28e-01	1.17e-01	-1.23e-01	-2.03e-01	-2.44e-02	1.52e-01	1.90e-01	1.67e-01	2.26e-02	7.85e-01
GOMF MONOATOMIC CATION BICARBONATE SYMPORTER ACTIVITY	13	5.91e-01	8.47e-01	0.2950	-8.69e-02	5.99e-02	1.75e-01	-1.97e-03	-2.13e-01	5.88e-01	7.08e-01	2.76e-01	9.90e-01	1.83e-01
GOBP CENTRAL NERVOUS SYSTEM MYELIN MAINTENANCE	5	8.59e-01	9.53e-01	0.2950	-7.14e-02	2.25e-01	-8.17e-02	1.14e-01	1.06e-01	7.82e-01	3.83e-01	7.52e-01	6.58e-01	6.81e-01
GOBP NEGATIVE REGULATION OF CYCLASE ACTIVITY	15	5.34e-01	8.21e-01	0.2950	-1.93e-01	2.66e-02	-9.51e-02	-9.41e-02	1.77e-01	1.97e-01	8.58e-01	5.24e-01	5.28e-01	2.36e-01
GOBP PROTEIN LOCALIZATION TO NUCLEOLUS	18	5.61e-01	8.33e-01	0.2950	1.71e-01	-7.83e-02	-1.17e-01	-1.86e-01	5.74e-02	2.09e-01	5.65e-01	3.92e-01	1.71e-01	6.73e-01
GOBP MACROPHAGE CYTOKINE PRODUCTION	36	5.48e-02	2.70e-01	0.2950	5.61e-02	2.76e-01	-6.56e-02	2.28e-02	5.10e-02	5.60e-01	4.12e-03	4.96e-01	8.13e-01	5.96e-01
GOBP SPHINGOMYELIN METABOLIC PROCESS	20	3.20e-01	6.68e-01	0.2950	-2.25e-02	2.01e-01	5.03e-02	-1.85e-01	-9.61e-02	8.62e-01	1.19e-01	6.97e-01	1.52e-01	4.57e-01
GOBP PEPTIDYL SERINE AUTOPHOSPHORYLATION	8	7.68e-01	9.24e-01	0.2950	-7.10e-02	1.80e-02	-7.57e-03	-2.00e-01	-2.04e-01	7.28e-01	9.30e-01	9.70e-01	3.28e-01	3.18e-01
GOBP TRANSFORMING GROWTH FACTOR BETA2 PRODUCTION	9	7.48e-01	9.15e-01	0.2950	1.23e-01	-1.87e-01	-4.75e-02	-1.79e-01	-5.05e-02	5.22e-01	3.32e-01	8.05e-01	3.53e-01	7.93e-01
GOCC H4 HISTONE ACETYLTRANSFERASE COMPLEX	36	1.70e-01	5.08e-01	0.2950	1.80e-01	-5.54e-02	-8.97e-02	-1.64e-01	1.28e-01	6.16e-02	5.65e-01	3.52e-01	8.79e-02	1.85e-01
GOBP MUSCLE HYPERTROPHY IN RESPONSE TO STRESS	31	1.65e-01	5.00e-01	0.2950	-6.84e-02	-4.02e-02	2.22e-01	4.19e-02	1.72e-01	5.10e-01	6.98e-01	3.25e-02	6.86e-01	9.78e-02
GOCC COSTAMERE	16	6.65e-01	8.82e-01	0.2950	-1.53e-02	3.37e-02	1.22e-01	2.34e-01	-1.25e-01	9.16e-01	8.16e-01	3.96e-01	1.05e-01	3.87e-01
GOMF CLATHRIN HEAVY CHAIN BINDING	10	6.52e-01	8.79e-01	0.2940	4.17e-02	2.67e-01	-7.50e-02	9.01e-02	2.48e-03	8.19e-01	1.44e-01	6.81e-01	6.22e-01	9.89e-01
GOBP TACHYKININ RECEPTOR SIGNALING PATHWAY	8	7.60e-01	9.20e-01	0.2940	1.53e-01	-1.58e-01	1.37e-01	-7.62e-02	1.17e-01	4.52e-01	4.39e-01	5.02e-01	7.09e-01	5.67e-01
GOBP POSTREPLICATION REPAIR	33	2.55e-01	6.12e-01	0.2940	1.20e-01	1.52e-02	-2.12e-01	-1.64e-01	-2.58e-03	2.33e-01	8.80e-01	3.49e-02	1.02e-01	9.80e-01
GOBP MONOATOMIC ANION HOMEOSTASIS	20	3.60e-01	7.04e-01	0.2940	-2.69e-01	1.02e-01	-1.77e-02	4.10e-02	-4.19e-02	3.71e-02	4.31e-01	8.91e-01	7.51e-01	7.46e-01
GOBP POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING	41	6.81e-02	3.09e-01	0.2940	-2.15e-01	8.67e-02	-3.83e-02	4.60e-03	-1.76e-01	1.70e-02	3.37e-01	6.71e-01	9.59e-01	5.07e-02
GOMF TROPOMYOSIN BINDING	15	6.66e-01	8.82e-01	0.2940	-1.48e-01	3.37e-02	6.77e-02	1.59e-01	-1.84e-01	3.23e-01	8.21e-01	6.50e-01	2.86e-01	2.18e-01
GOCC SCF UBIQUITIN LIGASE COMPLEX	65	1.01e-02	8.79e-02	0.2940	-4.45e-02	1.47e-01	-7.28e-02	-2.37e-01	3.40e-02	5.35e-01	3.98e-02	3.10e-01	9.41e-04	6.36e-01
GOBP CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS	20	5.39e-01	8.22e-01	0.2940	-8.29e-02	-4.53e-02	1.85e-01	2.03e-01	4.63e-02	5.21e-01	7.26e-01	1.52e-01	1.16e-01	7.20e-01
GOBP MAMMARY GLAND EPITHELIAL CELL PROLIFERATION	25	2.20e-01	5.75e-01	0.2940	7.54e-02	1.74e-01	-1.83e-02	-1.73e-01	-1.42e-01	5.14e-01	1.32e-01	8.74e-01	1.35e-01	2.19e-01
GOBP NEGATIVE REGULATION OF T CELL MIGRATION	6	9.02e-01	9.68e-01	0.2940	1.41e-01	1.33e-01	2.15e-01	-1.40e-02	4.82e-02	5.49e-01	5.73e-01	3.62e-01	9.53e-01	8.38e-01
GOBP NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION	33	2.19e-01	5.73e-01	0.2940	-4.38e-02	6.09e-02	2.04e-01	1.46e-01	1.34e-01	6.63e-01	5.45e-01	4.30e-02	1.47e-01	1.83e-01
GOBP CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS	31	1.05e-01	3.93e-01	0.2940	9.79e-02	-1.72e-02	6.48e-02	-2.25e-01	1.47e-01	3.46e-01	8.69e-01	5.32e-01	2.99e-02	1.58e-01
GOMF HISTONE UBIQUITIN LIGASE ACTIVITY	9	7.54e-01	9.17e-01	0.2940	1.47e-01	-9.96e-02	5.58e-03	-2.20e-01	7.79e-02	4.44e-01	6.05e-01	9.77e-01	2.52e-01	6.86e-01
GOMF FATTY ACID OMEGA HYDROXYLASE ACTIVITY	7	8.81e-01	9.61e-01	0.2940	1.43e-01	1.18e-01	1.76e-01	7.39e-02	-1.24e-01	5.14e-01	5.88e-01	4.19e-01	7.35e-01	5.69e-01
GOBP PROTEIN RNA COMPLEX DISASSEMBLY	8	8.47e-01	9.49e-01	0.2940	-3.99e-02	9.34e-02	-7.28e-02	-2.61e-01	-5.03e-02	8.45e-01	6.47e-01	7.21e-01	2.01e-01	8.05e-01
GOMF NUCLEOSOME BINDING	67	2.18e-02	1.49e-01	0.2940	4.79e-02	-8.29e-02	-1.57e-01	-2.24e-01	4.77e-02	4.98e-01	2.40e-01	2.66e-02	1.50e-03	5.00e-01
GOBP AMINO ACID TRANSMEMBRANE TRANSPORT	93	9.35e-04	1.47e-02	0.2940	-1.14e-01	1.44e-01	2.18e-01	5.37e-02	-4.54e-02	5.74e-02	1.66e-02	2.74e-04	3.71e-01	4.49e-01
GOBP MITOCHONDRIAL CALCIUM ION HOMEOSTASIS	24	2.50e-01	6.07e-01	0.2930	-3.38e-03	1.75e-01	2.49e-02	-2.34e-01	-2.69e-03	9.77e-01	1.39e-01	8.33e-01	4.68e-02	9.82e-01
GOBP RESPONSE TO IONIZING RADIATION	136	9.03e-05	2.18e-03	0.2930	7.77e-02	-1.86e-02	-1.42e-01	-2.06e-01	1.30e-01	1.18e-01	7.08e-01	4.22e-03	3.21e-05	8.86e-03
GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM CALCIUM ION CONCENTRATION	7	8.73e-01	9.58e-01	0.2930	-5.62e-02	7.06e-02	2.19e-02	-2.43e-01	1.35e-01	7.97e-01	7.46e-01	9.20e-01	2.65e-01	5.35e-01
GOCC TOR COMPLEX	11	7.84e-01	9.28e-01	0.2930	4.97e-02	1.26e-01	-2.29e-02	-1.87e-01	1.79e-01	7.75e-01	4.69e-01	8.95e-01	2.83e-01	3.03e-01
GOMF CARBONYL REDUCTASE NADPH ACTIVITY	9	8.29e-01	9.44e-01	0.2930	5.61e-02	2.37e-01	1.25e-02	-1.16e-01	1.15e-01	7.71e-01	2.19e-01	9.48e-01	5.45e-01	5.51e-01
GOCC NUCLEAR OUTER MEMBRANE	28	2.62e-01	6.19e-01	0.2930	7.66e-02	1.26e-02	8.57e-03	-1.13e-01	2.59e-01	4.83e-01	9.08e-01	9.37e-01	3.02e-01	1.76e-02
GOBP REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY	18	2.93e-01	6.47e-01	0.2930	-1.55e-01	-1.77e-01	1.48e-01	-9.19e-02	-1.07e-02	2.54e-01	1.93e-01	2.76e-01	5.00e-01	9.37e-01
GOBP NEGATIVE REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS	59	5.22e-03	5.52e-02	0.2930	-1.38e-01	1.38e-01	7.68e-02	-1.99e-01	4.88e-02	6.61e-02	6.74e-02	3.08e-01	8.17e-03	5.17e-01
GOCC APICAL DENDRITE	15	6.24e-01	8.66e-01	0.2930	1.62e-02	2.06e-02	2.03e-01	1.16e-01	-1.75e-01	9.14e-01	8.90e-01	1.73e-01	4.38e-01	2.41e-01
GOBP REGULATION OF SYNAPTIC TRANSMISSION CHOLINERGIC	8	7.44e-01	9.14e-01	0.2930	-6.93e-02	-2.41e-01	1.11e-01	-9.80e-02	3.29e-02	7.34e-01	2.38e-01	5.86e-01	6.31e-01	8.72e-01
GOBP HEPATOCYTE APOPTOTIC PROCESS	21	3.06e-01	6.59e-01	0.2930	9.93e-02	-1.64e-02	6.60e-02	-2.15e-01	1.58e-01	4.31e-01	8.97e-01	6.00e-01	8.81e-02	2.09e-01
GOBP ALANINE TRANSPORT	16	5.90e-01	8.47e-01	0.2930	-2.34e-01	-6.33e-02	1.33e-01	6.74e-02	-7.08e-02	1.06e-01	6.61e-01	3.58e-01	6.41e-01	6.24e-01
GOMF PEPTIDE HORMONE BINDING	48	1.14e-01	4.13e-01	0.2930	-4.85e-02	4.27e-02	1.87e-01	1.98e-01	-8.53e-02	5.61e-01	6.09e-01	2.52e-02	1.73e-02	3.07e-01
GOMF HISTONE H3K4 TRIMETHYLTRANSFERASE ACTIVITY	10	7.24e-01	9.04e-01	0.2930	2.74e-01	4.05e-02	8.66e-02	-3.08e-02	-2.09e-02	1.33e-01	8.24e-01	6.35e-01	8.66e-01	9.09e-01
GOBP PIGMENT ACCUMULATION	11	7.24e-01	9.04e-01	0.2930	-3.38e-02	2.11e-01	-6.02e-02	-7.31e-02	-1.76e-01	8.46e-01	2.25e-01	7.30e-01	6.75e-01	3.13e-01
GOBP ANTERIOR POSTERIOR PATTERN SPECIFICATION	209	7.06e-10	5.83e-08	0.2930	1.21e-01	6.88e-02	8.32e-03	-2.26e-01	1.23e-01	2.51e-03	8.65e-02	8.36e-01	1.80e-08	2.20e-03
GOBP URETERIC BUD ELONGATION	8	8.70e-01	9.57e-01	0.2930	9.90e-02	1.04e-01	2.59e-02	-9.26e-02	2.36e-01	6.28e-01	6.09e-01	8.99e-01	6.50e-01	2.48e-01
GOMF PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY	56	3.93e-02	2.18e-01	0.2930	2.16e-02	6.95e-02	-7.86e-02	-2.24e-01	1.55e-01	7.80e-01	3.68e-01	3.09e-01	3.74e-03	4.49e-02
GOCC SMC5 SMC6 COMPLEX	9	7.32e-01	9.08e-01	0.2920	-3.37e-02	-2.10e-01	1.81e-01	-8.56e-03	8.70e-02	8.61e-01	2.75e-01	3.48e-01	9.65e-01	6.51e-01
GOBP OLIGOPEPTIDE IMPORT ACROSS PLASMA MEMBRANE	5	9.33e-01	9.79e-01	0.2920	-1.97e-01	2.10e-01	-2.82e-03	-4.87e-02	-2.22e-02	4.47e-01	4.16e-01	9.91e-01	8.50e-01	9.32e-01
GOMF CARD DOMAIN BINDING	16	5.06e-01	8.06e-01	0.2920	1.23e-01	2.60e-01	-5.31e-02	-1.12e-03	-5.91e-03	3.94e-01	7.20e-02	7.13e-01	9.94e-01	9.67e-01
GOBP ER NUCLEUS SIGNALING PATHWAY	45	6.08e-02	2.90e-01	0.2920	-1.54e-01	8.71e-02	-9.80e-02	-2.11e-01	-1.31e-02	7.48e-02	3.12e-01	2.56e-01	1.43e-02	8.79e-01
GOBP NEURAL CREST FORMATION	15	6.66e-01	8.82e-01	0.2920	1.41e-01	3.11e-02	-4.71e-02	-1.42e-01	2.05e-01	3.43e-01	8.35e-01	7.52e-01	3.41e-01	1.69e-01
GOMF CHROMATIN DNA BINDING	110	3.96e-04	7.44e-03	0.2920	8.21e-02	2.83e-02	-8.92e-02	-2.36e-01	1.18e-01	1.37e-01	6.08e-01	1.06e-01	1.82e-05	3.20e-02
GOMF ADENOSINE RECEPTOR BINDING	7	8.47e-01	9.49e-01	0.2920	1.80e-01	2.54e-02	1.52e-01	5.08e-02	-1.63e-01	4.09e-01	9.07e-01	4.87e-01	8.16e-01	4.54e-01
GOMF APOLIPOPROTEIN RECEPTOR BINDING	7	8.91e-01	9.63e-01	0.2920	9.11e-02	4.94e-02	2.28e-01	1.04e-01	-1.09e-01	6.77e-01	8.21e-01	2.97e-01	6.33e-01	6.17e-01
GOMF PHOSPHOLIPASE ACTIVATOR ACTIVITY	13	6.48e-01	8.77e-01	0.2920	-1.28e-01	7.74e-02	1.10e-01	1.81e-02	2.25e-01	4.23e-01	6.29e-01	4.94e-01	9.10e-01	1.60e-01
GOCC DEATH INDUCING SIGNALING COMPLEX	9	7.95e-01	9.32e-01	0.2920	-3.75e-02	-5.83e-02	-4.16e-02	-2.75e-01	5.49e-02	8.46e-01	7.62e-01	8.29e-01	1.53e-01	7.76e-01
GOBP HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN	46	3.93e-02	2.18e-01	0.2920	-9.61e-02	-7.07e-03	-1.28e-03	2.43e-01	-1.30e-01	2.59e-01	9.34e-01	9.88e-01	4.33e-03	1.27e-01
GOCC SPECIFIC GRANULE MEMBRANE	88	6.89e-04	1.14e-02	0.2920	-1.01e-01	2.01e-01	1.41e-01	-5.04e-02	1.11e-01	1.02e-01	1.14e-03	2.23e-02	4.14e-01	7.11e-02
GOBP REGULATION OF CHROMATIN ORGANIZATION	44	7.92e-02	3.39e-01	0.2920	1.64e-01	2.60e-02	-4.06e-02	-1.99e-01	1.27e-01	5.92e-02	7.65e-01	6.41e-01	2.21e-02	1.45e-01
GOBP REGULATION OF MEMBRANE DEPOLARIZATION	45	5.99e-02	2.86e-01	0.2920	-1.87e-01	1.14e-01	9.23e-02	2.06e-02	-1.68e-01	2.95e-02	1.85e-01	2.84e-01	8.11e-01	5.19e-02
GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL CORTEX	9	6.97e-01	8.94e-01	0.2920	2.19e-02	1.11e-01	4.64e-02	-2.38e-01	-1.16e-01	9.09e-01	5.63e-01	8.10e-01	2.16e-01	5.46e-01
GOMF PROTEIN SERINE THREONINE KINASE INHIBITOR ACTIVITY	37	1.69e-01	5.05e-01	0.2920	-1.91e-02	1.16e-01	-1.54e-01	-2.18e-01	-1.39e-02	8.40e-01	2.24e-01	1.06e-01	2.15e-02	8.84e-01
GOBP NEUROPEPTIDE SIGNALING PATHWAY	102	3.32e-05	9.47e-04	0.2920	-1.13e-01	7.98e-02	1.81e-01	-1.06e-01	1.48e-01	4.80e-02	1.64e-01	1.60e-03	6.38e-02	9.74e-03
GOBP REGULATION OF VITAMIN D BIOSYNTHETIC PROCESS	7	8.34e-01	9.45e-01	0.2920	9.01e-03	-1.67e-01	-2.19e-01	8.09e-02	5.24e-02	9.67e-01	4.44e-01	3.16e-01	7.11e-01	8.10e-01
GOBP L ARGININE TRANSMEMBRANE TRANSPORT	14	7.00e-01	8.96e-01	0.2920	-1.92e-01	1.14e-01	1.51e-01	8.74e-02	-6.65e-02	2.13e-01	4.58e-01	3.27e-01	5.71e-01	6.67e-01
GOMF DOUBLE STRANDED TELOMERIC DNA BINDING	9	7.78e-01	9.27e-01	0.2920	1.05e-01	8.49e-02	-6.40e-02	-1.79e-01	-1.75e-01	5.86e-01	6.59e-01	7.40e-01	3.53e-01	3.62e-01
GOCC AUTOPHAGOSOME MEMBRANE	50	9.30e-02	3.68e-01	0.2920	5.78e-02	2.55e-02	-1.77e-01	-2.21e-01	2.49e-02	4.80e-01	7.55e-01	3.00e-02	6.79e-03	7.60e-01
GOBP NEURAL PLATE PATTERN SPECIFICATION	8	8.91e-01	9.63e-01	0.2920	1.18e-01	3.90e-02	-5.81e-02	-1.98e-01	1.65e-01	5.63e-01	8.49e-01	7.76e-01	3.33e-01	4.20e-01
GOMF BETA N ACETYLHEXOSAMINIDASE ACTIVITY	5	9.01e-01	9.68e-01	0.2920	-4.35e-02	-2.55e-01	5.14e-02	-1.23e-01	1.59e-02	8.66e-01	3.23e-01	8.42e-01	6.34e-01	9.51e-01
GOBP REGULATION OF HISTONE ACETYLATION	18	4.94e-01	7.99e-01	0.2920	2.47e-01	9.48e-04	-6.90e-02	-1.39e-01	-6.50e-03	6.98e-02	9.94e-01	6.12e-01	3.08e-01	9.62e-01
GOMF PEPTIDASE ACTIVATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS	23	3.73e-01	7.12e-01	0.2910	2.61e-02	2.13e-01	-6.63e-02	-1.86e-01	-1.03e-03	8.28e-01	7.74e-02	5.82e-01	1.22e-01	9.93e-01
GOBP POSITIVE REGULATION BY HOST OF VIRAL PROCESS	20	4.74e-01	7.87e-01	0.2910	1.76e-01	-1.34e-02	-6.84e-02	-2.09e-01	7.48e-02	1.73e-01	9.17e-01	5.97e-01	1.06e-01	5.63e-01
GOBP POSITIVE REGULATION OF DNA REPLICATION	37	2.20e-01	5.74e-01	0.2910	1.28e-01	-1.56e-02	-1.87e-01	-1.80e-01	3.00e-02	1.77e-01	8.70e-01	4.91e-02	5.88e-02	7.52e-01
GOBP SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT	22	3.87e-01	7.24e-01	0.2910	1.10e-01	1.28e-01	2.15e-01	1.26e-02	1.00e-01	3.74e-01	2.99e-01	8.10e-02	9.19e-01	4.17e-01
GOBP PENETRATION OF ZONA PELLUCIDA	9	6.84e-01	8.88e-01	0.2910	6.52e-02	2.19e-01	-1.35e-01	1.06e-01	-5.67e-02	7.35e-01	2.56e-01	4.83e-01	5.83e-01	7.68e-01
GOBP AMINO SUGAR CATABOLIC PROCESS	14	7.18e-01	9.02e-01	0.2910	-2.80e-02	3.99e-02	1.05e-01	1.67e-01	-2.09e-01	8.56e-01	7.96e-01	4.96e-01	2.81e-01	1.77e-01
GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY	8	8.05e-01	9.35e-01	0.2910	1.14e-01	-4.71e-02	-4.42e-02	-2.57e-01	-3.73e-02	5.75e-01	8.18e-01	8.29e-01	2.08e-01	8.55e-01
GOBP SKELETAL MUSCLE SATELLITE CELL DIFFERENTIATION	9	8.01e-01	9.34e-01	0.2910	-5.93e-02	-3.10e-02	-9.57e-02	-1.89e-01	-1.88e-01	7.58e-01	8.72e-01	6.19e-01	3.26e-01	3.29e-01
GOBP REGULATION OF METALLOENDOPEPTIDASE ACTIVITY	15	4.35e-01	7.58e-01	0.2910	-1.86e-01	1.66e-02	-1.34e-01	1.50e-01	-9.76e-02	2.13e-01	9.12e-01	3.71e-01	3.15e-01	5.13e-01
GOBP POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION	28	1.76e-01	5.16e-01	0.2910	-1.00e-01	-6.70e-02	1.50e-01	-6.52e-02	2.08e-01	3.60e-01	5.40e-01	1.71e-01	5.51e-01	5.63e-02
GOBP POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION	19	2.28e-01	5.81e-01	0.2910	-1.92e-02	6.45e-02	6.99e-02	-2.47e-01	-1.19e-01	8.85e-01	6.26e-01	5.98e-01	6.28e-02	3.68e-01
GOBP REGULATION OF AMINE METABOLIC PROCESS	31	1.54e-01	4.83e-01	0.2910	-6.06e-02	1.70e-01	1.25e-01	-2.05e-02	-1.90e-01	5.60e-01	1.01e-01	2.30e-01	8.43e-01	6.76e-02
GOBP TELOMERE ORGANIZATION	178	2.69e-06	1.04e-04	0.2910	6.39e-03	-8.23e-02	-1.52e-01	-2.08e-01	1.07e-01	8.83e-01	5.82e-02	4.80e-04	1.72e-06	1.39e-02
GOBP REGULATION OF ERAD PATHWAY	19	5.64e-01	8.35e-01	0.2910	3.89e-02	4.29e-03	-2.31e-01	-1.42e-01	-9.65e-02	7.69e-01	9.74e-01	8.10e-02	2.85e-01	4.67e-01
GOBP NUCLEAR PORE COMPLEX ASSEMBLY	11	5.99e-01	8.51e-01	0.2900	-4.24e-02	-8.70e-02	4.27e-02	-2.67e-01	4.36e-02	8.08e-01	6.17e-01	8.06e-01	1.25e-01	8.02e-01
GOBP REGULATION OF INTEGRIN ACTIVATION	17	4.50e-01	7.71e-01	0.2900	-2.21e-01	-3.80e-02	-3.77e-02	1.73e-01	-5.15e-02	1.14e-01	7.86e-01	7.88e-01	2.18e-01	7.13e-01
GOBP RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM	51	9.75e-02	3.78e-01	0.2900	5.04e-02	-1.28e-02	-2.00e-01	-2.02e-01	2.79e-02	5.33e-01	8.74e-01	1.36e-02	1.24e-02	7.30e-01
GOCC GOLGI CIS CISTERNA	14	7.16e-01	9.01e-01	0.2900	1.27e-01	-9.39e-02	-1.11e-01	-1.21e-01	1.79e-01	4.09e-01	5.43e-01	4.71e-01	4.33e-01	2.45e-01
GOMF MICROTUBULE PLUS END BINDING	21	3.52e-01	6.98e-01	0.2900	2.46e-01	5.86e-02	-5.63e-02	6.42e-02	1.14e-01	5.08e-02	6.42e-01	6.55e-01	6.11e-01	3.66e-01
GOMF ABC TYPE XENOBIOTIC TRANSPORTER ACTIVITY	14	7.29e-01	9.06e-01	0.2900	-7.41e-02	2.42e-03	1.00e-01	2.35e-01	-1.16e-01	6.31e-01	9.87e-01	5.16e-01	1.27e-01	4.53e-01
GOBP DNA CATABOLIC PROCESS	29	2.66e-01	6.21e-01	0.2900	1.83e-01	-2.94e-02	-9.06e-02	-1.99e-01	4.61e-02	8.87e-02	7.84e-01	3.98e-01	6.32e-02	6.68e-01
GOMF L ARGININE TRANSMEMBRANE TRANSPORTER ACTIVITY	12	7.90e-01	9.31e-01	0.2900	-1.58e-01	6.08e-02	1.16e-01	1.51e-01	-1.39e-01	3.44e-01	7.15e-01	4.88e-01	3.64e-01	4.04e-01
GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN CYCLIC AMIDES	15	5.13e-01	8.09e-01	0.2900	-2.25e-02	4.94e-02	-2.71e-01	-5.94e-02	6.39e-02	8.80e-01	7.40e-01	6.87e-02	6.90e-01	6.68e-01
GOMF RETINOIC ACID BINDING	26	2.30e-01	5.83e-01	0.2900	1.14e-02	1.89e-01	6.75e-02	2.09e-01	1.67e-02	9.20e-01	9.51e-02	5.52e-01	6.55e-02	8.82e-01
GOBP REGULATION OF DNA REPAIR	205	3.65e-07	1.89e-05	0.2900	1.00e-01	-2.82e-02	-1.55e-01	-2.10e-01	7.27e-02	1.35e-02	4.86e-01	1.26e-04	2.23e-07	7.27e-02
GOBP SPINAL CORD DEVELOPMENT	99	4.29e-04	7.97e-03	0.2900	1.24e-01	4.14e-02	-1.03e-03	-1.94e-01	1.71e-01	3.36e-02	4.76e-01	9.86e-01	8.44e-04	3.20e-03
GOBP PROTEIN DEGLUTAMYLATION	6	9.15e-01	9.72e-01	0.2900	1.17e-02	-5.48e-02	1.60e-01	2.08e-02	2.34e-01	9.61e-01	8.16e-01	4.96e-01	9.30e-01	3.21e-01
GOCC POSTSYNAPTIC CYTOSOL	13	6.59e-01	8.80e-01	0.2900	8.33e-02	1.73e-01	-5.69e-02	-1.84e-01	-1.01e-01	6.03e-01	2.80e-01	7.22e-01	2.51e-01	5.28e-01
GOMF RECEPTOR SERINE THREONINE KINASE BINDING	25	3.54e-01	6.99e-01	0.2900	-1.99e-01	7.81e-02	6.71e-02	1.44e-01	-1.15e-01	8.51e-02	4.99e-01	5.61e-01	2.14e-01	3.21e-01
GOBP NEGATIVE REGULATION OF CHOLESTEROL STORAGE	11	7.72e-01	9.25e-01	0.2900	-1.12e-01	-1.76e-02	1.62e-01	1.31e-01	1.66e-01	5.20e-01	9.20e-01	3.52e-01	4.51e-01	3.41e-01
GOMF EXTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY	68	1.80e-02	1.32e-01	0.2900	-6.52e-02	5.03e-02	2.11e-01	1.48e-01	1.04e-01	3.52e-01	4.73e-01	2.64e-03	3.51e-02	1.38e-01
GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY	69	6.99e-03	6.78e-02	0.2900	5.87e-02	-8.77e-02	-1.19e-01	-2.38e-01	-4.54e-02	3.99e-01	2.08e-01	8.74e-02	6.37e-04	5.14e-01
GOBP UREA CYCLE	10	7.83e-01	9.28e-01	0.2900	-1.13e-01	-6.82e-03	3.75e-03	-1.25e-01	2.35e-01	5.36e-01	9.70e-01	9.84e-01	4.93e-01	1.98e-01
GOBP OXYGEN TRANSPORT	15	6.65e-01	8.82e-01	0.2900	-9.33e-03	-2.91e-02	1.33e-01	2.51e-01	4.83e-02	9.50e-01	8.45e-01	3.72e-01	9.28e-02	7.46e-01
GOMF RNA CAP BINDING	20	3.92e-01	7.27e-01	0.2900	-5.32e-02	2.82e-01	-1.35e-02	-3.44e-02	6.14e-03	6.80e-01	2.89e-02	9.17e-01	7.90e-01	9.62e-01
GOBP REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS	13	5.63e-01	8.34e-01	0.2890	-1.08e-01	8.26e-02	1.42e-01	-1.87e-01	1.00e-01	4.99e-01	6.06e-01	3.75e-01	2.43e-01	5.31e-01
GOMF NARROW PORE CHANNEL ACTIVITY	19	5.81e-01	8.43e-01	0.2890	4.44e-02	-6.08e-02	1.38e-01	2.21e-01	-1.01e-01	7.37e-01	6.46e-01	2.96e-01	9.58e-02	4.45e-01
GOBP NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION	11	7.81e-01	9.28e-01	0.2890	-8.41e-02	-1.24e-01	-1.49e-01	-1.09e-01	1.65e-01	6.29e-01	4.77e-01	3.92e-01	5.33e-01	3.43e-01
GOBP INTEGRATED STRESS RESPONSE SIGNALING	42	1.03e-01	3.89e-01	0.2890	-7.79e-02	1.27e-01	-1.10e-01	-1.98e-01	1.02e-01	3.83e-01	1.54e-01	2.19e-01	2.67e-02	2.52e-01
GOCC H4 H2A HISTONE ACETYLTRANSFERASE COMPLEX	24	4.12e-01	7.43e-01	0.2890	1.80e-01	-1.01e-01	-1.05e-01	-1.35e-01	1.09e-01	1.26e-01	3.90e-01	3.75e-01	2.53e-01	3.57e-01
GOMF CALCIUM CHANNEL REGULATOR ACTIVITY	46	2.53e-02	1.63e-01	0.2890	4.51e-02	2.11e-01	1.13e-01	-1.57e-01	-5.88e-03	5.96e-01	1.35e-02	1.86e-01	6.60e-02	9.45e-01
GOBP PROTEIN LOCALIZATION TO CHROMATIN	56	1.49e-02	1.16e-01	0.2890	9.39e-02	-1.24e-01	-6.87e-02	-2.33e-01	2.49e-02	2.24e-01	1.09e-01	3.74e-01	2.58e-03	7.47e-01
GOBP DNA INTEGRITY CHECKPOINT SIGNALING	131	1.42e-04	3.17e-03	0.2890	1.29e-01	4.90e-02	-1.54e-01	-1.95e-01	5.50e-02	1.07e-02	3.33e-01	2.38e-03	1.19e-04	2.77e-01
GOCC PAR POLARITY COMPLEX	6	8.72e-01	9.58e-01	0.2890	2.22e-02	1.48e-01	-2.80e-02	2.29e-01	-8.83e-02	9.25e-01	5.30e-01	9.05e-01	3.31e-01	7.08e-01
GOBP SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR	168	8.02e-06	2.72e-04	0.2890	1.84e-02	9.53e-03	-1.46e-01	-2.32e-01	9.05e-02	6.81e-01	8.31e-01	1.12e-03	2.13e-07	4.30e-02
GOMF RNA POLYMERASE I TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING	8	8.66e-01	9.55e-01	0.2890	2.46e-01	-3.48e-02	-8.57e-02	-1.20e-01	1.03e-04	2.28e-01	8.65e-01	6.75e-01	5.58e-01	1.00e+00
GOBP CELLULAR RESPONSE TO LEUCINE	12	7.98e-01	9.32e-01	0.2890	8.78e-02	5.78e-02	-2.15e-01	-1.61e-01	1.88e-02	5.98e-01	7.29e-01	1.98e-01	3.33e-01	9.10e-01
GOBP REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM	24	4.06e-01	7.39e-01	0.2890	-8.62e-02	-5.41e-02	-1.20e-01	-2.40e-01	3.74e-02	4.65e-01	6.46e-01	3.09e-01	4.22e-02	7.51e-01
GOBP RETICULOPHAGY	18	5.58e-01	8.32e-01	0.2890	2.24e-01	-9.48e-02	-1.27e-01	-7.59e-02	5.05e-02	1.00e-01	4.86e-01	3.50e-01	5.77e-01	7.11e-01
GOCC POSTSYNAPTIC ACTIN CYTOSKELETON	5	9.38e-01	9.80e-01	0.2890	2.09e-02	1.82e-01	-2.24e-02	-2.17e-01	-4.92e-02	9.35e-01	4.80e-01	9.31e-01	4.02e-01	8.49e-01
GOMF MANNOSIDASE ACTIVITY	15	4.86e-01	7.94e-01	0.2890	1.43e-01	-1.29e-01	3.65e-02	-1.88e-01	9.79e-02	3.37e-01	3.87e-01	8.06e-01	2.07e-01	5.11e-01
GOMF CHLORIDE ION BINDING	10	8.50e-01	9.50e-01	0.2890	1.50e-01	-6.51e-02	-2.09e-01	-1.14e-01	-6.39e-03	4.11e-01	7.21e-01	2.53e-01	5.34e-01	9.72e-01
GOBP SINGLE STRAND BREAK REPAIR	11	8.08e-01	9.37e-01	0.2890	-8.21e-02	-1.96e-03	-1.77e-01	-1.87e-01	-1.02e-01	6.37e-01	9.91e-01	3.10e-01	2.83e-01	5.56e-01
GOBP REGULATION OF KIDNEY DEVELOPMENT	32	1.83e-01	5.25e-01	0.2890	2.15e-02	3.44e-02	-8.63e-02	-2.72e-01	-2.23e-02	8.33e-01	7.36e-01	3.98e-01	7.83e-03	8.27e-01
GOBP REGULATION OF HYALURONAN BIOSYNTHETIC PROCESS	8	8.23e-01	9.42e-01	0.2890	6.59e-02	1.74e-01	-2.07e-01	-4.53e-02	-6.30e-02	7.47e-01	3.94e-01	3.12e-01	8.25e-01	7.58e-01
GOBP MOTOR NEURON AXON GUIDANCE	23	3.89e-01	7.25e-01	0.2890	-1.56e-01	-1.41e-01	-8.27e-02	1.82e-02	-1.79e-01	1.96e-01	2.41e-01	4.93e-01	8.80e-01	1.38e-01
GOBP REGULATION OF ANIMAL ORGAN FORMATION	27	2.54e-01	6.11e-01	0.2890	1.16e-01	-1.41e-02	-1.02e-01	-2.32e-01	-7.48e-02	2.98e-01	8.99e-01	3.61e-01	3.70e-02	5.01e-01
GOBP POSITIVE REGULATION OF MRNA PROCESSING	28	3.95e-01	7.29e-01	0.2890	3.42e-02	-1.48e-02	-1.66e-01	-2.30e-01	4.04e-02	7.54e-01	8.92e-01	1.29e-01	3.53e-02	7.11e-01
GOBP NEGATIVE REGULATION OF MACROPHAGE CHEMOTAXIS	7	8.84e-01	9.61e-01	0.2890	9.23e-02	2.54e-01	2.87e-02	1.69e-02	9.62e-02	6.73e-01	2.45e-01	8.95e-01	9.38e-01	6.59e-01
GOBP REGULATION OF DNA BINDING	82	6.88e-03	6.71e-02	0.2890	7.25e-02	-4.25e-02	-1.04e-01	-1.90e-01	1.71e-01	2.56e-01	5.06e-01	1.04e-01	2.95e-03	7.33e-03
GOBP MEGAKARYOCYTE DEVELOPMENT	22	3.65e-01	7.05e-01	0.2890	-1.37e-01	1.81e-01	-9.78e-02	-1.09e-01	-1.03e-01	2.68e-01	1.42e-01	4.27e-01	3.77e-01	4.05e-01
GOMF METAL CATION PROTON ANTIPORTER ACTIVITY	23	2.12e-01	5.65e-01	0.2880	-7.01e-02	1.13e-01	2.36e-01	-9.87e-02	-5.26e-04	5.60e-01	3.48e-01	4.99e-02	4.13e-01	9.97e-01
GOMF WW DOMAIN BINDING	22	3.62e-01	7.04e-01	0.2880	-5.59e-02	1.41e-01	-5.08e-03	-7.90e-02	2.32e-01	6.50e-01	2.53e-01	9.67e-01	5.21e-01	5.92e-02
GOMF OLFACTORY RECEPTOR BINDING	6	8.62e-01	9.53e-01	0.2880	8.21e-02	-1.90e-02	-8.46e-03	2.42e-01	1.33e-01	7.27e-01	9.36e-01	9.71e-01	3.05e-01	5.73e-01
GOBP REGULATION OF MRNA PROCESSING	116	3.18e-04	6.22e-03	0.2880	3.03e-02	-1.03e-02	-1.34e-01	-2.53e-01	2.27e-02	5.74e-01	8.49e-01	1.29e-02	2.58e-06	6.73e-01
GOMF TRANSMITTER GATED CHANNEL ACTIVITY	56	4.38e-02	2.32e-01	0.2880	-3.86e-02	5.13e-02	2.00e-01	1.51e-01	1.28e-01	6.17e-01	5.06e-01	9.70e-03	5.09e-02	9.75e-02
GOBP PROTEIN SUMOYLATION	64	3.26e-02	1.93e-01	0.2880	7.06e-02	-4.50e-02	-1.38e-01	-1.71e-01	1.67e-01	3.29e-01	5.33e-01	5.63e-02	1.79e-02	2.10e-02
GOBP GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT	10	7.05e-01	8.97e-01	0.2880	4.89e-02	1.75e-01	1.68e-01	-7.50e-02	-1.28e-01	7.89e-01	3.38e-01	3.58e-01	6.81e-01	4.83e-01
GOBP DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION	14	7.23e-01	9.03e-01	0.2880	5.13e-02	-6.42e-02	-1.20e-01	-1.38e-01	2.07e-01	7.40e-01	6.78e-01	4.39e-01	3.70e-01	1.80e-01
GOCC SPINDLE MICROTUBULE	76	8.83e-03	8.04e-02	0.2880	9.79e-02	4.25e-02	-7.53e-02	-2.22e-01	1.29e-01	1.40e-01	5.22e-01	2.56e-01	8.11e-04	5.19e-02
GOBP NEGATIVE REGULATION OF DNA TEMPLATED DNA REPLICATION	9	8.37e-01	9.46e-01	0.2880	4.72e-02	2.44e-01	-2.00e-02	-1.25e-01	7.26e-02	8.06e-01	2.05e-01	9.17e-01	5.14e-01	7.06e-01
GOBP OSTEOCLAST PROLIFERATION	11	8.02e-01	9.34e-01	0.2880	-5.48e-03	2.25e-02	-5.80e-02	-2.28e-01	1.65e-01	9.75e-01	8.97e-01	7.39e-01	1.90e-01	3.44e-01
GOBP CELLULAR RESPONSE TO LEPTIN STIMULUS	17	6.29e-01	8.68e-01	0.2880	1.28e-01	-1.29e-01	-2.08e-01	-8.36e-02	-9.84e-03	3.62e-01	3.58e-01	1.38e-01	5.51e-01	9.44e-01
GOCC MYELIN SHEATH ABAXONAL REGION	6	9.27e-01	9.77e-01	0.2880	1.26e-01	1.90e-01	5.26e-02	-3.62e-02	1.64e-01	5.94e-01	4.20e-01	8.23e-01	8.78e-01	4.86e-01
GOBP SNRNA TRANSCRIPTION BY RNA POLYMERASE II	16	5.33e-01	8.20e-01	0.2880	5.82e-02	-1.20e-02	4.37e-03	-2.53e-01	1.24e-01	6.87e-01	9.34e-01	9.76e-01	7.94e-02	3.92e-01
GOBP PROTEIN LOCALIZATION TO MICROTUBULE	17	4.46e-01	7.69e-01	0.2880	-1.49e-01	-1.45e-01	-2.17e-02	-1.91e-01	-5.41e-02	2.88e-01	3.02e-01	8.77e-01	1.73e-01	6.99e-01
GOBP PROTOPORPHYRINOGEN IX METABOLIC PROCESS	10	8.28e-01	9.44e-01	0.2880	1.41e-01	1.58e-01	-1.13e-01	-1.34e-01	8.54e-02	4.40e-01	3.85e-01	5.36e-01	4.65e-01	6.40e-01
GOCC ACTIN FILAMENT	105	1.74e-04	3.74e-03	0.2880	-7.55e-02	2.15e-01	1.44e-01	-2.62e-03	-1.02e-01	1.81e-01	1.42e-04	1.10e-02	9.63e-01	7.06e-02
GOBP REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION	27	2.12e-01	5.65e-01	0.2880	-2.92e-03	-5.35e-02	-7.59e-02	-1.10e-01	-2.49e-01	9.79e-01	6.30e-01	4.95e-01	3.24e-01	2.48e-02
GOMF ISOPRENOID BINDING	44	2.31e-02	1.55e-01	0.2880	-3.31e-02	1.04e-01	-4.49e-02	2.30e-01	-1.27e-01	7.04e-01	2.32e-01	6.06e-01	8.28e-03	1.47e-01
GOMF 2 IRON 2 SULFUR CLUSTER BINDING	22	4.12e-01	7.43e-01	0.2880	4.54e-02	1.31e-01	-2.17e-01	-1.20e-01	-4.61e-02	7.12e-01	2.88e-01	7.79e-02	3.30e-01	7.08e-01
GOBP PROTEIN LOCALIZATION TO CILIUM	70	1.65e-02	1.25e-01	0.2880	-4.32e-02	-1.23e-01	-2.06e-01	-1.26e-01	-8.67e-02	5.32e-01	7.41e-02	2.94e-03	6.74e-02	2.10e-01
GOBP NEGATIVE REGULATION OF PLATELET ACTIVATION	17	5.17e-01	8.11e-01	0.2880	1.98e-02	2.65e-01	-2.07e-02	-5.72e-02	9.24e-02	8.88e-01	5.86e-02	8.82e-01	6.83e-01	5.10e-01
GOBP GLUCOCORTICOID BIOSYNTHETIC PROCESS	15	6.76e-01	8.85e-01	0.2880	5.10e-02	-6.94e-02	7.80e-02	2.09e-01	-1.60e-01	7.32e-01	6.42e-01	6.01e-01	1.61e-01	2.83e-01
GOBP NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE	22	1.60e-01	4.92e-01	0.2880	6.13e-02	-2.03e-02	2.74e-01	-6.12e-02	2.87e-03	6.19e-01	8.69e-01	2.63e-02	6.19e-01	9.81e-01
GOMF RDNA BINDING	10	8.32e-01	9.45e-01	0.2880	1.73e-01	-1.11e-02	-1.06e-01	-2.01e-01	2.85e-02	3.43e-01	9.52e-01	5.60e-01	2.70e-01	8.76e-01
GOBP POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS	19	4.89e-01	7.97e-01	0.2880	-8.82e-02	1.33e-01	1.42e-01	6.30e-02	1.82e-01	5.05e-01	3.14e-01	2.84e-01	6.34e-01	1.70e-01
GOBP POLYAMINE TRANSPORT	16	5.38e-01	8.22e-01	0.2880	1.12e-01	-1.69e-01	5.43e-03	1.10e-01	1.72e-01	4.37e-01	2.42e-01	9.70e-01	4.47e-01	2.35e-01
GOBP CELLULAR RESPONSE TO HISTAMINE	7	8.73e-01	9.58e-01	0.2880	-1.34e-01	7.93e-02	5.37e-02	2.36e-01	-1.00e-02	5.40e-01	7.16e-01	8.06e-01	2.80e-01	9.63e-01
GOCC AZUROPHIL GRANULE	151	5.14e-07	2.51e-05	0.2880	-1.69e-01	8.53e-02	5.75e-03	-1.94e-01	9.64e-02	3.32e-04	7.04e-02	9.03e-01	3.98e-05	4.09e-02
GOMF GALACTOSYLCERAMIDASE ACTIVITY	5	9.24e-01	9.75e-01	0.2880	1.67e-01	-1.37e-01	5.16e-02	4.86e-02	-1.76e-01	5.17e-01	5.95e-01	8.42e-01	8.51e-01	4.97e-01
GOBP SCHWANN CELL MIGRATION	5	9.53e-01	9.86e-01	0.2880	-2.46e-01	-1.67e-02	5.00e-02	8.34e-02	-1.10e-01	3.40e-01	9.49e-01	8.46e-01	7.47e-01	6.69e-01
GOCC OLIGOSACCHARYLTRANSFERASE COMPLEX	13	7.79e-01	9.28e-01	0.2870	6.44e-02	9.06e-02	-1.59e-01	-2.08e-01	4.51e-02	6.88e-01	5.72e-01	3.22e-01	1.95e-01	7.78e-01
GOBP RESPONSE TO FRUCTOSE	8	8.81e-01	9.61e-01	0.2870	-2.22e-03	1.42e-01	-1.22e-01	-1.53e-01	1.55e-01	9.91e-01	4.86e-01	5.51e-01	4.54e-01	4.46e-01
GOBP ACROSOME REACTION	40	1.82e-01	5.25e-01	0.2870	-7.66e-02	2.35e-03	1.17e-01	2.18e-01	-1.25e-01	4.02e-01	9.79e-01	2.01e-01	1.72e-02	1.70e-01
GOBP CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION	37	1.55e-01	4.83e-01	0.2870	-1.73e-01	9.55e-02	1.06e-01	1.76e-01	-3.55e-02	6.83e-02	3.15e-01	2.66e-01	6.37e-02	7.09e-01
GOBP CHROMOSOME LOCALIZATION	117	6.78e-04	1.13e-02	0.2870	7.91e-02	-7.25e-02	-1.53e-01	-1.91e-01	1.06e-01	1.40e-01	1.76e-01	4.38e-03	3.48e-04	4.83e-02
GOBP POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION	31	2.36e-01	5.91e-01	0.2870	-2.17e-01	1.16e-01	1.31e-01	6.41e-02	-2.93e-02	3.69e-02	2.64e-01	2.05e-01	5.37e-01	7.77e-01
GOBP ERROR FREE TRANSLESION SYNTHESIS	5	9.55e-01	9.87e-01	0.2870	-4.11e-03	-8.62e-02	-2.11e-01	-5.33e-02	-1.67e-01	9.87e-01	7.38e-01	4.15e-01	8.36e-01	5.18e-01
GOBP LEARNED VOCALIZATION BEHAVIOR OR VOCAL LEARNING	10	7.49e-01	9.15e-01	0.2870	4.01e-02	9.85e-02	9.89e-03	2.49e-01	-9.49e-02	8.26e-01	5.90e-01	9.57e-01	1.72e-01	6.03e-01
GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION	13	7.02e-01	8.96e-01	0.2870	-1.79e-01	-1.97e-01	-4.31e-02	4.74e-02	-8.75e-02	2.65e-01	2.19e-01	7.88e-01	7.67e-01	5.85e-01
GOBP NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS	18	4.98e-01	8.02e-01	0.2870	-7.34e-02	1.74e-01	7.94e-02	-6.01e-03	-2.02e-01	5.90e-01	2.02e-01	5.60e-01	9.65e-01	1.39e-01
GOBP OPTIC NERVE DEVELOPMENT	20	2.47e-01	6.04e-01	0.2870	-1.58e-01	-6.29e-02	1.21e-01	-1.18e-01	-1.58e-01	2.20e-01	6.26e-01	3.50e-01	3.62e-01	2.21e-01
GOBP REGULATION OF NEURON MATURATION	8	8.74e-01	9.58e-01	0.2870	-7.54e-02	-7.91e-02	2.44e-01	1.01e-01	3.06e-02	7.12e-01	6.99e-01	2.33e-01	6.21e-01	8.81e-01
GOBP PROTEIN DNA COMPLEX DISASSEMBLY	21	5.02e-01	8.03e-01	0.2870	-9.09e-02	-6.49e-02	-1.19e-01	-2.27e-01	6.41e-02	4.71e-01	6.07e-01	3.44e-01	7.14e-02	6.11e-01
GOMF SPHINGOLIPID BINDING	28	1.61e-01	4.93e-01	0.2870	-3.77e-02	2.23e-01	4.49e-02	1.52e-01	7.85e-02	7.30e-01	4.13e-02	6.81e-01	1.63e-01	4.72e-01
GOBP TOXIN METABOLIC PROCESS	14	6.28e-01	8.68e-01	0.2870	1.61e-01	-2.22e-01	-9.36e-03	3.48e-02	7.71e-02	2.98e-01	1.50e-01	9.52e-01	8.22e-01	6.17e-01
GOBP NEGATIVE REGULATION OF NEURON DIFFERENTIATION	72	7.16e-03	6.90e-02	0.2870	8.89e-02	1.45e-01	-6.58e-03	-1.95e-01	1.23e-01	1.92e-01	3.29e-02	9.23e-01	4.15e-03	7.06e-02
GOBP MITOTIC DNA INTEGRITY CHECKPOINT SIGNALING	84	6.89e-03	6.72e-02	0.2870	1.47e-01	4.73e-02	-1.51e-01	-1.80e-01	5.78e-02	1.97e-02	4.54e-01	1.67e-02	4.38e-03	3.60e-01
GOMF FATTY ACID DERIVATIVE BINDING	17	6.33e-01	8.71e-01	0.2870	1.17e-01	1.22e-01	-1.60e-01	-1.64e-01	3.47e-02	4.04e-01	3.83e-01	2.53e-01	2.41e-01	8.04e-01
GOBP REGULATION OF TERMINATION OF DNA TEMPLATED TRANSCRIPTION	5	9.10e-01	9.70e-01	0.2870	3.03e-02	1.45e-01	4.15e-02	-2.10e-01	-1.21e-01	9.07e-01	5.73e-01	8.72e-01	4.17e-01	6.40e-01
GOBP L GLUTAMATE IMPORT	38	1.54e-01	4.82e-01	0.2870	-1.11e-04	1.95e-01	1.12e-01	1.21e-01	-1.32e-01	9.99e-01	3.80e-02	2.33e-01	1.97e-01	1.59e-01
GOBP REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE	28	1.42e-01	4.63e-01	0.2870	-1.96e-02	2.26e-01	-9.96e-02	-2.22e-02	1.43e-01	8.58e-01	3.85e-02	3.62e-01	8.39e-01	1.90e-01
GOBP VENTRICULAR COMPACT MYOCARDIUM MORPHOGENESIS	8	7.85e-01	9.29e-01	0.2870	1.88e-01	1.17e-01	-9.29e-02	1.50e-01	-4.43e-02	3.56e-01	5.67e-01	6.49e-01	4.62e-01	8.28e-01
GOBP POSITIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION	16	3.90e-01	7.26e-01	0.2870	8.61e-02	1.41e-01	1.91e-01	-1.07e-01	-8.41e-02	5.51e-01	3.27e-01	1.86e-01	4.61e-01	5.60e-01
GOBP STARTLE RESPONSE	26	2.87e-01	6.40e-01	0.2870	-5.84e-02	3.16e-04	2.59e-01	4.38e-02	1.00e-01	6.06e-01	9.98e-01	2.25e-02	6.99e-01	3.76e-01
GOBP EPITHELIAL CELL CELL ADHESION	15	6.02e-01	8.54e-01	0.2870	8.29e-02	-7.69e-02	-9.19e-02	4.93e-02	-2.42e-01	5.78e-01	6.06e-01	5.38e-01	7.41e-01	1.05e-01
GOCC SWI SNF SUPERFAMILY TYPE COMPLEX	90	1.92e-03	2.61e-02	0.2870	9.80e-02	-1.70e-02	-6.74e-02	-2.33e-01	1.15e-01	1.08e-01	7.81e-01	2.69e-01	1.29e-04	5.90e-02
GOBP PARACRINE SIGNALING	6	9.00e-01	9.67e-01	0.2870	-2.12e-01	4.18e-02	-1.61e-01	-7.34e-02	6.20e-02	3.67e-01	8.59e-01	4.94e-01	7.56e-01	7.92e-01
GOBP SELF PROTEOLYSIS	12	6.85e-01	8.89e-01	0.2870	4.73e-02	1.97e-01	9.88e-02	-1.66e-01	6.30e-02	7.76e-01	2.37e-01	5.53e-01	3.21e-01	7.06e-01
GOBP NEURONAL SIGNAL TRANSDUCTION	7	9.07e-01	9.69e-01	0.2860	1.67e-01	7.48e-02	1.74e-02	-1.37e-01	1.72e-01	4.44e-01	7.32e-01	9.37e-01	5.29e-01	4.32e-01
GOMF HISTONE H3 KINASE ACTIVITY	11	7.28e-01	9.05e-01	0.2860	2.03e-01	1.62e-01	1.66e-02	-1.01e-01	-6.15e-02	2.43e-01	3.51e-01	9.24e-01	5.60e-01	7.24e-01
GOBP REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION	15	5.20e-01	8.13e-01	0.2860	1.03e-01	1.54e-01	1.63e-02	-1.15e-01	-1.86e-01	4.91e-01	3.03e-01	9.13e-01	4.41e-01	2.13e-01
GOBP REGULATION OF CELLULAR RESPONSE TO OXIDATIVE STRESS	22	4.96e-01	8.01e-01	0.2860	3.27e-02	4.86e-03	1.60e-01	1.70e-01	-1.63e-01	7.91e-01	9.68e-01	1.94e-01	1.67e-01	1.87e-01
GOMF MODIFIED AMINO ACID BINDING	81	2.12e-03	2.81e-02	0.2860	-1.55e-01	1.78e-01	9.33e-02	1.33e-01	-6.94e-03	1.59e-02	5.61e-03	1.46e-01	3.92e-02	9.14e-01
GOBP IMMUNOGLOBULIN V D J RECOMBINATION	8	8.46e-01	9.49e-01	0.2860	-2.13e-01	-3.51e-02	1.88e-02	-1.19e-01	1.44e-01	2.96e-01	8.63e-01	9.27e-01	5.60e-01	4.80e-01
GOBP TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY	65	3.80e-02	2.13e-01	0.2860	8.55e-02	-4.22e-02	-1.84e-01	-1.98e-01	8.65e-03	2.33e-01	5.56e-01	1.04e-02	5.89e-03	9.04e-01
GOBP NUCLEAR PORE ORGANIZATION	15	6.69e-01	8.83e-01	0.2860	1.92e-02	-5.99e-02	-6.03e-02	-2.25e-01	1.55e-01	8.98e-01	6.88e-01	6.86e-01	1.32e-01	3.00e-01
GOBP CORTICOSTEROID RECEPTOR SIGNALING PATHWAY	14	6.65e-01	8.82e-01	0.2860	1.38e-01	1.06e-01	1.48e-02	-1.92e-01	1.21e-01	3.71e-01	4.92e-01	9.24e-01	2.14e-01	4.34e-01
GOBP TOXIN TRANSPORT	11	7.49e-01	9.15e-01	0.2860	2.57e-02	-2.54e-01	-9.30e-02	8.14e-02	3.83e-02	8.83e-01	1.45e-01	5.93e-01	6.40e-01	8.26e-01
GOBP CELLULAR RESPONSE TO PH	26	3.14e-01	6.65e-01	0.2860	4.56e-02	2.60e-01	9.10e-02	3.55e-02	-5.28e-02	6.87e-01	2.20e-02	4.22e-01	7.54e-01	6.41e-01
GOBP RESPONSE TO GRAVITY	9	7.86e-01	9.29e-01	0.2860	1.85e-01	1.64e-01	-1.39e-01	1.37e-02	-3.34e-02	3.36e-01	3.95e-01	4.69e-01	9.43e-01	8.62e-01
GOBP NEGATIVE REGULATION OF TYPE II INTERFERON PRODUCTION	39	3.55e-02	2.04e-01	0.2860	-7.76e-02	2.44e-01	-9.09e-02	6.31e-02	-6.32e-02	4.02e-01	8.37e-03	3.26e-01	4.95e-01	4.95e-01
GOBP EXIT FROM MITOSIS	31	2.14e-01	5.67e-01	0.2860	1.09e-01	9.73e-02	-8.04e-02	-2.30e-01	-3.40e-02	2.95e-01	3.49e-01	4.39e-01	2.67e-02	7.43e-01
GOMF TYPE 1 FIBROBLAST GROWTH FACTOR RECEPTOR BINDING	5	8.61e-01	9.53e-01	0.2860	-7.41e-02	-5.10e-03	1.50e-01	-2.32e-01	-1.39e-03	7.74e-01	9.84e-01	5.61e-01	3.70e-01	9.96e-01
GOBP ENDOCRINE PANCREAS DEVELOPMENT	46	2.87e-02	1.78e-01	0.2860	1.22e-01	2.35e-02	3.98e-02	-2.33e-01	1.02e-01	1.53e-01	7.83e-01	6.41e-01	6.23e-03	2.30e-01
GOBP REGULATION OF CILIUM DEPENDENT CELL MOTILITY	27	3.00e-01	6.53e-01	0.2860	-1.02e-01	-1.83e-01	-8.51e-02	2.81e-03	-1.75e-01	3.58e-01	1.00e-01	4.44e-01	9.80e-01	1.16e-01
GOBP V D J RECOMBINATION	19	5.47e-01	8.27e-01	0.2860	1.26e-01	-8.69e-02	-5.20e-02	-1.48e-01	1.83e-01	3.40e-01	5.12e-01	6.95e-01	2.65e-01	1.66e-01
GOBP MAST CELL MIGRATION	13	6.24e-01	8.66e-01	0.2860	-9.68e-02	1.63e-01	1.22e-01	-7.48e-02	-1.59e-01	5.46e-01	3.09e-01	4.47e-01	6.41e-01	3.20e-01
GOMF PLUS END DIRECTED MICROTUBULE MOTOR ACTIVITY	16	5.03e-01	8.04e-01	0.2860	-1.95e-01	8.03e-02	-1.19e-01	5.39e-02	-1.42e-01	1.77e-01	5.78e-01	4.11e-01	7.09e-01	3.25e-01
GOBP THALAMUS DEVELOPMENT	11	7.62e-01	9.21e-01	0.2860	-1.98e-01	-1.33e-01	-1.25e-01	-6.63e-02	6.71e-02	2.54e-01	4.44e-01	4.74e-01	7.04e-01	7.00e-01
GOCC INTRACELLULAR PROTEIN CONTAINING COMPLEX	851	2.69e-31	1.20e-28	0.2860	6.34e-02	3.34e-02	-1.40e-01	-2.33e-01	5.32e-02	1.68e-03	9.82e-02	4.54e-12	8.28e-31	8.41e-03
GOBP CHONDROITIN SULFATE BIOSYNTHETIC PROCESS	18	4.64e-01	7.80e-01	0.2850	-4.17e-02	1.77e-01	3.36e-02	-6.81e-02	-2.06e-01	7.59e-01	1.93e-01	8.05e-01	6.17e-01	1.29e-01
GOBP REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION	10	8.21e-01	9.42e-01	0.2850	2.59e-02	2.28e-01	1.68e-01	1.09e-02	1.53e-02	8.87e-01	2.11e-01	3.57e-01	9.52e-01	9.33e-01
GOBP NEGATIVE REGULATION OF VIRAL GENOME REPLICATION	55	6.09e-02	2.90e-01	0.2850	-4.39e-02	-6.07e-02	-1.40e-01	-2.30e-01	5.75e-02	5.73e-01	4.36e-01	7.20e-02	3.18e-03	4.61e-01
GOBP DNA UNWINDING INVOLVED IN DNA REPLICATION	21	4.72e-01	7.86e-01	0.2850	-5.69e-02	5.48e-02	-1.15e-01	-2.44e-01	-5.03e-02	6.52e-01	6.64e-01	3.61e-01	5.32e-02	6.90e-01
GOBP PHOTOTRANSDUCTION	42	1.57e-01	4.86e-01	0.2850	8.46e-02	8.43e-03	1.79e-01	2.02e-01	-3.26e-02	3.43e-01	9.25e-01	4.43e-02	2.33e-02	7.15e-01
GOBP MATERNAL PLACENTA DEVELOPMENT	33	1.78e-01	5.19e-01	0.2850	1.39e-01	1.30e-01	9.81e-02	-9.87e-02	1.61e-01	1.68e-01	1.97e-01	3.29e-01	3.27e-01	1.10e-01
GOBP WATER SOLUBLE VITAMIN BIOSYNTHETIC PROCESS	11	8.14e-01	9.39e-01	0.2850	1.70e-01	1.03e-01	-9.41e-02	-1.72e-01	5.74e-02	3.28e-01	5.56e-01	5.89e-01	3.22e-01	7.41e-01
GOBP REGULATION OF BROWN FAT CELL DIFFERENTIATION	24	3.63e-01	7.05e-01	0.2850	8.19e-02	2.52e-01	7.57e-02	-2.70e-02	6.89e-02	4.88e-01	3.26e-02	5.21e-01	8.19e-01	5.59e-01
GOBP BRAINSTEM DEVELOPMENT	7	8.68e-01	9.56e-01	0.2850	2.44e-01	-1.21e-01	6.51e-02	-3.56e-03	5.38e-02	2.64e-01	5.78e-01	7.66e-01	9.87e-01	8.05e-01
GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING	24	4.28e-01	7.54e-01	0.2850	7.28e-02	1.14e-01	-1.21e-01	-2.20e-01	-1.05e-02	5.37e-01	3.36e-01	3.03e-01	6.24e-02	9.29e-01
GOBP BONE TRABECULA FORMATION	10	7.18e-01	9.02e-01	0.2850	-1.22e-01	-1.21e-01	9.45e-02	-1.48e-01	1.45e-01	5.05e-01	5.09e-01	6.05e-01	4.19e-01	4.26e-01
GOBP NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS	44	4.18e-02	2.27e-01	0.2850	-1.44e-01	1.24e-01	8.60e-02	-1.76e-01	8.31e-02	9.76e-02	1.55e-01	3.23e-01	4.40e-02	3.40e-01
GOMF CARBOXYPEPTIDASE ACTIVITY	45	8.88e-02	3.59e-01	0.2850	-2.03e-01	5.27e-02	1.58e-01	1.00e-01	4.73e-02	1.83e-02	5.40e-01	6.74e-02	2.44e-01	5.83e-01
GOBP AXONAL TRANSPORT OF MITOCHONDRION	16	3.90e-01	7.26e-01	0.2850	1.01e-01	-6.47e-02	1.33e-01	-1.81e-01	1.28e-01	4.85e-01	6.54e-01	3.56e-01	2.10e-01	3.75e-01
GOBP NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY	21	2.31e-01	5.85e-01	0.2850	4.83e-02	-2.46e-01	1.15e-01	-6.66e-02	2.55e-02	7.02e-01	5.08e-02	3.63e-01	5.97e-01	8.40e-01
GOBP MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY	16	5.97e-01	8.51e-01	0.2850	1.16e-01	2.45e-01	3.12e-02	-7.08e-02	4.37e-02	4.23e-01	9.02e-02	8.29e-01	6.24e-01	7.62e-01
GOBP POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	11	7.49e-01	9.15e-01	0.2850	-1.07e-01	1.98e-01	-1.75e-02	-8.02e-02	-1.53e-01	5.37e-01	2.55e-01	9.20e-01	6.45e-01	3.79e-01
GOCC SITE OF DNA DAMAGE	113	1.04e-03	1.60e-02	0.2850	4.90e-02	-1.34e-02	-1.79e-01	-2.15e-01	-7.35e-03	3.69e-01	8.06e-01	9.97e-04	7.76e-05	8.93e-01
GOBP REGULATION OF LIGASE ACTIVITY	7	8.94e-01	9.65e-01	0.2850	6.35e-02	-1.11e-01	-7.04e-02	-2.02e-02	2.44e-01	7.71e-01	6.12e-01	7.47e-01	9.26e-01	2.64e-01
GOBP POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS	25	1.28e-01	4.42e-01	0.2850	-1.69e-01	5.68e-02	-3.94e-02	2.10e-01	5.74e-02	1.43e-01	6.23e-01	7.33e-01	6.86e-02	6.19e-01
GOCC APICAL CORTEX	8	6.74e-01	8.85e-01	0.2850	-9.57e-02	6.77e-02	-8.24e-02	2.33e-01	7.90e-02	6.39e-01	7.40e-01	6.87e-01	2.54e-01	6.99e-01
GOBP SUPEROXIDE ANION GENERATION	36	1.36e-01	4.55e-01	0.2850	-2.81e-02	2.72e-01	6.61e-02	-3.98e-02	-4.34e-04	7.71e-01	4.66e-03	4.93e-01	6.80e-01	9.96e-01
GOBP RESPONSE TO ACETYLCHOLINE	36	1.77e-01	5.18e-01	0.2850	-7.63e-03	2.01e-01	1.56e-01	5.70e-02	1.13e-01	9.37e-01	3.66e-02	1.06e-01	5.54e-01	2.39e-01
GOCC MRNA CAP BINDING COMPLEX	11	7.61e-01	9.20e-01	0.2850	5.94e-02	2.42e-01	-9.31e-02	-9.96e-02	-1.27e-02	7.33e-01	1.64e-01	5.93e-01	5.67e-01	9.42e-01
GOMF ALANINE TRANSMEMBRANE TRANSPORTER ACTIVITY	14	6.45e-01	8.76e-01	0.2850	-1.67e-01	-1.50e-01	1.35e-01	5.36e-02	-9.63e-02	2.78e-01	3.31e-01	3.82e-01	7.28e-01	5.33e-01
GOCC T TUBULE	51	5.14e-02	2.60e-01	0.2840	-1.85e-01	-7.99e-02	-5.24e-04	1.33e-01	-1.51e-01	2.25e-02	3.24e-01	9.95e-01	9.97e-02	6.29e-02
GOBP METHYLGUANOSINE CAP DECAPPING	16	4.61e-01	7.78e-01	0.2840	2.01e-01	6.76e-03	3.49e-02	-1.97e-01	2.10e-02	1.63e-01	9.63e-01	8.09e-01	1.73e-01	8.84e-01
GOBP POSITIVE REGULATION OF AMINO ACID TRANSPORT	22	4.28e-01	7.54e-01	0.2840	-1.06e-01	1.79e-01	1.92e-01	-1.67e-03	3.09e-02	3.89e-01	1.47e-01	1.19e-01	9.89e-01	8.02e-01
GOBP REGULATION OF FLAGELLATED SPERM MOTILITY	18	5.32e-01	8.20e-01	0.2840	-1.09e-01	-2.49e-01	-6.59e-02	-2.05e-02	-4.92e-02	4.23e-01	6.78e-02	6.28e-01	8.80e-01	7.18e-01
GOBP MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE	43	1.54e-01	4.81e-01	0.2840	1.77e-02	-2.81e-02	-1.32e-01	-2.39e-01	7.16e-02	8.41e-01	7.50e-01	1.34e-01	6.65e-03	4.16e-01
GOMF NADPLUS PROTEIN ASPARTATE ADP RIBOSYLTRANSFERASE ACTIVITY	5	9.41e-01	9.82e-01	0.2840	1.31e-01	8.25e-02	-1.11e-01	-6.87e-03	-2.11e-01	6.12e-01	7.49e-01	6.67e-01	9.79e-01	4.14e-01
GOBP DNA BIOSYNTHETIC PROCESS	188	3.72e-06	1.39e-04	0.2840	6.62e-03	-5.51e-02	-1.76e-01	-2.11e-01	5.06e-02	8.76e-01	1.93e-01	3.29e-05	6.35e-07	2.32e-01
GOBP ANATOMICAL STRUCTURE REGRESSION	16	7.04e-01	8.97e-01	0.2840	5.43e-02	9.04e-02	1.97e-01	1.72e-01	3.54e-02	7.07e-01	5.31e-01	1.72e-01	2.34e-01	8.06e-01
GOBP NUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS	12	6.62e-01	8.81e-01	0.2840	-1.08e-01	1.76e-01	7.56e-02	-1.74e-01	-4.75e-02	5.16e-01	2.92e-01	6.50e-01	2.98e-01	7.76e-01
GOBP RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM	35	2.64e-01	6.19e-01	0.2840	-2.19e-02	-1.23e-02	1.86e-01	2.10e-01	3.74e-02	8.23e-01	9.00e-01	5.73e-02	3.13e-02	7.01e-01
GOBP CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS	23	3.10e-01	6.62e-01	0.2840	-2.76e-02	1.89e-01	1.39e-02	-1.19e-01	-1.73e-01	8.18e-01	1.16e-01	9.08e-01	3.23e-01	1.52e-01
GOBP POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT	16	5.50e-01	8.28e-01	0.2840	-9.87e-02	1.72e-01	1.71e-01	-8.88e-02	6.60e-02	4.94e-01	2.34e-01	2.36e-01	5.39e-01	6.48e-01
GOMF PEPTIDASE ACTIVATOR ACTIVITY	51	8.05e-02	3.42e-01	0.2840	4.44e-02	9.40e-02	-9.70e-02	-2.15e-01	1.19e-01	5.83e-01	2.45e-01	2.31e-01	7.93e-03	1.40e-01
GOBP PROTEIN LOCALIZATION TO CHROMOSOME	113	2.75e-04	5.47e-03	0.2840	5.18e-02	-1.25e-01	-1.04e-01	-2.18e-01	6.19e-02	3.41e-01	2.21e-02	5.52e-02	6.06e-05	2.56e-01
GOBP RESPONSE TO IRON ION	28	2.27e-01	5.80e-01	0.2840	6.00e-02	2.27e-01	1.43e-01	-6.20e-02	-3.76e-02	5.83e-01	3.78e-02	1.92e-01	5.70e-01	7.31e-01
GOBP RIBOSOME DISASSEMBLY	12	7.83e-01	9.28e-01	0.2840	1.40e-01	5.67e-02	-5.31e-02	-2.00e-01	1.21e-01	3.99e-01	7.34e-01	7.50e-01	2.30e-01	4.67e-01
GOBP TELOMERE MAINTENANCE	149	6.22e-05	1.62e-03	0.2840	-2.87e-03	-6.48e-02	-1.52e-01	-2.07e-01	1.01e-01	9.52e-01	1.72e-01	1.35e-03	1.26e-05	3.27e-02
GOBP VIRION ASSEMBLY	34	2.79e-01	6.32e-01	0.2840	5.22e-02	4.63e-02	-1.88e-01	-1.99e-01	-2.59e-02	5.99e-01	6.40e-01	5.76e-02	4.46e-02	7.94e-01
GOBP FRUCTOSE 1 6 BISPHOSPHATE METABOLIC PROCESS	9	8.10e-01	9.38e-01	0.2840	3.96e-02	-2.14e-01	-1.73e-02	1.47e-01	1.06e-01	8.37e-01	2.66e-01	9.28e-01	4.46e-01	5.83e-01
GOBP ENDODERMAL CELL FATE COMMITMENT	15	4.51e-01	7.71e-01	0.2840	-1.65e-01	-8.62e-02	5.39e-02	-2.00e-01	-5.45e-02	2.69e-01	5.63e-01	7.18e-01	1.80e-01	7.15e-01
GOBP MAINTENANCE OF GASTROINTESTINAL EPITHELIUM	23	3.38e-01	6.85e-01	0.2840	-6.74e-02	1.75e-01	-5.41e-02	4.78e-02	-2.00e-01	5.76e-01	1.47e-01	6.54e-01	6.91e-01	9.61e-02
GOCC METHYLTRANSFERASE COMPLEX	88	7.32e-03	7.01e-02	0.2840	1.03e-01	-2.34e-02	-1.66e-01	-2.03e-01	2.45e-02	9.64e-02	7.05e-01	7.22e-03	9.82e-04	6.91e-01
GOBP POSITIVE REGULATION OF DNA REPAIR	124	4.81e-04	8.60e-03	0.2840	1.06e-01	-3.09e-02	-1.44e-01	-1.99e-01	8.84e-02	4.06e-02	5.52e-01	5.50e-03	1.32e-04	8.93e-02
GOBP ATP METABOLIC PROCESS	124	5.33e-04	9.32e-03	0.2840	6.01e-02	-7.47e-02	-1.92e-01	-1.58e-01	9.67e-02	2.48e-01	1.51e-01	2.18e-04	2.39e-03	6.28e-02
GOBP CALMODULIN DEPENDENT KINASE SIGNALING PATHWAY	11	8.42e-01	9.48e-01	0.2840	5.52e-02	9.42e-02	-1.49e-01	-2.00e-01	7.88e-02	7.51e-01	5.89e-01	3.91e-01	2.51e-01	6.51e-01
GOBP LYMPH VESSEL MORPHOGENESIS	23	2.13e-01	5.66e-01	0.2830	4.51e-02	-2.18e-01	7.59e-02	-1.31e-01	8.83e-02	7.08e-01	7.01e-02	5.29e-01	2.76e-01	4.64e-01
GOBP POSITIVE REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION	7	8.79e-01	9.61e-01	0.2830	-2.14e-01	7.42e-02	1.34e-01	-5.63e-02	-8.95e-02	3.27e-01	7.34e-01	5.41e-01	7.96e-01	6.82e-01
GOBP POSITIVE REGULATION OF COLLATERAL SPROUTING	10	7.79e-01	9.28e-01	0.2830	-2.15e-01	1.10e-01	9.04e-02	-9.68e-02	6.69e-02	2.39e-01	5.49e-01	6.21e-01	5.96e-01	7.14e-01
GOCC XY BODY	15	6.83e-01	8.88e-01	0.2830	6.70e-03	7.86e-02	-3.50e-02	-1.85e-01	1.96e-01	9.64e-01	5.98e-01	8.14e-01	2.14e-01	1.89e-01
GOBP OLIGODENDROCYTE PROGENITOR PROLIFERATION	8	8.98e-01	9.67e-01	0.2830	1.15e-01	4.07e-02	1.97e-01	1.48e-01	-6.63e-02	5.73e-01	8.42e-01	3.34e-01	4.67e-01	7.46e-01
GOMF SINGLE STRANDED DNA EXODEOXYRIBONUCLEASE ACTIVITY	9	8.33e-01	9.45e-01	0.2830	-1.71e-02	-8.64e-03	6.38e-02	-1.14e-01	2.50e-01	9.29e-01	9.64e-01	7.40e-01	5.53e-01	1.93e-01
GOBP SENSORY PERCEPTION OF TASTE	66	1.87e-02	1.35e-01	0.2830	5.53e-02	-8.62e-02	1.40e-01	2.16e-01	5.85e-02	4.37e-01	2.26e-01	4.85e-02	2.43e-03	4.11e-01
GOBP REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION	17	6.74e-01	8.85e-01	0.2830	-4.79e-02	7.96e-03	-1.51e-01	-2.08e-01	1.09e-01	7.32e-01	9.55e-01	2.80e-01	1.38e-01	4.36e-01
GOBP AUTOPHAGY OF MITOCHONDRION	90	5.46e-03	5.67e-02	0.2830	6.28e-02	8.21e-03	-1.27e-01	-2.33e-01	7.62e-02	3.03e-01	8.93e-01	3.68e-02	1.35e-04	2.12e-01
GOMF NON MEMBRANE SPANNING PROTEIN TYROSINE PHOSPHATASE ACTIVITY	12	6.44e-01	8.75e-01	0.2830	-1.41e-01	1.85e-01	-5.66e-02	1.05e-01	-1.09e-01	3.97e-01	2.68e-01	7.34e-01	5.30e-01	5.11e-01
GOBP REGULATION OF MAST CELL ACTIVATION	38	5.62e-02	2.75e-01	0.2830	-2.23e-02	2.43e-01	-3.31e-02	2.25e-02	1.37e-01	8.12e-01	9.41e-03	7.24e-01	8.10e-01	1.44e-01
GOBP REGULATION OF NEUROINFLAMMATORY RESPONSE	41	1.14e-01	4.12e-01	0.2830	-1.54e-01	-1.61e-01	1.14e-01	1.31e-01	2.41e-02	8.86e-02	7.44e-02	2.07e-01	1.48e-01	7.89e-01
GOBP RESPONSE TO AMINE	45	2.38e-02	1.58e-01	0.2830	1.14e-01	1.55e-01	9.13e-02	-8.71e-02	-1.64e-01	1.84e-01	7.17e-02	2.89e-01	3.12e-01	5.65e-02
GOBP CELLULAR RESPONSE TO CAFFEINE	11	7.00e-01	8.96e-01	0.2830	-4.46e-02	-1.16e-01	-1.49e-01	1.63e-01	-1.25e-01	7.98e-01	5.04e-01	3.91e-01	3.48e-01	4.74e-01
GOBP POSITIVE REGULATION OF CHOLESTEROL METABOLIC PROCESS	15	5.67e-01	8.36e-01	0.2830	-3.49e-02	-7.40e-02	-4.94e-02	-8.78e-02	-2.51e-01	8.15e-01	6.20e-01	7.40e-01	5.56e-01	9.19e-02
GOMF SUMO BINDING	16	5.06e-01	8.06e-01	0.2830	2.21e-01	-3.78e-02	-1.29e-01	1.10e-01	-3.29e-02	1.26e-01	7.94e-01	3.71e-01	4.46e-01	8.20e-01
GOBP INCLUSION BODY ASSEMBLY	23	3.59e-01	7.03e-01	0.2830	1.33e-01	-2.44e-01	-3.94e-02	3.00e-02	1.09e-02	2.69e-01	4.24e-02	7.44e-01	8.03e-01	9.28e-01
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CILIUM	7	9.19e-01	9.74e-01	0.2830	1.26e-01	-1.01e-01	-7.67e-02	-9.59e-02	1.97e-01	5.62e-01	6.45e-01	7.25e-01	6.60e-01	3.66e-01
GOMF ISOMERASE ACTIVITY	154	1.37e-05	4.39e-04	0.2830	4.65e-02	5.45e-02	-1.40e-01	-2.33e-01	-3.13e-02	3.20e-01	2.43e-01	2.72e-03	5.95e-07	5.03e-01
GOBP LATE ENDOSOME TO VACUOLE TRANSPORT	36	2.69e-01	6.24e-01	0.2830	9.43e-02	-1.85e-02	-2.11e-01	-1.61e-01	1.94e-02	3.28e-01	8.48e-01	2.88e-02	9.39e-02	8.40e-01
GOBP RESPONSE TO L PHENYLALANINE DERIVATIVE	6	9.45e-01	9.82e-01	0.2830	-1.12e-02	3.71e-02	-7.20e-02	-1.91e-01	1.92e-01	9.62e-01	8.75e-01	7.60e-01	4.18e-01	4.16e-01
GOCC NEURONAL DENSE CORE VESICLE	25	3.04e-01	6.58e-01	0.2830	-9.02e-02	-3.09e-02	6.11e-02	-8.00e-02	2.46e-01	4.35e-01	7.89e-01	5.97e-01	4.89e-01	3.31e-02
GOBP NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION	24	3.41e-01	6.88e-01	0.2820	1.71e-01	-1.73e-02	7.38e-02	-9.22e-02	1.90e-01	1.47e-01	8.83e-01	5.31e-01	4.34e-01	1.06e-01
GOMF MOLECULAR SEQUESTERING ACTIVITY	38	8.08e-02	3.42e-01	0.2820	-2.00e-01	8.93e-02	2.92e-02	-1.71e-01	-4.40e-02	3.31e-02	3.41e-01	7.55e-01	6.86e-02	6.39e-01
GOMF TYPE II TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING	11	7.96e-01	9.32e-01	0.2820	2.98e-02	1.38e-01	1.09e-02	-1.30e-01	2.06e-01	8.64e-01	4.26e-01	9.50e-01	4.54e-01	2.36e-01
GOMF PROTON CHANNEL ACTIVITY	24	2.85e-01	6.39e-01	0.2820	6.10e-02	1.13e-02	-7.69e-02	-2.24e-01	-1.40e-01	6.05e-01	9.23e-01	5.14e-01	5.71e-02	2.34e-01
GOBP NEGATIVE REGULATION OF AMINO ACID TRANSPORT	16	5.05e-01	8.06e-01	0.2820	1.30e-01	1.05e-01	2.01e-02	2.27e-01	1.14e-02	3.68e-01	4.68e-01	8.89e-01	1.17e-01	9.37e-01
GOBP NEGATIVE REGULATION OF ANOIKIS	18	6.13e-01	8.59e-01	0.2820	8.09e-02	-3.75e-02	-2.42e-01	-1.03e-01	5.00e-02	5.53e-01	7.83e-01	7.55e-02	4.47e-01	7.14e-01
GOMF PHOSPHATIDYLSERINE 1 ACYLHYDROLASE ACTIVITY	11	7.37e-01	9.09e-01	0.2820	-2.12e-01	1.79e-01	3.10e-02	3.40e-02	1.75e-02	2.23e-01	3.03e-01	8.59e-01	8.45e-01	9.20e-01
GOBP TRIF DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY	11	7.66e-01	9.23e-01	0.2820	4.27e-02	2.69e-01	2.50e-02	-5.65e-02	-4.14e-02	8.06e-01	1.23e-01	8.86e-01	7.46e-01	8.12e-01
GOBP MITOCHONDRIAL MEMBRANE ORGANIZATION	112	1.16e-03	1.74e-02	0.2820	3.67e-02	-8.40e-03	-1.35e-01	-2.32e-01	7.86e-02	5.02e-01	8.78e-01	1.35e-02	2.23e-05	1.51e-01
GOMF CYTOKINE RECEPTOR ACTIVITY	87	8.65e-03	7.94e-02	0.2820	-5.52e-02	7.67e-02	1.54e-01	2.06e-01	-6.80e-02	3.74e-01	2.16e-01	1.30e-02	9.05e-04	2.73e-01
GOMF THREONINE TYPE ENDOPEPTIDASE ACTIVITY	9	8.96e-01	9.66e-01	0.2820	-1.67e-02	-1.23e-01	-1.63e-01	-1.85e-01	6.00e-02	9.31e-01	5.24e-01	3.98e-01	3.37e-01	7.55e-01
GOBP POSITIVE REGULATION OF HAIR FOLLICLE DEVELOPMENT	11	7.39e-01	9.11e-01	0.2820	7.64e-02	-2.29e-01	-6.91e-02	-9.28e-02	-9.02e-02	6.61e-01	1.89e-01	6.91e-01	5.94e-01	6.05e-01
GOBP NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION	59	1.55e-02	1.19e-01	0.2820	-1.47e-03	2.32e-01	-8.16e-02	-9.21e-02	-1.03e-01	9.84e-01	2.03e-03	2.78e-01	2.21e-01	1.73e-01
GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE	19	5.92e-01	8.47e-01	0.2820	8.93e-02	6.72e-02	-1.09e-01	-2.32e-01	3.38e-02	5.00e-01	6.12e-01	4.09e-01	7.96e-02	7.98e-01
GOBP REGULATION OF INCLUSION BODY ASSEMBLY	17	5.21e-01	8.14e-01	0.2820	9.96e-02	-2.55e-01	-7.92e-03	-2.85e-02	6.22e-02	4.77e-01	6.90e-02	9.55e-01	8.39e-01	6.57e-01
GOBP C4 DICARBOXYLATE TRANSPORT	27	3.42e-01	6.89e-01	0.2820	4.35e-03	2.37e-01	1.29e-01	8.24e-02	9.66e-03	9.69e-01	3.33e-02	2.46e-01	4.58e-01	9.31e-01
GOBP CELLULAR RESPONSE TO PROGESTERONE STIMULUS	7	9.09e-01	9.70e-01	0.2820	-3.36e-02	1.16e-02	1.43e-01	1.78e-01	1.61e-01	8.78e-01	9.58e-01	5.12e-01	4.15e-01	4.60e-01
GOBP CORPUS CALLOSUM MORPHOGENESIS	6	9.04e-01	9.68e-01	0.2820	9.14e-02	9.35e-02	-5.70e-03	-2.49e-01	-1.44e-02	6.98e-01	6.92e-01	9.81e-01	2.90e-01	9.51e-01
GOBP 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS	15	6.90e-01	8.92e-01	0.2820	-2.04e-01	3.32e-02	1.53e-01	1.12e-01	2.48e-02	1.70e-01	8.24e-01	3.04e-01	4.53e-01	8.68e-01
GOCC CILIARY TRANSITION FIBER	8	7.88e-01	9.30e-01	0.2820	8.28e-02	1.29e-01	5.62e-02	-1.44e-01	-1.79e-01	6.85e-01	5.28e-01	7.83e-01	4.79e-01	3.81e-01
GOBP NEGATIVE REGULATION OF MONONUCLEAR CELL MIGRATION	24	3.44e-01	6.91e-01	0.2820	-6.65e-02	-1.64e-01	7.90e-02	1.59e-01	1.29e-01	5.73e-01	1.64e-01	5.03e-01	1.78e-01	2.74e-01
GOCC BLOC 1 COMPLEX	9	8.48e-01	9.49e-01	0.2820	-1.87e-01	7.20e-02	-1.08e-01	-1.54e-01	-6.03e-02	3.31e-01	7.08e-01	5.73e-01	4.23e-01	7.54e-01
GOBP FC EPSILON RECEPTOR SIGNALING PATHWAY	24	3.62e-01	7.04e-01	0.2820	1.32e-02	2.48e-02	2.18e-01	2.21e-02	1.75e-01	9.11e-01	8.34e-01	6.41e-02	8.52e-01	1.39e-01
GOCC CHROMOSOMAL REGION	379	3.44e-13	4.00e-11	0.2820	9.97e-02	-3.23e-02	-1.37e-01	-2.11e-01	7.16e-02	8.58e-04	2.80e-01	4.58e-06	1.72e-12	1.68e-02
GOBP IODIDE TRANSPORT	9	8.16e-01	9.41e-01	0.2820	-2.42e-01	2.32e-02	7.18e-02	-6.92e-02	-1.02e-01	2.09e-01	9.04e-01	7.09e-01	7.19e-01	5.97e-01
GOBP MITRAL VALVE DEVELOPMENT	13	6.89e-01	8.91e-01	0.2820	2.63e-01	7.45e-02	4.55e-02	-2.96e-02	4.32e-02	1.01e-01	6.42e-01	7.76e-01	8.54e-01	7.87e-01
GOMF NEUROPEPTIDE RECEPTOR BINDING	33	1.94e-01	5.42e-01	0.2820	-1.09e-02	1.40e-01	1.83e-01	-3.00e-02	1.58e-01	9.13e-01	1.63e-01	6.84e-02	7.65e-01	1.15e-01
GOBP DNA METHYLATION	47	8.02e-02	3.41e-01	0.2820	2.02e-01	2.95e-03	-1.10e-01	-1.63e-01	-7.38e-03	1.67e-02	9.72e-01	1.94e-01	5.31e-02	9.30e-01
GOMF ARRESTIN FAMILY PROTEIN BINDING	9	7.90e-01	9.31e-01	0.2820	2.25e-01	7.57e-02	-5.28e-02	1.40e-01	-2.40e-02	2.42e-01	6.94e-01	7.84e-01	4.68e-01	9.01e-01
GOBP REGULATION OF CEREBELLAR GRANULE CELL PRECURSOR PROLIFERATION	11	7.23e-01	9.04e-01	0.2820	-2.29e-02	-1.60e-01	-6.73e-02	-2.08e-01	-7.41e-02	8.95e-01	3.58e-01	6.99e-01	2.33e-01	6.70e-01
GOBP REGULATION OF CELLULAR RESPIRATION	46	1.05e-01	3.93e-01	0.2820	1.79e-02	7.10e-02	-7.98e-02	-1.71e-01	1.96e-01	8.34e-01	4.05e-01	3.49e-01	4.51e-02	2.14e-02
GOMF STORE OPERATED CALCIUM CHANNEL ACTIVITY	9	7.61e-01	9.20e-01	0.2820	-5.20e-02	1.60e-01	1.04e-01	-1.99e-01	-2.22e-02	7.87e-01	4.07e-01	5.89e-01	3.00e-01	9.08e-01
GOBP NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY	18	5.49e-01	8.27e-01	0.2820	-1.98e-02	-8.74e-02	2.14e-01	9.18e-02	1.30e-01	8.85e-01	5.21e-01	1.16e-01	5.00e-01	3.39e-01
GOBP REGULATION OF VASCULAR PERMEABILITY	50	7.47e-02	3.28e-01	0.2820	-5.69e-02	1.56e-01	1.02e-01	1.18e-01	-1.65e-01	4.87e-01	5.65e-02	2.11e-01	1.47e-01	4.35e-02
GOBP PLASMINOGEN ACTIVATION	26	3.88e-01	7.25e-01	0.2820	-1.48e-01	-5.91e-02	4.63e-02	1.86e-01	-1.31e-01	1.91e-01	6.02e-01	6.82e-01	1.01e-01	2.46e-01
GOCC CLATHRIN SCULPTED VESICLE	12	7.34e-01	9.09e-01	0.2810	2.24e-01	-8.62e-02	-2.16e-02	-1.11e-01	9.27e-02	1.78e-01	6.05e-01	8.97e-01	5.05e-01	5.78e-01
GOBP POSITIVE REGULATION OF ORGANIC ACID TRANSPORT	44	1.26e-01	4.39e-01	0.2810	-4.79e-02	2.00e-01	1.66e-01	8.65e-02	-4.13e-02	5.83e-01	2.15e-02	5.70e-02	3.21e-01	6.36e-01
GOBP NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS	113	1.49e-03	2.14e-02	0.2810	7.97e-02	1.88e-02	-1.59e-01	-2.04e-01	7.36e-02	1.43e-01	7.30e-01	3.51e-03	1.75e-04	1.76e-01
GOBP CYCLIC NUCLEOTIDE CATABOLIC PROCESS	14	6.53e-01	8.79e-01	0.2810	-2.54e-01	-2.33e-02	5.75e-02	9.31e-02	4.32e-02	9.93e-02	8.80e-01	7.09e-01	5.46e-01	7.80e-01
GOBP ADHERENS JUNCTION ORGANIZATION	57	4.24e-02	2.28e-01	0.2810	-2.11e-02	-1.06e-01	1.90e-01	1.60e-01	7.67e-02	7.83e-01	1.67e-01	1.32e-02	3.66e-02	3.16e-01
GOBP EXTRAEMBRYONIC MEMBRANE DEVELOPMENT	13	7.54e-01	9.17e-01	0.2810	1.12e-02	-6.48e-02	-1.60e-01	-1.85e-01	-1.23e-01	9.44e-01	6.86e-01	3.17e-01	2.49e-01	4.44e-01
GOCC H3 HISTONE ACETYLTRANSFERASE COMPLEX	8	8.61e-01	9.53e-01	0.2810	2.10e-01	-2.73e-02	1.32e-02	1.24e-01	-1.36e-01	3.03e-01	8.93e-01	9.48e-01	5.42e-01	5.05e-01
GOBP SPINDLE ORGANIZATION	192	1.93e-06	7.94e-05	0.2810	1.23e-01	-1.82e-02	-1.40e-01	-2.01e-01	6.01e-02	3.39e-03	6.64e-01	8.24e-04	1.51e-06	1.51e-01
GOCC PORE COMPLEX	24	2.44e-01	6.01e-01	0.2810	-2.00e-01	-1.26e-01	-1.12e-01	9.43e-02	4.32e-02	9.00e-02	2.85e-01	3.44e-01	4.24e-01	7.14e-01
GOBP ADHERENS JUNCTION MAINTENANCE	7	9.28e-01	9.77e-01	0.2810	-6.01e-02	-1.37e-02	6.08e-02	2.10e-01	-1.66e-01	7.83e-01	9.50e-01	7.81e-01	3.37e-01	4.47e-01
GOMF ADP TRANSMEMBRANE TRANSPORTER ACTIVITY	9	8.51e-01	9.50e-01	0.2810	1.48e-01	9.31e-02	-1.11e-01	-1.67e-01	-9.16e-02	4.42e-01	6.29e-01	5.66e-01	3.86e-01	6.34e-01
GOBP MULTICELLULAR ORGANISMAL LEVEL CHEMICAL HOMEOSTASIS	73	1.01e-02	8.79e-02	0.2810	-1.53e-01	1.78e-01	1.16e-01	8.37e-02	-5.78e-02	2.36e-02	8.62e-03	8.53e-02	2.16e-01	3.93e-01
GOBP POSITIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY	31	2.92e-01	6.46e-01	0.2810	1.40e-02	6.78e-02	2.05e-01	1.03e-01	1.46e-01	8.93e-01	5.13e-01	4.79e-02	3.20e-01	1.59e-01
GOBP GROWTH INVOLVED IN HEART MORPHOGENESIS	5	9.48e-01	9.83e-01	0.2810	5.41e-03	-2.58e-01	2.67e-02	8.97e-02	6.12e-02	9.83e-01	3.18e-01	9.18e-01	7.28e-01	8.13e-01
GOBP VESICLE TARGETING ROUGH ER TO CIS GOLGI	25	4.13e-01	7.44e-01	0.2810	1.20e-01	9.78e-02	-1.04e-01	-2.10e-01	3.41e-03	2.98e-01	3.97e-01	3.66e-01	6.97e-02	9.76e-01
GOBP NEURON PROJECTION MAINTENANCE	11	7.80e-01	9.28e-01	0.2810	1.44e-01	1.33e-01	9.62e-02	9.20e-02	-1.51e-01	4.07e-01	4.46e-01	5.81e-01	5.97e-01	3.87e-01
GOBP PROLINE TRANSPORT	11	8.16e-01	9.41e-01	0.2810	-6.93e-02	-8.07e-02	2.24e-01	1.28e-01	3.40e-02	6.91e-01	6.43e-01	1.99e-01	4.63e-01	8.45e-01
GOCC TERTIARY GRANULE LUMEN	53	1.96e-02	1.39e-01	0.2810	-2.25e-01	1.12e-01	4.16e-02	1.45e-02	1.18e-01	4.62e-03	1.60e-01	6.01e-01	8.55e-01	1.38e-01
GOBP SYNAPTIC VESICLE BUDDING	10	8.81e-01	9.61e-01	0.2810	4.85e-02	-1.23e-01	-1.88e-01	-1.59e-01	2.77e-02	7.90e-01	5.00e-01	3.04e-01	3.83e-01	8.79e-01
GOMF DNA TOPOISOMERASE ACTIVITY	7	8.76e-01	9.59e-01	0.2810	1.08e-01	1.30e-01	2.09e-01	-5.45e-02	6.00e-02	6.22e-01	5.50e-01	3.38e-01	8.03e-01	7.83e-01
GOBP MITOTIC CYTOKINESIS	85	8.39e-03	7.74e-02	0.2810	7.31e-02	-4.14e-03	-1.31e-01	-2.31e-01	5.14e-02	2.44e-01	9.47e-01	3.62e-02	2.25e-04	4.13e-01
GOMF TRANSLATION REGULATOR ACTIVITY NUCLEIC ACID BINDING	98	3.19e-03	3.83e-02	0.2810	3.17e-02	4.99e-02	-1.83e-01	-2.03e-01	-3.01e-02	5.87e-01	3.93e-01	1.78e-03	5.27e-04	6.07e-01
GOMF DNA INSERTION OR DELETION BINDING	6	8.87e-01	9.62e-01	0.2810	8.36e-02	-7.46e-02	7.08e-02	-2.07e-01	1.36e-01	7.23e-01	7.52e-01	7.64e-01	3.81e-01	5.63e-01
GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO HYPOXIA	11	8.22e-01	9.42e-01	0.2810	-1.29e-01	-6.26e-02	-1.42e-01	-1.93e-01	-2.44e-02	4.58e-01	7.19e-01	4.14e-01	2.68e-01	8.89e-01
GOMF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY	150	3.88e-05	1.08e-03	0.2810	-3.38e-02	9.81e-02	1.35e-01	1.49e-01	-1.67e-01	4.75e-01	3.81e-02	4.44e-03	1.68e-03	4.27e-04
GOBP NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY	31	2.63e-01	6.19e-01	0.2810	5.38e-02	1.70e-01	1.39e-01	9.98e-02	1.32e-01	6.04e-01	1.02e-01	1.79e-01	3.36e-01	2.02e-01
GOBP INNER DYNEIN ARM ASSEMBLY	16	6.19e-01	8.63e-01	0.2800	-8.38e-02	-1.17e-02	-4.68e-02	-2.41e-01	1.06e-01	5.62e-01	9.36e-01	7.46e-01	9.49e-02	4.64e-01
GOBP VESICLE FUSION WITH GOLGI APPARATUS	9	8.29e-01	9.44e-01	0.2800	3.33e-02	-9.54e-02	-1.27e-01	-2.67e-02	2.27e-01	8.63e-01	6.20e-01	5.08e-01	8.90e-01	2.38e-01
GOBP REGULATION OF BONE REMODELING	49	6.00e-02	2.87e-01	0.2800	3.44e-02	1.79e-01	2.05e-01	3.32e-02	-4.69e-02	6.77e-01	3.02e-02	1.29e-02	6.88e-01	5.70e-01
GOCC TERTIARY GRANULE	157	9.38e-07	4.19e-05	0.2800	-2.05e-01	1.46e-01	9.98e-02	2.42e-03	7.32e-02	9.64e-06	1.54e-03	3.09e-02	9.58e-01	1.13e-01
GOBP CD8 POSITIVE ALPHA BETA T CELL ACTIVATION	28	2.06e-01	5.57e-01	0.2800	4.81e-02	2.33e-03	2.10e-01	6.23e-02	-1.69e-01	6.59e-01	9.83e-01	5.49e-02	5.68e-01	1.22e-01
GOBP REGULATION OF ATP BIOSYNTHETIC PROCESS	17	5.76e-01	8.41e-01	0.2800	2.24e-01	-1.01e-01	-3.17e-02	-3.62e-04	1.31e-01	1.10e-01	4.69e-01	8.21e-01	9.98e-01	3.50e-01
GOBP DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS	28	2.80e-01	6.33e-01	0.2800	6.28e-02	1.39e-01	-1.11e-01	-1.56e-01	-1.37e-01	5.65e-01	2.04e-01	3.07e-01	1.54e-01	2.09e-01
GOBP ICOSANOID TRANSPORT	63	6.85e-03	6.70e-02	0.2800	6.47e-02	-1.69e-02	3.35e-03	2.66e-01	-5.83e-02	3.74e-01	8.17e-01	9.63e-01	2.62e-04	4.23e-01
GOBP PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS	50	6.32e-02	2.95e-01	0.2800	4.31e-02	1.96e-01	-5.92e-02	-1.80e-01	4.72e-02	5.98e-01	1.64e-02	4.69e-01	2.76e-02	5.64e-01
GOMF INWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY	27	2.74e-01	6.28e-01	0.2800	5.25e-02	1.21e-01	4.05e-02	2.26e-01	-9.20e-02	6.37e-01	2.75e-01	7.15e-01	4.25e-02	4.08e-01
GOBP ENDOPLASMIC RETICULUM ORGANIZATION	95	4.56e-03	5.04e-02	0.2800	4.23e-02	7.83e-02	-1.62e-01	-2.03e-01	5.70e-02	4.76e-01	1.87e-01	6.43e-03	6.35e-04	3.37e-01
GOMF METHYL CPG BINDING	24	4.28e-01	7.54e-01	0.2800	-7.42e-02	-2.29e-02	-7.59e-02	-1.79e-01	1.86e-01	5.29e-01	8.46e-01	5.20e-01	1.28e-01	1.15e-01
GOBP CELL SUBSTRATE JUNCTION DISASSEMBLY	8	8.37e-01	9.46e-01	0.2800	9.61e-02	5.88e-02	2.33e-01	-3.37e-02	1.02e-01	6.38e-01	7.73e-01	2.55e-01	8.69e-01	6.16e-01
GOMF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE ACTIVITY	19	3.06e-01	6.59e-01	0.2800	-1.19e-01	7.95e-02	1.27e-01	-2.03e-01	-2.54e-02	3.71e-01	5.49e-01	3.37e-01	1.26e-01	8.48e-01
GOMF PROTEIN PHOSPHORYLATED AMINO ACID BINDING	58	2.26e-02	1.52e-01	0.2800	-7.15e-02	2.16e-01	1.27e-01	-6.83e-02	7.77e-02	3.46e-01	4.50e-03	9.50e-02	3.68e-01	3.06e-01
GOBP SERINE TRANSPORT	9	8.25e-01	9.43e-01	0.2800	-2.49e-01	-1.77e-02	1.20e-01	-2.94e-02	-2.87e-02	1.96e-01	9.27e-01	5.34e-01	8.78e-01	8.82e-01
GOMF SERINE TRANSMEMBRANE TRANSPORTER ACTIVITY	9	8.25e-01	9.43e-01	0.2800	-2.49e-01	-1.77e-02	1.20e-01	-2.94e-02	-2.87e-02	1.96e-01	9.27e-01	5.34e-01	8.78e-01	8.82e-01
GOBP RNA LOCALIZATION	182	2.26e-06	9.02e-05	0.2800	-5.67e-03	-5.52e-02	-1.35e-01	-2.38e-01	2.22e-02	8.95e-01	1.99e-01	1.67e-03	3.11e-08	6.05e-01
GOBP PEPTIDYL LYSINE TRIMETHYLATION	9	8.13e-01	9.39e-01	0.2800	6.57e-02	-2.34e-01	-3.22e-02	-1.29e-01	4.01e-02	7.33e-01	2.24e-01	8.67e-01	5.03e-01	8.35e-01
GOBP PROTEIN LOCALIZATION TO EARLY ENDOSOME	11	7.34e-01	9.09e-01	0.2800	-1.55e-01	-1.28e-01	-1.91e-02	1.94e-01	2.83e-03	3.74e-01	4.62e-01	9.13e-01	2.66e-01	9.87e-01
GOBP NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS	50	8.20e-02	3.45e-01	0.2800	-8.84e-03	5.01e-02	-8.10e-02	-1.79e-01	1.93e-01	9.14e-01	5.40e-01	3.22e-01	2.87e-02	1.84e-02
GOBP LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS	18	4.92e-01	7.99e-01	0.2800	1.37e-02	1.69e-01	2.02e-02	-2.21e-01	1.10e-02	9.20e-01	2.14e-01	8.82e-01	1.04e-01	9.35e-01
GOBP XENOBIOTIC CATABOLIC PROCESS	24	2.40e-01	5.96e-01	0.2800	1.58e-01	-1.20e-02	-5.57e-02	1.28e-01	1.84e-01	1.81e-01	9.19e-01	6.37e-01	2.79e-01	1.19e-01
GOBP REGULATION OF PROTEIN KINASE A SIGNALING	20	4.62e-01	7.78e-01	0.2800	-1.05e-01	-2.47e-01	5.20e-02	5.79e-02	-3.25e-03	4.17e-01	5.55e-02	6.87e-01	6.54e-01	9.80e-01
GOBP RESPIRATORY ELECTRON TRANSPORT CHAIN	107	9.84e-04	1.53e-02	0.2800	7.16e-02	-9.05e-02	-1.23e-01	-2.20e-01	4.03e-02	2.01e-01	1.06e-01	2.84e-02	8.61e-05	4.72e-01
GOBP POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEPARATION	18	4.29e-01	7.54e-01	0.2800	1.84e-01	-1.01e-01	-4.28e-02	-1.58e-01	-8.47e-02	1.76e-01	4.56e-01	7.53e-01	2.46e-01	5.34e-01
GOBP NEGATIVE REGULATION OF PROTEIN ACETYLATION	8	8.63e-01	9.54e-01	0.2800	-5.10e-02	2.09e-01	-3.40e-02	-2.14e-03	-1.75e-01	8.03e-01	3.06e-01	8.68e-01	9.92e-01	3.91e-01
GOBP REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY	20	5.42e-01	8.24e-01	0.2800	7.52e-02	1.10e-01	1.64e-01	9.14e-02	1.58e-01	5.60e-01	3.94e-01	2.03e-01	4.79e-01	2.21e-01
GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY	42	1.98e-01	5.47e-01	0.2800	1.31e-02	-4.87e-02	-1.56e-01	-2.20e-01	5.32e-02	8.83e-01	5.85e-01	7.97e-02	1.36e-02	5.51e-01
GOBP ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS	9	7.84e-01	9.28e-01	0.2800	-5.56e-02	-9.07e-02	2.53e-01	1.50e-02	5.13e-02	7.73e-01	6.38e-01	1.89e-01	9.38e-01	7.90e-01
GOMF CYCLASE ACTIVITY	21	5.30e-01	8.19e-01	0.2790	-6.17e-02	7.81e-02	1.25e-01	2.29e-01	-9.15e-03	6.25e-01	5.36e-01	3.22e-01	6.90e-02	9.42e-01
GOBP DNA SYNTHESIS INVOLVED IN DNA REPAIR	39	1.59e-01	4.90e-01	0.2790	-4.76e-02	-2.03e-04	-2.43e-01	-1.24e-01	3.82e-02	6.07e-01	9.98e-01	8.68e-03	1.81e-01	6.79e-01
GOBP POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT	13	7.01e-01	8.96e-01	0.2790	-6.03e-02	-2.41e-01	-1.11e-01	5.46e-02	2.83e-02	7.06e-01	1.32e-01	4.88e-01	7.33e-01	8.60e-01
GOBP GRANULOCYTE DIFFERENTIATION	40	1.25e-01	4.36e-01	0.2790	7.66e-02	2.27e-01	4.63e-04	-9.84e-02	1.04e-01	4.02e-01	1.30e-02	9.96e-01	2.81e-01	2.54e-01
GOCC ASYMMETRIC GLUTAMATERGIC EXCITATORY SYNAPSE	13	5.41e-01	8.24e-01	0.2790	-5.77e-02	9.39e-02	-7.83e-02	4.37e-02	2.40e-01	7.19e-01	5.58e-01	6.25e-01	7.85e-01	1.34e-01
GOBP CELL DIFFERENTIATION IN HINDBRAIN	21	4.13e-01	7.44e-01	0.2790	6.71e-02	-2.24e-01	2.58e-02	-2.13e-02	1.48e-01	5.95e-01	7.50e-02	8.38e-01	8.66e-01	2.40e-01
GOCC CYTOSOLIC REGION	19	4.86e-01	7.95e-01	0.2790	5.87e-02	2.40e-01	2.65e-02	-5.01e-02	-1.16e-01	6.58e-01	7.00e-02	8.41e-01	7.05e-01	3.80e-01
GOBP MEMBRANE BIOGENESIS	59	7.33e-02	3.23e-01	0.2790	9.82e-02	-7.39e-03	-1.86e-01	-1.70e-01	6.61e-02	1.92e-01	9.22e-01	1.33e-02	2.35e-02	3.80e-01
GOBP REGULATION OF STRIATED MUSCLE TISSUE DEVELOPMENT	18	5.10e-01	8.07e-01	0.2790	3.63e-02	1.05e-01	1.64e-01	-9.39e-02	1.73e-01	7.90e-01	4.40e-01	2.30e-01	4.91e-01	2.04e-01
GOBP NUCLEOSIDE SALVAGE	8	8.67e-01	9.55e-01	0.2790	-8.70e-02	1.45e-01	-9.89e-02	-1.17e-01	1.60e-01	6.70e-01	4.77e-01	6.28e-01	5.67e-01	4.32e-01
GOBP NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT	29	4.07e-01	7.40e-01	0.2790	-4.31e-02	2.27e-02	2.18e-01	1.55e-01	-6.16e-02	6.88e-01	8.32e-01	4.20e-02	1.48e-01	5.66e-01
GOCC PLATELET ALPHA GRANULE MEMBRANE	16	6.81e-01	8.88e-01	0.2790	4.57e-02	3.03e-02	1.47e-01	2.22e-01	6.19e-02	7.52e-01	8.34e-01	3.09e-01	1.24e-01	6.68e-01
GOBP ANTIMICROBIAL HUMORAL RESPONSE	117	1.87e-04	3.93e-03	0.2790	-1.49e-01	-1.40e-01	1.20e-01	9.85e-02	-1.09e-01	5.49e-03	8.70e-03	2.52e-02	6.56e-02	4.19e-02
GOCC DENDRITE MEMBRANE	36	1.63e-01	4.97e-01	0.2790	1.46e-01	3.40e-02	1.12e-01	-1.93e-02	2.06e-01	1.30e-01	7.24e-01	2.44e-01	8.41e-01	3.27e-02
GOBP NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY	13	5.61e-01	8.33e-01	0.2790	-9.29e-02	-1.68e-01	7.34e-02	-1.74e-01	7.14e-02	5.62e-01	2.94e-01	6.47e-01	2.77e-01	6.56e-01
GOBP ONE CARBON COMPOUND TRANSPORT	60	3.86e-02	2.15e-01	0.2790	-1.28e-01	9.58e-02	7.69e-02	1.22e-01	-1.77e-01	8.63e-02	1.99e-01	3.03e-01	1.02e-01	1.78e-02
GOBP CONNECTIVE TISSUE REPLACEMENT	20	5.00e-01	8.03e-01	0.2790	4.08e-03	8.98e-02	1.91e-01	-4.21e-03	1.82e-01	9.75e-01	4.87e-01	1.39e-01	9.74e-01	1.60e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS II	28	2.08e-01	5.59e-01	0.2790	-1.86e-01	1.03e-01	8.34e-02	-1.57e-01	2.70e-02	8.78e-02	3.47e-01	4.45e-01	1.50e-01	8.05e-01
GOMF POLY PYRIMIDINE TRACT BINDING	26	1.90e-01	5.35e-01	0.2790	4.79e-03	2.88e-02	1.84e-01	-1.42e-01	1.51e-01	9.66e-01	7.99e-01	1.03e-01	2.12e-01	1.83e-01
GOBP REGULATION OF T CELL MEDIATED CYTOTOXICITY	48	4.27e-02	2.29e-01	0.2790	-1.68e-01	-3.04e-02	1.78e-01	2.08e-02	-1.27e-01	4.35e-02	7.16e-01	3.27e-02	8.03e-01	1.28e-01
GOBP NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE	36	2.05e-01	5.56e-01	0.2790	-2.08e-01	1.22e-02	8.91e-02	1.51e-01	-5.83e-02	3.05e-02	8.99e-01	3.55e-01	1.18e-01	5.45e-01
GOCC TRANSCRIPTION REPRESSOR COMPLEX	73	8.54e-03	7.86e-02	0.2790	2.12e-02	1.55e-01	3.82e-03	-1.13e-01	2.01e-01	7.54e-01	2.20e-02	9.55e-01	9.55e-02	3.00e-03
GOBP NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY	14	6.46e-01	8.76e-01	0.2790	-1.26e-01	-5.80e-02	2.06e-01	1.41e-02	1.26e-01	4.16e-01	7.07e-01	1.82e-01	9.27e-01	4.15e-01
GOBP REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION	57	1.28e-02	1.04e-01	0.2780	-1.08e-01	1.78e-02	2.42e-01	-2.44e-02	8.14e-02	1.59e-01	8.16e-01	1.60e-03	7.50e-01	2.88e-01
GOBP TRANSLATIONAL ELONGATION	68	4.11e-02	2.24e-01	0.2780	-1.04e-04	7.42e-03	-1.85e-01	-2.04e-01	3.93e-02	9.99e-01	9.16e-01	8.26e-03	3.62e-03	5.75e-01
GOBP MORPHOGENESIS OF AN EPITHELIAL BUD	14	5.17e-01	8.11e-01	0.2780	3.69e-02	-1.50e-01	2.35e-02	-2.28e-01	3.80e-02	8.11e-01	3.32e-01	8.79e-01	1.40e-01	8.05e-01
GOBP IRON SULFUR CLUSTER ASSEMBLY	27	3.98e-01	7.31e-01	0.2780	4.92e-02	6.21e-02	-1.52e-01	-2.11e-01	-5.75e-02	6.58e-01	5.77e-01	1.70e-01	5.73e-02	6.05e-01
GOMF D GLUCOSE TRANSMEMBRANE TRANSPORTER ACTIVITY	12	6.80e-01	8.87e-01	0.2780	-1.58e-02	4.99e-02	6.54e-02	2.44e-01	1.06e-01	9.24e-01	7.65e-01	6.95e-01	1.44e-01	5.27e-01
GOBP RIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS	14	6.90e-01	8.91e-01	0.2780	-5.75e-02	2.16e-01	1.33e-01	-2.92e-03	-9.81e-02	7.09e-01	1.61e-01	3.87e-01	9.85e-01	5.25e-01
GOMF CARBOHYDRATE KINASE ACTIVITY	20	5.06e-01	8.06e-01	0.2780	2.01e-01	1.21e-01	1.32e-01	6.86e-02	1.62e-02	1.19e-01	3.50e-01	3.08e-01	5.95e-01	9.00e-01
GOBP REGULATION OF AMYLOID BETA CLEARANCE	20	4.60e-01	7.78e-01	0.2780	-1.83e-01	-1.41e-01	-1.53e-01	-1.12e-02	1.62e-02	1.56e-01	2.74e-01	2.36e-01	9.31e-01	9.00e-01
GOBP ORGANELLE DISASSEMBLY	137	2.11e-04	4.38e-03	0.2780	9.28e-02	2.38e-02	-1.22e-01	-2.12e-01	8.95e-02	6.08e-02	6.31e-01	1.34e-02	1.75e-05	7.05e-02
GOBP TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY	17	6.12e-01	8.58e-01	0.2780	-4.01e-02	1.54e-01	1.54e-01	2.17e-02	1.67e-01	7.75e-01	2.73e-01	2.72e-01	8.77e-01	2.32e-01
GOCC UBIQUITIN LIGASE COMPLEX	299	1.88e-11	1.87e-09	0.2780	1.05e-02	5.80e-02	-9.53e-02	-2.54e-01	2.05e-02	7.55e-01	8.45e-02	4.60e-03	4.44e-14	5.42e-01
GOBP PEPTIDYL SERINE DEPHOSPHORYLATION	14	6.25e-01	8.66e-01	0.2780	-2.32e-03	7.48e-02	-6.25e-02	-1.75e-01	-1.93e-01	9.88e-01	6.28e-01	6.86e-01	2.57e-01	2.12e-01
GOBP REGULATION OF T CELL DIFFERENTIATION IN THYMUS	26	3.25e-01	6.73e-01	0.2780	2.15e-01	9.03e-02	7.31e-02	-6.80e-02	1.14e-01	5.82e-02	4.25e-01	5.19e-01	5.48e-01	3.13e-01
GOBP AUTOPHAGIC CELL DEATH	9	7.87e-01	9.30e-01	0.2780	-1.85e-01	9.52e-02	-1.79e-01	-3.99e-02	-9.57e-03	3.36e-01	6.21e-01	3.51e-01	8.36e-01	9.60e-01
GOBP HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS	52	3.82e-02	2.14e-01	0.2780	2.61e-03	-8.87e-02	3.75e-02	-5.60e-02	2.55e-01	9.74e-01	2.69e-01	6.40e-01	4.85e-01	1.49e-03
GOBP NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC	8	8.64e-01	9.54e-01	0.2780	9.24e-02	1.00e-01	-4.38e-02	2.96e-02	-2.36e-01	6.51e-01	6.23e-01	8.30e-01	8.85e-01	2.47e-01
GOBP PERICARDIUM DEVELOPMENT	19	4.00e-01	7.33e-01	0.2780	1.14e-01	9.33e-02	1.86e-01	-1.05e-01	9.78e-02	3.88e-01	4.81e-01	1.60e-01	4.26e-01	4.60e-01
GOBP EPHRIN RECEPTOR SIGNALING PATHWAY	49	5.24e-02	2.63e-01	0.2780	-7.89e-02	8.21e-02	2.27e-01	3.89e-02	-1.05e-01	3.39e-01	3.20e-01	5.92e-03	6.38e-01	2.03e-01
GOBP REGULATION OF PLATELET ACTIVATION	47	7.54e-02	3.29e-01	0.2780	-2.82e-02	2.49e-01	1.19e-01	-6.81e-03	2.20e-02	7.38e-01	3.20e-03	1.60e-01	9.36e-01	7.95e-01
GOBP DEOXYRIBONUCLEOTIDE METABOLIC PROCESS	42	1.05e-01	3.93e-01	0.2780	3.36e-02	1.04e-01	-1.00e-01	-2.15e-01	-9.50e-02	7.07e-01	2.44e-01	2.60e-01	1.61e-02	2.87e-01
GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER	54	4.76e-02	2.46e-01	0.2780	6.16e-02	-1.24e-02	1.73e-01	9.81e-02	1.83e-01	4.34e-01	8.75e-01	2.76e-02	2.12e-01	2.01e-02
GOCC KINOCILIUM	9	8.57e-01	9.53e-01	0.2780	7.44e-02	9.41e-02	-2.30e-01	-9.75e-02	-2.04e-02	6.99e-01	6.25e-01	2.33e-01	6.13e-01	9.15e-01
GOMF CALCIUM INDUCED CALCIUM RELEASE ACTIVITY	6	9.24e-01	9.75e-01	0.2780	1.38e-01	-1.84e-01	-6.65e-02	1.84e-02	-1.40e-01	5.59e-01	4.36e-01	7.78e-01	9.38e-01	5.53e-01
GOBP ARF PROTEIN SIGNAL TRANSDUCTION	21	3.55e-01	7.00e-01	0.2780	7.22e-02	1.67e-01	1.81e-01	-4.62e-02	-9.53e-02	5.67e-01	1.85e-01	1.51e-01	7.14e-01	4.49e-01
GOBP POSITIVE REGULATION OF LIPID KINASE ACTIVITY	26	3.72e-01	7.11e-01	0.2770	-1.30e-01	-1.73e-02	1.36e-01	7.67e-02	-1.88e-01	2.52e-01	8.79e-01	2.29e-01	4.98e-01	9.71e-02
GOBP POSITIVE REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE	11	8.24e-01	9.43e-01	0.2770	3.81e-02	-2.82e-02	-5.21e-02	-1.37e-01	2.30e-01	8.27e-01	8.71e-01	7.65e-01	4.31e-01	1.86e-01
GOBP CRANIOFACIAL SUTURE MORPHOGENESIS	18	6.37e-01	8.73e-01	0.2770	-7.85e-02	-1.04e-01	-2.18e-01	-1.11e-01	2.93e-03	5.64e-01	4.46e-01	1.09e-01	4.14e-01	9.83e-01
GOBP PENTOSE METABOLIC PROCESS	11	8.50e-01	9.50e-01	0.2770	6.79e-02	-1.28e-02	-2.35e-01	-1.29e-01	-2.33e-03	6.97e-01	9.42e-01	1.77e-01	4.57e-01	9.89e-01
GOMF RNA 2 O METHYLTRANSFERASE ACTIVITY	8	9.18e-01	9.74e-01	0.2770	2.89e-02	-7.50e-02	-2.12e-01	-1.29e-01	-9.39e-02	8.87e-01	7.14e-01	2.99e-01	5.29e-01	6.46e-01
GOBP AMINO ACID ACTIVATION	43	1.83e-01	5.25e-01	0.2770	1.31e-01	-3.05e-02	-1.61e-01	-1.80e-01	1.89e-02	1.37e-01	7.29e-01	6.76e-02	4.13e-02	8.30e-01
GOBP RESPONSE TO HYDROSTATIC PRESSURE	7	8.60e-01	9.53e-01	0.2770	-1.92e-03	-5.64e-02	1.93e-01	3.57e-02	-1.87e-01	9.93e-01	7.96e-01	3.76e-01	8.70e-01	3.91e-01
GOBP PYRIMIDINE RIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS	7	9.27e-01	9.77e-01	0.2770	1.39e-01	-1.16e-02	-1.40e-01	-1.87e-01	-5.09e-02	5.23e-01	9.58e-01	5.22e-01	3.90e-01	8.16e-01
GOMF FILAMIN BINDING	14	5.31e-01	8.20e-01	0.2770	-1.69e-01	-1.05e-01	-9.17e-02	1.65e-01	3.85e-02	2.74e-01	4.96e-01	5.53e-01	2.84e-01	8.03e-01
GOBP REGULATION OF SISTER CHROMATID COHESION	15	4.31e-01	7.56e-01	0.2770	1.41e-01	-1.60e-01	3.11e-02	-1.55e-01	-7.89e-02	3.45e-01	2.84e-01	8.35e-01	2.98e-01	5.97e-01
GOBP ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE	24	2.31e-01	5.85e-01	0.2770	1.13e-01	-1.14e-01	3.54e-02	-2.10e-01	7.62e-02	3.38e-01	3.36e-01	7.64e-01	7.54e-02	5.18e-01
GOCC ENDOPEPTIDASE COMPLEX	83	1.59e-02	1.21e-01	0.2770	7.78e-03	-1.33e-02	-2.06e-01	-1.80e-01	3.92e-02	9.02e-01	8.34e-01	1.15e-03	4.66e-03	5.37e-01
GOBP WHITE FAT CELL DIFFERENTIATION	17	5.85e-01	8.45e-01	0.2770	-1.18e-01	8.68e-02	1.66e-01	-1.19e-02	1.66e-01	3.99e-01	5.36e-01	2.37e-01	9.32e-01	2.36e-01
GOBP POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION	10	6.62e-01	8.81e-01	0.2770	-7.11e-02	9.54e-02	-2.46e-01	3.42e-02	-2.98e-02	6.97e-01	6.01e-01	1.78e-01	8.52e-01	8.70e-01
GOBP GLUCOSAMINE CONTAINING COMPOUND CATABOLIC PROCESS	9	8.43e-01	9.49e-01	0.2770	1.44e-01	7.29e-02	1.49e-01	8.48e-02	-1.46e-01	4.56e-01	7.05e-01	4.40e-01	6.60e-01	4.47e-01
GOBP PEXOPHAGY	6	9.48e-01	9.83e-01	0.2770	-1.25e-01	1.37e-04	-1.30e-01	-2.10e-01	-6.26e-03	5.97e-01	1.00e+00	5.80e-01	3.74e-01	9.79e-01
GOCC CATALYTIC COMPLEX	1609	5.51e-54	4.70e-51	0.2770	6.75e-02	6.76e-03	-1.43e-01	-2.22e-01	4.95e-02	6.24e-06	6.51e-01	1.37e-21	6.31e-50	9.28e-04
GOCC FILAMENTOUS ACTIN	28	2.29e-01	5.83e-01	0.2760	5.79e-02	1.53e-01	1.11e-01	-9.46e-03	-1.93e-01	5.96e-01	1.60e-01	3.10e-01	9.31e-01	7.75e-02
GOBP PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER	35	2.08e-01	5.59e-01	0.2760	2.17e-01	-8.23e-02	-8.81e-02	-1.11e-01	4.91e-02	2.62e-02	3.99e-01	3.67e-01	2.56e-01	6.15e-01
GOMF METHYLATION DEPENDENT PROTEIN BINDING	69	1.87e-02	1.35e-01	0.2760	1.62e-01	-7.24e-02	-6.63e-02	-1.55e-01	1.28e-01	1.96e-02	2.98e-01	3.41e-01	2.61e-02	6.59e-02
GOBP CGMP BIOSYNTHETIC PROCESS	10	8.30e-01	9.44e-01	0.2760	1.11e-01	3.21e-02	1.15e-01	1.46e-01	1.68e-01	5.43e-01	8.60e-01	5.28e-01	4.23e-01	3.57e-01
GOBP BILE ACID AND BILE SALT TRANSPORT	28	4.00e-01	7.33e-01	0.2760	1.25e-02	-1.38e-02	1.16e-01	2.43e-01	-6.08e-02	9.09e-01	8.99e-01	2.90e-01	2.62e-02	5.78e-01
GOBP TETRAPYRROLE CATABOLIC PROCESS	13	4.65e-01	7.81e-01	0.2760	-8.31e-02	1.12e-01	-6.97e-02	2.27e-01	2.06e-02	6.04e-01	4.86e-01	6.63e-01	1.56e-01	8.98e-01
GOBP NUCLEOSIDE TRANSMEMBRANE TRANSPORT	8	8.81e-01	9.61e-01	0.2760	6.79e-02	-3.61e-02	-2.60e-02	1.20e-01	-2.35e-01	7.39e-01	8.60e-01	8.99e-01	5.57e-01	2.49e-01
GOBP REGULATION OF TRANSLATION IN RESPONSE TO STRESS	19	4.49e-01	7.70e-01	0.2760	-1.22e-01	1.71e-01	1.39e-01	-1.12e-01	-1.80e-02	3.57e-01	1.96e-01	2.95e-01	4.00e-01	8.92e-01
GOBP DNA MODIFICATION	99	3.56e-03	4.18e-02	0.2760	1.61e-01	1.52e-02	-1.32e-01	-1.63e-01	7.66e-02	5.63e-03	7.94e-01	2.27e-02	4.97e-03	1.88e-01
GOBP REGULATION OF RENAL SYSTEM PROCESS	21	3.97e-01	7.31e-01	0.2760	-3.62e-02	-3.98e-02	-9.23e-02	1.83e-01	-1.77e-01	7.74e-01	7.52e-01	4.64e-01	1.47e-01	1.60e-01
GOBP POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY	27	2.64e-01	6.19e-01	0.2760	-1.05e-01	-1.64e-01	1.86e-01	5.97e-02	-1.42e-02	3.44e-01	1.40e-01	9.47e-02	5.91e-01	8.99e-01
GOBP REGULATION OF AMPA RECEPTOR ACTIVITY	23	4.82e-01	7.93e-01	0.2760	-1.06e-02	-1.75e-01	-1.31e-01	-1.68e-01	-8.71e-03	9.30e-01	1.46e-01	2.77e-01	1.63e-01	9.42e-01
GOCC SYNAPTIC CLEFT	21	5.51e-01	8.28e-01	0.2760	-1.65e-01	1.04e-01	1.74e-01	8.76e-02	4.48e-03	1.89e-01	4.09e-01	1.67e-01	4.87e-01	9.72e-01
GOMF STRUCTURAL CONSTITUENT OF POSTSYNAPSE	17	4.38e-01	7.60e-01	0.2760	-8.38e-02	-1.74e-02	2.08e-01	-9.82e-02	1.27e-01	5.50e-01	9.01e-01	1.38e-01	4.84e-01	3.64e-01
GOBP NUCLEOSIDE TRANSPORT	10	8.24e-01	9.43e-01	0.2760	-2.55e-02	-3.97e-02	-2.97e-02	4.89e-02	-2.66e-01	8.89e-01	8.28e-01	8.71e-01	7.89e-01	1.46e-01
GOBP POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY	12	7.21e-01	9.02e-01	0.2760	-6.53e-02	-2.10e-01	1.23e-01	6.61e-02	-9.09e-02	6.95e-01	2.08e-01	4.59e-01	6.92e-01	5.86e-01
GOMF AMINO ACID BINDING	47	2.93e-02	1.80e-01	0.2760	-3.26e-02	2.42e-01	-2.03e-02	2.31e-02	1.25e-01	6.99e-01	4.15e-03	8.09e-01	7.84e-01	1.37e-01
GOBP FUCOSE METABOLIC PROCESS	16	6.44e-01	8.75e-01	0.2760	-4.89e-02	5.33e-02	-1.25e-01	-1.30e-01	1.96e-01	7.35e-01	7.12e-01	3.85e-01	3.68e-01	1.76e-01
GOBP MICROTUBULE NUCLEATION	43	1.48e-01	4.72e-01	0.2760	1.56e-01	1.55e-02	-9.26e-02	-1.98e-01	6.32e-02	7.76e-02	8.60e-01	2.93e-01	2.49e-02	4.74e-01
GOMF CXCR CHEMOKINE RECEPTOR BINDING	18	5.32e-01	8.20e-01	0.2760	1.25e-02	-3.51e-02	-1.50e-01	6.52e-02	-2.19e-01	9.27e-01	7.96e-01	2.70e-01	6.32e-01	1.08e-01
GOCC CONDENSED CHROMOSOME CENTROMERIC REGION	171	9.39e-06	3.14e-04	0.2760	1.37e-01	-2.16e-02	-1.16e-01	-2.00e-01	5.79e-02	2.04e-03	6.26e-01	8.80e-03	6.30e-06	1.91e-01
GOBP POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION	56	5.01e-03	5.36e-02	0.2760	5.30e-02	1.37e-01	1.32e-01	-1.92e-01	-6.75e-03	4.93e-01	7.53e-02	8.74e-02	1.29e-02	9.30e-01
GOBP NEGATIVE REGULATION OF PHOSPHOLIPASE ACTIVITY	6	8.77e-01	9.59e-01	0.2760	-2.83e-02	1.81e-02	-2.04e-02	2.73e-01	1.01e-02	9.04e-01	9.39e-01	9.31e-01	2.47e-01	9.66e-01
GOBP NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS	43	1.27e-01	4.40e-01	0.2760	-4.66e-03	1.14e-01	-1.24e-01	-2.07e-01	-6.76e-02	9.58e-01	1.97e-01	1.58e-01	1.86e-02	4.43e-01
GOBP TRIGLYCERIDE BIOSYNTHETIC PROCESS	39	1.46e-01	4.68e-01	0.2760	2.33e-03	1.88e-01	2.18e-02	-1.47e-01	1.35e-01	9.80e-01	4.17e-02	8.14e-01	1.12e-01	1.44e-01
GOBP BASE CONVERSION OR SUBSTITUTION EDITING	19	5.33e-01	8.20e-01	0.2760	2.32e-01	3.34e-02	9.92e-02	1.00e-01	3.13e-02	7.97e-02	8.01e-01	4.54e-01	4.48e-01	8.13e-01
GOBP RESPONSE TO LIGHT INTENSITY	16	6.45e-01	8.75e-01	0.2760	1.22e-01	2.05e-01	1.04e-01	6.27e-02	-6.57e-02	4.00e-01	1.56e-01	4.71e-01	6.64e-01	6.49e-01
GOBP PSEUDOPODIUM ORGANIZATION	15	6.10e-01	8.58e-01	0.2760	-8.54e-02	2.17e-01	-1.13e-01	-9.25e-02	1.99e-02	5.67e-01	1.46e-01	4.49e-01	5.35e-01	8.94e-01
GOBP NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY	12	7.15e-01	9.01e-01	0.2760	-3.26e-02	-2.57e-01	7.16e-02	2.76e-02	5.17e-02	8.45e-01	1.23e-01	6.68e-01	8.69e-01	7.57e-01
GOBP POSITIVE REGULATION OF CATECHOLAMINE SECRETION	12	8.11e-01	9.38e-01	0.2750	-4.06e-02	1.98e-01	1.61e-01	7.85e-02	-5.18e-02	8.08e-01	2.34e-01	3.34e-01	6.38e-01	7.56e-01
GOBP EPIGENETIC PROGRAMMING IN THE ZYGOTIC PRONUCLEI	8	8.74e-01	9.58e-01	0.2750	1.85e-01	-1.48e-01	-7.90e-03	7.73e-02	1.16e-01	3.64e-01	4.68e-01	9.69e-01	7.05e-01	5.69e-01
GOBP BASEMENT MEMBRANE ORGANIZATION	36	2.83e-01	6.36e-01	0.2750	-2.32e-02	-4.02e-02	2.08e-01	1.72e-01	-2.95e-02	8.10e-01	6.77e-01	3.08e-02	7.43e-02	7.60e-01
GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX CLASS III	7	8.29e-01	9.44e-01	0.2750	1.14e-01	1.48e-01	-1.94e-01	5.82e-02	-1.19e-02	6.03e-01	4.99e-01	3.75e-01	7.90e-01	9.57e-01
GOBP MAINTENANCE OF SISTER CHROMATID COHESION	11	6.25e-01	8.66e-01	0.2750	2.46e-02	-7.12e-02	1.33e-01	-1.96e-01	1.19e-01	8.88e-01	6.83e-01	4.47e-01	2.60e-01	4.95e-01
GOBP CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS	23	3.87e-01	7.24e-01	0.2750	1.61e-01	1.90e-01	1.06e-01	-4.62e-02	-7.39e-03	1.80e-01	1.14e-01	3.79e-01	7.01e-01	9.51e-01
GOBP CARDIAC MUSCLE CELL ACTION POTENTIAL	72	2.73e-02	1.72e-01	0.2750	-1.26e-01	5.91e-02	1.20e-01	1.68e-01	-1.17e-01	6.36e-02	3.86e-01	7.80e-02	1.39e-02	8.61e-02
GOMF TRANSLATION TERMINATION FACTOR ACTIVITY	6	9.09e-01	9.70e-01	0.2750	-5.66e-02	-1.50e-01	-4.62e-02	-2.11e-01	-5.88e-02	8.10e-01	5.25e-01	8.44e-01	3.72e-01	8.03e-01
GOBP POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT	6	9.53e-01	9.85e-01	0.2750	6.35e-02	1.05e-01	-6.80e-02	-1.83e-01	1.51e-01	7.88e-01	6.57e-01	7.73e-01	4.38e-01	5.23e-01
GOBP REGULATION OF CONNECTIVE TISSUE REPLACEMENT	15	6.82e-01	8.88e-01	0.2750	-8.60e-02	8.53e-02	2.03e-01	2.31e-02	1.38e-01	5.64e-01	5.67e-01	1.72e-01	8.77e-01	3.55e-01
GOBP GASTRULATION WITH MOUTH FORMING SECOND	26	1.99e-01	5.48e-01	0.2750	1.89e-01	-3.09e-02	1.30e-01	-1.12e-01	9.65e-02	9.50e-02	7.85e-01	2.51e-01	3.22e-01	3.94e-01
GOBP REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY	14	7.24e-01	9.04e-01	0.2750	-1.43e-01	-4.46e-02	-9.77e-02	-2.08e-01	1.77e-02	3.53e-01	7.73e-01	5.27e-01	1.78e-01	9.09e-01
GOBP REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY	29	3.10e-01	6.62e-01	0.2750	6.83e-02	8.01e-02	4.20e-02	-9.75e-02	2.31e-01	5.25e-01	4.55e-01	6.95e-01	3.64e-01	3.15e-02
GOMF TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY	81	9.36e-03	8.34e-02	0.2750	-6.54e-02	-3.87e-02	1.66e-01	1.30e-01	-1.59e-01	3.09e-01	5.47e-01	9.72e-03	4.29e-02	1.34e-02
GOBP REGULATION OF MONOCYTE DIFFERENTIATION	20	4.36e-01	7.60e-01	0.2750	-4.36e-02	1.26e-01	-1.19e-01	3.89e-02	-2.05e-01	7.36e-01	3.28e-01	3.55e-01	7.63e-01	1.13e-01
GOCC PROTEIN COMPLEX INVOLVED IN CELL CELL ADHESION	5	9.59e-01	9.88e-01	0.2750	-3.18e-02	7.66e-02	2.34e-02	8.32e-02	-2.47e-01	9.02e-01	7.67e-01	9.28e-01	7.47e-01	3.38e-01
GOBP REGULATION OF MEIOTIC CELL CYCLE	66	4.00e-02	2.20e-01	0.2750	7.16e-02	-9.11e-02	-1.18e-01	-1.63e-01	1.48e-01	3.15e-01	2.01e-01	9.77e-02	2.23e-02	3.82e-02
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL DEVELOPMENT	6	9.39e-01	9.81e-01	0.2750	2.02e-01	1.35e-01	-6.18e-02	-1.12e-01	-7.60e-04	3.91e-01	5.68e-01	7.93e-01	6.33e-01	9.97e-01
GOMF NUCLEOCYTOPLASMIC CARRIER ACTIVITY	32	2.61e-01	6.18e-01	0.2750	6.38e-02	2.00e-02	-1.83e-01	-1.01e-01	-1.66e-01	5.32e-01	8.45e-01	7.40e-02	3.23e-01	1.04e-01
GOBP MACROPHAGE APOPTOTIC PROCESS	14	7.00e-01	8.96e-01	0.2750	-1.64e-01	4.72e-02	-9.53e-02	-1.45e-01	-1.27e-01	2.87e-01	7.60e-01	5.37e-01	3.47e-01	4.11e-01
GOBP POSITIVE REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION	24	3.96e-01	7.29e-01	0.2750	-9.10e-02	2.41e-01	8.88e-02	-7.44e-03	3.66e-02	4.40e-01	4.13e-02	4.51e-01	9.50e-01	7.56e-01
GOBP LENS MORPHOGENESIS IN CAMERA TYPE EYE	21	2.63e-01	6.19e-01	0.2750	-3.03e-02	3.59e-02	1.72e-01	-1.86e-01	9.62e-02	8.10e-01	7.76e-01	1.73e-01	1.41e-01	4.46e-01
GOBP CELLULAR RESPONSE TO OXYGEN RADICAL	23	4.47e-01	7.70e-01	0.2750	-4.41e-02	-1.05e-01	-2.26e-01	-2.88e-02	-1.02e-01	7.14e-01	3.81e-01	6.05e-02	8.11e-01	3.98e-01
GOBP REGULATION OF MRNA SPLICING VIA SPLICEOSOME	95	3.90e-03	4.48e-02	0.2750	2.58e-02	1.48e-02	-1.19e-01	-2.44e-01	2.88e-02	6.64e-01	8.03e-01	4.55e-02	3.93e-05	6.28e-01
GOMF CATALYTIC ACTIVITY ACTING ON RNA	387	1.38e-12	1.55e-10	0.2750	7.58e-02	-3.95e-02	-1.64e-01	-2.02e-01	9.15e-03	1.05e-02	1.83e-01	2.85e-08	7.91e-12	7.57e-01
GOMF QUINONE BINDING	15	5.41e-01	8.24e-01	0.2740	-1.22e-01	2.30e-01	-7.26e-03	6.84e-02	5.44e-02	4.14e-01	1.23e-01	9.61e-01	6.47e-01	7.15e-01
GOBP CARTILAGE CONDENSATION	19	5.51e-01	8.28e-01	0.2740	1.25e-01	5.02e-02	1.12e-01	1.29e-01	1.67e-01	3.46e-01	7.05e-01	3.98e-01	3.29e-01	2.07e-01
GOBP PROTEIN AUTO ADP RIBOSYLATION	11	7.66e-01	9.23e-01	0.2740	1.82e-01	5.29e-02	-8.03e-02	-6.08e-02	-1.71e-01	2.96e-01	7.61e-01	6.45e-01	7.27e-01	3.26e-01
GOBP MAINTENANCE OF DNA REPEAT ELEMENTS	7	7.83e-01	9.28e-01	0.2740	4.80e-02	-1.01e-01	1.42e-01	-1.94e-01	7.00e-02	8.26e-01	6.42e-01	5.16e-01	3.73e-01	7.48e-01
GOMF K63 LINKED DEUBIQUITINASE ACTIVITY	11	7.99e-01	9.33e-01	0.2740	1.06e-02	1.84e-01	1.07e-01	6.70e-02	1.60e-01	9.51e-01	2.92e-01	5.39e-01	7.00e-01	3.59e-01
GOBP POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE	26	2.95e-01	6.49e-01	0.2740	-5.69e-02	1.74e-01	1.25e-01	-1.35e-01	8.93e-02	6.15e-01	1.25e-01	2.69e-01	2.34e-01	4.31e-01
GOBP RENAL SYSTEM VASCULATURE MORPHOGENESIS	8	8.76e-01	9.59e-01	0.2740	1.38e-01	1.32e-01	1.91e-01	3.00e-02	-3.92e-02	4.98e-01	5.19e-01	3.51e-01	8.83e-01	8.48e-01
GOMF TELOMERASE INHIBITOR ACTIVITY	5	9.49e-01	9.83e-01	0.2740	1.22e-01	4.33e-02	-1.97e-01	-4.42e-02	1.33e-01	6.36e-01	8.67e-01	4.46e-01	8.64e-01	6.06e-01
GOCC INTEGRATOR COMPLEX	16	7.29e-01	9.07e-01	0.2740	5.35e-02	-6.07e-02	-1.81e-01	-1.79e-01	-6.31e-02	7.11e-01	6.74e-01	2.10e-01	2.16e-01	6.62e-01
GOMF PEPTIDE RECEPTOR ACTIVITY	122	4.63e-04	8.40e-03	0.2740	-1.59e-01	4.68e-02	1.90e-01	1.05e-01	1.73e-02	2.37e-03	3.72e-01	2.87e-04	4.42e-02	7.41e-01
GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CONTRACTION	9	8.42e-01	9.48e-01	0.2740	-1.73e-02	-1.87e-01	-4.96e-02	1.11e-02	1.93e-01	9.28e-01	3.32e-01	7.97e-01	9.54e-01	3.16e-01
GOBP NEGATIVE REGULATION OF CELLULAR SENESCENCE	25	3.93e-01	7.27e-01	0.2740	4.17e-02	1.62e-01	-4.42e-02	-2.12e-01	1.79e-02	7.18e-01	1.62e-01	7.02e-01	6.65e-02	8.77e-01
GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION	39	1.44e-01	4.65e-01	0.2740	-1.15e-01	2.01e-01	9.31e-02	1.13e-01	-2.83e-03	2.13e-01	3.01e-02	3.15e-01	2.21e-01	9.76e-01
GOBP NEGATIVE REGULATION OF MACROPHAGE MIGRATION	14	7.11e-01	8.99e-01	0.2740	1.98e-01	3.51e-02	1.53e-01	8.68e-02	6.04e-02	2.00e-01	8.20e-01	3.21e-01	5.74e-01	6.96e-01
GOBP XENOBIOTIC TRANSPORT	59	2.39e-02	1.58e-01	0.2740	-9.20e-02	-5.29e-02	3.01e-02	2.45e-01	-5.39e-02	2.21e-01	4.82e-01	6.89e-01	1.14e-03	4.74e-01
GOMF DNA BINDING TRANSCRIPTION REPRESSOR ACTIVITY	320	1.56e-12	1.74e-10	0.2740	3.23e-02	3.39e-02	-2.78e-02	-2.33e-01	1.34e-01	3.21e-01	2.97e-01	3.93e-01	8.02e-13	3.91e-05
GOBP TRANSPORT OF VIRUS	21	4.47e-01	7.69e-01	0.2740	-2.09e-01	4.79e-03	-3.67e-02	-1.70e-01	-3.36e-02	9.79e-02	9.70e-01	7.71e-01	1.77e-01	7.90e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN	68	1.33e-03	1.95e-02	0.2740	-1.70e-01	-3.05e-03	9.26e-02	-1.51e-01	-1.20e-01	1.51e-02	9.65e-01	1.87e-01	3.13e-02	8.58e-02
GOBP ADRENAL GLAND DEVELOPMENT	27	2.98e-01	6.52e-01	0.2740	-5.36e-02	1.81e-01	-4.94e-02	-9.30e-02	-1.68e-01	6.30e-01	1.04e-01	6.57e-01	4.03e-01	1.31e-01
GOBP REGULATION OF CELL PROJECTION SIZE	12	6.59e-01	8.80e-01	0.2740	-8.66e-02	-9.85e-02	-7.71e-02	2.23e-01	-4.58e-02	6.03e-01	5.55e-01	6.44e-01	1.81e-01	7.83e-01
GOMF STEROL TRANSFER ACTIVITY	23	2.89e-01	6.43e-01	0.2740	-7.33e-02	-9.81e-03	-2.58e-01	1.24e-02	-5.25e-02	5.43e-01	9.35e-01	3.24e-02	9.18e-01	6.63e-01
GOBP EYE PHOTORECEPTOR CELL DEVELOPMENT	34	5.60e-02	2.74e-01	0.2740	1.25e-01	-1.89e-02	2.31e-01	-2.44e-02	-7.17e-02	2.08e-01	8.49e-01	2.00e-02	8.05e-01	4.70e-01
GOCC GTPASE COMPLEX	38	1.47e-01	4.70e-01	0.2740	-7.01e-02	2.14e-01	-6.28e-03	-1.34e-01	7.70e-02	4.54e-01	2.24e-02	9.47e-01	1.51e-01	4.11e-01
GOMF THIOESTERASE BINDING	9	8.22e-01	9.42e-01	0.2730	-1.72e-01	7.51e-02	9.33e-03	-1.49e-01	-1.32e-01	3.72e-01	6.96e-01	9.61e-01	4.39e-01	4.94e-01
GOMF JUN KINASE BINDING	11	7.92e-01	9.31e-01	0.2730	2.15e-01	-5.54e-02	6.77e-02	5.34e-02	1.34e-01	2.17e-01	7.50e-01	6.97e-01	7.59e-01	4.41e-01
GOBP ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT	127	8.96e-04	1.42e-02	0.2730	6.01e-02	2.42e-02	-1.56e-01	-2.03e-01	6.81e-02	2.42e-01	6.38e-01	2.33e-03	7.51e-05	1.85e-01
GOBP PROTEIN NITROSYLATION	15	6.15e-01	8.60e-01	0.2730	-1.95e-01	8.50e-03	-1.03e-01	7.87e-02	-1.41e-01	1.92e-01	9.55e-01	4.89e-01	5.98e-01	3.45e-01
GOMF GDP PHOSPHATASE ACTIVITY	10	8.35e-01	9.46e-01	0.2730	3.69e-02	1.99e-01	-1.04e-02	-1.78e-01	4.11e-02	8.40e-01	2.75e-01	9.54e-01	3.29e-01	8.22e-01
GOMF IONOTROPIC GLUTAMATE RECEPTOR BINDING	21	4.15e-01	7.45e-01	0.2730	-1.42e-01	-1.76e-01	-1.76e-02	-1.51e-01	2.31e-02	2.60e-01	1.63e-01	8.89e-01	2.31e-01	8.54e-01
GOBP CHORIO ALLANTOIC FUSION	7	7.96e-01	9.32e-01	0.2730	1.00e-02	-1.32e-01	2.33e-01	-4.30e-02	-3.28e-02	9.63e-01	5.45e-01	2.87e-01	8.44e-01	8.81e-01
GOBP REGULATION OF TOLERANCE INDUCTION	19	6.49e-01	8.77e-01	0.2730	-1.31e-02	6.98e-02	1.96e-01	1.52e-01	9.01e-02	9.22e-01	5.99e-01	1.39e-01	2.52e-01	4.96e-01
GOBP CELLULAR RESPONSE TO STEROL DEPLETION	16	6.88e-01	8.90e-01	0.2730	-1.40e-01	-4.19e-02	-1.71e-01	-1.23e-01	-9.27e-02	3.31e-01	7.72e-01	2.35e-01	3.95e-01	5.21e-01
GOMF SOLUTE PROTON SYMPORTER ACTIVITY	24	5.17e-01	8.12e-01	0.2730	-7.26e-02	1.19e-01	1.88e-01	1.29e-01	5.57e-02	5.38e-01	3.14e-01	1.10e-01	2.75e-01	6.36e-01
GOCC MITOCHONDRIAL ENVELOPE	747	1.17e-24	3.51e-22	0.2730	2.45e-02	9.61e-03	-1.54e-01	-2.23e-01	1.95e-02	2.55e-01	6.55e-01	7.43e-13	3.03e-25	3.64e-01
GOMF MHC PROTEIN COMPLEX BINDING	34	1.86e-01	5.30e-01	0.2730	-2.50e-01	-5.75e-02	-5.48e-02	-7.27e-02	1.16e-02	1.15e-02	5.62e-01	5.81e-01	4.63e-01	9.07e-01
GOBP REGULATION OF LAMELLIPODIUM MORPHOGENESIS	11	8.11e-01	9.38e-01	0.2730	2.21e-02	1.64e-01	2.15e-01	1.45e-02	2.33e-02	8.99e-01	3.45e-01	2.17e-01	9.33e-01	8.94e-01
GOBP SENSORY PERCEPTION OF SWEET TASTE	7	8.90e-01	9.63e-01	0.2730	3.18e-02	-5.11e-02	2.56e-01	6.49e-02	-2.90e-02	8.84e-01	8.15e-01	2.40e-01	7.66e-01	8.94e-01
GOCC INHIBITORY SYNAPSE	14	4.55e-01	7.74e-01	0.2730	-2.41e-02	-1.24e-02	8.64e-02	-2.57e-01	-9.46e-03	8.76e-01	9.36e-01	5.76e-01	9.57e-02	9.51e-01
GOBP POSTSYNAPTIC DENSITY PROTEIN 95 CLUSTERING	9	8.40e-01	9.47e-01	0.2730	-5.38e-02	-5.12e-02	2.20e-01	2.04e-02	1.41e-01	7.80e-01	7.90e-01	2.53e-01	9.16e-01	4.63e-01
GOBP REGULATION OF ANOIKIS	24	5.06e-01	8.06e-01	0.2730	1.54e-01	-7.64e-02	-1.83e-01	-9.54e-02	4.92e-02	1.93e-01	5.17e-01	1.21e-01	4.19e-01	6.77e-01
GOBP NEGATIVE REGULATION OF TELOMERE CAPPING	8	9.06e-01	9.69e-01	0.2730	-5.48e-02	-1.28e-01	-2.16e-01	-4.66e-02	-7.87e-02	7.88e-01	5.30e-01	2.91e-01	8.20e-01	7.00e-01
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS	23	4.40e-01	7.63e-01	0.2730	-1.25e-01	-1.69e-01	-8.41e-02	-8.54e-02	1.25e-01	3.00e-01	1.59e-01	4.85e-01	4.78e-01	2.99e-01
GOBP RESPONSE TO HEPATOCYTE GROWTH FACTOR	17	6.26e-01	8.67e-01	0.2730	-8.46e-02	1.56e-01	1.35e-01	9.90e-02	1.22e-01	5.46e-01	2.66e-01	3.36e-01	4.80e-01	3.83e-01
GOBP ANTIBACTERIAL HUMORAL RESPONSE	60	3.24e-02	1.93e-01	0.2730	-7.77e-02	-1.64e-01	1.29e-01	1.15e-01	-1.07e-01	2.98e-01	2.81e-02	8.42e-02	1.23e-01	1.51e-01
GOBP ATRIOVENTRICULAR CANAL DEVELOPMENT	13	7.45e-01	9.14e-01	0.2730	6.66e-05	1.86e-01	8.60e-02	-7.81e-02	1.62e-01	1.00e+00	2.46e-01	5.91e-01	6.26e-01	3.12e-01
GOBP INTESTINAL EPITHELIAL CELL DEVELOPMENT	17	4.11e-01	7.43e-01	0.2720	6.58e-02	1.58e-02	2.48e-01	-6.74e-02	6.01e-02	6.39e-01	9.10e-01	7.66e-02	6.30e-01	6.68e-01
GOBP RESPONSE TO GLYCOPROTEIN	11	7.19e-01	9.02e-01	0.2720	-7.14e-02	-5.08e-02	8.52e-02	-1.88e-01	1.55e-01	6.82e-01	7.70e-01	6.25e-01	2.80e-01	3.74e-01
GOBP PROTEIN DNA COMPLEX ASSEMBLY	200	4.32e-06	1.59e-04	0.2720	4.61e-02	-8.96e-02	-1.55e-01	-1.85e-01	7.47e-02	2.61e-01	2.89e-02	1.53e-04	6.15e-06	6.86e-02
GOCC NUCLEOTIDE ACTIVATED PROTEIN KINASE COMPLEX	15	6.45e-01	8.75e-01	0.2720	-7.77e-02	-8.82e-03	-9.17e-02	-8.05e-02	2.31e-01	6.02e-01	9.53e-01	5.39e-01	5.89e-01	1.22e-01
GOBP COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE	24	4.92e-01	7.99e-01	0.2720	1.33e-01	7.54e-02	-1.04e-01	-1.98e-01	3.05e-02	2.61e-01	5.22e-01	3.79e-01	9.29e-02	7.96e-01
GOBP REGULATION OF MICROTUBULE NUCLEATION	17	6.98e-01	8.95e-01	0.2720	-1.65e-02	8.60e-02	-1.68e-01	-1.96e-01	-1.73e-03	9.06e-01	5.39e-01	2.30e-01	1.63e-01	9.90e-01
GOBP POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE	11	7.95e-01	9.32e-01	0.2720	-3.80e-02	-8.72e-02	-1.09e-01	1.07e-01	-2.04e-01	8.27e-01	6.16e-01	5.30e-01	5.40e-01	2.41e-01
GOBP TRICARBOXYLIC ACID CYCLE	29	3.89e-01	7.25e-01	0.2720	1.13e-01	-4.77e-03	-1.87e-01	-1.43e-01	-7.63e-02	2.91e-01	9.65e-01	8.17e-02	1.81e-01	4.77e-01
GOBP CGMP MEDIATED SIGNALING	30	1.91e-01	5.37e-01	0.2720	1.04e-01	-3.76e-02	1.79e-02	2.43e-01	4.70e-02	3.23e-01	7.22e-01	8.65e-01	2.10e-02	6.56e-01
GOBP NEGATIVE REGULATION OF CENTROSOME DUPLICATION	12	7.39e-01	9.11e-01	0.2720	1.84e-01	1.09e-01	1.20e-02	8.11e-02	1.46e-01	2.69e-01	5.12e-01	9.42e-01	6.27e-01	3.80e-01
GOBP EPITHELIAL CELL MATURATION	24	3.30e-01	6.78e-01	0.2720	5.59e-02	-1.30e-02	-3.25e-02	-2.63e-01	1.70e-02	6.35e-01	9.12e-01	7.83e-01	2.55e-02	8.85e-01
GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY	110	1.03e-03	1.59e-02	0.2720	1.64e-03	3.07e-02	-1.15e-01	-2.45e-01	-2.26e-03	9.76e-01	5.77e-01	3.65e-02	9.35e-06	9.67e-01
GOBP MICROVILLUS ORGANIZATION	28	3.71e-01	7.11e-01	0.2720	-1.42e-01	1.34e-01	7.91e-02	9.96e-02	-1.41e-01	1.95e-01	2.18e-01	4.69e-01	3.62e-01	1.98e-01
GOBP PYRAMIDAL NEURON DIFFERENTIATION	12	7.76e-01	9.26e-01	0.2720	-1.99e-01	-7.93e-02	1.25e-01	8.34e-02	7.48e-02	2.33e-01	6.34e-01	4.53e-01	6.17e-01	6.54e-01
GOBP REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY	63	2.40e-02	1.58e-01	0.2720	-3.21e-02	1.98e-01	1.16e-01	4.35e-03	1.42e-01	6.59e-01	6.55e-03	1.11e-01	9.52e-01	5.08e-02
GOBP METANEPHROS MORPHOGENESIS	30	1.33e-01	4.50e-01	0.2720	7.85e-02	3.55e-02	6.84e-02	-2.42e-01	5.86e-02	4.57e-01	7.36e-01	5.17e-01	2.20e-02	5.78e-01
GOBP TYPE B PANCREATIC CELL PROLIFERATION	27	4.16e-01	7.46e-01	0.2720	-3.61e-02	1.13e-01	-1.18e-01	-1.87e-01	1.04e-01	7.46e-01	3.09e-01	2.89e-01	9.18e-02	3.51e-01
GOBP ATRIAL CARDIAC MUSCLE TISSUE MORPHOGENESIS	6	9.18e-01	9.74e-01	0.2720	-7.45e-03	-1.26e-01	-5.30e-02	4.36e-02	2.31e-01	9.75e-01	5.93e-01	8.22e-01	8.53e-01	3.28e-01
GOBP LYMPHOCYTE COSTIMULATION	46	1.40e-01	4.60e-01	0.2720	-1.01e-01	1.24e-01	1.49e-01	1.60e-01	1.79e-02	2.37e-01	1.44e-01	8.07e-02	5.99e-02	8.34e-01
GOMF NUCLEOTIDYLTRANSFERASE ACTIVITY	137	4.71e-04	8.48e-03	0.2720	6.64e-02	-6.93e-02	-1.93e-01	-1.65e-01	-7.59e-03	1.80e-01	1.61e-01	9.63e-05	8.39e-04	8.78e-01
GOBP REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL	10	8.18e-01	9.41e-01	0.2720	-3.12e-02	2.42e-01	-7.20e-02	-9.41e-02	4.32e-03	8.64e-01	1.84e-01	6.93e-01	6.06e-01	9.81e-01
GOBP MULTIVESICULAR BODY ORGANIZATION	32	3.96e-01	7.29e-01	0.2720	2.48e-02	1.17e-02	-1.89e-01	-1.91e-01	3.04e-02	8.08e-01	9.09e-01	6.45e-02	6.16e-02	7.66e-01
GOBP N TERMINAL PROTEIN AMINO ACID MODIFICATION	27	2.99e-01	6.53e-01	0.2720	1.17e-01	1.65e-01	-2.40e-02	-1.68e-01	-6.30e-02	2.92e-01	1.38e-01	8.29e-01	1.30e-01	5.71e-01
GOBP BERGMANN GLIAL CELL DIFFERENTIATION	11	8.13e-01	9.39e-01	0.2720	-1.93e-01	2.39e-02	-9.84e-02	-1.62e-01	-1.57e-02	2.69e-01	8.91e-01	5.72e-01	3.53e-01	9.28e-01
GOBP SODIUM ION IMPORT ACROSS PLASMA MEMBRANE	23	4.81e-01	7.92e-01	0.2720	-3.01e-02	2.28e-01	1.41e-01	2.95e-02	8.79e-03	8.03e-01	5.83e-02	2.42e-01	8.07e-01	9.42e-01
GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION	38	1.68e-01	5.04e-01	0.2720	-6.10e-04	1.62e-01	1.67e-01	-3.15e-02	1.37e-01	9.95e-01	8.49e-02	7.56e-02	7.37e-01	1.43e-01
GOMF CARGO RECEPTOR ACTIVITY	63	2.73e-02	1.72e-01	0.2710	-1.12e-01	9.06e-02	3.00e-02	1.59e-01	-1.63e-01	1.23e-01	2.14e-01	6.80e-01	2.86e-02	2.53e-02
GOMF BASIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY	17	6.59e-01	8.80e-01	0.2710	-1.82e-01	-9.76e-03	1.19e-01	7.23e-02	-1.45e-01	1.94e-01	9.44e-01	3.97e-01	6.06e-01	2.99e-01
GOBP POSITIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS	10	8.29e-01	9.44e-01	0.2710	1.13e-01	-7.55e-02	-2.07e-01	7.29e-03	-1.10e-01	5.36e-01	6.79e-01	2.56e-01	9.68e-01	5.47e-01
GOCC ENDOPLASMIC RETICULUM EXIT SITE	28	2.22e-01	5.76e-01	0.2710	2.51e-01	-5.25e-02	2.24e-02	-1.20e-02	-8.47e-02	2.15e-02	6.31e-01	8.37e-01	9.12e-01	4.38e-01
GOBP SNRNA CATABOLIC PROCESS	5	9.63e-01	9.90e-01	0.2710	-1.66e-01	-1.98e-02	-1.27e-01	-1.27e-01	-1.15e-01	5.20e-01	9.39e-01	6.23e-01	6.22e-01	6.55e-01
GOMF FATTY ACID BINDING	47	1.28e-01	4.42e-01	0.2710	-8.83e-02	1.59e-01	1.17e-01	1.44e-01	-7.91e-02	2.95e-01	5.99e-02	1.64e-01	8.86e-02	3.48e-01
GOBP GOLGI LOCALIZATION	14	6.68e-01	8.83e-01	0.2710	7.82e-02	-5.15e-02	5.37e-02	-1.63e-01	1.88e-01	6.12e-01	7.39e-01	7.28e-01	2.92e-01	2.22e-01
GOMF FOUR WAY JUNCTION DNA BINDING	16	6.38e-01	8.73e-01	0.2710	-6.59e-02	1.16e-01	-7.81e-02	-1.20e-01	1.88e-01	6.48e-01	4.20e-01	5.89e-01	4.07e-01	1.94e-01
GOBP CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION	15	6.43e-01	8.75e-01	0.2710	-7.73e-03	3.70e-02	3.29e-02	2.07e-02	-2.66e-01	9.59e-01	8.04e-01	8.25e-01	8.89e-01	7.48e-02
GOMF CHROMATIN PROTEIN ADAPTOR ACTIVITY	14	8.02e-01	9.34e-01	0.2710	1.13e-01	-1.93e-02	-1.57e-01	-1.48e-01	1.18e-01	4.65e-01	9.01e-01	3.11e-01	3.36e-01	4.45e-01
GOCC TRANSCRIPTION REGULATOR COMPLEX	481	3.56e-17	5.52e-15	0.2710	6.45e-02	1.05e-01	-6.43e-02	-2.09e-01	1.03e-01	1.53e-02	8.31e-05	1.57e-02	3.84e-15	1.15e-04
GOCC GROWTH CONE MEMBRANE	8	8.48e-01	9.49e-01	0.2710	-1.90e-01	-5.73e-02	-1.67e-01	5.11e-02	-6.10e-02	3.52e-01	7.79e-01	4.14e-01	8.02e-01	7.65e-01
GOCC WNT SIGNALOSOME	13	4.19e-01	7.48e-01	0.2710	-3.70e-02	-1.20e-01	1.67e-01	-1.57e-01	-7.12e-02	8.17e-01	4.53e-01	2.99e-01	3.26e-01	6.57e-01
GOMF NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY	28	3.70e-01	7.10e-01	0.2710	5.88e-02	4.26e-02	-8.96e-02	-2.45e-01	1.59e-02	5.90e-01	6.97e-01	4.12e-01	2.51e-02	8.84e-01
GOBP GLUCOSE 6 PHOSPHATE METABOLIC PROCESS	27	1.92e-01	5.38e-01	0.2710	7.76e-02	1.42e-01	-2.15e-01	-6.53e-03	2.97e-02	4.85e-01	2.00e-01	5.34e-02	9.53e-01	7.89e-01
GOBP PROSTATE GLANDULAR ACINUS DEVELOPMENT	10	7.96e-01	9.32e-01	0.2710	1.00e-01	-8.45e-02	2.04e-01	3.50e-02	1.15e-01	5.83e-01	6.44e-01	2.64e-01	8.48e-01	5.29e-01
GOBP GLYCOSYLCERAMIDE METABOLIC PROCESS	16	6.00e-01	8.52e-01	0.2710	-1.89e-01	-6.41e-02	2.49e-02	-5.61e-02	-1.72e-01	1.90e-01	6.57e-01	8.63e-01	6.98e-01	2.33e-01
GOBP RESPONSE TO AUDITORY STIMULUS	31	3.33e-01	6.81e-01	0.2710	3.39e-02	-3.61e-02	7.55e-02	1.81e-01	-1.80e-01	7.44e-01	7.28e-01	4.67e-01	8.09e-02	8.32e-02
GOBP PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT	24	4.32e-01	7.56e-01	0.2710	1.28e-01	7.13e-02	1.71e-01	2.37e-02	1.49e-01	2.79e-01	5.45e-01	1.48e-01	8.41e-01	2.06e-01
GOBP INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY	6	9.46e-01	9.82e-01	0.2710	4.27e-02	-2.20e-01	-9.58e-02	-5.08e-02	1.06e-01	8.56e-01	3.51e-01	6.84e-01	8.29e-01	6.53e-01
GOBP POSITIVE REGULATION OF CHROMOSOME SEGREGATION	27	4.58e-01	7.77e-01	0.2710	1.43e-01	4.18e-02	-1.07e-01	-1.53e-01	1.28e-01	1.98e-01	7.07e-01	3.38e-01	1.70e-01	2.50e-01
GOMF LIPID PHOSPHATASE ACTIVITY	19	2.91e-01	6.45e-01	0.2700	-1.34e-01	-1.22e-02	1.44e-01	-1.59e-01	-9.50e-02	3.12e-01	9.27e-01	2.77e-01	2.30e-01	4.73e-01
GOBP REGULATION OF SKELETAL MUSCLE CONTRACTION	15	6.71e-01	8.83e-01	0.2700	1.92e-01	1.05e-01	-1.29e-01	-5.49e-02	-7.52e-02	1.99e-01	4.80e-01	3.87e-01	7.13e-01	6.14e-01
GOCC ENDOLYSOSOME	26	2.70e-01	6.24e-01	0.2700	3.66e-02	1.62e-01	1.15e-02	-1.92e-01	-9.19e-02	7.47e-01	1.53e-01	9.19e-01	8.97e-02	4.17e-01
GOBP PARTURITION	14	5.31e-01	8.19e-01	0.2700	2.26e-01	-4.34e-02	7.14e-02	-9.77e-02	-7.37e-02	1.43e-01	7.79e-01	6.44e-01	5.27e-01	6.33e-01
GOCC ACROSOMAL MEMBRANE	32	8.04e-02	3.42e-01	0.2700	-9.66e-02	3.61e-02	7.40e-02	-2.12e-01	-1.10e-01	3.44e-01	7.24e-01	4.69e-01	3.79e-02	2.83e-01
GOBP WOUND HEALING SPREADING OF EPIDERMAL CELLS	21	3.96e-01	7.30e-01	0.2700	8.44e-02	1.45e-01	2.84e-02	1.12e-01	1.78e-01	5.03e-01	2.50e-01	8.22e-01	3.74e-01	1.59e-01
GOBP CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION	12	6.47e-01	8.76e-01	0.2700	1.01e-02	1.26e-01	4.72e-02	-2.08e-01	-1.07e-01	9.52e-01	4.49e-01	7.77e-01	2.12e-01	5.20e-01
GOBP REGULATION OF EPIDERMIS DEVELOPMENT	66	4.94e-03	5.32e-02	0.2700	-1.58e-02	1.32e-01	7.81e-02	-2.18e-01	4.32e-02	8.24e-01	6.45e-02	2.72e-01	2.20e-03	5.44e-01
GOBP POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS	21	3.41e-01	6.88e-01	0.2700	-7.41e-02	7.54e-02	-1.82e-01	-4.29e-02	1.64e-01	5.56e-01	5.50e-01	1.50e-01	7.34e-01	1.92e-01
GOBP TRANSPOSITION	38	1.15e-01	4.14e-01	0.2700	-1.15e-01	-6.54e-02	1.96e-01	-2.96e-03	1.30e-01	2.21e-01	4.85e-01	3.61e-02	9.75e-01	1.65e-01
GOBP CELL AGGREGATION	23	4.37e-01	7.60e-01	0.2700	-1.54e-02	-8.55e-02	1.95e-01	7.16e-02	1.49e-01	8.98e-01	4.78e-01	1.06e-01	5.52e-01	2.15e-01
GOMF POLYPEPTIDE N ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY	19	6.55e-01	8.80e-01	0.2700	5.81e-02	-5.23e-02	1.56e-01	1.97e-01	-5.92e-02	6.61e-01	6.93e-01	2.39e-01	1.36e-01	6.55e-01
GOBP SEMINIFEROUS TUBULE DEVELOPMENT	14	4.69e-01	7.84e-01	0.2700	8.52e-02	5.99e-02	1.36e-01	-2.09e-01	-2.18e-03	5.81e-01	6.98e-01	3.77e-01	1.76e-01	9.89e-01
GOMF DNA BINDING TRANSCRIPTION ACTIVATOR ACTIVITY	452	3.45e-17	5.43e-15	0.2700	4.90e-02	5.76e-02	-3.38e-02	-2.30e-01	1.16e-01	7.44e-02	3.59e-02	2.18e-01	5.53e-17	2.53e-05
GOCC CHROMOSOME CENTROMERIC REGION	242	6.77e-08	3.94e-06	0.2700	1.40e-01	-3.61e-02	-1.17e-01	-1.86e-01	6.08e-02	1.82e-04	3.33e-01	1.67e-03	6.07e-07	1.03e-01
GOBP ACETATE ESTER TRANSPORT	9	8.20e-01	9.42e-01	0.2700	1.69e-01	-1.55e-01	9.94e-02	-9.04e-03	1.01e-01	3.80e-01	4.21e-01	6.06e-01	9.63e-01	5.98e-01
GOMF GENERAL TRANSCRIPTION INITIATION FACTOR BINDING	52	1.31e-01	4.47e-01	0.2700	6.92e-02	-1.08e-01	-1.56e-01	-1.59e-01	8.19e-02	3.88e-01	1.79e-01	5.13e-02	4.69e-02	3.07e-01
GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION	31	2.02e-01	5.53e-01	0.2700	8.75e-02	2.24e-01	-1.15e-01	-4.02e-02	1.65e-02	3.99e-01	3.12e-02	2.66e-01	6.98e-01	8.74e-01
GOBP RESPONSE TO DOPAMINE	70	2.50e-02	1.62e-01	0.2700	1.84e-02	1.55e-01	2.05e-01	5.86e-02	5.59e-02	7.91e-01	2.51e-02	3.02e-03	3.96e-01	4.18e-01
GOBP APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT	42	1.17e-01	4.18e-01	0.2700	9.65e-02	-5.48e-02	8.84e-03	-1.72e-01	1.76e-01	2.79e-01	5.39e-01	9.21e-01	5.44e-02	4.82e-02
GOCC BRCA1 C COMPLEX	6	9.35e-01	9.80e-01	0.2700	2.60e-01	1.77e-02	-6.23e-02	1.87e-02	2.48e-02	2.70e-01	9.40e-01	7.92e-01	9.37e-01	9.16e-01
GOBP POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVITY	14	7.48e-01	9.15e-01	0.2700	1.30e-01	7.59e-02	-5.34e-03	-8.86e-02	2.05e-01	3.99e-01	6.23e-01	9.72e-01	5.66e-01	1.83e-01
GOBP REGULATION OF HOMOTYPIC CELL CELL ADHESION	34	1.93e-01	5.41e-01	0.2700	2.66e-02	1.79e-01	1.89e-01	-5.22e-03	-6.48e-02	7.88e-01	7.05e-02	5.65e-02	9.58e-01	5.13e-01
GOCC DNA POLYMERASE COMPLEX	18	5.84e-01	8.45e-01	0.2700	1.59e-01	2.69e-02	-1.61e-01	-4.49e-02	1.37e-01	2.41e-01	8.44e-01	2.38e-01	7.41e-01	3.14e-01
GOBP LUNG EPITHELIUM DEVELOPMENT	44	8.79e-02	3.59e-01	0.2700	-1.20e-01	2.14e-01	1.65e-02	-9.96e-02	-4.99e-02	1.68e-01	1.42e-02	8.50e-01	2.53e-01	5.67e-01
GOCC NUCLEAR SPECK	395	1.05e-12	1.19e-10	0.2700	3.59e-02	1.78e-02	-1.23e-01	-2.27e-01	6.86e-02	2.20e-01	5.45e-01	2.82e-05	1.03e-14	1.93e-02
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL CORTEX	6	9.30e-01	9.78e-01	0.2700	8.84e-02	1.54e-01	1.86e-01	6.75e-03	-8.04e-02	7.08e-01	5.14e-01	4.30e-01	9.77e-01	7.33e-01
GOBP DNA REPAIR	561	1.88e-17	3.05e-15	0.2700	4.05e-02	-1.33e-02	-1.50e-01	-2.12e-01	5.84e-02	1.01e-01	5.91e-01	1.14e-09	9.03e-18	1.80e-02
GOBP AORTA MORPHOGENESIS	38	1.67e-01	5.04e-01	0.2690	6.38e-02	1.26e-01	7.49e-02	8.65e-03	2.17e-01	4.96e-01	1.79e-01	4.24e-01	9.26e-01	2.08e-02
GOBP POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING	21	5.22e-01	8.15e-01	0.2690	-4.63e-03	-3.90e-02	2.73e-02	2.35e-01	-1.23e-01	9.71e-01	7.57e-01	8.28e-01	6.24e-02	3.29e-01
GOBP MESENCHYME MORPHOGENESIS	60	2.84e-02	1.77e-01	0.2690	1.04e-01	6.26e-02	-9.98e-03	-2.22e-01	9.17e-02	1.64e-01	4.01e-01	8.94e-01	2.91e-03	2.19e-01
GOBP VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT	58	2.08e-02	1.45e-01	0.2690	2.43e-01	2.02e-03	-9.52e-02	6.07e-02	3.10e-02	1.40e-03	9.79e-01	2.10e-01	4.24e-01	6.83e-01
GOBP MOTOR BEHAVIOR	22	4.13e-01	7.44e-01	0.2690	1.10e-01	5.98e-02	-5.10e-02	-2.26e-01	-5.77e-02	3.71e-01	6.27e-01	6.79e-01	6.69e-02	6.39e-01
GOBP ESTABLISHMENT OF SPINDLE ORIENTATION	42	2.39e-01	5.95e-01	0.2690	1.09e-01	-3.63e-02	-1.74e-01	-1.68e-01	2.34e-02	2.20e-01	6.84e-01	5.08e-02	5.90e-02	7.93e-01
GOBP ENDOSOME TO LYSOSOME TRANSPORT	70	2.42e-02	1.59e-01	0.2690	6.80e-02	1.21e-01	-3.45e-02	-1.77e-01	1.44e-01	3.25e-01	8.01e-02	6.17e-01	1.03e-02	3.78e-02
GOCC MEIOTIC SPINDLE	15	6.16e-01	8.60e-01	0.2690	-1.10e-01	1.32e-01	6.32e-02	6.35e-02	1.87e-01	4.60e-01	3.75e-01	6.72e-01	6.70e-01	2.11e-01
GOBP SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT	40	2.56e-01	6.13e-01	0.2690	-2.82e-02	5.88e-02	1.60e-01	2.06e-01	-3.62e-03	7.58e-01	5.20e-01	7.91e-02	2.41e-02	9.68e-01
GOBP LENS FIBER CELL MORPHOGENESIS	6	8.75e-01	9.59e-01	0.2690	-1.46e-01	-6.04e-02	7.46e-02	-1.88e-01	-8.08e-02	5.35e-01	7.98e-01	7.52e-01	4.25e-01	7.32e-01
GOBP REGULATION OF PEPTIDYL LYSINE ACETYLATION	28	3.43e-01	6.90e-01	0.2690	2.12e-01	8.27e-02	-4.15e-02	-1.35e-01	3.17e-02	5.27e-02	4.49e-01	7.04e-01	2.18e-01	7.72e-01
GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE SIGNAL SEQUENCE RECOGNITION	6	9.36e-01	9.80e-01	0.2690	2.25e-01	-7.13e-02	1.92e-02	8.14e-02	9.95e-02	3.41e-01	7.62e-01	9.35e-01	7.30e-01	6.73e-01
GOBP DERMATAN SULFATE METABOLIC PROCESS	8	8.91e-01	9.63e-01	0.2690	-5.03e-02	1.05e-01	-6.02e-02	-2.32e-01	-3.67e-02	8.06e-01	6.05e-01	7.68e-01	2.56e-01	8.57e-01
GOMF PHOSPHATIDYLCHOLINE FLIPPASE ACTIVITY	5	8.96e-01	9.66e-01	0.2690	-5.72e-02	-8.17e-02	-1.36e-01	2.06e-01	3.96e-02	8.25e-01	7.52e-01	5.99e-01	4.25e-01	8.78e-01
GOBP DORSAL VENTRAL PATTERN FORMATION	97	1.77e-03	2.45e-02	0.2690	-1.29e-02	7.19e-02	-2.39e-02	-2.29e-01	1.19e-01	8.27e-01	2.21e-01	6.85e-01	9.73e-05	4.36e-02
GOBP CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL	18	6.03e-01	8.55e-01	0.2690	-1.49e-01	-1.44e-01	6.41e-02	1.57e-01	2.76e-02	2.74e-01	2.90e-01	6.38e-01	2.50e-01	8.39e-01
GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY	26	2.70e-01	6.24e-01	0.2690	2.26e-02	-9.26e-02	-6.62e-02	-2.11e-01	-1.20e-01	8.42e-01	4.14e-01	5.59e-01	6.26e-02	2.91e-01
GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE	32	3.76e-01	7.15e-01	0.2690	4.29e-02	7.83e-02	-1.55e-01	-2.00e-01	2.25e-02	6.74e-01	4.44e-01	1.30e-01	5.07e-02	8.26e-01
GOMF PROTEIN KINASE C ACTIVITY	16	6.54e-01	8.79e-01	0.2690	-1.04e-01	2.20e-01	9.52e-02	-8.52e-03	6.25e-02	4.72e-01	1.28e-01	5.10e-01	9.53e-01	6.65e-01
GOBP MYELOID DENDRITIC CELL DIFFERENTIATION	20	5.36e-01	8.22e-01	0.2690	-5.07e-02	1.33e-01	1.00e-02	1.18e-01	-1.94e-01	6.95e-01	3.02e-01	9.38e-01	3.61e-01	1.32e-01
GOBP MITOCHONDRIAL TRANSPORT	180	2.57e-05	7.66e-04	0.2690	2.39e-02	3.16e-02	-1.55e-01	-2.11e-01	4.38e-02	5.80e-01	4.65e-01	3.21e-04	1.04e-06	3.11e-01
GOBP RESPONSE TO COPPER ION	35	2.12e-01	5.65e-01	0.2690	-1.43e-01	8.43e-02	-1.00e-01	-1.54e-01	-1.05e-01	1.43e-01	3.88e-01	3.05e-01	1.16e-01	2.83e-01
GOBP MIRNA MEDIATED GENE SILENCING BY MRNA DESTABILIZATION	61	1.23e-02	1.02e-01	0.2690	-1.08e-01	-1.17e-01	2.11e-01	2.30e-02	4.24e-02	1.44e-01	1.15e-01	4.38e-03	7.56e-01	5.67e-01
GOMF HEPARAN SULFATE PROTEOGLYCAN BINDING	18	6.21e-01	8.64e-01	0.2690	-1.09e-01	-1.68e-02	2.16e-01	8.14e-02	-8.24e-02	4.22e-01	9.02e-01	1.13e-01	5.50e-01	5.45e-01
GOBP ESTABLISHMENT OF RNA LOCALIZATION	146	6.42e-05	1.67e-03	0.2690	-1.18e-02	-2.58e-02	-1.15e-01	-2.41e-01	-2.89e-03	8.06e-01	5.91e-01	1.61e-02	5.05e-07	9.52e-01
GOBP REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY	21	5.43e-01	8.25e-01	0.2690	2.07e-02	-7.23e-02	9.82e-02	1.36e-01	-1.96e-01	8.70e-01	5.66e-01	4.36e-01	2.80e-01	1.21e-01
GOBP CELLULAR RESPIRATION	216	1.48e-06	6.31e-05	0.2690	6.38e-02	-4.21e-02	-1.44e-01	-2.10e-01	3.68e-02	1.06e-01	2.87e-01	2.59e-04	1.02e-07	3.52e-01
GOBP VIRAL BUDDING	25	5.57e-01	8.32e-01	0.2680	7.08e-02	-1.23e-02	-1.97e-01	-1.64e-01	3.53e-02	5.40e-01	9.15e-01	8.86e-02	1.55e-01	7.60e-01
GOBP RESPONSE TO 2 3 7 8 TETRACHLORODIBENZODIOXINE	5	9.56e-01	9.87e-01	0.2680	-1.51e-01	7.45e-02	2.92e-02	-1.43e-01	1.50e-01	5.58e-01	7.73e-01	9.10e-01	5.80e-01	5.63e-01
GOBP REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS	28	2.91e-01	6.45e-01	0.2680	1.86e-01	1.26e-01	-1.67e-02	3.89e-02	1.40e-01	8.86e-02	2.47e-01	8.79e-01	7.22e-01	1.99e-01
GOBP T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE	82	3.97e-03	4.53e-02	0.2680	-1.26e-01	2.29e-01	5.31e-02	-2.12e-02	-1.74e-02	4.84e-02	3.35e-04	4.06e-01	7.40e-01	7.86e-01
GOBP REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION	12	7.70e-01	9.24e-01	0.2680	-1.22e-01	1.67e-01	8.40e-02	-5.82e-02	1.36e-01	4.64e-01	3.16e-01	6.15e-01	7.27e-01	4.13e-01
GOMF TRANSMEMBRANE EPHRIN RECEPTOR ACTIVITY	15	5.92e-01	8.47e-01	0.2680	9.26e-02	1.83e-02	1.55e-01	3.93e-02	-1.94e-01	5.35e-01	9.02e-01	2.99e-01	7.92e-01	1.94e-01
GOBP EMBRYONIC SKELETAL SYSTEM DEVELOPMENT	126	2.63e-04	5.26e-03	0.2680	1.34e-01	6.33e-02	-8.53e-04	-1.30e-01	1.82e-01	9.28e-03	2.20e-01	9.87e-01	1.18e-02	4.29e-04
GOCC ACETYLCHOLINE GATED CHANNEL COMPLEX	15	6.82e-01	8.88e-01	0.2680	-1.72e-01	-7.32e-02	-1.52e-01	-8.60e-02	7.98e-02	2.48e-01	6.23e-01	3.09e-01	5.64e-01	5.92e-01
GOBP T CELL MEDIATED CYTOTOXICITY	57	2.62e-02	1.67e-01	0.2680	-2.00e-01	-2.70e-02	1.65e-01	-1.39e-03	-6.27e-02	8.89e-03	7.24e-01	3.16e-02	9.86e-01	4.13e-01
GOCC ROUGH ENDOPLASMIC RETICULUM	55	8.67e-02	3.56e-01	0.2680	4.37e-02	1.08e-01	-9.20e-02	-2.10e-01	7.52e-02	5.75e-01	1.67e-01	2.38e-01	6.98e-03	3.35e-01
GOBP REGULATION OF DNA RECOMBINATION	128	1.06e-03	1.62e-02	0.2680	1.15e-01	-1.59e-02	-1.48e-01	-1.67e-01	9.25e-02	2.40e-02	7.55e-01	3.95e-03	1.09e-03	7.08e-02
GOBP ADHERENS JUNCTION ASSEMBLY	13	7.56e-01	9.18e-01	0.2680	6.89e-02	4.39e-02	3.32e-02	-1.73e-01	1.85e-01	6.67e-01	7.84e-01	8.36e-01	2.81e-01	2.48e-01
GOBP CELLULAR RESPONSE TO GONADOTROPIN RELEASING HORMONE	5	9.65e-01	9.90e-01	0.2680	-2.15e-02	-6.77e-02	-2.39e-01	-5.70e-02	-7.87e-02	9.34e-01	7.93e-01	3.54e-01	8.25e-01	7.60e-01
GOBP POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS	21	4.21e-01	7.49e-01	0.2680	-2.29e-01	-3.40e-02	-2.14e-02	1.33e-01	-9.91e-03	6.92e-02	7.87e-01	8.65e-01	2.92e-01	9.37e-01
GOMF CATALYTIC ACTIVITY ACTING ON A NUCLEIC ACID	595	2.60e-18	4.67e-16	0.2680	8.40e-02	-2.63e-02	-1.60e-01	-1.93e-01	3.47e-02	4.67e-04	2.73e-01	2.25e-11	9.43e-16	1.49e-01
GOBP POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY	17	7.16e-01	9.01e-01	0.2680	9.21e-02	3.56e-02	-8.93e-02	-1.59e-01	1.69e-01	5.11e-01	7.99e-01	5.24e-01	2.55e-01	2.27e-01
GOBP DETECTION OF CALCIUM ION	13	7.99e-01	9.33e-01	0.2680	-1.42e-01	1.46e-01	1.43e-01	7.23e-02	-6.61e-02	3.74e-01	3.61e-01	3.72e-01	6.52e-01	6.80e-01
GOBP BILE ACID BIOSYNTHETIC PROCESS	36	2.67e-01	6.23e-01	0.2680	-1.47e-01	5.49e-02	7.14e-02	1.47e-01	-1.42e-01	1.26e-01	5.68e-01	4.58e-01	1.26e-01	1.40e-01
GOCC FICOLIN 1 RICH GRANULE LUMEN	121	3.71e-04	7.09e-03	0.2680	-8.41e-02	1.25e-01	-1.24e-01	-1.76e-01	4.90e-02	1.10e-01	1.72e-02	1.84e-02	8.00e-04	3.52e-01
GOCC SODIUM POTASSIUM EXCHANGING ATPASE COMPLEX	11	8.21e-01	9.42e-01	0.2680	-9.15e-02	-2.30e-01	-8.20e-02	-5.74e-02	-2.23e-02	5.99e-01	1.87e-01	6.38e-01	7.42e-01	8.98e-01
GOBP CARDIAC MUSCLE CELL CONTRACTION	72	3.73e-02	2.11e-01	0.2680	-9.73e-02	2.10e-02	1.25e-01	2.04e-01	-6.70e-02	1.53e-01	7.58e-01	6.60e-02	2.78e-03	3.25e-01
GOMF T CELL RECEPTOR BINDING	11	6.18e-01	8.62e-01	0.2680	1.40e-01	-1.28e-01	1.55e-01	-1.01e-01	3.64e-02	4.22e-01	4.61e-01	3.73e-01	5.62e-01	8.35e-01
GOBP LAMELLIPODIUM MORPHOGENESIS	18	5.01e-01	8.03e-01	0.2680	8.06e-04	2.01e-01	1.18e-01	-1.17e-01	-6.25e-02	9.95e-01	1.41e-01	3.88e-01	3.92e-01	6.46e-01
GOBP CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT	16	6.59e-01	8.80e-01	0.2680	1.68e-01	9.04e-02	-3.45e-02	-1.83e-01	2.31e-02	2.45e-01	5.31e-01	8.11e-01	2.05e-01	8.73e-01
GOBP SISTER CHROMATID SEGREGATION	221	1.98e-07	1.09e-05	0.2670	1.04e-01	-5.00e-02	-9.03e-02	-2.10e-01	7.57e-02	7.59e-03	2.00e-01	2.07e-02	7.05e-08	5.24e-02
GOBP POSITIVE REGULATION OF MICROTUBULE NUCLEATION	7	9.36e-01	9.80e-01	0.2670	-1.13e-01	1.53e-01	1.53e-01	9.06e-02	5.88e-02	6.03e-01	4.83e-01	4.83e-01	6.78e-01	7.88e-01
GOMF CALCIUM MONOATOMIC CATION ANTIPORTER ACTIVITY	13	8.32e-01	9.45e-01	0.2670	-3.26e-02	2.91e-02	1.46e-01	2.19e-01	-1.91e-02	8.39e-01	8.56e-01	3.63e-01	1.72e-01	9.05e-01
GOBP MITOCHONDRIAL TRANSMEMBRANE TRANSPORT	59	4.44e-02	2.35e-01	0.2670	-6.46e-02	6.56e-02	-6.70e-02	-2.38e-01	4.47e-02	3.91e-01	3.84e-01	3.73e-01	1.60e-03	5.53e-01
GOBP CELLULAR RESPONSE TO AMYLOID BETA	44	1.94e-01	5.42e-01	0.2670	-5.44e-02	-2.71e-02	1.22e-01	1.59e-01	-1.66e-01	5.32e-01	7.56e-01	1.62e-01	6.76e-02	5.72e-02
GOMF SEQUENCE SPECIFIC DNA BINDING	1562	2.47e-57	2.29e-54	0.2670	7.55e-02	4.70e-03	-5.22e-02	-2.27e-01	1.06e-01	6.39e-07	7.57e-01	5.73e-04	4.11e-51	2.76e-12
GOBP MITOTIC NUCLEAR DIVISION	269	2.28e-08	1.48e-06	0.2670	1.17e-01	-2.64e-02	-1.26e-01	-1.94e-01	5.89e-02	9.42e-04	4.56e-01	3.82e-04	4.31e-08	9.66e-02
GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS	33	2.24e-01	5.77e-01	0.2670	1.05e-02	5.07e-02	5.17e-02	-1.80e-01	1.83e-01	9.17e-01	6.14e-01	6.07e-01	7.38e-02	6.82e-02
GOBP REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE	12	8.39e-01	9.47e-01	0.2670	-1.44e-01	9.18e-02	1.74e-01	8.90e-02	-6.31e-02	3.87e-01	5.82e-01	2.98e-01	5.93e-01	7.05e-01
GOBP SPERMATID NUCLEUS DIFFERENTIATION	27	3.78e-01	7.17e-01	0.2670	-1.58e-01	7.75e-03	-7.67e-02	-1.65e-01	1.15e-01	1.55e-01	9.44e-01	4.90e-01	1.38e-01	3.01e-01
GOCC A BAND	33	2.62e-01	6.19e-01	0.2670	5.48e-02	7.52e-02	3.33e-02	1.44e-01	-2.02e-01	5.86e-01	4.55e-01	7.40e-01	1.54e-01	4.44e-02
GOBP RESPONSE TO MITOCHONDRIAL DEPOLARISATION	19	6.04e-01	8.55e-01	0.2670	-7.33e-02	1.50e-01	-1.05e-01	-1.74e-01	4.53e-02	5.80e-01	2.58e-01	4.28e-01	1.89e-01	7.32e-01
GOMF NUCLEAR LOCALIZATION SEQUENCE BINDING	24	5.30e-01	8.19e-01	0.2670	1.86e-02	-1.38e-01	-1.58e-01	-1.56e-01	-4.76e-02	8.75e-01	2.42e-01	1.79e-01	1.85e-01	6.87e-01
GOBP LIPID OXIDATION	112	5.00e-04	8.85e-03	0.2670	1.04e-01	1.44e-01	-1.45e-01	-9.72e-02	9.47e-02	5.76e-02	8.25e-03	7.90e-03	7.57e-02	8.35e-02
GOBP REGULATION OF GRANULOCYTE DIFFERENTIATION	16	6.55e-01	8.80e-01	0.2670	2.21e-01	1.25e-01	7.09e-02	4.04e-02	7.06e-03	1.26e-01	3.88e-01	6.24e-01	7.79e-01	9.61e-01
GOMF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY	1361	2.49e-53	1.82e-50	0.2670	7.68e-02	1.29e-03	-2.58e-02	-2.26e-01	1.16e-01	2.00e-06	9.37e-01	1.10e-01	1.09e-44	7.11e-13
GOBP PLASMA MEMBRANE RAFT ASSEMBLY	7	9.18e-01	9.74e-01	0.2670	6.94e-02	-1.31e-02	5.58e-02	-1.37e-01	2.10e-01	7.51e-01	9.52e-01	7.98e-01	5.31e-01	3.35e-01
GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE	37	2.48e-01	6.05e-01	0.2670	-7.71e-02	-1.49e-01	7.22e-02	1.55e-01	-1.18e-01	4.17e-01	1.18e-01	4.47e-01	1.03e-01	2.16e-01
GOBP MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT	18	4.52e-01	7.72e-01	0.2670	1.66e-01	4.80e-02	1.03e-02	-1.91e-01	-6.81e-02	2.23e-01	7.25e-01	9.40e-01	1.60e-01	6.17e-01
GOBP LYMPHOID PROGENITOR CELL DIFFERENTIATION	24	5.25e-01	8.16e-01	0.2670	-5.49e-03	3.67e-02	-7.66e-02	-1.98e-01	1.56e-01	9.63e-01	7.56e-01	5.16e-01	9.25e-02	1.85e-01
GOCC POSTSYNAPTIC ENDOSOME	13	7.93e-01	9.31e-01	0.2670	6.37e-02	-4.84e-02	-1.12e-01	-2.28e-01	-1.30e-04	6.91e-01	7.63e-01	4.85e-01	1.54e-01	9.99e-01
GOMF LIGASE ACTIVITY FORMING CARBON OXYGEN BONDS	39	2.88e-01	6.42e-01	0.2670	1.05e-01	-6.82e-02	-1.68e-01	-1.62e-01	2.76e-02	2.56e-01	4.61e-01	6.89e-02	8.00e-02	7.66e-01
GOMF CYCLOHYDROLASE ACTIVITY	5	9.64e-01	9.90e-01	0.2660	1.45e-01	-4.74e-02	-5.52e-02	-3.26e-02	2.09e-01	5.74e-01	8.54e-01	8.31e-01	9.00e-01	4.19e-01
GOBP ETHER METABOLIC PROCESS	26	4.44e-01	7.67e-01	0.2660	1.97e-01	8.37e-02	-6.37e-02	-1.09e-01	9.57e-02	8.16e-02	4.60e-01	5.74e-01	3.37e-01	3.98e-01
GOBP REGULATION OF MYOSIN LIGHT CHAIN PHOSPHATASE ACTIVITY	7	9.20e-01	9.74e-01	0.2660	-7.35e-02	-2.04e-01	-3.89e-02	1.42e-01	-4.60e-02	7.36e-01	3.49e-01	8.59e-01	5.15e-01	8.33e-01
GOBP CELL PROLIFERATION IN HINDBRAIN	16	5.72e-01	8.39e-01	0.2660	-6.38e-02	-1.55e-01	-3.14e-02	-2.05e-01	-1.07e-02	6.58e-01	2.84e-01	8.28e-01	1.56e-01	9.41e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II	34	1.54e-01	4.82e-01	0.2660	-2.00e-01	6.77e-02	1.21e-01	-1.06e-01	1.27e-02	4.30e-02	4.95e-01	2.21e-01	2.84e-01	8.98e-01
GOBP PROTEIN PALMITOYLATION	28	2.49e-01	6.06e-01	0.2660	-2.07e-01	4.86e-02	8.83e-02	-1.31e-01	2.33e-02	5.76e-02	6.56e-01	4.19e-01	2.30e-01	8.31e-01
GOCC AP 2 ADAPTOR COMPLEX	10	6.53e-01	8.79e-01	0.2660	-7.30e-04	-1.78e-02	1.85e-01	-8.06e-02	-1.72e-01	9.97e-01	9.22e-01	3.10e-01	6.59e-01	3.46e-01
GOBP REGULATION OF NAD P H OXIDASE ACTIVITY	7	9.44e-01	9.82e-01	0.2660	4.47e-03	7.37e-02	2.07e-01	1.15e-01	-9.57e-02	9.84e-01	7.36e-01	3.42e-01	5.98e-01	6.61e-01
GOBP CAVEOLA ASSEMBLY	5	8.87e-01	9.62e-01	0.2660	-5.86e-02	-6.75e-02	2.04e-01	-1.45e-01	1.63e-02	8.20e-01	7.94e-01	4.31e-01	5.74e-01	9.50e-01
GOBP NUCLEAR EXPORT	156	5.82e-05	1.54e-03	0.2660	1.82e-02	6.71e-02	-1.25e-01	-2.24e-01	-1.05e-02	6.95e-01	1.48e-01	7.07e-03	1.36e-06	8.21e-01
GOMF NEUREXIN FAMILY PROTEIN BINDING	9	8.84e-01	9.61e-01	0.2660	7.41e-02	1.44e-01	9.71e-02	1.88e-01	-2.13e-03	7.00e-01	4.56e-01	6.14e-01	3.30e-01	9.91e-01
GOBP NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS	27	3.07e-01	6.60e-01	0.2660	5.32e-02	1.24e-01	-2.01e-01	-7.49e-02	8.15e-02	6.33e-01	2.64e-01	7.13e-02	5.01e-01	4.63e-01
GOCC NONHOMOLOGOUS END JOINING COMPLEX	9	8.44e-01	9.49e-01	0.2660	-8.06e-02	1.19e-01	-1.07e-01	-8.40e-02	1.77e-01	6.75e-01	5.35e-01	5.79e-01	6.62e-01	3.57e-01
GOBP CELLULAR EXTRAVASATION	71	1.65e-02	1.25e-01	0.2660	-1.50e-01	1.71e-01	1.37e-01	1.08e-03	-2.79e-04	2.92e-02	1.25e-02	4.55e-02	9.87e-01	9.97e-01
GOBP FATTY ACID BETA OXIDATION	74	1.20e-02	9.95e-02	0.2660	1.40e-01	1.34e-01	-1.45e-01	-8.11e-02	7.23e-02	3.73e-02	4.55e-02	3.06e-02	2.28e-01	2.83e-01
GOBP MYELOID LEUKOCYTE CYTOKINE PRODUCTION	50	5.02e-02	2.55e-01	0.2660	4.02e-03	2.35e-01	-1.02e-01	-6.64e-02	-1.94e-02	9.61e-01	3.97e-03	2.13e-01	4.17e-01	8.13e-01
GOCC TRANSFERASE COMPLEX	789	9.21e-25	2.94e-22	0.2660	5.77e-02	1.60e-02	-1.34e-01	-2.17e-01	4.66e-02	5.88e-03	4.45e-01	1.75e-10	3.65e-25	2.61e-02
GOCC ORGANELLE MEMBRANE CONTACT SITE	44	1.29e-01	4.44e-01	0.2660	-3.69e-02	1.82e-01	-3.76e-02	-1.51e-01	1.07e-01	6.72e-01	3.62e-02	6.66e-01	8.22e-02	2.18e-01
GOMF ATPASE REGULATOR ACTIVITY	47	1.97e-01	5.45e-01	0.2650	3.32e-02	1.53e-02	-1.48e-01	-2.11e-01	5.19e-02	6.94e-01	8.56e-01	7.88e-02	1.24e-02	5.38e-01
GOBP DNA LIGATION	16	7.55e-01	9.17e-01	0.2650	1.04e-01	6.33e-02	-1.50e-01	-1.50e-01	1.03e-01	4.70e-01	6.61e-01	2.99e-01	3.00e-01	4.75e-01
GOBP NEGATIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS	8	8.67e-01	9.56e-01	0.2650	-2.06e-01	4.06e-02	1.02e-01	-7.90e-02	-9.74e-02	3.12e-01	8.42e-01	6.16e-01	6.99e-01	6.33e-01
GOBP CEREBELLAR GRANULAR LAYER DEVELOPMENT	12	7.69e-01	9.24e-01	0.2650	1.96e-03	-2.17e-01	-4.02e-03	1.42e-01	5.57e-02	9.91e-01	1.93e-01	9.81e-01	3.93e-01	7.38e-01
GOBP PROTEIN N LINKED GLYCOSYLATION VIA ASPARAGINE	23	4.58e-01	7.76e-01	0.2650	-1.81e-03	-5.01e-02	-6.57e-02	-2.50e-01	3.54e-02	9.88e-01	6.77e-01	5.85e-01	3.82e-02	7.69e-01
GOBP PYRIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS	28	2.57e-01	6.14e-01	0.2650	-9.19e-02	-9.10e-03	1.18e-02	2.28e-02	2.47e-01	4.00e-01	9.34e-01	9.14e-01	8.34e-01	2.35e-02
GOBP PLATELET ACTIVATING FACTOR METABOLIC PROCESS	8	8.94e-01	9.65e-01	0.2650	1.39e-01	-1.03e-01	8.45e-02	1.29e-01	-1.29e-01	4.97e-01	6.14e-01	6.79e-01	5.28e-01	5.26e-01
GOBP REGULATION OF FILOPODIUM ASSEMBLY	47	1.63e-01	4.96e-01	0.2650	-5.88e-02	1.50e-01	1.43e-01	1.15e-01	-1.04e-01	4.85e-01	7.60e-02	8.94e-02	1.72e-01	2.19e-01
GOCC SCAR COMPLEX	12	7.24e-01	9.04e-01	0.2650	6.86e-02	7.74e-03	-2.26e-01	3.16e-02	-1.17e-01	6.81e-01	9.63e-01	1.76e-01	8.50e-01	4.84e-01
GOMF MRNA 5 UTR BINDING	23	4.72e-01	7.86e-01	0.2650	-2.16e-03	7.79e-02	-2.15e-01	-8.88e-02	-1.01e-01	9.86e-01	5.18e-01	7.47e-02	4.61e-01	4.00e-01
GOBP PROTEOGLYCAN CATABOLIC PROCESS	9	8.81e-01	9.61e-01	0.2650	2.02e-01	-2.50e-02	-1.60e-01	-3.80e-02	-4.13e-02	2.93e-01	8.97e-01	4.06e-01	8.44e-01	8.30e-01
GOBP REGULATION OF STEM CELL POPULATION MAINTENANCE	71	1.16e-02	9.75e-02	0.2650	6.49e-02	-1.05e-01	-1.25e-02	-1.85e-01	1.43e-01	3.45e-01	1.25e-01	8.55e-01	6.96e-03	3.66e-02
GOCC POSTSYNAPTIC DENSITY INTRACELLULAR COMPONENT	13	7.46e-01	9.14e-01	0.2650	1.49e-01	2.71e-02	-1.30e-01	-4.16e-02	-1.70e-01	3.54e-01	8.66e-01	4.17e-01	7.95e-01	2.89e-01
GOBP POSITIVE REGULATION OF VACUOLE ORGANIZATION	23	5.63e-01	8.34e-01	0.2650	-2.48e-02	5.93e-02	-1.98e-01	-1.63e-01	-1.90e-02	8.37e-01	6.23e-01	1.00e-01	1.76e-01	8.75e-01
GOBP REGULATION OF MACROPHAGE MIGRATION	45	1.31e-01	4.48e-01	0.2650	-5.50e-02	6.80e-02	1.47e-01	1.39e-01	1.47e-01	5.23e-01	4.30e-01	8.76e-02	1.06e-01	8.86e-02
GOBP PURINE RIBONUCLEOTIDE SALVAGE	7	9.24e-01	9.75e-01	0.2650	-1.70e-01	1.07e-02	-4.93e-02	-1.79e-01	8.39e-02	4.37e-01	9.61e-01	8.21e-01	4.13e-01	7.01e-01
GOBP AUTOPHAGOSOME MEMBRANE DOCKING	7	9.47e-01	9.83e-01	0.2650	-5.26e-02	4.39e-02	-1.88e-01	-1.73e-01	1.04e-03	8.09e-01	8.41e-01	3.88e-01	4.27e-01	9.96e-01
GOBP PERISTALSIS	12	7.83e-01	9.28e-01	0.2650	1.85e-01	2.23e-02	-6.09e-02	1.67e-04	1.78e-01	2.67e-01	8.94e-01	7.15e-01	9.99e-01	2.85e-01
GOBP NEGATIVE REGULATION OF STEM CELL PROLIFERATION	26	4.24e-01	7.51e-01	0.2650	-1.26e-01	-1.70e-01	-1.06e-01	-8.41e-02	-8.56e-02	2.68e-01	1.34e-01	3.52e-01	4.58e-01	4.50e-01
GOMF PROTEIN DEMETHYLASE ACTIVITY	25	4.77e-01	7.90e-01	0.2650	1.81e-01	1.07e-01	-9.88e-02	-1.15e-01	5.40e-02	1.18e-01	3.53e-01	3.93e-01	3.20e-01	6.40e-01
GOBP NUCLEUS ORGANIZATION	142	4.74e-04	8.51e-03	0.2650	3.19e-02	1.21e-02	-1.37e-01	-2.16e-01	5.95e-02	5.11e-01	8.04e-01	4.85e-03	8.93e-06	2.21e-01
GOBP HEART VALVE DEVELOPMENT	72	5.30e-03	5.55e-02	0.2650	1.50e-01	1.45e-01	8.33e-02	-1.38e-01	2.26e-02	2.75e-02	3.37e-02	2.22e-01	4.28e-02	7.40e-01
GOBP NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING	21	5.15e-01	8.10e-01	0.2650	-1.11e-01	2.27e-01	7.66e-02	-1.41e-03	1.83e-02	3.77e-01	7.20e-02	5.43e-01	9.91e-01	8.85e-01
GOBP NEGATIVE REGULATION OF GRANULOCYTE DIFFERENTIATION	8	8.96e-01	9.66e-01	0.2650	9.69e-02	2.45e-01	1.75e-02	-1.61e-02	-3.31e-03	6.35e-01	2.30e-01	9.32e-01	9.37e-01	9.87e-01
GOBP NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION	12	7.91e-01	9.31e-01	0.2640	-2.58e-02	1.96e-01	1.33e-01	-6.50e-02	9.52e-02	8.77e-01	2.40e-01	4.25e-01	6.97e-01	5.68e-01
GOBP POSITIVE REGULATION OF HISTONE ACETYLATION	10	8.38e-01	9.46e-01	0.2640	2.09e-01	-5.96e-02	-1.40e-01	1.66e-02	5.47e-02	2.53e-01	7.44e-01	4.44e-01	9.27e-01	7.64e-01
GOCC LOW DENSITY LIPOPROTEIN PARTICLE	12	7.92e-01	9.31e-01	0.2640	7.28e-02	2.39e-01	2.64e-02	-3.89e-02	7.11e-02	6.62e-01	1.51e-01	8.74e-01	8.15e-01	6.70e-01
GOCC PLATELET DENSE GRANULE	20	3.97e-01	7.31e-01	0.2640	-9.14e-02	-5.58e-02	-1.10e-01	1.91e-01	-9.90e-02	4.79e-01	6.66e-01	3.94e-01	1.39e-01	4.43e-01
GOBP RESPONSE TO ARSENIC CONTAINING SUBSTANCE	31	3.91e-01	7.26e-01	0.2640	7.58e-02	1.15e-01	-1.16e-01	-1.67e-01	9.68e-02	4.65e-01	2.69e-01	2.62e-01	1.07e-01	3.51e-01
GOMF BICARBONATE TRANSMEMBRANE TRANSPORTER ACTIVITY	30	3.11e-01	6.62e-01	0.2640	-4.61e-02	1.11e-02	6.42e-02	5.97e-02	-2.45e-01	6.62e-01	9.16e-01	5.43e-01	5.71e-01	2.03e-02
GOBP VITAMIN E METABOLIC PROCESS	6	9.52e-01	9.85e-01	0.2640	-1.83e-01	1.03e-01	1.03e-01	1.23e-01	-1.32e-02	4.38e-01	6.63e-01	6.63e-01	6.01e-01	9.55e-01
GOBP POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS	17	6.31e-01	8.69e-01	0.2640	6.44e-02	2.34e-01	-4.64e-02	-9.16e-02	-2.48e-02	6.46e-01	9.54e-02	7.40e-01	5.13e-01	8.59e-01
GOBP SENSORY PERCEPTION OF TEMPERATURE STIMULUS	27	2.86e-01	6.40e-01	0.2640	6.84e-02	1.11e-01	1.11e-01	3.45e-03	-2.01e-01	5.38e-01	3.19e-01	3.16e-01	9.75e-01	7.03e-02
GOMF PHOSPHATIDYLINOSITOL 4 PHOSPHATE BINDING	28	3.48e-01	6.94e-01	0.2640	-1.58e-01	1.20e-01	3.84e-02	-6.08e-03	-1.70e-01	1.48e-01	2.71e-01	7.25e-01	9.56e-01	1.19e-01
GOBP MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION	17	6.27e-01	8.67e-01	0.2640	9.39e-02	-1.99e-01	-6.95e-02	-1.27e-01	2.08e-02	5.02e-01	1.56e-01	6.20e-01	3.64e-01	8.82e-01
GOBP REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT	19	4.61e-01	7.78e-01	0.2640	-8.85e-02	1.56e-01	1.49e-01	-1.16e-01	-4.31e-02	5.04e-01	2.40e-01	2.60e-01	3.79e-01	7.45e-01
GOBP REGULATION OF TELOMERE MAINTENANCE	98	8.41e-03	7.74e-02	0.2640	3.58e-02	-4.18e-02	-1.20e-01	-2.02e-01	1.07e-01	5.41e-01	4.74e-01	4.02e-02	5.45e-04	6.65e-02
GOMF CAMP RESPONSE ELEMENT BINDING	12	7.81e-01	9.28e-01	0.2640	1.42e-01	2.18e-01	2.51e-02	3.44e-02	1.28e-02	3.93e-01	1.91e-01	8.80e-01	8.36e-01	9.39e-01
GOBP NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION	21	4.59e-01	7.77e-01	0.2640	2.34e-02	2.55e-01	1.20e-02	3.88e-02	4.74e-02	8.53e-01	4.27e-02	9.24e-01	7.58e-01	7.07e-01
GOMF ATP DEPENDENT ACTIVITY ACTING ON DNA	113	3.27e-03	3.91e-02	0.2640	6.10e-02	-8.45e-02	-1.36e-01	-1.84e-01	7.96e-02	2.63e-01	1.21e-01	1.25e-02	7.09e-04	1.44e-01
GOMF APOLIPOPROTEIN BINDING	17	7.31e-01	9.08e-01	0.2640	-1.21e-01	1.85e-03	1.57e-01	1.73e-01	2.35e-02	3.88e-01	9.89e-01	2.62e-01	2.18e-01	8.67e-01
GOBP NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS	15	6.60e-01	8.80e-01	0.2640	-5.66e-02	-2.18e-01	-7.77e-02	7.24e-02	8.70e-02	7.04e-01	1.43e-01	6.02e-01	6.27e-01	5.60e-01
GOBP PYRUVATE TRANSPORT	7	9.21e-01	9.74e-01	0.2640	-4.45e-03	1.00e-01	5.63e-02	-1.72e-01	1.64e-01	9.84e-01	6.47e-01	7.96e-01	4.31e-01	4.52e-01
GOCC NUCLEAR ENVELOPE LUMEN	10	8.66e-01	9.55e-01	0.2640	3.35e-02	-1.03e-01	1.99e-01	1.32e-01	2.63e-02	8.55e-01	5.73e-01	2.75e-01	4.69e-01	8.85e-01
GOBP VESICLE BUDDING FROM MEMBRANE	81	1.01e-02	8.84e-02	0.2640	1.02e-01	9.54e-02	-9.53e-02	-1.99e-01	-3.72e-02	1.11e-01	1.38e-01	1.38e-01	1.97e-03	5.63e-01
GOBP REGULATION OF EXECUTION PHASE OF APOPTOSIS	17	7.27e-01	9.05e-01	0.2640	-5.92e-02	1.15e-01	2.04e-01	9.28e-02	4.99e-02	6.73e-01	4.10e-01	1.45e-01	5.08e-01	7.22e-01
GOBP POSITIVE REGULATION OF NEURON PROJECTION ARBORIZATION	8	8.88e-01	9.62e-01	0.2640	1.21e-01	-1.94e-01	-8.82e-03	6.53e-02	-1.12e-01	5.52e-01	3.41e-01	9.66e-01	7.49e-01	5.82e-01
GOBP N ACYLPHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS	9	8.46e-01	9.49e-01	0.2640	6.62e-02	-9.03e-02	-2.22e-01	4.65e-02	-7.60e-02	7.31e-01	6.39e-01	2.50e-01	8.09e-01	6.93e-01
GOBP FOLIC ACID TRANSPORT	10	8.31e-01	9.45e-01	0.2640	1.64e-01	1.72e-01	1.04e-01	-4.78e-02	-6.81e-03	3.69e-01	3.47e-01	5.70e-01	7.94e-01	9.70e-01
GOBP CELL JUNCTION DISASSEMBLY	27	4.91e-01	7.98e-01	0.2640	-2.92e-02	1.47e-02	2.27e-01	1.29e-01	1.40e-02	7.93e-01	8.95e-01	4.09e-02	2.47e-01	9.00e-01
GOBP ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME	66	2.89e-02	1.78e-01	0.2640	9.24e-03	1.36e-02	-8.94e-02	-2.47e-01	-7.95e-03	8.97e-01	8.48e-01	2.09e-01	5.10e-04	9.11e-01
GOBP HISTONE H3 K4 METHYLATION	18	5.86e-01	8.45e-01	0.2640	1.40e-01	1.93e-01	-6.22e-02	-3.12e-02	8.78e-02	3.02e-01	1.57e-01	6.48e-01	8.18e-01	5.19e-01
GOBP ACTIN FILAMENT BASED MOVEMENT	128	8.98e-04	1.42e-02	0.2640	-5.02e-02	-1.83e-02	9.86e-02	2.16e-01	-1.00e-01	3.26e-01	7.21e-01	5.42e-02	2.37e-05	4.99e-02
GOBP REGULATION OF GLUCOCORTICOID METABOLIC PROCESS	11	8.70e-01	9.57e-01	0.2630	-1.23e-01	7.94e-02	2.00e-01	8.86e-02	-1.04e-02	4.79e-01	6.49e-01	2.51e-01	6.11e-01	9.52e-01
GOBP POSITIVE REGULATION OF LIPID STORAGE	27	3.69e-01	7.09e-01	0.2630	-3.01e-02	-5.29e-02	-1.06e-01	-2.08e-01	-1.07e-01	7.87e-01	6.34e-01	3.41e-01	6.19e-02	3.37e-01
GOBP REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS	18	5.58e-01	8.32e-01	0.2630	-7.20e-02	1.89e-01	6.94e-02	-1.53e-01	8.16e-03	5.97e-01	1.65e-01	6.10e-01	2.60e-01	9.52e-01
GOBP DNA LIGATION INVOLVED IN DNA REPAIR	5	9.53e-01	9.86e-01	0.2630	-5.61e-02	1.71e-01	-8.78e-02	-7.84e-02	1.52e-01	8.28e-01	5.08e-01	7.34e-01	7.62e-01	5.56e-01
GOMF NUCLEOTIDASE ACTIVITY	14	5.85e-01	8.45e-01	0.2630	1.52e-01	1.96e-02	1.54e-01	-1.23e-01	8.27e-02	3.24e-01	8.99e-01	3.17e-01	4.27e-01	5.92e-01
GOBP NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION	26	3.09e-01	6.62e-01	0.2630	1.06e-01	-5.07e-02	-4.09e-02	-2.32e-01	-1.20e-02	3.49e-01	6.55e-01	7.18e-01	4.10e-02	9.16e-01
GOBP ERYTHROCYTE DEVELOPMENT	37	2.79e-01	6.32e-01	0.2630	-5.35e-02	6.02e-02	-1.83e-01	-1.66e-01	-3.79e-02	5.73e-01	5.26e-01	5.35e-02	8.00e-02	6.90e-01
GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION	16	6.46e-01	8.76e-01	0.2630	-2.23e-01	9.38e-02	-2.85e-02	1.71e-02	-9.79e-02	1.22e-01	5.16e-01	8.44e-01	9.06e-01	4.98e-01
GOBP NEGATIVE REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE	6	8.88e-01	9.62e-01	0.2630	5.45e-02	-3.15e-02	1.43e-03	-2.31e-01	-1.09e-01	8.17e-01	8.94e-01	9.95e-01	3.27e-01	6.44e-01
GOCC PROTEIN KINASE COMPLEX	135	7.04e-04	1.16e-02	0.2630	-1.58e-02	3.04e-02	-1.32e-01	-2.07e-01	8.77e-02	7.52e-01	5.42e-01	8.32e-03	3.16e-05	7.84e-02
GOBP ERBB2 ERBB4 SIGNALING PATHWAY	5	9.46e-01	9.82e-01	0.2630	-3.19e-02	5.31e-02	-3.02e-03	2.47e-01	-6.54e-02	9.02e-01	8.37e-01	9.91e-01	3.39e-01	8.00e-01
GOCC AUTOPHAGOSOME	110	2.56e-03	3.25e-02	0.2630	3.28e-02	9.30e-02	-1.35e-01	-2.03e-01	-7.47e-03	5.53e-01	9.21e-02	1.46e-02	2.34e-04	8.92e-01
GOMF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR BINDING	12	6.52e-01	8.79e-01	0.2630	-9.37e-02	-7.01e-03	-2.34e-01	8.68e-03	7.41e-02	5.74e-01	9.66e-01	1.60e-01	9.58e-01	6.57e-01
GOBP FLOOR PLATE DEVELOPMENT	11	7.57e-01	9.19e-01	0.2630	8.69e-02	-1.39e-01	-1.65e-01	7.37e-02	9.92e-02	6.18e-01	4.26e-01	3.45e-01	6.72e-01	5.69e-01
GOBP CELLULAR RESPONSE TO ALDOSTERONE	7	8.38e-01	9.47e-01	0.2630	1.79e-01	-6.39e-02	1.55e-01	-3.47e-02	-8.81e-02	4.12e-01	7.70e-01	4.78e-01	8.74e-01	6.87e-01
GOBP ENDOSOME ORGANIZATION	92	9.12e-03	8.21e-02	0.2630	8.65e-02	1.16e-01	-1.35e-01	-1.63e-01	5.71e-02	1.51e-01	5.45e-02	2.48e-02	6.89e-03	3.44e-01
GOMF HORMONE BINDING	83	2.70e-02	1.71e-01	0.2630	-1.06e-01	4.95e-02	1.68e-01	1.50e-01	-6.87e-02	9.53e-02	4.35e-01	8.20e-03	1.83e-02	2.79e-01
GOBP METANEPHRIC NEPHRON DEVELOPMENT	40	8.61e-02	3.55e-01	0.2630	8.77e-02	2.88e-02	8.92e-02	-1.91e-01	1.26e-01	3.37e-01	7.52e-01	3.29e-01	3.62e-02	1.69e-01
GOBP BRANCHED CHAIN AMINO ACID METABOLIC PROCESS	26	4.20e-01	7.48e-01	0.2620	1.82e-01	5.64e-02	9.57e-02	1.18e-01	9.71e-02	1.08e-01	6.19e-01	3.98e-01	2.98e-01	3.91e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH GROUP OF DONORS	27	2.99e-01	6.53e-01	0.2620	-1.54e-01	1.33e-01	6.02e-02	-1.52e-01	-2.42e-02	1.65e-01	2.31e-01	5.88e-01	1.72e-01	8.28e-01
GOBP PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING	9	8.63e-01	9.54e-01	0.2620	-2.40e-01	1.36e-02	-8.06e-02	-6.67e-02	1.55e-02	2.13e-01	9.44e-01	6.75e-01	7.29e-01	9.36e-01
GOBP MACROMOLECULE METHYLATION	195	7.40e-06	2.54e-04	0.2620	7.47e-02	-5.65e-02	-1.27e-01	-2.07e-01	3.42e-02	7.21e-02	1.73e-01	2.22e-03	6.31e-07	4.11e-01
GOBP ENDOCARDIAL CUSHION FUSION	5	9.32e-01	9.79e-01	0.2620	7.89e-02	-1.19e-01	9.42e-03	-2.19e-01	1.55e-02	7.60e-01	6.45e-01	9.71e-01	3.95e-01	9.52e-01
GOBP NOREPINEPHRINE TRANSPORT	22	5.19e-01	8.13e-01	0.2620	1.72e-01	1.17e-02	-2.12e-02	-1.69e-01	9.99e-02	1.62e-01	9.24e-01	8.64e-01	1.69e-01	4.17e-01
GOBP VESICLE TARGETING	65	3.23e-02	1.92e-01	0.2620	1.66e-01	7.14e-02	-2.68e-02	-1.72e-01	7.72e-02	2.08e-02	3.19e-01	7.08e-01	1.66e-02	2.82e-01
GOBP ACETYL COA METABOLIC PROCESS	31	3.16e-01	6.66e-01	0.2620	1.22e-01	-6.35e-02	6.33e-03	-1.12e-01	1.93e-01	2.40e-01	5.41e-01	9.51e-01	2.82e-01	6.25e-02
GOMF INSULIN LIKE GROWTH FACTOR RECEPTOR BINDING	16	6.75e-01	8.85e-01	0.2620	8.94e-02	2.36e-01	1.26e-02	-3.77e-02	6.10e-02	5.36e-01	1.03e-01	9.31e-01	7.94e-01	6.73e-01
GOMF NEUROTRANSMITTER RECEPTOR ACTIVITY	92	8.39e-03	7.74e-02	0.2620	-1.45e-02	5.77e-02	1.85e-01	1.26e-01	1.23e-01	8.10e-01	3.39e-01	2.17e-03	3.70e-02	4.11e-02
GOBP SYNAPTIC VESICLE MATURATION	23	4.66e-01	7.82e-01	0.2620	-3.60e-02	-1.47e-01	-9.57e-03	-1.02e-01	1.88e-01	7.65e-01	2.24e-01	9.37e-01	3.95e-01	1.18e-01
GOBP REGULATION OF PROTEIN DEACETYLATION	31	3.20e-01	6.68e-01	0.2620	1.54e-01	-1.23e-01	-3.75e-02	-1.01e-01	1.36e-01	1.39e-01	2.36e-01	7.18e-01	3.32e-01	1.91e-01
GOBP THYMIC T CELL SELECTION	23	3.57e-01	7.02e-01	0.2620	9.97e-02	4.46e-02	2.26e-01	-2.97e-02	6.75e-02	4.08e-01	7.11e-01	6.01e-02	8.05e-01	5.75e-01
GOMF LIPOPROTEIN PARTICLE RECEPTOR BINDING	29	2.89e-01	6.43e-01	0.2620	-2.64e-03	-9.49e-02	-6.40e-02	-5.90e-02	-2.28e-01	9.80e-01	3.76e-01	5.51e-01	5.82e-01	3.36e-02
GOBP P BODY ASSEMBLY	20	5.78e-01	8.42e-01	0.2620	1.98e-01	6.22e-03	-1.22e-01	-9.25e-02	-7.65e-02	1.26e-01	9.62e-01	3.43e-01	4.74e-01	5.54e-01
GOBP GOLGI TO PLASMA MEMBRANE TRANSPORT	57	1.76e-02	1.30e-01	0.2620	-1.21e-01	1.01e-01	3.69e-02	-1.90e-01	-8.07e-02	1.15e-01	1.89e-01	6.30e-01	1.33e-02	2.92e-01
GOBP REGULATION OF HEART MORPHOGENESIS	10	7.32e-01	9.08e-01	0.2620	-8.44e-02	-1.02e-01	5.50e-02	-1.20e-01	-1.83e-01	6.44e-01	5.77e-01	7.63e-01	5.11e-01	3.15e-01
GOBP ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY	79	2.41e-02	1.59e-01	0.2620	-3.38e-02	-1.23e-02	2.01e-01	1.42e-01	8.04e-02	6.04e-01	8.50e-01	2.00e-03	2.85e-02	2.17e-01
GOBP PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS	29	3.23e-01	6.72e-01	0.2620	-6.04e-02	2.14e-01	5.83e-02	-1.14e-01	5.23e-02	5.74e-01	4.64e-02	5.87e-01	2.87e-01	6.26e-01
GOBP ALDEHYDE BIOSYNTHETIC PROCESS	16	7.14e-01	9.01e-01	0.2620	-1.93e-01	1.32e-02	3.62e-02	1.24e-01	-1.20e-01	1.81e-01	9.27e-01	8.02e-01	3.90e-01	4.08e-01
GOBP MITOCHONDRION LOCALIZATION	46	1.70e-01	5.08e-01	0.2620	6.57e-02	7.52e-02	-5.67e-02	-1.59e-01	1.73e-01	4.40e-01	3.78e-01	5.06e-01	6.22e-02	4.22e-02
GOMF PHOSPHOLIPASE INHIBITOR ACTIVITY	14	6.84e-01	8.88e-01	0.2620	1.36e-01	1.69e-01	-1.24e-01	-3.26e-03	-7.75e-02	3.78e-01	2.74e-01	4.23e-01	9.83e-01	6.15e-01
GOBP REGULATION OF GTP BINDING	11	8.04e-01	9.35e-01	0.2620	-2.35e-01	6.43e-02	-2.06e-02	-8.05e-02	4.36e-02	1.76e-01	7.12e-01	9.06e-01	6.44e-01	8.02e-01
GOCC MICROTUBULE ORGANIZING CENTER ATTACHMENT SITE	11	8.18e-01	9.41e-01	0.2610	1.28e-02	2.40e-01	3.94e-02	-6.95e-03	9.59e-02	9.41e-01	1.69e-01	8.21e-01	9.68e-01	5.82e-01
GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION	28	3.13e-01	6.64e-01	0.2610	-1.36e-02	9.44e-02	3.81e-02	-2.15e-01	1.07e-01	9.01e-01	3.87e-01	7.27e-01	4.85e-02	3.29e-01
GOBP POSITIVE REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS	6	9.67e-01	9.90e-01	0.2610	9.68e-02	-3.55e-02	-1.87e-01	-1.27e-01	8.12e-02	6.82e-01	8.80e-01	4.27e-01	5.91e-01	7.30e-01
GOBP L KYNURENINE METABOLIC PROCESS	7	9.04e-01	9.68e-01	0.2610	3.15e-02	-1.95e-01	-8.15e-02	1.06e-01	1.07e-01	8.85e-01	3.72e-01	7.09e-01	6.28e-01	6.23e-01
GOBP DICARBOXYLIC ACID BIOSYNTHETIC PROCESS	12	7.68e-01	9.24e-01	0.2610	-2.14e-01	-2.27e-02	-1.39e-01	-4.87e-02	1.22e-02	1.98e-01	8.92e-01	4.05e-01	7.70e-01	9.42e-01
GOBP THIAMINE TRANSPORT	8	9.32e-01	9.79e-01	0.2610	-9.02e-02	-1.14e-01	9.09e-02	1.66e-01	-1.06e-01	6.59e-01	5.75e-01	6.56e-01	4.17e-01	6.02e-01
GOBP CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT	9	8.19e-01	9.41e-01	0.2610	1.17e-01	-4.02e-02	1.23e-01	-1.28e-01	1.46e-01	5.43e-01	8.35e-01	5.21e-01	5.07e-01	4.48e-01
GOBP CELL ADHESION MOLECULE PRODUCTION	18	5.24e-01	8.16e-01	0.2610	-1.95e-02	3.67e-02	6.24e-02	2.14e-01	1.29e-01	8.86e-01	7.87e-01	6.47e-01	1.16e-01	3.42e-01
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN	20	6.55e-01	8.80e-01	0.2610	-9.07e-02	-1.14e-01	1.21e-01	1.74e-01	-4.80e-02	4.83e-01	3.79e-01	3.50e-01	1.78e-01	7.10e-01
GOBP NEGATIVE REGULATION OF COAGULATION	52	9.25e-02	3.67e-01	0.2610	-5.26e-02	1.17e-01	9.32e-02	2.04e-01	-3.91e-02	5.11e-01	1.43e-01	2.45e-01	1.11e-02	6.26e-01
GOBP POSITIVE REGULATION OF MACROPHAGE CYTOKINE PRODUCTION	23	3.77e-01	7.16e-01	0.2610	4.50e-02	2.49e-01	-4.16e-02	2.48e-02	4.05e-02	7.09e-01	3.84e-02	7.30e-01	8.37e-01	7.37e-01
GOBP MITOTIC SISTER CHROMATID COHESION	26	2.82e-01	6.35e-01	0.2610	1.17e-01	5.93e-02	7.03e-03	-2.25e-01	-2.16e-02	3.03e-01	6.01e-01	9.51e-01	4.71e-02	8.49e-01
GOBP INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS	29	4.34e-01	7.57e-01	0.2610	-2.22e-02	1.56e-01	1.96e-01	7.10e-02	-8.37e-03	8.36e-01	1.47e-01	6.78e-02	5.08e-01	9.38e-01
GOMF PROTEIN FOLDING CHAPERONE BINDING	129	1.85e-03	2.53e-02	0.2610	6.98e-02	-4.15e-02	-1.85e-01	-1.54e-01	6.22e-02	1.71e-01	4.16e-01	2.92e-04	2.58e-03	2.22e-01
GOBP ICOSANOID SECRETION	46	1.68e-01	5.04e-01	0.2610	4.11e-02	5.43e-02	1.05e-01	2.22e-01	-5.73e-02	6.29e-01	5.24e-01	2.18e-01	9.23e-03	5.01e-01
GOBP POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION	18	6.08e-01	8.57e-01	0.2610	-8.90e-02	5.60e-02	1.15e-01	7.15e-03	2.10e-01	5.13e-01	6.81e-01	4.00e-01	9.58e-01	1.24e-01
GOBP CELLULAR RESPONSE TO CAMP	49	1.49e-01	4.74e-01	0.2610	-9.14e-02	1.04e-01	1.60e-01	9.05e-02	-1.23e-01	2.68e-01	2.08e-01	5.23e-02	2.73e-01	1.36e-01
GOBP G PROTEIN COUPLED RECEPTOR INTERNALIZATION	10	8.72e-01	9.58e-01	0.2610	-4.91e-02	1.45e-01	1.90e-01	1.38e-02	9.20e-02	7.88e-01	4.28e-01	2.98e-01	9.40e-01	6.14e-01
GOBP NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING	16	6.53e-01	8.79e-01	0.2610	-6.77e-02	5.59e-02	1.22e-01	-8.44e-02	1.96e-01	6.39e-01	6.99e-01	3.99e-01	5.59e-01	1.75e-01
GOBP NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE	11	6.04e-01	8.55e-01	0.2610	-6.97e-02	-5.48e-02	-1.43e-01	1.85e-01	7.61e-02	6.89e-01	7.53e-01	4.13e-01	2.89e-01	6.62e-01
GOCC ACTIN FILAMENT BUNDLE	76	3.03e-02	1.85e-01	0.2610	-1.30e-01	7.79e-02	1.14e-01	1.19e-01	-1.34e-01	4.97e-02	2.41e-01	8.60e-02	7.32e-02	4.34e-02
GOBP MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE	19	4.28e-01	7.54e-01	0.2610	-4.03e-02	-4.52e-03	2.03e-02	2.28e-01	1.19e-01	7.61e-01	9.73e-01	8.78e-01	8.59e-02	3.68e-01
GOBP HYPOTHALAMUS DEVELOPMENT	24	5.26e-01	8.17e-01	0.2610	7.33e-02	4.67e-02	-2.94e-02	-1.82e-01	1.63e-01	5.34e-01	6.92e-01	8.03e-01	1.22e-01	1.68e-01
GOBP RECOMBINATIONAL REPAIR	169	1.12e-04	2.60e-03	0.2610	5.36e-02	-3.38e-02	-1.29e-01	-1.97e-01	9.15e-02	2.29e-01	4.48e-01	3.69e-03	9.69e-06	4.02e-02
GOBP NEGATIVE REGULATION OF KERATINOCYTE DIFFERENTIATION	9	8.41e-01	9.48e-01	0.2610	2.05e-01	-4.95e-02	1.50e-01	2.86e-02	2.14e-02	2.88e-01	7.97e-01	4.37e-01	8.82e-01	9.12e-01
GOMF NUCLEAR RECEPTOR COACTIVATOR ACTIVITY	52	9.60e-02	3.75e-01	0.2610	-2.24e-02	1.04e-01	-1.24e-01	-1.86e-01	-8.19e-02	7.80e-01	1.93e-01	1.23e-01	2.04e-02	3.07e-01
GOCC DENDRITIC SHAFT	40	2.33e-01	5.86e-01	0.2610	-3.25e-02	1.76e-01	1.29e-01	8.64e-02	-1.09e-01	7.22e-01	5.44e-02	1.58e-01	3.44e-01	2.33e-01
GOBP NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION	15	7.91e-01	9.31e-01	0.2610	-4.48e-02	-1.28e-01	-1.57e-01	-1.58e-01	-4.70e-03	7.64e-01	3.90e-01	2.93e-01	2.91e-01	9.75e-01
GOBP NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	27	3.59e-01	7.04e-01	0.2600	-1.02e-01	1.04e-01	1.17e-01	-8.11e-02	1.62e-01	3.58e-01	3.51e-01	2.92e-01	4.66e-01	1.44e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON SINGLE DONORS WITH INCORPORATION OF MOLECULAR OXYGEN	24	4.24e-01	7.51e-01	0.2600	-7.67e-02	1.47e-01	-3.79e-02	-1.74e-01	-9.21e-02	5.15e-01	2.12e-01	7.48e-01	1.39e-01	4.35e-01
GOBP L AMINO ACID TRANSPORT	84	1.78e-02	1.31e-01	0.2600	-1.03e-01	1.43e-01	1.66e-01	8.96e-02	-3.49e-02	1.03e-01	2.37e-02	8.46e-03	1.56e-01	5.80e-01
GOBP NEGATIVE REGULATION OF CELL MATURATION	8	8.30e-01	9.44e-01	0.2600	-8.00e-02	-1.55e-02	4.13e-03	1.80e-01	1.70e-01	6.95e-01	9.40e-01	9.84e-01	3.78e-01	4.06e-01
GOBP REGULATION OF CHROMOSOME SEGREGATION	129	6.17e-04	1.04e-02	0.2600	1.35e-01	-5.21e-02	-1.07e-01	-1.84e-01	3.98e-02	8.29e-03	3.07e-01	3.59e-02	3.04e-04	4.35e-01
GOMF OLIGOPEPTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY	6	9.47e-01	9.83e-01	0.2600	-8.98e-02	4.88e-02	-2.09e-01	-1.09e-01	4.30e-02	7.03e-01	8.36e-01	3.76e-01	6.43e-01	8.55e-01
GOBP DETERMINATION OF LIVER LEFT RIGHT ASYMMETRY	5	9.26e-01	9.76e-01	0.2600	-8.24e-02	-4.90e-02	9.92e-02	-2.08e-01	7.37e-02	7.50e-01	8.49e-01	7.01e-01	4.21e-01	7.75e-01
GOBP NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS	20	4.38e-01	7.60e-01	0.2600	-1.81e-01	-1.87e-03	4.03e-02	-1.60e-01	-8.75e-02	1.60e-01	9.88e-01	7.55e-01	2.16e-01	4.98e-01
GOMF SOLUTE INORGANIC ANION ANTIPORTER ACTIVITY	28	4.01e-01	7.34e-01	0.2600	-2.72e-02	-1.70e-01	-3.06e-03	1.32e-01	-1.43e-01	8.03e-01	1.19e-01	9.78e-01	2.28e-01	1.89e-01
GOMF SERINE TYPE EXOPEPTIDASE ACTIVITY	12	8.27e-01	9.44e-01	0.2600	-2.05e-01	7.85e-02	9.92e-02	9.43e-02	-2.88e-02	2.19e-01	6.38e-01	5.52e-01	5.72e-01	8.63e-01
GOBP MIRNA PROCESSING	45	1.11e-01	4.07e-01	0.2600	1.10e-01	1.23e-02	-8.68e-02	-2.08e-01	-7.04e-02	2.04e-01	8.87e-01	3.14e-01	1.60e-02	4.14e-01
GOBP T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE	116	3.80e-04	7.22e-03	0.2600	-1.53e-01	1.95e-01	7.12e-02	3.20e-02	1.39e-03	4.32e-03	2.83e-04	1.85e-01	5.51e-01	9.79e-01
GOBP NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION	44	2.08e-01	5.59e-01	0.2600	3.27e-02	1.01e-01	-1.20e-01	-1.69e-01	1.17e-01	7.07e-01	2.47e-01	1.70e-01	5.30e-02	1.79e-01
GOBP POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION	31	3.94e-01	7.29e-01	0.2600	6.80e-02	1.29e-01	-1.38e-01	-1.55e-01	6.01e-02	5.12e-01	2.15e-01	1.85e-01	1.36e-01	5.63e-01
GOBP EMBRYONIC BODY MORPHOGENESIS	11	8.44e-01	9.49e-01	0.2600	1.67e-01	1.49e-01	9.74e-02	2.96e-02	8.56e-02	3.38e-01	3.94e-01	5.76e-01	8.65e-01	6.23e-01
GOBP POSITIVE REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY	5	9.63e-01	9.90e-01	0.2600	1.40e-01	-7.64e-02	-1.80e-01	1.45e-02	-9.86e-02	5.88e-01	7.67e-01	4.87e-01	9.55e-01	7.03e-01
GOBP POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION	16	4.20e-01	7.48e-01	0.2600	-7.96e-02	-3.87e-03	2.05e-01	-1.38e-01	4.56e-04	5.81e-01	9.79e-01	1.55e-01	3.39e-01	9.97e-01
GOBP REGULATION OF MUSCLE ORGAN DEVELOPMENT	23	4.98e-01	8.02e-01	0.2600	4.25e-02	9.41e-02	1.10e-01	-5.71e-02	2.04e-01	7.24e-01	4.34e-01	3.61e-01	6.36e-01	9.04e-02
GOBP ANTIVIRAL INNATE IMMUNE RESPONSE	48	1.29e-01	4.44e-01	0.2600	9.07e-02	1.26e-01	-1.15e-01	-1.13e-01	1.32e-01	2.77e-01	1.31e-01	1.69e-01	1.76e-01	1.12e-01
GOCC CLATHRIN COAT OF COATED PIT	17	6.23e-01	8.65e-01	0.2600	-6.46e-02	1.92e-01	1.41e-01	-5.01e-02	-6.52e-02	6.45e-01	1.71e-01	3.15e-01	7.21e-01	6.41e-01
GOBP REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION	15	7.00e-01	8.96e-01	0.2600	2.17e-02	2.51e-01	1.92e-02	-2.51e-02	-5.33e-02	8.84e-01	9.17e-02	8.98e-01	8.66e-01	7.21e-01
GOMF NADPLUS BINDING	18	6.46e-01	8.76e-01	0.2600	9.50e-03	1.92e-01	-1.06e-01	-1.36e-01	3.07e-02	9.44e-01	1.58e-01	4.37e-01	3.19e-01	8.21e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H QUINONE OR SIMILAR COMPOUND AS ACCEPTOR	49	1.82e-01	5.24e-01	0.2600	3.26e-02	-1.39e-01	-1.74e-01	-1.25e-01	3.43e-02	6.93e-01	9.14e-02	3.51e-02	1.30e-01	6.78e-01
GOMF SOLUTE MONOATOMIC CATION SYMPORTER ACTIVITY	114	2.49e-03	3.19e-02	0.2600	-3.93e-02	1.17e-01	1.57e-01	1.08e-01	-1.27e-01	4.68e-01	3.11e-02	3.88e-03	4.57e-02	1.93e-02
GOMF CIS REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING	1138	3.60e-41	2.16e-38	0.2600	7.94e-02	1.66e-02	-3.33e-02	-2.19e-01	1.08e-01	6.20e-06	3.46e-01	5.80e-02	7.90e-36	7.29e-10
GOBP PODOSOME ASSEMBLY	19	3.78e-01	7.17e-01	0.2600	-1.06e-01	1.79e-01	-4.55e-02	1.48e-01	1.35e-03	4.23e-01	1.76e-01	7.31e-01	2.63e-01	9.92e-01
GOBP REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC	35	2.84e-01	6.37e-01	0.2600	-9.26e-02	1.60e-01	1.06e-01	5.33e-02	-1.39e-01	3.43e-01	1.02e-01	2.80e-01	5.85e-01	1.55e-01
GOCC SITE OF DOUBLE STRAND BREAK	82	3.19e-02	1.91e-01	0.2600	4.17e-02	-4.06e-02	-1.71e-01	-1.86e-01	-8.11e-03	5.14e-01	5.25e-01	7.48e-03	3.51e-03	8.99e-01
GOBP ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY	26	2.26e-01	5.79e-01	0.2600	-5.57e-02	-6.96e-02	1.21e-01	-1.72e-01	1.23e-01	6.23e-01	5.39e-01	2.85e-01	1.29e-01	2.77e-01
GOBP REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS	23	3.79e-01	7.18e-01	0.2600	-1.98e-01	1.42e-01	-6.19e-02	3.31e-02	-5.50e-02	1.00e-01	2.37e-01	6.07e-01	7.84e-01	6.48e-01
GOBP PULMONARY VALVE DEVELOPMENT	23	4.64e-01	7.80e-01	0.2600	8.54e-02	1.48e-01	1.94e-01	7.26e-03	-2.19e-02	4.78e-01	2.19e-01	1.08e-01	9.52e-01	8.56e-01
GOBP DENDRITIC CELL DIFFERENTIATION	44	8.61e-02	3.55e-01	0.2590	-1.51e-01	1.79e-01	-6.79e-02	-3.62e-03	-8.97e-02	8.37e-02	4.02e-02	4.36e-01	9.67e-01	3.03e-01
GOBP NEGATIVE REGULATION OF MIRNA METABOLIC PROCESS	26	4.19e-01	7.48e-01	0.2590	-9.05e-02	1.35e-01	-1.58e-02	-1.85e-01	8.02e-02	4.24e-01	2.32e-01	8.89e-01	1.03e-01	4.79e-01
GOBP POSITIVE REGULATION OF ATP DEPENDENT ACTIVITY	39	2.43e-01	6.00e-01	0.2590	9.84e-02	-8.62e-02	-1.74e-01	-8.98e-02	-1.09e-01	2.87e-01	3.52e-01	6.04e-02	3.32e-01	2.37e-01
GOBP NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING	6	9.44e-01	9.82e-01	0.2590	8.64e-02	-7.16e-02	4.07e-02	-1.25e-01	1.94e-01	7.14e-01	7.61e-01	8.63e-01	5.97e-01	4.11e-01
GOBP DETECTION OF TEMPERATURE STIMULUS	24	5.13e-01	8.09e-01	0.2590	6.02e-02	1.24e-01	9.35e-02	1.19e-01	-1.59e-01	6.09e-01	2.91e-01	4.28e-01	3.15e-01	1.77e-01
GOBP PHOSPHATIDYLINOSITOL MEDIATED SIGNALING	25	5.11e-01	8.08e-01	0.2590	-5.64e-02	-1.33e-01	1.46e-01	1.57e-01	1.98e-02	6.25e-01	2.48e-01	2.07e-01	1.75e-01	8.64e-01
GOBP BEHAVIORAL RESPONSE TO COCAINE	14	6.89e-01	8.91e-01	0.2590	2.42e-01	4.51e-02	2.11e-02	-3.76e-02	-6.73e-02	1.16e-01	7.70e-01	8.91e-01	8.08e-01	6.63e-01
GOBP REGULATION OF CELL CYCLE CHECKPOINT	45	2.29e-01	5.82e-01	0.2590	1.35e-01	-3.21e-02	-1.33e-01	-1.53e-01	8.29e-02	1.17e-01	7.09e-01	1.23e-01	7.58e-02	3.36e-01
GOMF SELENIUM BINDING	9	8.79e-01	9.61e-01	0.2590	2.26e-02	-2.26e-01	-9.45e-02	8.12e-02	-1.02e-02	9.07e-01	2.41e-01	6.23e-01	6.73e-01	9.58e-01
GOBP MESODERMAL CELL DIFFERENTIATION	34	2.54e-01	6.11e-01	0.2590	-1.12e-01	-7.27e-02	-2.78e-02	-1.19e-01	1.86e-01	2.59e-01	4.63e-01	7.79e-01	2.31e-01	6.11e-02
GOBP POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION	22	4.92e-01	7.98e-01	0.2590	3.30e-02	2.52e-01	2.15e-02	1.76e-02	-4.16e-02	7.89e-01	4.08e-02	8.61e-01	8.86e-01	7.35e-01
GOBP NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT	14	7.97e-01	9.32e-01	0.2590	3.38e-02	-2.21e-02	2.14e-01	1.34e-01	-4.34e-02	8.27e-01	8.86e-01	1.66e-01	3.86e-01	7.79e-01
GOBP RNA STABILIZATION	66	7.53e-03	7.15e-02	0.2590	-1.88e-01	2.85e-02	9.09e-02	-1.50e-01	1.92e-03	8.09e-03	6.89e-01	2.02e-01	3.53e-02	9.79e-01
GOBP REGULATION OF RNA EXPORT FROM NUCLEUS	13	7.38e-01	9.10e-01	0.2590	-1.32e-01	2.26e-02	-9.13e-03	-2.19e-01	3.10e-02	4.11e-01	8.88e-01	9.55e-01	1.71e-01	8.47e-01
GOBP PURINE NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS	10	8.48e-01	9.49e-01	0.2590	1.50e-02	2.15e-01	4.74e-04	7.29e-03	-1.43e-01	9.34e-01	2.39e-01	9.98e-01	9.68e-01	4.35e-01
GOBP POSITIVE REGULATION OF MUSCLE CONTRACTION	46	8.63e-02	3.55e-01	0.2590	-1.14e-01	1.08e-01	-2.72e-02	-1.67e-01	-1.16e-01	1.81e-01	2.05e-01	7.49e-01	4.96e-02	1.72e-01
GOBP HEART FIELD SPECIFICATION	17	6.06e-01	8.56e-01	0.2580	8.93e-03	9.31e-02	6.53e-02	-1.55e-03	-2.32e-01	9.49e-01	5.06e-01	6.41e-01	9.91e-01	9.77e-02
GOBP ENDOCARDIAL CUSHION DEVELOPMENT	54	5.01e-02	2.55e-01	0.2580	9.42e-02	1.18e-02	-7.13e-03	-2.27e-01	7.97e-02	2.31e-01	8.80e-01	9.28e-01	3.96e-03	3.11e-01
GOBP DNA DAMAGE RESPONSE	831	3.85e-24	1.13e-21	0.2580	3.43e-02	-5.33e-03	-1.37e-01	-2.09e-01	5.69e-02	9.34e-02	7.94e-01	1.96e-11	1.38e-24	5.29e-03
GOBP SOMATIC MOTOR NEURON DIFFERENTIATION	5	9.67e-01	9.90e-01	0.2580	1.16e-01	1.47e-01	-2.05e-03	-1.68e-01	5.85e-02	6.53e-01	5.69e-01	9.94e-01	5.15e-01	8.21e-01
GOBP RESPONSE TO LEPTIN	21	5.47e-01	8.27e-01	0.2580	1.22e-01	-2.92e-02	-2.10e-01	-2.32e-02	-7.91e-02	3.32e-01	8.17e-01	9.55e-02	8.54e-01	5.30e-01
GOBP CHROMOSOME CONDENSATION	46	2.14e-01	5.67e-01	0.2580	2.92e-02	-7.50e-02	-2.01e-01	-1.20e-01	7.24e-02	7.32e-01	3.79e-01	1.81e-02	1.59e-01	3.96e-01
GOBP PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS	31	2.38e-01	5.94e-01	0.2580	-4.88e-02	4.62e-03	-2.00e-02	-3.24e-03	2.53e-01	6.38e-01	9.64e-01	8.47e-01	9.75e-01	1.49e-02
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MICROTUBULE	5	9.55e-01	9.87e-01	0.2580	-1.87e-01	-1.60e-01	5.19e-02	-5.42e-02	-2.35e-02	4.69e-01	5.36e-01	8.41e-01	8.34e-01	9.28e-01
GOBP FEMALE MEIOTIC NUCLEAR DIVISION	38	3.05e-01	6.58e-01	0.2580	1.09e-01	-9.45e-02	-1.71e-01	-1.24e-01	-3.50e-02	2.44e-01	3.13e-01	6.83e-02	1.86e-01	7.09e-01
GOCC ACTOMYOSIN	76	3.54e-02	2.03e-01	0.2580	-9.28e-02	8.85e-02	1.42e-01	1.11e-01	-1.33e-01	1.62e-01	1.82e-01	3.27e-02	9.34e-02	4.48e-02
GOBP PROTEIN LOCALIZATION TO SITE OF DOUBLE STRAND BREAK	6	9.35e-01	9.80e-01	0.2580	-1.57e-01	-6.15e-02	2.79e-02	-1.63e-01	1.03e-01	5.05e-01	7.94e-01	9.06e-01	4.88e-01	6.63e-01
GOCC DNA REPAIR COMPLEX	22	5.90e-01	8.47e-01	0.2580	2.38e-02	6.77e-02	-1.18e-01	-1.35e-01	1.71e-01	8.47e-01	5.83e-01	3.39e-01	2.72e-01	1.66e-01
GOBP POSITIVE REGULATION OF CEREBELLAR GRANULE CELL PRECURSOR PROLIFERATION	8	8.47e-01	9.49e-01	0.2580	-6.33e-02	-1.08e-01	6.55e-03	-2.25e-01	-5.87e-03	7.57e-01	5.97e-01	9.74e-01	2.70e-01	9.77e-01
GOCC ASTROCYTE PROJECTION	19	7.22e-01	9.03e-01	0.2580	-1.24e-01	2.24e-02	1.30e-01	1.62e-01	-8.70e-02	3.49e-01	8.66e-01	3.27e-01	2.22e-01	5.12e-01
GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE III PROMOTER	8	8.92e-01	9.63e-01	0.2580	-3.83e-02	1.11e-01	6.16e-02	-1.93e-01	1.08e-01	8.51e-01	5.86e-01	7.63e-01	3.45e-01	5.97e-01
GOBP PROTEIN DESTABILIZATION	46	2.07e-01	5.57e-01	0.2580	8.99e-02	6.55e-02	-1.30e-01	-1.92e-01	1.71e-02	2.92e-01	4.42e-01	1.29e-01	2.40e-02	8.41e-01
GOBP NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION	28	2.25e-01	5.79e-01	0.2580	-8.89e-02	1.28e-01	1.49e-01	-1.20e-01	-7.42e-02	4.16e-01	2.42e-01	1.72e-01	2.72e-01	4.97e-01
GOCC SPERM PRINCIPAL PIECE	32	3.19e-01	6.67e-01	0.2580	-1.81e-01	-9.24e-02	-1.10e-01	-2.31e-02	-1.13e-01	7.71e-02	3.66e-01	2.84e-01	8.21e-01	2.70e-01
GOBP NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION	43	1.96e-01	5.44e-01	0.2580	7.68e-02	1.20e-01	9.43e-02	1.53e-01	-1.18e-01	3.83e-01	1.74e-01	2.85e-01	8.30e-02	1.82e-01
GOBP HEMATOPOIETIC OR LYMPHOID ORGAN DEVELOPMENT	98	3.09e-03	3.76e-02	0.2580	4.39e-02	-8.51e-03	-5.52e-02	-2.38e-01	6.83e-02	4.53e-01	8.84e-01	3.45e-01	4.68e-05	2.43e-01
GOMF G PROTEIN ACTIVITY	42	1.48e-01	4.71e-01	0.2580	1.98e-02	1.01e-01	-4.34e-02	-2.32e-01	-8.06e-03	8.24e-01	2.55e-01	6.27e-01	9.37e-03	9.28e-01
GOMF PROTEIN DISULFIDE ISOMERASE ACTIVITY	20	5.37e-01	8.22e-01	0.2570	-1.96e-01	-6.63e-03	-2.08e-02	-1.66e-01	-1.07e-02	1.30e-01	9.59e-01	8.72e-01	2.00e-01	9.34e-01
GOMF MAP KINASE ACTIVITY	16	7.70e-01	9.24e-01	0.2570	1.02e-01	-3.50e-02	-1.21e-01	-1.16e-01	1.63e-01	4.78e-01	8.08e-01	4.01e-01	4.23e-01	2.60e-01
GOMF FATZ BINDING	5	8.94e-01	9.65e-01	0.2570	-9.05e-03	1.59e-01	-1.57e-01	1.25e-01	2.08e-02	9.72e-01	5.38e-01	5.43e-01	6.29e-01	9.36e-01
GOMF G PROTEIN ALPHA SUBUNIT BINDING	29	2.05e-01	5.55e-01	0.2570	-1.22e-01	8.67e-02	1.52e-01	-1.01e-01	-1.02e-01	2.57e-01	4.19e-01	1.56e-01	3.46e-01	3.40e-01
GOMF STEROID DEHYDROGENASE ACTIVITY ACTING ON THE CH OH GROUP OF DONORS NAD OR NADP AS ACCEPTOR	29	2.53e-01	6.10e-01	0.2570	-1.77e-01	-1.70e-03	2.41e-02	1.75e-01	5.88e-02	9.92e-02	9.87e-01	8.22e-01	1.02e-01	5.84e-01
GOBP PROTEIN METHYLATION	75	3.36e-02	1.97e-01	0.2570	2.06e-02	-7.74e-02	-1.13e-01	-2.12e-01	4.44e-02	7.58e-01	2.46e-01	9.16e-02	1.49e-03	5.06e-01
GOMF MOLECULAR CARRIER ACTIVITY	92	1.07e-02	9.18e-02	0.2570	6.88e-02	3.06e-02	-1.99e-01	-1.25e-01	-7.16e-02	2.54e-01	6.12e-01	9.55e-04	3.85e-02	2.35e-01
GOBP MITOCHONDRION ORGANIZATION	522	5.56e-15	7.12e-13	0.2570	3.38e-02	4.77e-03	-1.37e-01	-2.11e-01	4.13e-02	1.86e-01	8.52e-01	9.30e-08	1.48e-16	1.06e-01
GOBP AUTONOMIC NERVOUS SYSTEM DEVELOPMENT	45	1.37e-01	4.57e-01	0.2570	2.02e-01	7.34e-02	5.45e-02	-4.65e-02	1.21e-01	1.91e-02	3.94e-01	5.27e-01	5.89e-01	1.59e-01
GOBP STEROID CATABOLIC PROCESS	24	3.11e-01	6.62e-01	0.2570	-9.70e-03	-3.66e-02	1.33e-03	2.43e-01	7.38e-02	9.34e-01	7.56e-01	9.91e-01	3.92e-02	5.31e-01
GOBP CELLULAR RESPONSE TO ATP	16	7.63e-01	9.22e-01	0.2570	-1.61e-02	2.05e-02	-1.88e-01	-1.43e-01	9.87e-02	9.11e-01	8.87e-01	1.94e-01	3.23e-01	4.94e-01
GOMF INSULIN RECEPTOR BINDING	21	5.93e-01	8.47e-01	0.2570	-5.01e-02	2.18e-01	1.07e-01	4.94e-02	-4.65e-02	6.91e-01	8.38e-02	3.98e-01	6.95e-01	7.12e-01
GOBP REGULATION OF RESTING MEMBRANE POTENTIAL	10	8.72e-01	9.58e-01	0.2570	-3.35e-02	-1.71e-01	1.44e-01	1.21e-01	-1.47e-02	8.55e-01	3.50e-01	4.29e-01	5.08e-01	9.36e-01
GOMF INTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY	29	4.52e-01	7.71e-01	0.2570	1.35e-02	1.71e-01	1.43e-01	1.26e-01	1.99e-02	9.00e-01	1.11e-01	1.84e-01	2.42e-01	8.53e-01
GOBP HEART TRABECULA FORMATION	15	7.20e-01	9.02e-01	0.2570	-8.30e-02	8.61e-02	-1.52e-02	1.32e-01	-1.84e-01	5.78e-01	5.64e-01	9.19e-01	3.77e-01	2.16e-01
GOBP MANCHETTE ASSEMBLY	6	8.98e-01	9.67e-01	0.2570	-6.11e-02	2.44e-02	1.52e-03	2.07e-01	1.37e-01	7.96e-01	9.18e-01	9.95e-01	3.80e-01	5.61e-01
GOBP TRANSLESION SYNTHESIS	25	5.71e-01	8.38e-01	0.2570	1.05e-01	1.38e-02	-1.89e-01	-1.37e-01	-2.04e-02	3.65e-01	9.05e-01	1.02e-01	2.36e-01	8.60e-01
GOBP REGULATION OF HORMONE BIOSYNTHETIC PROCESS	24	4.94e-01	7.99e-01	0.2570	-1.92e-01	6.80e-02	1.52e-01	1.88e-02	-2.83e-02	1.03e-01	5.64e-01	1.98e-01	8.74e-01	8.10e-01
GOCC BLEB	9	8.29e-01	9.44e-01	0.2570	4.51e-02	2.56e-02	1.79e-01	-1.07e-01	1.40e-01	8.15e-01	8.94e-01	3.51e-01	5.79e-01	4.67e-01
GOBP NEUROMUSCULAR SYNAPTIC TRANSMISSION	28	3.16e-01	6.66e-01	0.2570	6.27e-02	-1.99e-01	1.20e-01	8.24e-02	-3.06e-02	5.66e-01	6.80e-02	2.70e-01	4.51e-01	7.80e-01
GOMF G PROTEIN BETA GAMMA SUBUNIT COMPLEX BINDING	21	5.52e-01	8.29e-01	0.2570	-1.45e-01	1.02e-01	1.24e-01	2.06e-02	1.37e-01	2.51e-01	4.17e-01	3.27e-01	8.70e-01	2.78e-01
GOBP CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE	63	4.03e-02	2.21e-01	0.2570	4.66e-02	-9.36e-02	1.34e-03	-8.32e-02	2.19e-01	5.23e-01	1.99e-01	9.85e-01	2.53e-01	2.64e-03
GOCC INTEGRIN COMPLEX	30	1.67e-01	5.03e-01	0.2560	-7.23e-02	1.26e-01	-5.07e-02	1.93e-01	-6.99e-02	4.93e-01	2.33e-01	6.31e-01	6.71e-02	5.07e-01
GOCC CIS GOLGI NETWORK	55	1.09e-01	4.02e-01	0.2560	4.21e-02	9.87e-02	-8.42e-02	-2.12e-01	4.92e-02	5.89e-01	2.06e-01	2.80e-01	6.66e-03	5.28e-01
GOBP POSITIVE REGULATION OF FEVER GENERATION	7	9.55e-01	9.86e-01	0.2560	3.08e-02	9.46e-02	1.40e-01	1.91e-01	-6.81e-03	8.88e-01	6.65e-01	5.23e-01	3.83e-01	9.75e-01
GOMF CATALYTIC ACTIVITY ACTING ON DNA	232	3.52e-06	1.33e-04	0.2560	9.58e-02	-1.26e-02	-1.53e-01	-1.70e-01	6.45e-02	1.19e-02	7.40e-01	6.07e-05	8.15e-06	9.07e-02
GOMF DEMETHYLASE ACTIVITY	35	3.56e-01	7.02e-01	0.2560	1.50e-01	-3.95e-03	-1.74e-01	-1.14e-01	8.51e-03	1.26e-01	9.68e-01	7.54e-02	2.42e-01	9.31e-01
GOBP REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION	12	7.99e-01	9.33e-01	0.2560	1.46e-01	-1.04e-01	-5.88e-02	-1.72e-01	2.34e-02	3.81e-01	5.33e-01	7.24e-01	3.02e-01	8.88e-01
GOBP POSITIVE REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT	8	9.06e-01	9.69e-01	0.2560	-4.44e-02	1.63e-01	1.53e-01	-7.09e-02	9.29e-02	8.28e-01	4.24e-01	4.54e-01	7.28e-01	6.49e-01
GOCC PHAGOPHORE ASSEMBLY SITE MEMBRANE	20	5.65e-01	8.35e-01	0.2560	-1.05e-01	4.32e-02	-1.47e-02	-2.15e-01	7.92e-02	4.14e-01	7.38e-01	9.10e-01	9.64e-02	5.40e-01
GOBP NEUROTRANSMITTER BIOSYNTHETIC PROCESS	14	7.25e-01	9.05e-01	0.2560	1.97e-01	1.07e-01	5.10e-02	3.13e-02	-1.09e-01	2.03e-01	4.87e-01	7.41e-01	8.39e-01	4.82e-01
GOBP MIDGUT DEVELOPMENT	10	8.69e-01	9.56e-01	0.2560	-5.07e-03	-2.44e-01	-7.58e-02	8.54e-03	1.89e-02	9.78e-01	1.82e-01	6.78e-01	9.63e-01	9.17e-01
GOBP DNA DOUBLE STRAND BREAK PROCESSING	19	6.36e-01	8.72e-01	0.2560	-3.00e-02	1.96e-01	1.61e-01	-4.51e-03	1.22e-02	8.21e-01	1.39e-01	2.24e-01	9.73e-01	9.27e-01
GOCC MAIN AXON	67	8.38e-02	3.49e-01	0.2560	-3.95e-02	-3.94e-03	1.58e-01	1.68e-01	-1.05e-01	5.76e-01	9.56e-01	2.56e-02	1.77e-02	1.38e-01
GOBP REGULATION OF MYOFIBROBLAST DIFFERENTIATION	9	9.07e-01	9.69e-01	0.2560	-1.24e-01	-1.38e-01	-1.14e-01	-1.30e-01	-3.19e-02	5.18e-01	4.73e-01	5.54e-01	4.99e-01	8.69e-01
GOBP NEGATIVE REGULATION OF P38MAPK CASCADE	8	9.20e-01	9.74e-01	0.2560	-4.50e-02	1.15e-01	1.60e-01	7.40e-03	1.56e-01	8.26e-01	5.72e-01	4.33e-01	9.71e-01	4.44e-01
GOBP CELL CELL ADHESION INVOLVED IN GASTRULATION	11	8.29e-01	9.44e-01	0.2560	-1.49e-01	5.60e-02	-1.68e-01	-7.23e-02	-8.18e-02	3.92e-01	7.48e-01	3.35e-01	6.78e-01	6.39e-01
GOBP NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE	21	5.71e-01	8.38e-01	0.2560	-1.25e-01	-5.46e-02	-4.68e-02	-1.56e-01	1.43e-01	3.21e-01	6.65e-01	7.10e-01	2.16e-01	2.58e-01
GOBP REGULATION OF BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS	8	9.14e-01	9.72e-01	0.2560	-1.19e-01	-1.94e-01	-1.36e-02	1.12e-01	-3.08e-02	5.60e-01	3.42e-01	9.47e-01	5.83e-01	8.80e-01
GOBP POSITIVE REGULATION OF STEM CELL DIFFERENTIATION	21	6.01e-01	8.53e-01	0.2560	-1.14e-01	-5.32e-02	-7.75e-02	-1.70e-01	1.21e-01	3.66e-01	6.73e-01	5.38e-01	1.77e-01	3.37e-01
GOBP REGULATION OF METALLOPEPTIDASE ACTIVITY	22	4.07e-01	7.39e-01	0.2560	-1.87e-01	7.63e-03	-1.20e-01	8.62e-02	-9.22e-02	1.29e-01	9.51e-01	3.29e-01	4.84e-01	4.54e-01
GOBP NEGATIVE REGULATION OF RESPONSE TO WOUNDING	94	9.91e-03	8.70e-02	0.2560	-8.64e-02	7.78e-02	1.13e-01	1.95e-01	-3.41e-02	1.48e-01	1.92e-01	5.88e-02	1.08e-03	5.67e-01
GOBP RESPONSE TO INTERLEUKIN 7	12	8.48e-01	9.49e-01	0.2560	4.59e-02	4.28e-02	-6.24e-02	-2.23e-01	8.73e-02	7.83e-01	7.98e-01	7.08e-01	1.80e-01	6.01e-01
GOBP SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT	18	7.62e-01	9.20e-01	0.2560	-1.85e-02	-5.19e-02	-1.83e-01	-1.63e-01	4.76e-02	8.92e-01	7.03e-01	1.79e-01	2.32e-01	7.26e-01
GOBP PHOSPHATIDYLSERINE METABOLIC PROCESS	23	4.77e-01	7.90e-01	0.2550	-1.93e-01	1.17e-01	-3.64e-02	-8.34e-03	-1.13e-01	1.09e-01	3.30e-01	7.62e-01	9.45e-01	3.49e-01
GOBP DNA TEMPLATED DNA REPLICATION MAINTENANCE OF FIDELITY	54	1.53e-01	4.81e-01	0.2550	1.16e-01	2.42e-02	-1.60e-01	-1.59e-01	1.40e-02	1.39e-01	7.58e-01	4.22e-02	4.27e-02	8.58e-01
GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH	27	3.89e-01	7.25e-01	0.2550	-1.62e-01	1.07e-01	3.32e-02	-4.13e-02	-1.57e-01	1.45e-01	3.37e-01	7.65e-01	7.10e-01	1.57e-01
GOBP LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL	55	5.41e-02	2.68e-01	0.2550	-1.39e-01	1.44e-01	1.46e-01	-5.80e-02	2.05e-02	7.40e-02	6.45e-02	6.13e-02	4.57e-01	7.92e-01
GOBP POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY	41	1.44e-01	4.64e-01	0.2550	-8.41e-02	2.38e-01	1.27e-02	1.29e-02	-3.39e-02	3.51e-01	8.39e-03	8.88e-01	8.87e-01	7.08e-01
GOBP MELANIN METABOLIC PROCESS	24	4.89e-01	7.97e-01	0.2550	-5.37e-02	1.96e-01	9.28e-02	-3.77e-02	1.18e-01	6.49e-01	9.73e-02	4.31e-01	7.49e-01	3.16e-01
GOBP AMELOGENESIS	24	6.08e-01	8.57e-01	0.2550	-1.04e-01	-6.51e-02	1.33e-01	1.71e-01	-5.60e-02	3.76e-01	5.81e-01	2.59e-01	1.48e-01	6.35e-01
GOCC PHOTORECEPTOR OUTER SEGMENT MEMBRANE	16	6.77e-01	8.86e-01	0.2550	1.06e-01	2.19e-01	3.07e-02	6.18e-02	3.57e-02	4.63e-01	1.30e-01	8.32e-01	6.69e-01	8.05e-01
GOBP CATECHOLAMINE UPTAKE	18	6.31e-01	8.70e-01	0.2550	1.48e-01	-1.44e-01	-1.61e-02	-9.60e-02	1.14e-01	2.78e-01	2.90e-01	9.06e-01	4.81e-01	4.02e-01
GOBP POSITIVE REGULATION OF EPITHELIAL TUBE FORMATION	8	8.99e-01	9.67e-01	0.2550	-3.25e-03	-5.47e-02	-7.39e-02	-2.30e-01	-6.03e-02	9.87e-01	7.89e-01	7.18e-01	2.60e-01	7.68e-01
GOMF NEUROPEPTIDE RECEPTOR ACTIVITY	44	3.98e-02	2.19e-01	0.2550	-1.07e-01	-2.45e-02	1.99e-01	-1.03e-01	5.29e-02	2.21e-01	7.78e-01	2.25e-02	2.36e-01	5.44e-01
GOCC FEMALE GERM CELL NUCLEUS	17	6.82e-01	8.88e-01	0.2550	-1.04e-01	1.01e-01	-2.59e-02	-1.50e-01	1.43e-01	4.58e-01	4.70e-01	8.53e-01	2.83e-01	3.06e-01
GOBP POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION	16	7.10e-01	8.98e-01	0.2550	2.26e-01	1.50e-02	-7.18e-02	-1.44e-02	9.09e-02	1.17e-01	9.17e-01	6.19e-01	9.21e-01	5.29e-01
GOMF CALMODULIN DEPENDENT PROTEIN PHOSPHATASE ACTIVITY	5	9.70e-01	9.91e-01	0.2550	1.58e-01	8.94e-02	1.68e-01	5.75e-02	2.58e-02	5.42e-01	7.29e-01	5.16e-01	8.24e-01	9.20e-01
GOBP PROTEIN HYDROXYLATION	23	5.26e-01	8.17e-01	0.2550	2.16e-04	1.13e-01	-7.62e-02	-2.10e-01	-4.58e-02	9.99e-01	3.47e-01	5.27e-01	8.10e-02	7.04e-01
GOCC CLEAVAGE FURROW	51	1.44e-01	4.65e-01	0.2550	-4.88e-02	1.56e-02	-1.99e-01	-1.29e-01	-7.62e-02	5.47e-01	8.47e-01	1.38e-02	1.10e-01	3.46e-01
GOCC MICROFIBRIL	13	7.98e-01	9.32e-01	0.2550	-8.99e-02	-2.05e-01	-5.33e-02	7.93e-02	-7.61e-02	5.75e-01	2.01e-01	7.40e-01	6.20e-01	6.35e-01
GOBP ENDOCYTOSIS INVOLVED IN VIRAL ENTRY INTO HOST CELL	12	7.72e-01	9.25e-01	0.2550	-1.41e-01	-2.23e-02	-3.43e-02	-1.86e-01	-9.41e-02	3.99e-01	8.93e-01	8.37e-01	2.65e-01	5.72e-01
GOCC TRAMP COMPLEX	5	9.42e-01	9.82e-01	0.2550	-1.14e-02	1.44e-01	1.13e-01	-1.18e-01	-1.32e-01	9.65e-01	5.77e-01	6.63e-01	6.48e-01	6.10e-01
GOCC ENDOLYSOSOME MEMBRANE	17	6.39e-01	8.74e-01	0.2550	-1.11e-02	1.55e-01	-4.19e-02	-1.37e-01	-1.42e-01	9.37e-01	2.69e-01	7.65e-01	3.28e-01	3.10e-01
GOBP ACTION POTENTIAL	139	1.39e-03	2.01e-02	0.2550	-8.91e-02	3.58e-02	1.53e-01	1.74e-01	-4.22e-02	6.98e-02	4.66e-01	1.84e-03	3.82e-04	3.90e-01
GOBP INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY	88	5.93e-03	6.03e-02	0.2550	-2.66e-02	1.01e-01	1.04e-01	2.61e-02	2.06e-01	6.67e-01	9.98e-02	9.10e-02	6.72e-01	8.54e-04
GOMF PROTEIN SERINE THREONINE TYROSINE KINASE ACTIVITY	44	1.83e-01	5.25e-01	0.2550	1.07e-01	-6.72e-03	-9.43e-03	-9.13e-02	2.12e-01	2.21e-01	9.39e-01	9.14e-01	2.95e-01	1.49e-02
GOBP EPIBOLY	37	2.38e-01	5.93e-01	0.2550	1.26e-01	1.89e-01	6.58e-02	5.36e-02	7.74e-02	1.83e-01	4.69e-02	4.88e-01	5.73e-01	4.15e-01
GOMF INOSITOL 1 4 5 TRISPHOSPHATE BINDING	11	8.28e-01	9.44e-01	0.2550	7.67e-04	1.58e-01	1.79e-01	-1.65e-03	-8.71e-02	9.96e-01	3.63e-01	3.03e-01	9.92e-01	6.17e-01
GOBP REGULATION OF LYSOSOMAL PROTEIN CATABOLIC PROCESS	11	8.68e-01	9.56e-01	0.2550	1.82e-01	3.98e-02	-1.46e-01	-9.23e-02	-1.70e-02	2.96e-01	8.19e-01	4.02e-01	5.96e-01	9.22e-01
GOBP MEGAKARYOCYTE DIFFERENTIATION	61	7.52e-02	3.29e-01	0.2550	-1.53e-02	-3.21e-02	-9.19e-02	-2.28e-01	5.60e-02	8.36e-01	6.64e-01	2.15e-01	2.08e-03	4.49e-01
GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC CLASS II PROTEIN COMPLEX	14	6.80e-01	8.87e-01	0.2550	-1.96e-01	-5.19e-02	1.29e-01	-5.17e-02	-6.63e-02	2.04e-01	7.37e-01	4.03e-01	7.38e-01	6.68e-01
GOBP PROTEIN EXPORT FROM NUCLEUS	59	4.86e-02	2.49e-01	0.2540	-8.52e-03	1.90e-01	-3.89e-02	-1.54e-01	-5.81e-02	9.10e-01	1.15e-02	6.05e-01	4.12e-02	4.40e-01
GOBP BASEMENT MEMBRANE ASSEMBLY	9	9.34e-01	9.80e-01	0.2540	3.30e-03	2.64e-02	1.77e-01	1.59e-01	-8.50e-02	9.86e-01	8.91e-01	3.57e-01	4.08e-01	6.59e-01
GOBP REVERSE CHOLESTEROL TRANSPORT	20	5.20e-01	8.13e-01	0.2540	-1.02e-01	1.95e-01	-8.50e-02	-2.35e-02	-9.23e-02	4.29e-01	1.31e-01	5.10e-01	8.55e-01	4.75e-01
GOBP INOSITOL PHOSPHATE METABOLIC PROCESS	42	2.01e-01	5.50e-01	0.2540	-7.56e-02	1.83e-01	1.36e-01	2.64e-02	-7.79e-02	3.96e-01	3.97e-02	1.26e-01	7.68e-01	3.82e-01
GOMF CAMP DEPENDENT PROTEIN KINASE REGULATOR ACTIVITY	12	8.81e-01	9.61e-01	0.2540	3.71e-03	7.12e-02	1.53e-01	1.90e-01	-7.15e-03	9.82e-01	6.69e-01	3.60e-01	2.53e-01	9.66e-01
GOMF SH2 DOMAIN BINDING	40	1.87e-01	5.30e-01	0.2540	4.57e-02	1.74e-01	1.63e-01	1.26e-02	-7.50e-02	6.17e-01	5.74e-02	7.38e-02	8.90e-01	4.12e-01
GOBP REGULATION OF HISTONE MODIFICATION	36	2.86e-01	6.40e-01	0.2540	2.00e-01	3.48e-02	-4.87e-02	-1.28e-01	6.77e-02	3.77e-02	7.18e-01	6.13e-01	1.83e-01	4.82e-01
GOCC PROTEIN COMPLEX INVOLVED IN CELL ADHESION	56	5.97e-02	2.86e-01	0.2540	-1.25e-01	7.24e-02	5.29e-02	1.98e-01	-4.41e-02	1.05e-01	3.49e-01	4.94e-01	1.05e-02	5.68e-01
GOMF LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR BINDING	24	3.64e-01	7.05e-01	0.2540	6.14e-02	-5.90e-02	-4.59e-02	-1.15e-01	-2.05e-01	6.02e-01	6.17e-01	6.97e-01	3.28e-01	8.21e-02
GOBP POSITIVE REGULATION OF P38MAPK CASCADE	30	3.19e-01	6.67e-01	0.2540	-1.29e-01	1.20e-01	5.54e-02	-1.33e-01	1.13e-01	2.21e-01	2.54e-01	5.99e-01	2.08e-01	2.84e-01
GOBP TORC1 SIGNALING	95	1.12e-02	9.51e-02	0.2540	7.57e-02	1.26e-02	-1.18e-01	-2.11e-01	7.30e-03	2.02e-01	8.31e-01	4.60e-02	3.71e-04	9.02e-01
GOBP LYSOSOMAL MICROAUTOPHAGY	13	7.30e-01	9.07e-01	0.2540	-3.58e-02	-2.44e-01	3.56e-02	-3.91e-02	3.13e-02	8.23e-01	1.28e-01	8.24e-01	8.07e-01	8.45e-01
GOBP NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN	11	7.96e-01	9.32e-01	0.2540	-8.44e-02	1.46e-01	7.58e-02	-9.05e-02	-1.49e-01	6.28e-01	4.03e-01	6.64e-01	6.03e-01	3.91e-01
GOBP POSITIVE REGULATION OF OSSIFICATION	52	7.57e-02	3.30e-01	0.2540	-8.94e-02	9.27e-02	1.93e-01	-2.67e-02	9.99e-02	2.65e-01	2.47e-01	1.60e-02	7.40e-01	2.13e-01
GOBP REGULATION OF RESPONSE TO TUMOR CELL	22	4.44e-01	7.67e-01	0.2540	-1.55e-01	1.44e-01	-1.26e-01	-4.05e-02	-4.63e-02	2.07e-01	2.42e-01	3.06e-01	7.42e-01	7.07e-01
GOBP NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS	26	4.34e-01	7.57e-01	0.2540	-2.29e-02	-1.55e-01	-1.83e-01	3.00e-02	-7.60e-02	8.40e-01	1.72e-01	1.07e-01	7.91e-01	5.03e-01
GOBP ACTIN MEDIATED CELL CONTRACTION	101	7.71e-03	7.28e-02	0.2540	-4.85e-02	-4.54e-02	7.79e-02	2.09e-01	-1.01e-01	4.00e-01	4.30e-01	1.76e-01	2.74e-04	7.96e-02
GOBP NEGATIVE REGULATION OF CHEMOKINE PRODUCTION	29	2.59e-01	6.16e-01	0.2540	-3.51e-02	6.81e-02	1.62e-01	-1.25e-01	1.29e-01	7.44e-01	5.26e-01	1.30e-01	2.43e-01	2.30e-01
GOBP PROTEIN K48 LINKED UBIQUITINATION	64	4.59e-02	2.40e-01	0.2540	2.27e-02	8.02e-02	-8.97e-02	-2.17e-01	-4.86e-02	7.53e-01	2.67e-01	2.15e-01	2.65e-03	5.01e-01
GOBP ESTROGEN METABOLIC PROCESS	36	3.61e-01	7.04e-01	0.2540	4.13e-02	8.62e-02	1.39e-01	1.89e-01	-1.52e-02	6.68e-01	3.71e-01	1.49e-01	4.92e-02	8.75e-01
GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR	82	2.20e-02	1.50e-01	0.2540	8.20e-02	-5.93e-02	-1.14e-01	-2.03e-01	1.37e-02	1.99e-01	3.53e-01	7.49e-02	1.49e-03	8.30e-01
GOCC INCLUSION BODY	69	6.68e-02	3.05e-01	0.2540	1.54e-02	-2.91e-02	-1.29e-01	-2.14e-01	3.01e-02	8.25e-01	6.76e-01	6.39e-02	2.09e-03	6.65e-01
GOBP OVULATION	15	8.23e-01	9.42e-01	0.2540	5.53e-02	-1.02e-03	-1.88e-01	-1.59e-01	-3.27e-02	7.11e-01	9.95e-01	2.09e-01	2.87e-01	8.26e-01
GOBP NEUTRAL LIPID BIOSYNTHETIC PROCESS	45	1.47e-01	4.70e-01	0.2540	-1.70e-02	1.83e-01	4.32e-02	-1.16e-01	1.24e-01	8.44e-01	3.40e-02	6.16e-01	1.79e-01	1.49e-01
GOCC CHROMAFFIN GRANULE	13	5.20e-01	8.13e-01	0.2540	-4.52e-02	-1.37e-02	1.35e-01	-2.02e-01	-5.62e-02	7.78e-01	9.32e-01	3.98e-01	2.08e-01	7.26e-01
GOBP LIPID DROPLET ORGANIZATION	34	2.70e-01	6.24e-01	0.2540	2.23e-02	1.96e-02	-9.31e-02	-2.14e-01	-9.55e-02	8.22e-01	8.43e-01	3.47e-01	3.09e-02	3.35e-01
GOBP RESPONSE TO TESTOSTERONE	41	2.23e-01	5.76e-01	0.2540	2.19e-02	-1.06e-01	-1.08e-01	-2.02e-01	-8.61e-03	8.09e-01	2.38e-01	2.30e-01	2.51e-02	9.24e-01
GOMF HEXOSE TRANSMEMBRANE TRANSPORTER ACTIVITY	25	5.08e-01	8.07e-01	0.2540	8.94e-05	8.24e-02	6.16e-02	2.05e-01	-1.09e-01	9.99e-01	4.75e-01	5.94e-01	7.62e-02	3.46e-01
GOBP WATER TRANSPORT	28	5.30e-01	8.19e-01	0.2540	-3.73e-02	2.33e-02	1.06e-01	1.88e-01	-1.26e-01	7.33e-01	8.31e-01	3.34e-01	8.49e-02	2.48e-01
GOBP REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY SARCOPLASMIC RETICULUM	29	5.31e-01	8.19e-01	0.2540	5.04e-03	1.35e-02	1.76e-01	1.82e-01	3.54e-03	9.63e-01	9.00e-01	1.01e-01	8.92e-02	9.74e-01
GOBP CELLULAR RESPONSE TO ALDEHYDE	16	6.83e-01	8.88e-01	0.2540	1.67e-01	-1.49e-01	-1.91e-02	1.15e-01	-2.99e-02	2.48e-01	3.03e-01	8.95e-01	4.28e-01	8.36e-01
GOBP REGULATION OF ATP DEPENDENT ACTIVITY	61	1.17e-01	4.17e-01	0.2530	7.68e-02	-9.76e-02	-1.66e-01	-1.45e-01	1.11e-02	3.00e-01	1.87e-01	2.48e-02	4.96e-02	8.81e-01
GOBP RESPONSE TO UV	147	8.68e-04	1.38e-02	0.2530	1.02e-03	-3.36e-02	-1.43e-01	-1.83e-01	9.65e-02	9.83e-01	4.82e-01	2.73e-03	1.33e-04	4.34e-02
GOMF HYALURONONGLUCOSAMINIDASE ACTIVITY	8	8.42e-01	9.48e-01	0.2530	-9.79e-03	5.42e-02	1.12e-02	1.88e-01	1.60e-01	9.62e-01	7.91e-01	9.56e-01	3.56e-01	4.34e-01
GOMF GLYCOLIPID BINDING	28	2.01e-01	5.50e-01	0.2530	-1.00e-01	4.41e-02	5.64e-03	1.68e-01	1.54e-01	3.59e-01	6.87e-01	9.59e-01	1.23e-01	1.57e-01
GOBP REGULATION OF CHROMOSOME ORGANIZATION	239	5.10e-07	2.50e-05	0.2530	9.54e-02	-5.90e-02	-9.39e-02	-1.93e-01	7.55e-02	1.10e-02	1.16e-01	1.24e-02	2.88e-07	4.45e-02
GOMF TYPE I TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING	11	8.30e-01	9.44e-01	0.2530	-2.80e-03	2.20e-01	1.87e-02	-8.34e-02	-9.20e-02	9.87e-01	2.06e-01	9.15e-01	6.32e-01	5.97e-01
GOMF C2H2 ZINC FINGER DOMAIN BINDING	12	7.90e-01	9.31e-01	0.2530	1.74e-01	-6.72e-03	1.51e-01	4.33e-03	1.05e-01	2.96e-01	9.68e-01	3.66e-01	9.79e-01	5.29e-01
GOMF INSULIN LIKE GROWTH FACTOR BINDING	19	2.65e-01	6.21e-01	0.2530	-6.03e-02	1.06e-01	-1.19e-01	1.77e-01	6.10e-02	6.49e-01	4.23e-01	3.70e-01	1.81e-01	6.45e-01
GOBP GLUCOCORTICOID METABOLIC PROCESS	23	4.43e-01	7.66e-01	0.2530	7.86e-03	-8.90e-03	-7.07e-02	1.79e-01	-1.64e-01	9.48e-01	9.41e-01	5.57e-01	1.38e-01	1.72e-01
GOCC GOLGI TRANSPORT COMPLEX	9	8.60e-01	9.53e-01	0.2530	2.12e-01	8.59e-02	5.71e-02	-9.05e-02	-1.21e-02	2.70e-01	6.56e-01	7.67e-01	6.38e-01	9.50e-01
GOBP PROTEIN O LINKED GLYCOSYLATION VIA THREONINE	10	7.75e-01	9.26e-01	0.2530	-8.90e-02	-1.23e-01	1.98e-01	-3.31e-02	2.56e-02	6.26e-01	5.00e-01	2.78e-01	8.56e-01	8.89e-01
GOMF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY	26	5.32e-01	8.20e-01	0.2530	-1.07e-01	6.05e-02	1.58e-01	1.37e-01	7.27e-02	3.44e-01	5.93e-01	1.63e-01	2.28e-01	5.21e-01
GOBP NEGATIVE REGULATION OF PROTEIN MATURATION	27	3.35e-01	6.82e-01	0.2530	7.33e-02	1.83e-01	9.33e-02	-6.89e-02	-1.08e-01	5.10e-01	9.95e-02	4.01e-01	5.35e-01	3.32e-01
GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR	22	6.04e-01	8.55e-01	0.2530	-1.78e-02	8.48e-02	-1.80e-01	-1.41e-01	6.39e-02	8.85e-01	4.91e-01	1.43e-01	2.53e-01	6.04e-01
GOBP NEGATIVE REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT	12	6.78e-01	8.87e-01	0.2530	-4.16e-02	1.18e-01	1.44e-01	-1.53e-01	-6.30e-02	8.03e-01	4.79e-01	3.87e-01	3.58e-01	7.05e-01
GOMF TAT PROTEIN BINDING	10	8.37e-01	9.46e-01	0.2530	1.34e-01	6.63e-02	4.20e-02	1.76e-02	-1.99e-01	4.62e-01	7.17e-01	8.18e-01	9.23e-01	2.77e-01
GOBP INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS	74	6.94e-03	6.75e-02	0.2530	-1.45e-01	1.50e-01	4.03e-02	1.28e-01	4.76e-02	3.13e-02	2.52e-02	5.49e-01	5.67e-02	4.79e-01
GOBP POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION	26	4.04e-01	7.37e-01	0.2530	-2.31e-01	5.45e-02	5.85e-02	-6.60e-02	-7.02e-04	4.19e-02	6.31e-01	6.06e-01	5.60e-01	9.95e-01
GOBP PIGMENT BIOSYNTHETIC PROCESS	51	1.40e-01	4.60e-01	0.2530	-4.81e-03	9.60e-02	-6.46e-02	-1.57e-01	1.61e-01	9.53e-01	2.36e-01	4.25e-01	5.23e-02	4.72e-02
GOBP POSITIVE REGULATION OF FIBROBLAST MIGRATION	15	7.46e-01	9.14e-01	0.2530	2.38e-02	7.71e-02	7.39e-02	2.26e-01	-2.80e-02	8.73e-01	6.05e-01	6.20e-01	1.30e-01	8.51e-01
GOBP SODIUM ION TRANSMEMBRANE TRANSPORT	169	1.61e-04	3.49e-03	0.2530	-5.02e-02	1.17e-01	1.50e-01	1.25e-01	-9.62e-02	2.60e-01	8.59e-03	7.39e-04	4.92e-03	3.09e-02
GOCC CHROMOSOME	1811	1.78e-53	1.40e-50	0.2530	7.82e-02	2.59e-02	-8.00e-02	-2.02e-01	9.87e-02	3.30e-08	6.79e-02	1.60e-08	1.81e-46	3.07e-12
GOBP FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS	13	8.36e-01	9.46e-01	0.2530	1.12e-01	-1.30e-02	-2.08e-01	-8.57e-02	2.24e-02	4.84e-01	9.35e-01	1.94e-01	5.93e-01	8.89e-01
GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE BINDING	26	4.96e-01	8.00e-01	0.2530	-5.10e-03	1.53e-01	1.31e-01	1.13e-01	1.02e-01	9.64e-01	1.78e-01	2.47e-01	3.19e-01	3.66e-01
GOMF BETA TUBULIN BINDING	35	3.24e-01	6.72e-01	0.2530	-1.13e-02	-4.31e-02	-1.04e-01	-2.26e-01	-3.50e-03	9.08e-01	6.59e-01	2.88e-01	2.08e-02	9.71e-01
GOBP REGULATION OF ADHERENS JUNCTION ORGANIZATION	5	9.65e-01	9.90e-01	0.2520	-1.99e-01	-1.18e-01	-4.96e-02	-3.49e-02	8.03e-02	4.40e-01	6.48e-01	8.48e-01	8.92e-01	7.56e-01
GOBP REGULATION OF TRANSLATIONAL INITIATION	76	5.59e-02	2.74e-01	0.2520	2.40e-02	3.19e-02	-1.75e-01	-1.77e-01	1.54e-02	7.17e-01	6.30e-01	8.22e-03	7.79e-03	8.17e-01
GOBP POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS	33	2.15e-01	5.69e-01	0.2520	-1.79e-01	-2.54e-02	-3.06e-02	-9.38e-03	1.73e-01	7.52e-02	8.01e-01	7.61e-01	9.26e-01	8.49e-02
GOBP CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS	20	5.47e-01	8.27e-01	0.2520	-2.19e-01	3.50e-02	2.89e-02	-2.95e-02	1.13e-01	9.01e-02	7.86e-01	8.23e-01	8.19e-01	3.80e-01
GOBP NEURON NEURON SYNAPTIC TRANSMISSION	6	9.59e-01	9.88e-01	0.2520	-1.58e-01	1.18e-01	4.60e-02	4.71e-02	-1.43e-01	5.04e-01	6.15e-01	8.45e-01	8.42e-01	5.44e-01
GOBP CARDIAC NEURAL CREST CELL DEVELOPMENT INVOLVED IN OUTFLOW TRACT MORPHOGENESIS	13	7.80e-01	9.28e-01	0.2520	2.03e-01	1.39e-01	1.05e-02	-4.72e-02	-2.66e-02	2.04e-01	3.86e-01	9.48e-01	7.68e-01	8.68e-01
GOBP REGULATION OF MITOTIC CENTROSOME SEPARATION	9	8.89e-01	9.63e-01	0.2520	1.68e-01	-1.36e-01	-1.18e-01	4.78e-02	-2.36e-02	3.82e-01	4.80e-01	5.39e-01	8.04e-01	9.02e-01
GOBP MIDBRAIN DEVELOPMENT	86	7.09e-03	6.85e-02	0.2520	-8.91e-02	7.63e-02	-3.82e-03	-2.01e-01	9.77e-02	1.53e-01	2.21e-01	9.51e-01	1.30e-03	1.17e-01
GOBP SYNAPTIC TRANSMISSION DOPAMINERGIC	28	2.16e-01	5.70e-01	0.2520	8.47e-02	3.38e-02	1.24e-01	-1.81e-01	8.57e-02	4.38e-01	7.57e-01	2.57e-01	9.82e-02	4.32e-01
GOBP MEMBRANE REPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL	23	4.28e-01	7.54e-01	0.2520	-1.66e-01	1.67e-01	1.88e-02	8.80e-02	1.20e-02	1.69e-01	1.66e-01	8.76e-01	4.65e-01	9.21e-01
GOBP POSITIVE REGULATION OF MHC CLASS I BIOSYNTHETIC PROCESS	6	9.58e-01	9.87e-01	0.2520	-4.69e-02	-3.58e-02	2.28e-01	7.58e-02	4.99e-02	8.42e-01	8.79e-01	3.34e-01	7.48e-01	8.32e-01
GOBP REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY	28	4.58e-01	7.76e-01	0.2520	1.20e-01	8.92e-02	1.81e-01	7.22e-02	5.76e-02	2.72e-01	4.14e-01	9.80e-02	5.08e-01	5.98e-01
GOBP REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS	54	1.38e-01	4.57e-01	0.2520	-1.21e-01	1.21e-01	1.12e-01	1.17e-01	-8.89e-02	1.25e-01	1.24e-01	1.54e-01	1.36e-01	2.58e-01
GOBP FILOPODIUM ASSEMBLY	65	8.58e-02	3.54e-01	0.2520	-7.91e-02	1.26e-01	1.34e-01	1.25e-01	-8.90e-02	2.70e-01	7.95e-02	6.17e-02	8.20e-02	2.15e-01
GOBP POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION	68	1.32e-02	1.07e-01	0.2520	-1.61e-01	1.60e-01	7.79e-04	1.02e-01	-4.03e-02	2.17e-02	2.24e-02	9.91e-01	1.48e-01	5.65e-01
GOMF HORMONE RECEPTOR BINDING	29	4.15e-01	7.45e-01	0.2520	1.52e-02	8.07e-02	1.62e-01	1.98e-02	1.74e-01	8.88e-01	4.52e-01	1.32e-01	8.53e-01	1.05e-01
GOBP REGULATION OF CILIUM MOVEMENT	38	2.56e-01	6.13e-01	0.2520	-1.37e-01	-1.45e-01	-9.17e-02	-2.00e-03	-1.24e-01	1.45e-01	1.23e-01	3.28e-01	9.83e-01	1.85e-01
GOBP NEGATIVE REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION	189	3.78e-05	1.06e-03	0.2520	9.96e-02	-4.83e-03	-1.50e-01	-1.75e-01	-2.34e-02	1.82e-02	9.09e-01	3.88e-04	3.38e-05	5.80e-01
GOCC AP 1 ADAPTOR COMPLEX	11	8.20e-01	9.41e-01	0.2520	3.93e-03	3.85e-02	1.53e-01	-7.94e-02	1.79e-01	9.82e-01	8.25e-01	3.78e-01	6.48e-01	3.03e-01
GOMF RNA POLYMERASE BINDING	57	1.38e-01	4.57e-01	0.2520	1.02e-01	-5.35e-02	-1.06e-01	-1.58e-01	1.17e-01	1.83e-01	4.85e-01	1.65e-01	3.86e-02	1.25e-01
GOMF RNA METHYLTRANSFERASE ACTIVITY	59	1.43e-01	4.64e-01	0.2520	6.44e-02	-7.40e-03	-1.51e-01	-1.89e-01	2.74e-02	3.92e-01	9.22e-01	4.51e-02	1.21e-02	7.16e-01
GOBP CELLULAR RESPONSE TO HYDROGEN PEROXIDE	65	6.10e-02	2.90e-01	0.2520	8.13e-02	1.08e-01	-8.58e-02	-1.94e-01	9.43e-03	2.57e-01	1.32e-01	2.31e-01	6.80e-03	8.95e-01
GOBP REGULATION OF VIRAL GENOME REPLICATION	84	3.14e-02	1.89e-01	0.2520	3.47e-02	-5.05e-02	-1.26e-01	-2.04e-01	4.51e-02	5.83e-01	4.23e-01	4.65e-02	1.20e-03	4.75e-01
GOBP CYTIDINE TO URIDINE EDITING	12	7.96e-01	9.32e-01	0.2520	2.49e-01	-3.75e-02	8.63e-03	-2.50e-03	-4.89e-03	1.36e-01	8.22e-01	9.59e-01	9.88e-01	9.77e-01
GOBP POSITIVE REGULATION OF DNA METABOLIC PROCESS	286	8.39e-08	4.79e-06	0.2520	8.12e-02	-2.41e-02	-1.17e-01	-1.97e-01	6.07e-02	1.81e-02	4.84e-01	6.36e-04	1.03e-08	7.73e-02
GOMF HSP70 PROTEIN BINDING	50	2.04e-01	5.53e-01	0.2520	8.18e-02	-1.09e-01	-1.67e-01	-1.29e-01	4.81e-03	3.17e-01	1.82e-01	4.07e-02	1.14e-01	9.53e-01
GOBP AROMATIC AMINO ACID TRANSPORT	9	8.77e-01	9.59e-01	0.2520	-1.39e-01	-1.03e-01	-3.48e-03	-1.62e-01	8.48e-02	4.69e-01	5.94e-01	9.86e-01	4.01e-01	6.60e-01
GOMF HISTONE READER ACTIVITY	12	8.87e-01	9.62e-01	0.2520	7.99e-02	-4.16e-02	-1.70e-01	-1.31e-01	9.64e-02	6.32e-01	8.03e-01	3.09e-01	4.34e-01	5.63e-01
GOBP DNA REPLICATION	272	3.92e-07	1.97e-05	0.2520	5.42e-02	-1.13e-02	-1.49e-01	-1.94e-01	1.81e-02	1.24e-01	7.48e-01	2.39e-05	3.47e-08	6.08e-01
GOBP CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT	23	3.26e-01	6.74e-01	0.2520	1.40e-01	-1.38e-01	6.88e-02	-1.30e-01	5.31e-02	2.44e-01	2.50e-01	5.68e-01	2.82e-01	6.60e-01
GOMF CORECEPTOR ACTIVITY	47	1.61e-01	4.93e-01	0.2510	-1.98e-01	2.30e-02	1.11e-01	1.04e-01	1.98e-02	1.87e-02	7.85e-01	1.90e-01	2.18e-01	8.15e-01
GOCC TRANSFERASE COMPLEX TRANSFERRING PHOSPHORUS CONTAINING GROUPS	271	6.44e-07	3.01e-05	0.2510	6.48e-02	-6.01e-03	-1.61e-01	-1.66e-01	7.56e-02	6.62e-02	8.65e-01	5.39e-06	2.58e-06	3.23e-02
GOBP DOPAMINE BIOSYNTHETIC PROCESS	12	8.64e-01	9.54e-01	0.2510	-5.07e-02	6.15e-02	1.51e-01	9.80e-02	-1.56e-01	7.61e-01	7.12e-01	3.65e-01	5.57e-01	3.49e-01
GOBP REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY	43	1.78e-01	5.19e-01	0.2510	-6.19e-02	1.25e-01	-1.63e-01	-1.28e-01	2.94e-02	4.83e-01	1.55e-01	6.48e-02	1.47e-01	7.38e-01
GOBP VESICLE TETHERING INVOLVED IN EXOCYTOSIS	9	7.97e-01	9.32e-01	0.2510	1.45e-01	-7.18e-02	1.51e-01	-9.54e-02	7.23e-02	4.53e-01	7.09e-01	4.33e-01	6.20e-01	7.07e-01
GOBP REGULATION OF RNA SPLICING	163	3.19e-04	6.23e-03	0.2510	3.03e-02	1.74e-02	-1.20e-01	-2.04e-01	7.74e-02	5.04e-01	7.01e-01	8.19e-03	7.15e-06	8.80e-02
GOBP TUBULIN DEACETYLATION	19	6.93e-01	8.93e-01	0.2510	1.49e-01	5.32e-02	-3.48e-02	-1.20e-01	1.50e-01	2.62e-01	6.88e-01	7.93e-01	3.65e-01	2.57e-01
GOBP DETECTION OF VISIBLE LIGHT	46	2.18e-01	5.73e-01	0.2510	3.49e-02	5.49e-02	1.24e-01	2.08e-01	-1.24e-02	6.83e-01	5.19e-01	1.47e-01	1.44e-02	8.84e-01
GOBP HEPATOCYTE DIFFERENTIATION	15	6.57e-01	8.80e-01	0.2510	1.42e-01	-1.87e-02	-1.91e-01	5.90e-02	-5.10e-02	3.40e-01	9.00e-01	2.01e-01	6.92e-01	7.32e-01
GOBP CARDIAC NEURAL CREST CELL MIGRATION INVOLVED IN OUTFLOW TRACT MORPHOGENESIS	11	8.45e-01	9.49e-01	0.2510	1.74e-01	1.75e-01	3.52e-02	-2.89e-02	-1.14e-02	3.17e-01	3.15e-01	8.40e-01	8.68e-01	9.48e-01
GOCC PINOSOME	7	9.49e-01	9.83e-01	0.2510	1.55e-01	6.82e-02	-3.07e-02	-7.34e-02	1.68e-01	4.79e-01	7.55e-01	8.88e-01	7.37e-01	4.42e-01
GOBP T HELPER 1 TYPE IMMUNE RESPONSE	47	1.09e-01	4.02e-01	0.2510	-5.75e-02	2.19e-01	6.17e-02	7.94e-02	4.06e-02	4.95e-01	9.36e-03	4.64e-01	3.46e-01	6.30e-01
GOMF DICARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY	31	3.97e-01	7.31e-01	0.2510	-9.92e-02	8.34e-02	6.44e-02	1.81e-01	-9.58e-02	3.39e-01	4.22e-01	5.35e-01	8.03e-02	3.56e-01
GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY	14	7.70e-01	9.24e-01	0.2510	-5.15e-02	1.89e-01	1.47e-02	-9.47e-02	1.24e-01	7.39e-01	2.20e-01	9.24e-01	5.40e-01	4.23e-01
GOBP B CELL PROLIFERATION	96	1.45e-02	1.14e-01	0.2510	-4.52e-02	5.68e-02	1.86e-01	1.30e-01	7.82e-02	4.44e-01	3.36e-01	1.59e-03	2.79e-02	1.86e-01
GOMF NEUTRAL L AMINO ACID SODIUM SYMPORTER ACTIVITY	8	9.03e-01	9.68e-01	0.2510	-1.99e-01	8.81e-03	9.13e-02	-4.17e-02	-1.15e-01	3.29e-01	9.66e-01	6.55e-01	8.38e-01	5.73e-01
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY	309	9.21e-09	6.54e-07	0.2510	-1.39e-02	4.68e-02	-1.08e-01	-2.15e-01	5.16e-02	6.75e-01	1.57e-01	1.09e-03	7.84e-11	1.19e-01
GOBP DEADENYLATION DEPENDENT DECAPPING OF NUCLEAR TRANSCRIBED MRNA	11	7.44e-01	9.14e-01	0.2510	1.46e-01	4.13e-02	1.48e-01	-2.27e-02	-1.32e-01	4.01e-01	8.13e-01	3.94e-01	8.96e-01	4.50e-01
GOBP SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING	36	1.85e-01	5.28e-01	0.2510	-7.12e-02	-1.59e-01	1.17e-01	3.45e-02	-1.33e-01	4.60e-01	9.92e-02	2.23e-01	7.20e-01	1.67e-01
GOMF O METHYLTRANSFERASE ACTIVITY	20	6.71e-01	8.83e-01	0.2510	-5.87e-02	-1.20e-01	-1.46e-01	-1.16e-01	-1.03e-01	6.49e-01	3.53e-01	2.60e-01	3.71e-01	4.27e-01
GOMF L GLUTAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY	8	9.14e-01	9.72e-01	0.2510	-1.89e-01	9.99e-02	-4.04e-02	-1.13e-01	-5.36e-02	3.56e-01	6.25e-01	8.43e-01	5.79e-01	7.93e-01
GOBP TETRAHYDROFOLATE INTERCONVERSION	9	8.87e-01	9.62e-01	0.2510	-7.97e-02	1.26e-01	-3.48e-03	-7.10e-02	1.89e-01	6.79e-01	5.13e-01	9.86e-01	7.12e-01	3.27e-01
GOBP REGULATION OF DENDRITIC SPINE MAINTENANCE	12	8.37e-01	9.46e-01	0.2510	8.53e-02	7.51e-02	1.10e-01	1.38e-01	1.37e-01	6.09e-01	6.52e-01	5.08e-01	4.09e-01	4.11e-01
GOBP LATERAL VENTRICLE DEVELOPMENT	12	8.60e-01	9.53e-01	0.2510	-3.87e-02	1.95e-01	1.29e-01	7.27e-02	-3.61e-02	8.17e-01	2.41e-01	4.41e-01	6.63e-01	8.29e-01
GOBP TERTIARY ALCOHOL METABOLIC PROCESS	22	6.04e-01	8.55e-01	0.2510	4.36e-02	-5.77e-02	6.92e-02	2.23e-01	-5.35e-02	7.23e-01	6.40e-01	5.74e-01	6.96e-02	6.64e-01
GOBP POSITIVE REGULATION OF PROTEIN MATURATION	27	3.58e-01	7.03e-01	0.2510	-1.12e-01	1.64e-01	-3.60e-02	8.00e-02	-1.25e-01	3.15e-01	1.40e-01	7.46e-01	4.72e-01	2.60e-01
GOBP REGULATION OF MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL	9	8.98e-01	9.67e-01	0.2510	-1.26e-01	-1.91e-01	-7.41e-02	-2.46e-02	6.46e-02	5.12e-01	3.21e-01	7.00e-01	8.98e-01	7.37e-01
GOBP MEMBRANE REPOLARIZATION DURING ATRIAL CARDIAC MUSCLE CELL ACTION POTENTIAL	6	9.47e-01	9.83e-01	0.2510	1.28e-01	1.37e-01	6.72e-03	2.78e-03	-1.66e-01	5.87e-01	5.62e-01	9.77e-01	9.91e-01	4.81e-01
GOBP NEGATIVE REGULATION OF CELL KILLING	28	3.62e-01	7.04e-01	0.2510	1.31e-01	-1.27e-01	1.34e-01	6.34e-02	8.65e-02	2.28e-01	2.46e-01	2.20e-01	5.61e-01	4.28e-01
GOBP REGULATION OF LONG TERM SYNAPTIC DEPRESSION	12	8.92e-01	9.63e-01	0.2510	-1.71e-02	1.81e-02	1.41e-01	2.01e-01	-4.48e-02	9.18e-01	9.13e-01	3.99e-01	2.28e-01	7.88e-01
GOBP PEPTIDYL L CYSTEINE S PALMITOYLATION	20	5.13e-01	8.08e-01	0.2500	-1.59e-01	7.59e-02	1.55e-01	-8.50e-02	1.48e-02	2.17e-01	5.57e-01	2.29e-01	5.10e-01	9.08e-01
GOBP LYTIC VACUOLE ORGANIZATION	103	8.05e-03	7.52e-02	0.2500	7.97e-02	6.08e-02	-6.09e-02	-1.74e-01	1.36e-01	1.62e-01	2.87e-01	2.86e-01	2.22e-03	1.69e-02
GOBP GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS	21	5.68e-01	8.37e-01	0.2500	-7.11e-02	1.85e-01	-1.02e-01	-1.14e-01	-9.08e-03	5.73e-01	1.42e-01	4.19e-01	3.66e-01	9.43e-01
GOBP PHARYNGEAL SYSTEM DEVELOPMENT	30	3.91e-01	7.26e-01	0.2500	2.14e-01	8.13e-02	-7.79e-03	-4.12e-02	9.22e-02	4.26e-02	4.41e-01	9.41e-01	6.96e-01	3.82e-01
GOBP SALIVA SECRETION	13	8.31e-01	9.44e-01	0.2500	-1.01e-01	8.08e-03	9.84e-02	2.07e-01	5.87e-03	5.30e-01	9.60e-01	5.39e-01	1.97e-01	9.71e-01
GOBP PIECEMEAL MICROAUTOPHAGY OF THE NUCLEUS	10	8.63e-01	9.54e-01	0.2500	-3.11e-02	-2.08e-01	5.61e-03	-3.24e-02	1.31e-01	8.65e-01	2.54e-01	9.76e-01	8.59e-01	4.75e-01
GOBP POSITIVE REGULATION OF PODOSOME ASSEMBLY	10	7.55e-01	9.17e-01	0.2500	5.13e-02	1.21e-01	-1.32e-01	1.40e-01	-9.14e-02	7.79e-01	5.09e-01	4.70e-01	4.44e-01	6.17e-01
GOBP CHROMOSOME ORGANIZATION	604	7.97e-17	1.18e-14	0.2500	4.44e-02	-5.44e-02	-1.12e-01	-1.93e-01	8.84e-02	6.21e-02	2.24e-02	2.42e-06	5.49e-16	2.07e-04
GOBP REGULATION OF GLUTAMATE SECRETION	20	6.52e-01	8.79e-01	0.2500	-9.08e-02	-5.34e-04	1.32e-01	1.64e-01	9.98e-02	4.82e-01	9.97e-01	3.06e-01	2.05e-01	4.40e-01
GOMF ACYL COA OXIDASE ACTIVITY	7	8.36e-01	9.46e-01	0.2500	5.18e-02	1.23e-01	-1.01e-01	1.36e-01	1.27e-01	8.12e-01	5.73e-01	6.44e-01	5.34e-01	5.62e-01
GOBP REGULATION OF ACTION POTENTIAL	55	1.20e-01	4.24e-01	0.2500	8.19e-03	-1.00e-01	1.11e-01	1.99e-01	2.40e-02	9.16e-01	1.99e-01	1.54e-01	1.08e-02	7.58e-01
GOBP VITAMIN BIOSYNTHETIC PROCESS	24	6.13e-01	8.59e-01	0.2500	1.39e-01	4.00e-02	-1.56e-01	-1.25e-01	3.85e-02	2.39e-01	7.34e-01	1.86e-01	2.87e-01	7.44e-01
GOBP REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION	43	1.46e-01	4.69e-01	0.2500	-1.52e-01	1.22e-01	3.92e-02	-1.34e-01	6.90e-02	8.38e-02	1.67e-01	6.56e-01	1.28e-01	4.34e-01
GOCC CONDENSED CHROMOSOME	265	2.70e-07	1.42e-05	0.2500	9.29e-02	-9.85e-03	-8.66e-02	-1.86e-01	1.07e-01	9.25e-03	7.82e-01	1.52e-02	1.75e-07	2.80e-03
GOBP T HELPER 1 CELL DIFFERENTIATION	23	4.75e-01	7.88e-01	0.2500	-6.76e-03	2.27e-01	-7.98e-02	-6.05e-02	2.94e-02	9.55e-01	5.98e-02	5.08e-01	6.16e-01	8.07e-01
GOBP NEGATIVE REGULATION OF CILIUM ASSEMBLY	18	6.31e-01	8.69e-01	0.2500	6.60e-02	-1.44e-01	-2.12e-02	5.13e-02	1.85e-01	6.28e-01	2.90e-01	8.76e-01	7.06e-01	1.75e-01
GOBP AMP METABOLIC PROCESS	22	6.57e-01	8.80e-01	0.2500	-3.23e-02	-8.72e-02	-1.12e-01	-1.66e-01	1.17e-01	7.93e-01	4.79e-01	3.64e-01	1.79e-01	3.41e-01
GOBP CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION	58	1.17e-01	4.18e-01	0.2500	-1.27e-01	7.33e-02	1.50e-01	8.38e-02	-1.06e-01	9.38e-02	3.34e-01	4.82e-02	2.69e-01	1.63e-01
GOBP ERROR PRONE TRANSLESION SYNTHESIS	11	8.84e-01	9.61e-01	0.2500	1.87e-01	-5.36e-02	-9.93e-02	-1.02e-01	6.29e-02	2.82e-01	7.58e-01	5.69e-01	5.57e-01	7.18e-01
GOBP CHROMATIN LOOPING	11	7.81e-01	9.28e-01	0.2490	5.62e-02	-1.47e-01	1.61e-01	-1.01e-02	1.07e-01	7.47e-01	4.00e-01	3.55e-01	9.54e-01	5.38e-01
GOBP RHODOPSIN MEDIATED SIGNALING PATHWAY	12	8.13e-01	9.39e-01	0.2490	8.90e-02	1.70e-01	3.35e-02	3.96e-02	1.51e-01	5.93e-01	3.08e-01	8.41e-01	8.12e-01	3.66e-01
GOBP CELLULAR RESPONSE TO UV	87	3.23e-02	1.92e-01	0.2490	-1.43e-02	-4.02e-03	-1.53e-01	-1.71e-01	9.70e-02	8.17e-01	9.48e-01	1.36e-02	5.93e-03	1.18e-01
GOMF MDM2 MDM4 FAMILY PROTEIN BINDING	11	8.77e-01	9.59e-01	0.2490	1.28e-01	-9.65e-02	-1.29e-01	-1.28e-01	-5.90e-02	4.63e-01	5.79e-01	4.59e-01	4.63e-01	7.35e-01
GOBP CIRCADIAN SLEEP WAKE CYCLE	21	5.60e-01	8.33e-01	0.2490	-6.33e-03	2.16e-01	-3.83e-03	-1.31e-02	-1.24e-01	9.60e-01	8.70e-02	9.76e-01	9.17e-01	3.26e-01
GOBP BICARBONATE TRANSPORT	35	3.02e-01	6.56e-01	0.2490	-5.72e-02	1.42e-02	6.54e-02	6.22e-02	-2.25e-01	5.58e-01	8.84e-01	5.03e-01	5.24e-01	2.14e-02
GOBP MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION	35	3.59e-01	7.04e-01	0.2490	4.98e-02	-1.26e-01	-9.31e-02	-1.71e-01	7.72e-02	6.10e-01	1.99e-01	3.40e-01	8.00e-02	4.29e-01
GOMF VOLTAGE GATED CHLORIDE CHANNEL ACTIVITY	9	9.12e-01	9.71e-01	0.2490	1.39e-02	1.60e-01	1.19e-01	1.15e-01	9.50e-02	9.42e-01	4.06e-01	5.37e-01	5.50e-01	6.22e-01
GOMF LIPASE INHIBITOR ACTIVITY	18	5.60e-01	8.33e-01	0.2490	1.10e-02	1.60e-01	-1.87e-01	-4.00e-02	-2.60e-03	9.36e-01	2.41e-01	1.70e-01	7.69e-01	9.85e-01
GOBP REGULATION OF PHOSPHOLIPID TRANSPORT	15	7.54e-01	9.17e-01	0.2490	-1.05e-01	5.36e-02	-1.13e-01	-6.58e-02	-1.77e-01	4.82e-01	7.19e-01	4.51e-01	6.59e-01	2.36e-01
GOBP TRIGLYCERIDE CATABOLIC PROCESS	27	3.05e-01	6.58e-01	0.2490	-1.41e-01	-4.99e-03	9.95e-04	2.04e-01	2.05e-02	2.05e-01	9.64e-01	9.93e-01	6.61e-02	8.54e-01
GOBP CHONDROCYTE DEVELOPMENT	32	2.62e-01	6.19e-01	0.2490	-6.06e-02	1.60e-01	6.34e-02	-1.69e-01	1.12e-02	5.53e-01	1.16e-01	5.35e-01	9.84e-02	9.12e-01
GOBP AGGREPHAGY	10	7.92e-01	9.31e-01	0.2490	-1.26e-01	1.23e-01	-1.71e-01	4.75e-03	-4.03e-02	4.91e-01	5.00e-01	3.48e-01	9.79e-01	8.25e-01
GOBP REGULATION OF HEAT GENERATION	12	8.60e-01	9.53e-01	0.2490	1.23e-01	9.36e-02	1.35e-01	1.09e-01	8.85e-02	4.60e-01	5.75e-01	4.17e-01	5.13e-01	5.95e-01
GOBP POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING	42	2.43e-01	6.00e-01	0.2490	-3.88e-02	8.59e-03	1.00e-01	2.24e-01	-1.02e-03	6.64e-01	9.23e-01	2.61e-01	1.18e-02	9.91e-01
GOBP MYELOID LEUKOCYTE MIGRATION	230	5.76e-07	2.77e-05	0.2490	-1.28e-01	1.57e-01	1.06e-01	9.45e-02	-2.45e-02	7.87e-04	3.99e-05	5.60e-03	1.35e-02	5.23e-01
GOMF INOSITOL PHOSPHATE PHOSPHATASE ACTIVITY	17	6.91e-01	8.92e-01	0.2490	-3.73e-02	1.15e-01	1.56e-01	2.90e-02	-1.49e-01	7.90e-01	4.11e-01	2.65e-01	8.36e-01	2.89e-01
GOBP REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES	13	7.81e-01	9.28e-01	0.2490	9.54e-02	-1.95e-01	8.10e-04	6.46e-02	-1.03e-01	5.51e-01	2.23e-01	9.96e-01	6.87e-01	5.19e-01
GOCC AZUROPHIL GRANULE MEMBRANE	56	6.39e-02	2.98e-01	0.2490	-1.34e-01	1.52e-01	6.44e-02	-1.03e-01	7.71e-02	8.23e-02	4.84e-02	4.05e-01	1.83e-01	3.18e-01
GOBP VENTRICULAR CARDIAC MUSCLE TISSUE MORPHOGENESIS	47	7.00e-02	3.14e-01	0.2490	1.96e-01	-1.96e-02	-9.35e-02	1.16e-01	2.87e-02	1.99e-02	8.17e-01	2.67e-01	1.69e-01	7.34e-01
GOMF ACETYLCHOLINE BINDING	10	8.70e-01	9.57e-01	0.2490	-1.63e-01	-9.87e-02	-8.72e-02	-6.29e-02	1.19e-01	3.73e-01	5.89e-01	6.33e-01	7.31e-01	5.14e-01
GOBP ENTEROENDOCRINE CELL DIFFERENTIATION	36	2.11e-01	5.63e-01	0.2490	1.25e-01	-4.01e-02	-2.38e-03	-1.98e-01	7.54e-02	1.94e-01	6.77e-01	9.80e-01	4.03e-02	4.34e-01
GOBP ADENYLATE CYCLASE INHIBITING DOPAMINE RECEPTOR SIGNALING PATHWAY	5	9.74e-01	9.92e-01	0.2490	-3.85e-02	-1.57e-01	-1.18e-01	-6.11e-02	1.34e-01	8.81e-01	5.42e-01	6.48e-01	8.13e-01	6.03e-01
GOBP RESPONSE TO CADMIUM ION	56	9.83e-02	3.79e-01	0.2490	-9.75e-02	7.46e-02	-6.21e-02	-1.91e-01	7.96e-02	2.07e-01	3.34e-01	4.22e-01	1.33e-02	3.03e-01
GOBP AMMONIUM TRANSMEMBRANE TRANSPORT	12	8.35e-01	9.45e-01	0.2490	-1.55e-01	7.08e-02	-8.88e-02	-1.41e-01	7.12e-02	3.52e-01	6.71e-01	5.94e-01	3.98e-01	6.69e-01
GOMF AMMONIUM TRANSMEMBRANE TRANSPORTER ACTIVITY	12	8.35e-01	9.45e-01	0.2490	-1.55e-01	7.08e-02	-8.88e-02	-1.41e-01	7.12e-02	3.52e-01	6.71e-01	5.94e-01	3.98e-01	6.69e-01
GOBP NATURAL KILLER CELL DIFFERENTIATION	24	5.51e-01	8.28e-01	0.2490	-8.20e-02	8.39e-02	-9.83e-02	-1.91e-01	-4.53e-02	4.87e-01	4.77e-01	4.05e-01	1.06e-01	7.01e-01
GOBP MRNA METABOLIC PROCESS	741	2.60e-21	6.04e-19	0.2490	2.81e-02	-3.27e-02	-1.07e-01	-2.14e-01	5.46e-02	1.92e-01	1.30e-01	7.51e-07	3.84e-23	1.14e-02
GOBP REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION	21	6.58e-01	8.80e-01	0.2490	-8.80e-03	-1.73e-02	1.78e-01	1.23e-01	-1.20e-01	9.44e-01	8.91e-01	1.57e-01	3.29e-01	3.39e-01
GOMF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY	69	5.92e-02	2.84e-01	0.2490	-1.76e-02	3.21e-02	1.66e-01	1.33e-01	1.23e-01	8.01e-01	6.44e-01	1.68e-02	5.70e-02	7.68e-02
GOMF ASPARTIC TYPE PEPTIDASE ACTIVITY	26	3.58e-01	7.03e-01	0.2490	-1.07e-01	8.69e-02	4.00e-02	-1.09e-01	-1.71e-01	3.46e-01	4.43e-01	7.24e-01	3.35e-01	1.31e-01
GOBP POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE	216	2.73e-06	1.05e-04	0.2490	-1.59e-01	3.83e-02	6.88e-02	1.48e-01	-9.21e-02	5.58e-05	3.32e-01	8.12e-02	1.86e-04	1.96e-02
GOBP REGULATION OF NEURON MIGRATION	44	2.44e-01	6.02e-01	0.2480	-4.08e-02	-1.00e-01	1.69e-01	1.46e-01	-9.38e-03	6.39e-01	2.49e-01	5.23e-02	9.43e-02	9.14e-01
GOBP CATECHOL CONTAINING COMPOUND METABOLIC PROCESS	50	9.23e-02	3.67e-01	0.2480	-1.11e-02	1.31e-01	1.76e-01	6.04e-03	-1.16e-01	8.92e-01	1.09e-01	3.17e-02	9.41e-01	1.57e-01
GOBP ACROSOME ASSEMBLY	27	2.07e-01	5.58e-01	0.2480	-1.20e-02	4.93e-03	1.32e-01	-7.52e-02	-1.96e-01	9.14e-01	9.65e-01	2.34e-01	4.99e-01	7.85e-02
GOCC MULTIVESICULAR BODY MEMBRANE	28	4.73e-01	7.86e-01	0.2480	-5.45e-03	4.81e-02	-2.13e-01	-1.14e-01	2.62e-02	9.60e-01	6.59e-01	5.06e-02	2.96e-01	8.10e-01
GOBP PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY	103	1.01e-02	8.84e-02	0.2480	-9.31e-02	8.88e-02	1.43e-01	1.56e-01	1.43e-02	1.03e-01	1.19e-01	1.20e-02	6.27e-03	8.02e-01
GOBP VITAMIN D RECEPTOR SIGNALING PATHWAY	12	7.88e-01	9.30e-01	0.2480	-8.80e-03	1.32e-01	-2.00e-01	-6.08e-02	-2.39e-02	9.58e-01	4.29e-01	2.31e-01	7.15e-01	8.86e-01
GOBP MEMBRANE REPOLARIZATION	52	2.03e-01	5.53e-01	0.2480	-1.14e-01	6.16e-03	1.40e-01	1.67e-01	-3.23e-02	1.54e-01	9.39e-01	8.01e-02	3.78e-02	6.87e-01
GOMF TRANSFERASE ACTIVITY TRANSFERRING ALKYL OR ARYL OTHER THAN METHYL GROUPS	53	1.45e-01	4.66e-01	0.2480	9.13e-02	6.38e-02	-4.06e-02	-1.79e-01	1.24e-01	2.50e-01	4.22e-01	6.09e-01	2.40e-02	1.19e-01
GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR	125	3.38e-03	4.01e-02	0.2480	4.98e-02	-2.36e-02	-1.29e-01	-2.03e-01	2.18e-02	3.37e-01	6.49e-01	1.25e-02	8.74e-05	6.73e-01
GOBP GLOMERULAR EPITHELIUM DEVELOPMENT	24	5.74e-01	8.40e-01	0.2480	6.78e-02	-9.73e-02	8.77e-02	1.71e-01	-1.02e-01	5.65e-01	4.09e-01	4.57e-01	1.47e-01	3.87e-01
GOBP RESPIRATORY BURST	32	3.02e-01	6.55e-01	0.2480	-1.97e-01	7.22e-02	2.91e-02	-9.03e-02	9.24e-02	5.42e-02	4.80e-01	7.76e-01	3.77e-01	3.65e-01
GOBP POSITIVE REGULATION OF POST TRANSCRIPTIONAL GENE SILENCING	14	7.83e-01	9.28e-01	0.2480	8.26e-02	-1.20e-01	-6.01e-02	-1.82e-01	5.86e-02	5.93e-01	4.38e-01	6.97e-01	2.38e-01	7.04e-01
GOBP RECEPTOR MEDIATED ENDOCYTOSIS INVOLVED IN CHOLESTEROL TRANSPORT	8	9.10e-01	9.70e-01	0.2480	1.55e-01	1.49e-01	-2.14e-03	-2.54e-02	-1.21e-01	4.48e-01	4.65e-01	9.92e-01	9.01e-01	5.54e-01
GOMF NUCLEOSIDE DIPHOSPHATE KINASE ACTIVITY	18	7.21e-01	9.02e-01	0.2480	4.91e-02	1.56e-01	-1.13e-01	-1.42e-01	4.10e-02	7.18e-01	2.53e-01	4.06e-01	2.96e-01	7.63e-01
GOMF PEPTIDASE REGULATOR ACTIVITY	215	1.39e-05	4.44e-04	0.2480	-8.63e-02	-4.38e-02	1.21e-01	1.88e-01	-4.23e-02	2.92e-02	2.68e-01	2.15e-03	1.91e-06	2.85e-01
GOMF SIGNALING RECEPTOR COMPLEX ADAPTOR ACTIVITY	51	1.26e-01	4.37e-01	0.2480	2.16e-02	1.51e-01	1.87e-01	3.11e-02	-4.47e-02	7.89e-01	6.14e-02	2.08e-02	7.01e-01	5.81e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN NAD P H AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN	38	1.41e-01	4.62e-01	0.2480	-8.91e-02	-1.44e-02	1.47e-02	2.27e-01	3.64e-02	3.42e-01	8.78e-01	8.76e-01	1.53e-02	6.98e-01
GOBP CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS	41	2.76e-01	6.30e-01	0.2480	-1.06e-01	1.56e-01	1.42e-01	6.32e-02	-3.98e-02	2.39e-01	8.34e-02	1.17e-01	4.84e-01	6.59e-01
GOCC TRANS GOLGI NETWORK TRANSPORT VESICLE	36	2.50e-01	6.07e-01	0.2480	-1.12e-01	1.47e-01	-2.15e-02	-1.56e-01	-4.74e-02	2.45e-01	1.26e-01	8.24e-01	1.05e-01	6.23e-01
GOBP SKELETAL MUSCLE TISSUE REGENERATION	37	2.28e-01	5.82e-01	0.2480	8.61e-02	1.53e-01	-3.64e-03	9.30e-02	-1.48e-01	3.65e-01	1.08e-01	9.69e-01	3.28e-01	1.19e-01
GOBP ANTERIOR POSTERIOR AXIS SPECIFICATION	54	4.13e-02	2.25e-01	0.2480	2.60e-02	6.14e-02	1.46e-01	-1.33e-01	1.33e-01	7.41e-01	4.35e-01	6.27e-02	8.99e-02	9.18e-02
GOBP OLIGOSACCHARIDE CATABOLIC PROCESS	17	6.68e-01	8.82e-01	0.2470	5.00e-02	-1.67e-01	-6.64e-02	-4.40e-02	-1.56e-01	7.21e-01	2.32e-01	6.36e-01	7.54e-01	2.65e-01
GOMF CHEMOKINE BINDING	31	4.71e-01	7.86e-01	0.2470	-1.42e-01	-3.50e-02	1.01e-01	1.20e-01	-1.25e-01	1.72e-01	7.36e-01	3.32e-01	2.49e-01	2.30e-01
GOBP NEUROINFLAMMATORY RESPONSE	82	2.26e-02	1.52e-01	0.2470	-5.77e-02	-2.64e-02	1.96e-01	9.11e-02	1.01e-01	3.67e-01	6.79e-01	2.10e-03	1.54e-01	1.12e-01
GOBP IRON COORDINATION ENTITY TRANSPORT	12	8.27e-01	9.44e-01	0.2470	1.40e-01	-1.92e-01	-5.74e-02	-3.87e-02	9.93e-03	4.01e-01	2.50e-01	7.30e-01	8.17e-01	9.52e-01
GOBP SNARE COMPLEX ASSEMBLY	22	5.32e-01	8.20e-01	0.2470	1.71e-01	1.32e-01	-6.58e-02	-1.09e-03	9.97e-02	1.64e-01	2.82e-01	5.93e-01	9.93e-01	4.18e-01
GOBP ERAD PATHWAY	108	5.49e-03	5.69e-02	0.2470	-1.36e-03	6.70e-02	-1.01e-01	-2.16e-01	5.27e-03	9.81e-01	2.29e-01	7.00e-02	1.08e-04	9.25e-01
GOBP IRON ION IMPORT ACROSS PLASMA MEMBRANE	5	9.65e-01	9.90e-01	0.2470	-1.56e-01	-8.05e-02	2.91e-02	-1.25e-01	1.18e-01	5.45e-01	7.55e-01	9.10e-01	6.30e-01	6.48e-01
GOBP G1 TO G0 TRANSITION	19	6.49e-01	8.77e-01	0.2470	8.56e-02	9.09e-02	-4.29e-02	-2.09e-01	6.02e-03	5.18e-01	4.93e-01	7.46e-01	1.15e-01	9.64e-01
GOBP RESPONSE TO STEROL DEPLETION	18	6.95e-01	8.94e-01	0.2470	-1.69e-01	1.22e-02	-1.26e-01	-1.07e-01	-7.10e-02	2.14e-01	9.28e-01	3.53e-01	4.34e-01	6.02e-01
GOBP REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION	108	2.60e-04	5.23e-03	0.2470	7.54e-02	1.35e-01	9.38e-02	-1.68e-01	1.69e-02	1.76e-01	1.54e-02	9.23e-02	2.59e-03	7.61e-01
GOBP PURINE CONTAINING COMPOUND SALVAGE	14	7.58e-01	9.19e-01	0.2470	1.11e-02	2.50e-02	5.25e-02	-1.74e-01	1.65e-01	9.43e-01	8.72e-01	7.34e-01	2.60e-01	2.84e-01
GOBP REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT	17	7.19e-01	9.02e-01	0.2470	-1.91e-01	-7.12e-02	-1.04e-01	-8.17e-02	-4.29e-02	1.72e-01	6.11e-01	4.56e-01	5.60e-01	7.59e-01
GOBP ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE	74	3.04e-02	1.85e-01	0.2470	-9.32e-02	4.36e-02	-7.80e-02	-2.11e-01	-6.81e-03	1.65e-01	5.17e-01	2.46e-01	1.74e-03	9.19e-01
GOBP NERVOUS SYSTEM PROCESS	1381	2.00e-41	1.28e-38	0.2470	-4.90e-02	-9.39e-02	1.04e-01	1.97e-01	1.41e-02	2.27e-03	4.86e-09	7.97e-11	1.10e-34	3.81e-01
GOMF POTASSIUM CHANNEL ACTIVITY	120	5.08e-03	5.42e-02	0.2470	-3.95e-02	9.66e-02	1.41e-01	1.32e-01	-1.13e-01	4.54e-01	6.77e-02	7.58e-03	1.24e-02	3.28e-02
GOBP NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION	17	7.91e-01	9.31e-01	0.2470	6.30e-02	7.06e-02	-1.07e-01	-1.73e-01	1.04e-01	6.53e-01	6.14e-01	4.46e-01	2.18e-01	4.57e-01
GOBP PROTEIN DEACETYLATION	51	1.22e-01	4.29e-01	0.2470	1.73e-01	-3.56e-02	-1.21e-02	-1.25e-01	1.19e-01	3.27e-02	6.60e-01	8.81e-01	1.23e-01	1.43e-01
GOCC NBAF COMPLEX	16	4.68e-01	7.83e-01	0.2470	4.17e-03	-5.18e-02	1.55e-01	-1.74e-01	6.31e-02	9.77e-01	7.20e-01	2.85e-01	2.27e-01	6.62e-01
GOBP EXPORT ACROSS PLASMA MEMBRANE	78	2.81e-02	1.76e-01	0.2470	-2.01e-01	-2.11e-02	5.83e-02	1.12e-01	-6.41e-02	2.12e-03	7.48e-01	3.73e-01	8.78e-02	3.28e-01
GOBP MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER	5	9.19e-01	9.74e-01	0.2470	3.91e-02	-5.41e-03	8.35e-02	-1.51e-01	-1.72e-01	8.80e-01	9.83e-01	7.47e-01	5.59e-01	5.05e-01
GOBP PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION	13	7.95e-01	9.32e-01	0.2470	4.63e-02	-7.10e-02	5.69e-02	7.78e-02	-2.11e-01	7.73e-01	6.58e-01	7.22e-01	6.27e-01	1.88e-01
GOBP INTRACELLULAR PH REDUCTION	50	9.53e-02	3.73e-01	0.2470	-2.72e-02	2.44e-02	1.04e-01	-1.03e-01	1.95e-01	7.40e-01	7.65e-01	2.05e-01	2.06e-01	1.69e-02
GOBP NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION	53	1.45e-01	4.66e-01	0.2470	3.98e-02	1.79e-01	1.29e-01	9.59e-02	3.91e-02	6.16e-01	2.45e-02	1.04e-01	2.27e-01	6.23e-01
GOCC SNARE COMPLEX	47	1.82e-01	5.24e-01	0.2470	-3.47e-02	7.56e-02	-4.58e-02	-2.08e-01	9.33e-02	6.81e-01	3.70e-01	5.87e-01	1.37e-02	2.68e-01
GOMF PURINE NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY	24	5.40e-01	8.23e-01	0.2470	3.09e-02	4.68e-02	-6.81e-02	-2.30e-01	-5.21e-04	7.94e-01	6.92e-01	5.63e-01	5.08e-02	9.96e-01
GOBP MANNOSYLATION	22	5.37e-01	8.22e-01	0.2470	2.10e-01	-9.64e-02	-2.85e-02	7.58e-02	-2.89e-02	8.80e-02	4.34e-01	8.17e-01	5.38e-01	8.15e-01
GOCC BETA CATENIN TCF COMPLEX	13	8.32e-01	9.45e-01	0.2470	1.89e-01	6.98e-02	-1.17e-02	-9.07e-02	1.09e-01	2.38e-01	6.63e-01	9.42e-01	5.71e-01	4.95e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME	12	8.41e-01	9.48e-01	0.2460	-1.83e-01	-1.49e-01	2.61e-02	5.96e-02	-2.86e-02	2.73e-01	3.71e-01	8.76e-01	7.21e-01	8.64e-01
GOBP REGULATION OF ALPHA BETA T CELL DIFFERENTIATION	70	2.08e-02	1.45e-01	0.2460	-1.15e-01	2.15e-01	-1.21e-02	-2.44e-02	-2.27e-02	9.65e-02	1.85e-03	8.61e-01	7.24e-01	7.43e-01
GOBP MONOCARBOXYLIC ACID CATABOLIC PROCESS	128	2.76e-04	5.47e-03	0.2460	1.13e-01	1.81e-01	-3.31e-02	-1.46e-02	1.18e-01	2.77e-02	3.96e-04	5.18e-01	7.75e-01	2.14e-02
GOBP CALCIUM ION REGULATED EXOCYTOSIS	64	6.62e-02	3.03e-01	0.2460	-1.69e-01	3.21e-02	2.08e-02	7.99e-02	-1.56e-01	1.95e-02	6.57e-01	7.73e-01	2.69e-01	3.09e-02
GOMF TRANSCRIPTION REGULATOR ACTIVITY	1821	3.42e-58	3.50e-55	0.2460	7.71e-02	1.45e-02	-3.55e-02	-2.11e-01	9.36e-02	4.83e-08	3.04e-01	1.19e-02	1.16e-50	3.44e-11
GOBP DIOL BIOSYNTHETIC PROCESS	21	7.13e-01	9.00e-01	0.2460	-3.75e-03	-4.02e-02	-2.02e-01	-1.31e-01	3.12e-02	9.76e-01	7.50e-01	1.09e-01	2.98e-01	8.04e-01
GOBP GLOMERULUS VASCULATURE MORPHOGENESIS	6	9.22e-01	9.74e-01	0.2460	1.23e-01	8.49e-02	1.79e-01	-7.61e-02	-1.30e-02	6.01e-01	7.19e-01	4.47e-01	7.47e-01	9.56e-01
GOCC MITOCHONDRIAL MATRIX	466	3.98e-12	4.20e-10	0.2460	5.86e-02	-2.67e-03	-1.45e-01	-1.90e-01	8.98e-03	3.02e-02	9.21e-01	8.74e-08	1.95e-12	7.40e-01
GOBP POSITIVE REGULATION OF BONE MINERALIZATION	43	1.43e-01	4.64e-01	0.2460	-9.54e-02	8.19e-02	1.89e-01	-4.88e-02	8.20e-02	2.79e-01	3.53e-01	3.21e-02	5.80e-01	3.52e-01
GOBP VIRAL TRANSLATION	20	6.64e-01	8.82e-01	0.2460	-9.12e-06	4.66e-02	-1.31e-01	-1.60e-01	-1.25e-01	1.00e+00	7.18e-01	3.11e-01	2.16e-01	3.32e-01
GOBP POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY	26	5.43e-01	8.25e-01	0.2460	4.96e-02	1.37e-01	1.89e-01	5.90e-02	-1.39e-03	6.62e-01	2.26e-01	9.54e-02	6.02e-01	9.90e-01
GOBP NEGATIVE REGULATION OF TORC1 SIGNALING	45	2.36e-01	5.91e-01	0.2460	4.03e-02	-3.28e-02	-9.08e-02	-2.16e-01	5.30e-02	6.40e-01	7.04e-01	2.92e-01	1.21e-02	5.38e-01
GOBP POSITIVE REGULATION OF DEVELOPMENTAL PIGMENTATION	9	9.33e-01	9.79e-01	0.2460	6.23e-02	1.86e-02	1.14e-01	2.04e-01	-3.96e-02	7.46e-01	9.23e-01	5.52e-01	2.90e-01	8.37e-01
GOBP LUNG SECRETORY CELL DIFFERENTIATION	11	8.46e-01	9.49e-01	0.2460	-3.64e-02	1.08e-01	-9.63e-02	8.91e-04	-1.95e-01	8.34e-01	5.36e-01	5.80e-01	9.96e-01	2.62e-01
GOBP POSITIVE REGULATION OF HEART GROWTH	38	2.10e-01	5.61e-01	0.2460	-8.75e-02	-3.67e-02	1.83e-01	-3.60e-04	1.34e-01	3.51e-01	6.96e-01	5.07e-02	9.97e-01	1.54e-01
GOBP TRANSCRIPTION INITIATION COUPLED CHROMATIN REMODELING	38	3.62e-01	7.04e-01	0.2460	1.08e-02	8.47e-02	-1.23e-01	-1.94e-01	2.22e-02	9.08e-01	3.66e-01	1.91e-01	3.87e-02	8.13e-01
GOBP INTERMEDIATE FILAMENT BUNDLE ASSEMBLY	8	8.41e-01	9.48e-01	0.2460	-1.44e-01	-5.29e-02	1.09e-01	-1.53e-01	-4.30e-02	4.81e-01	7.96e-01	5.95e-01	4.55e-01	8.33e-01
GOBP REGULATION OF FEVER GENERATION	9	9.31e-01	9.78e-01	0.2460	1.07e-01	2.39e-02	1.63e-01	1.46e-01	-2.39e-02	5.80e-01	9.01e-01	3.97e-01	4.49e-01	9.01e-01
GOMF SINGLE STRANDED RNA BINDING	80	1.50e-02	1.16e-01	0.2460	-2.58e-02	-3.48e-02	-3.76e-02	-2.27e-01	7.32e-02	6.90e-01	5.90e-01	5.61e-01	4.38e-04	2.58e-01
GOBP SEQUESTERING OF TRIGLYCERIDE	18	6.66e-01	8.82e-01	0.2460	-8.67e-02	2.86e-02	3.17e-02	-8.23e-02	2.10e-01	5.24e-01	8.34e-01	8.16e-01	5.46e-01	1.22e-01
GOBP NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS	20	6.83e-01	8.88e-01	0.2460	5.90e-02	-4.15e-02	1.21e-01	1.91e-01	6.22e-02	6.48e-01	7.48e-01	3.50e-01	1.38e-01	6.30e-01
GOBP RENAL FILTRATION	25	3.00e-01	6.54e-01	0.2460	4.12e-02	-1.00e-01	-9.48e-02	1.97e-01	2.90e-02	7.22e-01	3.86e-01	4.12e-01	8.84e-02	8.02e-01
GOMF ELECTRON TRANSFER ACTIVITY	99	2.47e-02	1.61e-01	0.2460	5.85e-02	-1.19e-02	-1.60e-01	-1.71e-01	4.10e-02	3.14e-01	8.38e-01	5.84e-03	3.21e-03	4.81e-01
GOMF SULFATE TRANSMEMBRANE TRANSPORTER ACTIVITY	16	7.86e-01	9.29e-01	0.2460	-8.88e-02	-6.06e-02	1.11e-01	1.09e-01	-1.57e-01	5.38e-01	6.75e-01	4.43e-01	4.49e-01	2.78e-01
GOBP NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY	15	7.12e-01	9.00e-01	0.2460	-1.12e-02	-7.52e-02	5.34e-02	-1.48e-01	1.73e-01	9.40e-01	6.14e-01	7.20e-01	3.23e-01	2.46e-01
GOBP SODIUM ION HOMEOSTASIS	46	1.59e-01	4.91e-01	0.2460	4.98e-02	1.43e-02	1.41e-01	9.02e-02	-1.72e-01	5.59e-01	8.67e-01	9.84e-02	2.90e-01	4.34e-02
GOBP ESTABLISHMENT OF LYMPHOCYTE POLARITY	16	7.15e-01	9.01e-01	0.2450	-1.18e-01	1.83e-01	7.22e-02	5.94e-02	6.54e-02	4.15e-01	2.06e-01	6.17e-01	6.81e-01	6.51e-01
GOCC DENDRITIC SPINE HEAD	7	9.41e-01	9.82e-01	0.2450	6.60e-02	1.51e-01	8.06e-02	1.41e-01	8.15e-02	7.62e-01	4.88e-01	7.12e-01	5.18e-01	7.09e-01
GOBP POSITIVE REGULATION OF VASCULOGENESIS	12	7.45e-01	9.14e-01	0.2450	-9.09e-02	2.88e-02	1.01e-01	-7.14e-02	-1.89e-01	5.86e-01	8.63e-01	5.45e-01	6.69e-01	2.56e-01
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE	11	8.18e-01	9.41e-01	0.2450	9.75e-02	-1.53e-02	1.51e-01	5.79e-02	-1.56e-01	5.75e-01	9.30e-01	3.85e-01	7.39e-01	3.72e-01
GOMF OXYGEN BINDING	38	1.16e-01	4.16e-01	0.2450	-1.31e-02	-6.04e-02	-3.87e-02	2.34e-01	1.58e-02	8.89e-01	5.20e-01	6.80e-01	1.26e-02	8.66e-01
GOBP CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS	14	8.72e-01	9.58e-01	0.2450	-2.64e-02	5.81e-02	1.61e-01	1.60e-01	-6.76e-02	8.64e-01	7.07e-01	2.98e-01	2.99e-01	6.61e-01
GOBP REGULATION OF MUSCLE TISSUE DEVELOPMENT	45	1.77e-01	5.18e-01	0.2450	3.89e-02	1.23e-01	1.35e-01	-4.64e-02	1.52e-01	6.52e-01	1.53e-01	1.18e-01	5.90e-01	7.72e-02
GOBP POSITIVE REGULATION OF NEURON DIFFERENTIATION	91	1.04e-02	9.03e-02	0.2450	1.33e-02	1.20e-01	8.54e-03	-1.71e-01	1.27e-01	8.26e-01	4.78e-02	8.88e-01	4.73e-03	3.63e-02
GOBP DNA METABOLIC PROCESS	982	1.66e-25	5.49e-23	0.2450	5.46e-02	-2.13e-02	-1.29e-01	-1.91e-01	6.03e-02	3.79e-03	2.59e-01	8.22e-12	3.52e-24	1.39e-03
GOBP POSITIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS	39	1.81e-01	5.24e-01	0.2450	9.73e-02	-9.70e-02	3.68e-02	-1.40e-01	1.42e-01	2.93e-01	2.95e-01	6.91e-01	1.30e-01	1.24e-01
GOBP NEGATIVE REGULATION OF MOTOR NEURON APOPTOTIC PROCESS	11	8.75e-01	9.59e-01	0.2450	9.53e-02	1.50e-01	-3.88e-02	-1.63e-01	2.22e-02	5.84e-01	3.89e-01	8.24e-01	3.50e-01	8.99e-01
GOCC PCG PROTEIN COMPLEX	35	3.46e-01	6.93e-01	0.2450	1.27e-01	5.12e-02	-1.20e-02	-1.60e-01	1.24e-01	1.92e-01	6.00e-01	9.02e-01	1.01e-01	2.05e-01
GOBP NUCLEOBASE TRANSPORT	12	7.69e-01	9.24e-01	0.2450	-4.67e-03	1.29e-02	-5.66e-02	2.08e-01	-1.15e-01	9.78e-01	9.39e-01	7.34e-01	2.11e-01	4.91e-01
GOBP MAINTENANCE OF PROTEIN LOCATION IN CELL	60	6.70e-02	3.06e-01	0.2450	1.87e-02	4.07e-02	-6.54e-02	-2.31e-01	-1.36e-02	8.02e-01	5.86e-01	3.81e-01	1.92e-03	8.56e-01
GOCC BLOOD MICROPARTICLE	111	6.07e-04	1.03e-02	0.2450	-8.39e-04	-3.70e-02	-2.12e-02	2.27e-01	-8.28e-02	9.88e-01	5.01e-01	6.99e-01	3.69e-05	1.32e-01
GOBP DETECTION OF ABIOTIC STIMULUS	132	2.64e-03	3.33e-02	0.2450	2.09e-02	3.21e-02	1.53e-01	1.50e-01	-1.12e-01	6.79e-01	5.25e-01	2.36e-03	2.88e-03	2.64e-02
GOBP REGULATION OF GLUTAMATE RECEPTOR CLUSTERING	6	9.55e-01	9.87e-01	0.2450	-1.02e-01	8.50e-02	-5.76e-03	-2.00e-01	4.94e-02	6.66e-01	7.18e-01	9.81e-01	3.97e-01	8.34e-01
GOBP FEAR RESPONSE	43	1.89e-01	5.34e-01	0.2450	9.56e-02	1.55e-01	1.14e-01	3.67e-02	-1.11e-01	2.78e-01	7.87e-02	1.95e-01	6.77e-01	2.08e-01
GOMF DNA SECONDARY STRUCTURE BINDING	36	3.69e-01	7.09e-01	0.2450	-5.05e-02	-3.00e-02	-1.14e-01	-1.41e-01	1.53e-01	6.00e-01	7.55e-01	2.35e-01	1.43e-01	1.12e-01
GOBP BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS	51	1.35e-01	4.53e-01	0.2450	-1.42e-01	-2.11e-02	-1.69e-02	1.26e-01	-1.53e-01	7.98e-02	7.95e-01	8.34e-01	1.21e-01	5.94e-02
GOBP GLYCINE METABOLIC PROCESS	15	6.72e-01	8.84e-01	0.2450	-1.33e-01	-9.88e-02	-6.57e-02	1.67e-01	-1.75e-02	3.73e-01	5.08e-01	6.60e-01	2.63e-01	9.07e-01
GOBP SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS	19	6.43e-01	8.75e-01	0.2450	-5.03e-02	3.58e-02	6.87e-02	-2.56e-02	2.25e-01	7.04e-01	7.87e-01	6.04e-01	8.47e-01	8.95e-02
GOBP REGULATION OF NK T CELL PROLIFERATION	7	9.22e-01	9.74e-01	0.2450	-1.78e-01	-1.84e-02	1.37e-01	-7.00e-02	6.52e-02	4.15e-01	9.33e-01	5.31e-01	7.48e-01	7.65e-01
GOBP POSITIVE REGULATION OF AMINE TRANSPORT	39	2.45e-01	6.02e-01	0.2440	-7.22e-02	1.51e-01	1.77e-01	-1.03e-02	-1.65e-02	4.35e-01	1.03e-01	5.57e-02	9.11e-01	8.59e-01
GOBP NEGATIVE REGULATION OF JUN KINASE ACTIVITY	13	8.20e-01	9.41e-01	0.2440	-2.35e-02	8.43e-02	1.71e-01	-1.31e-02	1.51e-01	8.83e-01	5.99e-01	2.86e-01	9.35e-01	3.47e-01
GOBP LABYRINTHINE LAYER DEVELOPMENT	43	1.34e-01	4.53e-01	0.2440	-6.21e-02	8.64e-02	8.41e-02	-1.70e-01	1.12e-01	4.81e-01	3.27e-01	3.40e-01	5.42e-02	2.04e-01
GOMF UBIQUITIN LIKE PROTEIN LIGASE BINDING	310	2.18e-09	1.69e-07	0.2440	1.83e-02	1.17e-01	-5.39e-02	-2.05e-01	3.01e-02	5.80e-01	4.11e-04	1.03e-01	5.60e-10	3.62e-01
GOBP RESPONSE TO ATP	31	3.69e-01	7.09e-01	0.2440	5.19e-02	-6.08e-02	3.21e-02	-1.20e-01	1.95e-01	6.17e-01	5.58e-01	7.57e-01	2.49e-01	6.06e-02
GOBP POSITIVE REGULATION OF NON MOTILE CILIUM ASSEMBLY	8	9.35e-01	9.80e-01	0.2440	1.28e-01	-8.04e-02	-7.89e-02	-1.72e-01	2.66e-02	5.30e-01	6.94e-01	6.99e-01	3.98e-01	8.96e-01
GOMF MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE BINDING	15	7.47e-01	9.14e-01	0.2440	9.56e-03	1.21e-01	7.43e-02	6.22e-02	1.88e-01	9.49e-01	4.17e-01	6.18e-01	6.77e-01	2.06e-01
GOBP NUCLEOSOME ORGANIZATION	117	7.67e-03	7.26e-02	0.2440	-1.54e-02	-7.50e-02	-1.39e-01	-1.63e-01	8.95e-02	7.74e-01	1.61e-01	9.50e-03	2.36e-03	9.45e-02
GOCC SWI SNF COMPLEX	30	1.99e-01	5.48e-01	0.2440	4.21e-02	-5.80e-02	8.06e-02	-2.02e-01	8.55e-02	6.90e-01	5.82e-01	4.45e-01	5.60e-02	4.17e-01
GOMF PROTEIN ANTIGEN BINDING	7	9.36e-01	9.80e-01	0.2440	-1.11e-01	-3.43e-02	8.06e-02	-4.65e-02	1.94e-01	6.12e-01	8.75e-01	7.12e-01	8.31e-01	3.75e-01
GOBP PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS	16	5.90e-01	8.47e-01	0.2440	4.97e-02	1.27e-01	7.42e-02	-1.44e-01	-1.22e-01	7.31e-01	3.79e-01	6.07e-01	3.20e-01	3.99e-01
GOBP FATTY ACYL COA METABOLIC PROCESS	36	3.12e-01	6.64e-01	0.2440	-5.39e-03	1.86e-01	-1.33e-02	-1.43e-01	6.59e-02	9.55e-01	5.37e-02	8.90e-01	1.38e-01	4.94e-01
GOBP NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION	43	1.79e-01	5.20e-01	0.2440	4.07e-02	1.37e-01	3.96e-02	-1.74e-01	8.42e-02	6.44e-01	1.19e-01	6.53e-01	4.83e-02	3.39e-01
GOBP POSITIVE REGULATION OF URINE VOLUME	13	8.07e-01	9.36e-01	0.2440	1.25e-01	-5.45e-02	-8.18e-02	-1.78e-01	-5.10e-02	4.34e-01	7.34e-01	6.09e-01	2.68e-01	7.50e-01
GOBP POSITIVE REGULATION OF PROTEIN BINDING	59	4.34e-02	2.31e-01	0.2440	-2.56e-02	9.11e-02	-3.39e-02	-1.40e-01	-1.72e-01	7.34e-01	2.26e-01	6.53e-01	6.22e-02	2.21e-02
GOBP REGULATION OF TYPE B PANCREATIC CELL DEVELOPMENT	9	8.56e-01	9.52e-01	0.2440	5.45e-03	-1.32e-01	-2.95e-02	-1.94e-01	-5.75e-02	9.77e-01	4.93e-01	8.78e-01	3.12e-01	7.65e-01
GOBP LEFT RIGHT AXIS SPECIFICATION	13	8.08e-01	9.37e-01	0.2440	1.48e-01	-1.19e-01	-1.34e-01	4.01e-02	-6.24e-02	3.56e-01	4.58e-01	4.04e-01	8.02e-01	6.97e-01
GOBP NEGATIVE REGULATION OF WOUND HEALING	72	5.61e-02	2.75e-01	0.2440	-6.16e-02	9.60e-02	1.00e-01	1.87e-01	-3.98e-02	3.66e-01	1.59e-01	1.42e-01	6.19e-03	5.59e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO CILIUM	11	8.94e-01	9.65e-01	0.2440	-2.69e-02	-1.48e-01	-1.61e-01	-7.38e-02	7.29e-02	8.77e-01	3.94e-01	3.55e-01	6.72e-01	6.75e-01
GOBP DIGESTION	128	1.45e-03	2.08e-02	0.2440	-6.78e-02	1.18e-01	6.59e-02	1.51e-01	-1.17e-01	1.85e-01	2.09e-02	1.98e-01	3.25e-03	2.17e-02
GOCC BRUSH BORDER	103	1.49e-02	1.16e-01	0.2440	-3.42e-02	7.91e-02	1.28e-01	1.35e-01	-1.32e-01	5.49e-01	1.65e-01	2.51e-02	1.81e-02	2.04e-02
GOBP COPII COATED VESICLE CARGO LOADING	16	7.58e-01	9.19e-01	0.2440	9.72e-02	1.24e-01	-1.23e-01	-1.11e-01	-8.44e-02	5.01e-01	3.91e-01	3.95e-01	4.41e-01	5.59e-01
GOMF MYRISTOYLTRANSFERASE ACTIVITY	10	8.73e-01	9.58e-01	0.2440	1.35e-01	1.57e-01	-1.69e-02	-9.26e-02	-8.81e-02	4.61e-01	3.91e-01	9.26e-01	6.12e-01	6.29e-01
GOBP POSITIVE REGULATION OF ENDOCYTIC RECYCLING	8	8.98e-01	9.67e-01	0.2440	1.08e-01	1.52e-01	-1.16e-01	3.25e-02	-1.01e-01	5.98e-01	4.57e-01	5.69e-01	8.73e-01	6.22e-01
GOBP VASCULOGENESIS INVOLVED IN CORONARY VASCULAR MORPHOGENESIS	5	9.79e-01	9.93e-01	0.2440	-2.32e-02	-9.67e-02	1.63e-01	1.37e-01	6.35e-02	9.28e-01	7.08e-01	5.28e-01	5.95e-01	8.06e-01
GOBP ARGININE METABOLIC PROCESS	19	6.43e-01	8.75e-01	0.2440	-1.39e-01	1.72e-01	5.12e-02	-5.81e-02	6.68e-02	2.93e-01	1.95e-01	6.99e-01	6.61e-01	6.14e-01
GOBP NEURON PROJECTION ARBORIZATION	31	4.19e-01	7.48e-01	0.2440	-1.47e-02	-1.24e-01	8.62e-02	1.16e-01	-1.51e-01	8.88e-01	2.30e-01	4.06e-01	2.64e-01	1.46e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON METAL IONS	16	7.34e-01	9.09e-01	0.2430	5.32e-03	-2.23e-02	2.31e-01	6.25e-02	3.91e-02	9.71e-01	8.77e-01	1.10e-01	6.65e-01	7.87e-01
GOBP REGULATION OF NK T CELL ACTIVATION	11	8.40e-01	9.47e-01	0.2430	-1.91e-01	-9.88e-02	1.02e-01	-1.79e-02	4.61e-02	2.72e-01	5.70e-01	5.57e-01	9.18e-01	7.91e-01
GOMF CALCIUM ION BINDING	675	6.93e-18	1.18e-15	0.2430	-2.51e-02	5.78e-02	1.17e-01	1.95e-01	-6.14e-02	2.66e-01	1.05e-02	2.41e-07	6.10e-18	6.50e-03
GOBP PITUITARY GLAND DEVELOPMENT	40	3.54e-01	6.99e-01	0.2430	-2.76e-02	5.22e-02	-1.28e-01	-1.93e-01	4.51e-02	7.63e-01	5.68e-01	1.63e-01	3.43e-02	6.22e-01
GOBP SELECTIVE AUTOPHAGY	92	3.10e-02	1.87e-01	0.2430	6.66e-02	5.42e-02	-1.47e-01	-1.60e-01	6.90e-02	2.70e-01	3.69e-01	1.51e-02	8.00e-03	2.53e-01
GOBP BILE ACID METABOLIC PROCESS	49	2.52e-01	6.08e-01	0.2430	-6.43e-02	-3.15e-02	1.05e-01	1.69e-01	-1.20e-01	4.36e-01	7.03e-01	2.05e-01	4.04e-02	1.46e-01
GOBP FATTY ACYL COA BIOSYNTHETIC PROCESS	25	5.38e-01	8.22e-01	0.2430	-2.41e-02	1.37e-01	-4.60e-02	-1.93e-01	1.85e-02	8.35e-01	2.35e-01	6.90e-01	9.47e-02	8.73e-01
GOBP REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY	15	7.20e-01	9.02e-01	0.2430	-1.43e-01	-6.98e-03	5.51e-02	-4.41e-02	-1.84e-01	3.38e-01	9.63e-01	7.12e-01	7.67e-01	2.18e-01
GOBP HETEROTYPIC CELL CELL ADHESION	61	5.92e-02	2.84e-01	0.2430	-3.91e-02	7.91e-02	5.92e-02	2.17e-01	-2.89e-02	5.98e-01	2.85e-01	4.24e-01	3.41e-03	6.96e-01
GOMF EPHRIN RECEPTOR ACTIVITY	18	6.19e-01	8.63e-01	0.2430	9.63e-02	5.76e-02	1.18e-01	2.97e-02	-1.78e-01	4.79e-01	6.72e-01	3.87e-01	8.27e-01	1.91e-01
GOBP REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY	10	9.12e-01	9.71e-01	0.2430	1.54e-02	-3.01e-02	-2.08e-01	-7.93e-02	-9.21e-02	9.33e-01	8.69e-01	2.55e-01	6.64e-01	6.14e-01
GOBP RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS	31	4.19e-01	7.48e-01	0.2430	-1.22e-01	-8.11e-02	-8.21e-02	-1.26e-01	1.22e-01	2.40e-01	4.35e-01	4.29e-01	2.24e-01	2.39e-01
GOMF PROTEIN TYROSINE KINASE ACTIVATOR ACTIVITY	30	4.83e-01	7.93e-01	0.2430	-3.85e-02	-8.62e-02	1.72e-01	1.28e-01	-6.30e-02	7.15e-01	4.14e-01	1.03e-01	2.24e-01	5.51e-01
GOBP PREPULSE INHIBITION	13	7.99e-01	9.33e-01	0.2430	1.28e-02	-1.80e-01	1.07e-01	6.20e-02	1.06e-01	9.36e-01	2.62e-01	5.03e-01	6.99e-01	5.09e-01
GOBP REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY	44	2.04e-01	5.53e-01	0.2430	-7.19e-02	3.37e-02	-4.87e-02	-2.18e-01	5.38e-02	4.09e-01	6.99e-01	5.77e-01	1.25e-02	5.37e-01
GOBP N ACETYLNEURAMINATE METABOLIC PROCESS	11	8.51e-01	9.50e-01	0.2430	4.54e-02	1.86e-01	1.38e-01	-5.69e-02	4.60e-04	7.94e-01	2.85e-01	4.29e-01	7.44e-01	9.98e-01
GOBP CELLULAR METABOLIC COMPOUND SALVAGE	29	4.19e-01	7.48e-01	0.2430	3.95e-02	1.06e-01	1.01e-01	-9.85e-02	1.62e-01	7.12e-01	3.24e-01	3.45e-01	3.59e-01	1.31e-01
GOBP O GLYCAN PROCESSING	42	2.27e-01	5.80e-01	0.2430	-8.93e-02	1.74e-01	1.42e-01	-1.55e-02	1.54e-02	3.17e-01	5.10e-02	1.11e-01	8.62e-01	8.63e-01
GOMF HISTONE ACETYLTRANSFERASE BINDING	23	6.70e-01	8.83e-01	0.2430	1.99e-02	2.84e-02	-1.15e-01	-2.09e-01	2.62e-02	8.69e-01	8.14e-01	3.39e-01	8.24e-02	8.28e-01
GOMF MHC CLASS II PROTEIN COMPLEX BINDING	25	4.72e-01	7.86e-01	0.2430	-2.08e-01	-7.93e-02	5.36e-03	-9.17e-02	2.73e-02	7.13e-02	4.93e-01	9.63e-01	4.27e-01	8.13e-01
GOBP NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION	63	4.83e-02	2.48e-01	0.2430	-1.65e-01	1.34e-01	7.28e-02	7.08e-02	5.79e-02	2.36e-02	6.54e-02	3.18e-01	3.31e-01	4.26e-01
GOBP POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY	60	4.74e-02	2.44e-01	0.2430	7.32e-02	1.25e-01	3.70e-02	-1.86e-01	4.39e-02	3.27e-01	9.46e-02	6.20e-01	1.27e-02	5.56e-01
GOMF TRANSITION METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY	40	1.38e-01	4.58e-01	0.2430	-3.84e-02	1.28e-01	7.31e-02	-1.89e-01	9.37e-03	6.74e-01	1.62e-01	4.24e-01	3.90e-02	9.18e-01
GOMF SULFUR COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY	56	1.61e-01	4.93e-01	0.2420	-9.74e-02	3.26e-02	1.01e-01	1.12e-01	-1.60e-01	2.07e-01	6.73e-01	1.90e-01	1.48e-01	3.87e-02
GOCC NUCLEAR BODY	812	2.33e-21	5.67e-19	0.2420	5.58e-02	-3.40e-03	-1.10e-01	-2.00e-01	5.82e-02	6.91e-03	8.69e-01	9.12e-08	2.82e-22	4.85e-03
GOBP L SERINE METABOLIC PROCESS	12	7.91e-01	9.31e-01	0.2420	8.88e-02	1.34e-01	2.49e-02	1.23e-01	1.31e-01	5.94e-01	4.21e-01	8.81e-01	4.61e-01	4.32e-01
GOBP PORE COMPLEX ASSEMBLY	19	5.14e-01	8.09e-01	0.2420	-1.32e-01	2.07e-02	5.14e-02	-1.92e-01	-3.73e-02	3.21e-01	8.76e-01	6.98e-01	1.47e-01	7.79e-01
GOBP PYROPTOSIS	36	2.85e-01	6.38e-01	0.2420	-1.09e-01	8.72e-02	1.23e-01	-4.16e-02	1.49e-01	2.58e-01	3.65e-01	2.02e-01	6.66e-01	1.21e-01
GOBP REGULATION OF MITOTIC NUCLEAR DIVISION	118	4.78e-03	5.21e-02	0.2420	1.52e-01	-3.80e-02	-1.19e-01	-1.40e-01	1.22e-02	4.43e-03	4.76e-01	2.55e-02	8.42e-03	8.20e-01
GOBP INTRACELLULAR STEROL TRANSPORT	35	3.10e-01	6.62e-01	0.2420	-9.32e-02	1.57e-01	1.02e-02	-1.39e-01	7.41e-02	3.40e-01	1.07e-01	9.17e-01	1.53e-01	4.48e-01
GOBP ESTABLISHMENT OF BLOOD BRAIN BARRIER	14	7.62e-01	9.21e-01	0.2420	8.40e-02	4.46e-03	2.61e-02	-1.95e-01	1.13e-01	5.86e-01	9.77e-01	8.66e-01	2.07e-01	4.65e-01
GOBP PHOTORECEPTOR CELL MAINTENANCE	43	2.54e-01	6.10e-01	0.2420	-4.60e-02	-1.42e-01	3.23e-02	1.26e-01	-1.39e-01	6.02e-01	1.08e-01	7.14e-01	1.54e-01	1.14e-01
GOBP DOUBLE STRAND BREAK REPAIR	294	2.16e-07	1.17e-05	0.2420	5.18e-02	-3.09e-03	-1.12e-01	-2.01e-01	5.30e-02	1.27e-01	9.27e-01	9.58e-04	3.01e-09	1.18e-01
GOBP ADENYLATE CYCLASE MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY	240	1.33e-06	5.72e-05	0.2420	-9.76e-02	3.18e-02	1.71e-01	9.43e-02	9.91e-02	9.18e-03	3.96e-01	5.17e-06	1.18e-02	8.19e-03
GOBP REGULATION OF MYOBLAST FUSION	21	5.54e-01	8.30e-01	0.2420	1.07e-02	2.07e-01	2.17e-02	4.00e-02	1.16e-01	9.32e-01	1.01e-01	8.63e-01	7.51e-01	3.57e-01
GOBP INTERLEUKIN 12 MEDIATED SIGNALING PATHWAY	9	9.17e-01	9.74e-01	0.2420	-4.57e-02	1.57e-01	1.10e-01	9.78e-02	9.90e-02	8.12e-01	4.13e-01	5.67e-01	6.12e-01	6.07e-01
GOBP REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE	31	2.25e-01	5.79e-01	0.2420	-6.33e-02	2.04e-01	-7.48e-02	6.83e-02	-4.93e-02	5.42e-01	4.92e-02	4.71e-01	5.11e-01	6.35e-01
GOBP PROTEIN STABILIZATION	202	5.79e-05	1.54e-03	0.2410	2.47e-02	5.70e-02	-1.17e-01	-1.95e-01	5.24e-02	5.44e-01	1.62e-01	4.13e-03	1.77e-06	1.99e-01
GOMF ORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY	36	3.63e-01	7.05e-01	0.2410	6.93e-02	-2.51e-02	1.08e-01	1.99e-01	3.86e-02	4.72e-01	7.95e-01	2.64e-01	3.84e-02	6.88e-01
GOBP MORPHOGENESIS OF AN ENDOTHELIUM	17	5.98e-01	8.51e-01	0.2410	-1.58e-01	-4.01e-02	-1.34e-01	9.96e-02	-6.05e-02	2.58e-01	7.75e-01	3.40e-01	4.77e-01	6.66e-01
GOBP REGULATION OF DENDRITE EXTENSION	25	6.00e-01	8.52e-01	0.2410	-1.38e-01	3.81e-02	7.34e-02	1.59e-01	-8.37e-02	2.32e-01	7.42e-01	5.25e-01	1.69e-01	4.69e-01
GOBP FOLATE TRANSMEMBRANE TRANSPORT	5	9.73e-01	9.92e-01	0.2410	2.08e-01	1.17e-01	2.38e-02	2.53e-02	3.25e-03	4.21e-01	6.50e-01	9.26e-01	9.22e-01	9.90e-01
GOMF PROTEIN PHOSPHATASE 2A BINDING	27	4.62e-01	7.79e-01	0.2410	1.28e-01	-3.97e-02	7.53e-02	-4.72e-02	1.79e-01	2.49e-01	7.21e-01	4.98e-01	6.71e-01	1.07e-01
GOCC DOPAMINERGIC SYNAPSE	14	7.86e-01	9.29e-01	0.2410	-2.62e-03	1.27e-01	-1.62e-01	-6.80e-02	-1.05e-01	9.86e-01	4.12e-01	2.93e-01	6.60e-01	4.95e-01
GOBP APPENDAGE MORPHOGENESIS	142	2.63e-04	5.26e-03	0.2410	4.45e-02	1.67e-02	2.96e-02	-1.60e-01	1.71e-01	3.60e-01	7.31e-01	5.42e-01	9.90e-04	4.26e-04
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH2 GROUP OF DONORS	17	5.35e-01	8.21e-01	0.2410	-1.01e-01	-2.81e-02	-2.09e-01	5.81e-02	-2.16e-03	4.73e-01	8.41e-01	1.35e-01	6.78e-01	9.88e-01
GOCC EXTERNAL SIDE OF PLASMA MEMBRANE	359	1.45e-08	1.01e-06	0.2410	-5.93e-02	7.19e-02	1.62e-01	1.51e-01	-2.44e-02	5.34e-02	1.93e-02	1.41e-07	9.59e-07	4.27e-01
GOBP GANGLIOSIDE BIOSYNTHETIC PROCESS	17	6.99e-01	8.95e-01	0.2410	1.02e-03	2.14e-01	-1.45e-02	-2.15e-03	-1.10e-01	9.94e-01	1.27e-01	9.18e-01	9.88e-01	4.32e-01
GOBP REGULATION OF HEPATOCYTE PROLIFERATION	16	6.27e-01	8.67e-01	0.2410	-1.71e-01	-4.83e-02	-1.27e-01	2.14e-02	9.89e-02	2.36e-01	7.38e-01	3.78e-01	8.82e-01	4.93e-01
GOMF TRANSCRIPTION COACTIVATOR BINDING	42	2.89e-01	6.43e-01	0.2410	1.02e-01	1.31e-01	-9.76e-02	-1.42e-01	2.66e-02	2.54e-01	1.40e-01	2.74e-01	1.11e-01	7.66e-01
GOBP RETINOL METABOLIC PROCESS	50	8.86e-02	3.59e-01	0.2410	-1.40e-02	1.29e-02	-3.76e-02	2.02e-01	-1.24e-01	8.64e-01	8.75e-01	6.46e-01	1.35e-02	1.28e-01
GOBP POSITIVE REGULATION OF AMYLOID BETA CLEARANCE	8	9.42e-01	9.82e-01	0.2410	-1.38e-01	-3.18e-02	-1.49e-01	-9.39e-02	-8.30e-02	5.00e-01	8.76e-01	4.65e-01	6.46e-01	6.84e-01
GOBP REGULATION OF MACROPHAGE CHEMOTAXIS	28	4.16e-01	7.46e-01	0.2410	-4.51e-02	1.70e-01	6.77e-02	5.65e-02	1.39e-01	6.80e-01	1.19e-01	5.35e-01	6.05e-01	2.04e-01
GOBP REGULATION OF GLIAL CELL PROLIFERATION	37	3.09e-01	6.61e-01	0.2410	1.77e-01	1.06e-01	8.77e-02	1.19e-02	8.73e-02	6.29e-02	2.63e-01	3.56e-01	9.01e-01	3.58e-01
GOMF STEROL TRANSPORTER ACTIVITY	36	2.46e-01	6.04e-01	0.2410	-1.03e-01	7.05e-02	-7.91e-02	8.86e-02	-1.68e-01	2.83e-01	4.64e-01	4.11e-01	3.57e-01	8.14e-02
GOBP ADP METABOLIC PROCESS	8	9.49e-01	9.84e-01	0.2410	5.45e-03	6.62e-02	-8.58e-02	-2.11e-01	4.22e-02	9.79e-01	7.46e-01	6.74e-01	3.02e-01	8.36e-01
GOMF CYTOKINE ACTIVITY	223	1.21e-05	3.95e-04	0.2410	-1.29e-01	3.69e-02	9.32e-02	1.50e-01	-9.32e-02	8.85e-04	3.43e-01	1.65e-02	1.15e-04	1.64e-02
GOBP GLYCERALDEHYDE 3 PHOSPHATE METABOLIC PROCESS	6	9.56e-01	9.87e-01	0.2410	-1.76e-01	7.30e-02	-5.20e-03	-7.63e-02	1.25e-01	4.55e-01	7.57e-01	9.82e-01	7.46e-01	5.95e-01
GOBP COLLATERAL SPROUTING	26	6.35e-01	8.72e-01	0.2410	-5.00e-02	1.17e-01	1.49e-01	1.24e-01	-6.48e-02	6.59e-01	3.02e-01	1.89e-01	2.74e-01	5.67e-01
GOBP PURINE RIBONUCLEOSIDE METABOLIC PROCESS	20	6.37e-01	8.72e-01	0.2400	-1.19e-01	1.12e-01	7.87e-03	-1.10e-01	1.37e-01	3.57e-01	3.85e-01	9.51e-01	3.95e-01	2.87e-01
GOCC PROTEIN DNA COMPLEX	1325	3.04e-38	1.73e-35	0.2400	8.07e-02	4.22e-02	-4.11e-02	-1.90e-01	1.08e-01	8.15e-07	9.89e-03	1.20e-02	2.48e-31	4.38e-11
GOBP MAST CELL DIFFERENTIATION	6	9.37e-01	9.80e-01	0.2400	-3.61e-02	8.39e-02	4.41e-02	-1.16e-01	-1.85e-01	8.78e-01	7.22e-01	8.52e-01	6.24e-01	4.33e-01
GOBP CELL MIGRATION IN HINDBRAIN	16	5.38e-01	8.22e-01	0.2400	3.15e-02	4.09e-02	1.92e-01	-6.34e-02	-1.19e-01	8.27e-01	7.77e-01	1.83e-01	6.61e-01	4.10e-01
GOBP POSITIVE REGULATION OF GLIAL CELL PROLIFERATION	19	7.73e-01	9.25e-01	0.2400	-9.30e-03	1.19e-01	1.52e-01	1.43e-01	2.17e-03	9.44e-01	3.68e-01	2.52e-01	2.82e-01	9.87e-01
GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY	183	1.19e-04	2.72e-03	0.2400	-3.17e-02	4.51e-02	-1.12e-01	-2.04e-01	2.35e-02	4.60e-01	2.93e-01	9.26e-03	1.90e-06	5.84e-01
GOBP NEGATIVE REGULATION OF TOR SIGNALING	71	4.36e-02	2.32e-01	0.2400	8.62e-02	-3.79e-02	-5.23e-02	-2.06e-01	6.08e-02	2.09e-01	5.81e-01	4.46e-01	2.70e-03	3.75e-01
GOBP DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION	20	7.19e-01	9.02e-01	0.2400	-8.01e-02	1.53e-01	1.06e-01	1.10e-01	-6.71e-02	5.35e-01	2.37e-01	4.10e-01	3.94e-01	6.04e-01
GOMF 1 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY	10	8.31e-01	9.45e-01	0.2400	2.87e-02	-1.08e-01	2.03e-01	3.85e-02	-5.06e-02	8.75e-01	5.55e-01	2.66e-01	8.33e-01	7.82e-01
GOBP HOMOLOGOUS CHROMOSOME SEGREGATION	63	6.52e-02	3.01e-01	0.2400	4.32e-02	-8.45e-02	1.88e-02	-6.30e-02	2.10e-01	5.53e-01	2.46e-01	7.96e-01	3.87e-01	3.86e-03
GOBP FATTY ACID CATABOLIC PROCESS	104	3.58e-03	4.18e-02	0.2400	1.10e-01	1.72e-01	-4.02e-02	-3.57e-02	1.14e-01	5.33e-02	2.43e-03	4.79e-01	5.29e-01	4.37e-02
GOCC FILOPODIUM MEMBRANE	17	7.04e-01	8.97e-01	0.2400	9.87e-02	-1.30e-01	1.28e-01	6.84e-02	9.89e-02	4.81e-01	3.53e-01	3.60e-01	6.25e-01	4.80e-01
GOBP LUNG MORPHOGENESIS	54	8.89e-02	3.59e-01	0.2400	-1.17e-01	4.93e-02	2.49e-02	-1.71e-01	1.07e-01	1.36e-01	5.31e-01	7.52e-01	2.94e-02	1.74e-01
GOBP GALACTOSE METABOLIC PROCESS	8	9.23e-01	9.75e-01	0.2400	-3.43e-02	1.81e-01	5.52e-02	-1.41e-01	2.67e-02	8.67e-01	3.76e-01	7.87e-01	4.89e-01	8.96e-01
GOBP ESTROUS CYCLE	16	7.92e-01	9.31e-01	0.2400	-7.87e-02	2.20e-02	-1.63e-01	-1.14e-01	-1.06e-01	5.86e-01	8.79e-01	2.58e-01	4.30e-01	4.64e-01
GOMF G PROTEIN COUPLED GLUTAMATE RECEPTOR BINDING	10	8.85e-01	9.62e-01	0.2400	1.22e-01	1.00e-01	1.38e-01	-4.90e-02	1.06e-01	5.06e-01	5.83e-01	4.50e-01	7.88e-01	5.62e-01
GOBP NEGATIVE REGULATION OF DNA METABOLIC PROCESS	135	4.95e-03	5.32e-02	0.2400	5.72e-03	-3.64e-02	-1.74e-01	-1.57e-01	3.44e-02	9.09e-01	4.66e-01	4.72e-04	1.67e-03	4.90e-01
GOBP INTESTINAL EPITHELIAL CELL DIFFERENTIATION	27	3.44e-01	6.91e-01	0.2400	6.50e-02	7.43e-02	1.38e-01	-1.38e-01	9.72e-02	5.59e-01	5.04e-01	2.14e-01	2.13e-01	3.82e-01
GOBP TRNA METHYLATION	38	4.34e-01	7.57e-01	0.2400	6.95e-02	-6.37e-02	-1.33e-01	-1.65e-01	5.81e-02	4.58e-01	4.97e-01	1.55e-01	7.77e-02	5.35e-01
GOMF NUCLEAR ESTROGEN RECEPTOR BINDING	39	2.53e-01	6.10e-01	0.2400	1.04e-01	1.53e-01	-8.36e-02	-7.73e-02	-1.01e-01	2.61e-01	9.80e-02	3.66e-01	4.04e-01	2.76e-01
GOBP REGULATION OF VITAMIN D RECEPTOR SIGNALING PATHWAY	10	8.66e-01	9.55e-01	0.2400	-1.49e-02	2.12e-01	-9.84e-02	-4.98e-02	-3.22e-03	9.35e-01	2.46e-01	5.90e-01	7.85e-01	9.86e-01
GOBP REGULATION OF CYTOPLASMIC TRANSLATIONAL INITIATION	7	9.44e-01	9.82e-01	0.2390	1.56e-01	-1.29e-01	-5.84e-02	5.31e-02	1.01e-01	4.76e-01	5.54e-01	7.89e-01	8.08e-01	6.43e-01
GOBP BLASTOCYST DEVELOPMENT	113	5.61e-03	5.76e-02	0.2390	-1.59e-02	-4.46e-02	-8.80e-02	-2.12e-01	4.75e-02	7.70e-01	4.12e-01	1.06e-01	9.61e-05	3.83e-01
GOBP RESPONSE TO GONADOTROPIN RELEASING HORMONE	7	9.38e-01	9.80e-01	0.2390	-5.10e-02	1.76e-01	5.80e-02	-1.43e-01	-8.66e-04	8.15e-01	4.20e-01	7.91e-01	5.13e-01	9.97e-01
GOBP HISTONE UBIQUITINATION	8	8.48e-01	9.49e-01	0.2390	-2.85e-03	-1.49e-01	6.44e-02	-1.74e-01	2.06e-02	9.89e-01	4.65e-01	7.52e-01	3.93e-01	9.20e-01
GOBP NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS	169	7.60e-04	1.23e-02	0.2390	4.58e-02	5.29e-03	-1.36e-01	-1.66e-01	9.56e-02	3.04e-01	9.06e-01	2.28e-03	2.00e-04	3.21e-02
GOBP NEGATIVE REGULATION OF MRNA METABOLIC PROCESS	90	3.44e-03	4.07e-02	0.2390	-1.20e-01	8.36e-02	4.53e-02	-1.84e-01	3.52e-03	4.94e-02	1.70e-01	4.57e-01	2.57e-03	9.54e-01
GOBP RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN	155	4.65e-04	8.41e-03	0.2390	-5.40e-02	5.79e-02	-1.04e-01	-2.00e-01	6.98e-04	2.46e-01	2.14e-01	2.60e-02	1.65e-05	9.88e-01
GOBP BROWN FAT CELL DIFFERENTIATION	53	1.45e-01	4.66e-01	0.2390	-1.05e-02	1.67e-01	-3.10e-02	-1.42e-01	8.86e-02	8.95e-01	3.52e-02	6.97e-01	7.29e-02	2.65e-01
GOBP PROTEIN TARGETING TO LYSOSOME	31	3.90e-01	7.26e-01	0.2390	-9.59e-02	6.11e-02	-3.44e-02	-9.82e-02	1.83e-01	3.55e-01	5.56e-01	7.40e-01	3.44e-01	7.83e-02
GOBP PROTEIN DEGLYCOSYLATION	15	8.58e-01	9.53e-01	0.2390	-5.25e-03	-1.04e-01	-1.67e-01	-1.35e-01	-7.70e-03	9.72e-01	4.84e-01	2.63e-01	3.65e-01	9.59e-01
GOBP AMINO ACID TRANSPORT	142	1.77e-03	2.45e-02	0.2390	-6.89e-02	1.10e-01	1.81e-01	8.46e-02	2.46e-02	1.56e-01	2.43e-02	2.02e-04	8.16e-02	6.12e-01
GOBP REGULATION OF MITOTIC CYTOKINESIS	11	8.30e-01	9.44e-01	0.2390	4.62e-02	-1.74e-01	1.76e-02	-1.26e-01	9.20e-02	7.91e-01	3.18e-01	9.19e-01	4.68e-01	5.97e-01
GOBP POSITIVE REGULATION OF CELL SUBSTRATE ADHESION	121	4.57e-03	5.04e-02	0.2390	-1.29e-01	8.78e-02	8.75e-02	1.09e-01	-1.15e-01	1.42e-02	9.54e-02	9.63e-02	3.85e-02	2.90e-02
GOBP MYOTUBE DIFFERENTIATION INVOLVED IN SKELETAL MUSCLE REGENERATION	8	8.90e-01	9.63e-01	0.2390	-1.18e-01	1.41e-01	2.16e-02	1.07e-01	1.06e-01	5.62e-01	4.91e-01	9.16e-01	6.00e-01	6.02e-01
GOBP REGULATION OF ERYTHROCYTE DIFFERENTIATION	44	1.77e-01	5.18e-01	0.2390	-7.40e-02	1.42e-01	3.89e-02	-1.61e-01	6.12e-02	3.96e-01	1.02e-01	6.55e-01	6.40e-02	4.82e-01
GOBP NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY	26	5.80e-01	8.43e-01	0.2390	-5.77e-02	2.13e-03	2.12e-01	8.97e-02	-2.65e-02	6.10e-01	9.85e-01	6.14e-02	4.29e-01	8.15e-01
GOBP POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS	51	1.56e-01	4.84e-01	0.2390	-1.32e-01	-3.43e-02	1.73e-01	5.94e-02	7.16e-02	1.04e-01	6.71e-01	3.28e-02	4.63e-01	3.76e-01
GOMF GABA RECEPTOR BINDING	18	4.22e-01	7.49e-01	0.2390	1.17e-01	-9.04e-02	1.66e-01	-8.75e-02	-6.88e-03	3.91e-01	5.06e-01	2.24e-01	5.20e-01	9.60e-01
GOMF LIGAND GATED CHANNEL ACTIVITY	139	2.76e-03	3.45e-02	0.2390	-2.98e-02	1.09e-01	1.52e-01	1.44e-01	1.53e-02	5.44e-01	2.66e-02	1.95e-03	3.30e-03	7.56e-01
GOBP MALE GENITALIA DEVELOPMENT	23	5.85e-01	8.45e-01	0.2390	-1.67e-02	-2.05e-01	-2.87e-02	1.10e-01	-3.99e-02	8.90e-01	8.84e-02	8.11e-01	3.60e-01	7.40e-01
GOBP DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION	28	4.80e-01	7.92e-01	0.2390	5.69e-02	-8.08e-02	-1.65e-02	-1.61e-01	1.45e-01	6.02e-01	4.60e-01	8.80e-01	1.40e-01	1.85e-01
GOBP GOLGI ORGANIZATION	139	3.19e-03	3.83e-02	0.2390	1.21e-01	-2.81e-02	-1.39e-01	-1.42e-01	4.72e-02	1.39e-02	5.68e-01	4.76e-03	3.92e-03	3.37e-01
GOBP DNA REPLICATION CHECKPOINT SIGNALING	18	7.02e-01	8.96e-01	0.2390	7.62e-02	3.75e-02	4.68e-02	-1.46e-01	1.62e-01	5.76e-01	7.83e-01	7.31e-01	2.84e-01	2.34e-01
GOMF HISTONE H4 METHYLTRANSFERASE ACTIVITY	17	5.76e-01	8.41e-01	0.2380	9.51e-02	2.11e-02	3.31e-02	-2.15e-01	-1.23e-02	4.97e-01	8.80e-01	8.13e-01	1.25e-01	9.30e-01
GOBP REGULATION OF DEFENSE RESPONSE TO BACTERIUM	20	5.94e-01	8.49e-01	0.2380	-1.62e-01	-9.02e-02	-6.45e-02	1.26e-01	-5.09e-02	2.10e-01	4.85e-01	6.17e-01	3.31e-01	6.93e-01
GOBP REGULATION OF SISTER CHROMATID SEGREGATION	104	7.11e-03	6.86e-02	0.2380	1.29e-01	-5.45e-02	-6.95e-02	-1.75e-01	4.33e-02	2.31e-02	3.37e-01	2.21e-01	2.08e-03	4.46e-01
GOBP IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE	55	1.25e-01	4.36e-01	0.2380	5.72e-02	1.57e-01	-3.74e-02	-1.66e-01	1.04e-02	4.63e-01	4.44e-02	6.32e-01	3.35e-02	8.94e-01
GOBP UBIQUITIN DEPENDENT ERAD PATHWAY	82	3.28e-02	1.94e-01	0.2380	-5.11e-02	6.70e-02	-8.38e-02	-2.06e-01	7.83e-03	4.24e-01	2.94e-01	1.90e-01	1.24e-03	9.02e-01
GOBP VIRAL TRANSCRIPTION	50	1.95e-01	5.44e-01	0.2380	1.35e-01	-8.66e-02	-6.98e-02	-1.38e-01	8.36e-02	9.86e-02	2.89e-01	3.93e-01	9.04e-02	3.06e-01
GOBP LABYRINTHINE LAYER MORPHOGENESIS	22	5.80e-01	8.43e-01	0.2380	-1.62e-01	6.60e-03	1.09e-01	-1.39e-02	1.35e-01	1.87e-01	9.57e-01	3.78e-01	9.10e-01	2.72e-01
GOMF NEUREGULIN BINDING	5	9.73e-01	9.92e-01	0.2380	9.49e-03	-3.93e-02	-1.64e-01	3.90e-02	-1.63e-01	9.71e-01	8.79e-01	5.25e-01	8.80e-01	5.28e-01
GOBP REGULATION OF HYDROGEN PEROXIDE MEDIATED PROGRAMMED CELL DEATH	14	7.92e-01	9.31e-01	0.2380	-2.13e-01	5.26e-02	-1.46e-02	4.90e-02	-7.59e-02	1.67e-01	7.33e-01	9.25e-01	7.51e-01	6.23e-01
GOBP POSITIVE REGULATION OF ORGANELLE ASSEMBLY	82	6.44e-02	2.99e-01	0.2380	6.64e-02	2.72e-02	-1.55e-01	-1.66e-01	3.94e-03	2.99e-01	6.70e-01	1.51e-02	9.47e-03	9.51e-01
GOBP CHROMOSOME SEGREGATION	406	3.90e-10	3.35e-08	0.2380	9.10e-02	-2.74e-02	-9.79e-02	-1.75e-01	8.56e-02	1.65e-03	3.43e-01	7.14e-04	1.33e-09	3.06e-03
GOCC CD40 RECEPTOR COMPLEX	11	8.08e-01	9.37e-01	0.2380	-3.38e-02	-8.29e-02	4.65e-02	-1.92e-01	9.91e-02	8.46e-01	6.34e-01	7.89e-01	2.71e-01	5.69e-01
GOBP SKELETAL MUSCLE CELL DIFFERENTIATION	71	1.85e-02	1.34e-01	0.2380	7.57e-02	8.18e-02	6.42e-02	-1.85e-01	7.77e-02	2.70e-01	2.34e-01	3.49e-01	7.13e-03	2.57e-01
GOBP REGULATION OF NEURON PROJECTION REGENERATION	29	5.36e-01	8.22e-01	0.2380	-1.09e-01	-3.64e-02	1.82e-01	1.02e-01	2.94e-03	3.11e-01	7.34e-01	8.93e-02	3.44e-01	9.78e-01
GOBP REGULATION OF ACTIN FILAMENT BASED MOVEMENT	39	3.60e-01	7.04e-01	0.2380	-2.24e-02	-3.50e-02	8.70e-02	2.14e-01	-4.10e-02	8.09e-01	7.05e-01	3.47e-01	2.09e-02	6.57e-01
GOMF HYDROLASE ACTIVITY HYDROLYZING N GLYCOSYL COMPOUNDS	37	2.37e-01	5.93e-01	0.2380	7.08e-02	1.69e-01	-1.12e-01	-1.16e-02	-1.02e-01	4.56e-01	7.46e-02	2.39e-01	9.03e-01	2.85e-01
GOMF METAL DEPENDENT DEUBIQUITINASE ACTIVITY	10	9.16e-01	9.73e-01	0.2380	-8.16e-02	-1.03e-01	-1.23e-01	-1.22e-01	-9.78e-02	6.55e-01	5.74e-01	5.02e-01	5.05e-01	5.92e-01
GOBP PHOSPHATE ION TRANSPORT	28	4.55e-01	7.74e-01	0.2380	-1.28e-01	1.92e-01	4.92e-02	-3.24e-02	5.79e-03	2.42e-01	7.90e-02	6.52e-01	7.66e-01	9.58e-01
GOBP REGULATION OF HETEROTYPIC CELL CELL ADHESION	24	3.14e-01	6.65e-01	0.2380	6.09e-03	5.34e-02	-3.96e-02	2.27e-01	2.67e-02	9.59e-01	6.51e-01	7.37e-01	5.45e-02	8.21e-01
GOBP HYDROGEN PEROXIDE CATABOLIC PROCESS	30	3.03e-01	6.56e-01	0.2380	-6.54e-02	-6.54e-02	1.19e-02	1.17e-01	1.85e-01	5.35e-01	5.35e-01	9.10e-01	2.66e-01	8.00e-02
GOMF HISTONE H4K12 ACETYLTRANSFERASE ACTIVITY	12	8.60e-01	9.53e-01	0.2380	9.89e-02	1.19e-01	-1.28e-01	-7.65e-02	1.01e-01	5.53e-01	4.74e-01	4.42e-01	6.46e-01	5.45e-01
GOBP NEGATIVE REGULATION OF METALLOPEPTIDASE ACTIVITY	12	8.90e-01	9.63e-01	0.2380	-6.88e-02	-2.80e-02	4.70e-02	1.26e-01	-1.81e-01	6.80e-01	8.67e-01	7.78e-01	4.50e-01	2.76e-01
GOBP NEURAL PLATE DEVELOPMENT	8	9.34e-01	9.80e-01	0.2380	6.25e-02	-2.02e-01	-7.08e-02	-8.30e-02	-7.53e-03	7.59e-01	3.24e-01	7.29e-01	6.84e-01	9.71e-01
GOBP CELL VOLUME HOMEOSTASIS	34	3.30e-01	6.78e-01	0.2380	-1.35e-01	1.56e-01	-7.36e-03	-8.08e-02	-8.64e-02	1.74e-01	1.16e-01	9.41e-01	4.15e-01	3.83e-01
GOBP REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS	77	5.83e-02	2.82e-01	0.2380	-3.08e-02	4.92e-02	-1.07e-01	-2.04e-01	1.11e-02	6.40e-01	4.55e-01	1.05e-01	1.99e-03	8.66e-01
GOBP PEPTIDYL LYSINE DIMETHYLATION	11	7.26e-01	9.05e-01	0.2380	-1.48e-02	4.40e-02	1.48e-01	-1.79e-01	1.49e-02	9.32e-01	8.00e-01	3.96e-01	3.03e-01	9.32e-01
GOCC OUTER KINETOCHORE	20	7.36e-01	9.09e-01	0.2380	1.14e-01	-9.07e-03	-9.95e-02	-1.80e-01	2.92e-02	3.77e-01	9.44e-01	4.41e-01	1.62e-01	8.21e-01
GOMF POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING	52	2.02e-01	5.53e-01	0.2380	-5.42e-02	7.60e-02	-1.38e-01	-1.62e-01	4.76e-02	4.99e-01	3.43e-01	8.45e-02	4.31e-02	5.53e-01
GOCC MICROBODY MEMBRANE	62	1.30e-01	4.46e-01	0.2370	-7.06e-03	5.68e-02	-1.25e-01	-1.92e-01	-2.70e-02	9.23e-01	4.39e-01	8.82e-02	9.07e-03	7.13e-01
GOBP EATING BEHAVIOR	37	1.12e-01	4.10e-01	0.2370	-1.07e-02	6.90e-02	1.93e-01	-1.19e-01	6.31e-03	9.10e-01	4.67e-01	4.22e-02	2.09e-01	9.47e-01
GOMF ADENOSINE DEAMINASE ACTIVITY	13	8.49e-01	9.49e-01	0.2370	1.13e-01	1.20e-01	1.36e-01	6.55e-03	1.03e-01	4.79e-01	4.53e-01	3.97e-01	9.67e-01	5.22e-01
GOBP NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE	60	8.82e-02	3.59e-01	0.2370	-8.24e-02	1.71e-01	4.42e-02	1.83e-02	-1.34e-01	2.69e-01	2.17e-02	5.54e-01	8.07e-01	7.29e-02
GOBP CERAMIDE TRANSPORT	17	7.58e-01	9.19e-01	0.2370	-3.98e-03	1.66e-01	1.30e-01	-1.86e-02	1.07e-01	9.77e-01	2.35e-01	3.53e-01	8.94e-01	4.46e-01
GOCC PERICHROMATIN FIBRILS	5	9.74e-01	9.92e-01	0.2370	2.62e-02	5.41e-02	-7.96e-02	-1.73e-01	-1.27e-01	9.19e-01	8.34e-01	7.58e-01	5.02e-01	6.22e-01
GOBP RNA PROCESSING	1248	2.24e-29	9.18e-27	0.2370	2.00e-02	-6.33e-02	-1.73e-01	-1.43e-01	3.53e-02	2.34e-01	1.67e-04	8.50e-25	1.45e-17	3.60e-02
GOBP REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION	71	3.38e-02	1.98e-01	0.2370	-8.02e-02	2.19e-01	2.63e-02	1.89e-02	-2.45e-02	2.43e-01	1.40e-03	7.02e-01	7.83e-01	7.21e-01
GOMF CALCIUM RELEASE CHANNEL ACTIVITY	18	7.31e-01	9.08e-01	0.2370	2.01e-01	6.62e-02	-2.25e-02	-8.96e-02	5.28e-02	1.40e-01	6.27e-01	8.69e-01	5.11e-01	6.98e-01
GOBP RECEPTOR CATABOLIC PROCESS	27	4.64e-01	7.80e-01	0.2370	-4.74e-02	7.80e-02	-1.12e-01	9.49e-03	-1.87e-01	6.70e-01	4.83e-01	3.13e-01	9.32e-01	9.21e-02
GOBP DNA RECOMBINATION	318	2.40e-07	1.28e-05	0.2370	6.42e-02	-2.09e-02	-1.19e-01	-1.69e-01	9.26e-02	4.88e-02	5.22e-01	2.56e-04	2.07e-07	4.50e-03
GOBP CELLULAR RESPONSE TO SALT STRESS	14	7.96e-01	9.32e-01	0.2370	-3.96e-02	1.93e-01	5.56e-02	1.99e-02	1.16e-01	7.98e-01	2.10e-01	7.18e-01	8.97e-01	4.51e-01
GOBP POSITIVE REGULATION OF MAINTENANCE OF SISTER CHROMATID COHESION	6	9.76e-01	9.93e-01	0.2370	-1.12e-01	6.37e-02	1.70e-01	8.14e-02	-6.31e-02	6.35e-01	7.87e-01	4.72e-01	7.30e-01	7.89e-01
GOBP REGULATION OF OLIGODENDROCYTE DIFFERENTIATION	45	1.91e-01	5.38e-01	0.2370	1.15e-01	1.60e-02	4.39e-02	-1.34e-01	1.50e-01	1.83e-01	8.53e-01	6.10e-01	1.19e-01	8.16e-02
GOBP T CELL HOMEOSTASIS	44	2.13e-01	5.67e-01	0.2360	2.11e-02	-1.52e-02	-1.08e-01	-1.33e-01	-1.61e-01	8.08e-01	8.62e-01	2.16e-01	1.26e-01	6.49e-02
GOCC SPECIFIC GRANULE	155	1.27e-04	2.89e-03	0.2360	-1.39e-01	1.48e-01	9.34e-02	-3.69e-02	6.85e-02	2.85e-03	1.49e-03	4.49e-02	4.28e-01	1.41e-01
GOMF NUCLEASE ACTIVITY	206	1.31e-04	2.98e-03	0.2360	1.17e-02	-3.51e-04	-1.57e-01	-1.76e-01	1.13e-02	7.72e-01	9.93e-01	1.03e-04	1.31e-05	7.80e-01
GOMF KINASE INHIBITOR ACTIVITY	75	6.09e-02	2.90e-01	0.2360	-7.55e-02	7.61e-02	-1.20e-01	-1.68e-01	4.45e-02	2.58e-01	2.54e-01	7.35e-02	1.20e-02	5.05e-01
GOBP MITOTIC G2 M TRANSITION CHECKPOINT	50	2.60e-01	6.17e-01	0.2360	1.21e-01	1.56e-02	-9.85e-02	-1.58e-01	7.85e-02	1.38e-01	8.49e-01	2.28e-01	5.26e-02	3.37e-01
GOBP REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS	44	1.42e-01	4.63e-01	0.2360	-1.52e-01	9.68e-02	3.08e-02	2.94e-02	1.47e-01	8.03e-02	2.67e-01	7.23e-01	7.35e-01	9.27e-02
GOCC HOST CELLULAR COMPONENT	9	9.30e-01	9.78e-01	0.2360	-1.30e-01	4.94e-02	-9.96e-02	-1.52e-01	5.82e-02	4.99e-01	7.97e-01	6.05e-01	4.29e-01	7.62e-01
GOBP LUNG CELL DIFFERENTIATION	28	4.76e-01	7.89e-01	0.2360	-1.16e-01	1.76e-01	3.09e-02	5.16e-03	-1.02e-01	2.87e-01	1.07e-01	7.77e-01	9.62e-01	3.50e-01
GOBP BONE TRABECULA MORPHOGENESIS	13	7.78e-01	9.27e-01	0.2360	-1.85e-01	1.45e-02	7.62e-02	-1.23e-01	2.04e-02	2.48e-01	9.28e-01	6.34e-01	4.43e-01	8.99e-01
GOMF ORGANIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY	158	1.03e-03	1.59e-02	0.2360	-5.68e-02	1.30e-01	1.56e-01	9.86e-02	-4.08e-02	2.18e-01	4.75e-03	7.26e-04	3.25e-02	3.76e-01
GOBP STRESS GRANULE ASSEMBLY	29	3.60e-01	7.04e-01	0.2360	-1.03e-01	1.07e-01	2.16e-02	-1.62e-01	-8.30e-02	3.37e-01	3.19e-01	8.41e-01	1.30e-01	4.39e-01
GOBP MEIOTIC CHROMOSOME SEGREGATION	89	2.79e-02	1.75e-01	0.2360	7.19e-02	-7.13e-02	-5.65e-02	-1.10e-01	1.74e-01	2.41e-01	2.45e-01	3.57e-01	7.31e-02	4.57e-03
GOBP MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS	45	1.82e-01	5.25e-01	0.2360	-1.42e-01	1.30e-01	-8.21e-02	-7.19e-02	-8.16e-02	9.89e-02	1.31e-01	3.41e-01	4.04e-01	3.44e-01
GOBP TRANSMISSION OF NERVE IMPULSE	68	6.60e-02	3.03e-01	0.2360	-2.14e-02	-7.07e-02	1.79e-01	8.80e-02	1.02e-01	7.60e-01	3.13e-01	1.06e-02	2.09e-01	1.46e-01
GOCC EXTERNAL ENCAPSULATING STRUCTURE	538	2.14e-13	2.58e-11	0.2360	-8.24e-02	-1.23e-02	8.60e-02	1.78e-01	-9.83e-02	1.07e-03	6.26e-01	6.43e-04	1.58e-12	9.66e-05
GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY	13	8.63e-01	9.54e-01	0.2360	1.17e-01	-1.31e-01	-1.02e-01	-1.20e-01	7.32e-03	4.65e-01	4.14e-01	5.25e-01	4.52e-01	9.64e-01
GOBP REGULATION OF DNA REPLICATION	121	7.04e-03	6.81e-02	0.2360	5.25e-02	-4.88e-02	-1.14e-01	-1.92e-01	2.66e-02	3.18e-01	3.54e-01	3.03e-02	2.65e-04	6.13e-01
GOBP SYNAPTIC MEMBRANE ADHESION	25	5.76e-01	8.41e-01	0.2360	-2.49e-02	2.93e-02	1.98e-01	4.14e-02	1.16e-01	8.29e-01	8.00e-01	8.71e-02	7.20e-01	3.16e-01
GOBP NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY	15	7.90e-01	9.31e-01	0.2360	5.66e-02	2.15e-01	-2.50e-02	-7.28e-02	1.46e-02	7.04e-01	1.49e-01	8.67e-01	6.25e-01	9.22e-01
GOBP PHOSPHOLIPID CATABOLIC PROCESS	55	1.06e-01	3.95e-01	0.2360	-1.30e-01	1.41e-01	8.61e-02	-6.45e-02	8.47e-02	9.44e-02	7.04e-02	2.69e-01	4.08e-01	2.77e-01
GOBP EMBRYONIC PLACENTA DEVELOPMENT	86	1.57e-02	1.21e-01	0.2360	1.40e-02	9.09e-02	-9.47e-03	-2.09e-01	5.70e-02	8.22e-01	1.45e-01	8.79e-01	7.91e-04	3.61e-01
GOMF 1 PHOSPHATIDYLINOSITOL BINDING	15	7.46e-01	9.14e-01	0.2360	4.34e-02	-7.29e-02	3.67e-02	1.35e-01	1.70e-01	7.71e-01	6.25e-01	8.06e-01	3.66e-01	2.54e-01
GOBP POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION	17	7.76e-01	9.26e-01	0.2360	4.05e-02	-5.20e-02	1.24e-01	1.58e-01	1.06e-01	7.72e-01	7.11e-01	3.77e-01	2.61e-01	4.51e-01
GOCC CATION TRANSPORTING ATPASE COMPLEX	18	7.27e-01	9.05e-01	0.2360	-2.80e-02	-1.78e-01	-6.73e-02	-1.30e-01	3.83e-02	8.37e-01	1.90e-01	6.21e-01	3.39e-01	7.79e-01
GOCC RNA POLYMERASE II TRANSCRIPTION REGULATOR COMPLEX	233	6.61e-06	2.31e-04	0.2360	4.12e-02	1.11e-01	-8.29e-02	-1.80e-01	4.84e-02	2.78e-01	3.51e-03	2.93e-02	2.23e-06	2.03e-01
GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE	35	3.13e-01	6.64e-01	0.2360	5.78e-03	2.09e-01	-8.19e-02	-7.01e-02	-1.49e-02	9.53e-01	3.23e-02	4.02e-01	4.73e-01	8.79e-01
GOMF THIAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY	7	9.59e-01	9.88e-01	0.2360	-9.83e-03	-1.04e-01	5.35e-03	1.66e-01	-1.30e-01	9.64e-01	6.34e-01	9.80e-01	4.46e-01	5.50e-01
GOBP POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS	8	9.19e-01	9.74e-01	0.2360	-1.37e-01	9.30e-02	-4.01e-02	1.11e-01	-1.19e-01	5.02e-01	6.49e-01	8.44e-01	5.87e-01	5.59e-01
GOBP REGULATION OF PROTEIN STABILITY	305	3.52e-07	1.85e-05	0.2360	4.65e-02	5.84e-02	-1.35e-01	-1.76e-01	2.61e-02	1.63e-01	7.93e-02	5.20e-05	1.16e-07	4.33e-01
GOMF EPIDERMAL GROWTH FACTOR RECEPTOR BINDING	33	4.58e-01	7.76e-01	0.2360	-1.85e-02	2.79e-02	1.23e-01	1.88e-01	6.22e-02	8.54e-01	7.82e-01	2.22e-01	6.13e-02	5.36e-01
GOBP FOREBRAIN VENTRICULAR ZONE PROGENITOR CELL DIVISION	5	9.83e-01	9.94e-01	0.2360	-7.39e-02	-1.78e-03	1.82e-01	9.10e-02	9.28e-02	7.75e-01	9.95e-01	4.81e-01	7.25e-01	7.19e-01
GOBP INORGANIC ANION TRANSMEMBRANE TRANSPORT	125	6.51e-03	6.48e-02	0.2350	-1.13e-01	9.31e-02	1.40e-01	1.17e-01	-3.06e-02	2.93e-02	7.21e-02	7.06e-03	2.42e-02	5.55e-01
GOBP MICROTUBULE SEVERING	8	9.40e-01	9.81e-01	0.2350	-5.43e-02	1.47e-01	-5.40e-02	-1.65e-01	-2.61e-02	7.90e-01	4.71e-01	7.91e-01	4.19e-01	8.98e-01
GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN EXECUTION PHASE OF APOPTOSIS	7	9.40e-01	9.81e-01	0.2350	1.64e-01	3.99e-02	-1.48e-01	2.99e-03	6.95e-02	4.52e-01	8.55e-01	4.97e-01	9.89e-01	7.50e-01
GOBP CATECHOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS	22	6.04e-01	8.55e-01	0.2350	-7.29e-02	1.36e-01	8.12e-02	-1.29e-02	-1.57e-01	5.54e-01	2.68e-01	5.10e-01	9.17e-01	2.02e-01
GOCC ESC E Z COMPLEX	9	9.31e-01	9.79e-01	0.2350	1.52e-01	6.85e-02	-7.29e-02	-1.49e-01	-2.26e-03	4.30e-01	7.22e-01	7.05e-01	4.39e-01	9.91e-01
GOBP HEPARIN METABOLIC PROCESS	17	6.61e-01	8.81e-01	0.2350	1.41e-01	-7.94e-02	-5.58e-02	1.61e-01	1.31e-02	3.14e-01	5.71e-01	6.90e-01	2.51e-01	9.26e-01
GOBP POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION	51	1.68e-01	5.04e-01	0.2350	1.05e-01	1.81e-01	3.56e-02	-6.59e-02	7.77e-02	1.94e-01	2.57e-02	6.60e-01	4.16e-01	3.37e-01
GOBP NEGATIVE REGULATION OF FATTY ACID OXIDATION	14	7.71e-01	9.25e-01	0.2350	-9.12e-02	1.57e-01	5.08e-02	6.43e-02	1.24e-01	5.55e-01	3.08e-01	7.42e-01	6.77e-01	4.20e-01
GOBP REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY	34	3.15e-01	6.65e-01	0.2350	1.02e-01	1.29e-01	-3.46e-02	-9.84e-02	-1.31e-01	3.01e-01	1.92e-01	7.27e-01	3.20e-01	1.86e-01
GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY	62	1.48e-01	4.72e-01	0.2350	-6.62e-02	2.63e-02	-1.26e-01	-1.80e-01	4.10e-02	3.68e-01	7.20e-01	8.56e-02	1.42e-02	5.77e-01
GOBP REGULATION OF LYSOSOMAL LUMEN PH	27	5.09e-01	8.07e-01	0.2350	6.90e-02	-3.77e-02	1.06e-02	-1.55e-01	1.58e-01	5.35e-01	7.35e-01	9.24e-01	1.64e-01	1.55e-01
GOBP MESENCHYMAL TO EPITHELIAL TRANSITION	18	4.85e-01	7.94e-01	0.2350	5.65e-02	-8.54e-03	7.70e-02	-2.14e-01	6.31e-03	6.78e-01	9.50e-01	5.72e-01	1.16e-01	9.63e-01
GOMF ENZYME SUBSTRATE ADAPTOR ACTIVITY	61	1.35e-01	4.53e-01	0.2350	-3.38e-03	5.93e-02	-7.62e-02	-2.07e-01	5.50e-02	9.64e-01	4.23e-01	3.03e-01	5.22e-03	4.57e-01
GOBP NOSE DEVELOPMENT	16	7.82e-01	9.28e-01	0.2350	7.34e-03	1.88e-01	-2.79e-02	-1.06e-01	8.77e-02	9.59e-01	1.93e-01	8.47e-01	4.63e-01	5.44e-01
GOMF SPECTRIN BINDING	26	5.52e-01	8.29e-01	0.2350	-2.38e-02	1.20e-01	1.84e-01	3.30e-02	-7.23e-02	8.34e-01	2.88e-01	1.05e-01	7.71e-01	5.23e-01
GOBP REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT	16	6.90e-01	8.91e-01	0.2350	-1.07e-01	-1.65e-02	-8.52e-03	-2.04e-01	-4.05e-02	4.60e-01	9.09e-01	9.53e-01	1.57e-01	7.79e-01
GOBP ACTIN FILAMENT DEPOLYMERIZATION	57	1.43e-01	4.64e-01	0.2350	6.58e-02	1.56e-01	8.87e-02	1.11e-01	-7.94e-02	3.90e-01	4.18e-02	2.46e-01	1.49e-01	3.00e-01
GOBP REGULATION OF DNA METABOLIC PROCESS	506	2.65e-12	2.91e-10	0.2350	7.04e-02	-3.58e-02	-1.11e-01	-1.84e-01	5.04e-02	6.71e-03	1.67e-01	1.89e-05	1.27e-12	5.24e-02
GOBP REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY	43	2.60e-01	6.17e-01	0.2350	8.18e-02	1.51e-01	7.09e-02	-1.43e-03	1.43e-01	3.53e-01	8.58e-02	4.21e-01	9.87e-01	1.05e-01
GOBP SEMI LUNAR VALVE DEVELOPMENT	47	1.15e-01	4.15e-01	0.2350	6.60e-02	1.13e-01	1.19e-01	-1.34e-01	7.65e-02	4.34e-01	1.80e-01	1.58e-01	1.12e-01	3.64e-01
GOBP TYPE B PANCREATIC CELL DIFFERENTIATION	30	2.78e-01	6.32e-01	0.2350	1.56e-01	-8.23e-02	4.65e-02	-1.41e-01	4.30e-02	1.38e-01	4.35e-01	6.60e-01	1.83e-01	6.84e-01
GOMF NEUROTRANSMITTER TRANSMEMBRANE TRANSPORTER ACTIVITY	20	5.60e-01	8.32e-01	0.2350	1.95e-01	1.63e-02	1.24e-01	-3.30e-02	1.02e-02	1.31e-01	9.00e-01	3.36e-01	7.98e-01	9.37e-01
GOBP MULTICELLULAR ORGANISMAL MOVEMENT	57	1.03e-01	3.89e-01	0.2350	9.73e-03	8.53e-02	-1.76e-01	-9.14e-02	9.19e-02	8.99e-01	2.65e-01	2.18e-02	2.33e-01	2.30e-01
GOBP RETINAL METABOLIC PROCESS	18	7.53e-01	9.16e-01	0.2350	1.30e-01	9.39e-02	1.14e-01	1.03e-01	-7.52e-02	3.38e-01	4.91e-01	4.03e-01	4.50e-01	5.81e-01
GOBP POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION	18	7.75e-01	9.26e-01	0.2340	7.06e-03	1.79e-01	1.38e-01	5.75e-02	2.38e-02	9.59e-01	1.89e-01	3.11e-01	6.73e-01	8.61e-01
GOCC SET1C COMPASS COMPLEX	14	8.43e-01	9.49e-01	0.2340	4.42e-02	1.42e-01	-1.15e-01	-1.35e-01	-3.54e-02	7.75e-01	3.56e-01	4.55e-01	3.83e-01	8.19e-01
GOBP GLYCEROL ETHER METABOLIC PROCESS	21	6.54e-01	8.79e-01	0.2340	2.21e-01	-6.70e-03	-1.25e-02	-3.59e-02	6.84e-02	7.98e-02	9.58e-01	9.21e-01	7.76e-01	5.87e-01
GOMF PALMITOYL COA HYDROLASE ACTIVITY	15	6.12e-01	8.58e-01	0.2340	-1.77e-01	5.60e-02	-7.11e-02	1.01e-01	7.33e-02	2.36e-01	7.07e-01	6.33e-01	5.00e-01	6.23e-01
GOBP NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING	15	7.59e-01	9.19e-01	0.2340	-3.40e-02	1.96e-01	-6.04e-02	-1.09e-02	-1.08e-01	8.19e-01	1.90e-01	6.85e-01	9.42e-01	4.68e-01
GOBP NEGATIVE REGULATION OF AXON EXTENSION	43	2.23e-01	5.77e-01	0.2340	-2.03e-01	5.45e-02	6.45e-02	7.23e-02	3.36e-02	2.10e-02	5.36e-01	4.64e-01	4.12e-01	7.03e-01
GOBP CYSTEINE METABOLIC PROCESS	11	8.40e-01	9.47e-01	0.2340	-6.66e-02	9.27e-02	1.85e-01	-7.19e-02	5.09e-02	7.02e-01	5.94e-01	2.89e-01	6.80e-01	7.70e-01
GOBP MICROTUBULE BASED PROTEIN TRANSPORT	14	8.03e-01	9.34e-01	0.2340	1.61e-01	4.15e-02	3.91e-02	1.60e-01	1.46e-02	2.97e-01	7.88e-01	8.00e-01	3.01e-01	9.25e-01
GOBP 10 FORMYLTETRAHYDROFOLATE METABOLIC PROCESS	6	9.72e-01	9.92e-01	0.2340	-1.15e-01	1.27e-01	1.58e-01	2.47e-02	1.05e-02	6.25e-01	5.91e-01	5.04e-01	9.17e-01	9.65e-01
GOMF PHOSPHATIDYLINOSITOL TRISPHOSPHATE PHOSPHATASE ACTIVITY	9	8.97e-01	9.66e-01	0.2340	4.78e-02	-1.50e-01	-5.82e-02	-1.30e-01	-9.91e-02	8.04e-01	4.37e-01	7.62e-01	4.99e-01	6.07e-01
GOBP PIGMENT GRANULE ORGANIZATION	37	3.02e-01	6.55e-01	0.2340	-1.18e-01	1.18e-01	-1.90e-02	-1.01e-01	1.28e-01	2.14e-01	2.13e-01	8.41e-01	2.89e-01	1.79e-01
GOCC LATERAL PLASMA MEMBRANE	64	4.47e-02	2.36e-01	0.2340	1.45e-01	-9.93e-03	1.56e-01	6.21e-02	-7.42e-02	4.51e-02	8.91e-01	3.09e-02	3.90e-01	3.05e-01
GOBP CELLULAR RESPONSE TO OSMOTIC STRESS	51	1.40e-01	4.60e-01	0.2340	-1.15e-01	1.77e-01	4.00e-02	-6.11e-02	7.05e-02	1.55e-01	2.91e-02	6.21e-01	4.50e-01	3.84e-01
GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS	14	8.30e-01	9.44e-01	0.2340	-4.45e-02	-1.37e-01	1.58e-02	7.25e-02	-1.69e-01	7.73e-01	3.76e-01	9.19e-01	6.38e-01	2.73e-01
GOCC INSULIN RESPONSIVE COMPARTMENT	7	8.88e-01	9.63e-01	0.2340	-8.33e-02	-5.10e-03	7.75e-02	-1.93e-01	-6.78e-02	7.03e-01	9.81e-01	7.23e-01	3.78e-01	7.56e-01
GOBP PEPTIDE BIOSYNTHETIC PROCESS	803	1.81e-19	3.50e-17	0.2340	-2.80e-02	-2.96e-02	-1.41e-01	-1.82e-01	-7.39e-03	1.77e-01	1.53e-01	1.01e-11	1.97e-18	7.22e-01
GOBP REGULATION OF PINOCYTOSIS	12	8.82e-01	9.61e-01	0.2340	-1.13e-01	7.73e-02	-1.16e-01	-1.47e-01	2.85e-02	4.98e-01	6.43e-01	4.85e-01	3.79e-01	8.64e-01
GOBP NEUROTRANSMITTER METABOLIC PROCESS	25	5.80e-01	8.43e-01	0.2340	1.24e-01	1.32e-01	1.24e-01	5.72e-02	-5.65e-02	2.84e-01	2.54e-01	2.82e-01	6.20e-01	6.25e-01
GOBP INTERLEUKIN 12 PRODUCTION	62	1.01e-01	3.86e-01	0.2340	-1.29e-01	1.00e-01	1.13e-01	1.04e-01	6.51e-02	7.87e-02	1.71e-01	1.23e-01	1.57e-01	3.75e-01
GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY	14	8.13e-01	9.39e-01	0.2340	-8.15e-02	1.38e-01	9.21e-02	1.09e-01	9.26e-02	5.98e-01	3.72e-01	5.51e-01	4.79e-01	5.49e-01
GOBP REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT	16	7.71e-01	9.25e-01	0.2340	-3.78e-02	-1.16e-01	-3.74e-02	1.10e-02	-1.95e-01	7.94e-01	4.20e-01	7.96e-01	9.39e-01	1.77e-01
GOBP REGULATION OF EPINEPHRINE SECRETION	7	9.54e-01	9.86e-01	0.2340	1.95e-01	2.43e-02	8.55e-02	3.07e-02	8.87e-02	3.73e-01	9.11e-01	6.95e-01	8.88e-01	6.84e-01
GOBP REGULATION OF B CELL PROLIFERATION	62	1.25e-01	4.37e-01	0.2330	-8.51e-02	9.83e-02	1.54e-01	7.45e-02	9.13e-02	2.46e-01	1.80e-01	3.61e-02	3.11e-01	2.14e-01
GOMF TRANSFERASE ACTIVITY TRANSFERRING NITROGENOUS GROUPS	26	4.97e-01	8.02e-01	0.2330	9.41e-02	1.25e-01	1.63e-01	-3.42e-02	4.86e-02	4.06e-01	2.70e-01	1.51e-01	7.62e-01	6.68e-01
GOBP APPENDAGE DEVELOPMENT	177	7.23e-05	1.84e-03	0.2330	2.97e-02	3.38e-02	-4.71e-03	-1.86e-01	1.33e-01	4.95e-01	4.38e-01	9.14e-01	1.96e-05	2.21e-03
GOBP RESPONSE TO LIPOTEICHOIC ACID	10	9.03e-01	9.68e-01	0.2330	2.05e-01	1.01e-01	-2.84e-02	-3.02e-03	3.76e-02	2.62e-01	5.80e-01	8.76e-01	9.87e-01	8.37e-01
GOCC CHROMAFFIN GRANULE MEMBRANE	9	7.76e-01	9.26e-01	0.2330	-1.85e-02	-2.17e-02	1.76e-01	-1.13e-01	-1.01e-01	9.24e-01	9.10e-01	3.62e-01	5.59e-01	6.02e-01
GOMF CARGO ADAPTOR ACTIVITY	18	6.75e-01	8.85e-01	0.2330	-2.66e-02	1.78e-01	1.07e-01	-7.47e-02	-7.07e-02	8.45e-01	1.92e-01	4.30e-01	5.83e-01	6.03e-01
GOCC ENVELOPE	1183	3.75e-28	1.48e-25	0.2330	2.00e-02	2.04e-02	-1.27e-01	-1.91e-01	2.82e-02	2.46e-01	2.37e-01	1.84e-13	1.13e-28	1.02e-01
GOBP NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS	38	2.91e-01	6.45e-01	0.2330	-9.27e-02	9.81e-02	-3.26e-02	-1.86e-01	-2.38e-02	3.23e-01	2.95e-01	7.28e-01	4.75e-02	8.00e-01
GOCC MEMBRANE COAT	93	3.42e-02	1.99e-01	0.2330	7.20e-02	8.18e-02	-1.08e-01	-1.74e-01	2.44e-02	2.30e-01	1.73e-01	7.32e-02	3.72e-03	6.84e-01
GOBP POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM	33	2.42e-01	5.99e-01	0.2330	-7.65e-02	8.08e-02	4.86e-02	-1.94e-01	-4.21e-02	4.47e-01	4.22e-01	6.29e-01	5.33e-02	6.75e-01
GOBP REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY	55	1.48e-01	4.72e-01	0.2330	-1.12e-01	-4.36e-02	1.82e-01	7.03e-02	-4.22e-02	1.52e-01	5.76e-01	1.94e-02	3.67e-01	5.88e-01
GOBP NEGATIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE	8	9.22e-01	9.75e-01	0.2330	-2.08e-02	-6.46e-02	-4.71e-02	8.26e-03	2.18e-01	9.19e-01	7.52e-01	8.18e-01	9.68e-01	2.86e-01
GOBP POSITIVE REGULATION OF B CELL ACTIVATION	79	3.39e-02	1.98e-01	0.2330	-1.03e-03	1.74e-01	1.30e-02	-8.05e-02	1.31e-01	9.87e-01	7.45e-03	8.41e-01	2.16e-01	4.34e-02
GOBP POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION	52	1.86e-01	5.28e-01	0.2330	-2.44e-02	4.33e-02	1.48e-01	7.52e-02	1.56e-01	7.61e-01	5.89e-01	6.57e-02	3.48e-01	5.15e-02
GOMF PRENYLTRANSFERASE ACTIVITY	16	6.91e-01	8.92e-01	0.2330	-4.00e-02	-9.09e-02	5.23e-03	-2.04e-01	5.31e-02	7.82e-01	5.29e-01	9.71e-01	1.58e-01	7.13e-01
GOBP REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS	13	8.47e-01	9.49e-01	0.2330	-3.49e-03	-2.06e-01	-6.86e-02	7.03e-02	-4.65e-02	9.83e-01	1.99e-01	6.68e-01	6.61e-01	7.71e-01
GOBP EMBRYONIC PLACENTA MORPHOGENESIS	27	4.70e-01	7.85e-01	0.2330	-1.64e-01	1.87e-02	4.68e-02	-1.04e-01	1.18e-01	1.40e-01	8.67e-01	6.74e-01	3.50e-01	2.88e-01
GOBP ESTABLISHMENT OF SKIN BARRIER	33	3.75e-01	7.15e-01	0.2330	-2.24e-01	2.53e-02	4.70e-02	2.38e-02	2.57e-02	2.60e-02	8.02e-01	6.41e-01	8.13e-01	7.99e-01
GOBP CRANIAL SKELETAL SYSTEM DEVELOPMENT	70	7.43e-02	3.26e-01	0.2330	1.26e-01	1.52e-02	-5.00e-02	-5.92e-02	1.79e-01	6.78e-02	8.26e-01	4.70e-01	3.91e-01	9.65e-03
GOBP POSITIVE REGULATION OF B CELL PROLIFERATION	43	2.96e-01	6.50e-01	0.2330	-3.03e-02	1.57e-01	1.37e-01	3.42e-02	9.21e-02	7.31e-01	7.41e-02	1.20e-01	6.98e-01	2.96e-01
GOBP VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT	10	9.01e-01	9.68e-01	0.2330	9.41e-02	-4.30e-02	-2.91e-02	3.55e-03	2.06e-01	6.06e-01	8.14e-01	8.73e-01	9.85e-01	2.59e-01
GOBP FEMALE GENITALIA DEVELOPMENT	19	5.28e-01	8.18e-01	0.2330	1.29e-02	-2.42e-02	-1.43e-01	1.56e-01	-9.26e-02	9.22e-01	8.55e-01	2.81e-01	2.38e-01	4.84e-01
GOMF SODIUM CHANNEL REGULATOR ACTIVITY	37	3.37e-01	6.85e-01	0.2330	-3.52e-02	1.97e-01	4.49e-02	4.31e-02	-1.01e-01	7.11e-01	3.79e-02	6.37e-01	6.50e-01	2.89e-01
GOBP BEHAVIORAL RESPONSE TO PAIN	19	6.43e-01	8.75e-01	0.2330	-5.45e-02	-1.23e-01	-2.13e-02	1.89e-01	1.68e-05	6.81e-01	3.54e-01	8.72e-01	1.55e-01	1.00e+00
GOBP RESPONSE TO MAGNESIUM ION	20	7.51e-01	9.16e-01	0.2330	-3.79e-02	-4.38e-02	5.06e-02	1.50e-01	-1.60e-01	7.69e-01	7.34e-01	6.95e-01	2.44e-01	2.16e-01
GOBP CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS	31	3.98e-01	7.32e-01	0.2320	3.91e-02	1.94e-01	2.36e-02	-7.27e-02	-9.47e-02	7.06e-01	6.14e-02	8.20e-01	4.84e-01	3.62e-01
GOMF CULLIN FAMILY PROTEIN BINDING	24	4.49e-01	7.70e-01	0.2320	-2.52e-02	2.34e-02	-1.67e-02	-2.03e-01	-1.07e-01	8.31e-01	8.43e-01	8.87e-01	8.56e-02	3.64e-01
GOBP CLATHRIN COAT ASSEMBLY	17	7.36e-01	9.09e-01	0.2320	-9.03e-02	1.89e-01	6.36e-02	6.49e-02	4.50e-02	5.19e-01	1.78e-01	6.50e-01	6.43e-01	7.48e-01
GOCC SEPTIN CYTOSKELETON	14	7.94e-01	9.31e-01	0.2320	4.76e-02	8.99e-02	-4.12e-02	-1.66e-02	2.04e-01	7.58e-01	5.60e-01	7.90e-01	9.14e-01	1.86e-01
GOBP PROTEIN POLY ADP RIBOSYLATION	10	9.12e-01	9.71e-01	0.2320	9.71e-02	1.00e-01	-1.39e-02	-1.75e-01	6.13e-02	5.95e-01	5.84e-01	9.39e-01	3.38e-01	7.37e-01
GOCC UNCONVENTIONAL MYOSIN COMPLEX	9	8.79e-01	9.61e-01	0.2320	2.67e-02	-2.85e-03	1.37e-02	-6.84e-02	-2.20e-01	8.90e-01	9.88e-01	9.43e-01	7.22e-01	2.53e-01
GOMF NUCLEOSIDE BINDING	8	9.36e-01	9.80e-01	0.2320	1.08e-01	6.60e-02	-1.85e-01	-4.32e-02	-4.39e-02	5.98e-01	7.47e-01	3.65e-01	8.32e-01	8.30e-01
GOBP ACYLGLYCEROL HOMEOSTASIS	41	1.40e-01	4.60e-01	0.2320	-1.90e-01	4.46e-02	-8.86e-02	3.97e-03	8.91e-02	3.51e-02	6.22e-01	3.26e-01	9.65e-01	3.23e-01
GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II	891	9.74e-24	2.77e-21	0.2320	6.91e-02	4.56e-02	-4.33e-02	-1.85e-01	1.04e-01	4.70e-04	2.10e-02	2.85e-02	5.92e-21	1.29e-07
GOBP CELL FATE COMMITMENT	279	4.23e-09	3.18e-07	0.2320	4.63e-02	7.33e-02	4.25e-02	-1.91e-01	9.06e-02	1.83e-01	3.51e-02	2.22e-01	4.23e-08	9.21e-03
GOMF UBIQUITIN LIKE PROTEIN CONJUGATING ENZYME ACTIVITY	36	3.61e-01	7.04e-01	0.2320	-1.05e-01	1.27e-01	-4.90e-02	-1.54e-01	2.27e-02	2.75e-01	1.86e-01	6.11e-01	1.10e-01	8.14e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN	36	1.76e-01	5.17e-01	0.2320	-1.20e-01	5.30e-02	1.48e-01	-1.04e-01	-6.35e-02	2.14e-01	5.82e-01	1.24e-01	2.82e-01	5.10e-01
GOBP NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION	49	2.05e-01	5.56e-01	0.2320	-1.49e-01	-6.53e-03	7.98e-02	1.58e-01	1.67e-02	7.06e-02	9.37e-01	3.34e-01	5.63e-02	8.40e-01
GOBP POSITIVE REGULATION OF RNA SPLICING	37	4.19e-01	7.48e-01	0.2320	2.75e-02	7.63e-02	-1.07e-01	-1.88e-01	-2.12e-02	7.72e-01	4.22e-01	2.60e-01	4.79e-02	8.24e-01
GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION	37	4.47e-01	7.70e-01	0.2320	-7.40e-02	-5.30e-02	-1.22e-01	-1.70e-01	4.08e-02	4.36e-01	5.77e-01	2.01e-01	7.29e-02	6.68e-01
GOMF ORGANOPHOSPHATE ESTER TRANSMEMBRANE TRANSPORTER ACTIVITY	34	4.29e-01	7.54e-01	0.2320	-1.04e-02	5.22e-02	-6.90e-02	-2.14e-01	1.37e-02	9.16e-01	5.98e-01	4.86e-01	3.06e-02	8.90e-01
GOCC PHAGOCYTIC CUP	28	4.69e-01	7.84e-01	0.2320	-1.24e-01	1.83e-01	-7.02e-03	-6.76e-02	1.80e-02	2.56e-01	9.43e-02	9.49e-01	5.36e-01	8.69e-01
GOBP SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS	77	6.94e-02	3.12e-01	0.2320	9.54e-02	8.26e-02	-6.85e-02	-1.71e-01	6.13e-02	1.48e-01	2.10e-01	2.99e-01	9.42e-03	3.52e-01
GOBP FOAM CELL DIFFERENTIATION	41	3.19e-01	6.67e-01	0.2320	-7.85e-02	-5.14e-02	-1.82e-02	9.11e-02	-1.90e-01	3.84e-01	5.69e-01	8.40e-01	3.13e-01	3.50e-02
GOBP REGULATION OF PROTEIN ACETYLATION	38	2.99e-01	6.53e-01	0.2320	1.58e-01	9.62e-02	-1.65e-02	-1.38e-01	-5.08e-03	9.17e-02	3.05e-01	8.60e-01	1.41e-01	9.57e-01
GOBP RESPONSE TO VASOPRESSIN	8	8.81e-01	9.61e-01	0.2320	5.56e-02	-1.05e-02	1.25e-01	-2.64e-02	-1.85e-01	7.85e-01	9.59e-01	5.42e-01	8.97e-01	3.65e-01
GOCC HISTONE METHYLTRANSFERASE COMPLEX	57	1.44e-01	4.65e-01	0.2320	1.66e-01	8.44e-02	-6.89e-02	-1.19e-01	-8.10e-04	2.98e-02	2.71e-01	3.68e-01	1.21e-01	9.92e-01
GOBP PROTEIN DNA COMPLEX ORGANIZATION	793	2.29e-19	4.35e-17	0.2310	9.17e-02	-1.56e-02	-8.64e-02	-1.72e-01	8.81e-02	1.11e-05	4.55e-01	3.51e-05	1.48e-16	2.43e-05
GOCC CEREBELLAR MOSSY FIBER	7	8.93e-01	9.64e-01	0.2310	-6.60e-02	-5.53e-02	2.01e-01	-7.56e-02	3.88e-03	7.62e-01	8.00e-01	3.57e-01	7.29e-01	9.86e-01
GOBP REGULATION OF RELAXATION OF MUSCLE	14	8.39e-01	9.47e-01	0.2310	-2.41e-02	1.77e-01	1.00e-01	4.84e-02	9.56e-02	8.76e-01	2.51e-01	5.15e-01	7.54e-01	5.36e-01
GOBP NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION	90	3.03e-02	1.85e-01	0.2310	1.03e-01	2.94e-02	-1.33e-01	-1.36e-01	-7.83e-02	9.23e-02	6.30e-01	2.95e-02	2.62e-02	1.99e-01
GOBP MUCUS SECRETION	18	7.76e-01	9.26e-01	0.2310	6.74e-02	1.61e-01	1.44e-01	4.79e-02	9.24e-03	6.21e-01	2.38e-01	2.90e-01	7.25e-01	9.46e-01
GOBP REGULATION OF ADENYLATE CYCLASE ACTIVITY	44	2.65e-01	6.21e-01	0.2310	-7.76e-02	6.01e-02	1.46e-01	4.13e-02	1.44e-01	3.73e-01	4.90e-01	9.35e-02	6.35e-01	9.77e-02
GOMF HISTONE H3 ACETYLTRANSFERASE ACTIVITY	14	8.46e-01	9.49e-01	0.2310	6.85e-03	1.20e-01	-2.85e-02	-1.10e-01	1.61e-01	9.65e-01	4.37e-01	8.54e-01	4.74e-01	2.96e-01
GOBP CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN	106	1.19e-02	9.91e-02	0.2310	-5.63e-02	6.54e-02	-8.88e-02	-1.95e-01	1.00e-03	3.17e-01	2.45e-01	1.14e-01	5.09e-04	9.86e-01
GOBP INTRA GOLGI VESICLE MEDIATED TRANSPORT	33	5.39e-01	8.23e-01	0.2310	9.74e-02	5.18e-02	-1.14e-01	-1.61e-01	4.89e-02	3.33e-01	6.07e-01	2.56e-01	1.10e-01	6.27e-01
GOMF PHOSPHORIC DIESTER HYDROLASE ACTIVITY	86	7.30e-02	3.23e-01	0.2310	-2.42e-02	5.95e-02	1.34e-01	1.65e-01	-6.41e-02	6.98e-01	3.40e-01	3.11e-02	8.24e-03	3.04e-01
GOBP MODULATION OF PROCESS OF ANOTHER ORGANISM	19	6.57e-01	8.80e-01	0.2310	-5.87e-02	1.04e-01	1.53e-01	-8.39e-02	9.31e-02	6.58e-01	4.31e-01	2.48e-01	5.27e-01	4.82e-01
GOBP PROTEIN LIPID COMPLEX ORGANIZATION	54	1.35e-01	4.53e-01	0.2310	-1.10e-01	1.41e-01	1.67e-02	9.16e-02	-1.14e-01	1.64e-01	7.39e-02	8.32e-01	2.44e-01	1.48e-01
GOBP CELLULAR RESPONSE TO PARATHYROID HORMONE STIMULUS	8	9.39e-01	9.81e-01	0.2310	-6.25e-02	1.82e-01	6.56e-02	8.17e-03	1.09e-01	7.59e-01	3.72e-01	7.48e-01	9.68e-01	5.93e-01
GOBP POSITIVE REGULATION OF BEHAVIOR	24	4.63e-01	7.80e-01	0.2310	6.96e-02	6.03e-02	1.97e-01	-9.62e-04	-7.76e-02	5.55e-01	6.09e-01	9.47e-02	9.93e-01	5.11e-01
GOBP CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS	15	7.71e-01	9.25e-01	0.2310	-1.63e-01	1.25e-01	-2.09e-02	-6.29e-02	8.20e-02	2.74e-01	4.02e-01	8.89e-01	6.73e-01	5.82e-01
GOBP NEGATIVE REGULATION OF MACROPHAGE APOPTOTIC PROCESS	7	9.57e-01	9.87e-01	0.2310	-1.57e-01	-4.21e-02	1.51e-01	3.92e-02	-4.92e-02	4.72e-01	8.47e-01	4.88e-01	8.58e-01	8.22e-01
GOCC CENTRIOLAR SUBDISTAL APPENDAGE	9	7.91e-01	9.31e-01	0.2310	3.32e-02	2.15e-02	1.54e-01	-1.66e-01	-2.15e-02	8.63e-01	9.11e-01	4.24e-01	3.88e-01	9.11e-01
GOBP REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION	20	6.59e-01	8.80e-01	0.2310	2.33e-02	1.01e-01	2.65e-03	-2.03e-01	3.80e-02	8.57e-01	4.35e-01	9.84e-01	1.16e-01	7.69e-01
GOCC RECYCLING ENDOSOME MEMBRANE	99	5.21e-03	5.51e-02	0.2310	-1.16e-01	9.44e-02	-1.20e-02	-1.36e-01	-1.11e-01	4.60e-02	1.05e-01	8.36e-01	1.98e-02	5.55e-02
GOCC SPECIFIC GRANULE LUMEN	60	1.00e-01	3.84e-01	0.2310	-1.95e-01	8.40e-02	8.55e-02	8.05e-03	2.52e-02	8.83e-03	2.61e-01	2.52e-01	9.14e-01	7.36e-01
GOBP METHIONINE BIOSYNTHETIC PROCESS	12	8.13e-01	9.39e-01	0.2310	9.97e-02	3.06e-02	4.77e-02	-1.89e-01	6.74e-02	5.50e-01	8.54e-01	7.75e-01	2.58e-01	6.86e-01
GOMF NUCLEOBASE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY	50	1.74e-01	5.14e-01	0.2310	8.38e-02	-7.27e-03	-7.41e-02	-1.99e-01	-3.29e-02	3.05e-01	9.29e-01	3.64e-01	1.49e-02	6.87e-01
GOBP CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES	16	7.50e-01	9.16e-01	0.2310	-2.03e-01	-7.39e-02	3.64e-02	-6.16e-02	3.85e-02	1.60e-01	6.09e-01	8.01e-01	6.70e-01	7.90e-01
GOBP HEART VALVE MORPHOGENESIS	60	5.85e-02	2.82e-01	0.2310	1.46e-01	1.03e-01	9.04e-02	-1.08e-01	4.10e-02	5.11e-02	1.69e-01	2.26e-01	1.49e-01	5.82e-01
GOMF MANNOSE BINDING	24	6.00e-01	8.52e-01	0.2310	-1.14e-01	3.09e-02	-5.03e-02	-2.19e-02	-1.90e-01	3.32e-01	7.93e-01	6.70e-01	8.52e-01	1.07e-01
GOBP POSITIVE REGULATION OF CONNECTIVE TISSUE REPLACEMENT	12	8.59e-01	9.53e-01	0.2310	-6.78e-02	3.27e-02	2.08e-01	8.79e-03	6.46e-02	6.84e-01	8.45e-01	2.12e-01	9.58e-01	6.98e-01
GOBP POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT	23	6.03e-01	8.54e-01	0.2310	-6.91e-03	1.59e-01	9.88e-02	-2.56e-03	-1.35e-01	9.54e-01	1.88e-01	4.12e-01	9.83e-01	2.63e-01
GOMF PHOSPHOPROTEIN BINDING	88	1.79e-02	1.32e-01	0.2300	-4.38e-02	1.95e-01	6.80e-02	-8.51e-02	3.55e-02	4.77e-01	1.55e-03	2.70e-01	1.68e-01	5.65e-01
GOCC GLIAL CELL PROJECTION	36	5.02e-01	8.03e-01	0.2300	-8.61e-02	8.01e-02	1.44e-01	1.13e-01	-7.51e-02	3.72e-01	4.05e-01	1.34e-01	2.41e-01	4.35e-01
GOBP NEGATIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY	6	9.61e-01	9.89e-01	0.2300	3.14e-02	-2.19e-01	9.71e-03	1.24e-02	-6.37e-02	8.94e-01	3.54e-01	9.67e-01	9.58e-01	7.87e-01
GOBP POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY	16	7.97e-01	9.32e-01	0.2300	1.10e-01	1.49e-01	3.81e-02	-9.70e-02	8.82e-02	4.45e-01	3.01e-01	7.92e-01	5.02e-01	5.41e-01
GOBP AMINOGLYCOSIDE ANTIBIOTIC METABOLIC PROCESS	10	8.75e-01	9.59e-01	0.2300	1.83e-02	-5.09e-02	-8.21e-04	2.24e-01	-9.39e-04	9.20e-01	7.81e-01	9.96e-01	2.20e-01	9.96e-01
GOBP AMINO SUGAR METABOLIC PROCESS	40	2.16e-01	5.70e-01	0.2300	1.46e-01	5.81e-02	7.28e-03	-1.53e-02	-1.68e-01	1.11e-01	5.25e-01	9.36e-01	8.67e-01	6.61e-02
GOBP INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE	132	6.16e-03	6.21e-02	0.2300	-9.94e-02	1.84e-02	9.09e-02	1.62e-01	-9.05e-02	4.87e-02	7.15e-01	7.13e-02	1.27e-03	7.26e-02
GOBP T CELL MEDIATED IMMUNITY	121	3.08e-03	3.76e-02	0.2300	-1.54e-01	8.55e-02	1.48e-01	7.69e-03	-3.78e-03	3.51e-03	1.04e-01	4.80e-03	8.84e-01	9.43e-01
GOBP PROTEIN KINASE A SIGNALING	37	4.61e-01	7.78e-01	0.2300	-9.85e-02	-6.44e-02	1.27e-01	1.28e-01	-8.14e-02	3.00e-01	4.98e-01	1.80e-01	1.79e-01	3.91e-01
GOBP ENDOCARDIAL CUSHION MORPHOGENESIS	44	1.74e-01	5.14e-01	0.2300	1.20e-01	4.55e-02	5.21e-02	-1.63e-01	8.57e-02	1.68e-01	6.01e-01	5.50e-01	6.21e-02	3.25e-01
GOBP MEMBRANE PROTEIN PROTEOLYSIS	56	1.14e-01	4.12e-01	0.2300	-1.10e-01	1.02e-01	-4.32e-02	-1.20e-01	-1.18e-01	1.54e-01	1.86e-01	5.76e-01	1.19e-01	1.25e-01
GOBP MODIFIED AMINO ACID TRANSPORT	47	2.85e-01	6.38e-01	0.2300	2.05e-02	1.45e-01	1.04e-01	1.37e-01	-4.43e-02	8.07e-01	8.48e-02	2.16e-01	1.05e-01	5.99e-01
GOBP POSITIVE REGULATION OF LOW DENSITY LIPOPROTEIN RECEPTOR ACTIVITY	5	9.60e-01	9.88e-01	0.2300	5.43e-02	1.43e-01	-1.23e-01	7.74e-02	-9.21e-02	8.34e-01	5.80e-01	6.34e-01	7.64e-01	7.21e-01
GOBP GLYCOSPHINGOLIPID CATABOLIC PROCESS	13	7.10e-01	8.99e-01	0.2300	-1.62e-02	-1.18e-01	4.89e-02	-1.89e-01	2.06e-02	9.19e-01	4.60e-01	7.60e-01	2.37e-01	8.98e-01
GOBP MACROPHAGE CHEMOTAXIS	41	2.22e-01	5.76e-01	0.2300	-1.31e-01	1.34e-01	3.02e-02	-4.75e-03	1.30e-01	1.48e-01	1.37e-01	7.38e-01	9.58e-01	1.50e-01
GOBP MATURE B CELL DIFFERENTIATION	34	3.72e-01	7.12e-01	0.2300	-6.90e-02	1.17e-01	1.83e-01	-7.27e-03	-3.21e-02	4.86e-01	2.40e-01	6.46e-02	9.42e-01	7.46e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS ANTIGEN	45	1.14e-01	4.12e-01	0.2300	-1.23e-01	-3.95e-02	1.82e-01	-3.07e-02	-4.69e-02	1.53e-01	6.47e-01	3.47e-02	7.22e-01	5.86e-01
GOMF CALMODULIN DEPENDENT PROTEIN KINASE ACTIVITY	24	6.47e-01	8.76e-01	0.2300	1.19e-01	1.06e-01	-1.17e-01	-1.13e-01	-3.12e-02	3.12e-01	3.68e-01	3.20e-01	3.39e-01	7.91e-01
GOBP OUTFLOW TRACT SEPTUM MORPHOGENESIS	26	5.56e-01	8.31e-01	0.2300	-2.39e-02	-4.55e-03	1.99e-01	3.73e-02	1.07e-01	8.33e-01	9.68e-01	7.91e-02	7.42e-01	3.46e-01
GOBP POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION	33	4.29e-01	7.54e-01	0.2300	1.08e-01	1.29e-01	7.03e-02	1.40e-01	-1.08e-02	2.84e-01	1.99e-01	4.85e-01	1.64e-01	9.15e-01
GOBP RESPONSE TO LEAD ION	19	7.15e-01	9.01e-01	0.2300	1.25e-02	2.07e-01	-3.00e-02	-9.57e-02	-4.55e-03	9.25e-01	1.19e-01	8.21e-01	4.70e-01	9.73e-01
GOBP PROTEASOMAL PROTEIN CATABOLIC PROCESS	509	3.44e-13	4.00e-11	0.2300	2.54e-02	5.47e-02	-7.57e-02	-2.07e-01	2.87e-02	3.26e-01	3.48e-02	3.45e-03	1.38e-15	2.68e-01
GOBP OLEFINIC COMPOUND BIOSYNTHETIC PROCESS	28	4.83e-01	7.93e-01	0.2300	-1.69e-02	-1.85e-01	-2.19e-02	1.34e-01	1.50e-02	8.77e-01	9.09e-02	8.41e-01	2.21e-01	8.91e-01
GOBP POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS	31	3.88e-01	7.25e-01	0.2300	8.88e-02	-5.73e-03	3.18e-02	1.01e-01	1.83e-01	3.92e-01	9.56e-01	7.59e-01	3.28e-01	7.71e-02
GOMF CHANNEL INHIBITOR ACTIVITY	35	2.94e-01	6.48e-01	0.2300	-8.95e-02	1.22e-01	2.24e-02	-1.64e-01	-5.26e-02	3.59e-01	2.13e-01	8.19e-01	9.38e-02	5.90e-01
GOBP REGULATION OF MICROTUBULE BASED MOVEMENT	50	2.05e-01	5.55e-01	0.2300	-1.09e-01	-1.73e-01	-8.26e-02	-5.70e-02	-2.99e-02	1.81e-01	3.43e-02	3.12e-01	4.86e-01	7.14e-01
GOBP POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS	41	3.40e-01	6.87e-01	0.2300	-1.33e-02	-1.64e-01	-8.50e-02	-1.19e-01	6.52e-02	8.83e-01	6.90e-02	3.46e-01	1.86e-01	4.70e-01
GOBP VACUOLE ORGANIZATION	219	6.01e-05	1.57e-03	0.2300	1.88e-02	5.61e-02	-1.12e-01	-1.56e-01	1.12e-01	6.32e-01	1.52e-01	4.42e-03	7.09e-05	4.17e-03
GOBP NEGATIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION	5	9.84e-01	9.94e-01	0.2300	-1.12e-01	1.13e-01	1.16e-01	1.13e-01	3.32e-02	6.63e-01	6.63e-01	6.52e-01	6.60e-01	8.98e-01
GOBP RESPONSE TO DIETARY EXCESS	34	3.98e-01	7.32e-01	0.2300	-4.15e-02	1.27e-01	1.25e-02	-1.63e-01	9.13e-02	6.75e-01	2.02e-01	8.99e-01	9.97e-02	3.57e-01
GOMF MHC PROTEIN BINDING	32	2.37e-01	5.93e-01	0.2300	-1.65e-01	2.31e-02	-2.19e-02	1.23e-01	9.68e-02	1.06e-01	8.21e-01	8.30e-01	2.28e-01	3.43e-01
GOBP POSTSYNAPSE ASSEMBLY	35	4.75e-01	7.88e-01	0.2300	3.14e-02	1.03e-01	1.40e-01	1.27e-01	7.37e-02	7.47e-01	2.90e-01	1.51e-01	1.95e-01	4.51e-01
GOBP REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING	59	1.27e-01	4.40e-01	0.2300	-1.69e-01	4.89e-02	9.89e-03	3.94e-02	-1.42e-01	2.44e-02	5.16e-01	8.95e-01	6.01e-01	5.98e-02
GOBP POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY	60	1.44e-01	4.65e-01	0.2300	-6.78e-02	1.71e-01	9.45e-02	8.94e-02	-4.55e-02	3.64e-01	2.21e-02	2.05e-01	2.31e-01	5.42e-01
GOMF ABC TYPE TRANSPORTER ACTIVITY	46	2.99e-01	6.53e-01	0.2300	1.40e-03	-2.46e-02	5.54e-02	1.86e-01	-1.20e-01	9.87e-01	7.73e-01	5.15e-01	2.87e-02	1.60e-01
GOBP MYELOID LEUKOCYTE MEDIATED IMMUNITY	105	5.06e-03	5.41e-02	0.2300	-3.83e-03	1.53e-01	1.37e-01	-7.25e-02	7.22e-02	9.46e-01	6.75e-03	1.50e-02	2.00e-01	2.01e-01
GOCC STEREOCILIUM BUNDLE	60	1.54e-01	4.82e-01	0.2300	-9.08e-02	4.40e-02	4.35e-02	1.05e-01	-1.72e-01	2.24e-01	5.55e-01	5.60e-01	1.60e-01	2.11e-02
GOBP POSITIVE REGULATION OF NEURON MIGRATION	17	5.12e-01	8.08e-01	0.2300	5.65e-02	-8.48e-02	1.87e-01	-4.15e-02	-7.54e-02	6.87e-01	5.45e-01	1.82e-01	7.67e-01	5.90e-01
GOBP CELL ADHESION MEDIATED BY INTEGRIN	86	2.77e-02	1.74e-01	0.2300	-9.55e-02	1.20e-01	4.91e-02	1.40e-01	-8.46e-02	1.26e-01	5.40e-02	4.31e-01	2.50e-02	1.75e-01
GOMF GLUTATHIONE PEROXIDASE ACTIVITY	20	6.83e-01	8.88e-01	0.2290	2.62e-03	1.67e-01	1.48e-01	-4.32e-02	3.15e-02	9.84e-01	1.95e-01	2.53e-01	7.38e-01	8.07e-01
GOBP POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION	45	3.22e-01	6.70e-01	0.2290	1.20e-01	-5.56e-03	-5.17e-02	-1.23e-01	1.43e-01	1.65e-01	9.49e-01	5.48e-01	1.54e-01	9.58e-02
GOBP NEGATIVE REGULATION OF ORGAN GROWTH	35	3.72e-01	7.12e-01	0.2290	-1.03e-01	1.57e-01	1.63e-02	-6.85e-03	-1.31e-01	2.92e-01	1.08e-01	8.67e-01	9.44e-01	1.81e-01
GOBP NEGATIVE REGULATION OF MUSCLE HYPERTROPHY	36	2.59e-01	6.16e-01	0.2290	-1.36e-01	2.40e-02	1.79e-01	-3.80e-02	-1.39e-02	1.59e-01	8.03e-01	6.31e-02	6.93e-01	8.86e-01
GOBP SUBSTRATE DEPENDENT CELL MIGRATION CELL EXTENSION	8	9.22e-01	9.74e-01	0.2290	-1.94e-02	1.89e-01	2.64e-02	1.26e-01	1.22e-02	9.24e-01	3.56e-01	8.97e-01	5.37e-01	9.52e-01
GOCC PRESYNAPTIC ENDOCYTIC ZONE	9	9.12e-01	9.71e-01	0.2290	-8.85e-02	1.04e-01	-4.85e-03	-1.80e-01	-3.63e-02	6.46e-01	5.87e-01	9.80e-01	3.49e-01	8.51e-01
GOBP VACUOLAR LOCALIZATION	82	4.25e-02	2.29e-01	0.2290	6.31e-02	1.65e-01	-3.42e-02	-1.14e-01	8.48e-02	3.23e-01	9.74e-03	5.93e-01	7.42e-02	1.84e-01
GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III	17	7.88e-01	9.30e-01	0.2290	8.17e-02	-3.76e-02	-6.13e-02	-1.95e-01	5.00e-02	5.60e-01	7.88e-01	6.62e-01	1.63e-01	7.21e-01
GOBP VACUOLAR ACIDIFICATION	32	4.09e-01	7.42e-01	0.2290	-2.30e-02	2.46e-02	3.99e-02	-1.60e-01	1.55e-01	8.21e-01	8.10e-01	6.96e-01	1.17e-01	1.28e-01
GOBP DIGESTIVE SYSTEM PROCESS	102	7.61e-03	7.22e-02	0.2290	-4.66e-02	1.36e-01	2.05e-02	1.36e-01	-1.13e-01	4.16e-01	1.74e-02	7.20e-01	1.78e-02	4.83e-02
GOBP REGULATION OF KERATINOCYTE DIFFERENTIATION	40	1.32e-01	4.49e-01	0.2290	-5.99e-03	9.64e-02	1.08e-01	-1.77e-01	1.54e-03	9.48e-01	2.91e-01	2.37e-01	5.24e-02	9.87e-01
GOMF PHOSPHOLIPASE BINDING	20	6.29e-01	8.68e-01	0.2290	1.67e-01	7.86e-02	-4.58e-02	5.78e-02	1.14e-01	1.97e-01	5.43e-01	7.23e-01	6.54e-01	3.79e-01
GOBP MORPHOGENESIS OF AN EPITHELIAL SHEET	59	1.22e-01	4.28e-01	0.2290	1.80e-01	1.13e-01	6.61e-02	2.79e-02	4.57e-02	1.70e-02	1.33e-01	3.80e-01	7.11e-01	5.44e-01
GOBP VENOUS BLOOD VESSEL DEVELOPMENT	16	7.20e-01	9.02e-01	0.2290	1.20e-01	4.45e-02	6.06e-02	-1.62e-01	7.69e-02	4.07e-01	7.58e-01	6.75e-01	2.61e-01	5.94e-01
GOCC CLUSTER OF ACTIN BASED CELL PROJECTIONS	157	1.74e-03	2.43e-02	0.2290	-5.43e-02	5.89e-02	1.03e-01	1.22e-01	-1.43e-01	2.40e-01	2.02e-01	2.65e-02	8.31e-03	2.00e-03
GOBP AMYLOID FIBRIL FORMATION	38	3.07e-01	6.60e-01	0.2290	3.16e-02	8.51e-02	-7.71e-02	-4.19e-02	-1.91e-01	7.36e-01	3.64e-01	4.11e-01	6.55e-01	4.20e-02
GOCC TRANSCRIPTION ELONGATION FACTOR COMPLEX	47	2.23e-01	5.76e-01	0.2290	-2.23e-02	-8.19e-02	-9.30e-02	-1.77e-01	-7.12e-02	7.91e-01	3.31e-01	2.70e-01	3.58e-02	3.98e-01
GOCC PHOTORECEPTOR OUTER SEGMENT	85	2.34e-02	1.56e-01	0.2290	-6.60e-02	6.76e-03	4.48e-02	2.12e-01	-3.08e-02	2.93e-01	9.14e-01	4.75e-01	7.32e-04	6.24e-01
GOBP GLIAL CELL MIGRATION	57	1.13e-01	4.10e-01	0.2290	-9.70e-02	-7.61e-02	1.80e-01	4.47e-02	5.13e-02	2.05e-01	3.21e-01	1.87e-02	5.59e-01	5.03e-01
GOBP POSITIVE REGULATION OF BMP SIGNALING PATHWAY	40	2.53e-01	6.09e-01	0.2290	1.08e-01	1.41e-01	8.61e-02	-1.07e-01	4.46e-02	2.38e-01	1.23e-01	3.46e-01	2.42e-01	6.26e-01
GOMF HISTONE H4K5 ACETYLTRANSFERASE ACTIVITY	11	9.18e-01	9.74e-01	0.2290	9.40e-02	1.29e-01	-6.40e-02	-1.34e-01	6.88e-02	5.89e-01	4.58e-01	7.13e-01	4.43e-01	6.93e-01
GOBP MEMBRANE DEPOLARIZATION	78	6.78e-02	3.08e-01	0.2280	-9.64e-02	1.13e-01	8.73e-02	7.81e-02	-1.29e-01	1.41e-01	8.55e-02	1.82e-01	2.33e-01	4.97e-02
GOMF DISORDERED DOMAIN SPECIFIC BINDING	29	3.24e-01	6.72e-01	0.2280	-5.65e-02	-1.33e-01	2.15e-02	-1.75e-01	1.47e-02	5.99e-01	2.15e-01	8.41e-01	1.03e-01	8.91e-01
GOBP RESPONSE TO CATECHOLAMINE	86	4.60e-02	2.40e-01	0.2280	2.78e-02	1.19e-01	1.77e-01	5.30e-02	5.41e-02	6.56e-01	5.66e-02	4.43e-03	3.96e-01	3.86e-01
GOMF INSULIN LIKE GROWTH FACTOR I BINDING	13	6.76e-01	8.85e-01	0.2280	-1.10e-01	9.99e-02	-1.49e-01	8.64e-02	-2.00e-02	4.92e-01	5.33e-01	3.53e-01	5.90e-01	9.01e-01
GOBP MEMBRANE DOCKING	91	1.72e-02	1.28e-01	0.2280	-1.10e-01	1.18e-01	-1.32e-02	-1.54e-01	4.76e-02	7.01e-02	5.16e-02	8.28e-01	1.13e-02	4.33e-01
GOBP WALKING BEHAVIOR	35	1.86e-01	5.30e-01	0.2280	-7.81e-02	-1.74e-01	8.29e-02	-9.13e-02	-2.43e-02	4.24e-01	7.54e-02	3.96e-01	3.50e-01	8.04e-01
GOCC I BAND	141	3.58e-03	4.18e-02	0.2280	-6.52e-02	-1.02e-02	6.19e-02	1.66e-01	-1.28e-01	1.82e-01	8.34e-01	2.05e-01	6.83e-04	8.71e-03
GOBP REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS	46	3.70e-01	7.10e-01	0.2280	8.44e-02	-7.55e-02	-1.38e-01	-1.39e-01	2.65e-02	3.22e-01	3.76e-01	1.05e-01	1.03e-01	7.56e-01
GOMF MONOATOMIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY	130	8.95e-03	8.11e-02	0.2280	-8.55e-02	8.03e-02	1.35e-01	1.40e-01	-2.19e-02	9.23e-02	1.14e-01	8.08e-03	5.86e-03	6.67e-01
GOBP CAMP MEDIATED SIGNALING	53	2.23e-01	5.77e-01	0.2280	-7.43e-02	8.84e-02	1.88e-01	5.52e-02	-1.42e-02	3.49e-01	2.66e-01	1.79e-02	4.87e-01	8.58e-01
GOBP THIOESTER BIOSYNTHETIC PROCESS	43	3.62e-01	7.04e-01	0.2280	8.48e-02	4.74e-02	-4.92e-02	-1.57e-01	1.24e-01	3.36e-01	5.91e-01	5.77e-01	7.45e-02	1.60e-01
GOBP SOMATIC STEM CELL POPULATION MAINTENANCE	65	1.02e-01	3.87e-01	0.2280	7.51e-02	-2.12e-02	-6.16e-02	-2.01e-01	3.96e-02	2.95e-01	7.68e-01	3.91e-01	5.09e-03	5.81e-01
GOBP REGULATION OF KETONE BIOSYNTHETIC PROCESS	21	6.86e-01	8.89e-01	0.2280	-1.98e-01	-7.16e-02	-3.95e-02	5.54e-03	-7.79e-02	1.17e-01	5.70e-01	7.54e-01	9.65e-01	5.37e-01
GOBP POSITIVE REGULATION OF CARTILAGE DEVELOPMENT	31	4.82e-01	7.93e-01	0.2280	-1.68e-01	1.11e-01	5.95e-02	1.45e-02	-8.67e-02	1.05e-01	2.86e-01	5.66e-01	8.89e-01	4.04e-01
GOCC COP9 SIGNALOSOME	16	7.75e-01	9.26e-01	0.2280	1.95e-01	-9.32e-03	-2.94e-02	-1.13e-01	4.70e-03	1.77e-01	9.49e-01	8.39e-01	4.32e-01	9.74e-01
GOBP FEMALE MEIOSIS I	13	8.60e-01	9.53e-01	0.2280	-5.25e-02	-1.74e-01	-7.54e-02	-1.02e-01	-5.04e-02	7.43e-01	2.77e-01	6.38e-01	5.24e-01	7.53e-01
GOBP SULFUR AMINO ACID METABOLIC PROCESS	32	4.79e-01	7.91e-01	0.2280	7.92e-02	8.35e-02	4.89e-02	-6.81e-02	1.77e-01	4.38e-01	4.14e-01	6.32e-01	5.05e-01	8.23e-02
GOBP PROTEIN AUTOUBIQUITINATION	67	9.84e-02	3.79e-01	0.2270	5.03e-02	-4.65e-02	-1.24e-01	-1.35e-01	-1.16e-01	4.77e-01	5.10e-01	7.82e-02	5.69e-02	1.00e-01
GOMF DIACYLGLYCEROL BINDING	13	8.48e-01	9.49e-01	0.2270	-1.26e-01	1.53e-01	2.19e-03	-1.04e-01	3.67e-02	4.30e-01	3.39e-01	9.89e-01	5.14e-01	8.19e-01
GOCC CHYLOMICRON	12	8.79e-01	9.61e-01	0.2270	-2.04e-01	-2.87e-02	-2.90e-02	1.01e-02	-9.10e-02	2.21e-01	8.64e-01	8.62e-01	9.52e-01	5.85e-01
GOBP PANCREAS DEVELOPMENT	78	2.51e-02	1.62e-01	0.2270	6.97e-02	-2.76e-02	9.83e-03	-1.91e-01	9.79e-02	2.88e-01	6.74e-01	8.81e-01	3.55e-03	1.35e-01
GOMF METALLOAMINOPEPTIDASE ACTIVITY	24	6.10e-01	8.58e-01	0.2270	1.75e-01	6.65e-02	5.03e-02	1.18e-01	-1.44e-02	1.37e-01	5.73e-01	6.70e-01	3.18e-01	9.03e-01
GOBP LYMPHOCYTE MIGRATION	114	6.40e-03	6.40e-02	0.2270	-1.69e-01	9.00e-02	6.33e-02	9.67e-02	-4.29e-02	1.87e-03	9.69e-02	2.43e-01	7.46e-02	4.28e-01
GOCC SECRETORY GRANULE MEMBRANE	302	2.06e-08	1.38e-06	0.2270	-1.23e-01	1.56e-01	1.06e-01	-2.67e-02	1.52e-02	2.29e-04	3.06e-06	1.55e-03	4.25e-01	6.50e-01
GOCC TRANS GOLGI NETWORK TRANSPORT VESICLE MEMBRANE	19	7.39e-01	9.11e-01	0.2270	-7.97e-02	1.94e-01	8.42e-02	1.64e-03	-2.80e-02	5.47e-01	1.44e-01	5.25e-01	9.90e-01	8.33e-01
GOBP PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS	42	3.85e-01	7.23e-01	0.2270	6.89e-02	9.18e-02	-1.33e-01	-1.44e-01	1.28e-03	4.40e-01	3.03e-01	1.36e-01	1.06e-01	9.89e-01
GOBP LAMELLIPODIUM ASSEMBLY	67	1.05e-01	3.94e-01	0.2270	-1.68e-01	8.72e-02	8.03e-02	8.12e-02	-5.30e-02	1.74e-02	2.17e-01	2.56e-01	2.50e-01	4.53e-01
GOMF PHOSPHATIDYLINOSITOL 3 KINASE REGULATORY SUBUNIT BINDING	10	9.25e-01	9.76e-01	0.2270	4.10e-02	5.22e-02	1.14e-01	1.41e-01	1.19e-01	8.22e-01	7.75e-01	5.33e-01	4.39e-01	5.13e-01
GOBP POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY	45	3.71e-01	7.10e-01	0.2270	7.25e-02	-8.79e-02	-1.11e-01	-1.47e-01	6.83e-02	4.00e-01	3.08e-01	1.98e-01	8.79e-02	4.28e-01
GOMF TITIN BINDING	13	8.43e-01	9.48e-01	0.2270	1.99e-01	3.38e-02	2.78e-02	-8.44e-02	5.43e-02	2.14e-01	8.33e-01	8.62e-01	5.98e-01	7.34e-01
GOMF RNA POLYMERASE II SPECIFIC DNA BINDING TRANSCRIPTION FACTOR BINDING	330	4.26e-08	2.63e-06	0.2270	5.99e-02	8.14e-02	-6.27e-02	-1.87e-01	4.80e-02	6.16e-02	1.10e-02	5.02e-02	4.81e-09	1.34e-01
GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS	17	8.01e-01	9.33e-01	0.2270	-5.54e-02	1.29e-01	-8.76e-02	-1.48e-01	4.94e-02	6.93e-01	3.59e-01	5.32e-01	2.91e-01	7.24e-01
GOBP RESPONSE TO COCAINE	47	1.11e-01	4.06e-01	0.2270	1.09e-01	9.90e-02	4.55e-02	-1.62e-01	-4.13e-02	1.97e-01	2.40e-01	5.89e-01	5.50e-02	6.24e-01
GOBP PURINE RIBONUCLEOSIDE SALVAGE	6	9.52e-01	9.85e-01	0.2270	-3.12e-02	1.96e-01	-1.07e-01	-1.67e-02	1.45e-02	8.95e-01	4.05e-01	6.49e-01	9.43e-01	9.51e-01
GOMF GLYCOSAMINOGLYCAN BINDING	233	4.24e-05	1.18e-03	0.2270	-1.29e-01	2.65e-03	1.25e-01	1.13e-01	-8.03e-02	6.94e-04	9.44e-01	1.04e-03	2.91e-03	3.47e-02
GOBP PHAGOCYTOSIS	228	2.48e-06	9.81e-05	0.2270	-1.32e-01	1.47e-01	8.50e-02	-2.83e-02	6.55e-02	5.82e-04	1.30e-04	2.70e-02	4.62e-01	8.83e-02
GOCC CYTOPLASMIC SIDE OF ENDOPLASMIC RETICULUM MEMBRANE	16	7.71e-01	9.25e-01	0.2270	-3.50e-02	2.75e-02	-2.92e-02	-2.20e-01	1.57e-02	8.08e-01	8.49e-01	8.40e-01	1.28e-01	9.13e-01
GOBP AORTA DEVELOPMENT	65	1.04e-01	3.90e-01	0.2270	1.39e-01	1.09e-01	1.13e-01	1.73e-02	8.52e-02	5.31e-02	1.30e-01	1.15e-01	8.09e-01	2.35e-01
GOBP NUCLEAR CHROMOSOME SEGREGATION	306	5.01e-07	2.46e-05	0.2270	7.71e-02	-4.44e-02	-7.86e-02	-1.67e-01	9.64e-02	2.03e-02	1.81e-01	1.80e-02	4.85e-07	3.71e-03
GOMF PHOSPHOLIPASE ACTIVITY	107	3.06e-02	1.86e-01	0.2270	-5.35e-02	8.61e-02	1.26e-01	1.47e-01	-5.90e-02	3.39e-01	1.24e-01	2.39e-02	8.56e-03	2.92e-01
GOBP SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS	65	1.31e-01	4.47e-01	0.2270	3.57e-02	1.06e-01	-7.24e-02	-1.81e-01	2.60e-02	6.19e-01	1.39e-01	3.13e-01	1.14e-02	7.17e-01
GOBP MACROAUTOPHAGY	317	9.54e-07	4.25e-05	0.2270	3.72e-02	1.49e-02	-1.13e-01	-1.81e-01	6.33e-02	2.54e-01	6.49e-01	5.17e-04	2.87e-08	5.26e-02
GOMF TRANSFERASE ACTIVITY TRANSFERRING ONE CARBON GROUPS	210	4.76e-05	1.30e-03	0.2260	1.00e-01	-5.36e-02	-8.62e-02	-1.73e-01	3.05e-02	1.21e-02	1.81e-01	3.14e-02	1.52e-05	4.46e-01
GOBP T CELL SELECTION	52	8.77e-02	3.58e-01	0.2260	4.88e-02	9.73e-02	1.86e-01	-6.32e-02	2.62e-02	5.42e-01	2.25e-01	2.01e-02	4.31e-01	7.43e-01
GOBP REGULATION OF HAIR FOLLICLE DEVELOPMENT	18	6.18e-01	8.62e-01	0.2260	1.15e-01	-1.74e-02	9.27e-03	-7.57e-02	-1.78e-01	3.97e-01	8.98e-01	9.46e-01	5.78e-01	1.90e-01
GOBP PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY	29	4.09e-01	7.42e-01	0.2260	-1.36e-01	1.51e-02	1.74e-01	-4.08e-02	2.46e-02	2.04e-01	8.88e-01	1.05e-01	7.04e-01	8.19e-01
GOMF MONOOXYGENASE ACTIVITY	102	4.33e-03	4.86e-02	0.2260	-1.68e-02	2.78e-02	2.86e-02	2.22e-01	-9.81e-03	7.69e-01	6.27e-01	6.18e-01	1.08e-04	8.64e-01
GOBP HYPEROSMOTIC RESPONSE	26	5.52e-01	8.29e-01	0.2260	-1.11e-01	1.72e-01	2.41e-03	-9.17e-02	-3.12e-02	3.28e-01	1.30e-01	9.83e-01	4.18e-01	7.83e-01
GOBP SERINE FAMILY AMINO ACID CATABOLIC PROCESS	14	7.86e-01	9.29e-01	0.2260	1.40e-01	5.77e-02	4.06e-03	1.31e-01	1.05e-01	3.65e-01	7.08e-01	9.79e-01	3.96e-01	4.97e-01
GOBP CELLULAR DEFENSE RESPONSE	48	2.60e-01	6.16e-01	0.2260	-1.18e-01	3.68e-02	1.33e-02	8.05e-02	-1.71e-01	1.58e-01	6.59e-01	8.73e-01	3.35e-01	4.05e-02
GOBP METHYLATION	260	2.59e-06	1.01e-04	0.2260	9.50e-02	-5.38e-02	-8.67e-02	-1.76e-01	2.61e-02	8.32e-03	1.35e-01	1.61e-02	1.06e-06	4.68e-01
GOBP SPERM AXONEME ASSEMBLY	27	5.20e-01	8.13e-01	0.2260	-1.63e-01	-3.28e-02	-1.46e-01	-3.25e-02	-2.81e-02	1.42e-01	7.68e-01	1.88e-01	7.70e-01	8.00e-01
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM	42	3.63e-01	7.05e-01	0.2260	-2.22e-02	1.21e-02	-9.13e-02	-2.05e-01	5.29e-03	8.03e-01	8.92e-01	3.06e-01	2.16e-02	9.53e-01
GOBP SKELETAL MUSCLE CONTRACTION	43	1.72e-01	5.11e-01	0.2260	-4.06e-03	6.65e-02	-2.09e-01	-3.66e-02	3.72e-02	9.63e-01	4.51e-01	1.76e-02	6.78e-01	6.73e-01
GOBP TELOMERE MAINTENANCE VIA RECOMBINATION	14	7.55e-01	9.17e-01	0.2260	-6.54e-02	-3.43e-02	-1.69e-01	-6.40e-03	1.30e-01	6.72e-01	8.24e-01	2.74e-01	9.67e-01	3.99e-01
GOBP RESPONSE TO HYDROGEN PEROXIDE	95	3.97e-02	2.19e-01	0.2260	6.68e-02	1.02e-01	-1.01e-01	-1.56e-01	3.79e-02	2.60e-01	8.66e-02	8.90e-02	8.43e-03	5.23e-01
GOBP POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN	22	6.32e-01	8.70e-01	0.2260	-4.30e-02	-5.55e-02	-6.35e-02	1.49e-01	-1.40e-01	7.27e-01	6.52e-01	6.06e-01	2.26e-01	2.55e-01
GOBP POSITIVE REGULATION OF LYASE ACTIVITY	39	4.38e-01	7.60e-01	0.2260	2.80e-02	1.03e-01	1.43e-01	1.16e-01	7.32e-02	7.63e-01	2.65e-01	1.21e-01	2.08e-01	4.29e-01
GOBP PROTEIN K63 LINKED UBIQUITINATION	56	2.41e-01	5.98e-01	0.2260	8.45e-02	2.42e-02	-1.00e-01	-1.79e-01	3.21e-02	2.74e-01	7.54e-01	1.94e-01	2.05e-02	6.77e-01
GOBP VITAMIN D BIOSYNTHETIC PROCESS	10	8.97e-01	9.66e-01	0.2260	9.56e-02	-2.19e-02	-2.01e-01	-5.47e-03	3.16e-02	6.01e-01	9.05e-01	2.72e-01	9.76e-01	8.62e-01
GOMF VITAMIN TRANSMEMBRANE TRANSPORTER ACTIVITY	36	1.71e-01	5.09e-01	0.2250	-2.28e-02	1.84e-01	-4.80e-02	9.21e-02	7.50e-02	8.13e-01	5.63e-02	6.18e-01	3.39e-01	4.36e-01
GOBP REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	24	6.08e-01	8.57e-01	0.2250	-3.10e-02	-3.07e-02	-2.18e-03	-4.52e-02	2.16e-01	7.92e-01	7.95e-01	9.85e-01	7.02e-01	6.67e-02
GOBP PROTEIN TRANSPORT WITHIN LIPID BILAYER	6	9.63e-01	9.90e-01	0.2250	-1.39e-01	8.98e-02	4.93e-02	-1.44e-01	1.31e-02	5.56e-01	7.03e-01	8.34e-01	5.41e-01	9.56e-01
GOCC EUCHROMATIN	56	7.33e-02	3.23e-01	0.2250	-1.16e-02	-1.33e-01	3.87e-02	-1.44e-01	1.03e-01	8.80e-01	8.47e-02	6.16e-01	6.31e-02	1.81e-01
GOCC MICROTUBULE MINUS END	7	9.53e-01	9.85e-01	0.2250	-7.83e-02	2.04e-01	1.15e-02	3.81e-02	-3.56e-02	7.20e-01	3.50e-01	9.58e-01	8.61e-01	8.70e-01
GOBP REGULATION OF LEUKOCYTE DEGRANULATION	41	2.96e-01	6.50e-01	0.2250	-9.56e-02	1.66e-01	5.43e-02	-5.22e-02	9.04e-02	2.90e-01	6.55e-02	5.47e-01	5.63e-01	3.16e-01
GOBP REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS	11	8.64e-01	9.54e-01	0.2250	-1.31e-01	9.38e-02	7.34e-02	-1.39e-01	1.08e-02	4.53e-01	5.90e-01	6.73e-01	4.26e-01	9.51e-01
GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION	45	1.90e-01	5.36e-01	0.2250	-2.95e-02	8.09e-02	4.86e-02	2.01e-01	2.34e-02	7.32e-01	3.48e-01	5.73e-01	1.98e-02	7.86e-01
GOBP NEGATIVE REGULATION OF POST TRANSCRIPTIONAL GENE SILENCING	12	8.18e-01	9.41e-01	0.2250	9.80e-02	4.28e-02	4.46e-02	-3.72e-02	-1.89e-01	5.57e-01	7.97e-01	7.89e-01	8.24e-01	2.57e-01
GOBP NUCLEOTIDE TRANSMEMBRANE TRANSPORT	26	6.08e-01	8.58e-01	0.2250	9.26e-02	4.84e-02	1.52e-03	-1.58e-01	1.21e-01	4.14e-01	6.69e-01	9.89e-01	1.63e-01	2.86e-01
GOBP INNER EAR RECEPTOR CELL FATE COMMITMENT	5	9.75e-01	9.93e-01	0.2250	1.21e-01	1.70e-02	1.18e-02	1.07e-01	1.55e-01	6.39e-01	9.48e-01	9.64e-01	6.79e-01	5.49e-01
GOCC DENSE CORE GRANULE MEMBRANE	7	9.60e-01	9.88e-01	0.2250	-2.02e-01	2.56e-02	-1.16e-02	-3.37e-02	-8.76e-02	3.54e-01	9.07e-01	9.58e-01	8.77e-01	6.88e-01
GOBP REGULATION OF BONE MINERALIZATION	76	3.21e-02	1.91e-01	0.2250	-8.32e-02	6.39e-02	1.30e-01	-8.17e-02	1.26e-01	2.10e-01	3.36e-01	5.01e-02	2.18e-01	5.74e-02
GOBP OSTEOBLAST PROLIFERATION	36	2.87e-01	6.41e-01	0.2250	-4.54e-02	-9.16e-02	9.03e-02	-9.00e-02	1.54e-01	6.38e-01	3.42e-01	3.48e-01	3.50e-01	1.10e-01
GOBP CELLULAR RESPONSE TO UNFOLDED PROTEIN	88	3.04e-02	1.85e-01	0.2250	-6.93e-02	4.39e-02	-7.17e-02	-1.94e-01	-3.18e-02	2.61e-01	4.77e-01	2.45e-01	1.68e-03	6.06e-01
GOBP RESPONSE TO GROWTH HORMONE	34	3.94e-01	7.28e-01	0.2240	8.80e-02	1.72e-01	9.80e-02	-2.56e-02	-5.17e-02	3.74e-01	8.19e-02	3.23e-01	7.96e-01	6.02e-01
GOBP REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT	25	6.19e-01	8.63e-01	0.2240	9.43e-02	1.26e-01	6.69e-02	-8.42e-02	1.18e-01	4.15e-01	2.74e-01	5.62e-01	4.66e-01	3.07e-01
GOBP SLEEP	22	6.56e-01	8.80e-01	0.2240	-1.72e-02	2.02e-01	9.54e-03	-8.65e-02	-4.20e-02	8.89e-01	1.01e-01	9.38e-01	4.83e-01	7.33e-01
GOBP NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION	48	2.53e-01	6.09e-01	0.2240	1.37e-01	-1.29e-03	-1.95e-02	-1.44e-01	1.02e-01	1.01e-01	9.88e-01	8.16e-01	8.36e-02	2.21e-01
GOBP REGULATION OF URINE VOLUME	20	7.26e-01	9.05e-01	0.2240	8.84e-02	2.56e-02	-1.01e-01	-1.45e-01	-1.03e-01	4.94e-01	8.43e-01	4.35e-01	2.62e-01	4.23e-01
GOMF HEPARIN BINDING	169	1.77e-03	2.45e-02	0.2240	-1.06e-01	5.26e-03	1.38e-01	1.20e-01	-7.59e-02	1.79e-02	9.06e-01	1.98e-03	7.15e-03	8.87e-02
GOBP PHOSPHOLIPID DEPHOSPHORYLATION	37	2.20e-01	5.75e-01	0.2240	-1.10e-01	-1.45e-02	1.96e-02	-1.86e-01	-5.45e-02	2.47e-01	8.79e-01	8.37e-01	5.02e-02	5.66e-01
GOBP EXCITATORY CHEMICAL SYNAPTIC TRANSMISSION	10	9.46e-01	9.82e-01	0.2240	1.39e-03	2.05e-02	-1.04e-01	-1.47e-01	1.32e-01	9.94e-01	9.11e-01	5.67e-01	4.22e-01	4.70e-01
GOBP NADP METABOLIC PROCESS	41	3.61e-01	7.04e-01	0.2240	2.82e-02	1.41e-01	-8.77e-02	-1.17e-01	8.97e-02	7.55e-01	1.17e-01	3.31e-01	1.94e-01	3.20e-01
GOBP NEGATIVE REGULATION OF RESPIRATORY BURST	6	9.72e-01	9.92e-01	0.2240	-2.31e-02	2.13e-03	1.03e-01	5.73e-02	1.89e-01	9.22e-01	9.93e-01	6.63e-01	8.08e-01	4.22e-01
GOCC VACUOLAR LUMEN	167	1.08e-04	2.55e-03	0.2240	-1.22e-01	3.56e-02	4.54e-03	-1.70e-01	7.14e-02	6.73e-03	4.27e-01	9.19e-01	1.45e-04	1.11e-01
GOBP POSITIVE REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY	9	8.92e-01	9.63e-01	0.2240	2.54e-02	7.97e-02	1.96e-02	-2.01e-01	-4.93e-02	8.95e-01	6.79e-01	9.19e-01	2.97e-01	7.98e-01
GOBP REGULATION OF PROTEIN DEPOLYMERIZATION	81	6.26e-02	2.94e-01	0.2240	6.19e-02	1.63e-01	1.07e-01	8.08e-02	-4.15e-02	3.35e-01	1.10e-02	9.71e-02	2.09e-01	5.19e-01
GOBP B CELL HOMEOSTASIS	31	4.23e-01	7.50e-01	0.2240	-3.99e-02	1.12e-01	-8.19e-02	-6.53e-02	1.58e-01	7.01e-01	2.82e-01	4.30e-01	5.29e-01	1.27e-01
GOCC ATPASE DEPENDENT TRANSMEMBRANE TRANSPORT COMPLEX	24	6.93e-01	8.93e-01	0.2240	1.26e-02	-1.41e-01	-8.52e-02	-1.19e-01	9.38e-02	9.15e-01	2.33e-01	4.70e-01	3.14e-01	4.26e-01
GOBP PYRIMIDINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT	16	8.42e-01	9.48e-01	0.2240	3.10e-03	-6.62e-02	4.98e-02	1.36e-01	-1.57e-01	9.83e-01	6.46e-01	7.30e-01	3.46e-01	2.77e-01
GOMF PHOSPHATIDATE PHOSPHATASE ACTIVITY	14	6.18e-01	8.62e-01	0.2240	-5.74e-02	-7.53e-02	1.51e-01	-1.31e-01	-3.25e-02	7.10e-01	6.26e-01	3.28e-01	3.96e-01	8.33e-01
GOBP POSITIVE REGULATION OF CHOLESTEROL EFFLUX	27	5.52e-01	8.29e-01	0.2240	-2.21e-01	-9.43e-03	1.56e-03	7.81e-03	-3.24e-02	4.69e-02	9.32e-01	9.89e-01	9.44e-01	7.71e-01
GOBP POSITIVE REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE	16	6.72e-01	8.84e-01	0.2240	-1.00e-01	2.22e-02	-3.02e-02	1.96e-01	-7.08e-03	4.88e-01	8.78e-01	8.35e-01	1.74e-01	9.61e-01
GOBP CELL RECOGNITION	152	4.43e-03	4.92e-02	0.2240	-1.10e-01	2.87e-02	1.43e-01	1.21e-01	-4.44e-02	1.94e-02	5.41e-01	2.37e-03	9.85e-03	3.45e-01
GOBP REGULATION OF ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME	50	1.66e-01	5.02e-01	0.2230	2.31e-03	1.85e-02	-3.67e-02	-2.20e-01	-6.63e-03	9.77e-01	8.21e-01	6.53e-01	7.23e-03	9.35e-01
GOBP POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION	71	1.67e-02	1.26e-01	0.2230	-1.08e-01	6.28e-02	1.09e-01	-1.50e-01	-3.92e-03	1.16e-01	3.60e-01	1.13e-01	2.87e-02	9.54e-01
GOBP POSITIVE REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION	5	9.80e-01	9.93e-01	0.2230	1.91e-01	2.52e-02	-7.42e-02	-3.58e-02	-7.85e-02	4.60e-01	9.22e-01	7.74e-01	8.90e-01	7.61e-01
GOBP NEGATIVE REGULATION OF PEPTIDE SECRETION	44	2.47e-01	6.04e-01	0.2230	1.22e-01	1.47e-01	1.34e-02	-1.14e-01	-1.56e-02	1.62e-01	9.15e-02	8.77e-01	1.90e-01	8.58e-01
GOBP POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION	20	7.35e-01	9.09e-01	0.2230	-1.36e-01	1.22e-01	4.48e-02	2.51e-02	-1.18e-01	2.93e-01	3.47e-01	7.29e-01	8.46e-01	3.59e-01
GOBP POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT	52	1.93e-01	5.41e-01	0.2230	-1.14e-01	7.72e-02	1.70e-01	2.13e-03	4.48e-02	1.55e-01	3.36e-01	3.39e-02	9.79e-01	5.76e-01
GOBP REGULATION OF BLOOD VESSEL REMODELING	12	8.50e-01	9.50e-01	0.2230	7.14e-02	-5.54e-02	1.66e-01	-3.43e-03	1.18e-01	6.69e-01	7.40e-01	3.18e-01	9.84e-01	4.78e-01
GOBP REGULATION OF OSTEOBLAST PROLIFERATION	30	4.36e-01	7.60e-01	0.2230	-5.56e-02	-9.34e-02	1.15e-01	-2.50e-02	1.56e-01	5.98e-01	3.76e-01	2.76e-01	8.13e-01	1.40e-01
GOBP NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION	19	6.94e-01	8.93e-01	0.2230	-1.69e-01	5.32e-02	4.12e-02	-1.25e-01	3.32e-02	2.02e-01	6.88e-01	7.56e-01	3.46e-01	8.02e-01
GOBP GLIAL CELL DERIVED NEUROTROPHIC FACTOR RECEPTOR SIGNALING PATHWAY	9	9.42e-01	9.82e-01	0.2230	8.50e-02	1.45e-01	6.00e-02	-2.33e-02	1.32e-01	6.59e-01	4.51e-01	7.55e-01	9.04e-01	4.93e-01
GOMF HEAT SHOCK PROTEIN BINDING	124	1.83e-02	1.34e-01	0.2230	4.58e-02	-3.45e-02	-1.55e-01	-1.49e-01	-1.42e-02	3.79e-01	5.07e-01	2.84e-03	4.15e-03	7.84e-01
GOBP HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE	17	7.80e-01	9.28e-01	0.2230	-1.79e-02	-3.76e-02	-6.00e-02	1.18e-01	-1.75e-01	8.99e-01	7.89e-01	6.68e-01	4.00e-01	2.12e-01
GOBP EPIDERMIS MORPHOGENESIS	35	3.68e-01	7.08e-01	0.2230	-1.46e-01	1.09e-01	1.69e-02	-5.47e-02	1.15e-01	1.36e-01	2.62e-01	8.63e-01	5.76e-01	2.38e-01
GOBP CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION	175	3.75e-05	1.06e-03	0.2230	2.94e-02	1.79e-02	7.17e-02	-1.48e-01	1.47e-01	5.03e-01	6.83e-01	1.02e-01	7.25e-04	8.24e-04
GOBP REGULATION OF DEFENSE RESPONSE TO VIRUS	93	4.70e-02	2.43e-01	0.2230	-5.50e-02	1.39e-02	-1.24e-01	-1.46e-01	9.94e-02	3.59e-01	8.17e-01	3.84e-02	1.53e-02	9.76e-02
GOMF ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY	34	3.23e-01	6.71e-01	0.2230	2.36e-02	1.43e-01	7.95e-02	-6.88e-02	-1.32e-01	8.12e-01	1.48e-01	4.23e-01	4.87e-01	1.81e-01
GOBP CHONDROITIN SULFATE METABOLIC PROCESS	26	5.66e-01	8.35e-01	0.2230	4.22e-02	1.87e-01	3.91e-02	-2.85e-02	-1.03e-01	7.09e-01	9.94e-02	7.30e-01	8.01e-01	3.63e-01
GOBP REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION	30	5.43e-01	8.25e-01	0.2230	-2.37e-02	1.72e-01	9.96e-02	7.28e-02	6.37e-02	8.22e-01	1.02e-01	3.45e-01	4.90e-01	5.46e-01
GOBP REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY	31	4.96e-01	8.00e-01	0.2230	-1.06e-01	6.44e-02	-4.55e-02	-1.79e-01	1.00e-02	3.05e-01	5.35e-01	6.61e-01	8.53e-02	9.23e-01
GOBP PROTEIN K11 LINKED DEUBIQUITINATION	9	9.16e-01	9.73e-01	0.2230	-1.39e-01	-1.18e-01	-5.56e-02	2.77e-02	1.12e-01	4.72e-01	5.39e-01	7.73e-01	8.86e-01	5.61e-01
GOBP GOLGI VESICLE TRANSPORT	284	3.36e-06	1.28e-04	0.2230	4.93e-03	2.56e-02	-9.62e-02	-1.95e-01	3.82e-02	8.86e-01	4.58e-01	5.29e-03	1.46e-08	2.67e-01
GOBP HYDROGEN SULFIDE METABOLIC PROCESS	6	9.77e-01	9.93e-01	0.2230	-6.80e-02	1.49e-01	1.07e-01	3.02e-02	-1.01e-01	7.73e-01	5.26e-01	6.50e-01	8.98e-01	6.67e-01
GOBP REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY	138	2.57e-03	3.26e-02	0.2230	2.35e-02	9.84e-02	8.74e-03	-1.03e-01	1.69e-01	6.33e-01	4.60e-02	8.59e-01	3.74e-02	5.91e-04
GOBP POSITIVE REGULATION OF STRESS FIBER ASSEMBLY	51	2.32e-01	5.85e-01	0.2230	-2.04e-02	1.93e-01	8.47e-02	3.48e-02	-6.02e-02	8.01e-01	1.73e-02	2.95e-01	6.68e-01	4.57e-01
GOBP TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY	26	4.84e-01	7.93e-01	0.2230	-1.28e-02	1.28e-01	-7.47e-02	-2.58e-02	1.63e-01	9.10e-01	2.58e-01	5.10e-01	8.20e-01	1.49e-01
GOBP SYNAPTIC TRANSMISSION GABAERGIC	56	2.32e-01	5.85e-01	0.2220	4.20e-02	1.15e-01	1.72e-01	6.87e-02	1.60e-02	5.87e-01	1.37e-01	2.62e-02	3.74e-01	8.36e-01
GOBP REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION	52	1.65e-01	5.00e-01	0.2220	-1.57e-01	1.11e-01	6.96e-02	-7.40e-02	4.76e-02	5.03e-02	1.68e-01	3.85e-01	3.56e-01	5.53e-01
GOBP REGULATION OF DIGESTIVE SYSTEM PROCESS	37	2.81e-01	6.34e-01	0.2220	4.40e-04	1.99e-01	-1.96e-02	8.20e-02	-5.39e-02	9.96e-01	3.66e-02	8.37e-01	3.88e-01	5.70e-01
GOBP POSITIVE REGULATION OF CHEMOKINE PRODUCTION	70	7.24e-02	3.21e-01	0.2220	-5.57e-02	1.98e-01	3.11e-02	-6.07e-02	4.81e-02	4.20e-01	4.10e-03	6.53e-01	3.80e-01	4.87e-01
GOBP REGULATION OF TISSUE REMODELING	86	4.51e-02	2.37e-01	0.2220	-1.55e-02	9.22e-02	1.96e-01	4.49e-02	-1.76e-02	8.04e-01	1.39e-01	1.69e-03	4.72e-01	7.78e-01
GOMF DYNEIN INTERMEDIATE CHAIN BINDING	35	4.31e-01	7.55e-01	0.2220	1.61e-01	-3.34e-02	1.01e-01	1.09e-01	1.25e-03	9.85e-02	7.32e-01	2.99e-01	2.63e-01	9.90e-01
GOBP BLASTODERM SEGMENTATION	24	7.18e-01	9.02e-01	0.2220	7.12e-02	1.09e-01	1.41e-01	1.06e-01	-3.77e-02	5.46e-01	3.54e-01	2.33e-01	3.70e-01	7.49e-01
GOBP NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY	11	9.05e-01	9.69e-01	0.2220	-8.47e-02	-8.77e-02	-4.29e-02	-1.67e-01	6.85e-02	6.27e-01	6.14e-01	8.05e-01	3.37e-01	6.94e-01
GOCC MITOCHONDRION	1569	3.72e-33	1.81e-30	0.2220	1.92e-02	1.82e-02	-1.23e-01	-1.80e-01	3.65e-02	2.04e-01	2.29e-01	5.09e-16	1.16e-32	1.57e-02
GOMF DNA BINDING TRANSCRIPTION FACTOR BINDING	451	1.24e-10	1.13e-08	0.2220	5.05e-02	8.31e-02	-6.30e-02	-1.83e-01	5.07e-02	6.62e-02	2.49e-03	2.18e-02	2.90e-11	6.49e-02
GOBP ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS	25	6.15e-01	8.60e-01	0.2220	-6.75e-02	1.03e-01	-6.54e-02	-1.53e-01	-8.08e-02	5.59e-01	3.71e-01	5.71e-01	1.86e-01	4.84e-01
GOBP MICROVILLUS ASSEMBLY	20	7.32e-01	9.08e-01	0.2220	-7.42e-02	1.33e-01	8.02e-02	1.09e-02	-1.40e-01	5.65e-01	3.02e-01	5.34e-01	9.33e-01	2.80e-01
GOMF G PROTEIN COUPLED OPIOID RECEPTOR ACTIVITY	7	9.44e-01	9.82e-01	0.2220	-7.51e-02	-1.98e-01	5.63e-02	-3.53e-02	-9.76e-03	7.31e-01	3.65e-01	7.96e-01	8.72e-01	9.64e-01
GOBP MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY	18	7.47e-01	9.14e-01	0.2220	1.29e-01	-3.97e-02	1.48e-01	4.31e-02	8.55e-02	3.44e-01	7.71e-01	2.77e-01	7.52e-01	5.30e-01
GOBP POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION	17	7.93e-01	9.31e-01	0.2220	6.58e-02	-2.26e-02	1.01e-01	3.26e-02	1.82e-01	6.38e-01	8.72e-01	4.72e-01	8.16e-01	1.93e-01
GOBP UBIQUITIN DEPENDENT ENDOCYTOSIS	7	9.42e-01	9.82e-01	0.2220	9.08e-02	7.49e-02	9.83e-02	-1.43e-01	7.29e-02	6.77e-01	7.32e-01	6.53e-01	5.12e-01	7.38e-01
GOBP VITAMIN TRANSMEMBRANE TRANSPORT	21	4.25e-01	7.52e-01	0.2220	-1.54e-02	1.15e-01	-8.46e-02	1.69e-01	-1.16e-02	9.03e-01	3.60e-01	5.02e-01	1.81e-01	9.27e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION	110	3.04e-03	3.71e-02	0.2220	-1.55e-01	3.03e-02	1.06e-01	-4.59e-02	-1.05e-01	5.10e-03	5.83e-01	5.39e-02	4.05e-01	5.70e-02
GOBP CHLORIDE TRANSPORT	116	2.17e-02	1.49e-01	0.2220	-1.02e-01	8.10e-02	1.31e-01	1.20e-01	-2.34e-02	5.84e-02	1.32e-01	1.45e-02	2.51e-02	6.63e-01
GOCC RIPOPTOSOME	6	9.28e-01	9.77e-01	0.2220	6.35e-02	1.69e-02	5.61e-02	-1.81e-01	-9.47e-02	7.87e-01	9.43e-01	8.12e-01	4.43e-01	6.88e-01
GOBP HISTONE MODIFICATION	106	2.35e-02	1.56e-01	0.2220	1.32e-01	2.15e-02	-5.68e-02	-1.46e-01	8.38e-02	1.93e-02	7.02e-01	3.12e-01	9.63e-03	1.36e-01
GOBP ENDOCRINE PROCESS	87	1.83e-02	1.34e-01	0.2220	4.47e-02	6.66e-02	4.78e-02	1.10e-02	-2.01e-01	4.71e-01	2.83e-01	4.41e-01	8.60e-01	1.21e-03
GOBP ANOIKIS	33	5.46e-01	8.26e-01	0.2220	1.31e-01	-3.53e-02	-1.33e-01	-7.14e-02	8.95e-02	1.94e-01	7.26e-01	1.86e-01	4.78e-01	3.73e-01
GOBP POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY	65	5.56e-02	2.73e-01	0.2220	-1.26e-01	3.51e-02	1.74e-01	-3.82e-02	3.15e-03	7.79e-02	6.25e-01	1.50e-02	5.94e-01	9.65e-01
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO EARLY ENDOSOME	8	9.27e-01	9.77e-01	0.2220	-1.46e-01	-5.14e-02	1.79e-03	1.48e-01	5.79e-02	4.76e-01	8.01e-01	9.93e-01	4.68e-01	7.77e-01
GOBP NEGATIVE REGULATION OF CELL CYCLE PROCESS	307	1.46e-06	6.25e-05	0.2220	9.50e-02	-3.13e-03	-1.19e-01	-1.61e-01	1.27e-04	4.20e-03	9.25e-01	3.48e-04	1.19e-06	9.97e-01
GOCC PHAGOCYTIC VESICLE MEMBRANE	72	1.07e-02	9.21e-02	0.2220	-1.89e-02	9.09e-02	1.19e-01	-1.60e-01	-2.69e-02	7.82e-01	1.82e-01	8.04e-02	1.90e-02	6.94e-01
GOBP ACTOMYOSIN CONTRACTILE RING ORGANIZATION	10	9.25e-01	9.76e-01	0.2210	1.82e-02	-1.56e-03	4.46e-03	-1.67e-01	1.45e-01	9.21e-01	9.93e-01	9.81e-01	3.61e-01	4.29e-01
GOBP PROTEIN N LINKED GLYCOSYLATION	68	1.44e-01	4.65e-01	0.2210	8.30e-02	2.79e-02	-1.02e-01	-1.76e-01	-9.36e-03	2.37e-01	6.91e-01	1.45e-01	1.23e-02	8.94e-01
GOBP NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION	34	5.32e-01	8.20e-01	0.2210	-2.08e-02	-1.54e-01	-1.36e-01	-7.44e-02	3.17e-02	8.33e-01	1.21e-01	1.70e-01	4.53e-01	7.49e-01
GOBP UTERUS DEVELOPMENT	23	6.18e-01	8.62e-01	0.2210	1.87e-01	6.99e-02	1.32e-02	1.59e-02	-9.35e-02	1.21e-01	5.61e-01	9.12e-01	8.95e-01	4.38e-01
GOBP POSITIVE REGULATION OF ENDOCYTOSIS	146	1.26e-03	1.87e-02	0.2210	-1.64e-01	8.51e-02	1.14e-01	1.52e-02	4.09e-02	6.14e-04	7.58e-02	1.78e-02	7.52e-01	3.94e-01
GOBP POSITIVE REGULATION OF HORMONE METABOLIC PROCESS	15	8.01e-01	9.34e-01	0.2210	-4.76e-02	-1.22e-02	5.61e-02	6.80e-03	-2.08e-01	7.50e-01	9.35e-01	7.07e-01	9.64e-01	1.62e-01
GOBP RELAXATION OF CARDIAC MUSCLE	17	7.71e-01	9.25e-01	0.2210	-4.35e-02	-1.14e-01	1.91e-02	-9.71e-03	1.83e-01	7.56e-01	4.14e-01	8.91e-01	9.45e-01	1.91e-01
GOCC IMMUNOLOGICAL SYNAPSE	45	3.08e-01	6.61e-01	0.2210	2.22e-03	1.76e-01	1.07e-01	-6.40e-03	7.97e-02	9.79e-01	4.07e-02	2.14e-01	9.41e-01	3.55e-01
GOCC CILIARY BASE	44	4.27e-01	7.54e-01	0.2210	1.01e-01	-5.25e-02	-1.29e-01	-1.11e-01	8.36e-02	2.47e-01	5.47e-01	1.38e-01	2.03e-01	3.37e-01
GOBP NON MOTILE CILIUM ASSEMBLY	63	2.26e-01	5.79e-01	0.2210	3.11e-02	-8.23e-02	-1.21e-01	-1.50e-01	6.30e-02	6.70e-01	2.58e-01	9.74e-02	3.89e-02	3.87e-01
GOCC COLLAGEN CONTAINING EXTRACELLULAR MATRIX	407	6.94e-09	5.03e-07	0.2210	-9.02e-02	4.24e-03	7.98e-02	1.68e-01	-7.97e-02	1.80e-03	8.83e-01	5.74e-03	6.61e-09	5.81e-03
GOMF PROTEIN LIPID COMPLEX BINDING	31	5.38e-01	8.22e-01	0.2210	-1.37e-01	-1.27e-01	5.62e-02	7.46e-02	-7.22e-02	1.87e-01	2.20e-01	5.88e-01	4.72e-01	4.87e-01
GOBP MACROPHAGE ACTIVATION	108	1.41e-02	1.12e-01	0.2210	-3.04e-02	1.48e-01	1.12e-01	4.10e-02	1.09e-01	5.86e-01	7.68e-03	4.50e-02	4.62e-01	5.13e-02
GOBP PATTERN SPECIFICATION PROCESS	456	6.28e-13	7.22e-11	0.2210	5.15e-02	5.46e-02	1.44e-02	-1.87e-01	8.89e-02	5.97e-02	4.57e-02	5.99e-01	6.65e-12	1.14e-03
GOBP REGULATION OF FIBROBLAST MIGRATION	38	4.18e-01	7.48e-01	0.2210	-4.44e-02	1.82e-01	1.05e-01	3.23e-02	3.86e-02	6.36e-01	5.17e-02	2.61e-01	7.30e-01	6.80e-01
GOBP DNA STRAND RESECTION INVOLVED IN REPLICATION FORK PROCESSING	8	9.40e-01	9.81e-01	0.2210	1.42e-01	1.07e-01	-3.35e-02	7.80e-02	-9.97e-02	4.87e-01	5.99e-01	8.70e-01	7.03e-01	6.25e-01
GOBP MONONUCLEAR CELL MIGRATION	196	7.74e-05	1.93e-03	0.2210	-1.37e-01	1.31e-01	7.89e-02	8.19e-02	-6.23e-03	9.80e-04	1.52e-03	5.69e-02	4.81e-02	8.81e-01
GOCC GOLGI ASSOCIATED VESICLE	88	2.84e-02	1.77e-01	0.2210	-7.40e-02	1.29e-01	-4.03e-02	-1.53e-01	-4.21e-02	2.30e-01	3.62e-02	5.13e-01	1.33e-02	4.95e-01
GOBP MAMMARY GLAND ALVEOLUS DEVELOPMENT	18	7.95e-01	9.32e-01	0.2210	-1.95e-01	2.10e-02	6.52e-02	5.72e-02	-5.30e-02	1.52e-01	8.78e-01	6.32e-01	6.75e-01	6.97e-01
GOBP LINOLEIC ACID METABOLIC PROCESS	19	6.24e-01	8.66e-01	0.2210	3.87e-02	8.32e-02	5.56e-02	-1.93e-01	8.17e-03	7.70e-01	5.30e-01	6.75e-01	1.45e-01	9.51e-01
GOBP REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL	18	5.85e-01	8.45e-01	0.2210	-1.23e-01	-8.69e-02	9.46e-02	-1.26e-01	-3.55e-02	3.66e-01	5.23e-01	4.87e-01	3.54e-01	7.94e-01
GOBP FOLIC ACID METABOLIC PROCESS	15	8.44e-01	9.49e-01	0.2210	9.82e-02	-5.28e-02	-8.72e-02	-3.21e-02	1.66e-01	5.10e-01	7.23e-01	5.59e-01	8.30e-01	2.64e-01
GOBP BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS	19	7.23e-01	9.03e-01	0.2210	1.02e-01	-7.92e-02	1.50e-02	6.73e-02	-1.65e-01	4.43e-01	5.50e-01	9.10e-01	6.12e-01	2.12e-01
GOBP POSITIVE REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION	5	9.84e-01	9.94e-01	0.2210	7.57e-02	9.99e-02	1.23e-01	6.28e-02	-1.17e-01	7.69e-01	6.99e-01	6.33e-01	8.08e-01	6.49e-01
GOBP CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION	27	5.84e-01	8.45e-01	0.2210	-1.49e-01	7.61e-02	1.33e-01	1.47e-03	-5.50e-02	1.80e-01	4.94e-01	2.32e-01	9.89e-01	6.21e-01
GOMF NUCLEOBASE CONTAINING COMPOUND KINASE ACTIVITY	41	3.51e-01	6.96e-01	0.2210	-3.00e-02	1.03e-01	-2.99e-03	-1.67e-01	9.65e-02	7.40e-01	2.55e-01	9.74e-01	6.43e-02	2.85e-01
GOBP REGULATION OF PLASMINOGEN ACTIVATION	18	7.64e-01	9.22e-01	0.2210	-8.42e-02	1.10e-01	8.68e-02	-3.65e-03	-1.48e-01	5.36e-01	4.19e-01	5.24e-01	9.79e-01	2.77e-01
GOBP REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY	24	6.43e-01	8.75e-01	0.2210	6.44e-02	-1.78e-01	-4.16e-02	-7.67e-02	7.16e-02	5.85e-01	1.31e-01	7.24e-01	5.16e-01	5.44e-01
GOBP BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS	12	7.49e-01	9.15e-01	0.2200	-4.09e-02	-6.84e-02	5.63e-02	-1.94e-01	-4.07e-02	8.06e-01	6.82e-01	7.36e-01	2.46e-01	8.07e-01
GOCC MICROVILLUS	94	9.16e-03	8.23e-02	0.2200	-4.31e-02	1.54e-01	4.47e-02	1.35e-01	5.31e-02	4.70e-01	1.00e-02	4.53e-01	2.33e-02	3.74e-01
GOBP NEURAL NUCLEUS DEVELOPMENT	61	4.32e-02	2.31e-01	0.2200	-7.55e-02	8.99e-02	8.16e-02	-1.64e-01	-3.38e-02	3.08e-01	2.25e-01	2.70e-01	2.64e-02	6.48e-01
GOBP HISTONE H4 ACETYLATION	11	8.66e-01	9.55e-01	0.2200	1.09e-01	6.02e-02	4.84e-02	-1.70e-01	4.19e-02	5.31e-01	7.29e-01	7.81e-01	3.29e-01	8.10e-01
GOBP CELLULAR RESPONSE TO FATTY ACID	33	5.44e-01	8.25e-01	0.2200	-5.92e-03	1.52e-01	1.26e-01	8.25e-02	5.27e-02	9.53e-01	1.31e-01	2.11e-01	4.12e-01	6.00e-01
GOBP CELLULAR RESPONSE TO EPINEPHRINE STIMULUS	11	8.73e-01	9.58e-01	0.2200	1.26e-01	-1.63e-01	5.78e-02	3.29e-02	-3.90e-02	4.69e-01	3.49e-01	7.40e-01	8.50e-01	8.23e-01
GOBP REGULATION OF FIBROBLAST APOPTOTIC PROCESS	19	7.36e-01	9.09e-01	0.2200	4.81e-02	-5.89e-02	9.54e-02	-1.45e-02	1.83e-01	7.17e-01	6.57e-01	4.72e-01	9.13e-01	1.68e-01
GOBP AMIDE BIOSYNTHETIC PROCESS	935	4.81e-20	1.00e-17	0.2200	-2.29e-02	-1.56e-02	-1.27e-01	-1.78e-01	4.28e-03	2.35e-01	4.19e-01	5.15e-11	2.92e-20	8.25e-01
GOMF SODIUM BICARBONATE SYMPORTER ACTIVITY	6	9.84e-01	9.94e-01	0.2200	-8.76e-02	-6.46e-02	1.20e-01	1.24e-01	-8.16e-02	7.10e-01	7.84e-01	6.10e-01	5.98e-01	7.29e-01
GOBP L LYSINE TRANSPORT	7	9.79e-01	9.93e-01	0.2200	-6.09e-02	6.25e-02	1.24e-01	1.25e-01	-9.80e-02	7.80e-01	7.75e-01	5.69e-01	5.66e-01	6.53e-01
GOMF L LYSINE TRANSMEMBRANE TRANSPORTER ACTIVITY	7	9.79e-01	9.93e-01	0.2200	-6.09e-02	6.25e-02	1.24e-01	1.25e-01	-9.80e-02	7.80e-01	7.75e-01	5.69e-01	5.66e-01	6.53e-01
GOMF GLYCEROPHOSPHOLIPID FLIPPASE ACTIVITY	12	8.14e-01	9.39e-01	0.2200	-3.91e-02	1.07e-01	-4.44e-02	1.67e-01	-7.46e-02	8.15e-01	5.23e-01	7.90e-01	3.16e-01	6.55e-01
GOBP NEGATIVE REGULATION OF CHEMOTAXIS	65	1.47e-01	4.69e-01	0.2200	-1.62e-01	-1.58e-02	1.05e-01	1.02e-01	2.08e-02	2.36e-02	8.26e-01	1.44e-01	1.57e-01	7.72e-01
GOBP POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION	81	6.60e-02	3.03e-01	0.2200	-6.73e-02	1.01e-01	1.48e-01	3.29e-02	1.03e-01	2.95e-01	1.14e-01	2.13e-02	6.09e-01	1.10e-01
GOBP CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION	38	4.80e-01	7.92e-01	0.2200	9.59e-02	6.55e-02	-5.80e-02	-1.55e-01	8.55e-02	3.06e-01	4.85e-01	5.36e-01	9.73e-02	3.61e-01
GOBP MUSCLE CELL APOPTOTIC PROCESS	91	3.47e-02	2.01e-01	0.2200	-6.17e-02	5.82e-03	-5.80e-02	-1.10e-01	1.70e-01	3.09e-01	9.24e-01	3.39e-01	6.86e-02	5.05e-03
GOCC SYNAPSE ASSOCIATED EXTRACELLULAR MATRIX	12	9.18e-01	9.74e-01	0.2200	-1.18e-01	-8.56e-02	4.60e-02	1.17e-01	-1.06e-01	4.79e-01	6.08e-01	7.83e-01	4.82e-01	5.26e-01
GOBP ADRENERGIC RECEPTOR SIGNALING PATHWAY	32	3.47e-01	6.93e-01	0.2200	-4.00e-02	-9.14e-02	2.21e-02	-1.83e-01	6.54e-02	6.96e-01	3.71e-01	8.29e-01	7.28e-02	5.22e-01
GOBP POSITIVE REGULATION OF SYNAPSE MATURATION	9	9.60e-01	9.88e-01	0.2200	-1.12e-01	2.44e-03	1.53e-01	1.09e-01	1.84e-02	5.62e-01	9.90e-01	4.26e-01	5.70e-01	9.24e-01
GOCC FICOLIN 1 RICH GRANULE	180	1.11e-04	2.60e-03	0.2200	-1.17e-01	1.43e-01	-2.08e-02	-1.07e-01	4.49e-02	6.68e-03	9.08e-04	6.30e-01	1.29e-02	2.99e-01
GOBP REGULATION OF NOTCH SIGNALING PATHWAY	93	2.36e-02	1.57e-01	0.2200	8.44e-02	1.44e-01	6.64e-03	-1.40e-01	2.66e-02	1.59e-01	1.64e-02	9.12e-01	1.96e-02	6.58e-01
GOCC GBAF COMPLEX	14	8.60e-01	9.53e-01	0.2200	-4.73e-02	4.72e-02	1.02e-02	-1.53e-01	1.42e-01	7.59e-01	7.60e-01	9.47e-01	3.21e-01	3.57e-01
GOCC CLATHRIN VESICLE COAT	33	4.68e-01	7.83e-01	0.2200	-4.63e-02	2.00e-01	5.95e-02	-6.88e-03	4.85e-02	6.45e-01	4.64e-02	5.54e-01	9.45e-01	6.30e-01
GOMF FUCOSYLTRANSFERASE ACTIVITY	13	7.06e-01	8.97e-01	0.2200	-1.17e-01	5.15e-02	-9.82e-02	7.80e-02	1.27e-01	4.64e-01	7.48e-01	5.40e-01	6.26e-01	4.29e-01
GOBP POSITIVE REGULATION OF CYCLASE ACTIVITY	38	4.46e-01	7.69e-01	0.2190	1.89e-02	9.21e-02	1.38e-01	5.52e-02	1.32e-01	8.40e-01	3.26e-01	1.42e-01	5.56e-01	1.60e-01
GOBP REGULATION OF OSSIFICATION	116	5.63e-03	5.77e-02	0.2190	-7.83e-02	8.12e-02	8.23e-02	-6.39e-02	1.57e-01	1.45e-01	1.31e-01	1.26e-01	2.35e-01	3.52e-03
GOBP NEGATIVE REGULATION OF RNA CATABOLIC PROCESS	78	2.20e-02	1.50e-01	0.2190	-1.57e-01	2.88e-02	6.48e-02	-1.36e-01	9.24e-03	1.67e-02	6.60e-01	3.22e-01	3.81e-02	8.88e-01
GOBP ANDROGEN RECEPTOR SIGNALING PATHWAY	45	1.75e-01	5.15e-01	0.2190	-4.20e-02	9.30e-02	2.17e-02	-1.88e-01	-4.50e-02	6.26e-01	2.81e-01	8.01e-01	2.94e-02	6.01e-01
GOMF FRIZZLED BINDING	36	1.66e-01	5.02e-01	0.2190	-1.08e-01	-2.67e-02	1.19e-01	-1.42e-01	-3.90e-02	2.63e-01	7.82e-01	2.16e-01	1.41e-01	6.85e-01
GOMF ALDEHYDE DEHYDROGENASE NAD P PLUS ACTIVITY	17	7.49e-01	9.15e-01	0.2190	-2.52e-02	-1.57e-01	-6.84e-02	1.35e-01	-7.00e-03	8.57e-01	2.64e-01	6.25e-01	3.35e-01	9.60e-01
GOBP POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION	97	1.51e-02	1.17e-01	0.2190	-4.93e-02	2.07e-01	5.00e-03	-4.01e-02	3.46e-02	4.01e-01	4.27e-04	9.32e-01	4.95e-01	5.56e-01
GOBP POSITIVE REGULATION OF PROTEIN UBIQUITINATION	100	1.11e-02	9.47e-02	0.2190	5.41e-02	1.58e-01	3.77e-02	-1.37e-01	9.77e-03	3.50e-01	6.32e-03	5.15e-01	1.82e-02	8.66e-01
GOCC RIBBON SYNAPSE	15	8.29e-01	9.44e-01	0.2190	-8.79e-02	7.12e-02	1.31e-01	1.17e-02	-1.34e-01	5.56e-01	6.33e-01	3.80e-01	9.38e-01	3.68e-01
GOBP MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE	29	5.78e-01	8.42e-01	0.2190	-1.06e-01	1.44e-01	1.20e-01	8.07e-03	-4.14e-02	3.23e-01	1.80e-01	2.65e-01	9.40e-01	7.00e-01
GOBP SUBSTRATE ADHESION DEPENDENT CELL SPREADING	98	1.92e-02	1.37e-01	0.2190	-1.86e-01	5.84e-02	1.89e-03	3.03e-02	-9.54e-02	1.46e-03	3.18e-01	9.74e-01	6.05e-01	1.03e-01
GOBP PEPTIDYL LYSINE MODIFICATION	204	4.99e-04	8.85e-03	0.2190	1.01e-01	-4.56e-03	-1.01e-01	-1.44e-01	8.31e-02	1.27e-02	9.11e-01	1.29e-02	4.02e-04	4.07e-02
GOBP REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL	140	5.08e-03	5.42e-02	0.2190	2.39e-02	7.45e-02	1.71e-01	6.77e-02	8.96e-02	6.26e-01	1.28e-01	4.71e-04	1.67e-01	6.73e-02
GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS	32	5.57e-01	8.32e-01	0.2190	-5.27e-02	-4.93e-02	1.33e-01	1.30e-01	9.02e-02	6.06e-01	6.29e-01	1.93e-01	2.02e-01	3.77e-01
GOCC AP TYPE MEMBRANE COAT ADAPTOR COMPLEX	37	3.71e-01	7.10e-01	0.2190	4.66e-02	-3.75e-02	-4.02e-02	-2.05e-01	3.09e-02	6.24e-01	6.93e-01	6.72e-01	3.13e-02	7.45e-01
GOBP NERVE GROWTH FACTOR SIGNALING PATHWAY	13	8.48e-01	9.49e-01	0.2190	-1.46e-01	1.07e-01	6.01e-02	-9.69e-02	-4.82e-02	3.63e-01	5.04e-01	7.07e-01	5.45e-01	7.64e-01
GOBP SULFUR COMPOUND TRANSPORT	53	2.51e-01	6.08e-01	0.2190	-5.08e-02	4.32e-02	1.72e-01	7.05e-02	-9.48e-02	5.22e-01	5.87e-01	3.04e-02	3.74e-01	2.33e-01
GOBP REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY	92	1.83e-02	1.33e-01	0.2190	-1.50e-01	-2.10e-02	1.58e-01	4.40e-03	9.40e-04	1.28e-02	7.28e-01	8.93e-03	9.42e-01	9.88e-01
GOBP CELLULAR SENESCENCE	106	1.87e-02	1.35e-01	0.2190	-2.80e-02	7.49e-02	-1.94e-02	-1.62e-01	1.21e-01	6.19e-01	1.82e-01	7.29e-01	3.88e-03	3.07e-02
GOBP NUCLEOBASE CONTAINING COMPOUND TRANSPORT	205	6.57e-05	1.70e-03	0.2190	-5.45e-03	7.71e-04	-7.74e-02	-2.04e-01	-1.73e-02	8.93e-01	9.85e-01	5.59e-02	4.94e-07	6.69e-01
GOBP POSITIVE REGULATION OF CELLULAR EXTRAVASATION	15	8.38e-01	9.46e-01	0.2190	-1.48e-01	1.30e-01	3.32e-02	-1.37e-02	-8.77e-02	3.21e-01	3.84e-01	8.24e-01	9.27e-01	5.56e-01
GOBP COLLAGEN CATABOLIC PROCESS	44	3.11e-01	6.63e-01	0.2190	4.71e-02	-3.93e-02	-2.58e-03	1.60e-01	-1.35e-01	5.89e-01	6.52e-01	9.76e-01	6.55e-02	1.21e-01
GOBP UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY	35	5.72e-01	8.39e-01	0.2190	6.54e-02	-7.02e-03	-1.21e-01	-1.69e-01	4.87e-03	5.03e-01	9.43e-01	2.14e-01	8.28e-02	9.60e-01
GOBP RESPONSE TO GAMMA RADIATION	50	3.68e-01	7.08e-01	0.2190	1.29e-02	-5.98e-02	-1.13e-01	-1.43e-01	1.04e-01	8.75e-01	4.64e-01	1.66e-01	8.07e-02	2.04e-01
GOBP RESPONSE TO MUSCLE STRETCH	24	6.24e-01	8.66e-01	0.2180	2.06e-01	5.06e-02	-2.63e-02	4.17e-02	-1.03e-02	7.99e-02	6.68e-01	8.24e-01	7.23e-01	9.31e-01
GOBP DETECTION OF LIGHT STIMULUS	61	2.43e-01	6.00e-01	0.2180	4.33e-02	2.58e-02	1.20e-01	1.72e-01	-3.53e-02	5.59e-01	7.28e-01	1.05e-01	2.03e-02	6.33e-01
GOBP NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS	39	2.10e-01	5.61e-01	0.2180	-3.70e-02	-9.91e-02	-1.73e-01	8.06e-02	1.68e-03	6.89e-01	2.84e-01	6.12e-02	3.84e-01	9.86e-01
GOBP THYROID HORMONE GENERATION	22	5.79e-01	8.43e-01	0.2180	1.88e-01	2.20e-03	2.67e-02	-4.98e-02	-9.52e-02	1.26e-01	9.86e-01	8.28e-01	6.86e-01	4.40e-01
GOBP PROTEIN HETEROOLIGOMERIZATION	28	6.43e-01	8.75e-01	0.2180	1.45e-01	1.08e-02	-1.36e-01	-7.43e-02	5.04e-02	1.84e-01	9.21e-01	2.13e-01	4.96e-01	6.44e-01
GOMF TRANSFORMING GROWTH FACTOR BETA RECEPTOR ACTIVITY TYPE I	5	9.80e-01	9.93e-01	0.2180	1.31e-01	-7.99e-02	5.61e-03	1.47e-01	5.00e-02	6.12e-01	7.57e-01	9.83e-01	5.69e-01	8.47e-01
GOMF PHOSPHOLIPASE A2 ACTIVITY	34	4.08e-01	7.40e-01	0.2180	-5.34e-02	-3.86e-03	2.91e-02	2.09e-01	-1.95e-02	5.90e-01	9.69e-01	7.69e-01	3.51e-02	8.44e-01
GOBP GANGLION DEVELOPMENT	17	7.46e-01	9.14e-01	0.2180	1.10e-01	1.27e-01	5.05e-02	-1.29e-01	-6.99e-03	4.30e-01	3.63e-01	7.18e-01	3.57e-01	9.60e-01
GOBP NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY	32	4.51e-01	7.71e-01	0.2180	-8.11e-02	8.10e-02	7.90e-02	-1.12e-01	1.25e-01	4.27e-01	4.28e-01	4.39e-01	2.72e-01	2.20e-01
GOBP CHEMOKINE PRODUCTION	101	1.74e-02	1.29e-01	0.2180	-7.70e-02	1.65e-01	1.00e-01	-3.95e-02	5.53e-02	1.81e-01	4.25e-03	8.23e-02	4.93e-01	3.37e-01
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS	61	1.55e-01	4.84e-01	0.2180	5.09e-03	7.77e-02	-2.34e-02	-1.90e-01	6.93e-02	9.45e-01	2.94e-01	7.52e-01	1.01e-02	3.49e-01
GOMF MYOSIN BINDING	71	7.59e-02	3.31e-01	0.2180	-9.13e-02	2.35e-02	-1.22e-01	-4.40e-03	-1.54e-01	1.83e-01	7.32e-01	7.55e-02	9.49e-01	2.45e-02
GOBP BONE CELL DEVELOPMENT	17	8.35e-01	9.45e-01	0.2180	-1.44e-02	9.82e-02	1.49e-01	6.42e-02	-1.07e-01	9.18e-01	4.83e-01	2.87e-01	6.47e-01	4.46e-01
GOBP MYOBLAST FUSION	47	2.61e-01	6.18e-01	0.2180	-2.18e-02	1.19e-01	8.43e-02	1.49e-01	5.93e-02	7.96e-01	1.56e-01	3.17e-01	7.71e-02	4.82e-01
GOBP REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS	24	6.18e-01	8.62e-01	0.2180	-3.00e-02	4.22e-02	1.97e-02	-6.62e-03	-2.11e-01	7.99e-01	7.20e-01	8.67e-01	9.55e-01	7.37e-02
GOBP VISUAL BEHAVIOR	55	1.20e-01	4.26e-01	0.2180	-1.09e-01	-1.97e-03	6.64e-02	-3.52e-02	-1.74e-01	1.64e-01	9.80e-01	3.95e-01	6.51e-01	2.60e-02
GOCC PERIKARYON	142	6.21e-03	6.25e-02	0.2180	-6.57e-02	4.66e-02	1.71e-01	8.45e-02	-6.95e-02	1.77e-01	3.38e-01	4.51e-04	8.20e-02	1.53e-01
GOMF S ADENOSYLMETHIONINE DEPENDENT METHYLTRANSFERASE ACTIVITY	172	2.99e-04	5.90e-03	0.2180	1.18e-01	-4.91e-02	-6.58e-02	-1.64e-01	-2.00e-03	7.54e-03	2.66e-01	1.37e-01	2.09e-04	9.64e-01
GOBP NEUTROPHIL HOMEOSTASIS	20	7.61e-01	9.20e-01	0.2180	-5.35e-02	6.46e-03	1.58e-01	6.83e-02	-1.22e-01	6.79e-01	9.60e-01	2.21e-01	5.97e-01	3.44e-01
GOBP RESPONSE TO INTERLEUKIN 6	41	3.96e-01	7.30e-01	0.2180	-1.22e-02	4.99e-02	1.16e-01	7.74e-02	-1.59e-01	8.92e-01	5.81e-01	1.99e-01	3.91e-01	7.75e-02
GOMF TRANSCRIPTION ELONGATION FACTOR ACTIVITY	6	9.78e-01	9.93e-01	0.2180	2.99e-03	-2.46e-02	-8.17e-02	-1.99e-01	-2.72e-02	9.90e-01	9.17e-01	7.29e-01	3.99e-01	9.08e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON METAL IONS NAD OR NADP AS ACCEPTOR	6	9.75e-01	9.93e-01	0.2180	5.84e-03	-9.46e-02	1.29e-02	-5.15e-02	1.89e-01	9.80e-01	6.88e-01	9.57e-01	8.27e-01	4.23e-01
GOBP CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION	19	8.07e-01	9.36e-01	0.2180	-3.48e-04	1.96e-02	-1.74e-01	-1.07e-01	7.47e-02	9.98e-01	8.82e-01	1.90e-01	4.22e-01	5.73e-01
GOBP REGULATION OF RESPONSE TO OSMOTIC STRESS	16	8.03e-01	9.34e-01	0.2180	-5.75e-02	7.19e-02	1.10e-01	-7.97e-02	1.43e-01	6.90e-01	6.19e-01	4.48e-01	5.81e-01	3.20e-01
GOBP NEUTRAL LIPID CATABOLIC PROCESS	37	3.02e-01	6.55e-01	0.2180	-1.71e-01	1.20e-01	-5.04e-03	5.88e-02	1.12e-02	7.11e-02	2.06e-01	9.58e-01	5.36e-01	9.06e-01
GOBP POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION	27	5.92e-01	8.47e-01	0.2180	7.39e-02	1.24e-01	1.63e-01	8.30e-03	7.13e-03	5.06e-01	2.66e-01	1.43e-01	9.40e-01	9.49e-01
GOBP PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS	715	1.50e-16	2.10e-14	0.2180	1.73e-02	4.94e-02	-7.94e-02	-1.95e-01	1.49e-02	4.30e-01	2.43e-02	2.95e-04	5.67e-19	4.98e-01
GOMF DEACETYLASE ACTIVITY	36	5.17e-01	8.12e-01	0.2180	1.40e-01	8.19e-03	-7.07e-02	-1.37e-01	6.42e-02	1.47e-01	9.32e-01	4.63e-01	1.56e-01	5.05e-01
GOCC PTW PP1 PHOSPHATASE COMPLEX	7	9.46e-01	9.82e-01	0.2180	3.36e-02	1.30e-01	4.47e-02	-1.54e-01	-6.13e-02	8.78e-01	5.52e-01	8.38e-01	4.82e-01	7.79e-01
GOMF CALCIUM DEPENDENT PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY	7	9.68e-01	9.91e-01	0.2180	3.23e-02	1.43e-01	1.35e-01	2.94e-02	-8.17e-02	8.82e-01	5.13e-01	5.35e-01	8.93e-01	7.08e-01
GOBP POSITIVE REGULATION OF MEMBRANE PERMEABILITY	49	3.78e-01	7.17e-01	0.2180	4.98e-02	-9.47e-02	-1.14e-01	-1.37e-01	6.36e-02	5.47e-01	2.51e-01	1.68e-01	9.64e-02	4.41e-01
GOBP ENDOTHELIAL CELL CHEMOTAXIS	27	6.22e-01	8.65e-01	0.2180	-6.85e-02	-1.59e-01	-7.17e-02	-2.39e-03	-1.10e-01	5.38e-01	1.52e-01	5.19e-01	9.83e-01	3.21e-01
GOMF PHOSPHOTRANSFERASE ACTIVITY PHOSPHATE GROUP AS ACCEPTOR	34	4.84e-01	7.94e-01	0.2180	1.35e-01	1.36e-01	-4.34e-02	-9.40e-02	-6.87e-04	1.75e-01	1.70e-01	6.62e-01	3.43e-01	9.94e-01
GOBP NEGATIVE REGULATION OF MUSCLE CONTRACTION	23	6.66e-01	8.82e-01	0.2170	-1.15e-01	-1.47e-01	-8.70e-02	-1.20e-02	6.91e-02	3.41e-01	2.22e-01	4.70e-01	9.21e-01	5.66e-01
GOMF PHOSPHATIDYLSERINE FLOPPASE ACTIVITY	8	9.22e-01	9.75e-01	0.2170	-1.55e-01	-2.97e-02	-9.02e-02	1.74e-02	1.17e-01	4.46e-01	8.85e-01	6.59e-01	9.32e-01	5.65e-01
GOBP NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS	1211	5.87e-28	2.23e-25	0.2170	6.59e-02	5.12e-02	-4.49e-02	-1.75e-01	8.77e-02	1.13e-04	2.71e-03	8.47e-03	1.09e-24	2.71e-07
GOBP REGULATION OF T CELL MEDIATED IMMUNITY	93	3.65e-02	2.08e-01	0.2170	-1.08e-01	7.62e-02	1.71e-01	2.69e-02	-4.81e-03	7.26e-02	2.04e-01	4.46e-03	6.54e-01	9.36e-01
GOCC PODOSOME	31	3.47e-01	6.93e-01	0.2170	-1.27e-01	1.54e-01	-2.57e-02	8.06e-02	1.55e-02	2.20e-01	1.38e-01	8.05e-01	4.37e-01	8.81e-01
GOBP SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING	10	9.09e-01	9.70e-01	0.2170	9.27e-02	5.04e-02	-3.59e-03	-1.89e-01	1.58e-02	6.12e-01	7.83e-01	9.84e-01	3.00e-01	9.31e-01
GOBP ANATOMICAL STRUCTURE ARRANGEMENT	15	8.06e-01	9.36e-01	0.2170	3.38e-02	6.68e-02	1.82e-01	2.22e-02	-9.01e-02	8.21e-01	6.54e-01	2.23e-01	8.82e-01	5.46e-01
GOBP RETINA LAYER FORMATION	23	7.80e-01	9.28e-01	0.2170	-3.95e-02	1.22e-02	1.78e-01	1.17e-01	1.59e-02	7.43e-01	9.19e-01	1.40e-01	3.32e-01	8.95e-01
GOMF PHOSPHATIDYLINOSITOL PHOSPHATE 4 PHOSPHATASE ACTIVITY	8	9.56e-01	9.87e-01	0.2170	-1.83e-02	6.26e-02	1.00e-01	-3.02e-02	1.79e-01	9.29e-01	7.59e-01	6.24e-01	8.82e-01	3.81e-01
GOBP INTRACILIARY TRANSPORT	45	4.18e-01	7.48e-01	0.2170	1.23e-01	-2.13e-02	-1.23e-01	-9.87e-02	8.29e-02	1.54e-01	8.04e-01	1.55e-01	2.52e-01	3.36e-01
GOMF GLUCOSE BINDING	10	9.30e-01	9.78e-01	0.2170	1.19e-01	4.40e-02	5.84e-02	1.66e-01	-4.09e-03	5.13e-01	8.10e-01	7.49e-01	3.63e-01	9.82e-01
GOBP ACTIVATED T CELL PROLIFERATION	47	2.31e-01	5.85e-01	0.2170	-1.60e-01	-7.08e-03	6.46e-02	2.56e-02	1.29e-01	5.77e-02	9.33e-01	4.43e-01	7.61e-01	1.26e-01
GOBP AUTOPHAGOSOME ORGANIZATION	115	2.30e-02	1.54e-01	0.2170	-2.95e-02	5.40e-02	-1.23e-01	-1.47e-01	8.22e-02	5.85e-01	3.17e-01	2.31e-02	6.53e-03	1.28e-01
GOBP MAST CELL ACTIVATION	66	9.42e-02	3.71e-01	0.2170	1.34e-02	2.04e-01	3.74e-02	6.35e-02	1.73e-03	8.51e-01	4.21e-03	6.00e-01	3.72e-01	9.81e-01
GOBP POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION	15	8.12e-01	9.39e-01	0.2170	5.24e-02	1.55e-01	5.73e-02	-1.30e-01	8.83e-03	7.25e-01	2.97e-01	7.01e-01	3.84e-01	9.53e-01
GOMF CYCLIC NUCLEOTIDE DEPENDENT PROTEIN KINASE ACTIVITY	7	9.67e-01	9.90e-01	0.2170	9.36e-02	-7.33e-02	1.68e-02	-4.75e-03	1.81e-01	6.68e-01	7.37e-01	9.39e-01	9.83e-01	4.08e-01
GOBP CD40 SIGNALING PATHWAY	15	8.92e-01	9.63e-01	0.2170	-2.06e-02	1.94e-03	-1.80e-01	-1.19e-01	6.50e-03	8.90e-01	9.90e-01	2.28e-01	4.24e-01	9.65e-01
GOBP MITOTIC CELL CYCLE PROCESS	746	1.25e-15	1.64e-13	0.2170	8.33e-02	2.98e-02	-1.07e-01	-1.65e-01	2.36e-02	1.06e-04	1.67e-01	6.11e-07	1.78e-14	2.72e-01
GOBP WATER SOLUBLE VITAMIN METABOLIC PROCESS	58	1.99e-01	5.47e-01	0.2170	7.93e-02	1.25e-01	-6.29e-03	-7.38e-02	1.40e-01	2.96e-01	9.85e-02	9.34e-01	3.31e-01	6.58e-02
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE	61	9.02e-02	3.63e-01	0.2170	-1.59e-01	3.30e-02	1.99e-02	-1.30e-01	-5.97e-02	3.22e-02	6.56e-01	7.88e-01	7.97e-02	4.20e-01
GOMF PHOSPHATASE INHIBITOR ACTIVITY	44	3.08e-01	6.60e-01	0.2170	1.40e-02	2.04e-01	4.07e-02	6.02e-04	-6.00e-02	8.72e-01	1.93e-02	6.40e-01	9.94e-01	4.91e-01
GOBP PROTEIN LOCALIZATION TO CYTOSKELETON	57	2.05e-01	5.56e-01	0.2170	1.09e-01	-8.40e-02	-8.08e-02	-1.46e-01	9.35e-03	1.55e-01	2.73e-01	2.92e-01	5.58e-02	9.03e-01
GOBP REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION	14	8.21e-01	9.42e-01	0.2170	-7.39e-02	1.93e-01	1.37e-02	3.97e-02	4.89e-02	6.32e-01	2.11e-01	9.29e-01	7.97e-01	7.51e-01
GOBP POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION	71	7.93e-02	3.39e-01	0.2170	-6.82e-02	2.00e-01	3.13e-02	-3.16e-02	1.55e-02	3.20e-01	3.54e-03	6.48e-01	6.45e-01	8.22e-01
GOBP NUCLEAR BODY ORGANIZATION	15	7.45e-01	9.14e-01	0.2170	5.42e-02	1.17e-01	9.89e-02	-1.42e-01	-1.41e-02	7.16e-01	4.32e-01	5.07e-01	3.40e-01	9.25e-01
GOMF CALCIUM DEPENDENT PROTEIN KINASE ACTIVITY	23	6.88e-01	8.90e-01	0.2160	-1.59e-02	1.85e-01	4.38e-02	-4.85e-02	9.03e-02	8.95e-01	1.25e-01	7.16e-01	6.87e-01	4.53e-01
GOBP CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE	117	6.32e-03	6.33e-02	0.2160	-1.14e-01	1.71e-01	5.23e-02	-1.67e-02	4.08e-02	3.25e-02	1.44e-03	3.29e-01	7.56e-01	4.46e-01
GOBP P38MAPK CASCADE	57	1.78e-01	5.19e-01	0.2160	-3.99e-02	1.15e-01	5.37e-02	-8.09e-02	1.50e-01	6.02e-01	1.32e-01	4.83e-01	2.91e-01	5.01e-02
GOMF CARBON OXYGEN LYASE ACTIVITY	74	8.87e-02	3.59e-01	0.2160	2.15e-02	4.15e-02	-1.96e-01	-7.78e-02	-1.28e-02	7.49e-01	5.37e-01	3.54e-03	2.47e-01	8.49e-01
GOBP REGULATION OF MONOATOMIC ANION TRANSPORT	17	8.33e-01	9.45e-01	0.2160	-1.00e-01	-1.44e-01	6.13e-02	1.03e-01	-4.40e-02	4.74e-01	3.06e-01	6.62e-01	4.64e-01	7.53e-01
GOBP RELEASE OF CYTOCHROME C FROM MITOCHONDRIA	55	1.52e-01	4.79e-01	0.2160	-5.68e-03	5.33e-02	-2.32e-02	-2.08e-01	-1.58e-03	9.42e-01	4.94e-01	7.66e-01	7.53e-03	9.84e-01
GOBP PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS	46	3.31e-01	6.79e-01	0.2160	-9.15e-02	1.56e-01	1.18e-01	1.76e-02	-6.79e-03	2.83e-01	6.79e-02	1.67e-01	8.36e-01	9.36e-01
GOBP REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY	45	3.64e-01	7.05e-01	0.2160	-1.03e-01	1.42e-01	1.18e-01	4.28e-02	-1.75e-02	2.34e-01	9.91e-02	1.72e-01	6.19e-01	8.39e-01
GOBP LEUKOCYTE MEDIATED CYTOTOXICITY	131	1.54e-03	2.19e-02	0.2160	-1.54e-01	2.31e-02	1.34e-01	-4.17e-02	5.46e-02	2.40e-03	6.48e-01	8.22e-03	4.10e-01	2.80e-01
GOBP CELL CELL RECOGNITION	72	8.39e-02	3.49e-01	0.2160	-8.38e-02	1.16e-01	1.49e-01	-2.36e-04	-6.28e-02	2.19e-01	8.86e-02	2.85e-02	9.97e-01	3.57e-01
GOBP REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT	83	8.53e-02	3.53e-01	0.2160	-8.99e-02	-3.24e-03	1.53e-01	8.40e-02	-8.97e-02	1.57e-01	9.59e-01	1.57e-02	1.86e-01	1.58e-01
GOBP REGULATION OF NEUROBLAST PROLIFERATION	53	9.84e-02	3.79e-01	0.2160	1.30e-04	-6.91e-02	1.37e-01	-7.99e-02	1.29e-01	9.99e-01	3.84e-01	8.38e-02	3.14e-01	1.04e-01
GOBP REGULATION OF VASCULAR WOUND HEALING	13	8.22e-01	9.42e-01	0.2160	6.15e-02	-1.16e-01	-1.43e-01	8.22e-02	4.79e-02	7.01e-01	4.70e-01	3.72e-01	6.08e-01	7.65e-01
GOBP NEGATIVE REGULATION OF PROGRAMMED NECROTIC CELL DEATH	21	4.91e-01	7.98e-01	0.2160	5.44e-02	-5.40e-02	3.84e-02	-1.95e-01	-3.53e-02	6.66e-01	6.68e-01	7.61e-01	1.22e-01	7.80e-01
GOBP REGULATION OF INSULIN RECEPTOR SIGNALING PATHWAY	69	8.17e-02	3.44e-01	0.2160	2.89e-02	2.03e-01	-1.77e-02	-1.95e-02	-6.22e-02	6.78e-01	3.52e-03	8.00e-01	7.80e-01	3.72e-01
GOBP NEGATIVE REGULATION OF VIRAL PROCESS	91	8.57e-02	3.54e-01	0.2160	2.15e-02	-5.70e-02	-1.26e-01	-1.65e-01	6.56e-03	7.23e-01	3.48e-01	3.84e-02	6.62e-03	9.14e-01
GOBP INTRACELLULAR LIPID TRANSPORT	50	2.69e-01	6.23e-01	0.2160	-3.98e-02	1.42e-01	-3.78e-02	-1.25e-01	8.78e-02	6.26e-01	8.24e-02	6.43e-01	1.25e-01	2.83e-01
GOBP NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION	18	6.47e-01	8.77e-01	0.2160	-1.50e-02	4.41e-02	-8.26e-02	1.69e-01	-9.55e-02	9.12e-01	7.46e-01	5.44e-01	2.15e-01	4.83e-01
GOBP MRNA TRANSCRIPTION	47	3.56e-01	7.01e-01	0.2160	-1.17e-02	1.08e-01	-9.01e-02	-1.46e-01	7.35e-02	8.90e-01	2.01e-01	2.85e-01	8.32e-02	3.84e-01
GOBP MACROPHAGE MIGRATION	61	1.43e-01	4.64e-01	0.2160	-1.27e-01	5.29e-02	9.44e-02	8.95e-02	1.04e-01	8.60e-02	4.75e-01	2.02e-01	2.27e-01	1.62e-01
GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION	34	4.56e-01	7.75e-01	0.2160	-4.68e-02	-1.12e-01	1.19e-01	5.64e-02	1.21e-01	6.36e-01	2.59e-01	2.31e-01	5.69e-01	2.22e-01
GOBP RETINA HOMEOSTASIS	75	8.42e-02	3.50e-01	0.2160	1.46e-03	-1.65e-01	1.91e-02	9.88e-02	-9.64e-02	9.83e-01	1.37e-02	7.74e-01	1.39e-01	1.49e-01
GOCC MIDBODY	196	4.67e-04	8.44e-03	0.2160	5.39e-02	4.47e-02	-1.06e-01	-1.73e-01	-2.18e-02	1.93e-01	2.81e-01	1.02e-02	3.05e-05	5.99e-01
GOCC FEMALE PRONUCLEUS	10	9.37e-01	9.80e-01	0.2160	-6.17e-02	-1.03e-01	-1.72e-01	-2.48e-02	-4.28e-02	7.36e-01	5.74e-01	3.45e-01	8.92e-01	8.15e-01
GOBP REGULATION OF PROTEIN EXPORT FROM NUCLEUS	32	4.59e-01	7.77e-01	0.2160	-1.35e-02	1.48e-01	-9.95e-03	-1.26e-01	-9.23e-02	8.95e-01	1.47e-01	9.22e-01	2.19e-01	3.66e-01
GOBP VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS	46	3.89e-01	7.25e-01	0.2160	6.89e-02	5.03e-02	-1.66e-01	-1.09e-01	-2.37e-03	4.19e-01	5.55e-01	5.19e-02	2.03e-01	9.78e-01
GOBP SPINDLE LOCALIZATION	62	2.67e-01	6.22e-01	0.2160	8.54e-02	-1.06e-02	-1.53e-01	-1.24e-01	1.85e-02	2.45e-01	8.85e-01	3.69e-02	9.24e-02	8.01e-01
GOBP DIACYLGLYCEROL METABOLIC PROCESS	26	6.11e-01	8.58e-01	0.2160	-8.33e-02	1.36e-01	7.07e-02	-8.51e-02	9.42e-02	4.62e-01	2.31e-01	5.33e-01	4.52e-01	4.06e-01
GOMF CARBONATE DEHYDRATASE ACTIVITY	14	8.65e-01	9.55e-01	0.2150	-1.73e-01	-3.66e-02	6.48e-02	9.11e-02	5.05e-02	2.62e-01	8.13e-01	6.75e-01	5.55e-01	7.44e-01
GOBP SUBPALLIUM DEVELOPMENT	26	6.42e-01	8.75e-01	0.2150	-1.95e-01	-1.94e-03	1.73e-02	2.43e-02	-8.64e-02	8.51e-02	9.86e-01	8.78e-01	8.30e-01	4.46e-01
GOBP ESTABLISHMENT OF MITOCHONDRION LOCALIZATION	27	6.81e-01	8.87e-01	0.2150	9.18e-02	2.66e-02	-5.27e-02	-1.64e-01	8.64e-02	4.09e-01	8.11e-01	6.35e-01	1.39e-01	4.37e-01
GOMF CHROMATIN BINDING	551	2.65e-13	3.15e-11	0.2150	7.24e-02	4.01e-02	-3.16e-02	-1.84e-01	6.88e-02	3.67e-03	1.08e-01	2.04e-01	1.53e-13	5.75e-03
GOBP CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION	12	8.19e-01	9.41e-01	0.2150	6.31e-03	-8.01e-02	1.01e-01	-1.31e-01	1.12e-01	9.70e-01	6.31e-01	5.45e-01	4.31e-01	5.03e-01
GOMF TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING	26	4.54e-01	7.73e-01	0.2150	-3.40e-02	1.13e-01	9.03e-02	-1.44e-01	-5.75e-02	7.64e-01	3.17e-01	4.25e-01	2.02e-01	6.12e-01
GOBP NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION	13	8.82e-01	9.61e-01	0.2150	1.86e-01	1.03e-02	-7.97e-02	-4.17e-02	-5.93e-02	2.45e-01	9.49e-01	6.19e-01	7.94e-01	7.11e-01
GOBP XENOBIOTIC TRANSMEMBRANE TRANSPORT	16	8.32e-01	9.45e-01	0.2150	-1.15e-01	1.57e-01	6.58e-02	6.41e-02	-2.43e-03	4.26e-01	2.77e-01	6.49e-01	6.57e-01	9.87e-01
GOCC EXTRINSIC COMPONENT OF PRESYNAPTIC MEMBRANE	6	9.79e-01	9.93e-01	0.2150	1.20e-01	-5.20e-02	1.11e-01	9.68e-02	8.78e-02	6.12e-01	8.25e-01	6.39e-01	6.81e-01	7.10e-01
GOBP PLATELET AGGREGATION	71	8.34e-02	3.48e-01	0.2150	-7.76e-02	1.74e-01	-3.90e-02	-9.26e-02	5.68e-03	2.58e-01	1.14e-02	5.70e-01	1.77e-01	9.34e-01
GOMF TRNA CYTOSINE METHYLTRANSFERASE ACTIVITY	6	9.80e-01	9.93e-01	0.2150	4.80e-02	4.40e-02	1.61e-01	3.70e-02	1.21e-01	8.38e-01	8.52e-01	4.94e-01	8.75e-01	6.08e-01
GOBP POSITIVE REGULATION OF MEIOTIC CELL CYCLE	27	6.40e-01	8.74e-01	0.2150	-2.14e-02	-8.96e-02	-3.75e-02	-1.35e-01	1.34e-01	8.48e-01	4.20e-01	7.36e-01	2.23e-01	2.27e-01
GOBP ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY	152	1.11e-03	1.68e-02	0.2150	-1.36e-01	-8.13e-04	1.22e-01	2.63e-02	1.11e-01	3.92e-03	9.86e-01	9.61e-03	5.76e-01	1.78e-02
GOBP POSITIVE REGULATION OF PROTEIN ACETYLATION	24	7.13e-01	9.00e-01	0.2150	1.67e-01	6.91e-02	-4.50e-02	-8.43e-02	6.68e-02	1.57e-01	5.58e-01	7.03e-01	4.75e-01	5.71e-01
GOBP RESPONSE TO COLD	43	2.92e-01	6.46e-01	0.2150	-3.53e-02	1.16e-01	3.21e-02	-1.65e-01	5.46e-02	6.88e-01	1.87e-01	7.16e-01	6.05e-02	5.36e-01
GOCC VESICLE TETHERING COMPLEX	56	1.83e-01	5.25e-01	0.2150	1.48e-01	5.04e-02	-2.10e-03	-1.37e-01	5.47e-02	5.54e-02	5.14e-01	9.78e-01	7.64e-02	4.79e-01
GOBP CORONARY VASCULATURE DEVELOPMENT	48	3.44e-01	6.90e-01	0.2150	3.20e-02	8.15e-02	1.62e-01	8.11e-02	-7.58e-02	7.02e-01	3.28e-01	5.25e-02	3.31e-01	3.63e-01
GOBP POSITIVE REGULATION OF PHOSPHATASE ACTIVITY	27	5.71e-01	8.38e-01	0.2150	-1.12e-01	3.65e-02	7.84e-02	8.83e-02	1.35e-01	3.13e-01	7.43e-01	4.81e-01	4.27e-01	2.23e-01
GOBP NEGATIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS	15	8.69e-01	9.56e-01	0.2150	-9.11e-02	-2.29e-02	1.37e-01	6.85e-02	-1.17e-01	5.41e-01	8.78e-01	3.57e-01	6.46e-01	4.32e-01
GOMF PHOSPHATIDYLINOSITOL 5 PHOSPHATE BINDING	19	7.97e-01	9.32e-01	0.2150	-8.95e-02	8.32e-02	3.00e-02	1.18e-01	-1.28e-01	4.99e-01	5.30e-01	8.21e-01	3.72e-01	3.35e-01
GOBP NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY	65	6.71e-02	3.06e-01	0.2150	-1.14e-01	-6.07e-02	1.55e-01	2.54e-03	-7.47e-02	1.13e-01	3.98e-01	3.10e-02	9.72e-01	2.97e-01
GOBP REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS	30	6.96e-01	8.94e-01	0.2150	-6.95e-02	-2.54e-03	1.26e-01	1.46e-01	-6.31e-02	5.10e-01	9.81e-01	2.31e-01	1.67e-01	5.50e-01
GOBP ACUTE PHASE RESPONSE	46	2.50e-01	6.07e-01	0.2150	1.89e-01	-2.34e-02	-1.89e-02	9.76e-02	3.49e-03	2.67e-02	7.84e-01	8.25e-01	2.52e-01	9.67e-01
GOBP MONOATOMIC ANION TRANSPORT	161	4.59e-03	5.05e-02	0.2150	-9.88e-02	5.09e-02	1.16e-01	1.38e-01	-3.36e-02	3.06e-02	2.65e-01	1.09e-02	2.50e-03	4.62e-01
GOBP NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS	11	9.13e-01	9.71e-01	0.2150	1.37e-01	-1.06e-01	1.21e-02	1.20e-01	-3.93e-02	4.33e-01	5.42e-01	9.44e-01	4.90e-01	8.21e-01
GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY	107	1.51e-02	1.17e-01	0.2150	-4.54e-02	1.04e-01	3.23e-02	-1.24e-01	1.30e-01	4.17e-01	6.39e-02	5.63e-01	2.72e-02	2.01e-02
GOBP NEGATIVE REGULATION OF GLYCOGEN METABOLIC PROCESS	10	9.34e-01	9.80e-01	0.2150	-4.67e-02	7.44e-03	-1.32e-01	-2.51e-02	-1.61e-01	7.98e-01	9.67e-01	4.70e-01	8.91e-01	3.79e-01
GOBP POSITIVE REGULATION OF CELL MORPHOGENESIS	31	4.93e-01	7.99e-01	0.2150	9.15e-02	-8.62e-02	-3.44e-02	1.50e-01	-8.09e-02	3.78e-01	4.06e-01	7.40e-01	1.48e-01	4.35e-01
GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS	20	6.94e-01	8.93e-01	0.2150	-1.21e-01	1.12e-01	5.87e-02	-1.23e-01	-1.72e-02	3.48e-01	3.87e-01	6.49e-01	3.41e-01	8.94e-01
GOBP NEGATIVE REGULATION OF FAT CELL PROLIFERATION	5	9.89e-01	9.96e-01	0.2140	-6.30e-02	1.44e-01	1.33e-01	4.74e-02	3.54e-02	8.07e-01	5.77e-01	6.06e-01	8.54e-01	8.91e-01
GOBP RESPONSE TO PAIN	34	5.53e-01	8.30e-01	0.2140	-3.10e-02	-4.07e-02	1.83e-01	9.83e-02	4.46e-03	7.55e-01	6.81e-01	6.42e-02	3.21e-01	9.64e-01
GOMF 4 IRON 4 SULFUR CLUSTER BINDING	43	4.40e-01	7.63e-01	0.2140	2.06e-02	9.68e-02	-1.08e-01	-1.56e-01	1.44e-02	8.15e-01	2.72e-01	2.20e-01	7.76e-02	8.70e-01
GOBP SPECIFICATION OF ANIMAL ORGAN IDENTITY	35	3.00e-01	6.54e-01	0.2140	3.59e-02	6.36e-02	2.90e-03	-1.64e-01	-1.17e-01	7.13e-01	5.15e-01	9.76e-01	9.30e-02	2.32e-01
GOBP POSITIVE REGULATION OF INFLAMMATORY RESPONSE	148	3.52e-03	4.14e-02	0.2140	-6.40e-02	1.38e-01	1.35e-01	3.31e-02	5.73e-02	1.79e-01	3.69e-03	4.51e-03	4.87e-01	2.29e-01
GOBP NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY	24	6.76e-01	8.85e-01	0.2140	9.89e-02	-9.49e-02	-1.09e-01	3.94e-03	-1.23e-01	4.02e-01	4.21e-01	3.54e-01	9.73e-01	2.97e-01
GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION	42	3.80e-01	7.18e-01	0.2140	7.78e-02	1.48e-01	-5.94e-02	-1.18e-01	-2.12e-02	3.83e-01	9.67e-02	5.05e-01	1.87e-01	8.12e-01
GOBP NEGATIVE REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE	20	7.54e-01	9.17e-01	0.2140	-2.15e-02	-2.42e-02	-8.92e-02	-7.86e-02	-1.75e-01	8.68e-01	8.52e-01	4.90e-01	5.43e-01	1.75e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS	54	2.21e-01	5.76e-01	0.2140	-5.49e-02	1.20e-01	-1.03e-01	-1.11e-01	7.37e-02	4.85e-01	1.27e-01	1.92e-01	1.58e-01	3.49e-01
GOBP POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION	48	2.61e-01	6.18e-01	0.2140	-1.39e-01	1.46e-01	5.13e-02	4.89e-02	-2.04e-03	9.47e-02	8.03e-02	5.39e-01	5.58e-01	9.81e-01
GOBP PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS	49	2.99e-01	6.53e-01	0.2140	9.17e-02	4.59e-02	-1.51e-01	-7.10e-02	8.63e-02	2.67e-01	5.78e-01	6.79e-02	3.90e-01	2.96e-01
GOBP NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS	83	9.06e-02	3.63e-01	0.2140	-1.82e-02	8.55e-02	-1.10e-01	-1.59e-01	-2.47e-02	7.74e-01	1.78e-01	8.26e-02	1.22e-02	6.98e-01
GOMF CHROMO SHADOW DOMAIN BINDING	5	9.87e-01	9.95e-01	0.2140	-1.03e-01	7.10e-02	-1.11e-01	-1.27e-01	-4.15e-02	6.90e-01	7.83e-01	6.68e-01	6.23e-01	8.72e-01
GOMF TAU PROTEIN KINASE ACTIVITY	22	6.11e-01	8.58e-01	0.2140	5.66e-02	4.96e-02	-2.01e-02	-1.27e-01	-1.53e-01	6.46e-01	6.87e-01	8.70e-01	3.02e-01	2.14e-01
GOBP OVULATION FROM OVARIAN FOLLICLE	8	9.70e-01	9.92e-01	0.2140	1.44e-01	2.30e-02	-1.03e-01	-8.98e-02	7.68e-02	4.81e-01	9.10e-01	6.15e-01	6.60e-01	7.07e-01
GOBP REGULATION OF NEURON DIFFERENTIATION	192	1.84e-04	3.91e-03	0.2140	2.60e-02	9.46e-02	2.05e-02	-1.48e-01	1.17e-01	5.34e-01	2.38e-02	6.24e-01	3.93e-04	5.29e-03
GOBP ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS	305	5.88e-06	2.08e-04	0.2140	4.90e-02	3.60e-03	-1.04e-01	-1.78e-01	2.57e-02	1.41e-01	9.14e-01	1.78e-03	8.55e-08	4.40e-01
GOBP DEFENSE RESPONSE TO BACTERIUM	295	8.61e-06	2.91e-04	0.2140	-1.16e-01	-1.05e-02	9.04e-02	1.41e-01	-6.47e-02	6.32e-04	7.56e-01	7.55e-03	3.20e-05	5.60e-02
GOBP REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION	48	3.41e-01	6.88e-01	0.2140	-1.31e-01	8.62e-02	1.13e-01	8.69e-02	2.82e-02	1.18e-01	3.01e-01	1.75e-01	2.98e-01	7.36e-01
GOCC NEURON PROJECTION MEMBRANE	56	2.25e-01	5.78e-01	0.2140	1.01e-01	1.18e-03	1.58e-01	7.41e-02	6.99e-02	1.91e-01	9.88e-01	4.06e-02	3.37e-01	3.65e-01
GOBP PYRIMIDINE NUCLEOBASE CATABOLIC PROCESS	8	9.17e-01	9.74e-01	0.2130	-1.24e-01	-2.49e-02	-1.51e-01	7.48e-02	-3.45e-02	5.44e-01	9.03e-01	4.59e-01	7.14e-01	8.66e-01
GOBP POSITIVE CHEMOTAXIS	61	1.92e-01	5.38e-01	0.2130	-2.96e-02	1.01e-01	1.03e-01	1.45e-01	5.25e-02	6.89e-01	1.71e-01	1.65e-01	4.95e-02	4.78e-01
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE	436	1.69e-08	1.14e-06	0.2130	-5.64e-03	-3.05e-02	-1.11e-01	-1.75e-01	4.04e-02	8.40e-01	2.74e-01	7.56e-05	3.39e-10	1.48e-01
GOBP DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM	109	1.85e-02	1.34e-01	0.2130	-7.37e-02	-7.08e-02	9.68e-02	7.18e-02	-1.43e-01	1.84e-01	2.01e-01	8.07e-02	1.95e-01	9.70e-03
GOBP BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS	21	7.31e-01	9.08e-01	0.2130	-1.26e-01	-4.65e-02	4.89e-04	1.52e-01	-6.63e-02	3.17e-01	7.12e-01	9.97e-01	2.28e-01	5.99e-01
GOBP NEGATIVE REGULATION OF LIPID STORAGE	22	7.36e-01	9.09e-01	0.2130	-4.51e-02	-3.26e-02	1.23e-01	8.72e-02	1.40e-01	7.14e-01	7.91e-01	3.17e-01	4.79e-01	2.55e-01
GOBP REGULATION OF PROTEIN TARGETING TO MEMBRANE	33	5.45e-01	8.26e-01	0.2130	-4.90e-02	1.55e-01	9.22e-02	3.39e-02	-9.77e-02	6.26e-01	1.24e-01	3.59e-01	7.36e-01	3.31e-01
GOBP RESPONSE TO MINERALOCORTICOID	33	5.33e-01	8.20e-01	0.2130	6.28e-02	1.79e-01	9.35e-02	-2.91e-03	3.06e-02	5.32e-01	7.59e-02	3.53e-01	9.77e-01	7.61e-01
GOBP C TERMINAL PROTEIN AMINO ACID MODIFICATION	12	9.35e-01	9.80e-01	0.2130	-6.81e-03	-4.55e-02	-8.92e-02	-1.41e-01	1.24e-01	9.67e-01	7.85e-01	5.93e-01	3.97e-01	4.56e-01
GOBP ACIDIC AMINO ACID TRANSPORT	65	2.21e-01	5.76e-01	0.2130	-2.84e-02	1.16e-01	1.15e-01	1.32e-01	-2.18e-02	6.92e-01	1.06e-01	1.07e-01	6.61e-02	7.61e-01
GOMF ORGANIC ACID BINDING	207	3.43e-05	9.69e-04	0.2130	-4.33e-02	1.34e-01	6.33e-02	1.46e-01	1.78e-02	2.83e-01	9.22e-04	1.16e-01	2.91e-04	6.60e-01
GOCC POTASSIUM CHANNEL COMPLEX	88	6.19e-02	2.93e-01	0.2130	-4.96e-02	1.10e-01	1.49e-01	4.18e-02	-8.36e-02	4.21e-01	7.45e-02	1.60e-02	4.98e-01	1.75e-01
GOBP ACTIVATION OF PROTEIN KINASE B ACTIVITY	25	6.22e-01	8.65e-01	0.2130	-5.19e-02	-2.27e-02	-9.10e-02	9.44e-02	-1.58e-01	6.53e-01	8.44e-01	4.31e-01	4.14e-01	1.72e-01
GOMF CHEMOATTRACTANT ACTIVITY	34	3.92e-01	7.27e-01	0.2130	-5.64e-02	1.36e-01	3.37e-02	1.50e-01	9.75e-03	5.69e-01	1.70e-01	7.34e-01	1.30e-01	9.22e-01
GOBP NK T CELL ACTIVATION	12	8.70e-01	9.57e-01	0.2130	-1.44e-01	-1.31e-01	7.98e-02	-3.16e-02	-3.28e-03	3.87e-01	4.31e-01	6.32e-01	8.50e-01	9.84e-01
GOBP POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY	14	8.58e-01	9.53e-01	0.2130	-2.74e-02	1.19e-01	1.72e-01	-1.36e-02	-2.06e-02	8.59e-01	4.40e-01	2.64e-01	9.30e-01	8.94e-01
GOCC MHC CLASS II PROTEIN COMPLEX	15	7.90e-01	9.31e-01	0.2130	-1.64e-01	-1.92e-02	7.91e-02	-7.90e-02	-7.37e-02	2.71e-01	8.97e-01	5.96e-01	5.96e-01	6.21e-01
GOBP XENOBIOTIC METABOLIC PROCESS	117	6.99e-03	6.78e-02	0.2130	6.58e-02	2.85e-03	1.09e-02	1.87e-01	-7.59e-02	2.19e-01	9.58e-01	8.38e-01	4.72e-04	1.56e-01
GOBP POSITIVE REGULATION OF EXOSOMAL SECRETION	15	9.02e-01	9.68e-01	0.2130	-2.26e-02	-6.28e-03	-9.59e-02	-1.77e-01	6.37e-02	8.79e-01	9.66e-01	5.20e-01	2.35e-01	6.69e-01
GOCC RIBONUCLEOPROTEIN COMPLEX	1037	1.22e-19	2.44e-17	0.2130	-1.76e-03	-6.30e-02	-1.45e-01	-1.41e-01	1.86e-02	9.24e-01	6.06e-04	2.76e-15	1.63e-14	3.10e-01
GOBP POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION	31	5.68e-01	8.37e-01	0.2130	-9.42e-02	8.52e-02	-4.26e-02	-1.48e-01	7.41e-02	3.64e-01	4.12e-01	6.82e-01	1.55e-01	4.75e-01
GOMF CARBOHYDRATE DERIVATIVE TRANSMEMBRANE TRANSPORTER ACTIVITY	52	1.92e-01	5.38e-01	0.2120	2.33e-02	2.24e-02	-5.17e-02	-1.93e-01	-6.34e-02	7.72e-01	7.80e-01	5.19e-01	1.58e-02	4.29e-01
GOBP NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT	24	6.61e-01	8.81e-01	0.2120	1.09e-01	-3.96e-02	5.05e-02	1.32e-01	1.09e-01	3.57e-01	7.37e-01	6.69e-01	2.64e-01	3.55e-01
GOBP CAVEOLIN MEDIATED ENDOCYTOSIS	11	9.04e-01	9.68e-01	0.2120	-9.93e-02	-1.56e-01	-2.24e-02	-9.68e-02	-3.32e-02	5.69e-01	3.71e-01	8.98e-01	5.78e-01	8.49e-01
GOBP REGULATION OF MONOATOMIC ANION TRANSMEMBRANE TRANSPORT	9	9.39e-01	9.81e-01	0.2120	2.59e-02	-2.03e-01	3.48e-02	3.95e-02	2.04e-02	8.93e-01	2.92e-01	8.56e-01	8.38e-01	9.15e-01
GOMF NAD P H OXIDASE H2O2 FORMING ACTIVITY	8	9.46e-01	9.83e-01	0.2120	9.82e-02	6.29e-02	3.28e-02	1.26e-01	1.20e-01	6.30e-01	7.58e-01	8.72e-01	5.37e-01	5.55e-01
GOBP MICROGLIA DIFFERENTIATION	11	9.12e-01	9.71e-01	0.2120	1.12e-01	9.32e-02	9.50e-02	-7.74e-02	9.42e-02	5.22e-01	5.93e-01	5.85e-01	6.57e-01	5.88e-01
GOCC AMPA GLUTAMATE RECEPTOR COMPLEX	22	6.07e-01	8.57e-01	0.2120	-6.34e-02	-1.28e-01	4.38e-02	-1.29e-01	7.83e-02	6.06e-01	2.99e-01	7.22e-01	2.96e-01	5.25e-01
GOBP MONOCYTE DIFFERENTIATION	34	4.29e-01	7.54e-01	0.2120	-4.10e-02	1.34e-01	-1.12e-01	-2.65e-02	-1.10e-01	6.79e-01	1.75e-01	2.60e-01	7.89e-01	2.65e-01
GOCC OXIDOREDUCTASE COMPLEX	108	3.87e-02	2.15e-01	0.2120	6.91e-02	5.23e-02	-9.02e-02	-1.70e-01	1.97e-02	2.15e-01	3.48e-01	1.05e-01	2.23e-03	7.23e-01
GOMF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY	153	6.73e-03	6.61e-02	0.2120	-6.86e-02	8.59e-02	1.31e-01	9.02e-02	-8.79e-02	1.43e-01	6.66e-02	5.27e-03	5.41e-02	6.05e-02
GOMF LIPASE ACTIVITY	132	2.43e-02	1.59e-01	0.2120	-2.63e-02	6.52e-02	1.36e-01	1.38e-01	-5.27e-02	6.02e-01	1.96e-01	7.17e-03	6.33e-03	2.96e-01
GOMF ATPASE COUPLED INTRAMEMBRANE LIPID TRANSPORTER ACTIVITY	26	7.13e-01	9.00e-01	0.2120	-1.23e-01	-4.56e-05	4.51e-02	1.18e-01	-1.18e-01	2.79e-01	1.00e+00	6.90e-01	2.96e-01	2.97e-01
GOBP PEPTIDYL THREONINE DEPHOSPHORYLATION	18	8.54e-01	9.51e-01	0.2120	3.89e-03	1.20e-02	-1.83e-01	-1.07e-01	-1.36e-03	9.77e-01	9.30e-01	1.80e-01	4.31e-01	9.92e-01
GOBP REGULATION OF PHOSPHOLIPASE C ACTIVITY	39	5.46e-01	8.26e-01	0.2120	-5.70e-02	6.84e-02	1.10e-01	1.52e-01	-4.34e-02	5.38e-01	4.60e-01	2.35e-01	1.00e-01	6.39e-01
GOBP STRIATED MUSCLE ADAPTATION	55	1.23e-01	4.30e-01	0.2120	-8.49e-02	1.56e-02	1.14e-02	4.61e-02	1.88e-01	2.76e-01	8.41e-01	8.84e-01	5.54e-01	1.59e-02
GOCC PRONUCLEUS	14	8.73e-01	9.58e-01	0.2120	5.19e-02	-5.94e-02	-3.01e-02	8.06e-02	-1.77e-01	7.37e-01	7.00e-01	8.45e-01	6.02e-01	2.52e-01
GOBP LYMPH VESSEL DEVELOPMENT	31	3.08e-01	6.61e-01	0.2120	-1.32e-03	-7.78e-02	1.56e-01	-8.86e-02	8.28e-02	9.90e-01	4.54e-01	1.34e-01	3.93e-01	4.25e-01
GOBP POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION	23	6.83e-01	8.88e-01	0.2120	-2.47e-02	1.81e-01	3.90e-02	-9.84e-02	-1.40e-02	8.37e-01	1.32e-01	7.46e-01	4.14e-01	9.07e-01
GOBP HISTONE METHYLATION	35	5.43e-01	8.25e-01	0.2120	1.32e-01	6.58e-02	-1.02e-01	-7.85e-02	8.13e-02	1.77e-01	5.01e-01	2.97e-01	4.21e-01	4.05e-01
GOBP SULFATE TRANSPORT	17	8.29e-01	9.44e-01	0.2120	-7.69e-02	-9.20e-02	8.58e-02	6.50e-02	-1.38e-01	5.83e-01	5.11e-01	5.40e-01	6.42e-01	3.26e-01
GOBP NEGATIVE REGULATION OF SODIUM ION TRANSPORT	17	8.75e-01	9.59e-01	0.2120	-8.05e-02	1.07e-01	1.28e-01	8.25e-02	-6.12e-02	5.66e-01	4.44e-01	3.61e-01	5.56e-01	6.62e-01
GOBP REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY	27	5.55e-01	8.30e-01	0.2120	-1.90e-01	5.03e-02	-5.34e-02	-3.72e-02	4.68e-02	8.83e-02	6.51e-01	6.31e-01	7.38e-01	6.74e-01
GOBP REGULATION OF PROGRAMMED NECROTIC CELL DEATH	36	2.99e-01	6.53e-01	0.2120	2.77e-02	2.38e-04	5.68e-04	-2.09e-01	-2.44e-02	7.74e-01	9.98e-01	9.95e-01	3.03e-02	8.00e-01
GOBP REGULATORY T CELL DIFFERENTIATION	39	2.18e-01	5.72e-01	0.2120	-6.53e-02	3.05e-02	7.87e-03	1.65e-01	1.11e-01	4.80e-01	7.41e-01	9.32e-01	7.38e-02	2.32e-01
GOMF CYTOSKELETAL MOTOR ACTIVITY	111	4.04e-02	2.21e-01	0.2120	4.28e-03	1.92e-02	8.60e-02	1.65e-01	-9.98e-02	9.38e-01	7.26e-01	1.18e-01	2.74e-03	6.92e-02
GOBP PHOSPHATIDYLINOSITOL PHOSPHATE BIOSYNTHETIC PROCESS	63	1.42e-01	4.63e-01	0.2120	5.21e-03	1.71e-01	-2.55e-02	-1.12e-01	-4.80e-02	9.43e-01	1.89e-02	7.26e-01	1.23e-01	5.10e-01
GOBP REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION	20	5.49e-01	8.28e-01	0.2120	2.03e-02	-1.07e-01	1.35e-01	-2.54e-02	-1.19e-01	8.75e-01	4.08e-01	2.96e-01	8.44e-01	3.58e-01
GOBP CORPUS CALLOSUM DEVELOPMENT	26	4.37e-01	7.60e-01	0.2120	1.24e-01	5.20e-02	9.78e-02	-1.31e-01	-4.89e-03	2.75e-01	6.46e-01	3.88e-01	2.47e-01	9.66e-01
GOMF TBP CLASS PROTEIN BINDING	24	7.09e-01	8.98e-01	0.2120	5.06e-02	-9.96e-02	-2.17e-02	-9.01e-02	1.54e-01	6.68e-01	3.98e-01	8.54e-01	4.45e-01	1.92e-01
GOMF TRANSCRIPTION FACTOR BINDING	570	7.04e-12	7.20e-10	0.2120	4.98e-02	5.75e-02	-7.78e-02	-1.78e-01	3.46e-02	4.20e-02	1.90e-02	1.50e-03	3.49e-13	1.58e-01
GOBP MITOTIC RECOMBINATION	25	5.85e-01	8.45e-01	0.2120	5.91e-03	-5.24e-02	-1.05e-01	-9.07e-04	1.76e-01	9.59e-01	6.50e-01	3.62e-01	9.94e-01	1.28e-01
GOBP MORPHOGENESIS OF EMBRYONIC EPITHELIUM	150	1.59e-03	2.26e-02	0.2120	6.44e-02	2.80e-02	3.73e-03	-1.73e-01	9.97e-02	1.73e-01	5.54e-01	9.37e-01	2.59e-04	3.50e-02
GOBP RESPONSE TO INTERLEUKIN 17	17	6.94e-01	8.93e-01	0.2110	-9.56e-02	-3.68e-03	1.78e-01	-6.03e-02	-1.03e-02	4.95e-01	9.79e-01	2.03e-01	6.67e-01	9.41e-01
GOBP POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION	43	3.19e-01	6.68e-01	0.2110	7.87e-02	1.26e-01	9.09e-02	-9.30e-02	7.59e-02	3.72e-01	1.53e-01	3.02e-01	2.91e-01	3.89e-01
GOBP SECONDARY PALATE DEVELOPMENT	26	5.41e-01	8.24e-01	0.2110	1.79e-01	3.65e-02	8.90e-02	-9.32e-03	-5.86e-02	1.15e-01	7.47e-01	4.32e-01	9.34e-01	6.05e-01
GOBP NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS	27	5.92e-01	8.47e-01	0.2110	-1.02e-01	6.19e-03	1.80e-02	-2.76e-02	-1.82e-01	3.61e-01	9.56e-01	8.71e-01	8.04e-01	1.01e-01
GOBP EYE PHOTORECEPTOR CELL DIFFERENTIATION	47	1.51e-01	4.77e-01	0.2110	6.60e-02	-3.98e-02	1.93e-01	-1.05e-02	3.60e-02	4.34e-01	6.37e-01	2.19e-02	9.01e-01	6.69e-01
GOBP REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT	55	2.91e-01	6.44e-01	0.2110	-4.65e-02	1.48e-01	1.31e-01	4.95e-02	-2.82e-02	5.51e-01	5.71e-02	9.18e-02	5.25e-01	7.18e-01
GOBP NEGATIVE REGULATION OF OSTEOBLAST PROLIFERATION	15	8.79e-01	9.61e-01	0.2110	1.02e-01	4.87e-02	1.36e-01	5.76e-02	9.96e-02	4.93e-01	7.44e-01	3.61e-01	7.00e-01	5.04e-01
GOBP REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE	22	7.01e-01	8.96e-01	0.2110	8.13e-02	2.06e-02	-6.29e-02	3.46e-02	-1.80e-01	5.09e-01	8.67e-01	6.09e-01	7.79e-01	1.44e-01
GOMF AMYLOID BETA BINDING	82	5.94e-02	2.85e-01	0.2110	-2.60e-02	-4.71e-02	-1.75e-02	1.67e-01	-1.17e-01	6.84e-01	4.60e-01	7.84e-01	9.09e-03	6.73e-02
GOBP RIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS	28	6.11e-01	8.58e-01	0.2110	4.81e-02	2.37e-02	-7.20e-02	-1.85e-01	-4.79e-02	6.60e-01	8.28e-01	5.10e-01	8.99e-02	6.61e-01
GOBP FEEDING BEHAVIOR	102	1.13e-02	9.54e-02	0.2110	9.00e-02	1.07e-01	1.30e-01	-6.88e-02	5.77e-02	1.16e-01	6.17e-02	2.30e-02	2.30e-01	3.14e-01
GOBP NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS	38	4.94e-01	7.99e-01	0.2110	-1.12e-01	-1.29e-02	-8.75e-02	-1.47e-01	5.11e-02	2.33e-01	8.91e-01	3.51e-01	1.16e-01	5.86e-01
GOBP CELLULAR HYPEROSMOTIC RESPONSE	19	7.84e-01	9.28e-01	0.2110	-1.19e-01	1.61e-01	6.61e-02	-1.48e-02	3.06e-03	3.68e-01	2.25e-01	6.18e-01	9.11e-01	9.82e-01
GOMF WNT PROTEIN BINDING	31	4.28e-01	7.54e-01	0.2110	-4.47e-02	-1.83e-01	7.67e-02	-2.89e-02	4.71e-02	6.67e-01	7.71e-02	4.60e-01	7.80e-01	6.50e-01
GOBP PEPTIDYL CYSTEINE MODIFICATION	41	3.58e-01	7.03e-01	0.2110	-1.81e-01	2.30e-02	8.47e-03	-5.94e-02	-8.82e-02	4.52e-02	7.99e-01	9.25e-01	5.11e-01	3.29e-01
GOBP NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY	6	9.73e-01	9.92e-01	0.2110	1.68e-01	5.33e-03	1.24e-01	2.67e-02	3.28e-03	4.75e-01	9.82e-01	5.98e-01	9.10e-01	9.89e-01
GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY	50	2.52e-01	6.08e-01	0.2110	-4.09e-02	1.33e-01	-1.33e-02	-1.58e-01	-9.10e-03	6.17e-01	1.04e-01	8.70e-01	5.36e-02	9.11e-01
GOBP POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS	21	6.59e-01	8.80e-01	0.2110	5.50e-02	-3.76e-02	-4.09e-02	6.04e-02	1.86e-01	6.63e-01	7.65e-01	7.46e-01	6.32e-01	1.39e-01
GOBP REGULATION OF P38MAPK CASCADE	46	3.00e-01	6.54e-01	0.2110	-6.85e-02	1.06e-01	1.14e-01	-5.69e-02	1.11e-01	4.22e-01	2.13e-01	1.82e-01	5.04e-01	1.93e-01
GOBP CORONARY VASCULATURE MORPHOGENESIS	19	8.55e-01	9.52e-01	0.2110	2.97e-02	5.29e-02	1.67e-01	1.11e-01	-2.75e-02	8.23e-01	6.90e-01	2.09e-01	4.04e-01	8.36e-01
GOBP POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS	80	1.01e-01	3.86e-01	0.2110	-3.31e-02	1.07e-01	1.44e-01	3.69e-02	9.89e-02	6.09e-01	9.79e-02	2.61e-02	5.68e-01	1.26e-01
GOBP REGULATION OF CARDIAC CONDUCTION	26	7.12e-01	9.00e-01	0.2110	-1.74e-02	1.21e-01	8.88e-02	8.28e-02	-1.21e-01	8.78e-01	2.84e-01	4.33e-01	4.65e-01	2.86e-01
GOBP POSITIVE REGULATION OF ORGAN GROWTH	47	2.23e-01	5.76e-01	0.2100	-5.93e-02	-9.03e-02	1.45e-01	-8.77e-03	1.08e-01	4.82e-01	2.84e-01	8.64e-02	9.17e-01	2.02e-01
GOMF TRANSCRIPTION COREGULATOR BINDING	108	3.53e-02	2.03e-01	0.2100	6.52e-02	8.07e-02	-8.72e-02	-1.61e-01	-4.16e-03	2.42e-01	1.48e-01	1.18e-01	3.89e-03	9.40e-01
GOMF COPPER ION BINDING	58	1.16e-01	4.16e-01	0.2100	-1.72e-01	1.09e-01	-3.12e-02	3.74e-02	-1.65e-02	2.33e-02	1.50e-01	6.81e-01	6.22e-01	8.28e-01
GOBP NEGATIVE REGULATION OF LEUKOCYTE MIGRATION	53	3.77e-01	7.16e-01	0.2100	-5.93e-02	-4.47e-02	1.15e-01	1.57e-01	-2.56e-02	4.55e-01	5.74e-01	1.47e-01	4.76e-02	7.47e-01
GOMF LONG CHAIN FATTY ACID TRANSPORTER ACTIVITY	16	7.81e-01	9.28e-01	0.2100	-1.36e-01	1.28e-01	-8.33e-02	2.67e-03	-5.08e-02	3.48e-01	3.77e-01	5.64e-01	9.85e-01	7.25e-01
GOBP KERATINOCYTE DIFFERENTIATION	169	2.47e-03	3.17e-02	0.2100	-1.30e-01	-5.54e-02	1.17e-01	9.49e-02	-3.79e-02	3.43e-03	2.14e-01	8.79e-03	3.33e-02	3.96e-01
GOBP VESICLE CARGO LOADING	29	6.62e-01	8.81e-01	0.2100	4.74e-02	9.21e-02	-7.84e-02	-1.65e-01	5.53e-03	6.59e-01	3.91e-01	4.65e-01	1.24e-01	9.59e-01
GOBP MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY	54	2.43e-01	6.00e-01	0.2100	1.10e-01	5.14e-02	7.23e-02	-5.04e-02	1.47e-01	1.61e-01	5.13e-01	3.58e-01	5.22e-01	6.19e-02
GOBP ADAPTATION OF SIGNALING PATHWAY	20	7.79e-01	9.28e-01	0.2100	-7.71e-02	7.64e-02	1.70e-01	7.37e-03	5.79e-02	5.51e-01	5.54e-01	1.88e-01	9.54e-01	6.54e-01
GOBP PERIPHERAL NERVOUS SYSTEM DEVELOPMENT	80	1.44e-01	4.64e-01	0.2100	-5.49e-02	-1.37e-02	-1.13e-01	-1.58e-01	5.52e-02	3.96e-01	8.32e-01	7.98e-02	1.45e-02	3.93e-01
GOCC AXONEMAL MICROTUBULE	38	2.68e-01	6.23e-01	0.2100	1.75e-02	-5.39e-02	-2.07e-02	-1.81e-01	-8.73e-02	8.52e-01	5.65e-01	8.25e-01	5.33e-02	3.52e-01
GOBP GLYCEROPHOSPHOLIPID CATABOLIC PROCESS	34	4.91e-01	7.98e-01	0.2100	-1.48e-01	1.25e-01	6.59e-02	2.06e-02	4.46e-02	1.37e-01	2.08e-01	5.06e-01	8.35e-01	6.53e-01
GOMF O ACYLTRANSFERASE ACTIVITY	48	2.88e-01	6.41e-01	0.2100	1.58e-01	1.05e-01	-4.36e-02	-6.37e-02	-4.69e-02	5.83e-02	2.10e-01	6.01e-01	4.45e-01	5.74e-01
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS	13	9.00e-01	9.67e-01	0.2100	-7.90e-02	-1.76e-01	-4.39e-02	8.31e-04	-6.89e-02	6.22e-01	2.71e-01	7.84e-01	9.96e-01	6.67e-01
GOBP REGULATION OF OSTEOCLAST DIFFERENTIATION	68	2.10e-01	5.61e-01	0.2100	-3.16e-02	4.77e-02	1.74e-01	8.51e-02	5.72e-02	6.52e-01	4.97e-01	1.32e-02	2.25e-01	4.14e-01
GOCC CALCIUM CHANNEL COMPLEX	77	1.19e-01	4.23e-01	0.2100	-1.29e-01	8.04e-03	8.95e-02	5.73e-02	-1.27e-01	5.10e-02	9.03e-01	1.74e-01	3.85e-01	5.43e-02
GOBP POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS	92	6.38e-02	2.97e-01	0.2100	-7.30e-02	1.56e-01	9.93e-02	6.26e-02	-2.16e-02	2.26e-01	9.61e-03	9.99e-02	2.99e-01	7.20e-01
GOBP REGULATION OF DENDRITIC CELL CHEMOTAXIS	11	8.75e-01	9.59e-01	0.2100	-1.66e-01	9.95e-02	-7.81e-02	1.83e-02	4.07e-03	3.40e-01	5.68e-01	6.54e-01	9.17e-01	9.81e-01
GOBP IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY	312	8.95e-07	4.05e-05	0.2100	-5.81e-02	1.21e-01	1.23e-01	3.52e-02	9.79e-02	7.76e-02	2.33e-04	1.92e-04	2.85e-01	2.95e-03
GOBP PHOTORECEPTOR CELL DEVELOPMENT	49	9.95e-02	3.82e-01	0.2090	8.33e-02	2.42e-02	1.54e-01	-3.77e-02	-1.06e-01	3.13e-01	7.69e-01	6.23e-02	6.48e-01	1.99e-01
GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE	78	7.51e-02	3.29e-01	0.2090	-6.70e-02	1.70e-01	7.63e-04	-8.56e-02	5.47e-02	3.07e-01	9.25e-03	9.91e-01	1.91e-01	4.04e-01
GOBP NEGATIVE REGULATION OF MITOTIC CELL CYCLE	241	1.87e-04	3.93e-03	0.2090	6.84e-02	-1.05e-02	-1.28e-01	-1.49e-01	-2.39e-02	6.73e-02	7.79e-01	6.14e-04	7.06e-05	5.22e-01
GOBP NEGATIVE REGULATION OF CHOLESTEROL EFFLUX	22	7.07e-01	8.97e-01	0.2090	-6.02e-02	-9.03e-02	1.61e-02	-1.70e-02	1.78e-01	6.25e-01	4.63e-01	8.96e-01	8.90e-01	1.49e-01
GOBP INTERLEUKIN 6 PRODUCTION	165	5.28e-04	9.30e-03	0.2090	-1.09e-01	1.72e-01	3.46e-02	6.13e-04	3.43e-02	1.54e-02	1.41e-04	4.43e-01	9.89e-01	4.47e-01
GOBP TETRAHYDROFOLATE METABOLIC PROCESS	15	8.91e-01	9.63e-01	0.2090	-6.58e-02	-2.42e-02	-8.08e-02	-1.29e-01	1.25e-01	6.59e-01	8.71e-01	5.88e-01	3.87e-01	4.00e-01
GOBP CORTICOSPINAL TRACT MORPHOGENESIS	8	9.64e-01	9.90e-01	0.2090	-2.33e-02	-1.24e-01	1.16e-01	9.23e-02	-7.55e-02	9.09e-01	5.42e-01	5.68e-01	6.51e-01	7.11e-01
GOBP GAS TRANSPORT	22	5.48e-01	8.27e-01	0.2090	-1.17e-01	-1.08e-02	-3.53e-02	1.63e-01	4.70e-02	3.43e-01	9.30e-01	7.74e-01	1.86e-01	7.03e-01
GOBP ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION	42	3.56e-01	7.01e-01	0.2090	-5.16e-02	-5.86e-03	-6.98e-02	-1.12e-01	-1.54e-01	5.63e-01	9.48e-01	4.34e-01	2.07e-01	8.51e-02
GOBP RENAL SYSTEM VASCULATURE DEVELOPMENT	32	6.28e-01	8.68e-01	0.2090	6.25e-02	6.37e-03	1.05e-01	1.70e-01	1.19e-02	5.41e-01	9.50e-01	3.06e-01	9.68e-02	9.07e-01
GOBP CELL KILLING	212	5.11e-05	1.38e-03	0.2090	-1.62e-01	-5.59e-02	1.18e-01	2.04e-02	6.92e-03	4.78e-05	1.61e-01	3.06e-03	6.09e-01	8.62e-01
GOMF TRNA METHYLTRANSFERASE ACTIVITY	29	7.23e-01	9.03e-01	0.2090	8.45e-02	-3.99e-02	-1.06e-01	-1.33e-01	7.83e-02	4.31e-01	7.10e-01	3.22e-01	2.16e-01	4.65e-01
GOMF PEPTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY	10	9.44e-01	9.82e-01	0.2090	-1.51e-01	-3.94e-02	-7.92e-02	-1.02e-01	-5.29e-02	4.09e-01	8.29e-01	6.64e-01	5.76e-01	7.72e-01
GOMF RNA STEM LOOP BINDING	14	9.17e-01	9.73e-01	0.2090	-2.44e-02	-5.31e-02	-1.24e-01	-1.53e-01	-3.95e-02	8.75e-01	7.31e-01	4.23e-01	3.21e-01	7.98e-01
GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION	39	3.38e-01	6.85e-01	0.2090	7.12e-02	1.28e-01	2.28e-02	-1.41e-01	-4.24e-02	4.42e-01	1.65e-01	8.05e-01	1.28e-01	6.47e-01
GOBP POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL	122	7.75e-03	7.31e-02	0.2090	6.43e-02	1.31e-01	1.15e-02	-1.46e-01	2.86e-02	2.20e-01	1.24e-02	8.27e-01	5.24e-03	5.86e-01
GOBP POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS	26	5.85e-01	8.45e-01	0.2090	1.16e-01	-4.35e-02	-1.52e-01	4.99e-02	-5.23e-02	3.05e-01	7.01e-01	1.81e-01	6.60e-01	6.44e-01
GOBP EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION	13	8.26e-01	9.44e-01	0.2090	-1.59e-01	-5.39e-03	-9.92e-02	1.25e-02	9.12e-02	3.21e-01	9.73e-01	5.36e-01	9.38e-01	5.69e-01
GOBP POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY	39	4.47e-01	7.70e-01	0.2090	1.33e-01	1.11e-01	5.57e-02	-5.06e-02	8.94e-02	1.51e-01	2.32e-01	5.47e-01	5.85e-01	3.34e-01
GOBP NEGATIVE REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION	86	1.08e-01	3.99e-01	0.2090	5.24e-03	8.42e-02	-9.72e-02	-1.62e-01	3.10e-02	9.33e-01	1.77e-01	1.19e-01	9.61e-03	6.19e-01
GOBP NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY	75	1.25e-01	4.35e-01	0.2090	8.24e-02	1.24e-01	8.14e-02	9.72e-02	-7.23e-02	2.17e-01	6.25e-02	2.23e-01	1.46e-01	2.79e-01
GOBP HISTAMINE SECRETION	12	9.12e-01	9.71e-01	0.2090	1.85e-02	-1.11e-02	-1.42e-01	-8.73e-03	-1.51e-01	9.12e-01	9.47e-01	3.93e-01	9.58e-01	3.66e-01
GOBP CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT	27	6.97e-01	8.94e-01	0.2090	-5.04e-02	-8.85e-02	-7.26e-02	-1.24e-01	1.12e-01	6.50e-01	4.26e-01	5.14e-01	2.65e-01	3.14e-01
GOBP POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS	25	6.97e-01	8.94e-01	0.2090	1.37e-01	1.05e-01	-4.28e-02	-1.09e-01	-2.30e-03	2.35e-01	3.64e-01	7.11e-01	3.45e-01	9.84e-01
GOBP HISTAMINE TRANSPORT	15	8.49e-01	9.49e-01	0.2090	1.29e-01	-8.37e-02	-8.58e-02	6.60e-02	-8.97e-02	3.85e-01	5.75e-01	5.65e-01	6.58e-01	5.48e-01
GOCC FILOPODIUM	103	6.60e-02	3.03e-01	0.2090	-5.89e-02	8.16e-02	1.19e-01	1.38e-01	-1.23e-02	3.02e-01	1.52e-01	3.69e-02	1.55e-02	8.30e-01
GOMF GATED CHANNEL ACTIVITY	308	1.35e-05	4.37e-04	0.2090	-9.62e-02	6.55e-02	1.23e-01	1.16e-01	-3.73e-02	3.68e-03	4.81e-02	2.17e-04	4.45e-04	2.61e-01
GOBP LEUKOCYTE CHEMOTAXIS	230	4.26e-05	1.18e-03	0.2080	-1.25e-01	1.44e-01	6.77e-02	4.33e-02	-2.32e-02	1.08e-03	1.62e-04	7.70e-02	2.58e-01	5.44e-01
GOBP GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS	25	7.77e-01	9.26e-01	0.2080	-3.66e-02	-3.62e-02	-1.53e-01	-1.23e-01	4.61e-02	7.51e-01	7.54e-01	1.85e-01	2.85e-01	6.90e-01
GOBP SOMITOGENESIS	64	1.90e-01	5.36e-01	0.2080	9.11e-02	6.09e-02	-2.56e-02	-1.60e-01	7.12e-02	2.07e-01	4.00e-01	7.23e-01	2.66e-02	3.25e-01
GOBP LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY	26	7.04e-01	8.97e-01	0.2080	1.29e-01	3.28e-02	-7.86e-02	-1.39e-01	-1.22e-02	2.53e-01	7.72e-01	4.88e-01	2.21e-01	9.14e-01
GOMF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY	97	6.44e-02	2.99e-01	0.2080	-6.73e-03	1.12e-01	1.11e-01	8.25e-02	-1.08e-01	9.09e-01	5.62e-02	5.96e-02	1.60e-01	6.54e-02
GOBP CALCIUM ION TRANSPORT INTO CYTOSOL	28	6.35e-01	8.72e-01	0.2080	-1.02e-01	-7.31e-02	1.55e-01	6.14e-02	-5.15e-03	3.51e-01	5.03e-01	1.57e-01	5.74e-01	9.62e-01
GOBP NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS	18	8.00e-01	9.33e-01	0.2080	-1.53e-01	-7.77e-02	1.72e-02	-2.25e-02	-1.15e-01	2.61e-01	5.68e-01	9.00e-01	8.69e-01	4.00e-01
GOMF PHOSPHORYLATION DEPENDENT PROTEIN BINDING	6	9.70e-01	9.91e-01	0.2080	-1.82e-02	1.53e-01	3.04e-02	1.28e-01	4.75e-02	9.39e-01	5.15e-01	8.97e-01	5.88e-01	8.40e-01
GOBP CERAMIDE CATABOLIC PROCESS	20	7.70e-01	9.24e-01	0.2080	7.89e-04	-1.69e-01	-3.32e-02	-9.13e-02	7.37e-02	9.95e-01	1.91e-01	7.97e-01	4.80e-01	5.69e-01
GOMF ESTRADIOL 17 BETA DEHYDROGENASE NAD P ACTIVITY	18	8.62e-01	9.54e-01	0.2080	-1.06e-01	8.62e-02	1.22e-01	9.88e-02	1.12e-02	4.36e-01	5.27e-01	3.72e-01	4.68e-01	9.34e-01
GOBP POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS	33	5.12e-01	8.08e-01	0.2080	-1.20e-01	7.32e-02	5.85e-03	-9.58e-02	1.20e-01	2.32e-01	4.67e-01	9.54e-01	3.41e-01	2.35e-01
GOMF POLY A BINDING	23	5.49e-01	8.28e-01	0.2080	3.27e-02	-1.30e-01	3.50e-02	-1.51e-01	3.79e-02	7.86e-01	2.81e-01	7.72e-01	2.11e-01	7.53e-01
GOBP CONVERGENT EXTENSION INVOLVED IN GASTRULATION	9	8.45e-01	9.49e-01	0.2080	3.06e-02	-6.05e-02	1.35e-01	-8.86e-02	-1.12e-01	8.74e-01	7.53e-01	4.84e-01	6.45e-01	5.59e-01
GOBP NEGATIVE REGULATION OF CELL SIZE	9	9.38e-01	9.80e-01	0.2080	1.48e-01	-1.67e-02	-4.45e-02	-5.41e-02	-1.27e-01	4.41e-01	9.31e-01	8.17e-01	7.79e-01	5.10e-01
GOBP POSITIVE REGULATION OF LEUKOCYTE MIGRATION	141	3.09e-03	3.76e-02	0.2080	-1.18e-01	1.54e-01	4.67e-02	5.42e-02	-1.64e-02	1.52e-02	1.56e-03	3.38e-01	2.67e-01	7.36e-01
GOBP CHROMATIN REMODELING	577	2.48e-11	2.39e-09	0.2080	8.19e-02	-7.94e-03	-6.93e-02	-1.58e-01	8.10e-02	7.69e-04	7.44e-01	4.43e-03	8.07e-11	8.78e-04
GOBP POSITIVE REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION	146	3.65e-03	4.26e-02	0.2080	8.51e-02	1.15e-01	-1.11e-02	-1.45e-01	4.08e-02	7.61e-02	1.69e-02	8.17e-01	2.51e-03	3.95e-01
GOMF ARP2 3 COMPLEX BINDING	14	8.59e-01	9.53e-01	0.2080	-3.09e-02	8.81e-02	-1.02e-01	-6.32e-02	1.41e-01	8.41e-01	5.68e-01	5.08e-01	6.82e-01	3.60e-01
GOBP MUSCLE CELL CELLULAR HOMEOSTASIS	21	6.60e-01	8.80e-01	0.2080	1.38e-02	-8.82e-02	-3.65e-02	-1.62e-01	-8.68e-02	9.13e-01	4.84e-01	7.72e-01	1.99e-01	4.91e-01
GOMF RECEPTOR TYROSINE KINASE BINDING	78	8.98e-02	3.62e-01	0.2080	5.15e-02	1.91e-01	5.87e-02	-6.83e-03	-2.17e-02	4.32e-01	3.55e-03	3.70e-01	9.17e-01	7.40e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH2 GROUP OF DONORS OXYGEN AS ACCEPTOR	14	8.06e-01	9.36e-01	0.2080	-1.36e-01	-3.53e-02	-1.48e-01	3.84e-02	2.00e-03	3.78e-01	8.19e-01	3.39e-01	8.04e-01	9.90e-01
GOBP POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION	62	1.15e-01	4.15e-01	0.2080	-5.32e-02	2.37e-02	5.62e-02	-1.55e-01	1.11e-01	4.68e-01	7.47e-01	4.44e-01	3.43e-02	1.30e-01
GOBP REGULATION OF COLLAGEN METABOLIC PROCESS	41	3.80e-01	7.18e-01	0.2070	1.17e-01	1.25e-01	6.62e-02	-8.24e-02	5.01e-02	1.93e-01	1.67e-01	4.63e-01	3.61e-01	5.79e-01
GOBP NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS	1430	1.22e-29	5.22e-27	0.2070	4.86e-02	4.29e-02	-4.94e-02	-1.74e-01	7.85e-02	2.06e-03	6.62e-03	1.74e-03	2.96e-28	6.57e-07
GOCC ADHERENS JUNCTION	179	5.23e-03	5.52e-02	0.2070	-3.51e-02	-9.22e-04	1.44e-01	1.44e-01	-2.01e-02	4.18e-01	9.83e-01	9.13e-04	8.86e-04	6.42e-01
GOBP PROTEIN LIPID COMPLEX ASSEMBLY	30	5.66e-01	8.36e-01	0.2070	1.74e-01	8.13e-02	-5.04e-02	-1.78e-02	-5.69e-02	9.88e-02	4.41e-01	6.33e-01	8.66e-01	5.90e-01
GOBP REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY	21	4.86e-01	7.95e-01	0.2070	-2.10e-02	-9.58e-02	7.84e-02	-1.62e-01	-3.28e-02	8.68e-01	4.47e-01	5.34e-01	1.99e-01	7.95e-01
GOMF SODIUM ION BINDING	8	9.49e-01	9.83e-01	0.2070	-9.91e-02	-1.22e-01	-1.26e-01	4.26e-02	2.81e-02	6.27e-01	5.52e-01	5.38e-01	8.35e-01	8.90e-01
GOBP RESPONSE TO PLATELET DERIVED GROWTH FACTOR	21	7.72e-01	9.25e-01	0.2070	5.48e-02	1.63e-01	6.73e-02	3.88e-02	8.65e-02	6.64e-01	1.97e-01	5.94e-01	7.58e-01	4.93e-01
GOBP POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT	59	2.03e-01	5.53e-01	0.2070	7.34e-02	2.95e-02	2.43e-02	-1.37e-01	1.32e-01	3.29e-01	6.95e-01	7.47e-01	6.81e-02	8.06e-02
GOMF SIGNAL SEQUENCE BINDING	46	4.44e-01	7.67e-01	0.2070	8.87e-02	-1.36e-02	-1.09e-01	-1.51e-01	-1.28e-02	2.98e-01	8.73e-01	2.00e-01	7.61e-02	8.80e-01
GOBP NEGATIVE REGULATION OF MITOCHONDRIAL FUSION	7	9.61e-01	9.89e-01	0.2070	1.43e-02	1.70e-03	1.14e-01	-9.52e-02	1.44e-01	9.48e-01	9.94e-01	6.00e-01	6.63e-01	5.10e-01
GOBP PEPTIDE METABOLIC PROCESS	927	1.28e-17	2.11e-15	0.2070	-3.10e-02	-1.76e-02	-1.27e-01	-1.59e-01	-1.62e-02	1.10e-01	3.64e-01	5.87e-11	2.00e-16	4.04e-01
GOBP SOMITE DEVELOPMENT	82	1.30e-01	4.46e-01	0.2070	8.50e-02	4.24e-02	-6.93e-02	-1.60e-01	5.89e-02	1.83e-01	5.07e-01	2.78e-01	1.22e-02	3.56e-01
GOMF MYOSIN PHOSPHATASE ACTIVITY	71	1.06e-01	3.96e-01	0.2070	1.60e-01	1.16e-01	-7.51e-03	-5.41e-02	-3.11e-02	2.01e-02	9.01e-02	9.13e-01	4.31e-01	6.51e-01
GOBP T HELPER 17 TYPE IMMUNE RESPONSE	46	3.04e-01	6.57e-01	0.2070	3.02e-03	1.91e-01	-2.10e-02	-2.05e-02	-7.35e-02	9.72e-01	2.47e-02	8.05e-01	8.10e-01	3.88e-01
GOBP CYTOSKELETON DEPENDENT CYTOKINESIS	113	4.01e-02	2.20e-01	0.2070	3.44e-02	1.13e-02	-8.38e-02	-1.82e-01	4.02e-02	5.28e-01	8.35e-01	1.24e-01	8.55e-04	4.60e-01
GOBP DOPAMINE SECRETION	41	4.24e-01	7.51e-01	0.2070	-1.30e-01	1.28e-01	5.58e-02	7.08e-02	-4.02e-02	1.50e-01	1.58e-01	5.36e-01	4.32e-01	6.56e-01
GOCC PARANODE REGION OF AXON	12	9.42e-01	9.82e-01	0.2070	-7.19e-02	-4.92e-02	6.74e-02	1.55e-01	-8.23e-02	6.66e-01	7.68e-01	6.86e-01	3.53e-01	6.22e-01
GOMF SYMPORTER ACTIVITY	146	8.55e-03	7.86e-02	0.2070	-2.33e-02	8.98e-02	1.08e-01	8.24e-02	-1.26e-01	6.26e-01	6.09e-02	2.46e-02	8.58e-02	8.61e-03
GOCC RUFFLE MEMBRANE	99	2.93e-02	1.80e-01	0.2070	-6.78e-02	1.54e-01	-2.34e-02	-1.14e-01	-2.96e-02	2.44e-01	7.97e-03	6.88e-01	4.96e-02	6.10e-01
GOBP CENTRIOLE ASSEMBLY	47	3.80e-01	7.18e-01	0.2070	1.39e-01	1.62e-02	-7.47e-02	-1.33e-01	7.68e-05	9.96e-02	8.47e-01	3.76e-01	1.14e-01	9.99e-01
GOBP INTRACELLULAR PHOSPHATE ION HOMEOSTASIS	10	9.56e-01	9.87e-01	0.2070	7.57e-02	1.20e-01	1.08e-01	1.04e-01	-2.00e-02	6.78e-01	5.13e-01	5.54e-01	5.71e-01	9.13e-01
GOBP PROTEIN TARGETING TO VACUOLE	46	3.75e-01	7.15e-01	0.2070	-4.21e-03	8.07e-02	7.23e-03	-1.21e-01	1.47e-01	9.61e-01	3.44e-01	9.32e-01	1.55e-01	8.50e-02
GOBP METANEPHROS DEVELOPMENT	91	3.25e-02	1.93e-01	0.2070	9.04e-02	7.88e-03	6.00e-03	-1.72e-01	7.15e-02	1.36e-01	8.97e-01	9.21e-01	4.66e-03	2.39e-01
GOCC CLATHRIN COAT	47	3.23e-01	6.71e-01	0.2070	-4.91e-02	1.91e-01	4.58e-02	-3.54e-02	2.23e-02	5.60e-01	2.33e-02	5.87e-01	6.75e-01	7.92e-01
GOBP CELL COMMUNICATION BY ELECTRICAL COUPLING	34	5.32e-01	8.20e-01	0.2070	-8.89e-02	6.21e-02	1.36e-01	2.63e-02	-1.09e-01	3.70e-01	5.31e-01	1.71e-01	7.91e-01	2.70e-01
GOBP REGULATION OF VASCULOGENESIS	16	8.25e-01	9.44e-01	0.2070	3.24e-02	1.42e-01	1.25e-01	-2.18e-02	-7.47e-02	8.22e-01	3.27e-01	3.86e-01	8.80e-01	6.05e-01
GOBP REGULATION OF CYCLASE ACTIVITY	53	2.67e-01	6.23e-01	0.2070	-4.69e-02	9.48e-02	9.67e-02	3.05e-02	1.46e-01	5.55e-01	2.33e-01	2.23e-01	7.01e-01	6.60e-02
GOMF STEROID DEHYDROGENASE ACTIVITY	35	3.78e-01	7.17e-01	0.2070	-1.34e-01	9.85e-03	4.46e-03	1.56e-01	1.93e-02	1.70e-01	9.20e-01	9.64e-01	1.10e-01	8.43e-01
GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT TO PLASMA MEMBRANE	16	8.51e-01	9.50e-01	0.2070	6.87e-03	-3.50e-02	-9.65e-02	3.61e-02	-1.76e-01	9.62e-01	8.09e-01	5.04e-01	8.03e-01	2.24e-01
GOBP ERYTHROCYTE MATURATION	17	9.04e-01	9.68e-01	0.2070	1.95e-02	-5.52e-02	-1.34e-01	-1.39e-01	4.62e-02	8.89e-01	6.94e-01	3.38e-01	3.23e-01	7.42e-01
GOMF S ACYLTRANSFERASE ACTIVITY	27	5.92e-01	8.47e-01	0.2070	-1.01e-01	3.66e-02	5.17e-02	-1.35e-01	1.02e-01	3.65e-01	7.42e-01	6.42e-01	2.26e-01	3.57e-01
GOBP ACTIVATION OF PHOSPHOLIPASE C ACTIVITY	27	5.86e-01	8.45e-01	0.2070	-9.46e-03	2.59e-02	3.10e-02	2.02e-01	-2.18e-03	9.32e-01	8.15e-01	7.80e-01	6.86e-02	9.84e-01
GOBP LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE	34	4.87e-01	7.95e-01	0.2060	1.01e-01	4.72e-02	-3.08e-02	7.92e-02	-1.51e-01	3.07e-01	6.34e-01	7.56e-01	4.24e-01	1.27e-01
GOBP PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION	32	5.56e-01	8.31e-01	0.2060	1.00e-01	1.70e-01	4.84e-03	-5.95e-02	-1.33e-02	3.27e-01	9.64e-02	9.62e-01	5.61e-01	8.96e-01
GOMF DYNEIN LIGHT INTERMEDIATE CHAIN BINDING	28	7.00e-01	8.96e-01	0.2060	8.08e-02	9.86e-03	1.18e-01	1.36e-01	5.98e-02	4.59e-01	9.28e-01	2.80e-01	2.14e-01	5.84e-01
GOBP MYELOID DENDRITIC CELL ACTIVATION	29	5.95e-01	8.49e-01	0.2060	-8.47e-02	1.71e-01	6.93e-03	-2.92e-03	-7.74e-02	4.30e-01	1.11e-01	9.48e-01	9.78e-01	4.71e-01
GOBP CONVERGENT EXTENSION	15	7.20e-01	9.02e-01	0.2060	-3.75e-02	-5.61e-02	5.45e-02	-1.22e-01	-1.42e-01	8.01e-01	7.07e-01	7.15e-01	4.13e-01	3.42e-01
GOMF ALKALI METAL ION BINDING	19	6.81e-01	8.88e-01	0.2060	-1.30e-01	-8.29e-02	7.45e-02	-1.14e-01	1.92e-02	3.28e-01	5.32e-01	5.74e-01	3.91e-01	8.85e-01
GOBP HOMOLOGOUS RECOMBINATION	65	2.29e-01	5.82e-01	0.2060	1.00e-01	2.02e-02	-3.36e-02	-1.06e-01	1.40e-01	1.62e-01	7.79e-01	6.39e-01	1.38e-01	5.11e-02
GOBP REGULATION OF CELLULAR RESPONSE TO HYPOXIA	20	8.04e-01	9.35e-01	0.2060	-1.25e-01	-6.05e-02	-7.89e-02	-1.06e-01	7.57e-02	3.33e-01	6.39e-01	5.41e-01	4.12e-01	5.58e-01
GOBP REGULATION OF LONG CHAIN FATTY ACID IMPORT INTO CELL	8	9.46e-01	9.82e-01	0.2060	2.65e-02	6.95e-03	1.32e-02	-2.00e-01	3.96e-02	8.97e-01	9.73e-01	9.48e-01	3.27e-01	8.46e-01
GOBP CHEMOSENSORY BEHAVIOR	18	8.21e-01	9.42e-01	0.2060	1.73e-01	-6.04e-02	-4.24e-02	1.02e-02	8.30e-02	2.03e-01	6.58e-01	7.56e-01	9.40e-01	5.42e-01
GOMF NUCLEAR RETINOID X RECEPTOR BINDING	17	8.32e-01	9.45e-01	0.2060	-3.80e-02	1.59e-01	2.19e-02	7.86e-02	-9.45e-02	7.86e-01	2.55e-01	8.76e-01	5.75e-01	5.00e-01
GOBP REGULATION OF GLUCONEOGENESIS	51	3.50e-01	6.96e-01	0.2060	1.53e-01	5.18e-02	-5.97e-02	-7.19e-02	8.63e-02	5.81e-02	5.22e-01	4.61e-01	3.74e-01	2.86e-01
GOBP T CELL MIGRATION	67	1.36e-01	4.55e-01	0.2060	-1.99e-01	3.41e-02	1.20e-02	1.96e-02	-3.39e-02	4.90e-03	6.29e-01	8.66e-01	7.82e-01	6.31e-01
GOMF EXOGENOUS PROTEIN BINDING	78	5.09e-02	2.58e-01	0.2060	-1.59e-01	1.23e-01	-4.19e-02	-1.53e-02	2.64e-03	1.53e-02	6.04e-02	5.23e-01	8.16e-01	9.68e-01
GOBP VIRAL PROTEIN PROCESSING	31	5.60e-01	8.33e-01	0.2060	-1.01e-01	9.65e-02	1.20e-02	-1.37e-01	6.18e-02	3.28e-01	3.52e-01	9.08e-01	1.87e-01	5.52e-01
GOMF GLUCOSIDASE ACTIVITY	13	9.24e-01	9.75e-01	0.2060	-9.49e-02	-7.22e-02	1.27e-01	8.95e-02	-6.33e-02	5.54e-01	6.52e-01	4.28e-01	5.76e-01	6.93e-01
GOBP HEMATOPOIETIC STEM CELL PROLIFERATION	33	5.65e-01	8.35e-01	0.2060	4.86e-02	9.86e-02	-5.71e-02	-1.61e-01	-3.13e-02	6.29e-01	3.27e-01	5.70e-01	1.09e-01	7.56e-01
GOBP EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT	45	2.65e-01	6.20e-01	0.2060	1.53e-01	-1.19e-01	6.52e-02	1.73e-02	1.40e-02	7.59e-02	1.67e-01	4.49e-01	8.40e-01	8.71e-01
GOBP EMBRYONIC ORGAN MORPHOGENESIS	291	1.73e-06	7.20e-05	0.2060	1.03e-01	7.04e-02	2.82e-02	-1.24e-01	1.03e-01	2.57e-03	3.87e-02	4.07e-01	2.73e-04	2.54e-03
GOBP MITOTIC CELL CYCLE	898	1.21e-16	1.72e-14	0.2060	7.87e-02	3.40e-02	-1.01e-01	-1.53e-01	3.65e-02	6.30e-05	8.39e-02	3.18e-07	6.77e-15	6.34e-02
GOBP CYTOSOLIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY	138	1.11e-02	9.47e-02	0.2060	2.84e-02	9.55e-02	-8.78e-02	-1.13e-01	1.09e-01	5.64e-01	5.28e-02	7.49e-02	2.25e-02	2.66e-02
GOCC ATAC COMPLEX	13	9.15e-01	9.72e-01	0.2060	1.35e-01	8.28e-02	-2.79e-02	-4.61e-02	1.20e-01	4.00e-01	6.05e-01	8.62e-01	7.73e-01	4.56e-01
GOBP LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY	57	2.56e-01	6.13e-01	0.2050	-1.52e-02	1.81e-01	8.73e-02	1.38e-02	3.67e-02	8.43e-01	1.79e-02	2.54e-01	8.57e-01	6.32e-01
GOBP REGULATION OF MONOOXYGENASE ACTIVITY	42	4.77e-01	7.90e-01	0.2050	3.96e-02	7.41e-02	1.64e-01	5.36e-02	7.33e-02	6.57e-01	4.06e-01	6.58e-02	5.48e-01	4.11e-01
GOBP PLACENTA DEVELOPMENT	146	5.13e-03	5.46e-02	0.2050	1.55e-02	1.06e-01	-3.19e-02	-1.68e-01	3.78e-02	7.47e-01	2.65e-02	5.05e-01	4.60e-04	4.31e-01
GOCC DENDRITE CYTOPLASM	26	7.26e-01	9.05e-01	0.2050	7.48e-02	1.36e-01	1.15e-01	6.52e-02	-2.58e-02	5.09e-01	2.30e-01	3.11e-01	5.65e-01	8.20e-01
GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE BINDING	79	6.74e-02	3.06e-01	0.2050	-1.78e-02	1.85e-01	-3.76e-02	-2.56e-02	-7.55e-02	7.84e-01	4.56e-03	5.63e-01	6.94e-01	2.46e-01
GOBP BASIC AMINO ACID TRANSPORT	21	7.75e-01	9.26e-01	0.2050	-1.63e-01	4.94e-02	1.09e-01	5.71e-03	-3.68e-02	1.97e-01	6.95e-01	3.88e-01	9.64e-01	7.70e-01
GOCC STRIATED MUSCLE THIN FILAMENT	22	6.75e-01	8.85e-01	0.2050	-8.10e-02	1.33e-01	-8.92e-02	-5.26e-02	8.45e-02	5.11e-01	2.80e-01	4.69e-01	6.69e-01	4.92e-01
GOBP NEGATIVE REGULATION OF CELL CYCLE	391	6.27e-07	2.96e-05	0.2050	6.77e-02	-9.67e-03	-1.16e-01	-1.55e-01	9.97e-03	2.15e-02	7.43e-01	8.18e-05	1.54e-07	7.35e-01
GOBP POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION	14	8.96e-01	9.66e-01	0.2050	2.60e-02	-1.40e-01	2.90e-02	1.43e-01	-2.43e-02	8.66e-01	3.65e-01	8.51e-01	3.54e-01	8.75e-01
GOBP POSITIVE REGULATION OF INSULIN SECRETION	83	6.98e-02	3.14e-01	0.2050	1.01e-01	1.34e-01	1.71e-02	1.28e-02	1.17e-01	1.13e-01	3.52e-02	7.88e-01	8.40e-01	6.59e-02
GOCC ZYMOGEN GRANULE	14	7.99e-01	9.33e-01	0.2050	-1.74e-01	2.79e-02	-8.73e-02	5.54e-02	2.17e-02	2.61e-01	8.57e-01	5.72e-01	7.20e-01	8.88e-01
GOMF HISTONE MODIFYING ACTIVITY	188	1.10e-03	1.66e-02	0.2050	1.42e-01	2.54e-02	-3.28e-02	-1.10e-01	9.08e-02	8.19e-04	5.48e-01	4.37e-01	9.43e-03	3.18e-02
GOBP MITOCHONDRION DISTRIBUTION	16	8.32e-01	9.45e-01	0.2050	8.18e-02	1.21e-01	7.40e-03	3.56e-02	1.39e-01	5.71e-01	4.03e-01	9.59e-01	8.06e-01	3.35e-01
GOMF LIGASE ACTIVITY	159	4.42e-03	4.92e-02	0.2050	4.45e-02	8.30e-02	-9.18e-02	-1.54e-01	-3.29e-02	3.33e-01	7.09e-02	4.58e-02	8.31e-04	4.75e-01
GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY	31	6.13e-01	8.58e-01	0.2050	-1.05e-01	9.12e-02	1.18e-01	2.75e-02	8.89e-02	3.10e-01	3.79e-01	2.57e-01	7.91e-01	3.92e-01
GOBP GROWTH PLATE CARTILAGE DEVELOPMENT	20	7.81e-01	9.28e-01	0.2050	-1.28e-01	8.94e-02	-2.99e-02	-1.06e-01	7.44e-02	3.23e-01	4.89e-01	8.17e-01	4.12e-01	5.65e-01
GOBP APOPTOTIC CELL CLEARANCE	47	2.55e-01	6.12e-01	0.2050	-1.68e-01	-4.90e-02	-3.63e-02	5.04e-03	9.94e-02	4.60e-02	5.61e-01	6.66e-01	9.52e-01	2.38e-01
GOBP NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION	66	2.22e-01	5.76e-01	0.2050	1.55e-02	1.86e-02	-6.96e-02	-1.87e-01	3.83e-02	8.28e-01	7.94e-01	3.28e-01	8.57e-03	5.90e-01
GOBP ENDOCRINE SYSTEM DEVELOPMENT	137	4.90e-03	5.29e-02	0.2050	4.54e-02	1.12e-01	-2.04e-02	-1.64e-01	-4.00e-03	3.59e-01	2.31e-02	6.79e-01	9.43e-04	9.36e-01
GOBP CITRULLINE METABOLIC PROCESS	7	9.75e-01	9.92e-01	0.2050	1.22e-01	-3.79e-02	-1.49e-01	-1.08e-02	-5.70e-02	5.76e-01	8.62e-01	4.95e-01	9.61e-01	7.94e-01
GOBP REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN REGULATION OF CONTRACTION	7	9.65e-01	9.90e-01	0.2050	-2.94e-02	-1.45e-01	8.93e-02	-7.56e-03	1.10e-01	8.93e-01	5.08e-01	6.82e-01	9.72e-01	6.15e-01
GOBP DIENCEPHALON DEVELOPMENT	73	1.79e-01	5.20e-01	0.2050	-2.46e-02	6.64e-02	-7.10e-02	-1.70e-01	5.27e-02	7.17e-01	3.26e-01	2.94e-01	1.18e-02	4.36e-01
GOBP POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY	26	6.67e-01	8.82e-01	0.2050	-1.63e-01	2.81e-02	-9.44e-02	-7.42e-02	-7.44e-03	1.50e-01	8.04e-01	4.05e-01	5.13e-01	9.48e-01
GOBP EPIGENETIC REGULATION OF GENE EXPRESSION	210	1.20e-03	1.79e-02	0.2050	9.64e-02	-8.40e-03	-8.94e-02	-1.40e-01	7.03e-02	1.61e-02	8.34e-01	2.55e-02	4.75e-04	7.93e-02
GOBP MEMBRANE INVAGINATION	62	2.13e-01	5.67e-01	0.2050	-1.44e-01	4.76e-02	1.30e-01	2.69e-02	3.36e-02	4.91e-02	5.17e-01	7.70e-02	7.15e-01	6.47e-01
GOBP OUTER DYNEIN ARM ASSEMBLY	23	6.10e-01	8.58e-01	0.2050	-1.02e-01	1.61e-02	-3.78e-02	2.13e-02	1.71e-01	3.97e-01	8.94e-01	7.53e-01	8.59e-01	1.55e-01
GOBP DAMP METABOLIC PROCESS	7	9.67e-01	9.90e-01	0.2050	2.55e-02	1.29e-01	1.30e-01	-7.39e-02	4.71e-02	9.07e-01	5.56e-01	5.51e-01	7.35e-01	8.29e-01
GOBP NEGATIVE REGULATION OF PROTEIN UBIQUITINATION	69	1.60e-01	4.92e-01	0.2040	-5.37e-02	1.16e-01	-3.12e-02	-1.47e-01	5.35e-02	4.40e-01	9.62e-02	6.54e-01	3.44e-02	4.42e-01
GOBP POSITIVE REGULATION OF JNK CASCADE	83	1.38e-01	4.58e-01	0.2040	9.54e-03	1.12e-01	1.47e-01	7.14e-02	4.84e-02	8.81e-01	7.70e-02	2.06e-02	2.61e-01	4.46e-01
GOBP FLUID TRANSPORT	37	5.54e-01	8.30e-01	0.2040	-1.22e-03	5.79e-02	4.93e-02	1.49e-01	-1.17e-01	9.90e-01	5.42e-01	6.04e-01	1.16e-01	2.18e-01
GOBP SYNAPTIC VESICLE PRIMING	18	6.48e-01	8.77e-01	0.2040	-1.03e-01	7.12e-02	-1.46e-01	2.02e-02	6.47e-02	4.48e-01	6.01e-01	2.83e-01	8.82e-01	6.35e-01
GOBP PHASIC SMOOTH MUSCLE CONTRACTION	24	7.01e-01	8.96e-01	0.2040	1.59e-01	1.17e-01	4.48e-02	-2.44e-02	-9.05e-03	1.78e-01	3.20e-01	7.04e-01	8.36e-01	9.39e-01
GOBP REGULATION OF MACROAUTOPHAGY	150	1.19e-02	9.89e-02	0.2040	5.89e-02	1.65e-02	-6.71e-02	-1.55e-01	9.72e-02	2.13e-01	7.27e-01	1.56e-01	1.05e-03	4.00e-02
GOBP LEUKOCYTE MIGRATION	380	5.23e-08	3.19e-06	0.2040	-9.67e-02	1.50e-01	8.53e-02	4.95e-02	-6.37e-04	1.20e-03	4.82e-07	4.32e-03	9.74e-02	9.83e-01
GOCC RUFFLE	178	5.33e-04	9.32e-03	0.2040	-6.62e-02	1.79e-01	2.21e-03	-6.57e-02	-3.00e-02	1.28e-01	3.75e-05	9.59e-01	1.31e-01	4.90e-01
GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION	26	7.65e-01	9.22e-01	0.2040	-4.36e-02	-2.44e-02	7.31e-02	1.70e-01	-7.03e-02	7.00e-01	8.29e-01	5.19e-01	1.34e-01	5.35e-01
GOBP INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY	53	1.79e-01	5.20e-01	0.2040	-3.23e-04	5.36e-02	1.25e-03	-1.97e-01	-1.12e-02	9.97e-01	5.00e-01	9.87e-01	1.33e-02	8.88e-01
GOBP PROTEIN TRIMERIZATION	17	8.59e-01	9.53e-01	0.2040	-1.58e-01	6.01e-02	9.42e-02	5.81e-02	2.64e-02	2.58e-01	6.68e-01	5.01e-01	6.78e-01	8.50e-01
GOBP POSITIVE REGULATION OF RECEPTOR INTERNALIZATION	25	7.32e-01	9.08e-01	0.2040	-1.13e-01	-1.18e-01	8.55e-02	8.52e-02	-1.83e-02	3.29e-01	3.05e-01	4.59e-01	4.61e-01	8.74e-01
GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION	44	4.38e-01	7.60e-01	0.2040	-1.88e-02	-1.22e-01	1.05e-01	1.22e-01	2.29e-02	8.30e-01	1.60e-01	2.28e-01	1.63e-01	7.93e-01
GOBP ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY	178	1.38e-03	2.00e-02	0.2040	-2.57e-02	1.44e-01	1.14e-01	8.26e-03	8.48e-02	5.54e-01	9.06e-04	8.86e-03	8.49e-01	5.11e-02
GOBP EMBRYONIC RETINA MORPHOGENESIS IN CAMERA TYPE EYE	6	9.85e-01	9.95e-01	0.2040	1.23e-01	8.94e-02	1.05e-01	6.53e-02	5.66e-02	6.02e-01	7.05e-01	6.56e-01	7.82e-01	8.10e-01
GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II	1191	5.13e-26	1.75e-23	0.2040	3.31e-02	5.18e-02	-2.31e-02	-1.77e-01	7.63e-02	5.41e-02	2.61e-03	1.79e-01	5.35e-25	9.14e-06
GOBP SPERM EGG RECOGNITION	51	1.94e-01	5.42e-01	0.2040	-5.91e-02	2.40e-03	1.94e-01	-7.59e-04	-2.07e-02	4.65e-01	9.76e-01	1.65e-02	9.93e-01	7.98e-01
GOBP NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY	50	3.60e-01	7.04e-01	0.2040	-1.26e-01	9.82e-02	1.20e-01	3.55e-02	1.71e-02	1.22e-01	2.30e-01	1.42e-01	6.64e-01	8.34e-01
GOBP SEGMENTATION	99	5.09e-02	2.58e-01	0.2040	9.46e-02	7.27e-02	-2.23e-03	-1.34e-01	9.73e-02	1.04e-01	2.11e-01	9.69e-01	2.16e-02	9.44e-02
GOBP METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT	25	6.46e-01	8.76e-01	0.2040	4.69e-02	-9.09e-02	-6.85e-03	-1.60e-01	7.44e-02	6.85e-01	4.32e-01	9.53e-01	1.67e-01	5.20e-01
GOBP REGULATION OF MICROTUBULE BINDING	7	9.73e-01	9.92e-01	0.2040	3.14e-02	-5.55e-02	4.32e-02	2.55e-03	1.89e-01	8.86e-01	7.99e-01	8.43e-01	9.91e-01	3.88e-01
GOCC FILOPODIUM TIP	18	8.24e-01	9.43e-01	0.2040	-1.85e-02	8.38e-02	6.68e-02	2.60e-02	-1.70e-01	8.92e-01	5.38e-01	6.24e-01	8.49e-01	2.11e-01
GOBP NUCLEOTIDE EXCISION REPAIR	81	1.32e-01	4.50e-01	0.2040	-6.70e-03	-3.16e-02	-7.45e-02	-1.81e-01	4.48e-02	9.17e-01	6.23e-01	2.46e-01	4.82e-03	4.86e-01
GOBP MAST CELL MEDIATED IMMUNITY	55	2.78e-01	6.32e-01	0.2040	1.12e-01	1.49e-01	6.52e-02	1.65e-03	4.72e-02	1.49e-01	5.54e-02	4.03e-01	9.83e-01	5.45e-01
GOBP ENDOCARDIAL CUSHION FORMATION	31	4.71e-01	7.86e-01	0.2040	1.47e-01	-3.99e-02	1.02e-01	-4.70e-02	7.44e-02	1.56e-01	7.01e-01	3.25e-01	6.50e-01	4.74e-01
GOMF 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE BINDING	9	9.65e-01	9.90e-01	0.2030	1.07e-01	4.20e-02	1.13e-01	1.07e-01	-6.41e-02	5.79e-01	8.27e-01	5.58e-01	5.79e-01	7.39e-01
GOBP VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION	14	8.78e-01	9.61e-01	0.2030	-2.10e-02	-3.43e-02	6.50e-02	7.80e-02	1.72e-01	8.92e-01	8.24e-01	6.74e-01	6.14e-01	2.66e-01
GOBP THYROID HORMONE METABOLIC PROCESS	28	5.26e-01	8.17e-01	0.2030	1.65e-01	-5.81e-02	5.32e-02	8.85e-03	-8.87e-02	1.31e-01	5.94e-01	6.26e-01	9.35e-01	4.17e-01
GOBP NEUROEPITHELIAL CELL DIFFERENTIATION	38	5.78e-01	8.42e-01	0.2030	1.03e-01	3.06e-02	-8.92e-02	-1.46e-01	1.92e-02	2.70e-01	7.44e-01	3.41e-01	1.19e-01	8.37e-01
GOBP NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING	14	9.07e-01	9.69e-01	0.2030	-9.89e-02	5.66e-02	1.87e-02	1.03e-01	-1.32e-01	5.22e-01	7.14e-01	9.04e-01	5.05e-01	3.92e-01
GOCC FLEMMING BODY	34	4.90e-01	7.98e-01	0.2030	-3.59e-02	4.25e-02	-3.04e-02	-1.91e-01	-2.56e-02	7.17e-01	6.68e-01	7.59e-01	5.33e-02	7.96e-01
GOBP NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION	14	8.07e-01	9.36e-01	0.2030	-5.10e-02	-1.37e-03	-1.22e-01	9.79e-03	1.54e-01	7.41e-01	9.93e-01	4.30e-01	9.49e-01	3.18e-01
GOBP REGULATION OF LEUKOCYTE CHEMOTAXIS	119	1.96e-02	1.39e-01	0.2030	-9.64e-02	1.42e-01	7.80e-02	7.63e-02	1.10e-03	6.92e-02	7.58e-03	1.42e-01	1.51e-01	9.83e-01
GOBP BRANCHED CHAIN AMINO ACID CATABOLIC PROCESS	20	7.65e-01	9.22e-01	0.2030	1.44e-01	2.06e-02	2.19e-02	1.08e-01	8.96e-02	2.67e-01	8.73e-01	8.66e-01	4.02e-01	4.88e-01
GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION	71	6.84e-02	3.10e-01	0.2030	-5.86e-02	-7.69e-02	-6.13e-02	1.59e-01	-5.22e-02	3.93e-01	2.63e-01	3.72e-01	2.02e-02	4.47e-01
GOBP NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS	35	4.92e-01	7.99e-01	0.2030	5.68e-02	4.67e-02	-3.63e-02	-1.85e-01	-1.62e-02	5.61e-01	6.32e-01	7.11e-01	5.81e-02	8.68e-01
GOBP OLFACTORY BEHAVIOR	10	9.50e-01	9.84e-01	0.2030	1.71e-02	-6.70e-02	-4.12e-02	-1.69e-01	7.80e-02	9.25e-01	7.14e-01	8.21e-01	3.54e-01	6.69e-01
GOBP REGULATION OF GLYCOLYTIC PROCESS	50	3.29e-01	6.77e-01	0.2030	-7.31e-02	1.16e-01	-2.55e-02	-1.34e-01	6.18e-02	3.71e-01	1.57e-01	7.55e-01	1.01e-01	4.49e-01
GOMF METAL CLUSTER BINDING	66	2.14e-01	5.67e-01	0.2030	4.52e-02	1.21e-01	-1.10e-01	-1.09e-01	2.57e-02	5.26e-01	9.03e-02	1.21e-01	1.27e-01	7.19e-01
GOBP STEM CELL DIVISION	30	5.58e-01	8.32e-01	0.2030	-6.50e-02	1.26e-01	2.12e-02	-1.43e-01	-1.76e-02	5.38e-01	2.34e-01	8.41e-01	1.75e-01	8.68e-01
GOBP ASSOCIATIVE LEARNING	84	1.92e-02	1.37e-01	0.2030	-9.98e-02	-3.05e-02	1.09e-01	-5.14e-02	-1.25e-01	1.14e-01	6.29e-01	8.29e-02	4.15e-01	4.72e-02
GOBP POSITIVE REGULATION OF TYPE II INTERFERON PRODUCTION	74	1.50e-01	4.76e-01	0.2030	1.14e-02	-1.59e-02	1.12e-01	1.22e-01	1.16e-01	8.65e-01	8.13e-01	9.70e-02	7.05e-02	8.38e-02
GOBP NEGATIVE REGULATION OF B CELL ACTIVATION	30	5.53e-01	8.30e-01	0.2030	-7.74e-02	1.11e-01	-4.60e-02	6.61e-02	-1.28e-01	4.63e-01	2.92e-01	6.63e-01	5.31e-01	2.27e-01
GOBP REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION	262	2.98e-05	8.70e-04	0.2030	6.70e-02	9.26e-02	-4.07e-02	-1.59e-01	3.10e-02	6.18e-02	9.85e-03	2.57e-01	8.86e-06	3.88e-01
GOBP CONVERGENT EXTENSION INVOLVED IN ORGANOGENESIS	5	9.90e-01	9.96e-01	0.2030	6.20e-02	-1.43e-01	-1.04e-01	-5.00e-02	-5.95e-02	8.10e-01	5.81e-01	6.86e-01	8.46e-01	8.18e-01
GOBP GLUTAMATE SECRETION	28	6.81e-01	8.87e-01	0.2030	-4.21e-02	5.70e-02	9.21e-02	1.58e-01	5.06e-02	6.99e-01	6.02e-01	3.99e-01	1.48e-01	6.43e-01
GOBP PYRIMIDINE NUCLEOBASE METABOLIC PROCESS	20	8.09e-01	9.37e-01	0.2020	-1.21e-01	-1.16e-01	-1.09e-01	-2.34e-02	-2.08e-02	3.49e-01	3.68e-01	3.98e-01	8.56e-01	8.72e-01
GOBP REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY	68	1.32e-01	4.50e-01	0.2020	5.14e-02	4.69e-02	-5.21e-02	-1.74e-01	-5.58e-02	4.63e-01	5.04e-01	4.57e-01	1.30e-02	4.26e-01
GOMF POLY G BINDING	7	9.81e-01	9.93e-01	0.2020	-6.49e-02	7.88e-02	1.43e-01	5.08e-02	8.69e-02	7.66e-01	7.18e-01	5.12e-01	8.16e-01	6.91e-01
GOMF CARBOXY LYASE ACTIVITY	33	5.42e-01	8.24e-01	0.2020	8.14e-02	2.28e-02	-8.52e-02	-3.52e-02	-1.59e-01	4.18e-01	8.21e-01	3.97e-01	7.26e-01	1.14e-01
GOCC ASTER	10	9.29e-01	9.77e-01	0.2020	8.57e-02	-7.88e-02	-5.03e-02	-1.46e-01	-5.98e-02	6.39e-01	6.66e-01	7.83e-01	4.24e-01	7.43e-01
GOBP VACUOLAR TRANSPORT	163	5.61e-03	5.76e-02	0.2020	6.84e-02	3.84e-02	-3.55e-02	-1.40e-01	1.18e-01	1.32e-01	3.97e-01	4.34e-01	2.04e-03	9.36e-03
GOBP NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION	75	1.21e-01	4.26e-01	0.2020	-9.61e-02	1.53e-01	7.45e-02	3.77e-02	3.61e-02	1.50e-01	2.19e-02	2.65e-01	5.73e-01	5.89e-01
GOBP NEGATIVE REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY	9	9.65e-01	9.90e-01	0.2020	-1.18e-01	4.29e-02	1.53e-01	4.18e-02	7.95e-04	5.41e-01	8.24e-01	4.26e-01	8.28e-01	9.97e-01
GOMF TRANSCRIPTION COREPRESSOR BINDING	45	2.73e-01	6.28e-01	0.2020	5.12e-02	-3.76e-02	-3.81e-02	-1.80e-01	-5.51e-02	5.52e-01	6.63e-01	6.58e-01	3.68e-02	5.23e-01
GOBP PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING	14	8.18e-01	9.41e-01	0.2020	5.74e-02	-1.00e-02	-1.24e-01	1.21e-01	-8.63e-02	7.10e-01	9.48e-01	4.22e-01	4.32e-01	5.76e-01
GOBP EXTRACELLULAR VESICLE BIOGENESIS	25	7.46e-01	9.14e-01	0.2020	-9.65e-02	8.20e-03	-1.16e-01	-1.14e-01	7.04e-02	4.04e-01	9.43e-01	3.14e-01	3.24e-01	5.42e-01
GOBP ROOF OF MOUTH DEVELOPMENT	90	4.63e-02	2.41e-01	0.2020	8.48e-02	4.08e-02	-3.86e-03	-1.73e-01	4.46e-02	1.64e-01	5.04e-01	9.50e-01	4.53e-03	4.64e-01
GOBP DEOXYRIBONUCLEOSIDE METABOLIC PROCESS	11	9.44e-01	9.82e-01	0.2020	-2.96e-02	1.46e-01	5.85e-02	6.65e-02	-1.04e-01	8.65e-01	4.03e-01	7.37e-01	7.03e-01	5.49e-01
GOBP POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS	38	4.41e-01	7.63e-01	0.2020	8.40e-02	6.27e-02	-6.26e-02	-1.54e-02	1.60e-01	3.70e-01	5.03e-01	5.04e-01	8.69e-01	8.75e-02
GOBP RESPONSE TO NITRIC OXIDE	19	8.34e-01	9.45e-01	0.2020	-1.32e-01	-4.79e-02	-2.70e-02	5.91e-02	-1.30e-01	3.19e-01	7.18e-01	8.39e-01	6.56e-01	3.27e-01
GOBP RESPONSE TO FUNGICIDE	7	9.83e-01	9.94e-01	0.2020	2.89e-02	8.52e-02	1.60e-01	6.86e-02	4.98e-02	8.95e-01	6.96e-01	4.64e-01	7.53e-01	8.20e-01
GOBP REGULATION OF PROTEIN POLYUBIQUITINATION	26	6.59e-01	8.80e-01	0.2020	1.42e-01	6.35e-02	3.42e-02	-1.10e-01	5.71e-02	2.11e-01	5.75e-01	7.63e-01	3.31e-01	6.14e-01
GOMF SODIUM CHANNEL INHIBITOR ACTIVITY	8	8.81e-01	9.61e-01	0.2020	2.72e-02	-6.44e-02	1.23e-01	-1.13e-01	-9.02e-02	8.94e-01	7.52e-01	5.48e-01	5.81e-01	6.59e-01
GOBP FUCOSYLATION	17	8.33e-01	9.45e-01	0.2020	-1.14e-01	1.26e-01	-8.10e-03	-7.19e-02	8.08e-02	4.16e-01	3.67e-01	9.54e-01	6.08e-01	5.64e-01
GOBP MODULATION BY HOST OF VIRAL GENOME REPLICATION	23	8.41e-01	9.48e-01	0.2020	5.21e-02	-3.86e-02	-1.47e-01	-1.22e-01	-3.37e-05	6.65e-01	7.48e-01	2.23e-01	3.10e-01	1.00e+00
GOMF VOLTAGE GATED MONOATOMIC CATION CHANNEL ACTIVITY	150	1.29e-02	1.05e-01	0.2020	-9.50e-02	5.34e-02	8.83e-02	9.32e-02	-1.11e-01	4.46e-02	2.59e-01	6.20e-02	4.89e-02	1.88e-02
GOBP PROTEIN LOCALIZATION TO ORGANELLE	913	1.81e-16	2.51e-14	0.2020	1.01e-02	-2.44e-02	-1.01e-01	-1.71e-01	2.49e-02	6.05e-01	2.11e-01	2.13e-07	2.17e-18	2.03e-01
GOBP METANEPHRIC TUBULE MORPHOGENESIS	11	9.01e-01	9.68e-01	0.2020	-5.52e-02	7.66e-02	5.89e-02	-1.66e-01	2.92e-02	7.51e-01	6.60e-01	7.35e-01	3.42e-01	8.67e-01
GOCC PIGMENT GRANULE	109	1.58e-02	1.21e-01	0.2020	-8.04e-02	1.45e-01	-8.46e-02	-7.07e-02	3.18e-02	1.47e-01	8.96e-03	1.27e-01	2.02e-01	5.66e-01
GOBP RETINA MORPHOGENESIS IN CAMERA TYPE EYE	63	2.96e-01	6.50e-01	0.2020	5.88e-02	-6.22e-03	1.44e-01	1.27e-01	1.37e-02	4.19e-01	9.32e-01	4.80e-02	8.08e-02	8.50e-01
GOBP HEART TRABECULA MORPHOGENESIS	32	5.14e-01	8.09e-01	0.2010	9.87e-02	4.74e-02	7.10e-04	1.63e-01	-4.58e-02	3.34e-01	6.42e-01	9.94e-01	1.11e-01	6.54e-01
GOBP RAP PROTEIN SIGNAL TRANSDUCTION	12	8.72e-01	9.58e-01	0.2010	1.06e-01	9.91e-02	1.12e-01	-6.76e-02	-4.98e-02	5.25e-01	5.52e-01	5.03e-01	6.85e-01	7.65e-01
GOBP CHOLESTEROL STORAGE	25	7.71e-01	9.25e-01	0.2010	-1.78e-02	-8.26e-02	1.38e-01	1.17e-01	-2.51e-02	8.77e-01	4.75e-01	2.31e-01	3.12e-01	8.28e-01
GOCC POSTSYNAPTIC SPECIALIZATION MEMBRANE	117	3.65e-02	2.08e-01	0.2010	-4.16e-02	-4.24e-02	1.62e-01	9.55e-02	4.20e-02	4.37e-01	4.29e-01	2.52e-03	7.42e-02	4.33e-01
GOBP PROTEIN LOCALIZATION TO PRESYNAPSE	11	9.27e-01	9.76e-01	0.2010	1.54e-01	-6.84e-03	1.29e-02	1.28e-01	1.13e-02	3.76e-01	9.69e-01	9.41e-01	4.61e-01	9.48e-01
GOBP OOCYTE MATURATION	33	5.65e-01	8.35e-01	0.2010	1.03e-01	1.46e-01	2.19e-02	-8.77e-02	1.59e-02	3.04e-01	1.46e-01	8.28e-01	3.83e-01	8.74e-01
GOBP IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION	10	9.52e-01	9.85e-01	0.2010	9.30e-02	7.78e-02	-1.11e-01	-8.18e-02	-8.28e-02	6.10e-01	6.70e-01	5.44e-01	6.54e-01	6.50e-01
GOCC EXTRINSIC COMPONENT OF CYTOPLASMIC SIDE OF PLASMA MEMBRANE	69	1.52e-01	4.80e-01	0.2010	5.69e-03	1.78e-01	7.55e-02	-5.36e-02	1.71e-02	9.35e-01	1.07e-02	2.78e-01	4.41e-01	8.06e-01
GOBP REGULATION OF CYTOPLASMIC TRANSPORT	29	6.42e-01	8.75e-01	0.2010	-1.47e-01	-1.21e-01	-3.17e-02	-3.62e-02	-4.35e-02	1.71e-01	2.58e-01	7.68e-01	7.36e-01	6.85e-01
GOBP ORGANELLE FISSION	478	1.33e-08	9.26e-07	0.2010	7.18e-02	-2.38e-02	-6.50e-02	-1.42e-01	1.02e-01	7.17e-03	3.73e-01	1.49e-02	1.08e-07	1.38e-04
GOBP SODIUM ION TRANSPORT	235	3.80e-04	7.22e-03	0.2010	-3.90e-02	1.20e-01	1.17e-01	7.58e-02	-7.19e-02	3.03e-01	1.53e-03	2.09e-03	4.53e-02	5.75e-02
GOBP REGULATION OF ENDOTHELIAL CELL DEVELOPMENT	18	8.38e-01	9.46e-01	0.2010	6.88e-03	6.04e-02	8.06e-02	3.25e-02	1.71e-01	9.60e-01	6.57e-01	5.54e-01	8.12e-01	2.10e-01
GOBP CELL CHEMOTAXIS	304	4.78e-06	1.73e-04	0.2010	-1.21e-01	1.27e-01	8.44e-02	4.37e-02	-2.38e-02	2.92e-04	1.36e-04	1.14e-02	1.90e-01	4.75e-01
GOMF RNA POLYMERASE CORE ENZYME BINDING	41	4.99e-01	8.03e-01	0.2010	1.24e-01	-3.88e-02	-3.46e-02	-1.13e-01	9.83e-02	1.71e-01	6.67e-01	7.01e-01	2.12e-01	2.76e-01
GOMF SIGNALING ADAPTOR ACTIVITY	93	7.04e-02	3.15e-01	0.2010	2.76e-02	1.73e-01	9.62e-02	1.94e-03	1.57e-02	6.46e-01	3.85e-03	1.09e-01	9.74e-01	7.94e-01
GOBP POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS	44	4.36e-01	7.59e-01	0.2010	4.53e-02	6.21e-02	1.12e-01	9.72e-03	1.47e-01	6.03e-01	4.76e-01	1.97e-01	9.11e-01	9.13e-02
GOBP MITOCHONDRIAL DEPOLARIZATION	22	7.06e-01	8.97e-01	0.2010	-1.55e-01	4.51e-02	7.41e-02	-7.53e-02	-5.60e-02	2.09e-01	7.14e-01	5.47e-01	5.41e-01	6.49e-01
GOBP APOPTOTIC DNA FRAGMENTATION	19	7.13e-01	9.00e-01	0.2010	1.21e-01	-7.59e-02	1.57e-02	-1.39e-01	1.00e-02	3.60e-01	5.67e-01	9.05e-01	2.93e-01	9.40e-01
GOBP POSITIVE REGULATION OF RNA BINDING	6	9.83e-01	9.94e-01	0.2010	3.61e-02	-6.12e-02	-6.63e-02	2.52e-02	-1.74e-01	8.78e-01	7.95e-01	7.79e-01	9.15e-01	4.61e-01
GOBP MEIOSIS I CELL CYCLE PROCESS	132	1.28e-02	1.04e-01	0.2010	6.78e-02	-2.52e-03	1.98e-02	-8.86e-02	1.65e-01	1.78e-01	9.60e-01	6.95e-01	7.90e-02	1.03e-03
GOBP NUCLEAR TRANSPORT	312	2.28e-05	6.93e-04	0.2000	2.16e-02	9.27e-03	-9.54e-02	-1.73e-01	2.55e-02	5.12e-01	7.78e-01	3.75e-03	1.50e-07	4.39e-01
GOCC CATION CHANNEL COMPLEX	188	2.32e-03	3.03e-02	0.2000	-9.39e-02	5.35e-02	1.23e-01	6.50e-02	-9.58e-02	2.63e-02	2.06e-01	3.69e-03	1.25e-01	2.34e-02
GOMF CYTOKINE RECEPTOR BINDING	250	2.50e-04	5.06e-03	0.2000	-1.08e-01	7.54e-02	1.22e-01	8.79e-02	-1.32e-02	3.33e-03	4.00e-02	8.72e-04	1.67e-02	7.20e-01
GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION	22	7.94e-01	9.31e-01	0.2000	2.13e-02	-5.97e-02	5.39e-02	1.81e-01	-1.65e-02	8.63e-01	6.28e-01	6.62e-01	1.41e-01	8.94e-01
GOBP POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY	44	4.65e-01	7.81e-01	0.2000	8.09e-02	9.29e-02	1.38e-01	6.77e-02	-3.60e-02	3.53e-01	2.87e-01	1.13e-01	4.37e-01	6.79e-01
GOMF GROWTH FACTOR RECEPTOR BINDING	134	1.99e-02	1.40e-01	0.2000	-6.91e-02	1.31e-01	1.11e-01	7.59e-02	1.10e-02	1.67e-01	8.89e-03	2.70e-02	1.29e-01	8.26e-01
GOBP PROTEIN LOCALIZATION TO CELL CORTEX	11	8.55e-01	9.51e-01	0.2000	-6.68e-02	-3.48e-02	5.48e-02	-1.71e-01	-4.48e-02	7.01e-01	8.42e-01	7.53e-01	3.25e-01	7.97e-01
GOBP TRIGEMINAL NERVE DEVELOPMENT	10	9.45e-01	9.82e-01	0.2000	-4.79e-02	1.57e-01	6.44e-02	6.33e-02	7.10e-02	7.93e-01	3.91e-01	7.25e-01	7.29e-01	6.97e-01
GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE	31	5.86e-01	8.45e-01	0.2000	5.62e-02	-9.49e-03	-9.89e-02	3.54e-02	-1.60e-01	5.88e-01	9.27e-01	3.41e-01	7.33e-01	1.22e-01
GOMF DNA DIRECTED DNA POLYMERASE ACTIVITY	23	7.27e-01	9.05e-01	0.2000	1.62e-01	7.82e-03	-1.13e-01	8.02e-03	3.26e-02	1.80e-01	9.48e-01	3.49e-01	9.47e-01	7.87e-01
GOBP NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY	14	9.02e-01	9.68e-01	0.2000	-4.04e-02	-8.16e-02	-2.01e-02	-7.31e-02	1.61e-01	7.93e-01	5.97e-01	8.96e-01	6.36e-01	2.97e-01
GOBP NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA	19	7.74e-01	9.25e-01	0.2000	3.81e-02	1.10e-01	1.40e-01	-1.29e-02	-8.18e-02	7.74e-01	4.06e-01	2.92e-01	9.22e-01	5.37e-01
GOMF MONOATOMIC ANION MONOATOMIC CATION SYMPORTER ACTIVITY	24	7.02e-01	8.96e-01	0.2000	-1.12e-02	6.44e-03	3.52e-02	1.40e-02	-1.96e-01	9.24e-01	9.56e-01	7.65e-01	9.06e-01	9.69e-02
GOBP NEGATIVE REGULATION OF TRANSPORTER ACTIVITY	94	1.16e-01	4.15e-01	0.2000	-7.64e-02	-1.42e-02	1.47e-01	1.07e-01	2.90e-02	2.00e-01	8.12e-01	1.38e-02	7.29e-02	6.27e-01
GOBP PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM	68	1.19e-01	4.23e-01	0.2000	4.28e-02	5.45e-02	-2.60e-02	-1.82e-01	-3.52e-02	5.42e-01	4.37e-01	7.11e-01	9.36e-03	6.15e-01
GOMF NADP BINDING	50	2.64e-01	6.19e-01	0.2000	-8.17e-02	1.40e-01	-7.57e-02	-6.31e-02	6.36e-02	3.18e-01	8.78e-02	3.55e-01	4.40e-01	4.37e-01
GOBP UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS	49	4.12e-01	7.43e-01	0.2000	-7.82e-02	7.75e-03	-1.46e-01	-9.53e-02	-5.79e-02	3.44e-01	9.25e-01	7.74e-02	2.48e-01	4.83e-01
GOBP REGULATION OF MUSCLE HYPERTROPHY	69	1.12e-01	4.09e-01	0.2000	-1.32e-01	5.07e-02	1.34e-01	-4.26e-02	8.28e-03	5.73e-02	4.66e-01	5.48e-02	5.41e-01	9.05e-01
GOBP MITOTIC CELL CYCLE PHASE TRANSITION	450	6.02e-08	3.54e-06	0.2000	7.70e-02	3.56e-02	-1.04e-01	-1.48e-01	-4.23e-03	5.08e-03	1.95e-01	1.62e-04	7.51e-08	8.78e-01
GOBP POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION	24	7.07e-01	8.97e-01	0.2000	3.93e-02	-9.10e-02	8.22e-03	1.73e-01	-1.71e-04	7.39e-01	4.41e-01	9.44e-01	1.42e-01	9.99e-01
GOBP CHROMOSOME MOVEMENT TOWARDS SPINDLE POLE	7	9.73e-01	9.92e-01	0.2000	-1.24e-01	-9.68e-02	8.82e-02	1.82e-02	-8.35e-02	5.70e-01	6.58e-01	6.86e-01	9.33e-01	7.02e-01
GOCC GUANYL NUCLEOTIDE EXCHANGE FACTOR COMPLEX	17	8.31e-01	9.44e-01	0.1990	1.83e-01	-6.14e-03	5.55e-02	-2.41e-02	5.03e-02	1.91e-01	9.65e-01	6.92e-01	8.63e-01	7.19e-01
GOBP POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST	31	6.04e-01	8.55e-01	0.1990	-2.79e-02	1.74e-01	-4.54e-02	-8.06e-02	-5.14e-03	7.88e-01	9.28e-02	6.62e-01	4.37e-01	9.61e-01
GOBP MONOSACCHARIDE CATABOLIC PROCESS	49	4.01e-01	7.34e-01	0.1990	-4.67e-02	5.22e-03	-7.52e-02	-1.09e-01	1.42e-01	5.72e-01	9.50e-01	3.63e-01	1.87e-01	8.64e-02
GOBP OSTEOCLAST DIFFERENTIATION	103	9.71e-02	3.77e-01	0.1990	-2.16e-02	9.91e-02	1.45e-01	9.13e-02	-2.34e-03	7.05e-01	8.22e-02	1.09e-02	1.09e-01	9.67e-01
GOBP REGULATION OF NUCLEAR DIVISION	146	1.17e-02	9.79e-02	0.1990	1.36e-01	-4.75e-02	-7.91e-02	-1.09e-01	2.93e-02	4.51e-03	3.22e-01	9.88e-02	2.35e-02	5.41e-01
GOBP NEGATIVE REGULATION OF MACROAUTOPHAGY	31	6.94e-01	8.93e-01	0.1990	1.02e-01	-7.54e-02	-1.33e-01	-5.76e-02	5.05e-02	3.24e-01	4.67e-01	2.00e-01	5.79e-01	6.27e-01
GOBP ORGANIC ACID TRANSMEMBRANE TRANSPORT	146	1.49e-02	1.16e-01	0.1990	-3.32e-02	1.21e-01	1.44e-01	5.44e-02	-1.11e-02	4.88e-01	1.14e-02	2.64e-03	2.56e-01	8.16e-01
GOBP ACTIN FILAMENT BUNDLE ORGANIZATION	160	1.76e-03	2.44e-02	0.1990	-1.35e-01	1.20e-01	-2.51e-03	3.43e-02	-7.57e-02	3.17e-03	8.54e-03	9.56e-01	4.54e-01	9.85e-02
GOBP PARAXIAL MESODERM DEVELOPMENT	17	8.86e-01	9.62e-01	0.1990	1.11e-01	8.66e-02	-1.03e-01	-9.29e-02	2.32e-02	4.28e-01	5.36e-01	4.61e-01	5.07e-01	8.69e-01
GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION	33	5.99e-01	8.51e-01	0.1990	-1.18e-01	-1.18e-01	7.58e-02	7.33e-02	2.74e-02	2.42e-01	2.41e-01	4.51e-01	4.66e-01	7.86e-01
GOBP REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE	12	9.46e-01	9.82e-01	0.1990	1.33e-01	4.59e-02	-1.02e-01	-9.75e-02	1.02e-02	4.26e-01	7.83e-01	5.42e-01	5.59e-01	9.51e-01
GOBP CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION	89	6.28e-02	2.94e-01	0.1990	-9.74e-02	1.66e-01	2.14e-02	-3.34e-02	-3.09e-02	1.12e-01	6.72e-03	7.28e-01	5.86e-01	6.14e-01
GOBP CRANIAL NERVE MORPHOGENESIS	29	6.36e-01	8.72e-01	0.1990	1.01e-01	9.44e-02	1.42e-01	7.88e-03	1.48e-02	3.46e-01	3.79e-01	1.85e-01	9.41e-01	8.90e-01
GOBP HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE	32	5.29e-01	8.19e-01	0.1990	-6.84e-02	6.09e-02	-2.14e-02	-1.51e-01	-8.94e-02	5.03e-01	5.51e-01	8.34e-01	1.39e-01	3.81e-01
GOBP REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA	44	3.57e-01	7.02e-01	0.1990	4.07e-03	8.24e-02	-2.29e-02	-1.76e-01	-3.82e-02	9.63e-01	3.44e-01	7.93e-01	4.38e-02	6.61e-01
GOBP REGULATION OF CARBOHYDRATE CATABOLIC PROCESS	61	2.41e-01	5.98e-01	0.1990	-7.40e-02	1.17e-01	-3.90e-02	-1.33e-01	3.72e-02	3.18e-01	1.15e-01	5.98e-01	7.34e-02	6.15e-01
GOBP PROTEIN LOCALIZATION TO NUCLEUS	304	6.01e-05	1.57e-03	0.1990	2.64e-02	-5.03e-02	-1.04e-01	-1.53e-01	4.55e-02	4.29e-01	1.31e-01	1.88e-03	4.31e-06	1.72e-01
GOBP REGULATION OF BEHAVIOR	73	1.77e-01	5.18e-01	0.1990	2.68e-02	9.37e-02	1.58e-01	5.19e-02	-4.95e-02	6.92e-01	1.66e-01	1.98e-02	4.43e-01	4.65e-01
GOBP POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION	107	2.63e-02	1.67e-01	0.1990	4.56e-03	1.64e-01	9.33e-02	-6.20e-02	6.29e-03	9.35e-01	3.38e-03	9.54e-02	2.68e-01	9.11e-01
GOBP STRIATED MUSCLE CELL APOPTOTIC PROCESS	58	2.64e-01	6.19e-01	0.1990	6.15e-03	-1.93e-02	1.41e-03	-1.41e-01	1.38e-01	9.35e-01	8.00e-01	9.85e-01	6.31e-02	6.82e-02
GOBP GLYCOSAMINOGLYCAN CATABOLIC PROCESS	27	6.88e-01	8.90e-01	0.1990	-6.96e-02	1.06e-01	3.43e-02	3.17e-03	-1.49e-01	5.32e-01	3.41e-01	7.58e-01	9.77e-01	1.80e-01
GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION	20	8.02e-01	9.34e-01	0.1990	-8.54e-02	6.23e-02	1.63e-01	-3.45e-03	3.95e-02	5.09e-01	6.30e-01	2.06e-01	9.79e-01	7.60e-01
GOBP POSITIVE REGULATION OF GLYCOLYTIC PROCESS	22	7.84e-01	9.28e-01	0.1980	-1.08e-01	1.38e-01	8.63e-02	-4.02e-03	3.63e-02	3.80e-01	2.64e-01	4.83e-01	9.74e-01	7.68e-01
GOMF STAT FAMILY PROTEIN BINDING	11	9.39e-01	9.81e-01	0.1980	-6.52e-02	1.21e-01	6.68e-02	-4.55e-02	1.18e-01	7.08e-01	4.87e-01	7.01e-01	7.94e-01	4.99e-01
GOBP REGULATION OF CARDIOCYTE DIFFERENTIATION	32	5.61e-01	8.33e-01	0.1980	1.89e-02	1.78e-02	1.93e-01	2.49e-02	2.70e-02	8.53e-01	8.62e-01	5.87e-02	8.08e-01	7.91e-01
GOBP PURINE CONTAINING COMPOUND CATABOLIC PROCESS	57	3.40e-01	6.87e-01	0.1980	-1.43e-02	3.47e-02	-9.55e-02	-1.66e-01	-3.60e-02	8.52e-01	6.50e-01	2.12e-01	3.05e-02	6.38e-01
GOBP POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION	27	6.28e-01	8.68e-01	0.1980	-7.27e-02	8.58e-02	1.58e-01	-3.86e-02	3.57e-03	5.13e-01	4.41e-01	1.54e-01	7.28e-01	9.74e-01
GOBP POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE	118	3.19e-02	1.91e-01	0.1980	-6.46e-02	1.32e-01	1.08e-01	4.50e-02	6.22e-02	2.25e-01	1.31e-02	4.26e-02	3.99e-01	2.43e-01
GOBP POSITIVE REGULATION OF RNA METABOLIC PROCESS	1805	1.14e-35	6.13e-33	0.1980	3.95e-02	4.35e-02	-3.41e-02	-1.74e-01	6.67e-02	5.35e-03	2.15e-03	1.61e-02	1.60e-34	2.60e-06
GOBP REGULATION OF RNA BINDING	8	9.76e-01	9.93e-01	0.1980	1.14e-01	2.78e-03	-1.03e-01	-1.11e-01	-5.47e-02	5.75e-01	9.89e-01	6.13e-01	5.85e-01	7.89e-01
GOBP POSITIVE REGULATION OF CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION	11	9.01e-01	9.68e-01	0.1980	-6.73e-03	8.39e-02	-1.75e-01	-2.50e-02	3.13e-02	9.69e-01	6.30e-01	3.16e-01	8.86e-01	8.57e-01
GOMF ALCOHOL DEHYDROGENASE NADPPLUS ACTIVITY	23	6.60e-01	8.80e-01	0.1980	-7.18e-03	-5.60e-02	-9.69e-02	1.38e-01	-8.69e-02	9.52e-01	6.42e-01	4.21e-01	2.52e-01	4.70e-01
GOBP PROTEIN LOCALIZATION TO PHOTORECEPTOR OUTER SEGMENT	7	9.80e-01	9.93e-01	0.1980	1.08e-01	-6.12e-02	-1.14e-01	-3.86e-02	-9.68e-02	6.22e-01	7.79e-01	6.02e-01	8.60e-01	6.57e-01
GOCC SMOOTH ENDOPLASMIC RETICULUM	27	6.69e-01	8.83e-01	0.1980	-2.69e-02	1.25e-01	-4.81e-02	-2.24e-02	-1.41e-01	8.09e-01	2.61e-01	6.65e-01	8.41e-01	2.04e-01
GOBP SECRETORY GRANULE ORGANIZATION	63	1.78e-01	5.19e-01	0.1980	-8.86e-02	6.60e-02	-6.33e-03	-1.64e-01	1.07e-02	2.24e-01	3.65e-01	9.31e-01	2.47e-02	8.83e-01
GOBP REGULATION OF CALCIUM MEDIATED SIGNALING	81	1.81e-01	5.24e-01	0.1980	-6.33e-02	7.71e-02	1.21e-01	1.17e-01	3.09e-02	3.24e-01	2.30e-01	6.05e-02	6.89e-02	6.31e-01
GOMF NADP RETINOL DEHYDROGENASE ACTIVITY	13	8.99e-01	9.67e-01	0.1980	8.76e-02	1.70e-01	-4.85e-02	-5.37e-03	9.75e-03	5.84e-01	2.88e-01	7.62e-01	9.73e-01	9.51e-01
GOBP POSITIVE REGULATION OF T CELL PROLIFERATION	99	5.92e-02	2.84e-01	0.1980	-3.66e-03	1.39e-01	8.82e-02	7.65e-02	7.93e-02	9.50e-01	1.72e-02	1.30e-01	1.88e-01	1.73e-01
GOBP REGULATION OF BIOMINERAL TISSUE DEVELOPMENT	95	4.94e-02	2.52e-01	0.1980	-7.70e-02	5.91e-02	1.28e-01	-3.14e-02	1.10e-01	1.95e-01	3.20e-01	3.05e-02	5.96e-01	6.28e-02
GOCC TERMINAL BOUTON	43	5.28e-01	8.18e-01	0.1980	-7.10e-02	4.23e-02	1.30e-01	7.13e-02	-1.01e-01	4.20e-01	6.31e-01	1.40e-01	4.18e-01	2.50e-01
GOBP PERIPHERAL NERVOUS SYSTEM MYELIN MAINTENANCE	9	9.36e-01	9.80e-01	0.1980	-1.54e-01	-4.37e-02	-7.18e-02	3.02e-02	8.51e-02	4.22e-01	8.20e-01	7.09e-01	8.75e-01	6.58e-01
GOBP 2 OXOGLUTARATE METABOLIC PROCESS	15	8.92e-01	9.63e-01	0.1980	8.03e-02	1.46e-01	5.56e-02	5.83e-02	6.91e-02	5.90e-01	3.27e-01	7.09e-01	6.96e-01	6.43e-01
GOBP CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS	24	5.35e-01	8.21e-01	0.1980	2.52e-02	-1.64e-02	-8.24e-02	9.40e-02	1.50e-01	8.31e-01	8.90e-01	4.85e-01	4.25e-01	2.03e-01
GOMF METALLOENDOPEPTIDASE ACTIVITY	106	5.28e-02	2.64e-01	0.1970	2.44e-02	-1.18e-01	4.64e-02	1.39e-01	-5.39e-02	6.64e-01	3.54e-02	4.09e-01	1.34e-02	3.38e-01
GOBP PROTEIN ACETYLATION	97	5.40e-02	2.68e-01	0.1970	1.21e-01	6.10e-02	-7.90e-03	-1.37e-01	4.40e-02	3.99e-02	2.99e-01	8.93e-01	2.01e-02	4.54e-01
GOBP REGULATION OF CALCINEURIN MEDIATED SIGNALING	41	4.81e-01	7.92e-01	0.1970	-6.25e-02	5.12e-02	4.35e-03	1.26e-01	-1.29e-01	4.89e-01	5.70e-01	9.62e-01	1.63e-01	1.55e-01
GOBP REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION	341	7.65e-06	2.62e-04	0.1970	8.81e-02	5.96e-03	-9.50e-02	-1.48e-01	6.87e-03	5.18e-03	8.50e-01	2.56e-03	2.47e-06	8.27e-01
GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION	50	4.83e-01	7.93e-01	0.1970	-2.58e-02	-5.52e-02	-1.33e-01	-1.28e-01	-3.35e-02	7.52e-01	4.99e-01	1.05e-01	1.16e-01	6.82e-01
GOBP ENTRAINMENT OF CIRCADIAN CLOCK	30	4.59e-01	7.77e-01	0.1970	5.06e-02	8.46e-02	7.14e-02	-1.54e-01	-1.51e-02	6.31e-01	4.23e-01	4.98e-01	1.43e-01	8.86e-01
GOBP AMINOGLYCAN BIOSYNTHETIC PROCESS	73	1.22e-01	4.29e-01	0.1970	-1.19e-02	1.92e-01	-2.17e-02	-3.25e-02	-2.03e-02	8.60e-01	4.60e-03	7.49e-01	6.31e-01	7.64e-01
GOBP NEGATIVE REGULATION OF STEROID METABOLIC PROCESS	32	6.16e-01	8.60e-01	0.1970	-1.29e-01	7.58e-02	1.19e-01	8.30e-04	-4.84e-02	2.08e-01	4.58e-01	2.43e-01	9.94e-01	6.36e-01
GOMF FLAVIN ADENINE DINUCLEOTIDE BINDING	84	9.07e-02	3.63e-01	0.1970	9.54e-02	1.24e-01	-7.90e-02	-4.77e-02	7.71e-02	1.31e-01	4.99e-02	2.11e-01	4.50e-01	2.22e-01
GOBP MACROMOLECULE DEACYLATION	63	1.80e-01	5.22e-01	0.1970	8.32e-02	-7.15e-03	2.73e-02	-1.40e-01	1.08e-01	2.53e-01	9.22e-01	7.08e-01	5.50e-02	1.40e-01
GOBP RESPONSE TO EPINEPHRINE	14	8.85e-01	9.62e-01	0.1970	4.79e-02	-7.04e-02	1.68e-01	5.69e-02	1.15e-02	7.56e-01	6.48e-01	2.77e-01	7.12e-01	9.40e-01
GOBP CARDIAC MYOFIBRIL ASSEMBLY	19	8.45e-01	9.49e-01	0.1970	6.76e-02	5.59e-02	4.52e-02	9.84e-02	-1.39e-01	6.10e-01	6.73e-01	7.33e-01	4.58e-01	2.94e-01
GOBP GLYCOLIPID CATABOLIC PROCESS	16	7.56e-01	9.18e-01	0.1970	-6.68e-02	-1.25e-02	9.42e-02	-1.53e-01	4.29e-02	6.44e-01	9.31e-01	5.14e-01	2.89e-01	7.67e-01
GOMF TOXIC SUBSTANCE BINDING	10	8.65e-01	9.55e-01	0.1970	-9.27e-03	-1.06e-01	1.11e-01	-6.98e-02	-1.01e-01	9.60e-01	5.62e-01	5.42e-01	7.02e-01	5.79e-01
GOMF ADP BINDING	35	4.73e-01	7.86e-01	0.1970	-5.85e-02	1.59e-01	-4.23e-02	3.67e-02	-8.39e-02	5.49e-01	1.04e-01	6.65e-01	7.07e-01	3.90e-01
GOBP NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC	107	7.59e-02	3.31e-01	0.1970	9.96e-02	-9.41e-03	-5.93e-02	-1.26e-01	9.68e-02	7.51e-02	8.67e-01	2.89e-01	2.42e-02	8.37e-02
GOBP PIGMENT CELL DIFFERENTIATION	35	5.65e-01	8.35e-01	0.1970	-1.08e-01	6.92e-03	2.89e-02	1.55e-01	-4.91e-02	2.70e-01	9.44e-01	7.67e-01	1.14e-01	6.15e-01
GOMF DNA POLYMERASE ACTIVITY	29	7.47e-01	9.15e-01	0.1970	8.36e-02	-6.82e-02	-1.37e-01	-8.47e-02	-3.45e-02	4.36e-01	5.25e-01	2.02e-01	4.30e-01	7.48e-01
GOBP TETRAPYRROLE METABOLIC PROCESS	58	3.69e-01	7.09e-01	0.1970	8.77e-02	5.31e-02	-1.01e-01	-1.02e-01	8.78e-02	2.48e-01	4.84e-01	1.83e-01	1.81e-01	2.48e-01
GOCC CLATHRIN COATED PIT	73	1.52e-01	4.80e-01	0.1970	-7.89e-02	1.46e-01	1.03e-01	-2.12e-02	-1.60e-02	2.44e-01	3.15e-02	1.28e-01	7.54e-01	8.13e-01
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE	63	2.31e-01	5.85e-01	0.1970	-3.27e-04	5.81e-02	1.61e-02	-1.40e-01	1.24e-01	9.96e-01	4.25e-01	8.25e-01	5.43e-02	8.82e-02
GOBP PEPTIDYL TYROSINE DEPHOSPHORYLATION	30	7.42e-01	9.12e-01	0.1970	-3.84e-02	1.18e-01	1.20e-01	8.67e-02	-3.85e-02	7.16e-01	2.64e-01	2.56e-01	4.11e-01	7.15e-01
GOBP NEUROBLAST PROLIFERATION	80	4.81e-02	2.48e-01	0.1970	-7.68e-03	-4.08e-02	1.52e-01	-4.46e-02	1.10e-01	9.05e-01	5.28e-01	1.91e-02	4.91e-01	9.03e-02
GOBP TOLL LIKE RECEPTOR SIGNALING PATHWAY	67	1.89e-01	5.35e-01	0.1970	-1.77e-02	1.47e-01	1.01e-01	-5.05e-02	6.33e-02	8.02e-01	3.72e-02	1.54e-01	4.75e-01	3.70e-01
GOBP RESPONSE TO HEAT	99	8.33e-02	3.48e-01	0.1970	7.99e-02	-2.70e-02	-1.62e-01	-6.11e-02	3.91e-02	1.69e-01	6.42e-01	5.30e-03	2.94e-01	5.01e-01
GOBP ORNITHINE METABOLIC PROCESS	9	9.64e-01	9.90e-01	0.1970	-9.39e-02	-5.54e-02	-3.75e-02	-5.20e-03	-1.59e-01	6.26e-01	7.74e-01	8.46e-01	9.78e-01	4.08e-01
GOBP HOMOCYSTEINE METABOLIC PROCESS	13	9.42e-01	9.82e-01	0.1970	-5.16e-02	-8.82e-03	-1.09e-01	-1.23e-01	9.47e-02	7.47e-01	9.56e-01	4.98e-01	4.43e-01	5.54e-01
GOBP POSITIVE REGULATION OF T CELL MIGRATION	32	5.85e-01	8.45e-01	0.1960	-1.61e-01	5.24e-02	-2.26e-02	5.12e-02	-8.22e-02	1.15e-01	6.08e-01	8.25e-01	6.16e-01	4.21e-01
GOCC RECYCLING ENDOSOME	194	2.33e-04	4.76e-03	0.1960	-9.18e-02	5.41e-02	-1.46e-02	-1.05e-01	-1.26e-01	2.75e-02	1.94e-01	7.26e-01	1.13e-02	2.49e-03
GOBP CELLULAR RESPONSE TO INTERFERON BETA	26	5.61e-01	8.33e-01	0.1960	-4.36e-02	-8.35e-02	-5.88e-02	8.69e-02	1.37e-01	7.01e-01	4.61e-01	6.04e-01	4.43e-01	2.28e-01
GOBP ACTIVATION OF GTPASE ACTIVITY	91	7.22e-02	3.21e-01	0.1960	8.35e-02	8.23e-02	3.18e-02	7.24e-02	-1.36e-01	1.69e-01	1.75e-01	6.00e-01	2.33e-01	2.48e-02
GOMF MRNA METHYLTRANSFERASE ACTIVITY	12	9.41e-01	9.82e-01	0.1960	-3.69e-02	-3.24e-02	-9.58e-02	-1.42e-01	-8.16e-02	8.25e-01	8.46e-01	5.66e-01	3.93e-01	6.24e-01
GOBP FIBROBLAST APOPTOTIC PROCESS	25	7.25e-01	9.04e-01	0.1960	-2.67e-02	-4.32e-02	2.72e-02	-8.08e-02	1.69e-01	8.17e-01	7.08e-01	8.14e-01	4.84e-01	1.43e-01
GOCC INTERCELLULAR BRIDGE	90	1.35e-01	4.53e-01	0.1960	4.20e-02	4.80e-02	-1.45e-01	-1.10e-01	-3.67e-02	4.91e-01	4.31e-01	1.73e-02	7.22e-02	5.48e-01
GOCC ACTIN BASED CELL PROJECTION	217	1.20e-03	1.79e-02	0.1960	-7.52e-02	9.61e-02	9.04e-02	1.15e-01	-4.58e-02	5.63e-02	1.47e-02	2.17e-02	3.41e-03	2.45e-01
GOBP EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS	82	9.21e-02	3.67e-01	0.1960	-1.06e-01	1.34e-01	3.64e-02	-8.33e-02	2.98e-02	9.61e-02	3.56e-02	5.69e-01	1.92e-01	6.40e-01
GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION	26	6.69e-01	8.83e-01	0.1960	-6.00e-02	5.46e-02	-3.23e-02	-1.50e-01	-9.17e-02	5.96e-01	6.30e-01	7.76e-01	1.86e-01	4.19e-01
GOBP POSITIVE REGULATION OF TOR SIGNALING	65	3.14e-01	6.65e-01	0.1960	8.22e-02	3.21e-02	-8.29e-02	-1.50e-01	3.34e-02	2.52e-01	6.54e-01	2.48e-01	3.61e-02	6.41e-01
GOBP REGULATION OF CELL CYCLE	1068	3.86e-18	6.81e-16	0.1960	7.20e-02	1.21e-03	-9.01e-02	-1.54e-01	3.56e-02	6.95e-05	9.47e-01	6.53e-07	1.65e-17	4.92e-02
GOBP AMINOGLYCAN CATABOLIC PROCESS	33	6.57e-01	8.80e-01	0.1960	-3.40e-02	5.65e-02	7.09e-02	7.13e-02	-1.54e-01	7.35e-01	5.75e-01	4.81e-01	4.78e-01	1.25e-01
GOBP ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT	15	8.92e-01	9.63e-01	0.1960	2.71e-02	-1.72e-01	-2.87e-02	3.86e-02	-7.56e-02	8.56e-01	2.50e-01	8.47e-01	7.96e-01	6.12e-01
GOBP VERY LONG CHAIN FATTY ACID METABOLIC PROCESS	34	6.43e-01	8.75e-01	0.1950	-1.17e-01	-6.44e-02	-1.12e-01	-8.38e-02	-2.75e-02	2.37e-01	5.16e-01	2.59e-01	3.98e-01	7.82e-01
GOBP TERPENOID METABOLIC PROCESS	96	8.64e-02	3.55e-01	0.1950	-4.75e-03	-5.17e-03	2.83e-02	1.60e-01	-1.09e-01	9.36e-01	9.30e-01	6.32e-01	6.86e-03	6.61e-02
GOBP SMOOTHENED SIGNALING PATHWAY	140	9.28e-03	8.29e-02	0.1950	1.24e-02	-4.31e-02	-4.17e-02	-1.80e-01	4.55e-02	8.00e-01	3.79e-01	3.94e-01	2.43e-04	3.52e-01
GOBP T CELL DIFFERENTIATION IN THYMUS	84	7.67e-02	3.32e-01	0.1950	1.35e-01	6.07e-02	2.29e-02	-1.19e-01	4.11e-02	3.30e-02	3.36e-01	7.17e-01	6.03e-02	5.15e-01
GOBP RESPONSE TO HYDROPEROXIDE	18	8.60e-01	9.53e-01	0.1950	-1.33e-01	-2.59e-02	8.45e-02	9.00e-02	6.75e-02	3.30e-01	8.49e-01	5.35e-01	5.08e-01	6.20e-01
GOMF RNA NUCLEASE ACTIVITY	128	3.83e-02	2.14e-01	0.1950	-5.48e-03	-2.77e-02	-1.09e-01	-1.56e-01	-3.42e-02	9.15e-01	5.89e-01	3.29e-02	2.38e-03	5.04e-01
GOBP REGULATION OF CELL CYCLE PHASE TRANSITION	437	2.05e-07	1.12e-05	0.1950	8.48e-02	4.78e-03	-9.40e-02	-1.48e-01	5.08e-03	2.38e-03	8.64e-01	7.49e-04	1.07e-07	8.56e-01
GOBP REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY	13	8.93e-01	9.64e-01	0.1950	-1.42e-02	1.27e-01	4.17e-02	9.47e-02	1.05e-01	9.29e-01	4.27e-01	7.94e-01	5.54e-01	5.14e-01
GOBP REGULATION OF NUCLEOTIDE METABOLIC PROCESS	45	4.32e-01	7.56e-01	0.1950	1.13e-01	4.54e-02	-1.36e-01	-4.45e-02	5.23e-02	1.89e-01	5.98e-01	1.15e-01	6.06e-01	5.44e-01
GOMF NADPLUS PROTEIN ADP RIBOSYLTRANSFERASE ACTIVITY	28	6.88e-01	8.90e-01	0.1950	4.37e-02	-5.20e-03	-8.19e-02	-1.46e-01	-9.02e-02	6.89e-01	9.62e-01	4.53e-01	1.82e-01	4.09e-01
GOBP BONE MORPHOGENESIS	98	5.84e-02	2.82e-01	0.1950	-8.90e-02	4.41e-02	-5.37e-03	-1.26e-01	1.11e-01	1.28e-01	4.51e-01	9.27e-01	3.16e-02	5.74e-02
GOBP NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS	15	8.83e-01	9.61e-01	0.1950	-9.78e-02	1.53e-01	-4.98e-03	-5.57e-02	4.46e-02	5.12e-01	3.06e-01	9.73e-01	7.09e-01	7.65e-01
GOBP FOCAL ADHESION ASSEMBLY	83	1.85e-01	5.28e-01	0.1950	-2.20e-02	1.25e-01	1.26e-01	7.25e-02	-3.03e-02	7.29e-01	4.99e-02	4.77e-02	2.53e-01	6.33e-01
GOBP NEGATIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS	15	7.65e-01	9.22e-01	0.1950	8.68e-02	5.65e-02	-1.27e-01	8.02e-02	6.75e-02	5.61e-01	7.05e-01	3.93e-01	5.91e-01	6.51e-01
GOBP POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION	29	6.65e-01	8.82e-01	0.1950	1.11e-01	-9.59e-02	1.50e-02	1.04e-01	-7.34e-02	3.01e-01	3.72e-01	8.89e-01	3.33e-01	4.94e-01
GOBP TNFSF11 MEDIATED SIGNALING PATHWAY	5	9.91e-01	9.97e-01	0.1950	1.42e-01	5.95e-02	8.02e-02	8.79e-02	7.08e-03	5.82e-01	8.18e-01	7.56e-01	7.34e-01	9.78e-01
GOBP INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION	44	5.62e-01	8.34e-01	0.1950	-4.81e-02	-2.70e-02	1.27e-01	1.08e-01	-8.39e-02	5.81e-01	7.56e-01	1.44e-01	2.16e-01	3.36e-01
GOMF INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY	145	3.08e-02	1.86e-01	0.1950	-7.10e-02	3.72e-02	1.01e-01	1.37e-01	-4.92e-02	1.40e-01	4.39e-01	3.53e-02	4.38e-03	3.06e-01
GOMF TRANSCRIPTION COREPRESSOR ACTIVITY	177	5.94e-03	6.03e-02	0.1940	1.17e-01	5.25e-02	-5.81e-02	-1.13e-01	7.21e-02	7.36e-03	2.28e-01	1.82e-01	9.28e-03	9.79e-02
GOBP ASTROCYTE ACTIVATION	25	7.01e-01	8.96e-01	0.1940	-1.27e-01	-4.70e-02	4.09e-02	-7.14e-02	1.13e-01	2.72e-01	6.84e-01	7.23e-01	5.37e-01	3.29e-01
GOBP BONE REMODELING	89	1.02e-01	3.87e-01	0.1940	-2.59e-02	7.56e-02	1.63e-01	1.61e-02	6.73e-02	6.73e-01	2.18e-01	7.81e-03	7.92e-01	2.72e-01
GOBP RETROGRADE AXONAL TRANSPORT	21	6.49e-01	8.77e-01	0.1940	-4.69e-02	-6.08e-02	-1.21e-01	5.81e-02	1.17e-01	7.10e-01	6.29e-01	3.35e-01	6.45e-01	3.52e-01
GOBP GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS	34	6.10e-01	8.58e-01	0.1940	-8.42e-02	7.72e-02	1.91e-02	2.32e-02	-1.54e-01	3.95e-01	4.36e-01	8.47e-01	8.15e-01	1.19e-01
GOBP NEGATIVE REGULATION OF CATECHOLAMINE SECRETION	13	8.70e-01	9.57e-01	0.1940	1.33e-01	2.73e-02	2.15e-02	-6.64e-02	-1.20e-01	4.05e-01	8.65e-01	8.93e-01	6.78e-01	4.55e-01
GOMF RNA ENDONUCLEASE ACTIVITY	71	2.62e-01	6.19e-01	0.1940	2.30e-02	-6.64e-03	-1.06e-01	-1.58e-01	-3.08e-02	7.38e-01	9.23e-01	1.22e-01	2.14e-02	6.54e-01
GOBP PHOTOPERIODISM	28	4.59e-01	7.77e-01	0.1940	6.35e-02	-2.94e-02	4.54e-02	-1.75e-01	-4.52e-03	5.61e-01	7.88e-01	6.77e-01	1.08e-01	9.67e-01
GOBP ONCOGENE INDUCED CELL SENESCENCE	6	9.83e-01	9.94e-01	0.1940	-1.02e-01	7.89e-02	8.42e-02	-7.20e-02	9.34e-02	6.64e-01	7.38e-01	7.21e-01	7.60e-01	6.92e-01
GOCC CYTOPLASMIC STRESS GRANULE	83	1.14e-01	4.12e-01	0.1940	-1.09e-01	3.55e-02	-5.16e-02	-1.46e-01	-1.99e-02	8.49e-02	5.76e-01	4.16e-01	2.13e-02	7.54e-01
GOBP POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION	22	6.74e-01	8.85e-01	0.1940	-3.45e-02	-1.68e-01	8.31e-02	-2.09e-02	-2.98e-02	7.80e-01	1.72e-01	5.00e-01	8.65e-01	8.09e-01
GOBP AMYLOID BETA CLEARANCE	39	4.79e-01	7.91e-01	0.1940	-1.83e-01	-4.83e-02	7.28e-03	2.25e-02	3.52e-02	4.79e-02	6.02e-01	9.37e-01	8.08e-01	7.03e-01
GOBP POSTSYNAPTIC CYTOSKELETON ORGANIZATION	16	8.53e-01	9.51e-01	0.1940	-1.48e-01	-1.01e-01	5.21e-02	-3.61e-02	-3.87e-02	3.05e-01	4.86e-01	7.19e-01	8.02e-01	7.89e-01
GOBP RECEPTOR TRANSACTIVATION	5	9.90e-01	9.96e-01	0.1940	1.89e-01	3.96e-02	1.27e-02	1.39e-03	1.98e-03	4.63e-01	8.78e-01	9.61e-01	9.96e-01	9.94e-01
GOBP LEUKOCYTE DEGRANULATION	76	1.77e-01	5.19e-01	0.1940	1.07e-02	1.59e-01	8.96e-02	2.68e-02	5.82e-02	8.72e-01	1.64e-02	1.77e-01	6.86e-01	3.80e-01
GOCC MYOFILAMENT	26	6.57e-01	8.80e-01	0.1940	-2.14e-02	1.86e-01	-4.95e-02	-1.01e-02	-8.94e-03	8.50e-01	1.01e-01	6.62e-01	9.29e-01	9.37e-01
GOMF PEPTIDE N ACETYLTRANSFERASE ACTIVITY	46	4.63e-01	7.79e-01	0.1940	3.97e-02	7.22e-02	-1.94e-03	-1.39e-01	1.06e-01	6.41e-01	3.97e-01	9.82e-01	1.02e-01	2.12e-01
GOBP EPITHELIAL CELL MORPHOGENESIS	29	7.19e-01	9.02e-01	0.1940	-8.40e-02	-1.07e-01	1.05e-01	8.96e-02	-6.31e-03	4.34e-01	3.19e-01	3.29e-01	4.03e-01	9.53e-01
GOBP CELL CYCLE PHASE TRANSITION	549	2.98e-09	2.30e-07	0.1940	7.56e-02	2.94e-02	-9.74e-02	-1.46e-01	-4.99e-03	2.44e-03	2.39e-01	9.54e-05	4.47e-09	8.41e-01
GOBP SECRETION BY TISSUE	44	5.02e-01	8.03e-01	0.1940	-1.74e-02	1.59e-01	8.37e-02	6.87e-02	-1.02e-02	8.41e-01	6.77e-02	3.37e-01	4.30e-01	9.07e-01
GOMF 14 3 3 PROTEIN BINDING	32	5.93e-01	8.48e-01	0.1940	2.36e-02	7.33e-02	1.51e-01	-3.23e-02	8.82e-02	8.18e-01	4.73e-01	1.40e-01	7.52e-01	3.88e-01
GOBP RESPONSE TO ELECTRICAL STIMULUS	44	3.05e-01	6.58e-01	0.1930	-1.02e-01	5.07e-02	1.27e-01	-5.64e-02	-7.25e-02	2.44e-01	5.61e-01	1.45e-01	5.17e-01	4.05e-01
GOBP POSITIVE REGULATION OF VIRAL PROCESS	62	2.96e-01	6.50e-01	0.1930	-8.82e-03	1.25e-01	-7.54e-02	-1.23e-01	3.26e-02	9.04e-01	8.96e-02	3.05e-01	9.46e-02	6.57e-01
GOBP REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY	87	1.64e-01	4.98e-01	0.1930	3.07e-02	3.79e-02	-5.06e-02	-1.37e-01	1.17e-01	6.20e-01	5.41e-01	4.14e-01	2.76e-02	5.86e-02
GOBP EMBRYONIC ORGAN DEVELOPMENT	445	1.57e-08	1.07e-06	0.1930	7.84e-02	7.04e-02	9.79e-03	-1.28e-01	9.93e-02	4.60e-03	1.09e-02	7.23e-01	3.85e-06	3.27e-04
GOMF INTEGRIN BINDING	150	1.23e-02	1.02e-01	0.1930	-2.44e-02	1.03e-01	6.61e-02	1.37e-01	-5.46e-02	6.07e-01	2.91e-02	1.62e-01	3.78e-03	2.49e-01
GOBP POSITIVE REGULATION OF CILIUM ASSEMBLY	28	7.88e-01	9.30e-01	0.1930	1.04e-01	6.67e-03	-1.00e-01	-1.01e-01	7.94e-02	3.43e-01	9.51e-01	3.58e-01	3.55e-01	4.67e-01
GOMF SERINE HYDROLASE ACTIVITY	190	3.48e-03	4.11e-02	0.1930	-1.06e-01	4.64e-02	9.98e-02	5.94e-02	-1.02e-01	1.17e-02	2.70e-01	1.77e-02	1.58e-01	1.54e-02
GOBP MITOTIC INTRA S DNA DAMAGE CHECKPOINT SIGNALING	17	8.68e-01	9.56e-01	0.1930	1.37e-01	-8.86e-02	-4.63e-02	-9.20e-02	1.39e-02	3.30e-01	5.27e-01	7.41e-01	5.12e-01	9.21e-01
GOBP NEGATIVE REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE	15	8.84e-01	9.61e-01	0.1930	1.13e-01	8.78e-02	-8.12e-02	-4.39e-03	-1.00e-01	4.47e-01	5.56e-01	5.86e-01	9.76e-01	5.01e-01
GOBP REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE	48	2.50e-01	6.07e-01	0.1930	-5.36e-02	-1.64e-02	5.19e-02	-1.62e-01	7.23e-02	5.20e-01	8.44e-01	5.34e-01	5.24e-02	3.86e-01
GOBP PURINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS	10	9.18e-01	9.74e-01	0.1930	1.00e-02	1.12e-01	9.79e-02	-1.13e-01	-4.83e-02	9.56e-01	5.41e-01	5.92e-01	5.36e-01	7.91e-01
GOBP REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	35	4.44e-01	7.67e-01	0.1930	-1.03e-01	7.64e-02	-1.08e-02	2.12e-02	1.42e-01	2.92e-01	4.34e-01	9.12e-01	8.28e-01	1.45e-01
GOBP LUNG ALVEOLUS DEVELOPMENT	47	3.87e-01	7.24e-01	0.1930	3.10e-02	-1.50e-01	-1.33e-02	-7.59e-02	8.87e-02	7.13e-01	7.57e-02	8.75e-01	3.68e-01	2.93e-01
GOBP INTEGRIN ACTIVATION	26	5.83e-01	8.45e-01	0.1930	-9.85e-02	-4.75e-02	-5.43e-02	1.49e-01	-5.45e-03	3.85e-01	6.75e-01	6.32e-01	1.88e-01	9.62e-01
GOMF HISTONE METHYLTRANSFERASE ACTIVITY	67	1.32e-01	4.48e-01	0.1930	1.28e-01	-3.51e-02	4.82e-02	-1.02e-01	8.24e-02	6.93e-02	6.19e-01	4.95e-01	1.50e-01	2.43e-01
GOBP INSULIN RECEPTOR SIGNALING PATHWAY	123	2.20e-02	1.50e-01	0.1930	-1.71e-02	1.76e-01	2.52e-02	-6.81e-02	2.67e-02	7.43e-01	7.64e-04	6.29e-01	1.92e-01	6.09e-01
GOBP PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS	39	4.93e-01	7.99e-01	0.1930	-9.54e-02	1.39e-01	4.58e-02	-8.10e-02	-1.50e-03	3.02e-01	1.33e-01	6.21e-01	3.81e-01	9.87e-01
GOBP CARBOHYDRATE PHOSPHORYLATION	22	8.11e-01	9.38e-01	0.1930	1.12e-01	1.32e-01	6.76e-02	4.78e-02	-1.60e-02	3.61e-01	2.85e-01	5.83e-01	6.98e-01	8.96e-01
GOBP POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS	54	3.59e-01	7.04e-01	0.1930	7.47e-02	-5.38e-02	-4.89e-02	-1.54e-01	5.04e-02	3.42e-01	4.94e-01	5.34e-01	5.04e-02	5.21e-01
GOMF METAL CATION MONOATOMIC CATION ANTIPORTER ACTIVITY	39	4.87e-01	7.95e-01	0.1930	-4.27e-02	9.32e-02	1.61e-01	-9.08e-03	-2.49e-02	6.45e-01	3.14e-01	8.22e-02	9.22e-01	7.88e-01
GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION	61	2.29e-01	5.82e-01	0.1920	-1.09e-01	1.35e-02	7.48e-02	-2.65e-02	1.37e-01	1.40e-01	8.56e-01	3.12e-01	7.20e-01	6.51e-02
GOBP SMAD PROTEIN SIGNAL TRANSDUCTION	83	1.19e-01	4.23e-01	0.1920	-8.25e-02	1.46e-01	7.48e-02	-1.53e-02	-5.50e-02	1.94e-01	2.12e-02	2.39e-01	8.10e-01	3.87e-01
GOBP CELL CELL JUNCTION ASSEMBLY	152	1.87e-02	1.35e-01	0.1920	-3.48e-02	-6.39e-02	1.38e-01	1.13e-01	-2.08e-03	4.59e-01	1.74e-01	3.41e-03	1.60e-02	9.65e-01
GOCC SPINDLE	404	1.55e-06	6.53e-05	0.1920	6.68e-02	-4.30e-03	-8.79e-02	-1.56e-01	2.42e-02	2.12e-02	8.82e-01	2.43e-03	7.93e-08	4.04e-01
GOBP T CELL LINEAGE COMMITMENT	31	5.45e-01	8.26e-01	0.1920	-3.99e-02	1.24e-01	6.92e-02	-1.17e-01	-3.81e-02	7.01e-01	2.31e-01	5.05e-01	2.59e-01	7.13e-01
GOMF STEROL BINDING	61	2.84e-01	6.37e-01	0.1920	-1.14e-01	1.96e-02	-1.22e-02	7.68e-02	-1.33e-01	1.24e-01	7.92e-01	8.70e-01	3.00e-01	7.29e-02
GOCC GAP JUNCTION	29	7.50e-01	9.16e-01	0.1920	3.00e-02	8.67e-02	8.87e-02	9.76e-02	-1.06e-01	7.80e-01	4.19e-01	4.09e-01	3.63e-01	3.25e-01
GOCC CELL CORTEX REGION	38	6.27e-01	8.67e-01	0.1920	-2.58e-02	-6.54e-02	8.04e-02	1.60e-01	-5.03e-03	7.84e-01	4.85e-01	3.91e-01	8.84e-02	9.57e-01
GOBP PROTEIN LOCALIZATION TO GOLGI APPARATUS	29	6.81e-01	8.88e-01	0.1920	-1.41e-01	-7.69e-02	-4.11e-02	-7.39e-02	6.23e-02	1.87e-01	4.74e-01	7.02e-01	4.91e-01	5.61e-01
GOMF ACYLTRANSFERASE ACTIVITY TRANSFERRING GROUPS OTHER THAN AMINO ACYL GROUPS	203	8.47e-04	1.36e-02	0.1920	8.69e-02	1.41e-01	-3.38e-02	-9.12e-02	-1.05e-02	3.28e-02	5.47e-04	4.06e-01	2.51e-02	7.97e-01
GOMF CASPASE BINDING	13	8.72e-01	9.58e-01	0.1920	-1.33e-01	1.39e-03	9.51e-02	-1.01e-01	-4.37e-03	4.06e-01	9.93e-01	5.53e-01	5.29e-01	9.78e-01
GOMF STEROID BINDING	97	9.21e-02	3.67e-01	0.1920	-1.28e-01	-2.34e-02	3.32e-03	5.90e-02	-1.28e-01	2.96e-02	6.90e-01	9.55e-01	3.15e-01	2.87e-02
GOBP BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS	36	5.79e-01	8.43e-01	0.1920	-7.01e-02	1.62e-04	-1.45e-02	-1.49e-01	9.79e-02	4.67e-01	9.99e-01	8.80e-01	1.22e-01	3.09e-01
GOBP CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION	29	6.83e-01	8.88e-01	0.1920	3.11e-02	-5.12e-02	1.68e-01	6.84e-02	2.11e-02	7.72e-01	6.33e-01	1.18e-01	5.24e-01	8.44e-01
GOBP REGULATION OF PEPTIDYL CYSTEINE S NITROSYLATION	10	9.61e-01	9.89e-01	0.1920	-9.72e-02	-1.22e-01	1.40e-02	4.15e-02	-1.03e-01	5.94e-01	5.04e-01	9.39e-01	8.20e-01	5.74e-01
GOBP ARACHIDONIC ACID METABOLIC PROCESS	55	1.79e-01	5.20e-01	0.1920	6.15e-02	3.51e-02	4.89e-04	1.73e-01	4.45e-02	4.30e-01	6.53e-01	9.95e-01	2.68e-02	5.68e-01
GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS	47	3.89e-01	7.25e-01	0.1920	-1.67e-01	7.90e-02	-5.99e-03	-4.50e-02	-2.45e-02	4.76e-02	3.49e-01	9.43e-01	5.93e-01	7.71e-01
GOBP REGULATION OF CHOLESTEROL STORAGE	19	8.99e-01	9.67e-01	0.1920	-2.92e-02	-6.25e-02	1.06e-01	1.39e-01	-3.92e-02	8.26e-01	6.37e-01	4.24e-01	2.95e-01	7.68e-01
GOCC SPINDLE POLE	166	2.47e-03	3.17e-02	0.1920	8.56e-02	-3.13e-02	-4.66e-02	-1.62e-01	-6.68e-03	5.70e-02	4.87e-01	3.00e-01	3.17e-04	8.82e-01
GOBP FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS	43	4.89e-01	7.97e-01	0.1920	-5.08e-02	4.73e-02	-9.22e-03	-1.50e-01	9.70e-02	5.64e-01	5.91e-01	9.17e-01	8.94e-02	2.71e-01
GOMF UBIQUITIN BINDING	99	8.60e-02	3.55e-01	0.1920	6.50e-03	1.06e-01	-3.07e-02	-1.47e-01	5.29e-02	9.11e-01	6.87e-02	5.98e-01	1.12e-02	3.63e-01
GOBP ORGANELLE TRANSPORT ALONG MICROTUBULE	84	1.46e-01	4.67e-01	0.1920	3.94e-02	4.58e-03	-2.96e-02	-1.63e-01	8.85e-02	5.32e-01	9.42e-01	6.39e-01	1.00e-02	1.61e-01
GOBP REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE	35	5.68e-01	8.37e-01	0.1920	7.11e-03	-4.54e-03	-2.40e-02	7.71e-03	-1.90e-01	9.42e-01	9.63e-01	8.06e-01	9.37e-01	5.21e-02
GOBP NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT	42	4.83e-01	7.93e-01	0.1920	-1.07e-02	3.25e-02	-8.86e-02	-2.56e-02	-1.64e-01	9.05e-01	7.16e-01	3.21e-01	7.74e-01	6.53e-02
GOMF CYSTEINE TYPE ENDOPEPTIDASE REGULATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS	38	5.61e-01	8.33e-01	0.1910	-2.66e-03	1.03e-01	-3.87e-02	-7.76e-02	1.36e-01	9.77e-01	2.70e-01	6.80e-01	4.08e-01	1.47e-01
GOBP NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL	22	8.43e-01	9.48e-01	0.1910	1.36e-01	-5.82e-02	-8.91e-02	-5.62e-02	6.00e-02	2.69e-01	6.36e-01	4.70e-01	6.48e-01	6.26e-01
GOBP ORGANELLE MEMBRANE FUSION	118	3.45e-02	2.00e-01	0.1910	6.60e-02	1.38e-01	-4.47e-02	-1.04e-01	-2.17e-02	2.15e-01	9.75e-03	4.02e-01	5.10e-02	6.84e-01
GOMF BASAL TRANSCRIPTION MACHINERY BINDING	58	3.57e-01	7.02e-01	0.1910	1.22e-01	-5.95e-02	-4.49e-02	-6.72e-02	1.08e-01	1.08e-01	4.33e-01	5.54e-01	3.76e-01	1.56e-01
GOCC VESICLE COAT	61	3.22e-01	6.71e-01	0.1910	8.49e-02	1.21e-01	-6.37e-02	-1.00e-01	2.68e-02	2.51e-01	1.03e-01	3.89e-01	1.76e-01	7.18e-01
GOBP CERAMIDE BIOSYNTHETIC PROCESS	68	2.13e-01	5.66e-01	0.1910	1.56e-02	1.47e-01	-2.67e-02	-1.16e-01	-2.04e-02	8.24e-01	3.60e-02	7.03e-01	9.68e-02	7.71e-01
GOBP POSITIVE REGULATION OF RECEPTOR RECYCLING	14	7.96e-01	9.32e-01	0.1910	3.95e-02	-1.25e-01	9.57e-02	-4.51e-02	-9.00e-02	7.98e-01	4.17e-01	5.35e-01	7.70e-01	5.60e-01
GOBP POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS	19	8.73e-01	9.58e-01	0.1910	-7.50e-02	-1.36e-01	-9.18e-02	-5.95e-02	2.09e-02	5.71e-01	3.05e-01	4.89e-01	6.53e-01	8.74e-01
GOMF CHANNEL REGULATOR ACTIVITY	135	1.26e-02	1.03e-01	0.1910	-3.20e-02	1.60e-01	7.94e-02	-3.41e-02	-4.92e-02	5.21e-01	1.32e-03	1.11e-01	4.94e-01	3.24e-01
GOBP LEARNING	145	1.35e-03	1.97e-02	0.1910	-2.16e-02	-1.43e-02	1.15e-01	-7.46e-03	-1.50e-01	6.54e-01	7.66e-01	1.64e-02	8.77e-01	1.85e-03
GOBP MYOFIBROBLAST DIFFERENTIATION	14	9.05e-01	9.69e-01	0.1910	-6.81e-02	3.00e-02	2.02e-02	-3.20e-02	1.72e-01	6.59e-01	8.46e-01	8.96e-01	8.36e-01	2.66e-01
GOBP NCRNA TRANSCRIPTION	134	1.27e-02	1.04e-01	0.1910	2.68e-02	1.48e-02	-3.26e-02	-1.85e-01	1.95e-02	5.92e-01	7.68e-01	5.14e-01	2.25e-04	6.96e-01
GOBP SALIVARY GLAND DEVELOPMENT	33	5.98e-01	8.51e-01	0.1910	-4.84e-02	-9.21e-02	-7.10e-02	1.06e-01	-9.62e-02	6.30e-01	3.60e-01	4.80e-01	2.90e-01	3.39e-01
GOBP NEGATIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION	8	9.70e-01	9.91e-01	0.1910	-5.63e-02	3.07e-02	1.71e-01	2.02e-02	-5.28e-02	7.83e-01	8.81e-01	4.03e-01	9.21e-01	7.96e-01
GOMF NON MEMBRANE SPANNING PROTEIN TYROSINE KINASE ACTIVITY	43	4.72e-01	7.86e-01	0.1910	7.01e-02	9.84e-02	1.45e-01	4.10e-03	2.72e-02	4.26e-01	2.64e-01	9.96e-02	9.63e-01	7.57e-01
GOBP CELLULAR RESPONSE TO HEAT	62	4.21e-01	7.49e-01	0.1910	2.61e-02	-6.14e-02	-1.43e-01	-1.07e-01	7.87e-03	7.22e-01	4.03e-01	5.08e-02	1.47e-01	9.15e-01
GOBP MITOTIC NUCLEAR MEMBRANE DISASSEMBLY	7	9.67e-01	9.90e-01	0.1910	1.11e-01	8.16e-02	4.16e-02	-8.05e-02	-9.63e-02	6.12e-01	7.09e-01	8.49e-01	7.12e-01	6.59e-01
GOBP ATRIAL SEPTUM DEVELOPMENT	23	8.13e-01	9.39e-01	0.1910	2.33e-02	7.12e-02	-2.26e-02	-1.60e-01	6.78e-02	8.47e-01	5.55e-01	8.51e-01	1.83e-01	5.74e-01
GOBP NEGATIVE REGULATION OF ENDOCYTOSIS	75	1.76e-01	5.16e-01	0.1910	-8.52e-02	7.03e-02	-7.56e-02	-1.08e-01	-8.31e-02	2.02e-01	2.92e-01	2.58e-01	1.07e-01	2.14e-01
GOBP UREA METABOLIC PROCESS	12	9.35e-01	9.80e-01	0.1910	-5.76e-02	-9.86e-02	1.36e-01	5.29e-02	4.64e-02	7.30e-01	5.54e-01	4.16e-01	7.51e-01	7.81e-01
GOBP VESICLE DOCKING	64	2.23e-01	5.76e-01	0.1910	-1.08e-01	7.92e-02	-7.80e-04	-1.31e-01	3.72e-02	1.36e-01	2.73e-01	9.91e-01	7.04e-02	6.07e-01
GOBP MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL	29	6.84e-01	8.88e-01	0.1910	-1.27e-01	9.69e-02	4.78e-02	9.16e-02	-7.81e-03	2.35e-01	3.66e-01	6.56e-01	3.93e-01	9.42e-01
GOBP POSITIVE REGULATION OF VIRAL GENOME REPLICATION	30	6.97e-01	8.94e-01	0.1910	1.56e-01	-2.69e-02	-3.71e-02	-8.91e-02	4.51e-02	1.40e-01	7.99e-01	7.25e-01	3.99e-01	6.69e-01
GOBP ANIMAL ORGAN FORMATION	66	1.87e-01	5.31e-01	0.1910	2.62e-02	1.95e-02	-1.89e-02	-1.85e-01	2.36e-02	7.13e-01	7.85e-01	7.90e-01	9.22e-03	7.41e-01
GOBP NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS	54	4.58e-01	7.77e-01	0.1900	4.58e-02	5.42e-02	-6.59e-02	-1.50e-01	6.62e-02	5.61e-01	4.91e-01	4.02e-01	5.64e-02	4.00e-01
GOBP 3 UTR MEDIATED MRNA STABILIZATION	20	7.66e-01	9.23e-01	0.1900	-1.41e-01	-1.26e-02	5.64e-02	-1.11e-01	2.23e-02	2.73e-01	9.22e-01	6.63e-01	3.88e-01	8.63e-01
GOMF GTPASE ACTIVITY	305	6.94e-06	2.41e-04	0.1900	-4.54e-03	6.56e-02	-3.99e-02	-1.74e-01	-1.04e-02	8.92e-01	4.87e-02	2.31e-01	1.74e-07	7.56e-01
GOBP SUPEROXIDE METABOLIC PROCESS	65	2.27e-01	5.80e-01	0.1900	-5.97e-02	1.76e-01	3.44e-02	9.84e-03	-2.24e-02	4.06e-01	1.42e-02	6.31e-01	8.91e-01	7.54e-01
GOBP CARDIAC ATRIUM DEVELOPMENT	37	5.82e-01	8.43e-01	0.1900	-7.36e-03	6.57e-02	3.00e-02	-1.11e-01	1.37e-01	9.38e-01	4.89e-01	7.52e-01	2.43e-01	1.50e-01
GOBP ZINC ION TRANSPORT	28	5.43e-01	8.25e-01	0.1900	-8.61e-02	1.05e-02	4.82e-02	-1.61e-01	-1.73e-02	4.30e-01	9.23e-01	6.59e-01	1.39e-01	8.74e-01
GOBP REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION	155	1.09e-02	9.33e-02	0.1900	2.99e-02	1.13e-01	-5.50e-02	-1.40e-01	-1.17e-03	5.21e-01	1.49e-02	2.38e-01	2.72e-03	9.80e-01
GOBP REGULATION OF PROTEIN UBIQUITINATION	180	1.98e-03	2.67e-02	0.1900	1.89e-02	1.24e-01	6.07e-03	-1.40e-01	3.02e-02	6.62e-01	4.15e-03	8.88e-01	1.21e-03	4.84e-01
GOMF PROTEASOME BINDING	17	8.72e-01	9.58e-01	0.1900	-1.01e-01	-1.84e-03	-1.51e-01	-5.16e-02	-1.74e-02	4.70e-01	9.90e-01	2.79e-01	7.12e-01	9.01e-01
GOBP CELL ADHESION INVOLVED IN HEART MORPHOGENESIS	6	9.69e-01	9.91e-01	0.1900	4.96e-02	-2.89e-02	8.42e-02	-1.46e-01	6.63e-02	8.33e-01	9.03e-01	7.21e-01	5.35e-01	7.79e-01
GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS	18	8.57e-01	9.53e-01	0.1900	-2.25e-02	-3.43e-02	1.69e-01	5.75e-02	-5.20e-02	8.69e-01	8.01e-01	2.15e-01	6.73e-01	7.02e-01
GOMF PEPTIDE LYSINE N ACETYLTRANSFERASE ACTIVITY	42	5.39e-01	8.23e-01	0.1900	4.03e-02	6.95e-02	1.07e-02	-1.16e-01	1.27e-01	6.52e-01	4.36e-01	9.05e-01	1.92e-01	1.56e-01
GOCC CILIARY TIP	45	5.59e-01	8.32e-01	0.1900	9.77e-02	-5.77e-02	-1.28e-01	-6.38e-02	5.32e-02	2.57e-01	5.03e-01	1.38e-01	4.59e-01	5.37e-01
GOCC MEMBRANE MICRODOMAIN	279	1.17e-04	2.68e-03	0.1900	-6.70e-02	8.49e-02	1.40e-01	4.12e-02	5.65e-02	5.42e-02	1.47e-02	5.98e-05	2.37e-01	1.04e-01
GOBP MODULATION BY HOST OF VIRAL PROCESS	45	4.91e-01	7.98e-01	0.1900	1.17e-01	-1.02e-01	-5.64e-02	-8.33e-02	4.23e-02	1.73e-01	2.38e-01	5.13e-01	3.33e-01	6.23e-01
GOBP ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER	14	9.26e-01	9.76e-01	0.1900	-5.82e-02	-1.50e-02	-2.56e-02	-1.39e-01	1.12e-01	7.06e-01	9.23e-01	8.68e-01	3.69e-01	4.69e-01
GOBP ELECTRON TRANSPORT CHAIN	155	1.93e-02	1.38e-01	0.1900	7.88e-02	-5.45e-02	-8.02e-02	-1.36e-01	4.25e-02	9.03e-02	2.42e-01	8.50e-02	3.41e-03	3.61e-01
GOBP REGULATION OF ASTROCYTE DIFFERENTIATION	31	7.35e-01	9.09e-01	0.1900	-2.61e-02	-5.56e-02	-6.59e-02	-1.41e-01	8.90e-02	8.01e-01	5.92e-01	5.26e-01	1.74e-01	3.91e-01
GOBP REPLACEMENT OSSIFICATION	30	6.32e-01	8.70e-01	0.1900	-1.42e-01	9.10e-02	4.00e-02	5.42e-02	5.38e-02	1.77e-01	3.89e-01	7.04e-01	6.07e-01	6.10e-01
GOBP POSITIVE REGULATION OF LYMPHOCYTE MIGRATION	39	3.75e-01	7.15e-01	0.1900	-1.02e-01	8.87e-02	-3.62e-02	1.18e-01	-4.81e-02	2.70e-01	3.38e-01	6.95e-01	2.01e-01	6.03e-01
GOBP DIGESTIVE TRACT MORPHOGENESIS	48	2.84e-01	6.38e-01	0.1900	5.95e-02	-6.79e-02	3.73e-02	-1.39e-01	8.38e-02	4.76e-01	4.16e-01	6.55e-01	9.54e-02	3.15e-01
GOBP TRANSCYTOSIS	20	8.22e-01	9.42e-01	0.1900	-2.30e-02	1.59e-01	2.88e-02	-9.24e-02	-2.89e-02	8.59e-01	2.19e-01	8.23e-01	4.75e-01	8.23e-01
GOBP REGULATION OF MACROPHAGE APOPTOTIC PROCESS	11	9.48e-01	9.83e-01	0.1890	-1.53e-01	4.07e-02	-2.26e-02	-5.80e-02	-8.42e-02	3.81e-01	8.15e-01	8.97e-01	7.39e-01	6.29e-01
GOBP CELLULAR RESPONSE TO CALCIUM ION	83	1.15e-01	4.15e-01	0.1890	-8.56e-02	1.57e-01	1.95e-02	-4.87e-02	-3.57e-02	1.78e-01	1.36e-02	7.58e-01	4.43e-01	5.74e-01
GOBP POSITIVE REGULATION OF TRANSLATION	127	4.26e-02	2.29e-01	0.1890	2.87e-02	-2.81e-02	-9.06e-02	-1.60e-01	-1.98e-02	5.76e-01	5.84e-01	7.79e-02	1.82e-03	7.00e-01
GOBP MAMMARY GLAND DUCT MORPHOGENESIS	27	6.63e-01	8.81e-01	0.1890	9.63e-02	-8.16e-02	1.05e-01	5.78e-02	-7.53e-02	3.86e-01	4.63e-01	3.47e-01	6.03e-01	4.98e-01
GOBP CELLULAR RESPONSE TO ESTRADIOL STIMULUS	37	3.84e-01	7.22e-01	0.1890	4.28e-02	-5.37e-02	7.69e-02	-1.32e-01	8.89e-02	6.52e-01	5.72e-01	4.18e-01	1.66e-01	3.50e-01
GOBP SCHWANN CELL DEVELOPMENT	30	7.05e-01	8.97e-01	0.1890	-1.11e-01	-1.00e-01	-4.72e-02	-9.33e-03	-1.05e-01	2.91e-01	3.42e-01	6.54e-01	9.30e-01	3.19e-01
GOBP NEGATIVE REGULATION OF HORMONE SECRETION	65	1.74e-01	5.14e-01	0.1890	8.14e-02	1.27e-01	3.00e-02	-9.70e-02	-5.28e-02	2.57e-01	7.67e-02	6.76e-01	1.76e-01	4.62e-01
GOBP POSTSYNAPTIC DENSITY ASSEMBLY	21	8.30e-01	9.44e-01	0.1890	-2.02e-02	9.72e-02	7.58e-02	1.78e-03	1.42e-01	8.73e-01	4.41e-01	5.48e-01	9.89e-01	2.60e-01
GOCC SERINE TYPE PEPTIDASE COMPLEX	13	9.39e-01	9.81e-01	0.1890	-1.29e-01	-1.06e-01	1.48e-02	7.19e-02	-4.91e-02	4.19e-01	5.08e-01	9.26e-01	6.54e-01	7.59e-01
GOBP TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION	183	2.58e-03	3.28e-02	0.1890	-6.15e-02	1.43e-01	1.04e-01	-1.96e-02	1.68e-02	1.51e-01	8.36e-04	1.53e-02	6.47e-01	6.95e-01
GOBP AXONEMAL DYNEIN COMPLEX ASSEMBLY	39	5.53e-01	8.30e-01	0.1890	-4.93e-02	1.52e-02	-5.78e-02	-7.83e-02	1.54e-01	5.94e-01	8.69e-01	5.32e-01	3.97e-01	9.69e-02
GOMF ATPASE ACTIVATOR ACTIVITY	25	8.00e-01	9.33e-01	0.1890	-2.48e-02	9.80e-02	-6.50e-02	-1.46e-01	7.84e-03	8.30e-01	3.96e-01	5.74e-01	2.07e-01	9.46e-01
GOMF NEUROTRANSMITTER RECEPTOR REGULATOR ACTIVITY	13	8.81e-01	9.61e-01	0.1890	1.08e-03	9.92e-02	4.43e-02	-1.28e-01	-8.65e-02	9.95e-01	5.36e-01	7.82e-01	4.23e-01	5.89e-01
GOBP INTERLEUKIN 33 MEDIATED SIGNALING PATHWAY	7	9.80e-01	9.93e-01	0.1890	4.62e-02	7.53e-02	1.50e-01	3.12e-02	-6.68e-02	8.32e-01	7.30e-01	4.92e-01	8.86e-01	7.60e-01
GOBP POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION	158	9.19e-03	8.24e-02	0.1890	-3.80e-02	1.33e-01	9.16e-02	3.99e-02	8.06e-02	4.10e-01	3.81e-03	4.69e-02	3.87e-01	8.05e-02
GOBP REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS	72	1.70e-01	5.08e-01	0.1890	8.03e-03	1.57e-01	1.23e-03	-3.78e-02	-9.74e-02	9.06e-01	2.11e-02	9.86e-01	5.79e-01	1.53e-01
GOBP POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION	61	2.63e-01	6.19e-01	0.1890	1.26e-01	-4.80e-02	3.47e-02	8.80e-02	-9.27e-02	8.91e-02	5.16e-01	6.39e-01	2.35e-01	2.10e-01
GOBP POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS	85	3.80e-02	2.13e-01	0.1890	7.69e-03	1.25e-01	-2.64e-03	9.16e-02	1.08e-01	9.02e-01	4.69e-02	9.66e-01	1.44e-01	8.52e-02
GOBP CELL CYCLE	1732	3.72e-27	1.31e-24	0.1890	5.32e-02	1.73e-02	-7.91e-02	-1.55e-01	4.60e-02	2.32e-04	2.31e-01	4.45e-08	5.32e-27	1.46e-03
GOBP EMBRYONIC HEART TUBE MORPHOGENESIS	70	1.62e-01	4.96e-01	0.1890	5.67e-02	4.45e-02	9.22e-03	-1.67e-01	4.99e-02	4.12e-01	5.20e-01	8.94e-01	1.57e-02	4.71e-01
GOBP SNRNA TRANSCRIPTION BY RNA POLYMERASE III	8	9.49e-01	9.84e-01	0.1890	9.99e-02	-2.59e-02	1.57e-01	-1.36e-02	-6.35e-03	6.25e-01	8.99e-01	4.41e-01	9.47e-01	9.75e-01
GOMF UDP XYLOSYLTRANSFERASE ACTIVITY	11	9.20e-01	9.74e-01	0.1890	1.22e-01	8.16e-02	-2.73e-02	1.09e-01	3.89e-02	4.85e-01	6.39e-01	8.75e-01	5.32e-01	8.23e-01
GOBP NEPHRON MORPHOGENESIS	77	8.69e-02	3.56e-01	0.1890	4.44e-02	-6.82e-03	1.81e-02	-1.75e-01	5.13e-02	5.00e-01	9.18e-01	7.83e-01	7.96e-03	4.36e-01
GOBP PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL	106	9.18e-02	3.66e-01	0.1890	8.88e-02	5.27e-02	-9.99e-02	-1.18e-01	-3.28e-02	1.14e-01	3.48e-01	7.56e-02	3.64e-02	5.60e-01
GOBP REGULATION OF MYOBLAST PROLIFERATION	25	8.29e-01	9.44e-01	0.1890	2.31e-02	-8.47e-03	1.23e-01	1.28e-01	5.72e-02	8.42e-01	9.42e-01	2.86e-01	2.67e-01	6.20e-01
GOMF HEXOSAMINIDASE ACTIVITY	15	8.89e-01	9.63e-01	0.1890	3.48e-03	-1.43e-02	-2.93e-02	-4.31e-03	1.86e-01	9.81e-01	9.24e-01	8.44e-01	9.77e-01	2.13e-01
GOBP FACULTATIVE HETEROCHROMATIN FORMATION	40	5.69e-01	8.38e-01	0.1890	1.05e-01	-1.77e-02	-2.61e-02	-1.31e-01	7.99e-02	2.49e-01	8.46e-01	7.75e-01	1.53e-01	3.82e-01
GOBP PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION	23	7.71e-01	9.25e-01	0.1890	-1.35e-01	7.02e-03	-2.04e-02	-1.13e-01	-6.32e-02	2.61e-01	9.54e-01	8.65e-01	3.49e-01	6.00e-01
GOCC NUCLEAR PERIPHERY	142	2.05e-02	1.43e-01	0.1880	5.08e-02	1.62e-02	-3.29e-02	-1.62e-01	7.33e-02	2.96e-01	7.39e-01	4.98e-01	8.65e-04	1.32e-01
GOMF PHOSPHATIDYLINOSITOL KINASE ACTIVITY	26	7.18e-01	9.02e-01	0.1880	-9.52e-02	1.02e-01	2.95e-04	-1.12e-01	-5.91e-02	4.01e-01	3.70e-01	9.98e-01	3.22e-01	6.02e-01
GOBP REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS	58	3.18e-01	6.67e-01	0.1880	-4.37e-02	1.16e-01	-1.55e-02	-1.39e-01	2.48e-02	5.65e-01	1.26e-01	8.38e-01	6.78e-02	7.44e-01
GOBP POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS	32	6.32e-01	8.70e-01	0.1880	-9.28e-02	1.07e-01	3.57e-04	-6.47e-02	1.06e-01	3.64e-01	2.94e-01	9.97e-01	5.26e-01	3.00e-01
GOBP POSITIVE REGULATION OF GTPASE ACTIVITY	216	1.47e-03	2.11e-02	0.1880	-3.05e-02	1.24e-01	6.75e-02	7.20e-02	-9.78e-02	4.40e-01	1.76e-03	8.75e-02	6.82e-02	1.33e-02
GOBP REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY	28	7.58e-01	9.19e-01	0.1880	-4.96e-02	-1.72e-02	1.66e-01	6.88e-02	-1.74e-02	6.50e-01	8.75e-01	1.27e-01	5.29e-01	8.73e-01
GOBP REGULATION OF MONONUCLEAR CELL MIGRATION	118	2.71e-02	1.72e-01	0.1880	-1.21e-01	9.69e-02	5.14e-02	9.21e-02	2.04e-02	2.37e-02	6.89e-02	3.35e-01	8.39e-02	7.02e-01
GOBP POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION	50	3.84e-01	7.23e-01	0.1880	-7.47e-02	1.35e-01	-3.91e-02	-7.20e-02	-6.99e-02	3.61e-01	9.88e-02	6.33e-01	3.78e-01	3.92e-01
GOBP RESPONSE TO INTERLEUKIN 1	131	2.96e-02	1.82e-01	0.1880	-1.24e-01	5.34e-02	7.98e-02	1.03e-01	1.86e-02	1.45e-02	2.91e-01	1.15e-01	4.28e-02	7.13e-01
GOBP POSITIVE REGULATION OF MYOBLAST PROLIFERATION	14	9.26e-01	9.76e-01	0.1880	5.59e-02	1.40e-01	1.07e-01	-1.18e-02	3.39e-02	7.17e-01	3.65e-01	4.89e-01	9.39e-01	8.26e-01
GOCC PHAGOCYTIC VESICLE	131	8.73e-03	7.99e-02	0.1880	-9.26e-02	1.06e-01	8.19e-02	-9.40e-02	-4.72e-03	6.73e-02	3.62e-02	1.05e-01	6.32e-02	9.26e-01
GOBP REGULATION OF VASOCONSTRICTION	61	4.03e-01	7.35e-01	0.1880	-1.08e-01	-1.14e-02	9.06e-02	8.96e-02	-8.58e-02	1.46e-01	8.78e-01	2.21e-01	2.26e-01	2.46e-01
GOBP MESODERM DEVELOPMENT	124	4.85e-02	2.49e-01	0.1880	9.76e-03	1.15e-02	-3.61e-02	-1.54e-01	1.00e-01	8.51e-01	8.24e-01	4.87e-01	3.07e-03	5.42e-02
GOBP RESPONSE TO ANTIBIOTIC	36	5.44e-01	8.25e-01	0.1880	7.38e-02	1.45e-01	-6.25e-02	-4.03e-03	-7.01e-02	4.43e-01	1.33e-01	5.17e-01	9.67e-01	4.67e-01
GOBP REGULATION OF CELLULAR RESPONSE TO HEAT	16	9.03e-01	9.68e-01	0.1880	2.92e-03	4.68e-02	-7.51e-02	-1.44e-01	-8.05e-02	9.84e-01	7.46e-01	6.03e-01	3.17e-01	5.77e-01
GOBP GLUTAMINE TRANSPORT	9	9.66e-01	9.90e-01	0.1880	-6.75e-02	1.40e-01	5.94e-02	-8.21e-02	2.68e-02	7.26e-01	4.67e-01	7.58e-01	6.70e-01	8.89e-01
GOBP CHROMOSOME ATTACHMENT TO THE NUCLEAR ENVELOPE	7	9.81e-01	9.93e-01	0.1880	-1.17e-02	1.93e-02	1.19e-01	-2.25e-02	1.41e-01	9.57e-01	9.29e-01	5.85e-01	9.18e-01	5.18e-01
GOMF CATALYTIC ACTIVITY ACTING ON A GLYCOPROTEIN	22	8.17e-01	9.41e-01	0.1880	-3.46e-04	1.47e-01	1.11e-01	-2.86e-02	1.79e-02	9.98e-01	2.32e-01	3.67e-01	8.16e-01	8.85e-01
GOBP CELLULAR RESPONSE TO INTERLEUKIN 1	104	6.29e-02	2.95e-01	0.1870	-1.18e-01	6.09e-02	7.42e-02	9.73e-02	5.12e-02	3.81e-02	2.83e-01	1.91e-01	8.66e-02	3.67e-01
GOBP RECEPTOR CLUSTERING	53	4.19e-01	7.48e-01	0.1870	4.96e-02	1.21e-01	8.85e-02	2.21e-02	9.88e-02	5.32e-01	1.28e-01	2.65e-01	7.81e-01	2.13e-01
GOBP REGULATION OF LEUKOCYTE MIGRATION	217	1.05e-03	1.61e-02	0.1870	-9.45e-02	1.28e-01	7.29e-02	6.50e-02	-1.35e-02	1.64e-02	1.12e-03	6.42e-02	9.90e-02	7.31e-01
GOBP G PROTEIN COUPLED OPIOID RECEPTOR SIGNALING PATHWAY	10	9.59e-01	9.88e-01	0.1870	4.68e-03	-1.76e-01	-3.28e-04	4.50e-02	4.33e-02	9.80e-01	3.34e-01	9.99e-01	8.05e-01	8.13e-01
GOBP ECTOPIC GERM CELL PROGRAMMED CELL DEATH	17	8.90e-01	9.63e-01	0.1870	1.21e-01	3.27e-02	1.81e-02	1.02e-02	1.37e-01	3.88e-01	8.15e-01	8.97e-01	9.42e-01	3.26e-01
GOBP REGULATION OF SUPEROXIDE METABOLIC PROCESS	30	7.11e-01	8.99e-01	0.1870	-5.79e-03	1.25e-01	7.41e-02	2.84e-02	-1.14e-01	9.56e-01	2.34e-01	4.82e-01	7.88e-01	2.80e-01
GOBP REGULATION OF STEM CELL DIFFERENTIATION	78	1.31e-01	4.48e-01	0.1870	4.19e-02	3.61e-03	-3.43e-02	-1.79e-01	-2.60e-03	5.23e-01	9.56e-01	6.01e-01	6.22e-03	9.68e-01
GOBP VESICLE ORGANIZATION	350	6.30e-06	2.21e-04	0.1870	2.63e-02	1.06e-01	-5.16e-02	-1.43e-01	1.15e-02	3.98e-01	6.60e-04	9.71e-02	4.62e-06	7.12e-01
GOCC MICROVILLUS MEMBRANE	32	5.12e-01	8.08e-01	0.1870	2.35e-02	1.67e-01	-4.50e-02	6.67e-02	-1.38e-02	8.18e-01	1.03e-01	6.59e-01	5.14e-01	8.92e-01
GOBP VIRAL GENOME REPLICATION	124	6.26e-02	2.94e-01	0.1870	-2.00e-03	-4.46e-02	-9.04e-02	-1.57e-01	1.08e-02	9.69e-01	3.91e-01	8.20e-02	2.49e-03	8.36e-01
GOBP POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY	30	6.73e-01	8.84e-01	0.1870	1.34e-01	8.24e-02	8.01e-02	2.77e-02	-5.51e-02	2.04e-01	4.35e-01	4.47e-01	7.93e-01	6.01e-01
GOBP MAINTENANCE OF POSTSYNAPTIC SPECIALIZATION STRUCTURE	7	9.79e-01	9.93e-01	0.1870	-8.66e-03	-1.19e-01	-3.56e-02	-1.38e-01	1.64e-02	9.68e-01	5.85e-01	8.71e-01	5.26e-01	9.40e-01
GOBP REGULATION OF CELL MATRIX ADHESION	121	7.15e-02	3.19e-01	0.1870	2.72e-02	9.24e-02	9.22e-02	1.22e-01	-4.76e-02	6.05e-01	7.92e-02	7.99e-02	2.02e-02	3.65e-01
GOBP TROPHOBLAST CELL MIGRATION	17	8.47e-01	9.49e-01	0.1870	-1.39e-01	-4.22e-02	8.09e-02	-6.07e-02	5.94e-02	3.20e-01	7.63e-01	5.64e-01	6.65e-01	6.71e-01
GOBP RETINAL GANGLION CELL AXON GUIDANCE	22	8.26e-01	9.44e-01	0.1870	-1.59e-01	-8.38e-02	2.33e-02	3.19e-02	-3.50e-02	1.98e-01	4.96e-01	8.50e-01	7.95e-01	7.76e-01
GOBP REGULATION OF POSTSYNAPTIC DENSITY ASSEMBLY	11	9.35e-01	9.80e-01	0.1870	-2.04e-02	1.56e-01	-1.77e-02	-1.89e-03	9.90e-02	9.07e-01	3.69e-01	9.19e-01	9.91e-01	5.70e-01
GOBP REGULATION OF MITOTIC CELL CYCLE	507	9.80e-08	5.54e-06	0.1870	7.75e-02	2.18e-02	-8.45e-02	-1.43e-01	2.70e-02	2.80e-03	4.02e-01	1.13e-03	3.23e-08	2.98e-01
GOBP DENDRITE EXTENSION	34	6.94e-01	8.93e-01	0.1870	-1.65e-02	-2.84e-02	5.14e-02	1.69e-01	-5.28e-02	8.68e-01	7.74e-01	6.04e-01	8.90e-02	5.94e-01
GOBP REGULATION OF OVARIAN FOLLICLE DEVELOPMENT	6	9.86e-01	9.95e-01	0.1870	-1.02e-01	4.08e-02	-1.17e-01	-2.59e-02	-9.20e-02	6.65e-01	8.62e-01	6.20e-01	9.13e-01	6.96e-01
GOBP NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE	18	8.76e-01	9.59e-01	0.1870	-9.07e-02	-9.34e-02	6.24e-02	9.69e-02	6.79e-02	5.05e-01	4.93e-01	6.47e-01	4.76e-01	6.18e-01
GOMF VOLTAGE GATED MONOATOMIC ANION CHANNEL ACTIVITY	13	8.59e-01	9.53e-01	0.1870	-1.01e-01	1.04e-01	-9.82e-02	1.44e-02	6.42e-02	5.30e-01	5.18e-01	5.40e-01	9.29e-01	6.88e-01
GOBP KERATINOCYTE DEVELOPMENT	13	9.35e-01	9.80e-01	0.1870	-7.57e-02	-3.26e-02	-6.88e-02	-1.29e-01	-8.16e-02	6.36e-01	8.39e-01	6.68e-01	4.21e-01	6.10e-01
GOBP NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND	34	5.08e-01	8.07e-01	0.1870	5.01e-02	-7.46e-02	1.09e-01	-5.05e-02	1.10e-01	6.13e-01	4.52e-01	2.69e-01	6.10e-01	2.65e-01
GOMF HYALURONIC ACID BINDING	24	8.53e-01	9.51e-01	0.1870	-1.09e-01	-1.88e-02	9.75e-02	1.12e-01	-2.28e-02	3.54e-01	8.74e-01	4.09e-01	3.43e-01	8.46e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS OXYGEN AS ACCEPTOR	10	9.07e-01	9.69e-01	0.1870	4.21e-02	9.96e-03	-1.51e-01	9.50e-02	-3.30e-02	8.18e-01	9.57e-01	4.08e-01	6.03e-01	8.57e-01
GOBP REGULATION OF SYNAPTIC VESICLE RECYCLING	24	7.34e-01	9.09e-01	0.1860	-1.20e-02	1.07e-01	3.21e-02	-1.48e-01	3.27e-03	9.19e-01	3.62e-01	7.85e-01	2.08e-01	9.78e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS	46	2.78e-01	6.31e-01	0.1860	6.94e-02	-2.41e-02	-4.44e-02	1.65e-01	1.24e-02	4.16e-01	7.77e-01	6.03e-01	5.28e-02	8.85e-01
GOBP ENDOPLASMIC RETICULUM LOCALIZATION	10	9.41e-01	9.82e-01	0.1860	2.50e-02	6.12e-02	-1.61e-03	-1.65e-01	-5.51e-02	8.91e-01	7.38e-01	9.93e-01	3.65e-01	7.63e-01
GOBP CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT	54	2.72e-01	6.26e-01	0.1860	1.39e-01	-8.95e-02	6.08e-02	-1.95e-02	5.72e-02	7.69e-02	2.55e-01	4.40e-01	8.04e-01	4.67e-01
GOMF AMP BINDING	15	9.11e-01	9.71e-01	0.1860	-8.42e-04	-5.32e-02	6.84e-02	1.35e-01	9.41e-02	9.95e-01	7.21e-01	6.46e-01	3.64e-01	5.28e-01
GOMF PROTEIN CYSTEINE S STEAROYLTRANSFERASE ACTIVITY	6	9.74e-01	9.92e-01	0.1860	1.22e-01	-6.79e-03	2.55e-02	-1.32e-01	-3.94e-02	6.04e-01	9.77e-01	9.14e-01	5.75e-01	8.67e-01
GOBP NK T CELL PROLIFERATION	8	9.49e-01	9.84e-01	0.1860	-1.09e-01	-7.70e-02	9.87e-02	-8.40e-02	-1.12e-02	5.94e-01	7.06e-01	6.29e-01	6.81e-01	9.56e-01
GOBP VITAMIN TRANSPORT	52	2.13e-01	5.67e-01	0.1860	-5.50e-02	1.39e-01	-2.02e-02	5.07e-02	9.71e-02	4.93e-01	8.36e-02	8.01e-01	5.27e-01	2.26e-01
GOMF JUN KINASE KINASE KINASE ACTIVITY	11	9.60e-01	9.88e-01	0.1860	7.56e-02	1.25e-01	1.06e-01	9.49e-03	4.54e-02	6.64e-01	4.74e-01	5.44e-01	9.57e-01	7.94e-01
GOBP HIPPOCAMPUS DEVELOPMENT	90	3.42e-02	1.99e-01	0.1860	1.99e-02	4.47e-03	6.18e-02	-1.61e-01	6.60e-02	7.44e-01	9.42e-01	3.11e-01	8.22e-03	2.79e-01
GOMF LRR DOMAIN BINDING	16	8.76e-01	9.59e-01	0.1860	6.90e-02	-1.61e-01	-2.39e-04	-4.90e-02	3.81e-02	6.33e-01	2.65e-01	9.99e-01	7.34e-01	7.92e-01
GOBP NEGATIVE REGULATION OF HEMOPOIESIS	114	4.27e-02	2.29e-01	0.1860	4.17e-02	1.75e-01	5.85e-04	-4.37e-02	-1.49e-02	4.41e-01	1.23e-03	9.91e-01	4.20e-01	7.84e-01
GOBP LIPOPROTEIN CATABOLIC PROCESS	15	8.07e-01	9.36e-01	0.1860	-7.44e-02	2.11e-02	1.17e-01	-1.21e-01	-1.51e-02	6.18e-01	8.87e-01	4.34e-01	4.16e-01	9.19e-01
GOBP AMPA GLUTAMATE RECEPTOR CLUSTERING	10	9.65e-01	9.90e-01	0.1860	-1.02e-01	5.47e-04	-6.72e-02	-1.18e-02	-1.39e-01	5.75e-01	9.98e-01	7.13e-01	9.48e-01	4.46e-01
GOBP EPITHELIAL TO MESENCHYMAL TRANSITION	175	4.82e-04	8.60e-03	0.1860	2.83e-02	6.58e-02	5.14e-02	-1.61e-01	2.68e-02	5.19e-01	1.33e-01	2.41e-01	2.33e-04	5.41e-01
GOBP NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY	55	2.28e-01	5.81e-01	0.1860	-5.29e-02	-5.32e-02	1.18e-01	2.54e-03	-1.22e-01	4.97e-01	4.95e-01	1.31e-01	9.74e-01	1.16e-01
GOBP REGULATION OF MODIFICATION OF POSTSYNAPTIC STRUCTURE	9	9.83e-01	9.94e-01	0.1860	-5.66e-02	7.65e-02	1.24e-01	8.80e-02	-4.78e-02	7.69e-01	6.91e-01	5.19e-01	6.47e-01	8.04e-01
GOBP RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS	211	6.96e-03	6.76e-02	0.1860	1.33e-02	2.36e-03	-1.01e-01	-1.40e-01	6.72e-02	7.40e-01	9.53e-01	1.13e-02	4.65e-04	9.25e-02
GOCC PHAGOPHORE ASSEMBLY SITE	37	6.74e-01	8.85e-01	0.1860	-7.53e-02	1.31e-02	-8.84e-02	-1.38e-01	4.18e-02	4.28e-01	8.90e-01	3.52e-01	1.46e-01	6.60e-01
GOBP REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY	57	4.91e-01	7.98e-01	0.1860	5.28e-02	-2.04e-02	-9.13e-02	-1.42e-01	5.19e-02	4.91e-01	7.90e-01	2.33e-01	6.35e-02	4.98e-01
GOBP APOPTOTIC MITOCHONDRIAL CHANGES	105	9.51e-02	3.73e-01	0.1860	3.00e-02	8.88e-03	-9.03e-02	-1.51e-01	-5.02e-02	5.95e-01	8.75e-01	1.10e-01	7.56e-03	3.74e-01
GOBP NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS	158	6.15e-03	6.21e-02	0.1850	-2.07e-02	5.27e-02	2.54e-02	-1.44e-01	9.88e-02	6.54e-01	2.53e-01	5.82e-01	1.76e-03	3.21e-02
GOBP POSITIVE REGULATION OF CATION CHANNEL ACTIVITY	47	4.62e-01	7.79e-01	0.1850	1.35e-02	-3.62e-02	1.13e-01	7.40e-02	-1.21e-01	8.73e-01	6.68e-01	1.81e-01	3.80e-01	1.50e-01
GOMF MODIFICATION DEPENDENT PROTEIN BINDING	165	2.31e-02	1.55e-01	0.1850	5.86e-02	8.37e-03	-7.35e-02	-1.42e-01	7.23e-02	1.94e-01	8.53e-01	1.03e-01	1.60e-03	1.09e-01
GOBP BRAIN MORPHOGENESIS	37	5.86e-01	8.45e-01	0.1850	2.75e-02	-1.14e-01	8.07e-03	-3.94e-02	1.38e-01	7.72e-01	2.28e-01	9.32e-01	6.78e-01	1.48e-01
GOBP LYSOSOMAL TRANSPORT	128	5.69e-02	2.77e-01	0.1850	3.78e-02	2.87e-02	-4.07e-02	-1.27e-01	1.20e-01	4.60e-01	5.75e-01	4.26e-01	1.33e-02	1.89e-02
GOBP LAMELLIPODIUM ORGANIZATION	86	1.54e-01	4.82e-01	0.1850	-1.17e-01	1.16e-01	6.39e-02	3.10e-02	-4.79e-02	6.17e-02	6.29e-02	3.05e-01	6.20e-01	4.43e-01
GOBP REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY	52	4.51e-01	7.71e-01	0.1850	-7.60e-02	6.97e-02	1.36e-01	3.62e-02	-6.23e-02	3.43e-01	3.84e-01	8.92e-02	6.52e-01	4.37e-01
GOBP ERYTHROCYTE HOMEOSTASIS	134	2.49e-02	1.61e-01	0.1850	-4.41e-02	1.14e-01	-2.01e-02	-1.33e-01	3.77e-02	3.78e-01	2.26e-02	6.87e-01	8.07e-03	4.52e-01
GOBP PROCESS UTILIZING AUTOPHAGIC MECHANISM	551	2.12e-08	1.40e-06	0.1850	3.21e-02	3.03e-02	-7.17e-02	-1.59e-01	4.53e-02	1.97e-01	2.24e-01	3.99e-03	1.83e-10	6.92e-02
GOMF EFFLUX TRANSMEMBRANE TRANSPORTER ACTIVITY	15	9.05e-01	9.69e-01	0.1850	-1.58e-01	-7.35e-02	1.35e-02	4.62e-02	3.89e-02	2.88e-01	6.22e-01	9.28e-01	7.57e-01	7.94e-01
GOBP REGULATION OF PHOSPHOLIPASE ACTIVITY	57	3.87e-01	7.24e-01	0.1850	-7.00e-02	-7.77e-03	4.68e-02	1.60e-01	-3.72e-02	3.60e-01	9.19e-01	5.41e-01	3.61e-02	6.27e-01
GOBP LENS DEVELOPMENT IN CAMERA TYPE EYE	85	8.38e-02	3.49e-01	0.1850	1.21e-01	1.06e-01	5.49e-02	-6.11e-02	-4.02e-02	5.42e-02	9.01e-02	3.81e-01	3.30e-01	5.22e-01
GOMF MITOGEN ACTIVATED PROTEIN KINASE P38 BINDING	7	9.83e-01	9.94e-01	0.1850	1.71e-02	6.75e-02	1.70e-01	1.68e-02	1.71e-02	9.38e-01	7.57e-01	4.37e-01	9.39e-01	9.38e-01
GOCC CELL SURFACE	838	3.85e-12	4.15e-10	0.1850	-7.18e-02	5.83e-02	1.09e-01	1.14e-01	-2.98e-02	4.17e-04	4.14e-03	8.17e-08	2.28e-08	1.43e-01
GOBP REGULATION OF PHOSPHATASE ACTIVITY	59	3.65e-01	7.05e-01	0.1850	-3.12e-02	1.62e-01	7.89e-02	3.02e-02	2.46e-03	6.78e-01	3.18e-02	2.94e-01	6.88e-01	9.74e-01
GOBP BARBED END ACTIN FILAMENT CAPPING	24	7.16e-01	9.01e-01	0.1850	7.99e-02	1.15e-01	-3.07e-02	1.02e-01	-5.69e-02	4.98e-01	3.30e-01	7.94e-01	3.86e-01	6.29e-01
GOCC GOLGI LUMEN	96	8.47e-02	3.51e-01	0.1850	-1.42e-01	1.00e-02	3.85e-02	-1.70e-02	-1.11e-01	1.65e-02	8.65e-01	5.14e-01	7.74e-01	6.09e-02
GOCC VESICLE LUMEN	311	1.14e-05	3.77e-04	0.1850	-1.28e-01	6.28e-02	-4.44e-02	-9.99e-02	4.28e-02	1.01e-04	5.69e-02	1.78e-01	2.44e-03	1.94e-01
GOBP MAINTENANCE OF PROTEIN LOCATION	85	1.68e-01	5.04e-01	0.1850	-4.96e-03	4.86e-02	-6.26e-02	-1.66e-01	-1.47e-02	9.37e-01	4.38e-01	3.18e-01	8.12e-03	8.15e-01
GOCC POSTSYNAPTIC DENSITY MEMBRANE	94	1.54e-01	4.82e-01	0.1850	-4.96e-02	-5.95e-02	1.40e-01	9.21e-02	3.63e-03	4.06e-01	3.19e-01	1.90e-02	1.23e-01	9.52e-01
GOBP REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION	66	3.65e-01	7.05e-01	0.1850	-1.59e-02	1.24e-01	1.21e-01	6.09e-02	-5.94e-03	8.24e-01	8.14e-02	8.88e-02	3.92e-01	9.33e-01
GOMF ENDONUCLEASE ACTIVITY	118	1.21e-01	4.26e-01	0.1850	1.10e-02	-1.51e-02	-1.35e-01	-1.25e-01	6.50e-03	8.36e-01	7.77e-01	1.15e-02	1.94e-02	9.03e-01
GOBP REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY	51	4.01e-01	7.34e-01	0.1840	-4.99e-02	-1.26e-01	1.07e-01	6.23e-02	-1.87e-02	5.37e-01	1.19e-01	1.88e-01	4.42e-01	8.17e-01
GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY	48	6.22e-01	8.64e-01	0.1840	-2.52e-02	1.47e-02	1.25e-01	1.29e-01	-3.26e-02	7.63e-01	8.60e-01	1.35e-01	1.23e-01	6.96e-01
GOBP POSITIVE REGULATION OF PEPTIDE SECRETION	110	3.08e-02	1.86e-01	0.1840	6.98e-02	1.40e-01	8.72e-03	6.08e-02	7.64e-02	2.06e-01	1.13e-02	8.74e-01	2.71e-01	1.66e-01
GOCC SEROTONIN RECEPTOR COMPLEX	8	9.82e-01	9.93e-01	0.1840	1.01e-01	-1.64e-02	1.13e-01	1.01e-01	-2.48e-02	6.22e-01	9.36e-01	5.80e-01	6.19e-01	9.03e-01
GOBP EXTRACELLULAR MATRIX DISASSEMBLY	60	3.78e-01	7.17e-01	0.1840	-2.56e-02	1.16e-02	6.12e-02	7.47e-02	-1.55e-01	7.31e-01	8.76e-01	4.12e-01	3.17e-01	3.84e-02
GOBP HIPPO SIGNALING	42	5.92e-01	8.47e-01	0.1840	-1.40e-02	-9.46e-02	3.21e-02	1.07e-01	-1.11e-01	8.75e-01	2.89e-01	7.19e-01	2.28e-01	2.14e-01
GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE	33	6.78e-01	8.87e-01	0.1840	-1.07e-01	1.06e-01	6.93e-02	7.84e-02	1.56e-02	2.86e-01	2.92e-01	4.91e-01	4.36e-01	8.77e-01
GOCC FIBRILLAR CENTER	144	3.46e-02	2.01e-01	0.1840	5.48e-02	4.85e-02	-6.96e-02	-1.53e-01	2.05e-02	2.56e-01	3.15e-01	1.49e-01	1.57e-03	6.71e-01
GOBP PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS	85	1.91e-01	5.38e-01	0.1840	8.12e-03	1.01e-01	-6.63e-02	-1.38e-01	7.07e-03	8.97e-01	1.06e-01	2.91e-01	2.77e-02	9.10e-01
GOCC NUCLEAR INNER MEMBRANE	54	3.93e-01	7.27e-01	0.1840	-5.63e-02	1.25e-01	-4.20e-02	-1.15e-01	-1.22e-02	4.74e-01	1.12e-01	5.94e-01	1.45e-01	8.77e-01
GOBP NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY	22	7.92e-01	9.31e-01	0.1840	5.47e-03	8.04e-02	-1.16e-01	-5.21e-02	1.06e-01	9.65e-01	5.14e-01	3.47e-01	6.72e-01	3.89e-01
GOBP DEFENSE RESPONSE TO SYMBIONT	323	1.04e-04	2.46e-03	0.1840	9.78e-03	1.07e-02	-8.21e-02	-1.15e-01	1.17e-01	7.63e-01	7.40e-01	1.11e-02	3.76e-04	3.02e-04
GOBP CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS	18	8.71e-01	9.58e-01	0.1840	1.05e-02	-1.64e-01	-1.44e-02	-4.75e-02	6.72e-02	9.39e-01	2.29e-01	9.16e-01	7.27e-01	6.22e-01
GOBP GLOMERULUS DEVELOPMENT	68	3.13e-01	6.64e-01	0.1840	1.04e-02	-8.59e-02	1.11e-01	1.09e-01	-4.67e-02	8.82e-01	2.21e-01	1.12e-01	1.21e-01	5.06e-01
GOMF SIALYLTRANSFERASE ACTIVITY	21	8.62e-01	9.54e-01	0.1840	-9.22e-02	6.83e-02	9.99e-02	3.03e-02	-9.88e-02	4.65e-01	5.88e-01	4.28e-01	8.10e-01	4.33e-01
GOBP POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS	38	3.39e-01	6.86e-01	0.1840	2.88e-02	-5.83e-02	-8.64e-02	1.29e-01	7.35e-02	7.58e-01	5.34e-01	3.57e-01	1.68e-01	4.33e-01
GOMF PROTEIN MEMBRANE ADAPTOR ACTIVITY	36	6.01e-01	8.53e-01	0.1840	-1.42e-03	6.81e-02	-5.72e-02	-1.22e-01	-1.04e-01	9.88e-01	4.79e-01	5.53e-01	2.04e-01	2.79e-01
GOBP RESPONSE TO DSRNA	52	2.24e-01	5.78e-01	0.1840	-4.93e-02	8.24e-02	-3.33e-02	3.48e-02	1.49e-01	5.38e-01	3.04e-01	6.78e-01	6.64e-01	6.28e-02
GOBP CELLULAR RESPONSE TO RADIATION	170	1.76e-02	1.30e-01	0.1840	2.16e-02	2.57e-02	-5.32e-02	-1.32e-01	1.11e-01	6.26e-01	5.63e-01	2.31e-01	2.92e-03	1.27e-02
GOBP POSITIVE REGULATION OF MUSCLE HYPERTROPHY	36	5.59e-01	8.32e-01	0.1840	-1.54e-01	4.43e-03	7.90e-02	-5.26e-02	3.32e-02	1.11e-01	9.63e-01	4.12e-01	5.85e-01	7.30e-01
GOBP INFLAMMATORY CELL APOPTOTIC PROCESS	24	6.91e-01	8.92e-01	0.1840	-1.74e-02	8.58e-03	1.71e-02	-8.12e-02	-1.63e-01	8.83e-01	9.42e-01	8.85e-01	4.91e-01	1.68e-01
GOBP NUCLEOPHAGY	18	8.98e-01	9.67e-01	0.1840	-6.88e-02	-4.42e-02	-5.71e-02	-1.01e-01	1.17e-01	6.13e-01	7.46e-01	6.75e-01	4.59e-01	3.92e-01
GOBP NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION	25	6.68e-01	8.82e-01	0.1840	-1.51e-01	-2.69e-02	-7.63e-02	4.07e-02	5.26e-02	1.92e-01	8.16e-01	5.09e-01	7.25e-01	6.49e-01
GOBP POSITIVE REGULATION OF LIPID TRANSPORT	86	1.56e-01	4.84e-01	0.1840	-4.65e-02	1.40e-01	5.56e-02	2.11e-02	-9.15e-02	4.56e-01	2.47e-02	3.73e-01	7.35e-01	1.42e-01
GOBP POSITIVE REGULATION OF NATURAL KILLER CELL DIFFERENTIATION	7	9.79e-01	9.93e-01	0.1840	1.81e-02	9.96e-02	-1.55e-02	-1.02e-01	-1.14e-01	9.34e-01	6.48e-01	9.43e-01	6.42e-01	6.03e-01
GOBP BONE MINERALIZATION	116	2.01e-02	1.41e-01	0.1840	-9.62e-02	-1.60e-02	1.15e-01	-5.50e-02	8.87e-02	7.35e-02	7.67e-01	3.19e-02	3.06e-01	9.91e-02
GOBP REGULATION OF MICROTUBULE DEPOLYMERIZATION	26	7.78e-01	9.27e-01	0.1840	9.18e-02	1.53e-01	2.34e-02	-3.25e-02	1.97e-02	4.18e-01	1.78e-01	8.36e-01	7.74e-01	8.62e-01
GOMF PROTEIN TYROSINE KINASE BINDING	116	6.18e-02	2.92e-01	0.1840	9.27e-03	1.64e-01	7.30e-02	3.83e-02	1.89e-03	8.63e-01	2.32e-03	1.75e-01	4.76e-01	9.72e-01
GOCC NUCLEOLUS	1318	2.22e-18	4.06e-16	0.1830	-3.62e-04	-4.28e-02	-1.39e-01	-1.11e-01	-4.41e-03	9.82e-01	9.10e-03	1.75e-17	1.22e-11	7.88e-01
GOBP INFLAMMATORY RESPONSE TO WOUNDING	27	6.71e-01	8.83e-01	0.1830	-6.19e-02	4.27e-02	3.79e-02	9.78e-02	1.30e-01	5.77e-01	7.01e-01	7.33e-01	3.79e-01	2.41e-01
GOBP PHOSPHATIDYLCHOLINE METABOLIC PROCESS	74	2.45e-01	6.02e-01	0.1830	-6.82e-02	8.98e-02	2.83e-02	7.64e-02	-1.20e-01	3.10e-01	1.82e-01	6.74e-01	2.56e-01	7.54e-02
GOBP PURINE NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS	18	8.03e-01	9.34e-01	0.1830	3.53e-02	9.74e-02	5.12e-02	-1.32e-01	-5.43e-02	7.95e-01	4.75e-01	7.07e-01	3.34e-01	6.90e-01
GOBP REGULATION OF HYPERSENSITIVITY	7	9.84e-01	9.94e-01	0.1830	-1.04e-01	8.38e-02	-2.44e-02	-1.14e-01	4.61e-02	6.33e-01	7.01e-01	9.11e-01	6.01e-01	8.33e-01
GOCC LATERAL PART OF CELL	5	9.92e-01	9.97e-01	0.1830	5.32e-02	5.49e-02	-1.41e-01	-2.52e-02	-8.49e-02	8.37e-01	8.32e-01	5.85e-01	9.22e-01	7.42e-01
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE	259	3.23e-04	6.28e-03	0.1830	-4.46e-02	4.13e-02	-6.58e-02	-1.59e-01	-1.67e-02	2.17e-01	2.52e-01	6.84e-02	1.06e-05	6.43e-01
GOMF DNA BINDING BENDING	16	9.23e-01	9.75e-01	0.1830	-9.79e-02	2.97e-02	-1.02e-01	-1.10e-01	-2.31e-02	4.98e-01	8.37e-01	4.78e-01	4.47e-01	8.73e-01
GOCC GERM CELL NUCLEUS	68	2.16e-01	5.70e-01	0.1830	-4.67e-02	3.23e-02	-7.05e-02	-5.49e-02	1.49e-01	5.05e-01	6.45e-01	3.15e-01	4.34e-01	3.32e-02
GOBP IMMUNE SYSTEM DEVELOPMENT	198	3.59e-03	4.19e-02	0.1830	3.95e-02	3.69e-02	-2.57e-02	-1.56e-01	7.49e-02	3.38e-01	3.71e-01	5.33e-01	1.54e-04	6.94e-02
GOBP REGULATION OF RESPONSE TO OXIDATIVE STRESS	31	7.61e-01	9.20e-01	0.1830	2.00e-02	-4.55e-03	6.87e-02	1.10e-01	-1.28e-01	8.47e-01	9.65e-01	5.08e-01	2.90e-01	2.19e-01
GOBP MYELOID CELL DEVELOPMENT	80	1.55e-01	4.83e-01	0.1830	-7.16e-02	1.38e-01	-4.33e-02	-6.22e-02	-5.88e-02	2.68e-01	3.24e-02	5.03e-01	3.36e-01	3.63e-01
GOBP POSITIVE REGULATION OF PROTEOGLYCAN BIOSYNTHETIC PROCESS	5	9.94e-01	9.97e-01	0.1830	-1.26e-01	9.23e-02	9.16e-02	2.68e-02	3.86e-03	6.26e-01	7.21e-01	7.23e-01	9.17e-01	9.88e-01
GOBP SYNAPSE ASSEMBLY	184	1.94e-02	1.38e-01	0.1830	-4.81e-02	2.76e-02	1.39e-01	1.01e-01	-2.59e-02	2.61e-01	5.19e-01	1.12e-03	1.76e-02	5.45e-01
GOMF K48 LINKED DEUBIQUITINASE ACTIVITY	13	9.29e-01	9.78e-01	0.1830	-2.14e-03	5.82e-02	-9.95e-02	-5.39e-02	1.31e-01	9.89e-01	7.16e-01	5.35e-01	7.36e-01	4.13e-01
GOBP CIRCADIAN REGULATION OF GENE EXPRESSION	66	2.32e-01	5.85e-01	0.1830	1.31e-01	8.84e-02	4.48e-02	-7.66e-02	2.61e-02	6.67e-02	2.14e-01	5.29e-01	2.82e-01	7.13e-01
GOBP PROTON TRANSMEMBRANE TRANSPORT	141	1.73e-02	1.29e-01	0.1830	1.83e-02	3.69e-02	-1.93e-02	-1.72e-01	4.11e-02	7.07e-01	4.50e-01	6.93e-01	4.15e-04	3.99e-01
GOBP REGULATION OF FATTY ACID BETA OXIDATION	19	8.48e-01	9.49e-01	0.1830	1.43e-01	6.41e-02	-9.37e-02	6.05e-03	-7.68e-03	2.81e-01	6.29e-01	4.79e-01	9.64e-01	9.54e-01
GOBP MULTICELLULAR ORGANISMAL RESPONSE TO STRESS	89	2.35e-01	5.90e-01	0.1830	2.27e-02	7.13e-02	1.23e-01	1.01e-01	-5.11e-02	7.11e-01	2.45e-01	4.56e-02	1.00e-01	4.05e-01
GOBP POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY	48	5.59e-01	8.32e-01	0.1830	-8.74e-02	-2.21e-02	5.64e-02	1.37e-01	-5.70e-02	2.95e-01	7.91e-01	4.99e-01	1.00e-01	4.94e-01
GOBP REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN	48	5.44e-01	8.25e-01	0.1830	-9.49e-02	8.04e-02	8.64e-02	5.22e-02	-8.79e-02	2.55e-01	3.35e-01	3.00e-01	5.32e-01	2.92e-01
GOBP VESICLE DOCKING INVOLVED IN EXOCYTOSIS	42	5.00e-01	8.03e-01	0.1830	-1.52e-01	1.75e-03	-2.77e-03	-1.01e-01	-7.93e-03	8.78e-02	9.84e-01	9.75e-01	2.59e-01	9.29e-01
GOBP NEURAL TUBE DEVELOPMENT	160	2.44e-02	1.59e-01	0.1830	4.10e-02	1.48e-02	-5.58e-02	-1.52e-01	7.22e-02	3.71e-01	7.46e-01	2.24e-01	9.03e-04	1.15e-01
GOBP RESPONSE TO L GLUTAMATE	14	9.46e-01	9.82e-01	0.1830	-1.28e-02	-1.26e-02	9.43e-02	8.84e-02	-1.28e-01	9.34e-01	9.35e-01	5.41e-01	5.67e-01	4.08e-01
GOMF XENOBIOTIC TRANSMEMBRANE TRANSPORTER ACTIVITY	37	4.85e-01	7.94e-01	0.1830	5.25e-02	1.34e-02	-5.12e-02	1.47e-01	-7.90e-02	5.81e-01	8.88e-01	5.90e-01	1.22e-01	4.06e-01
GOBP PROSTANOID BIOSYNTHETIC PROCESS	31	4.72e-01	7.86e-01	0.1830	-3.29e-02	-2.46e-02	-1.57e-01	8.12e-02	-2.12e-02	7.51e-01	8.13e-01	1.31e-01	4.34e-01	8.38e-01
GOMF VOLTAGE GATED CHANNEL ACTIVITY	191	7.36e-03	7.04e-02	0.1820	-1.07e-01	5.94e-02	5.83e-02	9.14e-02	-8.15e-02	1.10e-02	1.57e-01	1.65e-01	2.93e-02	5.21e-02
GOMF PROTEOGLYCAN BINDING	36	6.53e-01	8.79e-01	0.1820	-4.38e-02	-7.26e-02	7.92e-02	6.82e-02	-1.23e-01	6.49e-01	4.51e-01	4.11e-01	4.79e-01	2.01e-01
GOBP RESPIRATORY SYSTEM PROCESS	37	6.88e-01	8.90e-01	0.1820	4.67e-02	6.48e-02	1.49e-01	6.90e-02	-7.26e-03	6.23e-01	4.95e-01	1.18e-01	4.68e-01	9.39e-01
GOMF SALT TRANSMEMBRANE TRANSPORTER ACTIVITY	560	4.21e-08	2.61e-06	0.1820	-4.69e-02	8.15e-02	1.02e-01	8.25e-02	-8.49e-02	5.77e-02	9.72e-04	3.83e-05	8.38e-04	5.89e-04
GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	18	8.89e-01	9.63e-01	0.1820	1.85e-02	-2.54e-02	-8.36e-02	-4.78e-02	1.51e-01	8.92e-01	8.52e-01	5.39e-01	7.25e-01	2.66e-01
GOBP NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY	46	5.07e-01	8.06e-01	0.1820	-4.14e-02	-1.34e-02	1.12e-01	4.12e-02	1.31e-01	6.27e-01	8.75e-01	1.90e-01	6.28e-01	1.25e-01
GOBP REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS	13	9.33e-01	9.79e-01	0.1820	-3.24e-02	-9.56e-02	-4.75e-02	-1.02e-02	1.44e-01	8.40e-01	5.51e-01	7.67e-01	9.49e-01	3.70e-01
GOBP COCHLEA DEVELOPMENT	46	3.71e-01	7.10e-01	0.1820	1.38e-01	-3.11e-02	1.08e-01	-9.71e-03	3.81e-02	1.07e-01	7.15e-01	2.04e-01	9.09e-01	6.55e-01
GOBP PHOSPHOLIPID BIOSYNTHETIC PROCESS	242	3.67e-04	7.02e-03	0.1820	4.60e-02	9.19e-02	-3.95e-02	-1.42e-01	-2.72e-02	2.18e-01	1.38e-02	2.89e-01	1.36e-04	4.66e-01
GOBP PROSTATE GLAND MORPHOGENESIS	27	4.96e-01	8.00e-01	0.1820	1.57e-02	-7.24e-02	5.80e-02	-1.53e-01	-2.65e-02	8.88e-01	5.15e-01	6.02e-01	1.68e-01	8.11e-01
GOCC NEURON PROJECTION TERMINUS	123	3.29e-02	1.94e-01	0.1820	-3.67e-02	3.69e-02	1.73e-01	2.18e-02	-1.07e-02	4.83e-01	4.80e-01	9.40e-04	6.76e-01	8.38e-01
GOBP REGULATION OF ACUTE INFLAMMATORY RESPONSE	46	5.17e-01	8.12e-01	0.1820	-3.46e-03	1.62e-01	7.25e-02	-1.69e-02	3.59e-02	9.68e-01	5.72e-02	3.95e-01	8.43e-01	6.74e-01
GOBP EMBRYONIC HEART TUBE DEVELOPMENT	83	1.43e-01	4.64e-01	0.1820	6.09e-02	5.24e-02	6.09e-03	-1.52e-01	5.81e-02	3.38e-01	4.09e-01	9.24e-01	1.64e-02	3.60e-01
GOBP PROTEIN CATABOLIC PROCESS	930	4.55e-15	5.89e-13	0.1820	-9.72e-04	4.03e-02	-6.44e-02	-1.65e-01	7.46e-03	9.60e-01	3.72e-02	8.68e-04	1.38e-17	7.00e-01
GOBP REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY	8	9.76e-01	9.93e-01	0.1820	-1.09e-01	5.49e-03	5.32e-02	6.30e-03	1.35e-01	5.94e-01	9.79e-01	7.94e-01	9.75e-01	5.07e-01
GOBP RESPONSE TO PROSTAGLANDIN	31	6.90e-01	8.92e-01	0.1820	-1.26e-01	4.64e-02	2.77e-02	1.15e-01	-3.12e-02	2.25e-01	6.55e-01	7.89e-01	2.66e-01	7.64e-01
GOBP EPITHELIAL TUBE FORMATION	136	1.69e-02	1.27e-01	0.1820	2.09e-02	1.67e-02	-1.44e-03	-1.69e-01	6.21e-02	6.75e-01	7.37e-01	9.77e-01	6.77e-04	2.11e-01
GOBP REGULATION OF PROTEIN MATURATION	68	2.62e-01	6.19e-01	0.1820	-7.12e-03	1.30e-01	4.63e-02	1.16e-02	-1.18e-01	9.19e-01	6.47e-02	5.09e-01	8.69e-01	9.22e-02
GOMF CARBON NITROGEN LYASE ACTIVITY	13	9.45e-01	9.82e-01	0.1820	6.60e-02	1.47e-01	4.29e-02	-1.13e-02	7.17e-02	6.80e-01	3.59e-01	7.89e-01	9.44e-01	6.54e-01
GOBP REGULATION OF SPROUTING ANGIOGENESIS	62	2.18e-01	5.72e-01	0.1820	-1.30e-01	1.23e-01	-2.98e-02	6.93e-04	1.26e-02	7.70e-02	9.38e-02	6.85e-01	9.92e-01	8.64e-01
GOBP POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION	74	1.19e-01	4.23e-01	0.1820	2.52e-03	2.24e-02	-1.31e-02	-1.71e-01	-5.47e-02	9.70e-01	7.39e-01	8.45e-01	1.08e-02	4.16e-01
GOBP REGULATION OF GTPASE ACTIVITY	279	4.85e-04	8.65e-03	0.1820	-5.29e-02	9.17e-02	7.47e-02	9.01e-02	-8.99e-02	1.29e-01	8.36e-03	3.18e-02	9.61e-03	9.72e-03
GOBP REGULATION OF MITOCHONDRION ORGANIZATION	147	1.23e-02	1.01e-01	0.1820	8.48e-02	3.31e-02	-3.38e-02	-1.53e-01	-1.16e-02	7.59e-02	4.89e-01	4.79e-01	1.36e-03	8.08e-01
GOBP POSITIVE REGULATION OF NK T CELL ACTIVATION	9	9.62e-01	9.89e-01	0.1820	-9.32e-02	-9.63e-02	9.46e-02	-2.49e-02	7.36e-02	6.28e-01	6.17e-01	6.23e-01	8.97e-01	7.02e-01
GOBP AXO DENDRITIC PROTEIN TRANSPORT	9	9.83e-01	9.94e-01	0.1820	4.61e-02	1.95e-02	1.33e-01	1.09e-01	2.90e-02	8.11e-01	9.19e-01	4.90e-01	5.71e-01	8.80e-01
GOBP HYALURONAN METABOLIC PROCESS	33	6.20e-01	8.63e-01	0.1810	3.17e-02	1.24e-01	1.04e-02	1.18e-01	-4.89e-02	7.53e-01	2.16e-01	9.18e-01	2.40e-01	6.27e-01
GOMF INTRAMEMBRANE LIPID TRANSPORTER ACTIVITY	41	5.74e-01	8.40e-01	0.1810	-7.04e-02	-1.55e-03	-5.25e-02	4.25e-02	-1.53e-01	4.35e-01	9.86e-01	5.60e-01	6.37e-01	9.01e-02
GOBP ORGANOPHOSPHATE CATABOLIC PROCESS	142	2.08e-02	1.45e-01	0.1810	-5.06e-02	1.19e-01	-2.46e-02	-1.25e-01	5.00e-03	2.98e-01	1.43e-02	6.12e-01	1.03e-02	9.18e-01
GOBP MEMBRANE DISASSEMBLY	11	9.44e-01	9.82e-01	0.1810	-3.38e-02	-1.19e-02	-7.66e-03	-5.13e-02	-1.70e-01	8.46e-01	9.46e-01	9.65e-01	7.68e-01	3.29e-01
GOCC CENTRIOLE	151	2.35e-02	1.56e-01	0.1810	1.15e-01	-4.06e-02	-6.35e-02	-1.16e-01	2.28e-02	1.48e-02	3.89e-01	1.78e-01	1.37e-02	6.28e-01
GOBP MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION	21	7.99e-01	9.33e-01	0.1810	-2.03e-02	1.77e-01	-3.58e-02	3.46e-03	-1.00e-03	8.72e-01	1.61e-01	7.77e-01	9.78e-01	9.94e-01
GOBP MYELIN ASSEMBLY	24	8.07e-01	9.36e-01	0.1810	6.43e-02	-1.26e-01	5.84e-02	9.06e-02	-3.54e-02	5.86e-01	2.85e-01	6.20e-01	4.42e-01	7.64e-01
GOBP NON MEMBRANE BOUNDED ORGANELLE ASSEMBLY	387	3.19e-05	9.21e-04	0.1810	5.17e-02	-1.35e-02	-1.11e-01	-1.33e-01	-3.59e-03	8.09e-02	6.48e-01	1.71e-04	7.24e-06	9.03e-01
GOBP GLOMERULAR MESANGIUM DEVELOPMENT	18	8.83e-01	9.61e-01	0.1810	-4.15e-02	-4.73e-02	-1.63e-02	1.44e-01	-8.97e-02	7.61e-01	7.28e-01	9.05e-01	2.91e-01	5.10e-01
GOBP APOPTOTIC SIGNALING PATHWAY	599	7.31e-10	5.98e-08	0.1810	-1.15e-02	6.62e-02	-4.20e-02	-1.60e-01	3.14e-02	6.30e-01	5.64e-03	7.93e-02	2.23e-11	1.89e-01
GOBP POSITIVE REGULATION OF CELL SIZE	10	9.64e-01	9.90e-01	0.1810	1.22e-01	-1.04e-01	-6.53e-02	4.66e-02	-3.03e-02	5.06e-01	5.71e-01	7.21e-01	7.99e-01	8.68e-01
GOCC APICAL PART OF CELL	450	2.54e-06	9.98e-05	0.1810	-1.19e-02	7.43e-02	8.62e-02	1.13e-01	-8.35e-02	6.66e-01	6.88e-03	1.71e-03	3.99e-05	2.40e-03
GOBP MESODERM MORPHOGENESIS	76	2.13e-01	5.66e-01	0.1810	-5.24e-03	2.42e-02	5.18e-05	-1.49e-01	9.95e-02	9.37e-01	7.15e-01	9.99e-01	2.43e-02	1.34e-01
GOBP POSITIVE REGULATION OF CELLULAR RESPIRATION	13	9.34e-01	9.80e-01	0.1810	6.58e-02	6.04e-02	5.34e-03	1.71e-02	1.57e-01	6.81e-01	7.06e-01	9.73e-01	9.15e-01	3.28e-01
GOBP DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN	17	8.86e-01	9.62e-01	0.1810	2.88e-02	1.28e-01	-1.56e-02	-5.29e-02	-1.11e-01	8.37e-01	3.59e-01	9.12e-01	7.05e-01	4.26e-01
GOCC EXCITATORY SYNAPSE	57	3.05e-01	6.58e-01	0.1810	-6.58e-02	-2.84e-02	3.87e-02	1.51e-01	5.70e-02	3.90e-01	7.11e-01	6.14e-01	4.81e-02	4.57e-01
GOBP CARDIAC CONDUCTION	94	1.51e-01	4.78e-01	0.1810	-1.19e-01	9.19e-02	8.19e-02	3.43e-02	-4.83e-02	4.64e-02	1.23e-01	1.70e-01	5.65e-01	4.18e-01
GOBP NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT	36	7.51e-01	9.16e-01	0.1810	-2.26e-02	7.57e-02	1.05e-01	1.05e-01	-6.69e-02	8.14e-01	4.32e-01	2.77e-01	2.73e-01	4.87e-01
GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE	192	2.92e-03	3.59e-02	0.1810	-1.10e-01	1.03e-01	7.43e-02	1.42e-02	6.47e-02	8.33e-03	1.35e-02	7.59e-02	7.35e-01	1.22e-01
GOBP MUSCLE HYPERTROPHY	103	6.77e-02	3.07e-01	0.1810	-8.32e-02	9.80e-03	1.52e-01	2.88e-03	5.02e-02	1.45e-01	8.64e-01	7.52e-03	9.60e-01	3.79e-01
GOBP KETONE CATABOLIC PROCESS	14	9.34e-01	9.80e-01	0.1810	-2.66e-02	9.64e-02	3.51e-02	-5.86e-02	1.34e-01	8.63e-01	5.32e-01	8.20e-01	7.04e-01	3.84e-01
GOBP POSITIVE REGULATION OF STEROL TRANSPORT	38	6.24e-01	8.66e-01	0.1810	-9.70e-02	9.11e-02	1.56e-02	6.61e-02	-1.02e-01	3.01e-01	3.31e-01	8.68e-01	4.81e-01	2.77e-01
GOBP DEFINITIVE HEMOPOIESIS	19	8.53e-01	9.51e-01	0.1810	1.37e-01	6.96e-02	9.40e-02	-5.35e-04	-1.25e-02	2.99e-01	6.00e-01	4.78e-01	9.97e-01	9.25e-01
GOMF NUCLEAR RECEPTOR BINDING	132	4.26e-02	2.29e-01	0.1810	2.22e-02	6.95e-02	-5.80e-02	-1.55e-01	-9.66e-03	6.59e-01	1.68e-01	2.50e-01	2.15e-03	8.48e-01
GOBP EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING	658	2.53e-10	2.21e-08	0.1810	5.72e-02	4.07e-02	-4.23e-02	-1.51e-01	5.55e-02	1.23e-02	7.46e-02	6.40e-02	3.51e-11	1.51e-02
GOBP REGULATION OF PROTEIN IMPORT INTO NUCLEUS	57	4.29e-01	7.54e-01	0.1810	8.70e-02	-5.14e-02	-2.74e-02	-9.95e-02	1.09e-01	2.56e-01	5.02e-01	7.21e-01	1.94e-01	1.56e-01
GOBP RETINAL CELL APOPTOTIC PROCESS	7	9.82e-01	9.94e-01	0.1800	-4.74e-02	-6.66e-02	3.27e-02	1.92e-02	1.56e-01	8.28e-01	7.60e-01	8.81e-01	9.30e-01	4.74e-01
GOBP CEREBELLAR CORTEX FORMATION	24	7.69e-01	9.24e-01	0.1800	-4.39e-03	-1.52e-01	6.63e-02	9.60e-03	7.10e-02	9.70e-01	1.98e-01	5.74e-01	9.35e-01	5.47e-01
GOBP MYELOID LEUKOCYTE ACTIVATION	235	8.15e-04	1.32e-02	0.1800	-7.45e-02	1.35e-01	8.17e-02	1.43e-02	4.23e-02	4.90e-02	3.48e-04	3.10e-02	7.05e-01	2.64e-01
GOBP IMPORT ACROSS PLASMA MEMBRANE	202	9.04e-03	8.16e-02	0.1800	-8.01e-02	4.34e-02	7.39e-02	1.16e-01	-7.25e-02	4.97e-02	2.88e-01	7.01e-02	4.40e-03	7.57e-02
GOBP NATURAL KILLER CELL DEGRANULATION	10	9.52e-01	9.85e-01	0.1800	1.00e-01	-4.53e-02	-6.28e-02	5.69e-02	1.15e-01	5.84e-01	8.04e-01	7.31e-01	7.55e-01	5.28e-01
GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY TRANSPOSING C C BONDS	14	9.27e-01	9.77e-01	0.1800	7.28e-03	1.32e-01	9.06e-02	-1.07e-02	-8.22e-02	9.62e-01	3.93e-01	5.57e-01	9.44e-01	5.94e-01
GOBP REGULATION OF NATURAL KILLER CELL ACTIVATION	41	4.92e-01	7.99e-01	0.1800	-6.42e-02	9.38e-02	2.30e-02	-8.22e-02	-1.11e-01	4.77e-01	2.99e-01	7.99e-01	3.62e-01	2.19e-01
GOCC RECEPTOR COMPLEX	380	5.91e-05	1.56e-03	0.1800	-4.33e-02	2.46e-02	1.41e-01	9.97e-02	-1.22e-02	1.47e-01	4.10e-01	2.33e-06	8.41e-04	6.83e-01
GOBP LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE	201	1.75e-03	2.44e-02	0.1800	-8.41e-02	1.53e-01	2.72e-02	-3.67e-02	-3.84e-03	3.97e-02	1.91e-04	5.06e-01	3.70e-01	9.25e-01
GOBP INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION	34	6.65e-01	8.82e-01	0.1800	-1.46e-01	8.69e-02	2.13e-02	-1.23e-02	-5.41e-02	1.40e-01	3.80e-01	8.30e-01	9.01e-01	5.85e-01
GOBP POST TRANSLATIONAL PROTEIN MODIFICATION	993	1.16e-14	1.45e-12	0.1800	4.52e-02	3.21e-02	-7.58e-02	-1.52e-01	2.01e-02	1.59e-02	8.70e-02	5.30e-05	4.26e-16	2.83e-01
GOMF MECHANOSENSITIVE MONOATOMIC ION CHANNEL ACTIVITY	16	9.47e-01	9.83e-01	0.1800	-5.39e-02	-2.95e-02	1.07e-01	1.11e-01	-7.07e-02	7.09e-01	8.38e-01	4.61e-01	4.43e-01	6.24e-01
GOBP NEGATIVE REGULATION BY HOST OF VIRAL PROCESS	14	9.19e-01	9.74e-01	0.1800	9.20e-02	-1.47e-01	3.13e-03	2.26e-02	-4.31e-02	5.51e-01	3.42e-01	9.84e-01	8.84e-01	7.80e-01
GOBP PEPTIDYL LYSINE ACETYLATION	64	3.57e-01	7.02e-01	0.1800	1.10e-01	5.00e-02	-3.85e-02	-1.24e-01	3.26e-02	1.30e-01	4.89e-01	5.95e-01	8.64e-02	6.52e-01
GOBP REGULATION OF FATTY ACID OXIDATION	33	6.49e-01	8.77e-01	0.1800	2.94e-02	1.49e-01	3.53e-03	2.92e-03	9.71e-02	7.70e-01	1.40e-01	9.72e-01	9.77e-01	3.34e-01
GOBP METANEPHRIC GLOMERULUS DEVELOPMENT	16	9.07e-01	9.69e-01	0.1800	2.18e-02	-3.05e-02	1.65e-01	4.52e-02	4.12e-02	8.80e-01	8.33e-01	2.53e-01	7.54e-01	7.75e-01
GOBP INTRACELLULAR PROTEIN TRANSPORT	837	3.67e-12	3.99e-10	0.1800	-9.81e-04	3.53e-02	-8.82e-02	-1.53e-01	5.44e-03	9.62e-01	8.31e-02	1.46e-05	6.01e-14	7.89e-01
GOBP NEGATIVE REGULATION OF LIPASE ACTIVITY	15	8.72e-01	9.58e-01	0.1800	-1.04e-01	5.66e-02	1.59e-02	1.04e-01	8.52e-02	4.88e-01	7.04e-01	9.15e-01	4.84e-01	5.68e-01
GOBP ACTIN NUCLEATION	53	4.26e-01	7.52e-01	0.1800	-7.39e-02	-9.34e-03	-6.49e-02	-8.43e-02	-1.24e-01	3.52e-01	9.06e-01	4.14e-01	2.88e-01	1.17e-01
GOBP IMMUNE RESPONSE TO TUMOR CELL	26	7.21e-01	9.02e-01	0.1800	-8.06e-02	9.49e-02	-1.16e-01	-4.92e-02	3.01e-02	4.77e-01	4.02e-01	3.06e-01	6.64e-01	7.91e-01
GOBP DETERMINATION OF ADULT LIFESPAN	35	6.66e-01	8.82e-01	0.1800	-3.06e-02	-1.45e-01	-6.92e-02	-1.04e-02	7.37e-02	7.54e-01	1.38e-01	4.79e-01	9.15e-01	4.51e-01
GOBP PROTEIN POLYUBIQUITINATION	218	3.88e-03	4.48e-02	0.1800	3.60e-02	3.74e-02	-5.16e-02	-1.54e-01	5.68e-02	3.60e-01	3.41e-01	1.89e-01	8.98e-05	1.48e-01
GOBP REGULATION OF JNK CASCADE	127	9.06e-02	3.63e-01	0.1800	-1.51e-02	8.57e-02	1.32e-01	7.89e-02	3.19e-02	7.69e-01	9.52e-02	1.02e-02	1.25e-01	5.35e-01
GOBP ZYMOGEN ACTIVATION	57	3.78e-01	7.17e-01	0.1800	-1.51e-01	3.86e-02	-1.78e-02	-9.29e-03	-8.72e-02	4.89e-02	6.14e-01	8.16e-01	9.03e-01	2.55e-01
GOBP UROGENITAL SYSTEM DEVELOPMENT	66	1.53e-01	4.81e-01	0.1800	5.71e-03	-2.55e-02	2.25e-02	-1.73e-01	3.51e-02	9.36e-01	7.20e-01	7.52e-01	1.53e-02	6.22e-01
GOBP EMBRYONIC PATTERN SPECIFICATION	68	3.54e-01	7.00e-01	0.1800	1.12e-02	1.88e-02	1.62e-01	6.89e-02	2.91e-02	8.74e-01	7.89e-01	2.11e-02	3.26e-01	6.79e-01
GOMF METALLODIPEPTIDASE ACTIVITY	8	9.79e-01	9.93e-01	0.1800	-1.50e-01	4.86e-02	4.57e-02	7.15e-02	1.19e-02	4.62e-01	8.12e-01	8.23e-01	7.26e-01	9.54e-01
GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC	15	9.21e-01	9.74e-01	0.1790	-1.42e-01	5.96e-02	-3.02e-02	-3.64e-02	-7.96e-02	3.42e-01	6.89e-01	8.39e-01	8.07e-01	5.93e-01
GOBP INDUCTION OF POSITIVE CHEMOTAXIS	13	9.40e-01	9.81e-01	0.1790	5.64e-02	7.17e-02	4.99e-02	6.09e-02	1.33e-01	7.25e-01	6.54e-01	7.55e-01	7.04e-01	4.07e-01
GOBP NEGATIVE REGULATION OF ACTIN NUCLEATION	9	9.76e-01	9.93e-01	0.1790	2.60e-02	1.29e-01	-7.89e-02	-8.30e-02	-4.10e-02	8.93e-01	5.02e-01	6.82e-01	6.66e-01	8.31e-01
GOBP POSITIVE REGULATION OF STEM CELL PROLIFERATION	53	3.67e-01	7.07e-01	0.1790	-2.90e-02	-8.34e-02	3.24e-02	-8.60e-02	1.26e-01	7.15e-01	2.94e-01	6.84e-01	2.79e-01	1.12e-01
GOBP CHOLESTEROL CATABOLIC PROCESS	9	9.51e-01	9.85e-01	0.1790	-9.74e-02	9.45e-02	2.26e-03	1.06e-01	5.00e-02	6.13e-01	6.24e-01	9.91e-01	5.82e-01	7.95e-01
GOMF PROTEIN METHYLTRANSFERASE ACTIVITY	92	9.84e-02	3.79e-01	0.1790	8.40e-02	-4.52e-02	1.77e-03	-1.33e-01	7.30e-02	1.64e-01	4.54e-01	9.77e-01	2.75e-02	2.26e-01
GOBP NEGATIVE REGULATION OF AXONOGENESIS	60	3.83e-01	7.21e-01	0.1790	-1.31e-01	8.65e-02	6.69e-02	5.45e-02	-4.18e-03	7.95e-02	2.46e-01	3.70e-01	4.65e-01	9.55e-01
GOBP INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	50	4.27e-01	7.54e-01	0.1790	-5.22e-03	1.45e-01	8.34e-03	-5.51e-02	-8.95e-02	9.49e-01	7.68e-02	9.19e-01	5.01e-01	2.73e-01
GOBP NEGATIVE REGULATION OF BLOOD CIRCULATION	24	7.77e-01	9.27e-01	0.1790	-6.76e-02	-1.22e-01	6.52e-02	-1.18e-02	9.05e-02	5.66e-01	3.00e-01	5.80e-01	9.21e-01	4.43e-01
GOBP ADULT LOCOMOTORY BEHAVIOR	80	9.40e-02	3.71e-01	0.1790	1.54e-02	7.85e-03	7.22e-02	-1.35e-01	9.12e-02	8.12e-01	9.03e-01	2.64e-01	3.68e-02	1.59e-01
GOBP PURINE NUCLEOBASE METABOLIC PROCESS	19	9.20e-01	9.74e-01	0.1790	2.91e-02	-2.16e-02	-1.55e-01	-8.03e-02	-1.05e-02	8.26e-01	8.71e-01	2.41e-01	5.45e-01	9.37e-01
GOBP NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY	30	7.45e-01	9.14e-01	0.1790	1.18e-01	-7.64e-03	5.06e-02	1.02e-01	-7.17e-02	2.65e-01	9.42e-01	6.31e-01	3.34e-01	4.97e-01
GOBP REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION	89	1.36e-01	4.54e-01	0.1790	-2.69e-02	1.47e-01	1.26e-02	-9.75e-02	-1.54e-04	6.60e-01	1.66e-02	8.37e-01	1.12e-01	9.98e-01
GOBP REGULATION OF MAINTENANCE OF SISTER CHROMATID COHESION	7	9.89e-01	9.96e-01	0.1790	-5.92e-02	7.23e-02	1.47e-01	3.62e-02	-1.73e-02	7.86e-01	7.41e-01	5.00e-01	8.68e-01	9.37e-01
GOBP NEGATIVE REGULATION OF FIBRINOLYSIS	13	9.30e-01	9.78e-01	0.1790	3.77e-02	-1.67e-01	7.69e-03	8.79e-03	-5.13e-02	8.14e-01	2.98e-01	9.62e-01	9.56e-01	7.49e-01
GOBP GALACTOSE CATABOLIC PROCESS	5	9.84e-01	9.94e-01	0.1790	-1.24e-02	-1.30e-01	3.11e-02	-1.16e-01	-1.76e-02	9.62e-01	6.14e-01	9.04e-01	6.52e-01	9.46e-01
GOBP POSITIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT	148	2.85e-02	1.77e-01	0.1790	-4.79e-02	-4.62e-02	1.44e-01	7.34e-02	-3.71e-02	3.15e-01	3.32e-01	2.48e-03	1.23e-01	4.36e-01
GOBP ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY	25	7.76e-01	9.26e-01	0.1790	-4.41e-02	-3.86e-02	5.32e-02	8.15e-02	1.38e-01	7.03e-01	7.38e-01	6.45e-01	4.81e-01	2.33e-01
GOBP REGULATION OF NITRIC OXIDE METABOLIC PROCESS	57	2.36e-01	5.91e-01	0.1790	-7.61e-02	1.53e-04	-9.10e-02	-6.39e-03	1.33e-01	3.20e-01	9.98e-01	2.35e-01	9.33e-01	8.15e-02
GOMF STRUCTURAL CONSTITUENT OF MUSCLE	41	4.32e-01	7.56e-01	0.1790	3.70e-03	-7.82e-02	-4.88e-02	1.53e-01	-1.68e-03	9.67e-01	3.86e-01	5.89e-01	9.01e-02	9.85e-01
GOBP REGULATION OF CENTRIOLE REPLICATION	23	8.53e-01	9.51e-01	0.1790	1.49e-01	4.59e-02	-6.20e-02	-5.07e-02	3.53e-02	2.17e-01	7.03e-01	6.06e-01	6.74e-01	7.70e-01
GOCC MONOATOMIC ION CHANNEL COMPLEX	285	6.72e-04	1.12e-02	0.1790	-9.94e-02	6.06e-02	1.14e-01	7.05e-02	-1.94e-02	3.87e-03	7.84e-02	9.40e-04	4.05e-02	5.73e-01
GOBP CRANIAL NERVE DEVELOPMENT	61	2.64e-01	6.19e-01	0.1780	5.38e-02	1.06e-01	1.27e-01	-4.02e-02	-2.12e-04	4.67e-01	1.52e-01	8.64e-02	5.87e-01	9.98e-01
GOBP PROTEIN CONTAINING COMPLEX ASSEMBLY	1521	3.01e-20	6.42e-18	0.1780	2.78e-02	3.12e-02	-1.04e-01	-1.36e-01	2.88e-02	7.03e-02	4.24e-02	1.06e-11	8.76e-19	6.07e-02
GOBP NEGATIVE REGULATION OF BINDING	118	1.29e-01	4.44e-01	0.1780	4.62e-02	-2.00e-02	-7.67e-02	-1.33e-01	7.49e-02	3.86e-01	7.08e-01	1.50e-01	1.23e-02	1.60e-01
GOBP POSITIVE REGULATION OF LIPASE ACTIVITY	59	3.44e-01	6.90e-01	0.1780	-1.25e-01	-3.36e-02	1.31e-03	1.17e-01	-3.81e-02	9.68e-02	6.56e-01	9.86e-01	1.21e-01	6.13e-01
GOBP CALCINEURIN MEDIATED SIGNALING	48	5.69e-01	8.38e-01	0.1780	-6.56e-02	4.98e-02	3.85e-02	9.61e-02	-1.20e-01	4.32e-01	5.50e-01	6.45e-01	2.49e-01	1.52e-01
GOBP PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS	83	2.13e-01	5.66e-01	0.1780	-1.04e-02	9.77e-02	-7.19e-02	-9.58e-02	8.83e-02	8.70e-01	1.24e-01	2.57e-01	1.31e-01	1.64e-01
GOMF LIGASE ACTIVITY FORMING CARBON NITROGEN BONDS	49	4.97e-01	8.02e-01	0.1780	-7.14e-02	9.77e-02	-3.05e-02	-1.22e-01	3.52e-02	3.87e-01	2.37e-01	7.12e-01	1.38e-01	6.70e-01
GOMF PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY	89	1.42e-01	4.63e-01	0.1780	1.32e-01	7.68e-02	-9.86e-03	-9.09e-02	4.17e-03	3.09e-02	2.10e-01	8.72e-01	1.38e-01	9.46e-01
GOBP RESPONSE TO ENDOPLASMIC RETICULUM STRESS	257	6.18e-04	1.04e-02	0.1780	-1.20e-02	6.96e-02	-5.45e-02	-1.54e-01	-3.72e-04	7.41e-01	5.48e-02	1.32e-01	2.03e-05	9.92e-01
GOBP NEGATIVE REGULATION OF PEPTIDASE ACTIVITY	125	1.02e-01	3.87e-01	0.1780	-2.70e-02	-5.87e-02	1.06e-01	1.23e-01	-3.55e-02	6.02e-01	2.57e-01	4.05e-02	1.77e-02	4.93e-01
GOMF MITOGEN ACTIVATED PROTEIN KINASE BINDING	29	6.79e-01	8.87e-01	0.1780	4.65e-02	9.67e-02	8.64e-04	-1.18e-01	-7.92e-02	6.65e-01	3.67e-01	9.94e-01	2.70e-01	4.61e-01
GOMF ALCOHOL BINDING	87	1.13e-01	4.11e-01	0.1780	-1.10e-01	6.85e-02	-4.11e-02	6.28e-02	-9.68e-02	7.66e-02	2.70e-01	5.08e-01	3.11e-01	1.19e-01
GOBP UBIQUITIN DEPENDENT GLYCOPROTEIN ERAD PATHWAY	7	9.74e-01	9.92e-01	0.1780	-9.34e-02	1.72e-02	1.35e-01	-6.35e-02	1.88e-02	6.69e-01	9.37e-01	5.35e-01	7.71e-01	9.31e-01
GOMF MANNOSYL OLIGOSACCHARIDE 1 2 ALPHA MANNOSIDASE ACTIVITY	7	9.74e-01	9.92e-01	0.1780	-9.34e-02	1.72e-02	1.35e-01	-6.35e-02	1.88e-02	6.69e-01	9.37e-01	5.35e-01	7.71e-01	9.31e-01
GOBP BIOGENIC AMINE METABOLIC PROCESS	87	1.57e-01	4.85e-01	0.1780	-5.73e-02	1.06e-01	8.60e-02	-3.72e-04	-9.91e-02	3.55e-01	8.76e-02	1.66e-01	9.95e-01	1.10e-01
GOBP POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY	143	2.49e-02	1.62e-01	0.1780	-9.59e-02	5.05e-02	1.41e-01	9.73e-03	9.91e-03	4.77e-02	2.97e-01	3.70e-03	8.41e-01	8.38e-01
GOBP REGULATION OF SKELETAL MUSCLE CELL PROLIFERATION	15	9.44e-01	9.82e-01	0.1780	1.24e-01	4.86e-02	-5.00e-02	-9.40e-02	5.04e-02	4.04e-01	7.45e-01	7.37e-01	5.29e-01	7.35e-01
GOBP LIVER MORPHOGENESIS	25	7.69e-01	9.24e-01	0.1780	-1.64e-01	9.63e-03	1.35e-02	1.28e-02	6.67e-02	1.57e-01	9.34e-01	9.07e-01	9.12e-01	5.64e-01
GOBP LEUKOCYTE AGGREGATION	12	9.27e-01	9.77e-01	0.1780	6.60e-03	1.70e-01	-3.57e-02	3.58e-02	3.32e-03	9.68e-01	3.07e-01	8.30e-01	8.30e-01	9.84e-01
GOBP REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS	159	1.21e-02	9.98e-02	0.1780	-3.69e-02	7.26e-02	4.00e-02	-1.01e-01	1.15e-01	4.22e-01	1.14e-01	3.85e-01	2.84e-02	1.22e-02
GOBP NOTCH SIGNALING PATHWAY	173	4.21e-03	4.74e-02	0.1780	2.27e-02	1.07e-01	3.26e-02	-1.33e-01	3.14e-02	6.07e-01	1.50e-02	4.59e-01	2.63e-03	4.76e-01
GOBP REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY	33	7.27e-01	9.05e-01	0.1780	1.48e-02	2.41e-03	7.84e-02	1.50e-01	5.30e-02	8.83e-01	9.81e-01	4.36e-01	1.36e-01	5.98e-01
GOBP NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY	32	7.30e-01	9.07e-01	0.1780	-7.35e-02	-8.80e-02	-1.29e-01	-1.68e-02	-3.96e-02	4.72e-01	3.89e-01	2.07e-01	8.70e-01	6.99e-01
GOCC LATE ENDOSOME MEMBRANE	165	1.50e-02	1.17e-01	0.1780	-1.80e-02	9.58e-02	-4.52e-02	-1.42e-01	3.61e-03	6.90e-01	3.38e-02	3.16e-01	1.69e-03	9.36e-01
GOBP REGULATION OF IMMUNOGLOBULIN PRODUCTION	70	3.10e-01	6.62e-01	0.1780	4.89e-02	1.31e-01	-2.07e-02	-9.78e-02	4.41e-02	4.79e-01	5.72e-02	7.65e-01	1.57e-01	5.23e-01
GOBP PLASMA LIPOPROTEIN PARTICLE CLEARANCE	54	4.19e-01	7.48e-01	0.1780	4.97e-02	4.78e-02	6.72e-03	6.02e-02	-1.52e-01	5.27e-01	5.44e-01	9.32e-01	4.44e-01	5.29e-02
GOBP TRANSITION METAL ION TRANSPORT	93	5.13e-02	2.59e-01	0.1780	-3.80e-02	5.64e-02	6.84e-02	-1.44e-01	3.77e-02	5.26e-01	3.48e-01	2.54e-01	1.60e-02	5.30e-01
GOBP RIBONUCLEOPROTEIN COMPLEX LOCALIZATION	9	9.78e-01	9.93e-01	0.1780	-7.33e-02	8.52e-02	-9.22e-02	-1.02e-01	7.75e-04	7.03e-01	6.58e-01	6.32e-01	5.96e-01	9.97e-01
GOBP REGULATION OF CHOLESTEROL METABOLIC PROCESS	40	5.14e-01	8.09e-01	0.1780	1.25e-02	3.66e-02	-2.34e-02	-7.87e-02	-1.53e-01	8.91e-01	6.89e-01	7.98e-01	3.89e-01	9.46e-02
GOBP POSITIVE REGULATION OF MACROAUTOPHAGY	71	3.79e-01	7.17e-01	0.1780	5.86e-02	7.02e-02	-7.68e-02	-1.16e-01	6.28e-02	3.93e-01	3.07e-01	2.63e-01	9.23e-02	3.60e-01
GOBP REGULATION OF CELL CYCLE G2 M PHASE TRANSITION	110	1.61e-01	4.92e-01	0.1780	3.77e-02	4.35e-02	-8.65e-02	-1.38e-01	4.06e-02	4.95e-01	4.31e-01	1.17e-01	1.23e-02	4.62e-01
GOBP SPHINGOLIPID CATABOLIC PROCESS	32	6.40e-01	8.74e-01	0.1780	-2.92e-02	-9.14e-02	2.84e-02	-1.08e-01	9.88e-02	7.75e-01	3.71e-01	7.81e-01	2.89e-01	3.33e-01
GOBP REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY	132	5.21e-02	2.62e-01	0.1770	-2.02e-02	7.19e-02	-3.36e-02	-1.47e-01	5.77e-02	6.89e-01	1.54e-01	5.04e-01	3.65e-03	2.52e-01
GOMF CYTOKINE BINDING	133	7.80e-02	3.35e-01	0.1770	-6.53e-02	5.28e-02	1.35e-01	6.67e-02	-4.22e-02	1.93e-01	2.93e-01	7.18e-03	1.84e-01	4.01e-01
GOBP NEUROTRANSMITTER REUPTAKE	34	6.75e-01	8.85e-01	0.1770	1.63e-01	1.58e-02	2.38e-02	5.79e-02	2.69e-02	9.98e-02	8.73e-01	8.10e-01	5.59e-01	7.86e-01
GOMF PALMITOYLTRANSFERASE ACTIVITY	34	6.94e-01	8.93e-01	0.1770	-3.89e-02	8.66e-03	-7.41e-03	-1.41e-01	9.97e-02	6.95e-01	9.30e-01	9.40e-01	1.55e-01	3.14e-01
GOBP REGULATION OF NUCLEOTIDE EXCISION REPAIR	28	5.33e-01	8.20e-01	0.1770	-1.03e-02	-4.49e-02	9.23e-02	-1.39e-01	3.84e-02	9.25e-01	6.81e-01	3.98e-01	2.03e-01	7.25e-01
GOBP PROGRAMMED NECROTIC CELL DEATH	56	4.51e-01	7.71e-01	0.1770	2.62e-02	-4.08e-04	-7.15e-02	-1.58e-01	-2.35e-02	7.35e-01	9.96e-01	3.55e-01	4.02e-02	7.61e-01
GOBP CELL JUNCTION ASSEMBLY	422	2.54e-05	7.59e-04	0.1770	-5.35e-02	1.31e-02	1.31e-01	1.02e-01	-3.21e-02	5.94e-02	6.45e-01	4.07e-06	3.48e-04	2.59e-01
GOBP REGULATION OF LYASE ACTIVITY	57	3.86e-01	7.24e-01	0.1770	-4.00e-02	9.08e-02	7.29e-02	5.31e-02	1.16e-01	6.01e-01	2.36e-01	3.41e-01	4.88e-01	1.30e-01
GOBP INTRACELLULAR IRON ION HOMEOSTASIS	66	2.18e-01	5.73e-01	0.1770	-2.74e-02	1.15e-01	1.01e-01	-8.46e-02	1.12e-02	7.00e-01	1.06e-01	1.57e-01	2.35e-01	8.75e-01
GOCC NEUROTRANSMITTER RECEPTOR COMPLEX	42	5.20e-01	8.13e-01	0.1770	-1.06e-01	-1.24e-01	6.13e-02	-1.47e-03	3.47e-02	2.37e-01	1.65e-01	4.92e-01	9.87e-01	6.98e-01
GOBP DICARBOXYLIC ACID TRANSPORT	98	1.50e-01	4.76e-01	0.1770	1.85e-03	1.03e-01	6.62e-02	1.25e-01	-2.88e-02	9.75e-01	7.87e-02	2.57e-01	3.23e-02	6.23e-01
GOBP INTRACELLULAR TRANSPORT	1507	5.57e-21	1.24e-18	0.1770	1.78e-02	4.45e-02	-8.14e-02	-1.48e-01	2.46e-02	2.49e-01	3.91e-03	1.28e-07	7.05e-22	1.10e-01
GOMF HISTONE H3 METHYLTRANSFERASE ACTIVITY	42	5.02e-01	8.03e-01	0.1770	1.35e-01	-3.52e-03	1.02e-01	-6.71e-03	5.14e-02	1.29e-01	9.69e-01	2.52e-01	9.40e-01	5.65e-01
GOCC CELL DIVISION SITE	70	3.71e-01	7.11e-01	0.1770	1.17e-02	5.18e-02	-1.35e-01	-1.01e-01	-3.83e-03	8.65e-01	4.54e-01	5.04e-02	1.42e-01	9.56e-01
GOBP REGULATION OF HEART RATE	99	2.00e-01	5.50e-01	0.1770	1.10e-02	7.98e-02	9.14e-02	1.23e-01	-3.93e-02	8.50e-01	1.70e-01	1.16e-01	3.51e-02	4.99e-01
GOBP IMPORT INTO NUCLEUS	162	3.83e-02	2.14e-01	0.1770	2.38e-02	-8.31e-02	-8.89e-02	-1.12e-01	5.90e-02	6.02e-01	6.81e-02	5.09e-02	1.39e-02	1.95e-01
GOBP OLIGODENDROCYTE DEVELOPMENT	44	5.96e-01	8.50e-01	0.1770	1.44e-01	-2.00e-02	-8.21e-02	-5.81e-02	-1.15e-02	9.86e-02	8.19e-01	3.46e-01	5.05e-01	8.95e-01
GOBP SKELETAL SYSTEM MORPHOGENESIS	226	1.99e-03	2.67e-02	0.1770	2.81e-02	5.24e-02	1.06e-02	-1.07e-01	1.28e-01	4.66e-01	1.75e-01	7.84e-01	5.61e-03	9.51e-04
GOMF DYNEIN LIGHT CHAIN BINDING	9	9.65e-01	9.90e-01	0.1770	-2.72e-03	9.51e-02	-1.33e-01	-1.55e-02	-6.54e-02	9.89e-01	6.21e-01	4.89e-01	9.36e-01	7.34e-01
GOBP RNA CATABOLIC PROCESS	348	2.32e-06	9.26e-05	0.1770	-4.73e-02	-2.00e-02	-1.66e-02	-1.66e-01	3.01e-02	1.30e-01	5.21e-01	5.96e-01	1.05e-07	3.35e-01
GOBP NEGATIVE REGULATION OF MACROPHAGE ACTIVATION	17	9.03e-01	9.68e-01	0.1770	-8.66e-02	6.01e-02	7.26e-02	4.34e-02	1.14e-01	5.37e-01	6.68e-01	6.04e-01	7.57e-01	4.14e-01
GOBP POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY	98	1.72e-01	5.11e-01	0.1770	-8.69e-02	5.11e-02	1.36e-01	4.62e-02	-2.06e-02	1.37e-01	3.82e-01	1.96e-02	4.29e-01	7.24e-01
GOBP REGULATION OF GLIAL CELL DIFFERENTIATION	78	2.63e-01	6.19e-01	0.1770	6.22e-02	-2.29e-02	-2.14e-02	-1.26e-01	1.03e-01	3.43e-01	7.26e-01	7.44e-01	5.50e-02	1.14e-01
GOMF MONOCARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY	58	4.92e-01	7.99e-01	0.1770	2.81e-02	9.53e-02	1.10e-01	7.80e-02	-5.76e-02	7.12e-01	2.09e-01	1.48e-01	3.04e-01	4.48e-01
GOBP AMINO ACID IMPORT ACROSS PLASMA MEMBRANE	44	5.63e-01	8.34e-01	0.1770	-8.44e-02	6.42e-02	5.10e-02	1.01e-02	-1.32e-01	3.33e-01	4.61e-01	5.59e-01	9.08e-01	1.30e-01
GOBP CELL CYCLE G2 M PHASE TRANSITION	148	6.68e-02	3.05e-01	0.1770	2.67e-02	2.18e-02	-9.93e-02	-1.40e-01	2.53e-02	5.75e-01	6.47e-01	3.71e-02	3.29e-03	5.96e-01
GOBP CELL CELL ADHESION	918	7.80e-12	7.83e-10	0.1770	-4.06e-02	4.18e-02	1.30e-01	1.04e-01	7.74e-03	3.68e-02	3.16e-02	2.13e-11	8.96e-08	6.91e-01
GOBP POST GOLGI VESICLE MEDIATED TRANSPORT	101	5.70e-02	2.77e-01	0.1770	-9.15e-02	1.21e-03	-9.28e-04	-1.51e-01	-1.55e-02	1.12e-01	9.83e-01	9.87e-01	8.95e-03	7.87e-01
GOMF ALPHA TUBULIN BINDING	37	6.46e-01	8.76e-01	0.1770	1.32e-01	5.25e-02	2.39e-02	-7.82e-02	6.67e-02	1.66e-01	5.80e-01	8.01e-01	4.10e-01	4.82e-01
GOMF P53 BINDING	64	3.65e-01	7.05e-01	0.1770	7.98e-02	5.52e-02	-2.87e-02	-1.40e-01	3.69e-02	2.70e-01	4.45e-01	6.91e-01	5.25e-02	6.09e-01
GOMF ACETYLGLUCOSAMINYLTRANSFERASE ACTIVITY	42	5.74e-01	8.40e-01	0.1770	7.66e-02	1.52e-01	3.48e-02	-2.61e-02	-2.23e-02	3.91e-01	8.91e-02	6.96e-01	7.70e-01	8.02e-01
GOBP MONOSACCHARIDE METABOLIC PROCESS	249	3.10e-03	3.77e-02	0.1770	5.96e-02	5.03e-02	-7.46e-02	-1.24e-01	6.57e-02	1.05e-01	1.72e-01	4.28e-02	7.82e-04	7.43e-02
GOBP CELL PROLIFERATION IN FOREBRAIN	26	8.30e-01	9.44e-01	0.1770	-1.96e-02	-1.05e-01	-5.37e-02	-8.76e-02	9.65e-02	8.63e-01	3.56e-01	6.35e-01	4.39e-01	3.95e-01
GOBP POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN	63	3.60e-01	7.04e-01	0.1770	-6.83e-02	7.98e-02	1.18e-01	-2.03e-03	7.88e-02	3.49e-01	2.73e-01	1.05e-01	9.78e-01	2.79e-01
GOBP POSITIVE REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY	18	8.34e-01	9.45e-01	0.1770	8.35e-02	-9.78e-04	1.69e-02	-4.23e-02	-1.49e-01	5.40e-01	9.94e-01	9.01e-01	7.56e-01	2.74e-01
GOMF RNA POLYMERASE II GENERAL TRANSCRIPTION INITIATION FACTOR BINDING	23	8.56e-01	9.52e-01	0.1770	9.72e-02	-1.09e-01	-5.13e-02	-3.06e-02	7.92e-02	4.20e-01	3.65e-01	6.70e-01	7.99e-01	5.11e-01
GOMF ANTIGEN BINDING	66	2.95e-01	6.49e-01	0.1760	-9.89e-02	-2.59e-02	1.31e-01	1.73e-02	5.67e-02	1.65e-01	7.16e-01	6.56e-02	8.08e-01	4.25e-01
GOBP PIGMENT METABOLIC PROCESS	74	2.22e-01	5.76e-01	0.1760	2.36e-02	1.41e-01	-1.68e-02	-2.88e-02	9.73e-02	7.25e-01	3.54e-02	8.03e-01	6.68e-01	1.48e-01
GOBP RESPONSE TO REDOX STATE	14	9.34e-01	9.80e-01	0.1760	-9.74e-02	1.36e-02	-4.28e-02	-9.97e-02	-9.85e-02	5.28e-01	9.30e-01	7.82e-01	5.18e-01	5.24e-01
GOBP AXIS SPECIFICATION	91	9.49e-02	3.72e-01	0.1760	6.77e-02	3.68e-02	8.80e-02	-8.73e-02	9.91e-02	2.65e-01	5.45e-01	1.47e-01	1.50e-01	1.02e-01
GOBP NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS	25	6.67e-01	8.82e-01	0.1760	2.42e-02	-3.19e-02	9.40e-02	-1.19e-01	8.11e-02	8.34e-01	7.82e-01	4.16e-01	3.04e-01	4.83e-01
GOBP LIPOPROTEIN LOCALIZATION	21	8.74e-01	9.59e-01	0.1760	4.66e-02	6.51e-03	2.54e-02	1.47e-01	-8.18e-02	7.12e-01	9.59e-01	8.40e-01	2.44e-01	5.16e-01
GOBP POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION	71	1.98e-01	5.47e-01	0.1760	-1.08e-01	8.46e-02	7.15e-02	-8.48e-02	-5.98e-03	1.17e-01	2.18e-01	2.97e-01	2.17e-01	9.31e-01
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS	62	4.09e-01	7.42e-01	0.1760	-2.24e-02	3.57e-02	-7.79e-02	-1.47e-01	-4.03e-02	7.60e-01	6.27e-01	2.89e-01	4.53e-02	5.83e-01
GOMF HISTONE H3K14 ACETYLTRANSFERASE ACTIVITY	9	9.67e-01	9.90e-01	0.1760	-1.44e-02	1.26e-01	3.96e-02	-1.03e-01	-5.27e-02	9.40e-01	5.13e-01	8.37e-01	5.92e-01	7.84e-01
GOBP INTERLEUKIN 8 PRODUCTION	96	2.11e-01	5.63e-01	0.1760	-9.58e-02	4.19e-02	1.15e-01	6.47e-02	-5.16e-02	1.05e-01	4.79e-01	5.11e-02	2.73e-01	3.82e-01
GOBP MYOBLAST DIFFERENTIATION	109	6.53e-02	3.01e-01	0.1760	3.45e-02	8.35e-02	9.12e-03	-1.48e-01	3.14e-02	5.33e-01	1.32e-01	8.69e-01	7.74e-03	5.71e-01
GOBP PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION	772	1.02e-10	9.59e-09	0.1760	2.69e-02	3.10e-02	-7.92e-02	-1.51e-01	1.46e-02	2.03e-01	1.43e-01	1.80e-04	8.88e-13	4.89e-01
GOBP REGULATION OF ENDOCYTOSIS	281	9.37e-05	2.24e-03	0.1760	-1.28e-01	9.20e-02	6.71e-02	-4.07e-02	3.38e-03	2.25e-04	7.95e-03	5.31e-02	2.40e-01	9.22e-01
GOCC MICROBODY	143	5.60e-02	2.74e-01	0.1760	3.35e-03	6.62e-02	-9.62e-02	-1.31e-01	-1.44e-02	9.45e-01	1.72e-01	4.70e-02	6.92e-03	7.67e-01
GOBP POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE	46	5.47e-01	8.27e-01	0.1760	-8.95e-02	-1.54e-02	1.03e-02	1.35e-02	-1.50e-01	2.93e-01	8.57e-01	9.04e-01	8.74e-01	7.91e-02
GOBP CELL ADHESION	1462	1.81e-18	3.36e-16	0.1760	-4.87e-02	4.50e-02	1.18e-01	1.11e-01	-1.43e-02	1.84e-03	3.96e-03	3.43e-14	1.25e-12	3.59e-01
GOBP POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT	81	1.84e-01	5.27e-01	0.1760	4.62e-02	-6.44e-02	1.41e-01	6.80e-02	-1.28e-02	4.72e-01	3.16e-01	2.84e-02	2.90e-01	8.43e-01
GOBP REGULATION OF PRESYNAPSE ORGANIZATION	28	6.02e-01	8.54e-01	0.1760	3.35e-02	7.12e-02	6.95e-02	-1.37e-01	-3.28e-02	7.59e-01	5.15e-01	5.24e-01	2.09e-01	7.64e-01
GOBP OUTFLOW TRACT MORPHOGENESIS	82	1.02e-01	3.87e-01	0.1760	9.46e-02	3.76e-02	6.09e-02	-1.20e-01	4.80e-02	1.38e-01	5.56e-01	3.40e-01	5.96e-02	4.53e-01
GOBP EMBRYONIC AXIS SPECIFICATION	39	6.60e-01	8.80e-01	0.1760	5.59e-02	9.30e-02	1.12e-01	4.01e-03	8.03e-02	5.46e-01	3.15e-01	2.25e-01	9.65e-01	3.86e-01
GOBP NOTOCHORD DEVELOPMENT	19	8.80e-01	9.61e-01	0.1760	5.90e-02	9.69e-02	-2.28e-02	-1.28e-01	-3.45e-02	6.56e-01	4.65e-01	8.63e-01	3.36e-01	7.95e-01
GOMF G PROTEIN COUPLED RECEPTOR BINDING	272	5.55e-04	9.60e-03	0.1760	-1.02e-01	7.13e-02	1.20e-01	2.73e-02	1.38e-02	3.75e-03	4.29e-02	6.56e-04	4.38e-01	6.95e-01
GOMF SMAD BINDING	75	1.14e-01	4.13e-01	0.1760	-3.85e-02	7.55e-02	1.01e-01	-1.14e-01	2.03e-02	5.64e-01	2.58e-01	1.31e-01	8.66e-02	7.61e-01
GOBP ENDOLYSOSOMAL TOLL LIKE RECEPTOR SIGNALING PATHWAY	41	4.86e-01	7.94e-01	0.1760	-8.95e-02	8.13e-02	-5.95e-02	-3.07e-02	1.08e-01	3.21e-01	3.67e-01	5.09e-01	7.34e-01	2.30e-01
GOMF ATP HYDROLYSIS ACTIVITY	392	8.21e-05	2.02e-03	0.1760	2.18e-02	-6.58e-02	-1.13e-01	-1.11e-01	2.96e-02	4.59e-01	2.54e-02	1.16e-04	1.63e-04	3.15e-01
GOBP REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN	20	8.44e-01	9.49e-01	0.1760	-5.79e-02	-1.15e-01	2.55e-02	-7.77e-02	8.70e-02	6.54e-01	3.74e-01	8.44e-01	5.48e-01	5.01e-01
GOBP ICOSANOID BIOSYNTHETIC PROCESS	55	2.74e-01	6.28e-01	0.1760	-2.72e-03	1.91e-02	1.58e-02	1.61e-01	6.46e-02	9.72e-01	8.07e-01	8.39e-01	3.86e-02	4.07e-01
GOBP CELL CYCLE PROCESS	1242	4.02e-17	6.14e-15	0.1750	6.15e-02	1.88e-02	-6.98e-02	-1.42e-01	3.91e-02	2.65e-04	2.66e-01	3.50e-05	3.03e-17	2.06e-02
GOBP REGULATION OF CELL CYCLE PROCESS	711	6.57e-10	5.51e-08	0.1750	7.45e-02	-3.96e-03	-7.43e-02	-1.38e-01	2.32e-02	7.07e-04	8.57e-01	7.39e-04	3.19e-10	2.92e-01
GOBP ACTIN POLYMERIZATION OR DEPOLYMERIZATION	185	4.77e-03	5.21e-02	0.1750	-2.56e-02	1.49e-01	7.05e-03	-2.19e-02	-8.67e-02	5.49e-01	4.93e-04	8.69e-01	6.08e-01	4.18e-02
GOBP LIMBIC SYSTEM DEVELOPMENT	117	2.04e-02	1.43e-01	0.1750	1.38e-02	1.21e-02	6.09e-02	-1.45e-01	7.54e-02	7.96e-01	8.21e-01	2.55e-01	6.72e-03	1.59e-01
GOCC OUTER MEMBRANE	229	4.87e-03	5.27e-02	0.1750	-1.54e-04	3.71e-02	-6.52e-02	-1.49e-01	5.40e-02	9.97e-01	3.34e-01	8.91e-02	1.02e-04	1.59e-01
GOBP POLYSACCHARIDE CATABOLIC PROCESS	21	8.54e-01	9.51e-01	0.1750	-1.51e-01	-3.41e-02	-7.57e-02	-6.93e-03	-3.05e-02	2.30e-01	7.87e-01	5.48e-01	9.56e-01	8.09e-01
GOBP CELLULAR RESPONSE TO INORGANIC SUBSTANCE	218	5.94e-04	1.01e-02	0.1750	-9.68e-02	9.63e-02	4.50e-02	-9.89e-02	-1.73e-02	1.38e-02	1.42e-02	2.52e-01	1.19e-02	6.59e-01
GOBP IRON ION TRANSPORT	53	2.08e-01	5.59e-01	0.1750	4.43e-02	3.88e-03	1.18e-01	-1.11e-01	4.99e-02	5.77e-01	9.61e-01	1.36e-01	1.64e-01	5.30e-01
GOBP PROTEIN K48 LINKED DEUBIQUITINATION	25	8.12e-01	9.38e-01	0.1750	2.58e-02	1.03e-01	-7.31e-02	-5.76e-02	-1.04e-01	8.24e-01	3.73e-01	5.27e-01	6.18e-01	3.70e-01
GOBP EPITHELIAL STRUCTURE MAINTENANCE	33	7.26e-01	9.05e-01	0.1750	-1.00e-01	7.28e-02	8.75e-03	2.70e-02	-1.20e-01	3.19e-01	4.69e-01	9.31e-01	7.88e-01	2.31e-01
GOBP RESPONSE TO INTERFERON BETA	33	6.83e-01	8.88e-01	0.1750	-5.56e-02	-2.35e-02	-3.46e-02	-3.61e-02	1.56e-01	5.81e-01	8.16e-01	7.31e-01	7.19e-01	1.20e-01
GOBP BONE MATURATION	25	7.83e-01	9.28e-01	0.1750	-8.84e-02	1.08e-01	-7.46e-03	-3.47e-02	9.97e-02	4.44e-01	3.52e-01	9.49e-01	7.64e-01	3.88e-01
GOBP EPIDERMAL CELL DIFFERENTIATION	236	2.35e-03	3.06e-02	0.1750	-1.03e-01	-5.30e-02	1.09e-01	6.56e-02	-2.80e-02	6.19e-03	1.60e-01	3.89e-03	8.27e-02	4.59e-01
GOMF UDP GLYCOSYLTRANSFERASE ACTIVITY	139	6.22e-02	2.93e-01	0.1750	1.89e-02	1.26e-01	9.19e-02	7.18e-02	-2.63e-02	7.01e-01	1.04e-02	6.15e-02	1.44e-01	5.92e-01
GOBP FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS	26	8.61e-01	9.53e-01	0.1750	4.52e-02	3.60e-02	-5.35e-02	-1.04e-01	1.16e-01	6.90e-01	7.51e-01	6.37e-01	3.58e-01	3.06e-01
GOBP POSITIVE REGULATION OF MONOATOMIC ION TRANSPORT	201	1.95e-02	1.38e-01	0.1750	-5.10e-02	1.66e-02	1.27e-01	9.78e-02	-4.32e-02	2.12e-01	6.85e-01	1.89e-03	1.68e-02	2.91e-01
GOBP NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS	272	1.98e-03	2.67e-02	0.1740	4.36e-03	2.16e-02	-9.77e-02	-1.16e-01	8.34e-02	9.01e-01	5.40e-01	5.54e-03	9.88e-04	1.79e-02
GOCC SPINDLE MIDZONE	35	7.48e-01	9.15e-01	0.1740	-1.06e-02	-4.06e-02	-7.15e-02	-1.52e-01	2.16e-02	9.14e-01	6.78e-01	4.64e-01	1.20e-01	8.25e-01
GOBP REGULATION OF MYOTUBE DIFFERENTIATION	48	5.50e-01	8.28e-01	0.1740	7.96e-02	8.32e-02	6.44e-02	-2.74e-02	1.11e-01	3.40e-01	3.19e-01	4.40e-01	7.43e-01	1.85e-01
GOBP MEMBRANE LIPID CATABOLIC PROCESS	38	6.28e-01	8.68e-01	0.1740	-2.26e-02	-6.28e-02	2.34e-02	-7.43e-02	1.41e-01	8.10e-01	5.03e-01	8.03e-01	4.28e-01	1.33e-01
GOMF PHOSPHOLIPID TRANSPORTER ACTIVITY	63	3.16e-01	6.66e-01	0.1740	-1.46e-02	7.84e-02	-8.48e-02	-5.44e-03	-1.30e-01	8.41e-01	2.82e-01	2.45e-01	9.40e-01	7.51e-02
GOBP TYPE B PANCREATIC CELL DEVELOPMENT	24	6.58e-01	8.80e-01	0.1740	1.14e-01	-8.03e-02	5.67e-02	-7.86e-02	-3.87e-02	3.33e-01	4.96e-01	6.31e-01	5.05e-01	7.43e-01
GOBP NEUROTRANSMITTER RECEPTOR INTERNALIZATION	30	7.31e-01	9.08e-01	0.1740	-1.07e-03	1.06e-01	3.78e-03	-1.38e-01	1.02e-03	9.92e-01	3.14e-01	9.71e-01	1.91e-01	9.92e-01
GOBP GLUCOSE CATABOLIC PROCESS	25	8.78e-01	9.60e-01	0.1740	7.25e-03	3.98e-02	-1.07e-01	-1.11e-01	7.02e-02	9.50e-01	7.31e-01	3.56e-01	3.35e-01	5.44e-01
GOBP N GLYCAN PROCESSING	17	9.21e-01	9.74e-01	0.1740	6.71e-02	-1.02e-01	-1.23e-01	1.22e-03	-1.94e-02	6.32e-01	4.69e-01	3.80e-01	9.93e-01	8.90e-01
GOCC EXTRINSIC COMPONENT OF PLASMA MEMBRANE	122	8.66e-02	3.56e-01	0.1740	5.15e-02	2.15e-02	1.48e-01	6.31e-02	3.45e-02	3.26e-01	6.82e-01	4.66e-03	2.29e-01	5.11e-01
GOBP REGULATION OF B CELL ACTIVATION	123	6.28e-02	2.94e-01	0.1740	-3.26e-02	1.30e-01	-1.28e-02	-8.88e-02	6.50e-02	5.32e-01	1.27e-02	8.07e-01	8.89e-02	2.13e-01
GOCC PLASMA MEMBRANE RAFT	112	1.56e-01	4.85e-01	0.1740	-4.14e-02	2.54e-02	1.38e-01	8.12e-02	4.76e-02	4.49e-01	6.42e-01	1.16e-02	1.38e-01	3.84e-01
GOMF TRANSCRIPTION COREGULATOR ACTIVITY	460	2.11e-06	8.58e-05	0.1740	6.51e-02	4.58e-02	-6.11e-02	-1.41e-01	1.99e-02	1.66e-02	9.22e-02	2.47e-02	2.31e-07	4.64e-01
GOBP REGULATION OF BIOLOGICAL PROCESS INVOLVED IN SYMBIOTIC INTERACTION	63	4.12e-01	7.43e-01	0.1740	2.53e-02	-1.89e-02	-1.24e-02	-9.76e-02	1.40e-01	7.29e-01	7.95e-01	8.65e-01	1.80e-01	5.49e-02
GOBP MODIFICATION OF POSTSYNAPTIC STRUCTURE	21	8.54e-01	9.51e-01	0.1740	-1.05e-03	-9.85e-02	-6.72e-03	1.01e-02	-1.43e-01	9.93e-01	4.35e-01	9.57e-01	9.36e-01	2.57e-01
GOBP NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY	170	8.86e-03	8.06e-02	0.1740	-4.18e-02	8.20e-02	4.25e-02	-1.10e-01	8.90e-02	3.47e-01	6.51e-02	3.40e-01	1.37e-02	4.53e-02
GOCC TRIGLYCERIDE RICH PLASMA LIPOPROTEIN PARTICLE	19	8.54e-01	9.51e-01	0.1740	-1.27e-01	-5.20e-02	-1.02e-01	6.76e-03	2.92e-02	3.38e-01	6.95e-01	4.39e-01	9.59e-01	8.26e-01
GOBP POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS	100	1.26e-01	4.39e-01	0.1740	-5.22e-03	1.37e-01	4.63e-02	-7.16e-02	6.43e-02	9.28e-01	1.80e-02	4.24e-01	2.16e-01	2.66e-01
GOBP ANTEROGRADE AXONAL TRANSPORT	49	5.96e-01	8.50e-01	0.1740	-4.88e-03	1.28e-03	-9.11e-02	-9.31e-02	1.15e-01	9.53e-01	9.88e-01	2.70e-01	2.59e-01	1.64e-01
GOBP EAR MORPHOGENESIS	123	4.73e-02	2.44e-01	0.1740	5.85e-02	1.33e-02	5.29e-02	-9.16e-02	1.24e-01	2.63e-01	7.99e-01	3.11e-01	7.93e-02	1.75e-02
GOBP REGULATION OF FATTY ACID TRANSPORT	31	7.52e-01	9.16e-01	0.1740	6.02e-02	1.16e-01	1.05e-01	1.67e-02	-4.06e-02	5.62e-01	2.62e-01	3.12e-01	8.72e-01	6.95e-01
GOBP INTRACELLULAR SODIUM ION HOMEOSTASIS	22	7.52e-01	9.16e-01	0.1740	1.46e-01	-2.96e-02	4.87e-02	-6.67e-02	-3.13e-02	2.34e-01	8.10e-01	6.93e-01	5.88e-01	7.99e-01
GOBP PRIMARY ALCOHOL METABOLIC PROCESS	101	1.55e-01	4.84e-01	0.1740	-2.33e-02	-2.13e-02	2.78e-02	1.50e-01	-7.69e-02	6.86e-01	7.12e-01	6.30e-01	9.30e-03	1.82e-01
GOBP BINDING OF SPERM TO ZONA PELLUCIDA	38	6.11e-01	8.58e-01	0.1740	-9.15e-02	-3.14e-02	1.43e-01	1.76e-02	-7.56e-03	3.29e-01	7.38e-01	1.28e-01	8.51e-01	9.36e-01
GOBP INORGANIC ANION TRANSPORT	162	3.36e-02	1.97e-01	0.1730	-1.02e-01	5.35e-02	7.84e-02	1.02e-01	-1.80e-02	2.49e-02	2.40e-01	8.52e-02	2.55e-02	6.92e-01
GOCC CYTOPLASMIC MICROTUBULE	96	1.04e-01	3.90e-01	0.1730	1.25e-02	7.70e-03	-3.22e-02	-1.69e-01	-1.69e-02	8.32e-01	8.96e-01	5.86e-01	4.22e-03	7.75e-01
GOBP CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS	29	7.45e-01	9.14e-01	0.1730	-9.45e-02	4.38e-02	1.29e-01	-4.81e-03	-5.16e-02	3.78e-01	6.83e-01	2.31e-01	9.64e-01	6.31e-01
GOBP REGULATION OF LYMPHOCYTE MIGRATION	65	2.64e-01	6.19e-01	0.1730	-9.20e-02	5.22e-02	1.27e-02	1.35e-01	-2.42e-02	1.99e-01	4.67e-01	8.60e-01	6.06e-02	7.36e-01
GOBP LIPID MODIFICATION	185	2.00e-02	1.41e-01	0.1730	7.26e-02	7.22e-02	-8.32e-02	-9.87e-02	5.36e-02	8.84e-02	9.02e-02	5.10e-02	2.07e-02	2.09e-01
GOBP AMIDE METABOLIC PROCESS	1219	8.81e-16	1.17e-13	0.1730	-1.78e-02	-2.19e-03	-1.06e-01	-1.35e-01	-1.11e-02	2.96e-01	8.97e-01	4.43e-10	1.74e-15	5.14e-01
GOBP NEGATIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION	7	9.87e-01	9.95e-01	0.1730	-1.94e-02	1.44e-01	2.35e-02	7.25e-02	-5.43e-02	9.29e-01	5.08e-01	9.14e-01	7.40e-01	8.03e-01
GOBP POSITIVE REGULATION OF FIBROBLAST PROLIFERATION	52	2.79e-01	6.32e-01	0.1730	1.17e-02	6.00e-02	-1.42e-01	-1.13e-03	7.90e-02	8.84e-01	4.54e-01	7.75e-02	9.89e-01	3.24e-01
GOMF FIBROBLAST GROWTH FACTOR RECEPTOR BINDING	24	8.00e-01	9.33e-01	0.1730	-1.01e-01	-8.35e-02	-1.19e-02	-1.13e-01	-3.60e-03	3.91e-01	4.79e-01	9.20e-01	3.40e-01	9.76e-01
GOBP POSTSYNAPTIC MEMBRANE ORGANIZATION	35	5.77e-01	8.42e-01	0.1730	-3.97e-02	2.86e-02	1.10e-01	-9.13e-02	8.45e-02	6.84e-01	7.70e-01	2.61e-01	3.50e-01	3.87e-01
GOBP MICROTUBULE ORGANIZING CENTER ORGANIZATION	150	5.96e-02	2.85e-01	0.1730	1.10e-01	-1.97e-02	-1.01e-01	-7.94e-02	3.02e-02	2.00e-02	6.77e-01	3.25e-02	9.31e-02	5.24e-01
GOMF NUCLEAR RECEPTOR ACTIVITY	51	5.34e-01	8.21e-01	0.1730	-8.93e-02	1.12e-01	8.55e-02	1.55e-02	-4.44e-02	2.70e-01	1.68e-01	2.91e-01	8.48e-01	5.83e-01
GOBP FATTY ACID DERIVATIVE METABOLIC PROCESS	66	3.35e-01	6.82e-01	0.1730	-1.84e-02	1.16e-01	1.69e-02	-1.14e-01	5.24e-02	7.96e-01	1.02e-01	8.12e-01	1.09e-01	4.62e-01
GOBP POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY	35	6.62e-01	8.81e-01	0.1730	8.31e-02	6.25e-02	1.10e-01	-3.52e-02	7.60e-02	3.95e-01	5.22e-01	2.60e-01	7.18e-01	4.37e-01
GOBP NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY	80	2.37e-01	5.93e-01	0.1730	2.43e-02	1.50e-01	-8.43e-03	-5.70e-02	5.88e-02	7.07e-01	2.02e-02	8.96e-01	3.78e-01	3.63e-01
GOBP GLIAL CELL APOPTOTIC PROCESS	15	9.44e-01	9.82e-01	0.1730	-1.10e-01	-7.98e-02	8.64e-02	6.31e-02	-9.46e-04	4.61e-01	5.92e-01	5.62e-01	6.72e-01	9.95e-01
GOBP METENCEPHALON DEVELOPMENT	106	8.08e-02	3.42e-01	0.1730	-2.92e-02	-2.78e-02	2.62e-03	-1.46e-01	8.38e-02	6.04e-01	6.21e-01	9.63e-01	9.49e-03	1.36e-01
GOBP PROTEIN TARGETING	316	3.81e-04	7.22e-03	0.1730	-1.42e-02	4.15e-02	-8.54e-02	-1.44e-01	-4.39e-03	6.65e-01	2.05e-01	9.03e-03	1.12e-05	8.93e-01
GOBP RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM	70	3.45e-01	6.91e-01	0.1730	7.60e-02	1.12e-01	9.67e-02	1.31e-02	4.58e-02	2.71e-01	1.06e-01	1.62e-01	8.49e-01	5.07e-01
GOBP PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING	24	8.19e-01	9.41e-01	0.1730	-1.61e-02	-1.28e-02	1.82e-02	1.12e-02	-1.70e-01	8.92e-01	9.14e-01	8.77e-01	9.24e-01	1.49e-01
GOBP POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY	27	7.65e-01	9.22e-01	0.1730	5.62e-02	5.64e-02	1.53e-01	4.34e-03	9.55e-03	6.13e-01	6.12e-01	1.69e-01	9.69e-01	9.32e-01
GOCC VACUOLAR MEMBRANE	463	1.19e-06	5.18e-05	0.1730	-3.32e-02	6.40e-02	-4.34e-02	-1.43e-01	4.85e-02	2.21e-01	1.82e-02	1.09e-01	1.36e-07	7.40e-02
GOBP REGULATION OF CELL KILLING	110	1.15e-01	4.14e-01	0.1730	-1.06e-01	1.18e-03	1.31e-01	3.78e-02	5.81e-03	5.55e-02	9.83e-01	1.74e-02	4.93e-01	9.16e-01
GOBP CD4 POSITIVE ALPHA BETA T CELL ACTIVATION	111	9.48e-02	3.72e-01	0.1730	-3.72e-02	1.58e-01	5.67e-02	-1.66e-02	-3.70e-03	4.98e-01	4.03e-03	3.02e-01	7.63e-01	9.46e-01
GOBP IMMATURE B CELL DIFFERENTIATION	12	9.13e-01	9.71e-01	0.1730	2.90e-02	-3.91e-03	7.70e-02	-1.41e-01	5.69e-02	8.62e-01	9.81e-01	6.44e-01	3.98e-01	7.33e-01
GOCC SARCOPLASMIC RETICULUM MEMBRANE	42	5.30e-01	8.19e-01	0.1730	8.04e-02	6.90e-02	2.39e-02	1.29e-01	3.66e-02	3.67e-01	4.39e-01	7.88e-01	1.47e-01	6.81e-01
GOMF AMIDINE LYASE ACTIVITY	7	9.90e-01	9.96e-01	0.1730	6.33e-02	4.51e-02	-3.39e-02	-5.01e-02	1.42e-01	7.72e-01	8.36e-01	8.77e-01	8.19e-01	5.16e-01
GOMF ATPASE COUPLED MONOATOMIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY	50	4.97e-01	8.02e-01	0.1730	1.04e-01	-6.13e-02	-2.37e-02	-1.09e-01	5.22e-02	2.03e-01	4.53e-01	7.72e-01	1.82e-01	5.23e-01
GOMF KINASE REGULATOR ACTIVITY	245	2.38e-03	3.09e-02	0.1730	-4.12e-02	2.20e-02	-4.89e-02	-1.42e-01	7.03e-02	2.67e-01	5.53e-01	1.88e-01	1.23e-04	5.81e-02
GOBP CELLULAR RESPONSE TO TYPE II INTERFERON	112	5.92e-02	2.84e-01	0.1730	-1.46e-02	1.26e-02	5.43e-02	1.25e-01	1.04e-01	7.90e-01	8.18e-01	3.20e-01	2.20e-02	5.77e-02
GOBP MACROPHAGE DIFFERENTIATION	61	2.97e-01	6.51e-01	0.1730	-3.72e-02	9.16e-02	1.05e-01	-8.18e-02	4.81e-02	6.16e-01	2.16e-01	1.56e-01	2.69e-01	5.16e-01
GOMF TRANSCRIPTION COACTIVATOR ACTIVITY	257	1.27e-03	1.87e-02	0.1730	3.94e-02	4.32e-02	-5.16e-02	-1.53e-01	1.39e-02	2.77e-01	2.34e-01	1.55e-01	2.31e-05	7.01e-01
GOBP EMBRYONIC HEMOPOIESIS	23	8.45e-01	9.49e-01	0.1730	-5.02e-02	2.11e-02	-3.07e-02	-1.61e-01	8.65e-03	6.77e-01	8.61e-01	7.99e-01	1.82e-01	9.43e-01
GOBP POSITIVE REGULATION OF PROTEIN SECRETION	142	2.11e-02	1.46e-01	0.1720	8.61e-02	1.17e-01	-1.91e-03	3.00e-02	8.81e-02	7.65e-02	1.62e-02	9.69e-01	5.37e-01	7.00e-02
GOBP RIBONUCLEOTIDE CATABOLIC PROCESS	48	5.67e-01	8.36e-01	0.1720	-7.21e-02	4.36e-02	-6.91e-02	-1.26e-01	-4.33e-02	3.87e-01	6.01e-01	4.07e-01	1.30e-01	6.04e-01
GOBP NEGATIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY	8	9.88e-01	9.96e-01	0.1720	-3.55e-02	2.03e-03	1.17e-01	9.07e-02	8.02e-02	8.62e-01	9.92e-01	5.65e-01	6.57e-01	6.95e-01
GOBP CENTROSOME DUPLICATION	74	3.62e-01	7.04e-01	0.1720	1.26e-01	1.48e-02	-8.77e-02	-6.96e-02	3.37e-02	6.16e-02	8.26e-01	1.92e-01	3.01e-01	6.16e-01
GOBP REGULATION OF PH	95	8.06e-02	3.42e-01	0.1720	4.87e-03	3.84e-02	9.79e-02	-9.69e-02	9.60e-02	9.35e-01	5.18e-01	9.92e-02	1.03e-01	1.06e-01
GOBP PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS	123	8.46e-02	3.51e-01	0.1720	8.55e-03	7.45e-02	-4.96e-02	-1.47e-01	3.52e-03	8.70e-01	1.54e-01	3.42e-01	4.91e-03	9.46e-01
GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	60	2.75e-01	6.29e-01	0.1720	1.72e-02	7.04e-02	-3.61e-02	1.48e-02	1.51e-01	8.18e-01	3.46e-01	6.28e-01	8.43e-01	4.27e-02
GOBP REGULATION OF APOPTOTIC SIGNALING PATHWAY	380	1.62e-05	5.13e-04	0.1720	-3.84e-02	5.21e-02	-4.67e-02	-1.51e-01	1.99e-02	1.99e-01	8.14e-02	1.18e-01	4.16e-07	5.06e-01
GOBP PHENOL CONTAINING COMPOUND METABOLIC PROCESS	105	1.32e-01	4.49e-01	0.1720	8.79e-03	7.93e-02	1.36e-01	3.82e-02	-5.74e-02	8.76e-01	1.60e-01	1.60e-02	4.99e-01	3.10e-01
GOCC MITOTIC SPINDLE	174	4.01e-02	2.21e-01	0.1720	1.04e-02	1.80e-02	-9.44e-02	-1.41e-01	1.83e-02	8.13e-01	6.82e-01	3.18e-02	1.31e-03	6.76e-01
GOBP NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY	36	6.81e-01	8.87e-01	0.1720	1.17e-02	8.03e-02	2.44e-02	-1.27e-01	7.91e-02	9.03e-01	4.05e-01	8.00e-01	1.87e-01	4.11e-01
GOBP REGULATION OF CELLULAR SENESCENCE	52	5.22e-01	8.14e-01	0.1720	3.79e-02	6.82e-02	1.96e-02	-1.01e-01	1.14e-01	6.36e-01	3.95e-01	8.07e-01	2.10e-01	1.54e-01
GOBP DNA DEALKYLATION	37	7.00e-01	8.96e-01	0.1720	1.11e-01	-5.82e-03	-2.01e-03	-8.78e-02	9.77e-02	2.43e-01	9.51e-01	9.83e-01	3.55e-01	3.04e-01
GOBP ERK1 AND ERK2 CASCADE	331	1.37e-04	3.07e-03	0.1720	-1.11e-01	4.96e-02	5.43e-02	9.85e-02	-4.72e-02	5.41e-04	1.21e-01	8.96e-02	2.06e-03	1.40e-01
GOMF TAU PROTEIN BINDING	42	7.21e-01	9.02e-01	0.1720	5.43e-02	1.33e-02	-9.02e-02	-1.35e-01	1.20e-02	5.43e-01	8.81e-01	3.12e-01	1.31e-01	8.93e-01
GOBP AMINE METABOLIC PROCESS	107	1.49e-01	4.74e-01	0.1720	-3.32e-02	9.59e-02	7.54e-02	5.15e-02	-1.04e-01	5.53e-01	8.67e-02	1.78e-01	3.57e-01	6.21e-02
GOMF HYDROLASE ACTIVITY ACTING ON ACID ANHYDRIDES	755	5.35e-10	4.56e-08	0.1720	1.05e-02	3.18e-03	-7.92e-02	-1.52e-01	1.18e-02	6.25e-01	8.82e-01	2.13e-04	1.30e-12	5.82e-01
GOBP NUCLEOBASE METABOLIC PROCESS	38	7.18e-01	9.02e-01	0.1720	-3.62e-02	-7.71e-02	-1.41e-01	-4.36e-02	-2.13e-02	6.99e-01	4.11e-01	1.33e-01	6.42e-01	8.20e-01
GOBP MACROMOLECULE CATABOLIC PROCESS	1345	1.97e-20	4.28e-18	0.1720	-1.61e-02	2.61e-02	-5.05e-02	-1.61e-01	6.19e-03	3.22e-01	1.08e-01	1.89e-03	3.30e-23	7.03e-01
GOBP REGULATION OF HAIR CYCLE	27	7.34e-01	9.09e-01	0.1720	1.21e-01	2.46e-02	3.81e-02	-3.45e-03	-1.13e-01	2.75e-01	8.25e-01	7.32e-01	9.75e-01	3.11e-01
GOBP GLUTAMATE REUPTAKE	6	9.92e-01	9.97e-01	0.1720	-7.67e-03	1.36e-01	6.26e-02	2.43e-02	8.08e-02	9.74e-01	5.65e-01	7.91e-01	9.18e-01	7.32e-01
GOMF DYNEIN HEAVY CHAIN BINDING	16	8.61e-01	9.53e-01	0.1720	-1.75e-02	5.05e-02	-1.62e-01	1.85e-03	1.83e-02	9.04e-01	7.26e-01	2.62e-01	9.90e-01	8.99e-01
GOBP MEMBRANE FISSION	42	6.76e-01	8.85e-01	0.1710	6.37e-02	-1.92e-02	-6.01e-02	-1.43e-01	3.00e-02	4.75e-01	8.30e-01	5.00e-01	1.09e-01	7.36e-01
GOBP POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION	24	7.19e-01	9.02e-01	0.1710	-1.90e-02	6.12e-02	6.93e-02	-8.57e-02	-1.15e-01	8.72e-01	6.03e-01	5.57e-01	4.67e-01	3.31e-01
GOBP REGULATION OF REGULATED SECRETORY PATHWAY	115	7.58e-02	3.31e-01	0.1710	-8.69e-02	1.36e-01	3.41e-02	-4.13e-02	-2.18e-02	1.07e-01	1.17e-02	5.28e-01	4.45e-01	6.86e-01
GOBP POTASSIUM ION TRANSPORT	234	6.28e-03	6.30e-02	0.1710	-7.08e-02	3.93e-02	1.04e-01	7.08e-02	-8.44e-02	6.22e-02	3.01e-01	6.35e-03	6.21e-02	2.62e-02
GOBP POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION	12	9.72e-01	9.92e-01	0.1710	-5.93e-03	1.23e-01	1.01e-01	5.09e-02	-3.80e-02	9.72e-01	4.61e-01	5.44e-01	7.60e-01	8.19e-01
GOBP NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	20	9.18e-01	9.74e-01	0.1710	1.47e-02	4.77e-02	-1.16e-01	-1.05e-01	-4.98e-02	9.09e-01	7.12e-01	3.70e-01	4.17e-01	7.00e-01
GOBP ORGANELLE FUSION	156	2.95e-02	1.81e-01	0.1710	5.12e-02	1.15e-01	-4.06e-02	-1.09e-01	-3.50e-03	2.69e-01	1.29e-02	3.82e-01	1.93e-02	9.40e-01
GOMF MONOATOMIC CATION CHANNEL ACTIVITY	323	3.54e-04	6.80e-03	0.1710	-7.65e-02	6.80e-02	7.70e-02	6.60e-02	-9.28e-02	1.81e-02	3.57e-02	1.74e-02	4.13e-02	4.15e-03
GOBP OLFACTORY LOBE DEVELOPMENT	36	6.73e-01	8.84e-01	0.1710	-4.22e-03	-4.35e-02	4.20e-02	-5.90e-02	1.49e-01	9.65e-01	6.52e-01	6.63e-01	5.40e-01	1.22e-01
GOCC KATANIN COMPLEX	5	9.95e-01	9.98e-01	0.1710	-4.94e-02	-1.03e-02	-8.12e-02	-1.10e-01	-9.05e-02	8.48e-01	9.68e-01	7.53e-01	6.72e-01	7.26e-01
GOBP REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY	116	8.84e-02	3.59e-01	0.1710	4.28e-02	1.28e-01	1.03e-01	3.86e-03	-2.05e-02	4.26e-01	1.73e-02	5.44e-02	9.43e-01	7.03e-01
GOBP NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY	231	5.62e-03	5.76e-02	0.1710	-2.49e-03	4.20e-02	-6.07e-02	-1.48e-01	4.38e-02	9.48e-01	2.72e-01	1.12e-01	1.05e-04	2.51e-01
GOBP REGULATION OF EMBRYONIC DEVELOPMENT	89	1.60e-01	4.92e-01	0.1710	4.91e-02	4.32e-02	1.42e-02	-1.42e-01	6.77e-02	4.24e-01	4.81e-01	8.17e-01	2.03e-02	2.69e-01
GOMF CALCIUM DEPENDENT PROTEIN BINDING	77	2.23e-01	5.76e-01	0.1710	3.85e-02	8.89e-02	-2.57e-02	5.84e-02	-1.26e-01	5.60e-01	1.78e-01	6.96e-01	3.76e-01	5.62e-02
GOBP REGULATION OF PROTEIN K63 LINKED UBIQUITINATION	13	9.48e-01	9.83e-01	0.1710	6.98e-02	8.87e-02	7.08e-02	-8.06e-02	7.11e-02	6.63e-01	5.80e-01	6.59e-01	6.15e-01	6.57e-01
GOBP MYELOID CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE	95	1.55e-01	4.83e-01	0.1710	-3.96e-02	1.12e-01	6.78e-02	4.22e-02	9.37e-02	5.05e-01	5.95e-02	2.53e-01	4.77e-01	1.15e-01
GOMF NITRIC OXIDE SYNTHASE BINDING	10	9.70e-01	9.91e-01	0.1710	-9.29e-02	1.09e-03	-7.57e-02	4.78e-02	-1.12e-01	6.11e-01	9.95e-01	6.78e-01	7.93e-01	5.40e-01
GOCC MALE PRONUCLEUS	8	9.86e-01	9.95e-01	0.1710	1.90e-02	-7.26e-02	-1.19e-01	-8.89e-03	-9.66e-02	9.26e-01	7.22e-01	5.61e-01	9.65e-01	6.36e-01
GOMF HISTONE H3K9 MONOMETHYLTRANSFERASE ACTIVITY	6	9.73e-01	9.92e-01	0.1710	3.80e-02	5.55e-02	-8.99e-02	9.20e-02	8.98e-02	8.72e-01	8.14e-01	7.03e-01	6.96e-01	7.03e-01
GOBP GLIAL CELL PROLIFERATION	53	5.40e-01	8.23e-01	0.1710	1.07e-01	4.13e-02	9.14e-02	7.07e-02	5.17e-02	1.79e-01	6.03e-01	2.50e-01	3.73e-01	5.15e-01
GOBP NEURON CELLULAR HOMEOSTASIS	59	1.64e-01	4.97e-01	0.1700	-1.89e-02	-1.27e-01	6.77e-02	-8.44e-02	-3.06e-02	8.02e-01	9.23e-02	3.68e-01	2.62e-01	6.85e-01
GOBP IRON ION TRANSMEMBRANE TRANSPORT	27	6.65e-01	8.82e-01	0.1700	1.62e-02	-1.93e-02	7.78e-02	-1.32e-01	6.96e-02	8.84e-01	8.62e-01	4.84e-01	2.34e-01	5.31e-01
GOBP RESPONSE TO ESTRADIOL	109	1.00e-01	3.84e-01	0.1700	1.14e-01	3.16e-02	-2.23e-02	-1.20e-01	1.52e-02	3.95e-02	5.69e-01	6.87e-01	3.11e-02	7.84e-01
GOBP CELLULAR RESPONSE TO VIRUS	79	2.09e-01	5.61e-01	0.1700	-6.35e-02	-9.78e-02	1.96e-02	3.11e-02	1.19e-01	3.29e-01	1.33e-01	7.63e-01	6.32e-01	6.83e-02
GOBP POSITIVE REGULATION OF SYNAPSE ASSEMBLY	56	5.29e-01	8.19e-01	0.1700	5.63e-02	8.14e-02	1.25e-01	4.47e-02	4.12e-02	4.66e-01	2.92e-01	1.07e-01	5.63e-01	5.94e-01
GOMF EXCITATORY EXTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY	35	7.75e-01	9.26e-01	0.1700	-6.44e-02	6.03e-02	1.31e-01	5.14e-02	3.85e-02	5.10e-01	5.37e-01	1.80e-01	5.98e-01	6.94e-01
GOBP G1 TO G0 TRANSITION INVOLVED IN CELL DIFFERENTIATION	6	9.93e-01	9.97e-01	0.1700	4.22e-02	-4.80e-02	-7.88e-02	-1.29e-01	-4.51e-02	8.58e-01	8.39e-01	7.38e-01	5.84e-01	8.48e-01
GOMF DEAMINASE ACTIVITY	33	7.41e-01	9.12e-01	0.1700	1.44e-01	2.07e-02	-9.62e-03	-7.65e-02	4.25e-02	1.51e-01	8.37e-01	9.24e-01	4.47e-01	6.73e-01
GOBP POSITIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION	61	3.94e-01	7.29e-01	0.1700	-4.37e-02	1.52e-01	2.21e-02	-4.39e-02	3.91e-02	5.55e-01	3.99e-02	7.66e-01	5.53e-01	5.97e-01
GOBP REGULATION OF GLYCOPROTEIN METABOLIC PROCESS	58	3.82e-01	7.20e-01	0.1700	8.28e-02	-6.64e-02	-9.40e-02	5.97e-02	-7.30e-02	2.76e-01	3.82e-01	2.16e-01	4.31e-01	3.36e-01
GOMF BETA CATENIN BINDING	80	2.45e-01	6.02e-01	0.1700	2.66e-02	5.65e-02	1.52e-01	3.35e-02	-3.06e-02	6.81e-01	3.82e-01	1.90e-02	6.04e-01	6.36e-01
GOBP POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION	112	7.70e-02	3.33e-01	0.1700	1.16e-01	6.28e-02	-2.39e-02	-9.60e-02	-4.03e-02	3.33e-02	2.51e-01	6.62e-01	7.91e-02	4.61e-01
GOBP NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORTER ACTIVITY	70	3.34e-01	6.81e-01	0.1700	-5.79e-02	-2.25e-02	1.46e-01	3.88e-02	4.80e-02	4.02e-01	7.45e-01	3.49e-02	5.75e-01	4.88e-01
GOBP CELL DIVISION	613	1.47e-07	8.21e-06	0.1700	5.39e-02	2.82e-02	-7.89e-02	-1.34e-01	3.07e-02	2.26e-02	2.33e-01	8.44e-04	1.35e-08	1.95e-01
GOBP MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION	129	6.26e-02	2.94e-01	0.1700	5.77e-02	1.08e-01	-1.54e-02	-1.16e-01	9.94e-03	2.58e-01	3.36e-02	7.62e-01	2.27e-02	8.45e-01
GOBP HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION	132	6.14e-02	2.91e-01	0.1700	9.15e-03	6.62e-02	2.04e-02	-1.05e-01	1.14e-01	8.56e-01	1.89e-01	6.86e-01	3.70e-02	2.39e-02
GOCC CENTROSOME	607	3.18e-08	1.99e-06	0.1700	7.07e-02	1.15e-03	-4.79e-02	-1.37e-01	5.29e-02	2.94e-03	9.61e-01	4.39e-02	7.78e-09	2.60e-02
GOBP ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS	21	8.26e-01	9.44e-01	0.1700	-3.24e-02	-7.60e-02	-1.49e-02	-8.28e-02	-1.22e-01	7.97e-01	5.47e-01	9.06e-01	5.11e-01	3.32e-01
GOBP SKELETAL MUSCLE SATELLITE CELL PROLIFERATION	17	9.24e-01	9.75e-01	0.1700	6.95e-02	1.57e-02	-1.43e-01	-3.27e-02	-4.61e-02	6.20e-01	9.11e-01	3.06e-01	8.15e-01	7.42e-01
GOBP REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS	14	8.97e-01	9.66e-01	0.1700	1.14e-02	7.94e-02	1.20e-01	-8.83e-02	-1.07e-02	9.41e-01	6.07e-01	4.36e-01	5.67e-01	9.45e-01
GOBP REGULATION OF LIPASE ACTIVITY	76	2.39e-01	5.96e-01	0.1700	-1.07e-01	-1.92e-02	1.70e-02	1.29e-01	-8.96e-03	1.05e-01	7.73e-01	7.98e-01	5.25e-02	8.93e-01
GOBP EXTRINSIC APOPTOTIC SIGNALING PATHWAY	221	9.86e-04	1.53e-02	0.1700	-5.18e-02	1.10e-01	6.32e-02	-9.85e-02	1.95e-02	1.85e-01	4.91e-03	1.06e-01	1.16e-02	6.17e-01
GOBP REGULATION OF SMOOTHENED SIGNALING PATHWAY	84	1.49e-01	4.74e-01	0.1700	-2.09e-02	-1.61e-02	1.45e-02	-1.54e-01	6.37e-02	7.40e-01	7.98e-01	8.18e-01	1.45e-02	3.13e-01
GOBP PHOSPHATIDYLGLYCEROL METABOLIC PROCESS	33	6.52e-01	8.79e-01	0.1700	-1.44e-01	8.24e-03	-6.92e-02	4.27e-02	-3.79e-02	1.53e-01	9.35e-01	4.91e-01	6.71e-01	7.06e-01
GOBP PROTEIN DEPOLYMERIZATION	111	1.10e-01	4.05e-01	0.1700	6.69e-02	1.40e-01	4.77e-02	3.19e-02	-3.87e-02	2.23e-01	1.10e-02	3.85e-01	5.61e-01	4.82e-01
GOBP VASCULAR TRANSPORT	84	1.55e-01	4.83e-01	0.1700	4.53e-03	2.52e-02	-2.38e-02	1.42e-01	-8.66e-02	9.43e-01	6.90e-01	7.06e-01	2.50e-02	1.70e-01
GOBP POSITIVE REGULATION OF MAP KINASE ACTIVITY	85	2.90e-01	6.44e-01	0.1690	-4.06e-03	8.67e-02	1.14e-01	5.41e-02	-7.32e-02	9.48e-01	1.67e-01	7.01e-02	3.89e-01	2.43e-01
GOBP POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION	34	7.12e-01	9.00e-01	0.1690	-1.38e-01	8.81e-02	5.75e-03	-1.10e-02	-4.00e-02	1.62e-01	3.74e-01	9.54e-01	9.12e-01	6.87e-01
GOBP REGULATION OF ENDOCYTIC RECYCLING	20	9.03e-01	9.68e-01	0.1690	-8.50e-03	-8.87e-02	-8.37e-02	1.82e-02	-1.16e-01	9.48e-01	4.92e-01	5.17e-01	8.88e-01	3.70e-01
GOBP PROTEIN MATURATION	515	1.82e-06	7.50e-05	0.1690	-9.29e-03	4.13e-02	-9.20e-02	-1.35e-01	-8.99e-03	7.18e-01	1.08e-01	3.53e-04	1.48e-07	7.27e-01
GOBP ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS	1758	3.47e-22	9.09e-20	0.1690	-1.52e-02	1.77e-02	-8.77e-02	-1.43e-01	2.40e-03	2.89e-01	2.17e-01	9.77e-10	2.50e-23	8.67e-01
GOBP PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS	10	9.69e-01	9.91e-01	0.1690	-3.39e-02	1.56e-01	2.17e-02	3.32e-02	4.06e-02	8.53e-01	3.94e-01	9.06e-01	8.56e-01	8.24e-01
GOBP PLATELET ACTIVATION	128	6.52e-02	3.01e-01	0.1690	-6.08e-02	1.17e-01	-3.27e-02	-9.62e-02	3.11e-02	2.35e-01	2.27e-02	5.23e-01	6.02e-02	5.44e-01
GOBP T FOLLICULAR HELPER CELL DIFFERENTIATION	7	9.83e-01	9.94e-01	0.1690	-1.98e-02	3.20e-02	7.72e-03	-6.87e-02	-1.50e-01	9.28e-01	8.84e-01	9.72e-01	7.53e-01	4.93e-01
GOBP MONOCARBOXYLIC ACID TRANSPORT	173	2.88e-02	1.78e-01	0.1690	3.79e-02	1.98e-02	6.12e-02	1.46e-01	-3.99e-02	3.90e-01	6.54e-01	1.65e-01	9.06e-04	3.66e-01
GOBP REGULATION OF VIRAL PROCESS	163	6.67e-02	3.05e-01	0.1690	1.23e-02	5.28e-03	-8.67e-02	-1.35e-01	5.09e-02	7.87e-01	9.07e-01	5.62e-02	2.95e-03	2.62e-01
GOMF PHOSPHATIDYLINOSITOL 3 KINASE BINDING	24	8.94e-01	9.65e-01	0.1690	2.53e-02	7.83e-02	-8.85e-02	-1.12e-01	3.63e-02	8.30e-01	5.07e-01	4.53e-01	3.42e-01	7.58e-01
GOBP VASOCONSTRICTION	80	4.10e-01	7.42e-01	0.1690	-7.14e-02	2.27e-02	1.08e-01	1.04e-01	-2.02e-02	2.69e-01	7.26e-01	9.45e-02	1.09e-01	7.55e-01
GOMF PASSIVE TRANSMEMBRANE TRANSPORTER ACTIVITY	482	5.70e-06	2.02e-04	0.1690	-8.34e-02	7.49e-02	8.66e-02	7.73e-02	-4.94e-02	1.72e-03	4.84e-03	1.13e-03	3.65e-03	6.31e-02
GOBP RESPONSE TO PROSTAGLANDIN E	23	7.60e-01	9.20e-01	0.1690	-9.37e-02	5.91e-02	-4.62e-02	1.11e-01	-4.20e-02	4.37e-01	6.23e-01	7.01e-01	3.57e-01	7.27e-01
GOCC ENDOCYTIC VESICLE LUMEN	23	8.56e-01	9.52e-01	0.1690	-1.52e-01	-3.53e-02	1.91e-02	-2.41e-02	-5.62e-02	2.07e-01	7.70e-01	8.74e-01	8.42e-01	6.41e-01
GOBP POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY	44	5.49e-01	8.27e-01	0.1690	5.95e-02	1.24e-01	1.91e-02	-7.60e-02	-5.78e-02	4.95e-01	1.54e-01	8.26e-01	3.83e-01	5.07e-01
GOCC HIGH DENSITY LIPOPROTEIN PARTICLE	25	8.25e-01	9.43e-01	0.1680	-1.11e-01	1.24e-01	1.41e-02	-1.97e-02	6.57e-03	3.35e-01	2.84e-01	9.03e-01	8.64e-01	9.55e-01
GOBP PROTEIN COMPLEX OLIGOMERIZATION	249	2.56e-03	3.25e-02	0.1680	7.12e-02	1.02e-01	-2.24e-02	-9.75e-02	5.40e-02	5.30e-02	5.68e-03	5.42e-01	8.06e-03	1.42e-01
GOBP CELL CYCLE G1 S PHASE TRANSITION	263	2.22e-03	2.91e-02	0.1680	5.84e-02	3.88e-02	-8.52e-02	-1.22e-01	-3.53e-02	1.03e-01	2.78e-01	1.73e-02	6.51e-04	3.24e-01
GOBP BIOMINERAL TISSUE DEVELOPMENT	165	2.35e-02	1.56e-01	0.1680	-6.61e-02	-5.52e-03	1.21e-01	3.30e-02	9.05e-02	1.43e-01	9.03e-01	7.25e-03	4.65e-01	4.49e-02
GOBP VASCULAR WOUND HEALING	22	8.13e-01	9.39e-01	0.1680	6.71e-02	-3.35e-02	-1.10e-02	1.10e-01	1.02e-01	5.86e-01	7.86e-01	9.29e-01	3.70e-01	4.09e-01
GOBP RENAL SYSTEM PROCESS	117	5.85e-02	2.82e-01	0.1680	-2.65e-02	6.11e-02	-8.75e-03	1.29e-01	-8.38e-02	6.21e-01	2.54e-01	8.70e-01	1.56e-02	1.18e-01
GOMF ACTIN FILAMENT BINDING	203	5.27e-03	5.54e-02	0.1680	-9.42e-04	1.23e-01	4.19e-02	1.04e-01	-2.53e-02	9.82e-01	2.57e-03	3.04e-01	1.08e-02	5.35e-01
GOCC NUCLEAR MEMBRANE	296	8.65e-04	1.38e-02	0.1680	2.24e-02	4.80e-02	-4.10e-02	-1.42e-01	5.86e-02	5.08e-01	1.55e-01	2.25e-01	2.48e-05	8.30e-02
GOBP REGULATION OF LYMPHOCYTE DIFFERENTIATION	206	4.72e-03	5.18e-02	0.1680	-4.39e-02	1.49e-01	1.90e-02	-5.69e-02	2.15e-02	2.77e-01	2.26e-04	6.38e-01	1.59e-01	5.95e-01
GOBP CELLULAR RESPONSE TO STRESS	1864	1.10e-23	3.05e-21	0.1680	2.72e-03	4.70e-02	-6.51e-02	-1.43e-01	3.45e-02	8.46e-01	7.74e-04	3.19e-06	9.95e-25	1.35e-02
GOBP MAINTENANCE OF SYNAPSE STRUCTURE	25	8.26e-01	9.44e-01	0.1680	4.04e-03	-1.12e-01	4.86e-02	1.54e-02	1.14e-01	9.72e-01	3.31e-01	6.74e-01	8.94e-01	3.25e-01
GOBP KIDNEY MORPHOGENESIS	94	5.88e-02	2.83e-01	0.1680	3.94e-02	5.30e-03	3.63e-02	-1.58e-01	1.75e-02	5.09e-01	9.29e-01	5.43e-01	8.07e-03	7.70e-01
GOBP NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY	24	7.75e-01	9.26e-01	0.1680	-6.69e-02	3.78e-02	5.23e-02	-1.37e-01	2.74e-02	5.71e-01	7.49e-01	6.57e-01	2.45e-01	8.16e-01
GOBP POSTSYNAPTIC SPECIALIZATION ASSEMBLY	26	8.53e-01	9.51e-01	0.1680	-1.34e-02	9.68e-02	9.37e-02	1.92e-02	9.74e-02	9.06e-01	3.93e-01	4.08e-01	8.66e-01	3.90e-01
GOBP TUBE FORMATION	149	3.82e-02	2.14e-01	0.1680	2.36e-02	2.11e-02	-9.18e-03	-1.45e-01	7.81e-02	6.19e-01	6.57e-01	8.47e-01	2.27e-03	9.97e-02
GOBP NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION	65	4.11e-01	7.43e-01	0.1680	9.71e-02	1.02e-01	1.47e-02	-6.93e-02	5.72e-02	1.76e-01	1.54e-01	8.38e-01	3.34e-01	4.25e-01
GOBP NEURON MIGRATION	166	5.34e-03	5.56e-02	0.1680	-1.77e-02	-7.73e-02	1.46e-01	1.58e-02	1.54e-02	6.94e-01	8.57e-02	1.16e-03	7.25e-01	7.33e-01
GOBP GANGLIOSIDE METABOLIC PROCESS	28	8.04e-01	9.35e-01	0.1680	7.95e-04	1.20e-01	-5.28e-02	-6.95e-02	-7.79e-02	9.94e-01	2.71e-01	6.29e-01	5.24e-01	4.76e-01
GOBP NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION	34	7.85e-01	9.28e-01	0.1680	1.22e-01	2.59e-02	-3.62e-02	-6.35e-02	8.49e-02	2.18e-01	7.94e-01	7.15e-01	5.22e-01	3.92e-01
GOMF PHOSPHATIDYLCHOLINE BINDING	28	7.96e-01	9.32e-01	0.1680	-8.71e-02	1.31e-01	2.00e-02	-3.96e-02	3.74e-02	4.25e-01	2.30e-01	8.55e-01	7.17e-01	7.32e-01
GOCC GOLGI CISTERNA MEMBRANE	73	3.49e-01	6.95e-01	0.1680	-9.94e-02	3.82e-02	-6.53e-02	-1.11e-01	-1.08e-02	1.42e-01	5.72e-01	3.35e-01	1.00e-01	8.73e-01
GOBP REGULATION OF MACROPHAGE DIFFERENTIATION	24	7.65e-01	9.22e-01	0.1680	-3.06e-02	8.76e-02	8.70e-02	-7.74e-02	-7.68e-02	7.95e-01	4.58e-01	4.61e-01	5.12e-01	5.15e-01
GOMF TRANSFORMING GROWTH FACTOR BETA BINDING	23	7.94e-01	9.31e-01	0.1670	2.26e-02	5.04e-02	1.56e-01	-2.65e-02	-3.80e-03	8.51e-01	6.76e-01	1.96e-01	8.26e-01	9.75e-01
GOBP SUBSTRATE DEPENDENT CELL MIGRATION	25	8.57e-01	9.53e-01	0.1670	1.03e-01	-2.96e-02	5.62e-02	1.15e-01	1.17e-02	3.74e-01	7.98e-01	6.27e-01	3.19e-01	9.19e-01
GOBP ACTIVIN RECEPTOR SIGNALING PATHWAY	44	6.11e-01	8.58e-01	0.1670	3.46e-02	5.81e-02	-1.99e-02	-1.50e-01	2.00e-02	6.91e-01	5.05e-01	8.20e-01	8.43e-02	8.18e-01
GOBP ANTERIOR POSTERIOR AXON GUIDANCE	7	9.91e-01	9.96e-01	0.1670	8.32e-02	6.32e-02	8.95e-02	1.33e-02	9.43e-02	7.03e-01	7.72e-01	6.82e-01	9.51e-01	6.66e-01
GOBP ORGANIC ACID TRANSPORT	340	7.43e-04	1.21e-02	0.1670	-8.08e-03	6.42e-02	1.01e-01	1.16e-01	-1.32e-02	7.98e-01	4.21e-02	1.43e-03	2.34e-04	6.76e-01
GOBP REGULATION OF MACROPHAGE ACTIVATION	60	4.83e-01	7.93e-01	0.1670	-4.53e-03	8.70e-02	9.06e-02	4.99e-02	9.82e-02	9.52e-01	2.44e-01	2.25e-01	5.03e-01	1.88e-01
GOBP POSITIVE REGULATION OF CHEMOTAXIS	139	9.66e-02	3.76e-01	0.1670	-6.60e-02	9.06e-02	9.14e-02	8.26e-02	-1.24e-02	1.79e-01	6.50e-02	6.27e-02	9.28e-02	8.01e-01
GOBP PROTEIN LOCALIZATION TO VACUOLE	85	2.42e-01	5.99e-01	0.1670	-1.76e-02	5.68e-02	1.70e-02	-1.16e-01	1.03e-01	7.79e-01	3.65e-01	7.87e-01	6.49e-02	1.01e-01
GOBP REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY	19	9.10e-01	9.70e-01	0.1670	-1.30e-01	3.87e-02	1.98e-02	8.24e-02	-4.60e-02	3.25e-01	7.70e-01	8.81e-01	5.34e-01	7.28e-01
GOBP CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL	197	2.49e-02	1.62e-01	0.1670	-4.33e-02	1.51e-02	8.53e-02	1.36e-01	-5.08e-03	2.95e-01	7.15e-01	3.89e-02	1.03e-03	9.02e-01
GOMF METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY	426	2.87e-05	8.40e-04	0.1670	-4.90e-02	7.46e-02	9.63e-02	5.83e-02	-8.46e-02	8.31e-02	8.23e-03	6.53e-04	3.90e-02	2.73e-03
GOBP NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION	55	4.75e-01	7.88e-01	0.1670	2.59e-02	-1.09e-01	6.31e-03	-4.56e-02	1.15e-01	7.40e-01	1.62e-01	9.35e-01	5.58e-01	1.42e-01
GOBP PEPTIDYL THREONINE MODIFICATION	107	9.43e-02	3.72e-01	0.1670	-5.34e-02	7.76e-02	3.01e-02	-1.26e-01	4.48e-02	3.40e-01	1.65e-01	5.91e-01	2.39e-02	4.23e-01
GOBP REGULATION OF MYOBLAST DIFFERENTIATION	72	2.99e-01	6.53e-01	0.1670	7.61e-02	6.47e-02	5.36e-02	-9.08e-02	8.15e-02	2.64e-01	3.42e-01	4.32e-01	1.83e-01	2.32e-01
GOBP REGULATION OF CHONDROCYTE DEVELOPMENT	6	9.92e-01	9.97e-01	0.1660	9.69e-03	1.35e-01	-3.78e-03	-1.37e-02	-9.65e-02	9.67e-01	5.68e-01	9.87e-01	9.54e-01	6.82e-01
GOBP NUCLEAR MIGRATION	25	8.43e-01	9.48e-01	0.1660	8.46e-02	3.72e-02	-8.40e-02	-2.73e-02	1.07e-01	4.64e-01	7.47e-01	4.67e-01	8.13e-01	3.56e-01
GOBP PROTEIN LOCALIZATION TO LYSOSOME	57	5.15e-01	8.10e-01	0.1660	-5.30e-02	3.00e-02	-2.64e-02	-1.16e-01	9.89e-02	4.89e-01	6.96e-01	7.30e-01	1.30e-01	1.96e-01
GOMF SIGNALING RECEPTOR REGULATOR ACTIVITY	507	3.60e-06	1.35e-04	0.1660	-1.07e-01	3.76e-02	7.48e-02	8.26e-02	-4.91e-02	3.90e-05	1.47e-01	3.92e-03	1.45e-03	5.82e-02
GOBP HORMONE METABOLIC PROCESS	229	1.42e-02	1.12e-01	0.1660	-8.18e-03	-1.36e-02	8.56e-02	1.18e-01	-7.85e-02	8.31e-01	7.23e-01	2.55e-02	2.12e-03	4.07e-02
GOBP REGULATION OF ESTABLISHMENT OF PLANAR POLARITY	51	3.40e-01	6.87e-01	0.1660	-2.55e-02	-4.39e-02	1.15e-01	-1.04e-02	-1.08e-01	7.53e-01	5.87e-01	1.55e-01	8.97e-01	1.81e-01
GOBP ESTABLISHMENT OF TISSUE POLARITY	67	2.16e-01	5.69e-01	0.1660	-3.91e-02	-7.12e-02	1.27e-01	4.26e-03	-6.92e-02	5.80e-01	3.14e-01	7.17e-02	9.52e-01	3.27e-01
GOBP HETEROCHROMATIN ORGANIZATION	89	3.28e-01	6.76e-01	0.1660	3.81e-02	-6.66e-03	-5.36e-02	-1.19e-01	9.50e-02	5.34e-01	9.14e-01	3.82e-01	5.23e-02	1.21e-01
GOBP SYNCYTIUM FORMATION	65	4.92e-01	7.99e-01	0.1660	-4.10e-02	7.61e-02	9.70e-02	9.72e-02	3.50e-02	5.67e-01	2.88e-01	1.76e-01	1.75e-01	6.26e-01
GOBP REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS	91	1.97e-01	5.45e-01	0.1660	-5.03e-02	1.01e-01	-5.49e-03	4.15e-02	-1.14e-01	4.07e-01	9.59e-02	9.28e-01	4.94e-01	5.94e-02
GOBP DETERMINATION OF LEFT RIGHT ASYMMETRY IN LATERAL MESODERM	8	9.88e-01	9.95e-01	0.1660	-2.81e-02	-8.68e-02	1.06e-01	7.65e-02	-4.58e-02	8.91e-01	6.71e-01	6.03e-01	7.08e-01	8.23e-01
GOCC CELL CELL CONTACT ZONE	70	4.91e-01	7.98e-01	0.1660	-4.07e-02	-3.52e-03	1.07e-01	9.22e-02	-7.64e-02	5.56e-01	9.59e-01	1.20e-01	1.82e-01	2.69e-01
GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION	56	4.94e-01	7.99e-01	0.1660	-6.78e-02	9.20e-03	8.17e-02	7.21e-02	1.05e-01	3.80e-01	9.05e-01	2.90e-01	3.51e-01	1.75e-01
GOBP CELL JUNCTION ORGANIZATION	713	2.64e-08	1.67e-06	0.1660	-5.84e-02	1.55e-02	1.26e-01	7.98e-02	-3.86e-02	7.85e-03	4.81e-01	8.78e-09	2.85e-04	7.88e-02
GOBP SENSORY PERCEPTION OF MECHANICAL STIMULUS	177	5.29e-02	2.64e-01	0.1660	-1.99e-02	3.99e-03	8.06e-02	1.14e-01	-8.76e-02	6.48e-01	9.27e-01	6.42e-02	9.19e-03	4.45e-02
GOBP NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS	102	1.36e-01	4.55e-01	0.1660	-9.20e-02	1.20e-01	1.81e-02	-6.50e-02	-5.59e-03	1.08e-01	3.63e-02	7.52e-01	2.56e-01	9.22e-01
GOBP REGULATION OF RUFFLE ASSEMBLY	32	7.69e-01	9.24e-01	0.1660	-3.38e-02	8.40e-02	-8.15e-02	-5.71e-02	-9.66e-02	7.41e-01	4.11e-01	4.25e-01	5.76e-01	3.44e-01
GOBP TRANSPORT ALONG MICROTUBULE	164	6.48e-02	3.00e-01	0.1660	6.81e-02	1.59e-02	-6.31e-02	-1.19e-01	6.57e-02	1.32e-01	7.25e-01	1.63e-01	8.40e-03	1.46e-01
GOBP TELENCEPHALON GLIAL CELL MIGRATION	26	7.14e-01	9.01e-01	0.1660	-4.77e-02	-6.49e-02	1.43e-01	-2.22e-02	-1.71e-03	6.74e-01	5.67e-01	2.07e-01	8.45e-01	9.88e-01
GOBP MIRNA MEDIATED GENE SILENCING BY INHIBITION OF TRANSLATION	90	2.06e-01	5.56e-01	0.1660	-9.29e-02	-1.35e-01	-1.57e-02	-1.00e-02	9.40e-03	1.28e-01	2.63e-02	7.97e-01	8.70e-01	8.78e-01
GOBP RESPONSE TO TUMOR CELL	42	5.61e-01	8.33e-01	0.1660	-2.37e-02	7.75e-02	-9.89e-02	-4.12e-02	9.67e-02	7.91e-01	3.85e-01	2.67e-01	6.44e-01	2.78e-01
GOBP CELL CELL JUNCTION ORGANIZATION	208	2.43e-02	1.59e-01	0.1660	-3.71e-02	-2.35e-02	1.24e-01	9.90e-02	-2.04e-02	3.56e-01	5.60e-01	2.13e-03	1.39e-02	6.13e-01
GOBP GLYCEROLIPID CATABOLIC PROCESS	64	3.47e-01	6.93e-01	0.1660	-1.36e-01	8.06e-02	1.56e-02	4.47e-02	5.14e-03	5.90e-02	2.65e-01	8.29e-01	5.36e-01	9.43e-01
GOBP RESPONSE TO INSULIN	262	5.45e-04	9.47e-03	0.1660	-3.41e-03	1.31e-01	5.71e-02	-8.19e-02	1.62e-02	9.24e-01	2.62e-04	1.12e-01	2.24e-02	6.52e-01
GOMF PHOSPHATIDYLINOSITOL BISPHOSPHATE BINDING	102	1.10e-01	4.05e-01	0.1650	-4.22e-02	1.49e-01	-2.66e-02	3.19e-03	-5.12e-02	4.62e-01	9.22e-03	6.43e-01	9.56e-01	3.71e-01
GOBP NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY	98	1.35e-01	4.54e-01	0.1650	-3.69e-02	6.69e-02	8.75e-02	-7.23e-02	9.30e-02	5.28e-01	2.52e-01	1.34e-01	2.16e-01	1.12e-01
GOBP TAXIS	442	7.84e-06	2.67e-04	0.1650	-1.04e-01	8.97e-02	8.09e-02	4.39e-02	5.95e-03	1.80e-04	1.22e-03	3.55e-03	1.13e-01	8.30e-01
GOMF PHOSPHOLIPID TRANSFER ACTIVITY	25	8.29e-01	9.44e-01	0.1650	5.35e-02	1.49e-01	-4.49e-02	-1.92e-02	-1.32e-03	6.43e-01	1.99e-01	6.98e-01	8.68e-01	9.91e-01
GOBP POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION	20	8.92e-01	9.64e-01	0.1650	6.75e-02	3.45e-02	1.44e-01	2.06e-02	2.23e-02	6.01e-01	7.89e-01	2.66e-01	8.74e-01	8.63e-01
GOBP CELLULAR PIGMENTATION	60	4.32e-01	7.56e-01	0.1650	-8.40e-02	1.22e-01	-1.19e-02	-7.22e-02	8.31e-03	2.60e-01	1.03e-01	8.73e-01	3.33e-01	9.11e-01
GOCC CONTRACTILE FIBER	238	2.47e-03	3.17e-02	0.1650	-3.20e-02	1.03e-02	-1.91e-03	1.26e-01	-1.01e-01	3.95e-01	7.85e-01	9.60e-01	8.18e-04	7.09e-03
GOBP REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS	54	1.80e-01	5.22e-01	0.1650	-2.18e-02	7.02e-02	-9.99e-02	1.09e-01	-3.97e-03	7.82e-01	3.72e-01	2.04e-01	1.67e-01	9.60e-01
GOCC MITOTIC SPINDLE POLE	35	7.96e-01	9.32e-01	0.1650	-5.46e-02	-9.92e-02	-9.67e-02	-6.93e-02	1.52e-02	5.76e-01	3.10e-01	3.22e-01	4.78e-01	8.76e-01
GOBP POSITIVE REGULATION OF BINDING	122	1.07e-01	3.97e-01	0.1650	-1.64e-02	2.55e-02	-5.90e-02	-1.49e-01	-2.44e-02	7.54e-01	6.27e-01	2.60e-01	4.47e-03	6.41e-01
GOMF POLY PURINE TRACT BINDING	28	6.53e-01	8.79e-01	0.1650	8.74e-03	-1.16e-01	6.36e-02	-9.25e-02	3.33e-02	9.36e-01	2.89e-01	5.60e-01	3.97e-01	7.61e-01
GOBP B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE	84	2.02e-01	5.52e-01	0.1650	3.83e-02	1.21e-01	3.02e-02	-9.99e-02	-1.30e-02	5.44e-01	5.51e-02	6.33e-01	1.13e-01	8.37e-01
GOBP REGULATION OF BINDING	253	5.32e-03	5.56e-02	0.1650	2.22e-02	2.61e-02	-5.62e-02	-1.44e-01	4.74e-02	5.43e-01	4.75e-01	1.24e-01	8.43e-05	1.95e-01
GOBP REGULATION OF MORPHOGENESIS OF AN EPITHELIUM	62	3.16e-01	6.66e-01	0.1650	-1.00e-01	-1.84e-02	7.33e-03	-1.27e-01	-2.35e-02	1.71e-01	8.02e-01	9.20e-01	8.39e-02	7.49e-01
GOBP MAINTENANCE OF CELL NUMBER	179	1.72e-02	1.28e-01	0.1650	9.22e-02	-3.99e-02	-1.75e-02	-1.10e-01	6.76e-02	3.34e-02	3.57e-01	6.86e-01	1.09e-02	1.19e-01
GOBP REGULATION OF AUTOPHAGY	337	3.45e-04	6.63e-03	0.1650	5.44e-02	2.21e-02	-4.32e-02	-1.39e-01	4.90e-02	8.62e-02	4.85e-01	1.73e-01	1.11e-05	1.22e-01
GOBP PHOSPHATIDYLINOSITOL METABOLIC PROCESS	146	6.16e-02	2.92e-01	0.1650	-2.03e-02	8.23e-02	-4.73e-02	-1.33e-01	6.30e-03	6.72e-01	8.60e-02	3.24e-01	5.60e-03	8.95e-01
GOBP PURINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT	35	7.32e-01	9.08e-01	0.1650	1.12e-01	-3.04e-02	7.76e-02	2.79e-02	8.23e-02	2.51e-01	7.56e-01	4.27e-01	7.75e-01	3.99e-01
GOBP POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION	165	7.82e-02	3.36e-01	0.1640	-6.35e-02	1.47e-02	1.08e-01	1.06e-01	-5.02e-03	1.59e-01	7.45e-01	1.70e-02	1.91e-02	9.11e-01
GOMF METALLOEXOPEPTIDASE ACTIVITY	64	5.84e-01	8.45e-01	0.1640	-2.00e-02	3.00e-02	1.13e-01	1.13e-01	-4.14e-03	7.82e-01	6.78e-01	1.17e-01	1.17e-01	9.54e-01
GOBP NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS	57	4.60e-01	7.78e-01	0.1640	-8.21e-02	1.01e-01	-2.45e-03	-5.64e-02	-8.30e-02	2.84e-01	1.87e-01	9.74e-01	4.61e-01	2.78e-01
GOBP PROTEIN O LINKED GLYCOSYLATION VIA SERINE	10	9.73e-01	9.92e-01	0.1640	8.26e-02	-7.86e-02	-8.95e-02	2.86e-02	7.19e-02	6.51e-01	6.67e-01	6.24e-01	8.75e-01	6.94e-01
GOCC SIDE OF MEMBRANE	674	1.55e-07	8.56e-06	0.1640	-3.57e-02	7.82e-02	1.09e-01	8.23e-02	-2.92e-02	1.14e-01	5.35e-04	1.28e-06	2.70e-04	1.96e-01
GOBP ACTIVATION OF PROTEIN KINASE ACTIVITY	85	3.03e-01	6.56e-01	0.1640	-8.26e-02	9.29e-02	1.05e-01	1.94e-02	1.14e-02	1.88e-01	1.39e-01	9.47e-02	7.57e-01	8.56e-01
GOBP GLYCOSYLCERAMIDE CATABOLIC PROCESS	6	9.75e-01	9.92e-01	0.1640	1.55e-02	1.50e-03	1.16e-01	-8.81e-02	-7.48e-02	9.48e-01	9.95e-01	6.24e-01	7.09e-01	7.51e-01
GOBP RESPONSE TO OXYGEN RADICAL	27	8.50e-01	9.50e-01	0.1640	6.89e-03	-5.21e-02	-1.52e-01	-3.00e-02	-1.34e-02	9.51e-01	6.39e-01	1.72e-01	7.87e-01	9.04e-01
GOBP REGULATION OF CHEMOTAXIS	220	9.75e-03	8.61e-02	0.1640	-9.35e-02	6.48e-02	9.46e-02	6.02e-02	3.70e-02	1.68e-02	9.77e-02	1.56e-02	1.24e-01	3.44e-01
GOBP REGULATION OF MAP KINASE ACTIVITY	138	8.87e-02	3.59e-01	0.1640	-1.79e-02	9.66e-02	1.28e-01	2.83e-02	-8.83e-03	7.16e-01	5.00e-02	9.54e-03	5.66e-01	8.58e-01
GOBP MEIOTIC CELL CYCLE	275	1.69e-03	2.37e-02	0.1640	5.46e-02	-3.15e-02	-1.73e-02	-1.03e-01	1.09e-01	1.19e-01	3.68e-01	6.22e-01	3.21e-03	1.86e-03
GOBP RECEPTOR RECYCLING	46	3.97e-01	7.31e-01	0.1640	-2.05e-02	2.88e-02	3.10e-02	-1.21e-01	-9.92e-02	8.10e-01	7.35e-01	7.16e-01	1.54e-01	2.44e-01
GOBP CELLULAR RESPONSE TO STARVATION	171	4.60e-02	2.40e-01	0.1640	-4.26e-02	1.01e-02	-7.30e-02	-1.39e-01	1.21e-02	3.37e-01	8.19e-01	9.94e-02	1.68e-03	7.84e-01
GOBP RETINAL ROD CELL DIFFERENTIATION	14	8.51e-01	9.50e-01	0.1640	-3.61e-03	-4.42e-02	8.59e-02	-1.08e-01	-7.57e-02	9.81e-01	7.75e-01	5.78e-01	4.83e-01	6.24e-01
GOBP INTRACELLULAR RECEPTOR SIGNALING PATHWAY	338	1.99e-04	4.17e-03	0.1640	-1.70e-02	9.74e-02	-1.90e-02	-1.17e-01	5.50e-02	5.91e-01	2.08e-03	5.48e-01	2.28e-04	8.24e-02
GOBP ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS	22	9.17e-01	9.74e-01	0.1640	-1.84e-02	9.78e-02	1.05e-01	5.59e-02	5.13e-02	8.81e-01	4.27e-01	3.93e-01	6.50e-01	6.77e-01
GOBP LONG CHAIN FATTY ACID METABOLIC PROCESS	102	1.18e-01	4.22e-01	0.1640	7.69e-02	8.43e-02	-8.93e-04	3.70e-02	1.11e-01	1.80e-01	1.41e-01	9.88e-01	5.19e-01	5.23e-02
GOBP ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS	52	6.57e-01	8.80e-01	0.1640	-5.63e-02	8.50e-02	8.62e-02	8.46e-02	-4.20e-02	4.83e-01	2.89e-01	2.82e-01	2.91e-01	6.01e-01
GOBP MITOCHONDRIAL FUSION	32	7.92e-01	9.31e-01	0.1630	-1.37e-02	5.13e-05	-4.16e-02	-1.56e-01	1.96e-02	8.93e-01	1.00e+00	6.84e-01	1.26e-01	8.48e-01
GOMF UBIQUITIN LIKE PROTEIN BINDING	117	1.79e-01	5.20e-01	0.1630	2.34e-02	6.95e-02	-5.79e-02	-1.28e-01	4.11e-02	6.62e-01	1.94e-01	2.79e-01	1.71e-02	4.42e-01
GOBP POSITIVE REGULATION OF SISTER CHROMATID COHESION	9	9.62e-01	9.89e-01	0.1630	7.14e-02	-3.54e-02	2.10e-02	-7.03e-02	-1.22e-01	7.11e-01	8.54e-01	9.13e-01	7.15e-01	5.26e-01
GOMF GUANYL NUCLEOTIDE BINDING	370	1.78e-04	3.82e-03	0.1630	1.49e-02	6.50e-02	-6.08e-02	-1.36e-01	1.01e-02	6.22e-01	3.19e-02	4.47e-02	7.55e-06	7.38e-01
GOMF SCAFFOLD PROTEIN BINDING	64	5.54e-01	8.30e-01	0.1630	-8.40e-02	3.23e-02	1.14e-01	7.39e-02	-5.87e-03	2.45e-01	6.55e-01	1.15e-01	3.07e-01	9.35e-01
GOBP GLYCOSYL COMPOUND CATABOLIC PROCESS	34	6.92e-01	8.93e-01	0.1630	9.89e-02	7.66e-02	4.53e-02	-1.75e-02	-9.26e-02	3.18e-01	4.39e-01	6.48e-01	8.60e-01	3.50e-01
GOBP CARDIAC MUSCLE TISSUE MORPHOGENESIS	61	3.81e-01	7.19e-01	0.1630	1.43e-01	3.05e-03	-4.31e-02	5.94e-02	2.44e-02	5.26e-02	9.67e-01	5.60e-01	4.23e-01	7.42e-01
GOCC CLATHRIN COATED ENDOCYTIC VESICLE	85	4.03e-01	7.36e-01	0.1630	2.12e-02	3.01e-02	9.16e-02	1.25e-01	-3.51e-02	7.35e-01	6.32e-01	1.44e-01	4.66e-02	5.76e-01
GOBP NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY	134	1.15e-01	4.15e-01	0.1630	1.08e-02	5.68e-02	-5.07e-02	-1.38e-01	4.01e-02	8.29e-01	2.57e-01	3.11e-01	5.82e-03	4.23e-01
GOBP ADULT BEHAVIOR	141	2.21e-02	1.50e-01	0.1630	5.61e-02	4.38e-02	1.03e-01	-7.46e-02	7.28e-02	2.50e-01	3.70e-01	3.49e-02	1.26e-01	1.36e-01
GOBP LYMPHOCYTE APOPTOTIC PROCESS	80	2.68e-01	6.23e-01	0.1630	-6.40e-02	1.11e-01	2.09e-02	-9.66e-02	1.62e-02	3.23e-01	8.53e-02	7.46e-01	1.35e-01	8.02e-01
GOBP ACUTE INFLAMMATORY RESPONSE	101	2.03e-01	5.53e-01	0.1630	9.76e-02	8.98e-02	6.26e-02	4.27e-02	5.62e-02	9.00e-02	1.19e-01	2.77e-01	4.59e-01	3.29e-01
GOBP MESONEPHRIC TUBULE MORPHOGENESIS	64	2.14e-01	5.67e-01	0.1630	1.98e-02	-6.77e-03	3.67e-02	-1.57e-01	1.08e-02	7.84e-01	9.25e-01	6.12e-01	3.01e-02	8.81e-01
GOBP CALCIUM MEDIATED SIGNALING	203	2.37e-02	1.57e-01	0.1630	-8.61e-02	5.10e-02	1.07e-01	6.78e-02	2.11e-02	3.44e-02	2.10e-01	8.82e-03	9.58e-02	6.04e-01
GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS	37	4.96e-01	8.01e-01	0.1630	-4.40e-03	-1.67e-02	-3.92e-02	1.19e-01	1.02e-01	9.63e-01	8.60e-01	6.80e-01	2.10e-01	2.83e-01
GOBP POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION	26	8.38e-01	9.47e-01	0.1630	-1.12e-01	3.06e-02	-1.93e-02	-6.77e-02	8.97e-02	3.24e-01	7.87e-01	8.65e-01	5.50e-01	4.29e-01
GOBP REGULATION OF CELL MATURATION	20	9.30e-01	9.78e-01	0.1630	-8.17e-02	7.93e-02	8.28e-02	8.01e-02	1.31e-02	5.27e-01	5.39e-01	5.21e-01	5.35e-01	9.20e-01
GOBP POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY	140	5.34e-02	2.66e-01	0.1620	-5.74e-02	3.85e-02	-3.16e-02	-1.43e-01	-1.29e-02	2.41e-01	4.32e-01	5.18e-01	3.48e-03	7.92e-01
GOCC POSTSYNAPTIC SPECIALIZATION INTRACELLULAR COMPONENT	17	9.24e-01	9.75e-01	0.1620	3.70e-02	1.15e-01	-2.43e-03	-4.12e-02	-9.98e-02	7.92e-01	4.10e-01	9.86e-01	7.69e-01	4.76e-01
GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY	83	3.65e-01	7.05e-01	0.1620	5.60e-02	2.19e-02	-1.05e-01	-7.20e-02	8.03e-02	3.78e-01	7.30e-01	9.67e-02	2.57e-01	2.06e-01
GOBP CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE	290	5.80e-04	9.95e-03	0.1620	-6.37e-02	1.42e-01	4.48e-02	-1.47e-03	1.59e-03	6.18e-02	3.00e-05	1.89e-01	9.66e-01	9.63e-01
GOBP RETROGRADE TRANSPORT ENDOSOME TO GOLGI	93	3.07e-01	6.60e-01	0.1620	-3.52e-02	5.28e-02	-9.25e-02	-1.16e-01	1.58e-02	5.58e-01	3.79e-01	1.23e-01	5.26e-02	7.93e-01
GOMF PHOSPHATIDYLINOSITOL 3 PHOSPHATE BINDING	42	6.64e-01	8.82e-01	0.1620	8.13e-04	5.98e-02	8.70e-02	2.92e-02	-1.19e-01	9.93e-01	5.03e-01	3.29e-01	7.43e-01	1.80e-01
GOCC PLASMA MEMBRANE SIGNALING RECEPTOR COMPLEX	178	1.99e-02	1.40e-01	0.1620	-9.22e-02	4.46e-02	1.14e-01	-1.15e-03	5.28e-02	3.38e-02	3.04e-01	8.72e-03	9.79e-01	2.25e-01
GOCC RNAI EFFECTOR COMPLEX	357	8.03e-05	1.99e-03	0.1620	-2.82e-02	-1.14e-01	3.19e-02	1.04e-01	2.48e-02	3.59e-01	2.13e-04	3.00e-01	7.40e-04	4.21e-01
GOBP HEART FORMATION	33	6.80e-01	8.87e-01	0.1620	5.11e-02	7.85e-02	3.39e-02	-1.27e-01	-1.25e-02	6.11e-01	4.35e-01	7.36e-01	2.06e-01	9.01e-01
GOMF LIGAND GATED MONOATOMIC CATION CHANNEL ACTIVITY	107	2.51e-01	6.07e-01	0.1620	-4.72e-03	8.93e-02	8.34e-02	9.07e-02	-5.49e-02	9.33e-01	1.10e-01	1.36e-01	1.05e-01	3.26e-01
GOBP REGULATION OF MEMBRANE PERMEABILITY	71	4.49e-01	7.71e-01	0.1620	5.69e-02	-5.33e-02	-5.71e-02	-1.23e-01	4.15e-02	4.07e-01	4.37e-01	4.05e-01	7.30e-02	5.45e-01
GOBP INTEGRIN MEDIATED SIGNALING PATHWAY	110	4.17e-02	2.27e-01	0.1620	-8.38e-02	4.04e-02	-9.48e-03	1.30e-01	2.11e-02	1.29e-01	4.65e-01	8.64e-01	1.81e-02	7.02e-01
GOBP CYTOKINESIS	177	3.03e-02	1.85e-01	0.1620	4.55e-03	1.36e-02	-3.96e-02	-1.51e-01	3.92e-02	9.17e-01	7.55e-01	3.63e-01	5.17e-04	3.68e-01
GOBP REGULATION OF LEUKOCYTE MEDIATED IMMUNITY	235	3.72e-03	4.31e-02	0.1620	-8.75e-02	8.84e-02	1.03e-01	-9.15e-03	-7.37e-03	2.09e-02	1.95e-02	6.63e-03	8.09e-01	8.46e-01
GOBP REGULATION OF NEURONAL SYNAPTIC PLASTICITY	53	5.09e-01	8.07e-01	0.1620	-5.81e-02	-9.39e-02	-1.62e-02	-2.94e-02	-1.13e-01	4.65e-01	2.37e-01	8.39e-01	7.11e-01	1.53e-01
GOBP GLYCEROLIPID BIOSYNTHETIC PROCESS	234	4.55e-03	5.04e-02	0.1620	2.32e-02	1.02e-01	-1.73e-02	-1.21e-01	1.63e-02	5.41e-01	7.00e-03	6.49e-01	1.46e-03	6.68e-01
GOBP RIBOSOMAL SMALL SUBUNIT EXPORT FROM NUCLEUS	8	9.91e-01	9.96e-01	0.1620	1.24e-02	9.36e-02	-7.32e-02	-1.09e-01	5.86e-03	9.52e-01	6.47e-01	7.20e-01	5.94e-01	9.77e-01
GOBP REGULATION OF CELL CYCLE G1 S PHASE TRANSITION	197	1.58e-02	1.21e-01	0.1620	7.85e-02	-3.06e-03	-6.09e-02	-1.26e-01	-1.96e-02	5.76e-02	9.41e-01	1.41e-01	2.29e-03	6.36e-01
GOBP REGULATION OF LIPID KINASE ACTIVITY	38	6.50e-01	8.77e-01	0.1620	-1.02e-01	6.06e-04	1.01e-01	-1.57e-02	-7.29e-02	2.76e-01	9.95e-01	2.83e-01	8.67e-01	4.37e-01
GOMF LIGAND GATED CALCIUM CHANNEL ACTIVITY	27	8.96e-01	9.65e-01	0.1620	3.83e-02	3.21e-02	-7.69e-02	-9.92e-02	8.86e-02	7.31e-01	7.73e-01	4.89e-01	3.72e-01	4.25e-01
GOBP STRIATED MUSCLE CELL DEVELOPMENT	73	4.07e-01	7.40e-01	0.1620	2.02e-02	3.66e-04	1.86e-02	1.00e-01	-1.23e-01	7.65e-01	9.96e-01	7.84e-01	1.38e-01	6.81e-02
GOBP INTERNAL PROTEIN AMINO ACID ACETYLATION	53	5.84e-01	8.45e-01	0.1610	1.18e-01	-3.47e-03	-3.07e-02	-9.67e-02	4.18e-02	1.36e-01	9.65e-01	6.99e-01	2.23e-01	5.99e-01
GOBP CELL CELL JUNCTION MAINTENANCE	18	9.24e-01	9.75e-01	0.1610	-9.52e-02	9.54e-02	-2.39e-02	-4.60e-02	-7.21e-02	4.84e-01	4.84e-01	8.60e-01	7.36e-01	5.96e-01
GOCC PROTEIN PHOSPHATASE TYPE 2A COMPLEX	16	9.37e-01	9.80e-01	0.1610	-4.13e-03	-8.19e-02	-3.71e-02	-2.68e-02	-1.31e-01	9.77e-01	5.70e-01	7.97e-01	8.53e-01	3.64e-01
GOBP BONE RESORPTION	65	4.30e-01	7.55e-01	0.1610	-4.39e-02	8.54e-02	1.26e-01	-9.88e-03	2.74e-02	5.41e-01	2.34e-01	7.83e-02	8.90e-01	7.03e-01
GOBP MODULATION BY SYMBIONT OF ENTRY INTO HOST	54	6.05e-01	8.55e-01	0.1610	2.60e-02	-3.22e-02	-8.08e-02	-6.04e-02	1.19e-01	7.41e-01	6.82e-01	3.05e-01	4.43e-01	1.31e-01
GOBP NEGATIVE REGULATION OF TRANSFERASE ACTIVITY	222	7.28e-03	6.98e-02	0.1610	-1.80e-02	5.16e-02	-1.48e-02	-1.38e-01	6.13e-02	6.45e-01	1.85e-01	7.04e-01	4.00e-04	1.15e-01
GOMF N METHYLTRANSFERASE ACTIVITY	97	1.87e-01	5.31e-01	0.1610	1.03e-01	-3.76e-02	-1.80e-02	-1.09e-01	4.38e-02	8.07e-02	5.22e-01	7.60e-01	6.47e-02	4.56e-01
GOBP REGULATION OF STEM CELL PROLIFERATION	91	2.14e-01	5.67e-01	0.1610	-4.52e-02	-8.72e-02	-1.55e-02	-1.07e-01	6.85e-02	4.56e-01	1.51e-01	7.99e-01	7.85e-02	2.59e-01
GOBP POSITIVE REGULATION OF GLUCOSE IMPORT	35	6.98e-01	8.94e-01	0.1610	-7.96e-02	1.31e-01	-2.47e-02	1.45e-02	-3.90e-02	4.15e-01	1.79e-01	8.00e-01	8.82e-01	6.90e-01
GOBP T CELL RECEPTOR SIGNALING PATHWAY	133	1.04e-01	3.90e-01	0.1610	1.98e-02	1.04e-01	8.64e-02	9.60e-03	8.40e-02	6.94e-01	3.77e-02	8.54e-02	8.48e-01	9.43e-02
GOBP RESPONSE TO CAFFEINE	15	9.54e-01	9.86e-01	0.1610	4.01e-02	-8.33e-02	-7.59e-02	2.82e-03	-1.08e-01	7.88e-01	5.76e-01	6.11e-01	9.85e-01	4.71e-01
GOBP NEGATIVE REGULATION OF GROWTH	233	2.65e-03	3.34e-02	0.1610	-8.78e-02	7.98e-02	2.45e-03	-1.08e-01	3.91e-03	2.09e-02	3.58e-02	9.49e-01	4.36e-03	9.18e-01
GOBP CELL MATRIX ADHESION	231	1.16e-02	9.75e-02	0.1610	-2.36e-02	8.17e-02	6.28e-02	1.09e-01	-5.39e-02	5.36e-01	3.25e-02	1.00e-01	4.47e-03	1.58e-01
GOBP POSITIVE REGULATION OF MAPK CASCADE	460	4.76e-05	1.30e-03	0.1610	-7.12e-02	6.85e-02	8.19e-02	8.44e-02	-4.74e-02	8.89e-03	1.18e-02	2.60e-03	1.91e-03	8.16e-02
GOMF ACETYLTRANSFERASE ACTIVITY	87	2.56e-01	6.13e-01	0.1610	8.86e-02	8.30e-02	-2.80e-02	-9.78e-02	-2.75e-02	1.53e-01	1.81e-01	6.52e-01	1.15e-01	6.57e-01
GOCC DENDRITIC SPINE MEMBRANE	13	9.45e-01	9.82e-01	0.1610	1.45e-02	-8.23e-02	-5.41e-02	5.42e-02	1.14e-01	9.28e-01	6.08e-01	7.35e-01	7.35e-01	4.77e-01
GOBP REGULATION OF POTASSIUM ION TRANSPORT	99	2.80e-01	6.33e-01	0.1610	-6.59e-02	1.69e-02	9.64e-02	6.15e-02	-8.98e-02	2.57e-01	7.71e-01	9.73e-02	2.91e-01	1.22e-01
GOBP STRESS FIBER ASSEMBLY	108	1.22e-01	4.30e-01	0.1600	-6.86e-02	1.23e-01	-2.27e-02	9.24e-03	-7.37e-02	2.18e-01	2.78e-02	6.84e-01	8.68e-01	1.86e-01
GOCC CELL CELL JUNCTION	485	7.52e-05	1.89e-03	0.1600	-3.64e-02	2.86e-02	1.11e-01	9.99e-02	-3.48e-02	1.69e-01	2.81e-01	2.72e-05	1.64e-04	1.89e-01
GOBP ENDOMEMBRANE SYSTEM ORGANIZATION	564	2.22e-06	8.97e-05	0.1600	2.92e-02	5.94e-02	-9.03e-02	-1.14e-01	-1.03e-02	2.37e-01	1.59e-02	2.47e-04	3.49e-06	6.74e-01
GOCC PML BODY	104	2.51e-01	6.08e-01	0.1600	3.08e-02	-4.37e-02	-5.02e-02	-1.24e-01	7.08e-02	5.87e-01	4.41e-01	3.76e-01	2.95e-02	2.12e-01
GOBP REGULATION OF LAMELLIPODIUM ASSEMBLY	37	7.45e-01	9.14e-01	0.1600	-1.45e-01	1.94e-02	6.69e-03	2.51e-03	-6.56e-02	1.28e-01	8.38e-01	9.44e-01	9.79e-01	4.90e-01
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE	19	9.13e-01	9.71e-01	0.1600	7.91e-03	-7.28e-02	-5.29e-02	-1.23e-01	-4.80e-02	9.52e-01	5.83e-01	6.90e-01	3.53e-01	7.17e-01
GOBP MYELOID CELL APOPTOTIC PROCESS	38	7.31e-01	9.08e-01	0.1600	-4.45e-02	-1.96e-02	-6.39e-02	-8.20e-02	-1.12e-01	6.35e-01	8.35e-01	4.96e-01	3.82e-01	2.34e-01
GOCC MICROBODY LUMEN	51	6.14e-01	8.60e-01	0.1600	5.41e-02	6.61e-02	-1.15e-01	-6.34e-02	3.42e-02	5.04e-01	4.14e-01	1.57e-01	4.33e-01	6.73e-01
GOBP RESPONSE TO ALKALOID	90	1.77e-01	5.18e-01	0.1600	7.04e-02	7.33e-02	1.73e-02	-1.22e-01	1.69e-03	2.49e-01	2.30e-01	7.76e-01	4.47e-02	9.78e-01
GOBP REGULATION OF CELL SHAPE	134	1.73e-01	5.13e-01	0.1600	-4.09e-02	7.03e-02	9.39e-02	9.40e-02	-3.63e-02	4.14e-01	1.60e-01	6.04e-02	6.03e-02	4.68e-01
GOBP NEURON PROJECTION REGENERATION	54	5.80e-01	8.43e-01	0.1600	-6.98e-02	-1.08e-01	4.69e-02	8.23e-02	1.28e-02	3.75e-01	1.71e-01	5.51e-01	2.96e-01	8.71e-01
GOBP REGULATION OF SODIUM ION TRANSPORT	80	3.24e-01	6.72e-01	0.1600	-7.36e-02	1.27e-01	6.02e-02	-1.43e-02	-1.43e-02	2.55e-01	4.96e-02	3.52e-01	8.24e-01	8.25e-01
GOBP LIVER REGENERATION	28	8.41e-01	9.48e-01	0.1600	-2.37e-02	1.12e-01	5.38e-02	-6.02e-02	7.73e-02	8.28e-01	3.06e-01	6.22e-01	5.81e-01	4.79e-01
GOBP INNER EAR RECEPTOR CELL DEVELOPMENT	45	6.79e-01	8.87e-01	0.1600	-1.02e-01	8.21e-02	7.43e-02	4.63e-02	2.77e-02	2.37e-01	3.40e-01	3.88e-01	5.91e-01	7.48e-01
GOBP POSITIVE REGULATION OF STEROID METABOLIC PROCESS	27	8.58e-01	9.53e-01	0.1600	-5.36e-02	-7.16e-02	-1.49e-02	1.08e-01	-7.57e-02	6.30e-01	5.20e-01	8.94e-01	3.33e-01	4.96e-01
GOBP INTERLEUKIN 17 PRODUCTION	46	6.65e-01	8.82e-01	0.1600	1.24e-02	1.46e-01	5.83e-02	1.98e-02	1.61e-02	8.85e-01	8.66e-02	4.94e-01	8.16e-01	8.50e-01
GOBP EXTRACELLULAR MATRIX ASSEMBLY	42	6.70e-01	8.83e-01	0.1600	-1.78e-02	2.93e-02	1.08e-01	-2.00e-02	1.11e-01	8.42e-01	7.42e-01	2.26e-01	8.23e-01	2.14e-01
GOBP LOCOMOTOR RHYTHM	15	9.66e-01	9.90e-01	0.1600	8.12e-02	-3.12e-02	-4.76e-02	-6.34e-02	1.08e-01	5.86e-01	8.34e-01	7.49e-01	6.71e-01	4.69e-01
GOBP OLIGODENDROCYTE DIFFERENTIATION	102	2.10e-01	5.61e-01	0.1600	1.00e-01	1.48e-02	-1.02e-02	-1.04e-01	6.66e-02	8.08e-02	7.96e-01	8.59e-01	7.05e-02	2.45e-01
GOBP POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS	19	8.20e-01	9.41e-01	0.1600	4.37e-02	-3.92e-02	6.04e-02	-1.33e-01	2.48e-02	7.41e-01	7.67e-01	6.49e-01	3.14e-01	8.51e-01
GOBP RESPONSE TO VIRUS	419	2.12e-04	4.40e-03	0.1600	2.23e-02	8.81e-03	-8.86e-02	-9.98e-02	8.44e-02	4.34e-01	7.57e-01	1.87e-03	4.58e-04	3.03e-03
GOBP POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE	132	8.33e-02	3.48e-01	0.1600	-3.23e-02	1.39e-01	1.22e-02	-5.71e-02	4.30e-02	5.22e-01	5.97e-03	8.09e-01	2.58e-01	3.94e-01
GOBP REGULATION OF GENE SILENCING BY REGULATORY NCRNA	29	7.72e-01	9.25e-01	0.1600	7.14e-02	-3.71e-02	-2.05e-02	-1.36e-01	-1.03e-02	5.06e-01	7.30e-01	8.48e-01	2.05e-01	9.24e-01
GOBP REGULATION OF DENDRITE DEVELOPMENT	91	3.32e-01	6.80e-01	0.1600	-1.75e-02	1.90e-02	9.98e-02	7.22e-02	-9.82e-02	7.73e-01	7.54e-01	9.98e-02	2.34e-01	1.06e-01
GOBP SYNAPSE ORGANIZATION	446	7.77e-05	1.93e-03	0.1600	-6.49e-02	1.64e-02	1.23e-01	6.85e-02	-3.27e-02	1.88e-02	5.53e-01	7.96e-06	1.31e-02	2.36e-01
GOBP POSITIVE REGULATION OF MITOCHONDRIAL FISSION	21	8.24e-01	9.43e-01	0.1600	-3.47e-02	3.00e-02	8.30e-02	-1.23e-01	3.71e-02	7.83e-01	8.12e-01	5.10e-01	3.30e-01	7.69e-01
GOBP LEUKOCYTE MEDIATED IMMUNITY	376	6.67e-05	1.72e-03	0.1590	-7.86e-02	1.09e-01	8.45e-02	-1.22e-02	-3.40e-03	8.86e-03	2.70e-04	4.91e-03	6.84e-01	9.10e-01
GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING	24	8.16e-01	9.41e-01	0.1590	-6.45e-02	-1.14e-02	1.04e-01	-6.64e-02	7.74e-02	5.84e-01	9.23e-01	3.80e-01	5.73e-01	5.11e-01
GOBP VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE	144	3.61e-02	2.06e-01	0.1590	-5.46e-02	8.07e-02	2.41e-03	-1.17e-01	-4.79e-02	2.58e-01	9.44e-02	9.60e-01	1.56e-02	3.21e-01
GOBP MEMBRANE RAFT ORGANIZATION	26	8.08e-01	9.37e-01	0.1590	-1.77e-02	9.36e-02	1.17e-01	-4.68e-02	-1.98e-02	8.76e-01	4.09e-01	3.01e-01	6.80e-01	8.61e-01
GOBP POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET	7	9.88e-01	9.95e-01	0.1590	-4.13e-02	1.34e-01	1.73e-02	4.74e-02	5.67e-02	8.50e-01	5.39e-01	9.37e-01	8.28e-01	7.95e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H	75	5.23e-01	8.15e-01	0.1590	5.92e-02	-1.21e-02	-9.48e-02	-1.09e-01	3.06e-02	3.75e-01	8.57e-01	1.56e-01	1.03e-01	6.47e-01
GOCC GOLGI ASSOCIATED VESICLE MEMBRANE	54	5.11e-01	8.08e-01	0.1590	7.67e-03	1.01e-01	-3.16e-04	-1.21e-01	-1.97e-02	9.22e-01	1.98e-01	9.97e-01	1.23e-01	8.03e-01
GOMF 2 OXOGLUTARATE DEPENDENT DIOXYGENASE ACTIVITY	54	5.86e-01	8.45e-01	0.1590	8.06e-02	7.67e-02	-1.57e-02	-1.08e-01	3.31e-02	3.05e-01	3.30e-01	8.42e-01	1.70e-01	6.74e-01
GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX	28	8.37e-01	9.46e-01	0.1590	-1.57e-02	1.14e-01	-8.17e-02	-6.49e-02	-3.49e-02	8.86e-01	2.96e-01	4.54e-01	5.52e-01	7.49e-01
GOBP IMMUNE EFFECTOR PROCESS	604	8.95e-08	5.09e-06	0.1590	-1.01e-01	1.02e-01	6.43e-02	2.05e-02	-5.99e-03	2.07e-05	1.76e-05	6.93e-03	3.90e-01	8.01e-01
GOBP HAIR CELL DIFFERENTIATION	52	6.20e-01	8.63e-01	0.1590	-2.79e-02	-5.05e-02	1.12e-01	7.06e-02	-6.60e-02	7.28e-01	5.29e-01	1.61e-01	3.78e-01	4.10e-01
GOMF GTP DEPENDENT PROTEIN BINDING	21	9.00e-01	9.67e-01	0.1590	4.02e-02	1.22e-01	-1.64e-02	-5.92e-02	-7.04e-02	7.50e-01	3.32e-01	8.97e-01	6.38e-01	5.76e-01
GOBP NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS	145	7.66e-02	3.32e-01	0.1590	-9.93e-03	-5.98e-02	-4.41e-02	-5.57e-02	1.29e-01	8.36e-01	2.14e-01	3.60e-01	2.47e-01	7.42e-03
GOBP IN UTERO EMBRYONIC DEVELOPMENT	382	1.57e-04	3.43e-03	0.1590	3.16e-02	1.49e-02	-5.00e-02	-1.45e-01	2.33e-02	2.89e-01	6.18e-01	9.34e-02	1.14e-06	4.34e-01
GOCC SARCOLEMMA	136	9.01e-02	3.63e-01	0.1590	-1.98e-02	3.14e-04	1.31e-02	1.35e-01	-8.07e-02	6.91e-01	9.95e-01	7.92e-01	6.63e-03	1.04e-01
GOBP REGULATION OF MULTICELLULAR ORGANISM GROWTH	62	3.17e-01	6.66e-01	0.1590	6.07e-02	4.32e-02	4.20e-02	-1.33e-01	1.92e-02	4.08e-01	5.56e-01	5.67e-01	7.11e-02	7.94e-01
GOBP NEGATIVE REGULATION OF EXOCYTOSIS	31	7.17e-01	9.02e-01	0.1590	-1.12e-01	-1.14e-02	9.72e-02	-5.62e-02	3.46e-03	2.82e-01	9.12e-01	3.49e-01	5.88e-01	9.73e-01
GOBP NEGATIVE REGULATION OF AMINE TRANSPORT	28	8.23e-01	9.42e-01	0.1590	1.17e-01	4.81e-02	-4.80e-03	7.49e-02	-6.02e-02	2.85e-01	6.60e-01	9.65e-01	4.93e-01	5.81e-01
GOMF DIOXYGENASE ACTIVITY	86	3.48e-01	6.94e-01	0.1590	1.71e-02	7.63e-02	-4.26e-02	-1.29e-01	2.47e-02	7.84e-01	2.22e-01	4.94e-01	3.88e-02	6.92e-01
GOBP REGULATION OF EXOSOMAL SECRETION	19	9.50e-01	9.84e-01	0.1590	-3.05e-02	-2.37e-02	-1.08e-01	-8.92e-02	6.38e-02	8.18e-01	8.58e-01	4.15e-01	5.01e-01	6.30e-01
GOBP REGULATION OF THE FORCE OF HEART CONTRACTION	26	9.03e-01	9.68e-01	0.1590	-1.91e-02	-4.03e-02	-1.24e-01	-6.75e-02	-5.67e-02	8.66e-01	7.22e-01	2.74e-01	5.51e-01	6.17e-01
GOBP GERM CELL MIGRATION	8	9.73e-01	9.92e-01	0.1590	8.75e-02	-1.84e-02	1.83e-02	-8.74e-02	-9.58e-02	6.68e-01	9.28e-01	9.29e-01	6.69e-01	6.39e-01
GOBP HEXOSE CATABOLIC PROCESS	42	6.86e-01	8.89e-01	0.1580	-6.49e-02	7.58e-03	-6.18e-02	-6.37e-02	1.14e-01	4.67e-01	9.32e-01	4.89e-01	4.75e-01	2.02e-01
GOBP NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT	133	9.51e-02	3.73e-01	0.1580	-1.37e-01	3.53e-02	1.55e-02	1.15e-02	-6.96e-02	6.55e-03	4.82e-01	7.57e-01	8.18e-01	1.66e-01
GOCC SPERM MIDPIECE	51	5.94e-01	8.49e-01	0.1580	-5.77e-02	-7.05e-02	-1.84e-02	-7.94e-04	-1.28e-01	4.76e-01	3.84e-01	8.20e-01	9.92e-01	1.13e-01
GOBP NEGATIVE REGULATION OF VIRAL LIFE CYCLE	26	9.13e-01	9.71e-01	0.1580	7.86e-02	-4.54e-02	-9.73e-02	-7.60e-02	3.98e-02	4.88e-01	6.88e-01	3.90e-01	5.02e-01	7.25e-01
GOMF PENTOSYLTRANSFERASE ACTIVITY	53	6.63e-01	8.81e-01	0.1580	-1.83e-02	-2.12e-02	-9.70e-02	-1.11e-01	-5.16e-02	8.17e-01	7.90e-01	2.22e-01	1.64e-01	5.16e-01
GOBP BIOLOGICAL PROCESS INVOLVED IN INTERACTION WITH HOST	203	2.08e-02	1.45e-01	0.1580	-5.48e-02	6.79e-02	-6.66e-02	-1.07e-01	3.89e-02	1.78e-01	9.52e-02	1.02e-01	8.42e-03	3.39e-01
GOBP PHOTORECEPTOR CELL DIFFERENTIATION	63	2.25e-01	5.78e-01	0.1580	3.68e-02	8.25e-03	1.46e-01	-4.91e-02	3.93e-03	6.13e-01	9.10e-01	4.56e-02	5.00e-01	9.57e-01
GOMF MRNA 3 UTR BINDING	230	5.79e-03	5.90e-02	0.1580	-1.17e-01	-7.61e-02	6.51e-02	2.87e-02	-2.25e-02	2.24e-03	4.68e-02	8.88e-02	4.54e-01	5.56e-01
GOCC P BODY	98	1.71e-01	5.10e-01	0.1580	7.55e-02	3.01e-03	-3.91e-02	-1.26e-01	-4.38e-02	1.97e-01	9.59e-01	5.03e-01	3.11e-02	4.54e-01
GOBP RESPONSE TO ALDOSTERONE	16	9.23e-01	9.75e-01	0.1580	2.03e-02	1.10e-01	5.48e-02	-8.44e-02	-4.78e-02	8.88e-01	4.45e-01	7.04e-01	5.59e-01	7.40e-01
GOBP INTERFERON MEDIATED SIGNALING PATHWAY	100	1.50e-01	4.76e-01	0.1580	2.66e-03	1.44e-02	-8.26e-02	-2.64e-02	1.31e-01	9.63e-01	8.04e-01	1.53e-01	6.49e-01	2.33e-02
GOBP POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY	101	2.21e-01	5.76e-01	0.1580	-3.83e-03	9.61e-02	1.76e-02	-8.93e-02	8.62e-02	9.47e-01	9.52e-02	7.60e-01	1.21e-01	1.34e-01
GOBP REGULATION OF HORMONE METABOLIC PROCESS	39	7.34e-01	9.09e-01	0.1580	-7.82e-02	8.62e-02	1.41e-02	5.28e-03	-1.06e-01	3.98e-01	3.51e-01	8.79e-01	9.55e-01	2.53e-01
GOBP GLYCEROPHOSPHOLIPID BIOSYNTHETIC PROCESS	198	1.51e-02	1.17e-01	0.1580	3.72e-02	8.34e-02	-3.08e-02	-1.24e-01	-1.85e-02	3.67e-01	4.31e-02	4.55e-01	2.68e-03	6.54e-01
GOBP REGULATION OF LAMELLIPODIUM ORGANIZATION	49	6.57e-01	8.80e-01	0.1580	-1.09e-01	6.42e-02	6.74e-02	2.07e-02	-6.29e-02	1.87e-01	4.37e-01	4.14e-01	8.02e-01	4.46e-01
GOCC PHOTORECEPTOR INNER SEGMENT	68	3.51e-01	6.97e-01	0.1580	5.84e-02	-4.78e-02	-2.03e-02	1.33e-01	-3.34e-02	4.05e-01	4.96e-01	7.73e-01	5.78e-02	6.34e-01
GOBP AMYLOID BETA METABOLIC PROCESS	64	2.32e-01	5.85e-01	0.1580	-7.17e-03	9.12e-02	-1.01e-01	6.03e-02	-5.28e-02	9.21e-01	2.07e-01	1.64e-01	4.04e-01	4.65e-01
GOBP SMOOTH MUSCLE CELL MIGRATION	86	3.15e-01	6.65e-01	0.1580	-6.57e-02	-1.59e-02	4.35e-02	1.36e-01	-5.47e-03	2.92e-01	7.99e-01	4.85e-01	2.97e-02	9.30e-01
GOBP STEROL BIOSYNTHETIC PROCESS	63	4.22e-01	7.49e-01	0.1580	7.80e-04	-3.06e-02	-4.48e-02	-1.40e-01	-4.75e-02	9.91e-01	6.74e-01	5.38e-01	5.41e-02	5.14e-01
GOBP ERBB SIGNALING PATHWAY	122	1.48e-01	4.71e-01	0.1580	-6.31e-02	1.06e-01	7.48e-02	5.35e-02	3.43e-02	2.29e-01	4.30e-02	1.53e-01	3.08e-01	5.12e-01
GOBP NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION	60	5.27e-01	8.17e-01	0.1580	3.85e-02	7.57e-02	2.52e-02	8.01e-02	-1.03e-01	6.06e-01	3.11e-01	7.36e-01	2.83e-01	1.67e-01
GOBP VIRAL GENE EXPRESSION	99	2.91e-01	6.45e-01	0.1580	4.29e-02	-2.11e-03	-4.93e-02	-1.36e-01	4.54e-02	4.61e-01	9.71e-01	3.96e-01	1.94e-02	4.35e-01
GOMF MHC CLASS II RECEPTOR ACTIVITY	9	9.64e-01	9.90e-01	0.1580	-7.43e-02	-6.87e-03	1.08e-01	-7.10e-02	-5.08e-02	7.00e-01	9.72e-01	5.75e-01	7.12e-01	7.92e-01
GOBP CATECHOLAMINE SECRETION	60	5.04e-01	8.04e-01	0.1570	-4.73e-02	1.42e-01	3.63e-02	-3.08e-02	1.98e-03	5.26e-01	5.63e-02	6.26e-01	6.79e-01	9.79e-01
GOBP MITOCHONDRIAL FISSION	40	5.44e-01	8.25e-01	0.1570	-1.68e-02	-4.40e-03	1.08e-01	-9.03e-02	6.87e-02	8.54e-01	9.62e-01	2.38e-01	3.23e-01	4.52e-01
GOBP ENERGY HOMEOSTASIS	76	3.66e-01	7.05e-01	0.1570	-1.42e-02	9.50e-02	1.02e-02	-1.14e-01	5.03e-02	8.31e-01	1.52e-01	8.78e-01	8.66e-02	4.48e-01
GOBP REGULATION OF IMMUNE EFFECTOR PROCESS	369	9.08e-05	2.19e-03	0.1570	-9.92e-02	1.14e-01	4.29e-02	6.43e-03	-1.11e-02	1.06e-03	1.76e-04	1.57e-01	8.32e-01	7.13e-01
GOBP AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS	25	8.83e-01	9.61e-01	0.1570	9.47e-03	-1.35e-01	-5.10e-02	3.24e-02	-5.39e-02	9.35e-01	2.44e-01	6.59e-01	7.79e-01	6.41e-01
GOBP PEPTIDYL LYSINE METHYLATION	48	7.15e-01	9.01e-01	0.1570	9.11e-02	1.29e-03	-4.28e-02	-8.76e-02	8.34e-02	2.75e-01	9.88e-01	6.08e-01	2.94e-01	3.17e-01
GOBP SYNAPTIC TRANSMISSION GLUTAMATERGIC	106	3.10e-01	6.62e-01	0.1570	-2.75e-02	-3.00e-02	1.10e-01	9.96e-02	-3.10e-02	6.24e-01	5.94e-01	4.94e-02	7.63e-02	5.81e-01
GOBP MICROTUBULE DEPOLYMERIZATION	42	6.94e-01	8.93e-01	0.1570	4.09e-02	1.21e-01	5.61e-03	-9.13e-02	2.95e-03	6.47e-01	1.74e-01	9.50e-01	3.06e-01	9.74e-01
GOMF ZINC ION TRANSMEMBRANE TRANSPORTER ACTIVITY	24	7.85e-01	9.29e-01	0.1570	-4.42e-02	3.97e-03	2.26e-02	-1.20e-01	-8.89e-02	7.08e-01	9.73e-01	8.48e-01	3.10e-01	4.51e-01
GOBP CLATHRIN DEPENDENT ENDOCYTOSIS	47	5.01e-01	8.03e-01	0.1570	-2.50e-02	3.10e-02	1.50e-01	-2.53e-02	-9.96e-03	7.67e-01	7.13e-01	7.59e-02	7.64e-01	9.06e-01
GOCC PHOSPHOLIPID TRANSLOCATING ATPASE COMPLEX	13	9.63e-01	9.90e-01	0.1570	-6.07e-02	2.54e-02	-6.32e-02	4.71e-02	-1.19e-01	7.05e-01	8.74e-01	6.93e-01	7.69e-01	4.58e-01
GOBP VENTRICULAR SEPTUM MORPHOGENESIS	43	4.93e-01	7.99e-01	0.1570	1.08e-01	-3.44e-03	9.11e-02	-6.55e-02	1.78e-02	2.19e-01	9.69e-01	3.01e-01	4.57e-01	8.40e-01
GOBP LIPOPROTEIN BIOSYNTHETIC PROCESS	91	3.66e-01	7.05e-01	0.1570	-2.35e-02	2.90e-02	-6.71e-02	-1.34e-01	2.89e-02	6.99e-01	6.33e-01	2.68e-01	2.74e-02	6.33e-01
GOBP DEMETHYLATION	51	6.52e-01	8.79e-01	0.1570	1.00e-01	5.86e-03	-5.43e-03	-5.54e-02	1.07e-01	2.15e-01	9.42e-01	9.47e-01	4.94e-01	1.87e-01
GOMF FERROUS IRON BINDING	24	9.15e-01	9.72e-01	0.1570	8.94e-02	4.54e-02	-5.73e-02	-6.48e-02	8.41e-02	4.48e-01	7.00e-01	6.27e-01	5.83e-01	4.76e-01
GOMF PROTEIN PHOSPHATASE 1 BINDING	24	8.53e-01	9.51e-01	0.1570	-5.91e-02	4.65e-02	-7.20e-02	4.82e-02	-1.07e-01	6.16e-01	6.93e-01	5.42e-01	6.83e-01	3.65e-01
GOMF PHOSPHATIDYLINOSITOL PHOSPHATE BINDING	168	2.90e-02	1.79e-01	0.1570	-3.00e-02	1.39e-01	-1.26e-02	-2.01e-02	-6.27e-02	5.02e-01	1.94e-03	7.78e-01	6.54e-01	1.61e-01
GOBP MOTOR NEURON APOPTOTIC PROCESS	21	9.20e-01	9.74e-01	0.1570	-3.49e-02	1.96e-02	-6.75e-02	-1.12e-01	-7.69e-02	7.82e-01	8.77e-01	5.92e-01	3.75e-01	5.42e-01
GOBP REGULATION OF MITOCHONDRIAL FUSION	11	9.72e-01	9.92e-01	0.1570	1.03e-01	-3.00e-02	-1.08e-02	1.78e-02	-1.12e-01	5.54e-01	8.63e-01	9.50e-01	9.18e-01	5.19e-01
GOBP RUFFLE ASSEMBLY	45	6.56e-01	8.80e-01	0.1570	-2.57e-02	5.31e-02	-4.79e-02	-1.10e-01	-8.15e-02	7.66e-01	5.38e-01	5.78e-01	2.01e-01	3.44e-01
GOBP NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY	14	9.37e-01	9.80e-01	0.1570	3.95e-02	1.81e-02	9.59e-03	1.32e-01	7.24e-02	7.98e-01	9.07e-01	9.50e-01	3.94e-01	6.39e-01
GOBP ACTIN FILAMENT ORGANIZATION	441	1.20e-05	3.94e-04	0.1570	-5.71e-02	1.31e-01	3.08e-02	1.42e-02	-5.34e-02	3.99e-02	2.21e-06	2.68e-01	6.09e-01	5.43e-02
GOBP NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS	38	7.04e-01	8.97e-01	0.1570	-3.21e-03	3.18e-02	-3.78e-02	-8.03e-02	-1.25e-01	9.73e-01	7.35e-01	6.86e-01	3.91e-01	1.82e-01
GOBP CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES	148	1.35e-01	4.53e-01	0.1570	7.17e-03	1.49e-03	-8.49e-02	-1.31e-01	9.86e-05	8.80e-01	9.75e-01	7.45e-02	5.79e-03	9.98e-01
GOBP POSITIVE REGULATION OF CALCIUM ION TRANSPORT	112	2.94e-01	6.48e-01	0.1570	1.23e-02	-6.89e-03	1.01e-01	1.18e-01	-1.39e-02	8.22e-01	9.00e-01	6.36e-02	3.15e-02	7.99e-01
GOBP MICROTUBULE POLYMERIZATION	91	3.15e-01	6.66e-01	0.1570	7.56e-02	8.69e-02	-3.15e-02	-9.88e-02	2.26e-02	2.13e-01	1.52e-01	6.04e-01	1.03e-01	7.10e-01
GOBP REGULATION OF NEURON APOPTOTIC PROCESS	223	7.73e-03	7.30e-02	0.1570	1.61e-02	3.75e-02	-8.46e-04	-1.36e-01	6.59e-02	6.78e-01	3.35e-01	9.83e-01	4.62e-04	8.98e-02
GOBP SECOND MESSENGER MEDIATED SIGNALING	298	3.90e-03	4.48e-02	0.1570	-6.46e-02	5.47e-02	1.05e-01	7.33e-02	3.12e-02	5.52e-02	1.04e-01	1.83e-03	2.96e-02	3.54e-01
GOBP NODAL SIGNALING PATHWAY	16	8.84e-01	9.61e-01	0.1570	-1.59e-02	-5.87e-02	1.16e-01	-6.94e-02	4.95e-02	9.12e-01	6.85e-01	4.20e-01	6.31e-01	7.32e-01
GOCC 9PLUS0 NON MOTILE CILIUM	119	1.85e-01	5.28e-01	0.1570	-3.52e-02	-1.84e-03	4.83e-02	1.41e-01	-3.27e-02	5.08e-01	9.72e-01	3.63e-01	7.90e-03	5.38e-01
GOBP REGULATION OF MRNA METABOLIC PROCESS	338	4.33e-05	1.19e-03	0.1560	-3.12e-02	-3.36e-02	-9.57e-03	-1.48e-01	1.64e-02	3.25e-01	2.88e-01	7.62e-01	2.73e-06	6.04e-01
GOCC ENDOPLASMIC RETICULUM GOLGI INTERMEDIATE COMPARTMENT	127	1.51e-01	4.77e-01	0.1560	-4.03e-02	6.08e-02	-8.53e-02	-9.64e-02	5.08e-02	4.33e-01	2.37e-01	9.67e-02	6.07e-02	3.22e-01
GOCC SECRETORY GRANULE	855	7.80e-12	7.83e-10	0.1560	-1.12e-01	9.33e-02	2.58e-02	-4.53e-02	2.44e-02	3.04e-08	3.57e-06	1.99e-01	2.44e-02	2.25e-01
GOBP IP 10 PRODUCTION	5	9.96e-01	9.98e-01	0.1560	-6.38e-02	7.44e-02	2.85e-02	-1.42e-02	1.18e-01	8.05e-01	7.73e-01	9.12e-01	9.56e-01	6.49e-01
GOBP PRE MIRNA PROCESSING	17	9.30e-01	9.78e-01	0.1560	5.79e-02	8.44e-03	-5.22e-03	-1.42e-01	2.71e-02	6.79e-01	9.52e-01	9.70e-01	3.10e-01	8.47e-01
GOBP NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS	21	7.94e-01	9.31e-01	0.1560	-9.10e-02	-1.65e-02	-8.04e-02	8.88e-02	3.94e-02	4.71e-01	8.96e-01	5.24e-01	4.81e-01	7.54e-01
GOBP RESPONSE TO AXON INJURY	79	3.34e-01	6.81e-01	0.1560	-1.12e-01	-8.23e-02	3.33e-02	4.71e-03	-6.32e-02	8.53e-02	2.06e-01	6.08e-01	9.42e-01	3.31e-01
GOBP POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY	36	8.17e-01	9.41e-01	0.1560	-2.80e-02	1.68e-02	-4.32e-02	-1.11e-01	9.57e-02	7.71e-01	8.62e-01	6.54e-01	2.48e-01	3.20e-01
GOBP POSITIVE REGULATION OF PROTEIN POLYMERIZATION	88	2.70e-01	6.24e-01	0.1560	-6.66e-02	1.27e-01	1.26e-02	-6.07e-02	-8.42e-03	2.80e-01	3.97e-02	8.38e-01	3.25e-01	8.91e-01
GOBP POSITIVE REGULATION OF NEUROBLAST PROLIFERATION	37	5.91e-01	8.47e-01	0.1560	-5.30e-02	-2.73e-02	8.27e-02	-1.05e-01	5.55e-02	5.77e-01	7.74e-01	3.84e-01	2.71e-01	5.59e-01
GOBP POSITIVE REGULATION OF COAGULATION	30	6.92e-01	8.92e-01	0.1560	-5.03e-02	-5.03e-02	2.71e-02	-1.36e-01	-1.39e-02	6.33e-01	6.34e-01	7.98e-01	1.98e-01	8.95e-01
GOBP ALPHA BETA T CELL DIFFERENTIATION	119	1.33e-01	4.50e-01	0.1560	-3.70e-02	1.40e-01	3.74e-02	-4.27e-02	-6.74e-03	4.86e-01	8.14e-03	4.81e-01	4.21e-01	8.99e-01
GOBP REGULATION OF PROTEIN AUTOPHOSPHORYLATION	39	6.80e-01	8.87e-01	0.1560	7.70e-02	-4.38e-02	4.70e-03	9.76e-02	8.33e-02	4.05e-01	6.36e-01	9.60e-01	2.91e-01	3.68e-01
GOBP CARDIAC SEPTUM MORPHOGENESIS	72	2.39e-01	5.95e-01	0.1560	6.91e-02	5.24e-02	1.19e-01	-5.12e-02	9.73e-03	3.11e-01	4.42e-01	8.12e-02	4.53e-01	8.86e-01
GOBP CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION	35	5.82e-01	8.43e-01	0.1560	-3.95e-02	-7.02e-02	1.01e-01	-7.77e-02	3.86e-02	6.86e-01	4.72e-01	2.99e-01	4.26e-01	6.93e-01
GOBP NEGATIVE REGULATION OF PROTEIN BINDING	76	5.20e-01	8.13e-01	0.1560	4.44e-03	-2.40e-02	-8.55e-02	-1.27e-01	1.51e-02	9.47e-01	7.18e-01	1.97e-01	5.52e-02	8.20e-01
GOBP PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS	24	9.07e-01	9.69e-01	0.1560	-2.50e-02	9.42e-03	-6.98e-02	-1.30e-01	-4.14e-02	8.32e-01	9.36e-01	5.54e-01	2.69e-01	7.26e-01
GOCC SCHAFFER COLLATERAL CA1 SYNAPSE	88	3.02e-01	6.55e-01	0.1560	-1.15e-02	6.14e-02	1.38e-01	8.79e-03	3.71e-02	8.52e-01	3.20e-01	2.57e-02	8.87e-01	5.48e-01
GOBP PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE	219	7.44e-03	7.10e-02	0.1560	-7.53e-02	1.28e-01	1.88e-02	-3.64e-02	2.35e-02	5.47e-02	1.10e-03	6.32e-01	3.54e-01	5.48e-01
GOBP BENZENE CONTAINING COMPOUND METABOLIC PROCESS	26	8.17e-01	9.41e-01	0.1560	2.01e-02	-4.77e-02	5.03e-03	1.02e-01	1.06e-01	8.59e-01	6.74e-01	9.65e-01	3.69e-01	3.50e-01
GOBP PROTEIN HOMOTETRAMERIZATION	57	5.18e-01	8.12e-01	0.1560	1.17e-01	9.78e-02	-1.61e-02	1.47e-02	-2.21e-02	1.26e-01	2.02e-01	8.34e-01	8.47e-01	7.73e-01
GOBP NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY	24	9.22e-01	9.75e-01	0.1560	5.03e-02	3.64e-02	-1.17e-01	-7.85e-02	2.38e-02	6.69e-01	7.58e-01	3.21e-01	5.06e-01	8.40e-01
GOBP RESPONSE TO REACTIVE OXYGEN SPECIES	194	5.34e-02	2.66e-01	0.1560	2.71e-02	4.35e-02	-6.95e-02	-1.24e-01	3.69e-02	5.14e-01	2.96e-01	9.50e-02	2.84e-03	3.76e-01
GOBP KETONE BIOSYNTHETIC PROCESS	48	7.13e-01	9.00e-01	0.1560	3.04e-02	-1.10e-01	-9.91e-02	-3.57e-02	9.19e-03	7.15e-01	1.87e-01	2.35e-01	6.69e-01	9.12e-01
GOBP RESPONSE TO TYPE I INTERFERON	83	2.63e-01	6.19e-01	0.1560	-2.40e-02	6.24e-02	-9.01e-02	-4.81e-02	9.66e-02	7.05e-01	3.26e-01	1.56e-01	4.49e-01	1.28e-01
GOBP MONOSACCHARIDE BIOSYNTHETIC PROCESS	96	3.54e-01	7.00e-01	0.1560	6.26e-02	4.80e-02	-9.80e-02	-9.14e-02	5.83e-03	2.89e-01	4.16e-01	9.70e-02	1.22e-01	9.21e-01
GOBP HEMATOPOIETIC STEM CELL HOMEOSTASIS	20	9.12e-01	9.71e-01	0.1560	3.09e-02	1.19e-01	-2.84e-02	5.93e-03	-9.04e-02	8.11e-01	3.56e-01	8.26e-01	9.63e-01	4.84e-01
GOBP PALLIUM DEVELOPMENT	180	6.39e-03	6.40e-02	0.1550	5.81e-03	-1.17e-02	5.72e-02	-1.21e-01	7.84e-02	8.93e-01	7.86e-01	1.86e-01	5.18e-03	6.97e-02
GOBP COLLAGEN BIOSYNTHETIC PROCESS	46	6.21e-01	8.64e-01	0.1550	3.15e-02	1.04e-01	3.83e-04	-1.05e-01	-3.81e-02	7.11e-01	2.25e-01	9.96e-01	2.18e-01	6.55e-01
GOBP AXONEME ASSEMBLY	92	2.59e-01	6.16e-01	0.1550	-6.52e-02	2.89e-02	-1.13e-01	-6.56e-02	4.41e-02	2.79e-01	6.31e-01	6.05e-02	2.77e-01	4.65e-01
GOBP REGULATION OF GOLGI ORGANIZATION	17	9.44e-01	9.82e-01	0.1550	-7.34e-03	9.43e-02	7.32e-02	-5.76e-02	8.07e-02	9.58e-01	5.01e-01	6.01e-01	6.81e-01	5.64e-01
GOBP G0 TO G1 TRANSITION	36	6.38e-01	8.73e-01	0.1550	2.82e-02	6.90e-04	1.16e-02	-1.52e-01	-1.06e-02	7.69e-01	9.94e-01	9.04e-01	1.14e-01	9.13e-01
GOBP MRNA CATABOLIC PROCESS	294	2.53e-04	5.09e-03	0.1550	-5.01e-02	-3.01e-02	1.52e-03	-1.40e-01	3.52e-02	1.39e-01	3.75e-01	9.64e-01	3.81e-05	2.99e-01
GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE	121	1.08e-01	3.98e-01	0.1550	1.02e-01	7.31e-02	-7.65e-03	-8.71e-02	-2.66e-02	5.21e-02	1.65e-01	8.84e-01	9.79e-02	6.14e-01
GOBP PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS	16	9.42e-01	9.82e-01	0.1550	1.23e-01	5.60e-02	3.52e-02	-6.50e-02	2.09e-02	3.96e-01	6.98e-01	8.08e-01	6.52e-01	8.85e-01
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE	33	8.02e-01	9.34e-01	0.1550	-1.53e-02	-4.87e-02	2.39e-02	3.51e-02	-1.40e-01	8.79e-01	6.28e-01	8.12e-01	7.27e-01	1.64e-01
GOBP REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION	98	1.76e-01	5.17e-01	0.1550	3.30e-02	4.87e-03	3.90e-02	-1.14e-01	9.17e-02	5.72e-01	9.34e-01	5.05e-01	5.13e-02	1.17e-01
GOBP NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY	35	8.06e-01	9.36e-01	0.1550	-9.21e-02	-5.60e-02	9.43e-02	5.15e-02	2.90e-02	3.46e-01	5.67e-01	3.34e-01	5.98e-01	7.66e-01
GOMF TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY BINDING	46	6.66e-01	8.82e-01	0.1550	-3.42e-02	3.70e-02	4.34e-02	-4.61e-02	1.32e-01	6.88e-01	6.64e-01	6.10e-01	5.88e-01	1.21e-01
GOBP ESTABLISHMENT OF ENDOTHELIAL BARRIER	51	5.99e-01	8.52e-01	0.1550	-8.22e-02	8.63e-02	1.89e-02	-5.54e-02	7.96e-02	3.10e-01	2.86e-01	8.15e-01	4.94e-01	3.25e-01
GOBP MIRNA METABOLIC PROCESS	101	1.61e-01	4.93e-01	0.1550	-3.11e-02	9.35e-02	5.66e-03	-1.05e-01	-5.64e-02	5.90e-01	1.05e-01	9.22e-01	6.78e-02	3.28e-01
GOBP RECEPTOR METABOLIC PROCESS	71	3.80e-01	7.18e-01	0.1550	-3.54e-02	2.77e-02	-3.86e-02	-9.37e-02	-1.08e-01	6.06e-01	6.87e-01	5.74e-01	1.72e-01	1.16e-01
GOBP NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS	30	8.19e-01	9.41e-01	0.1550	7.67e-02	1.11e-01	2.85e-02	-1.59e-02	-6.83e-02	4.67e-01	2.93e-01	7.87e-01	8.80e-01	5.18e-01
GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS	18	9.43e-01	9.82e-01	0.1550	-5.54e-02	-7.80e-02	7.64e-02	6.12e-02	7.19e-02	6.84e-01	5.66e-01	5.75e-01	6.53e-01	5.98e-01
GOBP CYCLIC NUCLEOTIDE MEDIATED SIGNALING	80	5.22e-01	8.14e-01	0.1550	-1.71e-02	2.88e-02	1.16e-01	9.66e-02	9.88e-03	7.92e-01	6.56e-01	7.41e-02	1.35e-01	8.79e-01
GOBP RESPONSE TO NITROSATIVE STRESS	10	9.72e-01	9.92e-01	0.1550	5.76e-02	4.31e-02	-5.04e-03	-1.15e-01	-7.42e-02	7.53e-01	8.13e-01	9.78e-01	5.29e-01	6.84e-01
GOBP APOPTOTIC PROCESS	1853	4.25e-22	1.09e-19	0.1550	7.00e-03	7.73e-02	-2.55e-02	-1.27e-01	3.18e-02	6.18e-01	3.44e-08	6.92e-02	1.02e-19	2.35e-02
GOMF CHOLESTEROL BINDING	51	5.61e-01	8.33e-01	0.1550	-9.32e-02	5.97e-02	-1.68e-02	7.92e-02	-7.13e-02	2.50e-01	4.61e-01	8.35e-01	3.28e-01	3.79e-01
GOMF LYSINE N METHYLTRANSFERASE ACTIVITY	60	3.16e-01	6.66e-01	0.1540	1.22e-01	-3.98e-02	6.33e-02	-5.73e-02	-1.46e-03	1.01e-01	5.94e-01	3.96e-01	4.43e-01	9.84e-01
GOMF LIPOPOLYSACCHARIDE BINDING	38	7.43e-01	9.14e-01	0.1540	-7.73e-02	9.71e-02	5.71e-02	-2.61e-02	-6.71e-02	4.10e-01	3.00e-01	5.43e-01	7.81e-01	4.74e-01
GOMF MAGNESIUM ION BINDING	212	3.33e-02	1.96e-01	0.1540	3.50e-02	5.86e-02	-5.18e-02	-1.00e-01	8.01e-02	3.79e-01	1.41e-01	1.94e-01	1.17e-02	4.45e-02
GOBP GLUCOSE METABOLIC PROCESS	183	7.11e-02	3.17e-01	0.1540	6.00e-02	3.47e-02	-6.32e-02	-1.15e-01	4.23e-02	1.61e-01	4.18e-01	1.40e-01	7.25e-03	3.24e-01
GOBP REGULATION OF INSULIN SECRETION	161	6.36e-02	2.97e-01	0.1540	7.38e-02	1.06e-01	5.55e-02	-1.37e-02	6.17e-02	1.06e-01	2.00e-02	2.24e-01	7.63e-01	1.77e-01
GOBP NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY	154	6.40e-02	2.98e-01	0.1540	9.17e-02	8.86e-02	4.24e-03	-8.29e-02	2.49e-02	4.96e-02	5.76e-02	9.28e-01	7.57e-02	5.94e-01
GOBP ENERGY RESERVE METABOLIC PROCESS	84	3.22e-01	6.70e-01	0.1540	-1.19e-02	1.20e-01	1.86e-02	-9.09e-02	2.42e-02	8.50e-01	5.72e-02	7.68e-01	1.50e-01	7.01e-01
GOBP NEURAL TUBE FORMATION	103	2.40e-01	5.97e-01	0.1540	5.36e-02	2.62e-02	-1.97e-02	-1.32e-01	4.88e-02	3.47e-01	6.45e-01	7.29e-01	2.07e-02	3.92e-01
GOBP REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE	182	4.92e-02	2.51e-01	0.1540	-6.79e-02	8.69e-02	9.98e-02	2.68e-02	2.94e-02	1.14e-01	4.32e-02	2.02e-02	5.33e-01	4.95e-01
GOBP POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH	30	7.66e-01	9.23e-01	0.1540	4.45e-02	-9.13e-03	1.42e-01	-6.03e-03	3.80e-02	6.73e-01	9.31e-01	1.78e-01	9.54e-01	7.19e-01
GOBP REGULATION OF POSTSYNAPSE ORGANIZATION	96	3.27e-01	6.76e-01	0.1540	2.16e-02	4.68e-02	1.34e-01	5.37e-02	-1.50e-02	7.15e-01	4.28e-01	2.35e-02	3.63e-01	8.00e-01
GOBP POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT	150	6.38e-02	2.97e-01	0.1540	4.71e-03	8.94e-03	-8.84e-03	-1.42e-01	5.86e-02	9.21e-01	8.50e-01	8.52e-01	2.75e-03	2.15e-01
GOBP GENITALIA MORPHOGENESIS	11	9.63e-01	9.90e-01	0.1540	2.22e-02	-3.05e-02	-9.63e-03	9.80e-02	1.12e-01	8.99e-01	8.61e-01	9.56e-01	5.74e-01	5.20e-01
GOMF HISTONE BINDING	220	1.33e-02	1.07e-01	0.1540	4.22e-02	2.42e-02	-3.22e-02	-1.40e-01	2.30e-02	2.80e-01	5.35e-01	4.11e-01	3.31e-04	5.56e-01
GOBP POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION	17	9.21e-01	9.74e-01	0.1540	5.53e-03	9.34e-02	8.17e-02	-4.35e-02	-7.96e-02	9.68e-01	5.05e-01	5.60e-01	7.56e-01	5.70e-01
GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN LINEAR AMIDES	70	5.83e-01	8.44e-01	0.1540	2.07e-02	2.35e-02	-1.15e-01	-9.67e-02	7.23e-03	7.65e-01	7.34e-01	9.57e-02	1.62e-01	9.17e-01
GOBP ACTIVATION OF INNATE IMMUNE RESPONSE	262	2.61e-03	3.30e-02	0.1540	-1.65e-02	8.57e-02	-3.42e-02	-5.12e-02	1.11e-01	6.46e-01	1.70e-02	3.41e-01	1.54e-01	2.06e-03
GOBP GENERATION OF PRECURSOR METABOLITES AND ENERGY	468	1.11e-04	2.60e-03	0.1540	3.80e-02	2.50e-02	-6.99e-02	-1.27e-01	2.06e-02	1.59e-01	3.54e-01	9.60e-03	2.31e-06	4.45e-01
GOBP DEVELOPMENTAL PIGMENTATION	47	6.53e-01	8.79e-01	0.1540	-6.81e-02	-3.29e-02	7.82e-03	1.29e-01	-3.48e-02	4.19e-01	6.96e-01	9.26e-01	1.26e-01	6.80e-01
GOMF PROTEIN TYROSINE KINASE ACTIVITY	140	1.42e-01	4.63e-01	0.1540	3.23e-02	6.10e-03	1.16e-01	7.95e-02	-5.20e-02	5.09e-01	9.01e-01	1.77e-02	1.04e-01	2.88e-01
GOMF CARBOHYDRATE BINDING	260	6.78e-03	6.64e-02	0.1540	-6.00e-02	6.25e-02	6.69e-02	1.07e-01	7.69e-03	9.57e-02	8.27e-02	6.33e-02	2.85e-03	8.31e-01
GOBP PROSTATE GLAND DEVELOPMENT	49	3.65e-01	7.05e-01	0.1540	4.34e-02	-1.32e-02	7.07e-02	-1.28e-01	1.38e-02	5.99e-01	8.73e-01	3.92e-01	1.22e-01	8.67e-01
GOBP DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN	26	8.82e-01	9.61e-01	0.1530	9.41e-04	5.73e-02	3.46e-03	3.97e-02	-1.37e-01	9.93e-01	6.13e-01	9.76e-01	7.26e-01	2.28e-01
GOCC BASOLATERAL PLASMA MEMBRANE	240	2.01e-02	1.41e-01	0.1530	-2.50e-02	4.06e-02	6.18e-02	1.21e-01	-5.27e-02	5.05e-01	2.79e-01	9.89e-02	1.23e-03	1.59e-01
GOBP REGULATION OF PROTEIN DEPHOSPHORYLATION	75	3.86e-01	7.24e-01	0.1530	-5.42e-02	1.08e-01	-1.97e-02	-7.58e-02	-5.27e-02	4.17e-01	1.06e-01	7.68e-01	2.56e-01	4.30e-01
GOBP REGULATION OF HIPPO SIGNALING	25	8.64e-01	9.54e-01	0.1530	7.60e-02	-1.04e-01	6.88e-02	4.69e-02	1.99e-04	5.10e-01	3.68e-01	5.52e-01	6.85e-01	9.99e-01
GOBP EMBRYONIC MORPHOGENESIS	603	2.42e-07	1.29e-05	0.1530	4.82e-02	5.71e-02	7.40e-03	-1.14e-01	7.00e-02	4.31e-02	1.66e-02	7.56e-01	1.76e-06	3.31e-03
GOBP REGULATION OF VACUOLE ORGANIZATION	53	6.87e-01	8.90e-01	0.1530	-1.11e-02	1.98e-02	-1.27e-01	-8.11e-02	1.42e-02	8.89e-01	8.04e-01	1.09e-01	3.07e-01	8.58e-01
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS	91	2.77e-01	6.31e-01	0.1530	3.59e-02	-7.10e-02	-3.41e-02	-1.23e-01	2.89e-02	5.54e-01	2.42e-01	5.74e-01	4.23e-02	6.34e-01
GOBP TOR SIGNALING	157	5.30e-02	2.65e-01	0.1530	5.41e-02	5.23e-03	-2.19e-02	-1.39e-01	2.60e-02	2.42e-01	9.10e-01	6.36e-01	2.62e-03	5.74e-01
GOBP SCHWANN CELL DIFFERENTIATION	38	7.83e-01	9.28e-01	0.1530	-8.20e-02	-9.57e-02	-5.24e-02	-4.49e-02	-5.32e-02	3.82e-01	3.08e-01	5.76e-01	6.32e-01	5.71e-01
GOBP AXON GUIDANCE	223	1.45e-02	1.14e-01	0.1530	-3.96e-03	-3.45e-02	1.36e-01	6.20e-02	8.22e-04	9.19e-01	3.75e-01	4.79e-04	1.11e-01	9.83e-01
GOBP REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST	43	6.89e-01	8.91e-01	0.1530	-5.36e-02	1.18e-01	-5.32e-02	-6.05e-02	1.41e-02	5.43e-01	1.81e-01	5.46e-01	4.93e-01	8.73e-01
GOBP POSITIVE REGULATION OF HORMONE SECRETION	139	8.46e-02	3.51e-01	0.1530	6.34e-02	1.29e-01	1.98e-02	2.92e-02	3.81e-02	1.97e-01	8.54e-03	6.88e-01	5.52e-01	4.38e-01
GOBP MEIOTIC CELL CYCLE PROCESS	209	2.52e-02	1.62e-01	0.1530	5.10e-02	-2.75e-03	-2.57e-03	-7.86e-02	1.21e-01	2.04e-01	9.45e-01	9.49e-01	5.02e-02	2.61e-03
GOCC CONNEXIN COMPLEX	19	9.63e-01	9.90e-01	0.1530	-6.14e-02	2.45e-02	9.78e-02	8.27e-02	-5.09e-02	6.43e-01	8.53e-01	4.61e-01	5.32e-01	7.01e-01
GOBP NEGATIVE REGULATION OF HEART RATE	11	9.73e-01	9.92e-01	0.1530	1.03e-01	-1.03e-01	-1.26e-02	-3.39e-02	-2.67e-02	5.54e-01	5.52e-01	9.43e-01	8.46e-01	8.78e-01
GOBP HETEROCYCLE CATABOLIC PROCESS	516	5.32e-06	1.90e-04	0.1530	-2.78e-02	6.69e-03	-4.49e-02	-1.43e-01	1.18e-02	2.81e-01	7.95e-01	8.07e-02	2.87e-08	6.45e-01
GOBP REGULATION OF MEIOTIC NUCLEAR DIVISION	33	8.07e-01	9.36e-01	0.1530	4.32e-02	-2.17e-02	5.70e-02	-3.67e-02	1.28e-01	6.68e-01	8.30e-01	5.71e-01	7.15e-01	2.03e-01
GOBP ENDODERMAL CELL DIFFERENTIATION	48	5.49e-01	8.28e-01	0.1530	-9.21e-02	-5.07e-02	7.84e-02	-2.06e-02	-7.54e-02	2.70e-01	5.43e-01	3.48e-01	8.05e-01	3.66e-01
GOBP REGULATION OF PROGRAMMED CELL DEATH	1466	8.97e-17	1.31e-14	0.1530	5.01e-03	6.78e-02	-2.57e-02	-1.26e-01	4.68e-02	7.48e-01	1.40e-05	9.94e-02	7.42e-16	2.70e-03
GOCC SECRETORY VESICLE	1019	2.05e-13	2.50e-11	0.1530	-1.09e-01	9.20e-02	2.38e-02	-4.37e-02	1.93e-02	3.42e-09	6.80e-07	1.98e-01	1.83e-02	2.98e-01
GOBP CARDIAC MUSCLE CONTRACTION	131	2.13e-01	5.66e-01	0.1530	-4.85e-02	5.66e-02	8.03e-02	1.04e-01	-1.93e-02	3.38e-01	2.63e-01	1.13e-01	3.89e-02	7.03e-01
GOBP REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE	183	2.83e-02	1.77e-01	0.1530	-6.12e-02	1.29e-01	2.34e-02	-3.90e-02	2.90e-02	1.53e-01	2.63e-03	5.85e-01	3.63e-01	4.99e-01
GOBP REGULATION OF OSTEOCLAST DEVELOPMENT	11	9.79e-01	9.93e-01	0.1530	-3.13e-02	6.44e-02	1.34e-01	-2.04e-03	8.45e-03	8.57e-01	7.11e-01	4.40e-01	9.91e-01	9.61e-01
GOBP REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY	76	5.35e-01	8.21e-01	0.1530	1.16e-02	7.60e-02	1.08e-01	7.38e-02	1.78e-02	8.62e-01	2.52e-01	1.05e-01	2.66e-01	7.88e-01
GOBP PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS	28	8.73e-01	9.58e-01	0.1520	-6.53e-02	-1.43e-02	-5.47e-02	6.25e-03	-1.25e-01	5.50e-01	8.96e-01	6.17e-01	9.54e-01	2.51e-01
GOMF FIBRONECTIN BINDING	29	8.69e-01	9.57e-01	0.1520	-1.24e-01	5.40e-02	4.37e-02	1.83e-02	-5.20e-02	2.48e-01	6.15e-01	6.84e-01	8.64e-01	6.28e-01
GOBP CELL SUBSTRATE JUNCTION ORGANIZATION	100	3.42e-01	6.88e-01	0.1520	-1.29e-02	1.04e-01	7.89e-02	6.75e-02	-3.82e-02	8.24e-01	7.26e-02	1.73e-01	2.43e-01	5.09e-01
GOBP POSITIVE REGULATION OF CELL CYCLE	317	2.73e-03	3.43e-02	0.1520	8.56e-02	3.56e-02	-5.07e-02	-1.06e-01	2.65e-02	8.75e-03	2.76e-01	1.21e-01	1.13e-03	4.16e-01
GOBP SARCOMERE ORGANIZATION	45	6.63e-01	8.81e-01	0.1520	8.91e-03	-1.67e-02	-2.68e-02	1.17e-01	-9.13e-02	9.18e-01	8.46e-01	7.56e-01	1.73e-01	2.89e-01
GOBP T CELL DIFFERENTIATION	300	8.00e-04	1.30e-02	0.1520	-1.18e-02	1.10e-01	7.59e-02	-6.16e-02	3.74e-02	7.26e-01	1.06e-03	2.38e-02	6.66e-02	2.65e-01
GOBP POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT	48	7.32e-01	9.08e-01	0.1520	-1.20e-02	4.62e-02	1.02e-01	6.57e-02	7.82e-02	8.86e-01	5.80e-01	2.21e-01	4.31e-01	3.49e-01
GOBP RENAL TUBULE DEVELOPMENT	99	1.19e-01	4.23e-01	0.1520	6.06e-02	1.74e-02	3.81e-02	-1.30e-01	2.79e-02	2.97e-01	7.65e-01	5.12e-01	2.52e-02	6.32e-01
GOCC RIBONUCLEOPROTEIN GRANULE	259	4.30e-03	4.83e-02	0.1520	-3.29e-02	2.74e-02	-4.14e-02	-1.39e-01	-1.92e-02	3.63e-01	4.48e-01	2.51e-01	1.21e-04	5.94e-01
GOBP CHONDROCYTE PROLIFERATION	24	8.90e-01	9.63e-01	0.1520	-4.66e-02	-1.30e-01	6.98e-03	-7.32e-03	6.37e-02	6.93e-01	2.72e-01	9.53e-01	9.50e-01	5.89e-01
GOBP REGULATION OF MUSCLE CELL DIFFERENTIATION	155	8.02e-02	3.41e-01	0.1520	1.17e-02	9.55e-02	8.08e-02	-1.91e-02	8.35e-02	8.01e-01	4.01e-02	8.25e-02	6.81e-01	7.28e-02
GOBP BIOLOGICAL PROCESS INVOLVED IN INTRASPECIES INTERACTION BETWEEN ORGANISMS	48	5.15e-01	8.10e-01	0.1520	4.15e-02	4.30e-02	1.32e-01	-4.10e-02	1.90e-02	6.19e-01	6.06e-01	1.13e-01	6.23e-01	8.20e-01
GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION	93	2.94e-01	6.48e-01	0.1520	-1.19e-02	4.21e-02	6.43e-02	2.08e-04	1.31e-01	8.43e-01	4.83e-01	2.84e-01	9.97e-01	2.94e-02
GOBP FAT CELL PROLIFERATION	14	9.49e-01	9.84e-01	0.1520	-1.93e-02	2.74e-03	3.59e-02	-1.33e-01	6.12e-02	9.00e-01	9.86e-01	8.16e-01	3.89e-01	6.92e-01
GOMF PROTON TRANSMEMBRANE TRANSPORTER ACTIVITY	129	8.11e-02	3.43e-01	0.1520	2.89e-02	4.75e-02	2.33e-03	-1.41e-01	7.78e-03	5.70e-01	3.51e-01	9.64e-01	5.67e-03	8.79e-01
GOBP REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY	26	8.59e-01	9.53e-01	0.1520	1.32e-01	-1.66e-02	3.21e-02	-4.72e-02	4.68e-02	2.45e-01	8.84e-01	7.77e-01	6.77e-01	6.79e-01
GOBP MAINTENANCE OF LENS TRANSPARENCY	7	9.86e-01	9.95e-01	0.1520	-1.06e-01	1.48e-02	-1.02e-01	3.00e-02	-1.74e-02	6.29e-01	9.46e-01	6.39e-01	8.91e-01	9.37e-01
GOBP SKELETAL MUSCLE ORGAN DEVELOPMENT	169	2.86e-02	1.78e-01	0.1520	4.98e-02	4.50e-02	2.50e-02	-1.23e-01	5.16e-02	2.64e-01	3.12e-01	5.75e-01	5.62e-03	2.47e-01
GOBP CELL SUBSTRATE ADHESION	342	1.85e-03	2.53e-02	0.1520	-6.01e-02	7.99e-02	6.42e-02	7.97e-02	-5.04e-02	5.62e-02	1.11e-02	4.12e-02	1.13e-02	1.10e-01
GOBP REGULATION OF INFLAMMATORY RESPONSE	406	1.40e-04	3.13e-03	0.1520	-6.86e-02	9.72e-02	7.71e-02	2.79e-02	4.62e-02	1.76e-02	7.77e-04	7.72e-03	3.34e-01	1.10e-01
GOBP INFLAMMASOME MEDIATED SIGNALING PATHWAY	39	7.69e-01	9.24e-01	0.1520	5.67e-02	6.80e-02	-9.77e-03	-1.19e-01	2.97e-02	5.40e-01	4.63e-01	9.16e-01	1.98e-01	7.48e-01
GOMF GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY	216	1.36e-02	1.09e-01	0.1520	-4.17e-02	1.08e-01	5.71e-02	-7.39e-03	-7.94e-02	2.91e-01	6.29e-03	1.48e-01	8.52e-01	4.42e-02
GOBP POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY	120	1.75e-01	5.15e-01	0.1520	-6.48e-02	7.50e-03	1.32e-01	2.81e-02	2.00e-02	2.20e-01	8.87e-01	1.22e-02	5.95e-01	7.05e-01
GOBP CELLULAR RESPONSE TO XENOBIOTIC STIMULUS	183	1.54e-02	1.19e-01	0.1520	8.39e-02	2.93e-02	-1.52e-02	1.13e-01	-4.44e-02	5.02e-02	4.94e-01	7.23e-01	8.15e-03	3.00e-01
GOBP POSITIVE REGULATION OF LIPID LOCALIZATION	111	1.71e-01	5.09e-01	0.1510	-4.18e-02	1.06e-01	3.25e-02	-3.00e-02	-8.99e-02	4.46e-01	5.45e-02	5.54e-01	5.85e-01	1.02e-01
GOMF ORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY	232	2.17e-02	1.49e-01	0.1510	-4.99e-02	9.17e-02	9.12e-02	3.90e-02	-4.66e-02	1.90e-01	1.61e-02	1.68e-02	3.06e-01	2.21e-01
GOBP POSITIVE REGULATION OF JUN KINASE ACTIVITY	31	8.40e-01	9.48e-01	0.1510	-7.05e-04	1.39e-01	5.01e-02	-3.13e-02	-1.47e-02	9.95e-01	1.82e-01	6.29e-01	7.63e-01	8.87e-01
GOBP POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION	35	8.18e-01	9.41e-01	0.1510	-5.38e-02	8.83e-02	8.60e-02	-2.65e-03	6.93e-02	5.82e-01	3.66e-01	3.79e-01	9.78e-01	4.78e-01
GOBP NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE	43	7.53e-01	9.16e-01	0.1510	-1.04e-01	4.06e-02	5.20e-02	8.74e-02	-9.93e-03	2.38e-01	6.45e-01	5.55e-01	3.22e-01	9.10e-01
GOMF PROTEIN KINASE A REGULATORY SUBUNIT BINDING	24	9.23e-01	9.75e-01	0.1510	3.59e-02	-9.51e-02	-7.20e-02	-3.99e-02	7.60e-02	7.61e-01	4.20e-01	5.41e-01	7.35e-01	5.19e-01
GOBP PROTEIN HOMOOLIGOMERIZATION	188	3.79e-02	2.13e-01	0.1510	5.57e-02	1.07e-01	5.41e-03	-8.06e-02	4.27e-02	1.88e-01	1.15e-02	8.98e-01	5.65e-02	3.13e-01
GOBP REGULATION OF FIBROBLAST PROLIFERATION	87	3.22e-01	6.71e-01	0.1510	-3.70e-03	-3.38e-02	-1.31e-01	-3.43e-02	5.70e-02	9.52e-01	5.86e-01	3.41e-02	5.80e-01	3.58e-01
GOBP HORMONE BIOSYNTHETIC PROCESS	64	5.22e-01	8.14e-01	0.1510	-8.17e-02	-4.93e-02	1.11e-01	3.62e-02	1.41e-02	2.58e-01	4.95e-01	1.26e-01	6.17e-01	8.46e-01
GOCC PERINEURONAL NET	10	9.85e-01	9.95e-01	0.1510	-1.27e-01	-5.00e-02	4.17e-02	1.36e-02	-4.67e-02	4.85e-01	7.84e-01	8.19e-01	9.41e-01	7.98e-01
GOBP REGULATION OF COAGULATION	73	5.11e-01	8.08e-01	0.1510	-5.25e-02	1.02e-01	6.80e-02	6.92e-02	-1.47e-02	4.38e-01	1.31e-01	3.15e-01	3.07e-01	8.28e-01
GOBP GLUTATHIONE METABOLIC PROCESS	45	8.05e-01	9.35e-01	0.1510	5.61e-02	2.40e-02	-9.29e-02	-9.51e-02	3.76e-02	5.15e-01	7.81e-01	2.81e-01	2.70e-01	6.62e-01
GOBP MULTIVESICULAR BODY SORTING PATHWAY	46	7.70e-01	9.24e-01	0.1510	8.09e-02	4.88e-02	-8.05e-02	-8.20e-02	2.57e-02	3.42e-01	5.67e-01	3.45e-01	3.36e-01	7.63e-01
GOBP EXTRACELLULAR TRANSPORT	45	6.64e-01	8.82e-01	0.1510	-1.21e-01	5.18e-03	2.05e-02	8.63e-02	1.28e-02	1.59e-01	9.52e-01	8.12e-01	3.17e-01	8.82e-01
GOBP CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS	33	8.29e-01	9.44e-01	0.1510	-4.42e-02	9.62e-02	3.85e-03	-8.46e-02	6.65e-02	6.61e-01	3.39e-01	9.69e-01	4.00e-01	5.09e-01
GOBP REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS	182	6.98e-02	3.14e-01	0.1510	2.64e-03	5.01e-02	-4.86e-02	-1.27e-01	4.27e-02	9.51e-01	2.43e-01	2.58e-01	3.18e-03	3.20e-01
GOMF ANKYRIN BINDING	19	9.45e-01	9.82e-01	0.1510	-9.28e-02	-5.31e-02	-3.48e-02	4.81e-02	-8.84e-02	4.84e-01	6.89e-01	7.93e-01	7.17e-01	5.05e-01
GOBP NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS	31	6.96e-01	8.94e-01	0.1510	1.23e-02	7.80e-02	-8.40e-02	7.95e-02	-5.62e-02	9.05e-01	4.52e-01	4.19e-01	4.44e-01	5.88e-01
GOMF TETRAPYRROLE BINDING	143	2.16e-02	1.48e-01	0.1510	3.91e-02	5.23e-02	-9.26e-03	1.28e-01	4.56e-02	4.19e-01	2.81e-01	8.48e-01	8.36e-03	3.46e-01
GOBP EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS	30	8.11e-01	9.38e-01	0.1510	-5.02e-03	2.29e-02	-4.05e-03	-1.49e-01	1.09e-02	9.62e-01	8.28e-01	9.69e-01	1.59e-01	9.18e-01
GOCC DENSE CORE GRANULE	38	7.13e-01	9.00e-01	0.1510	-5.76e-02	1.52e-02	7.64e-02	-7.44e-02	8.83e-02	5.39e-01	8.72e-01	4.15e-01	4.27e-01	3.46e-01
GOBP REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION	94	3.12e-01	6.64e-01	0.1510	4.22e-02	9.15e-02	9.18e-02	-1.44e-02	6.26e-02	4.80e-01	1.25e-01	1.24e-01	8.10e-01	2.94e-01
GOBP MESENCHYMAL CELL DIFFERENTIATION	255	1.36e-03	1.98e-02	0.1510	3.79e-02	5.16e-02	3.56e-02	-1.26e-01	3.88e-02	2.97e-01	1.56e-01	3.28e-01	5.39e-04	2.87e-01
GOBP SPHINGOID METABOLIC PROCESS	22	9.04e-01	9.68e-01	0.1510	8.78e-03	-6.26e-02	3.89e-03	-1.11e-01	8.01e-02	9.43e-01	6.11e-01	9.75e-01	3.68e-01	5.16e-01
GOBP MICROTUBULE ANCHORING	23	9.02e-01	9.68e-01	0.1510	1.07e-02	1.06e-01	8.01e-02	-5.64e-02	4.29e-02	9.30e-01	3.81e-01	5.06e-01	6.39e-01	7.22e-01
GOBP PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS	40	8.33e-01	9.45e-01	0.1510	4.18e-02	-1.18e-02	-6.91e-02	-1.23e-01	3.03e-02	6.48e-01	8.98e-01	4.50e-01	1.79e-01	7.40e-01
GOBP NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT	23	9.26e-01	9.76e-01	0.1510	4.09e-02	-1.37e-02	-1.16e-01	-3.84e-02	-7.73e-02	7.34e-01	9.10e-01	3.37e-01	7.50e-01	5.21e-01
GOBP MYELOID CELL HOMEOSTASIS	165	5.14e-02	2.60e-01	0.1510	-5.42e-02	8.87e-02	1.09e-02	-1.00e-01	4.09e-02	2.30e-01	4.94e-02	8.08e-01	2.61e-02	3.65e-01
GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC	32	8.10e-01	9.38e-01	0.1500	-6.32e-02	-1.34e-01	2.51e-02	-6.19e-04	-5.77e-03	5.36e-01	1.90e-01	8.06e-01	9.95e-01	9.55e-01
GOBP ORGANELLE LOCALIZATION	588	1.15e-05	3.77e-04	0.1500	3.52e-02	2.26e-02	-5.06e-02	-1.17e-01	6.75e-02	1.45e-01	3.49e-01	3.61e-02	1.18e-06	5.14e-03
GOBP POSITIVE REGULATION OF CIRCADIAN RHYTHM	18	8.69e-01	9.57e-01	0.1500	2.87e-02	5.46e-03	3.10e-02	-1.14e-01	-8.87e-02	8.33e-01	9.68e-01	8.20e-01	4.04e-01	5.15e-01
GOBP POSITIVE REGULATION OF MYELINATION	17	8.77e-01	9.60e-01	0.1500	7.35e-03	3.85e-02	-2.99e-02	1.23e-01	7.16e-02	9.58e-01	7.83e-01	8.31e-01	3.81e-01	6.09e-01
GOBP ORGANOPHOSPHATE BIOSYNTHETIC PROCESS	561	2.02e-05	6.25e-04	0.1500	1.85e-02	4.70e-02	-6.57e-02	-1.22e-01	2.98e-02	4.55e-01	5.70e-02	7.82e-03	8.01e-07	2.27e-01
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION	1616	6.79e-17	1.02e-14	0.1500	-1.18e-03	4.03e-02	-5.75e-02	-1.32e-01	1.21e-02	9.37e-01	6.94e-03	1.16e-04	6.87e-19	4.17e-01
GOCC MYELIN SHEATH	42	7.77e-01	9.27e-01	0.1500	-2.49e-02	5.68e-02	-3.73e-02	-9.26e-02	9.37e-02	7.80e-01	5.24e-01	6.76e-01	2.99e-01	2.93e-01
GOBP NEURON MATURATION	47	6.44e-01	8.75e-01	0.1500	-1.18e-01	1.78e-02	5.89e-02	-2.95e-02	-6.31e-02	1.62e-01	8.33e-01	4.85e-01	7.26e-01	4.54e-01
GOMF PHOSPHATIDYLINOSITOL PHOSPHATE PHOSPHATASE ACTIVITY	26	8.27e-01	9.44e-01	0.1500	-8.10e-02	-7.25e-02	1.94e-02	-1.01e-01	5.52e-03	4.75e-01	5.22e-01	8.64e-01	3.70e-01	9.61e-01
GOCC VACUOLE	809	2.14e-09	1.67e-07	0.1500	-5.77e-02	6.34e-02	-2.92e-02	-1.18e-01	2.14e-02	5.28e-03	2.18e-03	1.58e-01	1.24e-08	3.01e-01
GOBP NEGATIVE REGULATION OF CATABOLIC PROCESS	323	3.91e-04	7.39e-03	0.1500	-9.11e-02	5.82e-02	1.33e-02	-1.03e-01	1.09e-02	4.87e-03	7.23e-02	6.80e-01	1.52e-03	7.36e-01
GOBP PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS	32	8.84e-01	9.61e-01	0.1500	-3.03e-02	2.59e-02	-1.09e-01	-9.40e-02	1.32e-02	7.66e-01	8.00e-01	2.86e-01	3.57e-01	8.98e-01
GOBP ASTRAL MICROTUBULE ORGANIZATION	10	9.77e-01	9.93e-01	0.1500	1.11e-01	4.65e-02	4.81e-02	-7.57e-02	6.76e-03	5.45e-01	7.99e-01	7.92e-01	6.79e-01	9.70e-01
GOMF HYDROLASE ACTIVITY HYDROLYZING O GLYCOSYL COMPOUNDS	89	2.89e-01	6.43e-01	0.1500	5.55e-02	-9.73e-02	7.29e-02	6.00e-02	-3.15e-02	3.65e-01	1.13e-01	2.34e-01	3.28e-01	6.08e-01
GOCC MALE GERM CELL NUCLEUS	52	5.43e-01	8.25e-01	0.1500	-3.99e-02	2.74e-02	-6.76e-02	-2.32e-02	1.22e-01	6.19e-01	7.32e-01	3.99e-01	7.72e-01	1.27e-01
GOBP REGULATION OF MEMBRANE LIPID DISTRIBUTION	60	5.69e-01	8.37e-01	0.1500	-7.19e-02	7.60e-02	2.78e-03	3.43e-03	-1.07e-01	3.35e-01	3.09e-01	9.70e-01	9.63e-01	1.51e-01
GOBP NEGATIVE REGULATION OF MAPK CASCADE	163	8.74e-02	3.57e-01	0.1500	-5.89e-02	8.96e-02	9.24e-02	2.10e-02	4.41e-02	1.94e-01	4.85e-02	4.18e-02	6.44e-01	3.31e-01
GOBP REGULATION OF POLYSACCHARIDE METABOLIC PROCESS	44	7.18e-01	9.02e-01	0.1500	4.36e-03	1.22e-01	-1.57e-02	-7.89e-02	-3.00e-02	9.60e-01	1.60e-01	8.57e-01	3.65e-01	7.31e-01
GOMF ACTIN MONOMER BINDING	24	8.86e-01	9.62e-01	0.1500	1.04e-02	1.46e-02	-8.60e-02	3.79e-02	-1.15e-01	9.30e-01	9.01e-01	4.66e-01	7.48e-01	3.30e-01
GOBP POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION	26	9.10e-01	9.70e-01	0.1490	-8.89e-03	7.54e-02	1.25e-01	2.25e-02	1.87e-02	9.37e-01	5.06e-01	2.69e-01	8.42e-01	8.69e-01
GOBP REGULATION OF MEMBRANE POTENTIAL	422	6.87e-04	1.14e-02	0.1490	-4.20e-02	3.50e-02	1.19e-01	6.82e-02	2.06e-02	1.39e-01	2.17e-01	2.64e-05	1.63e-02	4.67e-01
GOBP ENDOCYTOSIS	681	5.58e-08	3.34e-06	0.1490	-7.25e-02	1.10e-01	6.25e-02	-1.69e-02	2.59e-02	1.26e-03	9.26e-07	5.43e-03	4.53e-01	2.49e-01
GOBP IMMUNE RESPONSE REGULATING SIGNALING PATHWAY	458	2.78e-05	8.16e-04	0.1490	-3.13e-02	1.06e-01	5.25e-02	-1.01e-02	8.51e-02	2.52e-01	1.04e-04	5.43e-02	7.12e-01	1.79e-03
GOBP REGULATION OF PEPTIDE TRANSPORT	195	3.50e-02	2.02e-01	0.1490	6.92e-02	1.18e-01	3.70e-02	2.00e-03	4.78e-02	9.59e-02	4.66e-03	3.72e-01	9.62e-01	2.50e-01
GOMF GROWTH FACTOR BINDING	130	2.15e-01	5.69e-01	0.1490	-6.31e-02	8.49e-03	5.67e-02	1.18e-01	-3.11e-02	2.14e-01	8.67e-01	2.64e-01	1.98e-02	5.40e-01
GOCC CLATHRIN COATED ENDOCYTIC VESICLE MEMBRANE	67	6.23e-01	8.65e-01	0.1490	-4.23e-03	-6.86e-03	1.05e-01	8.58e-02	-6.16e-02	9.52e-01	9.23e-01	1.38e-01	2.24e-01	3.83e-01
GOBP MUCOPOLYSACCHARIDE METABOLIC PROCESS	89	2.93e-01	6.47e-01	0.1490	3.49e-02	1.39e-01	-7.20e-03	1.58e-02	-3.57e-02	5.70e-01	2.31e-02	9.06e-01	7.96e-01	5.61e-01
GOBP POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION	124	1.59e-01	4.90e-01	0.1490	-6.20e-02	1.26e-01	4.27e-02	-9.73e-03	2.38e-02	2.33e-01	1.55e-02	4.11e-01	8.52e-01	6.47e-01
GOBP REGULATION OF SIGNALING RECEPTOR ACTIVITY	102	2.60e-01	6.17e-01	0.1490	-5.07e-02	-8.53e-02	9.86e-02	5.06e-02	6.85e-03	3.76e-01	1.37e-01	8.53e-02	3.78e-01	9.05e-01
GOBP NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION	23	8.86e-01	9.62e-01	0.1490	-4.96e-02	-8.88e-02	-2.09e-02	-9.44e-02	-4.97e-02	6.81e-01	4.61e-01	8.62e-01	4.33e-01	6.80e-01
GOBP POST EMBRYONIC DEVELOPMENT	91	2.85e-01	6.39e-01	0.1490	1.30e-01	1.61e-02	2.84e-03	-6.77e-02	1.65e-02	3.14e-02	7.91e-01	9.63e-01	2.64e-01	7.85e-01
GOBP MALE SEX DIFFERENTIATION	163	3.17e-02	1.90e-01	0.1490	9.01e-02	5.31e-02	6.59e-02	-7.19e-02	4.09e-02	4.71e-02	2.42e-01	1.47e-01	1.13e-01	3.68e-01
GOBP ESTABLISHMENT OF ORGANELLE LOCALIZATION	454	3.98e-04	7.46e-03	0.1490	5.60e-02	6.95e-03	-6.00e-02	-1.07e-01	6.24e-02	4.07e-02	8.00e-01	2.85e-02	9.33e-05	2.26e-02
GOBP RIBONUCLEOSIDE CATABOLIC PROCESS	20	9.26e-01	9.76e-01	0.1490	8.25e-02	4.43e-02	-4.54e-02	2.11e-02	-1.04e-01	5.23e-01	7.32e-01	7.25e-01	8.70e-01	4.20e-01
GOBP NEUROMUSCULAR PROCESS CONTROLLING BALANCE	51	7.05e-01	8.97e-01	0.1490	1.69e-03	5.44e-02	9.57e-02	3.05e-02	9.51e-02	9.83e-01	5.01e-01	2.37e-01	7.06e-01	2.40e-01
GOBP POSITIVE REGULATION OF INTRACELLULAR TRANSPORT	190	6.04e-02	2.88e-01	0.1490	1.88e-02	9.95e-03	-2.84e-02	-1.20e-01	8.07e-02	6.55e-01	8.13e-01	4.99e-01	4.48e-03	5.50e-02
GOCC PERINUCLEAR ENDOPLASMIC RETICULUM	19	9.50e-01	9.84e-01	0.1490	2.06e-02	1.25e-01	5.20e-02	5.59e-02	-9.84e-03	8.76e-01	3.44e-01	6.95e-01	6.73e-01	9.41e-01
GOBP NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION	161	4.45e-02	2.35e-01	0.1480	-2.28e-02	1.40e-01	-2.07e-02	4.39e-03	-3.87e-02	6.18e-01	2.18e-03	6.50e-01	9.23e-01	3.97e-01
GOBP LACTATION	37	7.76e-01	9.26e-01	0.1480	-9.77e-02	1.17e-02	-8.92e-03	-5.49e-02	-9.63e-02	3.04e-01	9.02e-01	9.25e-01	5.63e-01	3.11e-01
GOCC COPII COATED ER TO GOLGI TRANSPORT VESICLE	87	5.01e-01	8.03e-01	0.1480	2.65e-03	2.81e-02	-9.12e-02	-1.13e-01	1.20e-02	9.66e-01	6.50e-01	1.41e-01	6.84e-02	8.47e-01
GOBP RUFFLE ORGANIZATION	57	4.87e-01	7.96e-01	0.1480	1.13e-03	7.73e-02	3.18e-02	-5.86e-02	-1.08e-01	9.88e-01	3.13e-01	6.78e-01	4.44e-01	1.59e-01
GOBP HEAD MORPHOGENESIS	35	7.37e-01	9.09e-01	0.1480	4.10e-02	4.13e-02	1.01e-02	-1.36e-01	-7.79e-03	6.75e-01	6.72e-01	9.18e-01	1.64e-01	9.36e-01
GOCC ENDOSOME LUMEN	37	7.15e-01	9.01e-01	0.1480	-1.66e-02	9.83e-02	7.59e-02	-6.85e-02	-4.02e-02	8.61e-01	3.01e-01	4.24e-01	4.71e-01	6.73e-01
GOMF HYDRO LYASE ACTIVITY	57	6.43e-01	8.75e-01	0.1480	4.38e-02	2.18e-02	-1.30e-01	-4.98e-02	-1.24e-02	5.67e-01	7.76e-01	8.88e-02	5.15e-01	8.71e-01
GOBP REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT	430	7.72e-04	1.25e-02	0.1480	-6.59e-02	3.35e-02	1.02e-01	7.11e-02	-3.16e-02	1.90e-02	2.33e-01	2.72e-04	1.14e-02	2.61e-01
GOCC NUCLEAR ENVELOPE	464	3.13e-04	6.13e-03	0.1480	1.66e-02	3.64e-02	-6.64e-02	-1.19e-01	4.32e-02	5.39e-01	1.79e-01	1.42e-02	1.17e-05	1.11e-01
GOBP PIGMENT GRANULE LOCALIZATION	23	9.07e-01	9.69e-01	0.1480	6.31e-02	4.33e-02	-4.92e-02	-3.95e-02	-1.10e-01	6.00e-01	7.19e-01	6.83e-01	7.43e-01	3.61e-01
GOMF TRANSMEMBRANE TRANSPORTER BINDING	126	1.71e-01	5.09e-01	0.1480	-5.46e-02	9.56e-02	3.06e-02	1.30e-02	-9.34e-02	2.90e-01	6.38e-02	5.54e-01	8.01e-01	7.02e-02
GOBP ENDOTHELIAL CELL APOPTOTIC PROCESS	67	3.74e-01	7.14e-01	0.1480	-2.11e-02	-8.54e-02	-4.25e-02	6.51e-02	9.03e-02	7.65e-01	2.27e-01	5.48e-01	3.57e-01	2.01e-01
GOBP REGULATION OF ACTIN FILAMENT LENGTH	148	8.71e-02	3.57e-01	0.1480	-1.96e-02	1.32e-01	7.27e-03	4.20e-03	-6.40e-02	6.81e-01	5.64e-03	8.79e-01	9.30e-01	1.79e-01
GOBP RESPONSE TO TYPE II INTERFERON	134	1.28e-01	4.42e-01	0.1480	-3.82e-03	4.57e-02	6.29e-02	9.11e-02	8.69e-02	9.39e-01	3.61e-01	2.09e-01	6.86e-02	8.25e-02
GOBP INNER EAR MORPHOGENESIS	103	1.85e-01	5.27e-01	0.1480	2.93e-02	2.53e-02	1.07e-01	-4.28e-02	8.37e-02	6.07e-01	6.57e-01	5.94e-02	4.53e-01	1.42e-01
GOMF PRIMARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY	145	1.63e-01	4.96e-01	0.1480	5.08e-02	-2.83e-02	-7.64e-02	-1.11e-01	-2.06e-02	2.91e-01	5.57e-01	1.12e-01	2.14e-02	6.69e-01
GOBP DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS	217	1.63e-02	1.24e-01	0.1480	5.28e-02	6.18e-02	4.72e-02	-7.75e-02	8.39e-02	1.80e-01	1.16e-01	2.31e-01	4.90e-02	3.31e-02
GOBP ESTABLISHMENT OF EPITHELIAL CELL POLARITY	33	8.57e-01	9.53e-01	0.1480	-2.73e-02	8.55e-02	8.89e-02	8.90e-03	7.62e-02	7.86e-01	3.95e-01	3.77e-01	9.29e-01	4.49e-01
GOBP TYPE II INTERFERON PRODUCTION	111	2.23e-01	5.76e-01	0.1480	-4.50e-02	6.80e-02	6.01e-02	9.85e-02	4.33e-02	4.13e-01	2.16e-01	2.74e-01	7.31e-02	4.30e-01
GOBP AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS	67	2.56e-01	6.13e-01	0.1480	-7.42e-03	8.10e-02	-1.14e-01	4.09e-02	-2.46e-02	9.16e-01	2.52e-01	1.07e-01	5.63e-01	7.27e-01
GOBP REGULATION OF PROTEIN BINDING	139	1.33e-01	4.50e-01	0.1480	4.87e-03	4.66e-02	-4.48e-02	-1.31e-01	-2.28e-02	9.21e-01	3.42e-01	3.61e-01	7.79e-03	6.43e-01
GOBP SYNAPSE MATURATION	33	8.19e-01	9.41e-01	0.1480	-7.11e-02	2.74e-02	1.27e-01	4.99e-04	2.57e-03	4.80e-01	7.85e-01	2.08e-01	9.96e-01	9.80e-01
GOCC PRESYNAPTIC MEMBRANE	158	8.89e-02	3.59e-01	0.1480	2.16e-02	-6.10e-03	1.36e-01	5.36e-02	-8.55e-03	6.40e-01	8.95e-01	3.29e-03	2.45e-01	8.53e-01
GOBP CELLULAR RESPONSE TO INSULIN STIMULUS	203	1.80e-02	1.32e-01	0.1480	1.94e-02	1.12e-01	5.26e-02	-7.57e-02	2.06e-02	6.34e-01	5.98e-03	1.97e-01	6.31e-02	6.12e-01
GOMF ALDO KETO REDUCTASE NADP ACTIVITY	30	8.46e-01	9.49e-01	0.1480	3.87e-02	3.24e-02	-6.20e-02	2.44e-02	-1.22e-01	7.14e-01	7.59e-01	5.57e-01	8.17e-01	2.48e-01
GOBP POSITIVE REGULATION OF REPRODUCTIVE PROCESS	83	1.55e-01	4.83e-01	0.1480	-4.67e-02	-3.89e-02	3.53e-02	-1.24e-01	-3.92e-02	4.62e-01	5.40e-01	5.78e-01	5.12e-02	5.37e-01
GOBP REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION	122	2.38e-01	5.93e-01	0.1480	-7.06e-03	9.25e-02	1.12e-01	2.62e-02	5.05e-03	8.93e-01	7.77e-02	3.31e-02	6.17e-01	9.23e-01
GOBP LATERAL MESODERM DEVELOPMENT	15	9.60e-01	9.88e-01	0.1480	-1.17e-01	-4.36e-02	5.09e-03	-7.34e-02	2.82e-02	4.33e-01	7.70e-01	9.73e-01	6.23e-01	8.50e-01
GOBP MORPHOGENESIS OF A POLARIZED EPITHELIUM	89	2.81e-01	6.34e-01	0.1480	-6.51e-02	-7.24e-02	1.09e-01	2.02e-02	1.16e-03	2.88e-01	2.38e-01	7.54e-02	7.42e-01	9.85e-01
GOBP ONE CARBON METABOLIC PROCESS	37	7.90e-01	9.31e-01	0.1480	-7.66e-02	6.46e-02	-2.02e-03	-5.95e-02	9.05e-02	4.20e-01	4.96e-01	9.83e-01	5.31e-01	3.41e-01
GOBP LIPID IMPORT INTO CELL	20	9.05e-01	9.69e-01	0.1470	3.40e-02	-9.74e-03	1.85e-02	-1.36e-01	4.04e-02	7.92e-01	9.40e-01	8.86e-01	2.92e-01	7.54e-01
GOBP HEMOSTASIS	220	1.46e-02	1.14e-01	0.1470	-8.46e-02	1.13e-01	2.62e-02	-2.69e-02	1.89e-02	3.06e-02	3.82e-03	5.03e-01	4.92e-01	6.29e-01
GOBP MUSCLE ADAPTATION	117	1.82e-01	5.24e-01	0.1470	-7.42e-02	6.21e-02	5.08e-02	-1.38e-02	9.80e-02	1.66e-01	2.46e-01	3.43e-01	7.96e-01	6.72e-02
GOBP POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS	255	1.02e-02	8.86e-02	0.1470	-9.38e-02	8.69e-02	6.11e-02	3.91e-02	9.79e-03	9.89e-03	1.69e-02	9.32e-02	2.82e-01	7.88e-01
GOBP REGULATION OF SKELETAL MUSCLE SATELLITE CELL PROLIFERATION	12	9.78e-01	9.93e-01	0.1470	7.70e-02	8.99e-02	-8.26e-02	-2.91e-02	-2.84e-03	6.44e-01	5.90e-01	6.20e-01	8.61e-01	9.86e-01
GOCC BASAL PART OF CELL	291	1.11e-02	9.47e-02	0.1470	-4.57e-02	3.76e-02	5.70e-02	1.07e-01	-5.87e-02	1.80e-01	2.70e-01	9.46e-02	1.65e-03	8.49e-02
GOBP NEURAL RETINA DEVELOPMENT	78	3.88e-01	7.25e-01	0.1470	7.01e-02	4.28e-02	1.17e-01	6.76e-04	3.58e-02	2.85e-01	5.13e-01	7.47e-02	9.92e-01	5.84e-01
GOMF N6 METHYLADENOSINE CONTAINING RNA BINDING	10	9.86e-01	9.95e-01	0.1470	-1.30e-01	-1.87e-02	-3.95e-02	-5.31e-02	3.62e-03	4.77e-01	9.18e-01	8.29e-01	7.71e-01	9.84e-01
GOCC PROTEIN PHOSPHATASE TYPE 1 COMPLEX	18	9.08e-01	9.69e-01	0.1470	7.90e-02	5.11e-02	8.60e-02	-7.32e-02	4.60e-03	5.62e-01	7.07e-01	5.27e-01	5.91e-01	9.73e-01
GOBP ORGANIC CATION TRANSPORT	62	6.12e-01	8.58e-01	0.1470	9.26e-02	6.62e-02	7.90e-02	4.55e-02	1.96e-02	2.07e-01	3.68e-01	2.82e-01	5.36e-01	7.90e-01
GOBP REGULATION OF NCRNA TRANSCRIPTION	91	2.65e-01	6.20e-01	0.1470	-2.64e-02	4.11e-02	3.45e-03	-1.38e-01	1.31e-02	6.63e-01	4.98e-01	9.55e-01	2.29e-02	8.29e-01
GOBP NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS	54	6.76e-01	8.85e-01	0.1470	3.60e-02	8.06e-02	-9.59e-02	-6.73e-02	-9.34e-03	6.47e-01	3.06e-01	2.23e-01	3.92e-01	9.05e-01
GOBP NEGATIVE REGULATION OF PROTEIN SECRETION	71	4.22e-01	7.49e-01	0.1470	1.02e-02	1.08e-01	3.62e-02	-9.14e-02	-7.11e-03	8.82e-01	1.14e-01	5.97e-01	1.83e-01	9.17e-01
GOMF NUCLEAR RETINOIC ACID RECEPTOR BINDING	26	8.96e-01	9.66e-01	0.1470	-9.84e-02	6.18e-02	-5.78e-02	-6.20e-02	-2.96e-02	3.85e-01	5.86e-01	6.10e-01	5.84e-01	7.94e-01
GOCC ASTROCYTE END FOOT	9	9.92e-01	9.97e-01	0.1470	-7.67e-02	-3.06e-02	9.29e-02	6.86e-02	3.74e-02	6.90e-01	8.74e-01	6.29e-01	7.22e-01	8.46e-01
GOBP NEGATIVE REGULATION OF KINASE ACTIVITY	189	2.99e-02	1.83e-01	0.1470	-1.45e-02	5.64e-02	2.98e-02	-1.10e-01	7.27e-02	7.31e-01	1.81e-01	4.80e-01	9.42e-03	8.48e-02
GOBP DENDRITE MORPHOGENESIS	129	2.76e-01	6.30e-01	0.1470	-3.24e-03	1.66e-03	1.19e-01	8.47e-02	-1.73e-02	9.49e-01	9.74e-01	2.01e-02	9.65e-02	7.34e-01
GOBP REGULATION OF KERATINOCYTE PROLIFERATION	46	6.65e-01	8.82e-01	0.1470	1.54e-02	-1.36e-01	-1.59e-02	-3.64e-02	-3.54e-02	8.57e-01	1.11e-01	8.52e-01	6.69e-01	6.78e-01
GOBP COBALT ION TRANSPORT	6	9.95e-01	9.98e-01	0.1470	-8.27e-03	2.01e-02	5.92e-02	-7.19e-02	1.11e-01	9.72e-01	9.32e-01	8.02e-01	7.60e-01	6.37e-01
GOBP RESPONSE TO FATTY ACID	55	6.65e-01	8.82e-01	0.1470	5.16e-02	1.18e-01	5.53e-02	6.54e-04	4.24e-02	5.08e-01	1.29e-01	4.78e-01	9.93e-01	5.87e-01
GOBP VESICLE CYTOSKELETAL TRAFFICKING	68	6.18e-01	8.62e-01	0.1470	-2.31e-02	7.65e-02	8.62e-02	8.52e-02	2.11e-02	7.42e-01	2.76e-01	2.19e-01	2.24e-01	7.63e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS NAD OR NADP AS ACCEPTOR	38	6.91e-01	8.92e-01	0.1470	5.14e-02	-7.04e-03	-8.58e-03	1.33e-01	3.03e-02	5.84e-01	9.40e-01	9.27e-01	1.55e-01	7.46e-01
GOBP REGULATION OF RECEPTOR RECYCLING	25	7.72e-01	9.25e-01	0.1470	5.57e-02	-6.95e-02	9.57e-02	-2.65e-02	-6.08e-02	6.30e-01	5.47e-01	4.08e-01	8.19e-01	5.99e-01
GOBP POSITIVE REGULATION OF FAT CELL DIFFERENTIATION	67	5.33e-01	8.20e-01	0.1470	-2.76e-02	1.10e-01	3.51e-02	-4.39e-02	7.42e-02	6.96e-01	1.20e-01	6.20e-01	5.34e-01	2.94e-01
GOBP NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION	108	9.24e-02	3.67e-01	0.1460	-8.20e-02	-4.68e-02	-6.78e-02	8.83e-02	1.10e-02	1.41e-01	4.01e-01	2.23e-01	1.13e-01	8.44e-01
GOBP REGULATION OF CELL JUNCTION ASSEMBLY	199	3.12e-02	1.88e-01	0.1460	-1.78e-02	5.71e-02	1.28e-01	1.81e-02	-3.45e-02	6.66e-01	1.65e-01	1.88e-03	6.60e-01	4.01e-01
GOBP VIRAL LIFE CYCLE	307	7.53e-03	7.15e-02	0.1460	-5.09e-02	1.75e-02	-8.90e-02	-1.02e-01	1.44e-02	1.25e-01	5.98e-01	7.29e-03	2.13e-03	6.64e-01
GOMF PROTEIN HETERODIMERIZATION ACTIVITY	302	1.10e-02	9.37e-02	0.1460	2.22e-02	-2.61e-02	-6.71e-02	-1.20e-01	3.73e-02	5.06e-01	4.36e-01	4.48e-02	3.44e-04	2.64e-01
GOBP CELLULAR RESPONSE TO ABIOTIC STIMULUS	318	3.48e-03	4.11e-02	0.1460	-1.93e-02	6.19e-02	-2.46e-02	-1.01e-01	7.98e-02	5.53e-01	5.77e-02	4.51e-01	1.97e-03	1.44e-02
GOBP POSITIVE REGULATION OF MRNA METABOLIC PROCESS	189	7.01e-03	6.79e-02	0.1460	-3.67e-02	-6.51e-02	1.95e-02	-1.24e-01	9.65e-03	3.85e-01	1.23e-01	6.44e-01	3.35e-03	8.19e-01
GOBP TRANSFORMING GROWTH FACTOR BETA PRODUCTION	41	8.10e-01	9.38e-01	0.1460	5.85e-02	8.39e-02	9.12e-02	3.10e-02	4.04e-02	5.17e-01	3.53e-01	3.13e-01	7.31e-01	6.55e-01
GOBP REGULATION OF OXIDOREDUCTASE ACTIVITY	77	5.29e-01	8.19e-01	0.1460	4.51e-02	5.43e-02	1.14e-01	5.61e-02	-1.34e-02	4.94e-01	4.10e-01	8.31e-02	3.95e-01	8.39e-01
GOBP VASCULAR PROCESS IN CIRCULATORY SYSTEM	261	5.80e-03	5.91e-02	0.1460	-6.54e-02	6.31e-02	1.85e-02	1.01e-01	-5.10e-02	6.89e-02	7.92e-02	6.07e-01	5.05e-03	1.56e-01
GOBP CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC	110	2.74e-01	6.29e-01	0.1460	1.97e-02	9.73e-02	1.02e-01	3.06e-03	3.35e-02	7.20e-01	7.79e-02	6.52e-02	9.56e-01	5.44e-01
GOBP MICROTUBULE CYTOSKELETON ORGANIZATION	624	2.00e-05	6.21e-04	0.1460	3.02e-02	3.46e-02	-8.93e-02	-9.93e-02	3.73e-02	1.97e-01	1.40e-01	1.40e-04	2.28e-05	1.12e-01
GOBP CARBOHYDRATE DERIVATIVE TRANSPORT	83	4.50e-01	7.71e-01	0.1460	-4.66e-02	5.16e-02	-5.53e-02	-1.15e-01	-1.77e-02	4.63e-01	4.17e-01	3.84e-01	7.12e-02	7.80e-01
GOBP IMMUNOGLOBULIN PRODUCTION	102	3.36e-01	6.84e-01	0.1460	1.67e-02	1.00e-01	-4.50e-02	-8.77e-02	3.55e-02	7.70e-01	7.98e-02	4.32e-01	1.26e-01	5.36e-01
GOBP REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY	233	2.14e-02	1.48e-01	0.1460	-2.22e-02	4.19e-02	1.31e-01	3.56e-02	-2.36e-02	5.60e-01	2.71e-01	5.52e-04	3.49e-01	5.35e-01
GOMF PROTEIN TYROSINE PHOSPHATASE ACTIVITY	94	4.14e-01	7.44e-01	0.1460	-2.85e-02	1.09e-01	7.57e-02	4.86e-02	-2.29e-02	6.32e-01	6.78e-02	2.04e-01	4.15e-01	7.01e-01
GOBP NEGATIVE REGULATION OF BMP SIGNALING PATHWAY	67	3.89e-01	7.26e-01	0.1460	-5.95e-02	7.21e-02	5.69e-02	-9.16e-02	-3.11e-02	4.00e-01	3.08e-01	4.21e-01	1.95e-01	6.60e-01
GOBP ANIMAL ORGAN MATURATION	29	8.70e-01	9.57e-01	0.1460	-4.40e-02	6.40e-02	-1.67e-02	-5.17e-02	1.11e-01	6.82e-01	5.51e-01	8.76e-01	6.30e-01	3.01e-01
GOBP POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION	263	8.38e-03	7.74e-02	0.1460	-4.22e-02	1.12e-01	7.25e-02	-1.59e-02	3.79e-02	2.39e-01	1.76e-03	4.31e-02	6.56e-01	2.90e-01
GOBP HYALURONAN CATABOLIC PROCESS	16	9.60e-01	9.88e-01	0.1460	1.18e-02	9.32e-02	2.70e-02	1.04e-01	-2.94e-02	9.35e-01	5.19e-01	8.51e-01	4.71e-01	8.39e-01
GOCC MICROTUBULE ORGANIZING CENTER	806	5.76e-08	3.43e-06	0.1460	5.69e-02	2.29e-02	-4.23e-02	-1.21e-01	3.35e-02	6.02e-03	2.69e-01	4.12e-02	5.56e-09	1.05e-01
GOBP DIOL METABOLIC PROCESS	30	8.75e-01	9.59e-01	0.1460	-6.45e-02	-5.60e-02	-5.40e-02	-8.04e-02	-6.75e-02	5.41e-01	5.95e-01	6.08e-01	4.46e-01	5.22e-01
GOBP POSITIVE REGULATION OF TRANSPORTER ACTIVITY	89	4.24e-01	7.51e-01	0.1460	-4.10e-02	8.80e-03	1.24e-01	4.87e-02	-4.09e-02	5.04e-01	8.86e-01	4.29e-02	4.27e-01	5.05e-01
GOBP PEPTIDE CATABOLIC PROCESS	22	9.49e-01	9.84e-01	0.1460	4.40e-03	7.33e-02	1.14e-01	4.69e-02	-2.47e-02	9.71e-01	5.52e-01	3.55e-01	7.03e-01	8.41e-01
GOMF LYSINE ACETYLATED HISTONE BINDING	24	8.84e-01	9.61e-01	0.1460	-1.05e-01	4.03e-02	4.59e-02	-8.02e-02	-1.02e-02	3.75e-01	7.33e-01	6.97e-01	4.96e-01	9.31e-01
GOBP REGULATION OF NEUROTRANSMITTER UPTAKE	18	9.42e-01	9.82e-01	0.1460	1.10e-02	6.11e-02	-5.44e-02	-2.76e-02	1.17e-01	9.36e-01	6.54e-01	6.90e-01	8.40e-01	3.92e-01
GOBP SPERM MOTILITY	127	1.83e-01	5.25e-01	0.1450	-5.35e-02	-1.11e-01	-5.26e-02	3.61e-02	-4.25e-02	2.98e-01	3.01e-02	3.06e-01	4.83e-01	4.08e-01
GOBP REGULATION OF HEART GROWTH	68	5.21e-01	8.14e-01	0.1450	-8.91e-02	2.77e-02	1.11e-01	6.38e-03	-9.54e-03	2.04e-01	6.93e-01	1.14e-01	9.28e-01	8.92e-01
GOBP NEGATIVE REGULATION OF STEROL TRANSPORT	31	8.47e-01	9.49e-01	0.1450	-8.83e-02	-5.82e-02	-5.44e-03	-2.66e-02	9.59e-02	3.95e-01	5.75e-01	9.58e-01	7.98e-01	3.55e-01
GOMF MODIFIED AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY	35	8.46e-01	9.49e-01	0.1450	4.47e-04	4.60e-02	5.56e-02	1.26e-01	7.41e-03	9.96e-01	6.38e-01	5.69e-01	1.97e-01	9.40e-01
GOMF FLOPPASE ACTIVITY	15	9.65e-01	9.90e-01	0.1450	-6.92e-02	1.16e-01	-1.24e-03	1.35e-02	-5.29e-02	6.43e-01	4.38e-01	9.93e-01	9.28e-01	7.23e-01
GOBP PROTEIN TRANSPORT TO VACUOLE INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY	15	9.24e-01	9.75e-01	0.1450	-6.11e-02	-1.26e-02	1.02e-01	-8.21e-02	9.14e-03	6.82e-01	9.33e-01	4.94e-01	5.82e-01	9.51e-01
GOBP REGULATION OF AMINO ACID TRANSPORT	41	8.21e-01	9.42e-01	0.1450	-2.71e-02	9.87e-02	7.65e-02	6.64e-02	1.95e-02	7.64e-01	2.74e-01	3.97e-01	4.62e-01	8.29e-01
GOBP REGULATION OF CENTROSOME CYCLE	54	7.28e-01	9.06e-01	0.1450	7.73e-02	-4.35e-03	-1.03e-01	-5.28e-02	4.26e-02	3.26e-01	9.56e-01	1.93e-01	5.02e-01	5.89e-01
GOBP REGULATION OF JUN KINASE ACTIVITY	43	7.99e-01	9.33e-01	0.1450	-8.22e-03	7.23e-02	1.07e-01	2.21e-02	6.16e-02	9.26e-01	4.12e-01	2.24e-01	8.02e-01	4.85e-01
GOBP BIOLOGICAL PROCESS INVOLVED IN INTERACTION WITH SYMBIONT	112	1.94e-01	5.42e-01	0.1450	-9.55e-03	-1.19e-01	4.47e-04	-5.42e-02	6.21e-02	8.61e-01	2.94e-02	9.93e-01	3.22e-01	2.57e-01
GOBP RESPONSE TO LEUKEMIA INHIBITORY FACTOR	101	2.89e-01	6.43e-01	0.1450	-2.85e-02	-3.41e-02	-5.81e-02	-9.08e-02	-8.65e-02	6.21e-01	5.54e-01	3.13e-01	1.15e-01	1.33e-01
GOBP REGULATION OF T CELL APOPTOTIC PROCESS	39	7.77e-01	9.27e-01	0.1450	5.55e-02	5.84e-02	1.87e-03	-1.18e-01	2.50e-02	5.48e-01	5.28e-01	9.84e-01	2.02e-01	7.87e-01
GOBP REGULATION OF GLYCOGEN METABOLIC PROCESS	36	7.89e-01	9.30e-01	0.1450	-9.34e-03	1.11e-01	2.68e-02	-8.63e-02	-2.26e-02	9.23e-01	2.50e-01	7.81e-01	3.70e-01	8.15e-01
GOBP HINDBRAIN DEVELOPMENT	148	6.27e-02	2.94e-01	0.1450	-4.42e-03	-2.19e-03	2.82e-02	-1.23e-01	7.18e-02	9.26e-01	9.63e-01	5.53e-01	9.98e-03	1.32e-01
GOBP POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION	166	1.40e-01	4.61e-01	0.1450	-8.38e-02	1.96e-02	5.87e-02	9.06e-02	-4.39e-02	6.24e-02	6.64e-01	1.92e-01	4.39e-02	3.29e-01
GOBP PROTEIN CONTAINING COMPLEX DISASSEMBLY	240	1.46e-02	1.15e-01	0.1450	2.50e-02	7.46e-02	-2.99e-02	-1.17e-01	-1.22e-02	5.05e-01	4.66e-02	4.25e-01	1.75e-03	7.44e-01
GOBP NECROPTOTIC PROCESS	45	6.63e-01	8.81e-01	0.1450	8.26e-02	-1.31e-02	-1.12e-02	-1.17e-01	-8.38e-03	3.38e-01	8.79e-01	8.97e-01	1.73e-01	9.23e-01
GOBP REGULATION OF LEUKOCYTE PROLIFERATION	254	1.47e-02	1.15e-01	0.1450	-2.72e-02	9.23e-02	7.51e-02	4.38e-02	6.43e-02	4.56e-01	1.13e-02	3.93e-02	2.29e-01	7.76e-02
GOBP PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS	21	9.16e-01	9.73e-01	0.1450	-1.40e-02	9.74e-03	6.58e-02	5.36e-03	-1.28e-01	9.11e-01	9.38e-01	6.02e-01	9.66e-01	3.11e-01
GOBP NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS	17	9.63e-01	9.90e-01	0.1450	-9.56e-02	8.46e-03	-8.57e-02	-5.38e-02	-3.85e-02	4.95e-01	9.52e-01	5.41e-01	7.01e-01	7.83e-01
GOBP POSITIVE REGULATION OF DEVELOPMENTAL GROWTH	155	1.56e-01	4.84e-01	0.1450	-2.17e-02	1.53e-02	1.28e-01	5.42e-02	3.01e-02	6.41e-01	7.43e-01	5.95e-03	2.44e-01	5.17e-01
GOMF LIPID TRANSPORTER ACTIVITY	169	3.27e-02	1.93e-01	0.1450	-4.04e-02	3.82e-02	-2.92e-02	1.06e-01	-7.55e-02	3.64e-01	3.92e-01	5.12e-01	1.72e-02	9.05e-02
GOBP GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE	22	9.47e-01	9.83e-01	0.1450	2.43e-02	8.59e-02	-6.15e-02	-9.55e-02	4.38e-03	8.43e-01	4.85e-01	6.18e-01	4.38e-01	9.72e-01
GOBP MYOBLAST PROLIFERATION	34	8.95e-01	9.65e-01	0.1440	-2.91e-02	7.96e-02	9.58e-02	6.09e-02	-2.81e-02	7.69e-01	4.22e-01	3.34e-01	5.39e-01	7.77e-01
GOBP RESPONSE TO MUSCLE ACTIVITY	28	9.01e-01	9.68e-01	0.1440	4.60e-02	-1.31e-02	4.92e-02	1.26e-01	1.39e-02	6.73e-01	9.04e-01	6.52e-01	2.48e-01	8.99e-01
GOBP ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE	39	7.58e-01	9.19e-01	0.1440	-8.51e-02	-5.34e-02	2.35e-02	-6.89e-02	7.37e-02	3.58e-01	5.64e-01	8.00e-01	4.57e-01	4.26e-01
GOBP REGULATION OF BODY FLUID LEVELS	351	8.93e-04	1.42e-02	0.1440	-7.17e-02	1.19e-01	3.87e-02	5.19e-03	-7.61e-03	2.10e-02	1.32e-04	2.13e-01	8.67e-01	8.07e-01
GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION	92	2.90e-01	6.43e-01	0.1440	1.09e-01	3.95e-02	-1.14e-02	-7.69e-02	-3.68e-02	7.11e-02	5.13e-01	8.50e-01	2.02e-01	5.42e-01
GOBP REGULATION OF GLUCOSE METABOLIC PROCESS	99	4.07e-01	7.39e-01	0.1440	6.31e-02	6.15e-02	-3.65e-02	-8.68e-02	6.46e-02	2.78e-01	2.90e-01	5.30e-01	1.35e-01	2.67e-01
GOBP NEGATIVE REGULATION OF GTPASE ACTIVITY	21	9.31e-01	9.79e-01	0.1440	-4.43e-02	1.09e-01	4.32e-02	5.87e-02	4.15e-02	7.26e-01	3.89e-01	7.32e-01	6.42e-01	7.42e-01
GOBP ALPHA BETA T CELL ACTIVATION	167	6.23e-02	2.94e-01	0.1440	3.59e-02	8.85e-02	1.05e-01	-1.73e-02	1.54e-02	4.23e-01	4.85e-02	1.87e-02	7.00e-01	7.31e-01
GOCC ESCRT COMPLEX	27	9.40e-01	9.81e-01	0.1440	-1.08e-02	-3.78e-02	-9.70e-02	-9.91e-02	-2.52e-03	9.23e-01	7.34e-01	3.83e-01	3.73e-01	9.82e-01
GOBP REGULATION OF LONG TERM SYNAPTIC POTENTIATION	46	7.80e-01	9.28e-01	0.1440	-5.64e-02	4.89e-02	1.16e-01	3.19e-02	-2.49e-02	5.08e-01	5.66e-01	1.72e-01	7.08e-01	7.71e-01
GOBP POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS	30	8.84e-01	9.61e-01	0.1440	-3.64e-03	9.23e-02	6.16e-02	2.97e-02	8.65e-02	9.72e-01	3.82e-01	5.59e-01	7.78e-01	4.12e-01
GOMF SULFURIC ESTER HYDROLASE ACTIVITY	11	9.87e-01	9.95e-01	0.1440	-1.39e-02	4.64e-02	-1.49e-02	-1.18e-01	6.50e-02	9.36e-01	7.90e-01	9.32e-01	4.98e-01	7.09e-01
GOBP POLYOL METABOLIC PROCESS	103	2.49e-01	6.07e-01	0.1440	1.99e-02	1.19e-01	5.63e-02	-4.09e-02	-3.65e-02	7.27e-01	3.72e-02	3.24e-01	4.73e-01	5.22e-01
GOBP REGULATION OF GLIOGENESIS	106	3.09e-01	6.61e-01	0.1440	6.61e-02	1.94e-02	-3.82e-03	-1.02e-01	7.46e-02	2.39e-01	7.30e-01	9.46e-01	7.05e-02	1.84e-01
GOBP NEURON APOPTOTIC PROCESS	264	6.53e-03	6.49e-02	0.1440	7.62e-05	3.10e-02	-4.79e-03	-1.33e-01	4.53e-02	9.98e-01	3.87e-01	8.93e-01	2.04e-04	2.05e-01
GOBP CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS	300	2.89e-03	3.57e-02	0.1440	-6.48e-03	1.21e-01	7.06e-02	-2.75e-02	-1.52e-02	8.47e-01	3.11e-04	3.54e-02	4.12e-01	6.51e-01
GOBP RELAXATION OF MUSCLE	33	8.00e-01	9.33e-01	0.1440	8.84e-04	1.63e-02	-5.02e-03	2.68e-02	1.40e-01	9.93e-01	8.71e-01	9.60e-01	7.90e-01	1.64e-01
GOBP VESICLE TRANSPORT ALONG MICROTUBULE	45	7.67e-01	9.23e-01	0.1440	1.87e-02	9.47e-02	6.52e-03	-4.97e-02	9.39e-02	8.29e-01	2.72e-01	9.40e-01	5.64e-01	2.76e-01
GOBP VASODILATION	46	4.79e-01	7.91e-01	0.1440	-5.42e-02	8.14e-02	-9.35e-02	4.84e-02	-9.39e-04	5.25e-01	3.40e-01	2.72e-01	5.70e-01	9.91e-01
GOMF PROLINE RICH REGION BINDING	17	9.45e-01	9.82e-01	0.1440	8.21e-03	1.13e-01	-7.56e-02	-7.49e-03	-4.41e-02	9.53e-01	4.18e-01	5.90e-01	9.57e-01	7.53e-01
GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT	51	4.11e-01	7.43e-01	0.1440	7.13e-02	-2.73e-02	1.11e-01	-4.85e-02	-1.54e-02	3.78e-01	7.36e-01	1.72e-01	5.49e-01	8.50e-01
GOBP ENDOCHONDRAL BONE MORPHOGENESIS	59	5.92e-01	8.47e-01	0.1440	-1.02e-01	5.90e-02	2.35e-02	-4.90e-02	6.11e-02	1.75e-01	4.33e-01	7.55e-01	5.15e-01	4.17e-01
GOBP CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT	85	3.26e-01	6.74e-01	0.1430	-2.59e-03	-1.24e-02	1.20e-01	-1.15e-02	7.65e-02	9.67e-01	8.44e-01	5.55e-02	8.55e-01	2.23e-01
GOMF ACTIN BINDING	415	4.56e-04	8.33e-03	0.1430	-2.42e-02	9.15e-02	4.77e-02	8.85e-02	-3.87e-02	3.97e-01	1.39e-03	9.55e-02	1.97e-03	1.76e-01
GOBP NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS	193	2.93e-02	1.80e-01	0.1430	-1.17e-01	3.29e-02	2.04e-02	-7.28e-02	1.15e-02	5.18e-03	4.31e-01	6.26e-01	8.10e-02	7.82e-01
GOBP LEUKOCYTE CELL CELL ADHESION	400	4.54e-04	8.30e-03	0.1430	-5.32e-02	1.07e-01	7.17e-02	-1.43e-03	3.49e-02	6.79e-02	2.52e-04	1.39e-02	9.61e-01	2.31e-01
GOBP POSITIVE REGULATION OF CYTOKINESIS	42	7.00e-01	8.96e-01	0.1430	-2.62e-02	-1.19e-01	3.94e-02	-3.58e-02	5.32e-02	7.69e-01	1.82e-01	6.58e-01	6.88e-01	5.51e-01
GOBP GENITALIA DEVELOPMENT	46	6.69e-01	8.83e-01	0.1430	-1.64e-02	-5.87e-02	-2.74e-02	1.24e-01	-2.82e-02	8.47e-01	4.91e-01	7.48e-01	1.47e-01	7.40e-01
GOBP NEGATIVE REGULATION OF PROGRAMMED CELL DEATH	880	6.06e-09	4.49e-07	0.1430	4.20e-03	5.85e-02	-1.72e-02	-1.20e-01	4.95e-02	8.33e-01	3.22e-03	3.87e-01	1.68e-09	1.26e-02
GOBP POSITIVE REGULATION OF EXOCYTOSIS	73	3.83e-01	7.21e-01	0.1430	-8.81e-02	9.76e-02	-4.49e-03	5.61e-02	-6.25e-03	1.93e-01	1.49e-01	9.47e-01	4.07e-01	9.26e-01
GOBP RESPONSE TO VITAMIN	82	4.24e-01	7.51e-01	0.1430	-5.07e-02	1.05e-01	2.94e-02	-6.46e-02	4.27e-02	4.28e-01	1.00e-01	6.45e-01	3.12e-01	5.04e-01
GOCC PRESYNAPTIC ACTIVE ZONE	74	5.04e-01	8.04e-01	0.1430	-2.35e-02	-4.50e-02	1.24e-01	5.04e-02	-8.79e-03	7.27e-01	5.04e-01	6.61e-02	4.54e-01	8.96e-01
GOMF P TYPE TRANSMEMBRANE TRANSPORTER ACTIVITY	21	9.42e-01	9.82e-01	0.1430	4.21e-02	-1.25e-01	-3.88e-02	-3.69e-02	1.26e-02	7.38e-01	3.21e-01	7.58e-01	7.69e-01	9.21e-01
GOBP VENTRICULAR SEPTUM DEVELOPMENT	74	3.59e-01	7.04e-01	0.1430	4.93e-02	8.10e-02	9.24e-02	-4.05e-02	-3.57e-02	4.64e-01	2.28e-01	1.69e-01	5.46e-01	5.96e-01
GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN CYCLIC AMIDINES	36	8.37e-01	9.46e-01	0.1430	1.16e-01	1.38e-02	1.10e-02	-4.98e-02	6.46e-02	2.28e-01	8.86e-01	9.09e-01	6.05e-01	5.02e-01
GOBP POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS	16	9.54e-01	9.86e-01	0.1430	-2.26e-02	8.39e-02	-1.08e-01	-3.36e-02	-1.16e-02	8.76e-01	5.61e-01	4.56e-01	8.16e-01	9.36e-01
GOBP POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION	27	8.82e-01	9.61e-01	0.1430	6.71e-02	-3.01e-02	2.11e-02	-9.13e-02	7.89e-02	5.46e-01	7.87e-01	8.50e-01	4.11e-01	4.78e-01
GOBP REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT	109	2.94e-01	6.48e-01	0.1430	-7.48e-02	-8.32e-02	6.70e-02	5.55e-02	1.80e-02	1.77e-01	1.34e-01	2.27e-01	3.17e-01	7.46e-01
GOBP REGULATION OF T CELL MIGRATION	46	7.78e-01	9.27e-01	0.1430	-9.07e-02	4.21e-02	2.31e-02	4.35e-02	-8.93e-02	2.87e-01	6.22e-01	7.86e-01	6.09e-01	2.95e-01
GOBP MEMBRANE RAFT ASSEMBLY	11	9.85e-01	9.95e-01	0.1430	6.40e-03	8.69e-02	3.01e-02	-9.27e-02	5.75e-02	9.71e-01	6.18e-01	8.63e-01	5.94e-01	7.41e-01
GOBP ADAPTIVE THERMOGENESIS	165	8.32e-02	3.48e-01	0.1430	-8.57e-03	9.51e-02	3.69e-02	-7.72e-02	6.29e-02	8.49e-01	3.51e-02	4.14e-01	8.70e-02	1.63e-01
GOBP GLUTAMATE METABOLIC PROCESS	32	8.63e-01	9.54e-01	0.1430	-7.00e-02	-4.06e-02	-1.29e-02	-8.94e-02	7.52e-02	4.93e-01	6.91e-01	8.99e-01	3.82e-01	4.61e-01
GOBP NEGATIVE REGULATION OF LIPID LOCALIZATION	66	5.45e-01	8.26e-01	0.1430	-5.22e-02	-4.05e-02	7.13e-02	1.56e-02	1.03e-01	4.64e-01	5.69e-01	3.17e-01	8.27e-01	1.46e-01
GOBP CARDIAC MUSCLE CELL PROLIFERATION	57	6.03e-01	8.54e-01	0.1430	-1.07e-01	2.74e-02	1.91e-02	-2.54e-02	8.50e-02	1.64e-01	7.21e-01	8.03e-01	7.40e-01	2.67e-01
GOBP NEGATIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT	96	4.54e-01	7.73e-01	0.1430	-1.19e-02	5.17e-02	1.22e-01	5.05e-02	1.38e-03	8.40e-01	3.81e-01	3.82e-02	3.92e-01	9.81e-01
GOBP REGULATION OF AMYLOID FIBRIL FORMATION	16	9.68e-01	9.91e-01	0.1430	4.04e-02	8.86e-02	-7.09e-02	-5.71e-02	-5.04e-02	7.80e-01	5.39e-01	6.23e-01	6.93e-01	7.27e-01
GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY	51	5.15e-01	8.10e-01	0.1420	-6.40e-02	4.18e-03	4.06e-02	-9.07e-02	-7.92e-02	4.29e-01	9.59e-01	6.16e-01	2.63e-01	3.28e-01
GOBP NEGATIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN	9	9.91e-01	9.96e-01	0.1420	-1.17e-01	-3.95e-02	5.33e-02	8.52e-03	-4.59e-02	5.44e-01	8.37e-01	7.82e-01	9.65e-01	8.12e-01
GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS	43	7.56e-01	9.18e-01	0.1420	6.11e-02	9.96e-02	-2.82e-02	-2.84e-02	-7.01e-02	4.88e-01	2.59e-01	7.49e-01	7.47e-01	4.26e-01
GOMF PHOSPHATIDYLINOSITOL BINDING	260	8.19e-03	7.61e-02	0.1420	-2.65e-02	1.22e-01	-1.58e-02	-4.19e-02	-5.12e-02	4.61e-01	7.19e-04	6.61e-01	2.45e-01	1.55e-01
GOCC POSTSYNAPTIC MEMBRANE	256	2.63e-02	1.67e-01	0.1420	-1.43e-02	-3.63e-02	1.11e-01	7.54e-02	2.66e-02	6.93e-01	3.18e-01	2.29e-03	3.78e-02	4.64e-01
GOCC GOLGI STACK	128	2.46e-01	6.04e-01	0.1420	-2.04e-02	6.03e-02	-5.69e-02	-1.13e-01	-8.30e-03	6.91e-01	2.39e-01	2.66e-01	2.70e-02	8.71e-01
GOMF PROTEIN MACROMOLECULE ADAPTOR ACTIVITY	400	7.34e-04	1.20e-02	0.1420	-2.51e-03	6.38e-02	-2.65e-02	-1.20e-01	3.24e-02	9.31e-01	2.86e-02	3.63e-01	4.02e-05	2.66e-01
GOBP THIOESTER METABOLIC PROCESS	88	4.15e-01	7.46e-01	0.1420	3.98e-02	1.02e-01	-5.18e-02	-5.15e-02	5.30e-02	5.19e-01	9.85e-02	4.01e-01	4.04e-01	3.90e-01
GOBP MESENCHYME DEVELOPMENT	310	6.03e-04	1.03e-02	0.1420	3.91e-02	4.80e-02	2.86e-02	-1.22e-01	2.35e-02	2.37e-01	1.46e-01	3.86e-01	2.19e-04	4.76e-01
GOBP REGULATION OF ORGANIC ACID TRANSPORT	75	6.17e-01	8.62e-01	0.1420	7.37e-04	8.53e-02	9.65e-02	5.92e-02	-6.49e-04	9.91e-01	2.02e-01	1.49e-01	3.75e-01	9.92e-01
GOBP TRIPARTITE REGIONAL SUBDIVISION	19	9.64e-01	9.90e-01	0.1420	5.74e-02	4.54e-02	9.77e-02	4.51e-02	5.60e-02	6.65e-01	7.32e-01	4.61e-01	7.34e-01	6.73e-01
GOBP CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS	22	9.35e-01	9.80e-01	0.1420	-3.79e-02	3.51e-02	3.81e-02	-5.09e-02	1.16e-01	7.58e-01	7.76e-01	7.57e-01	6.79e-01	3.48e-01
GOMF GAP JUNCTION CHANNEL ACTIVITY	22	9.58e-01	9.88e-01	0.1420	-7.48e-02	4.79e-02	6.25e-02	6.75e-02	-6.08e-02	5.44e-01	6.97e-01	6.12e-01	5.84e-01	6.21e-01
GOBP DIGESTIVE SYSTEM DEVELOPMENT	142	1.08e-01	4.00e-01	0.1420	6.39e-02	2.17e-02	2.08e-02	-1.08e-01	5.76e-02	1.88e-01	6.55e-01	6.68e-01	2.58e-02	2.36e-01
GOBP REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY	133	2.19e-01	5.73e-01	0.1420	-2.71e-02	1.04e-01	7.31e-02	3.54e-02	4.40e-02	5.89e-01	3.89e-02	1.45e-01	4.81e-01	3.81e-01
GOBP BODY MORPHOGENESIS	46	6.88e-01	8.90e-01	0.1420	7.12e-02	6.70e-02	3.10e-02	-9.64e-02	1.46e-02	4.03e-01	4.32e-01	7.16e-01	2.58e-01	8.64e-01
GOMF ENZYME INHIBITOR ACTIVITY	370	5.18e-03	5.48e-02	0.1410	-5.82e-02	1.95e-02	6.74e-02	1.00e-01	-4.04e-02	5.45e-02	5.19e-01	2.60e-02	9.12e-04	1.82e-01
GOBP CELLULAR LIPID CATABOLIC PROCESS	220	1.94e-02	1.38e-01	0.1410	1.43e-02	9.27e-02	-2.39e-02	-2.57e-02	1.00e-01	7.15e-01	1.78e-02	5.41e-01	5.12e-01	1.06e-02
GOBP AMINE TRANSPORT	106	3.34e-01	6.82e-01	0.1410	-2.29e-02	1.23e-01	5.70e-02	3.50e-02	1.35e-03	6.84e-01	2.93e-02	3.10e-01	5.33e-01	9.81e-01
GOBP NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION	72	3.81e-01	7.19e-01	0.1410	-7.58e-02	-6.89e-02	-7.03e-02	6.76e-02	2.84e-03	2.66e-01	3.12e-01	3.03e-01	3.21e-01	9.67e-01
GOBP MYELOID LEUKOCYTE DIFFERENTIATION	227	2.27e-02	1.53e-01	0.1410	-1.27e-02	1.22e-01	6.46e-02	-2.21e-02	-2.05e-02	7.43e-01	1.61e-03	9.37e-02	5.67e-01	5.95e-01
GOBP REGULATION OF CATION CHANNEL ACTIVITY	115	3.50e-01	6.96e-01	0.1410	3.43e-02	2.43e-02	1.13e-01	6.49e-02	3.55e-02	5.26e-01	6.53e-01	3.65e-02	2.29e-01	5.11e-01
GOCC EARLY ENDOSOME MEMBRANE	181	1.33e-02	1.07e-01	0.1410	-6.94e-02	3.41e-03	3.53e-02	-1.15e-01	-2.49e-02	1.07e-01	9.37e-01	4.12e-01	7.56e-03	5.63e-01
GOBP NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY	27	9.21e-01	9.74e-01	0.1410	-8.19e-02	-6.12e-02	6.47e-02	7.04e-02	1.88e-02	4.61e-01	5.82e-01	5.61e-01	5.26e-01	8.66e-01
GOBP PRESYNAPSE ORGANIZATION	44	7.39e-01	9.11e-01	0.1410	-1.94e-02	2.04e-02	1.31e-01	2.84e-04	4.34e-02	8.23e-01	8.15e-01	1.31e-01	9.97e-01	6.18e-01
GOCC EXOCYTIC VESICLE	222	1.95e-02	1.38e-01	0.1410	-1.06e-01	8.54e-02	-1.13e-02	-3.36e-02	-1.48e-02	6.62e-03	2.84e-02	7.71e-01	3.89e-01	7.03e-01
GOBP RHYTHMIC BEHAVIOR	44	7.45e-01	9.14e-01	0.1410	5.20e-02	9.93e-02	-7.23e-02	-2.70e-02	-3.75e-02	5.51e-01	2.54e-01	4.07e-01	7.56e-01	6.67e-01
GOMF DEUBIQUITINASE ACTIVITY	89	4.10e-01	7.42e-01	0.1410	8.82e-02	6.43e-02	-5.87e-02	-4.87e-02	-4.68e-02	1.50e-01	2.95e-01	3.39e-01	4.27e-01	4.45e-01
GOBP REGULATION OF MIRNA METABOLIC PROCESS	83	4.29e-01	7.54e-01	0.1410	-4.40e-02	7.26e-02	-2.48e-02	-1.04e-01	-3.50e-02	4.88e-01	2.53e-01	6.97e-01	1.01e-01	5.82e-01
GOBP REGULATION OF MONOATOMIC CATION TRANSMEMBRANE TRANSPORT	298	1.85e-02	1.34e-01	0.1410	-4.56e-02	3.77e-02	1.13e-01	5.98e-02	3.85e-03	1.75e-01	2.63e-01	7.85e-04	7.56e-02	9.09e-01
GOBP CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS	128	2.09e-01	5.60e-01	0.1410	2.86e-02	-2.03e-02	5.15e-02	5.99e-02	-1.11e-01	5.77e-01	6.92e-01	3.15e-01	2.42e-01	2.95e-02
GOBP REGULATION OF DEPHOSPHORYLATION	101	3.15e-01	6.65e-01	0.1410	-5.82e-02	1.22e-01	2.02e-02	-2.52e-02	-2.08e-02	3.12e-01	3.34e-02	7.25e-01	6.61e-01	7.18e-01
GOMF SPHINGOLIPID TRANSPORTER ACTIVITY	18	9.58e-01	9.88e-01	0.1410	-9.36e-02	-2.93e-02	-2.71e-02	6.76e-02	-7.02e-02	4.92e-01	8.30e-01	8.42e-01	6.19e-01	6.06e-01
GOBP NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS	566	1.40e-04	3.13e-03	0.1410	-2.19e-03	2.71e-02	-8.59e-02	-1.01e-01	3.84e-02	9.29e-01	2.71e-01	4.74e-04	3.86e-05	1.19e-01
GOBP PROTEIN K63 LINKED DEUBIQUITINATION	27	8.99e-01	9.67e-01	0.1410	8.81e-02	1.01e-01	1.08e-02	4.13e-02	-6.21e-03	4.28e-01	3.64e-01	9.22e-01	7.10e-01	9.55e-01
GOBP RESPONSE TO OSMOTIC STRESS	79	4.70e-01	7.85e-01	0.1410	-2.66e-02	1.11e-01	-3.71e-02	-6.08e-02	4.22e-02	6.83e-01	8.92e-02	5.69e-01	3.50e-01	5.16e-01
GOBP REGULATION OF SYNAPSE MATURATION	20	9.67e-01	9.90e-01	0.1410	-2.16e-02	4.46e-02	1.21e-01	5.21e-02	9.39e-03	8.67e-01	7.30e-01	3.50e-01	6.87e-01	9.42e-01
GOBP REGULATION OF FAT CELL PROLIFERATION	10	9.87e-01	9.95e-01	0.1410	7.34e-02	9.73e-03	2.51e-02	3.33e-02	-1.12e-01	6.88e-01	9.58e-01	8.91e-01	8.55e-01	5.39e-01
GOMF THIOLESTER HYDROLASE ACTIVITY	37	8.17e-01	9.41e-01	0.1410	-1.14e-01	6.69e-03	-4.89e-03	-5.87e-02	5.75e-02	2.31e-01	9.44e-01	9.59e-01	5.37e-01	5.45e-01
GOCC CILIARY BASAL BODY	158	1.63e-01	4.96e-01	0.1410	8.50e-02	-2.12e-02	-4.19e-02	-9.06e-02	4.65e-02	6.53e-02	6.46e-01	3.64e-01	4.95e-02	3.13e-01
GOBP MAMMARY GLAND EPITHELIUM DEVELOPMENT	64	3.22e-01	6.70e-01	0.1410	5.27e-02	-2.08e-02	3.01e-02	-1.19e-01	-3.89e-02	4.66e-01	7.73e-01	6.77e-01	9.99e-02	5.90e-01
GOBP REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT	166	1.86e-01	5.30e-01	0.1410	-1.03e-02	-4.68e-03	1.14e-01	8.09e-02	6.28e-03	8.19e-01	9.17e-01	1.11e-02	7.20e-02	8.89e-01
GOBP ORGANIC ACID CATABOLIC PROCESS	245	6.73e-03	6.61e-02	0.1410	5.11e-02	1.13e-01	-2.00e-02	1.56e-02	6.14e-02	1.68e-01	2.36e-03	5.90e-01	6.75e-01	9.79e-02
GOBP REGULATION OF LEUKOCYTE DIFFERENTIATION	314	3.23e-03	3.88e-02	0.1410	-2.50e-02	1.26e-01	4.07e-02	-3.97e-02	8.87e-03	4.46e-01	1.27e-04	2.15e-01	2.27e-01	7.87e-01
GOBP REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS	41	8.45e-01	9.49e-01	0.1400	8.91e-02	-2.34e-02	-9.61e-02	-4.45e-02	-5.48e-03	3.24e-01	7.96e-01	2.87e-01	6.22e-01	9.52e-01
GOMF L ASCORBIC ACID BINDING	20	9.25e-01	9.75e-01	0.1400	-1.41e-02	5.12e-02	1.42e-03	-8.46e-02	-9.87e-02	9.13e-01	6.92e-01	9.91e-01	5.13e-01	4.45e-01
GOBP GLYCOSIDE METABOLIC PROCESS	20	9.47e-01	9.83e-01	0.1400	9.88e-02	-3.98e-02	1.10e-02	6.65e-02	-6.19e-02	4.44e-01	7.58e-01	9.32e-01	6.07e-01	6.32e-01
GOBP REGULATED EXOCYTOSIS	214	4.11e-02	2.24e-01	0.1400	-6.47e-02	1.07e-01	5.91e-02	2.58e-03	-2.58e-02	1.03e-01	7.22e-03	1.36e-01	9.48e-01	5.16e-01
GOCC ER TO GOLGI TRANSPORT VESICLE MEMBRANE	59	7.32e-01	9.08e-01	0.1400	9.37e-03	2.72e-02	-9.88e-02	-8.85e-02	-3.58e-02	9.01e-01	7.18e-01	1.89e-01	2.40e-01	6.35e-01
GOBP CELLULAR RESPONSE TO SALT	191	5.96e-02	2.85e-01	0.1400	-3.72e-02	1.24e-01	4.76e-02	-1.46e-02	1.82e-02	3.75e-01	3.00e-03	2.57e-01	7.28e-01	6.65e-01
GOBP INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY	31	8.91e-01	9.63e-01	0.1400	9.11e-02	4.83e-02	3.86e-02	-2.15e-02	8.43e-02	3.80e-01	6.42e-01	7.10e-01	8.36e-01	4.17e-01
GOMF NAD BINDING	55	5.92e-01	8.47e-01	0.1400	-5.29e-02	1.19e-01	-4.18e-02	-2.06e-02	2.55e-02	4.97e-01	1.28e-01	5.92e-01	7.92e-01	7.44e-01
GOBP STEROID HORMONE MEDIATED SIGNALING PATHWAY	132	9.14e-02	3.66e-01	0.1400	-1.29e-02	3.43e-02	2.18e-02	-1.33e-01	9.24e-03	7.97e-01	4.96e-01	6.66e-01	8.16e-03	8.55e-01
GOBP NEGATIVE REGULATION OF AMYLOID FIBRIL FORMATION	12	9.85e-01	9.95e-01	0.1400	7.96e-02	8.21e-02	-5.00e-02	-6.08e-02	-1.97e-02	6.33e-01	6.22e-01	7.64e-01	7.15e-01	9.06e-01
GOBP DNA INTEGRATION	8	9.90e-01	9.96e-01	0.1400	8.96e-02	8.23e-03	-5.43e-02	4.22e-02	8.27e-02	6.61e-01	9.68e-01	7.90e-01	8.36e-01	6.85e-01
GOBP CELLULAR RESPONSE TO MECHANICAL STIMULUS	69	5.02e-01	8.03e-01	0.1400	-5.57e-02	2.92e-02	-5.95e-02	-4.21e-02	1.02e-01	4.24e-01	6.75e-01	3.93e-01	5.45e-01	1.43e-01
GOMF CYSTEINE TYPE PEPTIDASE ACTIVITY	157	1.92e-01	5.38e-01	0.1400	6.21e-02	3.45e-02	-9.40e-02	-7.04e-02	2.84e-02	1.79e-01	4.55e-01	4.20e-02	1.28e-01	5.39e-01
GOMF ADENYLATE KINASE ACTIVITY	9	9.89e-01	9.96e-01	0.1400	-1.73e-02	1.37e-02	-3.33e-02	-1.28e-02	1.34e-01	9.28e-01	9.43e-01	8.63e-01	9.47e-01	4.87e-01
GOCC ENDOCYTIC VESICLE	325	3.50e-03	4.12e-02	0.1400	-5.54e-02	9.75e-02	7.58e-02	-1.04e-03	-3.63e-02	8.63e-02	2.50e-03	1.88e-02	9.74e-01	2.60e-01
GOBP LEUKOCYTE DIFFERENTIATION	594	2.58e-06	1.01e-04	0.1400	-2.62e-02	1.14e-01	6.12e-02	-4.55e-02	1.49e-02	2.74e-01	2.23e-06	1.08e-02	5.79e-02	5.36e-01
GOBP RNA DESTABILIZATION	162	2.20e-02	1.50e-01	0.1400	-3.55e-02	-7.51e-02	2.91e-02	-1.09e-01	7.15e-03	4.36e-01	9.91e-02	5.23e-01	1.68e-02	8.75e-01
GOMF TRANSFORMING GROWTH FACTOR BETA RECEPTOR ACTIVITY	13	9.72e-01	9.92e-01	0.1400	-1.17e-01	-1.21e-02	5.96e-02	-4.47e-02	-1.09e-02	4.63e-01	9.40e-01	7.10e-01	7.80e-01	9.46e-01
GOBP SPECIFICATION OF SYMMETRY	136	1.34e-01	4.52e-01	0.1400	-3.33e-03	-2.74e-03	-5.96e-03	-1.35e-01	3.62e-02	9.47e-01	9.56e-01	9.05e-01	6.56e-03	4.67e-01
GOBP RESPONSE TO ISCHEMIA	62	6.13e-01	8.59e-01	0.1400	-7.81e-03	1.19e-01	3.14e-02	-6.44e-02	1.80e-02	9.15e-01	1.06e-01	6.69e-01	3.80e-01	8.06e-01
GOBP MODIFICATION OF SYNAPTIC STRUCTURE	27	9.00e-01	9.67e-01	0.1400	-3.76e-02	5.86e-03	8.00e-02	2.14e-02	-1.06e-01	7.35e-01	9.58e-01	4.72e-01	8.47e-01	3.40e-01
GOBP POSITIVE REGULATION OF AUTOPHAGY	142	1.75e-01	5.15e-01	0.1400	5.70e-02	2.79e-02	-3.72e-02	-1.19e-01	7.15e-04	2.41e-01	5.66e-01	4.44e-01	1.44e-02	9.88e-01
GOBP REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS	52	7.70e-01	9.24e-01	0.1400	8.30e-02	-5.64e-02	-7.27e-02	-4.01e-02	5.10e-02	3.01e-01	4.82e-01	3.64e-01	6.17e-01	5.25e-01
GOMF UBIQUITIN LIKE PROTEIN PEPTIDASE ACTIVITY	101	3.91e-01	7.26e-01	0.1400	8.13e-02	4.10e-02	-7.80e-02	-6.27e-02	-3.53e-02	1.58e-01	4.76e-01	1.75e-01	2.76e-01	5.40e-01
GOBP ORGANONITROGEN COMPOUND CATABOLIC PROCESS	1268	4.72e-12	4.93e-10	0.1400	-5.96e-03	4.42e-02	-4.49e-02	-1.25e-01	2.41e-03	7.21e-01	8.20e-03	7.13e-03	8.21e-14	8.85e-01
GOBP REGULATION OF ERBB SIGNALING PATHWAY	70	6.05e-01	8.55e-01	0.1400	5.25e-03	1.07e-01	8.56e-02	7.37e-03	2.57e-02	9.39e-01	1.21e-01	2.16e-01	9.15e-01	7.10e-01
GOBP NEGATIVE REGULATION OF DNA REPLICATION	24	9.31e-01	9.78e-01	0.1400	-3.87e-02	1.69e-02	-5.22e-02	-5.98e-02	1.07e-01	7.43e-01	8.86e-01	6.58e-01	6.12e-01	3.64e-01
GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT	25	9.23e-01	9.75e-01	0.1400	8.25e-02	-5.49e-02	-5.76e-02	-6.23e-02	-4.99e-02	4.75e-01	6.35e-01	6.18e-01	5.90e-01	6.66e-01
GOBP REGULATION OF CYTOKINESIS	86	3.68e-01	7.09e-01	0.1400	5.46e-03	-6.18e-03	6.32e-03	-1.28e-01	5.46e-02	9.30e-01	9.21e-01	9.19e-01	4.02e-02	3.81e-01
GOBP REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL	79	6.09e-01	8.58e-01	0.1390	1.32e-02	4.47e-02	8.84e-02	9.39e-02	2.56e-02	8.39e-01	4.92e-01	1.74e-01	1.49e-01	6.94e-01
GOBP INFLAMMATORY RESPONSE	844	5.42e-08	3.27e-06	0.1390	-5.19e-02	9.81e-02	6.87e-02	4.06e-02	2.77e-02	1.04e-02	1.30e-06	6.98e-04	4.52e-02	1.72e-01
GOBP SYNAPTIC VESICLE TRANSPORT	40	8.36e-01	9.46e-01	0.1390	-2.90e-02	2.23e-02	-7.39e-02	-7.06e-02	8.74e-02	7.51e-01	8.07e-01	4.19e-01	4.40e-01	3.39e-01
GOBP REGULATION OF PROTEIN POLYMERIZATION	194	4.61e-02	2.40e-01	0.1390	-2.42e-02	1.30e-01	-9.06e-03	-2.85e-02	-3.24e-02	5.62e-01	1.81e-03	8.28e-01	4.94e-01	4.37e-01
GOMF SYNTAXIN 1 BINDING	19	9.57e-01	9.87e-01	0.1390	5.95e-02	-2.58e-02	2.37e-02	1.19e-01	-2.03e-02	6.54e-01	8.46e-01	8.58e-01	3.68e-01	8.78e-01
GOBP POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE	47	6.97e-01	8.94e-01	0.1390	1.25e-01	-2.23e-02	-6.16e-03	-1.33e-02	-5.60e-02	1.39e-01	7.91e-01	9.42e-01	8.74e-01	5.07e-01
GOBP CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS	267	1.77e-02	1.31e-01	0.1390	-1.99e-02	6.87e-02	-3.24e-02	-1.12e-01	2.43e-02	5.75e-01	5.32e-02	3.63e-01	1.57e-03	4.94e-01
GOBP POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS	34	8.86e-01	9.62e-01	0.1390	-1.01e-01	5.04e-02	7.52e-02	2.97e-02	-1.07e-02	3.08e-01	6.11e-01	4.48e-01	7.64e-01	9.14e-01
GOCC CORTICAL ACTIN CYTOSKELETON	71	5.47e-01	8.27e-01	0.1390	3.38e-02	1.17e-01	1.90e-02	2.10e-02	-6.08e-02	6.22e-01	8.76e-02	7.82e-01	7.60e-01	3.76e-01
GOBP NEGATIVE REGULATION OF CELL MATRIX ADHESION	37	8.70e-01	9.57e-01	0.1390	6.20e-02	8.39e-02	7.66e-02	4.32e-02	2.74e-02	5.14e-01	3.77e-01	4.20e-01	6.50e-01	7.73e-01
GOMF N ACYLTRANSFERASE ACTIVITY	84	4.53e-01	7.72e-01	0.1390	1.08e-02	1.30e-01	1.41e-02	-4.51e-02	1.24e-04	8.64e-01	3.88e-02	8.23e-01	4.75e-01	9.98e-01
GOBP TEMPERATURE HOMEOSTASIS	181	6.87e-02	3.10e-01	0.1390	2.21e-02	9.84e-02	4.19e-02	-7.21e-02	4.67e-02	6.08e-01	2.24e-02	3.31e-01	9.44e-02	2.79e-01
GOCC SYNAPTIC VESICLE MEMBRANE	122	2.24e-01	5.77e-01	0.1390	-8.83e-02	1.04e-01	2.39e-02	-1.07e-02	-1.05e-02	9.22e-02	4.82e-02	6.48e-01	8.38e-01	8.41e-01
GOBP REGULATION OF AUTOPHAGOSOME ASSEMBLY	42	8.30e-01	9.44e-01	0.1390	-7.17e-02	-7.48e-04	-9.86e-02	-6.36e-02	-1.94e-02	4.22e-01	9.93e-01	2.69e-01	4.76e-01	8.27e-01
GOBP REGULATION OF MRNA CATABOLIC PROCESS	239	2.52e-03	3.22e-02	0.1390	-6.82e-02	-3.40e-02	4.27e-02	-1.07e-01	1.58e-02	6.95e-02	3.66e-01	2.56e-01	4.47e-03	6.74e-01
GOBP REGULATION OF NEURON PROJECTION ARBORIZATION	14	9.67e-01	9.90e-01	0.1390	4.89e-02	-1.18e-01	1.12e-02	-4.91e-03	-5.27e-02	7.51e-01	4.45e-01	9.42e-01	9.75e-01	7.33e-01
GOBP PROTEIN ACYLATION	134	1.47e-01	4.69e-01	0.1390	5.78e-02	6.23e-02	1.51e-02	-1.07e-01	2.05e-02	2.48e-01	2.13e-01	7.62e-01	3.30e-02	6.81e-01
GOBP SEQUESTERING OF CALCIUM ION	137	2.56e-01	6.13e-01	0.1390	-7.18e-03	9.51e-02	7.44e-02	6.67e-02	1.20e-02	8.85e-01	5.46e-02	1.33e-01	1.78e-01	8.08e-01
GOBP LIPOPROTEIN METABOLIC PROCESS	129	2.47e-01	6.04e-01	0.1390	-6.82e-02	-5.19e-02	-4.33e-02	-9.10e-02	4.17e-02	1.81e-01	3.09e-01	3.96e-01	7.44e-02	4.14e-01
GOMF HISTONE H3K9ME2 METHYLTRANSFERASE ACTIVITY	7	9.95e-01	9.98e-01	0.1390	5.27e-02	3.26e-02	2.40e-02	5.11e-02	1.10e-01	8.09e-01	8.81e-01	9.13e-01	8.15e-01	6.13e-01
GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS	46	8.55e-01	9.51e-01	0.1390	4.97e-02	1.24e-02	-8.18e-02	-8.88e-02	4.46e-02	5.60e-01	8.85e-01	3.37e-01	2.97e-01	6.00e-01
GOBP REGULATION OF CELL MORPHOGENESIS	232	8.09e-02	3.42e-01	0.1390	-2.77e-02	4.76e-02	7.98e-02	8.62e-02	-4.87e-02	4.67e-01	2.12e-01	3.63e-02	2.37e-02	2.01e-01
GOBP ACTIVATION OF IMMUNE RESPONSE	498	2.31e-05	7.00e-04	0.1390	-5.60e-02	9.39e-02	3.12e-02	5.35e-03	7.89e-02	3.24e-02	3.32e-04	2.33e-01	8.38e-01	2.56e-03
GOMF LAMIN BINDING	15	9.77e-01	9.93e-01	0.1390	-2.69e-02	1.20e-01	4.12e-02	1.59e-02	-4.49e-02	8.57e-01	4.19e-01	7.82e-01	9.15e-01	7.63e-01
GOBP NEGATIVE REGULATION OF ORGANELLE ASSEMBLY	42	8.20e-01	9.41e-01	0.1390	5.91e-02	-4.99e-02	5.00e-02	1.01e-01	2.23e-02	5.08e-01	5.76e-01	5.75e-01	2.57e-01	8.02e-01
GOBP REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY	45	7.61e-01	9.20e-01	0.1380	-2.67e-02	1.16e-01	7.58e-03	-6.04e-02	-3.63e-02	7.56e-01	1.78e-01	9.30e-01	4.84e-01	6.73e-01
GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY	151	7.72e-02	3.33e-01	0.1380	-4.57e-02	8.54e-02	5.90e-02	-7.82e-02	-1.24e-02	3.32e-01	7.02e-02	2.11e-01	9.71e-02	7.92e-01
GOBP REGULATION OF SYNAPSE ASSEMBLY	104	3.58e-01	7.03e-01	0.1380	-8.13e-03	5.44e-02	1.22e-01	2.51e-02	-2.41e-02	8.86e-01	3.37e-01	3.17e-02	6.59e-01	6.72e-01
GOCC GOLGI CISTERNA	97	4.20e-01	7.48e-01	0.1380	-5.01e-02	4.97e-02	-5.05e-02	-1.07e-01	-1.16e-02	3.93e-01	3.98e-01	3.90e-01	6.88e-02	8.43e-01
GOBP NEGATIVE REGULATION OF WNT SIGNALING PATHWAY	167	1.44e-01	4.64e-01	0.1380	-4.17e-03	5.65e-02	-2.65e-02	-1.12e-01	5.08e-02	9.26e-01	2.07e-01	5.55e-01	1.24e-02	2.57e-01
GOBP CELLULAR RESPONSE TO LIGHT STIMULUS	114	3.78e-01	7.17e-01	0.1380	1.73e-02	2.73e-02	-6.22e-02	-7.68e-02	9.08e-02	7.49e-01	6.15e-01	2.52e-01	1.56e-01	9.38e-02
GOBP CYTOPLASMIC MICROTUBULE ORGANIZATION	59	7.21e-01	9.02e-01	0.1380	6.54e-02	6.07e-02	-2.91e-02	-6.10e-02	8.07e-02	3.85e-01	4.20e-01	6.99e-01	4.18e-01	2.84e-01
GOBP REGULATION OF SMOOTH MUSCLE CONTRACTION	61	5.40e-01	8.23e-01	0.1380	-6.19e-02	-2.82e-02	-9.98e-03	-1.11e-01	-4.47e-02	4.03e-01	7.03e-01	8.93e-01	1.34e-01	5.46e-01
GOBP GLYCOLIPID BIOSYNTHETIC PROCESS	72	6.06e-01	8.56e-01	0.1380	-2.35e-02	3.66e-02	-5.36e-02	-1.18e-01	-1.70e-02	7.31e-01	5.91e-01	4.32e-01	8.31e-02	8.03e-01
GOBP POSITIVE REGULATION OF HEMOPOIESIS	181	7.41e-02	3.26e-01	0.1380	-6.71e-02	1.07e-01	4.43e-02	-3.31e-02	5.58e-03	1.19e-01	1.32e-02	3.04e-01	4.42e-01	8.97e-01
GOBP REGULATION OF MYELOID CELL APOPTOTIC PROCESS	31	8.94e-01	9.65e-01	0.1380	-5.21e-02	-2.06e-02	-5.15e-02	2.41e-02	-1.12e-01	6.16e-01	8.43e-01	6.20e-01	8.16e-01	2.79e-01
GOBP EMBRYO DEVELOPMENT	1091	1.32e-10	1.19e-08	0.1380	3.46e-02	4.81e-02	-5.51e-03	-1.13e-01	5.21e-02	5.34e-02	7.26e-03	7.58e-01	3.12e-10	3.66e-03
GOBP REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION	45	7.68e-01	9.24e-01	0.1380	-1.09e-01	-7.63e-03	6.38e-02	2.34e-03	5.35e-02	2.04e-01	9.29e-01	4.59e-01	9.78e-01	5.34e-01
GOMF METALLOPEPTIDASE ACTIVITY	179	1.43e-01	4.63e-01	0.1380	1.28e-02	-5.58e-02	6.49e-02	1.05e-01	-2.07e-02	7.67e-01	1.98e-01	1.34e-01	1.53e-02	6.33e-01
GOCC PLASMA MEMBRANE PROTEIN COMPLEX	563	3.24e-05	9.30e-04	0.1380	-7.89e-02	3.89e-02	1.04e-01	1.80e-02	-1.86e-03	1.38e-03	1.14e-01	2.34e-05	4.65e-01	9.40e-01
GOBP POSITIVE REGULATION OF PROGRAMMED CELL DEATH	546	4.97e-05	1.35e-03	0.1370	-2.05e-03	6.23e-02	-3.05e-02	-1.18e-01	1.48e-02	9.35e-01	1.27e-02	2.23e-01	2.52e-06	5.53e-01
GOBP REGULATION OF TRANSLATION INITIATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS	8	9.90e-01	9.96e-01	0.1370	3.63e-02	7.75e-02	7.06e-02	-4.35e-02	-6.83e-02	8.59e-01	7.04e-01	7.30e-01	8.31e-01	7.38e-01
GOMF DYNACTIN BINDING	12	9.60e-01	9.88e-01	0.1370	2.60e-02	5.70e-04	6.36e-02	-1.17e-01	1.80e-02	8.76e-01	9.97e-01	7.03e-01	4.81e-01	9.14e-01
GOCC CAVEOLA	81	5.73e-01	8.39e-01	0.1370	-1.71e-02	-3.10e-02	1.06e-01	6.80e-02	4.15e-02	7.91e-01	6.30e-01	9.93e-02	2.90e-01	5.18e-01
GOMF MANNOSYL OLIGOSACCHARIDE MANNOSIDASE ACTIVITY	9	9.84e-01	9.94e-01	0.1370	-3.90e-02	-1.84e-03	9.90e-02	-7.04e-02	5.01e-02	8.39e-01	9.92e-01	6.07e-01	7.14e-01	7.95e-01
GOBP RAB PROTEIN SIGNAL TRANSDUCTION	16	9.57e-01	9.87e-01	0.1370	-4.74e-02	6.62e-02	9.44e-02	-4.23e-02	-3.79e-02	7.42e-01	6.47e-01	5.13e-01	7.70e-01	7.93e-01
GOBP CEREBRAL CORTEX DEVELOPMENT	118	1.77e-01	5.18e-01	0.1370	5.11e-03	-4.98e-02	1.63e-02	-1.10e-01	6.19e-02	9.24e-01	3.50e-01	7.60e-01	3.86e-02	2.45e-01
GOBP ACTIN FILAMENT BASED PROCESS	771	3.83e-07	1.94e-05	0.1370	-4.12e-02	9.63e-02	3.33e-02	4.40e-02	-6.88e-02	5.18e-02	5.39e-06	1.16e-01	3.78e-02	1.15e-03
GOBP REGULATION OF EPITHELIAL CELL DIFFERENTIATION	169	5.02e-02	2.55e-01	0.1370	-1.02e-02	3.82e-02	6.46e-02	-9.33e-02	6.56e-02	8.19e-01	3.91e-01	1.48e-01	3.65e-02	1.41e-01
GOBP POSITIVE REGULATION OF AMIDE METABOLIC PROCESS	155	2.47e-01	6.04e-01	0.1370	-4.10e-03	-1.89e-03	-7.40e-02	-1.15e-01	8.95e-03	9.30e-01	9.68e-01	1.12e-01	1.37e-02	8.47e-01
GOBP NEUROMUSCULAR PROCESS CONTROLLING POSTURE	18	9.50e-01	9.84e-01	0.1370	-4.89e-02	-4.29e-03	9.00e-02	3.45e-03	-9.05e-02	7.19e-01	9.75e-01	5.09e-01	9.80e-01	5.06e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS	140	2.80e-01	6.33e-01	0.1370	7.33e-02	-3.32e-02	-5.70e-02	-8.69e-02	3.79e-02	1.35e-01	4.98e-01	2.44e-01	7.58e-02	4.39e-01
GOBP ENTRY INTO HOST	157	9.03e-02	3.63e-01	0.1370	-8.74e-02	5.58e-02	-5.85e-02	-4.40e-02	5.08e-02	5.86e-02	2.28e-01	2.06e-01	3.41e-01	2.72e-01
GOBP SECONDARY METABOLIC PROCESS	54	7.29e-01	9.06e-01	0.1370	3.65e-02	6.73e-02	5.77e-02	6.85e-02	6.93e-02	6.42e-01	3.92e-01	4.63e-01	3.84e-01	3.78e-01
GOBP REGULATION OF ALPHA BETA T CELL ACTIVATION	107	3.78e-01	7.17e-01	0.1370	-5.80e-03	1.08e-01	8.22e-02	4.93e-03	1.43e-02	9.17e-01	5.36e-02	1.42e-01	9.30e-01	7.99e-01
GOBP NEUROTRANSMITTER UPTAKE	44	7.75e-01	9.26e-01	0.1370	1.19e-01	4.81e-02	-3.73e-02	6.67e-03	-2.87e-02	1.73e-01	5.81e-01	6.69e-01	9.39e-01	7.42e-01
GOBP APICAL JUNCTION ASSEMBLY	73	4.93e-01	7.99e-01	0.1370	-1.11e-01	-6.07e-02	4.09e-02	-2.67e-02	1.43e-02	1.00e-01	3.70e-01	5.46e-01	6.93e-01	8.33e-01
GOBP REGULATION OF B CELL MEDIATED IMMUNITY	58	6.21e-01	8.64e-01	0.1370	4.44e-02	1.02e-01	2.67e-02	-6.26e-02	-4.10e-02	5.59e-01	1.79e-01	7.25e-01	4.10e-01	5.89e-01
GOBP INSULIN SECRETION	193	6.69e-02	3.05e-01	0.1370	7.99e-02	9.33e-02	5.07e-02	-2.21e-02	2.23e-02	5.56e-02	2.54e-02	2.24e-01	5.96e-01	5.93e-01
GOBP CIRCULATORY SYSTEM PROCESS	577	5.91e-05	1.56e-03	0.1370	-1.20e-02	7.62e-02	6.11e-02	9.46e-02	-5.45e-03	6.24e-01	1.76e-03	1.21e-02	1.03e-04	8.23e-01
GOBP FACE MORPHOGENESIS	30	8.55e-01	9.52e-01	0.1370	3.34e-02	7.40e-02	8.12e-03	-9.28e-02	-5.80e-02	7.51e-01	4.83e-01	9.39e-01	3.79e-01	5.83e-01
GOBP REGULATION OF CELL SUBSTRATE ADHESION	212	1.07e-01	3.97e-01	0.1370	-3.15e-02	7.30e-02	8.01e-02	6.93e-02	-3.31e-02	4.29e-01	6.71e-02	4.44e-02	8.18e-02	4.06e-01
GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSPORT	66	7.10e-01	8.99e-01	0.1360	-5.66e-02	6.87e-02	6.86e-02	6.30e-02	-4.52e-02	4.26e-01	3.35e-01	3.35e-01	3.76e-01	5.26e-01
GOBP ORGANIC ANION TRANSPORT	428	3.41e-03	4.03e-02	0.1360	-1.93e-02	6.43e-02	8.42e-02	8.11e-02	-2.12e-02	4.93e-01	2.25e-02	2.81e-03	4.01e-03	4.51e-01
GOBP RESPONSE TO OXYGEN LEVELS	321	7.25e-03	6.96e-02	0.1360	2.34e-02	1.03e-01	-3.09e-02	-7.27e-02	3.51e-02	4.71e-01	1.54e-03	3.40e-01	2.51e-02	2.80e-01
GOBP ARGININE CATABOLIC PROCESS	11	9.80e-01	9.93e-01	0.1360	-1.17e-01	4.24e-02	-5.47e-02	1.27e-02	-4.80e-03	5.03e-01	8.08e-01	7.54e-01	9.42e-01	9.78e-01
GOMF ACETYLCHOLINE RECEPTOR ACTIVITY	21	9.23e-01	9.75e-01	0.1360	9.30e-02	4.05e-02	-5.96e-02	5.91e-02	-3.49e-02	4.61e-01	7.48e-01	6.36e-01	6.39e-01	7.82e-01
GOBP RESPONSE TO HISTAMINE	11	9.92e-01	9.97e-01	0.1360	-4.69e-02	5.49e-02	1.01e-01	4.32e-02	-3.45e-02	7.88e-01	7.52e-01	5.61e-01	8.04e-01	8.43e-01
GOBP NEGATIVE REGULATION OF CELL GROWTH	177	7.10e-02	3.17e-01	0.1360	-8.49e-02	5.31e-02	1.15e-02	-8.99e-02	1.57e-02	5.13e-02	2.23e-01	7.92e-01	3.91e-02	7.19e-01
GOBP NEGATIVE REGULATION OF HIPPO SIGNALING	12	9.83e-01	9.94e-01	0.1360	-3.84e-02	-1.55e-02	7.39e-02	-2.68e-02	1.03e-01	8.18e-01	9.26e-01	6.57e-01	8.72e-01	5.37e-01
GOBP CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS	39	8.41e-01	9.48e-01	0.1360	-6.88e-02	5.61e-02	1.03e-01	1.07e-03	-3.55e-03	4.57e-01	5.44e-01	2.67e-01	9.91e-01	9.69e-01
GOBP REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY	286	7.53e-03	7.15e-02	0.1360	-3.10e-02	4.81e-02	1.95e-02	-1.03e-01	6.53e-02	3.67e-01	1.61e-01	5.71e-01	2.83e-03	5.74e-02
GOBP NEGATIVE REGULATION OF PHOSPHORYLATION	320	2.83e-03	3.51e-02	0.1360	-4.98e-02	8.40e-02	3.65e-02	-8.08e-02	3.23e-02	1.26e-01	9.78e-03	2.61e-01	1.30e-02	3.20e-01
GOBP STEROL HOMEOSTASIS	99	4.17e-01	7.46e-01	0.1360	-7.91e-02	-1.72e-03	4.59e-02	2.36e-02	-9.75e-02	1.74e-01	9.76e-01	4.30e-01	6.84e-01	9.38e-02
GOBP REGULATION OF CHROMATIN BINDING	11	9.80e-01	9.93e-01	0.1360	-4.62e-02	-1.14e-01	3.72e-02	-4.29e-02	9.45e-03	7.91e-01	5.13e-01	8.31e-01	8.05e-01	9.57e-01
GOBP SYNAPTIC SIGNALING	746	8.90e-07	4.05e-05	0.1360	-1.15e-02	8.31e-02	1.05e-01	1.36e-02	-1.49e-02	5.93e-01	1.11e-04	1.10e-06	5.28e-01	4.90e-01
GOBP CELLULAR RESPONSE TO PEPTIDE	364	1.83e-03	2.52e-02	0.1360	4.33e-04	1.14e-01	6.75e-02	-1.68e-02	-2.06e-02	9.89e-01	1.75e-04	2.69e-02	5.83e-01	5.00e-01
GOCC CELL SUBSTRATE JUNCTION	418	3.31e-04	6.41e-03	0.1360	-6.97e-02	1.02e-01	-2.61e-02	-4.84e-02	3.27e-03	1.45e-02	3.28e-04	3.60e-01	8.97e-02	9.09e-01
GOBP MECHANORECEPTOR DIFFERENTIATION	67	6.68e-01	8.82e-01	0.1360	-6.91e-02	6.23e-02	9.57e-02	2.09e-02	1.04e-02	3.28e-01	3.78e-01	1.75e-01	7.67e-01	8.83e-01
GOBP RESPONSE TO METAL ION	344	1.44e-03	2.08e-02	0.1360	-6.28e-02	9.13e-02	2.95e-02	-6.09e-02	-3.88e-02	4.53e-02	3.62e-03	3.48e-01	5.22e-02	2.16e-01
GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT	48	8.09e-01	9.37e-01	0.1350	-5.01e-02	7.34e-02	1.00e-01	2.07e-02	1.52e-03	5.48e-01	3.79e-01	2.30e-01	8.04e-01	9.85e-01
GOBP REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT	106	3.15e-01	6.65e-01	0.1350	2.82e-03	3.10e-02	6.49e-03	-1.21e-01	5.23e-02	9.60e-01	5.81e-01	9.08e-01	3.18e-02	3.52e-01
GOMF GLUTAMATE RECEPTOR BINDING	42	8.11e-01	9.38e-01	0.1350	-2.94e-02	-6.85e-02	-1.59e-03	-6.55e-02	9.19e-02	7.42e-01	4.43e-01	9.86e-01	4.63e-01	3.03e-01
GOBP PROSTANOID METABOLIC PROCESS	49	7.88e-01	9.30e-01	0.1350	-2.56e-02	-1.02e-01	-5.69e-02	-1.25e-02	-6.18e-02	7.57e-01	2.16e-01	4.91e-01	8.80e-01	4.55e-01
GOCC EXTRINSIC COMPONENT OF POSTSYNAPTIC MEMBRANE	7	9.95e-01	9.97e-01	0.1350	8.58e-02	-2.65e-02	5.92e-03	-9.49e-02	3.41e-02	6.94e-01	9.03e-01	9.78e-01	6.64e-01	8.76e-01
GOBP PROTEIN POLYMERIZATION	271	1.16e-02	9.74e-02	0.1350	-7.78e-03	1.11e-01	-4.16e-02	-4.15e-02	-4.92e-02	8.25e-01	1.66e-03	2.38e-01	2.40e-01	1.63e-01
GOBP REGULATION OF RESPIRATORY BURST	15	9.76e-01	9.93e-01	0.1350	-8.77e-02	5.87e-02	-6.80e-03	-6.75e-02	5.01e-02	5.56e-01	6.94e-01	9.64e-01	6.51e-01	7.37e-01
GOBP CYTOSOLIC TRANSPORT	174	1.83e-01	5.25e-01	0.1350	-2.63e-02	3.40e-02	-7.44e-02	-9.99e-02	2.95e-02	5.50e-01	4.40e-01	9.03e-02	2.30e-02	5.01e-01
GOCC CYTOPLASMIC SIDE OF PLASMA MEMBRANE	164	1.06e-01	3.96e-01	0.1350	-3.39e-03	1.10e-01	5.30e-02	-2.51e-02	-5.23e-02	9.40e-01	1.53e-02	2.42e-01	5.79e-01	2.48e-01
GOMF KINESIN BINDING	43	7.10e-01	8.99e-01	0.1350	7.09e-02	7.53e-03	5.59e-02	-8.69e-02	4.99e-02	4.21e-01	9.32e-01	5.26e-01	3.24e-01	5.72e-01
GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	57	5.02e-01	8.03e-01	0.1350	-6.39e-02	7.52e-02	-9.11e-03	8.15e-02	4.20e-02	4.04e-01	3.26e-01	9.05e-01	2.87e-01	5.83e-01
GOCC EXTRINSIC COMPONENT OF SYNAPTIC MEMBRANE	13	9.80e-01	9.93e-01	0.1350	1.01e-01	-3.83e-02	5.42e-02	-6.42e-03	5.89e-02	5.26e-01	8.11e-01	7.35e-01	9.68e-01	7.13e-01
GOMF PHOSPHATE ION BINDING	11	9.77e-01	9.93e-01	0.1350	-1.41e-02	3.92e-02	-1.16e-01	2.81e-02	-4.74e-02	9.36e-01	8.22e-01	5.05e-01	8.72e-01	7.86e-01
GOMF LIPID KINASE ACTIVITY	40	8.25e-01	9.43e-01	0.1350	-5.04e-02	3.78e-02	1.16e-02	-9.80e-02	6.70e-02	5.81e-01	6.79e-01	8.99e-01	2.83e-01	4.63e-01
GOBP EYE MORPHOGENESIS	159	5.52e-02	2.71e-01	0.1350	5.02e-02	9.68e-04	1.19e-01	-1.90e-02	3.40e-02	2.74e-01	9.83e-01	9.62e-03	6.80e-01	4.59e-01
GOBP REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY	177	8.90e-02	3.59e-01	0.1350	-5.56e-02	3.28e-02	1.14e-01	9.80e-03	-3.00e-02	2.02e-01	4.51e-01	8.81e-03	8.22e-01	4.91e-01
GOBP REGULATION OF MONOATOMIC ION TRANSPORT	544	5.70e-04	9.82e-03	0.1350	-5.75e-02	4.25e-02	8.58e-02	6.97e-02	-2.93e-02	2.18e-02	9.04e-02	6.20e-04	5.42e-03	2.43e-01
GOBP AMIDE TRANSPORT	344	5.60e-03	5.76e-02	0.1350	9.68e-03	1.18e-01	6.21e-02	1.84e-02	-5.22e-03	7.58e-01	1.74e-04	4.79e-02	5.57e-01	8.68e-01
GOBP POSITIVE REGULATION OF CELL ACTIVATION	376	1.92e-03	2.61e-02	0.1350	-4.18e-02	1.10e-01	5.34e-02	-1.23e-02	3.60e-02	1.64e-01	2.45e-04	7.57e-02	6.83e-01	2.31e-01
GOBP DICARBOXYLIC ACID METABOLIC PROCESS	92	4.48e-01	7.70e-01	0.1350	-4.48e-02	-5.24e-02	-9.93e-02	-3.46e-02	4.85e-02	4.58e-01	3.85e-01	9.98e-02	5.66e-01	4.21e-01
GOBP B CELL MEDIATED IMMUNITY	127	2.16e-01	5.70e-01	0.1350	-1.86e-02	1.31e-01	-6.68e-03	-1.29e-02	-1.94e-02	7.17e-01	1.07e-02	8.97e-01	8.01e-01	7.06e-01
GOBP NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS	120	3.62e-01	7.04e-01	0.1350	-6.26e-02	7.91e-02	7.29e-02	5.15e-02	3.75e-03	2.36e-01	1.34e-01	1.68e-01	3.30e-01	9.43e-01
GOBP CARDIAC SEPTUM DEVELOPMENT	108	2.64e-01	6.19e-01	0.1350	5.26e-02	8.81e-02	7.89e-02	-3.53e-02	-1.16e-02	3.45e-01	1.14e-01	1.57e-01	5.26e-01	8.36e-01
GOBP NEGATIVE REGULATION OF AMIDE METABOLIC PROCESS	327	9.63e-03	8.54e-02	0.1350	-6.11e-02	-4.55e-02	-6.04e-02	-9.28e-02	-7.92e-03	5.75e-02	1.58e-01	6.04e-02	3.90e-03	8.05e-01
GOBP MAINTENANCE OF BLOOD BRAIN BARRIER	36	8.77e-01	9.60e-01	0.1350	-3.55e-03	1.08e-01	7.81e-02	3.73e-03	-2.08e-02	9.71e-01	2.64e-01	4.18e-01	9.69e-01	8.29e-01
GOBP AMINOGLYCAN METABOLIC PROCESS	118	2.73e-01	6.27e-01	0.1350	-1.23e-02	1.19e-01	5.75e-03	1.22e-02	-6.04e-02	8.18e-01	2.57e-02	9.14e-01	8.19e-01	2.57e-01
GOBP INTERMEMBRANE LIPID TRANSFER	54	6.00e-01	8.52e-01	0.1350	-1.73e-02	6.52e-02	-1.16e-01	-1.37e-02	-1.14e-03	8.26e-01	4.07e-01	1.42e-01	8.61e-01	9.88e-01
GOMF LIPID TRANSFER ACTIVITY	54	6.00e-01	8.52e-01	0.1350	-1.73e-02	6.52e-02	-1.16e-01	-1.37e-02	-1.14e-03	8.26e-01	4.07e-01	1.42e-01	8.61e-01	9.88e-01
GOBP HOMOTYPIC CELL CELL ADHESION	93	4.34e-01	7.58e-01	0.1350	-5.33e-02	1.00e-01	2.13e-02	-2.59e-03	-6.92e-02	3.75e-01	9.52e-02	7.23e-01	9.66e-01	2.49e-01
GOBP PURINE NUCLEOSIDE METABOLIC PROCESS	25	9.28e-01	9.77e-01	0.1350	-6.60e-02	6.91e-02	2.35e-02	-3.19e-02	8.61e-02	5.68e-01	5.50e-01	8.39e-01	7.83e-01	4.56e-01
GOBP OVARIAN FOLLICLE DEVELOPMENT	54	7.28e-01	9.06e-01	0.1350	-7.40e-02	-9.56e-03	-1.33e-02	-7.96e-02	7.75e-02	3.47e-01	9.03e-01	8.66e-01	3.11e-01	3.24e-01
GOBP REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION	19	9.48e-01	9.83e-01	0.1350	-5.46e-02	5.34e-02	1.95e-02	-1.09e-01	2.42e-03	6.81e-01	6.87e-01	8.83e-01	4.11e-01	9.85e-01
GOBP NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION	128	1.74e-01	5.14e-01	0.1340	-3.33e-02	7.73e-02	1.09e-02	-7.54e-02	-7.21e-02	5.16e-01	1.31e-01	8.31e-01	1.41e-01	1.59e-01
GOBP REGULATION OF RESPONSE TO WOUNDING	166	1.45e-01	4.67e-01	0.1340	-6.77e-02	5.44e-02	4.61e-02	9.14e-02	-8.24e-03	1.32e-01	2.26e-01	3.06e-01	4.22e-02	8.55e-01
GOBP VIRAL PROCESS	412	4.75e-03	5.19e-02	0.1340	-1.72e-02	1.83e-02	-7.28e-02	-1.04e-01	3.47e-02	5.49e-01	5.24e-01	1.12e-02	2.73e-04	2.27e-01
GOBP POSITIVE REGULATION OF CELL CYCLE PROCESS	249	4.38e-02	2.32e-01	0.1340	9.51e-02	1.04e-02	-4.93e-02	-7.93e-02	1.29e-02	9.73e-03	7.77e-01	1.80e-01	3.11e-02	7.25e-01
GOMF COLLAGEN BINDING	68	7.35e-01	9.09e-01	0.1340	2.36e-03	2.92e-02	7.41e-02	8.88e-02	-6.18e-02	9.73e-01	6.77e-01	2.91e-01	2.05e-01	3.78e-01
GOCC TRANSPORT VESICLE MEMBRANE	223	3.69e-02	2.09e-01	0.1340	-8.33e-02	9.19e-02	1.11e-02	-2.57e-02	-4.33e-02	3.20e-02	1.81e-02	7.76e-01	5.09e-01	2.65e-01
GOMF NUCLEOSIDE MONOPHOSPHATE KINASE ACTIVITY	19	9.66e-01	9.90e-01	0.1340	6.15e-02	-1.85e-02	-3.05e-04	-8.33e-02	8.34e-02	6.42e-01	8.89e-01	9.98e-01	5.30e-01	5.29e-01
GOBP ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS	294	9.17e-03	8.24e-02	0.1340	-7.02e-02	1.06e-01	2.14e-02	-3.68e-03	-3.58e-02	3.84e-02	1.69e-03	5.29e-01	9.14e-01	2.92e-01
GOBP POLYOL BIOSYNTHETIC PROCESS	62	6.87e-01	8.90e-01	0.1340	5.14e-02	1.05e-01	4.87e-02	-1.99e-02	3.75e-02	4.84e-01	1.51e-01	5.07e-01	7.87e-01	6.09e-01
GOMF MONOATOMIC ION TRANSMEMBRANE TRANSPORTER ACTIVITY	684	2.04e-05	6.28e-04	0.1340	-5.22e-02	7.30e-02	8.02e-02	3.99e-02	-4.29e-02	1.99e-02	1.14e-03	3.48e-04	7.52e-02	5.55e-02
GOBP NEGATIVE REGULATION OF IMMUNE RESPONSE	197	6.19e-02	2.93e-01	0.1340	-6.35e-02	1.02e-01	3.49e-02	1.18e-03	4.77e-02	1.24e-01	1.36e-02	3.98e-01	9.77e-01	2.49e-01
GOBP ARTERY MORPHOGENESIS	81	3.81e-01	7.19e-01	0.1340	4.05e-02	4.22e-02	-6.90e-02	4.96e-03	9.86e-02	5.29e-01	5.12e-01	2.83e-01	9.39e-01	1.25e-01
GOBP MONONUCLEAR CELL DIFFERENTIATION	461	1.94e-04	4.07e-03	0.1340	-2.69e-02	1.08e-01	4.01e-02	-5.99e-02	1.57e-02	3.21e-01	6.82e-05	1.40e-01	2.76e-02	5.64e-01
GOMF LAMININ BINDING	28	8.34e-01	9.45e-01	0.1340	-8.86e-02	5.73e-02	-5.89e-02	5.43e-02	-1.78e-02	4.17e-01	6.00e-01	5.90e-01	6.19e-01	8.70e-01
GOBP POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS	16	9.57e-01	9.87e-01	0.1340	-4.20e-02	9.07e-02	-1.11e-02	2.09e-02	8.55e-02	7.71e-01	5.30e-01	9.39e-01	8.85e-01	5.54e-01
GOBP REGULATION OF ACTIN FILAMENT ORGANIZATION	257	1.97e-02	1.39e-01	0.1340	-3.60e-02	1.11e-01	7.76e-03	-6.18e-03	-6.41e-02	3.21e-01	2.16e-03	8.30e-01	8.65e-01	7.66e-02
GOCC KINESIN COMPLEX	46	7.72e-01	9.25e-01	0.1340	-5.26e-02	1.57e-02	-1.13e-01	-2.81e-02	-3.44e-02	5.37e-01	8.54e-01	1.84e-01	7.42e-01	6.86e-01
GOBP IMPORT INTO CELL	897	4.99e-08	3.06e-06	0.1330	-6.43e-02	1.00e-01	5.98e-02	6.25e-03	5.13e-03	1.10e-03	3.52e-07	2.37e-03	7.51e-01	7.94e-01
GOBP REGULATION OF CALCIUM ION TRANSPORT	240	8.86e-02	3.59e-01	0.1330	-1.47e-02	4.29e-02	8.36e-02	9.35e-02	2.39e-03	6.94e-01	2.52e-01	2.56e-02	1.26e-02	9.49e-01
GOBP HEPATICOBILIARY SYSTEM DEVELOPMENT	140	2.77e-01	6.31e-01	0.1330	5.33e-02	5.44e-02	-1.61e-02	-8.45e-02	6.79e-02	2.76e-01	2.67e-01	7.42e-01	8.44e-02	1.66e-01
GOMF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY	143	2.77e-01	6.31e-01	0.1330	-6.05e-02	6.35e-02	4.80e-02	6.40e-02	-6.07e-02	2.11e-01	1.90e-01	3.22e-01	1.86e-01	2.10e-01
GOBP RESPONSE TO STARVATION	208	9.05e-02	3.63e-01	0.1330	-1.85e-02	-4.57e-03	-5.28e-02	-1.21e-01	1.82e-03	6.46e-01	9.09e-01	1.89e-01	2.65e-03	9.64e-01
GOBP CEREBELLAR CORTEX MORPHOGENESIS	34	8.82e-01	9.61e-01	0.1330	-3.61e-02	-1.13e-01	-1.50e-02	5.62e-03	-5.90e-02	7.16e-01	2.55e-01	8.80e-01	9.55e-01	5.52e-01
GOCC DISTAL AXON	261	4.32e-02	2.31e-01	0.1330	-9.51e-03	5.99e-02	1.13e-01	3.64e-02	2.03e-03	7.91e-01	9.56e-02	1.69e-03	3.12e-01	9.55e-01
GOCC CORTICAL CYTOSKELETON	101	4.09e-01	7.42e-01	0.1330	3.19e-02	8.44e-02	3.65e-02	3.26e-02	-8.49e-02	5.80e-01	1.43e-01	5.26e-01	5.71e-01	1.40e-01
GOBP POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT	202	9.23e-02	3.67e-01	0.1330	-6.70e-02	3.52e-04	9.90e-02	3.72e-02	-4.53e-02	1.01e-01	9.93e-01	1.52e-02	3.62e-01	2.67e-01
GOBP REGULATION OF BLOOD PRESSURE	175	1.02e-01	3.87e-01	0.1330	7.66e-02	5.09e-02	3.29e-02	8.44e-02	3.26e-02	8.04e-02	2.45e-01	4.53e-01	5.42e-02	4.57e-01
GOBP GLYCOSPHINGOLIPID METABOLIC PROCESS	62	6.15e-01	8.60e-01	0.1330	-4.67e-02	7.53e-02	3.42e-02	-4.06e-02	-8.40e-02	5.25e-01	3.05e-01	6.42e-01	5.81e-01	2.53e-01
GOBP REGULATION OF ADAPTIVE IMMUNE RESPONSE	198	8.01e-02	3.41e-01	0.1330	-6.09e-02	9.45e-02	3.68e-02	2.05e-03	-6.11e-02	1.40e-01	2.18e-02	3.72e-01	9.60e-01	1.38e-01
GOBP REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS	51	7.20e-01	9.02e-01	0.1330	8.16e-03	-7.36e-03	4.78e-02	-7.04e-02	1.02e-01	9.20e-01	9.28e-01	5.54e-01	3.84e-01	2.09e-01
GOBP NEGATIVE REGULATION OF CELL ACTIVATION	214	3.24e-02	1.93e-01	0.1330	-4.84e-02	1.23e-01	-4.59e-03	1.03e-02	-1.21e-02	2.23e-01	1.95e-03	9.08e-01	7.96e-01	7.60e-01
GOBP CENTROSOME SEPARATION	15	9.68e-01	9.90e-01	0.1330	6.34e-02	-2.80e-02	-2.70e-02	-8.41e-02	-7.13e-02	6.71e-01	8.51e-01	8.56e-01	5.73e-01	6.32e-01
GOMF UBIQUITIN CONJUGATING ENZYME BINDING	31	9.02e-01	9.68e-01	0.1330	-3.24e-02	1.19e-01	3.80e-02	2.62e-02	1.69e-02	7.55e-01	2.50e-01	7.14e-01	8.01e-01	8.71e-01
GOMF SECONDARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY	274	3.61e-02	2.06e-01	0.1330	-1.24e-02	5.58e-02	8.20e-02	5.02e-02	-7.20e-02	7.24e-01	1.12e-01	1.94e-02	1.53e-01	4.03e-02
GOBP POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY	271	1.73e-02	1.29e-01	0.1330	8.36e-03	1.05e-01	7.98e-02	-1.33e-02	-9.92e-03	8.13e-01	2.98e-03	2.38e-02	7.06e-01	7.79e-01
GOBP REGULATION OF MUSCLE ADAPTATION	92	4.42e-01	7.64e-01	0.1330	-7.39e-02	7.78e-02	4.78e-02	3.00e-03	6.24e-02	2.21e-01	1.97e-01	4.28e-01	9.60e-01	3.01e-01
GOBP CELL MIGRATION INVOLVED IN HEART DEVELOPMENT	21	9.29e-01	9.77e-01	0.1330	-1.59e-02	7.23e-02	7.82e-02	-4.32e-02	-6.49e-02	8.99e-01	5.66e-01	5.35e-01	7.32e-01	6.07e-01
GOBP CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY	155	1.77e-01	5.18e-01	0.1330	-4.01e-02	-7.91e-02	-5.55e-02	3.74e-02	-7.30e-02	3.89e-01	8.94e-02	2.33e-01	4.21e-01	1.17e-01
GOBP CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT	24	9.37e-01	9.80e-01	0.1330	7.47e-02	-3.03e-02	-1.05e-02	-9.64e-02	4.17e-02	5.26e-01	7.97e-01	9.29e-01	4.14e-01	7.23e-01
GOBP SYNAPTIC VESICLE ENDOSOMAL PROCESSING	8	9.94e-01	9.97e-01	0.1330	-6.98e-02	8.00e-02	-5.74e-02	-5.50e-02	6.36e-03	7.32e-01	6.95e-01	7.78e-01	7.87e-01	9.75e-01
GOBP AMINO ACID BIOSYNTHETIC PROCESS	74	5.65e-01	8.35e-01	0.1330	-2.89e-02	4.38e-02	5.15e-04	-1.15e-01	4.15e-02	6.67e-01	5.15e-01	9.94e-01	8.80e-02	5.37e-01
GOBP RESPONSE TO TEMPERATURE STIMULUS	165	2.26e-01	5.79e-01	0.1330	4.44e-02	4.92e-02	-7.61e-02	-8.61e-02	1.95e-03	3.26e-01	2.75e-01	9.17e-02	5.63e-02	9.65e-01
GOBP CARBOHYDRATE CATABOLIC PROCESS	155	2.31e-01	5.85e-01	0.1330	-3.24e-02	8.81e-03	-4.27e-02	-1.11e-01	4.85e-02	4.87e-01	8.50e-01	3.59e-01	1.72e-02	2.97e-01
GOBP CELLULAR RESPONSE TO VITAMIN	28	9.28e-01	9.77e-01	0.1330	4.43e-02	3.98e-02	2.10e-02	7.72e-02	-8.75e-02	6.85e-01	7.15e-01	8.47e-01	4.80e-01	4.23e-01
GOBP REGULATION OF METAL ION TRANSPORT	380	1.00e-02	8.77e-02	0.1330	-4.15e-02	6.23e-02	8.97e-02	6.21e-02	-8.53e-03	1.65e-01	3.71e-02	2.67e-03	3.75e-02	7.75e-01
GOBP MOTILE CILIUM ASSEMBLY	64	7.53e-01	9.17e-01	0.1320	-3.34e-02	-1.11e-02	-1.02e-01	-7.51e-02	-1.36e-02	6.44e-01	8.78e-01	1.57e-01	2.99e-01	8.51e-01
GOBP CELLULAR RESPONSE TO EXTERNAL STIMULUS	329	1.06e-02	9.14e-02	0.1320	-2.16e-02	7.05e-02	-3.26e-02	-9.59e-02	4.25e-02	5.01e-01	2.80e-02	3.09e-01	2.78e-03	1.85e-01
GOBP POSITIVE REGULATION OF VASCULATURE DEVELOPMENT	182	9.34e-02	3.70e-01	0.1320	-6.25e-02	8.47e-02	6.84e-02	-3.33e-02	2.52e-02	1.46e-01	4.88e-02	1.12e-01	4.39e-01	5.58e-01
GOBP POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION	59	6.10e-01	8.58e-01	0.1320	1.08e-01	-1.40e-02	-4.43e-03	-2.95e-02	-6.85e-02	1.51e-01	8.52e-01	9.53e-01	6.95e-01	3.63e-01
GOBP AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM	25	9.30e-01	9.78e-01	0.1320	8.99e-02	-3.32e-02	-1.91e-02	7.28e-02	-5.12e-02	4.36e-01	7.74e-01	8.69e-01	5.29e-01	6.57e-01
GOBP ACTIN FILAMENT SEVERING	16	9.17e-01	9.73e-01	0.1320	7.95e-03	3.20e-02	-1.02e-01	6.48e-02	4.10e-02	9.56e-01	8.25e-01	4.78e-01	6.53e-01	7.77e-01
GOBP POSITIVE REGULATION OF CELL ADHESION	466	1.08e-03	1.64e-02	0.1320	-6.20e-02	8.26e-02	7.59e-02	2.94e-02	-1.25e-02	2.19e-02	2.25e-03	4.97e-03	2.77e-01	6.44e-01
GOCC PHOTORECEPTOR CONNECTING CILIUM	39	7.59e-01	9.19e-01	0.1320	-5.16e-02	-9.50e-02	5.53e-02	-2.31e-02	-4.65e-02	5.77e-01	3.05e-01	5.50e-01	8.03e-01	6.16e-01
GOBP NEURAL PRECURSOR CELL PROLIFERATION	163	1.03e-01	3.88e-01	0.1320	1.92e-02	-5.06e-04	2.68e-02	-1.03e-01	7.60e-02	6.72e-01	9.91e-01	5.55e-01	2.36e-02	9.42e-02
GOBP CELLULAR RESPONSE TO NITROGEN COMPOUND	658	9.06e-06	3.05e-04	0.1320	-1.74e-02	1.13e-01	6.54e-02	-9.87e-03	-1.92e-03	4.46e-01	7.92e-07	4.22e-03	6.66e-01	9.33e-01
GOBP NATURAL KILLER CELL MEDIATED IMMUNITY	77	5.25e-01	8.16e-01	0.1320	-4.02e-02	-7.12e-02	9.54e-02	2.69e-02	2.99e-02	5.42e-01	2.80e-01	1.48e-01	6.83e-01	6.51e-01
GOBP REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL	72	6.56e-01	8.80e-01	0.1320	7.49e-03	-5.77e-03	-2.23e-02	-1.09e-01	7.05e-02	9.12e-01	9.33e-01	7.44e-01	1.11e-01	3.01e-01
GOBP REGULATION OF COLLATERAL SPROUTING	20	9.73e-01	9.92e-01	0.1320	1.66e-02	8.84e-02	7.37e-02	4.90e-02	-3.80e-02	8.97e-01	4.94e-01	5.68e-01	7.04e-01	7.68e-01
GOBP HINDBRAIN MORPHOGENESIS	44	8.43e-01	9.49e-01	0.1320	-5.91e-02	-5.77e-02	-6.11e-02	-5.60e-02	-6.08e-02	4.98e-01	5.08e-01	4.83e-01	5.20e-01	4.85e-01
GOCC ENDOCYTIC VESICLE MEMBRANE	186	6.16e-02	2.92e-01	0.1320	-2.47e-02	6.37e-02	8.74e-02	-1.20e-02	-7.01e-02	5.61e-01	1.34e-01	3.98e-02	7.79e-01	9.94e-02
GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS	135	3.76e-01	7.15e-01	0.1320	2.86e-02	9.25e-03	-1.04e-01	-7.39e-02	8.80e-03	5.66e-01	8.53e-01	3.63e-02	1.38e-01	8.60e-01
GOBP GLUCAN METABOLIC PROCESS	73	5.80e-01	8.43e-01	0.1320	-5.14e-02	9.27e-02	9.92e-03	-7.71e-02	7.13e-03	4.48e-01	1.71e-01	8.83e-01	2.55e-01	9.16e-01
GOBP REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY	15	9.72e-01	9.92e-01	0.1320	-8.21e-02	9.09e-03	1.34e-02	-5.67e-02	-8.41e-02	5.82e-01	9.51e-01	9.29e-01	7.04e-01	5.73e-01
GOBP NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY	33	8.23e-01	9.42e-01	0.1320	-5.47e-02	-2.16e-02	1.47e-02	-1.17e-01	-6.86e-03	5.87e-01	8.30e-01	8.84e-01	2.47e-01	9.46e-01
GOBP NEGATIVE REGULATION OF T CELL PROLIFERATION	66	3.26e-01	6.74e-01	0.1320	-3.50e-02	2.73e-02	-8.68e-02	8.79e-02	-7.90e-03	6.23e-01	7.02e-01	2.22e-01	2.17e-01	9.12e-01
GOBP ENDODERM FORMATION	57	5.38e-01	8.22e-01	0.1310	-7.10e-02	-6.92e-03	6.76e-02	-5.93e-02	-6.41e-02	3.54e-01	9.28e-01	3.77e-01	4.38e-01	4.03e-01
GOBP REGULATION OF AMIDE METABOLIC PROCESS	568	3.10e-04	6.08e-03	0.1310	-3.32e-02	-5.49e-03	-6.46e-02	-1.09e-01	9.73e-03	1.76e-01	8.23e-01	8.54e-03	8.86e-06	6.92e-01
GOBP CALCIUM ION HOMEOSTASIS	319	1.73e-02	1.29e-01	0.1310	-6.83e-02	6.27e-02	8.82e-02	2.90e-02	-1.30e-03	3.59e-02	5.41e-02	6.76e-03	3.73e-01	9.68e-01
GOBP GLANDULAR EPITHELIAL CELL DEVELOPMENT	36	7.27e-01	9.05e-01	0.1310	6.63e-02	-3.93e-02	3.42e-02	-9.96e-02	-1.35e-02	4.91e-01	6.83e-01	7.22e-01	3.01e-01	8.88e-01
GOCC LATE ENDOSOME	296	6.64e-03	6.54e-02	0.1310	-1.88e-02	8.32e-02	9.37e-03	-9.79e-02	-1.53e-02	5.78e-01	1.38e-02	7.82e-01	3.76e-03	6.51e-01
GOMF MOLECULAR ADAPTOR ACTIVITY	547	1.76e-04	3.78e-03	0.1310	1.14e-03	6.32e-02	-2.22e-02	-1.07e-01	3.51e-02	9.64e-01	1.15e-02	3.75e-01	1.85e-05	1.60e-01
GOBP PROTEIN O LINKED GLYCOSYLATION	96	4.85e-01	7.94e-01	0.1310	7.75e-02	4.75e-02	7.74e-02	4.82e-02	-2.41e-02	1.89e-01	4.21e-01	1.90e-01	4.14e-01	6.83e-01
GOBP HEAD DEVELOPMENT	721	3.86e-07	1.94e-05	0.1310	-9.31e-03	4.11e-03	3.38e-02	-8.91e-02	8.94e-02	6.70e-01	8.51e-01	1.22e-01	4.63e-05	4.35e-05
GOCC PROTEIN LIPID COMPLEX	38	8.59e-01	9.53e-01	0.1310	-5.66e-02	1.07e-01	2.98e-02	-3.92e-02	-1.42e-03	5.46e-01	2.53e-01	7.51e-01	6.76e-01	9.88e-01
GOBP FIBROBLAST PROLIFERATION	104	4.28e-01	7.54e-01	0.1310	-1.15e-02	-1.97e-02	-1.00e-01	-4.58e-02	6.62e-02	8.39e-01	7.29e-01	7.66e-02	4.19e-01	2.43e-01
GOBP LEUKOCYTE PROLIFERATION	330	1.43e-02	1.13e-01	0.1310	-3.15e-02	6.93e-02	7.82e-02	5.27e-02	4.90e-02	3.25e-01	3.05e-02	1.46e-02	9.98e-02	1.26e-01
GOBP REGULATION OF PROTEIN TARGETING	77	6.06e-01	8.55e-01	0.1310	-1.90e-02	6.59e-02	-5.75e-02	-8.07e-02	-5.06e-02	7.73e-01	3.18e-01	3.83e-01	2.21e-01	4.43e-01
GOBP GLYCOPROTEIN CATABOLIC PROCESS	33	8.94e-01	9.65e-01	0.1310	4.34e-03	-5.06e-03	-5.48e-02	-6.44e-02	-9.94e-02	9.66e-01	9.60e-01	5.86e-01	5.22e-01	3.23e-01
GOBP RECEPTOR LOCALIZATION TO SYNAPSE	57	7.27e-01	9.05e-01	0.1310	4.70e-02	-1.84e-02	8.59e-02	5.63e-02	-6.30e-02	5.40e-01	8.10e-01	2.62e-01	4.62e-01	4.10e-01
GOBP POSITIVE REGULATION OF SECRETION	304	1.36e-02	1.09e-01	0.1310	1.68e-02	1.17e-01	4.28e-02	2.71e-02	2.35e-02	6.14e-01	4.54e-04	2.00e-01	4.17e-01	4.81e-01
GOMF PHOSPHOLIPID BINDING	456	5.24e-04	9.24e-03	0.1310	-5.99e-02	1.04e-01	2.28e-02	5.87e-03	-4.49e-02	2.83e-02	1.34e-04	4.04e-01	8.30e-01	1.01e-01
GOBP SENSORY PERCEPTION OF LIGHT STIMULUS	208	1.61e-01	4.93e-01	0.1310	-2.58e-02	-2.63e-02	6.97e-02	9.95e-02	-3.04e-02	5.21e-01	5.13e-01	8.30e-02	1.34e-02	4.51e-01
GOBP NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS	24	8.54e-01	9.51e-01	0.1310	4.31e-02	2.05e-02	6.13e-02	-9.97e-02	-3.24e-02	7.15e-01	8.62e-01	6.03e-01	3.98e-01	7.83e-01
GOBP CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE	77	6.12e-01	8.58e-01	0.1300	2.01e-02	-4.80e-02	1.40e-02	6.79e-02	-9.75e-02	7.60e-01	4.67e-01	8.31e-01	3.03e-01	1.39e-01
GOBP REGULATION OF LIPID BIOSYNTHETIC PROCESS	180	7.08e-02	3.17e-01	0.1300	-3.06e-02	7.32e-02	5.41e-03	5.49e-03	1.03e-01	4.78e-01	9.01e-02	9.00e-01	8.99e-01	1.69e-02
GOBP PROTEIN LOCALIZATION TO SYNAPSE	73	3.85e-01	7.23e-01	0.1300	6.54e-02	-4.37e-02	9.36e-02	-3.19e-03	-4.52e-02	3.34e-01	5.19e-01	1.67e-01	9.62e-01	5.04e-01
GOBP NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS	46	7.94e-01	9.31e-01	0.1300	1.69e-02	-5.03e-02	-2.63e-02	-1.15e-01	1.84e-02	8.43e-01	5.55e-01	7.58e-01	1.79e-01	8.29e-01
GOMF SYNTAXIN BINDING	65	7.05e-01	8.97e-01	0.1300	-7.43e-02	3.07e-02	-5.16e-02	-8.74e-02	1.42e-02	3.00e-01	6.69e-01	4.72e-01	2.23e-01	8.43e-01
GOBP REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS	219	9.63e-02	3.76e-01	0.1300	-7.18e-03	3.33e-02	-3.93e-02	-1.15e-01	3.35e-02	8.55e-01	3.96e-01	3.16e-01	3.46e-03	3.94e-01
GOBP REGULATION OF LIPID TRANSPORT	153	2.00e-01	5.49e-01	0.1300	-8.75e-03	9.46e-02	8.22e-02	2.22e-03	-3.41e-02	8.52e-01	4.34e-02	7.91e-02	9.62e-01	4.67e-01
GOBP TYROSINE PHOSPHORYLATION OF STAT PROTEIN	79	5.03e-01	8.04e-01	0.1300	-2.07e-02	7.12e-02	9.12e-02	-4.37e-02	3.52e-02	7.51e-01	2.74e-01	1.61e-01	5.02e-01	5.89e-01
GOBP INTERLEUKIN 1 PRODUCTION	123	2.49e-01	6.06e-01	0.1300	-8.54e-02	8.66e-02	2.25e-02	2.58e-02	3.13e-02	1.02e-01	9.70e-02	6.66e-01	6.21e-01	5.49e-01
GOBP JNK CASCADE	154	2.87e-01	6.41e-01	0.1300	2.91e-03	7.27e-02	9.40e-02	4.74e-02	2.35e-02	9.50e-01	1.20e-01	4.40e-02	3.10e-01	6.14e-01
GOBP EPITHELIAL CELL APOPTOTIC PROCESS	143	2.68e-01	6.23e-01	0.1300	2.27e-02	-7.30e-02	-2.83e-02	-5.45e-02	8.54e-02	6.39e-01	1.32e-01	5.59e-01	2.60e-01	7.78e-02
GOBP TISSUE REMODELING	179	1.66e-01	5.01e-01	0.1300	-5.57e-02	4.79e-02	1.03e-01	2.36e-02	1.77e-02	1.99e-01	2.69e-01	1.72e-02	5.85e-01	6.82e-01
GOBP POSTSYNAPSE ORGANIZATION	177	1.37e-01	4.57e-01	0.1300	-3.17e-02	4.56e-02	1.13e-01	1.90e-02	-2.64e-02	4.66e-01	2.95e-01	9.53e-03	6.62e-01	5.44e-01
GOBP CELLULAR RESPONSE TO CHEMICAL STRESS	306	1.33e-02	1.07e-01	0.1300	-2.91e-02	8.66e-02	-2.00e-02	-8.99e-02	8.51e-03	3.82e-01	9.19e-03	5.48e-01	6.80e-03	7.98e-01
GOMF CARBON CARBON LYASE ACTIVITY	51	7.38e-01	9.10e-01	0.1300	4.53e-02	8.46e-03	-7.30e-02	3.16e-02	-9.20e-02	5.76e-01	9.17e-01	3.67e-01	6.97e-01	2.56e-01
GOMF ACYLTRANSFERASE ACTIVITY	666	5.63e-06	2.01e-04	0.1300	3.74e-02	7.43e-02	-2.34e-02	-9.32e-02	-2.71e-02	9.98e-02	1.08e-03	3.04e-01	4.05e-05	2.34e-01
GOBP MODULATION BY HOST OF SYMBIONT PROCESS	81	6.05e-01	8.55e-01	0.1300	8.02e-02	-6.14e-02	-3.44e-02	-5.29e-02	5.18e-02	2.12e-01	3.39e-01	5.92e-01	4.10e-01	4.20e-01
GOBP HEART GROWTH	94	4.57e-01	7.75e-01	0.1300	-9.83e-02	5.77e-03	7.51e-02	1.29e-03	3.91e-02	9.95e-02	9.23e-01	2.08e-01	9.83e-01	5.13e-01
GOBP CORTICAL CYTOSKELETON ORGANIZATION	50	7.79e-01	9.28e-01	0.1300	-8.99e-02	7.17e-02	-9.87e-04	-6.47e-03	-6.00e-02	2.71e-01	3.80e-01	9.90e-01	9.37e-01	4.63e-01
GOCC CILIARY TRANSITION ZONE	71	5.48e-01	8.27e-01	0.1300	-2.90e-02	-9.81e-02	-6.81e-03	-7.86e-02	1.35e-02	6.72e-01	1.53e-01	9.21e-01	2.52e-01	8.44e-01
GOBP NEGATIVE REGULATION OF AUTOPHAGY	86	5.48e-01	8.27e-01	0.1300	-2.12e-02	4.97e-02	4.44e-03	-7.19e-02	9.35e-02	7.34e-01	4.26e-01	9.43e-01	2.49e-01	1.34e-01
GOBP POSITIVE REGULATION OF CELL CELL ADHESION	310	1.61e-02	1.22e-01	0.1300	-4.60e-02	9.17e-02	7.07e-02	9.06e-03	3.50e-02	1.64e-01	5.48e-03	3.23e-02	7.84e-01	2.90e-01
GOBP POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS	15	9.80e-01	9.93e-01	0.1300	4.18e-02	3.00e-02	-1.25e-02	6.29e-02	-1.00e-01	7.79e-01	8.40e-01	9.33e-01	6.73e-01	5.01e-01
GOBP RESPONSE TO PEPTIDE HORMONE	412	1.04e-03	1.60e-02	0.1300	-1.92e-02	1.04e-01	6.65e-02	-3.48e-02	-4.53e-05	5.03e-01	2.96e-04	2.05e-02	2.26e-01	9.99e-01
GOBP REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY	276	8.95e-03	8.11e-02	0.1300	-9.88e-03	4.62e-02	2.30e-02	-1.14e-01	3.30e-02	7.78e-01	1.86e-01	5.10e-01	1.14e-03	3.46e-01
GOBP INORGANIC ION HOMEOSTASIS	514	2.50e-04	5.06e-03	0.1300	-5.58e-02	8.48e-02	8.00e-02	-4.87e-03	-8.36e-03	3.05e-02	9.99e-04	1.92e-03	8.50e-01	7.46e-01
GOBP PROTEIN LOCALIZATION TO POSTSYNAPSE	40	6.50e-01	8.77e-01	0.1300	4.49e-02	-2.79e-02	9.56e-02	-3.80e-02	-5.84e-02	6.23e-01	7.60e-01	2.95e-01	6.78e-01	5.23e-01
GOBP LYMPHOCYTE MEDIATED IMMUNITY	278	2.45e-02	1.60e-01	0.1290	-7.75e-02	7.68e-02	6.86e-02	-2.21e-03	-1.19e-02	2.62e-02	2.76e-02	4.89e-02	9.49e-01	7.33e-01
GOBP REGULATION OF CELLULAR RESPONSE TO STRESS	626	7.72e-05	1.93e-03	0.1290	8.67e-03	2.65e-02	-3.06e-02	-1.15e-01	4.30e-02	7.11e-01	2.58e-01	1.91e-01	9.25e-07	6.65e-02
GOBP NAD METABOLIC PROCESS	42	8.49e-01	9.49e-01	0.1290	-5.90e-02	1.53e-02	-1.40e-02	-6.92e-02	8.96e-02	5.08e-01	8.64e-01	8.75e-01	4.38e-01	3.15e-01
GOMF SIGNALING RECEPTOR BINDING	1396	2.04e-10	1.80e-08	0.1290	-6.46e-02	6.59e-02	8.03e-02	3.69e-02	-1.89e-02	5.16e-05	3.71e-05	4.85e-07	2.07e-02	2.37e-01
GOBP AMINOPHOSPHOLIPID TRANSPORT	8	9.90e-01	9.96e-01	0.1290	-3.99e-02	8.17e-02	-8.50e-02	1.71e-04	3.44e-02	8.45e-01	6.89e-01	6.77e-01	9.99e-01	8.66e-01
GOBP MULTICELLULAR ORGANISM GROWTH	143	2.29e-01	5.82e-01	0.1290	3.31e-02	6.14e-02	-7.08e-03	-1.07e-01	1.98e-02	4.94e-01	2.05e-01	8.84e-01	2.77e-02	6.83e-01
GOBP LEUKOCYTE APOPTOTIC PROCESS	118	3.10e-01	6.62e-01	0.1290	-4.83e-02	9.88e-02	9.19e-03	-5.44e-02	-3.92e-02	3.65e-01	6.38e-02	8.63e-01	3.07e-01	4.62e-01
GOCC PLASMA MEMBRANE REGION	1248	2.12e-08	1.40e-06	0.1290	-3.26e-02	5.11e-02	8.43e-02	6.60e-02	-3.91e-02	5.30e-02	2.38e-03	5.38e-07	8.87e-05	2.00e-02
GOMF PROTEIN KINASE C BINDING	50	7.64e-01	9.22e-01	0.1290	9.56e-02	3.23e-02	-4.07e-02	7.70e-03	-6.90e-02	2.42e-01	6.93e-01	6.18e-01	9.25e-01	3.98e-01
GOBP RESPONSE TO CAMP	81	4.55e-01	7.74e-01	0.1290	-4.73e-02	2.31e-02	1.10e-01	-9.91e-03	-4.06e-02	4.62e-01	7.19e-01	8.66e-02	8.77e-01	5.27e-01
GOBP RESPONSE TO VITAMIN D	36	9.32e-01	9.79e-01	0.1290	-3.71e-02	2.55e-02	8.96e-02	8.11e-02	3.05e-03	7.00e-01	7.91e-01	3.52e-01	4.00e-01	9.75e-01
GOBP ORGANELLE ASSEMBLY	957	2.65e-06	1.03e-04	0.1290	1.74e-02	2.93e-03	-7.39e-02	-1.02e-01	2.01e-02	3.63e-01	8.78e-01	1.08e-04	8.34e-08	2.93e-01
GOBP REGULATION OF VESICLE MEDIATED TRANSPORT	503	1.37e-04	3.08e-03	0.1290	-9.72e-02	6.37e-02	2.34e-02	-4.39e-02	-2.54e-02	1.90e-04	1.45e-02	3.70e-01	9.15e-02	3.29e-01
GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION	73	7.41e-01	9.12e-01	0.1290	-5.19e-02	-2.14e-03	9.25e-02	7.15e-02	-1.61e-02	4.44e-01	9.75e-01	1.72e-01	2.91e-01	8.13e-01
GOCC ENDOSOME MEMBRANE	524	8.10e-05	2.00e-03	0.1290	-3.33e-02	4.96e-02	-2.15e-02	-1.05e-01	-3.79e-02	1.93e-01	5.19e-02	3.99e-01	3.63e-05	1.37e-01
GOBP CEREBELLAR CORTEX DEVELOPMENT	49	8.29e-01	9.44e-01	0.1290	-7.10e-02	-4.60e-02	-5.52e-02	-7.90e-02	-9.85e-03	3.90e-01	5.78e-01	5.03e-01	3.39e-01	9.05e-01
GOBP REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY	402	1.97e-03	2.66e-02	0.1290	-2.40e-02	1.00e-01	-4.63e-02	-6.09e-02	-1.04e-02	4.09e-01	5.72e-04	1.11e-01	3.62e-02	7.19e-01
GOCC SARCOPLASMIC RETICULUM	72	5.73e-01	8.39e-01	0.1290	2.25e-02	7.58e-02	-8.02e-03	7.61e-02	-6.66e-02	7.41e-01	2.66e-01	9.06e-01	2.64e-01	3.28e-01
GOBP ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS	558	1.52e-04	3.34e-03	0.1290	-2.76e-02	1.34e-02	-3.63e-02	-1.19e-01	8.67e-03	2.66e-01	5.89e-01	1.43e-01	1.45e-06	7.26e-01
GOBP DENDRITE DEVELOPMENT	218	1.33e-01	4.50e-01	0.1290	-3.93e-02	7.10e-03	9.61e-02	5.98e-02	-4.62e-02	3.17e-01	8.57e-01	1.45e-02	1.28e-01	2.39e-01
GOBP QUINONE METABOLIC PROCESS	39	8.87e-01	9.62e-01	0.1290	8.23e-02	-4.50e-03	-9.30e-02	-3.06e-02	-1.27e-02	3.74e-01	9.61e-01	3.15e-01	7.41e-01	8.91e-01
GOMF MANGANESE ION BINDING	63	6.90e-01	8.92e-01	0.1290	-4.67e-02	3.51e-02	1.56e-02	-8.06e-02	7.99e-02	5.22e-01	6.30e-01	8.30e-01	2.69e-01	2.73e-01
GOCC CYTOPLASMIC SIDE OF MEMBRANE	200	7.57e-02	3.30e-01	0.1290	2.75e-03	1.02e-01	-1.62e-03	-6.73e-02	-3.89e-02	9.47e-01	1.26e-02	9.68e-01	1.01e-01	3.43e-01
GOBP SENSORY ORGAN MORPHOGENESIS	271	6.20e-03	6.25e-02	0.1290	5.49e-02	-4.74e-03	8.20e-02	-4.92e-02	6.58e-02	1.20e-01	8.93e-01	2.01e-02	1.63e-01	6.23e-02
GOCC TRANSPORT VESICLE	408	1.51e-03	2.16e-02	0.1280	-6.66e-02	6.75e-02	-2.76e-02	-6.03e-02	-5.58e-02	2.09e-02	1.93e-02	3.38e-01	3.66e-02	5.31e-02
GOBP MICROTUBULE BUNDLE FORMATION	121	3.38e-01	6.85e-01	0.1280	-2.90e-02	5.17e-02	-8.99e-02	-6.09e-02	3.46e-02	5.82e-01	3.26e-01	8.76e-02	2.48e-01	5.11e-01
GOBP POSITIVE REGULATION OF CANONICAL NF KAPPAB SIGNAL TRANSDUCTION	183	1.30e-01	4.46e-01	0.1280	-1.01e-02	1.09e-01	-1.88e-02	-6.29e-02	1.40e-02	8.13e-01	1.11e-02	6.61e-01	1.42e-01	7.43e-01
GOBP ADAPTIVE IMMUNE RESPONSE	443	4.54e-03	5.03e-02	0.1280	-4.37e-02	7.20e-02	8.13e-02	5.16e-02	-9.11e-03	1.15e-01	9.37e-03	3.35e-03	6.24e-02	7.42e-01
GOBP ENDOSOMAL TRANSPORT	239	8.87e-02	3.59e-01	0.1280	3.56e-03	5.94e-02	-6.83e-02	-9.03e-02	9.22e-03	9.25e-01	1.14e-01	6.90e-02	1.62e-02	8.06e-01
GOBP REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS	135	2.34e-01	5.89e-01	0.1280	-5.33e-02	6.94e-02	2.29e-02	-8.49e-02	3.22e-02	2.85e-01	1.64e-01	6.46e-01	8.87e-02	5.18e-01
GOBP APICAL PROTEIN LOCALIZATION	14	9.82e-01	9.93e-01	0.1280	3.52e-04	-1.05e-01	-5.03e-02	5.19e-02	1.35e-02	9.98e-01	4.97e-01	7.45e-01	7.37e-01	9.30e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE	39	6.37e-01	8.73e-01	0.1280	4.32e-04	-5.83e-02	7.36e-02	-7.73e-02	-4.01e-02	9.96e-01	5.29e-01	4.27e-01	4.04e-01	6.65e-01
GOBP REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION	276	2.77e-02	1.75e-01	0.1280	-9.09e-04	6.19e-02	1.45e-02	3.81e-02	-1.04e-01	9.79e-01	7.67e-02	6.78e-01	2.77e-01	2.85e-03
GOBP T CELL ACTIVATION	537	1.82e-04	3.87e-03	0.1280	-3.55e-02	9.82e-02	6.06e-02	-2.32e-02	3.52e-02	1.59e-01	9.92e-05	1.64e-02	3.58e-01	1.63e-01
GOBP CERAMIDE METABOLIC PROCESS	106	4.05e-01	7.38e-01	0.1280	2.58e-02	8.44e-02	-3.26e-02	-6.68e-02	-5.52e-02	6.47e-01	1.33e-01	5.62e-01	2.35e-01	3.26e-01
GOBP SULFUR COMPOUND METABOLIC PROCESS	292	2.15e-02	1.48e-01	0.1280	2.12e-02	1.10e-01	-6.39e-04	-4.79e-02	3.90e-02	5.34e-01	1.23e-03	9.85e-01	1.59e-01	2.52e-01
GOBP NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT	58	6.91e-01	8.92e-01	0.1280	-1.35e-02	3.01e-02	6.13e-03	-2.17e-02	-1.21e-01	8.59e-01	6.91e-01	9.36e-01	7.75e-01	1.10e-01
GOBP ACTOMYOSIN STRUCTURE ORGANIZATION	205	7.09e-02	3.17e-01	0.1280	-5.81e-03	6.54e-02	-5.67e-03	7.30e-02	-8.15e-02	8.86e-01	1.06e-01	8.89e-01	7.17e-02	4.42e-02
GOMF FLIPPASE ACTIVITY	15	9.82e-01	9.94e-01	0.1280	-3.07e-03	4.98e-03	-2.89e-02	5.76e-02	-1.10e-01	9.84e-01	9.73e-01	8.46e-01	6.99e-01	4.61e-01
GOBP NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT	139	4.16e-01	7.46e-01	0.1280	-2.04e-02	-6.34e-03	6.54e-02	9.66e-02	-4.72e-02	6.79e-01	8.97e-01	1.83e-01	4.94e-02	3.36e-01
GOMF SNARE BINDING	104	4.10e-01	7.42e-01	0.1280	-5.44e-02	1.01e-01	-1.55e-02	-5.09e-02	1.64e-02	3.37e-01	7.49e-02	7.85e-01	3.70e-01	7.73e-01
GOMF PROTEIN DOMAIN SPECIFIC BINDING	618	3.04e-05	8.84e-04	0.1280	6.98e-03	7.92e-02	9.62e-03	-9.24e-02	3.61e-02	7.67e-01	7.69e-04	6.83e-01	8.69e-05	1.26e-01
GOCC AXON CYTOPLASM	60	7.97e-01	9.32e-01	0.1280	2.09e-02	-1.40e-02	-4.46e-02	-1.07e-01	4.69e-02	7.79e-01	8.51e-01	5.50e-01	1.52e-01	5.30e-01
GOBP HORMONE MEDIATED SIGNALING PATHWAY	185	3.88e-02	2.16e-01	0.1280	-2.23e-02	3.93e-02	7.09e-02	-9.08e-02	3.08e-02	6.00e-01	3.56e-01	9.63e-02	3.32e-02	4.70e-01
GOBP CARDIAC VENTRICLE MORPHOGENESIS	72	7.01e-01	8.96e-01	0.1280	8.64e-02	4.01e-02	-2.30e-02	-6.14e-02	5.38e-02	2.05e-01	5.57e-01	7.36e-01	3.68e-01	4.30e-01
GOBP REGULATION OF HORMONE SECRETION	248	5.45e-02	2.69e-01	0.1270	5.41e-02	9.40e-02	6.30e-02	6.45e-03	2.13e-02	1.42e-01	1.07e-02	8.73e-02	8.61e-01	5.63e-01
GOMF EXTRACELLULAR MATRIX BINDING	54	7.12e-01	9.00e-01	0.1270	-6.30e-02	-2.03e-02	2.05e-02	9.68e-02	4.47e-02	4.23e-01	7.97e-01	7.94e-01	2.18e-01	5.70e-01
GOBP FAT CELL DIFFERENTIATION	243	7.03e-02	3.15e-01	0.1270	-2.38e-02	5.93e-02	-3.16e-02	-9.62e-02	4.30e-02	5.23e-01	1.11e-01	3.96e-01	9.81e-03	2.49e-01
GOMF KINASE ACTIVATOR ACTIVITY	126	2.36e-01	5.91e-01	0.1270	-3.64e-02	-1.65e-02	2.68e-02	-9.46e-02	7.00e-02	4.80e-01	7.49e-01	6.03e-01	6.67e-02	1.75e-01
GOBP EXOCRINE SYSTEM DEVELOPMENT	45	8.08e-01	9.37e-01	0.1270	-2.39e-02	1.88e-03	-1.13e-01	-8.11e-03	-5.24e-02	7.82e-01	9.83e-01	1.90e-01	9.25e-01	5.43e-01
GOBP POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION	61	6.98e-01	8.95e-01	0.1270	-5.81e-02	8.80e-02	5.33e-02	-3.25e-02	-3.36e-02	4.33e-01	2.35e-01	4.72e-01	6.60e-01	6.50e-01
GOBP NEGATIVE REGULATION OF CANONICAL NF KAPPAB SIGNAL TRANSDUCTION	52	8.16e-01	9.41e-01	0.1270	-8.77e-02	-1.14e-02	8.44e-02	3.37e-02	-7.77e-03	2.74e-01	8.87e-01	2.92e-01	6.74e-01	9.23e-01
GOBP FATTY ACID TRANSPORT	114	2.65e-01	6.19e-01	0.1270	1.36e-02	3.35e-02	2.75e-03	1.21e-01	-1.53e-02	8.02e-01	5.36e-01	9.60e-01	2.59e-02	7.78e-01
GOBP PROTEIN AUTOPROCESSING	28	9.36e-01	9.80e-01	0.1270	4.55e-02	-5.38e-02	-4.55e-03	-6.81e-02	8.05e-02	6.77e-01	6.22e-01	9.67e-01	5.33e-01	4.61e-01
GOBP T CELL PROLIFERATION	202	9.59e-02	3.75e-01	0.1270	-3.32e-02	9.99e-02	4.52e-02	2.67e-02	4.75e-02	4.16e-01	1.44e-02	2.68e-01	5.13e-01	2.45e-01
GOBP SYNAPTIC VESICLE EXOCYTOSIS	91	4.66e-01	7.81e-01	0.1270	-8.60e-02	5.39e-02	5.90e-02	-3.13e-02	-3.60e-02	1.56e-01	3.74e-01	3.31e-01	6.05e-01	5.52e-01
GOCC NEUROMUSCULAR JUNCTION	73	6.04e-01	8.55e-01	0.1270	-6.24e-02	7.73e-03	6.51e-02	3.76e-03	-8.86e-02	3.57e-01	9.09e-01	3.36e-01	9.56e-01	1.91e-01
GOBP REGULATION OF CATABOLIC PROCESS	1026	2.42e-08	1.56e-06	0.1270	-1.46e-02	3.22e-02	-2.77e-02	-1.18e-01	1.28e-02	4.29e-01	8.13e-02	1.33e-01	1.80e-10	4.88e-01
GOBP FOREBRAIN DEVELOPMENT	389	1.07e-03	1.63e-02	0.1270	-4.14e-04	4.89e-03	3.55e-02	-9.45e-02	7.62e-02	9.89e-01	8.69e-01	2.30e-01	1.37e-03	9.87e-03
GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION	60	6.46e-01	8.76e-01	0.1270	-5.26e-02	5.05e-02	9.54e-02	-3.99e-02	3.18e-03	4.81e-01	4.99e-01	2.01e-01	5.93e-01	9.66e-01
GOBP POSITIVE REGULATION OF LIPID METABOLIC PROCESS	139	2.13e-01	5.66e-01	0.1260	-3.51e-04	9.04e-02	3.16e-02	6.30e-02	5.34e-02	9.94e-01	6.56e-02	5.20e-01	2.00e-01	2.77e-01
GOBP REGULATORY NCRNA PROCESSING	83	5.59e-01	8.32e-01	0.1260	4.86e-03	1.41e-02	1.03e-02	-1.02e-01	7.27e-02	9.39e-01	8.24e-01	8.71e-01	1.09e-01	2.52e-01
GOBP CELLULAR RESPONSE TO OXYGEN LEVELS	160	2.33e-01	5.86e-01	0.1260	-3.52e-03	7.44e-02	-1.93e-02	-9.52e-02	3.14e-02	9.39e-01	1.04e-01	6.74e-01	3.78e-02	4.93e-01
GOBP POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION	100	3.48e-01	6.94e-01	0.1260	-5.60e-02	6.22e-02	6.47e-02	-6.87e-02	3.63e-03	3.33e-01	2.82e-01	2.63e-01	2.35e-01	9.50e-01
GOBP AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS	93	2.60e-01	6.16e-01	0.1260	2.20e-02	8.97e-02	-7.23e-02	4.58e-02	-8.97e-03	7.13e-01	1.35e-01	2.28e-01	4.45e-01	8.81e-01
GOMF PROTEIN DIMERIZATION ACTIVITY	1019	1.08e-06	4.79e-05	0.1260	3.27e-02	3.47e-02	-5.81e-02	-9.55e-02	3.35e-02	7.75e-02	6.13e-02	1.70e-03	2.50e-07	7.01e-02
GOBP NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS	370	2.55e-03	3.25e-02	0.1260	-4.58e-02	8.59e-02	3.68e-02	-7.07e-02	6.96e-03	1.30e-01	4.53e-03	2.24e-01	1.94e-02	8.18e-01
GOBP POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY	18	9.64e-01	9.90e-01	0.1260	-1.41e-02	-3.77e-02	-4.64e-03	3.67e-02	1.13e-01	9.17e-01	7.82e-01	9.73e-01	7.87e-01	4.05e-01
GOMF ATP DEPENDENT ACTIVITY	546	1.86e-03	2.53e-02	0.1260	3.48e-02	-3.52e-02	-6.92e-02	-9.01e-02	2.23e-02	1.64e-01	1.60e-01	5.66e-03	3.17e-04	3.72e-01
GOBP LIPOSACCHARIDE METABOLIC PROCESS	106	3.95e-01	7.29e-01	0.1260	-3.84e-02	4.73e-02	-1.20e-02	-1.09e-01	-1.25e-02	4.94e-01	4.00e-01	8.31e-01	5.35e-02	8.24e-01
GOBP POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS	65	7.37e-01	9.10e-01	0.1260	7.68e-02	5.50e-02	-6.59e-02	-4.87e-02	-1.19e-02	2.84e-01	4.43e-01	3.58e-01	4.97e-01	8.68e-01
GOBP HEMATOPOIETIC STEM CELL DIFFERENTIATION	36	9.22e-01	9.74e-01	0.1260	-2.84e-02	4.20e-02	-7.21e-02	-8.80e-02	-1.58e-02	7.68e-01	6.63e-01	4.54e-01	3.61e-01	8.70e-01
GOBP REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY	34	9.10e-01	9.70e-01	0.1260	3.76e-02	-2.61e-02	-3.16e-02	-1.11e-01	1.89e-02	7.04e-01	7.92e-01	7.50e-01	2.63e-01	8.49e-01
GOBP RIBONUCLEOSIDE METABOLIC PROCESS	34	9.17e-01	9.74e-01	0.1250	-2.04e-02	6.48e-02	-6.65e-03	-8.59e-02	6.08e-02	8.37e-01	5.13e-01	9.47e-01	3.86e-01	5.39e-01
GOBP REGULATION OF TRIGLYCERIDE METABOLIC PROCESS	43	7.70e-01	9.24e-01	0.1250	-5.91e-02	7.90e-02	-5.75e-02	-1.45e-02	4.98e-02	5.03e-01	3.70e-01	5.14e-01	8.70e-01	5.72e-01
GOBP PHOSPHOLIPID TRANSPORT	101	4.47e-01	7.70e-01	0.1250	-6.74e-02	6.84e-02	-2.42e-02	-2.96e-03	-7.69e-02	2.42e-01	2.35e-01	6.74e-01	9.59e-01	1.82e-01
GOCC ENDOPLASMIC RETICULUM GOLGI INTERMEDIATE COMPARTMENT MEMBRANE	75	5.81e-01	8.43e-01	0.1250	-5.56e-02	7.58e-02	-5.46e-02	-4.37e-02	4.46e-02	4.05e-01	2.57e-01	4.13e-01	5.13e-01	5.05e-01
GOBP CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS	613	4.96e-04	8.81e-03	0.1250	2.76e-02	4.55e-02	-6.33e-02	-9.31e-02	1.40e-02	2.44e-01	5.43e-02	7.41e-03	8.33e-05	5.55e-01
GOBP PROTEIN TARGETING TO MEMBRANE	120	2.90e-01	6.43e-01	0.1250	-3.16e-03	7.29e-02	-2.97e-03	-8.52e-02	-5.57e-02	9.52e-01	1.68e-01	9.55e-01	1.07e-01	2.92e-01
GOBP REGULATION OF GLUCOSE IMPORT	58	6.22e-01	8.65e-01	0.1250	1.92e-02	6.98e-03	-8.88e-02	5.85e-02	-6.29e-02	8.00e-01	9.27e-01	2.42e-01	4.41e-01	4.07e-01
GOBP PHOSPHOLIPID METABOLIC PROCESS	362	6.56e-03	6.50e-02	0.1250	-8.57e-03	7.58e-02	-2.19e-02	-9.57e-02	-1.47e-02	7.79e-01	1.32e-02	4.75e-01	1.76e-03	6.30e-01
GOBP ENDODERM DEVELOPMENT	81	3.26e-01	6.74e-01	0.1250	-1.95e-02	-4.13e-02	3.37e-02	-1.11e-01	-1.31e-02	7.62e-01	5.21e-01	6.00e-01	8.49e-02	8.39e-01
GOBP NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION	93	5.03e-01	8.04e-01	0.1250	6.59e-02	6.17e-02	4.05e-02	-5.70e-02	5.10e-02	2.72e-01	3.04e-01	5.00e-01	3.42e-01	3.95e-01
GOBP REGULATION OF STEROID METABOLIC PROCESS	101	5.21e-01	8.13e-01	0.1250	-8.55e-02	1.13e-02	3.34e-02	2.35e-02	-8.08e-02	1.38e-01	8.44e-01	5.62e-01	6.84e-01	1.61e-01
GOBP REGULATION OF TRANSMEMBRANE TRANSPORT	559	1.43e-03	2.07e-02	0.1250	-6.42e-02	3.20e-02	6.52e-02	6.54e-02	-4.42e-02	9.45e-03	1.96e-01	8.41e-03	8.20e-03	7.39e-02
GOBP ENDOTHELIUM DEVELOPMENT	142	2.56e-01	6.13e-01	0.1250	-9.60e-02	5.07e-02	4.46e-02	-4.74e-04	4.28e-02	4.82e-02	2.97e-01	3.59e-01	9.92e-01	3.78e-01
GOBP FOREBRAIN CELL MIGRATION	63	6.40e-01	8.74e-01	0.1250	-5.69e-02	-1.02e-01	3.74e-02	-1.42e-02	-1.99e-02	4.35e-01	1.62e-01	6.08e-01	8.45e-01	7.84e-01
GOBP EPIDERMIS DEVELOPMENT	369	1.17e-02	9.79e-02	0.1250	-9.65e-02	-1.17e-02	6.62e-02	4.04e-02	-1.13e-02	1.46e-03	7.00e-01	2.90e-02	1.83e-01	7.10e-01
GOBP REGULATION OF CARBOHYDRATE METABOLIC PROCESS	181	1.53e-01	4.80e-01	0.1250	-9.92e-03	1.01e-01	2.36e-02	-5.86e-02	3.50e-02	8.18e-01	1.87e-02	5.84e-01	1.74e-01	4.17e-01
GOBP RAC PROTEIN SIGNAL TRANSDUCTION	41	7.81e-01	9.28e-01	0.1250	9.29e-03	7.03e-02	7.70e-02	-5.38e-02	-4.10e-02	9.18e-01	4.36e-01	3.93e-01	5.51e-01	6.49e-01
GOBP REGULATION OF WOUND HEALING	129	2.80e-01	6.33e-01	0.1250	-3.68e-02	8.30e-02	2.58e-02	8.12e-02	-3.70e-03	4.70e-01	1.03e-01	6.13e-01	1.11e-01	9.42e-01
GOBP GLYCOLYTIC PROCESS	85	5.73e-01	8.39e-01	0.1250	-3.66e-02	5.76e-02	1.59e-03	-9.57e-02	4.10e-02	5.59e-01	3.58e-01	9.80e-01	1.27e-01	5.13e-01
GOBP AXO DENDRITIC TRANSPORT	74	7.36e-01	9.09e-01	0.1250	-1.62e-02	1.51e-02	-4.62e-02	-9.82e-02	5.70e-02	8.09e-01	8.23e-01	4.92e-01	1.44e-01	3.96e-01
GOMF COA HYDROLASE ACTIVITY	21	9.29e-01	9.78e-01	0.1240	-4.26e-02	-1.86e-02	-2.60e-02	5.96e-02	9.54e-02	7.35e-01	8.82e-01	8.37e-01	6.36e-01	4.49e-01
GOBP REGULATION OF MITOCHONDRIAL FISSION	30	9.00e-01	9.67e-01	0.1240	-1.62e-02	2.66e-02	5.93e-02	-8.03e-02	6.76e-02	8.78e-01	8.01e-01	5.74e-01	4.47e-01	5.22e-01
GOBP POSITIVE REGULATION OF HEART RATE	27	9.55e-01	9.87e-01	0.1240	2.62e-02	7.61e-02	8.63e-02	3.17e-02	-2.33e-02	8.13e-01	4.94e-01	4.37e-01	7.75e-01	8.34e-01
GOBP FACE DEVELOPMENT	49	7.67e-01	9.24e-01	0.1240	2.12e-02	6.60e-02	6.72e-03	-1.01e-01	-2.28e-02	7.97e-01	4.24e-01	9.35e-01	2.23e-01	7.83e-01
GOCC PLATELET ALPHA GRANULE	82	5.24e-01	8.15e-01	0.1240	1.09e-02	6.11e-02	1.27e-02	1.05e-01	-1.95e-02	8.64e-01	3.38e-01	8.43e-01	9.98e-02	7.60e-01
GOBP EXOCYTIC PROCESS	82	5.79e-01	8.42e-01	0.1240	-6.88e-02	3.93e-02	-2.31e-02	-6.64e-02	-6.50e-02	2.81e-01	5.39e-01	7.17e-01	2.99e-01	3.09e-01
GOBP MUSCLE ATROPHY	10	9.85e-01	9.95e-01	0.1240	-4.83e-02	5.59e-02	-6.51e-02	8.56e-03	7.51e-02	7.91e-01	7.60e-01	7.21e-01	9.63e-01	6.81e-01
GOCC PHOSPHATASE COMPLEX	51	6.76e-01	8.85e-01	0.1240	6.16e-02	-4.55e-03	1.06e-02	-5.46e-02	-9.21e-02	4.47e-01	9.55e-01	8.96e-01	5.00e-01	2.55e-01
GOBP FATTY ACID TRANSMEMBRANE TRANSPORT	19	9.81e-01	9.93e-01	0.1240	2.37e-02	-4.71e-02	-3.24e-02	-7.00e-02	8.15e-02	8.58e-01	7.22e-01	8.07e-01	5.97e-01	5.38e-01
GOBP POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION	66	7.84e-01	9.28e-01	0.1240	-1.71e-02	6.44e-02	8.77e-02	4.54e-02	3.43e-02	8.10e-01	3.65e-01	2.18e-01	5.23e-01	6.30e-01
GOBP NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY	139	3.03e-01	6.57e-01	0.1240	3.08e-02	9.60e-02	-4.63e-02	-4.82e-02	2.71e-02	5.31e-01	5.07e-02	3.46e-01	3.26e-01	5.81e-01
GOBP REGULATION OF PROTEIN SECRETION	261	5.35e-02	2.66e-01	0.1240	5.11e-02	8.86e-02	3.86e-02	-2.16e-02	5.43e-02	1.56e-01	1.37e-02	2.83e-01	5.49e-01	1.31e-01
GOBP NON CANONICAL WNT SIGNALING PATHWAY	66	4.35e-01	7.59e-01	0.1240	6.65e-02	-5.03e-02	8.10e-02	-3.84e-02	-1.90e-02	3.50e-01	4.79e-01	2.55e-01	5.89e-01	7.89e-01
GOMF PHOSPHATASE REGULATOR ACTIVITY	98	4.67e-01	7.83e-01	0.1240	8.45e-03	1.01e-01	1.92e-03	-4.93e-02	-5.07e-02	8.85e-01	8.28e-02	9.74e-01	3.99e-01	3.85e-01
GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION	482	7.23e-04	1.18e-02	0.1240	-3.20e-02	1.08e-01	2.69e-02	-1.48e-02	4.12e-02	2.28e-01	4.77e-05	3.12e-01	5.78e-01	1.22e-01
GOBP SPERM FLAGELLUM ASSEMBLY	39	8.04e-01	9.34e-01	0.1240	-4.85e-02	-4.04e-02	-1.01e-01	2.34e-02	2.29e-02	6.00e-01	6.62e-01	2.73e-01	8.00e-01	8.05e-01
GOMF N ACETYLTRANSFERASE ACTIVITY	60	7.31e-01	9.08e-01	0.1240	3.21e-02	6.28e-02	8.84e-03	-9.85e-02	2.43e-02	6.67e-01	4.00e-01	9.06e-01	1.87e-01	7.45e-01
GOBP MESONEPHROS DEVELOPMENT	99	2.01e-01	5.50e-01	0.1240	2.07e-02	2.28e-02	5.45e-02	-9.56e-02	-4.75e-02	7.22e-01	6.95e-01	3.49e-01	1.00e-01	4.14e-01
GOCC SITE OF POLARIZED GROWTH	162	3.23e-01	6.71e-01	0.1240	6.38e-03	6.89e-02	7.85e-02	6.45e-02	1.44e-02	8.88e-01	1.30e-01	8.47e-02	1.57e-01	7.51e-01
GOMF SULFUR COMPOUND BINDING	263	9.84e-02	3.79e-01	0.1240	-4.09e-02	3.74e-02	5.96e-02	6.36e-02	-6.80e-02	2.53e-01	2.96e-01	9.59e-02	7.56e-02	5.77e-02
GOBP MEMBRANE LIPID BIOSYNTHETIC PROCESS	148	2.69e-01	6.23e-01	0.1240	3.68e-03	5.36e-02	-1.98e-02	-1.09e-01	8.27e-03	9.38e-01	2.60e-01	6.77e-01	2.17e-02	8.62e-01
GOBP SINGLE FERTILIZATION	158	3.59e-01	7.04e-01	0.1240	1.43e-03	-7.44e-03	9.68e-02	7.58e-02	-9.89e-03	9.75e-01	8.72e-01	3.58e-02	9.99e-02	8.30e-01
GOBP NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS	418	1.70e-03	2.37e-02	0.1230	-4.16e-02	8.37e-02	2.16e-02	-7.67e-02	1.13e-02	1.44e-01	3.34e-03	4.49e-01	7.11e-03	6.93e-01
GOBP TIGHT JUNCTION ORGANIZATION	78	5.38e-01	8.22e-01	0.1230	-8.46e-02	-5.87e-02	6.42e-02	-1.83e-02	1.20e-02	1.96e-01	3.70e-01	3.27e-01	7.79e-01	8.55e-01
GOBP REGULATION OF CELL CELL ADHESION	476	2.48e-03	3.18e-02	0.1230	-4.22e-02	8.35e-02	7.53e-02	2.01e-02	1.93e-02	1.14e-01	1.79e-03	4.89e-03	4.52e-01	4.72e-01
GOBP SMOOTH MUSCLE CELL PROLIFERATION	160	1.99e-01	5.48e-01	0.1230	-5.47e-02	1.36e-02	4.41e-02	-6.91e-03	1.00e-01	2.32e-01	7.67e-01	3.36e-01	8.80e-01	2.88e-02
GOBP MONOATOMIC ION HOMEOSTASIS	579	1.35e-04	3.05e-03	0.1230	-5.96e-02	6.73e-02	8.36e-02	-1.11e-02	-7.29e-04	1.42e-02	5.65e-03	5.85e-04	6.48e-01	9.76e-01
GOBP REGULATION OF BMP SIGNALING PATHWAY	115	3.00e-01	6.54e-01	0.1230	-3.22e-02	7.55e-02	4.35e-02	-8.05e-02	-9.47e-03	5.51e-01	1.62e-01	4.21e-01	1.36e-01	8.61e-01
GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND	44	7.26e-01	9.05e-01	0.1230	-2.28e-02	-8.94e-02	4.87e-02	-6.29e-02	1.85e-02	7.93e-01	3.05e-01	5.76e-01	4.70e-01	8.32e-01
GOMF MONOATOMIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY	573	4.36e-04	8.06e-03	0.1230	-4.96e-02	6.24e-02	7.07e-02	2.14e-02	-5.80e-02	4.22e-02	1.07e-02	3.81e-03	3.81e-01	1.77e-02
GOBP RESPONSE TO ALCOHOL	246	9.38e-02	3.70e-01	0.1230	-5.41e-02	4.30e-02	7.13e-02	6.35e-02	3.57e-02	1.44e-01	2.45e-01	5.42e-02	8.62e-02	3.35e-01
GOBP CALCIUM ION TRANSPORT	426	9.04e-03	8.16e-02	0.1230	-1.20e-02	5.11e-02	5.65e-02	9.28e-02	-2.43e-02	6.71e-01	7.03e-02	4.55e-02	1.02e-03	3.89e-01
GOBP NEPHRON EPITHELIUM DEVELOPMENT	115	2.40e-01	5.96e-01	0.1230	5.53e-02	-3.60e-04	3.23e-02	-1.01e-01	2.72e-02	3.06e-01	9.95e-01	5.50e-01	6.02e-02	6.14e-01
GOBP RESPONSE TO NITROGEN COMPOUND	1076	6.92e-09	5.03e-07	0.1230	-2.87e-02	9.41e-02	5.87e-02	-4.13e-02	1.53e-02	1.12e-01	1.85e-07	1.14e-03	2.22e-02	3.97e-01
GOMF KINASE BINDING	737	2.71e-05	8.04e-04	0.1230	3.26e-02	6.80e-02	-1.20e-02	-8.79e-02	3.88e-02	1.32e-01	1.67e-03	5.80e-01	4.87e-05	7.29e-02
GOBP OLEFINIC COMPOUND METABOLIC PROCESS	155	2.00e-01	5.49e-01	0.1230	2.85e-02	-2.29e-02	-5.93e-03	1.10e-01	-4.04e-02	5.40e-01	6.22e-01	8.99e-01	1.84e-02	3.86e-01
GOBP POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION	179	1.64e-01	4.97e-01	0.1230	-2.54e-02	1.17e-01	2.42e-02	5.25e-03	3.27e-03	5.58e-01	6.78e-03	5.77e-01	9.04e-01	9.40e-01
GOCC CENTRIOLAR SATELLITE	107	5.80e-01	8.43e-01	0.1230	2.91e-02	-6.55e-02	-6.22e-02	-7.18e-02	2.93e-02	6.03e-01	2.42e-01	2.66e-01	1.99e-01	6.00e-01
GOBP LYMPHOCYTE ACTIVATION	753	4.57e-06	1.67e-04	0.1220	-3.31e-02	9.46e-02	3.21e-02	-5.77e-02	2.44e-02	1.22e-01	9.96e-06	1.34e-01	6.99e-03	2.54e-01
GOBP CORTICAL ACTIN CYTOSKELETON ORGANIZATION	42	8.59e-01	9.53e-01	0.1220	-8.40e-02	8.23e-02	-1.33e-03	3.15e-03	-3.38e-02	3.46e-01	3.56e-01	9.88e-01	9.72e-01	7.04e-01
GOBP NEGATIVE REGULATION OF DEFENSE RESPONSE	307	1.54e-02	1.19e-01	0.1220	-7.08e-02	4.35e-02	2.39e-02	-1.97e-02	8.44e-02	3.29e-02	1.90e-01	4.71e-01	5.53e-01	1.09e-02
GOMF PROTEIN SELF ASSOCIATION	70	6.79e-01	8.87e-01	0.1220	-2.20e-02	3.75e-02	-3.78e-02	-5.81e-02	-9.11e-02	7.50e-01	5.87e-01	5.84e-01	4.01e-01	1.88e-01
GOBP POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY	104	4.84e-01	7.93e-01	0.1220	-4.91e-02	6.06e-02	-6.19e-02	-5.11e-02	-4.96e-02	3.87e-01	2.85e-01	2.76e-01	3.68e-01	3.82e-01
GOBP NEGATIVE REGULATION OF LIPID TRANSPORT	48	8.23e-01	9.42e-01	0.1220	-2.88e-02	-5.92e-02	1.71e-02	-1.84e-02	1.00e-01	7.30e-01	4.78e-01	8.37e-01	8.25e-01	2.31e-01
GOBP EXECUTION PHASE OF APOPTOSIS	74	6.36e-01	8.72e-01	0.1220	2.24e-02	6.81e-03	5.41e-02	-5.01e-02	9.47e-02	7.40e-01	9.19e-01	4.21e-01	4.56e-01	1.59e-01
GOBP NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION	67	6.83e-01	8.88e-01	0.1220	4.32e-02	8.98e-02	6.29e-02	-3.27e-02	4.20e-04	5.41e-01	2.04e-01	3.73e-01	6.44e-01	9.95e-01
GOBP REGULATION OF CELLULAR CATABOLIC PROCESS	684	1.93e-05	6.01e-04	0.1220	-6.78e-03	8.13e-03	-2.12e-02	-1.19e-01	1.47e-02	7.63e-01	7.17e-01	3.45e-01	1.11e-07	5.12e-01
GOBP POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT	151	2.64e-01	6.19e-01	0.1220	-6.49e-02	-6.12e-02	6.68e-02	3.22e-02	-3.84e-02	1.69e-01	1.94e-01	1.56e-01	4.94e-01	4.15e-01
GOBP SKELETAL MUSCLE CELL PROLIFERATION	24	9.63e-01	9.90e-01	0.1220	5.59e-02	7.62e-02	-2.11e-02	-7.44e-02	-4.52e-04	6.35e-01	5.18e-01	8.58e-01	5.28e-01	9.97e-01
GOBP REGULATION OF T CELL ACTIVATION	366	1.14e-02	9.62e-02	0.1220	-1.06e-02	9.42e-02	6.02e-02	-8.98e-03	4.72e-02	7.29e-01	1.96e-03	4.78e-02	7.68e-01	1.21e-01
GOBP RECEPTOR INTERNALIZATION	122	3.93e-01	7.27e-01	0.1220	-2.83e-02	8.14e-02	8.60e-02	-7.23e-03	-5.30e-03	5.89e-01	1.20e-01	1.01e-01	8.90e-01	9.20e-01
GOBP SULFUR COMPOUND BIOSYNTHETIC PROCESS	148	2.99e-01	6.53e-01	0.1220	-4.35e-03	7.93e-02	8.77e-03	-6.84e-02	6.19e-02	9.27e-01	9.57e-02	8.54e-01	1.51e-01	1.94e-01
GOBP REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS	139	2.99e-01	6.53e-01	0.1220	1.58e-04	8.11e-02	-7.03e-03	-9.07e-02	-4.31e-03	9.97e-01	9.88e-02	8.86e-01	6.47e-02	9.30e-01
GOBP DENDRITIC SPINE MAINTENANCE	21	9.78e-01	9.93e-01	0.1220	-2.18e-02	-1.45e-02	5.57e-02	1.04e-01	1.31e-02	8.63e-01	9.08e-01	6.59e-01	4.07e-01	9.17e-01
GOBP CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS	170	1.57e-01	4.85e-01	0.1220	-1.55e-02	3.97e-02	-2.54e-02	-7.82e-02	-7.93e-02	7.28e-01	3.72e-01	5.68e-01	7.84e-02	7.43e-02
GOBP ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS	47	8.62e-01	9.54e-01	0.1220	-2.20e-02	-7.05e-02	-5.17e-02	1.08e-02	-8.13e-02	7.94e-01	4.03e-01	5.40e-01	8.98e-01	3.35e-01
GOCC GOLGI MEMBRANE	640	1.03e-04	2.45e-03	0.1220	-2.05e-02	7.19e-02	-3.17e-02	-9.01e-02	-1.16e-02	3.77e-01	1.92e-03	1.71e-01	1.00e-04	6.18e-01
GOBP REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION	12	9.89e-01	9.96e-01	0.1220	4.43e-02	8.26e-02	7.29e-02	-1.95e-02	-1.90e-02	7.91e-01	6.20e-01	6.62e-01	9.07e-01	9.09e-01
GOMF GTPASE ACTIVATOR ACTIVITY	243	1.35e-01	4.54e-01	0.1220	-2.18e-02	5.57e-02	6.16e-02	6.18e-02	-6.04e-02	5.58e-01	1.35e-01	9.81e-02	9.72e-02	1.05e-01
GOMF TRANSLATION REPRESSOR ACTIVITY	271	5.96e-02	2.85e-01	0.1220	-5.17e-02	-7.60e-02	4.10e-02	6.85e-02	3.61e-03	1.43e-01	3.13e-02	2.45e-01	5.23e-02	9.18e-01
GOCC CLATHRIN ADAPTOR COMPLEX	25	8.67e-01	9.55e-01	0.1220	-1.28e-02	3.94e-03	7.22e-02	-9.36e-02	-2.58e-02	9.12e-01	9.73e-01	5.32e-01	4.18e-01	8.23e-01
GOBP REGULATION OF TUBE SIZE	142	1.85e-01	5.28e-01	0.1220	-8.60e-02	4.79e-02	6.98e-03	6.80e-02	2.13e-02	7.69e-02	3.24e-01	8.86e-01	1.62e-01	6.62e-01
GOBP POSITIVE REGULATION OF DEPHOSPHORYLATION	51	7.48e-01	9.15e-01	0.1220	-6.89e-02	6.80e-02	-1.00e-02	1.59e-03	7.30e-02	3.95e-01	4.01e-01	9.01e-01	9.84e-01	3.67e-01
GOBP REGULATION OF LEUKOCYTE APOPTOTIC PROCESS	90	5.54e-01	8.30e-01	0.1220	-3.22e-02	1.05e-01	5.08e-03	-3.45e-02	-3.95e-02	5.98e-01	8.55e-02	9.34e-01	5.72e-01	5.18e-01
GOBP MYELIN MAINTENANCE	17	9.58e-01	9.88e-01	0.1220	-5.96e-02	-2.93e-02	-6.72e-02	3.33e-02	6.88e-02	6.70e-01	8.35e-01	6.32e-01	8.12e-01	6.23e-01
GOBP STRIATED MUSCLE CONTRACTION	175	1.44e-01	4.65e-01	0.1210	-5.55e-02	4.91e-02	1.77e-02	9.36e-02	-1.35e-02	2.06e-01	2.62e-01	6.86e-01	3.26e-02	7.58e-01
GOCC MICROTUBULE	441	9.46e-03	8.41e-02	0.1210	9.58e-03	3.90e-02	-4.81e-02	-9.78e-02	3.54e-02	7.30e-01	1.60e-01	8.34e-02	4.27e-04	2.03e-01
GOBP RESPONSE TO EXTRACELLULAR STIMULUS	499	2.00e-03	2.68e-02	0.1210	-1.23e-02	5.58e-02	-2.95e-02	-9.92e-02	2.77e-02	6.38e-01	3.28e-02	2.60e-01	1.48e-04	2.89e-01
GOBP NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE	71	7.19e-01	9.02e-01	0.1210	-2.44e-02	6.81e-02	5.82e-02	6.13e-02	4.84e-02	7.22e-01	3.21e-01	3.96e-01	3.71e-01	4.81e-01
GOCC TRANS GOLGI NETWORK MEMBRANE	100	4.90e-01	7.98e-01	0.1210	-2.98e-02	1.17e-01	1.10e-02	-3.57e-03	-8.42e-03	6.07e-01	4.36e-02	8.50e-01	9.51e-01	8.84e-01
GOMF ATPASE BINDING	82	5.87e-01	8.45e-01	0.1210	-3.34e-02	1.38e-02	-2.93e-02	-1.02e-01	-4.72e-02	6.01e-01	8.29e-01	6.46e-01	1.12e-01	4.60e-01
GOBP REGULATION OF ANIMAL ORGAN MORPHOGENESIS	121	1.38e-01	4.58e-01	0.1210	1.33e-02	2.84e-02	6.07e-02	-7.51e-02	-6.62e-02	8.00e-01	5.90e-01	2.49e-01	1.53e-01	2.08e-01
GOBP REGULATION OF DENDRITIC SPINE DEVELOPMENT	51	8.00e-01	9.33e-01	0.1210	-6.81e-02	5.09e-02	2.58e-02	8.24e-02	1.32e-03	4.00e-01	5.30e-01	7.50e-01	3.09e-01	9.87e-01
GOBP POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL	31	9.42e-01	9.82e-01	0.1210	1.77e-02	-4.31e-02	-9.32e-02	-2.94e-02	5.44e-02	8.65e-01	6.78e-01	3.69e-01	7.77e-01	6.00e-01
GOBP RESPONSE TO ESTROGEN	66	5.99e-01	8.51e-01	0.1210	7.75e-02	-2.12e-02	7.13e-02	-3.62e-02	4.28e-02	2.77e-01	7.66e-01	3.17e-01	6.11e-01	5.47e-01
GOBP POSITIVE REGULATION OF CELL MIGRATION BY VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY	8	9.97e-01	9.98e-01	0.1210	-7.55e-02	-3.21e-02	-3.26e-02	-7.77e-02	2.84e-02	7.12e-01	8.75e-01	8.73e-01	7.03e-01	8.89e-01
GOCC NEURON SPINE	168	3.67e-01	7.07e-01	0.1210	-3.91e-02	1.89e-02	6.28e-02	8.25e-02	-4.48e-02	3.82e-01	6.73e-01	1.60e-01	6.52e-02	3.16e-01
GOBP NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION	61	7.50e-01	9.16e-01	0.1210	-1.99e-02	-1.64e-03	4.50e-02	2.82e-02	1.07e-01	7.88e-01	9.82e-01	5.43e-01	7.03e-01	1.49e-01
GOCC MICROTUBULE CYTOSKELETON	1297	3.11e-08	1.95e-06	0.1210	3.73e-02	2.71e-02	-4.66e-02	-9.96e-02	1.98e-02	2.40e-02	1.01e-01	4.84e-03	1.68e-09	2.30e-01
GOCC CELL PROJECTION MEMBRANE	338	2.29e-02	1.54e-01	0.1210	-8.25e-03	8.95e-02	6.96e-02	1.57e-02	-3.79e-02	7.94e-01	4.70e-03	2.79e-02	6.20e-01	2.31e-01
GOBP POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION	96	5.09e-01	8.07e-01	0.1210	-1.67e-02	-8.34e-02	-3.93e-03	1.30e-02	8.47e-02	7.77e-01	1.58e-01	9.47e-01	8.26e-01	1.51e-01
GOBP POSITIVE REGULATION OF BLOOD PRESSURE	32	9.37e-01	9.80e-01	0.1210	7.55e-03	-2.15e-02	-5.67e-03	-4.67e-02	1.09e-01	9.41e-01	8.33e-01	9.56e-01	6.48e-01	2.87e-01
GOBP B CELL DIFFERENTIATION	142	2.69e-01	6.23e-01	0.1210	-5.46e-02	7.28e-02	6.21e-02	-4.36e-02	2.30e-02	2.61e-01	1.34e-01	2.01e-01	3.70e-01	6.36e-01
GOBP REGULATION OF PROTEIN CATABOLIC PROCESS	340	2.76e-02	1.74e-01	0.1210	-9.79e-03	5.18e-02	-4.33e-02	-9.93e-02	4.09e-03	7.56e-01	1.01e-01	1.70e-01	1.65e-03	8.97e-01
GOBP CELLULAR CATABOLIC PROCESS	1532	8.36e-10	6.74e-08	0.1210	1.95e-03	3.89e-02	-4.08e-02	-1.01e-01	3.37e-02	8.99e-01	1.09e-02	7.71e-03	3.79e-11	2.74e-02
GOMF CARBOXYLIC ESTER HYDROLASE ACTIVITY	150	3.23e-01	6.71e-01	0.1210	2.11e-03	8.30e-02	5.28e-02	6.69e-02	1.93e-02	9.64e-01	7.94e-02	2.65e-01	1.57e-01	6.83e-01
GOBP PLASMA MEMBRANE RAFT ORGANIZATION	11	9.96e-01	9.98e-01	0.1210	-2.12e-02	3.00e-02	-5.22e-02	-8.46e-02	5.74e-02	9.03e-01	8.63e-01	7.64e-01	6.27e-01	7.42e-01
GOBP B CELL ACTIVATION	261	5.08e-02	2.58e-01	0.1200	-3.16e-02	8.90e-02	3.44e-02	-5.35e-02	3.92e-02	3.79e-01	1.33e-02	3.39e-01	1.37e-01	2.76e-01
GOCC M BAND	21	9.73e-01	9.92e-01	0.1200	-3.05e-02	-4.73e-02	-3.73e-02	-3.15e-03	-9.97e-02	8.09e-01	7.08e-01	7.67e-01	9.80e-01	4.29e-01
GOBP AXONAL TRANSPORT	62	8.02e-01	9.34e-01	0.1200	-1.36e-03	-1.59e-02	-2.15e-02	-8.62e-02	7.97e-02	9.85e-01	8.29e-01	7.70e-01	2.40e-01	2.78e-01
GOBP STEM CELL DIFFERENTIATION	240	3.49e-02	2.02e-01	0.1200	3.30e-02	-1.91e-02	-2.18e-03	-1.13e-01	1.68e-02	3.79e-01	6.10e-01	9.54e-01	2.59e-03	6.54e-01
GOBP STEM CELL PROLIFERATION	120	2.77e-01	6.31e-01	0.1200	-1.34e-02	-1.68e-02	1.07e-02	-1.15e-01	2.48e-02	8.00e-01	7.51e-01	8.39e-01	2.93e-02	6.39e-01
GOBP GLYCEROPHOSPHOLIPID METABOLIC PROCESS	284	4.28e-02	2.29e-01	0.1200	-2.69e-02	8.46e-02	-3.71e-02	-6.95e-02	-1.89e-02	4.36e-01	1.42e-02	2.81e-01	4.38e-02	5.83e-01
GOBP RESPONSE TO RADIATION	410	1.27e-02	1.04e-01	0.1200	2.26e-02	-1.86e-02	-4.38e-02	-1.04e-01	2.96e-02	4.32e-01	5.19e-01	1.28e-01	3.07e-04	3.03e-01
GOBP POSTSYNAPTIC SPECIALIZATION ORGANIZATION	41	9.21e-01	9.74e-01	0.1200	-2.57e-02	2.70e-02	9.98e-02	4.61e-02	3.10e-02	7.76e-01	7.65e-01	2.69e-01	6.10e-01	7.31e-01
GOCC GLUTAMATERGIC SYNAPSE	387	1.18e-02	9.81e-02	0.1200	1.96e-02	4.55e-02	9.81e-02	3.57e-02	-3.28e-02	5.07e-01	1.25e-01	9.22e-04	2.28e-01	2.67e-01
GOBP CEREBRAL CORTEX CELL MIGRATION	45	6.88e-01	8.90e-01	0.1200	-1.47e-02	-4.37e-02	9.52e-02	-5.43e-02	1.71e-02	8.65e-01	6.12e-01	2.69e-01	5.29e-01	8.43e-01
GOBP NEGATIVE REGULATION OF JNK CASCADE	36	9.04e-01	9.68e-01	0.1200	-1.36e-02	8.30e-02	2.98e-02	1.40e-02	7.92e-02	8.88e-01	3.89e-01	7.57e-01	8.84e-01	4.11e-01
GOBP NEGATIVE REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION	36	9.11e-01	9.71e-01	0.1200	3.88e-02	-3.73e-02	6.30e-02	2.22e-02	8.39e-02	6.87e-01	6.99e-01	5.13e-01	8.17e-01	3.83e-01
GOBP CENTRIOLE CENTRIOLE COHESION	15	9.87e-01	9.95e-01	0.1200	4.25e-02	-3.29e-02	2.52e-02	-1.74e-02	1.03e-01	7.76e-01	8.25e-01	8.66e-01	9.07e-01	4.90e-01
GOBP CHOLESTEROL EFFLUX	73	6.62e-01	8.81e-01	0.1200	-1.06e-01	-1.42e-02	1.05e-02	-3.01e-02	4.42e-02	1.18e-01	8.34e-01	8.77e-01	6.57e-01	5.14e-01
GOBP CELL ACTIVATION	1058	5.34e-08	3.23e-06	0.1200	-3.63e-02	1.04e-01	2.79e-02	-3.14e-02	2.21e-02	4.59e-02	1.11e-08	1.25e-01	8.39e-02	2.24e-01
GOBP CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS	72	6.60e-01	8.80e-01	0.1200	-3.03e-02	1.06e-01	1.79e-02	1.47e-02	4.06e-02	6.57e-01	1.20e-01	7.93e-01	8.29e-01	5.51e-01
GOBP ATP TRANSPORT	17	9.80e-01	9.93e-01	0.1200	1.15e-01	-1.44e-02	2.04e-02	2.04e-02	4.45e-03	4.10e-01	9.18e-01	8.84e-01	8.84e-01	9.75e-01
GOMF ACTIVE MONOATOMIC ION TRANSMEMBRANE TRANSPORTER ACTIVITY	230	8.16e-02	3.44e-01	0.1200	8.73e-03	5.40e-02	7.30e-02	1.60e-02	-7.58e-02	8.20e-01	1.59e-01	5.63e-02	6.75e-01	4.75e-02
GOBP OOCYTE DIFFERENTIATION	64	7.47e-01	9.15e-01	0.1200	4.78e-02	7.47e-02	2.41e-02	-6.80e-02	3.51e-02	5.08e-01	3.01e-01	7.38e-01	3.47e-01	6.27e-01
GOBP CELLULAR COMPONENT DISASSEMBLY	478	1.67e-03	2.35e-02	0.1200	3.89e-02	3.68e-02	-2.33e-02	-1.04e-01	-2.24e-04	1.45e-01	1.69e-01	3.84e-01	9.29e-05	9.93e-01
GOBP RESPONSE TO BMP	170	1.58e-01	4.88e-01	0.1200	-2.32e-02	7.37e-02	4.75e-02	-7.44e-02	2.28e-02	6.02e-01	9.74e-02	2.86e-01	9.40e-02	6.08e-01
GOBP REGULATION OF STEROL TRANSPORT	80	6.49e-01	8.77e-01	0.1190	-7.90e-02	7.26e-02	4.54e-02	-1.70e-02	-2.03e-02	2.22e-01	2.62e-01	4.82e-01	7.93e-01	7.54e-01
GOBP FAT SOLUBLE VITAMIN METABOLIC PROCESS	45	8.13e-01	9.39e-01	0.1190	-3.43e-02	-5.63e-02	-4.53e-02	8.46e-02	-2.65e-02	6.90e-01	5.13e-01	5.99e-01	3.26e-01	7.58e-01
GOBP EXOCYTOSIS	329	2.16e-02	1.48e-01	0.1190	-5.10e-02	9.87e-02	3.61e-02	-7.18e-03	-2.29e-02	1.12e-01	2.08e-03	2.60e-01	8.23e-01	4.75e-01
GOBP LYMPHOCYTE HOMEOSTASIS	72	7.30e-01	9.07e-01	0.1190	3.57e-02	5.89e-02	-5.86e-02	-6.24e-02	-4.65e-02	6.01e-01	3.87e-01	3.90e-01	3.60e-01	4.95e-01
GOBP FORMATION OF PRIMARY GERM LAYER	126	3.19e-01	6.67e-01	0.1190	-3.35e-02	1.26e-02	1.02e-02	-1.07e-01	3.62e-02	5.15e-01	8.07e-01	8.44e-01	3.76e-02	4.82e-01
GOBP NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY	94	5.78e-01	8.42e-01	0.1190	-5.08e-03	8.84e-02	7.01e-02	-2.22e-02	3.02e-02	9.32e-01	1.38e-01	2.40e-01	7.09e-01	6.13e-01
GOBP NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION	49	7.83e-01	9.28e-01	0.1190	-4.32e-02	4.12e-02	1.47e-02	-1.00e-01	-1.80e-02	6.01e-01	6.18e-01	8.59e-01	2.25e-01	8.27e-01
GOBP REGULATION OF CELL ACTIVATION	626	1.34e-04	3.02e-03	0.1190	-3.55e-02	1.02e-01	2.44e-02	-3.12e-02	2.95e-02	1.30e-01	1.27e-05	2.98e-01	1.82e-01	2.08e-01
GOBP REGULATION OF INTRACELLULAR PROTEIN TRANSPORT	216	1.09e-01	4.02e-01	0.1190	-1.58e-02	1.77e-02	-2.81e-02	-1.12e-01	-1.32e-02	6.89e-01	6.54e-01	4.76e-01	4.46e-03	7.37e-01
GOMF INORGANIC MOLECULAR ENTITY TRANSMEMBRANE TRANSPORTER ACTIVITY	652	5.55e-04	9.60e-03	0.1190	-3.68e-02	6.76e-02	6.67e-02	4.00e-02	-4.61e-02	1.09e-01	3.23e-03	3.66e-03	8.11e-02	4.46e-02
GOBP CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND	14	9.85e-01	9.95e-01	0.1190	-1.69e-02	-6.63e-02	-9.31e-02	2.68e-02	-4.73e-03	9.13e-01	6.67e-01	5.47e-01	8.62e-01	9.76e-01
GOBP MAPK CASCADE	737	1.68e-04	3.63e-03	0.1190	-5.60e-02	6.52e-02	6.45e-02	4.28e-02	-2.66e-02	9.63e-03	2.58e-03	2.89e-03	4.80e-02	2.19e-01
GOMF HORMONE ACTIVITY	119	3.53e-01	6.99e-01	0.1190	-5.29e-02	1.99e-02	9.66e-02	-2.17e-02	3.26e-02	3.19e-01	7.07e-01	6.89e-02	6.83e-01	5.39e-01
GOBP TELENCEPHALON DEVELOPMENT	265	2.14e-02	1.48e-01	0.1180	-1.51e-02	-1.37e-02	5.53e-02	-7.10e-02	7.44e-02	6.73e-01	7.01e-01	1.21e-01	4.67e-02	3.71e-02
GOBP SYNAPTIC TRANSMISSION CHOLINERGIC	30	9.09e-01	9.70e-01	0.1180	6.50e-02	-1.74e-02	-1.45e-02	-5.71e-02	-7.77e-02	5.38e-01	8.69e-01	8.91e-01	5.88e-01	4.62e-01
GOBP NEGATIVE REGULATION OF REPRODUCTIVE PROCESS	72	7.27e-01	9.05e-01	0.1180	-5.53e-02	2.71e-02	7.38e-02	1.37e-02	6.79e-02	4.18e-01	6.90e-01	2.79e-01	8.40e-01	3.19e-01
GOMF PROTEIN KINASE A CATALYTIC SUBUNIT BINDING	13	9.90e-01	9.96e-01	0.1180	-5.42e-02	5.21e-02	5.12e-02	-1.10e-02	-7.50e-02	7.35e-01	7.45e-01	7.49e-01	9.45e-01	6.40e-01
GOBP REGULATION OF DENDRITE MORPHOGENESIS	57	8.33e-01	9.45e-01	0.1180	4.34e-02	1.00e-02	8.33e-02	5.62e-02	-4.40e-02	5.71e-01	8.96e-01	2.77e-01	4.63e-01	5.66e-01
GOMF DIPEPTIDASE ACTIVITY	16	9.79e-01	9.93e-01	0.1180	-1.59e-02	6.35e-02	6.35e-02	-6.91e-02	3.02e-02	9.13e-01	6.60e-01	6.60e-01	6.32e-01	8.34e-01
GOBP RESPONSE TO SALT STRESS	24	9.39e-01	9.81e-01	0.1180	-3.86e-03	8.54e-02	-4.33e-02	4.59e-02	-5.19e-02	9.74e-01	4.69e-01	7.14e-01	6.97e-01	6.60e-01
GOBP PROTEIN LOCALIZATION TO CELL PERIPHERY	336	8.00e-03	7.49e-02	0.1180	-5.31e-02	5.87e-02	7.79e-02	-3.42e-02	-2.21e-02	9.47e-02	6.46e-02	1.41e-02	2.82e-01	4.86e-01
GOBP SEX DIFFERENTIATION	266	7.06e-02	3.16e-01	0.1180	5.55e-02	5.29e-02	2.55e-02	-5.02e-02	7.02e-02	1.19e-01	1.37e-01	4.74e-01	1.59e-01	4.87e-02
GOBP MUSCLE STRUCTURE DEVELOPMENT	677	5.26e-05	1.41e-03	0.1180	2.91e-02	8.24e-02	4.53e-02	-5.17e-02	4.03e-02	1.96e-01	2.57e-04	4.46e-02	2.19e-02	7.38e-02
GOBP MONOAMINE TRANSPORT	86	6.50e-01	8.77e-01	0.1180	4.60e-02	9.46e-02	5.53e-03	-4.59e-02	2.74e-02	4.61e-01	1.29e-01	9.29e-01	4.62e-01	6.61e-01
GOBP BODY FLUID SECRETION	87	7.00e-01	8.96e-01	0.1180	-2.73e-02	7.92e-02	6.67e-02	3.56e-02	-3.47e-02	6.60e-01	2.01e-01	2.82e-01	5.66e-01	5.76e-01
GOBP REGULATION OF MICROTUBULE BASED PROCESS	248	1.46e-01	4.68e-01	0.1180	3.40e-03	4.17e-02	-6.02e-02	-9.23e-02	6.93e-03	9.27e-01	2.58e-01	1.03e-01	1.23e-02	8.51e-01
GOBP REGULATION OF ACTIN FILAMENT BASED PROCESS	360	1.85e-02	1.34e-01	0.1180	-1.40e-02	9.34e-02	3.29e-02	4.94e-02	-3.86e-02	6.48e-01	2.33e-03	2.84e-01	1.07e-01	2.09e-01
GOBP REGULATION OF ENDOTHELIAL CELL MIGRATION	220	9.87e-02	3.80e-01	0.1180	-9.48e-02	-3.65e-02	5.35e-03	5.95e-02	4.60e-03	1.53e-02	3.51e-01	8.91e-01	1.28e-01	9.06e-01
GOBP REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY	102	4.85e-01	7.94e-01	0.1180	-7.02e-02	7.82e-02	-3.62e-03	3.32e-02	-4.16e-02	2.21e-01	1.72e-01	9.50e-01	5.62e-01	4.68e-01
GOBP REGULATION OF CYTOPLASMIC TRANSLATION	30	9.42e-01	9.82e-01	0.1180	-7.74e-02	4.01e-02	-5.78e-02	-5.32e-02	1.04e-02	4.63e-01	7.04e-01	5.84e-01	6.14e-01	9.21e-01
GOBP REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS	114	3.64e-01	7.05e-01	0.1180	-7.84e-02	2.69e-02	7.32e-02	-4.04e-02	4.22e-03	1.48e-01	6.19e-01	1.77e-01	4.56e-01	9.38e-01
GOBP POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT	41	8.86e-01	9.62e-01	0.1180	-8.79e-02	7.52e-02	8.57e-03	-1.89e-02	-4.64e-03	3.30e-01	4.05e-01	9.24e-01	8.34e-01	9.59e-01
GOMF LIPID BINDING	808	1.27e-05	4.15e-04	0.1180	-5.85e-02	7.63e-02	2.26e-02	4.44e-02	-4.60e-02	4.73e-03	2.27e-04	2.75e-01	3.18e-02	2.62e-02
GOBP NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY	12	9.93e-01	9.97e-01	0.1180	1.34e-02	-8.92e-02	2.62e-02	5.74e-02	-4.12e-02	9.36e-01	5.92e-01	8.75e-01	7.31e-01	8.05e-01
GOBP REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS	113	4.95e-01	8.00e-01	0.1170	2.88e-03	-7.41e-02	-3.26e-02	-1.93e-02	8.29e-02	9.58e-01	1.74e-01	5.50e-01	7.23e-01	1.28e-01
GOBP MEMBRANE FUSION	174	1.98e-01	5.47e-01	0.1170	4.11e-02	8.39e-02	-7.82e-03	-5.62e-02	-4.29e-02	3.50e-01	5.61e-02	8.59e-01	2.01e-01	3.28e-01
GOBP REGULATION OF MIRNA TRANSCRIPTION	69	7.16e-01	9.01e-01	0.1170	-5.36e-02	8.06e-02	1.01e-02	-6.53e-02	-7.48e-03	4.41e-01	2.47e-01	8.85e-01	3.48e-01	9.14e-01
GOBP POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION	157	3.27e-01	6.76e-01	0.1170	-4.17e-02	7.37e-02	4.78e-02	6.58e-02	2.68e-04	3.68e-01	1.11e-01	3.01e-01	1.55e-01	9.95e-01
GOMF VITAMIN B6 BINDING	54	7.74e-01	9.25e-01	0.1170	6.77e-02	6.06e-02	5.64e-02	-4.70e-02	1.18e-02	3.90e-01	4.41e-01	4.74e-01	5.51e-01	8.80e-01
GOBP POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION	74	6.79e-01	8.87e-01	0.1170	-7.76e-02	4.24e-02	5.48e-02	-3.37e-02	4.25e-02	2.48e-01	5.28e-01	4.15e-01	6.16e-01	5.28e-01
GOBP SYNAPTIC VESICLE RECYCLING	76	7.45e-01	9.14e-01	0.1170	1.61e-03	1.65e-02	-2.59e-02	-1.04e-01	4.56e-02	9.81e-01	8.04e-01	6.97e-01	1.18e-01	4.92e-01
GOBP REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION	172	1.96e-01	5.45e-01	0.1170	4.26e-02	6.26e-02	-1.70e-02	-1.91e-02	-8.59e-02	3.36e-01	1.56e-01	7.00e-01	6.66e-01	5.21e-02
GOBP REGULATION OF ORGANELLE ASSEMBLY	231	2.03e-01	5.53e-01	0.1170	5.98e-02	9.58e-03	-7.07e-02	-6.36e-02	3.22e-02	1.17e-01	8.02e-01	6.40e-02	9.58e-02	3.99e-01
GOBP PROTEIN LOCALIZATION TO ENDOSOME	24	9.60e-01	9.88e-01	0.1170	-9.32e-02	-1.15e-02	2.18e-02	-1.45e-02	6.51e-02	4.29e-01	9.22e-01	8.54e-01	9.02e-01	5.81e-01
GOBP CARBOHYDRATE METABOLIC PROCESS	541	9.94e-04	1.54e-02	0.1170	2.22e-02	8.64e-02	1.64e-03	-7.32e-02	2.06e-02	3.77e-01	5.89e-04	9.48e-01	3.60e-03	4.12e-01
GOCC LAMELLIPODIUM MEMBRANE	22	9.38e-01	9.80e-01	0.1170	4.66e-02	-4.25e-02	1.71e-02	-4.32e-02	-8.71e-02	7.05e-01	7.30e-01	8.90e-01	7.26e-01	4.79e-01
GOBP ENDOTHELIAL CELL DEVELOPMENT	65	7.44e-01	9.14e-01	0.1170	-9.34e-02	4.77e-02	9.25e-03	-4.40e-02	2.58e-02	1.93e-01	5.06e-01	8.97e-01	5.39e-01	7.19e-01
GOBP RETINA DEVELOPMENT IN CAMERA TYPE EYE	156	3.04e-01	6.58e-01	0.1170	1.23e-02	4.26e-02	1.06e-01	1.95e-02	-2.25e-03	7.91e-01	3.58e-01	2.17e-02	6.75e-01	9.61e-01
GOBP EXCITATORY SYNAPSE ASSEMBLY	31	9.54e-01	9.86e-01	0.1170	2.07e-02	1.45e-02	7.02e-02	5.99e-02	6.72e-02	8.42e-01	8.89e-01	4.99e-01	5.64e-01	5.17e-01
GOBP RESPONSE TO TRANSFORMING GROWTH FACTOR BETA	286	3.05e-02	1.85e-01	0.1170	-4.48e-02	5.46e-02	6.88e-02	-4.50e-02	4.39e-02	1.92e-01	1.12e-01	4.54e-02	1.91e-01	2.02e-01
GOBP PYRUVATE METABOLIC PROCESS	112	5.26e-01	8.17e-01	0.1170	4.28e-02	8.05e-02	1.14e-02	-5.46e-02	4.71e-02	4.34e-01	1.41e-01	8.36e-01	3.18e-01	3.89e-01
GOMF ACETYLCHOLINE RECEPTOR BINDING	11	9.90e-01	9.96e-01	0.1170	3.60e-02	6.45e-02	7.95e-02	-2.96e-02	-3.14e-02	8.36e-01	7.11e-01	6.48e-01	8.65e-01	8.57e-01
GOBP PROTEIN LOCALIZATION TO CELL SURFACE	64	5.73e-01	8.39e-01	0.1170	-4.75e-02	1.55e-02	5.99e-02	-7.33e-02	-4.67e-02	5.11e-01	8.30e-01	4.07e-01	3.10e-01	5.18e-01
GOBP ALDEHYDE CATABOLIC PROCESS	14	9.73e-01	9.92e-01	0.1170	-4.85e-03	4.21e-02	-2.92e-02	1.05e-01	4.04e-04	9.75e-01	7.85e-01	8.50e-01	4.97e-01	9.98e-01
GOBP TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY	225	9.88e-02	3.80e-01	0.1170	-2.21e-02	6.21e-02	3.85e-02	-6.80e-02	5.64e-02	5.68e-01	1.08e-01	3.20e-01	7.86e-02	1.45e-01
GOBP SPERM CAPACITATION	30	9.63e-01	9.90e-01	0.1170	-3.68e-02	-2.82e-02	6.90e-02	7.85e-02	2.35e-02	7.27e-01	7.89e-01	5.13e-01	4.57e-01	8.24e-01
GOBP MAMMARY GLAND MORPHOGENESIS	41	7.76e-01	9.26e-01	0.1170	3.97e-03	-7.09e-02	7.05e-02	-1.83e-02	-5.71e-02	9.65e-01	4.32e-01	4.35e-01	8.39e-01	5.27e-01
GOBP POSITIVE REGULATION OF CELL DIFFERENTIATION	853	1.63e-06	6.85e-05	0.1170	-4.62e-02	7.25e-02	5.75e-02	-4.68e-02	2.66e-02	2.20e-02	3.26e-04	4.31e-03	2.03e-02	1.87e-01
GOMF AMINOACYLTRANSFERASE ACTIVITY	454	2.18e-03	2.88e-02	0.1170	1.37e-02	4.46e-02	-2.39e-02	-9.70e-02	-3.77e-02	6.17e-01	1.03e-01	3.82e-01	3.97e-04	1.69e-01
GOBP OVULATION CYCLE PROCESS	50	8.71e-01	9.58e-01	0.1170	-1.81e-02	5.31e-02	5.43e-02	8.15e-02	2.90e-02	8.25e-01	5.16e-01	5.07e-01	3.19e-01	7.22e-01
GOBP NEGATIVE REGULATION OF ORGANELLE ORGANIZATION	336	4.89e-02	2.50e-01	0.1170	7.81e-02	-8.09e-03	-6.68e-02	-5.41e-02	-4.90e-03	1.39e-02	7.99e-01	3.54e-02	8.82e-02	8.77e-01
GOBP PHOSPHOLIPID TRANSLOCATION	50	8.77e-01	9.59e-01	0.1160	-5.83e-02	1.99e-02	3.32e-02	2.78e-02	-8.89e-02	4.76e-01	8.07e-01	6.85e-01	7.34e-01	2.77e-01
GOBP STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE	225	1.46e-01	4.69e-01	0.1160	-2.94e-02	8.51e-02	6.44e-02	3.20e-03	3.61e-02	4.47e-01	2.78e-02	9.61e-02	9.34e-01	3.51e-01
GOBP RESPIRATORY SYSTEM DEVELOPMENT	207	1.06e-01	3.95e-01	0.1160	-6.60e-02	3.13e-02	1.83e-02	-8.53e-02	2.48e-02	1.01e-01	4.38e-01	6.50e-01	3.45e-02	5.39e-01
GOBP CARDIAC MUSCLE CELL DIFFERENTIATION	129	4.58e-01	7.77e-01	0.1160	2.22e-02	4.40e-02	1.00e-01	2.33e-02	2.21e-02	6.63e-01	3.88e-01	4.88e-02	6.48e-01	6.65e-01
GOBP POSITIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS	90	6.32e-01	8.70e-01	0.1160	-2.54e-02	7.65e-02	-4.30e-03	-7.84e-02	2.98e-02	6.77e-01	2.10e-01	9.44e-01	1.99e-01	6.25e-01
GOBP POSITIVE REGULATION OF ORGANELLE ORGANIZATION	495	7.53e-03	7.15e-02	0.1160	2.89e-02	3.92e-02	-4.44e-02	-9.22e-02	2.64e-02	2.70e-01	1.35e-01	9.05e-02	4.44e-04	3.15e-01
GOCC SYNAPTIC MEMBRANE	368	3.96e-02	2.19e-01	0.1160	-4.55e-03	-1.36e-02	9.57e-02	6.46e-02	-2.29e-03	8.81e-01	6.55e-01	1.62e-03	3.32e-02	9.40e-01
GOBP REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION	77	6.99e-01	8.95e-01	0.1160	1.30e-02	3.05e-02	-5.53e-03	6.08e-02	-9.34e-02	8.44e-01	6.43e-01	9.33e-01	3.56e-01	1.57e-01
GOBP REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY	45	8.67e-01	9.55e-01	0.1160	2.43e-02	-9.12e-02	-4.46e-02	5.07e-02	-8.40e-03	7.78e-01	2.90e-01	6.05e-01	5.56e-01	9.22e-01
GOCC VESICLE MEMBRANE	1170	1.19e-08	8.43e-07	0.1160	-5.15e-02	9.01e-02	2.92e-02	-4.16e-02	-1.39e-02	3.01e-03	2.05e-07	9.26e-02	1.66e-02	4.23e-01
GOBP REGULATION OF STEROID BIOSYNTHETIC PROCESS	79	7.09e-01	8.98e-01	0.1160	-9.86e-02	-3.14e-02	4.47e-02	2.67e-02	-1.09e-02	1.30e-01	6.29e-01	4.92e-01	6.82e-01	8.67e-01
GOBP POSITIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS	112	5.92e-01	8.47e-01	0.1160	-5.38e-03	3.82e-02	-3.83e-02	-9.34e-02	4.30e-02	9.22e-01	4.85e-01	4.84e-01	8.77e-02	4.32e-01
GOBP REGULATION OF CYTOSKELETON ORGANIZATION	491	1.71e-03	2.39e-02	0.1160	3.50e-04	1.09e-01	-9.98e-03	-3.37e-02	-1.76e-02	9.89e-01	3.32e-05	7.05e-01	2.01e-01	5.04e-01
GOBP NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION	88	5.74e-01	8.40e-01	0.1160	-3.49e-02	3.25e-02	-3.06e-03	9.37e-02	-4.94e-02	5.72e-01	5.98e-01	9.60e-01	1.29e-01	4.23e-01
GOBP PEPTIDYL TYROSINE MODIFICATION	266	1.40e-01	4.60e-01	0.1160	-3.76e-02	5.73e-02	7.00e-02	4.94e-02	-3.80e-02	2.91e-01	1.08e-01	4.94e-02	1.65e-01	2.86e-01
GOBP ANGIOGENESIS INVOLVED IN WOUND HEALING	31	8.81e-01	9.61e-01	0.1160	2.67e-02	1.68e-02	-1.36e-02	8.89e-02	6.64e-02	7.97e-01	8.71e-01	8.96e-01	3.92e-01	5.22e-01
GOBP CAMERA TYPE EYE MORPHOGENESIS	130	3.08e-01	6.61e-01	0.1160	3.30e-02	3.51e-02	9.87e-02	-2.06e-02	3.17e-02	5.16e-01	4.90e-01	5.20e-02	6.85e-01	5.33e-01
GOBP REGULATION OF CHOLESTEROL EFFLUX	54	8.11e-01	9.38e-01	0.1160	-9.89e-02	1.09e-02	2.72e-02	-3.61e-02	3.90e-02	2.08e-01	8.89e-01	7.30e-01	6.46e-01	6.20e-01
GOBP REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	34	9.09e-01	9.70e-01	0.1160	5.23e-02	5.70e-02	2.62e-02	-1.47e-02	-8.09e-02	5.98e-01	5.65e-01	7.92e-01	8.82e-01	4.15e-01
GOBP PROTEIN TETRAMERIZATION	88	6.39e-01	8.73e-01	0.1160	7.43e-02	6.22e-02	-5.72e-02	-2.67e-02	6.54e-03	2.28e-01	3.13e-01	3.53e-01	6.65e-01	9.16e-01
GOBP NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH	108	4.85e-01	7.94e-01	0.1160	-8.35e-02	7.86e-02	1.04e-02	1.01e-02	-7.06e-03	1.34e-01	1.58e-01	8.52e-01	8.56e-01	8.99e-01
GOBP GLANDULAR EPITHELIAL CELL DIFFERENTIATION	72	5.05e-01	8.05e-01	0.1160	-3.44e-02	-2.17e-02	4.77e-02	-9.69e-02	9.05e-03	6.14e-01	7.50e-01	4.84e-01	1.55e-01	8.94e-01
GOBP ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION	21	9.72e-01	9.92e-01	0.1160	-7.21e-03	2.90e-02	-1.87e-02	-2.94e-02	-1.06e-01	9.54e-01	8.18e-01	8.82e-01	8.16e-01	3.99e-01
GOBP POSITIVE REGULATION OF DEVELOPMENTAL PROCESS	1306	6.47e-10	5.47e-08	0.1160	-3.10e-02	7.75e-02	5.92e-02	-4.83e-02	2.36e-02	5.97e-02	2.54e-06	3.24e-04	3.38e-03	1.52e-01
GOBP NERVE DEVELOPMENT	94	5.61e-01	8.33e-01	0.1160	2.10e-02	9.17e-02	5.43e-02	-3.93e-02	-4.59e-03	7.25e-01	1.25e-01	3.63e-01	5.11e-01	9.39e-01
GOBP RESPONSE TO PEPTIDE	498	1.85e-03	2.53e-02	0.1150	-1.48e-02	9.49e-02	5.97e-02	-2.20e-02	-7.51e-03	5.71e-01	2.87e-04	2.24e-02	4.00e-01	7.74e-01
GOMF SH3 DOMAIN BINDING	114	6.09e-01	8.58e-01	0.1150	-2.00e-02	3.64e-02	8.81e-02	5.06e-02	3.59e-02	7.12e-01	5.02e-01	1.04e-01	3.50e-01	5.08e-01
GOCC GOLGI APPARATUS SUBCOMPARTMENT	348	2.48e-02	1.61e-01	0.1150	-3.71e-02	6.57e-02	-4.71e-02	-6.47e-02	-3.50e-02	2.34e-01	3.52e-02	1.31e-01	3.81e-02	2.63e-01
GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION	121	2.27e-01	5.80e-01	0.1150	3.88e-02	-2.63e-02	3.30e-02	-9.85e-02	1.68e-02	4.61e-01	6.17e-01	5.30e-01	6.12e-02	7.49e-01
GOBP C21 STEROID HORMONE BIOSYNTHETIC PROCESS	20	9.80e-01	9.93e-01	0.1150	-3.61e-02	-7.24e-02	-1.41e-02	1.60e-02	-7.93e-02	7.80e-01	5.75e-01	9.13e-01	9.02e-01	5.39e-01
GOBP LOCOMOTORY EXPLORATION BEHAVIOR	14	9.85e-01	9.95e-01	0.1150	-2.08e-02	1.09e-01	-2.62e-02	1.40e-02	-1.28e-02	8.93e-01	4.82e-01	8.65e-01	9.28e-01	9.34e-01
GOBP POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL	40	8.97e-01	9.66e-01	0.1150	6.13e-02	-3.04e-02	8.39e-02	3.92e-02	-1.26e-04	5.02e-01	7.39e-01	3.59e-01	6.68e-01	9.99e-01
GOBP EXPLORATION BEHAVIOR	28	9.52e-01	9.85e-01	0.1150	3.23e-02	4.85e-03	4.71e-02	-4.42e-02	8.95e-02	7.67e-01	9.65e-01	6.66e-01	6.86e-01	4.13e-01
GOBP RESPONSE TO RETINOIC ACID	105	5.24e-01	8.15e-01	0.1150	-7.60e-02	6.74e-02	-2.31e-02	-4.83e-02	7.96e-03	1.79e-01	2.33e-01	6.83e-01	3.92e-01	8.88e-01
GOBP MYOTUBE DIFFERENTIATION	127	4.98e-01	8.02e-01	0.1150	3.18e-02	5.75e-02	6.33e-02	3.19e-02	6.23e-02	5.37e-01	2.63e-01	2.18e-01	5.35e-01	2.25e-01
GOBP RECEPTOR MEDIATED ENDOCYTOSIS	251	6.11e-02	2.90e-01	0.1150	-5.20e-02	6.95e-02	5.84e-02	-3.25e-02	-3.48e-02	1.56e-01	5.80e-02	1.11e-01	3.75e-01	3.42e-01
GOBP MICROTUBULE BASED TRANSPORT	204	3.07e-01	6.60e-01	0.1150	3.22e-02	6.52e-03	-5.42e-02	-8.01e-02	5.27e-02	4.27e-01	8.72e-01	1.82e-01	4.86e-02	1.95e-01
GOBP NEGATIVE REGULATION OF BLOOD PRESSURE	46	8.80e-01	9.61e-01	0.1150	-5.55e-02	4.29e-02	5.38e-02	-2.86e-03	7.33e-02	5.15e-01	6.15e-01	5.27e-01	9.73e-01	3.90e-01
GOBP POSITIVE REGULATION OF MIRNA METABOLIC PROCESS	60	7.81e-01	9.28e-01	0.1150	-1.05e-02	7.92e-02	-4.38e-03	-6.04e-02	-5.59e-02	8.89e-01	2.89e-01	9.53e-01	4.19e-01	4.54e-01
GOBP BIOLOGICAL PROCESS INVOLVED IN SYMBIOTIC INTERACTION	304	7.30e-02	3.23e-01	0.1150	-4.77e-02	9.87e-03	-4.61e-02	-8.32e-02	4.18e-02	1.53e-01	7.67e-01	1.67e-01	1.26e-02	2.10e-01
GOMF STRUCTURAL MOLECULE ACTIVITY	749	1.35e-05	4.37e-04	0.1150	-6.12e-02	-7.08e-02	-5.62e-02	3.34e-02	-1.11e-02	4.34e-03	9.67e-04	8.89e-03	1.20e-01	6.06e-01
GOCC LEADING EDGE MEMBRANE	174	2.44e-01	6.00e-01	0.1150	-1.45e-02	8.73e-02	6.96e-02	-2.10e-02	1.04e-03	7.41e-01	4.70e-02	1.13e-01	6.33e-01	9.81e-01
GOMF EXOPEPTIDASE ACTIVITY	100	5.85e-01	8.45e-01	0.1150	-6.63e-02	1.93e-04	8.48e-02	1.25e-02	3.70e-02	2.52e-01	9.97e-01	1.43e-01	8.29e-01	5.23e-01
GOBP MYELOID CELL DIFFERENTIATION	413	6.97e-03	6.76e-02	0.1140	-1.27e-02	8.85e-02	1.31e-02	-7.00e-02	5.64e-03	6.58e-01	2.02e-03	6.49e-01	1.47e-02	8.44e-01
GOBP NUCLEOTIDE TRANSPORT	40	9.07e-01	9.69e-01	0.1140	3.39e-02	6.69e-02	1.68e-02	-7.82e-02	3.26e-02	7.10e-01	4.64e-01	8.54e-01	3.92e-01	7.21e-01
GOMF SULFOTRANSFERASE ACTIVITY	49	9.13e-01	9.71e-01	0.1140	-3.47e-02	3.76e-02	8.45e-02	4.66e-02	-3.42e-02	6.74e-01	6.49e-01	3.06e-01	5.73e-01	6.79e-01
GOBP HEMOPOIESIS	911	2.24e-06	9.01e-05	0.1140	-3.09e-03	8.47e-02	2.39e-02	-6.82e-02	2.59e-02	8.74e-01	1.44e-05	2.21e-01	4.81e-04	1.85e-01
GOBP ICOSANOID METABOLIC PROCESS	115	5.19e-01	8.13e-01	0.1140	3.73e-02	1.88e-02	4.26e-02	9.32e-02	2.89e-02	4.90e-01	7.27e-01	4.30e-01	8.44e-02	5.92e-01
GOBP REGULATION OF MOTOR NEURON APOPTOTIC PROCESS	15	9.88e-01	9.96e-01	0.1140	1.35e-02	2.48e-02	-1.67e-02	-1.09e-01	3.20e-03	9.28e-01	8.68e-01	9.11e-01	4.63e-01	9.83e-01
GOBP MONOATOMIC ION TRANSMEMBRANE TRANSPORT	973	3.24e-05	9.30e-04	0.1140	-4.33e-02	4.66e-02	7.90e-02	4.66e-02	-2.46e-02	2.21e-02	1.38e-02	3.02e-05	1.39e-02	1.95e-01
GOBP NEURON PROJECTION ORGANIZATION	84	7.39e-01	9.11e-01	0.1140	3.10e-04	1.97e-02	8.16e-02	5.04e-02	-5.87e-02	9.96e-01	7.55e-01	1.96e-01	4.24e-01	3.52e-01
GOMF TUMOR NECROSIS FACTOR RECEPTOR BINDING	29	9.62e-01	9.89e-01	0.1140	-8.30e-03	7.49e-02	5.59e-02	5.32e-02	3.74e-02	9.38e-01	4.85e-01	6.03e-01	6.20e-01	7.27e-01
GOBP CENTRAL NERVOUS SYSTEM DEVELOPMENT	967	2.31e-07	1.25e-05	0.1140	1.22e-02	1.08e-02	4.81e-02	-6.34e-02	8.02e-02	5.22e-01	5.68e-01	1.13e-02	8.43e-04	2.42e-05
GOBP REGULATION OF BLOOD CIRCULATION	247	1.91e-01	5.38e-01	0.1140	-3.26e-02	2.70e-02	8.61e-02	5.01e-02	-3.63e-02	3.78e-01	4.65e-01	1.98e-02	1.75e-01	3.26e-01
GOBP RESPONSE TO BACTERIUM	660	6.04e-04	1.03e-02	0.1140	-7.77e-02	1.94e-02	3.40e-02	6.74e-02	-3.02e-02	6.64e-04	3.95e-01	1.36e-01	3.13e-03	1.86e-01
GOBP CELL CELL SIGNALING	1625	2.93e-10	2.54e-08	0.1140	-2.10e-02	8.45e-02	7.32e-02	3.32e-03	-7.05e-03	1.59e-01	1.33e-08	8.63e-07	8.23e-01	6.36e-01
GOBP POSITIVE REGULATION OF DEFENSE RESPONSE	460	2.78e-03	3.48e-02	0.1140	-4.60e-02	7.79e-02	1.42e-02	-1.50e-02	6.62e-02	9.09e-02	4.17e-03	6.02e-01	5.82e-01	1.49e-02
GOBP MICROTUBULE BASED PROCESS	897	1.86e-04	3.93e-03	0.1140	2.74e-02	4.16e-03	-7.40e-02	-7.79e-02	2.60e-02	1.65e-01	8.33e-01	1.69e-04	7.61e-05	1.87e-01
GOBP PROTEIN LOCALIZATION TO PLASMA MEMBRANE	278	6.12e-02	2.91e-01	0.1140	-6.09e-02	6.33e-02	6.86e-02	-1.22e-02	-2.04e-02	8.05e-02	6.95e-02	4.91e-02	7.26e-01	5.58e-01
GOMF AMINOPEPTIDASE ACTIVITY	38	9.10e-01	9.70e-01	0.1140	1.10e-01	-2.53e-02	-9.42e-03	-7.30e-03	-1.00e-02	2.41e-01	7.88e-01	9.20e-01	9.38e-01	9.15e-01
GOBP REGULATION OF CIRCADIAN RHYTHM	110	4.67e-01	7.82e-01	0.1140	2.72e-02	6.45e-02	2.26e-02	-8.53e-02	1.72e-02	6.23e-01	2.43e-01	6.82e-01	1.22e-01	7.56e-01
GOBP LOCOMOTORY BEHAVIOR	198	7.40e-02	3.26e-01	0.1140	-1.52e-02	-7.82e-03	9.98e-02	-3.40e-02	3.94e-02	7.13e-01	8.50e-01	1.54e-02	4.09e-01	3.39e-01
GOBP TRABECULA MORPHOGENESIS	47	8.63e-01	9.54e-01	0.1140	2.76e-02	5.58e-02	5.13e-03	8.22e-02	-4.77e-02	7.43e-01	5.08e-01	9.51e-01	3.29e-01	5.71e-01
GOBP NUCLEOSIDE METABOLIC PROCESS	53	8.47e-01	9.49e-01	0.1140	-4.16e-02	6.91e-02	-6.61e-03	-7.99e-02	4.32e-03	6.00e-01	3.84e-01	9.34e-01	3.15e-01	9.57e-01
GOBP REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION	366	1.63e-02	1.24e-01	0.1140	-1.13e-02	1.04e-01	5.90e-03	-2.52e-02	-3.63e-02	7.11e-01	6.29e-04	8.46e-01	4.08e-01	2.33e-01
GOBP BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE	150	1.01e-01	3.84e-01	0.1140	4.11e-02	-2.16e-02	2.65e-02	-8.66e-02	-5.07e-02	3.85e-01	6.49e-01	5.75e-01	6.70e-02	2.84e-01
GOBP MEMORY	120	5.11e-01	8.08e-01	0.1140	-1.00e-02	4.36e-02	7.63e-02	2.64e-02	-6.65e-02	8.50e-01	4.10e-01	1.49e-01	6.17e-01	2.08e-01
GOBP POSITIVE REGULATION OF LOCOMOTION	587	1.02e-03	1.58e-02	0.1140	-8.06e-02	5.90e-02	5.19e-02	1.17e-02	9.60e-03	8.50e-04	1.47e-02	3.15e-02	6.28e-01	6.91e-01
GOBP REGULATION OF TRANSFERASE ACTIVITY	669	1.81e-04	3.87e-03	0.1130	-1.90e-02	3.66e-02	-1.66e-02	-1.04e-01	9.48e-03	4.03e-01	1.06e-01	4.64e-01	4.49e-06	6.76e-01
GOBP MUSCLE ORGAN DEVELOPMENT	342	2.32e-02	1.55e-01	0.1130	4.56e-02	5.50e-02	2.48e-02	-7.18e-02	4.45e-02	1.47e-01	8.03e-02	4.30e-01	2.24e-02	1.57e-01
GOBP NEGATIVE REGULATION OF SECRETION	163	3.02e-01	6.55e-01	0.1130	1.07e-02	8.52e-02	2.20e-02	-6.31e-02	3.20e-02	8.14e-01	6.06e-02	6.28e-01	1.65e-01	4.81e-01
GOBP STEM CELL DEVELOPMENT	87	7.02e-01	8.96e-01	0.1130	6.40e-02	5.19e-02	7.25e-03	-3.14e-02	7.08e-02	3.02e-01	4.02e-01	9.07e-01	6.13e-01	2.53e-01
GOBP FATTY ACID METABOLIC PROCESS	384	1.52e-02	1.18e-01	0.1130	1.16e-02	8.23e-02	-2.54e-02	-3.82e-02	6.20e-02	6.97e-01	5.65e-03	3.93e-01	1.99e-01	3.70e-02
GOBP REGULATION OF IMMUNE RESPONSE	865	7.08e-06	2.44e-04	0.1130	-5.92e-02	8.26e-02	3.25e-02	-8.13e-03	3.74e-02	3.12e-03	3.75e-05	1.05e-01	6.85e-01	6.21e-02
GOMF UBIQUITIN LIKE PROTEIN CONJUGATING ENZYME BINDING	37	8.93e-01	9.64e-01	0.1130	-3.46e-02	1.03e-01	-2.63e-02	-3.26e-03	1.76e-02	7.16e-01	2.78e-01	7.82e-01	9.73e-01	8.53e-01
GOBP POSITIVE REGULATION OF KINASE ACTIVITY	325	4.32e-02	2.31e-01	0.1130	-1.51e-02	7.50e-02	7.47e-02	7.95e-03	-3.64e-02	6.40e-01	2.01e-02	2.06e-02	8.05e-01	2.59e-01
GOBP NEGATIVE REGULATION OF SIGNALING	1396	1.45e-09	1.15e-07	0.1130	-2.32e-02	5.35e-02	8.23e-03	-8.86e-02	3.84e-02	1.47e-01	7.98e-04	6.06e-01	2.84e-08	1.61e-02
GOBP NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS	65	7.14e-01	9.01e-01	0.1130	-1.50e-03	-9.52e-03	-3.01e-03	3.43e-02	1.07e-01	9.83e-01	8.94e-01	9.67e-01	6.33e-01	1.35e-01
GOBP NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE	89	6.00e-01	8.53e-01	0.1130	1.45e-02	-2.78e-02	-2.49e-02	7.83e-03	1.05e-01	8.13e-01	6.51e-01	6.85e-01	8.98e-01	8.60e-02
GOBP GLAND DEVELOPMENT	428	6.27e-03	6.30e-02	0.1130	1.16e-02	5.59e-02	2.37e-03	-9.55e-02	1.89e-02	6.80e-01	4.75e-02	9.33e-01	7.01e-04	5.02e-01
GOBP REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION	61	7.82e-01	9.28e-01	0.1130	-3.07e-02	-1.92e-02	1.05e-01	1.91e-02	-9.98e-03	6.78e-01	7.96e-01	1.57e-01	7.96e-01	8.93e-01
GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION	313	6.99e-02	3.14e-01	0.1130	4.05e-02	6.11e-02	-1.02e-02	-5.62e-02	6.39e-02	2.18e-01	6.29e-02	7.56e-01	8.74e-02	5.19e-02
GOBP POSITIVE REGULATION OF GLIOGENESIS	68	8.00e-01	9.33e-01	0.1130	7.97e-02	2.04e-02	5.54e-03	-4.27e-02	6.40e-02	2.56e-01	7.71e-01	9.37e-01	5.43e-01	3.62e-01
GOBP POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS	13	9.87e-01	9.95e-01	0.1130	-7.73e-02	5.12e-02	-5.37e-04	3.55e-02	5.34e-02	6.29e-01	7.49e-01	9.97e-01	8.25e-01	7.39e-01
GOBP PEPTIDE TRANSPORT	254	1.16e-01	4.17e-01	0.1130	3.76e-02	9.76e-02	4.14e-02	4.96e-03	4.24e-03	3.02e-01	7.39e-03	2.56e-01	8.92e-01	9.07e-01
GOCC AXON	618	3.04e-03	3.71e-02	0.1130	-1.41e-02	5.34e-02	8.84e-02	4.22e-02	6.71e-03	5.49e-01	2.33e-02	1.75e-04	7.34e-02	7.76e-01
GOBP CELLULAR RESPONSE TO ALCOHOL	99	6.92e-01	8.92e-01	0.1130	-4.90e-02	4.19e-02	7.99e-02	4.06e-02	2.21e-02	3.99e-01	4.71e-01	1.69e-01	4.85e-01	7.04e-01
GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION	354	3.03e-02	1.85e-01	0.1130	-5.70e-02	8.43e-02	4.12e-02	2.46e-02	3.61e-03	6.55e-02	6.43e-03	1.83e-01	4.27e-01	9.07e-01
GOBP NEGATIVE REGULATION OF RECEPTOR BINDING	12	9.97e-01	9.98e-01	0.1120	-7.93e-03	-3.79e-02	-6.73e-02	-6.66e-02	4.69e-02	9.62e-01	8.20e-01	6.87e-01	6.89e-01	7.79e-01
GOBP RESPONSE TO ORGANOPHOSPHORUS	120	4.51e-01	7.71e-01	0.1120	-4.04e-02	2.90e-02	9.98e-02	-4.67e-03	1.40e-02	4.45e-01	5.84e-01	5.89e-02	9.30e-01	7.92e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY	129	3.39e-01	6.85e-01	0.1120	-3.58e-02	6.31e-02	7.12e-02	-4.23e-02	-2.17e-02	4.82e-01	2.16e-01	1.63e-01	4.07e-01	6.71e-01
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION	208	8.05e-02	3.42e-01	0.1120	-4.09e-02	4.19e-02	2.69e-02	-7.75e-02	-4.91e-02	3.09e-01	2.98e-01	5.04e-01	5.39e-02	2.22e-01
GOCC DENDRITIC TREE	589	3.65e-03	4.26e-02	0.1120	-5.05e-03	4.30e-02	9.59e-02	3.79e-02	6.92e-03	8.34e-01	7.43e-02	6.97e-05	1.16e-01	7.74e-01
GOCC TIGHT JUNCTION	122	4.89e-01	7.97e-01	0.1120	-8.45e-02	1.56e-02	6.82e-02	2.92e-03	-2.24e-02	1.07e-01	7.66e-01	1.93e-01	9.56e-01	6.69e-01
GOBP FEMALE GAMETE GENERATION	158	4.20e-01	7.48e-01	0.1120	7.33e-03	-5.31e-03	-4.74e-02	-5.49e-02	8.49e-02	8.74e-01	9.08e-01	3.04e-01	2.34e-01	6.56e-02
GOBP VASCULAR ENDOTHELIAL CELL PROLIFERATION	49	8.57e-01	9.53e-01	0.1120	-3.49e-03	1.81e-02	-4.40e-02	4.59e-02	-9.02e-02	9.66e-01	8.27e-01	5.94e-01	5.78e-01	2.75e-01
GOBP REGULATION OF INTRACELLULAR TRANSPORT	322	4.53e-02	2.37e-01	0.1120	-1.27e-02	9.29e-03	-2.94e-02	-1.07e-01	6.61e-04	6.96e-01	7.74e-01	3.64e-01	9.87e-04	9.84e-01
GOBP CELLULAR RESPONSE TO BIOTIC STIMULUS	254	9.52e-02	3.73e-01	0.1120	-9.48e-02	5.35e-02	2.13e-02	-1.29e-02	-1.71e-03	9.25e-03	1.42e-01	5.59e-01	7.23e-01	9.63e-01
GOCC TRANS GOLGI NETWORK	246	9.72e-02	3.77e-01	0.1120	-5.16e-02	8.31e-02	-2.97e-02	-3.06e-02	-3.29e-02	1.64e-01	2.47e-02	4.23e-01	4.09e-01	3.74e-01
GOMF PROTEIN HOMODIMERIZATION ACTIVITY	682	1.12e-03	1.68e-02	0.1120	2.12e-02	5.24e-02	-3.83e-02	-8.29e-02	3.04e-02	3.45e-01	1.97e-02	8.84e-02	2.22e-04	1.76e-01
GOCC EXTRINSIC COMPONENT OF SYNAPTIC VESICLE MEMBRANE	10	9.96e-01	9.98e-01	0.1120	-3.72e-02	4.15e-02	-4.41e-02	-5.67e-02	-6.47e-02	8.39e-01	8.20e-01	8.09e-01	7.56e-01	7.23e-01
GOBP AMINO ACID CATABOLIC PROCESS	108	3.29e-01	6.77e-01	0.1110	-1.05e-02	2.01e-02	-2.51e-02	1.06e-01	-6.07e-03	8.51e-01	7.19e-01	6.52e-01	5.69e-02	9.13e-01
GOCC CELL CORTEX	296	7.35e-02	3.24e-01	0.1110	-4.87e-03	8.25e-02	4.23e-02	6.12e-02	7.48e-03	8.85e-01	1.46e-02	2.11e-01	7.02e-02	8.25e-01
GOBP POSITIVE REGULATION OF IMMUNE RESPONSE	693	2.32e-04	4.75e-03	0.1110	-5.46e-02	6.81e-02	4.82e-02	9.00e-03	4.88e-02	1.43e-02	2.23e-03	3.07e-02	6.86e-01	2.86e-02
GOBP OSSIFICATION	424	9.23e-03	8.25e-02	0.1110	-5.87e-02	4.34e-02	5.09e-02	-1.71e-02	6.47e-02	3.82e-02	1.25e-01	7.20e-02	5.46e-01	2.22e-02
GOMF LYASE ACTIVITY	190	1.61e-01	4.93e-01	0.1110	2.58e-02	6.92e-02	-8.14e-02	-1.69e-02	-3.03e-03	5.40e-01	9.99e-02	5.29e-02	6.87e-01	9.43e-01
GOCC 9PLUS2 MOTILE CILIUM	166	3.61e-01	7.04e-01	0.1110	-6.65e-02	-4.83e-02	-2.70e-03	2.82e-02	-6.94e-02	1.39e-01	2.83e-01	9.52e-01	5.31e-01	1.23e-01
GOCC POSTSYNAPTIC SPECIALIZATION	331	7.21e-02	3.20e-01	0.1110	-2.67e-02	5.85e-03	9.91e-02	4.18e-02	7.02e-03	4.03e-01	8.55e-01	1.93e-03	1.91e-01	8.26e-01
GOBP NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE	46	8.92e-01	9.63e-01	0.1110	-4.96e-02	7.68e-02	3.37e-02	-1.25e-02	5.21e-02	5.61e-01	3.67e-01	6.92e-01	8.83e-01	5.41e-01
GOBP HORMONE TRANSPORT	311	6.02e-02	2.87e-01	0.1110	4.80e-02	9.06e-02	4.02e-02	1.14e-02	-1.04e-02	1.46e-01	5.99e-03	2.23e-01	7.30e-01	7.52e-01
GOBP REGULATION OF AXONOGENESIS	145	5.51e-01	8.28e-01	0.1110	-5.31e-02	9.98e-03	6.77e-02	6.62e-02	-2.17e-02	2.70e-01	8.36e-01	1.59e-01	1.69e-01	6.53e-01
GOBP PHOSPHATIDIC ACID METABOLIC PROCESS	34	9.39e-01	9.81e-01	0.1110	4.73e-02	-8.85e-02	-3.00e-02	-3.08e-02	-2.02e-02	6.33e-01	3.72e-01	7.62e-01	7.56e-01	8.39e-01
GOBP CARBOHYDRATE TRANSMEMBRANE TRANSPORT	131	2.75e-01	6.30e-01	0.1110	-9.21e-03	5.86e-02	-2.13e-02	8.58e-02	-3.17e-02	8.56e-01	2.47e-01	6.74e-01	9.00e-02	5.32e-01
GOBP NEGATIVE REGULATION OF HYDROLASE ACTIVITY	203	3.61e-01	7.04e-01	0.1110	-6.04e-03	7.02e-03	6.70e-02	7.64e-02	-4.38e-02	8.82e-01	8.63e-01	9.98e-02	6.07e-02	2.82e-01
GOBP ORGANOPHOSPHATE METABOLIC PROCESS	913	6.08e-05	1.59e-03	0.1110	-1.24e-02	4.75e-02	-4.75e-02	-8.56e-02	1.81e-02	5.24e-01	1.50e-02	1.49e-02	1.14e-05	3.55e-01
GOBP REACTIVE NITROGEN SPECIES METABOLIC PROCESS	76	5.65e-01	8.35e-01	0.1110	-4.24e-02	2.69e-02	-4.57e-02	1.37e-02	8.67e-02	5.22e-01	6.86e-01	4.91e-01	8.36e-01	1.92e-01
GOBP CIRCADIAN RHYTHM	196	1.93e-01	5.39e-01	0.1110	3.92e-02	6.04e-02	3.00e-02	-7.00e-02	3.61e-02	3.43e-01	1.45e-01	4.69e-01	9.11e-02	3.84e-01
GOBP CELLULAR RESPONSE TO KETONE	96	5.02e-01	8.03e-01	0.1110	-3.66e-02	5.96e-02	1.09e-02	4.48e-02	7.26e-02	5.35e-01	3.13e-01	8.53e-01	4.48e-01	2.19e-01
GOBP HYDROGEN PEROXIDE METABOLIC PROCESS	49	8.79e-01	9.61e-01	0.1110	1.78e-02	-5.67e-02	-2.55e-02	-3.12e-03	8.99e-02	8.29e-01	4.93e-01	7.58e-01	9.70e-01	2.76e-01
GOBP POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE	123	4.45e-01	7.67e-01	0.1110	-3.96e-02	4.57e-02	8.95e-02	-1.83e-02	1.62e-02	4.48e-01	3.82e-01	8.63e-02	7.26e-01	7.56e-01
GOBP MUSCLE CELL PROLIFERATION	230	1.37e-01	4.56e-01	0.1110	-3.86e-02	2.99e-02	2.06e-02	-2.53e-02	9.40e-02	3.13e-01	4.35e-01	5.90e-01	5.09e-01	1.41e-02
GOBP SMALL MOLECULE CATABOLIC PROCESS	364	1.58e-02	1.21e-01	0.1110	3.59e-02	8.33e-02	-2.95e-02	-1.16e-02	5.52e-02	2.40e-01	6.36e-03	3.35e-01	7.03e-01	7.05e-02
GOBP MEMBRANE ORGANIZATION	773	1.60e-04	3.49e-03	0.1110	8.35e-03	5.95e-02	-3.24e-02	-8.70e-02	-5.95e-03	6.93e-01	4.90e-03	1.25e-01	3.85e-05	7.78e-01
GOBP REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC	75	7.07e-01	8.97e-01	0.1110	-9.71e-03	-6.96e-02	4.20e-02	2.35e-02	-7.08e-02	8.84e-01	2.97e-01	5.30e-01	7.25e-01	2.89e-01
GOBP REGULATION OF MICROTUBULE POLYMERIZATION	59	8.42e-01	9.48e-01	0.1110	1.28e-04	9.62e-02	-5.26e-03	-5.28e-02	1.39e-02	9.99e-01	2.01e-01	9.44e-01	4.83e-01	8.54e-01
GOBP REGULATION OF CILIUM ASSEMBLY	92	7.05e-01	8.97e-01	0.1110	8.95e-02	-4.77e-03	-2.03e-02	-3.75e-02	4.88e-02	1.38e-01	9.37e-01	7.37e-01	5.34e-01	4.18e-01
GOBP MOLTING CYCLE PROCESS	92	4.41e-01	7.63e-01	0.1110	-1.58e-02	7.34e-03	6.92e-02	-7.81e-02	3.21e-02	7.94e-01	9.03e-01	2.51e-01	1.95e-01	5.94e-01
GOBP PURINE CONTAINING COMPOUND METABOLIC PROCESS	459	1.66e-02	1.25e-01	0.1100	-1.71e-02	3.27e-02	-7.03e-02	-6.73e-02	3.71e-02	5.29e-01	2.30e-01	9.85e-03	1.35e-02	1.73e-01
GOBP TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY	392	8.92e-03	8.10e-02	0.1100	-2.60e-02	4.71e-02	2.18e-02	-8.94e-02	2.86e-02	3.78e-01	1.09e-01	4.59e-01	2.36e-03	3.30e-01
GOBP REGULATORY NCRNA MEDIATED GENE SILENCING	597	1.29e-03	1.89e-02	0.1100	-1.71e-02	-6.53e-02	3.09e-02	7.77e-02	2.50e-02	4.75e-01	6.40e-03	1.97e-01	1.18e-03	2.96e-01
GOBP LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE	10	9.97e-01	9.98e-01	0.1100	-6.42e-02	-4.00e-02	-3.74e-02	-5.35e-02	4.68e-02	7.25e-01	8.26e-01	8.38e-01	7.70e-01	7.98e-01
GOBP BONE DEVELOPMENT	203	2.00e-01	5.49e-01	0.1100	-5.75e-02	6.21e-02	3.99e-02	-3.25e-02	4.86e-02	1.58e-01	1.27e-01	3.27e-01	4.25e-01	2.33e-01
GOBP REPRODUCTIVE SYSTEM DEVELOPMENT	289	7.20e-02	3.20e-01	0.1100	4.49e-02	5.39e-02	2.60e-02	-6.26e-02	5.14e-02	1.89e-01	1.15e-01	4.47e-01	6.73e-02	1.33e-01
GOBP CALCIUM ION TRANSMEMBRANE TRANSPORT	337	1.16e-01	4.16e-01	0.1100	-2.84e-02	3.16e-02	6.62e-02	7.26e-02	-2.56e-02	3.71e-01	3.19e-01	3.68e-02	2.19e-02	4.19e-01
GOBP BLOOD VESSEL REMODELING	46	9.04e-01	9.68e-01	0.1100	-9.17e-02	1.16e-02	-7.63e-03	5.20e-03	-5.90e-02	2.82e-01	8.92e-01	9.29e-01	9.51e-01	4.89e-01
GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION	49	8.90e-01	9.63e-01	0.1100	-3.32e-02	5.18e-02	5.08e-02	1.30e-02	7.46e-02	6.88e-01	5.31e-01	5.38e-01	8.75e-01	3.67e-01
GOBP TRABECULA FORMATION	26	9.75e-01	9.93e-01	0.1100	-6.40e-02	2.94e-02	1.59e-02	3.75e-02	-7.39e-02	5.72e-01	7.95e-01	8.88e-01	7.41e-01	5.14e-01
GOBP CHONDROCYTE DIFFERENTIATION	113	4.39e-01	7.61e-01	0.1100	-2.25e-02	2.41e-02	2.37e-02	-9.83e-02	2.75e-02	6.79e-01	6.58e-01	6.64e-01	7.11e-02	6.13e-01
GOMF NUCLEAR STEROID RECEPTOR ACTIVITY	25	9.73e-01	9.92e-01	0.1100	2.50e-02	-3.29e-02	6.57e-02	3.21e-02	7.07e-02	8.29e-01	7.76e-01	5.69e-01	7.81e-01	5.41e-01
GOBP REGULATION OF LYMPHOCYTE ACTIVATION	487	5.25e-03	5.53e-02	0.1100	-2.00e-02	9.22e-02	1.89e-02	-4.55e-02	2.69e-02	4.51e-01	4.93e-04	4.74e-01	8.53e-02	3.10e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE	172	2.69e-01	6.23e-01	0.1100	-4.06e-02	6.18e-02	7.86e-02	-1.95e-02	-5.42e-03	3.58e-01	1.62e-01	7.54e-02	6.59e-01	9.02e-01
GOBP VESICLE LOCALIZATION	208	2.45e-01	6.02e-01	0.1100	6.33e-02	4.83e-02	4.25e-03	-5.44e-02	5.22e-02	1.15e-01	2.30e-01	9.16e-01	1.76e-01	1.94e-01
GOBP HEART MORPHOGENESIS	262	5.91e-02	2.84e-01	0.1100	7.34e-02	3.80e-02	1.14e-02	-7.06e-02	-8.58e-03	4.09e-02	2.90e-01	7.50e-01	4.92e-02	8.11e-01
GOBP INTERLEUKIN 2 PRODUCTION	59	7.20e-01	9.02e-01	0.1100	-1.55e-02	5.66e-02	-7.31e-03	9.22e-02	2.46e-03	8.37e-01	4.52e-01	9.23e-01	2.21e-01	9.74e-01
GOMF UBIQUITIN LIKE PROTEIN LIGASE ACTIVITY	335	2.76e-02	1.74e-01	0.1100	3.29e-02	3.01e-02	-2.70e-02	-8.01e-02	-5.35e-02	3.01e-01	3.43e-01	3.96e-01	1.17e-02	9.26e-02
GOBP STRIATED MUSCLE TISSUE DEVELOPMENT	260	1.45e-01	4.66e-01	0.1090	4.67e-02	4.44e-02	7.98e-02	2.26e-02	3.08e-02	1.94e-01	2.17e-01	2.67e-02	5.30e-01	3.92e-01
GOBP NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS	461	6.88e-03	6.71e-02	0.1090	-7.60e-02	2.74e-02	4.43e-02	2.65e-02	5.27e-02	5.18e-03	3.13e-01	1.03e-01	3.30e-01	5.25e-02
GOBP VESICLE MEDIATED TRANSPORT	1459	3.43e-09	2.62e-07	0.1090	-2.47e-02	8.81e-02	1.52e-02	-5.59e-02	1.50e-02	1.15e-01	1.76e-08	3.32e-01	3.49e-04	3.37e-01
GOBP NEGATIVE REGULATION OF PROTEIN POLYMERIZATION	74	7.32e-01	9.08e-01	0.1090	6.85e-02	4.47e-02	-1.46e-02	4.27e-02	-5.68e-02	3.08e-01	5.06e-01	8.28e-01	5.25e-01	3.98e-01
GOBP CANONICAL NF KAPPAB SIGNAL TRANSDUCTION	282	9.16e-02	3.66e-01	0.1090	-1.66e-02	8.94e-02	-1.07e-02	-5.54e-02	2.22e-02	6.32e-01	9.74e-03	7.58e-01	1.10e-01	5.21e-01
GOBP NEGATIVE REGULATION OF CELL DEVELOPMENT	274	1.06e-01	3.95e-01	0.1090	3.08e-02	8.64e-02	3.56e-02	-3.15e-02	3.55e-02	3.80e-01	1.39e-02	3.10e-01	3.70e-01	3.12e-01
GOBP NEGATIVE REGULATION OF LIPID METABOLIC PROCESS	108	5.71e-01	8.38e-01	0.1090	-8.43e-02	5.11e-02	3.28e-02	3.24e-03	3.35e-02	1.30e-01	3.59e-01	5.56e-01	9.54e-01	5.47e-01
GOCC CELL LEADING EDGE	408	1.89e-02	1.36e-01	0.1090	-1.47e-02	9.64e-02	4.62e-02	-9.48e-03	-1.36e-02	6.11e-01	8.29e-04	1.10e-01	7.43e-01	6.36e-01
GOBP PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES	19	9.82e-01	9.94e-01	0.1090	-9.21e-02	1.64e-02	1.43e-02	-5.69e-03	5.43e-02	4.87e-01	9.02e-01	9.14e-01	9.66e-01	6.82e-01
GOBP REGULATION OF ORGANELLE ORGANIZATION	1148	4.63e-06	1.69e-04	0.1090	3.40e-02	4.07e-02	-4.02e-02	-8.61e-02	8.30e-03	5.24e-02	1.99e-02	2.15e-02	8.54e-07	6.35e-01
GOBP CARDIOCYTE DIFFERENTIATION	163	2.95e-01	6.49e-01	0.1090	2.50e-02	4.61e-02	9.20e-02	-1.09e-02	2.41e-02	5.81e-01	3.10e-01	4.26e-02	8.11e-01	5.95e-01
GOBP LONG CHAIN FATTY ACID TRANSPORT	66	6.71e-01	8.83e-01	0.1090	-1.26e-02	-2.89e-02	-6.16e-02	7.94e-02	-2.76e-02	8.59e-01	6.84e-01	3.87e-01	2.64e-01	6.98e-01
GOBP REGULATION OF ACTIN NUCLEATION	36	9.41e-01	9.82e-01	0.1090	7.74e-03	-1.84e-02	-4.88e-02	-5.69e-02	-7.65e-02	9.36e-01	8.48e-01	6.12e-01	5.55e-01	4.27e-01
GOBP POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS	1007	4.03e-06	1.50e-04	0.1090	-4.78e-02	7.81e-02	4.16e-02	-6.86e-03	4.13e-02	1.03e-02	2.77e-05	2.55e-02	7.13e-01	2.66e-02
GOBP NEGATIVE REGULATION OF CELL CELL ADHESION	195	2.73e-01	6.27e-01	0.1090	-3.16e-02	8.73e-02	3.35e-02	4.20e-02	-1.79e-02	4.46e-01	3.56e-02	4.20e-01	3.12e-01	6.67e-01
GOBP ISOPRENOID BIOSYNTHETIC PROCESS	29	9.57e-01	9.87e-01	0.1090	7.34e-02	-6.32e-02	-2.48e-02	-9.11e-03	-4.16e-02	4.94e-01	5.56e-01	8.17e-01	9.32e-01	6.98e-01
GOBP NEGATIVE REGULATION OF CELL DIFFERENTIATION	683	4.33e-04	8.04e-03	0.1090	1.37e-02	5.62e-02	1.54e-02	-7.45e-02	5.17e-02	5.40e-01	1.23e-02	4.93e-01	9.01e-04	2.13e-02
GOBP REGULATION OF FATTY ACID METABOLIC PROCESS	95	6.71e-01	8.83e-01	0.1090	4.20e-03	7.88e-02	-1.46e-03	-3.39e-02	6.65e-02	9.44e-01	1.84e-01	9.80e-01	5.68e-01	2.62e-01
GOBP FERTILIZATION	194	2.50e-01	6.07e-01	0.1090	2.75e-02	-4.49e-02	8.33e-02	4.48e-02	9.86e-03	5.09e-01	2.81e-01	4.55e-02	2.82e-01	8.13e-01
GOBP HEART PROCESS	245	2.56e-01	6.13e-01	0.1080	-7.54e-04	5.51e-02	7.37e-02	5.27e-02	-2.26e-02	9.84e-01	1.37e-01	4.69e-02	1.55e-01	5.42e-01
GOBP PROTEIN LOCALIZATION TO EXTRACELLULAR REGION	363	3.44e-02	2.00e-01	0.1080	2.20e-02	6.94e-02	3.79e-02	-4.58e-02	5.41e-02	4.72e-01	2.31e-02	2.15e-01	1.34e-01	7.68e-02
GOBP REGULATION OF TRANSPORTER ACTIVITY	254	2.27e-01	5.80e-01	0.1080	-4.18e-02	4.01e-02	7.36e-02	5.31e-02	1.23e-02	2.51e-01	2.71e-01	4.35e-02	1.45e-01	7.35e-01
GOBP EXTERNAL ENCAPSULATING STRUCTURE ORGANIZATION	311	1.42e-01	4.63e-01	0.1080	-1.50e-02	-2.60e-02	5.46e-02	7.58e-02	-4.60e-02	6.49e-01	4.31e-01	9.79e-02	2.16e-02	1.63e-01
GOCC NON MOTILE CILIUM	152	4.61e-01	7.78e-01	0.1080	-8.88e-03	-2.34e-03	4.10e-02	9.98e-02	-8.03e-05	8.50e-01	9.60e-01	3.83e-01	3.36e-02	9.99e-01
GOBP REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS	169	2.69e-01	6.23e-01	0.1080	-4.91e-02	4.22e-02	2.30e-02	-7.91e-02	2.70e-02	2.71e-01	3.43e-01	6.05e-01	7.59e-02	5.45e-01
GOBP POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY	133	3.17e-01	6.66e-01	0.1080	6.53e-03	6.24e-02	7.04e-02	-4.43e-02	-2.93e-02	8.97e-01	2.14e-01	1.61e-01	3.78e-01	5.60e-01
GOBP MUSCLE CELL DIFFERENTIATION	407	2.91e-02	1.79e-01	0.1080	1.38e-02	6.78e-02	7.05e-02	3.29e-03	4.35e-02	6.33e-01	1.89e-02	1.47e-02	9.09e-01	1.32e-01
GOBP NEGATIVE REGULATION OF PROTEOLYSIS	212	2.39e-01	5.95e-01	0.1080	-4.83e-02	3.69e-02	8.80e-02	1.23e-02	-8.39e-03	2.26e-01	3.54e-01	2.73e-02	7.57e-01	8.33e-01
GOBP REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION	219	2.65e-01	6.19e-01	0.1080	-4.68e-02	7.21e-02	5.04e-02	3.54e-02	-2.17e-02	2.33e-01	6.60e-02	1.99e-01	3.66e-01	5.80e-01
GOBP POSITIVE REGULATION OF CELLULAR CATABOLIC PROCESS	380	1.02e-02	8.85e-02	0.1080	1.00e-02	-1.68e-03	-6.26e-03	-1.07e-01	3.46e-04	7.37e-01	9.55e-01	8.34e-01	3.34e-04	9.91e-01
GOBP RESPONSE TO CORTICOSTEROID	142	4.51e-01	7.71e-01	0.1080	-6.55e-03	6.56e-02	8.43e-02	1.98e-03	-1.29e-02	8.93e-01	1.77e-01	8.28e-02	9.67e-01	7.91e-01
GOBP NEUTRAL LIPID METABOLIC PROCESS	127	4.85e-01	7.94e-01	0.1080	-8.28e-02	5.84e-02	-2.69e-03	-3.63e-02	2.78e-03	1.07e-01	2.56e-01	9.58e-01	4.80e-01	9.57e-01
GOBP NEGATIVE REGULATION OF MONOATOMIC ION TRANSPORT	126	6.44e-01	8.75e-01	0.1080	-1.77e-02	5.84e-02	6.39e-02	5.46e-02	-2.87e-02	7.32e-01	2.58e-01	2.15e-01	2.90e-01	5.79e-01
GOBP POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS	198	2.94e-01	6.48e-01	0.1080	-1.54e-02	3.76e-02	-2.40e-02	-9.44e-02	2.12e-02	7.09e-01	3.62e-01	5.61e-01	2.19e-02	6.08e-01
GOBP CILIUM MOVEMENT	194	2.57e-01	6.14e-01	0.1080	-3.72e-02	-6.37e-02	-3.71e-02	5.01e-02	-4.76e-02	3.72e-01	1.26e-01	3.73e-01	2.29e-01	2.53e-01
GOBP RIBOSE PHOSPHATE METABOLIC PROCESS	360	8.81e-02	3.59e-01	0.1080	-1.57e-02	1.32e-02	-5.82e-02	-7.85e-02	3.99e-02	6.09e-01	6.67e-01	5.78e-02	1.05e-02	1.93e-01
GOBP POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION	314	6.58e-02	3.03e-01	0.1080	-2.89e-02	9.00e-02	3.13e-02	-2.84e-02	2.93e-02	3.79e-01	6.12e-03	3.40e-01	3.87e-01	3.72e-01
GOBP ENDOTHELIAL CELL MIGRATION	270	8.67e-02	3.56e-01	0.1070	-9.08e-02	-1.54e-02	-2.20e-02	4.03e-02	-3.07e-02	1.02e-02	6.63e-01	5.35e-01	2.54e-01	3.85e-01
GOCC POSTSYNAPSE	614	3.75e-03	4.34e-02	0.1070	-8.76e-03	3.69e-02	9.24e-02	3.40e-02	-1.98e-02	7.11e-01	1.18e-01	9.17e-05	1.50e-01	4.01e-01
GOBP POLYSACCHARIDE METABOLIC PROCESS	96	6.66e-01	8.82e-01	0.1070	-1.81e-02	9.65e-02	4.39e-03	-4.27e-02	6.93e-03	7.59e-01	1.02e-01	9.41e-01	4.70e-01	9.07e-01
GOBP ORGANIC HYDROXY COMPOUND TRANSPORT	302	9.78e-02	3.78e-01	0.1070	-9.44e-03	8.33e-02	3.54e-02	2.57e-02	-5.07e-02	7.78e-01	1.28e-02	2.90e-01	4.43e-01	1.29e-01
GOBP REGULATION OF EXOCYTOSIS	176	3.28e-01	6.76e-01	0.1070	-6.85e-02	7.45e-02	2.26e-02	4.55e-03	-2.68e-02	1.17e-01	8.81e-02	6.05e-01	9.17e-01	5.39e-01
GOMF FAD BINDING	39	8.35e-01	9.45e-01	0.1070	4.14e-02	4.73e-02	-6.51e-02	5.37e-02	1.98e-02	6.55e-01	6.10e-01	4.82e-01	5.62e-01	8.31e-01
GOBP MUSCLE ORGAN MORPHOGENESIS	82	7.51e-01	9.16e-01	0.1070	9.16e-02	2.77e-02	1.44e-02	-2.26e-02	3.98e-02	1.52e-01	6.65e-01	8.21e-01	7.24e-01	5.34e-01
GOMF PURINE NUCLEOTIDE BINDING	1888	3.53e-09	2.68e-07	0.1070	1.52e-02	3.14e-02	-3.63e-02	-8.89e-02	3.19e-02	2.73e-01	2.40e-02	9.02e-03	1.60e-10	2.17e-02
GOBP POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS	1615	7.89e-10	6.41e-08	0.1070	-2.83e-02	7.94e-02	4.54e-02	-3.97e-02	2.65e-02	5.83e-02	1.03e-07	2.34e-03	7.83e-03	7.55e-02
GOBP POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS	351	1.84e-02	1.34e-01	0.1070	-4.87e-02	5.99e-02	-2.35e-02	-1.72e-02	6.80e-02	1.17e-01	5.38e-02	4.50e-01	5.80e-01	2.86e-02
GOBP RESPONSE TO DEXAMETHASONE	38	9.28e-01	9.77e-01	0.1070	7.73e-02	-2.15e-03	7.79e-03	6.81e-02	2.72e-02	4.09e-01	9.82e-01	9.34e-01	4.67e-01	7.72e-01
GOMF CALMODULIN BINDING	197	2.95e-01	6.48e-01	0.1070	-1.21e-02	3.05e-02	3.37e-02	9.48e-02	-1.28e-02	7.70e-01	4.60e-01	4.15e-01	2.17e-02	7.57e-01
GOBP CELLULAR RESPONSE TO OXIDATIVE STRESS	247	1.71e-01	5.09e-01	0.1070	-1.02e-03	5.95e-02	-1.94e-02	-8.62e-02	3.18e-03	9.78e-01	1.07e-01	6.00e-01	1.96e-02	9.31e-01
GOBP REGULATION OF LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE	6	9.98e-01	9.99e-01	0.1070	4.12e-03	-4.29e-02	6.01e-02	-5.44e-02	5.41e-02	9.86e-01	8.56e-01	7.99e-01	8.17e-01	8.19e-01
GOMF MOLECULAR FUNCTION INHIBITOR ACTIVITY	468	2.50e-02	1.62e-01	0.1060	-5.76e-02	4.73e-02	4.78e-02	3.88e-02	-4.44e-02	3.27e-02	7.95e-02	7.62e-02	1.51e-01	1.00e-01
GOBP REGULATION OF LIPID LOCALIZATION	183	2.64e-01	6.19e-01	0.1060	-1.87e-02	6.81e-02	7.17e-02	-1.55e-02	-3.03e-02	6.62e-01	1.12e-01	9.41e-02	7.18e-01	4.80e-01
GOCC MICROTUBULE PLUS END	24	9.75e-01	9.93e-01	0.1060	6.17e-02	2.18e-02	-4.03e-02	-5.50e-03	-7.32e-02	6.01e-01	8.54e-01	7.33e-01	9.63e-01	5.35e-01
GOBP RAS PROTEIN SIGNAL TRANSDUCTION	318	6.09e-02	2.90e-01	0.1060	1.56e-02	4.98e-02	-3.09e-02	-6.96e-02	-5.25e-02	6.33e-01	1.27e-01	3.43e-01	3.29e-02	1.08e-01
GOBP REGULATION OF HEMOPOIESIS	405	1.76e-02	1.30e-01	0.1060	-6.17e-03	8.04e-02	2.74e-02	-6.12e-02	1.62e-02	8.31e-01	5.47e-03	3.45e-01	3.45e-02	5.76e-01
GOBP POSITIVE REGULATION OF AXON EXTENSION	33	9.57e-01	9.87e-01	0.1060	1.22e-02	-5.99e-02	1.00e-02	8.52e-02	-1.28e-02	9.03e-01	5.51e-01	9.21e-01	3.97e-01	8.98e-01
GOMF WIDE PORE CHANNEL ACTIVITY	32	9.55e-01	9.87e-01	0.1060	-5.84e-02	5.58e-02	7.23e-03	-3.81e-02	5.69e-02	5.67e-01	5.85e-01	9.44e-01	7.09e-01	5.77e-01
GOBP NEUROTRANSMITTER SECRETION	138	5.20e-01	8.13e-01	0.1060	-8.36e-02	3.16e-02	4.22e-02	1.22e-02	-3.66e-02	9.00e-02	5.21e-01	3.92e-01	8.05e-01	4.58e-01
GOBP NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS	71	8.22e-01	9.42e-01	0.1060	-2.70e-02	1.55e-02	-2.93e-02	-9.68e-02	7.16e-03	6.95e-01	8.21e-01	6.69e-01	1.58e-01	9.17e-01
GOCC DYNEIN COMPLEX	53	7.86e-01	9.29e-01	0.1060	3.90e-02	-3.67e-02	-6.56e-02	6.07e-02	1.98e-02	6.24e-01	6.44e-01	4.08e-01	4.45e-01	8.03e-01
GOBP REGULATION OF LIPID CATABOLIC PROCESS	60	8.18e-01	9.41e-01	0.1060	1.56e-02	6.06e-02	-7.55e-02	-2.60e-02	3.11e-02	8.34e-01	4.17e-01	3.12e-01	7.28e-01	6.77e-01
GOBP NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION	24	9.71e-01	9.92e-01	0.1060	7.68e-02	5.36e-03	2.71e-02	-5.44e-02	4.03e-02	5.15e-01	9.64e-01	8.18e-01	6.45e-01	7.32e-01
GOBP NEGATIVE REGULATION OF PEPTIDYL CYSTEINE S NITROSYLATION	7	9.97e-01	9.98e-01	0.1060	-4.02e-02	-1.17e-02	6.97e-02	-6.67e-02	1.35e-02	8.54e-01	9.57e-01	7.49e-01	7.60e-01	9.51e-01
GOBP REGULATION OF CELL ADHESION	771	1.04e-03	1.60e-02	0.1060	-3.96e-02	5.65e-02	7.40e-02	3.15e-02	3.64e-03	6.13e-02	7.59e-03	4.75e-04	1.36e-01	8.63e-01
GOBP REGULATION OF EPITHELIAL CELL MIGRATION	282	5.16e-02	2.60e-01	0.1060	-8.76e-02	-6.91e-03	4.58e-04	3.79e-02	4.56e-02	1.14e-02	8.42e-01	9.89e-01	2.73e-01	1.87e-01
GOBP MUSCLE TISSUE DEVELOPMENT	422	1.72e-02	1.28e-01	0.1060	3.42e-02	5.34e-02	5.78e-02	-3.12e-02	5.35e-02	2.28e-01	5.98e-02	4.17e-02	2.72e-01	5.96e-02
GOBP NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS	65	8.19e-01	9.41e-01	0.1060	-5.83e-02	3.45e-02	3.16e-02	-9.00e-03	7.43e-02	4.17e-01	6.30e-01	6.60e-01	9.00e-01	3.00e-01
GOBP LONG TERM MEMORY	36	9.50e-01	9.84e-01	0.1060	5.99e-03	8.64e-02	2.53e-02	-4.25e-02	3.51e-02	9.50e-01	3.69e-01	7.93e-01	6.59e-01	7.16e-01
GOBP GLYCOSYLATION	214	2.24e-01	5.77e-01	0.1060	5.62e-02	7.09e-02	2.17e-03	-5.46e-02	7.30e-04	1.56e-01	7.39e-02	9.56e-01	1.68e-01	9.85e-01
GOMF PROTEIN CONTAINING COMPLEX BINDING	1668	7.98e-09	5.71e-07	0.1060	8.27e-03	4.65e-02	-1.58e-02	-8.84e-02	2.94e-02	5.74e-01	1.58e-03	2.82e-01	1.83e-09	4.55e-02
GOMF GROWTH FACTOR ACTIVITY	149	4.49e-01	7.70e-01	0.1050	-7.05e-02	2.24e-02	-3.45e-02	-3.23e-02	-5.86e-02	1.38e-01	6.37e-01	4.68e-01	4.96e-01	2.17e-01
GOBP GLUTAMINE METABOLIC PROCESS	24	9.80e-01	9.93e-01	0.1050	-5.19e-02	3.21e-02	-5.88e-02	-4.33e-02	-4.56e-02	6.60e-01	7.85e-01	6.18e-01	7.14e-01	6.99e-01
GOBP LOCOMOTION	1260	7.70e-07	3.56e-05	0.1050	-7.55e-02	5.51e-02	4.66e-02	1.39e-02	3.74e-03	6.60e-06	9.98e-04	5.43e-03	4.06e-01	8.23e-01
GOBP WOUND HEALING	407	1.73e-02	1.29e-01	0.1050	-3.74e-02	9.68e-02	1.31e-02	6.47e-03	1.14e-02	1.95e-01	8.08e-04	6.50e-01	8.23e-01	6.94e-01
GOBP NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION	179	3.41e-01	6.88e-01	0.1050	-9.77e-02	8.77e-03	2.95e-02	3.49e-04	-2.45e-02	2.42e-02	8.40e-01	4.96e-01	9.94e-01	5.72e-01
GOBP POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION	41	9.29e-01	9.77e-01	0.1050	-1.93e-02	3.27e-02	-7.26e-02	-4.23e-02	5.08e-02	8.31e-01	7.17e-01	4.21e-01	6.39e-01	5.74e-01
GOBP MESENCHYMAL CELL MIGRATION	61	8.82e-01	9.61e-01	0.1050	3.63e-04	5.52e-02	8.55e-02	1.66e-02	2.08e-02	9.96e-01	4.55e-01	2.48e-01	8.23e-01	7.78e-01
GOBP RESPONSE TO CALCIUM ION	139	4.66e-01	7.81e-01	0.1050	-7.89e-02	5.96e-02	2.55e-03	-3.26e-02	-1.43e-02	1.08e-01	2.25e-01	9.59e-01	5.08e-01	7.71e-01
GOCC MEMBRANE PROTEIN COMPLEX	1147	7.74e-07	3.57e-05	0.1050	-3.44e-02	4.71e-02	3.17e-03	-8.45e-02	2.21e-02	4.95e-02	7.21e-03	8.56e-01	1.39e-06	2.07e-01
GOBP POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS	17	9.90e-01	9.96e-01	0.1050	-4.84e-02	8.18e-02	3.99e-02	-1.95e-02	5.11e-03	7.30e-01	5.59e-01	7.76e-01	8.89e-01	9.71e-01
GOBP SKIN DEVELOPMENT	306	8.99e-02	3.62e-01	0.1050	-7.29e-02	-3.20e-02	6.52e-02	2.07e-02	-3.00e-03	2.83e-02	3.36e-01	4.99e-02	5.34e-01	9.28e-01
GOBP ALCOHOL CATABOLIC PROCESS	33	9.32e-01	9.79e-01	0.1050	-6.98e-02	-3.67e-02	-4.86e-02	4.87e-02	-7.26e-03	4.88e-01	7.15e-01	6.29e-01	6.28e-01	9.42e-01
GOBP CELLULAR RESPONSE TO DECREASED OXYGEN LEVELS	146	4.88e-01	7.97e-01	0.1050	-2.72e-03	7.01e-02	-1.01e-02	-7.51e-02	1.80e-02	9.55e-01	1.44e-01	8.34e-01	1.17e-01	7.08e-01
GOBP NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION	556	2.48e-03	3.18e-02	0.1050	-2.73e-02	6.16e-02	8.95e-03	-7.90e-02	1.15e-02	2.72e-01	1.30e-02	7.18e-01	1.44e-03	6.43e-01
GOBP REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS	38	8.60e-01	9.53e-01	0.1050	6.31e-02	-4.16e-02	6.56e-02	-2.82e-02	-1.35e-02	5.01e-01	6.57e-01	4.84e-01	7.63e-01	8.85e-01
GOBP PROTEIN LOCALIZATION TO ADHERENS JUNCTION	6	9.99e-01	1.00e+00	0.1050	-2.22e-02	-5.49e-03	1.43e-02	3.92e-02	9.34e-02	9.25e-01	9.81e-01	9.52e-01	8.68e-01	6.92e-01
GOBP SUPRAMOLECULAR FIBER ORGANIZATION	808	1.64e-04	3.54e-03	0.1050	-4.11e-02	8.01e-02	1.33e-02	1.58e-02	-4.95e-02	4.72e-02	1.09e-04	5.22e-01	4.45e-01	1.67e-02
GOBP POSITIVE REGULATION OF CELL DIVISION	88	6.85e-01	8.89e-01	0.1050	-6.91e-03	-1.80e-02	1.17e-02	2.32e-02	9.95e-02	9.11e-01	7.71e-01	8.50e-01	7.07e-01	1.07e-01
GOBP ALPHA AMINO ACID CATABOLIC PROCESS	88	6.04e-01	8.55e-01	0.1050	-4.11e-02	1.94e-03	-6.56e-03	9.59e-02	7.80e-05	5.05e-01	9.75e-01	9.15e-01	1.20e-01	9.99e-01
GOBP POLYSACCHARIDE BIOSYNTHETIC PROCESS	64	8.18e-01	9.41e-01	0.1050	-2.35e-03	1.04e-01	-4.86e-03	5.90e-03	-7.70e-03	9.74e-01	1.50e-01	9.46e-01	9.35e-01	9.15e-01
GOCC EXTRINSIC COMPONENT OF MEMBRANE	198	2.62e-01	6.19e-01	0.1040	4.83e-02	3.68e-02	8.41e-02	8.99e-03	9.13e-03	2.41e-01	3.72e-01	4.13e-02	8.27e-01	8.25e-01
GOBP CELLULAR RESPONSE TO RETINOIC ACID	67	8.39e-01	9.47e-01	0.1040	-3.39e-02	8.17e-02	3.97e-02	-7.01e-03	3.81e-02	6.31e-01	2.48e-01	5.74e-01	9.21e-01	5.89e-01
GOBP REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS	74	6.90e-01	8.91e-01	0.1040	-8.03e-02	-2.50e-02	-4.98e-02	3.49e-02	1.11e-02	2.32e-01	7.10e-01	4.59e-01	6.04e-01	8.69e-01
GOBP RESPONSE TO INORGANIC SUBSTANCE	507	4.15e-03	4.70e-02	0.1040	-3.15e-02	7.06e-02	1.13e-02	-6.55e-02	-2.20e-02	2.25e-01	6.52e-03	6.63e-01	1.15e-02	3.97e-01
GOBP REGULATION OF MYELOID CELL DIFFERENTIATION	206	1.51e-01	4.76e-01	0.1040	-1.53e-03	4.09e-02	6.98e-02	-5.56e-02	3.48e-02	9.70e-01	3.11e-01	8.40e-02	1.69e-01	3.89e-01
GOBP POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY	102	7.21e-01	9.02e-01	0.1040	-2.12e-02	-2.05e-02	8.69e-02	4.50e-02	-1.96e-02	7.11e-01	7.21e-01	1.29e-01	4.32e-01	7.32e-01
GOBP COGNITION	303	1.86e-02	1.35e-01	0.1040	-1.66e-02	-2.77e-03	8.23e-02	-1.75e-02	-5.86e-02	6.18e-01	9.34e-01	1.37e-02	6.01e-01	7.94e-02
GOBP POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY	191	2.83e-01	6.36e-01	0.1040	-6.85e-02	6.48e-02	-2.10e-02	-2.58e-02	-2.79e-02	1.03e-01	1.22e-01	6.16e-01	5.39e-01	5.06e-01
GOBP METANEPHRIC EPITHELIUM DEVELOPMENT	29	9.21e-01	9.74e-01	0.1040	3.53e-02	-6.80e-02	3.37e-02	-6.14e-02	-2.69e-03	7.42e-01	5.26e-01	7.54e-01	5.67e-01	9.80e-01
GOMF NUCLEOSIDE TRIPHOSPHATASE REGULATOR ACTIVITY	447	2.21e-02	1.50e-01	0.1040	-2.63e-02	6.36e-02	4.78e-02	9.93e-03	-6.03e-02	3.41e-01	2.12e-02	8.32e-02	7.19e-01	2.88e-02
GOBP HOMEOSTASIS OF NUMBER OF CELLS	298	7.78e-02	3.35e-01	0.1040	-1.56e-02	6.92e-02	1.21e-02	-7.46e-02	1.13e-03	6.42e-01	3.99e-02	7.18e-01	2.68e-02	9.73e-01
GOBP SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND	65	6.64e-01	8.82e-01	0.1030	-5.48e-04	-4.18e-02	3.89e-02	-8.54e-02	1.18e-02	9.94e-01	5.60e-01	5.87e-01	2.33e-01	8.69e-01
GOBP STRIATED MUSCLE CELL PROLIFERATION	80	7.62e-01	9.20e-01	0.1030	-4.98e-02	4.69e-02	3.83e-03	-3.07e-02	7.09e-02	4.41e-01	4.68e-01	9.53e-01	6.34e-01	2.73e-01
GOCC PRESYNAPTIC ACTIVE ZONE MEMBRANE	29	9.69e-01	9.91e-01	0.1030	-6.03e-02	2.53e-02	3.06e-02	-3.16e-03	-7.38e-02	5.74e-01	8.14e-01	7.75e-01	9.77e-01	4.92e-01
GOMF SMALL MOLECULE SENSOR ACTIVITY	38	9.07e-01	9.69e-01	0.1030	2.05e-02	1.98e-02	-3.49e-02	2.08e-02	9.05e-02	8.27e-01	8.32e-01	7.10e-01	8.24e-01	3.34e-01
GOBP NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION	143	5.12e-01	8.08e-01	0.1030	-2.41e-02	8.21e-02	3.46e-02	4.61e-02	-1.81e-03	6.19e-01	8.99e-02	4.75e-01	3.41e-01	9.70e-01
GOBP EAR DEVELOPMENT	217	2.24e-01	5.77e-01	0.1030	4.97e-03	4.10e-02	5.42e-02	-4.04e-02	6.62e-02	9.00e-01	2.98e-01	1.69e-01	3.05e-01	9.30e-02
GOBP NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT	147	3.65e-01	7.05e-01	0.1030	3.01e-02	2.85e-02	5.16e-02	-6.23e-02	4.88e-02	5.29e-01	5.52e-01	2.80e-01	1.92e-01	3.07e-01
GOBP ARTERY DEVELOPMENT	111	6.41e-01	8.75e-01	0.1030	6.96e-02	3.54e-02	-4.58e-02	-1.65e-02	4.65e-02	2.05e-01	5.20e-01	4.04e-01	7.65e-01	3.97e-01
GOBP REGULATION OF STRIATED MUSCLE CONTRACTION	92	7.73e-01	9.25e-01	0.1030	-3.22e-02	2.65e-02	2.93e-02	8.17e-02	-3.68e-02	5.94e-01	6.60e-01	6.27e-01	1.75e-01	5.42e-01
GOBP CELLULAR HOMEOSTASIS	779	9.34e-05	2.24e-03	0.1030	-4.64e-02	6.17e-02	3.79e-02	-5.59e-02	1.01e-02	2.77e-02	3.42e-03	7.18e-02	7.94e-03	6.33e-01
GOBP POSITIVE REGULATION OF CATABOLIC PROCESS	573	3.09e-03	3.76e-02	0.1030	-2.37e-03	1.41e-02	-1.23e-02	-1.00e-01	1.58e-02	9.23e-01	5.64e-01	6.14e-01	4.30e-05	5.18e-01
GOBP CELLULAR RESPONSE TO STEROID HORMONE STIMULUS	200	2.47e-01	6.04e-01	0.1030	-1.84e-02	3.71e-02	9.41e-03	-8.99e-02	2.61e-02	6.54e-01	3.66e-01	8.18e-01	2.84e-02	5.24e-01
GOBP POSITIVE REGULATION OF GENE EXPRESSION	1128	3.12e-06	1.19e-04	0.1030	-4.19e-02	7.55e-02	1.09e-02	-4.99e-02	2.22e-02	1.76e-02	1.90e-05	5.36e-01	4.68e-03	2.09e-01
GOBP TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY	105	6.86e-01	8.89e-01	0.1030	2.68e-02	7.93e-02	-1.23e-03	-2.76e-02	5.25e-02	6.36e-01	1.60e-01	9.83e-01	6.25e-01	3.53e-01
GOBP TISSUE MIGRATION	364	1.96e-02	1.39e-01	0.1030	-9.50e-02	1.65e-02	-2.91e-02	1.94e-02	2.25e-03	1.86e-03	5.89e-01	3.41e-01	5.25e-01	9.41e-01
GOBP REGULATION OF NERVOUS SYSTEM PROCESS	114	6.27e-01	8.67e-01	0.1030	-2.24e-02	5.12e-03	3.94e-02	8.47e-02	3.55e-02	6.79e-01	9.25e-01	4.68e-01	1.18e-01	5.13e-01
GOBP REGULATION OF OSTEOBLAST DIFFERENTIATION	143	4.31e-01	7.56e-01	0.1030	-5.28e-02	4.35e-02	6.33e-02	-3.59e-02	2.33e-02	2.76e-01	3.69e-01	1.92e-01	4.59e-01	6.31e-01
GOCC NEURON TO NEURON SYNAPSE	345	1.20e-01	4.24e-01	0.1030	-3.71e-02	4.03e-02	8.02e-02	3.05e-02	-1.23e-02	2.37e-01	1.98e-01	1.05e-02	3.30e-01	6.96e-01
GOBP NUCLEUS LOCALIZATION	33	9.67e-01	9.90e-01	0.1030	4.48e-02	-2.19e-02	-5.56e-03	-2.68e-02	8.53e-02	6.56e-01	8.27e-01	9.56e-01	7.90e-01	3.97e-01
GOCC NEURON PROJECTION CYTOPLASM	82	7.71e-01	9.25e-01	0.1020	2.51e-02	2.55e-02	1.71e-03	-8.78e-02	3.89e-02	6.94e-01	6.90e-01	9.79e-01	1.69e-01	5.43e-01
GOCC NEURON PROJECTION	1246	3.32e-05	9.47e-04	0.1020	-2.23e-02	3.85e-02	8.05e-02	4.50e-02	-2.79e-03	1.86e-01	2.21e-02	1.75e-06	7.58e-03	8.68e-01
GOMF PHOSPHATIDYLCHOLINE TRANSPORTER ACTIVITY	18	9.93e-01	9.97e-01	0.1020	-5.81e-02	-3.11e-02	5.03e-02	5.78e-02	1.49e-02	6.69e-01	8.19e-01	7.12e-01	6.71e-01	9.13e-01
GOBP MONOATOMIC CATION TRANSMEMBRANE TRANSPORT	813	9.17e-04	1.45e-02	0.1020	-4.03e-02	4.56e-02	7.31e-02	2.41e-02	-2.82e-02	5.09e-02	2.72e-02	3.96e-04	2.43e-01	1.72e-01
GOBP POSITIVE REGULATION OF WNT SIGNALING PATHWAY	138	4.51e-01	7.71e-01	0.1020	-1.77e-03	1.92e-02	9.56e-02	8.54e-03	-2.82e-02	9.71e-01	6.97e-01	5.24e-02	8.63e-01	5.68e-01
GOBP RESPONSE TO ACTIVITY	72	8.54e-01	9.51e-01	0.1020	5.60e-02	5.41e-02	5.73e-02	2.97e-02	1.23e-02	4.11e-01	4.27e-01	4.01e-01	6.63e-01	8.56e-01
GOBP RESPONSE TO NERVE GROWTH FACTOR	47	8.51e-01	9.50e-01	0.1020	7.44e-02	-3.68e-03	6.62e-02	-1.87e-02	-1.04e-02	3.78e-01	9.65e-01	4.32e-01	8.25e-01	9.02e-01
GOBP RESPONSE TO ETHANOL	117	6.95e-01	8.93e-01	0.1020	-3.99e-02	4.63e-02	6.68e-02	3.53e-02	3.04e-02	4.56e-01	3.87e-01	2.12e-01	5.10e-01	5.71e-01
GOBP NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS	499	8.39e-03	7.74e-02	0.1020	-3.14e-02	7.06e-02	2.54e-02	7.27e-03	6.08e-02	2.30e-01	6.90e-03	3.31e-01	7.81e-01	2.01e-02
GOBP REGULATION OF INNATE IMMUNE RESPONSE	403	2.27e-02	1.53e-01	0.1020	-2.41e-02	6.81e-02	-2.05e-02	-2.55e-02	6.37e-02	4.07e-01	1.89e-02	4.79e-01	3.79e-01	2.82e-02
GOBP RESPONSE TO MOLECULE OF BACTERIAL ORIGIN	353	4.68e-02	2.42e-01	0.1020	-7.80e-02	5.75e-02	1.41e-02	-5.49e-03	2.69e-02	1.18e-02	6.35e-02	6.48e-01	8.59e-01	3.85e-01
GOMF GAMMA TUBULIN BINDING	30	9.65e-01	9.90e-01	0.1020	-4.71e-02	-2.21e-03	-2.14e-03	-2.52e-02	-8.65e-02	6.55e-01	9.83e-01	9.84e-01	8.11e-01	4.12e-01
GOBP BEHAVIOR	629	5.91e-04	1.01e-02	0.1020	3.16e-03	3.01e-02	9.61e-02	-1.03e-02	8.93e-03	8.93e-01	1.98e-01	3.88e-05	6.58e-01	7.02e-01
GOBP REGULATION OF PIGMENTATION	17	9.92e-01	9.97e-01	0.1020	6.56e-02	1.53e-02	3.50e-02	6.25e-02	2.56e-02	6.40e-01	9.13e-01	8.02e-01	6.55e-01	8.55e-01
GOMF GTPASE BINDING	297	1.11e-01	4.08e-01	0.1020	-2.22e-02	6.32e-02	-2.33e-02	-5.72e-02	-4.48e-02	5.10e-01	6.09e-02	4.90e-01	9.02e-02	1.84e-01
GOBP REGULATION OF HEART CONTRACTION	199	4.32e-01	7.56e-01	0.1010	-1.64e-02	4.09e-02	7.22e-02	3.98e-02	-3.96e-02	6.89e-01	3.20e-01	7.93e-02	3.33e-01	3.36e-01
GOCC ANCHORING JUNCTION	863	4.77e-04	8.55e-03	0.1010	-4.87e-02	6.88e-02	4.83e-02	2.68e-02	-1.18e-02	1.52e-02	6.00e-04	1.60e-02	1.81e-01	5.55e-01
GOBP REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY	379	2.23e-02	1.51e-01	0.1010	2.61e-02	5.01e-02	2.99e-02	-7.62e-02	2.01e-02	3.82e-01	9.42e-02	3.18e-01	1.09e-02	5.02e-01
GOCC ACTIN CYTOSKELETON	484	2.33e-02	1.56e-01	0.1010	-8.32e-03	5.74e-02	2.30e-02	5.22e-02	-6.06e-02	7.54e-01	3.05e-02	3.86e-01	4.92e-02	2.24e-02
GOBP SECRETION	923	1.22e-04	2.78e-03	0.1010	-1.75e-02	9.02e-02	4.26e-02	-3.25e-03	-4.01e-03	3.68e-01	3.36e-06	2.83e-02	8.67e-01	8.36e-01
GOBP REGULATION OF CELL GROWTH	397	3.61e-02	2.06e-01	0.1010	-1.94e-02	7.10e-02	4.56e-04	-6.96e-02	2.40e-03	5.08e-01	1.51e-02	9.88e-01	1.72e-02	9.35e-01
GOBP POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY	229	8.32e-02	3.48e-01	0.1010	-2.09e-02	2.60e-02	5.52e-02	-7.72e-02	1.23e-02	5.87e-01	4.99e-01	1.50e-01	4.41e-02	7.48e-01
GOBP REGULATION OF FAT CELL DIFFERENTIATION	140	5.36e-01	8.21e-01	0.1010	-2.68e-03	6.19e-02	2.20e-02	-5.72e-02	5.17e-02	9.56e-01	2.06e-01	6.54e-01	2.43e-01	2.91e-01
GOBP RESPONSE TO OXIDATIVE STRESS	382	6.83e-02	3.09e-01	0.1010	2.71e-02	7.31e-02	-1.97e-02	-5.68e-02	2.35e-02	3.63e-01	1.42e-02	5.08e-01	5.68e-02	4.31e-01
GOBP POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS	141	4.53e-01	7.72e-01	0.1010	-1.47e-02	7.02e-02	2.43e-02	4.62e-02	4.85e-02	7.63e-01	1.50e-01	6.19e-01	3.44e-01	3.20e-01
GOBP MONOATOMIC ION TRANSPORT	1194	8.50e-05	2.08e-03	0.1010	-2.91e-02	4.44e-02	6.65e-02	5.00e-02	-2.17e-02	9.07e-02	9.69e-03	1.09e-04	3.61e-03	2.07e-01
GOBP REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY	25	9.73e-01	9.92e-01	0.1010	-4.71e-03	1.72e-02	6.56e-02	5.31e-03	-7.45e-02	9.67e-01	8.82e-01	5.70e-01	9.63e-01	5.19e-01
GOBP PEPTIDYL SERINE MODIFICATION	290	1.40e-01	4.60e-01	0.1010	1.23e-02	4.09e-02	2.20e-02	-5.94e-02	6.58e-02	7.19e-01	2.31e-01	5.19e-01	8.20e-02	5.37e-02
GOBP REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS	53	9.09e-01	9.70e-01	0.1010	2.30e-02	6.91e-02	6.69e-02	-7.89e-03	1.78e-02	7.72e-01	3.84e-01	3.99e-01	9.21e-01	8.23e-01
GOBP CELLULAR RESPONSE TO HORMONE STIMULUS	587	2.39e-03	3.09e-02	0.1010	-2.66e-02	7.00e-02	5.74e-02	-3.48e-02	-1.74e-03	2.70e-01	3.77e-03	1.74e-02	1.50e-01	9.42e-01
GOBP CYTOKINE PRODUCTION	835	2.13e-04	4.41e-03	0.1010	-4.94e-02	8.30e-02	2.37e-02	-5.00e-03	1.40e-02	1.54e-02	4.60e-05	2.44e-01	8.06e-01	4.91e-01
GOCC PRESYNAPSE	539	1.05e-02	9.10e-02	0.1000	-2.99e-02	6.69e-02	6.86e-02	-4.22e-03	-1.29e-03	2.35e-01	7.93e-03	6.45e-03	8.67e-01	9.59e-01
GOBP REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS	102	7.14e-01	9.01e-01	0.1000	5.86e-02	7.36e-02	1.47e-02	4.15e-03	3.15e-02	3.07e-01	1.99e-01	7.98e-01	9.42e-01	5.83e-01
GOMF PHOSPHORIC ESTER HYDROLASE ACTIVITY	342	1.02e-01	3.87e-01	0.1000	1.72e-02	6.65e-02	6.19e-02	1.91e-02	-3.41e-02	5.85e-01	3.46e-02	4.92e-02	5.44e-01	2.79e-01
GOBP MONOATOMIC CATION TRANSPORT	996	2.62e-04	5.26e-03	0.1000	-3.35e-02	5.60e-02	6.55e-02	2.86e-02	-2.64e-02	7.39e-02	2.78e-03	4.63e-04	1.27e-01	1.58e-01
GOBP REGULATION OF PROTEIN MODIFICATION PROCESS	1244	1.17e-06	5.14e-05	0.1000	5.39e-03	6.59e-02	1.53e-02	-7.01e-02	2.32e-02	7.49e-01	9.28e-05	3.63e-01	3.18e-05	1.70e-01
GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION	84	7.83e-01	9.28e-01	0.1000	-3.48e-02	-1.04e-02	6.50e-02	1.15e-02	6.62e-02	5.82e-01	8.70e-01	3.03e-01	8.55e-01	2.94e-01
GOBP CELL MATURATION	191	2.53e-01	6.10e-01	0.1000	-5.19e-02	2.61e-02	6.89e-03	-7.69e-02	-2.66e-02	2.16e-01	5.35e-01	8.70e-01	6.67e-02	5.26e-01
GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION	166	4.59e-01	7.77e-01	0.1000	-3.01e-02	1.85e-02	6.54e-02	2.14e-02	-6.36e-02	5.03e-01	6.81e-01	1.46e-01	6.34e-01	1.57e-01
GOBP MICROTUBULE ORGANIZING CENTER LOCALIZATION	32	9.57e-01	9.87e-01	0.1000	-4.25e-02	-5.54e-03	3.94e-02	-6.87e-03	-8.12e-02	6.78e-01	9.57e-01	6.99e-01	9.46e-01	4.27e-01
GOBP CYTOKINE MEDIATED SIGNALING PATHWAY	483	3.34e-02	1.96e-01	0.1000	-3.01e-02	7.10e-02	4.48e-02	4.22e-02	-1.64e-02	2.58e-01	7.48e-03	9.14e-02	1.12e-01	5.38e-01
GOBP NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS	44	9.43e-01	9.82e-01	0.1000	2.59e-02	4.29e-02	-1.77e-02	-8.41e-02	1.01e-02	7.66e-01	6.23e-01	8.39e-01	3.34e-01	9.08e-01
GOBP CELLULAR RESPONSE TO GLUCOCORTICOID STIMULUS	49	9.29e-01	9.78e-01	0.0998	-1.71e-02	5.10e-02	-6.23e-03	-5.04e-02	6.70e-02	8.36e-01	5.37e-01	9.40e-01	5.42e-01	4.17e-01
GOBP POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS	28	9.71e-01	9.92e-01	0.0998	-1.64e-02	7.82e-02	2.45e-02	3.71e-02	4.00e-02	8.80e-01	4.74e-01	8.23e-01	7.34e-01	7.14e-01
GOBP SPHINGOLIPID BIOSYNTHETIC PROCESS	110	6.15e-01	8.60e-01	0.0997	-5.80e-03	7.19e-02	1.45e-02	-6.22e-02	-2.56e-02	9.16e-01	1.92e-01	7.93e-01	2.60e-01	6.43e-01
GOCC ENDOSOME	986	2.23e-05	6.82e-04	0.0995	-4.09e-02	5.19e-02	-5.31e-03	-6.95e-02	-2.60e-02	2.98e-02	5.81e-03	7.78e-01	2.19e-04	1.67e-01
GOBP GLYCEROLIPID METABOLIC PROCESS	370	6.39e-02	2.98e-01	0.0994	-3.82e-02	6.69e-02	-2.46e-02	-5.43e-02	-2.00e-02	2.07e-01	2.72e-02	4.16e-01	7.29e-02	5.10e-01
GOBP POSITIVE REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION	65	9.09e-01	9.70e-01	0.0994	-2.74e-02	5.11e-02	5.40e-02	5.98e-02	-4.51e-03	7.02e-01	4.76e-01	4.51e-01	4.05e-01	9.50e-01
GOBP DEPHOSPHORYLATION	286	1.16e-01	4.16e-01	0.0994	-1.59e-02	7.83e-02	2.67e-02	-3.66e-02	-3.80e-02	6.43e-01	2.27e-02	4.37e-01	2.87e-01	2.69e-01
GOBP CELLULAR RESPONSE TO ALKALOID	35	9.53e-01	9.85e-01	0.0993	1.99e-02	9.65e-02	-9.10e-03	7.25e-03	4.43e-03	8.39e-01	3.23e-01	9.26e-01	9.41e-01	9.64e-01
GOBP TISSUE REGENERATION	73	8.22e-01	9.42e-01	0.0992	8.53e-02	3.61e-02	1.83e-03	1.85e-02	-3.03e-02	2.08e-01	5.94e-01	9.78e-01	7.85e-01	6.54e-01
GOBP SENSORY SYSTEM DEVELOPMENT	393	2.89e-02	1.79e-01	0.0991	3.74e-02	4.77e-02	7.61e-02	-1.54e-02	1.10e-02	2.03e-01	1.05e-01	9.64e-03	6.00e-01	7.09e-01
GOBP POSITIVE REGULATION OF TRANSPORT	855	3.58e-04	6.86e-03	0.0991	-4.46e-02	7.54e-02	4.45e-02	-9.23e-03	8.35e-03	2.69e-02	1.81e-04	2.70e-02	6.47e-01	6.79e-01
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS	37	9.47e-01	9.83e-01	0.0989	6.03e-02	1.68e-02	-4.87e-02	2.81e-03	5.90e-02	5.25e-01	8.60e-01	6.08e-01	9.76e-01	5.35e-01
GOBP REGULATION OF LIPID STORAGE	54	8.71e-01	9.57e-01	0.0988	-6.40e-02	-1.83e-02	8.97e-03	-7.24e-02	5.69e-04	4.16e-01	8.16e-01	9.09e-01	3.57e-01	9.94e-01
GOBP REGULATION OF CELL DIFFERENTIATION	1554	2.87e-08	1.81e-06	0.0986	-1.29e-02	6.47e-02	3.79e-02	-5.39e-02	3.20e-02	3.95e-01	2.06e-05	1.26e-02	3.86e-04	3.54e-02
GOCC ORGANELLE SUBCOMPARTMENT	1414	5.24e-06	1.88e-04	0.0985	1.18e-02	5.18e-02	-4.21e-02	-7.12e-02	6.07e-03	4.56e-01	1.10e-03	7.95e-03	7.19e-06	7.02e-01
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION	126	7.03e-01	8.96e-01	0.0984	-7.10e-02	-3.66e-03	4.53e-02	4.55e-02	-2.23e-02	1.69e-01	9.43e-01	3.80e-01	3.77e-01	6.66e-01
GOBP ISOPRENOID METABOLIC PROCESS	130	5.98e-01	8.51e-01	0.0984	3.10e-02	-1.37e-02	-1.51e-02	4.53e-02	-7.90e-02	5.42e-01	7.88e-01	7.66e-01	3.72e-01	1.20e-01
GOBP POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION	170	4.18e-01	7.47e-01	0.0983	-8.33e-02	7.73e-03	2.78e-02	1.80e-02	3.94e-02	6.09e-02	8.62e-01	5.31e-01	6.86e-01	3.75e-01
GOBP NEUROMUSCULAR PROCESS	159	5.08e-01	8.07e-01	0.0982	1.83e-02	3.84e-02	2.70e-02	-5.69e-03	8.42e-02	6.91e-01	4.03e-01	5.57e-01	9.01e-01	6.70e-02
GOBP REGULATION OF LOCOMOTION	1080	5.99e-05	1.57e-03	0.0982	-6.75e-02	4.85e-02	4.93e-02	1.54e-02	7.94e-03	1.79e-04	7.05e-03	6.26e-03	3.92e-01	6.59e-01
GOBP OLIGOSACCHARIDE METABOLIC PROCESS	65	8.69e-01	9.57e-01	0.0982	-6.19e-02	4.14e-02	-1.90e-02	-1.05e-04	-6.11e-02	3.88e-01	5.64e-01	7.91e-01	9.99e-01	3.94e-01
GOBP T CELL APOPTOTIC PROCESS	57	8.68e-01	9.56e-01	0.0982	7.05e-03	4.84e-02	2.84e-02	-7.70e-02	2.25e-02	9.27e-01	5.27e-01	7.11e-01	3.14e-01	7.69e-01
GOBP PROTEIN DEPHOSPHORYLATION	194	3.58e-01	7.03e-01	0.0981	-4.54e-02	6.35e-02	1.27e-02	-1.53e-02	-5.61e-02	2.76e-01	1.27e-01	7.60e-01	7.13e-01	1.78e-01
GOMF MICROTUBULE MOTOR ACTIVITY	67	8.95e-01	9.65e-01	0.0981	2.12e-02	2.06e-02	3.57e-02	8.37e-02	-2.13e-02	7.64e-01	7.70e-01	6.13e-01	2.36e-01	7.63e-01
GOBP ORGANOPHOSPHATE ESTER TRANSPORT	147	5.04e-01	8.05e-01	0.0980	-6.17e-02	4.67e-02	-3.74e-02	-1.58e-02	-4.44e-02	1.96e-01	3.28e-01	4.34e-01	7.41e-01	3.53e-01
GOCC APICAL JUNCTION COMPLEX	140	6.02e-01	8.54e-01	0.0980	-5.28e-02	5.03e-03	6.51e-02	2.18e-02	-4.55e-02	2.81e-01	9.18e-01	1.84e-01	6.55e-01	3.53e-01
GOBP LOCALIZATION WITHIN MEMBRANE	655	1.28e-03	1.89e-02	0.0980	-3.18e-02	4.25e-02	5.42e-03	-8.21e-02	-2.30e-03	1.66e-01	6.32e-02	8.13e-01	3.36e-04	9.20e-01
GOBP RESPONSE TO ENDOGENOUS STIMULUS	1694	6.63e-09	4.88e-07	0.0979	-1.99e-02	7.27e-02	4.88e-02	-3.78e-02	9.50e-03	1.74e-01	6.31e-07	8.40e-04	9.60e-03	5.15e-01
GOBP POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS	591	5.53e-03	5.71e-02	0.0978	-4.10e-02	7.28e-02	2.82e-02	5.65e-03	4.20e-02	8.86e-02	2.48e-03	2.42e-01	8.14e-01	8.13e-02
GOBP TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY	614	1.05e-02	9.10e-02	0.0978	-2.42e-02	7.58e-02	5.41e-02	1.36e-02	-1.12e-02	3.06e-01	1.34e-03	2.22e-02	5.65e-01	6.36e-01
GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS	118	6.43e-01	8.75e-01	0.0977	-7.35e-02	4.42e-02	3.50e-02	-1.86e-02	-2.48e-02	1.68e-01	4.07e-01	5.12e-01	7.27e-01	6.41e-01
GOBP CARBOHYDRATE BIOSYNTHETIC PROCESS	206	2.68e-01	6.23e-01	0.0975	-1.51e-02	9.55e-02	-1.23e-02	1.95e-03	-3.50e-03	7.08e-01	1.82e-02	7.60e-01	9.62e-01	9.31e-01
GOBP PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE	102	7.48e-01	9.15e-01	0.0975	4.04e-02	-5.40e-02	2.70e-02	6.15e-02	-2.14e-02	4.81e-01	3.46e-01	6.37e-01	2.83e-01	7.09e-01
GOBP GASTRULATION	188	2.43e-01	6.00e-01	0.0974	-1.91e-02	3.62e-02	3.15e-02	-8.24e-02	5.82e-03	6.52e-01	3.92e-01	4.56e-01	5.15e-02	8.91e-01
GOBP RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS	54	9.20e-01	9.74e-01	0.0974	-6.86e-03	1.16e-02	-3.47e-03	-8.06e-02	5.29e-02	9.31e-01	8.83e-01	9.65e-01	3.06e-01	5.01e-01
GOBP NEGATIVE REGULATION OF RESPONSE TO STIMULUS	1672	2.08e-08	1.39e-06	0.0974	-3.96e-02	5.62e-02	1.60e-02	-5.97e-02	3.05e-02	7.00e-03	1.30e-04	2.76e-01	4.77e-05	3.81e-02
GOBP REGULATION OF CELL DIVISION	176	5.01e-01	8.03e-01	0.0973	-7.31e-03	3.58e-02	-1.27e-02	-6.31e-02	6.33e-02	8.67e-01	4.13e-01	7.72e-01	1.49e-01	1.48e-01
GOBP REGULATION OF GROWTH	585	4.78e-03	5.21e-02	0.0973	-1.82e-02	6.22e-02	1.75e-02	-6.89e-02	1.47e-02	4.52e-01	1.02e-02	4.70e-01	4.41e-03	5.45e-01
GOBP EXPORT FROM CELL	867	4.10e-04	7.65e-03	0.0973	-2.90e-02	8.27e-02	3.95e-02	-1.49e-02	9.64e-04	1.47e-01	3.56e-05	4.85e-02	4.58e-01	9.62e-01
GOBP VITAMIN METABOLIC PROCESS	107	5.91e-01	8.47e-01	0.0972	3.12e-02	4.92e-02	-3.82e-02	8.85e-03	6.72e-02	5.77e-01	3.79e-01	4.95e-01	8.74e-01	2.29e-01
GOBP NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS	41	9.46e-01	9.82e-01	0.0972	-3.13e-02	3.72e-02	6.03e-02	-2.72e-02	5.20e-02	7.29e-01	6.80e-01	5.04e-01	7.64e-01	5.64e-01
GOCC SARCOPLASM	90	7.70e-01	9.24e-01	0.0972	2.52e-02	1.04e-02	3.72e-03	8.22e-02	-4.39e-02	6.80e-01	8.65e-01	9.51e-01	1.78e-01	4.71e-01
GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION	516	1.42e-02	1.12e-01	0.0972	5.89e-03	6.03e-02	6.57e-03	-7.38e-02	1.68e-02	8.19e-01	1.92e-02	7.98e-01	4.10e-03	5.14e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN	170	3.07e-01	6.60e-01	0.0971	-1.04e-03	2.96e-02	2.94e-03	9.23e-02	6.27e-03	9.81e-01	5.06e-01	9.47e-01	3.80e-02	8.88e-01
GOBP REGULATION OF SYSTEM PROCESS	539	2.55e-02	1.64e-01	0.0971	-4.05e-02	6.09e-02	4.53e-02	4.48e-02	-3.15e-03	1.07e-01	1.55e-02	7.22e-02	7.50e-02	9.01e-01
GOBP DENDRITIC SPINE MORPHOGENESIS	51	9.34e-01	9.80e-01	0.0971	1.10e-02	3.97e-02	7.50e-02	2.63e-02	-3.75e-02	8.92e-01	6.24e-01	3.54e-01	7.45e-01	6.43e-01
GOMF PHOSPHATASE BINDING	184	4.22e-01	7.49e-01	0.0970	-2.22e-02	5.83e-02	3.13e-02	-1.75e-02	6.50e-02	6.03e-01	1.72e-01	4.64e-01	6.83e-01	1.28e-01
GOBP POSITIVE REGULATION OF AXONOGENESIS	72	9.09e-01	9.70e-01	0.0969	-4.33e-02	-5.98e-03	6.17e-02	6.04e-02	-5.59e-03	5.26e-01	9.30e-01	3.65e-01	3.75e-01	9.35e-01
GOBP NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS	941	7.42e-05	1.88e-03	0.0968	1.56e-03	5.00e-02	2.03e-02	-7.36e-02	3.22e-02	9.35e-01	9.36e-03	2.92e-01	1.29e-04	9.45e-02
GOBP REGULATION OF IMMUNE SYSTEM PROCESS	1451	6.32e-07	2.97e-05	0.0968	-3.10e-02	7.54e-02	2.85e-02	-2.75e-02	3.39e-02	4.80e-02	1.53e-06	6.90e-02	7.93e-02	3.06e-02
GOBP SKIN EPIDERMIS DEVELOPMENT	124	5.03e-01	8.03e-01	0.0968	-4.88e-02	1.25e-02	5.66e-02	-5.34e-02	2.76e-02	3.48e-01	8.11e-01	2.76e-01	3.04e-01	5.95e-01
GOBP REGULATION OF SECRETION	601	1.06e-02	9.15e-02	0.0966	-9.53e-04	8.46e-02	4.61e-02	-1.40e-03	7.64e-03	9.68e-01	3.98e-04	5.34e-02	9.53e-01	7.49e-01
GOBP RESPONSE TO ORGANIC CYCLIC COMPOUND	871	2.33e-04	4.76e-03	0.0964	-1.21e-02	6.30e-02	5.22e-02	-3.71e-02	3.29e-02	5.45e-01	1.60e-03	8.87e-03	6.33e-02	9.94e-02
GOBP REGULATION OF CELLULAR COMPONENT SIZE	349	8.01e-02	3.41e-01	0.0963	-1.78e-02	9.20e-02	-1.79e-03	-6.99e-04	-2.24e-02	5.67e-01	3.16e-03	9.54e-01	9.82e-01	4.73e-01
GOBP PURINE NUCLEOTIDE TRANSPORT	34	9.57e-01	9.87e-01	0.0963	-1.10e-02	4.64e-02	3.53e-02	-6.97e-02	2.99e-02	9.12e-01	6.40e-01	7.22e-01	4.82e-01	7.63e-01
GOBP REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION	144	5.19e-01	8.13e-01	0.0962	-8.74e-02	-8.99e-03	6.19e-03	2.37e-03	3.86e-02	7.03e-02	8.52e-01	8.98e-01	9.61e-01	4.23e-01
GOBP CARBOHYDRATE DERIVATIVE METABOLIC PROCESS	980	1.06e-03	1.62e-02	0.0961	7.77e-03	3.31e-02	-5.36e-02	-7.18e-02	6.92e-03	6.81e-01	7.95e-02	4.50e-03	1.42e-04	7.14e-01
GOBP PROTEOGLYCAN BIOSYNTHETIC PROCESS	63	8.79e-01	9.61e-01	0.0960	-2.38e-02	3.75e-02	6.17e-02	3.42e-03	-5.85e-02	7.44e-01	6.06e-01	3.97e-01	9.63e-01	4.22e-01
GOCC ENDOPLASMIC RETICULUM LUMEN	295	1.99e-01	5.47e-01	0.0959	-6.72e-02	3.73e-02	2.42e-02	1.23e-02	-5.05e-02	4.72e-02	2.70e-01	4.74e-01	7.16e-01	1.35e-01
GOBP CANONICAL WNT SIGNALING PATHWAY	302	1.29e-01	4.43e-01	0.0959	-1.26e-02	5.70e-02	9.74e-03	-7.47e-02	1.06e-02	7.07e-01	8.83e-02	7.71e-01	2.55e-02	7.51e-01
GOCC LIPID DROPLET	93	8.02e-01	9.34e-01	0.0958	-1.42e-02	3.55e-02	-1.68e-02	-8.33e-02	2.22e-02	8.13e-01	5.54e-01	7.80e-01	1.65e-01	7.11e-01
GOBP TRIGLYCERIDE METABOLIC PROCESS	101	7.32e-01	9.08e-01	0.0958	-8.49e-02	3.77e-02	3.71e-04	-2.02e-02	-1.13e-02	1.40e-01	5.12e-01	9.95e-01	7.26e-01	8.44e-01
GOCC EARLY ENDOSOME	412	1.35e-02	1.09e-01	0.0957	-1.94e-02	3.46e-02	2.43e-02	-8.26e-02	-1.29e-02	4.99e-01	2.28e-01	3.98e-01	4.02e-03	6.53e-01
GOBP SENSORY PERCEPTION OF PAIN	76	8.66e-01	9.55e-01	0.0956	-4.08e-02	-1.74e-02	7.83e-02	3.07e-02	-9.18e-03	5.39e-01	7.93e-01	2.38e-01	6.43e-01	8.90e-01
GOBP NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT	139	6.19e-01	8.63e-01	0.0955	-3.76e-02	-4.29e-02	6.89e-02	3.36e-02	3.24e-03	4.44e-01	3.83e-01	1.61e-01	4.94e-01	9.47e-01
GOBP TISSUE HOMEOSTASIS	264	2.50e-01	6.07e-01	0.0954	-5.79e-02	-7.11e-03	5.70e-02	1.90e-02	-4.57e-02	1.05e-01	8.42e-01	1.11e-01	5.95e-01	2.01e-01
GOBP MOLTING CYCLE	112	5.37e-01	8.22e-01	0.0954	-2.08e-02	-7.77e-04	8.99e-02	-2.27e-02	8.10e-03	7.04e-01	9.89e-01	1.00e-01	6.78e-01	8.82e-01
GOBP POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE	28	9.80e-01	9.93e-01	0.0953	-1.18e-02	8.80e-02	7.55e-03	-1.49e-02	3.02e-02	9.14e-01	4.20e-01	9.45e-01	8.92e-01	7.82e-01
GOMF PHOSPHATIDYLCHOLINE FLOPPASE ACTIVITY	8	9.99e-01	1.00e+00	0.0950	3.46e-02	-2.10e-02	-4.85e-02	3.38e-02	-6.24e-02	8.65e-01	9.18e-01	8.12e-01	8.69e-01	7.60e-01
GOBP REGULATION OF DEFENSE RESPONSE	780	8.97e-04	1.42e-02	0.0949	-5.21e-02	6.51e-02	1.84e-02	-9.82e-03	4.03e-02	1.33e-02	1.97e-03	3.82e-01	6.41e-01	5.57e-02
GOBP REACTIVE OXYGEN SPECIES METABOLIC PROCESS	217	3.47e-01	6.93e-01	0.0948	-2.26e-02	6.42e-02	1.19e-02	-5.47e-02	3.51e-02	5.66e-01	1.03e-01	7.63e-01	1.65e-01	3.73e-01
GOBP ENDOTHELIAL CELL PROLIFERATION	197	3.07e-01	6.60e-01	0.0948	-6.80e-02	1.99e-03	-1.70e-02	5.81e-02	-2.63e-02	9.97e-02	9.62e-01	6.80e-01	1.59e-01	5.24e-01
GOMF MONOSACCHARIDE BINDING	73	8.44e-01	9.49e-01	0.0948	5.15e-02	1.30e-02	-3.07e-02	-3.03e-02	-6.57e-02	4.47e-01	8.48e-01	6.50e-01	6.55e-01	3.32e-01
GOBP REGULATION OF NEUROTRANSMITTER SECRETION	76	8.45e-01	9.49e-01	0.0948	-2.48e-02	-2.86e-03	7.45e-02	2.19e-02	-4.83e-02	7.09e-01	9.66e-01	2.61e-01	7.41e-01	4.66e-01
GOBP DOPAMINE TRANSPORT	55	9.37e-01	9.80e-01	0.0948	-4.61e-02	5.22e-02	5.09e-02	1.84e-02	-3.47e-02	5.54e-01	5.03e-01	5.14e-01	8.14e-01	6.56e-01
GOBP OVULATION CYCLE	72	8.73e-01	9.58e-01	0.0947	-4.85e-02	6.82e-02	2.91e-02	3.28e-02	-6.92e-03	4.77e-01	3.17e-01	6.70e-01	6.30e-01	9.19e-01
GOCC COATED VESICLE MEMBRANE	191	4.71e-01	7.85e-01	0.0947	3.84e-02	5.29e-02	-1.74e-02	-6.54e-02	1.10e-02	3.60e-01	2.08e-01	6.78e-01	1.19e-01	7.92e-01
GOBP RESPONSE TO MONOSACCHARIDE	200	3.89e-01	7.25e-01	0.0946	2.37e-02	2.97e-02	1.25e-02	-7.09e-02	4.81e-02	5.63e-01	4.68e-01	7.61e-01	8.38e-02	2.41e-01
GOBP GLUCAN BIOSYNTHETIC PROCESS	44	9.46e-01	9.82e-01	0.0945	-4.07e-02	8.12e-02	-3.75e-03	-2.09e-02	-1.53e-02	6.40e-01	3.51e-01	9.66e-01	8.11e-01	8.61e-01
GOBP SERINE FAMILY AMINO ACID METABOLIC PROCESS	37	9.44e-01	9.82e-01	0.0945	-7.10e-03	6.29e-03	-7.75e-03	2.48e-02	9.04e-02	9.40e-01	9.47e-01	9.35e-01	7.94e-01	3.41e-01
GOBP NEGATIVE REGULATION OF LOCOMOTION	395	1.40e-01	4.60e-01	0.0945	-5.84e-02	1.02e-02	5.56e-02	4.82e-02	-1.60e-03	4.64e-02	7.27e-01	5.78e-02	1.00e-01	9.56e-01
GOBP CARDIAC CELL DEVELOPMENT	92	7.75e-01	9.26e-01	0.0945	-2.86e-02	1.25e-02	8.69e-02	1.08e-02	-1.68e-02	6.35e-01	8.36e-01	1.50e-01	8.59e-01	7.80e-01
GOBP ANIMAL ORGAN MORPHOGENESIS	1011	3.24e-05	9.30e-04	0.0945	1.99e-02	5.14e-02	4.40e-02	-5.36e-02	3.29e-02	2.85e-01	5.73e-03	1.79e-02	3.96e-03	7.68e-02
GOBP REGULATION OF AXON EXTENSION	85	8.17e-01	9.41e-01	0.0945	-6.97e-02	3.05e-02	3.79e-02	1.33e-02	3.90e-02	2.67e-01	6.27e-01	5.46e-01	8.32e-01	5.34e-01
GOBP GLUCOSE IMPORT	75	6.97e-01	8.94e-01	0.0943	2.66e-02	-6.86e-03	-7.06e-02	3.95e-02	4.00e-02	6.90e-01	9.18e-01	2.91e-01	5.54e-01	5.49e-01
GOBP VASCULOGENESIS	81	6.61e-01	8.81e-01	0.0942	-3.49e-02	-9.14e-03	7.61e-02	-4.07e-02	-1.12e-02	5.87e-01	8.87e-01	2.36e-01	5.27e-01	8.62e-01
GOBP REGULATION OF RECEPTOR INTERNALIZATION	59	8.59e-01	9.53e-01	0.0942	5.81e-05	4.64e-02	6.93e-02	-2.19e-02	-3.79e-02	9.99e-01	5.37e-01	3.57e-01	7.71e-01	6.15e-01
GOMF PEPTIDE BINDING	302	2.91e-01	6.45e-01	0.0942	-3.28e-02	-1.11e-02	5.79e-02	5.10e-02	-4.15e-02	3.27e-01	7.41e-01	8.34e-02	1.28e-01	2.15e-01
GOBP NEUROTRANSMITTER TRANSPORT	198	4.59e-01	7.77e-01	0.0939	-3.25e-02	5.77e-02	4.99e-02	1.23e-02	-4.24e-02	4.30e-01	1.62e-01	2.26e-01	7.66e-01	3.04e-01
GOBP REGULATION OF KINASE ACTIVITY	561	7.85e-03	7.38e-02	0.0939	-1.30e-02	5.82e-02	2.42e-02	-6.70e-02	1.37e-02	6.00e-01	1.84e-02	3.28e-01	6.66e-03	5.80e-01
GOBP MUSCLE CELL MIGRATION	100	7.58e-01	9.19e-01	0.0938	-2.54e-02	8.19e-03	2.23e-02	8.71e-02	-8.79e-04	6.61e-01	8.87e-01	7.00e-01	1.32e-01	9.88e-01
GOCC SUPRAMOLECULAR POLYMER	978	1.52e-03	2.16e-02	0.0935	-4.92e-02	3.92e-03	3.30e-02	6.18e-02	-3.75e-02	9.12e-03	8.36e-01	8.10e-02	1.07e-03	4.71e-02
GOBP POSITIVE REGULATION OF CELL GROWTH	151	5.70e-01	8.38e-01	0.0935	2.67e-03	8.76e-02	1.38e-02	-2.63e-02	-1.31e-02	9.55e-01	6.31e-02	7.70e-01	5.76e-01	7.81e-01
GOBP MAMMARY GLAND DEVELOPMENT	125	4.38e-01	7.61e-01	0.0935	-5.12e-03	2.52e-02	5.11e-02	-7.39e-02	-6.63e-04	9.21e-01	6.27e-01	3.24e-01	1.54e-01	9.90e-01
GOBP REGULATION OF RESPONSE TO EXTERNAL STIMULUS	1081	7.43e-05	1.88e-03	0.0933	-5.44e-02	6.01e-02	3.22e-02	7.00e-03	3.26e-02	2.53e-03	8.49e-04	7.41e-02	6.97e-01	7.02e-02
GOMF PROTEIN PHOSPHATASE BINDING	139	6.09e-01	8.58e-01	0.0933	-4.89e-02	2.06e-02	1.09e-02	-4.30e-02	6.25e-02	3.19e-01	6.76e-01	8.25e-01	3.81e-01	2.03e-01
GOBP PLASMA MEMBRANE ORGANIZATION	161	5.27e-01	8.18e-01	0.0932	-1.23e-02	6.35e-02	-7.24e-03	6.24e-03	-6.64e-02	7.88e-01	1.64e-01	8.74e-01	8.91e-01	1.46e-01
GOBP RESPONSE TO SALT	350	1.27e-01	4.40e-01	0.0931	-1.40e-02	7.55e-02	4.32e-02	-2.19e-02	2.09e-02	6.54e-01	1.53e-02	1.65e-01	4.81e-01	5.01e-01
GOBP RESPONSE TO MECHANICAL STIMULUS	208	5.14e-01	8.09e-01	0.0931	1.05e-03	1.33e-02	4.96e-02	5.34e-02	-5.64e-02	9.79e-01	7.42e-01	2.18e-01	1.85e-01	1.61e-01
GOBP NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION	60	8.89e-01	9.63e-01	0.0931	1.50e-03	2.45e-02	-7.58e-03	-8.90e-02	-8.89e-03	9.84e-01	7.42e-01	9.19e-01	2.33e-01	9.05e-01
GOCC MICROTUBULE ASSOCIATED COMPLEX	149	5.91e-01	8.47e-01	0.0929	2.11e-02	-2.74e-02	-8.11e-02	-2.12e-03	-2.93e-02	6.57e-01	5.64e-01	8.76e-02	9.64e-01	5.38e-01
GOBP PROTEIN PROCESSING	233	3.20e-01	6.69e-01	0.0925	-4.85e-02	4.21e-02	-1.45e-02	-2.60e-02	-5.96e-02	2.02e-01	2.68e-01	7.04e-01	4.94e-01	1.17e-01
GOBP EPITHELIAL TUBE MORPHOGENESIS	325	5.98e-02	2.86e-01	0.0925	1.66e-02	1.84e-02	9.69e-03	-8.78e-02	-1.19e-02	6.07e-01	5.69e-01	7.64e-01	6.49e-03	7.13e-01
GOBP REGULATION OF HORMONE LEVELS	518	5.85e-02	2.82e-01	0.0925	3.09e-02	3.97e-02	5.44e-02	4.73e-02	-2.87e-02	2.28e-01	1.22e-01	3.42e-02	6.51e-02	2.64e-01
GOMF HEXOSYLTRANSFERASE ACTIVITY	190	4.51e-01	7.71e-01	0.0924	4.45e-02	7.75e-02	1.25e-02	1.56e-02	-1.20e-02	2.90e-01	6.54e-02	7.66e-01	7.11e-01	7.76e-01
GOBP ENDOCYTIC RECYCLING	82	8.76e-01	9.59e-01	0.0923	-1.76e-03	4.38e-02	-4.00e-02	-7.01e-02	-9.51e-03	9.78e-01	4.93e-01	5.32e-01	2.72e-01	8.82e-01
GOCC GOLGI APPARATUS	1535	5.64e-07	2.72e-05	0.0923	-2.46e-02	6.09e-02	-3.85e-03	-6.22e-02	-1.81e-02	1.08e-01	6.67e-05	8.01e-01	4.74e-05	2.37e-01
GOBP COLLAGEN METABOLIC PROCESS	103	7.49e-01	9.15e-01	0.0923	3.43e-02	3.99e-02	-3.01e-02	-9.84e-03	-6.89e-02	5.48e-01	4.84e-01	5.98e-01	8.63e-01	2.27e-01
GOBP CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT	201	5.32e-01	8.20e-01	0.0923	3.55e-02	2.72e-02	-2.28e-02	-5.97e-02	4.93e-02	3.85e-01	5.07e-01	5.77e-01	1.44e-01	2.28e-01
GOBP CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS	89	7.32e-01	9.08e-01	0.0922	-7.27e-02	-2.53e-02	-4.06e-02	2.53e-02	1.68e-02	2.36e-01	6.80e-01	5.08e-01	6.80e-01	7.84e-01
GOBP REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS	341	1.14e-01	4.12e-01	0.0922	-4.93e-02	4.38e-02	3.11e-02	-4.50e-02	3.40e-02	1.18e-01	1.64e-01	3.24e-01	1.53e-01	2.81e-01
GOBP CELLULAR RESPONSE TO VITAMIN D	21	9.93e-01	9.97e-01	0.0921	-7.44e-02	3.62e-02	2.69e-02	1.71e-02	-2.47e-02	5.55e-01	7.74e-01	8.31e-01	8.92e-01	8.44e-01
GOMF QUATERNARY AMMONIUM GROUP BINDING	50	9.37e-01	9.80e-01	0.0920	-5.24e-02	3.36e-02	1.26e-02	-2.89e-02	5.99e-02	5.22e-01	6.81e-01	8.78e-01	7.24e-01	4.63e-01
GOBP GLYCOLYTIC PROCESS THROUGH GLUCOSE 6 PHOSPHATE	19	9.93e-01	9.97e-01	0.0919	4.40e-02	5.33e-02	-3.65e-02	-1.91e-02	4.44e-02	7.40e-01	6.87e-01	7.83e-01	8.85e-01	7.38e-01
GOMF MICROTUBULE BINDING	261	3.87e-01	7.24e-01	0.0916	1.94e-02	3.50e-02	-3.05e-02	-7.06e-02	2.95e-02	5.89e-01	3.30e-01	3.97e-01	4.96e-02	4.13e-01
GOBP VENTRICULAR SYSTEM DEVELOPMENT	32	9.64e-01	9.90e-01	0.0914	-4.97e-02	1.73e-02	5.93e-02	-2.40e-02	-3.87e-02	6.27e-01	8.65e-01	5.61e-01	8.14e-01	7.05e-01
GOBP RESPONSE TO PURINE CONTAINING COMPOUND	136	5.77e-01	8.42e-01	0.0914	-2.91e-02	2.52e-02	7.75e-02	-1.93e-02	2.22e-02	5.57e-01	6.11e-01	1.19e-01	6.98e-01	6.55e-01
GOBP AMEBOIDAL TYPE CELL MIGRATION	478	2.63e-02	1.67e-01	0.0914	-8.76e-02	1.97e-02	-1.33e-02	-3.42e-03	9.41e-03	1.03e-03	4.62e-01	6.19e-01	8.98e-01	7.24e-01
GOCC SYNAPSE	1375	2.76e-05	8.13e-04	0.0911	-2.66e-02	5.56e-02	6.59e-02	8.91e-03	-9.15e-03	9.81e-02	5.42e-04	4.16e-05	5.80e-01	5.70e-01
GOCC NUCLEAR OUTER MEMBRANE ENDOPLASMIC RETICULUM MEMBRANE NETWORK	1143	5.32e-04	9.32e-03	0.0911	2.09e-02	4.32e-02	-3.51e-02	-6.52e-02	2.28e-02	2.33e-01	1.37e-02	4.52e-02	2.03e-04	1.95e-01
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL	42	9.34e-01	9.80e-01	0.0910	-1.53e-02	-2.02e-02	4.96e-02	-3.55e-03	-7.19e-02	8.63e-01	8.21e-01	5.78e-01	9.68e-01	4.20e-01
GOCC MICROTUBULE END	34	9.73e-01	9.92e-01	0.0910	2.57e-02	3.02e-02	-3.30e-02	-3.26e-03	-7.49e-02	7.95e-01	7.61e-01	7.39e-01	9.74e-01	4.50e-01
GOBP SPHINGOLIPID METABOLIC PROCESS	162	4.96e-01	8.00e-01	0.0908	6.38e-03	6.64e-02	1.76e-02	-3.87e-02	-4.45e-02	8.89e-01	1.45e-01	6.99e-01	3.95e-01	3.28e-01
GOCC AGGRESOME	33	9.86e-01	9.95e-01	0.0907	4.50e-02	-2.22e-02	-3.97e-02	-5.80e-02	2.78e-02	6.55e-01	8.26e-01	6.93e-01	5.64e-01	7.82e-01
GOMF HYDROLASE ACTIVITY ACTING ON GLYCOSYL BONDS	126	6.82e-01	8.88e-01	0.0906	6.41e-02	-9.46e-03	2.12e-02	3.66e-02	-4.73e-02	2.14e-01	8.54e-01	6.81e-01	4.78e-01	3.60e-01
GOBP ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY	976	3.92e-04	7.39e-03	0.0906	-2.69e-02	6.88e-02	4.68e-02	-2.23e-02	7.84e-03	1.54e-01	2.73e-04	1.33e-02	2.38e-01	6.79e-01
GOBP RESPONSE TO WOUNDING	538	2.44e-02	1.59e-01	0.0906	-4.12e-02	7.92e-02	1.54e-02	1.87e-03	-1.20e-03	1.02e-01	1.68e-03	5.42e-01	9.41e-01	9.62e-01
GOBP STEROID METABOLIC PROCESS	310	2.77e-01	6.31e-01	0.0905	-2.32e-02	4.99e-04	1.80e-02	6.90e-02	-5.06e-02	4.82e-01	9.88e-01	5.85e-01	3.66e-02	1.25e-01
GOBP VESICLE MEDIATED TRANSPORT IN SYNAPSE	208	3.86e-01	7.24e-01	0.0905	-2.17e-02	6.64e-02	1.47e-02	-5.56e-02	-2.70e-03	5.90e-01	9.89e-02	7.16e-01	1.67e-01	9.46e-01
GOBP REGULATION OF RECEPTOR BINDING	17	9.95e-01	9.98e-01	0.0905	9.96e-03	3.02e-02	1.50e-02	-8.94e-03	8.29e-02	9.43e-01	8.29e-01	9.15e-01	9.49e-01	5.54e-01
GOBP INTRACELLULAR GLUCOSE HOMEOSTASIS	152	4.99e-01	8.03e-01	0.0904	1.20e-03	3.67e-02	5.37e-02	-5.17e-02	3.57e-02	9.80e-01	4.35e-01	2.53e-01	2.71e-01	4.48e-01
GOMF VITAMIN BINDING	144	5.61e-01	8.33e-01	0.0904	1.10e-02	7.43e-02	-4.76e-02	-1.55e-02	4.50e-03	8.19e-01	1.24e-01	3.24e-01	7.47e-01	9.26e-01
GOCC PLATELET ALPHA GRANULE LUMEN	60	8.16e-01	9.41e-01	0.0904	2.39e-03	4.00e-02	-2.00e-02	7.78e-02	1.03e-02	9.74e-01	5.92e-01	7.89e-01	2.97e-01	8.90e-01
GOBP REGULATION OF TRANS SYNAPTIC SIGNALING	469	2.99e-02	1.83e-01	0.0903	5.45e-05	3.28e-02	8.07e-02	6.86e-05	-2.36e-02	9.98e-01	2.23e-01	2.75e-03	9.98e-01	3.81e-01
GOBP POTASSIUM ION HOMEOSTASIS	34	9.64e-01	9.90e-01	0.0902	-6.65e-02	1.25e-02	3.60e-02	-4.76e-02	-1.32e-03	5.02e-01	9.00e-01	7.16e-01	6.31e-01	9.89e-01
GOCC POLYMERIC CYTOSKELETAL FIBER	734	1.44e-02	1.14e-01	0.0902	-5.57e-02	2.15e-02	5.44e-02	2.95e-02	-2.71e-02	1.01e-02	3.20e-01	1.21e-02	1.74e-01	2.10e-01
GOBP CELL JUNCTION MAINTENANCE	45	9.51e-01	9.85e-01	0.0901	-5.76e-02	-9.04e-03	3.13e-02	-1.02e-02	6.03e-02	5.03e-01	9.16e-01	7.16e-01	9.06e-01	4.84e-01
GOCC SOMATODENDRITIC COMPARTMENT	799	6.05e-03	6.13e-02	0.0901	7.06e-03	2.66e-02	8.13e-02	2.47e-02	1.23e-02	7.35e-01	2.01e-01	9.39e-05	2.35e-01	5.54e-01
GOCC MULTIVESICULAR BODY	65	7.80e-01	9.28e-01	0.0901	-1.67e-03	5.24e-02	-6.02e-02	1.96e-02	3.69e-02	9.81e-01	4.65e-01	4.01e-01	7.85e-01	6.07e-01
GOBP NEGATIVE REGULATION OF CELL ADHESION	297	3.36e-01	6.84e-01	0.0900	-3.24e-02	3.60e-02	4.82e-02	5.86e-02	-2.35e-03	3.36e-01	2.86e-01	1.53e-01	8.25e-02	9.45e-01
GOBP CELL MOTILITY	1713	2.01e-06	8.25e-05	0.0900	-5.81e-02	4.14e-02	5.31e-02	1.00e-02	-9.79e-03	6.30e-05	4.42e-03	2.56e-04	4.90e-01	5.01e-01
GOBP NEUROTROPHIN SIGNALING PATHWAY	38	9.80e-01	9.93e-01	0.0900	1.82e-02	-1.87e-02	-4.95e-02	-6.95e-02	-1.16e-02	8.46e-01	8.42e-01	5.98e-01	4.59e-01	9.02e-01
GOBP POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS	772	3.47e-03	4.10e-02	0.0899	1.88e-02	6.92e-02	2.87e-02	-3.90e-02	2.45e-02	3.75e-01	1.07e-03	1.74e-01	6.52e-02	2.48e-01
GOBP RESPONSE TO NUTRIENT	147	6.34e-01	8.71e-01	0.0899	1.10e-02	5.87e-02	1.99e-02	-5.32e-02	3.60e-02	8.18e-01	2.20e-01	6.77e-01	2.66e-01	4.51e-01
GOBP SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION	460	4.04e-02	2.21e-01	0.0898	-1.79e-02	5.45e-02	4.48e-03	-3.37e-02	-6.02e-02	5.11e-01	4.52e-02	8.69e-01	2.16e-01	2.68e-02
GOMF PROTEIN KINASE A BINDING	49	9.42e-01	9.82e-01	0.0898	-5.99e-03	3.34e-02	2.04e-03	-5.90e-03	8.29e-02	9.42e-01	6.86e-01	9.80e-01	9.43e-01	3.15e-01
GOBP ASTROCYTE DIFFERENTIATION	84	7.99e-01	9.33e-01	0.0898	-5.68e-02	-3.07e-02	1.81e-02	-5.37e-02	2.59e-02	3.68e-01	6.26e-01	7.74e-01	3.95e-01	6.82e-01
GOBP CELLULAR COMPONENT MORPHOGENESIS	751	3.27e-03	3.91e-02	0.0898	9.53e-03	2.57e-03	8.18e-02	2.44e-02	-2.60e-02	6.57e-01	9.05e-01	1.36e-04	2.56e-01	2.25e-01
GOBP STRIATED MUSCLE CELL DIFFERENTIATION	298	3.12e-01	6.63e-01	0.0898	3.18e-02	4.43e-02	5.55e-02	3.42e-02	2.88e-02	3.45e-01	1.88e-01	9.91e-02	3.10e-01	3.93e-01
GOBP STEROL METABOLIC PROCESS	149	6.10e-01	8.58e-01	0.0896	5.65e-02	6.00e-02	-1.10e-02	-1.50e-02	-2.99e-02	2.34e-01	2.06e-01	8.16e-01	7.52e-01	5.29e-01
GOBP MUSCLE SYSTEM PROCESS	438	7.70e-02	3.33e-01	0.0896	-5.71e-02	4.92e-02	3.08e-02	3.60e-02	1.04e-02	4.05e-02	7.78e-02	2.69e-01	1.97e-01	7.08e-01
GOCC MOTILE CILIUM	248	3.50e-01	6.96e-01	0.0894	-1.71e-02	-8.13e-02	-2.67e-02	1.75e-02	-9.04e-03	6.42e-01	2.75e-02	4.69e-01	6.35e-01	8.06e-01
GOBP MUSCLE CONTRACTION	338	1.17e-01	4.19e-01	0.0893	-5.70e-02	3.58e-02	9.83e-03	5.78e-02	-3.07e-03	7.16e-02	2.58e-01	7.56e-01	6.78e-02	9.23e-01
GOBP PHOSPHORYLATION	1518	2.25e-06	9.01e-05	0.0892	-2.73e-03	5.67e-02	2.20e-02	-5.79e-02	3.01e-02	8.59e-01	2.21e-04	1.52e-01	1.65e-04	4.98e-02
GOBP REGULATION OF CANONICAL WNT SIGNALING PATHWAY	249	3.10e-01	6.62e-01	0.0892	-2.36e-02	5.21e-02	7.08e-03	-6.65e-02	1.46e-02	5.21e-01	1.57e-01	8.48e-01	7.09e-02	6.91e-01
GOBP POSITIVE REGULATION OF MIRNA TRANSCRIPTION	50	9.47e-01	9.83e-01	0.0892	-8.95e-05	8.34e-02	-1.02e-02	-2.90e-02	-7.60e-03	9.99e-01	3.08e-01	9.00e-01	7.23e-01	9.26e-01
GOBP MEMBRANE LIPID METABOLIC PROCESS	208	4.26e-01	7.53e-01	0.0890	3.35e-03	5.23e-02	-5.84e-03	-7.16e-02	-4.92e-03	9.34e-01	1.93e-01	8.85e-01	7.52e-02	9.03e-01
GOBP REGULATION OF POLYSACCHARIDE BIOSYNTHETIC PROCESS	38	9.61e-01	9.89e-01	0.0890	7.81e-03	7.55e-02	-3.74e-02	-4.69e-04	-2.78e-02	9.34e-01	4.21e-01	6.90e-01	9.96e-01	7.67e-01
GOBP CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS	121	7.79e-01	9.28e-01	0.0890	1.76e-02	-4.35e-02	-4.55e-02	-5.71e-02	-1.99e-02	7.38e-01	4.09e-01	3.88e-01	2.78e-01	7.05e-01
GOBP KERATINOCYTE PROLIFERATION	58	9.26e-01	9.76e-01	0.0889	-1.28e-02	-5.65e-02	4.46e-03	1.07e-02	-6.64e-02	8.66e-01	4.56e-01	9.53e-01	8.88e-01	3.82e-01
GOBP POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS	692	1.13e-02	9.57e-02	0.0888	-2.84e-02	6.90e-02	4.68e-02	-7.11e-03	8.76e-03	2.03e-01	1.97e-03	3.57e-02	7.50e-01	6.95e-01
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY	70	9.33e-01	9.79e-01	0.0888	-1.85e-02	4.69e-02	5.55e-02	3.38e-02	-3.36e-02	7.89e-01	4.98e-01	4.22e-01	6.25e-01	6.27e-01
GOBP CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND	1243	3.83e-05	1.07e-03	0.0885	-2.99e-02	6.62e-02	4.42e-02	-2.41e-02	-4.71e-03	7.64e-02	8.57e-05	8.79e-03	1.53e-01	7.80e-01
GOBP CELLULAR LIPID METABOLIC PROCESS	967	1.15e-03	1.72e-02	0.0885	7.20e-03	7.21e-02	-2.14e-02	-4.58e-02	5.01e-03	7.05e-01	1.46e-04	2.61e-01	1.59e-02	7.92e-01
GOBP FIBROBLAST MIGRATION	52	9.53e-01	9.86e-01	0.0884	-2.27e-02	6.03e-02	5.33e-02	-2.04e-03	2.86e-02	7.77e-01	4.52e-01	5.06e-01	9.80e-01	7.21e-01
GOBP REGULATION OF PHOSPHORUS METABOLIC PROCESS	1129	8.88e-05	2.15e-03	0.0884	-2.64e-02	6.27e-02	2.50e-02	-4.93e-02	1.13e-02	1.34e-01	3.82e-04	1.56e-01	5.23e-03	5.22e-01
GOBP POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT	34	9.65e-01	9.90e-01	0.0883	-2.99e-02	4.99e-02	-6.47e-02	-9.81e-03	-1.10e-02	7.63e-01	6.14e-01	5.14e-01	9.21e-01	9.12e-01
GOMF CADHERIN BINDING	329	2.32e-01	5.85e-01	0.0883	-9.56e-03	5.04e-02	-3.07e-02	-6.38e-02	-1.23e-02	7.66e-01	1.16e-01	3.39e-01	4.67e-02	7.01e-01
GOBP REGULATION OF EXCITATORY SYNAPSE ASSEMBLY	15	9.89e-01	9.96e-01	0.0883	-2.68e-02	4.55e-02	-3.29e-02	5.88e-02	2.18e-02	8.57e-01	7.60e-01	8.26e-01	6.94e-01	8.84e-01
GOBP CARBOHYDRATE TRANSPORT	153	4.90e-01	7.98e-01	0.0882	-4.18e-02	4.98e-02	-1.97e-02	4.76e-02	-3.00e-02	3.73e-01	2.87e-01	6.74e-01	3.10e-01	5.22e-01
GOBP REGULATION OF WNT SIGNALING PATHWAY	325	1.55e-01	4.83e-01	0.0880	-2.90e-02	5.50e-02	2.00e-02	-5.89e-02	3.63e-03	3.69e-01	8.85e-02	5.36e-01	6.78e-02	9.10e-01
GOBP GLYCOSYL COMPOUND METABOLIC PROCESS	79	8.87e-01	9.62e-01	0.0880	-3.19e-03	5.66e-02	-2.78e-02	-5.65e-02	-2.37e-02	9.61e-01	3.85e-01	6.69e-01	3.85e-01	7.16e-01
GOBP POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS	132	7.88e-01	9.30e-01	0.0879	-1.02e-02	1.23e-02	-3.59e-02	-6.74e-02	4.04e-02	8.40e-01	8.07e-01	4.76e-01	1.81e-01	4.23e-01
GOBP REGULATION OF CELLULAR LOCALIZATION	945	6.14e-04	1.04e-02	0.0879	1.12e-03	3.90e-02	8.73e-03	-7.43e-02	2.46e-02	9.54e-01	4.20e-02	6.49e-01	1.09e-04	2.00e-01
GOMF KINASE ACTIVITY	706	9.33e-03	8.32e-02	0.0878	2.61e-02	5.58e-02	2.47e-02	-4.41e-02	3.69e-02	2.38e-01	1.15e-02	2.64e-01	4.59e-02	9.52e-02
GOBP POSITIVE REGULATION OF HYDROLASE ACTIVITY	474	9.06e-02	3.63e-01	0.0875	-4.08e-02	5.48e-02	2.46e-02	3.31e-02	-3.58e-02	1.28e-01	4.08e-02	3.59e-01	2.17e-01	1.81e-01
GOBP SMALL MOLECULE METABOLIC PROCESS	1773	4.76e-06	1.73e-04	0.0875	5.59e-03	5.61e-02	-2.59e-02	-5.79e-02	2.14e-02	6.96e-01	8.75e-05	6.98e-02	5.21e-05	1.34e-01
GOBP RESPONSE TO HORMONE	838	1.65e-03	2.33e-02	0.0874	-2.00e-02	6.19e-02	5.15e-02	-2.74e-02	1.47e-03	3.25e-01	2.33e-03	1.14e-02	1.77e-01	9.42e-01
GOBP REGULATION OF HYDROLASE ACTIVITY	731	2.20e-02	1.50e-01	0.0874	-3.83e-02	4.22e-02	3.80e-02	3.97e-02	-3.69e-02	7.77e-02	5.21e-02	8.00e-02	6.72e-02	8.93e-02
GOBP CELL CELL SIGNALING BY WNT	441	6.77e-02	3.07e-01	0.0874	-9.87e-03	5.83e-02	7.50e-03	-6.39e-02	-3.73e-04	7.22e-01	3.58e-02	7.87e-01	2.14e-02	9.89e-01
GOBP PROTEIN CONTAINING COMPLEX LOCALIZATION	178	5.11e-01	8.08e-01	0.0874	6.87e-02	2.99e-02	1.05e-02	-4.32e-02	6.73e-03	1.14e-01	4.92e-01	8.10e-01	3.20e-01	8.77e-01
GOMF ADENYL NUCLEOTIDE BINDING	1566	6.70e-05	1.73e-03	0.0873	1.63e-02	2.82e-02	-2.87e-02	-6.77e-02	3.40e-02	2.83e-01	6.21e-02	5.78e-02	7.77e-06	2.48e-02
GOBP CELL PART MORPHOGENESIS	642	1.22e-02	1.01e-01	0.0872	1.47e-03	7.46e-03	8.46e-02	1.69e-02	-1.06e-02	9.49e-01	7.47e-01	2.55e-04	4.65e-01	6.47e-01
GOBP RHYTHMIC PROCESS	287	2.80e-01	6.33e-01	0.0871	2.25e-02	6.29e-02	1.41e-02	-5.05e-02	1.92e-02	5.12e-01	6.66e-02	6.82e-01	1.41e-01	5.76e-01
GOBP POSITIVE REGULATION OF PHOSPHORYLATION	630	1.71e-02	1.28e-01	0.0871	-2.14e-02	6.39e-02	5.14e-02	-1.87e-02	6.22e-03	3.58e-01	6.15e-03	2.77e-02	4.22e-01	7.90e-01
GOBP CELLULAR COMPONENT MAINTENANCE	71	8.95e-01	9.65e-01	0.0870	-6.64e-02	-1.40e-02	2.70e-02	3.22e-03	4.73e-02	3.34e-01	8.39e-01	6.95e-01	9.63e-01	4.91e-01
GOBP MULTICELLULAR ORGANISMAL LEVEL HOMEOSTASIS	780	2.87e-03	3.56e-02	0.0870	-3.01e-02	6.23e-02	3.83e-02	-3.61e-02	-2.41e-03	1.52e-01	3.07e-03	6.88e-02	8.64e-02	9.09e-01
GOBP ORGAN GROWTH	168	6.58e-01	8.80e-01	0.0869	-4.92e-02	1.77e-02	5.75e-02	2.71e-02	2.78e-02	2.71e-01	6.92e-01	1.98e-01	5.44e-01	5.34e-01
GOMF TRANSPORTER ACTIVITY	1171	4.61e-04	8.40e-03	0.0869	-4.10e-02	5.66e-02	3.23e-02	1.71e-02	-3.65e-02	1.81e-02	1.10e-03	6.27e-02	3.24e-01	3.52e-02
GOCC LYSOSOMAL LUMEN	91	8.45e-01	9.49e-01	0.0867	-4.46e-02	3.21e-02	-1.03e-02	-6.62e-02	-2.40e-03	4.62e-01	5.96e-01	8.65e-01	2.75e-01	9.68e-01
GOBP NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION	140	6.87e-01	8.90e-01	0.0866	-1.47e-02	6.35e-02	5.51e-02	-1.47e-02	2.14e-03	7.64e-01	1.95e-01	2.60e-01	7.63e-01	9.65e-01
GOMF TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS	865	6.56e-03	6.50e-02	0.0866	3.20e-02	3.27e-02	-1.75e-02	-6.69e-02	2.50e-02	1.11e-01	1.03e-01	3.82e-01	8.33e-04	2.13e-01
GOBP CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT	22	9.86e-01	9.95e-01	0.0866	-5.01e-02	-4.65e-02	4.34e-02	-3.02e-02	5.57e-03	6.84e-01	7.06e-01	7.24e-01	8.07e-01	9.64e-01
GOBP CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION	541	5.21e-02	2.62e-01	0.0864	1.27e-02	4.64e-03	8.01e-02	2.89e-02	-5.34e-03	6.13e-01	8.53e-01	1.43e-03	2.50e-01	8.32e-01
GOBP REGULATION OF SMALL MOLECULE METABOLIC PROCESS	325	2.03e-01	5.53e-01	0.0864	-2.66e-02	7.40e-02	-1.90e-02	-3.02e-02	-4.17e-03	4.09e-01	2.19e-02	5.56e-01	3.50e-01	8.97e-01
GOBP REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS	18	9.90e-01	9.96e-01	0.0864	1.94e-02	8.21e-04	7.00e-02	-3.61e-02	2.96e-02	8.87e-01	9.95e-01	6.07e-01	7.91e-01	8.28e-01
GOBP PROTEIN PHOSPHORYLATION	1268	4.52e-05	1.24e-03	0.0864	1.57e-03	5.69e-02	3.64e-02	-4.46e-02	3.01e-02	9.25e-01	6.61e-04	2.94e-02	7.53e-03	7.18e-02
GOBP REGULATION OF ANATOMICAL STRUCTURE SIZE	485	4.80e-02	2.47e-01	0.0863	-3.85e-02	7.51e-02	7.43e-03	1.57e-02	-4.77e-03	1.47e-01	4.59e-03	7.79e-01	5.53e-01	8.57e-01
GOBP REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS	81	7.90e-01	9.31e-01	0.0863	1.93e-02	2.70e-02	1.85e-02	-7.63e-02	-1.36e-02	7.65e-01	6.75e-01	7.73e-01	2.35e-01	8.32e-01
GOMF PDZ DOMAIN BINDING	84	8.16e-01	9.41e-01	0.0863	-6.24e-02	-1.74e-02	3.44e-02	-2.61e-02	-3.72e-02	3.23e-01	7.83e-01	5.86e-01	6.79e-01	5.56e-01
GOBP CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND	527	4.18e-02	2.27e-01	0.0862	-1.25e-02	6.15e-02	5.01e-02	-2.54e-02	1.86e-02	6.24e-01	1.57e-02	4.91e-02	3.19e-01	4.66e-01
GOMF PHOSPHATASE ACTIVITY	255	2.83e-01	6.36e-01	0.0862	3.15e-02	6.05e-02	4.26e-02	-2.59e-02	-1.70e-02	3.87e-01	9.59e-02	2.42e-01	4.76e-01	6.40e-01
GOBP ANATOMICAL STRUCTURE MATURATION	252	3.43e-01	6.90e-01	0.0862	-3.59e-02	2.86e-02	-6.84e-03	-7.26e-02	3.09e-03	3.27e-01	4.34e-01	8.52e-01	4.73e-02	9.33e-01
GOBP SIGNAL RELEASE	467	9.32e-02	3.69e-01	0.0862	5.35e-03	7.31e-02	4.09e-02	2.88e-03	-1.93e-02	8.43e-01	6.79e-03	1.30e-01	9.15e-01	4.75e-01
GOBP CHEMICAL HOMEOSTASIS	992	8.30e-04	1.34e-02	0.0861	-3.67e-02	5.45e-02	5.38e-02	-1.46e-02	5.03e-04	5.05e-02	3.69e-03	4.16e-03	4.36e-01	9.79e-01
GOBP AXON DEVELOPMENT	480	5.34e-02	2.66e-01	0.0861	1.64e-02	-7.05e-03	8.08e-02	1.56e-02	1.82e-02	5.39e-01	7.91e-01	2.43e-03	5.58e-01	4.95e-01
GOBP GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS	74	8.98e-01	9.67e-01	0.0861	-6.17e-02	3.94e-02	-1.28e-02	-4.03e-02	-1.60e-02	3.58e-01	5.58e-01	8.49e-01	5.49e-01	8.12e-01
GOMF ACETYLCHOLINE GATED MONOATOMIC CATION SELECTIVE CHANNEL ACTIVITY	22	9.93e-01	9.97e-01	0.0859	-5.82e-02	-3.14e-02	7.63e-03	5.40e-02	4.13e-03	6.36e-01	7.98e-01	9.51e-01	6.61e-01	9.73e-01
GOBP POSITIVE REGULATION OF NUCLEAR DIVISION	60	9.46e-01	9.82e-01	0.0859	4.88e-02	2.72e-02	5.10e-02	1.81e-02	3.64e-02	5.13e-01	7.16e-01	4.95e-01	8.09e-01	6.26e-01
GOBP REGULATION OF MUSCLE SYSTEM PROCESS	239	4.13e-01	7.44e-01	0.0857	-6.76e-02	4.60e-02	2.50e-02	2.34e-04	-6.01e-03	7.17e-02	2.20e-01	5.06e-01	9.95e-01	8.73e-01
GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS	155	7.26e-01	9.05e-01	0.0857	1.77e-02	4.26e-02	-2.31e-02	-6.25e-02	2.81e-02	7.04e-01	3.60e-01	6.20e-01	1.79e-01	5.46e-01
GOBP STEROID HORMONE BIOSYNTHETIC PROCESS	43	9.74e-01	9.92e-01	0.0857	-6.10e-02	-9.96e-03	-2.66e-03	2.28e-02	-5.48e-02	4.89e-01	9.10e-01	9.76e-01	7.96e-01	5.34e-01
GOBP REGULATION OF RESPONSE TO BIOTIC STIMULUS	488	4.51e-02	2.37e-01	0.0857	-3.43e-02	5.40e-02	-2.46e-02	-2.56e-02	4.47e-02	1.94e-01	4.12e-02	3.53e-01	3.33e-01	9.10e-02
GOBP CELL GROWTH	474	5.43e-02	2.68e-01	0.0856	-7.35e-03	6.04e-02	1.20e-02	-5.87e-02	-6.53e-03	7.84e-01	2.43e-02	6.54e-01	2.85e-02	8.07e-01
GOBP TRANSMEMBRANE TRANSPORT	1478	1.89e-04	3.97e-03	0.0856	-3.87e-02	3.90e-02	4.74e-02	3.21e-02	-3.21e-02	1.28e-02	1.22e-02	2.32e-03	3.92e-02	3.90e-02
GOBP GMP METABOLIC PROCESS	25	9.94e-01	9.97e-01	0.0853	-6.86e-03	-2.26e-02	-5.18e-02	-5.42e-02	-3.33e-02	9.53e-01	8.45e-01	6.54e-01	6.39e-01	7.73e-01
GOBP CELL MORPHOGENESIS	911	2.94e-03	3.61e-02	0.0853	-1.98e-02	1.68e-02	7.81e-02	1.69e-02	-1.45e-02	3.12e-01	3.89e-01	6.38e-05	3.87e-01	4.58e-01
GOMF PROTEIN SERINE THREONINE KINASE ACTIVITY	406	1.64e-01	4.97e-01	0.0853	2.98e-02	4.41e-02	8.01e-03	-4.73e-02	4.62e-02	3.02e-01	1.27e-01	7.82e-01	1.02e-01	1.10e-01
GOBP POSITIVE REGULATION OF GROWTH	236	4.70e-01	7.85e-01	0.0850	2.79e-04	5.34e-02	6.19e-02	1.76e-03	2.31e-02	9.94e-01	1.57e-01	1.01e-01	9.63e-01	5.41e-01
GOBP REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT	75	8.76e-01	9.59e-01	0.0850	1.89e-02	5.84e-03	-3.96e-02	3.95e-02	-6.09e-02	7.78e-01	9.30e-01	5.53e-01	5.54e-01	3.62e-01
GOBP BLOOD VESSEL ENDOTHELIAL CELL MIGRATION	170	5.65e-01	8.35e-01	0.0849	-7.55e-02	2.06e-03	-2.07e-02	-1.73e-02	2.79e-02	8.93e-02	9.63e-01	6.42e-01	6.98e-01	5.30e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PEROXIDE AS ACCEPTOR	54	9.59e-01	9.88e-01	0.0849	2.56e-02	4.88e-02	4.69e-02	3.11e-03	4.43e-02	7.45e-01	5.35e-01	5.51e-01	9.69e-01	5.74e-01
GOBP REGULATION OF SULFUR METABOLIC PROCESS	12	9.99e-01	1.00e+00	0.0849	-6.17e-02	-2.50e-02	2.37e-02	4.10e-02	-2.32e-02	7.12e-01	8.81e-01	8.87e-01	8.06e-01	8.89e-01
GOBP REGULATION OF EXTENT OF CELL GROWTH	101	8.47e-01	9.49e-01	0.0849	-4.88e-02	2.60e-02	4.24e-02	3.20e-02	3.63e-02	3.97e-01	6.51e-01	4.62e-01	5.78e-01	5.29e-01
GOMF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY	165	6.68e-01	8.83e-01	0.0848	3.63e-02	6.03e-02	3.37e-02	2.52e-02	-2.19e-02	4.22e-01	1.82e-01	4.55e-01	5.77e-01	6.28e-01
GOBP OOGENESIS	108	8.09e-01	9.37e-01	0.0847	-1.15e-02	-3.56e-03	-7.64e-03	-1.99e-02	8.11e-02	8.37e-01	9.49e-01	8.91e-01	7.21e-01	1.46e-01
GOBP RESPONSE TO CARBOHYDRATE	224	4.99e-01	8.03e-01	0.0846	2.66e-02	3.85e-02	1.06e-02	-4.89e-02	4.97e-02	4.92e-01	3.21e-01	7.85e-01	2.07e-01	2.00e-01
GOBP REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION	128	7.07e-01	8.97e-01	0.0846	-3.54e-02	-2.76e-02	3.81e-02	-1.82e-02	5.80e-02	4.89e-01	5.90e-01	4.57e-01	7.22e-01	2.57e-01
GOBP CARDIAC CHAMBER MORPHOGENESIS	127	6.64e-01	8.82e-01	0.0846	6.89e-02	2.19e-02	1.54e-02	-2.61e-02	-3.18e-02	1.80e-01	6.71e-01	7.64e-01	6.12e-01	5.37e-01
GOCC COATED VESICLE	296	3.32e-01	6.80e-01	0.0845	1.90e-02	5.32e-02	-1.65e-02	-6.07e-02	3.69e-04	5.73e-01	1.16e-01	6.24e-01	7.26e-02	9.91e-01
GOBP SENSORY ORGAN DEVELOPMENT	576	1.97e-02	1.40e-01	0.0844	2.43e-02	3.92e-02	6.14e-02	-2.56e-02	2.38e-02	3.18e-01	1.08e-01	1.18e-02	2.94e-01	3.29e-01
GOBP RESPONSE TO OXYGEN CONTAINING COMPOUND	1735	2.48e-06	9.81e-05	0.0841	-3.48e-02	6.21e-02	3.77e-02	-2.40e-02	3.30e-03	1.59e-02	1.73e-05	9.01e-03	9.65e-02	8.19e-01
GOBP FATTY ACID BIOSYNTHETIC PROCESS	159	6.67e-01	8.82e-01	0.0841	1.48e-02	5.45e-02	-3.27e-02	-3.06e-02	4.32e-02	7.48e-01	2.36e-01	4.76e-01	5.05e-01	3.47e-01
GOBP STEROID BIOSYNTHETIC PROCESS	176	6.30e-01	8.69e-01	0.0840	-5.47e-02	-1.23e-02	-2.22e-02	1.59e-02	-5.63e-02	2.11e-01	7.79e-01	6.12e-01	7.17e-01	1.98e-01
GOBP ENSHEATHMENT OF NEURONS	143	7.23e-01	9.04e-01	0.0840	-6.14e-02	-4.33e-02	-1.79e-02	-1.74e-02	-2.80e-02	2.05e-01	3.71e-01	7.12e-01	7.20e-01	5.63e-01
GOBP RESPONSE TO ABIOTIC STIMULUS	1078	9.71e-04	1.52e-02	0.0839	1.21e-03	5.22e-02	-3.59e-03	-6.40e-02	1.47e-02	9.46e-01	3.82e-03	8.42e-01	3.89e-04	4.13e-01
GOBP NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS	1187	5.58e-04	9.65e-03	0.0837	-3.18e-02	6.09e-02	4.58e-02	-3.82e-03	1.36e-02	6.52e-02	4.09e-04	7.84e-03	8.25e-01	4.31e-01
GOCC PERINUCLEAR REGION OF CYTOPLASM	700	2.12e-02	1.47e-01	0.0836	-2.12e-02	5.33e-02	-9.76e-03	-5.63e-02	2.11e-02	3.38e-01	1.63e-02	6.60e-01	1.12e-02	3.40e-01
GOBP RECEPTOR SIGNALING PATHWAY VIA STAT	177	6.55e-01	8.80e-01	0.0836	-3.46e-02	-5.79e-03	6.64e-02	2.40e-02	2.79e-02	4.27e-01	8.94e-01	1.28e-01	5.81e-01	5.22e-01
GOBP REGULATION OF PHOSPHORYLATION	1004	7.03e-04	1.16e-02	0.0836	-1.62e-02	5.40e-02	2.81e-02	-5.16e-02	1.92e-02	3.86e-01	3.80e-03	1.32e-01	5.71e-03	3.04e-01
GOBP NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION	24	9.93e-01	9.97e-01	0.0836	1.71e-02	4.78e-02	-1.63e-03	-6.54e-02	1.12e-02	8.85e-01	6.85e-01	9.89e-01	5.79e-01	9.25e-01
GOBP RESPONSE TO ACID CHEMICAL	131	7.48e-01	9.15e-01	0.0834	-3.18e-02	5.29e-02	4.50e-02	-2.18e-02	2.55e-02	5.30e-01	2.96e-01	3.74e-01	6.67e-01	6.14e-01
GOBP MUSCLE CELL DEVELOPMENT	191	5.98e-01	8.51e-01	0.0832	-1.51e-03	2.67e-02	7.72e-02	1.30e-02	8.86e-03	9.71e-01	5.24e-01	6.57e-02	7.57e-01	8.33e-01
GOMF MRNA BINDING	540	9.48e-02	3.72e-01	0.0832	-4.03e-02	-3.94e-02	-4.31e-02	-3.97e-02	1.75e-02	1.09e-01	1.17e-01	8.65e-02	1.15e-01	4.86e-01
GOBP SYNAPTIC VESICLE LOCALIZATION	53	9.51e-01	9.84e-01	0.0832	5.02e-02	7.34e-03	-4.33e-02	-2.30e-03	4.96e-02	5.27e-01	9.26e-01	5.85e-01	9.77e-01	5.32e-01
GOBP DEVELOPMENTAL MATURATION	317	2.24e-01	5.77e-01	0.0831	-3.70e-02	1.96e-02	1.88e-03	-7.12e-02	8.56e-03	2.57e-01	5.49e-01	9.54e-01	2.92e-02	7.93e-01
GOBP DENDRITIC SPINE DEVELOPMENT	85	8.91e-01	9.63e-01	0.0831	-3.86e-02	6.73e-02	2.29e-02	1.85e-02	-3.97e-03	5.38e-01	2.83e-01	7.15e-01	7.68e-01	9.50e-01
GOBP LONG TERM SYNAPTIC POTENTIATION	102	8.18e-01	9.41e-01	0.0830	9.06e-03	-6.56e-03	7.13e-02	2.25e-02	-3.43e-02	8.74e-01	9.09e-01	2.13e-01	6.94e-01	5.49e-01
GOBP GROWTH	881	3.76e-03	4.35e-02	0.0829	-8.56e-03	5.94e-02	5.07e-03	-5.68e-02	5.47e-03	6.66e-01	2.77e-03	7.98e-01	4.25e-03	7.83e-01
GOMF ANTIPORTER ACTIVITY	127	7.54e-01	9.17e-01	0.0829	-1.26e-03	6.43e-02	4.14e-02	-1.16e-02	-2.98e-02	9.80e-01	2.11e-01	4.20e-01	8.21e-01	5.62e-01
GOBP REGULATION OF RESPONSE TO STRESS	1430	1.03e-04	2.45e-03	0.0829	-2.56e-02	4.67e-02	-7.50e-03	-5.27e-02	3.46e-02	1.05e-01	3.13e-03	6.35e-01	8.38e-04	2.83e-02
GOBP REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION	101	8.47e-01	9.49e-01	0.0829	-2.75e-02	6.12e-02	5.21e-03	1.52e-02	-4.59e-02	6.33e-01	2.88e-01	9.28e-01	7.92e-01	4.26e-01
GOBP INNATE IMMUNE RESPONSE	896	6.24e-04	1.04e-02	0.0827	-4.43e-02	5.01e-02	6.71e-03	3.60e-02	3.19e-02	2.43e-02	1.10e-02	7.33e-01	6.73e-02	1.05e-01
GOBP DEFENSE RESPONSE	1720	2.04e-05	6.28e-04	0.0826	-4.31e-02	5.00e-02	3.63e-02	3.29e-02	8.04e-03	2.98e-03	5.57e-04	1.24e-02	2.31e-02	5.79e-01
GOBP HEART DEVELOPMENT	598	2.38e-02	1.58e-01	0.0825	2.55e-02	4.93e-02	4.18e-02	-3.93e-02	2.10e-02	2.87e-01	3.96e-02	8.10e-02	1.01e-01	3.80e-01
GOBP NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION	61	9.68e-01	9.90e-01	0.0824	8.64e-03	2.65e-02	5.31e-02	5.65e-02	-2.41e-03	9.07e-01	7.21e-01	4.73e-01	4.45e-01	9.74e-01
GOBP PEPTIDYL AMINO ACID MODIFICATION	885	6.76e-03	6.62e-02	0.0824	5.97e-03	5.51e-02	-2.09e-03	-5.66e-02	2.25e-02	7.63e-01	5.39e-03	9.16e-01	4.25e-03	2.55e-01
GOMF TUBULIN BINDING	357	2.68e-01	6.23e-01	0.0824	1.01e-02	4.93e-02	-1.05e-02	-6.09e-02	2.09e-02	7.42e-01	1.10e-01	7.33e-01	4.81e-02	4.97e-01
GOBP RESPONSE TO PROGESTERONE	40	9.69e-01	9.91e-01	0.0823	-7.80e-03	3.35e-02	-3.29e-02	3.23e-02	-5.89e-02	9.32e-01	7.14e-01	7.19e-01	7.23e-01	5.19e-01
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION	107	8.27e-01	9.44e-01	0.0823	-6.31e-02	4.22e-03	3.51e-02	-2.76e-03	-3.93e-02	2.60e-01	9.40e-01	5.31e-01	9.61e-01	4.83e-01
GOBP REGULATION OF TRANSPORT	1706	1.06e-05	3.51e-04	0.0823	-4.53e-02	5.94e-02	3.17e-02	-9.66e-03	-9.36e-03	1.87e-03	4.42e-05	2.92e-02	5.07e-01	5.20e-01
GOMF PROTEIN SERINE KINASE ACTIVITY	341	2.98e-01	6.52e-01	0.0822	4.54e-02	3.48e-02	6.53e-03	-3.58e-02	4.65e-02	1.50e-01	2.69e-01	8.36e-01	2.56e-01	1.40e-01
GOBP LIPID STORAGE	93	7.01e-01	8.96e-01	0.0819	-1.51e-02	-2.29e-02	3.42e-02	-6.91e-02	-3.67e-03	8.02e-01	7.03e-01	5.69e-01	2.49e-01	9.51e-01
GOBP REGULATION OF REPRODUCTIVE PROCESS	201	3.91e-01	7.26e-01	0.0819	-1.46e-02	-2.32e-02	1.43e-02	-7.37e-02	1.76e-02	7.21e-01	5.71e-01	7.26e-01	7.15e-02	6.67e-01
GOMF MOLECULAR FUNCTION ACTIVATOR ACTIVITY	1036	3.28e-03	3.92e-02	0.0814	-6.07e-02	3.70e-02	3.45e-02	1.09e-02	-1.59e-02	9.47e-04	4.38e-02	6.02e-02	5.53e-01	3.85e-01
GOBP REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS	888	4.39e-03	4.90e-02	0.0814	-3.36e-02	3.95e-02	6.03e-02	-4.98e-03	-1.64e-02	8.94e-02	4.56e-02	2.30e-03	8.01e-01	4.06e-01
GOBP SPROUTING ANGIOGENESIS	183	5.29e-01	8.19e-01	0.0813	-4.31e-02	5.66e-02	1.06e-03	3.85e-02	-8.49e-03	3.15e-01	1.87e-01	9.80e-01	3.70e-01	8.43e-01
GOBP REGULATION OF MYELINATION	45	9.67e-01	9.90e-01	0.0810	-1.61e-03	-5.85e-02	-3.53e-02	1.53e-02	4.07e-02	9.85e-01	4.97e-01	6.82e-01	8.59e-01	6.36e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE	103	8.51e-01	9.50e-01	0.0807	-5.45e-02	4.91e-02	2.11e-02	-1.73e-02	-1.95e-02	3.39e-01	3.89e-01	7.12e-01	7.61e-01	7.32e-01
GOBP MORPHOGENESIS OF AN EPITHELIUM	503	3.09e-02	1.87e-01	0.0807	9.98e-04	3.61e-02	3.88e-02	-5.98e-02	1.10e-02	9.69e-01	1.66e-01	1.36e-01	2.16e-02	6.72e-01
GOBP NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS	115	8.35e-01	9.46e-01	0.0806	1.83e-03	5.72e-02	-3.70e-02	-3.79e-02	2.04e-02	9.73e-01	2.90e-01	4.93e-01	4.83e-01	7.05e-01
GOBP POSITIVE REGULATION OF CELL DEVELOPMENT	426	1.58e-01	4.88e-01	0.0805	-2.62e-02	6.04e-02	4.18e-02	-1.86e-02	7.61e-03	3.53e-01	3.25e-02	1.39e-01	5.11e-01	7.88e-01
GOBP MONOCARBOXYLIC ACID METABOLIC PROCESS	605	4.21e-02	2.28e-01	0.0804	-5.91e-04	7.59e-02	7.19e-03	-3.48e-03	2.54e-02	9.80e-01	1.43e-03	7.63e-01	8.84e-01	2.86e-01
GOMF NADPH BINDING	15	9.95e-01	9.98e-01	0.0804	6.39e-02	-2.10e-02	1.76e-02	-2.67e-02	-3.04e-02	6.69e-01	8.88e-01	9.06e-01	8.58e-01	8.38e-01
GOBP REGULATION OF VASCULATURE DEVELOPMENT	337	2.70e-01	6.24e-01	0.0803	-5.67e-02	2.31e-02	4.35e-02	-8.71e-03	2.72e-02	7.34e-02	4.66e-01	1.70e-01	7.84e-01	3.92e-01
GOBP RESPONSE TO GROWTH FACTOR	729	1.37e-02	1.10e-01	0.0802	-1.56e-02	4.43e-02	2.36e-02	-5.39e-02	2.79e-02	4.74e-01	4.18e-02	2.79e-01	1.33e-02	1.99e-01
GOCC CLATHRIN COATED VESICLE MEMBRANE	126	8.23e-01	9.42e-01	0.0802	1.18e-02	6.34e-02	4.06e-02	-2.55e-03	2.50e-02	8.19e-01	2.19e-01	4.31e-01	9.61e-01	6.27e-01
GOBP REGULATION OF CELLULAR COMPONENT BIOGENESIS	953	4.88e-03	5.27e-02	0.0801	2.47e-03	6.11e-02	-8.80e-03	-5.07e-02	-4.98e-03	8.97e-01	1.40e-03	6.45e-01	7.96e-03	7.95e-01
GOBP ASTROCYTE DEVELOPMENT	42	9.80e-01	9.93e-01	0.0800	-5.56e-02	-5.06e-02	-1.43e-02	6.50e-03	-2.24e-02	5.33e-01	5.70e-01	8.73e-01	9.42e-01	8.02e-01
GOBP MULTI MULTICELLULAR ORGANISM PROCESS	197	7.00e-01	8.96e-01	0.0800	2.38e-02	3.04e-02	4.92e-02	4.82e-02	1.24e-02	5.64e-01	4.62e-01	2.34e-01	2.43e-01	7.63e-01
GOBP CARDIAC VENTRICLE DEVELOPMENT	127	7.47e-01	9.14e-01	0.0799	6.43e-02	3.22e-02	1.20e-02	-2.55e-02	-2.07e-02	2.11e-01	5.31e-01	8.16e-01	6.19e-01	6.87e-01
GOBP ALCOHOL BIOSYNTHETIC PROCESS	139	6.37e-01	8.73e-01	0.0799	-1.87e-02	3.73e-02	2.67e-02	-4.96e-02	-3.83e-02	7.04e-01	4.48e-01	5.86e-01	3.12e-01	4.35e-01
GOBP PROTEOLYSIS	1550	1.15e-04	2.66e-03	0.0796	-4.47e-03	3.34e-02	-2.34e-02	-6.71e-02	-1.20e-02	7.69e-01	2.81e-02	1.23e-01	1.03e-05	4.31e-01
GOBP REGULATION OF NEURON PROJECTION DEVELOPMENT	431	1.81e-01	5.24e-01	0.0795	-4.29e-02	-6.35e-03	4.22e-02	1.50e-02	-4.94e-02	1.27e-01	8.21e-01	1.33e-01	5.94e-01	7.86e-02
GOBP REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION	106	8.90e-01	9.63e-01	0.0795	-4.39e-02	1.21e-02	5.68e-02	2.62e-02	1.81e-02	4.34e-01	8.29e-01	3.12e-01	6.41e-01	7.47e-01
GOBP POSITIVE REGULATION OF BLOOD CIRCULATION	38	9.70e-01	9.91e-01	0.0794	2.85e-02	3.18e-02	1.47e-02	-3.44e-02	-5.55e-02	7.61e-01	7.35e-01	8.76e-01	7.14e-01	5.54e-01
GOBP CELLULAR RESPONSE TO NUTRIENT	45	9.79e-01	9.93e-01	0.0793	5.78e-02	5.00e-03	3.05e-04	-2.39e-02	4.84e-02	5.02e-01	9.54e-01	9.97e-01	7.81e-01	5.74e-01
GOBP REGULATION OF SYNAPTIC PLASTICITY	204	3.64e-01	7.05e-01	0.0791	1.34e-02	-2.76e-03	7.28e-02	-9.25e-03	-2.63e-02	7.42e-01	9.46e-01	7.32e-02	8.20e-01	5.17e-01
GOBP NEURAL CREST CELL DIFFERENTIATION	93	9.06e-01	9.69e-01	0.0790	4.65e-02	1.55e-02	6.16e-03	-3.31e-02	5.21e-02	4.39e-01	7.96e-01	9.18e-01	5.81e-01	3.86e-01
GOBP CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS	58	9.62e-01	9.90e-01	0.0790	1.27e-02	6.19e-02	1.56e-02	-2.49e-02	3.73e-02	8.67e-01	4.15e-01	8.37e-01	7.43e-01	6.23e-01
GOBP REGULATION OF CELL DEVELOPMENT	814	8.83e-03	8.04e-02	0.0790	2.44e-03	5.14e-02	3.61e-02	-4.06e-02	2.52e-02	9.06e-01	1.26e-02	8.02e-02	4.89e-02	2.22e-01
GOBP POSITIVE REGULATION OF SIGNALING	1720	1.37e-05	4.39e-04	0.0789	-1.55e-02	6.29e-02	3.84e-02	-2.25e-02	-7.35e-03	2.86e-01	1.45e-05	8.02e-03	1.21e-01	6.12e-01
GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS	67	9.18e-01	9.74e-01	0.0789	4.37e-02	3.59e-02	6.07e-03	-3.31e-02	-4.36e-02	5.37e-01	6.12e-01	9.31e-01	6.39e-01	5.37e-01
GOBP FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	81	9.23e-01	9.75e-01	0.0788	-3.15e-02	-4.73e-03	-3.04e-02	-5.70e-02	-3.19e-02	6.24e-01	9.41e-01	6.36e-01	3.75e-01	6.20e-01
GOBP PIGMENTATION	108	8.30e-01	9.44e-01	0.0788	-7.02e-02	1.93e-02	-2.72e-02	-1.06e-02	-6.91e-03	2.07e-01	7.28e-01	6.25e-01	8.49e-01	9.01e-01
GOBP POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS	1240	1.31e-03	1.92e-02	0.0786	2.29e-03	4.57e-02	-9.81e-03	-6.14e-02	1.51e-02	8.92e-01	6.80e-03	5.61e-01	2.77e-04	3.71e-01
GOBP REGULATION OF LIPID METABOLIC PROCESS	329	2.94e-01	6.48e-01	0.0785	-3.51e-02	5.67e-02	1.07e-02	-1.16e-02	3.82e-02	2.74e-01	7.70e-02	7.39e-01	7.18e-01	2.33e-01
GOBP POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS	479	1.19e-01	4.23e-01	0.0784	-3.34e-02	5.27e-02	-2.59e-03	-4.17e-02	-2.26e-02	2.11e-01	4.82e-02	9.23e-01	1.18e-01	3.96e-01
GOMF CYTOSKELETAL PROTEIN BINDING	945	5.53e-03	5.71e-02	0.0781	-2.00e-02	7.35e-02	6.53e-03	-2.77e-03	-1.58e-02	2.96e-01	1.30e-04	7.34e-01	8.85e-01	4.09e-01
GOBP KIDNEY EPITHELIUM DEVELOPMENT	145	4.89e-01	7.97e-01	0.0781	2.82e-02	4.03e-03	5.35e-02	-3.98e-02	-2.90e-02	5.58e-01	9.33e-01	2.66e-01	4.08e-01	5.46e-01
GOMF OXIDOREDUCTASE ACTIVITY	687	4.21e-02	2.28e-01	0.0780	1.67e-02	4.44e-02	-5.05e-02	-3.16e-02	1.72e-02	4.56e-01	4.74e-02	2.41e-02	1.58e-01	4.43e-01
GOBP PROTEIN LOCALIZATION TO CELL CELL JUNCTION	21	9.95e-01	9.98e-01	0.0779	5.98e-03	-2.64e-02	-4.74e-02	-2.50e-03	5.56e-02	9.62e-01	8.34e-01	7.07e-01	9.84e-01	6.59e-01
GOBP SKELETAL SYSTEM DEVELOPMENT	508	1.26e-01	4.37e-01	0.0778	1.69e-02	2.60e-02	1.82e-02	-4.44e-02	5.28e-02	5.13e-01	3.17e-01	4.84e-01	8.64e-02	4.16e-02
GOBP NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION	52	9.71e-01	9.92e-01	0.0778	-4.42e-02	3.54e-02	5.31e-02	-1.16e-03	5.81e-03	5.82e-01	6.59e-01	5.08e-01	9.88e-01	9.42e-01
GOBP BONE GROWTH	32	9.93e-01	9.97e-01	0.0776	-1.66e-02	-4.14e-03	6.61e-02	3.41e-02	1.39e-02	8.71e-01	9.68e-01	5.17e-01	7.38e-01	8.92e-01
GOBP DEVELOPMENTAL CELL GROWTH	225	6.63e-01	8.81e-01	0.0776	-2.97e-02	1.94e-02	5.91e-02	2.81e-02	-2.16e-02	4.42e-01	6.15e-01	1.26e-01	4.67e-01	5.76e-01
GOMF ENDOPEPTIDASE ACTIVITY	376	3.61e-01	7.04e-01	0.0775	-2.52e-02	-3.95e-03	2.26e-02	3.86e-02	-5.79e-02	4.01e-01	8.95e-01	4.51e-01	1.99e-01	5.40e-02
GOBP REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT	1422	9.00e-05	2.18e-03	0.0775	-2.19e-02	4.67e-02	3.52e-02	-4.19e-02	1.83e-02	1.66e-01	3.15e-03	2.61e-02	8.07e-03	2.48e-01
GOBP REGULATION OF DEVELOPMENTAL GROWTH	309	4.01e-01	7.34e-01	0.0774	-2.53e-02	4.90e-02	5.25e-02	-4.27e-03	1.32e-02	4.44e-01	1.38e-01	1.12e-01	8.97e-01	6.90e-01
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION	458	1.99e-01	5.48e-01	0.0774	2.35e-02	4.89e-02	4.30e-03	-4.36e-02	3.37e-02	3.88e-01	7.31e-02	8.75e-01	1.10e-01	2.17e-01
GOBP REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION	1705	2.15e-05	6.58e-04	0.0773	-3.66e-02	5.51e-02	2.43e-02	-2.95e-02	-1.18e-02	1.19e-02	1.52e-04	9.54e-02	4.26e-02	4.18e-01
GOCC CILIARY MEMBRANE	72	9.07e-01	9.69e-01	0.0773	4.30e-02	1.80e-02	6.12e-02	-7.47e-03	-5.47e-04	5.28e-01	7.91e-01	3.69e-01	9.13e-01	9.94e-01
GOBP EPITHELIAL CELL DIFFERENTIATION	713	1.77e-02	1.31e-01	0.0771	-5.26e-02	3.29e-03	5.39e-02	-1.37e-02	8.49e-03	1.68e-02	8.81e-01	1.41e-02	5.32e-01	6.99e-01
GOBP HOMEOSTATIC PROCESS	1655	1.79e-05	5.59e-04	0.0770	-3.00e-02	4.91e-02	4.07e-02	-3.10e-02	-3.53e-05	4.19e-02	8.68e-04	5.84e-03	3.56e-02	9.98e-01
GOBP INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS	62	9.57e-01	9.87e-01	0.0770	3.46e-02	5.94e-02	3.12e-02	-1.42e-02	5.37e-03	6.38e-01	4.19e-01	6.71e-01	8.47e-01	9.42e-01
GOCC CELL BODY	529	1.40e-01	4.60e-01	0.0765	-7.76e-03	-1.26e-03	7.21e-02	2.45e-02	-2.15e-03	7.60e-01	9.60e-01	4.57e-03	3.35e-01	9.33e-01
GOBP AMINOPHOSPHOLIPID TRANSLOCATION	6	1.00e+00	1.00e+00	0.0764	1.64e-02	-6.04e-02	-1.80e-02	3.67e-02	-1.60e-02	9.45e-01	7.98e-01	9.39e-01	8.76e-01	9.46e-01
GOMF AMINOPHOSPHOLIPID FLIPPASE ACTIVITY	6	1.00e+00	1.00e+00	0.0764	1.64e-02	-6.04e-02	-1.80e-02	3.67e-02	-1.60e-02	9.45e-01	7.98e-01	9.39e-01	8.76e-01	9.46e-01
GOMF TRANSFERASE ACTIVITY TRANSFERRING SULPHUR CONTAINING GROUPS	66	9.07e-01	9.69e-01	0.0763	1.27e-02	4.73e-03	5.23e-02	-6.87e-03	-5.35e-02	8.58e-01	9.47e-01	4.63e-01	9.23e-01	4.52e-01
GOMF STRUCTURAL CONSTITUENT OF CYTOSKELETON	103	7.56e-01	9.18e-01	0.0760	-2.41e-02	-1.86e-02	-2.58e-02	4.64e-02	4.51e-02	6.73e-01	7.45e-01	6.51e-01	4.16e-01	4.29e-01
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE	58	9.63e-01	9.90e-01	0.0759	-5.91e-03	1.70e-02	-8.35e-03	4.79e-02	-5.54e-02	9.38e-01	8.23e-01	9.12e-01	5.28e-01	4.65e-01
GOBP NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS	951	4.42e-03	4.92e-02	0.0759	-4.44e-02	2.61e-02	4.76e-03	-5.52e-02	-6.16e-03	2.03e-02	1.73e-01	8.04e-01	3.94e-03	7.48e-01
GOBP RESPONSE TO LIGHT STIMULUS	302	3.90e-01	7.26e-01	0.0758	-7.36e-03	-8.05e-03	-1.83e-02	-7.27e-02	-4.67e-03	8.26e-01	8.10e-01	5.85e-01	2.99e-02	8.89e-01
GOBP NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION	52	9.72e-01	9.92e-01	0.0757	-3.55e-02	4.26e-02	4.25e-04	2.85e-02	-4.30e-02	6.58e-01	5.95e-01	9.96e-01	7.22e-01	5.92e-01
GOBP GENERATION OF NEURONS	1416	1.36e-05	4.39e-04	0.0757	-3.45e-03	2.28e-02	6.28e-02	-3.29e-02	1.32e-02	8.28e-01	1.51e-01	7.45e-05	3.82e-02	4.05e-01
GOBP NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT	31	9.94e-01	9.97e-01	0.0756	2.59e-02	1.58e-02	-3.77e-02	-5.60e-02	-1.51e-02	8.03e-01	8.79e-01	7.16e-01	5.89e-01	8.84e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OH GROUP OF DONORS	131	7.91e-01	9.31e-01	0.0756	2.56e-02	5.31e-02	9.46e-03	4.64e-02	1.14e-03	6.13e-01	2.94e-01	8.52e-01	3.59e-01	9.82e-01
GOBP MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL	47	9.81e-01	9.93e-01	0.0753	3.66e-02	5.62e-02	1.83e-02	1.18e-03	2.89e-02	6.65e-01	5.05e-01	8.28e-01	9.89e-01	7.32e-01
GOBP REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY	57	9.70e-01	9.91e-01	0.0752	6.71e-02	1.65e-02	-2.03e-02	-8.66e-03	1.97e-02	3.81e-01	8.29e-01	7.91e-01	9.10e-01	7.97e-01
GOBP NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS	111	7.91e-01	9.31e-01	0.0751	-9.80e-03	6.74e-02	-1.32e-02	1.71e-02	2.33e-02	8.58e-01	2.20e-01	8.10e-01	7.56e-01	6.71e-01
GOBP ALCOHOL METABOLIC PROCESS	355	3.27e-01	6.76e-01	0.0751	1.30e-03	4.65e-02	1.29e-02	6.01e-03	-5.72e-02	9.66e-01	1.32e-01	6.76e-01	8.46e-01	6.41e-02
GOBP CILIUM ORGANIZATION	408	4.12e-01	7.43e-01	0.0750	3.39e-02	-6.00e-03	-4.76e-02	-4.30e-02	1.81e-02	2.41e-01	8.35e-01	9.88e-02	1.36e-01	5.31e-01
GOBP OSTEOBLAST DIFFERENTIATION	248	5.04e-01	8.05e-01	0.0750	-5.21e-02	1.75e-02	1.68e-02	-3.66e-02	3.12e-02	1.57e-01	6.34e-01	6.48e-01	3.21e-01	3.97e-01
GOBP ORGANIC ACID METABOLIC PROCESS	928	1.27e-02	1.04e-01	0.0750	4.93e-03	6.79e-02	5.68e-03	-1.47e-02	2.72e-02	7.99e-01	4.55e-04	7.69e-01	4.48e-01	1.60e-01
GOBP RESPONSE TO STEROID HORMONE	317	2.70e-01	6.24e-01	0.0750	-3.34e-03	4.18e-02	2.64e-02	-5.63e-02	1.91e-04	9.19e-01	2.01e-01	4.19e-01	8.50e-02	9.95e-01
GOBP CELLULAR RESPONSE TO LIPID	591	6.14e-02	2.91e-01	0.0749	-4.99e-02	3.17e-02	3.60e-02	-2.85e-02	2.17e-03	3.81e-02	1.87e-01	1.34e-01	2.37e-01	9.28e-01
GOBP POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS	67	9.52e-01	9.85e-01	0.0749	-3.52e-03	6.42e-02	2.93e-02	-2.49e-02	6.69e-04	9.60e-01	3.64e-01	6.79e-01	7.24e-01	9.92e-01
GOCC LAMELLIPODIUM	194	7.07e-01	8.97e-01	0.0748	-5.45e-03	6.58e-02	3.27e-02	3.66e-03	-1.25e-02	8.96e-01	1.14e-01	4.33e-01	9.30e-01	7.64e-01
GOBP NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION	161	7.87e-01	9.30e-01	0.0748	-4.48e-02	2.02e-02	2.79e-02	4.90e-02	1.24e-03	3.27e-01	6.59e-01	5.41e-01	2.83e-01	9.78e-01
GOBP EMBRYO IMPLANTATION	57	9.59e-01	9.88e-01	0.0747	-5.34e-02	-3.64e-02	-3.34e-02	1.69e-02	2.80e-04	4.85e-01	6.35e-01	6.62e-01	8.25e-01	9.97e-01
GOBP NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION	21	9.97e-01	9.98e-01	0.0747	-6.51e-02	1.66e-02	2.29e-02	2.49e-03	-2.33e-02	6.06e-01	8.95e-01	8.56e-01	9.84e-01	8.53e-01
GOBP POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION	44	9.79e-01	9.93e-01	0.0747	4.14e-02	4.38e-02	4.27e-02	-5.97e-03	-9.13e-03	6.35e-01	6.15e-01	6.24e-01	9.45e-01	9.17e-01
GOBP POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION	335	4.76e-01	7.89e-01	0.0746	-4.20e-02	-3.96e-03	2.33e-02	3.21e-02	-4.70e-02	1.86e-01	9.01e-01	4.63e-01	3.13e-01	1.39e-01
GOBP MORPHOGENESIS OF A BRANCHING STRUCTURE	194	3.69e-01	7.09e-01	0.0745	2.11e-02	6.70e-04	3.95e-02	-5.85e-02	-1.12e-02	6.13e-01	9.87e-01	3.43e-01	1.60e-01	7.88e-01
GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY	59	9.67e-01	9.90e-01	0.0744	-1.15e-02	-6.10e-02	-2.36e-02	-2.46e-02	-2.27e-02	8.78e-01	4.17e-01	7.53e-01	7.44e-01	7.63e-01
GOBP NEUROGENESIS	1643	4.29e-06	1.59e-04	0.0743	-2.04e-03	2.43e-02	6.27e-02	-2.93e-02	1.14e-02	8.90e-01	1.01e-01	2.26e-05	4.77e-02	4.42e-01
GOBP CYTOSKELETON ORGANIZATION	1438	2.24e-04	4.60e-03	0.0742	-2.31e-02	6.81e-02	-1.35e-02	-7.23e-03	-1.01e-02	1.43e-01	1.52e-05	3.92e-01	6.46e-01	5.20e-01
GOBP CELLULAR ALDEHYDE METABOLIC PROCESS	70	9.50e-01	9.84e-01	0.0742	-1.03e-02	3.89e-02	1.32e-02	5.68e-02	-2.19e-02	8.82e-01	5.73e-01	8.48e-01	4.11e-01	7.51e-01
GOBP DETOXIFICATION	152	8.24e-01	9.43e-01	0.0741	-4.32e-02	1.80e-02	2.30e-02	5.00e-02	-1.65e-02	3.58e-01	7.02e-01	6.25e-01	2.87e-01	7.26e-01
GOBP MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS	216	5.95e-01	8.49e-01	0.0739	-1.87e-02	6.17e-02	-6.68e-03	1.24e-02	-3.32e-02	6.35e-01	1.18e-01	8.66e-01	7.53e-01	4.01e-01
GOBP POSITIVE REGULATION OF TRANSFERASE ACTIVITY	398	1.81e-01	5.24e-01	0.0738	-1.73e-02	4.43e-02	2.30e-02	-4.01e-02	-3.23e-02	5.54e-01	1.29e-01	4.30e-01	1.70e-01	2.69e-01
GOBP TISSUE MORPHOGENESIS	618	3.59e-02	2.06e-01	0.0737	1.12e-02	3.88e-02	4.22e-02	-4.30e-02	1.29e-02	6.34e-01	9.94e-02	7.29e-02	6.79e-02	5.83e-01
GOBP POSITIVE REGULATION OF PROTEOLYSIS	339	4.14e-01	7.44e-01	0.0737	-3.05e-02	3.94e-02	-2.88e-02	-4.52e-02	8.96e-03	3.35e-01	2.13e-01	3.62e-01	1.53e-01	7.77e-01
GOMF CELL ADHESION MOLECULE BINDING	541	1.74e-01	5.14e-01	0.0737	-2.68e-02	4.57e-02	2.19e-02	3.96e-02	-2.40e-02	2.87e-01	6.90e-02	3.84e-01	1.15e-01	3.39e-01
GOBP RESPONSE TO NICOTINE	49	9.66e-01	9.90e-01	0.0734	-2.37e-02	4.37e-03	-3.51e-03	1.61e-02	6.73e-02	7.74e-01	9.58e-01	9.66e-01	8.46e-01	4.15e-01
GOBP ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS	242	5.68e-01	8.37e-01	0.0732	-3.02e-02	5.61e-02	1.29e-02	-2.10e-02	-2.65e-02	4.19e-01	1.33e-01	7.29e-01	5.74e-01	4.78e-01
GOBP POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS	109	8.90e-01	9.63e-01	0.0730	-2.88e-02	3.65e-02	5.96e-03	-4.48e-02	3.34e-02	6.03e-01	5.10e-01	9.14e-01	4.19e-01	5.46e-01
GOMF PROTEIN KINASE ACTIVITY	551	1.39e-01	4.60e-01	0.0729	3.15e-02	4.63e-02	3.79e-02	-1.50e-02	2.28e-02	2.06e-01	6.31e-02	1.28e-01	5.46e-01	3.59e-01
GOBP ORGANIC HYDROXY COMPOUND METABOLIC PROCESS	540	1.41e-01	4.61e-01	0.0729	1.69e-02	5.23e-02	2.01e-02	4.13e-03	-4.33e-02	5.02e-01	3.76e-02	4.25e-01	8.70e-01	8.54e-02
GOBP REGULATION OF DENDRITIC SPINE MORPHOGENESIS	39	9.78e-01	9.93e-01	0.0727	7.91e-03	1.57e-03	7.11e-02	-9.87e-04	-1.32e-02	9.32e-01	9.86e-01	4.42e-01	9.91e-01	8.86e-01
GOBP RESPONSE TO TOXIC SUBSTANCE	248	5.86e-01	8.45e-01	0.0725	7.23e-03	2.63e-02	2.30e-02	6.30e-02	3.80e-03	8.45e-01	4.76e-01	5.33e-01	8.73e-02	9.18e-01
GOCC TRANSPORTER COMPLEX	391	3.08e-01	6.60e-01	0.0725	-5.63e-02	3.07e-02	3.23e-02	-9.76e-03	-2.78e-03	5.60e-02	2.97e-01	2.73e-01	7.40e-01	9.25e-01
GOCC ACROSOMAL VESICLE	138	8.44e-01	9.49e-01	0.0725	-3.14e-02	-4.33e-02	-2.39e-02	-4.15e-02	-1.04e-02	5.24e-01	3.80e-01	6.28e-01	4.00e-01	8.33e-01
GOBP GLIOGENESIS	327	2.24e-01	5.77e-01	0.0725	1.06e-02	5.94e-03	4.98e-02	-4.26e-02	2.85e-02	7.41e-01	8.53e-01	1.22e-01	1.86e-01	3.75e-01
GOBP PROTEIN LOCALIZATION TO CELL JUNCTION	102	8.20e-01	9.41e-01	0.0725	3.24e-02	-2.79e-02	5.83e-02	-1.91e-03	-3.69e-03	5.71e-01	6.27e-01	3.09e-01	9.73e-01	9.49e-01
GOBP REGULATION OF ORGAN GROWTH	93	9.19e-01	9.74e-01	0.0724	-5.21e-02	1.84e-02	4.14e-02	-6.37e-03	2.09e-02	3.85e-01	7.59e-01	4.90e-01	9.15e-01	7.27e-01
GOBP EPITHELIUM DEVELOPMENT	1196	5.09e-04	9.00e-03	0.0724	-2.69e-02	3.32e-02	4.32e-02	-3.93e-02	-6.16e-04	1.17e-01	5.31e-02	1.19e-02	2.21e-02	9.71e-01
GOBP GLIAL CELL DIFFERENTIATION	246	4.10e-01	7.42e-01	0.0723	-3.34e-03	-1.48e-02	1.45e-02	-6.72e-02	1.61e-02	9.28e-01	6.90e-01	6.95e-01	6.93e-02	6.64e-01
GOBP POSITIVE REGULATION OF CATALYTIC ACTIVITY	887	2.52e-02	1.62e-01	0.0722	-2.27e-02	5.74e-02	2.89e-02	-6.79e-03	-2.29e-02	2.50e-01	3.71e-03	1.45e-01	7.32e-01	2.48e-01
GOCC CLATHRIN COATED VESICLE	201	7.12e-01	9.00e-01	0.0721	1.50e-02	6.75e-02	2.03e-02	1.30e-03	-2.95e-03	7.15e-01	9.90e-02	6.21e-01	9.75e-01	9.43e-01
GOBP RESPONSE TO TUMOR NECROSIS FACTOR	245	6.26e-01	8.67e-01	0.0721	1.16e-02	4.38e-02	2.32e-02	-8.56e-03	5.03e-02	7.55e-01	2.37e-01	5.31e-01	8.17e-01	1.75e-01
GOBP LIPID CATABOLIC PROCESS	328	2.94e-01	6.48e-01	0.0720	2.49e-02	4.49e-02	-7.69e-03	2.34e-02	4.41e-02	4.39e-01	1.62e-01	8.11e-01	4.66e-01	1.70e-01
GOBP POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION	974	2.26e-02	1.52e-01	0.0720	-4.52e-02	4.28e-02	3.13e-02	7.35e-03	-1.65e-02	1.69e-02	2.37e-02	9.85e-02	6.98e-01	3.82e-01
GOBP NEUROMUSCULAR JUNCTION DEVELOPMENT	50	9.77e-01	9.93e-01	0.0710	3.29e-02	-4.76e-02	2.26e-02	5.64e-03	3.39e-02	6.87e-01	5.61e-01	7.82e-01	9.45e-01	6.78e-01
GOBP LIPID BIOSYNTHETIC PROCESS	702	8.34e-02	3.48e-01	0.0710	2.94e-04	6.01e-02	-5.46e-03	-3.69e-02	5.39e-03	9.89e-01	6.65e-03	8.05e-01	9.56e-02	8.08e-01
GOMF GLYCOSYLTRANSFERASE ACTIVITY	265	5.65e-01	8.35e-01	0.0704	1.77e-02	6.23e-02	1.80e-03	-8.62e-03	-2.63e-02	6.21e-01	8.10e-02	9.60e-01	8.09e-01	4.61e-01
GOBP ORGANIC ACID BIOSYNTHETIC PROCESS	319	4.50e-01	7.71e-01	0.0700	-3.14e-02	5.76e-02	4.53e-03	-1.34e-02	1.99e-02	3.35e-01	7.69e-02	8.89e-01	6.80e-01	5.41e-01
GOBP EPITHELIAL CELL DEVELOPMENT	208	5.43e-01	8.25e-01	0.0700	4.12e-03	3.63e-02	2.89e-02	-4.96e-02	-1.63e-02	9.18e-01	3.67e-01	4.72e-01	2.18e-01	6.85e-01
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE	87	9.61e-01	9.89e-01	0.0699	-1.44e-03	2.20e-03	2.70e-02	6.07e-02	-2.16e-02	9.81e-01	9.72e-01	6.63e-01	3.28e-01	7.28e-01
GOBP NEGATIVE REGULATION OF MOLECULAR FUNCTION	752	4.84e-02	2.49e-01	0.0698	8.46e-03	2.53e-02	2.54e-02	-4.43e-02	3.94e-02	6.93e-01	2.37e-01	2.36e-01	3.86e-02	6.61e-02
GOBP DEFENSE RESPONSE TO OTHER ORGANISM	1131	3.19e-03	3.83e-02	0.0697	-4.75e-02	3.37e-02	9.80e-03	3.32e-02	1.63e-02	7.05e-03	5.59e-02	5.78e-01	5.99e-02	3.56e-01
GOMF ARYLSULFATASE ACTIVITY	9	1.00e+00	1.00e+00	0.0694	-3.60e-02	2.57e-02	-6.30e-03	-4.63e-02	2.61e-02	8.52e-01	8.94e-01	9.74e-01	8.10e-01	8.92e-01
GOBP NEGATIVE REGULATION OF TRANSPORT	452	2.76e-01	6.30e-01	0.0694	-2.64e-02	5.65e-02	5.52e-03	-1.14e-02	-2.75e-02	3.35e-01	3.94e-02	8.40e-01	6.78e-01	3.16e-01
GOBP NEPHRON DEVELOPMENT	152	6.01e-01	8.53e-01	0.0692	2.44e-02	-3.08e-02	3.71e-02	-4.32e-02	-1.20e-04	6.03e-01	5.12e-01	4.30e-01	3.58e-01	9.98e-01
GOBP NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION	149	8.28e-01	9.44e-01	0.0691	3.64e-02	2.11e-02	-2.81e-03	3.29e-02	-4.38e-02	4.44e-01	6.56e-01	9.53e-01	4.89e-01	3.56e-01
GOBP CARTILAGE DEVELOPMENT	199	6.89e-01	8.91e-01	0.0691	-1.73e-02	4.28e-02	4.67e-02	-2.12e-02	1.17e-03	6.73e-01	2.97e-01	2.56e-01	6.06e-01	9.77e-01
GOCC CILIARY PLASM	158	8.60e-01	9.53e-01	0.0690	-1.81e-02	1.65e-02	-4.61e-02	-3.91e-02	-2.27e-02	6.95e-01	7.21e-01	3.18e-01	3.97e-01	6.23e-01
GOMF ANTIOXIDANT ACTIVITY	80	9.43e-01	9.82e-01	0.0689	2.90e-02	5.42e-02	-3.91e-04	2.78e-02	-1.41e-02	6.53e-01	4.02e-01	9.95e-01	6.68e-01	8.27e-01
GOBP DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS	102	9.23e-01	9.75e-01	0.0689	4.65e-03	2.96e-02	5.98e-02	5.90e-04	1.64e-02	9.35e-01	6.05e-01	2.97e-01	9.92e-01	7.75e-01
GOBP NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION	152	8.19e-01	9.41e-01	0.0688	4.40e-02	1.89e-02	-6.07e-03	2.06e-02	-4.46e-02	3.49e-01	6.88e-01	8.97e-01	6.61e-01	3.43e-01
GOBP POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY	141	8.59e-01	9.53e-01	0.0688	-3.10e-02	3.99e-02	4.38e-02	-3.97e-03	-1.57e-02	5.25e-01	4.13e-01	3.69e-01	9.35e-01	7.48e-01
GOBP MYOTUBE CELL DEVELOPMENT	40	9.89e-01	9.96e-01	0.0686	2.43e-02	-1.76e-02	5.34e-02	1.69e-02	2.59e-02	7.90e-01	8.47e-01	5.59e-01	8.53e-01	7.77e-01
GOBP CARDIAC CHAMBER DEVELOPMENT	168	7.51e-01	9.16e-01	0.0686	4.46e-02	3.01e-02	1.45e-02	-1.03e-02	-3.86e-02	3.19e-01	5.00e-01	7.45e-01	8.18e-01	3.89e-01
GOBP NEGATIVE REGULATION OF FATTY ACID BETA OXIDATION	6	1.00e+00	1.00e+00	0.0682	-2.90e-02	-2.10e-03	2.53e-02	1.23e-03	-5.62e-02	9.02e-01	9.93e-01	9.15e-01	9.96e-01	8.11e-01
GOBP NEURON PROJECTION EXTENSION	167	8.68e-01	9.56e-01	0.0682	-1.07e-02	-5.27e-03	3.44e-02	3.71e-02	-4.41e-02	8.12e-01	9.06e-01	4.44e-01	4.08e-01	3.25e-01
GOBP ADIPOSE TISSUE DEVELOPMENT	57	9.80e-01	9.93e-01	0.0681	-1.39e-02	4.92e-02	1.26e-02	-3.06e-02	3.05e-02	8.56e-01	5.20e-01	8.69e-01	6.89e-01	6.91e-01
GOBP NEGATIVE REGULATION OF CATALYTIC ACTIVITY	461	2.25e-01	5.79e-01	0.0681	-2.10e-02	2.59e-02	2.63e-02	-4.46e-02	2.91e-02	4.40e-01	3.41e-01	3.33e-01	1.01e-01	2.85e-01
GOMF ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY	423	2.52e-01	6.09e-01	0.0679	1.23e-02	2.43e-02	2.96e-02	-3.43e-03	-5.46e-02	6.65e-01	3.91e-01	2.97e-01	9.04e-01	5.41e-02
GOBP LIPID LOCALIZATION	495	3.43e-01	6.90e-01	0.0678	-2.76e-02	4.11e-02	2.66e-02	2.99e-02	-2.32e-02	2.93e-01	1.18e-01	3.11e-01	2.55e-01	3.76e-01
GOBP MICROTUBULE BASED MOVEMENT	401	5.34e-01	8.21e-01	0.0677	6.10e-03	-3.41e-02	-4.67e-02	-3.35e-02	9.46e-03	8.34e-01	2.41e-01	1.09e-01	2.50e-01	7.45e-01
GOBP SPERMATID DIFFERENTIATION	201	7.06e-01	8.97e-01	0.0676	-3.80e-02	-4.99e-02	1.13e-02	-1.55e-02	1.64e-02	3.53e-01	2.23e-01	7.83e-01	7.04e-01	6.89e-01
GOBP RESPONSE TO XENOBIOTIC STIMULUS	418	3.61e-01	7.04e-01	0.0672	5.08e-02	4.41e-03	1.20e-02	2.82e-02	3.12e-02	7.47e-02	8.77e-01	6.74e-01	3.22e-01	2.73e-01
GOBP LEUKOCYTE HOMEOSTASIS	103	8.63e-01	9.54e-01	0.0670	1.22e-02	1.47e-02	8.47e-03	-4.78e-02	-4.20e-02	8.31e-01	7.96e-01	8.82e-01	4.01e-01	4.61e-01
GOBP PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION	283	7.10e-01	8.99e-01	0.0666	-2.04e-02	3.42e-02	4.73e-02	2.49e-02	1.35e-03	5.55e-01	3.23e-01	1.71e-01	4.70e-01	9.69e-01
GOBP NEURON DEVELOPMENT	1086	1.86e-03	2.54e-02	0.0666	-1.41e-02	5.76e-03	6.16e-02	-1.68e-02	-1.11e-02	4.32e-01	7.49e-01	6.03e-04	3.50e-01	5.37e-01
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE	101	9.55e-01	9.86e-01	0.0665	-2.62e-02	3.90e-02	3.99e-02	2.49e-02	2.71e-03	6.50e-01	4.98e-01	4.89e-01	6.65e-01	9.62e-01
GOBP POSITIVE REGULATION OF CHROMATIN BINDING	9	1.00e+00	1.00e+00	0.0665	-3.88e-02	1.27e-02	1.35e-03	-3.38e-02	-4.01e-02	8.40e-01	9.47e-01	9.94e-01	8.61e-01	8.35e-01
GOBP REGULATION OF CELL SIZE	176	8.36e-01	9.46e-01	0.0664	-2.98e-02	4.57e-02	2.84e-02	2.39e-02	6.67e-03	4.95e-01	2.95e-01	5.15e-01	5.85e-01	8.79e-01
GOBP REGULATION OF NEUROGENESIS	373	3.82e-01	7.21e-01	0.0655	9.23e-03	2.06e-02	3.70e-02	-3.37e-02	3.56e-02	7.59e-01	4.95e-01	2.19e-01	2.64e-01	2.37e-01
GOBP CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM	450	3.92e-01	7.27e-01	0.0654	5.44e-04	-1.15e-02	4.72e-02	2.05e-02	3.87e-02	9.84e-01	6.76e-01	8.59e-02	4.55e-01	1.59e-01
GOBP REGULATION OF RESPONSE TO CYTOKINE STIMULUS	175	8.27e-01	9.44e-01	0.0651	2.41e-02	4.91e-02	-1.76e-02	-2.34e-02	-1.99e-02	5.82e-01	2.63e-01	6.88e-01	5.93e-01	6.50e-01
GOBP REGULATION OF CATALYTIC ACTIVITY	1417	3.22e-03	3.87e-02	0.0650	-2.40e-02	4.57e-02	1.68e-02	-3.54e-02	-4.19e-03	1.31e-01	3.92e-03	2.90e-01	2.55e-02	7.92e-01
GOBP POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION	1065	1.37e-02	1.09e-01	0.0649	-2.10e-02	3.41e-02	1.50e-02	-4.87e-02	4.09e-03	2.48e-01	6.04e-02	4.09e-01	7.30e-03	8.21e-01
GOBP RESPONSE TO KETONE	197	7.53e-01	9.16e-01	0.0648	-1.70e-02	4.57e-02	1.66e-02	2.88e-02	2.68e-02	6.82e-01	2.69e-01	6.88e-01	4.85e-01	5.16e-01
GOBP REGULATION OF CHONDROCYTE DIFFERENTIATION	52	9.80e-01	9.93e-01	0.0648	-2.74e-02	2.16e-02	1.78e-03	-4.47e-02	-3.12e-02	7.33e-01	7.88e-01	9.82e-01	5.77e-01	6.97e-01
GOBP RESPONSE TO CYTOKINE	901	5.80e-02	2.81e-01	0.0647	-4.38e-03	6.09e-02	4.07e-03	-1.30e-02	1.65e-02	8.24e-01	1.93e-03	8.36e-01	5.07e-01	4.00e-01
GOBP GLYCOPROTEIN BIOSYNTHETIC PROCESS	290	6.11e-01	8.58e-01	0.0645	1.84e-02	5.23e-02	-1.06e-02	-1.71e-02	-2.61e-02	5.90e-01	1.25e-01	7.56e-01	6.17e-01	4.45e-01
GOBP POSITIVE REGULATION OF MOLECULAR FUNCTION	1207	6.00e-03	6.09e-02	0.0645	-1.59e-02	4.36e-02	2.69e-02	-3.17e-02	-1.68e-02	3.52e-01	1.08e-02	1.15e-01	6.39e-02	3.26e-01
GOBP POSITIVE REGULATION OF TROPHOBLAST CELL MIGRATION	7	1.00e+00	1.00e+00	0.0640	-1.32e-02	-2.26e-02	4.30e-02	-3.19e-02	-2.33e-02	9.52e-01	9.17e-01	8.44e-01	8.84e-01	9.15e-01
GOBP DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS	229	7.92e-01	9.31e-01	0.0638	-1.58e-02	-2.10e-03	4.62e-02	2.51e-02	-3.26e-02	6.80e-01	9.56e-01	2.29e-01	5.12e-01	3.96e-01
GOBP REGULATION OF CELLULAR KETONE METABOLIC PROCESS	139	8.58e-01	9.53e-01	0.0638	-4.61e-02	4.23e-02	-5.44e-03	2.47e-03	1.10e-02	3.48e-01	3.89e-01	9.12e-01	9.60e-01	8.24e-01
GOBP POSITIVE REGULATION OF CELL POPULATION PROLIFERATION	1211	1.66e-02	1.25e-01	0.0636	-1.09e-02	4.16e-02	3.12e-02	-2.38e-02	2.56e-02	5.21e-01	1.49e-02	6.76e-02	1.63e-01	1.33e-01
GOBP MALE GAMETE GENERATION	568	1.23e-01	4.30e-01	0.0636	-2.08e-02	-3.69e-02	2.81e-02	-2.92e-02	2.46e-02	3.97e-01	1.33e-01	2.53e-01	2.35e-01	3.16e-01
GOBP ALPHA AMINO ACID METABOLIC PROCESS	196	7.51e-01	9.16e-01	0.0633	-4.86e-02	3.21e-02	-7.02e-03	2.07e-02	-1.20e-02	2.41e-01	4.38e-01	8.65e-01	6.17e-01	7.73e-01
GOBP STEROL TRANSPORT	141	9.09e-01	9.70e-01	0.0632	-2.08e-02	4.81e-02	2.46e-02	5.55e-03	-2.48e-02	6.70e-01	3.24e-01	6.15e-01	9.09e-01	6.12e-01
GOMF TRANSLATION REGULATOR ACTIVITY	365	5.43e-01	8.25e-01	0.0631	-3.89e-02	-4.56e-02	-1.90e-02	7.87e-06	-5.59e-03	2.02e-01	1.34e-01	5.33e-01	1.00e+00	8.54e-01
GOBP LONG TERM SYNAPTIC DEPRESSION	30	9.95e-01	9.98e-01	0.0631	-5.29e-02	-6.33e-03	2.36e-02	-1.80e-02	-1.60e-02	6.16e-01	9.52e-01	8.23e-01	8.64e-01	8.79e-01
GOBP MAINTENANCE OF LOCATION IN CELL	224	7.72e-01	9.25e-01	0.0630	3.64e-03	5.40e-02	2.61e-02	-1.61e-02	9.42e-03	9.25e-01	1.63e-01	5.00e-01	6.78e-01	8.08e-01
GOMF ENZYME REGULATOR ACTIVITY	1202	2.55e-02	1.63e-01	0.0627	-2.90e-02	4.23e-02	2.65e-02	-3.39e-03	-2.41e-02	9.04e-02	1.36e-02	1.21e-01	8.43e-01	1.60e-01
GOBP POSITIVE REGULATION OF PEPTIDASE ACTIVITY	166	8.74e-01	9.58e-01	0.0625	-2.20e-02	3.82e-02	-1.46e-02	-3.55e-02	2.23e-02	6.25e-01	3.96e-01	7.45e-01	4.30e-01	6.20e-01
GOBP RESPONSE TO LIPID	890	6.86e-02	3.10e-01	0.0623	-2.69e-02	4.15e-02	2.11e-02	-2.94e-02	1.09e-02	1.73e-01	3.55e-02	2.84e-01	1.36e-01	5.82e-01
GOMF ENZYME ACTIVATOR ACTIVITY	542	2.64e-01	6.19e-01	0.0619	-1.74e-02	4.33e-02	1.21e-02	-3.86e-02	-3.99e-03	4.88e-01	8.48e-02	6.29e-01	1.24e-01	8.74e-01
GOBP REGULATION OF CELL PROJECTION ORGANIZATION	658	2.23e-01	5.77e-01	0.0617	-3.22e-02	1.00e-02	3.15e-02	6.81e-03	-4.04e-02	1.58e-01	6.62e-01	1.68e-01	7.66e-01	7.74e-02
GOMF IRON ION BINDING	145	8.44e-01	9.49e-01	0.0612	3.09e-02	2.04e-02	-2.52e-02	3.49e-02	-2.28e-02	5.20e-01	6.72e-01	6.01e-01	4.68e-01	6.36e-01
GOBP REGULATION OF CELL PROJECTION ASSEMBLY	218	7.88e-01	9.30e-01	0.0606	-1.13e-02	4.60e-02	3.65e-03	-1.66e-02	-3.38e-02	7.74e-01	2.42e-01	9.26e-01	6.74e-01	3.89e-01
GOBP SMALL MOLECULE BIOSYNTHETIC PROCESS	577	3.64e-01	7.05e-01	0.0598	-5.37e-03	4.18e-02	-1.92e-02	-3.63e-02	1.07e-02	8.26e-01	8.59e-02	4.31e-01	1.36e-01	6.60e-01
GOBP ESTABLISHMENT OF CELL POLARITY	153	9.02e-01	9.68e-01	0.0596	-1.30e-02	5.18e-02	1.23e-03	-1.87e-02	1.88e-02	7.82e-01	2.69e-01	9.79e-01	6.89e-01	6.87e-01
GOBP GLYCOPROTEIN METABOLIC PROCESS	357	6.34e-01	8.71e-01	0.0596	1.41e-02	3.60e-02	-3.05e-02	-2.93e-02	-1.65e-02	6.47e-01	2.42e-01	3.22e-01	3.42e-01	5.93e-01
GOMF AMIDE BINDING	381	6.83e-01	8.88e-01	0.0592	-1.61e-02	2.32e-02	2.70e-02	2.99e-02	-3.29e-02	5.89e-01	4.37e-01	3.66e-01	3.16e-01	2.71e-01
GOBP ODONTOGENESIS	126	9.07e-01	9.69e-01	0.0591	-2.23e-02	2.95e-02	2.78e-02	-3.64e-02	4.66e-03	6.65e-01	5.67e-01	5.90e-01	4.80e-01	9.28e-01
GOBP REGULATION OF MUSCLE CONTRACTION	163	9.00e-01	9.67e-01	0.0587	-5.55e-02	8.85e-03	4.99e-03	5.94e-03	-1.49e-02	2.21e-01	8.45e-01	9.12e-01	8.96e-01	7.43e-01
GOMF ATPASE COUPLED TRANSMEMBRANE TRANSPORTER ACTIVITY	92	9.65e-01	9.90e-01	0.0581	3.60e-02	-3.45e-02	7.51e-03	1.78e-02	-2.26e-02	5.51e-01	5.67e-01	9.01e-01	7.68e-01	7.08e-01
GOBP REGULATION OF NERVOUS SYSTEM DEVELOPMENT	445	3.89e-01	7.26e-01	0.0580	8.19e-03	1.75e-02	3.61e-02	-3.09e-02	2.71e-02	7.67e-01	5.28e-01	1.92e-01	2.64e-01	3.28e-01
GOBP GLIAL CELL DEVELOPMENT	118	9.56e-01	9.87e-01	0.0579	-1.11e-03	-1.74e-02	-2.61e-02	-4.52e-02	-1.81e-02	9.83e-01	7.44e-01	6.24e-01	3.96e-01	7.35e-01
GOBP COLLAGEN FIBRIL ORGANIZATION	63	9.87e-01	9.95e-01	0.0575	-3.10e-02	2.48e-02	-2.86e-02	-1.88e-02	-2.35e-02	6.70e-01	7.33e-01	6.94e-01	7.96e-01	7.47e-01
GOBP LIPID METABOLIC PROCESS	1343	3.16e-02	1.89e-01	0.0570	-4.89e-03	5.59e-02	1.59e-03	-8.81e-03	-4.08e-03	7.64e-01	5.85e-04	9.22e-01	5.88e-01	8.02e-01
GOBP CONNECTIVE TISSUE DEVELOPMENT	278	7.65e-01	9.22e-01	0.0563	-1.96e-02	3.51e-02	3.77e-02	-9.34e-03	6.83e-03	5.73e-01	3.14e-01	2.80e-01	7.89e-01	8.45e-01
GOBP NATURAL KILLER CELL ACTIVATION	91	9.85e-01	9.95e-01	0.0558	-1.64e-02	-9.32e-03	4.05e-02	3.34e-02	2.51e-03	7.87e-01	8.78e-01	5.04e-01	5.82e-01	9.67e-01
GOBP CARBOHYDRATE HOMEOSTASIS	246	7.91e-01	9.31e-01	0.0554	2.07e-02	3.21e-02	3.22e-02	-1.97e-02	1.34e-02	5.76e-01	3.86e-01	3.85e-01	5.94e-01	7.16e-01
GOBP CELLULAR OXIDANT DETOXIFICATION	94	9.66e-01	9.90e-01	0.0553	2.79e-02	3.35e-02	-1.09e-02	2.21e-02	-2.35e-02	6.40e-01	5.75e-01	8.55e-01	7.11e-01	6.93e-01
GOBP REGULATION OF NEUROTRANSMITTER TRANSPORT	92	9.70e-01	9.91e-01	0.0552	-2.17e-02	8.03e-03	4.57e-02	1.33e-03	-2.03e-02	7.19e-01	8.94e-01	4.48e-01	9.82e-01	7.36e-01
GOBP BIOLOGICAL PROCESS INVOLVED IN INTERSPECIES INTERACTION BETWEEN ORGANISMS	1605	5.71e-03	5.85e-02	0.0552	-3.91e-02	3.56e-02	-4.46e-03	1.33e-02	7.13e-03	8.99e-03	1.75e-02	7.66e-01	3.73e-01	6.34e-01
GOBP REGENERATION	181	9.35e-01	9.80e-01	0.0551	-9.40e-03	2.68e-03	1.80e-02	3.68e-02	-3.55e-02	8.27e-01	9.50e-01	6.76e-01	3.93e-01	4.10e-01
GOBP POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION	209	8.48e-01	9.49e-01	0.0551	-1.04e-02	-6.35e-04	4.78e-02	-1.56e-03	2.52e-02	7.96e-01	9.87e-01	2.34e-01	9.69e-01	5.30e-01
GOBP SEXUAL REPRODUCTION	985	7.48e-02	3.28e-01	0.0549	2.13e-02	-2.27e-02	1.17e-02	-3.45e-02	2.68e-02	2.58e-01	2.28e-01	5.36e-01	6.69e-02	1.55e-01
GOBP REGULATION OF GLYCOGEN BIOSYNTHETIC PROCESS	30	9.98e-01	9.99e-01	0.0547	-7.71e-03	4.91e-02	7.79e-03	1.15e-02	-1.83e-02	9.42e-01	6.42e-01	9.41e-01	9.13e-01	8.62e-01
GOBP CELLULAR RESPONSE TO ACID CHEMICAL	85	9.80e-01	9.93e-01	0.0546	-2.45e-02	2.10e-02	1.60e-03	-3.97e-02	1.90e-02	6.96e-01	7.38e-01	9.80e-01	5.27e-01	7.62e-01
GOBP ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY	55	9.94e-01	9.97e-01	0.0543	8.24e-03	3.48e-02	2.11e-02	5.83e-03	3.46e-02	9.16e-01	6.55e-01	7.87e-01	9.40e-01	6.57e-01
GOBP TUBE DEVELOPMENT	1120	8.15e-02	3.44e-01	0.0541	-8.17e-03	3.48e-02	1.82e-02	-3.30e-02	1.53e-02	6.44e-01	4.97e-02	3.05e-01	6.21e-02	3.88e-01
GOBP PROTEIN AUTOPHOSPHORYLATION	189	8.91e-01	9.63e-01	0.0536	4.21e-02	5.44e-03	2.33e-02	1.38e-02	-1.83e-02	3.18e-01	8.97e-01	5.81e-01	7.43e-01	6.65e-01
GOBP PROTEOGLYCAN METABOLIC PROCESS	86	9.79e-01	9.93e-01	0.0534	1.48e-02	2.66e-02	4.38e-02	-4.56e-04	-2.64e-03	8.12e-01	6.70e-01	4.83e-01	9.94e-01	9.66e-01
GOBP NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION	898	2.07e-01	5.58e-01	0.0532	-3.69e-02	2.05e-02	3.00e-02	-5.71e-03	1.05e-02	6.04e-02	2.97e-01	1.28e-01	7.72e-01	5.93e-01
GOBP RHO PROTEIN SIGNAL TRANSDUCTION	128	9.42e-01	9.82e-01	0.0526	-3.11e-02	1.95e-02	-2.85e-02	6.30e-03	-2.37e-02	5.43e-01	7.04e-01	5.77e-01	9.02e-01	6.43e-01
GOBP CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS	146	9.38e-01	9.81e-01	0.0525	1.15e-03	2.31e-02	1.66e-02	-3.65e-02	2.48e-02	9.81e-01	6.29e-01	7.29e-01	4.47e-01	6.05e-01
GOBP GERM CELL DEVELOPMENT	344	7.43e-01	9.14e-01	0.0520	7.12e-03	-2.10e-02	2.70e-02	9.31e-03	3.73e-02	8.21e-01	5.03e-01	3.90e-01	7.67e-01	2.34e-01
GOMF HYDROLASE ACTIVITY ACTING ON ESTER BONDS	717	4.04e-01	7.37e-01	0.0517	6.21e-03	3.22e-02	-1.30e-02	-3.76e-02	-3.96e-03	7.77e-01	1.42e-01	5.53e-01	8.64e-02	8.57e-01
GOBP MAINTENANCE OF LOCATION	334	6.96e-01	8.94e-01	0.0516	-4.14e-03	3.48e-02	2.76e-02	-2.57e-02	-1.71e-03	8.96e-01	2.74e-01	3.85e-01	4.20e-01	9.57e-01
GOBP ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY	223	8.91e-01	9.63e-01	0.0509	-8.31e-03	4.37e-02	-4.84e-03	-1.85e-02	1.55e-02	8.31e-01	2.60e-01	9.01e-01	6.34e-01	6.90e-01
GOBP LIPID HOMEOSTASIS	169	9.33e-01	9.79e-01	0.0506	-5.05e-02	8.10e-04	-4.84e-04	-2.10e-03	2.66e-03	2.57e-01	9.86e-01	9.91e-01	9.62e-01	9.52e-01
GOBP NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS	89	9.87e-01	9.95e-01	0.0505	-1.19e-04	-3.15e-02	8.21e-03	2.57e-02	-2.88e-02	9.98e-01	6.07e-01	8.93e-01	6.76e-01	6.39e-01
GOBP CIRCULATORY SYSTEM DEVELOPMENT	1175	1.56e-01	4.84e-01	0.0502	-1.58e-02	3.31e-02	3.31e-02	-5.13e-03	7.43e-03	3.60e-01	5.61e-02	5.58e-02	7.67e-01	6.68e-01
GOBP REGULATION OF CARTILAGE DEVELOPMENT	70	9.92e-01	9.97e-01	0.0502	-3.58e-02	1.75e-02	-8.28e-03	-9.73e-03	-2.77e-02	6.05e-01	8.00e-01	9.05e-01	8.88e-01	6.88e-01
GOBP REGULATION OF PROTEOLYSIS	587	5.13e-01	8.08e-01	0.0501	-2.27e-02	3.18e-02	-1.59e-03	-3.14e-02	9.67e-04	3.48e-01	1.89e-01	9.48e-01	1.94e-01	9.68e-01
GOBP UNSATURATED FATTY ACID METABOLIC PROCESS	108	9.75e-01	9.93e-01	0.0497	2.77e-02	-1.49e-02	-2.72e-02	1.35e-02	-2.36e-02	6.19e-01	7.89e-01	6.26e-01	8.09e-01	6.71e-01
GOBP NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION	689	5.34e-01	8.21e-01	0.0496	1.51e-02	2.36e-02	-2.65e-02	-3.12e-02	-1.54e-03	5.00e-01	2.90e-01	2.36e-01	1.62e-01	9.45e-01
GOBP DEVELOPMENTAL GROWTH	629	4.89e-01	7.97e-01	0.0496	-6.33e-03	4.37e-02	1.51e-02	-1.67e-02	2.18e-03	7.86e-01	6.12e-02	5.18e-01	4.75e-01	9.26e-01
GOBP ANIMAL ORGAN REGENERATION	60	9.95e-01	9.98e-01	0.0486	-7.21e-03	4.62e-02	9.77e-03	-2.34e-03	-8.54e-03	9.23e-01	5.36e-01	8.96e-01	9.75e-01	9.09e-01
GOBP CELLULAR RESPONSE TO TOXIC SUBSTANCE	123	9.76e-01	9.93e-01	0.0481	1.66e-02	6.84e-03	1.83e-02	3.55e-02	1.99e-02	7.50e-01	8.96e-01	7.26e-01	4.97e-01	7.03e-01
GOBP MULTICELLULAR ORGANISM REPRODUCTION	873	2.13e-01	5.66e-01	0.0473	2.04e-03	-1.07e-02	3.75e-02	-1.19e-02	2.39e-02	9.19e-01	5.90e-01	6.01e-02	5.50e-01	2.31e-01
GOBP POST TRANSCRIPTIONAL REGULATION OF GENE EXPRESSION	959	3.62e-01	7.04e-01	0.0470	-1.92e-02	-3.27e-02	-1.90e-02	-1.53e-02	1.32e-02	3.14e-01	8.65e-02	3.20e-01	4.22e-01	4.88e-01
GOBP REPRODUCTION	1408	5.18e-02	2.61e-01	0.0468	1.97e-02	-1.20e-02	2.40e-02	-2.23e-02	2.43e-02	2.15e-01	4.50e-01	1.32e-01	1.62e-01	1.27e-01
GOBP GAMETE GENERATION	721	2.88e-01	6.41e-01	0.0468	5.02e-03	-2.20e-02	2.06e-02	-2.80e-02	2.17e-02	8.19e-01	3.14e-01	3.47e-01	2.00e-01	3.21e-01
GOMF PEPTIDASE ACTIVITY	561	7.05e-01	8.97e-01	0.0467	-1.24e-02	9.43e-03	1.47e-02	2.17e-02	-3.54e-02	6.15e-01	7.03e-01	5.52e-01	3.79e-01	1.52e-01
GOBP CELL PROJECTION ASSEMBLY	586	6.42e-01	8.75e-01	0.0464	2.14e-03	2.53e-02	-1.40e-02	-3.55e-02	-7.13e-03	9.30e-01	2.96e-01	5.62e-01	1.42e-01	7.68e-01
GOBP DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION	914	2.48e-01	6.05e-01	0.0460	1.86e-02	2.99e-03	2.38e-02	-2.47e-02	2.43e-02	3.41e-01	8.78e-01	2.23e-01	2.06e-01	2.13e-01
GOBP MITOTIC DNA REPLICATION CHECKPOINT SIGNALING	10	1.00e+00	1.00e+00	0.0457	5.29e-03	-1.19e-02	1.34e-03	-2.95e-02	3.24e-02	9.77e-01	9.48e-01	9.94e-01	8.72e-01	8.59e-01
GOBP POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY	126	9.82e-01	9.93e-01	0.0451	-3.61e-03	3.76e-02	6.36e-03	-1.53e-02	1.81e-02	9.44e-01	4.66e-01	9.02e-01	7.67e-01	7.25e-01
GOMF PROTEASE BINDING	139	9.67e-01	9.90e-01	0.0449	-3.88e-02	1.55e-02	-1.53e-02	-4.67e-03	3.73e-03	4.29e-01	7.52e-01	7.55e-01	9.24e-01	9.39e-01
GOBP SMOOTH MUSCLE CONTRACTION	109	9.86e-01	9.95e-01	0.0446	-2.70e-02	2.45e-02	2.58e-03	-2.18e-02	1.34e-02	6.26e-01	6.59e-01	9.63e-01	6.95e-01	8.09e-01
GOBP POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT	272	9.04e-01	9.68e-01	0.0441	1.17e-02	9.53e-03	3.33e-02	-2.93e-03	2.45e-02	7.41e-01	7.87e-01	3.44e-01	9.34e-01	4.86e-01
GOBP EPITHELIAL CELL PROLIFERATION	467	7.73e-01	9.25e-01	0.0440	-2.87e-02	2.23e-02	2.42e-02	-2.29e-03	4.19e-03	2.87e-01	4.09e-01	3.70e-01	9.32e-01	8.77e-01
GOCC SUPRAMOLECULAR COMPLEX	1323	2.51e-01	6.07e-01	0.0436	-3.07e-02	1.16e-03	9.17e-03	2.98e-03	-2.94e-02	6.11e-02	9.43e-01	5.76e-01	8.56e-01	7.25e-02
GOMF ZINC ION BINDING	774	5.30e-01	8.19e-01	0.0433	2.26e-02	2.89e-02	-7.97e-03	-1.76e-02	-1.28e-02	2.86e-01	1.72e-01	7.06e-01	4.06e-01	5.46e-01
GOBP BLOOD VESSEL MORPHOGENESIS	679	7.07e-01	8.97e-01	0.0415	-2.52e-02	1.68e-02	2.54e-02	1.02e-02	7.34e-03	2.62e-01	4.55e-01	2.59e-01	6.51e-01	7.44e-01
GOBP ODONTOGENESIS OF DENTIN CONTAINING TOOTH	90	9.85e-01	9.95e-01	0.0412	-1.61e-02	-2.56e-02	1.60e-02	-2.26e-02	-4.09e-03	7.92e-01	6.75e-01	7.93e-01	7.11e-01	9.46e-01
GOBP FEMALE SEX DIFFERENTIATION	117	9.92e-01	9.97e-01	0.0404	1.89e-02	2.24e-02	1.95e-02	1.69e-02	1.03e-02	7.23e-01	6.76e-01	7.16e-01	7.52e-01	8.48e-01
GOBP REGULATION OF PEPTIDASE ACTIVITY	298	9.44e-01	9.82e-01	0.0399	-2.80e-02	-1.78e-03	2.52e-02	1.28e-02	-1.40e-03	4.05e-01	9.58e-01	4.54e-01	7.03e-01	9.67e-01
GOBP AXON EXTENSION	111	9.92e-01	9.97e-01	0.0397	-5.38e-03	1.97e-03	3.39e-02	1.14e-02	-1.64e-02	9.22e-01	9.71e-01	5.37e-01	8.35e-01	7.66e-01
GOBP RESPONSE TO FIBROBLAST GROWTH FACTOR	116	9.94e-01	9.97e-01	0.0393	-2.96e-03	8.28e-03	-2.78e-02	-2.54e-02	-7.03e-03	9.56e-01	8.78e-01	6.05e-01	6.36e-01	8.96e-01
GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY	187	9.78e-01	9.93e-01	0.0390	-9.59e-03	1.19e-02	-2.87e-03	-3.16e-02	1.69e-02	8.21e-01	7.80e-01	9.46e-01	4.57e-01	6.90e-01
GOBP CELLULAR KETONE METABOLIC PROCESS	220	9.34e-01	9.80e-01	0.0389	2.20e-02	5.12e-03	-9.75e-03	2.95e-02	5.64e-03	5.74e-01	8.96e-01	8.03e-01	4.50e-01	8.85e-01
GOBP CELL PROJECTION ORGANIZATION	1539	8.41e-02	3.50e-01	0.0386	-6.69e-03	8.32e-03	2.90e-02	-2.30e-02	-2.99e-03	6.61e-01	5.85e-01	5.75e-02	1.33e-01	8.45e-01
GOBP NEGATIVE REGULATION OF GENE EXPRESSION	1463	3.49e-01	6.95e-01	0.0383	-7.21e-03	1.86e-02	8.65e-04	-2.52e-02	2.08e-02	6.44e-01	2.35e-01	9.56e-01	1.07e-01	1.84e-01
GOMF TRANSITION METAL ION BINDING	1035	4.95e-01	8.00e-01	0.0383	5.91e-03	3.53e-02	-7.32e-03	-7.56e-03	-8.29e-03	7.48e-01	5.46e-02	6.90e-01	6.81e-01	6.52e-01
GOBP TUBE MORPHOGENESIS	914	5.49e-01	8.27e-01	0.0381	-7.96e-03	2.54e-02	2.26e-02	-1.37e-02	6.81e-03	6.83e-01	1.93e-01	2.47e-01	4.83e-01	7.27e-01
GOBP GLAND MORPHOGENESIS	119	9.88e-01	9.96e-01	0.0374	-2.74e-02	-1.25e-02	1.60e-02	-1.40e-02	6.56e-03	6.05e-01	8.14e-01	7.63e-01	7.92e-01	9.02e-01
GOBP AMINO ACID METABOLIC PROCESS	277	9.14e-01	9.72e-01	0.0373	-7.00e-04	3.06e-02	-2.09e-02	7.25e-04	4.00e-03	9.84e-01	3.81e-01	5.49e-01	9.83e-01	9.09e-01
GOBP RENAL SYSTEM DEVELOPMENT	316	8.41e-01	9.48e-01	0.0368	3.95e-03	5.42e-03	2.84e-02	-2.20e-02	-4.14e-03	9.04e-01	8.68e-01	3.86e-01	5.00e-01	8.99e-01
GOBP VASCULATURE DEVELOPMENT	794	7.32e-01	9.08e-01	0.0365	-2.26e-02	1.91e-02	1.99e-02	4.00e-03	6.69e-03	2.78e-01	3.59e-01	3.40e-01	8.48e-01	7.49e-01
GOCC CILIUM	704	7.60e-01	9.20e-01	0.0337	-1.61e-02	-1.95e-02	-2.69e-03	-2.13e-02	-6.16e-03	4.66e-01	3.77e-01	9.03e-01	3.37e-01	7.81e-01
GOBP ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS	1213	4.63e-01	7.80e-01	0.0335	-7.72e-03	1.92e-02	2.04e-02	-1.67e-02	-2.32e-05	6.51e-01	2.61e-01	2.31e-01	3.27e-01	9.99e-01
GOCC CYTOPLASMIC REGION	277	9.79e-01	9.93e-01	0.0334	-6.50e-03	6.52e-03	-1.52e-02	-2.83e-02	5.53e-04	8.52e-01	8.52e-01	6.64e-01	4.17e-01	9.87e-01
GOBP POSITIVE REGULATION OF NEUROGENESIS	228	9.79e-01	9.93e-01	0.0327	-7.23e-04	-2.43e-04	2.47e-02	-4.10e-03	2.10e-02	9.85e-01	9.95e-01	5.20e-01	9.15e-01	5.85e-01
GOBP POSITIVE REGULATION OF WOUND HEALING	61	9.99e-01	1.00e+00	0.0297	1.87e-02	2.05e-02	-8.36e-03	2.31e-03	-5.77e-03	8.00e-01	7.82e-01	9.10e-01	9.75e-01	9.38e-01
GOBP POSITIVE REGULATION OF RESPONSE TO WOUNDING	73	9.99e-01	1.00e+00	0.0294	5.25e-03	-1.95e-02	1.94e-02	6.87e-03	-5.74e-03	9.38e-01	7.73e-01	7.74e-01	9.19e-01	9.32e-01
GOBP REGULATION OF EPITHELIAL CELL PROLIFERATION	394	9.93e-01	9.97e-01	0.0206	-4.63e-03	6.41e-03	1.46e-02	-1.60e-03	1.20e-02	8.75e-01	8.27e-01	6.18e-01	9.56e-01	6.81e-01

---

Detailed Gene set reports

GOBP_DISRUPTION_OF_PLASMA_MEMBRANE_INTEGRITY_IN_ANOTHER_ORGANISM

GOBP_DISRUPTION_OF_PLASMA_MEMBRANE_INTEGRITY_IN_ANOTHER_ORGANISM

metric	value
setSize	6
pMANOVA	8.06e-07
p.adjustMANOVA	3.68e-05
s.dist	1.39
s.iageonset	-0.979
s.cloz	-0.633
s.cognit	-0.0482
s.igaf	-0.732
s.prs	0.162
p.iageonset	3.24e-05
p.cloz	0.0072
p.cognit	0.838
p.igaf	0.00189
p.prs	0.491

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	iageonset	igaf
DEFA1	-17881	-8537
DEFA1B	-17881	-8537
DEFA3	-17881	-8537
DEFA6	-17653	-6110
DEFA4	-17444	-6024

Click HERE to show all gene set members

All member genes

	iageonset	cloz	cognit	igaf	prs
DEFA1	-17881	-8237	8555	-8537	9391
DEFA1B	-17881	-8237	8555	-8537	9391
DEFA3	-17881	-8237	8555	-8537	9391
DEFA4	-17444	-8127	-4460	-6024	-12124
DEFA5	-17295	-5006	15451	4154	-10216
DEFA6	-17653	12455	-4046	-6110	-3462

---

---

GOMF_ALKANE_1_MONOOXYGENASE_ACTIVITY

GOMF_ALKANE_1_MONOOXYGENASE_ACTIVITY

metric	value
setSize	5
pMANOVA	0.00393
p.adjustMANOVA	0.045
s.dist	1.26
s.iageonset	-0.333
s.cloz	0.356
s.cognit	0.877
s.igaf	0.71
s.prs	-0.264
p.iageonset	0.197
p.cloz	0.168
p.cognit	0.000685
p.igaf	0.00597
p.prs	0.306

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	cognit	igaf
CYP4A11	16828	13384
CYP4A22	16638	13242
CYP4F12	16826	10869
CYP4F8	16092	7985
CYP4F2	11515	5619

Click HERE to show all gene set members

All member genes

	iageonset	cloz	cognit	igaf	prs
CYP4A11	3781	13132	16828	13384	-10980
CYP4A22	-17497	-7803	16638	13242	-331
CYP4F12	-14230	11125	16826	10869	7948
CYP4F2	-16098	3432	11515	5619	-7251
CYP4F8	-8866	13217	16092	7985	-10802

---

---

GOMF_CCR6_CHEMOKINE_RECEPTOR_BINDING

GOMF_CCR6_CHEMOKINE_RECEPTOR_BINDING

metric	value
setSize	5
pMANOVA	0.00329
p.adjustMANOVA	0.0393
s.dist	1.24
s.iageonset	-0.37
s.cloz	0.495
s.cognit	0.783
s.igaf	0.736
s.prs	0.0446
p.iageonset	0.152
p.cloz	0.0553
p.cognit	0.00244
p.igaf	0.00438
p.prs	0.863

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	cognit	igaf
DEFB114	16745	13392
DEFB133	14429	12872
CCL20	16166	8914
DEFB110	8752	12064
DEFB1	16651	5275

Click HERE to show all gene set members

All member genes

	iageonset	cloz	cognit	igaf	prs
CCL20	-15110	3897	16166	8914	8975
DEFB1	-11089	10363	16651	5275	-11222
DEFB110	176	9725	8752	12064	8148
DEFB114	-14658	10173	16745	13392	-10680
DEFB133	-14258	6563	14429	12872	303

---

---

GOBP_CHORIONIC_TROPHOBLAST_CELL_PROLIFERATION

GOBP_CHORIONIC_TROPHOBLAST_CELL_PROLIFERATION

metric	value
setSize	5
pMANOVA	0.000744
p.adjustMANOVA	0.0121
s.dist	1.19
s.iageonset	0.552
s.cloz	-0.45
s.cognit	0.308
s.igaf	-0.144
s.prs	0.893
p.iageonset	0.0324
p.cloz	0.0815
p.cognit	0.234
p.igaf	0.578
p.prs	0.000541

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	prs	iageonset
INSL4	9231	3940
BOK	7071	3805
FZD5	9176	1058

Click HERE to show all gene set members

All member genes

	iageonset	cloz	cognit	igaf	prs
ACVR1C	-12767	-3244	1857	-7408	7835
BOK	3805	8791	15208	535	7071
FZD5	1058	-3424	3808	-4246	9176
INSL4	3940	-7926	12435	12883	9231
NODAL	-389	-5289	13377	2526	8753

---

---

GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_ENDOGENOUS_LIPID_ANTIGEN_VIA_MHC_CLASS_IB

GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_ENDOGENOUS_LIPID_ANTIGEN_VIA_MHC_CLASS_IB

metric	value
setSize	5
pMANOVA	0.00526
p.adjustMANOVA	0.0553
s.dist	1.17
s.iageonset	-0.00739
s.cloz	-0.467
s.cognit	0.665
s.igaf	0.843
s.prs	-0.0927
p.iageonset	0.977
p.cloz	0.0706
p.cognit	0.01
p.igaf	0.00109
p.prs	0.72

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	igaf	cognit
CD1C	13040	15421
CD1E	12051	15006
CD1A	10967	16078
CD1B	12978	13366
CD1D	9382	6418

Click HERE to show all gene set members

All member genes

	iageonset	cloz	cognit	igaf	prs
CD1A	3265	-4350	16078	10967	8604
CD1B	3666	-4793	13366	12978	-11068
CD1C	-15718	-1878	15421	13040	6981
CD1D	-17419	2248	6418	9382	-10673
CD1E	-8847	-3254	15006	12051	-5849

---

---

GOMF_LIPID_ANTIGEN_BINDING

GOMF_LIPID_ANTIGEN_BINDING

metric	value
setSize	5
pMANOVA	0.00526
p.adjustMANOVA	0.0553
s.dist	1.17
s.iageonset	-0.00739
s.cloz	-0.467
s.cognit	0.665
s.igaf	0.843
s.prs	-0.0927
p.iageonset	0.977
p.cloz	0.0706
p.cognit	0.01
p.igaf	0.00109
p.prs	0.72

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	igaf	cognit
CD1C	13040	15421
CD1E	12051	15006
CD1A	10967	16078
CD1B	12978	13366
CD1D	9382	6418

Click HERE to show all gene set members

All member genes

	iageonset	cloz	cognit	igaf	prs
CD1A	3265	-4350	16078	10967	8604
CD1B	3666	-4793	13366	12978	-11068
CD1C	-15718	-1878	15421	13040	6981
CD1D	-17419	2248	6418	9382	-10673
CD1E	-8847	-3254	15006	12051	-5849

---

---

GOBP_LOBAR_BRONCHUS_EPITHELIUM_DEVELOPMENT

GOBP_LOBAR_BRONCHUS_EPITHELIUM_DEVELOPMENT

metric	value
setSize	5
pMANOVA	0.00289
p.adjustMANOVA	0.0357
s.dist	1.17
s.iageonset	0.0191
s.cloz	0.728
s.cognit	0.365
s.igaf	0.633
s.prs	-0.56
p.iageonset	0.941
p.cloz	0.00481
p.cognit	0.158
p.igaf	0.0143
p.prs	0.03

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	cloz	igaf
HOXA5	13656	13117
AGR2	13327	12747
IL13	11791	8440
ADAMTSL2	9307	9102
SPDEF	5426	3458

Click HERE to show all gene set members

All member genes

	iageonset	cloz	cognit	igaf	prs
ADAMTSL2	-4309	9307	10085	9102	-9425
AGR2	-15572	13327	16650	12747	-11770
HOXA5	-202	13656	16930	13117	-12348
IL13	3391	11791	2275	8440	6251
SPDEF	-16907	5426	3881	3458	-10362

---

---

GOMF_PIRNA_BINDING

GOMF_PIRNA_BINDING

metric	value
setSize	5
pMANOVA	0.0037
p.adjustMANOVA	0.043
s.dist	1.17
s.iageonset	-0.724
s.cloz	0.248
s.cognit	0.827
s.igaf	0.298
s.prs	-0.0732
p.iageonset	0.00506
p.cloz	0.337
p.cognit	0.00135
p.igaf	0.249
p.prs	0.777

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	cognit	iageonset
PIWIL1	16499	-17621
PIWIL3	16419	-16655
PIWIL2	15855	-12165
PIWIL4	12318	-15520
TEX19	14104	-12387

Click HERE to show all gene set members

All member genes

	iageonset	cloz	cognit	igaf	prs
PIWIL1	-17621	-4623	16499	-8125	-6990
PIWIL2	-12165	12256	15855	13046	-15
PIWIL3	-16655	470	16419	9587	-11305
PIWIL4	-15520	6305	12318	10326	2704
TEX19	-12387	12775	14104	3650	4671

---

---

GOMF_IMMUNOGLOBULIN_RECEPTOR_ACTIVITY

GOMF_IMMUNOGLOBULIN_RECEPTOR_ACTIVITY

metric	value
setSize	6
pMANOVA	0.00142
p.adjustMANOVA	0.0205
s.dist	1.14
s.iageonset	0.194
s.cloz	0.807
s.cognit	0.72
s.igaf	0.293
s.prs	-0.0493
p.iageonset	0.412
p.cloz	0.000617
p.cognit	0.00226
p.igaf	0.214
p.prs	0.834

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	cloz	cognit
FCGR3A	13337	16484
FCER2	13273	14242
FCER1G	12702	14715
CD200R1	12938	13411
FCER1A	9314	13349
PIGR	7850	10949

Click HERE to show all gene set members

All member genes

	iageonset	cloz	cognit	igaf	prs
CD200R1	2058	12938	13411	11307	-5188
FCER1A	-9582	9314	13349	12685	-10405
FCER1G	-16822	12702	14715	-8317	9314
FCER2	3491	13273	14242	5303	-10434
FCGR3A	3300	13337	16484	11409	9009
PIGR	-11283	7850	10949	1504	-3847

---

---

GOBP_PROTECTION_FROM_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY

GOBP_PROTECTION_FROM_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY

metric	value
setSize	6
pMANOVA	2.7e-06
p.adjustMANOVA	0.000104
s.dist	1.12
s.iageonset	0.197
s.cloz	-0.876
s.cognit	0.554
s.igaf	-0.385
s.prs	0.0499
p.iageonset	0.403
p.cloz	0.000204
p.cognit	0.0187
p.igaf	0.102
p.prs	0.832

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	cloz	cognit
HLA-A	-8036	16723
SERPINB4	-6649	13193
HLA-B	-7865	10857
HLA-G	-5821	14552
HLA-E	-6342	11320
SERPINB9	-6608	5618

Click HERE to show all gene set members

All member genes

	iageonset	cloz	cognit	igaf	prs
HLA-A	3640	-8036	16723	13389	-9900
HLA-B	-17566	-7865	10857	-8140	-7665
HLA-E	-11906	-6342	11320	-7480	-3654
HLA-G	-4141	-5821	14552	4720	8681
SERPINB4	-1574	-6649	13193	-5867	-1962
SERPINB9	2938	-6608	5618	-7385	9477

---

---

GOBP_MICROGLIAL_CELL_MEDIATED_CYTOTOXICITY

GOBP_MICROGLIAL_CELL_MEDIATED_CYTOTOXICITY

metric	value
setSize	5
pMANOVA	0.00516
p.adjustMANOVA	0.0548
s.dist	1.12
s.iageonset	-0.314
s.cloz	0.603
s.cognit	0.722
s.igaf	0.127
s.prs	0.501
p.iageonset	0.224
p.cloz	0.0196
p.cognit	0.00515
p.igaf	0.624
p.prs	0.0522

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	cognit	cloz
STAP1	16735	13220
SPI1	15768	11976
TYROBP	14647	12065
ITGAM	13913	5981
CX3CR1	8367	3403

Click HERE to show all gene set members

All member genes

	iageonset	cloz	cognit	igaf	prs
CX3CR1	-12463	3403	8367	6487	3250
ITGAM	-11887	5981	13913	10987	912
SPI1	-16815	11976	15768	1186	7632
STAP1	-11623	13220	16735	6140	7930
TYROBP	908	12065	14647	-5688	844

---

---

GOBP_PROXIMAL_DISTAL_PATTERN_FORMATION_INVOLVED_IN_NEPHRON_DEVELOPMENT

GOBP_PROXIMAL_DISTAL_PATTERN_FORMATION_INVOLVED_IN_NEPHRON_DEVELOPMENT

metric	value
setSize	5
pMANOVA	0.00338
p.adjustMANOVA	0.0401
s.dist	1.11
s.iageonset	-0.0219
s.cloz	0.204
s.cognit	0.0876
s.igaf	-0.842
s.prs	0.682
p.iageonset	0.932
p.cloz	0.429
p.cognit	0.734
p.igaf	0.00112
p.prs	0.00826

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	igaf	prs
IRX3	-7554	7904
IRX2	-7699	6572
OSR1	-6050	7373
IRX1	-5941	4987
HES5	-6747	3648

Click HERE to show all gene set members

All member genes

	iageonset	cloz	cognit	igaf	prs
HES5	-3745	4860	-81	-6747	3648
IRX1	-1105	10736	15889	-5941	4987
IRX2	-12601	2022	10881	-7699	6572
IRX3	-7360	1460	2090	-7554	7904
OSR1	-11039	5706	5843	-6050	7373

---

---

GOMF_PEPTIDOGLYCAN_IMMUNE_RECEPTOR_ACTIVITY

GOMF_PEPTIDOGLYCAN_IMMUNE_RECEPTOR_ACTIVITY

metric	value
setSize	5
pMANOVA	0.00239
p.adjustMANOVA	0.0309
s.dist	1.09
s.iageonset	-0.516
s.cloz	0.308
s.cognit	-0.0816
s.igaf	-0.44
s.prs	-0.789
p.iageonset	0.0459
p.cloz	0.233
p.cognit	0.752
p.igaf	0.0886
p.prs	0.00224

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	prs	iageonset
PGLYRP1	-10062	-16854
PGLYRP2	-10719	-15697
PGLYRP4	-9397	-17326
PGLYRP3	-10183	-14274

Click HERE to show all gene set members

All member genes

	iageonset	cloz	cognit	igaf	prs
CD14	1226	6655	-902	-8168	-9848
PGLYRP1	-16854	10557	2779	-6676	-10062
PGLYRP2	-15697	9822	-3415	-8300	-10719
PGLYRP3	-14274	6133	12899	11489	-10183
PGLYRP4	-17326	-2697	13983	-299	-9397

---

---

GOMF_KETOSTEROID_MONOOXYGENASE_ACTIVITY

GOMF_KETOSTEROID_MONOOXYGENASE_ACTIVITY

metric	value
setSize	5
pMANOVA	0.0145
p.adjustMANOVA	0.114
s.dist	1.08
s.iageonset	-0.293
s.cloz	-0.394
s.cognit	0.342
s.igaf	0.827
s.prs	-0.353
p.iageonset	0.257
p.cloz	0.127
p.cognit	0.185
p.igaf	0.00136
p.prs	0.172

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	igaf	cloz
AKR1C1	13340	-7311
AKR1C4	12981	-7113
AKR1C2	7526	-7283

Click HERE to show all gene set members

All member genes

	iageonset	cloz	cognit	igaf	prs
AKR1C1	3831	-7311	14598	13340	-8425
AKR1C2	-15185	-7283	12288	7526	374
AKR1C3	-12696	2229	-116	11650	3133
AKR1C4	-15490	-7113	14541	12981	-10243
AKR1D1	-11151	11459	7259	12027	-11121

---

---

GOBP_POSITIVE_REGULATION_OF_PYROPTOSIS

GOBP_POSITIVE_REGULATION_OF_PYROPTOSIS

metric	value
setSize	5
pMANOVA	0.00965
p.adjustMANOVA	0.0854
s.dist	1.08
s.iageonset	0.077
s.cloz	-0.807
s.cognit	-0.411
s.igaf	-0.399
s.prs	0.421
p.iageonset	0.765
p.cloz	0.00178
p.cognit	0.112
p.igaf	0.122
p.prs	0.103

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	cloz	prs
GBP3	-6367	8961
GBP2	-6528	6653
GBP1	-5377	6190
CASP3	-4488	5721

Click HERE to show all gene set members

All member genes

	iageonset	cloz	cognit	igaf	prs
CASP3	-10726	-4488	-3416	-7027	5721
GBP1	-9937	-5377	3586	-2894	6190
GBP2	2133	-6528	15213	-2713	6653
GBP3	1979	-6367	-3598	-7274	8961
GBP5	-13872	-7911	-4498	10191	-11337

---

---

GOMF_HEMOGLOBIN_ALPHA_BINDING

GOMF_HEMOGLOBIN_ALPHA_BINDING

metric	value
setSize	5
pMANOVA	0.0208
p.adjustMANOVA	0.145
s.dist	1.07
s.iageonset	-0.221
s.cloz	-0.0391
s.cognit	0.573
s.igaf	0.878
s.prs	-0.0503
p.iageonset	0.392
p.cloz	0.88
p.cognit	0.0265
p.igaf	0.000675
p.prs	0.846

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	igaf	cognit
HBD	12812	16581
HBG2	12653	16628
HBG1	12632	16122
HBE1	11642	14033

Click HERE to show all gene set members

All member genes

	iageonset	cloz	cognit	igaf	prs
HBB	-14261	10995	-2124	10562	2454
HBD	3472	-6124	16581	12812	358
HBE1	-15883	342	14033	11642	-9447
HBG1	-4767	-6436	16122	12632	8480
HBG2	-15344	12662	16628	12653	-11526

---

---

GOBP_LOBAR_BRONCHUS_DEVELOPMENT

GOBP_LOBAR_BRONCHUS_DEVELOPMENT

metric	value
setSize	6
pMANOVA	0.00407
p.adjustMANOVA	0.0463
s.dist	1.06
s.iageonset	-0.012
s.cloz	0.707
s.cognit	0.412
s.igaf	0.425
s.prs	-0.513
p.iageonset	0.959
p.cloz	0.00269
p.cognit	0.0808
p.igaf	0.0712
p.prs	0.0295

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	cloz	prs
HOXA5	13656	-12348
AGR2	13327	-11770
ADAMTSL2	9307	-9425
SPDEF	5426	-10362
WNT7B	9346	-4417

Click HERE to show all gene set members

All member genes

	iageonset	cloz	cognit	igaf	prs
ADAMTSL2	-4309	9307	10085	9102	-9425
AGR2	-15572	13327	16650	12747	-11770
HOXA5	-202	13656	16930	13117	-12348
IL13	3391	11791	2275	8440	6251
SPDEF	-16907	5426	3881	3458	-10362
WNT7B	-8766	9346	13044	-4277	-4417

---

---

GOBP_REGULATION_OF_CORTICOTROPIN_SECRETION

GOBP_REGULATION_OF_CORTICOTROPIN_SECRETION

metric	value
setSize	5
pMANOVA	0.00166
p.adjustMANOVA	0.0234
s.dist	1.06
s.iageonset	0.915
s.cloz	0.26
s.cognit	0.375
s.igaf	-0.245
s.prs	-0.0952
p.iageonset	0.000397
p.cloz	0.313
p.cognit	0.147
p.igaf	0.343
p.prs	0.712

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	iageonset	cognit
UCN	3838	15656
GHRL	2725	14728
CRHBP	3139	12000
RAB8B	1983	11781

Click HERE to show all gene set members

All member genes

	iageonset	cloz	cognit	igaf	prs
CRH	3830	4991	-3801	-4382	-7445
CRHBP	3139	-5204	12000	2369	8628
GHRL	2725	12317	14728	-6990	2047
RAB8B	1983	9863	11781	6100	-3237
UCN	3838	5897	15656	1624	-12139

---

---

GOMF_PHOSPHOLIPASE_A2_INHIBITOR_ACTIVITY

GOMF_PHOSPHOLIPASE_A2_INHIBITOR_ACTIVITY

metric	value
setSize	6
pMANOVA	0.000678
p.adjustMANOVA	0.0113
s.dist	1.05
s.iageonset	0.53
s.cloz	0.585
s.cognit	-0.366
s.igaf	0.167
s.prs	-0.557
p.iageonset	0.0246
p.cloz	0.0131
p.cognit	0.12
p.igaf	0.478
p.prs	0.0181

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	cloz	prs
ANXA9	12998	-9246
ANXA2	10928	-10412
ANXA1	7758	-11987
ANXA2P2	9002	-5200
ANXA3	1979	-9737

Click HERE to show all gene set members

All member genes

	iageonset	cloz	cognit	igaf	prs
ANXA1	3186	7758	-2752	10619	-11987
ANXA2	-2832	10928	7789	9413	-10412
ANXA2P2	-9318	9002	1834	-2945	-5200
ANXA3	-3256	1979	213	1912	-9737
ANXA9	1849	12998	-4614	-5310	-9246
SCGB1A1	3662	12108	9195	11903	1621

---

---

GOMF_FATTY_ACYL_COA_SYNTHASE_ACTIVITY

GOMF_FATTY_ACYL_COA_SYNTHASE_ACTIVITY

metric	value
setSize	6
pMANOVA	0.00151
p.adjustMANOVA	0.0216
s.dist	1.05
s.iageonset	0.345
s.cloz	0.849
s.cognit	0.133
s.igaf	0.379
s.prs	-0.306
p.iageonset	0.144
p.cloz	0.000318
p.cognit	0.573
p.igaf	0.108
p.prs	0.195

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	cloz	igaf
ACSM6	13017	11913
ACSM5	12098	11522
ACSM1	11833	8541
ACSM3	10760	8113
ACSM4	11240	7488

Click HERE to show all gene set members

All member genes

	iageonset	cloz	cognit	igaf	prs
ACSM1	1985	11833	12338	8541	-7674
ACSM2B	3556	13200	-4874	-8028	-11173
ACSM3	1611	10760	12044	8113	4066
ACSM4	-4508	11240	3972	7488	-10367
ACSM5	-10570	12098	8808	11522	7291
ACSM6	-10962	13017	12237	11913	-10575

---

---

GOBP_FOREBRAIN_NEURON_FATE_COMMITMENT

GOBP_FOREBRAIN_NEURON_FATE_COMMITMENT

metric	value
setSize	7
pMANOVA	0.000936
p.adjustMANOVA	0.0147
s.dist	1.03
s.iageonset	0.414
s.cloz	0.198
s.cognit	0.0219
s.igaf	-0.734
s.prs	0.56
p.iageonset	0.0578
p.cloz	0.363
p.cognit	0.92
p.igaf	0.000771
p.prs	0.0103

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	igaf	prs
NKX2-1	-7202	8418
TBR1	-7270	5426
BCL11B	-5898	6640
PAX6	-6703	3603
FEZF2	-4265	4951
GATA2	-437	5561

Click HERE to show all gene set members

All member genes

	iageonset	cloz	cognit	igaf	prs
ASCL1	-5433	8847	-3045	-7543	-1280
BCL11B	1721	-3177	15894	-5898	6640
FEZF2	-6876	1775	8645	-4265	4951
GATA2	-345	8974	3418	-437	5561
NKX2-1	-1079	2991	2110	-7202	8418
PAX6	-4814	6141	6160	-6703	3603
TBR1	114	8701	10241	-7270	5426

---

---

GOBP_STEM_CELL_FATE_SPECIFICATION

GOBP_STEM_CELL_FATE_SPECIFICATION

metric	value
setSize	6
pMANOVA	0.000421
p.adjustMANOVA	0.00783
s.dist	1.03
s.iageonset	-0.0106
s.cloz	0.498
s.cognit	0.246
s.igaf	-0.861
s.prs	0.0459
p.iageonset	0.964
p.cloz	0.0345
p.cognit	0.296
p.igaf	0.000258
p.prs	0.846

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	igaf	cloz
SFRP2	-7720	11028
SOX18	-7045	10869
SOX9	-6558	11105
GSC	-6489	6388
SOX17	-8178	5068
DMRTA2	-6092	4642

Click HERE to show all gene set members

All member genes

	iageonset	cloz	cognit	igaf	prs
DMRTA2	-4210	4642	4990	-6092	5931
GSC	-7399	6388	9620	-6489	2009
SFRP2	-64	11028	10142	-7720	-10416
SOX17	-16377	5068	5985	-8178	262
SOX18	-1421	10869	13919	-7045	-11392
SOX9	-12804	11105	7340	-6558	8322

---

---

GOBP_REGULATION_OF_APOPTOTIC_PROCESS_IN_BONE_MARROW_CELL

GOBP_REGULATION_OF_APOPTOTIC_PROCESS_IN_BONE_MARROW_CELL

metric	value
setSize	5
pMANOVA	0.0132
p.adjustMANOVA	0.107
s.dist	1.02
s.iageonset	0.065
s.cloz	-0.239
s.cognit	0.733
s.igaf	0.36
s.prs	0.565
p.iageonset	0.801
p.cloz	0.355
p.cognit	0.00451
p.igaf	0.164
p.prs	0.0285

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	cognit	prs
PTH	15424	9095
FGFR2	15413	7966
MIR146A	13445	4276
PLK2	12409	2484
LEF1	13343	268

Click HERE to show all gene set members

All member genes

	iageonset	cloz	cognit	igaf	prs
FGFR2	-17408	-7705	15413	10216	7966
LEF1	-1062	4746	13343	-1955	268
MIR146A	781	-5197	13445	10457	4276
PLK2	986	-809	12409	2696	2484
PTH	-14377	9446	15424	10482	9095

---

---

GOBP_REGULATION_OF_ACTIVATION_OF_JANUS_KINASE_ACTIVITY

GOBP_REGULATION_OF_ACTIVATION_OF_JANUS_KINASE_ACTIVITY

metric	value
setSize	7
pMANOVA	0.0027
p.adjustMANOVA	0.0339
s.dist	1.02
s.iageonset	-0.609
s.cloz	0.2
s.cognit	0.72
s.igaf	0.311
s.prs	-0.13
p.iageonset	0.00528
p.cloz	0.36
p.cognit	0.000967
p.igaf	0.154
p.prs	0.552

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	cognit	iageonset
IL23A	16097	-17754
CD300A	16527	-14139
AGT	15647	-14831
CCL5	9386	-17316
IL12B	15042	-10302
IL23R	14115	-9707
IL6R	10219	-11192

Click HERE to show all gene set members

All member genes

	iageonset	cloz	cognit	igaf	prs
AGT	-14831	12308	15647	6725	-11543
CCL5	-17316	734	9386	11825	-5334
CD300A	-14139	-5116	16527	12945	2016
IL12B	-10302	9447	15042	7799	6737
IL23A	-17754	7206	16097	-3434	-11826
IL23R	-9707	7809	14115	9845	5527
IL6R	-11192	1961	10219	-4772	-5225

---

---

GOBP_FLAVONE_METABOLIC_PROCESS

GOBP_FLAVONE_METABOLIC_PROCESS

metric	value
setSize	6
pMANOVA	0.00875
p.adjustMANOVA	0.08
s.dist	1.02
s.iageonset	0.237
s.cloz	0.319
s.cognit	0.406
s.igaf	0.703
s.prs	-0.471
p.iageonset	0.316
p.cloz	0.177
p.cognit	0.0853
p.igaf	0.00288
p.prs	0.0455

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	igaf	prs
UGT1A1	10294	-8023
LCT	7770	-8386
UGT1A8	10368	-6175
UGT1A10	10319	-6023
UGT1A9	10971	-5427
UGT1A7	11108	-5293

Click HERE to show all gene set members

All member genes

	iageonset	cloz	cognit	igaf	prs
LCT	-544	8693	12825	7770	-8386
UGT1A1	-9842	302	10304	10294	-8023
UGT1A10	-4028	7253	9901	10319	-6023
UGT1A7	-3759	7061	9985	11108	-5293
UGT1A8	-4190	6524	9678	10368	-6175
UGT1A9	-3644	7429	9781	10971	-5427

---

---

GOBP_XENOBIOTIC_GLUCURONIDATION

GOBP_XENOBIOTIC_GLUCURONIDATION

metric	value
setSize	6
pMANOVA	0.014
p.adjustMANOVA	0.112
s.dist	1.02
s.iageonset	-0.082
s.cloz	0.291
s.cognit	0.531
s.igaf	0.791
s.prs	-0.187
p.iageonset	0.728
p.cloz	0.216
p.cognit	0.0243
p.igaf	0.000788
p.prs	0.428

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	igaf	cognit
UGT2B11	12686	16765
UGT1A3	11241	14203
UGT1A7	11108	9985
UGT1A9	10971	9781
UGT1A1	10294	10304
UGT1A8	10368	9678

Click HERE to show all gene set members

All member genes

	iageonset	cloz	cognit	igaf	prs
UGT1A1	-9842	302	10304	10294	-8023
UGT1A3	-8106	731	14203	11241	-4460
UGT1A7	-3759	7061	9985	11108	-5293
UGT1A8	-4190	6524	9678	10368	-6175
UGT1A9	-3644	7429	9781	10971	-5427
UGT2B11	-17434	13426	16765	12686	8775

---

---

GOCC_B_CELL_RECEPTOR_COMPLEX

GOCC_B_CELL_RECEPTOR_COMPLEX

metric	value
setSize	5
pMANOVA	0.0125
p.adjustMANOVA	0.103
s.dist	1.02
s.iageonset	-0.222
s.cloz	0.446
s.cognit	0.628
s.igaf	-0.0647
s.prs	0.62
p.iageonset	0.39
p.cloz	0.0838
p.cognit	0.015
p.igaf	0.802
p.prs	0.0163

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	cognit	prs
LIME1	16626	6445
CD79A	15736	6180
CD79B	9768	8712
TMIGD2	10671	7559

Click HERE to show all gene set members

All member genes

	iageonset	cloz	cognit	igaf	prs
CD79A	-12134	13186	15736	-4484	6180
CD79B	2809	8858	9768	1272	8712
LIME1	-16126	13556	16626	11379	6445
SYK	-7495	8613	11456	7673	-1790
TMIGD2	-13871	-6147	10671	-7225	7559

---

---

GOBP_SPERMIDINE_TRANSPORT

GOBP_SPERMIDINE_TRANSPORT

metric	value
setSize	5
pMANOVA	0.00717
p.adjustMANOVA	0.0691
s.dist	1.01
s.iageonset	0.597
s.cloz	-0.393
s.cognit	-0.03
s.igaf	0.385
s.prs	0.6
p.iageonset	0.0208
p.cloz	0.128
p.cognit	0.908
p.igaf	0.135
p.prs	0.0201

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	prs	iageonset
SLC22A3	6442	2333
SLC22A2	4853	2210
SLC22A1	4475	2163

Click HERE to show all gene set members

All member genes

	iageonset	cloz	cognit	igaf	prs
SLC18B1	-2653	453	-3188	-4116	2027
SLC22A1	2163	-7026	-3549	2871	4475
SLC22A16	-5976	7315	7781	11212	8212
SLC22A2	2210	-3895	13649	11452	4853
SLC22A3	2333	-4806	13479	11885	6442

---

---

GOBP_COMPARTMENT_PATTERN_SPECIFICATION

GOBP_COMPARTMENT_PATTERN_SPECIFICATION

metric	value
setSize	5
pMANOVA	0.0092
p.adjustMANOVA	0.0825
s.dist	1
s.iageonset	0.628
s.cloz	0.561
s.cognit	0.465
s.igaf	-0.211
s.prs	0.198
p.iageonset	0.015
p.cloz	0.0298
p.cognit	0.0719
p.igaf	0.414
p.prs	0.444

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	iageonset	cloz
DLL1	3671	10314
PBX3	2848	13030
DLL3	2046	7929
NOTCH1	2275	1569

Click HERE to show all gene set members

All member genes

	iageonset	cloz	cognit	igaf	prs
DLL1	3671	10314	14331	11573	-4906
DLL3	2046	7929	12544	-5464	732
LFNG	-11031	11509	4979	-6570	5056
NOTCH1	2275	1569	12234	3190	3524
PBX3	2848	13030	11216	-2133	-482

---

---

GOCC_ALPHA_BETA_T_CELL_RECEPTOR_COMPLEX

GOCC_ALPHA_BETA_T_CELL_RECEPTOR_COMPLEX

metric	value
setSize	5
pMANOVA	0.00452
p.adjustMANOVA	0.0502
s.dist	1
s.iageonset	0.371
s.cloz	-0.427
s.cognit	0.631
s.igaf	-0.021
s.prs	0.536
p.iageonset	0.151
p.cloz	0.0983
p.cognit	0.0146
p.igaf	0.935
p.prs	0.038

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	cognit	prs
CD3D	15819	7359
CD3E	14879	7773
CD3G	16094	3732
CD247	15055	3266
PTPN6	2566	325

Click HERE to show all gene set members

All member genes

	iageonset	cloz	cognit	igaf	prs
CD247	-3996	6900	15055	-7138	3266
CD3D	3382	-5601	15819	1287	7359
CD3E	2617	-6009	14879	10761	7773
CD3G	-5607	-7273	16094	4937	3732
PTPN6	-10711	2155	2566	1163	325

---

---

GOBP_DETOXIFICATION_OF_NITROGEN_COMPOUND

GOBP_DETOXIFICATION_OF_NITROGEN_COMPOUND

metric	value
setSize	5
pMANOVA	0.00389
p.adjustMANOVA	0.0448
s.dist	0.995
s.iageonset	-0.229
s.cloz	-0.0877
s.cognit	0.755
s.igaf	-0.246
s.prs	0.548
p.iageonset	0.376
p.cloz	0.734
p.cognit	0.00347
p.igaf	0.341
p.prs	0.0337

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	cognit	prs
GSTM1	16563	9548
GSTM3	14560	6912
MTARC1	15166	4473
GSTM2	11312	3383

Click HERE to show all gene set members

All member genes

	iageonset	cloz	cognit	igaf	prs
GSTM1	-17763	-8244	16563	-8532	9548
GSTM2	-4127	2546	11312	-3753	3383
GSTM3	2013	11966	14560	9151	6912
MTARC1	-11118	1074	15166	9209	4473
MTARC2	-16202	1431	13609	-7387	-1169

---

---

GOBP_FLAVONOID_GLUCURONIDATION

GOBP_FLAVONOID_GLUCURONIDATION

metric	value
setSize	5
pMANOVA	0.0437
p.adjustMANOVA	0.232
s.dist	0.988
s.iageonset	0.0931
s.cloz	0.154
s.cognit	0.44
s.igaf	0.763
s.prs	-0.409
p.iageonset	0.718
p.cloz	0.55
p.cognit	0.0884
p.igaf	0.00315
p.prs	0.113

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	igaf	cognit
UGT1A3	11241	14203
UGT1A7	11108	9985
UGT1A9	10971	9781
UGT1A1	10294	10304
UGT1A8	10368	9678

Click HERE to show all gene set members

All member genes

	iageonset	cloz	cognit	igaf	prs
UGT1A1	-9842	302	10304	10294	-8023
UGT1A3	-8106	731	14203	11241	-4460
UGT1A7	-3759	7061	9985	11108	-5293
UGT1A8	-4190	6524	9678	10368	-6175
UGT1A9	-3644	7429	9781	10971	-5427

---

---

GOMF_ALCOHOL_DEHYDROGENASE_ACTIVITY_ZINC_DEPENDENT

GOMF_ALCOHOL_DEHYDROGENASE_ACTIVITY_ZINC_DEPENDENT

metric	value
setSize	7
pMANOVA	0.00292
p.adjustMANOVA	0.0359
s.dist	0.985
s.iageonset	0.000202
s.cloz	-0.368
s.cognit	0.0602
s.igaf	0.7
s.prs	-0.584
p.iageonset	0.999
p.cloz	0.0917
p.cognit	0.783
p.igaf	0.00135
p.prs	0.00746

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	igaf	prs
ADH1A	13367	-12170
ADH1C	13115	-11297
ADH4	11904	-12337
ADH6	12301	-10660
ADH1B	10557	-6236
ADH7	10374	-5404

Click HERE to show all gene set members

All member genes

	iageonset	cloz	cognit	igaf	prs
ADH1A	2455	-7701	12971	13367	-12170
ADH1B	-16220	-8146	14240	10557	-6236
ADH1C	-16633	12851	16853	13115	-11297
ADH4	3963	-7337	-4992	11904	-12337
ADH5	-1768	1155	686	-872	3584
ADH6	-8341	-7662	11256	12301	-10660
ADH7	-11947	7600	-4646	10374	-5404

---

---

GOBP_PLATELET_DEGRANULATION

GOBP_PLATELET_DEGRANULATION

metric	value
setSize	7
pMANOVA	0.00378
p.adjustMANOVA	0.0437
s.dist	0.984
s.iageonset	-0.157
s.cloz	0.54
s.cognit	0.54
s.igaf	0.531
s.prs	0.282
p.iageonset	0.473
p.cloz	0.0133
p.cognit	0.0133
p.igaf	0.015
p.prs	0.196

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	cloz	cognit
PLEK	13002	15107
LYN	11696	14548
TPH1	10024	13201
SYK	8613	11456
STXBP1	10301	8192
ABCC4	7366	5223

Click HERE to show all gene set members

All member genes

	iageonset	cloz	cognit	igaf	prs
ABCC4	-10298	7366	5223	6932	1771
LYN	-13629	11696	14548	9291	-1638
P2RX1	1514	-528	15476	6718	9450
PLEK	-15531	13002	15107	8136	8024
STXBP1	-2341	10301	8192	8360	-10310
SYK	-7495	8613	11456	7673	-1790
TPH1	-12742	10024	13201	10658	6474

---

---

GOBP_APOPTOTIC_PROCESS_IN_BONE_MARROW_CELL

GOBP_APOPTOTIC_PROCESS_IN_BONE_MARROW_CELL

metric	value
setSize	6
pMANOVA	0.00616
p.adjustMANOVA	0.0621
s.dist	0.98
s.iageonset	0.0909
s.cloz	-0.208
s.cognit	0.732
s.igaf	0.272
s.prs	0.546
p.iageonset	0.7
p.cloz	0.378
p.cognit	0.00191
p.igaf	0.248
p.prs	0.0205

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	cognit	prs
PTH	15424	9095
FGFR2	15413	7966
MIR146A	13445	4276
BCL2L1	13905	3557
PLK2	12409	2484
LEF1	13343	268

Click HERE to show all gene set members

All member genes

	iageonset	cloz	cognit	igaf	prs
BCL2L1	-4517	2154	13905	615	3557
FGFR2	-17408	-7705	15413	10216	7966
LEF1	-1062	4746	13343	-1955	268
MIR146A	781	-5197	13445	10457	4276
PLK2	986	-809	12409	2696	2484
PTH	-14377	9446	15424	10482	9095

---

---

GOCC_FC_RECEPTOR_COMPLEX

GOCC_FC_RECEPTOR_COMPLEX

metric	value
setSize	5
pMANOVA	0.0177
p.adjustMANOVA	0.131
s.dist	0.975
s.iageonset	-0.182
s.cloz	0.472
s.cognit	0.426
s.igaf	-0.231
s.prs	0.679
p.iageonset	0.481
p.cloz	0.0674
p.cognit	0.0991
p.igaf	0.37
p.prs	0.00858

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	prs	cloz
FCGR3A	9009	13337
FCER1G	9314	12702
CD247	3266	6900

Click HERE to show all gene set members

All member genes

	iageonset	cloz	cognit	igaf	prs
CD247	-3996	6900	15055	-7138	3266
FCER1G	-16822	12702	14715	-8317	9314
FCGR3A	3300	13337	16484	11409	9009
LILRA4	-17756	-6408	-3939	-8450	8927
MS4A2	-9344	12951	10858	11972	-219

---

---

GOCC_CLATHRIN_COMPLEX

GOCC_CLATHRIN_COMPLEX

metric	value
setSize	6
pMANOVA	0.00418
p.adjustMANOVA	0.0471
s.dist	0.975
s.iageonset	-0.209
s.cloz	0.706
s.cognit	-0.103
s.igaf	-0.0267
s.prs	-0.63
p.iageonset	0.375
p.cloz	0.00275
p.cognit	0.663
p.igaf	0.91
p.prs	0.00752

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	cloz	prs
SCN10A	12907	-11480
CLTA	11128	-9859
BAIAP2L2	9458	-9976
CLTCL1	8778	-9696
SCLT1	9775	-8106
CLTC	10706	-656

Click HERE to show all gene set members

All member genes

	iageonset	cloz	cognit	igaf	prs
BAIAP2L2	-15591	9458	4865	-5548	-9976
CLTA	-11591	11128	-2269	6414	-9859
CLTC	-8077	10706	10610	-1537	-656
CLTCL1	-6595	8778	2049	6206	-9696
SCLT1	-10109	9775	6908	-4013	-8106
SCN10A	-3383	12907	6865	11319	-11480

---

---

GOBP_ADENYLATE_CYCLASE_INHIBITING_SEROTONIN_RECEPTOR_SIGNALING_PATHWAY

GOBP_ADENYLATE_CYCLASE_INHIBITING_SEROTONIN_RECEPTOR_SIGNALING_PATHWAY

metric	value
setSize	7
pMANOVA	0.000666
p.adjustMANOVA	0.0111
s.dist	0.974
s.iageonset	0.318
s.cloz	0.166
s.cognit	0.644
s.igaf	-0.26
s.prs	0.58
p.iageonset	0.145
p.cloz	0.446
p.cognit	0.00316
p.igaf	0.233
p.prs	0.00789

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	cognit	prs
HTR1D	14385	8763
HTR1F	14454	8326
HTR1A	12295	8039
HTR5A	16123	4392
HTR1E	10936	5917
HTR1B	8618	4316

Click HERE to show all gene set members

All member genes

	iageonset	cloz	cognit	igaf	prs
DRD4	3336	12874	14392	-8292	-4928
HTR1A	-9605	5209	12295	-3666	8039
HTR1B	1913	8061	8618	-7635	4316
HTR1D	-12971	12234	14385	10052	8763
HTR1E	-9623	-5181	10936	160	5917
HTR1F	1876	5240	14454	10738	8326
HTR5A	992	-6662	16123	-4311	4392

---

---

GOBP_CELLULAR_RESPONSE_TO_TEMPERATURE_STIMULUS

GOBP_CELLULAR_RESPONSE_TO_TEMPERATURE_STIMULUS

metric	value
setSize	5
pMANOVA	0.0178
p.adjustMANOVA	0.131
s.dist	0.965
s.iageonset	0.56
s.cloz	0.476
s.cognit	0.426
s.igaf	-0.242
s.prs	0.388
p.iageonset	0.03
p.cloz	0.0652
p.cognit	0.0993
p.igaf	0.348
p.prs	0.133

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	iageonset	cloz
HTR1B	1913	8061
HTR2B	867	12953

Click HERE to show all gene set members

All member genes

	iageonset	cloz	cognit	igaf	prs
HTR1B	1913	8061	8618	-7635	4316
HTR2B	867	12953	16530	9675	4217
KCNK4	-5147	9762	10760	-1518	-9468
TRPM2	-860	10413	14416	-5392	8552
TRPV1	-693	-1493	2834	3736	6722

---

---

GOBP_POSITIVE_REGULATION_OF_GASTRO_INTESTINAL_SYSTEM_SMOOTH_MUSCLE_CONTRACTION

GOBP_POSITIVE_REGULATION_OF_GASTRO_INTESTINAL_SYSTEM_SMOOTH_MUSCLE_CONTRACTION

metric	value
setSize	5
pMANOVA	0.0017
p.adjustMANOVA	0.0237
s.dist	0.95
s.iageonset	0.431
s.cloz	0.256
s.cognit	0.262
s.igaf	-0.618
s.prs	-0.447
p.iageonset	0.0951
p.cloz	0.321
p.cognit	0.31
p.igaf	0.0166
p.prs	0.0836

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	igaf	prs
SPX	-7922	-11791
KIT	-5314	-11050
GHSR	-5860	-9062

Click HERE to show all gene set members

All member genes

	iageonset	cloz	cognit	igaf	prs
GHRL	2725	12317	14728	-6990	2047
GHSR	-3885	8008	11186	-5860	-9062
KIT	-15590	-31	8071	-5314	-11050
PTAFR	3251	12790	14553	4338	-1566
SPX	2490	-5439	-4347	-7922	-11791

---

---

GOBP_NEGATIVE_REGULATION_OF_NEUTROPHIL_ACTIVATION

GOBP_NEGATIVE_REGULATION_OF_NEUTROPHIL_ACTIVATION

metric	value
setSize	5
pMANOVA	0.0138
p.adjustMANOVA	0.11
s.dist	0.944
s.iageonset	-0.682
s.cloz	-0.298
s.cognit	0.58
s.igaf	-0.0101
s.prs	0.0357
p.iageonset	0.00829
p.cloz	0.248
p.cognit	0.0246
p.igaf	0.969
p.prs	0.89

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	iageonset	cognit
SPI1	-16815	15768
CD300A	-14139	16527
MIR125A	-15460	9817
BCR	-11805	10768
GRN	-13813	8773

Click HERE to show all gene set members

All member genes

	iageonset	cloz	cognit	igaf	prs
BCR	-11805	-3566	10768	-4678	-6789
CD300A	-14139	-5116	16527	12945	2016
GRN	-13813	-2128	8773	-62	3858
MIR125A	-15460	-3937	9817	2217	-11679
SPI1	-16815	11976	15768	1186	7632

---

---

GOMF_METAL_ION_SENSOR_ACTIVITY

GOMF_METAL_ION_SENSOR_ACTIVITY

metric	value
setSize	5
pMANOVA	0.0582
p.adjustMANOVA	0.282
s.dist	0.943
s.iageonset	0.0703
s.cloz	0.193
s.cognit	0.471
s.igaf	0.552
s.prs	-0.566
p.iageonset	0.785
p.cloz	0.455
p.cognit	0.068
p.igaf	0.0325
p.prs	0.0283

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	prs	igaf
EFCAB9	-12088	11852
EFHB	-10600	12758
SYT1	-11512	9136
SLC39A4	-9974	7081

Click HERE to show all gene set members

All member genes

	iageonset	cloz	cognit	igaf	prs
EFCAB9	2693	13606	11335	11852	-12088
EFHB	-8235	-634	16555	12758	-10600
EFHD1	-13376	-73	8274	1622	6198
SLC39A4	-12215	6819	15375	7081	-9974
SYT1	340	4444	4124	9136	-11512

---

---

GOBP_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_MATRIX_ADHESION_VIA_FIBRONECTIN

GOBP_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_MATRIX_ADHESION_VIA_FIBRONECTIN

metric	value
setSize	5
pMANOVA	0.0109
p.adjustMANOVA	0.0931
s.dist	0.943
s.iageonset	-0.458
s.cloz	-0.349
s.cognit	-0.626
s.igaf	0.269
s.prs	-0.306
p.iageonset	0.0762
p.cloz	0.177
p.cognit	0.0153
p.igaf	0.298
p.prs	0.236

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	cognit	iageonset
CEACAM6	-4226	-17327
RRAS	-2915	-13297
FUT1	-1528	-10173

Click HERE to show all gene set members

All member genes

	iageonset	cloz	cognit	igaf	prs
CEACAM6	-17327	-2167	-4226	9546	-2460
FUT1	-10173	-2794	-1528	9877	-4208
GFUS	-3869	-1078	693	-3974	-6363
RIN2	-15094	-3189	3438	10453	-2696
RRAS	-13297	3672	-2915	1015	-7963

---

---

GOBP_RRNA_PSEUDOURIDINE_SYNTHESIS

GOBP_RRNA_PSEUDOURIDINE_SYNTHESIS

metric	value
setSize	7
pMANOVA	0.0117
p.adjustMANOVA	0.0979
s.dist	0.942
s.iageonset	-0.0506
s.cloz	-0.484
s.cognit	-0.507
s.igaf	-0.516
s.prs	0.356
p.iageonset	0.817
p.cloz	0.0265
p.cognit	0.0203
p.igaf	0.018
p.prs	0.103

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	igaf	cognit
GAR1	-6116	-3168
NHP2	-2424	-2737
NOP10	-3987	-1416

Click HERE to show all gene set members

All member genes

	iageonset	cloz	cognit	igaf	prs
GAR1	-2672	-772	-3168	-6116	3907
NAF1	-13068	-6084	1040	-58	962
NHP2	-10528	-5055	-2737	-2424	7269
NOP10	289	-4557	-1416	-3987	4773
RPUSD1	-14617	6412	1130	-5254	-2898
RPUSD2	-5023	-4263	6610	-4435	1376
TSR3	-6773	-3833	1394	-351	2277

---

---

GOMF_IGE_BINDING

GOMF_IGE_BINDING

metric	value
setSize	5
pMANOVA	0.033
p.adjustMANOVA	0.194
s.dist	0.941
s.iageonset	-0.144
s.cloz	0.843
s.cognit	0.372
s.igaf	0.0854
s.prs	-0.0978
p.iageonset	0.578
p.cloz	0.0011
p.cognit	0.149
p.igaf	0.741
p.prs	0.705

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	cloz	cognit
FCER2	13273	14242
FCER1G	12702	14715
MS4A2	12951	10858
FCER1A	9314	13349

Click HERE to show all gene set members

All member genes

	iageonset	cloz	cognit	igaf	prs
FCER1A	-9582	9314	13349	12685	-10405
FCER1G	-16822	12702	14715	-8317	9314
FCER2	3491	13273	14242	5303	-10434
LGALS3	-10262	11561	-2921	-4798	-541
MS4A2	-9344	12951	10858	11972	-219

---

---

GOMF_ANKYRIN_REPEAT_BINDING

GOMF_ANKYRIN_REPEAT_BINDING

metric	value
setSize	6
pMANOVA	0.0326
p.adjustMANOVA	0.193
s.dist	0.941
s.iageonset	-0.0188
s.cloz	-0.296
s.cognit	-0.484
s.igaf	-0.695
s.prs	0.281
p.iageonset	0.936
p.cloz	0.21
p.cognit	0.0401
p.igaf	0.00318
p.prs	0.233

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	igaf	cognit
SHANK1	-8251	-4457
RELA	-5880	-2792

Click HERE to show all gene set members

All member genes

	iageonset	cloz	cognit	igaf	prs
HIF1AN	658	6496	3340	-4369	-1775
KIF21A	-13833	-5525	2664	-3350	2280
RELA	1844	7390	-2792	-5880	6321
SHANK1	-6730	-3553	-4457	-8251	5489
TERF1	-9486	-5164	1564	-5308	-3231
TNKS1BP1	-15269	-2811	3614	-4007	1112

---

---

GOBP_REGULATION_OF_NATURAL_KILLER_CELL_CHEMOTAXIS

GOBP_REGULATION_OF_NATURAL_KILLER_CELL_CHEMOTAXIS

metric	value
setSize	7
pMANOVA	0.000472
p.adjustMANOVA	0.00848
s.dist	0.939
s.iageonset	-0.166
s.cloz	-0.381
s.cognit	-0.0395
s.igaf	0.795
s.prs	0.276
p.iageonset	0.447
p.cloz	0.0806
p.cognit	0.856
p.igaf	0.000272
p.prs	0.207

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	igaf	cloz
KLRK1	12670	-7772
KLRC4-KLRK1	10247	-7781
CCL7	8827	-7103
CCL2	10470	-5903

Click HERE to show all gene set members

All member genes

	iageonset	cloz	cognit	igaf	prs
CCL2	-17243	-5903	-749	10470	-9319
CCL3	-17581	13350	13161	13222	6680
CCL4	3846	4216	-4276	10763	4577
CCL5	-17316	734	9386	11825	-5334
CCL7	1300	-7103	9958	8827	1863
KLRC4-KLRK1	-17160	-7781	-4748	10247	5047
KLRK1	2913	-7772	15981	12670	7954

---

---

GOBP_NITRIC_OXIDE_TRANSPORT

GOBP_NITRIC_OXIDE_TRANSPORT

metric	value
setSize	5
pMANOVA	0.0188
p.adjustMANOVA	0.135
s.dist	0.936
s.iageonset	0.0481
s.cloz	0.395
s.cognit	0.288
s.igaf	0.761
s.prs	0.237
p.iageonset	0.852
p.cloz	0.126
p.cognit	0.264
p.igaf	0.00321
p.prs	0.359

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	igaf	cloz
HBA1	10224	12796
HBB	10562	10995
AQP1	11137	9561
EDN1	8748	10014

Click HERE to show all gene set members

All member genes

	iageonset	cloz	cognit	igaf	prs
AQP1	-12380	9561	7037	11137	107
EDN1	1665	10014	6986	8748	-8084
HBA1	-11066	12796	16806	10224	2018
HBA2	4032	-8141	16927	13226	9577
HBB	-14261	10995	-2124	10562	2454

---

---

GOBP_MITOCHONDRIAL_RESPIRASOME_ASSEMBLY

GOBP_MITOCHONDRIAL_RESPIRASOME_ASSEMBLY

metric	value
setSize	10
pMANOVA	0.000564
p.adjustMANOVA	0.00973
s.dist	0.935
s.iageonset	0.245
s.cloz	-0.302
s.cognit	-0.428
s.igaf	-0.733
s.prs	0.0489
p.iageonset	0.179
p.cloz	0.0984
p.cognit	0.019
p.igaf	5.91e-05
p.prs	0.789

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	igaf	cognit
HIGD2B	-6620	-4761
HIGD1A	-7280	-3440
COX7A1	-8263	-2932
STMP1	-8270	-2577
COX7A2L	-6047	-2100
HIGD2A	-4624	-2405
RAB5IF	-3309	-146

Click HERE to show all gene set members

All member genes

	iageonset	cloz	cognit	igaf	prs
COX7A1	3314	-6175	-2932	-8263	9396
COX7A2	-12545	-3406	15729	-8375	6454
COX7A2L	-1399	7152	-2100	-6047	-2084
HIGD1A	-8748	-1763	-3440	-7280	2178
HIGD1B	251	4890	9930	-6013	-5162
HIGD1C	-6787	-120	5356	2703	-8851
HIGD2A	356	-2833	-2405	-4624	-4607
HIGD2B	-3109	-7313	-4761	-6620	-8432
RAB5IF	-17304	-4672	-146	-3309	6614
STMP1	3569	8304	-2577	-8270	-3993

---

---

GOMF_CXCR3_CHEMOKINE_RECEPTOR_BINDING

GOMF_CXCR3_CHEMOKINE_RECEPTOR_BINDING

metric	value
setSize	5
pMANOVA	0.0314
p.adjustMANOVA	0.189
s.dist	0.933
s.iageonset	-0.601
s.cloz	-0.658
s.cognit	-0.0173
s.igaf	0.153
s.prs	-0.231
p.iageonset	0.0198
p.cloz	0.0109
p.cognit	0.947
p.igaf	0.555
p.prs	0.371

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	cloz	iageonset
CXCL9	-8055	-17683
PF4	-6646	-17675
CXCL13	-7258	-16002

Click HERE to show all gene set members

All member genes

	iageonset	cloz	cognit	igaf	prs
CXCL10	870	-6031	10263	10330	9008
CXCL11	-17144	5513	307	2107	5789
CXCL13	-16002	-7258	-3244	11710	-11100
CXCL9	-17683	-8055	4664	4913	-11144
PF4	-17675	-6646	16879	-8531	-12138

---

---

Here is the session info with all the versions of packages used.

sessionInfo()

## R version 4.4.0 (2024-04-24)
## Platform: x86_64-pc-linux-gnu
## Running under: Ubuntu 22.04.4 LTS
## 
## Matrix products: default
## BLAS:   /usr/lib/x86_64-linux-gnu/blas/libblas.so.3.10.0 
## LAPACK: /usr/lib/x86_64-linux-gnu/lapack/liblapack.so.3.10.0
## 
## locale:
##  [1] LC_CTYPE=en_US.UTF-8       LC_NUMERIC=C              
##  [3] LC_TIME=en_US.UTF-8        LC_COLLATE=en_US.UTF-8    
##  [5] LC_MONETARY=en_US.UTF-8    LC_MESSAGES=en_US.UTF-8   
##  [7] LC_PAPER=en_US.UTF-8       LC_NAME=C                 
##  [9] LC_ADDRESS=C               LC_TELEPHONE=C            
## [11] LC_MEASUREMENT=en_US.UTF-8 LC_IDENTIFICATION=C       
## 
## time zone: Australia/Melbourne
## tzcode source: system (glibc)
## 
## attached base packages:
## [1] parallel  stats4    stats     graphics  grDevices utils     datasets 
## [8] methods   base     
## 
## other attached packages:
##  [1] pkgload_1.3.4                                      
##  [2] GGally_2.2.1                                       
##  [3] ggplot2_3.5.1                                      
##  [4] reshape2_1.4.4                                     
##  [5] gplots_3.1.3.1                                     
##  [6] gtools_3.9.5                                       
##  [7] tibble_3.2.1                                       
##  [8] dplyr_1.1.4                                        
##  [9] echarts4r_0.4.5                                    
## [10] plyr_1.8.9                                         
## [11] png_0.1-8                                          
## [12] gridExtra_2.3                                      
## [13] missMethyl_1.36.0                                  
## [14] beeswarm_0.4.0                                     
## [15] kableExtra_1.4.0                                   
## [16] mitch_1.15.6                                       
## [17] tictoc_1.2.1                                       
## [18] HGNChelper_0.8.1                                   
## [19] IlluminaHumanMethylationEPICanno.ilm10b4.hg19_0.6.0
## [20] IlluminaHumanMethylation450kanno.ilmn12.hg19_0.6.1 
## [21] minfi_1.48.0                                       
## [22] bumphunter_1.44.0                                  
## [23] locfit_1.5-9.9                                     
## [24] iterators_1.0.14                                   
## [25] foreach_1.5.2                                      
## [26] Biostrings_2.70.2                                  
## [27] XVector_0.42.0                                     
## [28] SummarizedExperiment_1.32.0                        
## [29] Biobase_2.62.0                                     
## [30] MatrixGenerics_1.14.0                              
## [31] matrixStats_1.3.0                                  
## [32] GenomicRanges_1.54.1                               
## [33] GenomeInfoDb_1.38.6                                
## [34] IRanges_2.36.0                                     
## [35] S4Vectors_0.40.2                                   
## [36] BiocGenerics_0.48.1                                
## [37] eulerr_7.0.2                                       
## [38] limma_3.58.1                                       
## 
## loaded via a namespace (and not attached):
##   [1] splines_4.4.0             later_1.3.2              
##   [3] BiocIO_1.12.0             bitops_1.0-7             
##   [5] filelock_1.0.3            preprocessCore_1.64.0    
##   [7] XML_3.99-0.16.1           lifecycle_1.0.4          
##   [9] lattice_0.22-6            MASS_7.3-60.2            
##  [11] base64_2.0.1              scrime_1.3.5             
##  [13] magrittr_2.0.3            sass_0.4.9               
##  [15] rmarkdown_2.26            jquerylib_0.1.4          
##  [17] yaml_2.3.8                httpuv_1.6.15            
##  [19] doRNG_1.8.6               askpass_1.2.0            
##  [21] DBI_1.2.2                 RColorBrewer_1.1-3       
##  [23] abind_1.4-5               zlibbioc_1.48.0          
##  [25] quadprog_1.5-8            purrr_1.0.2              
##  [27] RCurl_1.98-1.14           rappdirs_0.3.3           
##  [29] GenomeInfoDbData_1.2.11   genefilter_1.84.0        
##  [31] annotate_1.80.0           svglite_2.1.3            
##  [33] DelayedMatrixStats_1.24.0 codetools_0.2-20         
##  [35] DelayedArray_0.28.0       xml2_1.3.6               
##  [37] tidyselect_1.2.1          farver_2.1.1             
##  [39] beanplot_1.3.1            BiocFileCache_2.10.1     
##  [41] illuminaio_0.44.0         GenomicAlignments_1.38.2 
##  [43] jsonlite_1.8.8            multtest_2.58.0          
##  [45] survival_3.6-4            systemfonts_1.0.6        
##  [47] tools_4.4.0               progress_1.2.3           
##  [49] Rcpp_1.0.12               glue_1.7.0               
##  [51] SparseArray_1.2.4         xfun_0.43                
##  [53] HDF5Array_1.30.1          withr_3.0.0              
##  [55] fastmap_1.1.1             rhdf5filters_1.14.1      
##  [57] fansi_1.0.6               openssl_2.1.2            
##  [59] caTools_1.18.2            digest_0.6.35            
##  [61] R6_2.5.1                  mime_0.12                
##  [63] colorspace_2.1-0          biomaRt_2.58.2           
##  [65] RSQLite_2.3.6             utf8_1.2.4               
##  [67] tidyr_1.3.1               generics_0.1.3           
##  [69] data.table_1.15.4         rtracklayer_1.62.0       
##  [71] prettyunits_1.2.0         httr_1.4.7               
##  [73] htmlwidgets_1.6.4         S4Arrays_1.2.0           
##  [75] ggstats_0.6.0             pkgconfig_2.0.3          
##  [77] gtable_0.3.5              blob_1.2.4               
##  [79] siggenes_1.76.0           htmltools_0.5.8.1        
##  [81] scales_1.3.0              knitr_1.46               
##  [83] rstudioapi_0.16.0         tzdb_0.4.0               
##  [85] rjson_0.2.21              nlme_3.1-164             
##  [87] curl_5.2.1                org.Hs.eg.db_3.18.0      
##  [89] cachem_1.0.8              rhdf5_2.46.1             
##  [91] stringr_1.5.1             KernSmooth_2.23-22       
##  [93] AnnotationDbi_1.64.1      restfulr_0.0.15          
##  [95] GEOquery_2.70.0           pillar_1.9.0             
##  [97] grid_4.4.0                reshape_0.8.9            
##  [99] vctrs_0.6.5               promises_1.3.0           
## [101] dbplyr_2.5.0              xtable_1.8-4             
## [103] evaluate_0.23             readr_2.1.5              
## [105] GenomicFeatures_1.54.3    cli_3.6.2                
## [107] compiler_4.4.0            Rsamtools_2.18.0         
## [109] rlang_1.1.3               crayon_1.5.2             
## [111] rngtools_1.5.2            labeling_0.4.3           
## [113] nor1mix_1.3-3             mclust_6.1.1             
## [115] stringi_1.8.3             viridisLite_0.4.2        
## [117] BiocParallel_1.36.0       munsell_0.5.1            
## [119] Matrix_1.7-0              hms_1.1.3                
## [121] sparseMatrixStats_1.14.0  bit64_4.0.5              
## [123] Rhdf5lib_1.24.2           KEGGREST_1.42.0          
## [125] statmod_1.5.0             shiny_1.8.1.1            
## [127] highr_0.10                memoise_2.0.1.9000       
## [129] bslib_0.7.0               bit_4.0.5

END of report